Citrus Sinensis ID: 038835

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------
Protein Sequence
MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREHWSSKVLRGFLGLFLIQSLLAVFLHQS
Secondary Structure (PSIPRED)
ccccccccEEcccccEEEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHcccccccEEEcEEEEEccEEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccEEEcccccccccccccccccccEEccccccHHHccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccccccHHHHccccccccccccccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHcHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEcccccEEEEEEEEccccccEEEHHHHHHHHccccHHHHHHHHHHHHHcccccHEEHHHHccccccEEEEEEHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEcccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccHHHHHcccccccccHHHHcccccHHHHHHHHHHHcccccccccHHHHHcccHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccHHHHccc
Coil and Loop (DISEMBL)
MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLrkmshpniVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMhqrgyfhrdlkpenllvskdtikiadfglareinsrppfteyvstrwyrapEVLLQSYLYSSKVDMWAMGAIMAELItlrplfpgtseadEIYKICSvigtptqdswADGLLLARAINykfpqlvgvplsvlmpsanKDAVSLIASLcswdpskrptaaealqhpfsrVAFMFHHLSVPEQLLQEHLHLLGQREHWSSKVLRGFLGLFLIQSLLAVFLHQS
Flexible Loop (DISEMBL)
meryklikevgdgtfgsvwraiskqsgevvAIKKMKkkyysweecvnlrevkslrkmshpnivklkevireNDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIAdfglareinsrppfteyvstrwyrAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREHWSSKVLRGFLGLFLIQSLLAVFLHQS
Low Complexity Region (SEG)
MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPeqllqehlhllgqrehWSSKVLRGFLGLFLIQSLLAVFLHQS
Disordered region (IsUnstruct)
****KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPS****AAEALQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREHWSSKVLRGFLGLFLIQSLLAVFL***
Disordered Region (DISOPRED)
*ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF**************************************************
Disordered Region (DISEMBL)
MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREHWSSKVLRGFLGLFLIQSLLAVFLHQS
Disordered Region (DISPRO)
*ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREHWSSKVLRGFLGLFLIQSLLAVFLHQS
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREHWSSKVLRGFLGLFLIQSLLAVFLHQS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	337	2.2.26 [Sep-21-2011]
Q6Z8C8	459	Cyclin-dependent kinase F	no	no	0.836	0.614	0.776	1e-134
Q04859	622	Serine/threonine-protein	yes	no	0.905	0.490	0.585	1e-111
P20793	622	Serine/threonine-protein	yes	no	0.899	0.487	0.579	1e-110
P20794	623	Serine/threonine-protein	no	no	0.848	0.459	0.606	1e-110
Q84SN3	433	Cyclin-dependent kinase F	no	no	0.848	0.660	0.608	1e-108
Q9UPZ9	632	Serine/threonine-protein	no	no	0.884	0.471	0.592	1e-106
Q62726	629	Serine/threonine-protein	no	no	0.872	0.467	0.597	1e-106
Q9JKV2	629	Serine/threonine-protein	no	no	0.848	0.454	0.609	1e-106
P43294	443	Serine/threonine-protein	no	no	0.848	0.645	0.590	1e-102
Q55FJ6	507	Probable serine/threonine	yes	no	0.848	0.564	0.550	1e-101

>sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1

 Score =  479 bits (1232), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 219/282 (77%), Positives = 250/282 (88%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+R+K+IKEVGDGTFGSVWRAI+KQ+GEVVA+KKMK+KYYS+EEC++LREVKSLR+M+HP
Sbjct: 1   MDRFKMIKEVGDGTFGSVWRAINKQNGEVVAVKKMKRKYYSFEECMSLREVKSLRRMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRENDILYF+ EYMECNLYQLMKDR K FSEAEVRNWCFQ+FQ LAYMHQRG
Sbjct: 61  NIVKLKEVIRENDILYFIMEYMECNLYQLMKDRVKPFSEAEVRNWCFQIFQALAYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLVSKD IK+ADFGLARE+ S PP+TEYVSTRWYRAPEVLLQS +Y S V
Sbjct: 121 YFHRDLKPENLLVSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVLLQSSIYDSAV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL+TL PLFPGTSEADEI KIC+VIG+P + SW  GL LA  + ++FPQ+
Sbjct: 181 DMWAMGAIMAELLTLHPLFPGTSEADEILKICNVIGSPDEQSWPQGLSLAETMKFQFPQV 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            G  L+ +M S + +AV LI+SLCSWDP KRP AAE LQH F
Sbjct: 241 SGNQLAEVMTSVSSEAVDLISSLCSWDPCKRPKAAEVLQHTF 282

Oryza sativa subsp. japonica (taxid: 39947)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2

 Score =  402 bits (1034), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 182/311 (58%), Positives = 247/311 (79%), Gaps = 6/311 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M RY  +K++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct: 1   MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           N++KLKEVIREND LYFVFEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct: 61  NVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query: 121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           +D+WA+G+IMAEL T RPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct: 181 IDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF----HHLSVP 295
            + + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V  +     HHL   
Sbjct: 241 CIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGSSAHHLDT- 299

Query: 296 EQLLQEHLHLL 306
           +Q L + L  L
Sbjct: 300 KQTLHKQLQPL 310

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2

 Score =  400 bits (1027), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 179/309 (57%), Positives = 246/309 (79%), Gaps = 6/309 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M RY  ++++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct: 1   MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           N++KLKEVIREND LYF+FEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct: 61  NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query: 121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           +D+WA+G+IMAEL T RPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct: 181 IDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF----HHLSVP 295
            + + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V  +     HHL   
Sbjct: 241 CIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSAHHLDA- 299

Query: 296 EQLLQEHLH 304
           +Q L + L 
Sbjct: 300 KQTLHKQLQ 308

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2

 Score =  397 bits (1020), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 174/287 (60%), Positives = 237/287 (82%), Gaps = 1/287 (0%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M RY  ++++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct: 1   MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           N++KLKEVIREND LYF+FEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct: 61  NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query: 121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct: 121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           +D+WA+G+IMAEL  LRPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct: 181 IDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
            V + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V 
Sbjct: 241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVG 287

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1

 Score =  392 bits (1007), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 174/286 (60%), Positives = 230/286 (80%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           MERYK+I+E+GDGT G+V+RA + ++ E+VA+KKMK+K++ WEEC++LREVK+L+K++HP
Sbjct: 1   MERYKVIREIGDGTCGNVFRAYNTETNEIVAVKKMKRKFFQWEECISLREVKALQKLNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEV  EN  L+F+FE MECNLY ++++R+  FSE E+RN+  Q+ QGLAYMH  G
Sbjct: 61  NIVKLKEVTMENHELFFIFENMECNLYDVIRERQAAFSEEEIRNFMVQILQGLAYMHNNG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLV+  T+KIADFGLARE++S PP+T+YVSTRWYRAPEVLLQS  Y+  +
Sbjct: 121 YFHRDLKPENLLVTDGTVKIADFGLAREVSSSPPYTDYVSTRWYRAPEVLLQSSAYTPAI 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWA+GAI+AEL TL PLFPG SE D++YKIC+V+GTP    W +G+ L R+ ++ F Q+
Sbjct: 181 DMWAVGAILAELFTLSPLFPGGSETDQLYKICAVLGTPDHTVWPEGMNLPRSSSFNFFQI 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
               L  L+P+A  +A+ LI  LCSWDP +RPTA ++LQHPF  V 
Sbjct: 241 PPRNLWELIPNATLEAIDLIQQLCSWDPRRRPTAEQSLQHPFFNVG 286

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1

 Score =  386 bits (991), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 179/302 (59%), Positives = 238/302 (78%), Gaps = 4/302 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M RY  I+++GDGT+GSV    S +SGE++AIKKMK+K+YSWEEC+NLREVKSL+K++H 
Sbjct: 1   MNRYTTIRQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           N+VKLKEVIREND LYF+FEYM+ NLYQL+K+R K F E+ +RN  +Q+ QGLA++H+ G
Sbjct: 61  NVVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKHG 120

Query: 121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           +FHRDLKPENLL +  + +KIADFGLAREI S+PP+T+YVSTRWYRAPEVLL+S  YSS 
Sbjct: 121 FFHRDLKPENLLCMGPELVKIADFGLAREIRSKPPYTDYVSTRWYRAPEVLLRSTNYSSP 180

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           +D+WA+G IMAE+ TLRPLFPG SE D I+KIC V+GTP +  W +G  L+ A+N+++PQ
Sbjct: 181 IDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFRWPQ 240

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLL 299
            V   L  L+P+A+ +AV L+  +  WDP KRPTA++AL++P+ +V    H L    Q L
Sbjct: 241 CVPNNLKTLIPNASSEAVQLLRDMLQWDPKKRPTASQALRYPYFQVG---HPLGSTTQNL 297

Query: 300 QE 301
           Q+
Sbjct: 298 QD 299

May play a key role in the development of multiple organ systems and particularly in cardiac development.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1

 Score =  385 bits (989), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 178/298 (59%), Positives = 235/298 (78%), Gaps = 4/298 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M RY  IK++GDGT+GSV    S +SGE++AIKKMK+K+YSWEEC+NLREVKSL+K++H 
Sbjct: 1   MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIREND LYF+FEYM+ NLYQL+K+R K F E+ +RN  +Q+ QGLA++H+ G
Sbjct: 61  NIVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKHG 120

Query: 121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           +FHRDLKPENLL +  + +KIADFGLAREI SRPP+T+YVSTRWYRAPEVLL+S  YSS 
Sbjct: 121 FFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSSP 180

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           +D+WA+G IMAE+ TLRPLFPG SE D I+KIC V+GTP +  W +G  L+ A+N+ +PQ
Sbjct: 181 IDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFIWPQ 240

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQ 297
            +   L  L+P+A+ +A+ L+  L  WDP KRPTA++AL++P+ ++    H L +  Q
Sbjct: 241 CIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQIG---HPLGISTQ 295

May play a role in cardiac development.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2

 Score =  384 bits (987), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 175/287 (60%), Positives = 231/287 (80%), Gaps = 1/287 (0%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M RY  IK++GDGT+GSV    S +SGE++AIKKMK+K+YSWEEC+NLREVKSL+K++H 
Sbjct: 1   MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIREND LYF+FEYM+ NLYQL+K+R K F E+ +RN  +Q+ QGLA++H+ G
Sbjct: 61  NIVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKHG 120

Query: 121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           +FHRDLKPENLL +  + +KIADFGLAREI SRPP+T+YVSTRWYRAPEVLL+S  YSS 
Sbjct: 121 FFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSSP 180

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           +D+WA+G IMAE+ TLRPLFPG SE D I+KIC V+GTP +  W +G  L+ A+N+ +PQ
Sbjct: 181 IDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFLWPQ 240

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
            +   L  L+P+A+ +A+ L+  L  WDP KRPTA++AL++P+ ++ 
Sbjct: 241 CIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQIG 287

May play a role in cardiac development.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2

 Score =  370 bits (951), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 169/286 (59%), Positives = 229/286 (80%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M RYK+++E+GDGT GSV++A++ ++ EVVA+KKMK+K+Y WEECVNLREVK+LRK++HP
Sbjct: 9   MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 68

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +I+KLKE++RE++ L+F+FE M+ NLY +MK+RE+ FSE E+R++  Q+ QGLA+MH+ G
Sbjct: 69  HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKNG 128

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLV+ + +KIADFGLARE+ S PP+TEYVSTRWYRAPEVLLQS LY+  V
Sbjct: 129 YFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPAV 188

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWA+GAI+AEL  L PLFPG SE D++YKIC V+G P   ++ +   ++R ++    + 
Sbjct: 189 DMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTEF 248

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
               ++ L+P+A  +A+ LI  LCSWDP KRPTA EAL HPF  +A
Sbjct: 249 PQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMA 294

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1

 Score =  367 bits (943), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 159/289 (55%), Positives = 225/289 (77%), Gaps = 3/289 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           ME+Y+ IK+VGDG +G V +AI  ++GE+VAIK+MKKK+  W+EC+ LRE+K+L+K+ HP
Sbjct: 1   MEKYQFIKQVGDGAYGDVIKAIDVKTGEIVAIKRMKKKFSDWKECIQLREIKALKKLKHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKL E+I E D L+FVFEY+E NLY+ +KDR K   E  +RN  +Q+ Q L +MH  G
Sbjct: 61  NIVKLLEIILERDELFFVFEYLENNLYESIKDRTKLLPETTIRNIIYQILQALHFMHTNG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           +FHRDLKPEN+++  + +KIADFGLAREI S+PPFT+Y+STRWYRAPEVLL+   Y++ +
Sbjct: 121 FFHRDLKPENIMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLLRCTYYNAPI 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           D+WA+GAIMAEL +L+P+FPG+SE D+++KIC+++G+PT  +W DG+ LA ++ + FP +
Sbjct: 181 DIWAVGAIMAELYSLKPMFPGSSEIDQLFKICTIMGSPTSATWIDGIKLANSMGFTFPNV 240

Query: 241 VGV---PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
                 PLS L+P+AN+DA+ LI  L  +DP KRPT  +ALQH + +V+
Sbjct: 241 QPPSINPLSTLLPNANQDAIELITDLLQYDPLKRPTPLQALQHRYFKVS 289

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	337
224074450	453	predicted protein [Populus trichocarpa]	0.851	0.633	0.878	1e-151
255557681	455	mak, putative [Ricinus communis] gi|2235	0.851	0.630	0.874	1e-150
357484657	449	Serine/threonine protein kinase ICK [Med	0.851	0.639	0.874	1e-150
356496445	450	PREDICTED: cyclin-dependent kinase F-4-l	0.851	0.637	0.874	1e-149
356531493	455	PREDICTED: cyclin-dependent kinase F-4-l	0.851	0.630	0.867	1e-149
30684655	464	putative serine/threonine protein kinase	0.934	0.678	0.779	1e-148
18415242	461	putative serine/threonine protein kinase	0.934	0.683	0.779	1e-148
297800140	460	hypothetical protein ARALYDRAFT_492943 [	0.934	0.684	0.780	1e-148
4455158	290	kinase-like protein [Arabidopsis thalian	0.845	0.982	0.842	1e-146
356558874	450	PREDICTED: cyclin-dependent kinase F-4-l	0.851	0.637	0.853	1e-144

>gi|224074450|ref|XP_002304373.1| predicted protein [Populus trichocarpa] gi|222841805|gb|EEE79352.1| predicted protein [Populus trichocarpa]

 Score =  540 bits (1391), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 252/287 (87%), Positives = 269/287 (93%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           MERYKLIKEVGDGTFGSVWRAI+KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM+HP
Sbjct: 1   MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKL+EVIRENDILYFVFEYMECNLYQL KDREK FSEAEVRNWCFQVFQGLAYMHQRG
Sbjct: 61  NIVKLREVIRENDILYFVFEYMECNLYQLTKDREKLFSEAEVRNWCFQVFQGLAYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLVSK  IKIADFGLARE+NS+PP+TEYVSTRWYRAPEVLLQSYLYSSKV
Sbjct: 121 YFHRDLKPENLLVSKSIIKIADFGLAREVNSQPPYTEYVSTRWYRAPEVLLQSYLYSSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL TLRPLFPGTSEADEIYKICSVIG+PT D+WADGL LARAINY+FPQ 
Sbjct: 181 DMWAMGAIMAELFTLRPLFPGTSEADEIYKICSVIGSPTTDTWADGLNLARAINYQFPQF 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF 287
            GV L  L+PSA++DA++LI SLCSWDP  RP+AA+ALQHPF +  F
Sbjct: 241 AGVHLPTLIPSASEDAINLIKSLCSWDPCTRPSAADALQHPFFQSCF 287

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255557681|ref|XP_002519870.1| mak, putative [Ricinus communis] gi|223540916|gb|EEF42474.1| mak, putative [Ricinus communis]

 Score =  538 bits (1387), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 251/287 (87%), Positives = 271/287 (94%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           MERYKLIKEVGDGTFGSVWRAI+KQSGEVVAIKKMKKKYY+WEECVNLREVKSLR+M+HP
Sbjct: 1   MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYTWEECVNLREVKSLRRMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRENDILYFVFEYM+CNLYQL+KDR K F EAEVRNWCFQVFQGLAYMHQRG
Sbjct: 61  NIVKLKEVIRENDILYFVFEYMDCNLYQLIKDRVKLFPEAEVRNWCFQVFQGLAYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLV+K  IKIADFGLAREINS+PP+TEYVSTRWYRAPEVLLQSYLYSSKV
Sbjct: 121 YFHRDLKPENLLVTKGIIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYLYSSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL TLRPLFPGTSEADEIYKIC++IG+PT+DSWADGL LARAINY+FPQ 
Sbjct: 181 DMWAMGAIMAELFTLRPLFPGTSEADEIYKICNIIGSPTKDSWADGLNLARAINYQFPQF 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF 287
            GV LS L+PSA++DAV+LI SLCSWDPSKRP+A EALQHPF +  F
Sbjct: 241 GGVQLSALIPSASEDAVNLIKSLCSWDPSKRPSAGEALQHPFFQSCF 287

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357484657|ref|XP_003612616.1| Serine/threonine protein kinase ICK [Medicago truncatula] gi|355513951|gb|AES95574.1| Serine/threonine protein kinase ICK [Medicago truncatula]

 Score =  537 bits (1384), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 251/287 (87%), Positives = 267/287 (93%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           MERYK+IKEVGDGTFGSVWRAISKQ+GEVVAIKKMKKKYYSWEECVNLREVKSLRKM+HP
Sbjct: 1   MERYKIIKEVGDGTFGSVWRAISKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRE+DILYFVFEYMECNLYQLMKDREK FSE E+RNWCFQVFQGLAYMHQRG
Sbjct: 61  NIVKLKEVIRESDILYFVFEYMECNLYQLMKDREKLFSEGEIRNWCFQVFQGLAYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLV+KD IKIADFGLAREINS+PP+TEYVSTRWYRAPEVLLQSY+YSSKV
Sbjct: 121 YFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYIYSSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL +LRPLFPG SEADEIYKIC VIG PT DSWADGL LAR INY+FPQL
Sbjct: 181 DMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTTDSWADGLKLARDINYQFPQL 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF 287
            GV LS L+PSA+  A+SLI SLCSWDP KRPTA+EALQHPF +  F
Sbjct: 241 AGVNLSALIPSASDHAISLIQSLCSWDPCKRPTASEALQHPFFQSCF 287

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496445|ref|XP_003517078.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max]

 Score =  534 bits (1376), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 251/287 (87%), Positives = 268/287 (93%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           MERYKLIKEVGDGTFGSVWRAI+KQ+GEVVAIKKMKKKYYSWEECVNLREVKSLRKM+HP
Sbjct: 1   MERYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRE+DILYFVFEYMECNLYQLMKDREK FSE EVRNWCFQVFQGLAYMHQRG
Sbjct: 61  NIVKLKEVIRESDILYFVFEYMECNLYQLMKDREKLFSEGEVRNWCFQVFQGLAYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLV+KD IKIADFGLAREI+S+PP+TEYVSTRWYRAPEVLLQSYLY+SKV
Sbjct: 121 YFHRDLKPENLLVTKDFIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSYLYTSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL +LRPLFPG SEADEIYKIC VIG PT +SWADGL LAR INY+FPQL
Sbjct: 181 DMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTFESWADGLKLARDINYQFPQL 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF 287
            GV LS L+PSA+ DA+SLI SLCSWDP KRPTA+EALQHPF +  F
Sbjct: 241 AGVHLSALIPSASDDAISLITSLCSWDPCKRPTASEALQHPFFQSCF 287

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356531493|ref|XP_003534312.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max]

 Score =  534 bits (1376), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 249/287 (86%), Positives = 269/287 (93%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           MERYKLIKE+GDGTFG+VWRAI+KQ+GEVVAIKKMKKKYYSWEECVNLREVKSLRKM+HP
Sbjct: 1   MERYKLIKEIGDGTFGTVWRAINKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRE+DILYFVFEYMECNLYQLMKDREK FSEAEVRNWCFQVFQGLAYMHQRG
Sbjct: 61  NIVKLKEVIRESDILYFVFEYMECNLYQLMKDREKLFSEAEVRNWCFQVFQGLAYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLV+KD IKIADFGLAREI+S+PP+TEYVSTRWYRAPEVLLQSY+Y+SKV
Sbjct: 121 YFHRDLKPENLLVTKDFIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSYMYTSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL +LRPLFPG SEADEIYKIC VIG PT +SWADGL LAR INY+FPQL
Sbjct: 181 DMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTFESWADGLKLARDINYQFPQL 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF 287
            GV LS L+PSA+ DA+SLI SLCSWDP KRPTA+EALQHPF +  F
Sbjct: 241 AGVHLSALIPSASDDAISLITSLCSWDPCKRPTASEALQHPFFQSCF 287

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30684655|ref|NP_849407.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|332658742|gb|AEE84142.1| putative serine/threonine protein kinase [Arabidopsis thaliana]

 Score =  531 bits (1369), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 248/318 (77%), Positives = 280/318 (88%), Gaps = 3/318 (0%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+RYKLIKEVGDGTFGSVWRAI+KQ+GEVVAIKKMKKKYYSW+EC+NLREVKSLR+M+HP
Sbjct: 1   MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRENDILYFVFEYMECNLYQLMKDR+K F+EA+++NWCFQVFQGL+YMHQRG
Sbjct: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLVSKD IKIADFGLARE+NS PPFTEYVSTRWYRAPEVLLQSY+Y+SKV
Sbjct: 121 YFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL++LRP+FPG SEADEIYKICSVIGTPT+++W +GL LA  INY+FPQL
Sbjct: 181 DMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQL 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQ 300
            GVPLS LMPSA++DA++LI  LCSWDPS RPTAAE LQHPF +  F       P+  + 
Sbjct: 241 PGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLRPKPSVA 300

Query: 301 EHLHLLGQR---EHWSSK 315
                +G R   EH S K
Sbjct: 301 RTPPPVGPRGSFEHQSVK 318

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18415242|ref|NP_567574.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|13430556|gb|AAK25900.1|AF360190_1 putative kinase [Arabidopsis thaliana] gi|14532760|gb|AAK64081.1| putative kinase [Arabidopsis thaliana] gi|332658741|gb|AEE84141.1| putative serine/threonine protein kinase [Arabidopsis thaliana]

 Score =  531 bits (1368), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 248/318 (77%), Positives = 280/318 (88%), Gaps = 3/318 (0%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+RYKLIKEVGDGTFGSVWRAI+KQ+GEVVAIKKMKKKYYSW+EC+NLREVKSLR+M+HP
Sbjct: 1   MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRENDILYFVFEYMECNLYQLMKDR+K F+EA+++NWCFQVFQGL+YMHQRG
Sbjct: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLVSKD IKIADFGLARE+NS PPFTEYVSTRWYRAPEVLLQSY+Y+SKV
Sbjct: 121 YFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL++LRP+FPG SEADEIYKICSVIGTPT+++W +GL LA  INY+FPQL
Sbjct: 181 DMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQL 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQ 300
            GVPLS LMPSA++DA++LI  LCSWDPS RPTAAE LQHPF +  F       P+  + 
Sbjct: 241 PGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLRPKPSVA 300

Query: 301 EHLHLLGQR---EHWSSK 315
                +G R   EH S K
Sbjct: 301 RTPPPVGPRGSFEHQSVK 318

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297800140|ref|XP_002867954.1| hypothetical protein ARALYDRAFT_492943 [Arabidopsis lyrata subsp. lyrata] gi|297313790|gb|EFH44213.1| hypothetical protein ARALYDRAFT_492943 [Arabidopsis lyrata subsp. lyrata]

 Score =  529 bits (1363), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 246/315 (78%), Positives = 277/315 (87%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+RYKLIKEVGDGTFGSVWRAI+KQ+GEVVAIKKMKKKYYSW+EC+NLREVKSLR+M+HP
Sbjct: 1   MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRENDILYFVFEYMECNLYQLMKDR+K F+EA+++NWCFQVFQGL+YMHQRG
Sbjct: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLVSKD IKIADFGLARE+NS PPFTEYVSTRWYRAPEVLLQSY+Y+SKV
Sbjct: 121 YFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL++LRP+FPG SEADEIYKICSVIGTPT+++W +GL LA  INY+FPQL
Sbjct: 181 DMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQL 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQ 300
            GVPLS LMPSA++DA++LI  LCSWDP  RPTAAE LQHPF +  F       P+  + 
Sbjct: 241 PGVPLSSLMPSASEDAINLIERLCSWDPCSRPTAAEVLQHPFFQSCFYVPPSLRPKPSVA 300

Query: 301 EHLHLLGQREHWSSK 315
                 G  EH S K
Sbjct: 301 RTPPAWGSFEHQSVK 315

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|4455158|emb|CAA16700.1| kinase-like protein [Arabidopsis thaliana] gi|7268706|emb|CAB78913.1| kinase-like protein [Arabidopsis thaliana]

 Score =  525 bits (1351), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 240/285 (84%), Positives = 269/285 (94%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           + RYKLIKEVGDGTFGSVWRAI+KQ+GEVVAIKKMKKKYYSW+EC+NLREVKSLR+M+HP
Sbjct: 1   ISRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRENDILYFVFEYMECNLYQLMKDR+K F+EA+++NWCFQVFQGL+YMHQRG
Sbjct: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLVSKD IKIADFGLARE+NS PPFTEYVSTRWYRAPEVLLQSY+Y+SKV
Sbjct: 121 YFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL++LRP+FPG SEADEIYKICSVIGTPT+++W +GL LA  INY+FPQL
Sbjct: 181 DMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQL 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
            GVPLS LMPSA++DA++LI  LCSWDPS RPTAAE LQHPF +V
Sbjct: 241 PGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQV 285

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558874|ref|XP_003547727.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max]

 Score =  518 bits (1334), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 245/287 (85%), Positives = 262/287 (91%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           MERYKLIKEVGDGTFGSVWRAI+KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM+H 
Sbjct: 1   MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHA 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKLKEVIRE D L  VFEYME NLYQLMK+REK FSE EVRNWCFQVFQGLAYMHQRG
Sbjct: 61  NIVKLKEVIRECDTLCLVFEYMEYNLYQLMKNREKLFSENEVRNWCFQVFQGLAYMHQRG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           YFHRDLKPENLLV+KD IKIADFGLAREI+S PP+TEYVSTRWYRAPEVLLQS+LYSSKV
Sbjct: 121 YFHRDLKPENLLVTKDVIKIADFGLAREISSLPPYTEYVSTRWYRAPEVLLQSHLYSSKV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           DMWAMGAIMAEL TLRPLFPG+SEADEIYKICSV+G+PT +SWADGL LAR INY+FPQL
Sbjct: 181 DMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVLGSPTTESWADGLKLARDINYQFPQL 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF 287
            GV LS L+PS + DA+SL+ SLCSWDP KRPTAAE LQHPF +  F
Sbjct: 241 AGVHLSTLIPSRSDDAISLVTSLCSWDPCKRPTAAEVLQHPFFQSCF 287

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	337
TAIR|locus:2134746	464	AT4G19110 [Arabidopsis thalian	0.851	0.618	0.839	1.8e-135
TAIR|locus:2163583	499	AT5G45430 [Arabidopsis thalian	0.836	0.565	0.812	1.6e-127
UNIPROTKB|E1BWM1	625	MAK "Uncharacterized protein"	0.845	0.456	0.611	1.8e-101
UNIPROTKB|F1RV90	624	MAK "Uncharacterized protein"	0.866	0.467	0.599	1.8e-101
MGI|MGI:96913	622	Mak "male germ cell-associated	0.866	0.469	0.599	1.8e-101
UNIPROTKB|E1BDG4	623	MAK "Uncharacterized protein"	0.866	0.468	0.599	2.3e-101
UNIPROTKB|Q2YDJ7	382	MAK "Uncharacterized protein"	0.866	0.764	0.599	2.3e-101
RGD|3036	622	Mak "male germ cell-associated	0.866	0.469	0.592	4.9e-101
UNIPROTKB|P20793	622	Mak "Serine/threonine-protein	0.866	0.469	0.592	4.9e-101
UNIPROTKB|P20794	623	MAK "Serine/threonine-protein	0.845	0.457	0.608	1.3e-100

TAIR|locus:2134746 AT4G19110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1327 (472.2 bits), Expect = 1.8e-135, P = 1.8e-135
 Identities = 241/287 (83%), Positives = 270/287 (94%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M+RYKLIKEVGDGTFGSVWRAI+KQ+GEVVAIKKMKKKYYSW+EC+NLREVKSLR+M+HP
Sbjct:     1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             NIVKLKEVIRENDILYFVFEYMECNLYQLMKDR+K F+EA+++NWCFQVFQGL+YMHQRG
Sbjct:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQRG 120

Query:   121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
             YFHRDLKPENLLVSKD IKIADFGLARE+NS PPFTEYVSTRWYRAPEVLLQSY+Y+SKV
Sbjct:   121 YFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKV 180

Query:   181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
             DMWAMGAIMAEL++LRP+FPG SEADEIYKICSVIGTPT+++W +GL LA  INY+FPQL
Sbjct:   181 DMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQL 240

Query:   241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF 287
              GVPLS LMPSA++DA++LI  LCSWDPS RPTAAE LQHPF +  F
Sbjct:   241 PGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCF 287

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

TAIR|locus:2163583 AT5G45430 [Arabidopsis thaliana (taxid:3702)]

 Score = 1252 (445.8 bits), Expect = 1.6e-127, P = 1.6e-127
 Identities = 229/282 (81%), Positives = 258/282 (91%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             MERY L+KEVGDGTFG+VWRA++KQ+ EVVAIK+MKKKY+SWEECVNLREVKSL +M+HP
Sbjct:     1 MERYTLLKEVGDGTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMNHP 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             NIVKLKEVIRENDILYFVFEYMECNLYQLMKDR K F+E+++RNWCFQVFQGL+YMHQRG
Sbjct:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRPKHFAESDIRNWCFQVFQGLSYMHQRG 120

Query:   121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
             YFHRDLKPENLLVSKD IKIAD GLAREI+S PP+TEYVSTRWYRAPEVLLQSY+Y+SKV
Sbjct:   121 YFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYTSKV 180

Query:   181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
             DMWAMGAIMAEL++LRPLFPG SEADEIYKICSVIG+PT+++W +GL LA  INY+FPQ 
Sbjct:   181 DMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQFPQF 240

Query:   241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              GV LS +MP A+ DAV+LI  LCSWDP  RPT AEALQHPF
Sbjct:   241 PGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPF 282

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0045727 "positive regulation of translation" evidence=RCA

UNIPROTKB|E1BWM1 MAK "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1006 (359.2 bits), Expect = 1.8e-101, P = 1.8e-101
 Identities = 175/286 (61%), Positives = 240/286 (83%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M RY ++K++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct:     1 MNRYTIMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             N++KLKEVIREND LYFVFEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct:    61 NVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRNKLFPESVIRNMMYQILQGLAFIHKHG 120

Query:   121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct:   121 FFHRDMKPENLLCIGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSIYSSP 180

Query:   180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
             +D+WA+G+IMAEL TLRPLFPGTSE DEI+KIC V+GTP +  W +G  L+ A+N++FPQ
Sbjct:   181 IDIWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYHLSSAMNFRFPQ 240

Query:   240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
              V + L  L+P+A+ +A+ L++ + +W+P KRPTA++AL++P+ +V
Sbjct:   241 CVPISLKTLIPNASSEAIQLMSDMLNWNPKKRPTASQALKYPYFQV 286

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001750 "photoreceptor outer segment" evidence=IEA

GO:0001917 "photoreceptor inner segment" evidence=IEA

GO:0003713 "transcription coactivator activity" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0030496 "midbody" evidence=IEA

GO:0045494 "photoreceptor cell maintenance" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0072686 "mitotic spindle" evidence=IEA

UNIPROTKB|F1RV90 MAK "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 1006 (359.2 bits), Expect = 1.8e-101, P = 1.8e-101
 Identities = 178/297 (59%), Positives = 241/297 (81%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M RY  ++++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct:     1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             N++KLKEVIREND LYF+FEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct:    61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query:   121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct:   121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180

Query:   180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
             +D+WA+G+IMAEL TLRPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct:   181 IDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query:   240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF----HHL 292
                + L  L+P+A+ +A+ L+  + SWDP KRPTA++AL+HP+ +V  +     HHL
Sbjct:   241 CAPINLKTLIPNASNEAIQLMTEMLSWDPKKRPTASQALKHPYFQVGQVLGPSSHHL 297

GO:0072686 "mitotic spindle" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045494 "photoreceptor cell maintenance" evidence=IEA

GO:0030496 "midbody" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0003713 "transcription coactivator activity" evidence=IEA

GO:0001917 "photoreceptor inner segment" evidence=IEA

GO:0001750 "photoreceptor outer segment" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:96913 Mak "male germ cell-associated kinase" [Mus musculus (taxid:10090)]

 Score = 1006 (359.2 bits), Expect = 1.8e-101, P = 1.8e-101
 Identities = 178/297 (59%), Positives = 241/297 (81%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M RY  +K++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct:     1 MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             N++KLKEVIREND LYFVFEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct:    61 NVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query:   121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct:   121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180

Query:   180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
             +D+WA+G+IMAEL T RPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct:   181 IDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query:   240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF----HHL 292
              + + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V  +     HHL
Sbjct:   241 CIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGSSAHHL 297

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001750 "photoreceptor outer segment" evidence=IDA

GO:0001917 "photoreceptor inner segment" evidence=ISO

GO:0003713 "transcription coactivator activity" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005929 "cilium" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030496 "midbody" evidence=ISO

GO:0042995 "cell projection" evidence=IEA

GO:0045494 "photoreceptor cell maintenance" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0072686 "mitotic spindle" evidence=ISO

GO:2001141 "regulation of RNA biosynthetic process" evidence=ISO

UNIPROTKB|E1BDG4 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
 Identities = 178/297 (59%), Positives = 241/297 (81%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M RY  ++++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct:     1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             N++KLKEVIREND LYF+FEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct:    61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query:   121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S  YSS 
Sbjct:   121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSSP 180

Query:   180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
             +D+WA+G+IMAEL TLRPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct:   181 IDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query:   240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF----HHL 292
              V + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V  +     HHL
Sbjct:   241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSSHHL 297

GO:0072686 "mitotic spindle" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045494 "photoreceptor cell maintenance" evidence=IEA

GO:0030496 "midbody" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0003713 "transcription coactivator activity" evidence=IEA

GO:0001917 "photoreceptor inner segment" evidence=IEA

GO:0001750 "photoreceptor outer segment" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q2YDJ7 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
 Identities = 178/297 (59%), Positives = 241/297 (81%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M RY  ++++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct:     1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             N++KLKEVIREND LYF+FEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct:    61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query:   121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S  YSS 
Sbjct:   121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSSP 180

Query:   180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
             +D+WA+G+IMAEL TLRPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct:   181 IDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query:   240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF----HHL 292
              V + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V  +     HHL
Sbjct:   241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSSHHL 297

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

RGD|3036 Mak "male germ cell-associated kinase" [Rattus norvegicus (taxid:10116)]

 Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
 Identities = 176/297 (59%), Positives = 241/297 (81%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M RY  ++++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct:     1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             N++KLKEVIREND LYF+FEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct:    61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query:   121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct:   121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180

Query:   180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
             +D+WA+G+IMAEL T RPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct:   181 IDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query:   240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF----HHL 292
              + + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V  +     HHL
Sbjct:   241 CIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSAHHL 297

GO:0001750 "photoreceptor outer segment" evidence=ISO;ISS

GO:0001917 "photoreceptor inner segment" evidence=ISO;ISS

GO:0003713 "transcription coactivator activity" evidence=ISO;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;ISS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO;ISS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO;ISS

GO:0007275 "multicellular organismal development" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IEA

GO:0030154 "cell differentiation" evidence=IEA

GO:0030496 "midbody" evidence=ISO;ISS

GO:0045494 "photoreceptor cell maintenance" evidence=ISO;ISS

GO:0046777 "protein autophosphorylation" evidence=ISO;ISS

GO:0072686 "mitotic spindle" evidence=ISO;ISS

UNIPROTKB|P20793 Mak "Serine/threonine-protein kinase MAK" [Rattus norvegicus (taxid:10116)]

 Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
 Identities = 176/297 (59%), Positives = 241/297 (81%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M RY  ++++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct:     1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             N++KLKEVIREND LYF+FEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct:    61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query:   121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct:   121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180

Query:   180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
             +D+WA+G+IMAEL T RPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct:   181 IDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query:   240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF----HHL 292
              + + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V  +     HHL
Sbjct:   241 CIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPSAHHL 297

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P20794 MAK "Serine/threonine-protein kinase MAK" [Homo sapiens (taxid:9606)]

 Score = 998 (356.4 bits), Expect = 1.3e-100, P = 1.3e-100
 Identities = 174/286 (60%), Positives = 237/286 (82%)

Query:     1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
             M RY  ++++GDGT+GSV    S +SGE+VAIK+MK+K+YSW+EC+NLREVKSL+K++H 
Sbjct:     1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60

Query:    61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
             N++KLKEVIREND LYF+FEYM+ NLYQLMKDR K F E+ +RN  +Q+ QGLA++H+ G
Sbjct:    61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKHG 120

Query:   121 YFHRDLKPENLL-VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             +FHRD+KPENLL +  + +KIADFGLARE+ S+PP+T+YVSTRWYRAPEVLL+S +YSS 
Sbjct:   121 FFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSP 180

Query:   180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
             +D+WA+G+IMAEL  LRPLFPGTSE DEI+KIC V+GTP +  W +G  LA ++N++FPQ
Sbjct:   181 IDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQ 240

Query:   240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
              V + L  L+P+A+ +A+ L+  + +WDP KRPTA++AL+HP+ +V
Sbjct:   241 CVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQV 286

GO:0005737 "cytoplasm" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0007275 "multicellular organismal development" evidence=IEA

GO:0030154 "cell differentiation" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0007283 "spermatogenesis" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IDA;NAS

GO:0005524 "ATP binding" evidence=NAS

GO:0004672 "protein kinase activity" evidence=NAS

GO:0003713 "transcription coactivator activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0001917 "photoreceptor inner segment" evidence=IDA

GO:0045494 "photoreceptor cell maintenance" evidence=ISS

GO:0001750 "photoreceptor outer segment" evidence=ISS

GO:0072686 "mitotic spindle" evidence=IDA

GO:0030496 "midbody" evidence=IDA

GO:0005813 "centrosome" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.914
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	estExt_Genewise1_v1.C_LG_III1771	hypothetical protein (453 aa)
		(Populus trichocarpa)
Predicted Functional Partners:
	fgenesh4_pg.C_scaffold_1033000001	hypothetical protein (371 aa)			•						0.407

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	337
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	0.0
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-123
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-117
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-114
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-98
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-97
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-97
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-94
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-92
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-91
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-91
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-87
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-87
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-84
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-83
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-83
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-75
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-75
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-74
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-74
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-74
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-73
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-73
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-71
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-71
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-70
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-69
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-68
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-66
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-66
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-66
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-66
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-65
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-65
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-65
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-64
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-64
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-63
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-63
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-61
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-60
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-59
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-59
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-59
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-58
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-57
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-54
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-54
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-54
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-53
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-53
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-52
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-51
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-51
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-50
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-50
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-49
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-49
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-47
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-46
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-44
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-42
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-41
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-40
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-40
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-39
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-39
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-39
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-39
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-38
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-38
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-37
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-37
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-37
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-37
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-36
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-36
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-36
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-36
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-36
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-33
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-33
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-33
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-32
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-31
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-31
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-31
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-31
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-31
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-30
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-30
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-30
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-30
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-30
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-29
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-29
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-29
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-28
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-28
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-28
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-27
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-27
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-26
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-26
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-26
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-25
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-25
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-25
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-25
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-25
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-25
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-25
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-25
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-25
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-25
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-24
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-24
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-24
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-24
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-24
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-23
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-23
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-23
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-23
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-22
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-22
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-21
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-20
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-20
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-20
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-20
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-19
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-18
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-18
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-17
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-16
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-15
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-14
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-14
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-13
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-13
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.004

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  525 bits (1354), Expect = 0.0
 Identities = 189/282 (67%), Positives = 236/282 (83%), Gaps = 3/282 (1%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNI 62
           YK+IK++GDGTFGSV+ A +K++GE+VAIKKMKKK+YSWEEC+NLREVKSLRK+  HPNI
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           VKLKEV REND LYFVFEYME NLYQLMKDR+ K FSE+ +R+  +Q+ QGLA++H+ G+
Sbjct: 61  VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120

Query: 122 FHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           FHRDLKPENLLVS  + +KIADFGLAREI SRPP+T+YVSTRWYRAPE+LL+S  YSS V
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           D+WA+G IMAEL TLRPLFPG+SE D++YKICSV+GTPT+  W +G  LA  + ++FPQ 
Sbjct: 181 DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               L  L+P+A+ +A+ LI  +  WDP KRPTA++ALQHP+
Sbjct: 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  355 bits (913), Expect = e-123
 Identities = 131/282 (46%), Positives = 196/282 (69%), Gaps = 3/282 (1%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNI 62
           Y+ + ++G+GT+G V++A  K +GE+VAIKK+K ++ S       LRE+K L++++HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           +KL +V R    LY VFE+M+ +LY+L+KDR++   E+ ++++ +Q+ QGLA+ H  G  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120

Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           HRDLKPENLL++ +  +K+ADFGLAR   S   P+T YV TRWYRAPE+LL    YS+ V
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           D+W++G I AEL++ RPLFPG SE D+++KI   +GTP  + W     LAR   + FP+ 
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            G+PL  L P+A+  A+ L++ +  +DP KR TA +AL HP+
Sbjct: 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  339 bits (873), Expect = e-117
 Identities = 115/284 (40%), Positives = 184/284 (64%), Gaps = 8/284 (2%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMSHP 60
           Y+ ++++G+GT+G V++A  K++GE+VA+KK++    + EE +    LRE+  L+++ HP
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHP 58

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIVKL +VI     LY VFEY + +L + +  R    S   +++  +Q+ +GLAY H   
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRDLKP+N+L+++D  +K+ADFGLAR        +T  V T WYRAPE+LL S  YS+
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYST 178

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
            VD+W++G I AE+IT +PLFPG SE D+++KI  ++GTPT++SW     L       FP
Sbjct: 179 AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD-YKPTFP 237

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +     L  ++P  + + + L++ +  ++P+KR +A EAL+HP+
Sbjct: 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  333 bits (855), Expect = e-114
 Identities = 129/282 (45%), Positives = 196/282 (69%), Gaps = 4/282 (1%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNI 62
           YK++ ++G+GTF  V +A S+++G+  AIK MKK + S E+  NLRE+++LR++S HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 63  VKLKEVI--RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++L EV+  R+   L  VFE M+ NLY+L+K R++   E  V+++ +Q+ + L +MH+ G
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 121 YFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
            FHRD+KPEN+L+  D +K+ADFG  R I S+PP+TEY+STRWYRAPE LL    Y  K+
Sbjct: 121 IFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKM 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           D+WA+G +  E+++L PLFPGT+E D+I KI  V+GTP  +        +R +NY FP  
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKSRHMNYNFPSK 239

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            G  L  L+P+A+ + + L+  L ++DP +R TA +AL+HP+
Sbjct: 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  292 bits (750), Expect = 2e-98
 Identities = 114/287 (39%), Positives = 179/287 (62%), Gaps = 10/287 (3%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK-KYYSWEECVN---LREVKSLRKMS 58
           RY+  K++G+GT+  V++A  K++G +VAIKK+K  +    ++ +N   LRE+K L+++ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HPNI+ L +V      +  VFE+ME +L +++KD+    + A+++++     +GL Y+H 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP NLL++ D  +K+ADFGLAR   S     T  V TRWYRAPE+L  +  Y
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHY 180

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
              VDMW++G I AEL+   P  PG S+ D++ KI   +GTPT+++W     L   + +K
Sbjct: 181 GVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK 240

Query: 237 -FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            FP     PL  + P+A+ DA+ L+  L + +P+KR TA +AL+HP+
Sbjct: 241 PFP---PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  287 bits (738), Expect = 3e-97
 Identities = 112/281 (39%), Positives = 160/281 (56%), Gaps = 30/281 (10%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y++++++G+G+FG V+ A  K++G++VAIK +KKK    +    LRE+K L+K+ HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 64  KLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           +L +V  + D LY V EY E  +L+ L+K R    SE E R +  Q+   L Y+H +G  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           HRDLKPEN+L+ +D  +K+ADFGLAR+++     T +V T  Y APEVLL    Y   VD
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG-YGKAVD 178

Query: 182 MWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV 241
           +W++G I+ EL+T +P FPG  +  E++K    IG P                       
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPPP---------------- 219

Query: 242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                      + +A  LI  L   DP KR TA EALQHPF
Sbjct: 220 -------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 253

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  289 bits (742), Expect = 8e-97
 Identities = 114/293 (38%), Positives = 176/293 (60%), Gaps = 15/293 (5%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPN 61
           RY+L+K +G G +G V  A+ K++G  VAIKK+   +    +    LRE+K LR + H N
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 62  IVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           I+ L +++R         +Y V E ME +L++++K  +   ++  ++ + +Q+ +GL Y+
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP-LTDDHIQYFLYQILRGLKYL 119

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP----FTEYVSTRWYRAPEVLL 171
           H     HRDLKP N+LV+ +  +KI DFGLAR ++         TEYV TRWYRAPE+LL
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL 179

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
            S  Y+  +D+W++G I AEL+T +PLFPG    D++  I  V+GTP+++     +   +
Sbjct: 180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED-LKFITSEK 238

Query: 232 AINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           A NY    P+    PLS L P A+ +A+ L+  +  +DP KR TA EAL HP+
Sbjct: 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  282 bits (724), Expect = 1e-94
 Identities = 107/289 (37%), Positives = 177/289 (61%), Gaps = 13/289 (4%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNI 62
           Y+ I ++G+GT+G V++A +K++GE+VA+KK++ +       +  +RE+K L+K+ HPNI
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 63  VKLKEVIRENDI--LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           V+LKE++       +Y VFEYM+ +L  L+   E  F+E++++ +  Q+ +GL Y+H  G
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSR--PPFTEYVSTRWYRAPEVLLQSYLYS 177
             HRD+K  N+L++ D  +K+ADFGLAR    R    +T  V T WYR PE+LL +  Y 
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            +VDMW++G I+AEL   +P+F G++E +++ KI  + G+PT ++W     L    N K 
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240

Query: 238 PQ----LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +     +      L+  +   A+ L+  L + DP KR +A +ALQH +
Sbjct: 241 KKPYKRRLREFFKHLIDPS---ALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  277 bits (711), Expect = 1e-92
 Identities = 111/285 (38%), Positives = 174/285 (61%), Gaps = 6/285 (2%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHP 60
           RYK++  +G+G  G V++A  +++GE VA+KK+  ++          LRE+K+L+   HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA-LREIKALQACQHP 59

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            +VKL +V         V EYM  +L ++++D E+   EA+V+++   + +G+AYMH  G
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 121 YFHRDLKPENLLVS-KDTIKIADFGLAREINS--RPPFTEYVSTRWYRAPEVLLQSYLYS 177
             HRDLKP NLL+S    +KIADFGLAR  +      ++  V+TRWYRAPE+L  +  Y 
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
             VD+WA+G I AEL+   PLFPG ++ +++  +   +GTP +++W     L       F
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           P+   +PL  + P A+ +A+ L+  L  +DPSKR +AAEAL+HP+
Sbjct: 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  272 bits (697), Expect = 5e-91
 Identities = 108/283 (38%), Positives = 164/283 (57%), Gaps = 28/283 (9%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK-KYYSWEECVNLREVKSLRKMSHPNI 62
           Y+L++++G G+FG+V++A  K +G++VA+K +KK    S ++    RE++ LR++SHPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 63  VKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           V+L +   + D LY V EY E  +L+  +  R    SE E +    Q+ +GL Y+H  G 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            HRDLKPEN+L+ ++  +KIADFGLA+++  S    T +V T WY APEVLL    Y  K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           VD+W++G I+ EL+T +P F G +  D++  I  ++G P +                   
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK-------------- 225

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                      S +++A  LI    + DPSKRPTA E LQHP+
Sbjct: 226 ---------WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259

Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  274 bits (704), Expect = 6e-91
 Identities = 119/302 (39%), Positives = 184/302 (60%), Gaps = 30/302 (9%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRK 56
           + +Y++++++G G +G VW+AI +++ EVVA+KK+   + ++    +     RE+  L++
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI---FDAFRNATDAQRTFREIMFLQE 62

Query: 57  MS-HPNIVKLKEVIR-ENDI-LYFVFEYMECNLYQ-----LMKDREKCFSEAEVRNWCFQ 108
           +  HPNIVKL  VI+ END  +Y VFEYME +L+      +++D  K +         +Q
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYI-------MYQ 115

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR------EINSRPPFTEYVST 161
           + + L Y+H     HRDLKP N+L++ D  +K+ADFGLAR      E    P  T+YV+T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ- 220
           RWYRAPE+LL S  Y+  VDMW++G I+ E++  +PLFPGTS  +++ KI  VIG P+  
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235

Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           D  +     A  +    P     PL  L+P A+ DA+ L+  L  ++P+KR TA EAL+H
Sbjct: 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 281 PF 282
           P+
Sbjct: 296 PY 297

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  264 bits (678), Expect = 1e-87
 Identities = 117/291 (40%), Positives = 178/291 (61%), Gaps = 13/291 (4%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE---CVNLREVKSLRKMS 58
           + Y+ +  + +GT+G V+RA  K++GE+VA+KK+K      +E     +LRE+  L K+ 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQ 62

Query: 59  HPNIVKLKEVI---RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           HPNIV +KEV+     + I Y V EY+E +L  LM+  ++ F ++EV+    Q+  G+A+
Sbjct: 63  HPNIVTVKEVVVGSNLDKI-YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121

Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQS 173
           +H     HRDLK  NLL++ +  +KI DFGLARE  S   P+T+ V T WYRAPE+LL +
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             YS+ +DMW++G I AEL+T +PLFPG SE D++ KI  ++GTPT+  W     L  A 
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241

Query: 234 NYKFPQLVGVPLSVLMPSANKD--AVSLIASLCSWDPSKRPTAAEALQHPF 282
              F +     L    P+ +       L+  L ++DP+KR +A +AL+HP+
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  263 bits (675), Expect = 3e-87
 Identities = 113/289 (39%), Positives = 160/289 (55%), Gaps = 10/289 (3%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
            +Y+++  VG+G +G V +  +K +GE+VAIKK K+     E+     LREVK LR++ H
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRH 59

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIV LKE  R    LY VFEY+E  L +L++          VR++ +Q+ Q +AY H  
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREI--NSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              HRD+KPEN+LVS+   +K+ DFG AR +      P T+YV+TRWYRAPE+L+    Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
              VD+WA+G IMAEL+   PLFPG S+ D++Y I   +G              R     
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239

Query: 237 FPQLVGVPLSVLMPSANKD---AVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+    P S+      K    A+  + +    DP +R T  E LQHP+
Sbjct: 240 FPE-PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  256 bits (655), Expect = 2e-84
 Identities = 114/289 (39%), Positives = 189/289 (65%), Gaps = 17/289 (5%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKMSHP 60
           Y+ ++++G+GT+G V++A  K +GE+VA+KK++ +  + +E V    +RE+  L++++HP
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE--TEDEGVPSTAIREISLLKELNHP 58

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAYMHQ 118
           NIV+L +V+   + LY VFE+++ +L + M D           ++++ +Q+ QG+AY H 
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFLDLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSYL 175
               HRDLKP+NLL+ ++  +K+ADFGLAR   +  R  +T  V T WYRAPE+LL S  
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQ 176

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS+ VD+W++G I AE++  RPLFPG SE D++++I   +GTP +D W     L    +Y
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP---DY 233

Query: 236 K--FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           K  FP+     LS ++P+ ++D + L++ +  +DP+KR +A  ALQHP+
Sbjct: 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  252 bits (647), Expect = 4e-83
 Identities = 113/296 (38%), Positives = 172/296 (58%), Gaps = 27/296 (9%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM--- 57
           Y+ + E+G+G +G+V++A    +G  VA+KK++      EE +    LRE+  L+++   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLREIALLKQLESF 58

Query: 58  SHPNIVKLKEVI------RENDILYFVFEYMECNLYQLMKDREKC----FSEAEVRNWCF 107
            HPNIV+L +V       RE   L  VFE+++ +L   +    KC         +++   
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELK-LTLVFEHVDQDLATYL---SKCPKPGLPPETIKDLMR 114

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRA 166
           Q+ +G+ ++H     HRDLKP+N+LV+ D  +KIADFGLAR  +     T  V T WYRA
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRA 174

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEVLLQS  Y++ VDMW++G I AEL   RPLF GTSEAD++ KI  VIG P+++ W   
Sbjct: 175 PEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + L R+    FP          +P   ++ + L+  + +++P KR +A EALQHP+
Sbjct: 234 VSLPRS---SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  254 bits (651), Expect = 5e-83
 Identities = 110/299 (36%), Positives = 175/299 (58%), Gaps = 25/299 (8%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRKM 57
            RYK I+ +G G +G V  AI  +SG+ VAIKK+     +++        LRE+K LR  
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH---AFDVPTLAKRTLRELKILRHF 61

Query: 58  SHPNIVKLKEVIRENDIL----YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
            H NI+ +++++R         Y V + ME +L+ ++   +   +E  +R + +Q+ +GL
Sbjct: 62  KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP-LTEEHIRYFLYQLLRGL 120

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-----FTEYVSTRWYRAP 167
            Y+H     HRDLKP NLLV++D  ++I DFG+AR ++S P       TEYV+TRWYRAP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD----SW 223
           E+LL    Y++ +DMW++G I AE++  R LFPG +   ++  I SV+G+P+++      
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +D     R      P+   VP S + P A+ +A+ L++ +  +DP +R T  +ALQHPF
Sbjct: 241 SD---RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  236 bits (603), Expect = 1e-75
 Identities = 112/297 (37%), Positives = 175/297 (58%), Gaps = 23/297 (7%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM---KKKYYSWEECV-NLREVKSLRKM 57
            RY+ +  +G+G +G V  A  K +G  VAIKK+   + + +    C   LRE+K LR+ 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTF----CQRTLREIKILRRF 60

Query: 58  SHPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
            H NI+ + ++IR         +Y V E ME +LY+L+K +    S   ++ + +Q+ +G
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQILRG 118

Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPP----FTEYVSTRWYRAP 167
           L Y+H     HRDLKP NLL++ +  +KI DFGLAR  +         TEYV+TRWYRAP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           E++L S  Y+  +D+W++G I+AE+++ RPLFPG     ++  I  V+GTP+Q+   + +
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL-NCI 237

Query: 228 LLARAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +  RA NY    P    VP + L P+A+  A+ L+  + +++P KR T  EAL HP+
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  233 bits (596), Expect = 2e-75
 Identities = 106/286 (37%), Positives = 175/286 (61%), Gaps = 11/286 (3%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           +K ++++G+GT+ +V++  ++ +GE+VA+K++            +RE+  ++++ H NIV
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +L +VI   + L  VFEYM+ +L + M             V+++ +Q+ +G+A+ H+   
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLARE----INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            HRDLKP+NLL++K   +K+ADFGLAR     +N+   F+  V T WYRAP+VLL S  Y
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT---FSNEVVTLWYRAPDVLLGSRTY 178

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ +D+W++G IMAE+IT RPLFPGT+  D++ KI  ++GTPT+ +W  G+         
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-GISQLPEYKPT 237

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+     L  L P A+   + L+  L   +P  R +A +ALQHP+
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  231 bits (590), Expect = 2e-74
 Identities = 113/289 (39%), Positives = 185/289 (64%), Gaps = 16/289 (5%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKMSHP 60
           Y  I+++G+GT+G V++  +K++G++VA+KK++ +  S EE V    +RE+  L+++ HP
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHP 59

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKD--REKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIV L++V+ +   LY +FE++  +L + +    + +      V+++ +Q+ QG+ + H 
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSYL 175
           R   HRDLKP+NLL+ +K  IK+ADFGLAR   I  R  +T  V T WYRAPEVLL S  
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-YTHEVVTLWYRAPEVLLGSPR 178

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS+ VD+W++G I AE+ T +PLF G SE D++++I  ++GTPT+D W     L    +Y
Sbjct: 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP---DY 235

Query: 236 K--FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           K  FP+     L   + + ++D + L+  +  +DP+KR +A +AL HP+
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  230 bits (587), Expect = 5e-74
 Identities = 114/293 (38%), Positives = 185/293 (63%), Gaps = 18/293 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM 57
           M++Y+ ++++G+GT+G V++A  + + E +A+KK++ +    +E V    +RE+  L++M
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEM 58

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAE--VRNWCFQVFQGLAY 115
            H NIV+L++V+     LY VFEY++ +L + M D    F++    ++ + +Q+ +G+AY
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 116 MHQRGYFHRDLKPENLLV--SKDTIKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLL 171
            H     HRDLKP+NLL+    + +K+ADFGLAR   I  R  FT  V T WYRAPE+LL
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILL 176

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
            S  YS+ VD+W++G I AE++  +PLFPG SE DE++KI  ++GTP +++W     L  
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP- 235

Query: 232 AINYK--FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +YK  FP+     L+ ++P+     V L++ +   DPSKR TA  AL+H +
Sbjct: 236 --DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  229 bits (585), Expect = 8e-74
 Identities = 113/287 (39%), Positives = 178/287 (62%), Gaps = 13/287 (4%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKMSHP 60
           ++ ++++G+GT+G V++A +K +GEVVA+KK++    +  E V    +RE+  L++++HP
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHP 59

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           NIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H  
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    YS
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK- 236
           + VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W     L    +YK 
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP---DYKP 236

Query: 237 -FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            FP+      S ++P  ++D   L++ +  +DP+KR +A  AL HPF
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  227 bits (581), Expect = 7e-73
 Identities = 109/280 (38%), Positives = 162/280 (57%), Gaps = 5/280 (1%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           +G+GT+G V+RA    SGE+VA+KK++           +LRE+  L  + HPNIV+LKEV
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 69  I--RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
           +  +  D ++ V EY E +L  L+ +    FSE++V+    Q+ +GL Y+H+    HRDL
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDL 134

Query: 127 KPENLLVS-KDTIKIADFGLAREINSRP-PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWA 184
           K  NLL++ K  +KIADFGLAR       P T  V T WYRAPE+LL    Y++ +DMWA
Sbjct: 135 KVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWA 194

Query: 185 MGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVP 244
           +G I+AEL+  +PL PG SE +++  I  ++GTP +  W     L     +  P+     
Sbjct: 195 VGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNN 254

Query: 245 LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR 284
           L    P  ++  + L+  L  +DP KR TA EAL+  + +
Sbjct: 255 LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  227 bits (581), Expect = 8e-73
 Identities = 106/317 (33%), Positives = 162/317 (51%), Gaps = 39/317 (12%)

Query: 3   RYKLIKEVGDGTFGSVWRAISK--QSGEVVAIKKMK--KKYYSWEECVNLREVKSLRKMS 58
           +Y++   +G GT+G V++A  K  + G+  AIKK K  K+ Y+       RE+  LR++ 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 59  HPNIVKLKEVIRENDI--LYFVFEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQG 112
           H N+V L EV  E+    +Y +F+Y E +L+Q++K     +      + V++  +Q+  G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINS--RPPFTE--YVSTRW 163
           + Y+H     HRDLKP N+LV  +      +KI D GLAR  N+  +P       V T W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---------ADEIYKICSV 214
           YRAPE+LL +  Y+  +D+WA+G I AEL+TL P+F G             D++ +I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 215 IGTPTQDSWAD---------GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCS 265
           +GTPT+  W D          +   +   Y    L         P        L+  L  
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD--SQGFDLLRKLLE 298

Query: 266 WDPSKRPTAAEALQHPF 282
           +DP+KR TA EAL+HP+
Sbjct: 299 YDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  224 bits (572), Expect = 2e-71
 Identities = 100/307 (32%), Positives = 172/307 (56%), Gaps = 28/307 (9%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE---CVNLREVKSLRKM 57
           +  Y+++ ++G+GTFG V++A   ++G VVA+KK+     + ++      LRE+K L+K+
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH--NEKDGFPITALREIKILKKL 64

Query: 58  SHPNIVKLKEVI--------RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQV 109
            HPN+V L ++         R+   +Y V  YM+ +L  L+++     +E++++ +  Q+
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPP------------FT 156
            +G+ Y+H+    HRD+K  N+L+  +  +KIADFGLAR  +  PP            +T
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG 216
             V TRWYR PE+LL    Y++ VD+W +G + AE+ T RP+  G S+ D+++ I  + G
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244

Query: 217 TPTQDSWADGLLLARAIN-YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA 275
           TPT+++W     L      + F       L         + + L++ L S DP KR TA+
Sbjct: 245 TPTEETWPGWRSLPGCEGVHSFTNYPRT-LEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303

Query: 276 EALQHPF 282
           +AL+HP+
Sbjct: 304 DALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  224 bits (572), Expect = 4e-71
 Identities = 105/294 (35%), Positives = 171/294 (58%), Gaps = 20/294 (6%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRKMS 58
           +Y  IK +G G +G V  A + ++ E VAIKK+   +   +  ++    LRE+K LR + 
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---DNRIDAKRTLREIKLLRHLD 62

Query: 59  HPNIVKLKEVIRE------NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
           H N++ +K+++        ND+ Y V+E M+ +L+Q+++  +   S+   + + +Q+ +G
Sbjct: 63  HENVIAIKDIMPPPHREAFNDV-YIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRG 120

Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPF-TEYVSTRWYRAPEVL 170
           L Y+H     HRDLKP NLL++ +  +KI DFGLAR  + +  F TEYV TRWYRAPE+L
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           L    Y++ +D+W++G I AEL+  +PLFPG     ++  I  ++G+P+++     +   
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED-LGFIRNE 239

Query: 231 RAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +A  Y    P       + L P AN  A+ L+  +  +DPSKR T  EAL HP+
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  220 bits (563), Expect = 2e-70
 Identities = 111/288 (38%), Positives = 171/288 (59%), Gaps = 7/288 (2%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           +E YK + ++G+G++ +V++  SK +G++VA+K+++ ++        +RE   L+ + H 
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIV L ++I     L  VFEY++ +L Q M D     S   VR + FQ+ +GLAY HQR 
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR 123

Query: 121 YFHRDLKPENLLVS-KDTIKIADFGLAR--EINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
             HRDLKP+NLL+S +  +K+ADFGLAR   + S+  ++  V T WYR P+VLL S  YS
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           + +DMW +G I  E+ T RPLFPG+++  D+++KI  V+GTPT+++W           Y 
Sbjct: 183 TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242

Query: 237 FPQLVGVPLSVLMP--SANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP     PL    P          L      ++P KR +AAEA++HP+
Sbjct: 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  218 bits (558), Expect = 7e-69
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           +RY+ +  VG G +G V  A   ++G  VAIKK+ + + S        RE++ L+ M H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 61  NIVKLKEVIRENDIL------YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      L      Y V   M  +L  ++K ++   S+  ++   +Q+ +GL 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQFLVYQILRGLK 132

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP N+ V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 190

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T + LFPG+   D++ +I +++GTP  +     +    A 
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD-EELLQKISSESAR 249

Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY    PQ+       +   AN  A+ L+  +   DP KR TAAEAL HP+
Sbjct: 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  215 bits (549), Expect = 3e-68
 Identities = 110/298 (36%), Positives = 178/298 (59%), Gaps = 22/298 (7%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKMS 58
           + Y+ ++++G+GT+G V++A  K +G++VA+KK + +    EE +    LRE+  L+ +S
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE--MDEEGIPPTALREISLLQMLS 58

Query: 59  H-PNIVKLKEV--IREND---ILYFVFEYMECNLYQLM----KDREKCFSEAEVRNWCFQ 108
               IV+L +V  + E +    LY VFEY++ +L + M    +   +      ++++ +Q
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRP--PFTEYVSTRWY 164
           + +G+A+ H+ G  HRDLKP+NLLV K    +KIAD GL R   S P   +T  + T WY
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIVTLWY 177

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
           RAPEVLL S  YS+ VD+W++G I AE+   +PLFPG SE  ++  I  ++GTPT+  W 
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            G+   R   ++FPQ     LS  +P  + + + L+  +  +DP+KR +A  AL HP+
Sbjct: 238 -GVSKLRDW-HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  212 bits (541), Expect = 1e-66
 Identities = 112/298 (37%), Positives = 175/298 (58%), Gaps = 22/298 (7%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQS--GEVVAIKKMKK---KYYSWEECVNLREVKSLRKM 57
           RY+LIKE+G G +G V  A + ++   E VAIKK+     K    +    LRE+K LR  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA--LRELKLLRHF 58

Query: 58  -SHPNIVKL--KEVIRENDI--LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
             H NI  L   +++   +   LY   E ME +L+Q+++   +  ++A  +++ +Q+  G
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCG 117

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP----PF-TEYVSTRWYRA 166
           L Y+H     HRDLKP NLLV+ D  +KI DFGLAR  +  P     F TEYV+TRWYRA
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE++L    Y+  +D+W++G I+AEL+  +P+F G    D++ +I  V+GTP +++ +  
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR- 236

Query: 227 LLLARAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   +A NY    P +   P   + P+AN  A+ L+  L ++DP+KR +  EAL+HP+
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  211 bits (537), Expect = 2e-66
 Identities = 110/301 (36%), Positives = 180/301 (59%), Gaps = 5/301 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           ME Y  ++++G+GT+ +V++  SK +  +VA+K+++ ++     C  +REV  L+ + H 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIV L +++  +  L  VFEY++ +L Q M D     S   V+ + +Q+ +GLAY H+R 
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 121 YFHRDLKPENLLVS-KDTIKIADFGLAREINSRP--PFTEYVSTRWYRAPEVLLQSYLYS 177
             HRDLKP+NLL++ +  +K+ADFGLAR   S P   ++  V T WYR P+VLL S  YS
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           +++DMW +G I  E+ + RPLFPG++  DE++ I  ++GTPT+++W          NY F
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQ 297
           P+    PL    P  + + + L+     ++  KR +A EA++H + R      H S+PE 
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIH-SLPES 302

Query: 298 L 298
           +
Sbjct: 303 I 303

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  209 bits (534), Expect = 3e-66
 Identities = 105/285 (36%), Positives = 172/285 (60%), Gaps = 4/285 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           +E Y  + ++G+GT+ +V++  SK +  +VA+K+++ ++     C  +REV  L+ + H 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIV L ++I     L  VFEY++ +L Q + +     S   V+ + FQ+ +GL+Y H+R 
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 121 YFHRDLKPENLLVS-KDTIKIADFGLAREINSRP--PFTEYVSTRWYRAPEVLLQSYLYS 177
             HRDLKP+NLL++ K  +K+ADFGLAR   S P   ++  V T WYR P+VLL S  YS
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           + +DMW +G I+ E+ T RP+FPG++  +E++ I  ++GTPT+++W          +Y F
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           PQ    PL    P  + D + L++SL  ++   R +A  AL+H +
Sbjct: 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  206 bits (527), Expect = 6e-66
 Identities = 83/191 (43%), Positives = 119/191 (62%), Gaps = 4/191 (2%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G+G FG+V+ A  K++G+ VAIK +KK+  S      LRE++ L+K++HPNIVKL  V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 70  RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
            + + LY V EY E  +L  L+K+ E   SE E+     Q+ +GL Y+H  G  HRDLKP
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 129 ENLLVSKD--TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAM 185
           EN+L+  D   +K+ADFGL++ + S +      V T  Y APEVLL    YS K D+W++
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180

Query: 186 GAIMAELITLR 196
           G I+ EL  L+
Sbjct: 181 GVILYELPELK 191

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  208 bits (530), Expect = 1e-65
 Identities = 105/289 (36%), Positives = 176/289 (60%), Gaps = 15/289 (5%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKMSH 59
           +Y+ ++++G+GT+G+V++A ++++ E+VA+K+++      +E V    LRE+  L+++ H
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKH 58

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIV+L +V+  +  L  VFEY + +L +             V+++ FQ+ +GLA+ H  
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              HRDLKP+NLL++K+  +K+ADFGLAR   I  R  ++  V T WYR P+VL  + LY
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLY 177

Query: 177 SSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           S+ +DMW+ G I AEL    RPLFPG    D++ +I  ++GTPT++SW     +++  +Y
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG---VSKLPDY 234

Query: 236 KFPQLVG--VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           K   +      L  ++P  N     L+ +L   +P +R +A EALQHP+
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  206 bits (526), Expect = 6e-65
 Identities = 100/300 (33%), Positives = 161/300 (53%), Gaps = 34/300 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK--------MKKKYYSWEECVNLREVKS 53
           E+Y+ +  VG+G++G V +   K++G++VAIKK        M KK       + +RE++ 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK-------IAMREIRM 53

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           L+++ H N+V L EV R    LY VFE+++  +   ++       E+ VR + FQ+ +G+
Sbjct: 54  LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGI 113

Query: 114 AYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINS-RPPFTEYVSTRWYRAPEVLL 171
            + H     HRD+KPEN+LVS+  + K+ DFG AR + +    +T+YV+TRWYRAPE+L+
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
               Y   VD+WA+G ++ E++T  PLFPG S+ D++Y I   +G              +
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH--------Q 225

Query: 232 AINYKFPQLVGV---------PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            I  K P   G+         PL    P  +   + L       DP  RP++++ L H F
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  206 bits (526), Expect = 8e-65
 Identities = 102/285 (35%), Positives = 172/285 (60%), Gaps = 4/285 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           +E Y  + ++G+GT+ +V++  SK +  +VA+K+++ ++     C  +REV  L+ + H 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIV L ++I     L  VFEY++ +L Q + D     +   V+ + FQ+ +GL Y H+R 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 121 YFHRDLKPENLLVS-KDTIKIADFGLAREINSRPP--FTEYVSTRWYRAPEVLLQSYLYS 177
             HRDLKP+NLL++ +  +K+ADFGLAR   S P   ++  V T WYR P++LL S  YS
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           +++DMW +G I  E+ T RPLFPG++  ++++ I  ++GTPT+++W   L      +Y +
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           P+     L    P  + D   L++ L  ++  KR +A EA++HP+
Sbjct: 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  207 bits (528), Expect = 1e-64
 Identities = 114/300 (38%), Positives = 177/300 (59%), Gaps = 28/300 (9%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPN 61
           RYK+ + +G G++G V  AI   +GE VAIKK+   +    +    LRE+K LR + HP+
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 62  IVKLKEVI-----RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           IV++K ++     RE   +Y VFE ME +L+Q++K  +    E   + + +Q+ + L Y+
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-QFFLYQLLRALKYI 119

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAR-EINSRPP---FTEYVSTRWYRAPEVLL 171
           H    FHRDLKP+N+L + D  +KI DFGLAR   N  P    +T+YV+TRWYRAPE L 
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 178

Query: 172 QSYL--YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
            S+   Y+  +D+W++G I AE++T +PLFPG +   ++  I  ++GTP+ ++      +
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET------I 232

Query: 230 ARAINYKFPQLVG-------VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +R  N K  + +        VP S   P+A+  A+ L+  L ++DP  RPTA EAL  P+
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  206 bits (526), Expect = 2e-64
 Identities = 105/309 (33%), Positives = 164/309 (53%), Gaps = 33/309 (10%)

Query: 2   ERYKLI-KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---------EC----VN 47
           ERY      +G+GT+G V +A    +G++VAIKK+K    S +          C      
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 48  LREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCF 107
           LRE+K + ++ H NI+ L +V  E D +  V + M  +L +++  + +  +E++V+    
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR-LTESQVKCILL 126

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY-------- 158
           Q+  GL  +H+  + HRDL P N+ + SK   KIADFGLAR     P             
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 159 -------VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
                  V T WYRAPE+L+ +  Y   VDMW++G I AEL+T +PLFPG +E D++ +I
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246

Query: 212 CSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR 271
             ++GTP +D+W     L     +   +     L  + P+A+ DA+ L+ SL   +P +R
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRK--PKDLKTIFPNASDDAIDLLQSLLKLNPLER 304

Query: 272 PTAAEALQH 280
            +A EAL+H
Sbjct: 305 ISAKEALKH 313

Length = 335

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  201 bits (514), Expect = 5e-63
 Identities = 98/302 (32%), Positives = 169/302 (55%), Gaps = 38/302 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK---------MKKKYYSWEECVNLREVK 52
           E+Y+ + ++G+G++G V++  ++++G++VAIKK         +KK        + LRE++
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK--------IALREIR 52

Query: 53  SLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
            L+++ HPN+V L EV R    L+ VFEY +  +   ++   +   E  ++   +Q  Q 
Sbjct: 53  MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112

Query: 113 LAYMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPP---FTEYVSTRWYRAPE 168
           + + H+    HRD+KPEN+L++K   IK+ DFG AR +    P   +T+YV+TRWYRAPE
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT--GPGDDYTDYVATRWYRAPE 170

Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG--TP------TQ 220
           +L+    Y   VD+WA+G + AEL+T +PL+PG S+ D++Y I   +G   P      + 
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230

Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           + +  GL +      +       PL    P+ +  A+S +      DP++R +  E L+H
Sbjct: 231 NQFFKGLSIPEPETRE-------PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283

Query: 281 PF 282
           P+
Sbjct: 284 PY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  202 bits (516), Expect = 8e-63
 Identities = 116/291 (39%), Positives = 173/291 (59%), Gaps = 15/291 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           +RY+ +K+VG G +G+V  A+ +++G  VAIKK+ + + S        RE++ L+ M H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 61  NIVKLKEVIRENDIL------YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V   +  L      Y V  +M  +L +LMK  EK  SE  ++   +Q+ +GL 
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEK-LSEDRIQFLVYQMLKGLK 132

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP NL V++D  +KI DFGLAR+ +S    T YV TRWYRAPEV+L  
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNW 190

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAE++T +PLF G    D++ +I  V GTP+++ +   L    A 
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQSEDAK 249

Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY  K P+        L+P+AN  AV+++  +   D   R TAAEAL HP+
Sbjct: 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  196 bits (500), Expect = 8e-61
 Identities = 104/299 (34%), Positives = 168/299 (56%), Gaps = 20/299 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK----KKYYSWEECVNLREVKSLRK 56
           ++++ +I ++G+GT+G V++A  K +GE+VA+KK++    K+ +       +RE+K LR+
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFP---ITAIREIKILRQ 62

Query: 57  MSHPNIVKLKEVI----------RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWC 106
           ++H NIV LKE++          ++    Y VFEYM+ +L  L++     FSE  ++++ 
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINS--RPPFTEYVSTRW 163
            Q+ +GL Y H++ + HRD+K  N+L++ K  IK+ADFGLAR  NS    P+T  V T W
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW 223
           YR PE+LL    Y   +D+W+ G I+ EL T +P+F    E  ++  I  + G+P    W
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            D + L      K  +     L          A+ L+  + + DPSKR TA EAL  P+
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  195 bits (498), Expect = 4e-60
 Identities = 116/293 (39%), Positives = 163/293 (55%), Gaps = 20/293 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMS 58
           ERY  +K+VG G +GSV  AI K++GE VAIKK+ + + S  E       RE+  L+ M 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQ 72

Query: 59  HPNIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
           H N++ L +V        E    Y V  YM+ +L ++M       SE +V+   +Q+  G
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCG 129

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
           L Y+H  G  HRDLKP NL V++D  +KI DFGLAR  ++    T YV TRWYRAPEV+L
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVIL 187

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
               Y+  VD+W++G IMAE++T + LF G    D++ +I  V G P  + +   L    
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE-FVQKLEDKA 246

Query: 232 AINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           A +Y    P+      S L P A+  AV L+  +   D  KR TA EAL+HP+
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  194 bits (494), Expect = 1e-59
 Identities = 108/299 (36%), Positives = 169/299 (56%), Gaps = 23/299 (7%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRKM 57
            RY  ++ VG G FG V  A  + +G+ VAIKK+ K + +    V      RE+K L+ +
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST---PVLAKRTYRELKLLKHL 66

Query: 58  SHPNIVKLKEV-IRENDILYFVFEYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLA 114
            H NI+ L ++ I   + +YFV E +  +L++L+  R  EK F    ++ + +Q+ +GL 
Sbjct: 67  RHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF----IQYFLYQILRGLK 122

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP N+L++++  +KI DFGLAR     P  T YVSTR+YRAPE++L  
Sbjct: 123 YVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTW 180

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  +VD+W+ G I AE++  +PLFPG    ++   I  ++GTP  D   + +     +
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD-VINTICSENTL 239

Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFH 290
            +    P+   VP S    +A+  A+ L+  +  +DP KR +AAEAL HP+      +H
Sbjct: 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA---PYH 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  190 bits (486), Expect = 3e-59
 Identities = 89/287 (31%), Positives = 148/287 (51%), Gaps = 37/287 (12%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPN 61
           +Y++IK++G G+FG V+    K  G++  +K++     S +E  + L EVK L+K++HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKC---FSEAEVRNWCFQVFQGLAYMH 117
           I+K  E   E   L  V EY +  +L Q +K ++K    F E ++ +W  Q+   L Y+H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 118 QRGYFHRDLKPEN-LLVSKDTIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYL 175
            R   HRD+KP+N  L S   +K+ DFG+++ ++S     +  V T +Y +PE L Q+  
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE-LCQNKP 179

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y+ K D+W++G ++ EL TL+  F G +  +   KI    G                I  
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQY------------PPIPS 225

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           ++                 +  +L++SL   DP +RP+ A+ LQ PF
Sbjct: 226 QYSS---------------ELRNLVSSLLQKDPEERPSIAQILQSPF 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  191 bits (488), Expect = 6e-59
 Identities = 101/300 (33%), Positives = 158/300 (52%), Gaps = 23/300 (7%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM----KKKYYSWEECVNLREVKSLRKMS 58
           +Y+ + ++G GTFG V++A  K++ ++VA+KK+    +K+ +       LRE+K L+ + 
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP---ITALREIKILQLLK 69

Query: 59  HPNIVKLKEVIR-----ENDI---LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVF 110
           H N+V L E+ R      N      Y VFE+ E +L  L+ ++   F+ +E++     + 
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAR-----EINSRPPFTEYVSTRWY 164
            GL Y+H+    HRD+K  N+L++KD I K+ADFGLAR     + +    +T  V T WY
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW- 223
           R PE+LL    Y   +DMW  G IMAE+ T  P+  G +E  ++  I  + G+ T + W 
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249

Query: 224 -ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             D L L + +     Q   V   +     +  A+ LI  L   DP+KR  A  AL H F
Sbjct: 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  190 bits (483), Expect = 2e-58
 Identities = 110/294 (37%), Positives = 167/294 (56%), Gaps = 21/294 (7%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL---REVKSLRKMS- 58
           +Y+ + E+G G +G+V++A    SG  VA+K ++ +  + E+ + L   REV  L+++  
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQ--TNEDGLPLSTVREVALLKRLEA 58

Query: 59  --HPNIVKLKEVI------RENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQV 109
             HPNIV+L +V       RE  +   VFE+++ +L   L K          +++   Q 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVT-LVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF 117

Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
            +GL ++H     HRDLKPEN+LV S   +K+ADFGLAR  + +   T  V T WYRAPE
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177

Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           VLLQS  Y++ VDMW++G I AE+   +PLF G SEAD++ KI  +IG P +D W   + 
Sbjct: 178 VLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           L R     F      P+  ++P   +    L+  + +++P KR +A  ALQHPF
Sbjct: 237 LPRG---AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  185 bits (473), Expect = 3e-57
 Identities = 89/289 (30%), Positives = 137/289 (47%), Gaps = 39/289 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPN 61
            +   + +G G+FGSV+ A+ K +GE++A+K ++    S EE   L RE++ L  + HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 62  IVKLK--EVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           IV+    E   E + L    EY+   +L  L+K +     E  +R +  Q+ +GLAY+H 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINS---RPPFTEYVSTRWYRAPEVLLQSY 174
            G  HRD+K  N+LV  D  +K+ADFG A+ +              T ++ APEV+    
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIGTPTQDSWADGLLLARAI 233
            Y    D+W++G  + E+ T +P +         +YKI    G P +             
Sbjct: 180 -YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI-GSSGEPPE------------- 224

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               P+     LS       ++A   +      DP KRPTA E LQHPF
Sbjct: 225 ---IPEH----LS-------EEAKDFLRKCLRRDPKKRPTADELLQHPF 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  181 bits (461), Expect = 2e-54
 Identities = 97/307 (31%), Positives = 159/307 (51%), Gaps = 37/307 (12%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRKMS 58
           RY  ++ +G G+ G V+ A+     + VA+KK+        +  +    LRE+K +R++ 
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI-----VLTDPQSVKHALREIKIIRRLD 60

Query: 59  HPNIVKLKEVI--------------RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRN 104
           H NIVK+ EV+               E + +Y V EYME +L  +++  +   SE   R 
Sbjct: 61  HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARL 118

Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINS----RPPFTEY 158
           + +Q+ +GL Y+H     HRDLKP N+ ++ +   +KI DFGLAR ++     +   +E 
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           + T+WYR+P +LL    Y+  +DMWA G I AE++T +PLF G  E +++  I   +   
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238

Query: 219 TQDSWADGLLLARAINYKFPQLVGV---PLSVLMPSANKDAVSLIASLCSWDPSKRPTAA 275
            ++   D   L   I        G    PL  L+P  N +A+  +  + +++P  R TA 
Sbjct: 239 REE---DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295

Query: 276 EALQHPF 282
           EAL HP+
Sbjct: 296 EALMHPY 302

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  179 bits (455), Expect = 2e-54
 Identities = 104/294 (35%), Positives = 167/294 (56%), Gaps = 25/294 (8%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPN 61
           +++++  VG+G +G V +   K++ E+VAIKK K    + E +   LRE+K LR +   N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           IV+LKE  R    LY VFEY+E N+ +L+++        +VR++ +Q+ + + + H+   
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121

Query: 122 FHRDLKPENLLVS-KDTIKIADFGLAREIN--SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
            HRD+KPENLL+S  D +K+ DFG AR ++  S   +TEYV+TRWYR+PE+LL +  Y  
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGK 180

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGT-PTQDSWADGLLLARAINYKF 237
            VDMW++G I+ EL   +PLFPG SE D+++ I  V+G  P +            + Y  
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ---------MKLFYSN 231

Query: 238 PQLVGVPL-SVLMPSA---------NKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           P+  G+   +V  P +         +   + L+ +L   +P+ R    + L HP
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  179 bits (455), Expect = 9e-54
 Identities = 108/296 (36%), Positives = 164/296 (55%), Gaps = 25/296 (8%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 134

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 192

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR-- 231
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +      LL +  
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE------LLKKIS 246

Query: 232 ---AINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              A NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  177 bits (451), Expect = 1e-53
 Identities = 106/290 (36%), Positives = 164/290 (56%), Gaps = 17/290 (5%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y  ++++G+G++ +V++ IS+ +G++VA+K +  K         +RE   L+ + H NIV
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
            L ++I   + L FVFEYM  +L Q M           VR + FQ+ +GLAY+H +   H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 124 RDLKPENLLVSK-DTIKIADFGLAREINSRP--PFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           RDLKP+NLL+S    +K+ADFGLAR   S P   ++  V T WYR P+VLL +  YSS +
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185

Query: 181 DMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIGTPTQDSWADGLLLARAINYK--- 236
           D+W  G I  E++  +P FPG S+  +++ KI +V+G PT+D+W     +++  NYK   
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG---VSKLPNYKPEW 242

Query: 237 ----FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                PQ + V    L  S    A  L + +    P  R +A +AL HP+
Sbjct: 243 FLPCKPQQLRVVWKRL--SRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  177 bits (450), Expect = 1e-53
 Identities = 108/296 (36%), Positives = 169/296 (57%), Gaps = 22/296 (7%)

Query: 2   ERYKLIKEVGDGTFGSVWRAIS-KQSGEVVAIKKMKKKYYSWEECVNL---REVKSLRKM 57
           ++Y+ + E+G+G +G V++A   K  G  VA+K+++ +  + EE + L   REV  LR +
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHL 58

Query: 58  S---HPNIVKLKEVI------RENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCF 107
               HPN+V+L +V       RE   L  VFE+++ +L   L K  E       +++  F
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 117

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRA 166
           Q+ +GL ++H     HRDLKP+N+LV S   IK+ADFGLAR  + +   T  V T WYRA
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 177

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEVLLQS  Y++ VD+W++G I AE+   +PLF G+S+ D++ KI  VIG P ++ W   
Sbjct: 178 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + L R     F      P+   +   ++    L+    +++P+KR +A  AL HP+
Sbjct: 237 VALPRQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  173 bits (441), Expect = 1e-52
 Identities = 78/282 (27%), Positives = 139/282 (49%), Gaps = 33/282 (11%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHPNI 62
           +++++++G G FG V++A  K++G+ VAIK +K +     E+   + E++ L+K  HPNI
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEK--IINEIQILKKCKHPNI 59

Query: 63  VKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           VK      + D L+ V E+    +L  L+K   +  +E+++   C ++ +GL Y+H  G 
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
            HRD+K  N+L++ D  +K+ DFGL+ +++        V T ++ APEV+     Y  K 
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP-YDYKA 178

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           D+W++G    EL   +P +        ++KI +  G P   +             K+   
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKI-ATNGPPGLRN-----------PEKWS-- 224

Query: 241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                         +    +      +P KRPTA + L+HPF
Sbjct: 225 -------------DEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  174 bits (443), Expect = 1e-51
 Identities = 100/290 (34%), Positives = 159/290 (54%), Gaps = 14/290 (4%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIV 63
           +  + +G G FG VW     + G+ VA+KKM   + +   C    RE+K L    H N++
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 64  KLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
              ++++   I     +Y V E M+ +L++++    +  S   V+ + +Q+ +GL Y+H 
Sbjct: 63  SALDILQPPHIDPFEEIYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAR--EINSRPPFTEYVSTRWYRAPEVLLQSYL 175
            G  HRD+KP NLLV+ +  +KI DFGLAR  E +     T+ V T++YRAPE+L+ S  
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y+S VD+W++G I AEL+  R LF   S   ++  I  ++GTP+ ++       ARA   
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHIL 241

Query: 236 ---KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                P  + V L  L   A  +AV L+  +  +DP KR +AA+AL HP+
Sbjct: 242 RGPHKPPSLPV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  173 bits (439), Expect = 2e-51
 Identities = 102/290 (35%), Positives = 160/290 (55%), Gaps = 13/290 (4%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   +  + VA+KK+ + + S        RE++ L+ M H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      I   + +Y V   M  +L  ++K ++   S+  V+   +Q+ +GL 
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK--LSDEHVQFLIYQLLRGLK 132

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP N+ V++D  ++I DFGLAR+ +     T YV+TRWYRAPE++L  
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNW 190

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD-GLLLARA 232
             Y+  VD+W++G IMAEL+  + LFPG    D++ +I  V+GTP+ +         AR 
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                P +    L  +   AN  A+ L+  +   D  KR +A+EAL HP+
Sbjct: 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  167 bits (426), Expect = 2e-50
 Identities = 89/285 (31%), Positives = 146/285 (51%), Gaps = 37/285 (12%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPN 61
            Y+L   +G G FG V++ ++ ++G+ VAIK++  +    E   ++  E+  L+ + HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IVK    I  +D LY + EY E  +L Q++K +   F E+ V  + +QV QGLAY+H++G
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L +KD  +K+ADFG+A ++N         V T ++ APEV+  S   S+
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-ST 178

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
             D+W++G  + EL+T  P +   +    +++I      P                   P
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP------------------LP 220

Query: 239 QLVGVPL-SVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + +   L   LM    K            DP+ RPTA + L+HP+
Sbjct: 221 EGISPELKDFLMQCFQK------------DPNLRPTAKQLLKHPW 253

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  170 bits (430), Expect = 9e-50
 Identities = 99/331 (29%), Positives = 156/331 (47%), Gaps = 49/331 (14%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY--YSWEECVNLREVKSLRKMSHP- 60
           Y++++++G+G+FG V+ A  ++   +VA+K + KK    S E    LRE++ L  ++HP 
Sbjct: 2   YRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMH 117
           NIVKL +  ++   LY V EY++  +L  L+K    +   SE+E      Q+   L Y+H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 118 QRGYFHRDLKPENLLVSKDT--IKIADFGLAREINS-------RPPFTEYVSTRWYRAPE 168
            +G  HRD+KPEN+L+ +D   +K+ DFGLA+ +             +  V T  Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 169 VLLQSYL--YSSKVDMWAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSW 223
           VLL   L   SS  D+W++G  + EL+T  P F G   +    +  KI   + TP     
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP----- 233

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS 283
                LA  ++   P              +K A  L+  L + DP  R +++  L H   
Sbjct: 234 ----SLASPLSPSNP-----------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL- 277

Query: 284 RVAFMFHHLSVPEQLLQEHLHLLGQREHWSS 314
                  HL + E  L + L          S
Sbjct: 278 -----LAHLKLKESDLSDLLKPDDSAPLRLS 303

Length = 384

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  167 bits (424), Expect = 5e-49
 Identities = 104/318 (32%), Positives = 151/318 (47%), Gaps = 49/318 (15%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM----------KKKYYSWEECVNLREVK 52
           RY+ +K +G G  G V  A    +G+ VAIKK+          K+ Y         RE+ 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY---------RELV 67

Query: 53  SLRKMSHPNIVKLKEVIRENDIL------YFVFEYMECNLYQLMK---DREKCFSEAEVR 103
            ++ ++H NI+ L  V      L      Y V E M+ NL Q+++   D E+      + 
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER------MS 121

Query: 104 NWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTR 162
              +Q+  G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS 222
           +YRAPEV+L    Y   VD+W++G IM E+I    LFPGT   D+  KI   +GTP+ + 
Sbjct: 182 YYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240

Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSAN-------------KDAVSLIASLCSWDPS 269
            +      R      P+  G     L P                  A  L++ +   DP 
Sbjct: 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300

Query: 270 KRPTAAEALQHPFSRVAF 287
           KR +  +ALQHP+  V +
Sbjct: 301 KRISVDDALQHPYINVWY 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  164 bits (418), Expect = 8e-49
 Identities = 87/309 (28%), Positives = 133/309 (43%), Gaps = 62/309 (20%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS-HP 60
           +K  K +G+G+F +V  A  K++ +  AIK + K+    E+ V     E + L +++ HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            I+KL    ++ + LYFV EY     L Q ++       E   R +  ++   L Y+H +
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK 121

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE--------------------- 157
           G  HRDLKPEN+L+ KD  IKI DFG A+ ++                            
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGT 217
           +V T  Y +PE+L +        D+WA+G I+ +++T +P F G++E    Y     I  
Sbjct: 182 FVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTFQKI-- 234

Query: 218 PTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA--- 274
                          + Y FP           P+   DA  LI  L   DP  R      
Sbjct: 235 -------------LKLEYSFP-----------PNFPPDAKDLIEKLLVLDPQDRLGVNEG 270

Query: 275 -AEALQHPF 282
             E   HPF
Sbjct: 271 YDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  160 bits (405), Expect = 8e-47
 Identities = 102/291 (35%), Positives = 160/291 (54%), Gaps = 15/291 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+ ++++G+G++ +V++  SK +G++VA+K ++ +         +RE   L+ + H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           IV L ++I   + L  VFEY+  +L Q M           V+ + FQ+ +GL+Y+HQR  
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124

Query: 122 FHRDLKPENLLVSKDT--IKIADFGLAREINSRPP--FTEYVSTRWYRAPEVLLQSYLYS 177
            HRDLKP+NLL+S DT  +K+ADFGLAR   S P   ++  V T WYR P+VLL S  YS
Sbjct: 125 LHRDLKPQNLLIS-DTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSE-ADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           + +DMW +G I  E+I     FPG  +  D++ +I  V+GTP +D+W     L    ++K
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP---HFK 239

Query: 237 FPQLVGVPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +        L  + NK      A  L + L    P  R +A  AL H +
Sbjct: 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  162 bits (412), Expect = 2e-46
 Identities = 96/295 (32%), Positives = 163/295 (55%), Gaps = 25/295 (8%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK--KYYSWEECVNLREVKSLRKMSHPN 61
           YKL   +G+G+FG V+ AI   + E VAIKK+ +  +Y +       RE+  ++ ++H N
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------RELLIMKNLNHIN 120

Query: 62  IVKLK-----EVIREND---ILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
           I+ LK     E  ++N+    L  V E++   +++ MK             V+ + +Q+ 
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
           + LAY+H +   HRDLKP+NLL+  +T  +K+ DFG A+ + +      Y+ +R+YRAPE
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240

Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           ++L +  Y++ +D+W++G I+AE+I   P+F G S  D++ +I  V+GTPT+D      +
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK--EM 298

Query: 229 LARAINYKFPQLVGVPLSVLMPSAN-KDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                + KFP +    L  + P     DA++ I+    ++P KR    EAL  PF
Sbjct: 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353

Length = 440

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  156 bits (396), Expect = 6e-46
 Identities = 91/282 (32%), Positives = 134/282 (47%), Gaps = 42/282 (14%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKY---YSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G+FG V     K +G++ A+K +KKK        E   L E   L +++HP IVKL 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT-LTERNILSRINHPFIVKLH 59

Query: 67  EVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
              +  + LY V EY     L+  +  +E  FSE   R +  ++   L Y+H  G  +RD
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAAEIVLALEYLHSLGIIYRD 118

Query: 126 LKPENLLVSKDT-IKIADFGLAREINSRPPFT-EYVSTRWYRAPEVLLQSYLYSSKVDMW 183
           LKPEN+L+  D  IK+ DFGLA+E++S    T  +  T  Y APEVLL    Y   VD W
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWW 177

Query: 184 AMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV 243
           ++G ++ E++T +P F       EIY+   ++  P                 +FP     
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRK-EIYE--KILKDP----------------LRFP----- 213

Query: 244 PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA---LQHPF 282
                    + +A  LI+ L   DP+KR  +  A     HPF
Sbjct: 214 ------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (384), Expect = 4e-44
 Identities = 66/205 (32%), Positives = 112/205 (54%), Gaps = 21/205 (10%)

Query: 5   KLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
            L K++G+G FG V++        +    VA+K +K+   S ++    LRE + +RK+ H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE-DASEQQIEEFLREARIMRKLDH 60

Query: 60  PNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PN+VKL  V  E + LY V EYME  +L   ++      S +++ ++  Q+ +G+ Y+  
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVL 170
           + + HRDL   N LV ++  +KI+DFGL+R++       +Y          RW  APE  
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD----DDYYRKRGGKLPIRWM-APES- 174

Query: 171 LQSYLYSSKVDMWAMGAIMAELITL 195
           L+   ++SK D+W+ G ++ E+ TL
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  151 bits (383), Expect = 8e-44
 Identities = 65/204 (31%), Positives = 109/204 (53%), Gaps = 18/204 (8%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEV----VAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           +L K++G+G FG V++   K  GE     VA+K +K+     E    L E   ++K+SHP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L  V  + + LY V EYM   +L   ++   +  +  ++     Q+ +G+ Y+  +
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
            + HRDL   N LV+++  +KI+DFGL+R+I        Y          +W  APE  L
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM-APES-L 176

Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           +   ++SK D+W+ G ++ E+ TL
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  150 bits (382), Expect = 8e-44
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 22/206 (10%)

Query: 5   KLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
            L K++G+G FG V++             VA+K +K+   S ++    LRE + +RK+ H
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE-DASEQQIEEFLREARIMRKLDH 60

Query: 60  PNIVKLKEVIRENDILYFVFEYME---CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           PNIVKL  V  E + L  V EYM       Y L K+R K  S +++ ++  Q+ +G+ Y+
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDY-LRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST------RWYRAPEV 169
             + + HRDL   N LV ++  +KI+DFGL+R++        Y         RW  APE 
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYKVKGGKLPIRWM-APES 175

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITL 195
            L+   ++SK D+W+ G ++ E+ TL
Sbjct: 176 -LKEGKFTSKSDVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  149 bits (378), Expect = 3e-42
 Identities = 104/334 (31%), Positives = 160/334 (47%), Gaps = 32/334 (9%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A     G  VA+KK+ + + +        RE+  L+ ++H
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q++    D E+      +    +Q+ 
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER------MSYLLYQML 133

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM EL+    +F GT   D+  K+   +GTP+ +        
Sbjct: 194 IL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252

Query: 230 ARAINYKFPQLVGVPLSVLMPS------------ANKDAVSLIASLCSWDPSKRPTAAEA 277
            R      PQ  G+    L P                 A  L++ +   DP KR +  EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 278 LQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREH 311
           L+HP+  V +       P   + +    L +REH
Sbjct: 313 LRHPYITVWYDPAEAEAPPPQIYD--AQLEEREH 344

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  146 bits (368), Expect = 8e-41
 Identities = 106/334 (31%), Positives = 165/334 (49%), Gaps = 32/334 (9%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 129

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 190 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  EA
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308

Query: 278 LQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREH 311
           LQHP+  V +    +  P    Q +   L +REH
Sbjct: 309 LQHPYINVWYDPAEVEAPPP--QIYDKQLDEREH 340

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  142 bits (359), Expect = 3e-40
 Identities = 87/297 (29%), Positives = 138/297 (46%), Gaps = 52/297 (17%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y++++ +G G+FG+V +   K  G+++  K++     + +E   L  EV  LR++ HPNI
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 63  VKL--KEVIRENDILYFVFEYMEC---NLYQLM----KDREKCFSEAEVRNWCFQVFQGL 113
           V+   + + R N  LY V EY  C   +L QL+    K+R+    E  +     Q+   L
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEY--CEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLAL 118

Query: 114 AYMHQRGY-----FHRDLKPENL-LVSKDTIKIADFGLAREINSRPPFTE-YVSTRWYRA 166
              H R        HRDLKP N+ L + + +K+ DFGLA+ +     F + YV T +Y +
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE L     Y  K D+W++G ++ EL  L P F   ++     KI             +G
Sbjct: 179 PEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK------------EG 225

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAV-SLIASLCSWDPSKRPTAAEALQHPF 282
                    KF ++         P      +  +I S+ + DP KRP+  E LQ P 
Sbjct: 226 ---------KFRRI---------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  141 bits (357), Expect = 4e-40
 Identities = 84/288 (29%), Positives = 137/288 (47%), Gaps = 39/288 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK--KKYYSWEECVNL--REVKSLRKMS 58
           R++  + +G G+FGSV+  ++   G+  A+K++       + +E V    +E+  L K+ 
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNIV+     RE D LY   E +   +L +L+K +   F E  +R +  Q+  GL Y+H
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYLH 119

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            R   HRD+K  N+LV  +  +K+ADFG+A+++        +  + ++ APEV+ Q   Y
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
               D+W++G  + E+ T +P +        ++KI      P                  
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP----------------- 222

Query: 237 FPQLVGVP--LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                 +P  LS        +A   I      DPS RPTAAE L+HPF
Sbjct: 223 ------IPDHLS-------DEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  143 bits (361), Expect = 1e-39
 Identities = 110/351 (31%), Positives = 166/351 (47%), Gaps = 38/351 (10%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 136

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255

Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315

Query: 278 LQHPFSRVAFMFHHLS-----VPEQLLQEHLHLLGQREHWSSKVLRGFLGL 323
           LQHP+  V +           +P++ L E  H +   E W   + +  + L
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTI---EEWKELIYKEVMDL 363

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  140 bits (354), Expect = 1e-39
 Identities = 89/306 (29%), Positives = 135/306 (44%), Gaps = 69/306 (22%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKK--MKKKYYSWEECVNLREVKSLRKMSHPN 61
           Y+LI+ +G G    V+ AI   + E VAIK+  ++K   S +E    +EV+++ + +HPN
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL--RKEVQAMSQCNHPN 60

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQ 118
           +VK        D L+ V  Y+   +L  +MK         EA +     +V +GL Y+H 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREI-----NSRPPFTEYVSTRWYRAPEVLLQ 172
            G  HRD+K  N+L+ +D ++KIADFG++  +      +R     +V T  + APEV+ Q
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
            + Y  K D+W+ G    EL T    +                                 
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPY--------------------------------- 207

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSL----------------IASLCSWDPSKRPTAAE 276
              K+P     P+ VLM +   D  SL                I+     DPSKRPTA E
Sbjct: 208 --SKYP-----PMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Query: 277 ALQHPF 282
            L+H F
Sbjct: 261 LLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  140 bits (354), Expect = 2e-39
 Identities = 91/298 (30%), Positives = 144/298 (48%), Gaps = 61/298 (20%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E YK ++++G+G  G V++A  + +G+ VAIKKM+ +  + E  +N  E+  ++   HPN
Sbjct: 19  ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN--EILIMKDCKHPN 76

Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EYM+   L  ++       +E ++   C +V QGL Y+H + 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+SKD ++K+ADFG A ++   +      V T ++ APEV+ +   Y  
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGP 195

Query: 179 KVDMWAMGAIMA-ELIT----------LRPLFPGTSEADEIYKICSVIGTP---TQDSWA 224
           KVD+W++G IM  E+            LR LF  T++           G P     + W+
Sbjct: 196 KVDIWSLG-IMCIEMAEGEPPYLREPPLRALFLITTK-----------GIPPLKNPEKWS 243

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                                        KD ++    L   DP KRP+A E LQHPF
Sbjct: 244 PEF--------------------------KDFLNK--CLVK-DPEKRPSAEELLQHPF 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  137 bits (348), Expect = 9e-39
 Identities = 88/289 (30%), Positives = 134/289 (46%), Gaps = 45/289 (15%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           + +K +G G+ G V++   K +G++ A+KK+            LRE+K+LR    P +VK
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 65  LKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYF 122
                 +   +  V EYM+  +L  L+K   K   E  +     Q+ +GL Y+H  R   
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGK-IPEPVLAYIARQILKGLDYLHTKRHII 122

Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           HRD+KP NLL++    +KIADFG+++ + N+      +V T  Y +PE  +Q   YS   
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAA 181

Query: 181 DMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           D+W++G  + E    + P  P                 P Q S+ +   L +AI    P 
Sbjct: 182 DIWSLGLTLLECALGKFPFLP-----------------PGQPSFFE---LMQAICDGPP- 220

Query: 240 LVGVPLSVLMPSANKDAVS------LIASLCSWDPSKRPTAAEALQHPF 282
                     PS   +  S      + A L   DP KRP+AAE LQHPF
Sbjct: 221 ----------PSLPAEEFSPEFRDFISACLQK-DPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  137 bits (346), Expect = 1e-38
 Identities = 94/288 (32%), Positives = 148/288 (51%), Gaps = 40/288 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHPN 61
           RY++IK++G+G+FG ++ A +K   E   IK++   K    E+  + +EV  L KM HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMK----DREKCFSEAEVRNWCFQVFQGLAYMH 117
           IV      +EN  L+ V EY  C+   LMK     R   FSE ++ +W  Q+  GL ++H
Sbjct: 61  IVTFFASFQENGRLFIVMEY--CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 118 QRGYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEY-VSTRWYRAPEVLLQSY 174
            R   HRD+K +N+ +SK+ +  K+ DFG+AR++N         V T +Y +PE+  Q+ 
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC-QNR 177

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y++K D+W++G ++ EL TL+  F G +    + KIC                      
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC---------------------- 215

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               Q    P+S   P+ ++D  SLI+ L    P  RP+    L+ PF
Sbjct: 216 ----QGYFAPIS---PNFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  137 bits (347), Expect = 1e-38
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 25/208 (12%)

Query: 8   KEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K++G+G FG V++   K        VA+K +K+     E    L+E + ++K+ HPN+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 65  LKEVIRENDILYFVFEYMEC-NL--------YQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           L  V  E + LY V EYME  +L               +   S  ++ ++  Q+ +G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAP 167
           +  + + HRDL   N LV +D  +KI+DFGL+R++        Y          RW  AP
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKLPIRWM-AP 176

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITL 195
           E  L+  +++SK D+W+ G ++ E+ TL
Sbjct: 177 ES-LKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  136 bits (346), Expect = 2e-38
 Identities = 86/287 (29%), Positives = 126/287 (43%), Gaps = 48/287 (16%)

Query: 13  GTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKEVIR 70
           G +G V+ A  K +G++ AIK +KK     +  V+  L E   L +   P +VKL    +
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 71  ENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPE 129
               LY V EY+   +L  L+++      E   R +  ++   L Y+H  G  HRDLKP+
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPD 122

Query: 130 NLLVSKD-TIKIADFGLA------REINSRPPFTE---YVSTRWYRAPEVLL-QSYLYSS 178
           N+L+  +  +K+ DFGL+      R+IN      E    V T  Y APEV+L Q   +S 
Sbjct: 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG--HSK 180

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
            VD W++G I+ E +   P F G +  +    I                      N K  
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL---------------------NGKIE 219

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA---EALQHPF 282
               V +S        +A+ LI+ L   DP KR  A    E   HPF
Sbjct: 220 WPEDVEVS-------DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  135 bits (341), Expect = 1e-37
 Identities = 87/292 (29%), Positives = 142/292 (48%), Gaps = 52/292 (17%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--------LREVKSLRKMSHPN 61
           +G G+FGSV+  ++  SGE++A+K+++    S               RE+  L+++ H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           IV+      + D L    EY+       + +    F E  VRN+  Q+ +GL Y+H RG 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 122 FHRDLKPENLLV-SKDTIKIADFGLAR--EINS--------RPPFTEYVSTRWYRAPEVL 170
            HRD+K  N+LV +K  IKI+DFG+++  E NS        RP     V   ++ APEV+
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV---FWMAPEVV 184

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
            Q+  Y+ K D+W++G ++ E++T +  FP  ++   I+KI     +P            
Sbjct: 185 KQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPE----------- 231

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                  P            + + +A+  +      D +KRPTAAE L+HPF
Sbjct: 232 ------IPS-----------NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  134 bits (339), Expect = 2e-37
 Identities = 81/294 (27%), Positives = 144/294 (48%), Gaps = 54/294 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           E + +++++G+G++GSV++AI K++G+VVAIK +  +    E+   + +E+  L++   P
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58

Query: 61  NIVKLKEVIRENDILYFVFEYMEC---NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            IVK      +N  L+ V EY  C   ++  +MK   K  +E E+    +Q  +GL Y+H
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEY--CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYL 175
                HRD+K  N+L++++   K+ADFG++ ++          + T ++ APEV+ +   
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG- 175

Query: 176 YSSKVDMWAMG--AI-MAE----LITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           Y++K D+W++G  AI MAE       + P+         I+ I      P          
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPM-------RAIFMI------PN--------- 213

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                  K P  +  P        + +    +      DP +RP+A + LQHPF
Sbjct: 214 -------KPPPTLSDPEKW-----SPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  133 bits (336), Expect = 4e-37
 Identities = 87/289 (30%), Positives = 143/289 (49%), Gaps = 43/289 (14%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIK-----KMKKKYYSWEECVNLREVKSLRKM 57
           +Y  +K++G+G+FG      SK+ G+   IK     KM  K    E   + +EV  L  M
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK----EREESRKEVAVLSNM 56

Query: 58  SHPNIVKLKEVIRENDILYFVFEYME-CNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAY 115
            HPNIV+ +E   EN  LY V +Y E  +LY+ +   R   F E ++ +W  Q+   L +
Sbjct: 57  KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKH 116

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY-VSTRWYRAPEVLLQS 173
           +H R   HRD+K +N+ ++KD TIK+ DFG+AR +NS        + T +Y +PE+  ++
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-CEN 175

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y++K D+WA+G ++ E+ TL+  F   +  + + KI                     I
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI---------------------I 214

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              +P     P+S      + D  +L++ L   +P  RP+    L+  F
Sbjct: 215 RGSYP-----PVS---SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  134 bits (338), Expect = 7e-37
 Identities = 98/317 (30%), Positives = 158/317 (49%), Gaps = 51/317 (16%)

Query: 9   EVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +VG GT+G V++A  K  +  +  A+K+++    S   C   RE+  LR++ HPN++ L+
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC---REIALLRELKHPNVIALQ 64

Query: 67  EVI--RENDILYFVFEYMECNLYQLMK--------DREKCFSEAEVRNWCFQVFQGLAYM 116
           +V     +  ++ +F+Y E +L+ ++K         +      + V++  +Q+  G+ Y+
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 117 HQRGYFHRDLKPENLLV-----SKDTIKIADFGLAREINSR-PPFTEY---VSTRWYRAP 167
           H     HRDLKP N+LV      +  +KIAD G AR  NS   P  +    V T WYRAP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---------ADEIYKICSVIGTP 218
           E+LL +  Y+  +D+WA+G I AEL+T  P+F    E          D++ +I SV+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 219 TQDSWADGLLLARAINYKFPQL------VGVPLSVLMPSANKDAVS-------LIASLCS 265
               W D   +      ++P L           S L+    K  V        L+  L +
Sbjct: 245 ADKDWEDIRKMP-----EYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299

Query: 266 WDPSKRPTAAEALQHPF 282
            DP+KR T+ +ALQ P+
Sbjct: 300 MDPTKRITSEQALQDPY 316

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  133 bits (336), Expect = 1e-36
 Identities = 85/294 (28%), Positives = 128/294 (43%), Gaps = 55/294 (18%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREV-------KSLRK 56
           ++ IK +G G+FG V     K SG+  A+K + K      + V L++V       + L+ 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-----AKIVKLKQVEHVLNEKRILQS 57

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HP +V L    +++  LY V EY+    L+  ++ +   F E   R +  QV   L Y
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPVARFYAAQVVLALEY 116

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           +H     +RDLKPENLL+  D  IKI DFG A+ +  R  +T    T  Y APE+ + S 
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYT-LCGTPEYLAPEI-ILSK 173

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWADGLLLARAI 233
            Y   VD WA+G ++ E++   P F       +IY KI                      
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPPF-FDDNPIQIYEKILEG------------------- 213

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
             +FP              + DA  LI +L   D +KR         +   HP+
Sbjct: 214 KVRFPSFF-----------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  131 bits (333), Expect = 2e-36
 Identities = 77/267 (28%), Positives = 122/267 (45%), Gaps = 34/267 (12%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKY---YSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V     K      A+K +KK++      +E +   E + L + +HP IVKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI-FSEKEILEECNHPFIVKLY 59

Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
              ++   +Y + EY     L+ +++DR   F E   R +   V     Y+H RG  +RD
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGIIYRD 118

Query: 126 LKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWA 184
           LKPENLL+  +  +K+ DFG A+++ S      +  T  Y APE++L    Y   VD W+
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWS 177

Query: 185 MGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVP 244
           +G ++ EL+T RP F    + ++  +I + I             L      +FP  +   
Sbjct: 178 LGILLYELLTGRPPF--GEDDEDPMEIYNDI-------------LKGNGKLEFPNYID-- 220

Query: 245 LSVLMPSANKDAVSLIASLCSWDPSKR 271
                    K A  LI  L   +P +R
Sbjct: 221 ---------KAAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 2e-36
 Identities = 92/311 (29%), Positives = 140/311 (45%), Gaps = 81/311 (26%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRKM 57
           E Y+LI+ +G GT+G V++A    +GE+VAIK +K      E   +     +E+  L++ 
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-----LEPGDDFEIIQQEISMLKEC 57

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC---NLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
            HPNIV         D L+ V EY  C   +L  + +      SE ++   C +  +GLA
Sbjct: 58  RHPNIVAYFGSYLRRDKLWIVMEY--CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRWYRAPEV 169
           Y+H+ G  HRD+K  N+L+++D  +K+ADFG++ ++ +    R  F   + T ++ APEV
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF---IGTPYWMAPEV 172

Query: 170 LLQSYL--YSSKVDMWAMG--AI-MAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
                   Y  K D+WA+G  AI +AEL    P+F                         
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAEL--QPPMF------------------------- 205

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSL-------------IASLCSWDPSKR 271
             L   RA+              L+  +N     L             I    + DP KR
Sbjct: 206 -DLHPMRAL-------------FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR 251

Query: 272 PTAAEALQHPF 282
           PTA + LQHPF
Sbjct: 252 PTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  130 bits (329), Expect = 5e-36
 Identities = 79/285 (27%), Positives = 135/285 (47%), Gaps = 37/285 (12%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPN 61
            +K++K++G G++GSV++       +  A+K++     S +E  + + E++ L  ++HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKC---FSEAEVRNWCFQVFQGLAYMH 117
           I+  KE   + + L  V EY    +L + +  R+K      E E+     Q+ +GL  +H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 118 QRGYFHRDLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           ++   HRDLK  N LLV+ D +KI D G+++ +      T+ + T  Y APEV  +   Y
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVW-KGRPY 178

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S K D+W++G ++ E+ T  P F   S  D  YK+                        K
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------------K 217

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           +P     P+    P  ++D  + I S+    P  RP   + L  P
Sbjct: 218 YP-----PIP---PIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  132 bits (332), Expect = 6e-36
 Identities = 93/312 (29%), Positives = 153/312 (49%), Gaps = 41/312 (13%)

Query: 9   EVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +VG GT+G V++A  K  +     A+K+++    S   C   RE+  LR++ HPN++ L+
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC---REIALLRELKHPNVISLQ 64

Query: 67  EVI--RENDILYFVFEYMECNLYQLMK--------DREKCFSEAEVRNWCFQVFQGLAYM 116
           +V     +  ++ +F+Y E +L+ ++K         +        V++  +Q+  G+ Y+
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 117 HQRGYFHRDLKPENLLV-----SKDTIKIADFGLAREINSR-PPFTEY---VSTRWYRAP 167
           H     HRDLKP N+LV      +  +KIAD G AR  NS   P  +    V T WYRAP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---------ADEIYKICSVIGTP 218
           E+LL +  Y+  +D+WA+G I AEL+T  P+F    E          D++ +I +V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 219 TQDSWADGLLLAR----AINYKFPQLVGVPLSVLMP----SANKDAVSLIASLCSWDPSK 270
               W D   +        +++        L   M       +  A  L+  L + DP K
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 304

Query: 271 RPTAAEALQHPF 282
           R T+ +A+Q P+
Sbjct: 305 RITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  126 bits (317), Expect = 3e-34
 Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIK-----KMKKKYYSWEECVNLREVKSLRKM 57
           +Y+ I+ VG G FG V     K   ++V IK     +M K     E      E + L+ +
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD----ERLAAQNECQVLKLL 56

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAY 115
           SHPNI++  E   E+  L  V EY     L + ++ R      E  + ++  Q+   L +
Sbjct: 57  SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116

Query: 116 MHQRGYFHRDLKPENLLVSK--DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +H +   HRDLK +N+L+ K    +KI DFG+++ ++S+      V T  Y +PE L + 
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEG 175

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+ K D+WA+G ++ EL +L+  F   +    + KI S    P  D ++         
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSP-------- 227

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                                D   LI S+ + DPSKRP  ++ +  P
Sbjct: 228 ---------------------DLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  126 bits (318), Expect = 3e-34
 Identities = 87/298 (29%), Positives = 142/298 (47%), Gaps = 53/298 (17%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK---KKYYSWEECVNLREVKSLRKMSH 59
           R++   ++G GTFG V+ A++  +GE++A+K+++       + +E  +  E+K L  + H
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD--EMKVLELLKH 58

Query: 60  PNIVKLK--EVIRENDILYFVFEYMECN---LYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           PN+VK    EV RE   +Y   EY  C+   L +L++   +   E  +R +  Q+ +GLA
Sbjct: 59  PNLVKYYGVEVHREK--VYIFMEY--CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLA 113

Query: 115 YMHQRGYFHRDLKPEN-LLVSKDTIKIADFGLAREI--NSRPPFTE---YVSTRWYRAPE 168
           Y+H  G  HRD+KP N  L     IK+ DFG A ++  N+     E      T  Y APE
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 169 VLLQSYL--YSSKVDMWAMGAIMAELITLRPLFPGTSEADEI-YKICSVIGTPTQDSWAD 225
           V+       +    D+W++G ++ E+ T +  +       +I + + +  G         
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHK------- 224

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLC-SWDPSKRPTAAEALQHPF 282
                       P +   P S+ +    KD +      C   DP KRPTA+E LQHPF
Sbjct: 225 ------------PPI---PDSLQLSPEGKDFL----DRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  125 bits (315), Expect = 6e-34
 Identities = 80/281 (28%), Positives = 127/281 (45%), Gaps = 32/281 (11%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL- 65
           + E+G G  G V + + + +G+++A+K ++ +     +   LRE+  L K + P IV   
Sbjct: 6   LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 66  KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH-QRGYFH 123
                  DI     EYM+  +L +++K+ +    E  +      V +GL Y+H +    H
Sbjct: 66  GAFYNNGDI-SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 124 RDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           RD+KP N+LV S+  IK+ DFG++ + +NS      +V T  Y APE  +Q   YS K D
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPE-RIQGNDYSVKSD 181

Query: 182 MWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV 241
           +W++G  + EL T R  FP                           LL   +N   P+L 
Sbjct: 182 IWSLGLSLIELATGR--FP--------------YPPENDPPDGIFELLQYIVNEPPPRLP 225

Query: 242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               S        D    +      DP +RP+  E L+HPF
Sbjct: 226 SGKFS-------PDFQDFVNLCLIKDPRERPSYKELLEHPF 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  124 bits (313), Expect = 1e-33
 Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 35/285 (12%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPN 61
            Y  I+ +G G FG        +   +V  K++     S +E  + L E+  L  + HPN
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQR 119
           I+       +++ L    EY     LY  +  ++   F E  V  + FQ+   ++Y+H+ 
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 120 GYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYS 177
           G  HRD+K  N+ ++K   IK+ DFG+++ + S     E  V T +Y +PE L Q   Y+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE-LCQGVKYN 179

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            K D+WA+G ++ EL+TL+  F  T+  + + KI     TP    ++  L          
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL---------- 229

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                              +SL+ SL   DP KRPTA E L  P 
Sbjct: 230 -------------------ISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  124 bits (313), Expect = 1e-33
 Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 35/285 (12%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPN 61
           ++L++ +G G FG V     + + ++ A+K M K+    +  V   L E + L++++HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +V L    ++ + +Y V + +     +    ++  FSE +V+ W  ++   L Y+H +G 
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 122 FHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
            HRD+KP+N+L+ +   + I DF +A ++      T    T  Y APEV L    YS  V
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV-LCRQGYSVAV 180

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL 240
           D W++G    E +  +  + G S             T               I  K    
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSR------------TIRDQ-----------IRAKQ--- 214

Query: 241 VGVPLSVLMPSA-NKDAVSLIASLCSWDPSKR--PTAAEALQHPF 282
                 VL P+  + +A+  I  L   DP KR      +   HP+
Sbjct: 215 --ETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  124 bits (314), Expect = 2e-33
 Identities = 81/290 (27%), Positives = 137/290 (47%), Gaps = 44/290 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM----KKKYYSWEECVNLREVKSLRKM 57
           + +  ++E+G G+FG+V+ A   ++ EVVAIKKM    K+    W++   ++EV+ L+++
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI--IKEVRFLQQL 72

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            HPN ++ K         + V EY   +   +++  +K   E E+   C    QGLAY+H
Sbjct: 73  RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL--QSY 174
                HRD+K  N+L+++  T+K+ADFG A  ++   P   +V T ++ APEV+L     
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS---PANSFVGTPYWMAPEVILAMDEG 189

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPT--QDSWADGLLLARA 232
            Y  KVD+W++G    EL   +P     +    +Y I     +PT   + W+D       
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSSNDWSD------- 241

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                                    + + S     P  RP++ E L+H F
Sbjct: 242 ----------------------YFRNFVDSCLQKIPQDRPSSEELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  120 bits (303), Expect = 9e-32
 Identities = 83/287 (28%), Positives = 136/287 (47%), Gaps = 44/287 (15%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKM----KKKYYSWEECVNLREVKSLRKMSHPNI 62
           + E+G G+FG+V+ A +  + EVVA+KKM    K+    W++   ++EVK L+++ HPN 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI--IKEVKFLQQLKHPNT 83

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           ++ K    +    + V EY   +   L++  +K   E E+        QGLAY+H     
Sbjct: 84  IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 123 HRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL--QSYLYSSK 179
           HRD+K  N+L+++   +K+ADFG A + +   P   +V T ++ APEV+L      Y  K
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGK 200

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS--WADGLLLARAINYKF 237
           VD+W++G    EL   +P     +    +Y I     +PT  S  W D       ++Y  
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWTDS--FRGFVDYCL 257

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR 284
            ++                           P +RP +AE L+H F R
Sbjct: 258 QKI---------------------------PQERPASAELLRHDFVR 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  118 bits (298), Expect = 2e-31
 Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 42/290 (14%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR---------EVKSLRKMSHP 60
           +G GT+G V+ A++  +GE++A+K+++          + +         E+++L+ + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIV+        + L    EY+              F E  VR +  QV +GLAY+H +G
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAR---EINSRPPFTEYVSTRWYRAPEVL-LQSYL 175
             HRDLK +NLLV  D   KI+DFG+++   +I           + ++ APEV+   S  
Sbjct: 129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188

Query: 176 YSSKVDMWAMGAIMAELIT-LRPLFPGTSEA-DEIYKICSVIGTPTQDSWADGLLLARAI 233
           YS+KVD+W++G ++ E+    RP      EA   ++K+ +    P               
Sbjct: 189 YSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIAAMFKLGNKRSAPP-------------- 232

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS 283
                    +P  V   + +  A+  + +  + +P  RPTA E LQHPF 
Sbjct: 233 ---------IPPDVS-MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  118 bits (296), Expect = 3e-31
 Identities = 91/291 (31%), Positives = 138/291 (47%), Gaps = 43/291 (14%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRKMS 58
           RY L + +G G+FG+V+    K++     +K +K+    +    E     +E + L K+ 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 59  HPNIVKLKEVIRENDILYFVFEYME-----CNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           HP IVK      E D    + EY E     C L +L K   K  SE +V  W  Q+  G+
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEEL-KHTGKTLSENQVCEWFIQLLLGV 119

Query: 114 AYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQ 172
            YMHQR   HRDLK +N+ +  + +KI DFG++R +  S    T +  T +Y +PE L  
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG-TPTQDSWADGLLLAR 231
              Y SK D+W++G I+ E+  L   F G +    + +I  V G TP+            
Sbjct: 180 QG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI--VEGPTPS------------ 224

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                 P+     L+ +M            S+ + DPS RP+AAE L++PF
Sbjct: 225 -----LPETYSRQLNSIM-----------QSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 4e-31
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 28/204 (13%)

Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            +KE+G G FG V    WR         VAIK +++   S ++ +   E K + K+SHPN
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKID-----VAIKMIREGAMSEDDFIE--EAKVMMKLSHPN 60

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V  +   ++ V EYM   C L   +++R+       + + C  V + + Y+   
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGC-LLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
           G+ HRDL   N LV +D  +K++DFGLAR +       +Y S+       +W   PEV  
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKW-APPEVFD 174

Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
            S  +SSK D+W+ G +M E+ + 
Sbjct: 175 YSR-FSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 8e-31
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 7/209 (3%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPN 61
           ++++ +VG G +G V+ A  K +GE+VA+K+MKK        V   L E   L       
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +VKL    ++++ LY   EY+    ++ + +     SE   R +  ++F+ +  +H+ GY
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 122 FHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
            HRDLKPEN L+     IK+ DFGL++ I +       V +  Y APEV L+   Y   V
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA--NSVVGSPDYMAPEV-LRGKGYDFTV 179

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADEIY 209
           D W++G ++ E +   P F G S  +E +
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSG-STPNETW 207

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  116 bits (292), Expect = 9e-31
 Identities = 70/214 (32%), Positives = 118/214 (55%), Gaps = 5/214 (2%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           +Y +++ VG+G+FG         S +  A+K+++    S     + +E   L KM HPNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 63  VKLKEVIRENDILYFVFEYME-CNLYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           V  KE    +  LY V EY +  +L Q +K  R K F E  +  W  Q+  G+ ++H++ 
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT-EYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+ ++++  +K+ DFG AR + S   +   YV T +Y  PE+  ++  Y++
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW-ENMPYNN 179

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKIC 212
           K D+W++G I+ EL TL+  F   S  + I K+C
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVC 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 3e-30
 Identities = 88/306 (28%), Positives = 139/306 (45%), Gaps = 70/306 (22%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-----------RE 50
           E + L++ +G G+FG V++AI K++ +VVAIK            ++L           +E
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIK-----------VIDLEEAEDEIEDIQQE 49

Query: 51  VKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQV 109
           ++ L +   P I K      +   L+ + EY    +   L+K  +    E  +     +V
Sbjct: 50  IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREV 107

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRWY 164
             GL Y+H+ G  HRD+K  N+L+S++  +K+ADFG++ ++ S    R  F   V T ++
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF---VGTPFW 164

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRP----LFPGTSEADEIYKICSVIGTPTQ 220
            APEV+ QS  Y  K D+W++G    EL    P    L P         ++  +I  P  
Sbjct: 165 MAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLI--PKN 213

Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           +                P L G   S       KD VSL   L   DP +RP+A E L+H
Sbjct: 214 NP---------------PSLEGNKFSKPF----KDFVSL--CLNK-DPKERPSAKELLKH 251

Query: 281 PFSRVA 286
            F + A
Sbjct: 252 KFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 3e-30
 Identities = 83/295 (28%), Positives = 137/295 (46%), Gaps = 49/295 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           + +++I E+GDG FG V++A  K++G   A K ++ +  S EE  + + E+  L +  HP
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHP 62

Query: 61  NIVKLKEVIRENDILYFVFEYMECN---LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           NIV L E     + L+ + E+  C+   L  +M + E+  +E ++R  C Q+ + L ++H
Sbjct: 63  NIVGLYEAYFYENKLWILIEF--CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFG----LAREINSRPPFTEYVSTRWYRAPEVLL- 171
                HRDLK  N+L++ D  +K+ADFG        +  R  F   + T ++ APEV+  
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF---IGTPYWMAPEVVAC 177

Query: 172 ---QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
              +   Y  K D+W++G  + EL  + P     +    + KI                 
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--------------- 222

Query: 229 LARAINYKFPQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                          P ++  PS  +      + S    DP  RPTAAE L+HPF
Sbjct: 223 -------------SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  115 bits (289), Expect = 3e-30
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 43/287 (14%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIK-----KMKKKYYSWEECVNLREVKSLRKMS 58
           ++++ ++G G+FG V++ + K    V A+K     KM ++    EE ++  E + L K+ 
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR--EREEAID--EARVLAKLD 57

Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYM 116
              I++  E   +   L  V EY E  +L++L+K  R +   E +V  +  Q+  GLA++
Sbjct: 58  SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117

Query: 117 HQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSY 174
           H +   HRD+K  NL +   D +KI D G+A+ ++    F    V T +Y +PE L +  
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDK 176

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y+ K D+WA+G ++ E  T +  F   ++   I KI                     I 
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI---------------------IR 215

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
             FP  V    S       +    LI    + D  +RP   + L++P
Sbjct: 216 GVFPP-VSQMYS-------QQLAQLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  115 bits (289), Expect = 4e-30
 Identities = 66/215 (30%), Positives = 117/215 (54%), Gaps = 22/215 (10%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE-VVAIKKM-----------KKKYYSWEECVNLREV 51
           Y +++ +G G FG V++   K +G+ ++A+K++           +++  S  + V+  EV
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS--EV 59

Query: 52  KSLRK-MSHPNIVKLKEVIRENDILYFVFEYME-CNLYQL---MKDREKCFSEAEVRNWC 106
             +++ + HPNIV+  +   END LY V + +E   L +    +K++++ F+E  + N  
Sbjct: 60  TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 107 FQVFQGLAYMH-QRGYFHRDLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVSTRWY 164
            Q+   L Y+H ++   HRDL P N +L   D + I DFGLA++       T  V T  Y
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF 199
             PE+ +++  Y  K D+WA G I+ ++ TL+P F
Sbjct: 180 SCPEI-VKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  115 bits (290), Expect = 9e-30
 Identities = 87/285 (30%), Positives = 133/285 (46%), Gaps = 42/285 (14%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMSHPNIVKL 65
           K +G GTFG V     K +G+  A+K +KK+    ++ V   L E + L+   HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
           K   + +D L FV EY           RE+ FSE   R +  ++   L Y+H     +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 126 LKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMW 183
           LK ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y   VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWW 179

Query: 184 AMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG 242
            +G +M E++  R P +    + +++++                L+L   I  +FP+ + 
Sbjct: 180 GLGVVMYEMMCGRLPFY--NQDHEKLFE----------------LILMEEI--RFPRTL- 218

Query: 243 VPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
                     + +A SL+A L   DP +R       A E ++H F
Sbjct: 219 ----------SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  114 bits (287), Expect = 9e-30
 Identities = 65/224 (29%), Positives = 120/224 (53%), Gaps = 19/224 (8%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKK------MKKKYYSWEECVNLREVKSLRKM 57
           +K+ K++G G F  V++AI    G VVA+KK      M  K  + ++C  L+E+  L+++
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK--ARQDC--LKEIDLLKQL 59

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMK---DREKCFSEAEVRNWCFQVFQGL 113
            HPN++K      EN+ L  V E  +  +L +++K    +++   E  +  +  Q+   L
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT-EYVSTRWYRAPEVLL 171
            +MH +   HRD+KP N+ ++    +K+ D GL R  +S+       V T +Y +PE + 
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI 215
           ++  Y+ K D+W++G ++ E+  L+  F G  +   +Y +C  I
Sbjct: 180 ENG-YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  115 bits (290), Expect = 1e-29
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 42/285 (14%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMSHPNIV 63
           +  +G G  G+V++ I + +G + A+K +   Y + E+ V     RE++ LR ++HPN+V
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVV 135

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           K  ++   N  +  + E+M+        +      E  + +   Q+  G+AY+H+R   H
Sbjct: 136 KCHDMFDHNGEIQVLLEFMD----GGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVH 191

Query: 124 RDLKPENLLV-SKDTIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVL---LQSYLYSS 178
           RD+KP NLL+ S   +KIADFG++R +  +  P    V T  Y +PE +   L    Y  
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251

Query: 179 KV-DMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
              D+W++G  + E    R  FP               G   Q  WA    L  AI    
Sbjct: 252 YAGDIWSLGVSILEFYLGR--FP--------------FGVGRQGDWAS---LMCAICMSQ 292

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           P     P      +A+++    I+     +P+KR +A + LQHPF
Sbjct: 293 PP--EAP-----ATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330

Length = 353

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 2e-29
 Identities = 84/322 (26%), Positives = 133/322 (41%), Gaps = 76/322 (23%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKK-YYSWEECVNLREVKSLRKMSHP 60
           + +++IK +G G FG VW    K +G+V A+K ++K       +  ++R  + +  ++  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI--LADA 58

Query: 61  N---IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           +   IVKL    ++ + LY V EYM   +L  L+  ++  F E   R +  ++   L  +
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSV 117

Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLA--------------REINSRPPFTEYVST 161
           H+ G+ HRD+KP+N+L+  D  IK+ADFGL                  N        V  
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 162 RW----------------YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA 205
           R                 Y APEVL  +  Y  + D W++G I+ E++   P F   +  
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 206 DEIYKICSVIGTPTQDSWADGLLLARAINYK----FPQLVGVPLSVLMPSANKDAVSLIA 261
           +   KI                     IN+K    FP    V           +A+ LI 
Sbjct: 237 ETYNKI---------------------INWKESLRFPPDPPVS---------PEAIDLIC 266

Query: 262 SLCSWDPSKRPTAAE-ALQHPF 282
            L   DP  R  + E    HPF
Sbjct: 267 RLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 3e-29
 Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 59/296 (19%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR--------KMS 58
           +K +  G FGSV+ A  + +G+  AIK +KK      + +   +V +++        +  
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKK-----SDMIAKNQVTNVKAERAIMMIQGE 55

Query: 59  HPNIVKLKEVIRENDILYFVFEYM---EC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
            P + KL    +  D LY V EY+   +C +L + +        E   + +  +V  G+ 
Sbjct: 56  SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG----LPEDWAKQYIAEVVLGVE 111

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAR--EINSRPPFTEYVSTRWYRAPEVLL 171
            +HQRG  HRD+KPENLL+ +   +K+ DFGL+R    N +     +V T  Y APE +L
Sbjct: 112 DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETIL 166

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
                    D W++G ++ E +   P F     A           TP    + +  +L+R
Sbjct: 167 -GVGDDKMSDWWSLGCVIFEFLFGYPPF----HA----------ETPDA-VFDN--ILSR 208

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA---AEALQHPFSR 284
            IN+  P+ V           + +AV LI  L   DP+KR  A    E   HPF +
Sbjct: 209 RINW--PEEV-------KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  113 bits (283), Expect = 6e-29
 Identities = 74/228 (32%), Positives = 119/228 (52%), Gaps = 15/228 (6%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKM----KKKYYSWEECVNLREVKSLRKMSHPNI 62
           ++E+G G+FG+V+ A   ++ EVVAIKKM    K+    W++ +  +EVK L+++ HPN 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVKFLQRIKHPNS 87

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           ++ K         + V EY   +   L++  +K   E E+        QGLAY+H     
Sbjct: 88  IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 123 HRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL--QSYLYSSK 179
           HRD+K  N+L+++   +K+ADFG A   +   P   +V T ++ APEV+L      Y  K
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMAPEVILAMDEGQYDGK 204

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS--WAD 225
           VD+W++G    EL   +P     +    +Y I     +PT  S  W+D
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSD 251

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  111 bits (278), Expect = 3e-28
 Identities = 68/212 (32%), Positives = 111/212 (52%), Gaps = 12/212 (5%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKM----KKKYYSWEECVNLREVKSLRKMSHPNI 62
           ++E+G G+FG+V+ A   ++ EVVAIKKM    K+    W++ +  +EV+ L+K+ HPN 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQKLRHPNT 77

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           ++ +         + V EY   +   L++  +K   E E+        QGLAY+H     
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 123 HRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL--QSYLYSSK 179
           HRD+K  N+L+S+   +K+ DFG A  +    P   +V T ++ APEV+L      Y  K
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
           VD+W++G    EL   +P     +    +Y I
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  110 bits (277), Expect = 6e-28
 Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 49/291 (16%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---ECV-NLREVKSLRKMSHPNIV 63
           K +G G+FG V  A  K + E+ A+K +KK     +   EC    + V +L    HP + 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLT 59

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYMHQRGY 121
           +L    +  D L+FV EY   N   LM   ++   F E   R +  ++  GL ++H+RG 
Sbjct: 60  QLHSCFQTKDRLFFVMEY--VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI 117

Query: 122 FHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            +RDLK +N+L+  +  IKIADFG+ +E I      + +  T  Y APE+ L    Y   
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI-LSYQPYGPA 176

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           VD WA+G ++ E++  +  F G  E +                      L ++I      
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGDDEDE----------------------LFQSILED--- 211

Query: 240 LVGVPLSVLMP-SANKDAVSLIASLCSWDPSKR----PTAAEAL-QHPFSR 284
                  V  P   +K+A S++ S  + +P KR    PT  + +  HPF R
Sbjct: 212 ------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  108 bits (272), Expect = 8e-28
 Identities = 80/286 (27%), Positives = 137/286 (47%), Gaps = 38/286 (13%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNI 62
           Y  ++ VG G++G V     +  G+   IKK+  +  S  E     +E + L ++ HPNI
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 63  VKLKEVIR-ENDILYFVFEYMEC-NLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR 119
           V  +E    E+ +LY V  + E  +LY  +K+++ K   E +V  W  Q+   L Y+H++
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 120 GYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPF-TEYVSTRWYRAPEVLLQSYLYS 177
              HRDLK +N+ +++ + IK+ D G+AR + ++    +  + T +Y +PE L  +  Y+
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPYN 180

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            K D+WA+G  + E+ TL+  F        +Y+I                     I  K 
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI---------------------IEGKL 219

Query: 238 PQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           P          MP   + +   LIA++ S  P KRP+    L+ P+
Sbjct: 220 PP---------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  108 bits (271), Expect = 1e-27
 Identities = 69/294 (23%), Positives = 132/294 (44%), Gaps = 48/294 (16%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE----CVNLR-EVKSLRKMSHPNI 62
           +++G G F S ++A   ++G ++A+K++     +  E       LR E++ + +++HP+I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           +++     E+       E+M       +  +   F EA + N+  Q+ +GL+Y+H+    
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 123 HRDLKPENLLV--SKDTIKIADFGLAREINSRPPFT-----EYVSTRWYRAPEVLL-QSY 174
           HRD+K  NLL+  +   ++IADFG A  + ++         + + T  + APEVL  + Y
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADE---IYKICSVIGTPTQDSWADGLLLAR 231
             S   D+W++G ++ E+ T +P +     ++    I+KI S    P+            
Sbjct: 186 GRSC--DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS------------ 231

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLC-SWDPSKRPTAAEALQHPFSR 284
                            +P      +  +   C    P  RP + E L+HP  R
Sbjct: 232 -----------------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  108 bits (272), Expect = 2e-27
 Identities = 78/288 (27%), Positives = 139/288 (48%), Gaps = 34/288 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ AI   +G+ VAIK+M  +    +E + + E+  +R+  HPN
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI-INEILVMRENKHPN 77

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H   
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGP 194

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           KVD+W++G +  E++   P +   +    +Y I +  GTP                 + P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP---------------ELQNP 238

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
           +         + +  +D    +      D  KR +A E LQHPF ++A
Sbjct: 239 E--------KLSAIFRD---FLNRCLEMDVEKRGSAKELLQHPFLKIA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  107 bits (268), Expect = 3e-27
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 20/200 (10%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
            L++E+G G FG VW          VAIK +++   S E+ +   E + + K+SHP +V+
Sbjct: 7   TLVQEIGSGQFGLVWLG-YWLEKRKVAIKTIREGAMSEEDFI--EEAQVMMKLSHPKLVQ 63

Query: 65  LKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           L  V  E   +  VFE+ME  C L   ++ +   FS+  +   C  V +G+AY+      
Sbjct: 64  LYGVCTERSPICLVFEFMEHGC-LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI 122

Query: 123 HRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQSY 174
           HRDL   N LV ++  +K++DFG+ R +       +Y S+       +W  +PEV   S 
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLD----DQYTSSTGTKFPVKW-SSPEVFSFSK 177

Query: 175 LYSSKVDMWAMGAIMAELIT 194
            YSSK D+W+ G +M E+ +
Sbjct: 178 -YSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 3e-27
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 50/290 (17%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL +++G G FG VW      + +V A+K +K    S E    L+E + ++K+ H  
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTMSPEAF--LQEAQIMKKLRHDK 62

Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V  E + +Y V EYM   +L   +K  E K     ++ +   Q+ +G+AY+  R
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122

Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYL 175
            Y HRDL   N+LV ++ + KIADFGLAR I     +T     ++   + APE       
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEAANYGR- 180

Query: 176 YSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           ++ K D+W+ G ++ E++T  R  +PG +  + + ++                       
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV--------------------ERG 220

Query: 235 YKFPQLVGVP--LSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEALQH 280
           Y+ P+    P  L  LM             L  W  DP +RPT  E LQ 
Sbjct: 221 YRMPRPPNCPEELYDLM-------------LQCWDKDPEERPT-FEYLQS 256

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  108 bits (270), Expect = 6e-27
 Identities = 90/285 (31%), Positives = 133/285 (46%), Gaps = 42/285 (14%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMSHPNIVKL 65
           K +G GTFG V     K SG+  A+K +KK+    ++ V   L E + L+   HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
           K   +  D L FV EY+          RE+ FSE   R +  ++   L Y+H     +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 126 LKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMW 183
           LK ENL++ KD  IKI DFGL +E I        +  T  Y APEV L+   Y   VD W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV-LEDNDYGRAVDWW 179

Query: 184 AMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG 242
            +G +M E++  R P +    + +++++                L+L   I  KFP+   
Sbjct: 180 GLGVVMYEMMCGRLPFY--NQDHEKLFE----------------LILMEDI--KFPR--- 216

Query: 243 VPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
                   + + DA SL++ L   DP+KR       A E ++H F
Sbjct: 217 --------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  106 bits (266), Expect = 1e-26
 Identities = 68/195 (34%), Positives = 92/195 (47%), Gaps = 6/195 (3%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKE 67
           +G G FG V     K +G++ A KK+ KK       E + L E K L K+S   IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 68  VIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                D L  V   M      Y +    E  F EA    +  Q+  GL ++HQR   +RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 126 LKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWA 184
           LKPEN+L+     ++I+D GLA E+           T  Y APEV LQ  +Y   VD +A
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV-LQGEVYDFSVDWFA 179

Query: 185 MGAIMAELITLRPLF 199
           +G  + E+I  R  F
Sbjct: 180 LGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 86/321 (26%), Positives = 129/321 (40%), Gaps = 68/321 (21%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP 60
            +K IK +G G  G V+    K +G++ A+K + KK       V   L E + L  + HP
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 61  NIVKLKEVIRENDILYFVFEY-MECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQ 118
            +  L    +    L  V +Y     L++L++ +  KC SE   R +  +V   L Y+H 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEY------------------- 158
            G  +RDLKPEN+L+ +   I ++DF L+++ +  PP                       
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 159 -----------VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE 207
                      V T  Y APEV +    + S VD W +G ++ E++     F G++  + 
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Query: 208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWD 267
              I                 L + +   FP    V            A  LI  L   D
Sbjct: 241 FSNI-----------------LKKEVT--FPGSPPVS---------SSARDLIRKLLVKD 272

Query: 268 PSKR----PTAAEALQHPFSR 284
           PSKR      AAE  QHPF R
Sbjct: 273 PSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 2e-26
 Identities = 80/312 (25%), Positives = 144/312 (46%), Gaps = 74/312 (23%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMS-H 59
             ++L++ +G+GT+G V++A  K++G++VAIK M       +E   ++ E   LRK S H
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILRKYSNH 62

Query: 60  PNIVK-----LKEVIR-ENDILYFVFEYME----CNLYQLMKDREKCFSEAEVRNWCFQV 109
           PNI       +K+     +D L+ V E        +L + ++ + K   E  +     + 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTE-----YVSTRW 163
            +GLAY+H+    HRD+K +N+L++K+  +K+ DFG++ +++S    T      ++ T +
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS----TLGRRNTFIGTPY 178

Query: 164 YRAPEVLLQS----YLYSSKVDMWAMG--AI-MAE----LITLRPLFPGTSEADEIYKIC 212
           + APEV+         Y ++ D+W++G  AI +A+    L  + P+              
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------------- 224

Query: 213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSAN--KDAVSLIASLCSWDPSK 270
                             RA+ +K P+    P   L    N  K     I+     +  +
Sbjct: 225 ------------------RAL-FKIPR---NPPPTLKSPENWSKKFNDFISECLIKNYEQ 262

Query: 271 RPTAAEALQHPF 282
           RP   E L+HPF
Sbjct: 263 RPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  106 bits (265), Expect = 3e-26
 Identities = 87/291 (29%), Positives = 129/291 (44%), Gaps = 52/291 (17%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRKMSHPNIVKL 65
           VG G FG V     K +G++ A+K MKK     +E V+     R++ S+   + P I +L
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS--NSPWIPQL 66

Query: 66  KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
           +   ++ D LY V EY    +L  L+   E  F E   + +  ++   +  +HQ GY HR
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126

Query: 125 DLKPENLLVSK-DTIKIADFGLA------REINSRPPFTEYVSTRWYRAPEVL--LQSY- 174
           D+KPEN+L+ +   IK+ADFG A      + +NS+ P    V T  Y APEVL  +    
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP----VGTPDYIAPEVLTTMNGDG 182

Query: 175 --LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y  + D W++G I  E+I  R  F   + A     I +                 R 
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN---------------FQRF 227

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASL-CSWDPSKRPTAAEALQHPF 282
           +  KFP+          P  + D + LI SL C     +R        HPF
Sbjct: 228 L--KFPE---------DPKVSSDFLDLIQSLLCG--QKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  104 bits (261), Expect = 5e-26
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 34/282 (12%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
            ++G+G+ G V  A  K +G  VA+KKM  +K    E   N  EV  +R   HPNIV++ 
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN--EVVIMRDYQHPNIVEMY 82

Query: 67  EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
                 D L+ V E++E      +    +  +E ++   C  V + L+++H +G  HRD+
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQGVIHRDI 141

Query: 127 KPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWA 184
           K +++L++ D  +K++DFG   +++   P     V T ++ APEV+ +   Y ++VD+W+
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWS 200

Query: 185 MGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVP 244
           +G ++ E++   P +        + +I        +D+             K    V   
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRI--------RDN--------LPPKLKNLHKVSPR 244

Query: 245 LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
           L            S +  +   DP++R TAAE L HPF   A
Sbjct: 245 LR-----------SFLDRMLVRDPAQRATAAELLNHPFLAKA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  103 bits (259), Expect = 6e-26
 Identities = 72/201 (35%), Positives = 107/201 (53%), Gaps = 22/201 (10%)

Query: 6   LIKEVGDGTFGSVWRAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
            +KE+G G FG V     K  G+  VAIK +K+   S +E +   E K + K+SH  +V+
Sbjct: 8   FLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIE--EAKVMMKLSHEKLVQ 63

Query: 65  LKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           L  V  +   +Y V EYM   C L   +++  K F  +++   C  V +G+AY+  + + 
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGC-LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQSY 174
           HRDL   N LV     +K++DFGL+R +       EY S+       RW   PEVLL S 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLD----DEYTSSVGSKFPVRW-SPPEVLLYSK 177

Query: 175 LYSSKVDMWAMGAIMAELITL 195
            +SSK D+WA G +M E+ +L
Sbjct: 178 -FSSKSDVWAFGVLMWEVYSL 197

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-25
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            + K +G G FG V R   K  G+    VAIK +K      +    L E   + +  HPN
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66

Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I++L+ V+ ++  +  + EYME  +L + +++ +  F+  ++      +  G+ Y+ +  
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 121 YFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQS 173
           Y HRDL   N+LV+ + + K++DFGL+R +        Y      +  RW  APE  +  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGKIPIRW-TAPEA-IAY 182

Query: 174 YLYSSKVDMWAMGAIMAELIT 194
             ++S  D+W+ G +M E+++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  104 bits (261), Expect = 1e-25
 Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR-------- 55
           ++ +  +G G FG V  A  K++GE+ AIK +KK      + +   EV+SL         
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKK-----GDIIARDEVESLMCEKRIFET 55

Query: 56  --KMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQG 112
                HP +V L    +  D + FV EY    +L  +M      FSE     +   V  G
Sbjct: 56  ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLG 113

Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVL 170
           L Y+H+    +RDLK +NLL+  +  +KIADFGL +E +      + +  T  + APEVL
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY 209
            ++  Y+  VD W +G ++ E++     FPG  E +E++
Sbjct: 174 TETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVF 210

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  102 bits (256), Expect = 2e-25
 Identities = 69/219 (31%), Positives = 114/219 (52%), Gaps = 23/219 (10%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL+K++G G FG VW        +V AIK +K+   S      L E   ++++ HP 
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQG--SMSPEAFLAEANLMKQLQHPR 62

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME    +  L        +  ++ +   Q+ +G+A++ ++
Sbjct: 63  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LVS+    KIADFGLAR I       EY +        +W  APE + 
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIED----NEYTAREGAKFPIKW-TAPEAI- 175

Query: 172 QSY-LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEI 208
            +Y  ++ K D+W+ G ++ E++T  R  +PG +  + I
Sbjct: 176 -NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 68/222 (30%), Positives = 114/222 (51%), Gaps = 20/222 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS-------L 54
           +  + IK VG GTFG V     + S    A+K M        E + L++ +        L
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP-----EVIRLKQEQHVHNEKRVL 55

Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +++SHP I++L     +   LY + EY+    L+  +++  + FS +    +  ++   L
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCAL 114

Query: 114 AYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
            Y+H +   +RDLKPEN+L+ K+  IK+ DFG A+++  R  +T    T  Y APEV +Q
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWT-LCGTPEYLAPEV-IQ 171

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICS 213
           S  ++  VD WA+G ++ E++   P F   +    IY KI +
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDN-PFGIYEKILA 212

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  102 bits (256), Expect = 3e-25
 Identities = 77/288 (26%), Positives = 141/288 (48%), Gaps = 34/288 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ A+   +G+ VAI++M  +    +E + + E+  +R+  +PN
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 78

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGP 195

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           KVD+W++G +  E+I   P +   +    +Y I +  GTP   +               P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN---------------P 239

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
           +     LS +     +D ++    +   D  KR +A E LQH F ++A
Sbjct: 240 E----KLSAIF----RDFLNRCLDM---DVEKRGSAKELLQHQFLKIA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  103 bits (258), Expect = 3e-25
 Identities = 68/207 (32%), Positives = 109/207 (52%), Gaps = 12/207 (5%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRKMSHPNIV 63
           K +G G+FG V  A  K + EV AIK +KK     ++ V+     + + +L    HP + 
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLT 59

Query: 64  KLKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
            L    +  D L+FV EY+     ++Q+ + R+  F E   R +  +V   L ++H+ G 
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGV 117

Query: 122 FHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            +RDLK +N+L+  +   K+ADFG+ +E I +    T +  T  Y APE+ LQ   Y   
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI-LQELEYGPS 176

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEAD 206
           VD WA+G +M E++  +P F   +E D
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  102 bits (257), Expect = 3e-25
 Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 16/202 (7%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS--------LRKMSH 59
           K +G G+FG V  A  K  G+  A+K ++KK       +  +E K         L+ + H
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----ILKKKEQKHIMAERNVLLKNVKH 55

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P +V L    +  D LYFV +Y+          RE+ F E   R +  ++   L Y+H  
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115

Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              +RDLKPEN+L+ S+  + + DFGL +E I      + +  T  Y APEVL +   Y 
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YD 174

Query: 178 SKVDMWAMGAIMAELITLRPLF 199
             VD W +GA++ E++   P F
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  102 bits (254), Expect = 4e-25
 Identities = 68/207 (32%), Positives = 113/207 (54%), Gaps = 16/207 (7%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           E +++I E+GDG FG V++A +K++G + A K +  K  S EE  + + E+  L    HP
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHP 62

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIVKL +     + L+ + E+        +M + E+  +E ++R  C Q  + L Y+H+ 
Sbjct: 63  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLA----REINSRPPFTEYVSTRWYRAPEVLL--- 171
              HRDLK  N+L + D  IK+ADFG++    R I  R  F   + T ++ APEV++   
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF---IGTPYWMAPEVVMCET 179

Query: 172 -QSYLYSSKVDMWAMGAIMAELITLRP 197
            +   Y  K D+W++G  + E+  + P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  102 bits (254), Expect = 5e-25
 Identities = 76/288 (26%), Positives = 141/288 (48%), Gaps = 34/288 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ AI   +G+ VAIK+M  +    +E + + E+  +R+  +PN
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI-INEILVMRENKNPN 77

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H   
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGP 194

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           KVD+W++G +  E++   P +   +    +Y I +  GTP   +               P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQN---------------P 238

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
           +         + +  +D ++    +   D  +R +A E LQHPF ++A
Sbjct: 239 E--------RLSAVFRDFLNRCLEM---DVDRRGSAKELLQHPFLKLA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  101 bits (252), Expect = 5e-25
 Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 28/202 (13%)

Query: 7   IKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           +KE+G G FG V    WRA  K     VAIK + +   S E+ +   E K + K+SHP +
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIK-----VAIKAINEGAMSEEDFI--EEAKVMMKLSHPKL 61

Query: 63  VKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           V+L  V  +   LY V E+ME  C L   ++ R+   S+  + + C  V +G+ Y+ +  
Sbjct: 62  VQLYGVCTQQKPLYIVTEFMENGC-LLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQ 172
           + HRDL   N LVS    +K++DFG+ R +       EY S+       +W   PEV   
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGAKFPVKW-SPPEVFNF 175

Query: 173 SYLYSSKVDMWAMGAIMAELIT 194
           S  YSSK D+W+ G +M E+ T
Sbjct: 176 SK-YSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  102 bits (255), Expect = 6e-25
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 5/196 (2%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMSHPNIVKL 65
           K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
           K   + +D L FV EY           RE+ F+E   R +  ++   L Y+H R   +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 126 LKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMW 183
           +K ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y   VD W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWW 179

Query: 184 AMGAIMAELITLRPLF 199
            +G +M E++  R  F
Sbjct: 180 GLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  100 bits (251), Expect = 8e-25
 Identities = 79/293 (26%), Positives = 133/293 (45%), Gaps = 46/293 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E ++LI+ +G GT+G V++A +  +GE+ AIK +K +       V  +E+  ++   H N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ-QEIIMMKDCKHSN 67

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           IV         D L+   E+      Q +       SE+++     +  QGL Y+H +G 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 122 FHRDLKPENLLVSKDT-IKIADFGLAREINSR-PPFTEYVSTRWYRAPEV--LLQSYLYS 177
            HRD+K  N+L++ +  +K+ADFG++ +I +       ++ T ++ APEV  + +   Y+
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD-SWADGLLLARAINYK 236
              D+WA+G    EL  L+P                    P  D      L L    N++
Sbjct: 188 QLCDIWAVGITAIELAELQP--------------------PMFDLHPMRALFLMTKSNFQ 227

Query: 237 FPQLVGVPLSVLMPSANKDAVS-------LIASLCSWDPSKRPTAAEALQHPF 282
            P+L             KD +         +    + +P KRPTA + LQHPF
Sbjct: 228 PPKL-------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  101 bits (253), Expect = 1e-24
 Identities = 87/286 (30%), Positives = 132/286 (46%), Gaps = 43/286 (15%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMSHPNIVKL 65
           K +G GTFG V     K +G   A+K +KK+    ++ V   L E + L+   HP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH-QRGYFHR 124
           K   + +D L FV EY           RE+ FSE   R +  ++   L Y+H ++   +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 125 DLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           DLK ENL++ KD  IKI DFGL +E I        +  T  Y APEV L+   Y   VD 
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDW 179

Query: 183 WAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV 241
           W +G +M E++  R P +    + +++++                L+L   I  +FP+ +
Sbjct: 180 WGLGVVMYEMMCGRLPFY--NQDHEKLFE----------------LILMEEI--RFPRTL 219

Query: 242 GVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
                        +A SL++ L   DP +R       A E +QH F
Sbjct: 220 S-----------PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  100 bits (251), Expect = 1e-24
 Identities = 76/290 (26%), Positives = 140/290 (48%), Gaps = 39/290 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           E +++I E+GDG FG V++A +K++G + A K ++ K  S EE  + + E++ L   +HP
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHP 69

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            IVKL      +  L+ + E+        +M + ++  +E +++  C Q+ + L Y+H  
Sbjct: 70  YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGL-AREINSRPPFTEYVSTRWYRAPEVLLQSYL-- 175
              HRDLK  N+L++ D  IK+ADFG+ A+ + +      ++ T ++ APEV++   +  
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 176 --YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W++G  + E+  + P     +    + KI                      
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------------------- 229

Query: 234 NYKFPQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                     P ++  PS  + +    + +     P  RP+AA+ L+HPF
Sbjct: 230 --------SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 1e-24
 Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 54/288 (18%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           +L++++G G FG VW  +   +  V A+K +K      ++   L E + ++K+ HP +++
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPKDF--LAEAQIMKKLRHPKLIQ 65

Query: 65  LKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           L  V    + +Y V E M+    L  L     +     ++ +   QV  G+AY+  + Y 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125

Query: 123 HRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQSY 174
           HRDL   N+LV ++ I K+ADFGLAR I        Y +        +W  APE  L + 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKE----DIYEAREGAKFPIKW-TAPEAALYNR 180

Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
            +S K D+W+ G ++ E++T  R  +PG + A+ + ++                      
Sbjct: 181 -FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV--------------------DQ 219

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEALQ 279
            Y+ P   G P            +  I   C W  DP  RPT  E LQ
Sbjct: 220 GYRMPCPPGCP----------KELYDIMLDC-WKEDPDDRPT-FETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 99.5 bits (248), Expect = 2e-24
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 25/209 (11%)

Query: 10  VGDGTFGSVWRAISKQ-----SGEV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           +G G FG V+   +       SG + VA+K ++K     E+   L+E   +   +HPNIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 64  KLKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEA-----EVRNWCFQVFQGLAYM 116
           KL  V   N+  Y + E ME    L  L   R + F        E+ + C  V +G  Y+
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 117 HQRGYFHRDLKPENLLVSKD------TIKIADFGLAREINS----RPPFTEYVSTRWYRA 166
            Q  + HRDL   N LVS+        +KI DFGLAR+I      R      +  RW  A
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM-A 181

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           PE LL    ++++ D+W+ G +M E++TL
Sbjct: 182 PESLLDG-KFTTQSDVWSFGVLMWEILTL 209

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score =  101 bits (252), Expect = 3e-24
 Identities = 75/306 (24%), Positives = 131/306 (42%), Gaps = 41/306 (13%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y +IK +  G+ G V+ A      + V +K  +K          L E   L+ ++HP+++
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVI 120

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           ++K+ +    I   V  +   +LY  +  R +     +      Q+ +GL Y+H +   H
Sbjct: 121 RMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIH 180

Query: 124 RDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           RD+K EN+ +   D + I D G A+     P F     T    APEVL +   Y+SK D+
Sbjct: 181 RDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDK-YNSKADI 239

Query: 183 WAMGAIMAELI----TLRPLFPGTSEA------DEIYKICSVIGTPTQD--SWADGLLLA 230
           W+ G ++ E++    T+    P T E         + KI S +    ++        L+ 
Sbjct: 240 WSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVR 299

Query: 231 RAINY---------KFP--QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
             I Y         ++P  Q V +P+         D   L+  + ++D + RP+A E L 
Sbjct: 300 GFIEYASLERQPYTRYPCFQRVNLPI---------DGEFLVHKMLTFDAAMRPSAEEILN 350

Query: 280 HPFSRV 285
           +P    
Sbjct: 351 YPMFAQ 356

Length = 357

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 99.7 bits (248), Expect = 3e-24
 Identities = 74/280 (26%), Positives = 135/280 (48%), Gaps = 32/280 (11%)

Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  K +G+ VA+KKM  +     E +   EV  +R   H N+V +   
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL-FNEVVIMRDYHHENVVDMYNS 87

Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V + L+Y+H +G  HRD+K 
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146

Query: 129 ENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  IK++DFG   +++   P     V T ++ APEV +    Y ++VD+W++G
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV-ISRLPYGTEVDIWSLG 205

Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E+I   P +        + +I   +    +DS            +K   ++   L 
Sbjct: 206 IMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS------------HKVSSVLRGFLD 253

Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
           +++                 +PS+R TA E LQHPF ++A
Sbjct: 254 LMLVR---------------EPSQRATAQELLQHPFLKLA 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  100 bits (250), Expect = 3e-24
 Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 18/199 (9%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS-------LRKMSHPNI 62
           +G G+FG V  A  K +GE  AIK +KK+     E + +++V+        L ++SHP I
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKR-----EILKMKQVQHVAQEKSILMELSHPFI 80

Query: 63  VKLKEVIRENDILYFVFEY-MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           V +    ++ + +YF+ E+ +   L+  ++   + F     + +  ++     Y+H +  
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLHSKDI 139

Query: 122 FHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
            +RDLKPENLL+ +K  +K+ DFG A+++  R  FT    T  Y APEV +QS  +   V
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFT-LCGTPEYLAPEV-IQSKGHGKAV 196

Query: 181 DMWAMGAIMAELITLRPLF 199
           D W MG ++ E I   P F
Sbjct: 197 DWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 99.0 bits (247), Expect = 5e-24
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 36/218 (16%)

Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNL------RE 50
           +R+ K IK++G+G FG V    +  +   +GE VA+K +                   RE
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH------SGEEQHRSDFERE 56

Query: 51  VKSLRKMSHPNIVKLKEVIRE--NDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWC 106
           ++ LR + H NIVK K V  +     L  + EY+        L + R++   +  +  + 
Sbjct: 57  IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FS 115

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR--- 162
            Q+ +G+ Y+  + Y HRDL   N+LV S+D +KI+DFGLA+ +       +Y   +   
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED---KDYYYVKEPG 172

Query: 163 -----WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
                WY APE L     +SS  D+W+ G  + EL T 
Sbjct: 173 ESPIFWY-APECLRT-SKFSSASDVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.7 bits (246), Expect = 5e-24
 Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 52/295 (17%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK--------KKYYSWEECVNLREVKSLR 55
           ++  K +G G FG V+      +G  +A+K++         KK  +  EC    E++ L+
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC----EIQLLK 59

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK---CFSEAEVRNWCFQVFQG 112
            + H  IV+    +R+++ L    EYM       +KD+ K     +E   R +  Q+ +G
Sbjct: 60  NLQHERIVQYYGCLRDDETLSIFMEYMPGGS---VKDQLKAYGALTETVTRKYTRQILEG 116

Query: 113 LAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREIN----SRPPFTEYVSTRWYRAP 167
           + Y+H     HRD+K  N+L  S   +K+ DFG ++ +     S         T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EV+     Y  K D+W++G  + E++T +P +        I+KI +    PT        
Sbjct: 177 EVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT-------- 224

Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                 N + P  V             DA + +      +  KRP+A E L+H F
Sbjct: 225 ------NPQLPSHVSP-----------DARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 99.7 bits (248), Expect = 5e-24
 Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 6/197 (3%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKK-YYSWEECVNLREVKS--LRKMSHPNIVK 64
           K +G G+FG V  A  K  G   A+K ++KK     +E  ++   ++  L+ + HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
           L    +  + LYFV +Y+          RE+CF E   R +  +V   + Y+H     +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 125 DLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           DLKPEN+L+ S+  + + DFGL +E +      + +  T  Y APEV L+   Y   VD 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-LRKEPYDRTVDW 179

Query: 183 WAMGAIMAELITLRPLF 199
           W +GA++ E++   P F
Sbjct: 180 WCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.5 bits (243), Expect = 1e-23
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 30/206 (14%)

Query: 8   KEVGDGTFGSVWRAISKQS-GEV--VAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNI 62
           K++GDG+FG V R     S G+V  VA+K +K    S  + ++  L+E   +  + H N+
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENL 58

Query: 63  VKLKEVIRENDILYFVFEYMEC-NLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++L  V+  + ++  V E     +L   ++      F  + + ++  Q+  G+ Y+  + 
Sbjct: 59  IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 121 YFHRDLKPENLLV-SKDTIKIADFGLAR-----------EINSRPPFTEYVSTRWYRAPE 168
           + HRDL   N+L+ S D +KI DFGL R           E + + PF       W  APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA------WC-APE 170

Query: 169 VLLQSYLYSSKVDMWAMGAIMAELIT 194
             L++  +S   D+W  G  + E+ T
Sbjct: 171 S-LRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 68/205 (33%), Positives = 110/205 (53%), Gaps = 12/205 (5%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---EC-VNLREVKSLRKMSHPNIVKL 65
           +G G+FG V  A  K+SG + A+K +KK     +   EC +  + + SL + +HP + +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYMHQRGYFH 123
               +  D L+FV E++  N   LM   +K   F EA  R +  ++   L ++H +G  +
Sbjct: 62  YCCFQTPDRLFFVMEFV--NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119

Query: 124 RDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           RDLK +N+L+  +   K+ADFG+ +E I +    + +  T  Y APE+ LQ  LY   VD
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI-LQEMLYGPSVD 178

Query: 182 MWAMGAIMAELITLRPLFPGTSEAD 206
            WAMG ++ E++     F   +E D
Sbjct: 179 WWAMGVLLYEMLCGHAPFEAENEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 2e-23
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 30/219 (13%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQ--SGEV---VAIKKMKKKYYSWEECVNLREVKSLR 55
            E+  LI+E+G G+FG V+  ++K    GE    VAIK + +     E    L E   ++
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYMECN-----LYQLMKDREKC-----FSEAEVRNW 105
           + +  ++V+L  V+        V E M        L     + E        +  +    
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY------ 158
             ++  G+AY+  + + HRDL   N +V++D T+KI DFG+ R+I      T+Y      
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----TDYYRKGGK 180

Query: 159 --VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
             +  RW  APE L     +++K D+W+ G ++ E+ TL
Sbjct: 181 GLLPVRWM-APESLKDGV-FTTKSDVWSFGVVLWEMATL 217

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 97.5 bits (242), Expect = 3e-23
 Identities = 78/288 (27%), Positives = 144/288 (50%), Gaps = 34/288 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ AI   +G+ VAIK++  +    +E + + E+  ++++ +PN
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI-INEILVMKELKNPN 77

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  EA++   C +  Q L ++H   
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGP 194

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           KVD+W++G +  E++   P +   +    +Y I +  GTP   +               P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQN---------------P 238

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
           +     LS +     +D ++    +   D  KR +A E LQHPF ++A
Sbjct: 239 E----KLSPIF----RDFLNRCLEM---DVEKRGSAKELLQHPFLKLA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 96.6 bits (240), Expect = 3e-23
 Identities = 73/218 (33%), Positives = 113/218 (51%), Gaps = 21/218 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL K++G G FG VW A   +  +V A+K MK    S E    L E   ++ + H  
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVE--AFLAEANVMKTLQHDK 62

Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSE-AEVRNWCFQVFQGLAYMHQR 119
           +VKL  V+ +  I Y + E+M   +L   +K  E       ++ ++  Q+ +G+A++ QR
Sbjct: 63  LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LVS   + KIADFGLAR I       EY +        +W  APE + 
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKW-TAPEAIN 176

Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEI 208
               ++ K D+W+ G ++ E++T  R  +PG S  + I
Sbjct: 177 FGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 96.2 bits (239), Expect = 4e-23
 Identities = 68/216 (31%), Positives = 116/216 (53%), Gaps = 20/216 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL+K++G G FG VW      S +V A+K +K    S +    L E   ++ + H  
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQ--AFLEEANLMKTLQHDK 62

Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ + + +Y + EYM + +L   +K  E       ++ ++  Q+ +G+AY+ ++
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LVS+  + KIADFGLAR I       EY +        +W  APE  +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIED----NEYTAREGAKFPIKW-TAPEA-I 176

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEAD 206
               ++ K D+W+ G ++ E++T   + +PG S +D
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 97.4 bits (242), Expect = 5e-23
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 16/202 (7%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS--------LRKMSH 59
           K +G G+FG V  A  K  G+  A+K ++KK       +N +E K         L+ + H
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-----VLNRKEQKHIMAERNVLLKNVKH 55

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P +V L    +  + LYFV +++          RE+ F E   R +  ++   L Y+H  
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              +RDLKPEN+L+ S+  + + DFGL +E I      T +  T  Y APEV ++   Y 
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV-IRKQPYD 174

Query: 178 SKVDMWAMGAIMAELITLRPLF 199
           + VD W +GA++ E++   P F
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 96.6 bits (240), Expect = 7e-23
 Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 9/218 (4%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKK--YYSWEECVNLREVKSLRK-MSHPNIVK 64
           K +G G+FG V  A  K   +  A+K ++KK      EE   + E   L K + HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
           L    +  D LYFV +Y+          RE+CF E   R +  ++   L Y+H     +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 125 DLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           DLKPEN+L+ S+  I + DFGL +E I      + +  T  Y APEV L    Y   VD 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV-LHKQPYDRTVDW 179

Query: 183 WAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
           W +GA++ E++   P F   + A E+Y   +++  P Q
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTA-EMYD--NILNKPLQ 214

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 95.5 bits (237), Expect = 8e-23
 Identities = 74/211 (35%), Positives = 111/211 (52%), Gaps = 21/211 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +LIK++G+G FG VW      + +V A+K +K    S E    L E + ++K+ H  
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESF--LEEAQIMKKLRHDK 62

Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +KD E +      + +   QV  G+AY+ + 
Sbjct: 63  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121

Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LV    + KIADFGLAR I       EY +        +W  APE  L
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIED----NEYTARQGAKFPIKW-TAPEAAL 176

Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
               ++ K D+W+ G ++ EL+T  R  +PG
Sbjct: 177 YGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 95.9 bits (238), Expect = 8e-23
 Identities = 73/276 (26%), Positives = 132/276 (47%), Gaps = 32/276 (11%)

Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  K SG++VA+KKM  +     E +   EV  +R   H N+V++   
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNS 85

Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V + L+ +H +G  HRD+K 
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144

Query: 129 ENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +++   P  +  V T ++ APE L+    Y  +VD+W++G
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWSLG 203

Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P +        +  I        +D+    L     ++   P L G    
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPKLKNLHKVS---PSLKG---- 248

Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                        +  L   DP++R TAAE L+HPF
Sbjct: 249 ------------FLDRLLVRDPAQRATAAELLKHPF 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 95.2 bits (237), Expect = 9e-23
 Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 29/208 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR----EVKSLRKM 57
           E + L +++G G FG VW  + K    V AIK +K      ++ +  +    EV++L+++
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKS-----DDLLKQQDFQKEVQALKRL 59

Query: 58  SHPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAY 115
            H +++ L  V    + +Y + E ME  +L   ++  E +    A + +   QV +G+AY
Sbjct: 60  RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119

Query: 116 MHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREI--------NSRPPFTEYVSTRWYRA 166
           + ++   HRDL   N+LV +D + K+ADFGLAR I        + + P+      +W  A
Sbjct: 120 LEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY------KW-TA 172

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           PE       +S+K D+W+ G ++ E+ T
Sbjct: 173 PEAASHGT-FSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 1e-22
 Identities = 58/191 (30%), Positives = 101/191 (52%), Gaps = 20/191 (10%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G FG V     +  G+ VA+K +K    + +    L E   +  + HPN+V+L  V+
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAF--LAEASVMTTLRHPNLVQLLGVV 69

Query: 70  RENDILYFVFEYME-CNLYQLMKDREKCFSE-AEVRNWCFQVFQGLAYMHQRGYFHRDLK 127
            + + LY V EYM   +L   ++ R +     A+   +   V +G+ Y+ ++ + HRDL 
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129

Query: 128 PENLLVSKDTI-KIADFGLAREIN-----SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
             N+LVS+D + K++DFGLA+E +      + P       +W  APE L +   +S+K D
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------VKW-TAPEALREK-KFSTKSD 181

Query: 182 MWAMGAIMAEL 192
           +W+ G ++ E+
Sbjct: 182 VWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 71/278 (25%), Positives = 131/278 (47%), Gaps = 36/278 (12%)

Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  K SG  VA+K M  +     E +   EV  +R   H N+V++ + 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL-FNEVVIMRDYQHQNVVEMYKS 86

Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               + L+ + E+++      +  + +  +E ++   C  V Q L Y+H +G  HRD+K 
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145

Query: 129 ENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +I+   P     V T ++ APEV+ ++  Y ++VD+W++G
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLG 204

Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P  P  S+            +P Q                  +L   P  
Sbjct: 205 IMVIEMVDGEP--PYFSD------------SPVQ---------------AMKRLRDSPPP 235

Query: 247 VLMPSANKDAV--SLIASLCSWDPSKRPTAAEALQHPF 282
            L  +     V    +  + + +P +R TA E L HPF
Sbjct: 236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 2e-22
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 22/202 (10%)

Query: 8   KEVGDGTFGSVWRAI--SKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           KE+G G FGSV + +   K   EV VA+K +K+++ +  +   LRE   + ++ HP IV+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 65  LKEVIRENDILYFVFEYME---CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           L  V +  + L  V E         Y L K RE     ++++    QV  G+AY+  + +
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKY-LKKRRE--IPVSDLKELAHQVAMGMAYLESKHF 116

Query: 122 FHRDLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQS 173
            HRDL   N LLV++   KI+DFG++R +        Y +T       +WY APE  +  
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWY-APEC-INY 172

Query: 174 YLYSSKVDMWAMGAIMAELITL 195
             +SSK D+W+ G  + E  + 
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 61/198 (30%), Positives = 107/198 (54%), Gaps = 5/198 (2%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y+LI+ VG GT+G V++A +  +GE+ A+K +K +       +  +E+  +++  H NIV
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ-QEIFMVKECKHCNIV 69

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
                    + L+   EY      Q +       SE ++   C +  QGLAY+H +G  H
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129

Query: 124 RDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYRAPEV--LLQSYLYSSK 179
           RD+K  N+L++ +  +K+ADFG+A +I +       ++ T ++ APEV  + ++  Y+  
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189

Query: 180 VDMWAMGAIMAELITLRP 197
            D+WA+G    EL  L+P
Sbjct: 190 CDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 94.5 bits (235), Expect = 4e-22
 Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 43/286 (15%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---ECVNL-REVKSLRKMSHPNIV 63
           K +G G+FG V  A  K + E  AIK +KK     +   EC  + R V +L    HP + 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLT 59

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYMHQRGY 121
            L    +  + L+FV EY+  N   LM   +    F EA  R +  ++  GL ++H++G 
Sbjct: 60  HLFCTFQTKEHLFFVMEYL--NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            +RDLK +N+L+ KD  IKIADFG+ +E +N     + +  T  Y APE+ L+   Y+  
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI-LKGQKYNES 176

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           VD W+ G ++ E++  +  F G  E DE++    +   P                  FP+
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDE-DELFD-SILNDRP-----------------HFPR 217

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-PTAAEALQHPFSR 284
            +           +K+A   ++ L   DP+KR     +  QHPF R
Sbjct: 218 WI-----------SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 94.1 bits (234), Expect = 6e-22
 Identities = 85/295 (28%), Positives = 137/295 (46%), Gaps = 49/295 (16%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---ECVNLREVKSLRKMSHP 60
           +  +  +G G+FG V  A  K + E+ AIK +KK     +   EC  + E + L     P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECT-MVEKRVLALPGKP 60

Query: 61  N-IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYMH 117
             + +L    +  D LYFV EY+  N   LM   ++   F E     +  ++  GL ++H
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYV--NGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT--EYVSTRWYRAPEVLLQSY 174
            +G  +RDLK +N+++  +  IKIADFG+ +E N     T   +  T  Y APE++    
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFCGTPDYIAPEIIAYQ- 176

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y   VD WA G ++ E++  +P F G  E DE+++  S++                  N
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQ--SIMEH----------------N 217

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAAEALQ-HPFSR 284
             +P+           S +K+AVS+   L +  P+KR    PT    ++ H F R
Sbjct: 218 VSYPK-----------SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 92.8 bits (230), Expect = 7e-22
 Identities = 61/225 (27%), Positives = 119/225 (52%), Gaps = 15/225 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK----KKYYSWEECVNLREVKSLRK 56
           +  +++ K++G G F  V+RA     G  VA+KK++        +  +C+  +E+  L++
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQ 58

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLM---KDREKCFSEAEVRNWCFQVFQG 112
           ++HPN++K      E++ L  V E  +  +L +++   K +++   E  V  +  Q+   
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVL 170
           L +MH R   HRD+KP N+ ++    +K+ D GL R  +S+       V T +Y +PE +
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI 215
            ++  Y+ K D+W++G ++ E+  L+  F G  +   +Y +C  I
Sbjct: 179 HENG-YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 92.7 bits (230), Expect = 1e-21
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 23/207 (11%)

Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           K I+++G+G FG V    +      +GE VA+K +K +        +L +E++ LR + H
Sbjct: 7   KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYH 65

Query: 60  PNIVKLKEVIREN--DILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
            NIVK K +  E+  + +  + E++   +L + +   +   +  +   +  Q+ +G+ Y+
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 117 HQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR--------WYRAP 167
             R Y HRDL   N+LV S+  +KI DFGL + I +     EY + +        WY AP
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDLDSPVFWY-AP 181

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELIT 194
           E L+QS  Y +  D+W+ G  + EL+T
Sbjct: 182 ECLIQSKFYIAS-DVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 92.2 bits (229), Expect = 1e-21
 Identities = 78/295 (26%), Positives = 138/295 (46%), Gaps = 47/295 (15%)

Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 3   MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 60

Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 61  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120

Query: 117 HQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++ + K+ADFGL+R +     +T +   ++   + APE  L 
Sbjct: 121 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPES-LA 178

Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
              +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 219

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE---ALQHPF 282
           +    + P+  G P  V           L+ +   W+PS RP+ AE   A +  F
Sbjct: 220 KGYRMERPE--GCPPKVY---------ELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.3 bits (229), Expect = 1e-21
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 16/203 (7%)

Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K +G G FG V+R I K  G     VAIK +K  Y   +    L E   + + SH NI++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 65  LKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ +      + EYME   L + ++D +  FS  ++      +  G+ Y+    Y H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-----TRWYRAPEVLLQSYL-Y 176
           RDL   N+LV+ +   K++DFGL+R +   P  T   S      RW  APE +  +Y  +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW-TAPEAI--AYRKF 187

Query: 177 SSKVDMWAMGAIMAELITL--RP 197
           +S  D+W+ G +M E+++   RP
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.1 bits (229), Expect = 1e-21
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 8/200 (4%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREV---KSLRKMSHP 60
           Y+ ++ +G G +G+V+R     +G VVA+K +       +     REV     LR+   P
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NI K      +   L+ + EY E  ++  LMK      +E  +     +V   L Y+H+ 
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVALKYIHKV 120

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+K  N+LV+    +K+ DFG+A  +N      + +V T ++ APEV+ +   Y 
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180

Query: 178 SKVDMWAMGAIMAELITLRP 197
           +K D+W++G  + E+ T  P
Sbjct: 181 TKADIWSLGITIYEMATGNP 200

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.1 bits (229), Expect = 2e-21
 Identities = 75/215 (34%), Positives = 112/215 (52%), Gaps = 33/215 (15%)

Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K I+++G G FGSV    +  +   +GEVVA+KK++   +S  E +    RE++ L
Sbjct: 3   ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ---HSTAEHLRDFEREIEIL 59

Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQ 108
           + + H NIVK K V     R N  L  V EY+        L K RE+      +  +  Q
Sbjct: 60  KSLQHDNIVKYKGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRERLDHRKLLL-YASQ 116

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR----- 162
           + +G+ Y+  + Y HRDL   N+LV S++ +KI DFGL + +   P   EY   R     
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL---PQDKEYYKVREPGES 173

Query: 163 ---WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
              WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 174 PIFWY-APESLTES-KFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 46/223 (20%)

Query: 6   LIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVN------LREVKSL 54
           L +E+G+G FG V+         +   E+VA+K +K      E   N       RE + L
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK------ETASNDARKDFEREAELL 62

Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYME--------------CNLYQLMKDREKCFSEA 100
               H NIVK   V  E D    VFEYME                  +         + +
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 101 EVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEY- 158
           ++     Q+  G+ Y+  + + HRDL   N LV  D + KI DFG++R++ +    T+Y 
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT----TDYY 178

Query: 159 -------VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
                  +  RW     ++ + +   S  D+W+ G ++ E+ T
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTES--DVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 29/221 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM 57
           +R  L K +G+G FG V +A    +   +       KM K   + ++  +L     + KM
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 58  --SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCFSE 99
              H NI+ L  V  +   LY V EY    NL   ++ R               E+  ++
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 100 AEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY 158
            ++ ++ +QV +G+ ++  +   HRDL   N+LV++D  +KIADFGLAR+I+    + + 
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 159 VSTR----WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            + R    W  APE L    +Y+ + D+W+ G ++ E+ TL
Sbjct: 192 TNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLLWEIFTL 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.7 bits (225), Expect = 6e-21
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +RY K I+ +G+G FG V    +   +  +GE+VA+K +K++          +E+  L+ 
Sbjct: 3   KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT 62

Query: 57  MSHPNIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREK-CFSEAEVRNWCFQVFQGL 113
           + H NIVK K    E     L  + EY+   L  L     K   + A++  +  Q+ +G+
Sbjct: 63  LYHENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGM 120

Query: 114 AYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTR--------WY 164
           AY+H + Y HRDL   N+L+  D  +KI DFGLA+ +   P   EY   R        WY
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFWY 177

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
            A E  L+   +S   D+W+ G  + EL+T
Sbjct: 178 -AVEC-LKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 47/293 (16%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIK--------KMKKKYYSWEECVNLREVKSLRKMS 58
           +  +G+G  GSV +   K +G + A+K         ++K+         LRE++  +   
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI--------LRELEINKSCK 57

Query: 59  HPNIVKLKEVIREN--DILYFVFEYMEC----NLYQLMKDREKCFSEAEVRNWCFQVFQG 112
            P IVK      +     +    EY E     ++Y+ +K R     E  +      V +G
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 113 LAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
           L+Y+H R   HRD+KP N+L++ K  +K+ DFG++ E+ +    T +  T +Y APE  +
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE-RI 175

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFP--GTSEADEIYKICSVIGTPTQDSWADGLLL 229
           Q   YS   D+W++G  + E+   R  FP  G      I                   LL
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE------------------LL 217

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +  +N   P+L   P + +  S  ++    I      DP++RPT  + L+HP+
Sbjct: 218 SYIVNMPNPELKDEPGNGIKWS--EEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 90.1 bits (223), Expect = 8e-21
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 33/283 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++ +G G+FG V++ I  ++ +VVAIK +  +    E     +E+  L +   P 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           + K      +   L+ + EY+      L   R   F E ++     ++ +GL Y+H    
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGG-SALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            HRD+K  N+L+S+   +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y SK
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSK 181

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
            D+W++G    EL                       G P         +L        P 
Sbjct: 182 ADIWSLGITAIELAK---------------------GEPPNSDMHPMRVLFLIPKNNPPT 220

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           L G          +K     I +  + DPS RPTA E L+H F
Sbjct: 221 LTG--------EFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 90.1 bits (223), Expect = 8e-21
 Identities = 58/211 (27%), Positives = 115/211 (54%), Gaps = 13/211 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK----KKYYSWEECVNLREVKSLRK 56
           +  +++ K++G G F  V+RA      + VA+KK++        + ++CV  +E+  L++
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV--KEIDLLKQ 58

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLM---KDREKCFSEAEVRNWCFQVFQG 112
           ++HPN++K  +   E++ L  V E  +  +L Q++   K +++   E  V  +  Q+   
Sbjct: 59  LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVL 170
           + +MH R   HRD+KP N+ ++    +K+ D GL R  +S+       V T +Y +PE +
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPG 201
            ++  Y+ K D+W++G ++ E+  L+  F G
Sbjct: 179 HENG-YNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 14/213 (6%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---ECVNL-REVKSLRKMSHPNIV 63
           K +G G+FG V+ A  K + +  AIK +KK     +   EC  + + V SL    HP + 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-AWEHPFLT 59

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYMHQRGY 121
            L    +  + L+FV EY+  N   LM   + C  F       +  ++  GL ++H +G 
Sbjct: 60  HLYCTFQTKENLFFVMEYL--NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117

Query: 122 FHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLL-QSYLYSS 178
            +RDLK +N+L+  D  IKIADFG+ +E +        +  T  Y APE+LL Q Y  S 
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS- 176

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
            VD W+ G ++ E++  +  F G  E +    I
Sbjct: 177 -VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 92.1 bits (228), Expect = 2e-20
 Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 37/234 (15%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSH 59
           +  Y++IK++G+G FG V+    K++ E    K +  +     E   L  EV  +R++ H
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 60  PNIVKL--KEVIRENDILYFVFEYMECNLYQLMKDREKCF------SEAEVRNWCFQVFQ 111
            NIV+   + + + N  LY + E+  C+   L ++ +KC+       E  + +   Q+  
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEF--CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 112 GLAYMHQ-------RGYFHRDLKPENLLVS------------------KDTIKIADFGLA 146
            LAY H            HRDLKP+N+ +S                  +   KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 147 REINSRPPFTEYVSTRWYRAPEVLL-QSYLYSSKVDMWAMGAIMAELITLRPLF 199
           + I         V T +Y +PE+LL ++  Y  K DMWA+G I+ EL + +  F
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 90/329 (27%), Positives = 136/329 (41%), Gaps = 89/329 (27%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM----SHPNI 62
           IK +G G FG V     K +G + A+KK++K     +E V    V++ R +     +P +
Sbjct: 6   IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA--HVRAERDILAEADNPWV 63

Query: 63  VKLKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           VKL    ++ + LY + EY+     +  LMK  +  F+E E R +  +    +  +H+ G
Sbjct: 64  VKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 121 YFHRDLKPENLLV-SKDTIKIADFGL------------AREINSRPPFTEYVSTR----- 162
           Y HRD+KP+NLL+ +K  IK++DFGL             R ++   P             
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181

Query: 163 ------W----------------YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFP 200
                 W                Y APEV LQ+  Y+ + D W++G IM E++   P F 
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 201 GTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK----FPQLVGVPLSVLMPSANKDA 256
             +  +   KI                     IN+K    FP    VPLS        +A
Sbjct: 241 SDNPQETYRKI---------------------INWKETLQFPD--EVPLS-------PEA 270

Query: 257 VSLIASLCSWDPSKR---PTAAEALQHPF 282
             LI  LC  +  +R       E   HPF
Sbjct: 271 KDLIKRLCC-EAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 38/280 (13%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKE 67
           +G G+FG V +   + +  + A+K ++K +      V   L E   L +++ P IV LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 68  VIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLK 127
             +  + LY V  ++          RE  F  +  R +  ++   L  +H+    +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 128 PENLLVS-KDTIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKVDMWAM 185
           PEN+L+  +  I + DFGL +        T  +  T  Y APE+LL  + Y+  VD W +
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-GHGYTKAVDWWTL 179

Query: 186 GAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPL 245
           G ++ E++T  P F      +E+Y+   ++  P                 +FP       
Sbjct: 180 GVLLYEMLTGLPPFY-DENVNEMYR--KILQEP----------------LRFPDGF---- 216

Query: 246 SVLMPSANKDAVSLIASLCSWDPSKR---PTAAEALQHPF 282
                  ++DA  L+  L S DP++R     A E   HPF
Sbjct: 217 -------DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.7 bits (220), Expect = 3e-20
 Identities = 82/314 (26%), Positives = 132/314 (42%), Gaps = 75/314 (23%)

Query: 7   IKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++++G G FG V++A     +  +   +VA+K +K++  +  +    RE   + +  HPN
Sbjct: 10  VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 62  IVKLKEVIRENDILYFVFEYMEC-------------NLYQLMKDREKC---------FSE 99
           IVKL  V      +  +FEYM                   L                 S 
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 100 AEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPP 154
            E      QV  G+AY+ +R + HRDL   N LV ++  +KIADFGL+R I S    +  
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKIC 212
             + +  RW   PE +  +  Y+++ D+WA G ++ E+ +  ++P + G +  + IY + 
Sbjct: 190 ENDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYY-GMAHEEVIYYV- 245

Query: 213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSV--LMPSANKDAVSLIASLC-SWDPS 269
                       DG +L+       P     PL +  LM             LC S  PS
Sbjct: 246 -----------RDGNVLS------CPD--NCPLELYNLM------------RLCWSKLPS 274

Query: 270 KRPTAAE---ALQH 280
            RP+ A     LQ 
Sbjct: 275 DRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 3e-20
 Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 9/194 (4%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKE 67
           +++G G FG V++ + K + EV A+K  +       +   L+E + L++  HPNIVKL  
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 68  VIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
           V  +   +Y V E +   +L   ++ ++   +  ++         G+ Y+  +   HRDL
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119

Query: 127 KPENLLVS-KDTIKIADFGLARE----INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
              N LV   + +KI+DFG++RE    I +     + +  +W  APE  L    Y+S+ D
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEA-LNYGRYTSESD 177

Query: 182 MWAMGAIMAELITL 195
           +W+ G ++ E  +L
Sbjct: 178 VWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 52/297 (17%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK--------SLRKMS 58
           I+E+G G +G V +     +G ++A+K+++         VN +E K        S+R + 
Sbjct: 6   IEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT-------VNSQEQKRLLMDLDISMRSVD 58

Query: 59  HPNIVKL-KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVFQGLA 114
            P  V     + RE D+ +   E M+ +L +  K   D+     E  +      + + L 
Sbjct: 59  CPYTVTFYGALFREGDV-WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 115 YMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL-- 170
           Y+H +    HRD+KP N+L++++  +K+ DFG++  +      T     + Y APE +  
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP 177

Query: 171 -LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
            L    Y  K D+W++G  M EL T R  FP  S      ++  V+  P+          
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS---------- 225

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
                   PQL     S        +    +      +  +RP   E LQHPF  + 
Sbjct: 226 --------PQLPAEKFSP-------EFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 88.5 bits (219), Expect = 5e-20
 Identities = 80/273 (29%), Positives = 130/273 (47%), Gaps = 48/273 (17%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---ECVNL-REVKSLRKMSHPNIVKL 65
           +G G+FG V  A  K + E+ AIK +KK     +   EC  + + V +L+    P + +L
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP-PFLTQL 66

Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
               +  D LYFV EY+          +   F E +   +  ++  GL ++H+RG  +RD
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126

Query: 126 LKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQSYLYSS 178
           LK +N+++ S+  IKIADFG+ +E        + V+TR       Y APE++     Y  
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKE-----HMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGK 180

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
            VD WA G ++ E++  +P F G  E DE+++  S++                  N  +P
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQ--SIMEH----------------NVSYP 221

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR 271
           +           S +K+AVS+   L +  PSKR
Sbjct: 222 K-----------SLSKEAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (220), Expect = 5e-20
 Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 11/192 (5%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMSH---PNIVK 64
           +G GTFG V++   K +  + A+K + KK    ++ V   + E   L +      P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 65  LKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           LK   + +  LY V +YM      + L K+    FSE   + +  ++   L ++H+    
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 123 HRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKV 180
           +RDLKPEN+L+     I + DFGL++   +    T  +  T  Y APEVLL    Y+  V
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 181 DMWAMGAIMAEL 192
           D W++G ++ E+
Sbjct: 179 DFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 87.4 bits (216), Expect = 5e-20
 Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 21/211 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 62

Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 63  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121

Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY +        +W  APE  L
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKW-TAPEAAL 176

Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
               ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 177 YGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 87.6 bits (217), Expect = 6e-20
 Identities = 75/284 (26%), Positives = 128/284 (45%), Gaps = 43/284 (15%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK-MSHPNIVKLKEV 68
           +G GT+G V+ A    +   +AIK++ ++         L E  +L   + H NIV+    
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 69  IRENDILYFVFEYME----CNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
             EN    F   +ME     +L  L++ +      +E  +  +  Q+ +GL Y+H     
Sbjct: 74  DSENG---FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130

Query: 123 HRDLKPENLLVS--KDTIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYL-YSS 178
           HRD+K +N+LV+     +KI+DFG ++ +    P TE +  T  Y APEV+ +    Y +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
             D+W++G  + E+ T +P F               +G P    +  G+     I+ + P
Sbjct: 191 PADIWSLGCTIVEMATGKPPF-------------IELGEPQAAMFKVGMF---KIHPEIP 234

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +           S + +A + I      DP KR +A + LQ PF
Sbjct: 235 E-----------SLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.9 bits (215), Expect = 1e-19
 Identities = 72/265 (27%), Positives = 124/265 (46%), Gaps = 31/265 (11%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
             K+ K +G G FG V     K  G+    VAIK +K  Y   +    L E   + +  H
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64

Query: 60  PNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNI+ L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+  
Sbjct: 65  PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 119 RGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVST------RWYRAPEVLL 171
            GY HRDL   N+LV+ + + K++DFGL+R +   P    Y +       RW  APE  +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-AAYTTRGGKIPIRW-TAPEA-I 181

Query: 172 QSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ---- 220
               ++S  D+W+ G +M E+++   RP +  +++      +E Y++ + +  P      
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQL 241

Query: 221 --DSWADGLLLARAINYKFPQLVGV 243
             D W       R    KF Q+V +
Sbjct: 242 MLDCWQK----DRNERPKFEQIVSI 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 37/250 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYY--SWEECVNLREVKS 53
           +   + ++E+G+G FG V++        + S   VAIK +K+       +E    +E + 
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEF--RQEAEL 61

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYME-CNLYQLM------KDREKCFSEAEVRN-- 104
           +  + HPNIV L  V  +      +FEY+   +L++ +       D      +  V++  
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 105 WC-------FQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINS----R 152
            C        Q+  G+ Y+    + HRDL   N LV    T+KI+DFGL+R+I S    R
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181

Query: 153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYK 210
                 +  RW   PE +L    ++++ D+W+ G ++ E+ +  L+P + G S  + I  
Sbjct: 182 VQSKSLLPVRWM-PPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIEM 238

Query: 211 I--CSVIGTP 218
           I    ++  P
Sbjct: 239 IRSRQLLPCP 248

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKY--YSWEECVNLREVKSL 54
               + IK +G G FG+V++ +    GE     VAIK ++++    + +E   L E   +
Sbjct: 6   ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEI--LDEAYVM 63

Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
             + HP++V+L  +   + +   + + M    L   +++ +       + NWC Q+ +G+
Sbjct: 64  ASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122

Query: 114 AYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRA 166
           +Y+ ++   HRDL   N+LV +   +KI DFGLA+ ++      EY      V  +W  A
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKWM-A 179

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELIT 194
            E  +   +Y+ K D+W+ G  + EL+T
Sbjct: 180 LES-ILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.4 bits (211), Expect = 3e-19
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 13/207 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           +++  L + +G+G FG+V +   + +G+ VA+K +K    +      L E   + K+ H 
Sbjct: 5   LQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQ---AFLEETAVMTKLHHK 59

Query: 61  NIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCF-SEAEVRNWCFQVFQGLAYMHQ 118
           N+V+L  VI  N  LY V E M + NL   ++ R +   S  ++  +   V +G+ Y+  
Sbjct: 60  NLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118

Query: 119 RGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           +   HRDL   N+LVS+D + K++DFGLAR + S       +  +W  APE  L+   +S
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKW-TAPEA-LKHKKFS 175

Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTS 203
           SK D+W+ G ++ E+ +  R  +P  S
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.7 bits (212), Expect = 3e-19
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 17/206 (8%)

Query: 7   IKEV-GDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           I+EV G G FG V R   K  G+    VAIK +K  Y   +    L E   + +  HPNI
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 63  VKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           + L+ V+ ++  +  + E+ME   L   ++  +  F+  ++      +  G+ Y+ +  Y
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127

Query: 122 FHRDLKPENLLVSKDTI-KIADFGLAR---EINSRPPFTEY----VSTRWYRAPEVLLQS 173
            HRDL   N+LV+ + + K++DFGL+R   +  S P +T      +  RW  APE  +  
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEA-IAY 185

Query: 174 YLYSSKVDMWAMGAIMAELITL--RP 197
             ++S  D+W+ G +M E+++   RP
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.4 bits (211), Expect = 3e-19
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 12/196 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+  KL++ +G G FG V   +    G  VA+K +K    +      L E   + ++ H 
Sbjct: 5   MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHS 59

Query: 61  NIVKLKEVI-RENDILYFVFEYM-ECNLYQLMKDREKCFSEAE-VRNWCFQVFQGLAYMH 117
           N+V+L  VI  E   LY V EYM + +L   ++ R +     + +  +   V + + Y+ 
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119

Query: 118 QRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              + HRDL   N+LVS+D + K++DFGL +E +S    T  +  +W  APE L +   +
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALREK-KF 176

Query: 177 SSKVDMWAMGAIMAEL 192
           S+K D+W+ G ++ E+
Sbjct: 177 STKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.7 bits (209), Expect = 5e-19
 Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 21/211 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      + +V AIK +K      E    L+E + ++K+ H  
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPE--AFLQEAQIMKKLRHDK 62

Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V L  V+ E  I Y V E+M + +L   +K+ + K     ++ +   Q+  G+AY+ + 
Sbjct: 63  LVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LV  + + KIADFGLAR I       EY +        +W  APE  L
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIED----NEYTARQGAKFPIKW-TAPEAAL 176

Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
               ++ K D+W+ G ++ EL+T  R  +PG
Sbjct: 177 YGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.4 bits (211), Expect = 6e-19
 Identities = 56/224 (25%), Positives = 110/224 (49%), Gaps = 36/224 (16%)

Query: 6   LIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L K +G+G FG V +A    +  ++G   VA+K +K+   S E    L E   L++++HP
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63

Query: 61  NIVKLKEVIRENDILYFVFEY---------------MEC---------NLYQLMKDREKC 96
           +++KL     ++  L  + EY               +           N   L    E+ 
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 97  FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPF 155
            +  ++ ++ +Q+ +G+ Y+ +    HRDL   N+LV++    KI+DFGL+R++     +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 156 TE----YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            +     +  +W  A E L   ++Y+++ D+W+ G ++ E++TL
Sbjct: 184 VKRSKGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTL 225

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.7 bits (209), Expect = 6e-19
 Identities = 73/284 (25%), Positives = 135/284 (47%), Gaps = 35/284 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++++G G+FG V++ I  ++ +VVAIK +  +    E     +E+  L +   P 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           + K      ++  L+ + EY+   +   L++       E ++     ++ +GL Y+H   
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEK 121

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L+S+   +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y S
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDS 180

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           K D+W++G      IT   L  G     E++ +  +   P  +                P
Sbjct: 181 KADIWSLG------ITAIELAKGEPPHSELHPMKVLFLIPKNNP---------------P 219

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            L G        + +K     + +  + +PS RPTA E L+H F
Sbjct: 220 TLEG--------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 85.6 bits (212), Expect = 7e-19
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 9/213 (4%)

Query: 7   IKEVGDGTFGSVWRA---ISKQSGEVVAIKKMKKKYY--SWEECVNLR-EVKSLRKMSHP 60
           +K +G G +G V++        +G++ A+K +KK     + ++  + + E   L  + HP
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            IV L    +    LY + EY+      +  +RE  F E     +  ++   L ++HQ+G
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 121 YFHRDLKPEN-LLVSKDTIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSS 178
             +RDLKPEN LL ++  +K+ DFGL +E       T  +  T  Y APE+L++S  +  
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG-HGK 179

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
            VD W++GA+M +++T  P F   +    I KI
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 84.9 bits (210), Expect = 7e-19
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 12/209 (5%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPN 61
           ++  + +G G FG V     + +G++ A KK++KK       E + L E + L K++   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 62  IVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           +V L       D L  V   M     + ++Y +       F E     +  ++  GL  +
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDL 118

Query: 117 HQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H+    +RDLKPEN+L+     I+I+D GLA EI         V T  Y APEV +++  
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV-VKNER 177

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSE 204
           Y+   D W +G ++ E+I  +  F    E
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 84.6 bits (209), Expect = 7e-19
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSH---PNIVK 64
           +G G FG V+      +G++ A+K + KK    +  E + L E   L  +S    P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
           +       D L F+ + M          +   FSEAE+R +  ++  GL +MH R   +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 125 DLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMW 183
           DLKP N+L+ +   ++I+D GLA + + + P    V T  Y APEVL +   Y S  D +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWF 180

Query: 184 AMGAIMAELITLRPLFP 200
           ++G ++ +L  LR   P
Sbjct: 181 SLGCMLFKL--LRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 39/289 (13%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL---RKMSHPNIVKLK 66
           +G G++  V     K++  + A+K +KK+  + +E ++  + +     +  +HP +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 67  EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
              +    L+FV EY+          R++   E   R +  ++   L Y+H+RG  +RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 127 KPENLLV-SKDTIKIADFGLAREINSRPPFT--EYVSTRWYRAPEVLLQSYLYSSKVDMW 183
           K +N+L+ S+  IK+ D+G+ +E   RP  T   +  T  Y APE+ L+   Y   VD W
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEI-LRGEDYGFSVDWW 180

Query: 184 AMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS--WADGLLLARAINYKFPQLV 241
           A+G +M E++  R  F     +D           P Q++  +   ++L + I  + P+ +
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYLFQVILEKQI--RIPRSL 228

Query: 242 GVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTA--AEALQHPFSR 284
            V            A S++ S  + DP +R    P    A+   HPF R
Sbjct: 229 SV-----------KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 84.2 bits (208), Expect = 1e-18
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 6/200 (3%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKE 67
           +G G FG V     K +G++ A KK+ KK    +  E + L E + L K++ P IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 68  VIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                  L  V   M      Y +    E+      V ++  Q+  G+ ++H     +RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 126 LKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWA 184
           +KPEN+L+  +   +++D GLA E+      T+   T  Y APE+L +   YS  VD +A
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE-PYSYPVDWFA 179

Query: 185 MGAIMAELITLRPLFPGTSE 204
           MG  + E++  R  F    E
Sbjct: 180 MGCSIYEMVAGRTPFKDHKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 10/222 (4%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---ECVNLREVKSLRKMSHPNIVK 64
           K +G G+FG V  A  K  GE  A+K +KK     +   EC  + +        +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 65  LKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L    +  + L+FV E++   +L   ++D+ + F       +  ++  GL ++H +G  +
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIY 119

Query: 124 RDLKPENLLVSKD-TIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           RDLK +N+++ +D  IKIADFG+ +E +      + +  T  Y APE+ LQ   Y+  VD
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI-LQGLKYTFSVD 178

Query: 182 MWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW 223
            W+ G ++ E++  +  F G  E DE+++   V  TP    W
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTPHYPRW 218

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 7/194 (3%)

Query: 7   IKEVGDGTFGSVW---RAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNI 62
           +K +G G+FG V+   +     +G++ A+K +KK      + V  + E   L +++HP I
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           VKL    +    LY + +++          +E  F+E +V+ +  ++   L ++H  G  
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 123 HRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
           +RDLKPEN+L+ ++  IK+ DFGL++E I+       +  T  Y APEV +    ++   
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRGHTQSA 179

Query: 181 DMWAMGAIMAELIT 194
           D W+ G +M E++T
Sbjct: 180 DWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.0 bits (205), Expect = 2e-18
 Identities = 66/291 (22%), Positives = 126/291 (43%), Gaps = 52/291 (17%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKM----------KKKYYSWEECVNLREVKSLRKMSH 59
           +G G +G+V+  ++ Q G+++A+K++          +K+Y   +E     EV  L+ + H
Sbjct: 8   LGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQE-----EVDLLKSLKH 61

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIV+      +++ +    E++       + +R     E     +  Q+  G+AY+H  
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 120 GYFHRDLKPEN-LLVSKDTIKIADFGLAREI------NSRPPFTEYV-STRWYRAPEVLL 171
              HRD+K  N +L+    IK+ DFG AR +       +     + +  T ++ APEV+ 
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
           +S  Y  K D+W++G  + E+ T +P          ++ I +  G               
Sbjct: 182 ESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--------------- 225

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                        +  L  S +  A+  + S  + D  +RP+A + L+H F
Sbjct: 226 ------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 7/190 (3%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSH---PNIVK 64
           +G G FG V+      +G++ A+K + KK    +  E + L E   L  +S    P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
           +       D L F+ + M          +   FSE E+R +  ++  GL +MH R   +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 125 DLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMW 183
           DLKP N+L+ +   ++I+D GLA + + + P    V T  Y APEVL +   Y S  D +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWF 180

Query: 184 AMGAIMAELI 193
           ++G ++ +L+
Sbjct: 181 SLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 29/210 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK-----KMKKKYYS---WEECVNLREVKS 53
           E + +IK +G G FG V     K S +V A+K     +M K+  S   WEE    R++  
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE----RDI-- 96

Query: 54  LRKMSHPN---IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQV 109
              M+H N   IV+L    +++  LY V EYM   +L  LM + +    E   R +  +V
Sbjct: 97  ---MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEV 151

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPF--TEYVSTRWYRA 166
              L  +H  G+ HRD+KP+N+L+ K   +K+ADFG   ++++         V T  Y +
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYIS 211

Query: 167 PEVLL---QSYLYSSKVDMWAMGAIMAELI 193
           PEVL        Y  + D W++G  + E++
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 82.7 bits (204), Expect = 5e-18
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 33/237 (13%)

Query: 2   ERYKLIKEVGDGTFGSVW------------RAISKQSGE--VVAIKKMKKKYYSWEECVN 47
           ++ +L +++G+G FG V                 +  G+  +VA+K ++           
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 48  LREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDRE-----------K 95
           L+E+K + ++ +PNI++L  V   +D L  + EYME  +L Q +  RE            
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 96  CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS--- 151
             S A +     Q+  G+ Y+    + HRDL   N LV    TIKIADFG++R + S   
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 152 -RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE 207
            R      +  RW     +LL  +  +S  D+WA G  + E+ TL    P +  +DE
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTAS--DVWAFGVTLWEMFTLCKEQPYSLLSDE 239

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 82.7 bits (204), Expect = 7e-18
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 21/219 (9%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREV-KSLRKMSH--P 60
           +  +  +G G+FG V  A  K + E+ AIK +KK     ++ V    V K +  +S   P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 61  NIVKLKEVIRENDILYFVFEYMECN--LYQL-----MKDREKCFSEAEVRNWCFQVFQGL 113
            + +L    +  D LYFV EY+     +YQ+      K+    F  AE+         GL
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIA-------IGL 114

Query: 114 AYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLL 171
            ++H +G  +RDLK +N+++ S+  IKIADFG+ +E +        +  T  Y APE++ 
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
               Y   VD WA G ++ E++  +  F G  E DE+++
Sbjct: 175 YQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 35/284 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++ +G G+FG V++ I  ++ EVVAIK +  +    E     +E+  L +   P 
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I +      +   L+ + EY+   +   L+K       E  +     ++ +GL Y+H   
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSER 121

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L+S+   +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y  
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDF 180

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           K D+W++G    EL    P                    P  D     +L     N   P
Sbjct: 181 KADIWSLGITAIELAKGEP--------------------PNSDLHPMRVLFLIPKNSP-P 219

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            L G          +K     + +  + DP  RPTA E L+H F
Sbjct: 220 TLEG--------QYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 20/225 (8%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISK-QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
                 K +G G FG V  A    +SK  +   VA+K +K   +S E    + E+K +  
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 57  M-SHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQVFQ 111
           + +H NIV L         +  + EY  C     L  L + RE   +  ++ ++ +QV +
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEY--CCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152

Query: 112 GLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW---YRAP 167
           G+A++  +   HRDL   N+L++   I KI DFGLAR+I +   +    + R    + AP
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYK 210
           E +    +Y+ + D+W+ G ++ E+ +L   P +PG     + YK
Sbjct: 213 ESIFNC-VYTFESDVWSYGILLWEIFSLGSNP-YPGMPVDSKFYK 255

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 84/340 (24%), Positives = 135/340 (39%), Gaps = 96/340 (28%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLRE----VKSLRKM-- 57
           +  IK +G G FG V       +  + A+K ++K        V +R     VK+ R +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD------VLMRNQAAHVKAERDILA 56

Query: 58  --SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
              +  +VKL    ++ D LYFV +Y+       +  R   F E   R +  ++   +  
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116

Query: 116 MHQRGYFHRDLKPENLLVSKDT-IKIADFGL------------------AREINSRPPFT 156
           +H+ G+ HRD+KP+N+L+ +D  IK+ DFGL                   R+ +S  P  
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ-DSMEPSE 175

Query: 157 EY---------------------------VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIM 189
           E+                           V T  Y APEVLL++  Y+   D W++G I+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL 234

Query: 190 AELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLM 249
            E++  +P F     AD          TP +          + IN++    + +P     
Sbjct: 235 YEMLVGQPPF----LAD----------TPAETQL-------KVINWE--TTLHIP----- 266

Query: 250 PSAN--KDAVSLIASLCSWDPSKR---PTAAEALQHPFSR 284
             A   ++A  LI  LC      R     A E   HPF +
Sbjct: 267 SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 37/291 (12%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPN 61
           ++  + +G G FG V     + +G++ A K+++KK       E + L E + L K++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 62  IVKLKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V L       D L  V   M      + +       F E     +  ++  GL  +H+ 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 120 GYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              +RDLKPEN+L+     I+I+D GLA +I         V T  Y APEV L +  Y+ 
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEV-LNNQRYTL 180

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
             D W +G ++ E+I  +  F G  E  +  ++   +   T++ ++           KF 
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV-LETEEVYSA----------KF- 228

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPFSR 284
                         +++A S+   L + DP +R       A E  +HPF R
Sbjct: 229 --------------SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.3 bits (195), Expect = 4e-17
 Identities = 74/296 (25%), Positives = 127/296 (42%), Gaps = 55/296 (18%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMK--------KKYYSWEECVNLREVKSLRKMSH 59
           K +G G FG V+      +G  +A K+++         K  S  EC    E++ L+ + H
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQH 63

Query: 60  PNIVKLKEVIREN--DILYFVFEYMECNLYQLMKDREKCF---SEAEVRNWCFQVFQGLA 114
             IV+    +R+     L    EYM       +KD+ K +   +E+  R +  Q+ +G++
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGS---VKDQLKAYGALTESVTRKYTRQILEGMS 120

Query: 115 YMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREIN----SRPPFTEYVSTRWYRAPEV 169
           Y+H     HRD+K  N+L  S   +K+ DFG ++ +     S         T ++ +PEV
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
            +    Y  K D+W++G  + E++T +P +        I+KI +    PT          
Sbjct: 181 -ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN--------- 227

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
                   PQL         PS   +           +   RP+A E L+HPF+++
Sbjct: 228 --------PQL---------PSHISEHARDFLGCIFVEARHRPSAEELLRHPFAQL 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 71/240 (29%), Positives = 121/240 (50%), Gaps = 33/240 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSL 54
           +R  L K +G+G FG V RA    I K   +    VA+K +K      +    + E++ +
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 55  RKMS-HPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           + +  H NI+ L  V  +   LY + EY  + NL + ++ R               E+  
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  R   HRDL   N+LV++D + KIADFGLAR ++    + 
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL   P +PG    +E++K+
Sbjct: 192 KTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSP-YPGIP-VEELFKL 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 16/201 (7%)

Query: 25  QSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSHPNIVKL-KEVIRENDILYFVFEY 81
            +G  VAIK ++      E       RE     ++ HPNIV L         +L+ VFEY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 82  MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI--- 138
           +     + +   +      E      QV   LA  H +G  HRDLKP+N++VS+  +   
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 139 -KIADFGL------AREINSR--PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIM 189
            K+ DFG+       R+ +       TE + T  Y APE  L+    +   D++A G I 
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIF 179

Query: 190 AELITLRPLFPGTSEADEIYK 210
            E +T + +  G S A+ +Y+
Sbjct: 180 LECLTGQRVVQGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.4 bits (201), Expect = 6e-17
 Identities = 63/233 (27%), Positives = 98/233 (42%), Gaps = 36/233 (15%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           M+RY +I+ +G G  G V+ A        VA+KK+++            LRE K    + 
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFS------EAEVRNWCFQVF- 110
           HP IV +  +  + D +Y+   Y+E   L  L+K   +  S      E         +F 
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 111 ---QGLAYMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFT---------- 156
                + Y+H +G  HRDLKP+N+L+     + I D+G A                    
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 157 ---------EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFP 200
                    + V T  Y APE LL     S   D++A+G I+ +++TL   FP
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLS--FP 230

Length = 932

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 79.4 bits (196), Expect = 7e-17
 Identities = 79/301 (26%), Positives = 135/301 (44%), Gaps = 56/301 (18%)

Query: 4   YKLIKEVGDGTFGSVW---RAISKQSGEVVAIKKMKK-----KYYSWEECVNLREV-KSL 54
           ++L++ +G G +G V+   +     +G++ A+K +KK     K  + E     R+V +++
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEY-----MECNLYQLMKDREKCFSEAEVRNWCFQV 109
           R    P +V L    + +  L+ + +Y     +  +LYQ    RE  F+E+EVR +  ++
Sbjct: 62  R--RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REH-FTESEVRVYIAEI 114

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREI--NSRPPFTEYVSTRWYRA 166
              L ++HQ G  +RD+K EN+L+  +  + + DFGL++E           +  T  Y A
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 167 PEVLLQ-SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
           PEV+   S  +   VD W++G +  EL+T    F    E               Q+S ++
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE---------------QNSQSE 219

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKR---PTAAEALQHP 281
              ++R I    P           P   + +A   I  L   DP KR     A E   HP
Sbjct: 220 ---ISRRILKSKPP---------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267

Query: 282 F 282
           F
Sbjct: 268 F 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 27/209 (12%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-PNI 62
           ++L++ VG+GT+G V++    ++G++ AIK M       EE     E+  L+K SH  NI
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK--LEINMLKKYSHHRNI 75

Query: 63  VKL------KEVIRENDILYFVFEYMEC-NLYQLMKD-REKCFSEAEVRNWCFQVFQGLA 114
                    K     +D L+ V E+    ++  L+K+ +     E  +   C ++ +GLA
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFG----LAREINSRPPFTEYVSTRWYRAPEV 169
           ++H     HRD+K +N+L++++  +K+ DFG    L R +  R  F   + T ++ APEV
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---IGTPYWMAPEV 192

Query: 170 LL------QSYLYSSKVDMWAMGAIMAEL 192
           +        +Y Y S  D+W++G    E+
Sbjct: 193 IACDENPDATYDYRS--DIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 82/297 (27%), Positives = 142/297 (47%), Gaps = 46/297 (15%)

Query: 4   YKLIKEVGDGTFGSVW--RAIS-KQSGEVVAIKKMKK-----KYYSWEECVNLREVKSLR 55
           ++L+K +G G +G V+  R +S   SG++ A+K +KK     K  + E     R+V    
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           + S P +V L    + +  L+ + +Y+    L+  +  RE+ F E EV+ +  ++   L 
Sbjct: 62  RQS-PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALE 119

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEY--VSTRWYRAPEVLL 171
           ++H+ G  +RD+K EN+L+  +  + + DFGL++E +       Y    T  Y AP+++ 
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179

Query: 172 QSYLYSSK-VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
                  K VD W+MG +M EL+T     P T + ++             +S A+   ++
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGAS--PFTVDGEK-------------NSQAE---IS 221

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAAEAL-QHPF 282
           R I    P     P    M +  KD   +I  L   DP KR    P+ A+ + +HPF
Sbjct: 222 RRILKSEP-----PYPQEMSALAKD---IIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 55/168 (32%), Positives = 82/168 (48%), Gaps = 26/168 (15%)

Query: 48  LREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDRE----------KC 96
           L+EVK L ++S PNI +L  V   +  L  + EYME  +L Q ++             K 
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 97  FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLARE------- 148
            S + +     Q+  G+ Y+    + HRDL   N LV K+ TIKIADFG++R        
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 149 -INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            +  R P    +  RW     VLL    +++K D+WA G  + E++TL
Sbjct: 187 RVQGRAP----LPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILTL 228

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 16/195 (8%)

Query: 8   KEVGDGTFGSVWRAI--SKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMSHPNI 62
            E+G G FG+V + +   K+S + VA+K +K    + +  +    LRE   ++++ +P I
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDNPYI 58

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           V++   I E +    V E  E         + K  +E  +     QV  G+ Y+ +  + 
Sbjct: 59  VRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117

Query: 123 HRDLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST-----RWYRAPEVLLQSYLY 176
           HRDL   N LLV++   KI+DFGL++ + +   + +  +      +WY APE  +  Y +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APEC-MNYYKF 175

Query: 177 SSKVDMWAMGAIMAE 191
           SSK D+W+ G +M E
Sbjct: 176 SSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.2 bits (192), Expect = 1e-16
 Identities = 61/212 (28%), Positives = 110/212 (51%), Gaps = 23/212 (10%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-PNI 62
           ++L++ VG+GT+G V++    ++G++ AIK M       EE    +E+  L+K SH  NI
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK--QEINMLKKYSHHRNI 65

Query: 63  VKL-KEVIREN-----DILYFVFEYMEC-NLYQLMKD-REKCFSEAEVRNWCFQVFQGLA 114
                  I++N     D L+ V E+    ++  L+K+ +     E  +   C ++ +GL+
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFG----LAREINSRPPFTEYVSTRWYRAPEV 169
           ++HQ    HRD+K +N+L++++  +K+ DFG    L R +  R  F   + T ++ APEV
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---IGTPYWMAPEV 182

Query: 170 LL----QSYLYSSKVDMWAMGAIMAELITLRP 197
           +         Y  K D+W++G    E+    P
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 55/299 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--------KKKYYSWEECVNLREVKS 53
             ++L K +G G FG V+      +G  +A+K++          K  +  EC    E++ 
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EIQL 57

Query: 54  LRKMSHPNIVKLKEVIR--ENDILYFVFEYMECNLYQLMKDREKCF---SEAEVRNWCFQ 108
           L+ + H  IV+    +R  E   L    EYM       +KD+ K +   +E   R +  Q
Sbjct: 58  LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS---IKDQLKAYGALTENVTRRYTRQ 114

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREIN----SRPPFTEYVSTRW 163
           + QG++Y+H     HRD+K  N+L  S   +K+ DFG ++ I     S         T +
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW 223
           + +PEV+     Y  K D+W++   + E++T +P +        I+KI +    PT+   
Sbjct: 175 WMSPEVI-SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK--- 227

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                         P L         P    DA          +  +RPTA   L+HPF
Sbjct: 228 --------------PML---------PDGVSDACRDFLKQIFVEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 79/289 (27%), Positives = 131/289 (45%), Gaps = 38/289 (13%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH--PNI 62
           + + E+G GT G V++   K++G V+A+K+M++     E    L ++  + K SH  P I
Sbjct: 18  ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYI 76

Query: 63  VK-LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-G 120
           VK     I ++D+     E M   L +L+K  +    E  +      + + L Y+ ++ G
Sbjct: 77  VKCYGYFITDSDVF-ICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLA-REINSRPPFTEYVSTRWYRAPEVLLQSYL--- 175
             HRD+KP N+L+     +K+ DFG++ R ++S+   T       Y APE +        
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-TRSAGCAAYMAPERIDPPDPNPK 194

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y  + D+W++G  + EL T    FP        YK C            +  +L + +  
Sbjct: 195 YDIRADVWSLGISLVELAT--GQFP--------YKNCK----------TEFEVLTKILQE 234

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR 284
           + P L   P +      + D  S +    + D  KRP   E LQHPF R
Sbjct: 235 EPPSL---PPNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 72/263 (27%), Positives = 115/263 (43%), Gaps = 41/263 (15%)

Query: 50  EVKSLRKMSHPNIVKLKEVIRENDILYFVFEY-----MECNLYQLMKDREKCFSEAEVRN 104
           E+  L    H  IVK  +  + +D L  + EY     +   + Q +K+    F E EV  
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP-FQEYEVGL 173

Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENL-LVSKDTIKIADFGLAREINSRPPF---TEYVS 160
             +Q+   L  +H R   HRDLK  N+ L+    IK+ DFG +++ +        + +  
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
           T +Y APE L +   YS K DMW++G I+ EL+TL   F G S+ + + ++      P  
Sbjct: 234 TPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-- 290

Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                           FP     P+S  M        +L+  L S +P+ RPT  + L  
Sbjct: 291 ----------------FP----CPVSSGMK-------ALLDPLLSKNPALRPTTQQLLHT 323

Query: 281 PFSR-VAFMFHHLSVPEQLLQEH 302
            F + VA +F  +    + +  H
Sbjct: 324 EFLKYVANLFQDIVRHSETISPH 346

Length = 478

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 47/297 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHP 60
           ++Y + + +G G  G+V  A     GE  A+K +  +  S  +    + EV  L      
Sbjct: 32  KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFF 91

Query: 61  NIVKLKEVIREND--------ILYFVFEYMEC-NLYQLMKDREKC---FSEAEVRNWCFQ 108
           +IVK  E   + D        ++  V +Y    +L Q +K R K    F E E      Q
Sbjct: 92  SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 109 VFQGLAYMHQRGYFHRDLKPEN-LLVSKDTIKIADFGLAREIN---SRPPFTEYVSTRWY 164
           V   + ++H +   HRD+K  N LL S   +K+ DFG ++      S      +  T +Y
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
            APE+  +   YS K DM+++G ++ EL+TL+  F G +  + ++K  +    P      
Sbjct: 212 VAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP------ 264

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                                  L PS + +   ++ +L S DP +RP++++ L  P
Sbjct: 265 -----------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 35/226 (15%)

Query: 7   IKEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNL---REVKSLRKMS 58
           I  +G G FG V+ A +K   E     +V +K ++K     +E +     RE+   RK+S
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLS 66

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLM--------KDREKCFSEAEVRNWCFQV 109
           H N+V+L  + RE +  Y + EY +  +L Q +        K +    S  +    C Q+
Sbjct: 67  HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY-------VST 161
             G+ ++    + HRDL   N LVS    +K++   L++++ +     EY       +  
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS----EYYKLRNALIPL 182

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE 207
           RW  APE + +   +S+K D+W+ G +M E+ T   L P    +DE
Sbjct: 183 RWL-APEAVQED-DFSTKSDVWSFGVLMWEVFTQGEL-PFYGLSDE 225

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 52/195 (26%), Positives = 98/195 (50%), Gaps = 6/195 (3%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL---RKMSHPNIVKLK 66
           +G G++  V     K++ ++ A+K +KK+    +E ++  + +     +  S+P +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 67  EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
              +    L+ V EY+          R++   E   R +  ++   L ++H+RG  +RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 127 KPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWA 184
           K +N+L+  D  IK+ D+G+ +E +      + +  T  Y APE+ L+   Y   VD WA
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI-LRGEEYGFSVDWWA 181

Query: 185 MGAIMAELITLRPLF 199
           +G +M E++  R  F
Sbjct: 182 LGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 66/240 (27%), Positives = 119/240 (49%), Gaps = 33/240 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               ++  
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +QV +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR++N+   + 
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194

Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL   P +PG    +E++K+
Sbjct: 195 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSP-YPGIP-VEELFKL 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 69/240 (28%), Positives = 121/240 (50%), Gaps = 33/240 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +     ++   V  +  KM K   + ++  +L     + 
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77

Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR-----EKCF---------- 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R     E C+          
Sbjct: 78  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137

Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL   P +PG    +E++K+
Sbjct: 198 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSP-YPGVP-VEELFKL 254

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 34/249 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK-KYYSWEECVNLREVKSLRKMSHP 60
           +R+K++  +G+GTFG V  A  ++  E  A+K ++    Y+ +  + ++ ++ +R+    
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188

Query: 61  NIVKLKEVIR--ENDILYFVF---EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           +   L ++ R  +N+  +      +Y  C L  +MK     FS   +    FQ    L Y
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDY 246

Query: 116 MHQRGYF-HRDLKPENLLV-SKDT----------------IKIADF-GLAREINSRPPFT 156
            H   +  H DLKPEN+L+ + DT                ++I D  G   E +SR   T
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR---T 303

Query: 157 EYVSTRWYRAPEVLLQ-SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI 215
             VSTR YR+PEV+L   ++YS+  DMW+MG I+ EL T + L+      + ++ +   +
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361

Query: 216 GTPTQDSWA 224
           G    + WA
Sbjct: 362 GRLPSE-WA 369

Length = 467

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.9 bits (189), Expect = 5e-16
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 18/176 (10%)

Query: 48  LREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDRE----------KC 96
           L+E+K + ++  PNI++L  V   +D L  + EYME  +L Q +   E            
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 97  FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS---- 151
            S + +     Q+  G+ Y+    + HRDL   N LV K+ TIKIADFG++R + S    
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE 207
           R      +  RW     +LL  +  +S  D+WA G  + E++TL    P +  +DE
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTAS--DVWAFGVTLWEILTLCKEQPYSQLSDE 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 66/238 (27%), Positives = 118/238 (49%), Gaps = 31/238 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           R  L K +G+G FG V  A +      K +  V    KM K   + ++  +L     + K
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72

Query: 57  M--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCFS 98
           M   H NI+ L     ++  LY + EY  + NL + ++ R               E+  +
Sbjct: 73  MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 99  EAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTE 157
             ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR++++   + +
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKI 211
             + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 193 TTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKL 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 7/202 (3%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSG-EVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           E +  I+ +G G+FG V  A  K      VAIK+ +K     ++ V+    E K L  ++
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP  V L    ++   LY V E++    +     R K F       +  Q+     Y+  
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
               +RDLKPENLL+ KD  IK+ DFG A+ +++R        T  Y APE+LL +  + 
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--YTLCGTPEYIAPEILL-NVGHG 206

Query: 178 SKVDMWAMGAIMAELITLRPLF 199
              D W +G  + E++   P F
Sbjct: 207 KAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 9/222 (4%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           ++ I E+G G  G V++   K SG ++A K +  +         +RE++ L + + P IV
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 64  KLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GY 121
                   +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++   
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKI 125

Query: 122 FHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYSVQ 182

Query: 180 VDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQ 220
            D+W+MG  + E+   R P+ P  ++  E+   C V G P +
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 26/233 (11%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK--------KKYYSWEECVNLREVKSLR 55
           ++L K +G G FG V+      +G  +A+K+++         K  +  EC    E++ L+
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC----EIQLLK 59

Query: 56  KMSHPNIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCF---SEAEVRNWCFQVF 110
            + H  IV+    +R+     L    E+M       +KD+ K +   +E   R +  Q+ 
Sbjct: 60  NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGS---IKDQLKSYGALTENVTRKYTRQIL 116

Query: 111 QGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREIN----SRPPFTEYVSTRWYR 165
           +G++Y+H     HRD+K  N+L  S   +K+ DFG ++ +     S         T ++ 
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           +PEV +    Y  K D+W++G  + E++T +P +        I+KI +    P
Sbjct: 177 SPEV-ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 228

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 8e-16
 Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 45/298 (15%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIK--------KMKKKYYSWEECVNLREVKSLRK 56
           + I ++G G  GSV +     +G V+A K         ++K+         LRE++ + +
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--------LRELQIMHE 59

Query: 57  MSHPNIVKL-KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
              P IV      + EN+I     E+M+C     +  +        +      V +GL Y
Sbjct: 60  CRSPYIVSFYGAFLNENNIC-MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118

Query: 116 MHQRGYF-HRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQ 172
           ++      HRD+KP N+LV S+  IK+ DFG++ E INS      +V T  Y +PE  +Q
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPE-RIQ 175

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y+ K D+W++G  + EL   +  F  ++  D+        G        D  LL + 
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD--------GQDDPMGILD--LLQQI 225

Query: 233 INYKFPQLVGVPLSVLMPSAN--KDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM 288
           +    P+L         PS++  +D    + +    DP++RPT  +    P    A  
Sbjct: 226 VQEPPPRL---------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 76.2 bits (187), Expect = 8e-16
 Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 53/301 (17%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HP 60
           + +++I+ +G GT+G V++ ++K++G   A+K +   +   EE     E   L+ +S HP
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE--AEYNILKALSDHP 75

Query: 61  NIVKL-----KEVIRENDILYFVFEYMECN------LYQLMKDREKCFSEAEVRNWCFQV 109
           N+VK      K+ ++  D L+ V E   CN      L +    R +   E  +     + 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLEL--CNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 110 FQGLAYMHQRGYFHRDLKPEN-LLVSKDTIKIADFGLAREI-NSRPPFTEYVSTRWYRAP 167
             GL ++H     HRD+K  N LL ++  +K+ DFG++ ++ ++R      V T ++ AP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193

Query: 168 EVL-----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS 222
           EV+     L S  Y ++ D+W++G    EL    P                    P  D 
Sbjct: 194 EVIACEQQLDS-TYDARCDVWSLGITAIELGDGDP--------------------PLAD- 231

Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKRPTAAEALQHP 281
               L   RA+ +K P+    P ++  P   + +    I    + D  KRPT ++ LQH 
Sbjct: 232 ----LHPMRAL-FKIPR--NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284

Query: 282 F 282
           F
Sbjct: 285 F 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 14/226 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V +   K SG ++A K +  +         +RE++ L + + P 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K+ ++   E  +      V +GLAY+ ++ 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREKH 123

Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYS 180

Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDS 222
            + D+W+MG  + EL   R P+ P  ++  E     ++ G P  D 
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDAKELE-----AIFGRPVVDG 221

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 76.8 bits (189), Expect = 8e-16
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 8/196 (4%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSL--RKMSHPNIVKLK 66
           +G G++  V     K++  + A+K +KK+  + +E ++ ++  K +     +HP +V L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 67  EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
              +    L+FV E++          R++   E   R +  ++   L ++H+RG  +RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 127 KPENLLVSKDT-IKIADFGLAREINSRPPFT--EYVSTRWYRAPEVLLQSYLYSSKVDMW 183
           K +N+L+  +  IK+ D+G+ +E   RP  T   +  T  Y APE+ L+   Y   VD W
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEI-LRGEDYGFSVDWW 180

Query: 184 AMGAIMAELITLRPLF 199
           A+G +M E++  R  F
Sbjct: 181 ALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 75.4 bits (185), Expect = 9e-16
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 10/195 (5%)

Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKE 67
           + +G G FG V+    +     VA+K  ++      +   L+E + L++ SHPNIV+L  
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 68  VIRENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
           V  +   +Y V E ++   +   ++         E+         G+ Y+  +   HRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 127 KPENLLVS-KDTIKIADFGLARE----INSRPPFTEYVSTRWYRAPEVLLQSY-LYSSKV 180
              N LV+ K+ +KI+DFG++RE    + +     + +  +W  APE L  +Y  YSS+ 
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL--NYGRYSSES 177

Query: 181 DMWAMGAIMAELITL 195
           D+W+ G ++ E  +L
Sbjct: 178 DVWSFGILLWEAFSL 192

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNI 62
           +++I+ +G GT+G V++  +K+ G + A+K +       EE     E   L+ +  HPN+
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE--AEYNILQSLPNHPNV 81

Query: 63  VKLKEVIREND-----ILYFVFEYMECN---LYQLMKDREKC---FSEAEVRNWCFQVFQ 111
           VK   +  + D      L+ V E   CN   + +L+K    C     EA +    +    
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLEL--CNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 112 GLAYMHQRGYFHRDLKPEN-LLVSKDTIKIADFGLAREINS-RPPFTEYVSTRWYRAPEV 169
           GL ++H     HRD+K  N LL ++  +K+ DFG++ ++ S R      V T ++ APEV
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199

Query: 170 LL--QSYLYS--SKVDMWAMGAIMAEL 192
           +   Q Y YS  ++ D+W++G    EL
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK--------KYYSWEECVNLREVKS 53
           E Y+++K +G G FG V     K + +V A+K + K          + WEE    R++ +
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 98

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQG 112
               + P +V+L    +++  LY V EYM   +L  LM + +    E   R +  +V   
Sbjct: 99  F--ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLA 154

Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPF--TEYVSTRWYRAPEV 169
           L  +H  G+ HRD+KP+N+L+ K   +K+ADFG   ++N          V T  Y +PEV
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214

Query: 170 LLQS---YLYSSKVDMWAMGAIMAELI 193
           L        Y  + D W++G  + E++
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 14/220 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRAI-SKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           E   L + +G+G FG V++ +      E   VA+K  K           L+E   +R+  
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 59  HPNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HP+IVKL  VI EN + + V E      L   ++  +     A +  + +Q+   LAY+ 
Sbjct: 66  HPHIVKLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQS 173
            + + HRD+   N+LV S D +K+ DFGL+R +     +         +W  APE  +  
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-APES-INF 182

Query: 174 YLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
             ++S  D+W  G  M E++ L  +P F G    D I +I
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNNDVIGRI 221

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 11/207 (5%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKE 67
           +G G FG V     + +G++ A KK+ KK     +     + E + L K+    IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 68  VIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
             +    L  V   M       ++Y + ++    F E     +  Q+  GL ++HQR   
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRII 119

Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKV 180
           +RDLKPEN+L+  D  ++I+D GLA E+      T+ Y  T  + APE LLQ   Y   V
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE-LLQGEEYDFSV 178

Query: 181 DMWAMGAIMAELITLRPLFPGTSEADE 207
           D +A+G  + E+I  R  F    E  E
Sbjct: 179 DYFALGVTLYEMIAARGPFRARGEKVE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 6/195 (3%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPN 61
           ++  + +G G FG V     + +G++ A KK++KK       E + L E + L K++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 62  IVKLKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V L       D L  V   M      + +    E  F E     +  ++  GL  +HQ 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 120 GYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              +RDLKPEN+L+     I+I+D GLA  +         V T  Y APEV +++  Y+ 
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV-VKNERYTF 180

Query: 179 KVDMWAMGAIMAELI 193
             D WA+G ++ E+I
Sbjct: 181 SPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 4   YKLIKEVGDGTFGSVW---RAISKQSGEVVAIKKMKK-----KYYSWEECVNLREVKSLR 55
           ++L+K +G G +G V+   +     +G++ A+K ++K     K  + E     R V    
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEY-----MECNLYQLMKDREKCFSEAEVRNWCFQVF 110
           + S P +V L    +    L+ + +Y     M  +LYQ        FSE EVR +  ++ 
Sbjct: 62  RQS-PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEII 115

Query: 111 QGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY--VSTRWYRAP 167
             L ++H+ G  +RD+K EN+L+ S+  + + DFGL++E  S      Y    T  Y AP
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELIT 194
           E++     +   VD W++G ++ EL+T
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 73.5 bits (180), Expect = 4e-15
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 12/193 (6%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G FG V++   K    V A+K  K+      +   L E + L++  HPNIVKL  V 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 70  RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
            +   +Y V E +   +    ++ ++      ++  +      G+AY+  +   HRDL  
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121

Query: 129 ENLLVSKDTI-KIADFGLARE----INSRPPFTEYVSTRWYRAPEVLLQSY-LYSSKVDM 182
            N LV ++ + KI+DFG++R+    I S     + +  +W  APE L  +Y  YSS+ D+
Sbjct: 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-IPIKW-TAPEAL--NYGRYSSESDV 177

Query: 183 WAMGAIMAELITL 195
           W+ G ++ E  +L
Sbjct: 178 WSYGILLWETFSL 190

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 5e-15
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 45/290 (15%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           + E+G G +GSV++ + + +G  +A+K+++ +    +    + E+  L K   P IV   
Sbjct: 6   LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 67  EVIRENDILYFVFEYMEC----NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM-HQRGY 121
                   +Y   EYM+      LY      E    E  +R   + V +GL ++  +   
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG-IPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 122 FHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL-----LQSYL 175
            HRD+KP N+LV     +K+ DFG++  + +    T  +  + Y APE +      Q+  
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERIKSGGPNQNPT 183

Query: 176 YSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVI--GTPTQDSWADGLLLARA 232
           Y+ + D+W++G  + E+   R P  P T     I+   S I  G P              
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSAIVDGDPPT------------ 229

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                          L    + DA   +A   +  P++RPT A+ L+HP+
Sbjct: 230 ---------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 40/235 (17%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKK-YYSWEECVNLR-EVKSLRKMSHPN 61
           ++ +K +G G FG V     K +G + A+K ++K      E+  ++R E   L +     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +VK+    ++   LY + E++       +  ++   SE   + +  +    +  +HQ G+
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 122 FHRDLKPENLLV-SKDTIKIADFGLA------------REINSRPP----FTEYVSTR-- 162
            HRD+KP+NLL+ +K  +K++DFGL             R +   PP    F    S R  
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 163 --W----------------YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF 199
             W                Y APEV +Q+  Y+   D W++G IM E++   P F
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.6 bits (181), Expect = 8e-15
 Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 34/301 (11%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           + E+G G  G V + + + SG ++A K +  +         +RE+K L + + P IV   
Sbjct: 6   LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFY 65

Query: 67  EVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHR 124
                +  +    E+M+  +L Q++K +     E  +      V +GL Y+ +     HR
Sbjct: 66  GAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124

Query: 125 DLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           D+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   Y+ + D+
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYTVQSDI 181

Query: 183 WAMGAIMAELIT------------LRPLFP---GTSEADEIYKICSVIGTPTQDSWADGL 227
           W++G  + E+              L  +F       EA E ++  S     +    A   
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFE 241

Query: 228 LLARAINYKFPQLVGVPLSVLMPSA--NKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
           LL   +N   P+L         PS   + +    +      +P +R    E  +HPF + 
Sbjct: 242 LLDYIVNEPPPKL---------PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Query: 286 A 286
           A
Sbjct: 293 A 293

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 15/202 (7%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVV----AIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K +K +G G FG+V++ I    GE V    AIK + +          + E   +  M HP
Sbjct: 10  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++V+L  V     I           L   + + +       + NWC Q+ +G+ Y+ +R 
Sbjct: 70  HLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129

Query: 121 YFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQS 173
             HRDL   N+LV S + +KI DFGLAR +       EY      +  +W     +  + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE--KEYNADGGKMPIKWMALECIHYRK 187

Query: 174 YLYSSKVDMWAMGAIMAELITL 195
           + + S  D+W+ G  + EL+T 
Sbjct: 188 FTHQS--DVWSYGVTIWELMTF 207

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 57/216 (26%), Positives = 110/216 (50%), Gaps = 34/216 (15%)

Query: 6   LIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L +E+G+G FG V+ A       +Q   +VA+K +K    +  +  + RE + L  + H 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQHE 67

Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMK------------DREKCFSEAEVRNWCF 107
           +IVK   V  E D L  VFEYM+  +L + ++            +R    +++++ +   
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY-------- 158
           Q+  G+ Y+  + + HRDL   N LV ++  +KI DFG++R++ S    T+Y        
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS----TDYYRVGGHTM 183

Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           +  RW     ++ +   ++++ D+W++G ++ E+ T
Sbjct: 184 LPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 19/205 (9%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 60  PNIVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           P++ +L  +   + +   + + M   C L  + + ++   S+  + NWC Q+ +G+ Y+ 
Sbjct: 69  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQ-YLLNWCVQIAKGMNYLE 126

Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVL 170
           +R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE--KEYHAEGGKVPIKWMALESIL 184

Query: 171 LQSYLYSSKVDMWAMGAIMAELITL 195
            + Y + S  D+W+ G  + EL+T 
Sbjct: 185 HRIYTHQS--DVWSYGVTVWELMTF 207

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 25/208 (12%)

Query: 10  VGDGTFGSVWRAISKQSG-EVVAIKKMKKKYYSWEECVNLR-EVKSLRKMS-HPNIVKLK 66
           +G+G FG V RA+ K+ G ++ A  KM K++ S  +  +   E++ L K+  HPNI+ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 67  EVIRENDILYFVFEYMEC-NLYQLMKD-----------RE----KCFSEAEVRNWCFQVF 110
                   LY   EY    NL   ++            +E       +  ++  +   V 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAR--EINSRPPFTEYVSTRWYRAP 167
            G+ Y+ ++ + HRDL   N+LV ++   KIADFGL+R  E+  +      +  RW  A 
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGR-LPVRWM-AI 187

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITL 195
           E L  S +Y++K D+W+ G ++ E+++L
Sbjct: 188 ESLNYS-VYTTKSDVWSFGVLLWEIVSL 214

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 71.3 bits (174), Expect = 3e-14
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 25/208 (12%)

Query: 10  VGDGTFGSVWRAISKQSG-EVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSH-PNIVKLK 66
           +G+G FG V +A  K+ G  + A  K  K+Y S ++  +   E++ L K+ H PNI+ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 67  EVIRENDILYFVFEYMEC-NLYQLMKD-----------RE----KCFSEAEVRNWCFQVF 110
                   LY   EY    NL   ++                     S  ++ ++   V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR--EINSRPPFTEYVSTRWYRAP 167
           +G+ Y+ Q+ + HRDL   N+LV ++   KIADFGL+R  E+  +      +  RW  A 
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVRWM-AI 180

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITL 195
           E L  S +Y++  D+W+ G ++ E+++L
Sbjct: 181 ESLNYS-VYTTNSDVWSYGVLLWEIVSL 207

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK--------KYYSWEECVNLREVKS 53
           E Y ++K +G G FG V     K S +V A+K + K          + WEE    R++ +
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 98

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQG 112
               + P +V+L    +++  LY V EYM   +L  LM + +    E   + +  +V   
Sbjct: 99  F--ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLA 154

Query: 113 LAYMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPF--TEYVSTRWYRAPEV 169
           L  +H  G  HRD+KP+N+L+ K   +K+ADFG   +++          V T  Y +PEV
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 170 LLQS---YLYSSKVDMWAMGAIMAELI 193
           L        Y  + D W++G  + E++
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 12/163 (7%)

Query: 50  EVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEA----EVRNW 105
           E+ +L +++H NI+K++E++R     Y + +  + +LY  M D    + +     + R  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272

Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEY--VST 161
             Q+   + Y+H +   HRD+K EN+ ++ D  I + DFG A      R  F +Y  V T
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGT 331

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGT 202
               +PE+L     Y    D+W+ G I+ ++++    P+  G 
Sbjct: 332 VATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGG 373

Length = 501

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 54/214 (25%), Positives = 105/214 (49%), Gaps = 22/214 (10%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  I+K     +    VAIK + +     E    L E   +++
Sbjct: 6   EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E    +A     ++    
Sbjct: 66  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE----YVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I     + +     +  
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 186 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 217

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 71.0 bits (174), Expect = 4e-14
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 18/199 (9%)

Query: 10  VGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+      S       A+K + +     E    L+E   ++  SHPN++ L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 67  EVIRENDIL-YFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            +   ++     V  YM+  +L   ++      +  ++  +  QV +G+ Y+  + + HR
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122

Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEV--------LLQSYL 175
           DL   N +L    T+K+ADFGLAR+I  +    EY S   +   ++         LQ+  
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYDK----EYYSVHNHTGAKLPVKWMALESLQTQK 178

Query: 176 YSSKVDMWAMGAIMAELIT 194
           +++K D+W+ G ++ EL+T
Sbjct: 179 FTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 41/307 (13%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
             + K   D     + +   K +  +VA+KK+     S E+   L +E+ + R++ HPNI
Sbjct: 4   TLIGKCFEDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 63  VKLKEVIRENDILYFVFEYME---CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQ 118
           +        +  LY V   M    C    L+K        E  +      V   L Y+H 
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCE--DLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREI-----NSRPPF---TEYVSTRWYRAPEV 169
           +G+ HR +K  ++L+S D  + ++    +  +       R         V    + +PEV
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179

Query: 170 LLQSYL-YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           L Q+   Y+ K D++++G    EL      F     A ++  +  V GT          L
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDM-PATQML-LEKVRGTVPC-------L 230

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIAS------------LC-SWDPSKRPTAA 275
           L ++    +   +    S      N+D+V    +            LC   DP  RP+A+
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290

Query: 276 EALQHPF 282
           + L H F
Sbjct: 291 QLLNHSF 297

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 5e-14
 Identities = 78/336 (23%), Positives = 134/336 (39%), Gaps = 80/336 (23%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM-KKKYYSWEECVNLR-EVKSLRKMSH 59
           E +  +K +G G FG V     K +G++ A+K + K + +  ++  +++ E   L +   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P +V L    ++   LY + E++       M  +   FSE   R +  +    +  +H+ 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 120 GYFHRDLKPENLLVSKDT-IKIADFGLA-----------------REINSRPPFTE---- 157
           G+ HRD+KP+N+L+ +   IK++DFGL+                  + N           
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 158 ------YVSTR-----WYR----------------APEVLLQSYLYSSKVDMWAMGAIMA 190
                  +S++     W +                APE+ LQ   Y  + D W++GAIM 
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMF 239

Query: 191 ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMP 250
           E +   P F   +  +   KI          +W + L         FP    + LSV   
Sbjct: 240 ECLIGWPPFCSENSHETYRKII---------NWRETL--------YFPD--DIHLSV--- 277

Query: 251 SANKDAVSLIASLCSWDPSK--RPTAAEALQHPFSR 284
               +A  LI  L +   ++  R  A E   HPF R
Sbjct: 278 ----EAEDLIRRLITNAENRLGRGGAHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 25/227 (11%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           KL K +G+G FGSV      Q       VA+K MK   +++ E    L E   ++   HP
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61

Query: 61  NIVKLKEV-IRENDILYF-----VFEYMECN------LYQLMKDREKCFSEAEVRNWCFQ 108
           N++KL  V    + +        +  +M+        LY  +    +      +  +   
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRW 163
           +  G+ Y+  R + HRDL   N ++ +D T+ +ADFGL+++I S    R      +  +W
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIY 209
             A E L    +Y+SK D+WA G  M E+ T  +  +PG  E  EIY
Sbjct: 182 I-AIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIY 225

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 40/237 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK-KYYSWEECVNLR-EVKSLRKMSH 59
           E ++ +K +G G FG V     K +G V A+K ++K      E+  ++R E   L +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
             +VK+    ++   LY + E++       +  ++   +E E + +  +    +  +HQ 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLA------------REINSRPP--FT-------- 156
           G+ HRD+KP+NLL+ SK  +K++DFGL             R +N   P  FT        
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 157 --------------EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF 199
                           V T  Y APEV +Q+  Y+   D W++G IM E++   P F
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 36/215 (16%)

Query: 9   EVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           E+G+G FG V+ A     + +Q   +VA+K +K+   S  +    RE + L  + H +IV
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTVLQHQHIV 70

Query: 64  KLKEVIRENDILYFVFEYME-CNLYQLMKDR---EKCFSEAE-----------VRNWCFQ 108
           +   V  E   L  VFEYM   +L + ++      K  +  E           +     Q
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY--------V 159
           +  G+ Y+    + HRDL   N LV +   +KI DFG++R+I S    T+Y        +
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTML 186

Query: 160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             RW     +L +   ++++ D+W+ G ++ E+ T
Sbjct: 187 PIRWMPPESILYRK--FTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.3 bits (172), Expect = 8e-14
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 31/231 (13%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQ---SGEVVAIKKMKKKYYS---WEECVNLREVKSLRKM 57
           + L + +G G FGSV  A  K    S + VA+K +K   +S    EE   LRE   +++ 
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEF--LREAACMKEF 58

Query: 58  SHPNIVKLKEV-IREND---------ILYFVFEYMECNLYQLMK---DREKCFSEAEVRN 104
            HPN++KL  V +R            IL F+ ++ + + + LM    +         +  
Sbjct: 59  DHPNVIKLIGVSLRSRAKGRLPIPMVILPFM-KHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYV 159
           +   +  G+ Y+  + + HRDL   N +++++ T+ +ADFGL+++I S    R      +
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIY 209
             +W  A E L  + +Y++  D+WA G  M E++T  +  + G  E  EIY
Sbjct: 178 PVKWL-ALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIY 225

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 30/218 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQ--SGEV---VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+   ++    GE    VA+K + +     E    L E   ++ 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSE-----AEVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 66  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY------- 158
            ++  G+AY++ + + HRDL   N +V+ D T+KI DFG+ R+I      T+Y       
Sbjct: 126 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE----TDYYRKGGKG 181

Query: 159 -VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            +  RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 182 LLPVRWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 217

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 6   LIKEVGDGTFGSVWRA-ISKQSGEV----VAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L++ +G G FG V+      + G+     VA+K + +     +E   L E   + K +H 
Sbjct: 10  LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMK------DREKCFSEAEVRNWCFQVFQGL 113
           NIV+L  V  E    + + E M   +L   ++      +R    +  ++      V +G 
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 114 AYMHQRGYFHRDLKPENLLVS----KDTIKIADFGLAREINSRPPFTEY--------VST 161
            Y+ +  + HRD+   N L++        KIADFG+AR+I        Y        +  
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR----ASYYRKGGRAMLPI 185

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           +W   PE  L   +++SK D+W+ G ++ E+ +L
Sbjct: 186 KWM-PPEAFLDG-IFTSKTDVWSFGVLLWEIFSL 217

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 89/324 (27%), Positives = 130/324 (40%), Gaps = 92/324 (28%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E ++ IK + +G +G+V+    K++ +  A+KK+ K+        NL     LR      
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ--------NL----ILRN----- 43

Query: 62  IVKLKEVIRENDILYF---------------------VFEYMEC-NLYQLMKDREKCFSE 99
             ++++V  E DIL F                     V EY+E  +   L+K+      +
Sbjct: 44  --QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD 101

Query: 100 AEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAR----------- 147
              R +  +    L Y+H  G  HRDLKP+NLL+ S   IK+ DFGL++           
Sbjct: 102 M-ARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160

Query: 148 ----EINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAE-LITLRPLFPG 201
               E ++R    + V  T  Y APEV+L+   Y   VD WAMG I+ E L+   P F  
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGD 219

Query: 202 TSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIA 261
           T E      I   I  P  D                     +P          DA  LI+
Sbjct: 220 TPEELFGQVISDDIEWPEGDE-------------------ALPA---------DAQDLIS 251

Query: 262 SLCSWDPSKR---PTAAEALQHPF 282
            L   +P +R     A E  QH F
Sbjct: 252 RLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 80/334 (23%), Positives = 135/334 (40%), Gaps = 90/334 (26%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR-------KMSH 59
           IK +G G FG V  A    +  + A+K ++KK     + +N  +V  ++       +  +
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKK-----DVLNRNQVAHVKAERDILAEADN 60

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
             +VKL    ++ D LYFV +Y+       +  R + F E   R +  ++   +  +H+ 
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120

Query: 120 GYFHRDLKPENLLVSKDT-IKIADFGL--------------------------------- 145
           G+ HRD+KP+N+L+  D  IK+ DFGL                                 
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 146 ---------------AREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMA 190
                          A + + R      V T  Y APEVLL+   Y+   D W++G I+ 
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILF 239

Query: 191 ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMP 250
           E++  +P F              +  TPT+          + IN++    + +P  V + 
Sbjct: 240 EMLVGQPPF--------------LAPTPTETQ-------LKVINWE--NTLHIPPQVKL- 275

Query: 251 SANKDAVSLIASLC--SWDPSKRPTAAEALQHPF 282
             + +AV LI  LC  + +   R  A +   HPF
Sbjct: 276 --SPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 12/192 (6%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKE 67
           +G G FG V     + +G++ A KK++KK       E + L E + L K++   +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 68  VIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
                D L  V   M     + ++Y +       F E     +  ++  GL  + +    
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 123 HRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           +RDLKPEN+L+  +  I+I+D GLA +I         V T  Y APEV + +  Y+   D
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV-INNEKYTFSPD 183

Query: 182 MWAMGAIMAELI 193
            W +G ++ E+I
Sbjct: 184 WWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 26/184 (14%)

Query: 48  LREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMK-----DREKCFSEAE 101
           L+EVK L ++  PNI++L  V  + D L  + EYME  +L Q +      D+E+  ++A 
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 102 VRNWCF-------------QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR 147
               C              Q+  G+ Y+    + HRDL   N LV ++ TIKIADFG++R
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 148 EINS----RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS 203
            + +    R      +  RW     +L+  +  +S  D+WA G  + E++ L    P   
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS--DVWAFGVTLWEILMLCKEQPYGE 244

Query: 204 EADE 207
             DE
Sbjct: 245 LTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 18/163 (11%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-------LREVKS 53
           +E + ++K +  G FG V+    K + ++ A+K +KK      + +N         E  +
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA-----DMINKNMVHQVQAERDA 57

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           L     P IV L   ++  + +Y V EY+     + +      F E     +  +V   L
Sbjct: 58  LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALAL 117

Query: 114 AYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLA-----REIN 150
            Y+H+ G  HRDLKP+N+L+S +  IK+ DFGL+     RE+N
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN 160

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 19/204 (9%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K +K +G G FG+V++ I    GE     VAIK +++          L E   +  +  P
Sbjct: 10  KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69

Query: 61  NIVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            + +L  +   + +   V + M   C L  + +++++  S+ ++ NWC Q+ +G++Y+ +
Sbjct: 70  YVCRLLGICLTSTV-QLVTQLMPYGCLLDYVRENKDRIGSQ-DLLNWCVQIAKGMSYLEE 127

Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
               HRDL   N+LV S + +KI DFGLAR ++     TEY      V  +W     +L 
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE--TEYHADGGKVPIKWMALESILH 185

Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + + + S  D+W+ G  + EL+T 
Sbjct: 186 RRFTHQS--DVWSYGVTVWELMTF 207

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.0 bits (167), Expect = 4e-13
 Identities = 44/140 (31%), Positives = 74/140 (52%), Gaps = 10/140 (7%)

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +PN +KL   +        + +Y++  +L+ L+K +E   SEAEV+    Q+ + L  +H
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 118 QRGYFHRDLKPENLL--VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL-QSY 174
           +    H D+K EN+L   +KD I + D+GL + I +    + Y  T  Y +PE +   +Y
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNY 183

Query: 175 LYSSKVDMWAMGAIMAELIT 194
             S   D WA+G +  EL+T
Sbjct: 184 DVS--FDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 27/209 (12%)

Query: 10  VGDGTFGSVWRAISKQSGEVV--AIKKMKKKYYSWEECVNLR-EVKSLRKMS-HPNIVKL 65
           +G+G FG V +A  K+ G  +  AIK+MK+ Y S ++  +   E++ L K+  HPNI+ L
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 66  KEVIRENDILYFVFEYM-ECNLYQLMKDRE---------------KCFSEAEVRNWCFQV 109
                    LY   EY    NL   ++                     S  ++ ++   V
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAR--EINSRPPFTEYVSTRWYRA 166
            +G+ Y+ Q+ + HRDL   N+LV ++ + KIADFGL+R  E+  +      +  RW  A
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVRWM-A 191

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            E L  S +Y++  D+W+ G ++ E+++L
Sbjct: 192 IESLNYS-VYTTNSDVWSYGVLLWEIVSL 219

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 29/215 (13%)

Query: 6   LIKEVGDGTFGSVWRA----ISKQSGE-VVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L +E+G+G FG V+ A    +S    + +VA+K +K    +  +    RE + L  + H 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTNLQHE 67

Query: 61  NIVKLKEVIRENDILYFVFEYM---ECNLY--------QLMKDREKCFSEAEV-----RN 104
           +IVK   V  + D L  VFEYM   + N +         ++ D +   ++ E+      +
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT----EYV 159
              Q+  G+ Y+  + + HRDL   N LV  +  +KI DFG++R++ S   +       +
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             RW     ++ +   ++++ D+W+ G I+ E+ T
Sbjct: 188 PIRWMPPESIMYRK--FTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 5/146 (3%)

Query: 50  EVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQV 109
           E + LR++SHP ++ L +V     +   V      +LY  +  R +    A+V     Q+
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQL 269

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFG---LAREINSRPPFTEYVSTRWYR 165
              + Y+H  G  HRD+K EN+LV+  + I + DFG    AR   S P       T    
Sbjct: 270 LSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAE 191
           APEVL     Y+  VD+W+ G ++ E
Sbjct: 330 APEVLAGD-PYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 67.3 bits (164), Expect = 6e-13
 Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 12/192 (6%)

Query: 9   EVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           E+G G FG V + + K   +   VAIK +K +         +RE + + ++ +P IV++ 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 67  EVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
            V  E + L  V E      L + +  ++   + + V     QV  G+ Y+  + + HRD
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120

Query: 126 LKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST-----RWYRAPEVLLQSYLYSSK 179
           L   N LLV++   KI+DFGL++ + +   + +  S      +WY APE +     +SS+
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY-APECIN-FRKFSSR 178

Query: 180 VDMWAMGAIMAE 191
            D+W+ G  M E
Sbjct: 179 SDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 67.3 bits (164), Expect = 7e-13
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 10/202 (4%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           K+ + +G G FG + R   K   +    VAI  ++      +    L E  +L +  H N
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67

Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV+L+ VI   + +  V EYM    L   ++  E      ++      +  G+ Y+ + G
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 121 YFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEY--VSTRWYRAPEVLLQSYLYS 177
           Y H+ L    +LV+ D + KI+ F   +E  S   +T     S   + APE  +Q + +S
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA-IQYHHFS 186

Query: 178 SKVDMWAMGAIMAELITL--RP 197
           S  D+W+ G +M E+++   RP
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-----ECVNLREVKS-LR 55
           + ++++K +G G FG V     K +G+V A+K + K    WE     E    RE +  L 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK----WEMLKRAETACFREERDVLV 56

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEY-MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
                 I  L    ++ + LY V +Y +  +L  L+   E    E   R +  ++   + 
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVS--TRWYRAPEVLL 171
            +HQ GY HRD+KP+N+L+ K+  I++ADFG    + +       V+  T  Y +PE+ L
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI-L 175

Query: 172 QSY-----LYSSKVDMWAMGAIMAELI 193
           Q+       Y  + D W++G  M E++
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 24/225 (10%)

Query: 6   LIKEVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNI 62
           L K +G+G FGSV      Q   +  VA+K MK    +  E  + L E   +++  HPN+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 63  VKLKEVIREND------ILYFVFEYMECN------LYQLMKDREKCFSEAEVRNWCFQVF 110
           ++L  V  +            +  +M+        LY  + D  +      +  +   + 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRWYR 165
            G+ Y+  + + HRDL   N +++++  + +ADFGL+++I +    R      +  +W  
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIY 209
                L   +Y++K D+W+ G  M E+ T  +  +PG  E  EIY
Sbjct: 183 IES--LADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 38/183 (20%)

Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW 163
           + FQV +G+ ++  R   HRDL   N+L+S  + +KI DFGLAR+I   P +      R 
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 164 ---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPT 219
              + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C  +   T
Sbjct: 244 PLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGT 299

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEA 277
           +          RA +Y  P++    L                    W  +PS+RPT +E 
Sbjct: 300 R---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQRPTFSEL 332

Query: 278 LQH 280
           ++H
Sbjct: 333 VEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 54/223 (24%), Positives = 106/223 (47%), Gaps = 30/223 (13%)

Query: 5   KLIKEVGDGTFGSVWRA----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           + ++E+G+  FG +++           ++VAIK +K      +     +E   + ++ HP
Sbjct: 8   RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67

Query: 61  NIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREK-----CFSE-----------AEVR 103
           NIV L  V+ +   +  +FEY+ + +L++ +  R       C S+            +  
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 104 NWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINS----RPPFTEY 158
           +   Q+  G+ Y+    + H+DL   N+L+ +   +KI+D GL+REI S    R      
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLF 199
           +  RW   PE ++    +SS  D+W+ G ++ E+ +  L+P +
Sbjct: 188 LPIRWM-PPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 73/291 (25%), Positives = 119/291 (40%), Gaps = 51/291 (17%)

Query: 8   KEVGDGTFGSVW--RAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL 65
            E+G+G FG V    A    S   V +K+++      E+ + L+EV+  R+++HPN+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 66  KEVIRENDILYFVFEYMECNLYQLM----KDREKCFSEAEVR---NWCFQVFQGLAYMHQ 118
                E+     V E+  C L  L      +R      A+         +V  GL ++HQ
Sbjct: 61  LGQCIESIPYLLVLEF--CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT----EYVSTRWYRAPEVL--L 171
             + H DL   N  ++ D ++KI D+GLA E      +       V  RW  APE++   
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIR 177

Query: 172 QSYLYSSKV----DMWAMGAIMAELITL--RPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
              L         ++W++G  M EL T   +P +P  S+   + ++              
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQV-------------- 222

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE 276
             +  + I    PQL  +  S        D    +   C  DP  RPTA E
Sbjct: 223 --VREQDIKLPKPQL-DLKYS--------DRWYEVMQFCWLDPETRPTAEE 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 39/288 (13%)

Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-PNIVKLKE 67
           E+G G FG+V + + K SG ++A+K+++      E+   L ++  + + S  P IVK   
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 68  VI-RENDILYFVFEYMEC---NLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQR-GY 121
            + RE D  +   E M+      Y+ + +  K    E  +        + L Y+ +    
Sbjct: 71  ALFREGDC-WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI 129

Query: 122 FHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL--YSS 178
            HRD+KP N+L+     IK+ DFG++ ++      T     R Y APE +  S    Y  
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDV 189

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVI-GTPTQDSWADGLLLARAINYK 236
           + D+W++G  + E+ T +  FP   + + ++ ++  V+ G P                  
Sbjct: 190 RSDVWSLGITLYEVATGK--FP-YPKWNSVFDQLTQVVKGDP------------------ 228

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR 284
            P L          S     V+ I      D SKRP   E L+HPF +
Sbjct: 229 -PIL--SNSEEREFS--PSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 36/181 (19%)

Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRW 163
           + FQV +G+ ++  R   HRDL   N+L+S+ + +KI DFGLAR+I   P +    S R 
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 164 ---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKICSVIGTP 218
              + APE +    +Y+++ D+W+ G ++ E+ +L   P +PG    +E  +        
Sbjct: 239 PLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASP-YPGVQINEEFCQ-------- 288

Query: 219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL 278
                 DG  + RA     P++  + L+                    DP +RPT +  +
Sbjct: 289 ---RLKDGTRM-RAPENATPEIYRIMLACW----------------QGDPKERPTFSALV 328

Query: 279 Q 279
           +
Sbjct: 329 E 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-----ECVNLREVKS-LR 55
           + +++IK +G G FG V     K +  + A+K + K    WE     E    RE ++ L 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK----WEMLKRAETACFREERNVLV 56

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEY-MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
                 I  L    ++ + LY V +Y +  +L  L+   E    E   R +  ++   + 
Sbjct: 57  NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVS--TRWYRAPEVL- 170
            +HQ  Y HRD+KP+N+L+  +  I++ADFG   ++N        V+  T  Y +PE+L 
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 171 -LQSYL--YSSKVDMWAMGAIMAELI 193
            ++  +  Y  + D W++G  M E++
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-----ECVNLREVKS-LR 55
           E ++++K +G G FG V     K + +V A+K + K    WE     E    RE +  L 
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK----WEMLKRAETACFREERDVLV 56

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEY-MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
              +  I  L    ++ + LY V +Y +  +L  L+   E    E   R +  ++   + 
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREI--NSRPPFTEYVSTRWYRAPEVLL 171
            +HQ  Y HRD+KP+N+L+  +  I++ADFG   ++  +     +  V T  Y +PE+L 
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 172 Q----SYLYSSKVDMWAMGAIMAELI 193
                   Y  + D W++G  M E++
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 47/200 (23%), Positives = 91/200 (45%), Gaps = 13/200 (6%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK----SLRKMSHP 60
           + +K +G G FG+V + I    G+ + I    K           +E+     ++  + H 
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 61  NIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            IV+L   I     L  V +     +L   ++          + NWC Q+ +G+ Y+ + 
Sbjct: 70  YIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREI---NSRPPFTEY-VSTRWYRAPEVLLQSY 174
              HR+L   N+L+  D+I +IADFG+A  +   + +  ++E+    +W     +L   Y
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 175 LYSSKVDMWAMGAIMAELIT 194
            + S  D+W+ G  + E+++
Sbjct: 189 THQS--DVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 32/95 (33%), Positives = 55/95 (57%), Gaps = 5/95 (5%)

Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW 163
           + FQV +G+ ++  R   HRDL   N+L+S  + +KI DFGLAR+I   P +      R 
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 164 ---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
              + APE +    +Y+++ D+W+ G ++ E+ +L
Sbjct: 238 PLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSL 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 7/156 (4%)

Query: 49  REVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQ 108
           RE+  L+ +SH  I+ L    R    +  V    +C+L+  + DR       +      +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRR 193

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINS---RPPFTEYVSTRWY 164
           + + LAY+H RG  HRD+K EN+ + + +   + DFG A ++++    P    +  T   
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAE-LITLRPLF 199
            +PE LL    Y +K D+W+ G ++ E  +    LF
Sbjct: 254 NSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 81/314 (25%), Positives = 132/314 (42%), Gaps = 46/314 (14%)

Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM----SHPNI 62
           IK +G G FG V  A    +  + A+K ++KK       V    VK+ R +     +  +
Sbjct: 6   IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQV--AHVKAERDILAEADNEWV 63

Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           V+L    ++ D LYFV +Y+       +  R   F E   R +  ++   +  +H+ G+ 
Sbjct: 64  VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123

Query: 123 HRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           HRD+KP+N+L+ +D  IK+ DFGL         F     +++Y++ + + Q  +  S  +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLC------TGFRWTHDSKYYQSGDHVRQDSMDFS--N 175

Query: 182 MWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP-------------TQ--DSWADG 226
            W   A       L+PL    +   +     S++GTP             TQ  D W+ G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 227 LLLARAINYKFPQLVGVPLSVLM-----------PSANK---DAVSLIASLCSW--DPSK 270
           ++L   +  + P L   PL   M           P   K   +A  LI  LC    D   
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLG 295

Query: 271 RPTAAEALQHPFSR 284
           +  A E   HPF +
Sbjct: 296 KNGADEIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 48/284 (16%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIK--------KMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +G G  G+V++A    +  ++A+K        +++K+  S        E++ L K   P 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS--------ELEILYKCDSPY 60

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I+         + +    E+M+        D  +   E  +      V +GL Y+     
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKI 116

Query: 122 FHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            HRD+KP N+LV ++  +K+ DFG++ + +NS      YV T  Y APE +     Y   
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMAPERISGEQ-YGIH 173

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYK-ICSVIGTPTQDSWADGLLLARAINYKFP 238
            D+W++G    EL   R  +P      +I K   S++  P Q       LL   ++   P
Sbjct: 174 SDVWSLGISFMELALGRFPYP------QIQKNQGSLM--PLQ-------LLQCIVDEDPP 218

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            L   P+           V  I       P +RP     + HPF
Sbjct: 219 VL---PVGQFSEK----FVHFITQCMRKQPKERPAPENLMDHPF 255

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRK 56
           +R  L   + +GTFG ++  I    K   E     K  K + S E  V   L+E   L  
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-EIQVTLLLQESCLLYG 64

Query: 57  MSHPNIVKLKEV-IRENDILYFVFEYMEC-NLYQLMK-------DREKCFSEAEVRNWCF 107
           +SH NI+ +  V I + +  + ++ YM   NL   ++       +  +  S  ++ +   
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF---------TE 157
           Q+  G++Y+H+RG  H+D+   N ++ ++  +KI D  L+R++     F          E
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL-----FPMDYHCLGDNE 179

Query: 158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
               +W  A E L+    YSS  D+W+ G ++ EL+TL
Sbjct: 180 NRPVKWM-ALESLVNK-EYSSASDVWSFGVLLWELMTL 215

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 20/198 (10%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           + +++    G  G  +  I  ++ E V IK  ++   + E  +       LR ++HP+I+
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHI-------LRAINHPSII 146

Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDREK---CFSEAEVRNWCFQVFQGLAYMHQRG 120
           +LK     N     +    + +LY  +  +     C   A  R+    V + + Y+H+  
Sbjct: 147 QLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERS----VLRAIQYLHENR 202

Query: 121 YFHRDLKPENLLVSK-DTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
             HRD+K EN+ ++    + + DFG A    +IN+   +  +  T    APE+L +   Y
Sbjct: 203 IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARD-PY 260

Query: 177 SSKVDMWAMGAIMAELIT 194
              VD+W+ G ++ E+ T
Sbjct: 261 GPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 35/117 (29%), Positives = 60/117 (51%), Gaps = 20/117 (17%)

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREI----------NSRPPF 155
            QV QG+ ++  +   HRD+   N+L++     KI DFGLAR+I          N+R P 
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP- 277

Query: 156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
                 +W  APE +    +Y+ + D+W+ G ++ E+ +L +  +PG     + YK+
Sbjct: 278 -----VKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 34/129 (26%), Positives = 71/129 (55%), Gaps = 6/129 (4%)

Query: 88  QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLA 146
           +++++ E      ++ ++ +QV +G++++  +   HRDL   N+L++   I KI DFGLA
Sbjct: 202 EILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261

Query: 147 REINSRPPFTEYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGT 202
           R+I +   +    + R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG 
Sbjct: 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGM 320

Query: 203 SEADEIYKI 211
               + YK+
Sbjct: 321 PVDSKFYKM 329

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 25/209 (11%)

Query: 8   KEVGDGTFGSVW--RAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL 65
           KE+G+G FG V      S  +   V +K+++      E+   L E +  R + H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAE--------VRNWCFQVFQGLAYMH 117
                E      V E+  C L  L      C  +AE        ++    ++  GL ++H
Sbjct: 61  LGQCTEVTPYLLVMEF--CPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEIALGLLHLH 117

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLA----REINSRPPFTEYVSTRWYRAPEVL-- 170
           +  + H DL   N L++ D T+KI D+GL+    +E     P   +V  RW  APE++  
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVDE 176

Query: 171 LQSYLY----SSKVDMWAMGAIMAELITL 195
           +   L     + + ++W++G  + EL  L
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFEL 205

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 8/119 (6%)

Query: 89  LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAR 147
           L  D  +  +  ++ ++ +QV +G+ ++  +   HRDL   N+L+++  I KI DFGLAR
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285

Query: 148 EI----NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
           +I    N     + ++  +W  APE +  + LY++  D+W+ G ++ E+ +L    +PG
Sbjct: 286 DIMHDSNYVSKGSTFLPVKWM-APESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 7/94 (7%)

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVST---- 161
           +QV  G+ ++  +   HRDL   N+L+ +   +KI DFGLAR+I     +    ST    
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           +W  APE +  + LY++  D+W+ G ++ E+ TL
Sbjct: 306 KWM-APESIFNN-LYTTLSDVWSFGILLWEIFTL 337

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 18/156 (11%)

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYM 116
           HPNI+    V      L+ +  +M   +   L+K    +  SEA + N  F   +GL Y+
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117

Query: 117 HQRGYFHRDLKPENLLVSKDTIKIADFGL------------AREINSRPPFTEYVSTRWY 164
           HQ GY HR++K  ++L+S D + ++  GL            A+ +   P F+  V   W 
Sbjct: 118 HQNGYIHRNIKASHILISGDGL-VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WL 175

Query: 165 RAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLF 199
            +PE+L Q  Y Y+ K D++++G    EL T R  F
Sbjct: 176 -SPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 44/261 (16%)

Query: 5   KLIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREV----KSLR 55
           + ++E+G+  FG V++         +  + VAIK +K K         LRE       +R
Sbjct: 8   RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-----GPLREEFKHEAMMR 62

Query: 56  -KMSHPNIVKLKEVIRENDILYFVFEYME-CNLYQLM---------------KDREKCFS 98
            ++ HPNIV L  V+ +   L  +F Y    +L++ +               K  +    
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 99  EAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPF-- 155
            A+  +   Q+  G+ ++      H+DL   N+LV  K  +KI+D GL RE+ +   +  
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182

Query: 156 --TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
                +  RW  +PE ++    +S   D+W+ G ++ E+ +  L+P + G S  D I  I
Sbjct: 183 MGNSLLPIRWM-SPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQDVIEMI 239

Query: 212 CSVIGTPTQD---SWADGLLL 229
            +    P  D   +W   L+L
Sbjct: 240 RNRQVLPCPDDCPAWVYTLML 260

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 1e-08
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 20/203 (9%)

Query: 8   KEVGDGTFGSVWRA--ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL 65
           +E+G+G FG V  +   +      V +K++K    S E+   L++    R + HPNI++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 66  KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEV----RNWCFQVFQGLAYMHQRG 120
                E      VFEY E  +L   +   +     +++    R  C ++  G+ +MH+  
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC-EIAAGVTHMHKHN 119

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLA----REINSRPPFTEYVSTRWYRAPEVL--LQS 173
           + H DL   N  ++ D T+K+ D+G+     +E        + V  RW  APE++     
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHG 178

Query: 174 YLYSSK----VDMWAMGAIMAEL 192
            L +++     ++WA+G  + EL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 43/163 (26%), Positives = 71/163 (43%), Gaps = 27/163 (16%)

Query: 51  VKSLRKMSH-------------PNIVKLKEVIRENDILYFVFEYME-----CNLYQLMKD 92
           +K LRK S              PN+V L + I   D ++ V ++ E      ++ + +  
Sbjct: 23  LKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI 82

Query: 93  REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINS 151
            E+C     V+ W  ++   L  +H+ G   RDL P N+L+  +  I++  F    E+  
Sbjct: 83  PEEC-----VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-- 135

Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
                       Y APEV   S   +   D W++GAI+ EL+T
Sbjct: 136 EDSCDGEAVENMYCAPEVGGISEE-TEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 25/188 (13%)

Query: 24  KQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM 82
           K +GE V ++++  +  + E    L+ E+   +  +HPNIV  +     ++ L+ V  +M
Sbjct: 22  KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81

Query: 83  ECNLYQLMKDR-----EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDT 137
               Y   KD          SE  +      V + L Y+H  GY HR +K  ++L+S D 
Sbjct: 82  A---YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 138

Query: 138 IKIADFGL------------AREINSRPPFTEYVSTRWYRAPEVLLQSYL-YSSKVDMWA 184
            K+   GL             R ++  P ++  V    + +PEVL Q+   Y +K D+++
Sbjct: 139 -KVYLSGLRSNLSMINHGQRLRVVHDFPKYS--VKVLPWLSPEVLQQNLQGYDAKSDIYS 195

Query: 185 MGAIMAEL 192
           +G    EL
Sbjct: 196 VGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 4e-06
 Identities = 23/40 (57%), Positives = 28/40 (70%), Gaps = 1/40 (2%)

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA 146
           QV  GL  +H+ G  HRD+KPENLLV+ D  +KI DFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 37/199 (18%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +  G  G+ ++  S ++G    +K++          +   E+  + K+ HPNIVKL  + 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIPSSEIADMGKLQHPNIVKLIGLC 752

Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-------GY 121
           R     Y + EY+E  NL +++++     S    R     + + L ++H R       G 
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808

Query: 122 FHRDLKPENLLVS-KDTIKIADFGLAREINSRP-----PFTEYVSTRWYRAPEVLLQSYL 175
               L PE +++  KD              S P         ++S+  Y APE   ++  
Sbjct: 809 ----LSPEKIIIDGKDE--------PHLRLSLPGLLCTDTKCFISSA-YVAPET-RETKD 854

Query: 176 YSSKVDMWAMGAIMAELIT 194
            + K D++  G I+ EL+T
Sbjct: 855 ITEKSDIYGFGLILIELLT 873

Length = 968

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 37/200 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           + + L K++G+G FG V++A      SK+ G+ V   K   +Y + E  +N R  ++   
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVL--KKATEYGAVEIWMNERVRRACPN 189

Query: 57  MSHPNIVKLKEVIREN--DILYFVFEYM-ECNLYQLMKDRE-------KCFSEAE----- 101
                +    E +     D  + V+ Y  E  L  LM+ +E           + +     
Sbjct: 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG 249

Query: 102 -------VRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS--KDTIKIADFGLARE---- 148
                  ++    Q+   L  +H  G  HRD+KP+N++ S    + KI D G A +    
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG 309

Query: 149 INSRPPFTEYVSTRWYRAPE 168
           IN  P   E++    Y APE
Sbjct: 310 INYIP--KEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 23/197 (11%)

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +R++SH +IV L  V   +     V E++E     L   R+   S+     W F+V + L
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQL 114

Query: 114 A----YMHQRGYFHRDLKPENLLVSKDT--------IKIADFGLAREINSRPPFTEYVST 161
           A    Y+  +   H ++  +N+L++++         IK++D G+   + SR    E +  
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP- 173

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELI--TLRPLFPGT-SEADEIYKICSVIGTP 218
            W  APE +  S   S   D W+ G  + E+      PL   T +E +  Y+   ++ TP
Sbjct: 174 -WI-APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTP 231

Query: 219 TQDSWADGLLLARAINY 235
           +    AD  L+   +NY
Sbjct: 232 SCKELAD--LMTHCMNY 246

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.1 bits (92), Expect = 0.001
 Identities = 13/32 (40%), Positives = 18/32 (56%)

Query: 116 MHQRGYFHRDLKPENLLVSKDTIKIADFGLAR 147
           +H  G  H DL   N+++S   I + DFGLA 
Sbjct: 111 LHSAGIIHGDLTTSNMILSGGKIYLIDFGLAE 142

Length = 211

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 12/35 (34%), Positives = 18/35 (51%)

Query: 113 LAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAR 147
           +  +H+ G  H DL   N+++S   I   DFGL  
Sbjct: 105 VGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGE 139

Length = 204

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 24/76 (31%), Positives = 42/76 (55%), Gaps = 5/76 (6%)

Query: 75  LYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENL 131
           +Y+ F  +E  L +  K+   R KC ++  ++N    +   L Y+H+ G  H D+KPEN+
Sbjct: 99  MYYRFILLE-KLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENI 157

Query: 132 LV-SKDTIKIADFGLA 146
           +V   +   I D+G+A
Sbjct: 158 MVDGNNRGYIIDYGIA 173

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	337
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.94
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
smart00090	237	RIO RIO-like kinase.	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.6
KOG1243	690	consensus Protein kinase [General function predict	99.58
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.53
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.45
KOG3087	229	consensus Serine/threonine protein kinase [General	99.42
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.37
COG4248	637	Uncharacterized protein with protein kinase and he	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.22
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.16
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.99
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.98
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.89
PRK09902	216	hypothetical protein; Provisional	98.71
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.54
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
PF01636	239	APH: Phosphotransferase enzyme family This family	98.5
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.45
PLN02876	822	acyl-CoA dehydrogenase	98.44
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.35
KOG2270	520	consensus Serine/threonine protein kinase involved	98.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.19
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.18
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.11
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.08
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.06
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.03
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.01
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.72
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.69
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.63
PRK05231	319	homoserine kinase; Provisional	97.62
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.61
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.57
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.49
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.48
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.44
PLN02236	344	choline kinase	97.37
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.27
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.22
PRK12396	409	5-methylribose kinase; Reviewed	97.21
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.19
PLN02756	418	S-methyl-5-thioribose kinase	96.92
PTZ00384	383	choline kinase; Provisional	96.91
PRK10593	297	hypothetical protein; Provisional	96.71
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.42
PHA03111	444	Ser/Thr kinase; Provisional	96.33
PTZ00296	442	choline kinase; Provisional	96.32
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.29
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.11
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	96.01
PRK11768	325	serine/threonine protein kinase; Provisional	95.72
PRK06148	1013	hypothetical protein; Provisional	95.25
PRK10271	188	thiK thiamine kinase; Provisional	94.91
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.54

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-69  Score=471.17  Aligned_cols=288  Identities=68%  Similarity=1.195  Sum_probs=278.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCC-EEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIREND-ILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv   78 (337)
                      |+||.++++||.|.||.||+|+.+.+|+.||||.+++.....++...++|++.|++|+ ||||+++.+++.+++ .+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            6899999999999999999999999999999999999998888888899999999998 999999999998777 99999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee-CCcEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~-~~~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ||||+.++.+.++.++..|++..++.|+.||++||+|+|++|+.|||+||+|||+. .+.+||+|||+|+...+.++++.
T Consensus        89 fE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTe  168 (538)
T KOG0661|consen   89 FEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTE  168 (538)
T ss_pred             HHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcch
Confidence            99999999999999999999999999999999999999999999999999999999 55999999999999999999999


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ++.|+||+|||++.....|+.+.|+|++|||++|+.+-+|.|.|.++.+++.+|++.+|.|..+.|..+..++...++.+
T Consensus       169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~  248 (538)
T KOG0661|consen  169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF  248 (538)
T ss_pred             hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC
Confidence            99999999999999888999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      |...+.+.....+..+.++.++|.+||.+||.+||||+++|+||||+....
T Consensus       249 P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  249 PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            999999999999999999999999999999999999999999999997554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1e-65  Score=425.29  Aligned_cols=285  Identities=32%  Similarity=0.602  Sum_probs=255.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |++|+.+.++|+|+||+||+|+++.||+.||||++.....+. -....++|+++|++|+|+|+|.++++|..+..+++||
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            899999999999999999999999999999999987654433 2344479999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~~~  157 (337)
                      |||+.+.++.+......+++..++.+++|++.|+.|||+++++||||||+||||+.+ .+||||||+|+... +...++.
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            999999999998877779999999999999999999999999999999999999987 99999999999887 6677888


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ++.|.||+|||.+.++..|+.++|||++||++.||++|.+.|.|.++.+++..|...+|..+++...--.....+....+
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            99999999999999988999999999999999999999999999999999999999999887765544444444455567


Q ss_pred             CCCCCC-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVGV-PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      |+.... +...-.+.++..+.||+.+||+.||++|++.+|+|.||||+.
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            766643 344556888999999999999999999999999999999954

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-64  Score=430.48  Aligned_cols=260  Identities=33%  Similarity=0.492  Sum_probs=223.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH------HhHHHHHHHHHhcCCCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE------ECVNLREVKSLRKMSHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   75 (337)
                      +.|.+.+.||+|+||.|-+|..+.||+.||||++++......      .....+|+++|++|+|||||+++++|+..+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            468899999999999999999999999999999987654431      12235899999999999999999999999999


Q ss_pred             EEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCC
Q 038835           76 YFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREIN  150 (337)
Q Consensus        76 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~  150 (337)
                      ||||||++|| +++.+.. ++.+.+..-+.+++|++.|+.|||++||+||||||+|||++.+    .+||+|||+|+..+
T Consensus       252 YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g  330 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG  330 (475)
T ss_pred             EEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence            9999999975 5555554 5569999999999999999999999999999999999999765    79999999999998


Q ss_pred             CCCCCccccccccccCchhhcCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCccchhhhh
Q 038835          151 SRPPFTEYVSTRWYRAPEVLLQS--YLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD-EIYKICSVIGTPTQDSWADGL  227 (337)
Q Consensus       151 ~~~~~~~~~gt~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~  227 (337)
                      ......+.||||.|.|||++.+.  ..+..++|+||+||++|-+++|.+||.+..... ..++|..+-....        
T Consensus       331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~--------  402 (475)
T KOG0615|consen  331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG--------  402 (475)
T ss_pred             cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc--------
Confidence            88888999999999999998754  234458999999999999999999998877655 5555554422221        


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                                        +..|..++.++++||..||..||++|||++|+|+||||+....
T Consensus       403 ------------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  403 ------------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             ------------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence                              2335678999999999999999999999999999999997553

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-62  Score=398.48  Aligned_cols=286  Identities=42%  Similarity=0.728  Sum_probs=258.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++|...++||+|.||.||+|.+..||+.||||+++.....+ -....++|++.|+.++|+||+.++++|...+.+.+|+
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            579999999999999999999999999999999998764432 2344579999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Ccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~  157 (337)
                      |||+.++...++++...++..+++.|+.++++||+|||++.|+||||||+|+||+++ .+||+|||+|+..++... ...
T Consensus        81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            999999999999999999999999999999999999999999999999999999876 999999999998876543 344


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+-|.+|+|||.+.+.+.|+..+|+||.||++.||+.|.|.|.|.++.+++..|...+|.|.++.|.+.........+. 
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~-  239 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-  239 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh-
Confidence            5899999999999999999999999999999999999999999999999999999999999999999988777776665 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                       ...+++.....+..+.++.||+.+||..||.+|+|+.|+|+||||...+.
T Consensus       240 -~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  240 -QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             -cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence             22233444467888999999999999999999999999999999997443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-62  Score=439.25  Aligned_cols=258  Identities=34%  Similarity=0.526  Sum_probs=231.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +|+.++.||+|+|+.||.+++..+|+.||+|++.+.....  ......+|+++.++|+|||||+++++|++.+++|||.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            5999999999999999999999999999999998754432  23344689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      +|..+.+..+.++.++++|.+++.+++||+.||.|||+++|+|||||..|+|++++ +|||+|||+|...... ....+.
T Consensus        99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~Tl  178 (592)
T KOG0575|consen   99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTL  178 (592)
T ss_pred             ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccccee
Confidence            99988888887888889999999999999999999999999999999999999999 9999999999988754 556789


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      ||||.|.|||++... ..+..+||||+||++|.||.|+|||...+-.+.+.+|...                   ++.+|
T Consensus       179 CGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------------~Y~~P  238 (592)
T KOG0575|consen  179 CGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------------EYSMP  238 (592)
T ss_pred             cCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------------------Ccccc
Confidence            999999999999744 7899999999999999999999999999988888888654                   33333


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCC
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH  291 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  291 (337)
                                 ..+|.++++||.+||++||.+|||++++|.|+||.....+..
T Consensus       239 -----------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~  280 (592)
T KOG0575|consen  239 -----------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPAR  280 (592)
T ss_pred             -----------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence                       368999999999999999999999999999999976555443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-62  Score=427.69  Aligned_cols=285  Identities=36%  Similarity=0.656  Sum_probs=253.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC--CEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN--DILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv   78 (337)
                      +.|+.+++||+|.||.||+|++..||+.||+|++..+.... ......+||.+|++|+||||+++.++..+.  +.+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            56889999999999999999999999999999998766433 334447999999999999999999998766  789999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC--CCC
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR--PPF  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~--~~~  155 (337)
                      ||||+.+|...+...+-.|++.+|+.+++||++||+|||++||+|||||.+|||||.+ .+||+|||+|+.+...  ..+
T Consensus       197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~  276 (560)
T KOG0600|consen  197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY  276 (560)
T ss_pred             EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCccc
Confidence            9999999999988877789999999999999999999999999999999999999986 9999999999966543  467


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ++.+.|.+|+|||++.+...|+.++|+||+|||+.||+.|+|.|.|.++.+++..|...+|.|.+..|. ...+.....+
T Consensus       277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~  355 (560)
T KOG0600|consen  277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIF  355 (560)
T ss_pred             ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCccccc
Confidence            889999999999999999999999999999999999999999999999999999999999999999998 4433333344


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      +.....+....+....++..+.+|+..||..||.+|.||.++|+|+||...+
T Consensus       356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p  407 (560)
T KOG0600|consen  356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP  407 (560)
T ss_pred             CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence            4444444555666788999999999999999999999999999999995443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-59  Score=399.43  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=220.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC-EEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND-ILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~   81 (337)
                      +.+.++.||+|+.|+||++.|+.|++.+|+|++..........+..+|+++++..+||+||.+|+.|.++. ..+|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            55678899999999999999999999999999966655555667789999999999999999999999998 49999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      |+|+.++.+....+.++|.....+++++++||.|||+ .+||||||||+|||++.. +|||||||.+...... ...+++
T Consensus       160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfv  238 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFV  238 (364)
T ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hccccc
Confidence            9999999888877779999999999999999999995 999999999999999875 9999999999987655 557899


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGT--SEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ||..|||||-+.+. .|+.++||||||++++|++.|+.||...  ......+.+...+..+++                 
T Consensus       239 GT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP-----------------  300 (364)
T KOG0581|consen  239 GTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP-----------------  300 (364)
T ss_pred             ccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC-----------------
Confidence            99999999999876 8999999999999999999999999774  112223333332222211                 


Q ss_pred             CCCCCCcccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMP-SANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                       .        .+. .+|+++++||..||++||.+|||+.|+++|||+...
T Consensus       301 -~--------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  301 -R--------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             -C--------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence             1        112 489999999999999999999999999999999863

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-59  Score=395.02  Aligned_cols=286  Identities=40%  Similarity=0.686  Sum_probs=250.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee-----CCEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE-----NDILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (337)
                      +|..++.||.|+||.|+.|.++.||+.||||++....... ...+..+|+++|+.++|+||+.+.+++..     -+.+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            4566799999999999999999999999999998655443 34455799999999999999999999854     46799


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC---C
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS---R  152 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~---~  152 (337)
                      +|+|+|+.++...+. .+..+++..+..++.||+.||+|+|+.|++|||+||+|+|++.+ .+|+||||+|+..++   .
T Consensus       103 iV~elMetDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  103 LVFELMETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             EehhHHhhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            999999766666554 45559999999999999999999999999999999999999998 999999999998864   4


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh-hhHH
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL-LLAR  231 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~  231 (337)
                      ...+.++-|.+|+|||++.....|+.+.||||+|||+.||++|++.|.|.+..+++..|....|.|+.+....-. ...+
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence            455788999999999999888899999999999999999999999999999999999999999999877665432 2333


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF  289 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  289 (337)
                      ..-...|...+.++....+..++.+.+|+.+||..||.+|+|++|+|+|||+...-.+
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence            3455678888888899999999999999999999999999999999999999864433

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.1e-59  Score=389.29  Aligned_cols=288  Identities=40%  Similarity=0.662  Sum_probs=254.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEe--eCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIR--ENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~l   77 (337)
                      +++|+.+.+|++|.||.||+|+++.|++.||+|.++.+.... -....++|+.+|.+.+|||||.+.++..  +-+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            467999999999999999999999999999999998654221 1223379999999999999999999865  4467999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~  155 (337)
                      |||||+.++.+.+..-..+|...+++.++.|++.|++|||++.|+||||||+|+|++.. .+|++|||+|+.+++. .++
T Consensus       155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~  234 (419)
T KOG0663|consen  155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY  234 (419)
T ss_pred             eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence            99999999988888777789999999999999999999999999999999999999865 9999999999999866 456


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      +..+-|.+|+|||++.+.+.|+++.|+||+|||+.||+.++|.|.|....+++.+|...+|.|.+..|.+-.........
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            77899999999999999999999999999999999999999999999999999999999999999999988777666666


Q ss_pred             cCCCCCCCcccccCCC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          236 KFPQLVGVPLSVLMPS--ANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .+++..-.......+.  ++....+|+..+|..||.+|.||+|.|+|+||.+.+.
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence            6666555444444443  5599999999999999999999999999999997443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-59  Score=377.26  Aligned_cols=287  Identities=32%  Similarity=0.486  Sum_probs=242.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +.|++-+.||+|+|+.|+++.+..||+.+|+|+++....... ...+.+|+.+-+.|+||||+++++.+.+....|+|||
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            468899999999999999999999999999999986655433 3334589999999999999999999999999999999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCCCC
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~~~  155 (337)
                      +|.|+ +...+..+ ..++|..+-.+++||++||.|||.+||||||+||+|+++-+.    .+||+|||.|...++....
T Consensus        91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~  169 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW  169 (355)
T ss_pred             cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence            99985 55666665 347999999999999999999999999999999999999542    7999999999999977777


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+|||.|+|||++... +|+.++|||+.||++|.|+.|++||.+.+.....++|..+--..+.+              
T Consensus       170 ~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~--------------  234 (355)
T KOG0033|consen  170 HGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP--------------  234 (355)
T ss_pred             ccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc--------------
Confidence            889999999999999776 78999999999999999999999999998888888887653222222              


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCC-CCCChhhhHHhhhhhccccchhh
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH-LSVPEQLLQEHLHLLGQREHWSS  314 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  314 (337)
                                  .|+.+++++++||++||..||.+|+|+.|+|+|||+++...... ...++  .-+++..++.+++.++
T Consensus       235 ------------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~d--tvd~lrkfNarRKLKg  300 (355)
T KOG0033|consen  235 ------------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQD--TVDCLKKFNARRKLKG  300 (355)
T ss_pred             ------------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHH--HHHHHHHhhHHHHHHH
Confidence                        35789999999999999999999999999999999987543322 22222  2356666777777776


Q ss_pred             hhhh
Q 038835          315 KVLR  318 (337)
Q Consensus       315 ~~~~  318 (337)
                      .++.
T Consensus       301 avLt  304 (355)
T KOG0033|consen  301 AILT  304 (355)
T ss_pred             HHHH
Confidence            6553

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4e-57  Score=388.46  Aligned_cols=260  Identities=31%  Similarity=0.525  Sum_probs=227.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +.+|.+.+.||.|+||+||+|+++.++..||||.+.+...... ...+..|+.+|+.++|||||.++++.+.++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            3689999999999999999999999999999999988765433 334468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-------cEEEeeCCCcccCCCC
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-------TIKIADFGLAREINSR  152 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-------~~kL~Dfg~a~~~~~~  152 (337)
                      |||+||.+.....+.+.++|..++.++.||+.||++||+++||||||||+|||++.+       .+||+|||+|+...+.
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999987776666666679999999999999999999999999999999999999753       5899999999999988


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ....+.||+|.|||||++... .|+.|+|+||+|+++|+|++|++||...+..+....+......               
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~---------------  232 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI---------------  232 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc---------------
Confidence            888899999999999999765 7899999999999999999999999999988887655432111               


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                                  .+......+....+++...|+.+|.+|.+..+-+.||+......
T Consensus       233 ------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  233 ------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             ------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence                        11122456778889999999999999999999999999876543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.7e-57  Score=383.62  Aligned_cols=285  Identities=39%  Similarity=0.742  Sum_probs=251.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCC-cccceeEEeeCC-----
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPN-IVKLKEVIREND-----   73 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~-----   73 (337)
                      |+.|+.+++||+|+||+||+|+++.+|+.||+|++...... .......+|+.+++.|+|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            35688899999999999999999999999999999876542 23344579999999999999 999999987766     


Q ss_pred             -EEEEEEeecCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCccc
Q 038835           74 -ILYFVFEYMECNLYQLMKDRE---KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLARE  148 (337)
Q Consensus        74 -~~~lv~e~~~~~l~~~~~~~~---~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~  148 (337)
                       .+++||||++.++-..+....   ..++...++.+++||+.||+|||++||+||||||+||||++. .+||+|||+|+.
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence             899999999999988887665   358889999999999999999999999999999999999986 999999999998


Q ss_pred             CC-CCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh
Q 038835          149 IN-SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL  227 (337)
Q Consensus       149 ~~-~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  227 (337)
                      .+ +...++..++|.+|+|||++.+...|+...||||+||+++||+++++.|.+.++.+++..|....+.|....|....
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            77 45557888999999999999998889999999999999999999999999999999999999999999999999876


Q ss_pred             hhHHhhhccCCCCC-CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          228 LLARAINYKFPQLV-GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       228 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ....... .++... +..+....+..+++..+++.+||+.+|.+|.|++.+|.||||+..
T Consensus       250 ~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  250 SLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             ccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            5444433 444444 445666667777899999999999999999999999999999863

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-57  Score=387.17  Aligned_cols=279  Identities=37%  Similarity=0.676  Sum_probs=246.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN-----DILYF   77 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   77 (337)
                      .|.-.+++|.|+||.||.|...++++.||||++-.+..-     .-+|+++|+.++|||||++..+|...     -...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            477889999999999999999999999999998765321     13799999999999999999888532     24579


Q ss_pred             EEeecCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCC
Q 038835           78 VFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSR  152 (337)
Q Consensus        78 v~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~  152 (337)
                      |||||+.++...+..   .+..++.-.++-+++||++||.|||+.||+||||||.|+|+|.+  .+||||||+|+.....
T Consensus       100 VleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  100 VLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            999999999888774   35568889999999999999999999999999999999999976  8999999999999988


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .+..+++.|+.|+|||.+.+...|+.+.||||.||++.||+.|++.|.|.+..+++..|...+|.|+.+......-..  
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y--  257 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY--  257 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc--
Confidence            888899999999999999999999999999999999999999999999999999999999999999988765443221  


Q ss_pred             hhccCCCCCCCcccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          233 INYKFPQLVGVPLSV-LMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .+.++|+..+.++.. +....++++.+|+.++|+.+|.+|.++.|+++||||+.-..
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            255678887777766 67889999999999999999999999999999999986443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-57  Score=382.99  Aligned_cols=254  Identities=32%  Similarity=0.508  Sum_probs=223.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|+++++||+|+||+|+.++.+.|++.+|+|++++......  .....+|.++|..++||+||+++..|++.+.+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            689999999999999999999999999999999988765443  344468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~~~  157 (337)
                      ||+.||-+-...++.+.++|..++-++..|+.||.|||++|||||||||+|||++.+ .++|+|||+++..- ......+
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~t  184 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRT  184 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcccc
Confidence            999987665556666679999999999999999999999999999999999999986 99999999998543 3344566


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .|||+.|||||++.+. .|+..+|.||||+++|+|++|.+||.+.+..+..++|...-                      
T Consensus       185 fcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k----------------------  241 (357)
T KOG0598|consen  185 FCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK----------------------  241 (357)
T ss_pred             ccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----------------------
Confidence            8999999999999876 89999999999999999999999999999988888886531                      


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC----CHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP----TAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~~~~  285 (337)
                             ....+..++.+++++|+++|++||++|.    ++.++-+||||..
T Consensus       242 -------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  242 -------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             -------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence                   0111234789999999999999999995    7899999999975

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-57  Score=398.63  Aligned_cols=252  Identities=36%  Similarity=0.596  Sum_probs=223.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHH--HHHHHHHhcC-CCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKM-SHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      .+|.+++.||+|+|++|++|+++.+++.||||++.+...-.+.+..  ..|-.+|.+| .||.|++++..|.+...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            5899999999999999999999999999999999887654433322  4688999999 899999999999999999999


Q ss_pred             EeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      +||+++ ++++.+.+. +.|++...+.++.||+.||+|||++|||||||||+|||++.+ .++|+|||.|...++...  
T Consensus       153 Le~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~  231 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ  231 (604)
T ss_pred             EEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence            999985 567766655 559999999999999999999999999999999999999998 999999999987643211  


Q ss_pred             ------------CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccc
Q 038835          155 ------------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS  222 (337)
Q Consensus       155 ------------~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  222 (337)
                                  ..+++||..|.+||++..+ ..++.+|||+|||++|.|+.|.|||.+.++.-..++|...        
T Consensus       232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l--------  302 (604)
T KOG0592|consen  232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL--------  302 (604)
T ss_pred             cCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--------
Confidence                        1558999999999999766 6799999999999999999999999999999999998765        


Q ss_pred             hhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                 .+.||           +.+++.++|||+++|..||.+|+|+++|.+||||..
T Consensus       303 -----------~y~fp-----------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  303 -----------DYEFP-----------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             -----------cccCC-----------CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence                       34444           577899999999999999999999999999999975

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-55  Score=388.74  Aligned_cols=283  Identities=36%  Similarity=0.679  Sum_probs=243.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      |++|++.+.||.|+||.||+|.++.+++.||+|++.............+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            57899999999999999999999999999999998765433333445689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      |+++++.+.+...+..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...... ......
T Consensus        84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~  163 (288)
T cd07871          84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE  163 (288)
T ss_pred             CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCc
Confidence            99998888877666668999999999999999999999999999999999999876 9999999998765432 223456


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .|++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++...|.............++
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (288)
T cd07871         164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP  243 (288)
T ss_pred             eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence            78999999999877667899999999999999999999999999999999999999999988888765544444444444


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .....+.....+..+.++++||.+||+.||.+|||++|+++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            443333344456788999999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-56  Score=401.19  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=228.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEccccc-C-ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-Y-SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      .-|++++.||.|+.|.|.+|++..||+.+|||++.+.. . ........+|+-+|+.+.||||+.++++++++.++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45899999999999999999999999999999998762 2 223444568999999999999999999999999999999


Q ss_pred             eecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           80 EYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        80 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ||++| ++++.+.++++ ++|.+++++++||+.|+.|||..+|+|||+||+|+|++.. ++||+|||+|....++..+.+
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99986 57777766554 9999999999999999999999999999999999999875 899999999998888888899


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .||+|+|.|||++.+.++.+.++||||+|||+|.||+|+.||++.+-...+.++..+...                    
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--------------------  230 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--------------------  230 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--------------------
Confidence            999999999999999988899999999999999999999999998888888887665222                    


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                                ++..+|+++++||++||..||.+|.|.+||++|||+....
T Consensus       231 ----------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  231 ----------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             ----------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence                      2257899999999999999999999999999999998643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-55  Score=392.94  Aligned_cols=253  Identities=34%  Similarity=0.539  Sum_probs=222.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC----hHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS----WEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   76 (337)
                      .+|.+++.||+|+||+|+.|.+..+|..||+|++.+....    .......+|+.++++++ ||||+++++++.....+|
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            5899999999999999999999999999999988775221    12333357999999998 999999999999999999


Q ss_pred             EEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccC-CCC
Q 038835           77 FVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREI-NSR  152 (337)
Q Consensus        77 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~-~~~  152 (337)
                      +||||+.| ++++.+.+ .+++.|..++.+++|++.|++|||++||+||||||+|||++.+  ++||+|||++... ...
T Consensus        97 ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~  175 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED  175 (370)
T ss_pred             EEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence            99999997 78888877 5669999999999999999999999999999999999999986  9999999999988 566


Q ss_pred             CCCccccccccccCchhhcCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSY-LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ..+.+.+||+.|+|||++.+.. ..+.++||||+||++|.|++|+.||.+.+.......|...                 
T Consensus       176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-----------------  238 (370)
T KOG0583|consen  176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-----------------  238 (370)
T ss_pred             CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----------------
Confidence            7778999999999999998765 4468999999999999999999999998877777665443                 


Q ss_pred             hhhccCCCCCCCcccccCCCC-ChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                        .+.+|           ..+ |+++++||++||..||.+|+|+.+++.||||+.
T Consensus       239 --~~~~p-----------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 --EFKIP-----------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             --CccCC-----------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence              22222           234 899999999999999999999999999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.8e-55  Score=385.41  Aligned_cols=257  Identities=32%  Similarity=0.500  Sum_probs=220.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH--hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE--CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|+++.+||+||||.||+|+.+.||..+|+|++++..+....  ...+.|-++|...+.|.||+++..|.+.+++|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            47899999999999999999999999999999999987654322  2235788999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC------
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS------  151 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~------  151 (337)
                      |||++||..-.+..+.+.|+|..++.++.+++.|+.-||+.|+|||||||+|+|||.. .+||+|||++.....      
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~  299 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES  299 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence            9999987666555556679999999999999999999999999999999999999986 999999999853211      


Q ss_pred             ------------------CC------------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHH
Q 038835          152 ------------------RP------------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIM  189 (337)
Q Consensus       152 ------------------~~------------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il  189 (337)
                                        ..                        ...+.+|||.|+|||++.+. .|+..+|.||||||+
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWSLGCIM  378 (550)
T ss_pred             hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHHHHHHH
Confidence                              00                        01256899999999999877 699999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCC
Q 038835          190 AELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPS  269 (337)
Q Consensus       190 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  269 (337)
                      ||||.|.|||.+.+..+...+|.+..                 ....+|.-         ...+++++|||.+||. ||.
T Consensus       379 yEmLvGyPPF~s~tp~~T~rkI~nwr-----------------~~l~fP~~---------~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  379 YEMLVGYPPFCSETPQETYRKIVNWR-----------------ETLKFPEE---------VDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHh-----------------hhccCCCc---------CcccHHHHHHHHHHhc-CHH
Confidence            99999999999999999999887641                 12233332         3467999999999999 999


Q ss_pred             CCC---CHHHHhcCcCccc
Q 038835          270 KRP---TAAEALQHPFSRV  285 (337)
Q Consensus       270 ~Rp---t~~ell~hp~~~~  285 (337)
                      +|.   +++||.+||||+.
T Consensus       432 ~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  432 NRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HhcCcccHHHHhcCCcccc
Confidence            997   5999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-55  Score=390.49  Aligned_cols=255  Identities=29%  Similarity=0.533  Sum_probs=224.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ..|....+||+|+.|.||.|....+++.||+|.+...... ...-.++|+.+|+.++|+|||++++.|-.++.+|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4688899999999999999999999999999999876443 233446999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      |+|+.+.++..... ++|.+|+.+++.++.||+|||.+||+|||||.+|||++.+ .+||+|||++.+.... ....+.+
T Consensus       352 m~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmV  430 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMV  430 (550)
T ss_pred             cCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccccc
Confidence            99987877766544 8999999999999999999999999999999999999876 9999999999887755 4668899


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      |||+|||||++... .|+++.||||||+++.||+.|.|||-..+....++.|.... .|                     
T Consensus       431 GTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~P---------------------  487 (550)
T KOG0578|consen  431 GTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TP---------------------  487 (550)
T ss_pred             CCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-CC---------------------
Confidence            99999999998654 89999999999999999999999999988888888776542 11                     


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                           -....+.+|++++||+.+||+.||.+|+||.|||+||||+.+
T Consensus       488 -----~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  488 -----KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             -----CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                 112236789999999999999999999999999999999643

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-55  Score=359.03  Aligned_cols=252  Identities=31%  Similarity=0.481  Sum_probs=223.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHh--HHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEEC--VNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||.|+||.|.+++++.+|..+|+|++.++..-.-..  ...+|..+|+.+.||+++++.+.+.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            468999999999999999999999999999999998765433222  225799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||.+|+-+....++.+.++++.++.++.||+.||+|||+++|++||+||+|||+|++ .+||+|||+|+...+.  ..+
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~T  200 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWT  200 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEE
Confidence            9999986444444444559999999999999999999999999999999999999987 9999999999998766  467


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .||||.|+|||++... .|+.++|-|+|||++|||+.|.+||.+.+..+..++|+++                   ++++
T Consensus       201 lCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-------------------~v~f  260 (355)
T KOG0616|consen  201 LCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-------------------KVKF  260 (355)
T ss_pred             ecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------------cccC
Confidence            8999999999998665 8999999999999999999999999999999999999875                   3344


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCC-----CCHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R-----pt~~ell~hp~~~~  285 (337)
                      |           +.+++++++||.++|++|-.+|     ....+|..||||+.
T Consensus       261 P-----------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  261 P-----------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             C-----------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            4           5789999999999999999999     36789999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-56  Score=365.44  Aligned_cols=244  Identities=28%  Similarity=0.500  Sum_probs=208.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHH-HHHHHHHhcCCCCCccccee-EEe-eCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIVKLKE-VIR-ENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~e~~~l~~l~h~~iv~~~~-~~~-~~~~~~lv   78 (337)
                      .+|+|.++||+|.||.||++.+..+|..+|.|.++-..++...... .+|+.+|++|+|||||++++ .|. ++..++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3599999999999999999999999999999999876666544433 68999999999999999998 444 44559999


Q ss_pred             EeecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--cC--ccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           79 FEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQ--RG--YFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        79 ~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~--~~--i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      ||||++|.+..+++    ....++|..+|.++.|++.||.+||+  .+  ++||||||.||+++.+ .|||+|||+++..
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999876665543    35679999999999999999999999  55  9999999999999986 9999999999988


Q ss_pred             CCCCCC-ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          150 NSRPPF-TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       150 ~~~~~~-~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      ++...+ .+.+|||+||+||.+.++ .|+.+|||||+||++|||..-++||.+.+-.+...+|.++..+|.+        
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--------  249 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--------  249 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--------
Confidence            766443 568999999999999776 8999999999999999999999999999777776666654211111        


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA  274 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  274 (337)
                                          ...+|.++..+|..|+..||..||+.
T Consensus       250 --------------------~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  250 --------------------DEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             --------------------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence                                14678999999999999999999985

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.1e-53  Score=378.63  Aligned_cols=286  Identities=36%  Similarity=0.685  Sum_probs=245.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      |++|.+.+.||+|+||.||+|.++.+++.||+|.+.............+|+.++++++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            67899999999999999999999999999999998765443333445689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      |+++++.+.+...+..+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||.+...... ......
T Consensus        85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  164 (309)
T cd07872          85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE  164 (309)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccc
Confidence            99999988887766678999999999999999999999999999999999999876 9999999998765432 223445


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+....+....+.+....|..........+..++
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
T cd07872         165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP  244 (309)
T ss_pred             cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcC
Confidence            78999999999877667899999999999999999999999999998999999999998888888765544444445555


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ...........+.++.+++++|.+||+.||.+|||++|+++||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            443333333446788999999999999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-53  Score=378.80  Aligned_cols=284  Identities=34%  Similarity=0.586  Sum_probs=229.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.............+|+.+++.++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            68999999999999999999999999999999997654333334456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      +++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...... .......
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  164 (303)
T cd07869          85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV  164 (303)
T ss_pred             CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCc
Confidence            9999998887766679999999999999999999999999999999999999875 8999999998754322 2334567


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE-ADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      ||+.|+|||++.+...++.++||||+||++|+|++|.+||.+..+ .+.+..+....+.+....|.............+.
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (303)
T cd07869         165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFT  244 (303)
T ss_pred             ccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccccc
Confidence            899999999987666788999999999999999999999988654 4556666666777776666543321111111111


Q ss_pred             CCCCCccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          239 QLVGVPLSVL--MPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ...+......  ....++++.+||.+||+.||.+|||+.|+++||||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~  293 (303)
T cd07869         245 LYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD  293 (303)
T ss_pred             ccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence            1111111111  1235678999999999999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-54  Score=371.26  Aligned_cols=267  Identities=28%  Similarity=0.367  Sum_probs=223.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +.|++...||.|..++||+|....+++.||||++..+..+..-..+.+|+..|+.++||||++++..|..+..+|+||+|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            68999999999999999999999999999999999888777767778999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----
Q 038835           82 MECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----  153 (337)
Q Consensus        82 ~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----  153 (337)
                      |.+|....+.+.  ...++|..|+.++++++.||.|||++|.||||||+.||||+.+ .|||+|||.+.......     
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~  185 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT  185 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence            997655544432  3459999999999999999999999999999999999999876 99999999876543221     


Q ss_pred             CCccccccccccCchhh-cCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          154 PFTEYVSTRWYRAPEVL-LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .+.+.+||++|||||++ .+...|+.|+||||||+++.||++|..||....+.+++-.-.+.  .|+.....        
T Consensus       186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn--~pp~~~t~--------  255 (516)
T KOG0582|consen  186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN--DPPTLLTS--------  255 (516)
T ss_pred             eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--CCCCcccc--------
Confidence            12567999999999994 44567999999999999999999999999999988776544332  22211100        


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                                .........++..++++|..||++||++|||++++|+|+||+....
T Consensus       256 ----------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  256 ----------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             ----------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence                      0011112456779999999999999999999999999999987554

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.9e-55  Score=386.25  Aligned_cols=255  Identities=32%  Similarity=0.518  Sum_probs=224.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |++|-+.+.||+|.||.||+|+.|.|.+.||+|.+.+..... +.....+|+++++.++||||+.+++.|+...++|+|+
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            899999999999999999999999999999999998766554 4455678999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||+.|++...+.. ++.++|+.++.++.+++.||.|||+++|+|||+||.|||++.+ ++|+||||+|+..+.. ...+.
T Consensus        81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            9999977766654 5559999999999999999999999999999999999999987 9999999999988765 34466


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .-|||.|||||++.+. .|+..+|.||+||++|||..|+|||...+..+....|....-                     
T Consensus       160 ikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v---------------------  217 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV---------------------  217 (808)
T ss_pred             ccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC---------------------
Confidence            7899999999999865 899999999999999999999999987766666555543210                     


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                               ..++..+..++.|+..+|.+||.+|.|..+++.|||.+...
T Consensus       218 ---------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  218 ---------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             ---------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence                     11246789999999999999999999999999999987643

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-53  Score=386.21  Aligned_cols=279  Identities=36%  Similarity=0.622  Sum_probs=235.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-C-----CCcccceeEEeeCCEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-H-----PNIVKLKEVIRENDILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~   76 (337)
                      +|.|.+.||+|+||.|-+|.+..|++.||||+++....-  ..+...|+.+|..|+ |     -|+|+++++|...+++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            799999999999999999999999999999999875332  223357999999996 4     47999999999999999


Q ss_pred             EEEeecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC---CcEEEeeCCCcccCCCC
Q 038835           77 FVFEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK---DTIKIADFGLAREINSR  152 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~---~~~kL~Dfg~a~~~~~~  152 (337)
                      ||+|.++.+|.+.++.. ..+++...++.+++||+.||.+||+.||||+||||+|||+..   ..||++|||+|...+..
T Consensus       265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~  344 (586)
T KOG0667|consen  265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR  344 (586)
T ss_pred             eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence            99999999999999865 456999999999999999999999999999999999999964   39999999999876554


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .  .+++-++.|+|||++.+. +|+.+.|+||||||++||.+|.|.|.|.+..+++..|.+.+|.|+....+......++
T Consensus       345 v--ytYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf  421 (586)
T KOG0667|consen  345 V--YTYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF  421 (586)
T ss_pred             c--eeeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence            3  488999999999999987 8999999999999999999999999999999999999999999998877665554444


Q ss_pred             hhc-c-CC--------------------------CCCCC----cccccCC-CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          233 INY-K-FP--------------------------QLVGV----PLSVLMP-SANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       233 ~~~-~-~~--------------------------~~~~~----~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ++. . .+                          +...+    .+....+ .....+.|||.+||.+||.+|+|+.++|+
T Consensus       422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            433 1 00                          00000    0111111 34466899999999999999999999999


Q ss_pred             CcCcccc
Q 038835          280 HPFSRVA  286 (337)
Q Consensus       280 hp~~~~~  286 (337)
                      |||+...
T Consensus       502 Hpfl~~~  508 (586)
T KOG0667|consen  502 HPFLTGT  508 (586)
T ss_pred             Ccccccc
Confidence            9999853

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=369.51  Aligned_cols=256  Identities=30%  Similarity=0.490  Sum_probs=210.1

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC--EEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND--ILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e   80 (337)
                      +|..++.||+|+||.||++.++.+|...|+|.+....... ...+.+|+.+|.+|+|||||++++......  .+++.||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            5788899999999999999999999999999987752222 344568999999999999999999854444  6999999


Q ss_pred             ecCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-C-cEEEeeCCCcccCCC----CC
Q 038835           81 YMECNLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-D-TIKIADFGLAREINS----RP  153 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~-~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-~-~~kL~Dfg~a~~~~~----~~  153 (337)
                      |+.++.+..+..+.+ .++|+.++.+.+||++||+|||++|++||||||+|||++. + .+||+|||.+.....    ..
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~  176 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD  176 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence            999877776666544 7999999999999999999999999999999999999998 4 999999999987764    12


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGT-SEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ......||+.|||||++..+...+.++||||+||++.||++|++||... ...+.+..+....                 
T Consensus       177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----------------  239 (313)
T KOG0198|consen  177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----------------  239 (313)
T ss_pred             ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----------------
Confidence            2345789999999999985433346999999999999999999999873 3322222221110                 


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                                 ..+.+++.+|.++++||.+|+++||.+||||+++|.|||.+...
T Consensus       240 -----------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  240 -----------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             -----------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                       11134467899999999999999999999999999999997643

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-52  Score=374.48  Aligned_cols=256  Identities=37%  Similarity=0.546  Sum_probs=227.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH--hHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE--CVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +.|++.+.||.|.||.||+|.++.||+.+|+|++.+.......  ....+|+.+|+++. ||||+.+++.|++...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            4699999999999999999999999999999999887665432  34568999999998 99999999999999999999


Q ss_pred             EeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccCCCC
Q 038835           79 FEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINSR  152 (337)
Q Consensus        79 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~~~~  152 (337)
                      ||++.| .+++.+...  .++|..+..+++|++.|++|||+.|++|||+||+|+|+...     .+|++|||+|......
T Consensus       115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence            999996 577777766  39999999999999999999999999999999999999542     6999999999998886


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ......+||+.|+|||++... .|+..+|+||+|+++|.|++|.+||.+.+..+....+......               
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~---------------  256 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD---------------  256 (382)
T ss_pred             ceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC---------------
Confidence            677889999999999998755 7899999999999999999999999999988887766654322               


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                 .....|+.++..++++|+.||..||.+|+|+.++|+|||++..
T Consensus       257 -----------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  257 -----------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             -----------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence                       2234457789999999999999999999999999999999874

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-54  Score=354.24  Aligned_cols=257  Identities=32%  Similarity=0.505  Sum_probs=224.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC---hHHh----HHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS---WEEC----VNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|.-.+.||.|..++|.+|.++.||+.+|+|++......   .+..    ....|+.+|+++ .||+|+.+.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4677888999999999999999999999999998643221   1111    225799999998 7999999999999999


Q ss_pred             EEEEEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC
Q 038835           74 ILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS  151 (337)
Q Consensus        74 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~  151 (337)
                      -+++|||.|+. .+++.+.+. -.++|...+++++|+++|+.|||.++||||||||+|||++++ ++||+|||+|....+
T Consensus        97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999985 677776654 459999999999999999999999999999999999999998 999999999999999


Q ss_pred             CCCCccccccccccCchhhcC-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQ-----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      ...+...||||+|+|||.+.+     .+.|+...|+|++||++|.|+.|.+||......-++..|.++......+.|   
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW---  252 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW---  252 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch---
Confidence            999999999999999999864     356899999999999999999999999988777777777776555555554   


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                             .++|.+++|||.+||+.||.+|.|++|+|+||||..
T Consensus       253 -----------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  253 -----------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             -----------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence                                   457899999999999999999999999999999964

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.7e-52  Score=367.67  Aligned_cols=285  Identities=35%  Similarity=0.670  Sum_probs=239.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +++|++.+.||.|+||.||+|.++.+++.||+|.+.............+|+.+++.++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            57899999999999999999999999999999998755433333445689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      |+++++.+.+......+++..++.++.||+.||.|||++|++|+||||+||+++.+ .++|+|||.+...... ......
T Consensus        85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (301)
T cd07873          85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE  164 (301)
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccc
Confidence            99998888887766678999999999999999999999999999999999999876 8999999998765432 222345


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....+....+.+....|..............+
T Consensus       165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (301)
T cd07873         165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP  244 (301)
T ss_pred             ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence            67899999999877666889999999999999999999999998888888888888888888777654332222233333


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ...........+.+++++.++|.+||+.||.+|||++|+++||||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            33322233344678899999999999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6e-52  Score=365.45  Aligned_cols=281  Identities=35%  Similarity=0.631  Sum_probs=226.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++.+.||+|+||.||+|.++.+++.+|+|++....... ......+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            58999999999999999999999999999999987643322 23344689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCcc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTE  157 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~  157 (337)
                      |+++++++.+......+++..++.++.||+.||.|||+.|++||||||+||+++.+ .+||+|||.+.......  ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE  160 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence            99999888877666679999999999999999999999999999999999999876 89999999998764322  2234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|++.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+....+..+...+.............+
T Consensus       161 ~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         161 YVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             cccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            6789999999998765 579999999999999999999999999888777777776665554433332111111111111


Q ss_pred             CCCCC--CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVG--VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +....  ..........|.++.+||.+||+.||++|||++++|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            11100  00112234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.3e-52  Score=386.07  Aligned_cols=278  Identities=33%  Similarity=0.585  Sum_probs=227.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC--------C
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN--------D   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~   73 (337)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++...        .
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            47999999999999999999999999999999886532     1224799999999999999999886432        2


Q ss_pred             EEEEEEeecCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCccc
Q 038835           74 ILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLARE  148 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~  148 (337)
                      .+++||||+++++.+.+.   ..+..+++..++.++.||+.||+|||++||+||||||+|||++.+  .+||+|||+|..
T Consensus       141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            477999999998876654   235569999999999999999999999999999999999999854  699999999987


Q ss_pred             CCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          149 INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       149 ~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      ..........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+.++....+.+..+.+.....
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~  300 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP  300 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence            76555555678999999999987766789999999999999999999999999999999999988888877655543211


Q ss_pred             hHHhhhccCCCCCCCccc-ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          229 LARAINYKFPQLVGVPLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                        ......++......+. .++...++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       301 --~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        301 --NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             --hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence              1112233332222211 2234678899999999999999999999999999999763

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-53  Score=364.15  Aligned_cols=250  Identities=29%  Similarity=0.506  Sum_probs=224.0

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHh--HHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEEC--VNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ||++.+.||+|.||+|-+|.+...|+.||||.++++....+..  .+.+|+++|..|+||||+.++++|++++.+.||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            7999999999999999999999999999999999877655433  33689999999999999999999999999999999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      |..+| +.+++.++ +.++|.+++++++||..|+.|||+++++|||||.+|||+|.| ++||+|||++..+.....+.++
T Consensus       134 YaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF  212 (668)
T KOG0611|consen  134 YASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF  212 (668)
T ss_pred             ecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence            99865 66666554 459999999999999999999999999999999999999987 9999999999999888888999


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      ||+|.|.+||++.+.+.-++.+|.||||+++|.|+.|..||+|.+......+|..+-                     +.
T Consensus       213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga---------------------Yr  271 (668)
T KOG0611|consen  213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA---------------------YR  271 (668)
T ss_pred             cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc---------------------cc
Confidence            999999999999888777899999999999999999999999998887777775541                     11


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                .+.-+.++..||+.||..||++|.|++++..|=|+.
T Consensus       272 ----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  272 ----------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                      145568899999999999999999999999997765

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-53  Score=368.59  Aligned_cols=258  Identities=34%  Similarity=0.520  Sum_probs=216.2

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-------------HhHHHHHHHHHhcCCCCCccccee
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-------------ECVNLREVKSLRKMSHPNIVKLKE   67 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------------~~~~~~e~~~l~~l~h~~iv~~~~   67 (337)
                      +++|++++.||+|.||+|-+|.+..+|+.||||++.+......             .....+|+.+|++|.|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            5789999999999999999999999999999999976432211             113358999999999999999999


Q ss_pred             EEee--CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCC
Q 038835           68 VIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFG  144 (337)
Q Consensus        68 ~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg  144 (337)
                      +..+  .+.+|||+|||..+-....-....-+++.+++.+++.++.||+|||.+||+||||||+|+|++.+ +|||+|||
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG  255 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG  255 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence            9875  46899999999976655443333339999999999999999999999999999999999999876 99999999


Q ss_pred             CcccCC------CCCCCccccccccccCchhhcCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 038835          145 LAREIN------SRPPFTEYVSTRWYRAPEVLLQS---YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI  215 (337)
Q Consensus       145 ~a~~~~------~~~~~~~~~gt~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  215 (337)
                      .+....      ....+...+|||.|+|||.+.++   ...+.+.||||+||+||.|+.|+.||.+....+...+|.+..
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p  335 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP  335 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence            988662      22334557999999999998873   345778999999999999999999999999988888886531


Q ss_pred             CCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                         ..+|+         .+.+..+++|||.+||.+||++|+++.++..|||....
T Consensus       336 -------------------L~fP~---------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  336 -------------------LEFPE---------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             -------------------ccCCC---------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                               11222         13578999999999999999999999999999998753

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.2e-51  Score=366.81  Aligned_cols=284  Identities=37%  Similarity=0.645  Sum_probs=224.9

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIREN-----DILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (337)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+...... .......+|+.+++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            699999999999999999999999999999998753322 2233456899999999999999999987533     3589


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      +||||+++++.+.+... ..+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||.+.......  
T Consensus        81 lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          81 VVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            99999998887776544 458999999999999999999999999999999999999876 89999999987543221  


Q ss_pred             --CCccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 --PFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 --~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                        .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+.......
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  239 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK  239 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence              12346799999999998642 467899999999999999999999999988888887777777776655443321100


Q ss_pred             -HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          231 -RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                       ...-...............+..++++.++|.+||+.||++|||++|+++||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence             000001111122223333456788999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.7e-51  Score=360.28  Aligned_cols=278  Identities=36%  Similarity=0.662  Sum_probs=225.0

Q ss_pred             cCceEeeeecccCceEEEEEEECC-CCcEEEEEEcccccCCh-HHhHHHHHHHHHhcC---CCCCcccceeEEe-----e
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-SGEVVAIKKMKKKYYSW-EECVNLREVKSLRKM---SHPNIVKLKEVIR-----E   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~   71 (337)
                      ++|++++.||+|+||.||+|.+.. +|+.||+|.+....... ......+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            589999999999999999999854 57889999887543322 122334677666655   7999999999874     3


Q ss_pred             CCEEEEEEeecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           72 NDILYFVFEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      ...+++||||+++++.+.+... ...+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||.+...
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            4568999999999888877653 3458999999999999999999999999999999999999876 9999999999876


Q ss_pred             CCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          150 NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       150 ~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      ..........||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.++.+.+..+....+.+....|......
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         161 SFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             cCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            655444567899999999998665 6799999999999999999999999999999999999988887777666543321


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ...   .+......+.....+.++..+.++|.+||+.||++|||+.|+|+||||
T Consensus       240 ~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         240 PRQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cch---hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            111   111222223334446788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-50  Score=368.22  Aligned_cols=282  Identities=34%  Similarity=0.536  Sum_probs=225.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------C
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------D   73 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~   73 (337)
                      +++|++.+.||+|+||.||++.++.+|+.||+|++....... ......+|+.+++.++||||+++++++...      .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999999999999999997654332 233446899999999999999999998644      3


Q ss_pred             EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           74 ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ..|+||||+++++...+..   .+++..+..++.||+.||.|||++||+||||||+||+++.+ .+||+|||++......
T Consensus       100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  176 (359)
T cd07876         100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN  176 (359)
T ss_pred             eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence            5799999999988876643   37899999999999999999999999999999999999876 9999999999876554


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+....+.+....+.........
T Consensus       177 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (359)
T cd07876         177 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN  255 (359)
T ss_pred             ccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            444567899999999998765 6899999999999999999999999998888888777777776665443332211111


Q ss_pred             hhccCCCCCCCc------------ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVP------------LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .....+......            ........++++++||.+||+.||++|||+.|+|+||||...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence            111111111111            111223456789999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-53  Score=366.78  Aligned_cols=254  Identities=27%  Similarity=0.424  Sum_probs=222.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      .|...+.||+|.||.||+|.+..+++.||+|++..+....+......|+.++.+++++||.++|+.+..+..+|++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            57888999999999999999999999999999998877766666678999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Cccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~~~g  160 (337)
                      .||....+.+.+..+.|..+..++++++.||.|||..+.+|||||+.|||+..+ .+||+|||.+.+...... ..+++|
T Consensus        94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvG  173 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVG  173 (467)
T ss_pred             cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccc
Confidence            998877777777767999999999999999999999999999999999999886 999999999988765533 378999


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      ||.|||||++.+. .|+.++||||||++++||++|.||+.+..+...+..                          .|.-
T Consensus       174 TPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl--------------------------Ipk~  226 (467)
T KOG0201|consen  174 TPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL--------------------------IPKS  226 (467)
T ss_pred             cccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe--------------------------ccCC
Confidence            9999999999854 899999999999999999999999988776322221                          1211


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .+   +.....+|+.+++||..||.+||+.||||.++|+|+|++..
T Consensus       227 ~P---P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  227 AP---PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             CC---CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            11   12224788999999999999999999999999999999863

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-52  Score=319.90  Aligned_cols=283  Identities=35%  Similarity=0.664  Sum_probs=250.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |.+|+-.++||+|.||+||+++++++++.||+|.++.+..++ -....++|+-+++.|+|.|||+++++.-.+..+-+||
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            678999999999999999999999999999999998765433 2345579999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~  157 (337)
                      |||..++-..+-+.++.++.+.++.++.|++.||.|||++++.|||+||.|+||+++ ++||+|||+|+..+-.. -++.
T Consensus        81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence            999999999998888889999999999999999999999999999999999999987 99999999999876443 3456


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      .+-|.+|++|.++.+.+.|+++.|+||.||++.|+.. |+|.|.+.+..+++.+|...++.|..+.|...........+ 
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y-  239 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY-  239 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc-
Confidence            7889999999999999899999999999999999987 88999999999999999999999999999876544333221 


Q ss_pred             CCCCC-CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          237 FPQLV-GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                       |... -.++..+.|.++..-+|++.++|.-+|.+|++++++|+||||.+
T Consensus       240 -p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  240 -PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             -CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence             1111 13466677888889999999999999999999999999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-50  Score=357.68  Aligned_cols=251  Identities=28%  Similarity=0.377  Sum_probs=211.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++......  .......+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            5899999999999999999999999999999998754322  12233467999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||++++.+.........+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++......  ....
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~  158 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL  158 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence            999976555444445569999999999999999999999999999999999999876 9999999998866433  2345


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....                   ..+ 
T Consensus       159 ~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------------~~~-  217 (291)
T cd05612         159 CGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------------LEF-  217 (291)
T ss_pred             cCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------cCC-
Confidence            799999999998655 67999999999999999999999999887766655553320                   011 


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                                ....++.++++|.+||+.||.+||+     ++++++||||+.
T Consensus       218 ----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         218 ----------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             ----------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence                      1345789999999999999999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.6e-50  Score=364.07  Aligned_cols=282  Identities=34%  Similarity=0.524  Sum_probs=226.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------C
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------D   73 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~   73 (337)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....... ......+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            478999999999999999999999999999999997654332 233446899999999999999999987543      4


Q ss_pred             EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           74 ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ..|+||||+++++...+..   .+++..++.++.|++.||+|||++||+||||||+||+++.+ .+||+|||++...+..
T Consensus       103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  179 (364)
T cd07875         103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  179 (364)
T ss_pred             eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence            5799999999988877643   37899999999999999999999999999999999999876 9999999999876655


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+.........
T Consensus       180 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         180 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             CcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence            444567899999999998765 6899999999999999999999999999988888888887777665443332211111


Q ss_pred             hhccCCCCCC------------CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVG------------VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .....+....            ..........+.+++++|.+||+.||.+|||+.|+|+||||...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            1111111111            11112223356789999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.5e-50  Score=354.34  Aligned_cols=277  Identities=37%  Similarity=0.657  Sum_probs=224.6

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcC---CCCCcccceeEEee-----CC
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKM---SHPNIVKLKEVIRE-----ND   73 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~   73 (337)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+........ .....+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            69999999999999999999999999999999875432221 12234566666554   79999999998754     35


Q ss_pred             EEEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC
Q 038835           74 ILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS  151 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~  151 (337)
                      ..+++|||+.+++.+.+.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            689999999998887776543 458999999999999999999999999999999999999876 899999999987765


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ........||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+.++....+.+....|....... 
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  238 (288)
T cd07863         161 QMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP-  238 (288)
T ss_pred             cccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc-
Confidence            5444567889999999998765 68999999999999999999999999998888888888887777666665422111 


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                        ...+............+.++.++.++|.+||+.||.+|||+.|++.||||
T Consensus       239 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 --RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             --ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence              11122222223334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-52  Score=343.37  Aligned_cols=254  Identities=30%  Similarity=0.435  Sum_probs=213.9

Q ss_pred             cCceEe-eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEee----CCEE
Q 038835            2 ERYKLI-KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRE----NDIL   75 (337)
Q Consensus         2 ~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~   75 (337)
                      ++|.+- ++||-|-.|+|-.|.++.||+.+|+|++...      ...++|+++.... .|||||.++++|++    ...+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            567764 4689999999999999999999999998642      2335788887766 79999999999864    3578


Q ss_pred             EEEEeecCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccC
Q 038835           76 YFVFEYMEC-NLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREI  149 (337)
Q Consensus        76 ~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~  149 (337)
                      .+|||.|+| +|++.+.+++ ..++|.++..|++||..|+.|||+.+|.||||||+|+|....    .+||+|||+|+..
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            999999997 5777777664 469999999999999999999999999999999999999753    7999999999998


Q ss_pred             CCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCccchhh
Q 038835          150 NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE----ADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       150 ~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      .....+.+.+.||+|.|||++... .|+..+|+||+||++|.|++|.|||.....    ..+-.+|..+....+.+.   
T Consensus       215 ~~~~~L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE---  290 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE---  290 (400)
T ss_pred             CCCccccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh---
Confidence            877777888999999999998544 799999999999999999999999976554    244445544443333333   


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                                             |+.+|.+++|+|+++|..+|.+|.|+.+++.|||+.....
T Consensus       291 -----------------------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  291 -----------------------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             -----------------------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence                                   4568899999999999999999999999999999986443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-50  Score=363.43  Aligned_cols=252  Identities=28%  Similarity=0.406  Sum_probs=212.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++.+.||+|+||.||+|.++.+|+.||+|++.......  ......+|+.++++++||||+++++++.+++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999997643221  223446899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||+.++.+.........+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++.......  ..
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  174 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FT  174 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ce
Confidence            9999886555444455568999999999999999999999999999999999999876 99999999998764432  34


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....                   ..+
T Consensus       175 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-------------------~~~  234 (329)
T PTZ00263        175 LCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-------------------LKF  234 (329)
T ss_pred             ecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------cCC
Confidence            6899999999998765 67899999999999999999999998877665555443210                   011


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                                 +..++..+++||.+||+.||.+||+     +++++.||||..
T Consensus       235 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        235 -----------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             -----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence                       1346788999999999999999996     799999999976

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-51  Score=331.13  Aligned_cols=253  Identities=29%  Similarity=0.478  Sum_probs=222.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|-||.||.|+.++++-.||+|++.+.....  ......+|+.+...|+||||++++++|-+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            478999999999999999999999999999999998764322  234456899999999999999999999999999999


Q ss_pred             EeecCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC
Q 038835           79 FEYMEC-NLYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        79 ~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~  155 (337)
                      +||... +++..+.. ....+++...+.+++|++.||.|||.++++||||||+|+|++.. .+|++|||.+.... ....
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR  179 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKR  179 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCc
Confidence            999985 56666663 35669999999999999999999999999999999999999875 99999999998765 4555


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      .+.|||..|.|||...+. ..+..+|+|++|++.||++.|.+||...+..+..++|...                   +.
T Consensus       180 ~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------------------~~  239 (281)
T KOG0580|consen  180 KTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------------------DL  239 (281)
T ss_pred             eeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------------------cc
Confidence            789999999999988665 7899999999999999999999999998877888777654                   22


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+|           ..++.+++|+|.+||.++|.+|.+..|++.|||+..
T Consensus       240 ~~p-----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  240 KFP-----------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             cCC-----------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            333           578899999999999999999999999999999763

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.9e-50  Score=365.88  Aligned_cols=283  Identities=34%  Similarity=0.567  Sum_probs=229.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCC-----EEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREND-----ILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~   76 (337)
                      +|++++.||+|+||.||++.+..+|+.||+|++....... ......+|+.+++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5889999999999999999999999999999987543222 2334568999999999999999999998766     789


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC--C
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR--P  153 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~--~  153 (337)
                      +||||+.+++.+.+.. ...+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++......  .
T Consensus        81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            9999999888777654 4459999999999999999999999999999999999999887 9999999999765432  2


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ......+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....+..........
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  239 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH  239 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence            23445789999999998876668999999999999999999999999999999999998888887765554332111111


Q ss_pred             hccCCCCCCC--cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          234 NYKFPQLVGV--PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       234 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ....+...+.  .........++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            1111111110  0112234568899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.2e-50  Score=362.66  Aligned_cols=283  Identities=33%  Similarity=0.525  Sum_probs=225.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------C
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------D   73 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~   73 (337)
                      +++|++.+.||+|+||.||++.+..+++.+|+|.+....... ......+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            478999999999999999999999999999999997654332 233446899999999999999999988543      3


Q ss_pred             EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           74 ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ..|+||||+++++...+..   .+++..++.++.|++.||.|||++|++||||||+|||++.+ .+||+|||++......
T Consensus        96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_pred             eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence            5799999999988876643   37899999999999999999999999999999999999876 9999999999876655


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+.........
T Consensus       173 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (355)
T cd07874         173 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_pred             cccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence            445567899999999998765 6899999999999999999999999998888887777777666655443322111111


Q ss_pred             hhccCCCC------------CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          233 INYKFPQL------------VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       233 ~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      .....+..            ............+.+++++|.+||+.||++|||+.|+|+||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence            10000000            00011122234567899999999999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-51  Score=364.02  Aligned_cols=255  Identities=31%  Similarity=0.547  Sum_probs=227.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHh-HHHHHHHHHhcCCCCCcccceeEEeeCCE-EEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEEC-VNLREVKSLRKMSHPNIVKLKEVIRENDI-LYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv   78 (337)
                      |++|.+++++|+|+||.++++.++.+++.+|+|.+.......... ....|+.+++++.|||||.+.+.|+.++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            689999999999999999999999999999999998776555433 45789999999999999999999998887 9999


Q ss_pred             EeecCCCHHHHHh-hc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-C
Q 038835           79 FEYMECNLYQLMK-DR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-P  154 (337)
Q Consensus        79 ~e~~~~~l~~~~~-~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~  154 (337)
                      |+||+|+.+...+ +. +..++|+.+..|+.|++.|+.|||+++|+|||||+.|||++++ .|+|+|||+|+..++.. .
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            9999987665444 33 4679999999999999999999999999999999999999987 88999999999998776 5


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      ..+.+|||.|++||++.+. +|+.++|||||||++|||++-+++|.+.+-.....+|......|..              
T Consensus       163 a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp--------------  227 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP--------------  227 (426)
T ss_pred             hheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC--------------
Confidence            6789999999999988665 8999999999999999999999999999999888888776543332              


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                     ..++.+++.+|..||..+|..||++.++|.+|..+.
T Consensus       228 ---------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  228 ---------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             ---------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                           457899999999999999999999999999998764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-50  Score=360.94  Aligned_cols=247  Identities=34%  Similarity=0.468  Sum_probs=207.2

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.||+|+||.||+|.++.+|+.||+|++......  .......+|+.+++.++||||+++++++..++..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999764322  12234467999999999999999999999999999999999987


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCcccccccc
Q 038835           86 LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRW  163 (337)
Q Consensus        86 l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~~  163 (337)
                      .+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++..... .......+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            665555556679999999999999999999999999999999999999876 899999999875422 223345689999


Q ss_pred             ccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCC
Q 038835          164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV  243 (337)
Q Consensus       164 ~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
                      |+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+...                   ...       
T Consensus       161 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------------------~~~-------  213 (323)
T cd05571         161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------EIR-------  213 (323)
T ss_pred             ccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------------------CCC-------
Confidence            9999998665 6899999999999999999999999887665544443221                   001       


Q ss_pred             cccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          244 PLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       244 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                          .+..+++++.++|.+||+.||++||     ++.++++||||+.
T Consensus       214 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         214 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             ----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence                1245789999999999999999999     8999999999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-50  Score=369.01  Aligned_cols=253  Identities=30%  Similarity=0.489  Sum_probs=220.5

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|.++++||+|.||+|+++..+.+++.+|||+++++..-..  -.....|..++... +||.+++++..|..++++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            4789999999999999999999999999999999998765432  22335677777777 69999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~  155 (337)
                      ||||+.||.+..+.. ...+++..++-|+..|+.||.|||++||||||||.+|||+|.. .+||+|||+++..- .....
T Consensus       447 vmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T  525 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT  525 (694)
T ss_pred             EEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence            999999988444333 3459999999999999999999999999999999999999976 99999999998765 44556


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ++.||||.|+|||++.+. .|+.++|.|||||++|+||.|.+||.+.++++....|...                   +.
T Consensus       526 sTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------------------~~  585 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------------------EV  585 (694)
T ss_pred             ccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------CC
Confidence            789999999999999876 8999999999999999999999999999999998888653                   11


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                      .+           +..+|.++.++++++|.+||++|..     +.+|.+||||+.
T Consensus       586 ~y-----------P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  586 RY-----------PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             CC-----------CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            12           2467899999999999999999984     689999999986

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-49  Score=363.26  Aligned_cols=276  Identities=22%  Similarity=0.328  Sum_probs=214.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .+|++++.||+|+||.||+|.++.+++.||+|.....       ...+|+.++++++||||+++++++..+...++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~-------~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG-------GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh-------hhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            4799999999999999999999999999999975432       236899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC--CCCccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR--PPFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~--~~~~~~  158 (337)
                      +.+++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|......  ......
T Consensus       165 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        165 YKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence            998888777654 458999999999999999999999999999999999999876 8999999998754322  223456


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCccchhhhh-hhH
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS-------EADEIYKICSVIGTPTQDSWADGL-LLA  230 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~-~~~  230 (337)
                      +||+.|+|||++.+. .++.++||||+||++|+|++|..||.+..       ....+..+....+.++........ ...
T Consensus       244 ~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        244 AGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             cCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            899999999998765 68999999999999999999997765432       234566666665554433221111 000


Q ss_pred             Hhh---hccCCCCC-CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          231 RAI---NYKFPQLV-GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       231 ~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ...   ........ ..+.......++.++.++|.+||+.||.+|||++|+|+||||+..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            000   00000000 000001112456789999999999999999999999999999863

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-50  Score=360.36  Aligned_cols=259  Identities=29%  Similarity=0.453  Sum_probs=216.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......  ......+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997653221  2233467999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||++|+.+..+......+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++.....  .....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~  158 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV  158 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence            999987666666656679999999999999999999999999999999999999876 999999999986644  23456


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+........                 .+
T Consensus       159 ~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----------------~~  220 (333)
T cd05600         159 VGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ-----------------RP  220 (333)
T ss_pred             ccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc-----------------CC
Confidence            899999999998766 789999999999999999999999998877666655543211100                 00


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .     .......++.++.++|.+||..+|.+|||++++++||||..
T Consensus       221 ~-----~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         221 V-----YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             C-----CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            0     00001356899999999999999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.4e-50  Score=352.21  Aligned_cols=256  Identities=26%  Similarity=0.370  Sum_probs=210.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .|++.+.||+|+||.||+|.++.+|+.||+|.+.......  ......+|+.+++.++|+||+.+++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3889999999999999999999999999999987643322  22334689999999999999999999999999999999


Q ss_pred             ecCCCHHH-HHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           81 YMECNLYQ-LMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        81 ~~~~~l~~-~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |++++.+. .+.. ....+++..+..++.|++.||+|||++|++||||||+|||++++ .++|+|||++...........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99986554 4333 23468999999999999999999999999999999999999876 999999999987654444455


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.........+.......                   
T Consensus       161 ~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------  220 (285)
T cd05631         161 RVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-------------------  220 (285)
T ss_pred             CCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-------------------
Confidence            6899999999998765 68999999999999999999999998766543332222211100                   


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                             .......++.++.+||++||+.||.+|||     ++++++||||..
T Consensus       221 -------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         221 -------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             -------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence                   01122457899999999999999999997     899999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-49  Score=349.47  Aligned_cols=283  Identities=39%  Similarity=0.689  Sum_probs=230.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +++|++.+.||.|++|.||+|.++.+|+.||+|.+.............+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999999999999999998765433223344689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      |+++++.+.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .++|+|||.+...... ......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (291)
T cd07844          84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE  163 (291)
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccccc
Confidence            99998888777666678999999999999999999999999999999999999876 8999999998754322 122334


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS-EADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .++..|+|||.+.+...++.++||||+|+++|+|++|++||.+.. ..+....+....+.+....|.............+
T Consensus       164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (291)
T cd07844         164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF  243 (291)
T ss_pred             ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccc
Confidence            578899999998765567899999999999999999999998766 4566677777777777776665543333333333


Q ss_pred             CCCCCCcccccCCCCC--hhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPSAN--KDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +...........+.++  .++.++|.+||+.||.+|||+.++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            2222222222233445  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.8e-50  Score=359.96  Aligned_cols=251  Identities=29%  Similarity=0.399  Sum_probs=211.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC-cEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG-EVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.++.++ ..||+|.+......  .......+|+.+++.++||||+++++++.+++..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            67999999999999999999877655 68999998754322  1223346799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||+.++.+..+..+...+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++......  ...
T Consensus       110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~  187 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYT  187 (340)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cce
Confidence            9999887665555556679999999999999999999999999999999999999876 8999999999876433  245


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+.......+....                   .. 
T Consensus       188 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-------------------~~-  246 (340)
T PTZ00426        188 LCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-------------------IY-  246 (340)
T ss_pred             ecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-------------------CC-
Confidence            6899999999998765 67899999999999999999999999877665555543221                   01 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                                .++.+++++.++|++||+.||.+|+     |++++++||||.+
T Consensus       247 ----------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        247 ----------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             ----------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence                      1245678999999999999999995     8999999999986

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-49  Score=361.56  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=209.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.+.....  ......+|+.+++.++||||+++++.+.++..+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999997643221  2233457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----  153 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----  153 (337)
                      ||++|+.+..+..+...+++..++.++.|++.||+|||++||+||||||+|||++.+ .+||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            999986665555555669999999999999999999999999999999999999876 99999999987543210     


Q ss_pred             -------------------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 038835          154 -------------------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGT  202 (337)
Q Consensus       154 -------------------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  202 (337)
                                                     .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                           01245899999999998765 6899999999999999999999999988


Q ss_pred             CcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCC---CCCCHHHHhc
Q 038835          203 SEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPS---KRPTAAEALQ  279 (337)
Q Consensus       203 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~Rpt~~ell~  279 (337)
                      +..+...++......                 ..+|.         ...++++++++|.+|+. +|.   .||+++|+++
T Consensus       240 ~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~  292 (363)
T cd05628         240 TPQETYKKVMNWKET-----------------LIFPP---------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CHHHHHHHHHcCcCc-----------------ccCCC---------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence            777666655432100                 01111         12467899999999875 444   4589999999


Q ss_pred             CcCcccc
Q 038835          280 HPFSRVA  286 (337)
Q Consensus       280 hp~~~~~  286 (337)
                      ||||+..
T Consensus       293 hp~f~~~  299 (363)
T cd05628         293 NPFFEGV  299 (363)
T ss_pred             CCCCCCC
Confidence            9999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=356.32  Aligned_cols=255  Identities=29%  Similarity=0.497  Sum_probs=231.7

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      |.+.+.||+|-|++|-+|++..||+.||+|++.+...+.. ...+..|++-|+.+.|||||++|++......+|+|+|+-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            7788899999999999999999999999999998776653 344568999999999999999999999999999999998


Q ss_pred             CC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC--CcEEEeeCCCcccCCCCCCCcccc
Q 038835           83 EC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK--DTIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        83 ~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~--~~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      ++ ++.+++++....+.|+.++.++.||+.|+.|||+..+|||||||+|+.+..  +-|||+|||++..+.+...+.+.|
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsC  179 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSC  179 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhccc
Confidence            86 788999998888999999999999999999999999999999999998875  489999999999999999999999


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      |+..|.|||++.+.....+++||||||||+|.|++|++||...++-+.+-.|+..                   .+..| 
T Consensus       180 GSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-------------------KYtvP-  239 (864)
T KOG4717|consen  180 GSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-------------------KYTVP-  239 (864)
T ss_pred             chhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-------------------cccCc-
Confidence            9999999999999877778999999999999999999999999998888777543                   22333 


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                                ..+|.+.++||..||..||++|.|.++|..++|++....
T Consensus       240 ----------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  240 ----------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             ----------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence                      477899999999999999999999999999999986543

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.6e-49  Score=346.02  Aligned_cols=280  Identities=37%  Similarity=0.715  Sum_probs=228.6

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++++.||+|++|.||+|.++.+|+.||+|.+....... ......+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5899999999999999999999999999999987543222 223446899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           82 MECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        82 ~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      +++++.+.+...  +..+++..++.++.||+.||.|||++|++|+||+|+||+++.+ .++|+|||++...... .....
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH  160 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence            998887776543  2568999999999999999999999999999999999999876 8999999998765432 22234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+....+....+....+.+....|......... ...+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  239 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY-KNTF  239 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH-Hhhc
Confidence            567899999999876656789999999999999999999999998887777777777777766666543322221 1122


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +.............+++++.++|.+||..||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            2222222223345688999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-49  Score=348.17  Aligned_cols=279  Identities=35%  Similarity=0.658  Sum_probs=227.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++.+.||+|++|.||+|.++.+|+.+|+|.+....... ......+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            6999999999999999999999999999999987543222 123345799999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      +++++.+.+.+....+++..++.++.||+.||.|||++|++||||||+||+++.+ .++|+|||.+...... .......
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV  160 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence            9999988887666679999999999999999999999999999999999999876 8999999998765432 2234457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +++.|+|||.+.+...++.++||||+||++|+|++|..| |.+.+..+.+..+....+.+....|..........  .++
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  238 (284)
T cd07839         161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK--PYP  238 (284)
T ss_pred             cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc--ccC
Confidence            789999999987766679999999999999999998766 56666667777777777777766665433222211  111


Q ss_pred             CCCC-CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QLVG-VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .... ..+....+.++++++++|.+||+.||.+|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            1111 11223345688999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.1e-49  Score=345.72  Aligned_cols=279  Identities=46%  Similarity=0.850  Sum_probs=229.0

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeC--CEEEEEEe
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREN--DILYFVFE   80 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e   80 (337)
                      |++.+.||+|++|.||++.++.+++.+|+|.+.............+|+..++++ +|+|++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            789999999999999999999999999999987654333333445789999988 499999999999877  88999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCCCCccccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVS  160 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~~~~~~~g  160 (337)
                      |+++++++.+......+++..++.++.|++.||+|||++|++||||+|+||+++.+.+||+|||.+.............+
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~~  160 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYIS  160 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCCC
Confidence            99999998887766679999999999999999999999999999999999999999999999999987765555455678


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      ++.|+|||.+..+..++.++||||+||++|+|++|.+||.+.+..+....+....+.+.... ..........+..++..
T Consensus       161 ~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  239 (282)
T cd07831         161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHMNYNFPSK  239 (282)
T ss_pred             CcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccccccCccc
Confidence            99999999876655678899999999999999999999999888887777777666555432 22111111222233332


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .........+..+.++.++|.+||..||++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            2222223335678999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-49  Score=357.64  Aligned_cols=281  Identities=36%  Similarity=0.635  Sum_probs=223.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   74 (337)
                      ++|++++.||.|+||.||+|.+..+++.||+|++....... ......+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            68999999999999999999999999999999987643322 223345899999999999999999987533      45


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .|+++|++++++...+. . ..+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++...... 
T Consensus        95 ~~~~~~~~~~~l~~~~~-~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  171 (343)
T cd07878          95 VYLVTNLMGADLNNIVK-C-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-  171 (343)
T ss_pred             EEEEeecCCCCHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence            79999999777765543 2 348999999999999999999999999999999999999876 9999999999876443 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh-HHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL-ARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~  232 (337)
                       ....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....+...... ...
T Consensus       172 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07878         172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK  250 (343)
T ss_pred             -cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence             245689999999999877557899999999999999999999999998888888888777766655433221100 000


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .....+..............++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            111122222222223334567889999999999999999999999999999863

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5e-49  Score=350.50  Aligned_cols=288  Identities=38%  Similarity=0.639  Sum_probs=233.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeC--CEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIREN--DILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l   77 (337)
                      +++|++.+.||.|++|.||+|.++.+|+.||+|.+........ .....+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            5789999999999999999999999999999999875433221 22335799999999999999999998654  57899


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~  155 (337)
                      ||||+++++.+.+......+++..++.++.||+.||.|||+.|++||||||+||+++.+ .+||+|||.+...... ...
T Consensus        86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~  165 (309)
T cd07845          86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM  165 (309)
T ss_pred             EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC
Confidence            99999998887776655679999999999999999999999999999999999999876 9999999999876543 222


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+..+....+....+.+....|...........+
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
T cd07845         166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF  245 (309)
T ss_pred             CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence            34456888999999877667899999999999999999999999999999999999888888877777654332222222


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      ..+..............++++.++|.+||+.||++|||+.++++||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~  298 (309)
T cd07845         246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL  298 (309)
T ss_pred             cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence            22211111112222346889999999999999999999999999999986443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-49  Score=361.81  Aligned_cols=256  Identities=30%  Similarity=0.494  Sum_probs=210.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||.|+||.||+|.++.+|+.||+|++.......  ......+|+.+++.++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            58999999999999999999999999999999997643221  2233457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----  153 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----  153 (337)
                      ||++|+.+..+......+++..++.++.||+.||+|||++|++||||||+|||++.+ .++|+|||++.......     
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            999987666555555669999999999999999999999999999999999999876 89999999986542210     


Q ss_pred             ----------------------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 038835          154 ----------------------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF  199 (337)
Q Consensus       154 ----------------------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (337)
                                                        .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCCC
Confidence                                              01134799999999998665 6899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC---HHH
Q 038835          200 PGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT---AAE  276 (337)
Q Consensus       200 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e  276 (337)
                      .+.+..+....+.....                 ...++.         ...+++++.++|.+||. +|.+|++   ++|
T Consensus       240 ~~~~~~~~~~~i~~~~~-----------------~~~~~~---------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         240 CSDNPQETYRKIINWKE-----------------TLQFPD---------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             CCCCHHHHHHHHHcCCC-----------------ccCCCC---------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            98877665554432100                 001111         12468899999999997 9999998   999


Q ss_pred             HhcCcCccc
Q 038835          277 ALQHPFSRV  285 (337)
Q Consensus       277 ll~hp~~~~  285 (337)
                      +++||||..
T Consensus       293 ll~h~~~~~  301 (364)
T cd05599         293 IKSHPFFKG  301 (364)
T ss_pred             HhcCCCcCC
Confidence            999999975

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.7e-49  Score=345.63  Aligned_cols=282  Identities=40%  Similarity=0.735  Sum_probs=236.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++.+.||.|++|.||+|.++.+|+.||+|++...... .......+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            699999999999999999999999999999998765432 2234456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~~  158 (337)
                      +++++.+.+.....++++..++.++.||+.||.|||+.|++|+||||+||+++.+ .++|+|||.+.......  .....
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ  160 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence            9667777776666779999999999999999999999999999999999999876 89999999988765433  23456


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .|+..|+|||.+.+...++.++||||+||++|+|++|.+||.+.++.+....+....+.+....|.............++
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07832         161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP  240 (286)
T ss_pred             cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence            78999999999876656789999999999999999999999998888888888888888777666654433333333334


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                      ...........+..+.++.++|.+||..||.+|||++++++||||.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            3333334444567789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.7e-49  Score=352.87  Aligned_cols=275  Identities=24%  Similarity=0.325  Sum_probs=213.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||++.++.+|..+|+|.+.............+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            68999999999999999999999999999999997654333334557899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      ++++.+..+......+++..+..++.|++.||.|||++ +++||||||+||+++.+ .+||+|||++...... ......
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  163 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV  163 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCC
Confidence            99876666666556699999999999999999999986 69999999999999876 8999999998765432 224567


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchh---------------
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA---------------  224 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---------------  224 (337)
                      ||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+...........+.               
T Consensus       164 g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (331)
T cd06649         164 GTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG  242 (331)
T ss_pred             CCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence            99999999998765 68999999999999999999999998766544322211100000000000               


Q ss_pred             ---------hhhhhHHhh-hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          225 ---------DGLLLARAI-NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       225 ---------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                               ........+ +...+       .......++++++||.+||+.||++|||+.|+++||||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         243 HGMDSRPAMAIFELLDYIVNEPPP-------KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             cccccccchhHHHHHHHHHhCCCc-------CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                     000000000 00000       0011346789999999999999999999999999999985

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-49  Score=351.43  Aligned_cols=246  Identities=28%  Similarity=0.424  Sum_probs=204.8

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      ||+|+||.||+|.++.+++.||+|++.....  ........+|+.++++++||||+++++++...+..|+||||++++.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999999999999999999875432  12233446799999999999999999999999999999999998666


Q ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccccccccc
Q 038835           88 QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYR  165 (337)
Q Consensus        88 ~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~gt~~~~  165 (337)
                      .........+++..++.++.||+.||.|||++|++||||||+||+++.+ .++|+|||++...... ......+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            5454445569999999999999999999999999999999999999876 9999999998754322 2234567999999


Q ss_pred             CchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcc
Q 038835          166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPL  245 (337)
Q Consensus       166 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (337)
                      |||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+...                   .           
T Consensus       161 aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-------------------~-----------  209 (312)
T cd05585         161 APELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-------------------P-----------  209 (312)
T ss_pred             CHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-------------------C-----------
Confidence            99998765 6899999999999999999999999887765554443221                   0           


Q ss_pred             cccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCcCcccc
Q 038835          246 SVLMPSANKDAVSLIASLCSWDPSKRP---TAAEALQHPFSRVA  286 (337)
Q Consensus       246 ~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~  286 (337)
                      ...+..+++++.++|.+||+.||.+||   ++.|++.||||...
T Consensus       210 ~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         210 LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            011245788999999999999999997   58999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-49  Score=360.87  Aligned_cols=256  Identities=29%  Similarity=0.434  Sum_probs=207.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|.+++.||+|+||.||++.++.+|+.||+|++.+....  .......+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            5899999999999999999999999999999998654321  12233457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----  153 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----  153 (337)
                      ||++|+.+.........+++..++.++.|++.||+|||++||+||||||+|||++.+ .+||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999876555555555669999999999999999999999999999999999999876 99999999986321100     


Q ss_pred             -------------------------------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHH
Q 038835          154 -------------------------------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMA  190 (337)
Q Consensus       154 -------------------------------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~  190 (337)
                                                                 .....+||+.|+|||++.+. .++.++||||+||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~  239 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMF  239 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhhh
Confidence                                                       00125799999999998665 6899999999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC
Q 038835          191 ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK  270 (337)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  270 (337)
                      +|++|.+||.+.+..+....+......                 ..++.         ...++.++.++|.+||. +|.+
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRET-----------------LYFPD---------DIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCc-----------------cCCCC---------CCCCCHHHHHHHHHHhc-CHhh
Confidence            999999999887776665554431000                 01111         12467899999999997 7776


Q ss_pred             C---CCHHHHhcCcCccc
Q 038835          271 R---PTAAEALQHPFSRV  285 (337)
Q Consensus       271 R---pt~~ell~hp~~~~  285 (337)
                      |   +|+.|+++||||..
T Consensus       293 r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         293 RLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             cCCCCCHHHHhcCCCcCC
Confidence            5   59999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.6e-49  Score=353.34  Aligned_cols=247  Identities=34%  Similarity=0.469  Sum_probs=206.5

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.||+|+||.||++.++.+|+.||+|++......  .......+|+.+++.++||||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999999999999999999765332  22234467999999999999999999999999999999999987


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCcccccccc
Q 038835           86 LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRW  163 (337)
Q Consensus        86 l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~~  163 (337)
                      .+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++..... .......+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            665555555669999999999999999999999999999999999999876 999999999875432 222345679999


Q ss_pred             ccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCC
Q 038835          164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV  243 (337)
Q Consensus       164 ~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
                      |+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...                   ..        
T Consensus       161 y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-------------------~~--------  212 (328)
T cd05593         161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------DI--------  212 (328)
T ss_pred             ccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-------------------Cc--------
Confidence            9999998765 6799999999999999999999999877665544433211                   00        


Q ss_pred             cccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          244 PLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       244 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                         ..+..++.++.++|.+||+.||.+|+     ++.++++||||..
T Consensus       213 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         213 ---KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             ---cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence               11245789999999999999999997     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.2e-49  Score=361.00  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=208.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      .+|++++.||+|+||.||+|.++.+++.||+|++.+....  .......+|+.++++++||||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            4799999999999999999999999999999999764322  12234467999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC------
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR------  152 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~------  152 (337)
                      ||++++.+.....+...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            999986554444445568999999999999999999999999999999999999876 9999999987532100      


Q ss_pred             ------------------------------------------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHH
Q 038835          153 ------------------------------------------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMA  190 (337)
Q Consensus       153 ------------------------------------------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~  190 (337)
                                                                ......+||+.|+|||++.+. .++.++||||+||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~  239 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY  239 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHHH
Confidence                                                      001235799999999998765 6899999999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC
Q 038835          191 ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK  270 (337)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  270 (337)
                      +|++|++||.+.+..+....+.......                 ..+         ....+++++.++|.+|+. ||.+
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~~p---------~~~~~s~~~~~li~~l~~-~p~~  292 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSL-----------------HIP---------PQAKLSPEASDLIIKLCR-GPED  292 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCc-----------------CCC---------CcccCCHHHHHHHHHHcc-CHhH
Confidence            9999999999887665554443211000                 011         113578999999999874 9999


Q ss_pred             CCC---HHHHhcCcCccc
Q 038835          271 RPT---AAEALQHPFSRV  285 (337)
Q Consensus       271 Rpt---~~ell~hp~~~~  285 (337)
                      |++   ++++++||||+.
T Consensus       293 R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         293 RLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             cCCCCCHHHHhcCCCcCC
Confidence            997   999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.9e-49  Score=359.27  Aligned_cols=257  Identities=29%  Similarity=0.430  Sum_probs=207.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ..|++++.||+|+||.||+|.++.+|+.||+|++.......  ......+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            36999999999999999999999999999999997643322  2234467999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC------
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR------  152 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~------  152 (337)
                      ||++|+.+..+..+...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            999986665555555669999999999999999999999999999999999999876 9999999987532100      


Q ss_pred             ------------------------------------------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHH
Q 038835          153 ------------------------------------------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMA  190 (337)
Q Consensus       153 ------------------------------------------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~  190 (337)
                                                                ......+||+.|+|||++.+. .++.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~  239 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILF  239 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHHH
Confidence                                                      001235799999999998765 6899999999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcC--CCC
Q 038835          191 ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCS--WDP  268 (337)
Q Consensus       191 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dP  268 (337)
                      +|++|.+||...+..+....+......                 ...+.         ...+++++.++|.+||.  .+|
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~~~---------~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENT-----------------LHIPP---------QVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHccccc-----------------cCCCC---------CCCCCHHHHHHHHHHccCcccc
Confidence            999999999887765554444321000                 01110         13478999999999664  455


Q ss_pred             CCCCCHHHHhcCcCccc
Q 038835          269 SKRPTAAEALQHPFSRV  285 (337)
Q Consensus       269 ~~Rpt~~ell~hp~~~~  285 (337)
                      ..|+|++++++||||+.
T Consensus       294 ~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         294 LGRNGADDIKAHPFFSE  310 (381)
T ss_pred             cCCCCHHHHhcCcccCC
Confidence            56999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.3e-49  Score=352.26  Aligned_cols=247  Identities=32%  Similarity=0.469  Sum_probs=207.1

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.||+|+||.||++.++.+|+.||+|++......  .......+|+.+++.++||||+++++.+..++..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999765322  12233457999999999999999999999999999999999987


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCcccccccc
Q 038835           86 LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRW  163 (337)
Q Consensus        86 l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~~  163 (337)
                      .+.........+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++..... ........||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            666555555679999999999999999999999999999999999999876 999999998875422 222345679999


Q ss_pred             ccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCC
Q 038835          164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV  243 (337)
Q Consensus       164 ~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
                      |+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                   ...       
T Consensus       161 y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------------------~~~-------  213 (323)
T cd05595         161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------EIR-------  213 (323)
T ss_pred             cCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------CCC-------
Confidence            9999998665 6799999999999999999999999887765555444221                   001       


Q ss_pred             cccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          244 PLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       244 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                          .+..+++++.++|.+||+.||.+|+     ++.++++||||..
T Consensus       214 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         214 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             ----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence                1245789999999999999999998     9999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.1e-49  Score=357.89  Aligned_cols=257  Identities=27%  Similarity=0.395  Sum_probs=212.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||++.++.+|+.||+|++.+.....  ......+|+.+++.++||||+++++++.+++..|+||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999997543221  2223457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ||++|+.+..+.... .+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||.+.......  ...
T Consensus       123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~  201 (370)
T cd05596         123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD  201 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence            999987665555443 48999999999999999999999999999999999999876 99999999998764332  224


Q ss_pred             cccccccccCchhhcCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          157 EYVSTRWYRAPEVLLQS---YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ..+||+.|+|||++.+.   ..++.++|||||||++|+|++|.+||.+.+.......+......                
T Consensus       202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----------------  265 (370)
T cd05596         202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS----------------  265 (370)
T ss_pred             CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc----------------
Confidence            56899999999998643   24788999999999999999999999988776666555432100                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK--RPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~~~~  285 (337)
                       ..++.         ...+|.++.++|.+||+.+|.+  |+|++++++||||+.
T Consensus       266 -~~~~~---------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         266 -LTFPD---------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             -CCCCC---------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence             01111         1357899999999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-49  Score=357.73  Aligned_cols=256  Identities=32%  Similarity=0.521  Sum_probs=213.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......  .......+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            5899999999999999999999999999999999764322  22334467999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----  153 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----  153 (337)
                      ||++++.+..+......+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999876555444444669999999999999999999999999999999999999876 99999999987654332     


Q ss_pred             -------------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 038835          154 -------------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEI  208 (337)
Q Consensus       154 -------------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  208 (337)
                                               ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                     22446799999999998766 7899999999999999999999999988766655


Q ss_pred             HHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCcCccc
Q 038835          209 YKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-AAEALQHPFSRV  285 (337)
Q Consensus       209 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell~hp~~~~  285 (337)
                      ..+......                 ..++.         ...+++++.++|.+||. ||.+||+ ++++++||||+.
T Consensus       240 ~~i~~~~~~-----------------~~~p~---------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         240 NKIINWKES-----------------LRFPP---------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHhccCCc-----------------ccCCC---------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            554431000                 01111         12368999999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-48  Score=347.40  Aligned_cols=274  Identities=32%  Similarity=0.586  Sum_probs=211.2

Q ss_pred             eeeecccCceEEEEEEEC--CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee--CCEEEEEEeec
Q 038835            7 IKEVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE--NDILYFVFEYM   82 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~   82 (337)
                      +++||+|+||.||+|.++  .+++.+|+|.+......   ....+|+.++++++||||+++++++..  +...+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc---HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            578999999999999976  46788999998754332   234589999999999999999999854  46789999999


Q ss_pred             CCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-----CcEEEeeCCCcccC
Q 038835           83 ECNLYQLMKDR--------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-----DTIKIADFGLAREI  149 (337)
Q Consensus        83 ~~~l~~~~~~~--------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-----~~~kL~Dfg~a~~~  149 (337)
                      ++++...+...        ...+++..++.++.||+.||.|||++||+||||||+|||++.     +.+||+|||++...
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            99887766421        235899999999999999999999999999999999999942     27999999999765


Q ss_pred             CCCC----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHhC
Q 038835          150 NSRP----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---------ADEIYKICSVIG  216 (337)
Q Consensus       150 ~~~~----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~~~~  216 (337)
                      ....    .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+...         .+.+..+....+
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG  242 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence            4321    234568899999999988766789999999999999999999999975443         356677777778


Q ss_pred             CCCccchhhhhhhHHhhh----c---cCCCCC-CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          217 TPTQDSWADGLLLARAIN----Y---KFPQLV-GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~----~---~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .+....|...........    +   .+.... ...........+.++.+||++||+.||.+|||++|+|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            777777765432111100    0   000000 000011112345679999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.1e-49  Score=360.41  Aligned_cols=256  Identities=29%  Similarity=0.438  Sum_probs=208.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......  ......+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987543211  2233457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC------
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR------  152 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~------  152 (337)
                      ||++++.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|......      
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            999986665555555668999999999999999999999999999999999999876 9999999987532100      


Q ss_pred             --------------------------------------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh
Q 038835          153 --------------------------------------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT  194 (337)
Q Consensus       153 --------------------------------------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  194 (337)
                                                            ......+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeehhh
Confidence                                                  001135799999999998765 67999999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC--
Q 038835          195 LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP--  272 (337)
Q Consensus       195 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp--  272 (337)
                      |++||.+.+..+....+......                 ...+         ....+++++.++|.+|+ .+|.+|+  
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~~---------~~~~~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETT-----------------LHIP---------SQAKLSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCcc-----------------ccCC---------CCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence            99999888766555443321000                 0001         11357889999999987 5999999  


Q ss_pred             -CHHHHhcCcCccc
Q 038835          273 -TAAEALQHPFSRV  285 (337)
Q Consensus       273 -t~~ell~hp~~~~  285 (337)
                       |+.++++||||+.
T Consensus       293 ~t~~ell~h~~~~~  306 (376)
T cd05598         293 NGADEIKAHPFFKG  306 (376)
T ss_pred             CCHHHHhCCCCcCC
Confidence             9999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-48  Score=344.25  Aligned_cols=283  Identities=41%  Similarity=0.712  Sum_probs=232.4

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeC--CEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIREN--DILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l   77 (337)
                      +++|++.+.||.|++|.||+|.++.+++.+|+|.++....... .....+|+.++++++||||+++++++...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4689999999999999999999999999999999975433321 22335799999999999999999998777  89999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~  155 (337)
                      |+||+++++.+.+......+++..++.++.||+.||+|||++|++|+||||+||+++.+ .++|+|||.+...... ...
T Consensus        84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            99999988877776655669999999999999999999999999999999999999886 9999999998876543 333


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+...++....+.+....|..........+.
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK  243 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence            45678899999999876656788999999999999999999999999998888888888888888777765433322222


Q ss_pred             cCCCCCCCcccccCCC--CChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          236 KFPQLVGVPLSVLMPS--ANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .+............+.  +++.+.++|.+||+.||++|||+.|++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            2222111111111222  58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.5e-48  Score=340.79  Aligned_cols=280  Identities=38%  Similarity=0.717  Sum_probs=232.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      +|++.+.||.|++|.||+|.++.+|+.||+|.+.............+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            59999999999999999999999999999999876544333344568999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           83 ECNLYQLMKDRE--KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        83 ~~~l~~~~~~~~--~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      ++++.+.+....  ..+++..+..++.|++.||.|||++|++||||+|+||+++++ .++|+|||.+...... ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (284)
T cd07836          81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE  160 (284)
T ss_pred             CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence            998887776543  468999999999999999999999999999999999999876 9999999998765432 122345


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+...++......+....|....... .....++
T Consensus       161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  239 (284)
T cd07836         161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP-EYKPTFP  239 (284)
T ss_pred             cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc-hhccccc
Confidence            678999999998766567899999999999999999999999999888888888888777777775544221 1122233


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ...........+..+.++.++|.+||+.||.+|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            322222333345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-48  Score=348.82  Aligned_cols=247  Identities=29%  Similarity=0.465  Sum_probs=205.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+|+.||+|++.+....  ........|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999998764321  1223335788888776 799999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.|++.||+|||++|++||||||+|||++.+ .+||+|||++..... ........||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            7666555555669999999999999999999999999999999999999876 899999999875432 22234567999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+....                   .       
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-------------------~-------  213 (320)
T cd05590         161 DYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-------------------V-------  213 (320)
T ss_pred             cccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-------------------C-------
Confidence            99999998655 67999999999999999999999999887766665553210                   0       


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTA------AEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~~~~  285 (337)
                          ...+.++.++.++|.+||+.||.+||++      +++++||||..
T Consensus       214 ----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         214 ----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence                0113467899999999999999999998      99999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.4e-48  Score=348.32  Aligned_cols=250  Identities=30%  Similarity=0.447  Sum_probs=206.9

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHH---HhcCCCCCcccceeEEeeCCEEEEE
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKS---LRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      |++.+.||+|+||.||+|.++.+|+.||+|++.+.....  ......+|+++   ++.++||||+++++++..++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999997643211  12233445544   4567899999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~  156 (337)
                      |||++++.+...... ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++..... .....
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999998766655543 459999999999999999999999999999999999999876 999999998875432 22234


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+....                   . 
T Consensus       160 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-------------------~-  218 (324)
T cd05589         160 TFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-------------------V-  218 (324)
T ss_pred             ccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------C-
Confidence            56899999999998765 67999999999999999999999999887766655543310                   0 


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                                .....++.++.++|.+||+.||.+||     ++.++++||||+.
T Consensus       219 ----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         219 ----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             ----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence                      01235688999999999999999999     7999999999976

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.3e-48  Score=348.42  Aligned_cols=252  Identities=29%  Similarity=0.441  Sum_probs=209.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCC-CcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHP-NIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~   79 (337)
                      +|++++.||+|+||.||+|.++.+++.||+|++.+....  ........|+.+++.++|+ +|+.+++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999765322  2223345788999999765 5888999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~~~  157 (337)
                      ||++++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999986665555555568999999999999999999999999999999999999876 89999999987532 2222345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+....                   .. 
T Consensus       161 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-------------------~~-  219 (324)
T cd05587         161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-------------------VS-  219 (324)
T ss_pred             ecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------CC-
Confidence            6799999999998765 67999999999999999999999999887766655543210                   01 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA-----AEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  285 (337)
                                .+..++.++.+++.+||..||.+|++.     +++++||||+.
T Consensus       220 ----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         220 ----------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             ----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence                      123568899999999999999999986     89999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.4e-48  Score=339.41  Aligned_cols=282  Identities=36%  Similarity=0.603  Sum_probs=222.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|.+.+.||+|+||.||+|.++.+|+.||+|.+.............+|+.+++.++|+||+++++++..++..|+||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            57999999999999999999999999999999987654333333446899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      +.+++++.+......+++..++.++.|++.||.|||+.|++|+||||+||+++.+ .++|+|||.+...... .......
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  164 (291)
T cd07870          85 MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV  164 (291)
T ss_pred             ccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCcc
Confidence            9999888877655668899999999999999999999999999999999999876 8999999998764322 2224456


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE-ADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +++.|+|||.+.+...++.++||||+||++|+|++|.+||.+..+ .+.+..+....+.+....|.............++
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (291)
T cd07870         165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL  244 (291)
T ss_pred             ccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhcc
Confidence            789999999987655678899999999999999999999977554 3555666666666655554443322111111111


Q ss_pred             CCCCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QLVGVPLSVLMP--SANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ..........+.  ..+.++.+++.+||..||.+|||++|++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         245 PCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            111111111111  236789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.3e-49  Score=353.05  Aligned_cols=257  Identities=31%  Similarity=0.426  Sum_probs=212.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|.+.+.||+|+||.||+|.++.+|+.||+|++......  .......+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            5799999999999999999999999999999999865432  12333457999999999999999999999999999999


Q ss_pred             eecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--C
Q 038835           80 EYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--F  155 (337)
Q Consensus        80 e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~  155 (337)
                      ||++++.+ +.+.+....+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++........  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            99987555 4444444679999999999999999999999999999999999999876 999999999987654322  2


Q ss_pred             ccccccccccCchhhcC-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          156 TEYVSTRWYRAPEVLLQ-----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      ....||+.|+|||++..     ...++.++|||||||++|+|++|..||.+.+..+....+......             
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------  227 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF-------------  227 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc-------------
Confidence            33579999999999863     335788999999999999999999999888776665555432100             


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                          ..++.         .+.++.++.+||.+||+ ||.+|||++++++||||+.
T Consensus       228 ----~~~~~---------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         228 ----LKFPE---------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             ----cCCCC---------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence                01111         13578999999999998 9999999999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3e-48  Score=363.87  Aligned_cols=280  Identities=25%  Similarity=0.347  Sum_probs=212.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC------CCCcccceeEEeeC-CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS------HPNIVKLKEVIREN-DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~-~~   74 (337)
                      ++|++++.||+|+||.||+|.+..+++.||+|+++....  .......|+.+++.+.      |.+++++++++..+ ..
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            579999999999999999999999999999999864321  1122235666666654      45688888888654 57


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-----------------
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-----------------  136 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-----------------  136 (337)
                      +++|||++++++++.+.+. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.+                 
T Consensus       207 ~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        207 MCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             EEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            8999999988888877665 459999999999999999999998 599999999999999754                 


Q ss_pred             cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 038835          137 TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG  216 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  216 (337)
                      .+||+|||.+.....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+
T Consensus       286 ~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g  362 (467)
T PTZ00284        286 RVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG  362 (467)
T ss_pred             eEEECCCCccccCcc--ccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence            399999998765332  23457899999999998765 789999999999999999999999999998888888888777


Q ss_pred             CCCccchhhh-----hhhHHhhhccCCCCCCCcc-------cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          217 TPTQDSWADG-----LLLARAINYKFPQLVGVPL-------SVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       217 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                      .++...+...     ...........+.......       .......++.+.|||.+||+.||.+|||++|+|+||||+
T Consensus       363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~  442 (467)
T PTZ00284        363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL  442 (467)
T ss_pred             CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence            6654322110     0000000000000000000       000011246688999999999999999999999999998


Q ss_pred             ccc
Q 038835          285 VAF  287 (337)
Q Consensus       285 ~~~  287 (337)
                      ...
T Consensus       443 ~~~  445 (467)
T PTZ00284        443 KYY  445 (467)
T ss_pred             ccC
Confidence            643

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-47  Score=338.96  Aligned_cols=284  Identities=37%  Similarity=0.719  Sum_probs=231.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |++|++.+.||.|++|.||++.++.+|+.||+|.+....... ......+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            689999999999999999999999999999999987643322 2234467999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCC-CCC
Q 038835           80 EYMECNLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSR-PPF  155 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~-~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~-~~~  155 (337)
                      ||+++++.+.+..... .+++..++.++.||+.||+|||++|++|+||+|+||+++.+  .+||+|||.+...... ...
T Consensus        81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            9999888877755432 36889999999999999999999999999999999999853  7999999999765432 223


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+..+...++....+.+....|.+........ .
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK-S  239 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh-h
Confidence            445778999999998765567899999999999999999999999888888888887777777777776433322221 1


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ..+...........+..++++.++|.+||+.||++||++.++++||||.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence            11211122222334678899999999999999999999999999999986

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-48  Score=350.61  Aligned_cols=247  Identities=33%  Similarity=0.467  Sum_probs=206.5

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.||+|+||.||++.++.+|+.||+|++.......  ......+|+++++.++||||+++++.+..++..|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997653322  2233457999999999999999999999999999999999987


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           86 LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        86 l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      .+.........+++..++.++.||+.||+|||+ +|++||||||+|||++.+ .+||+|||++..... ........||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            666655556679999999999999999999997 799999999999999876 899999999875332 22334567999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                   ...      
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-------------------~~~------  214 (325)
T cd05594         161 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------EIR------  214 (325)
T ss_pred             ccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-------------------CCC------
Confidence            99999998765 6799999999999999999999999887765554443221                   001      


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                           ....+++++.++|.+||+.||++|+     ++.++++||||..
T Consensus       215 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         215 -----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence                 1245789999999999999999997     9999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.3e-48  Score=353.76  Aligned_cols=257  Identities=27%  Similarity=0.390  Sum_probs=210.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||++.++.+++.+|+|++.+....  .......+|+.+++.++||||+++++++.+++..|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5799999999999999999999999999999998753222  12233457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ||++++.+..+.... .+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|.......  ...
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~  201 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD  201 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecc
Confidence            999876555555443 48999999999999999999999999999999999999876 99999999998764332  224


Q ss_pred             cccccccccCchhhcCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          157 EYVSTRWYRAPEVLLQS---YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ..+||+.|+|||++.+.   ..++.++|+||+||++|+|++|.+||.+.+..+....+......                
T Consensus       202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------------  265 (370)
T cd05621         202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS----------------  265 (370)
T ss_pred             cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc----------------
Confidence            56899999999998653   23788999999999999999999999988776666555432111                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK--RPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~~~~  285 (337)
                       ..++.         ...++..++++|.+||..+|.+  |+|++|+++||||+.
T Consensus       266 -~~~p~---------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         266 -LNFPE---------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             -cCCCC---------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence             01111         1246889999999999855543  899999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-47  Score=336.98  Aligned_cols=282  Identities=33%  Similarity=0.632  Sum_probs=222.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++....... ......+|+.++++++|||++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            58999999999999999999999999999999886543221 22334689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~  158 (337)
                      |+++++++.+......+++..++.++.||+.||.|||+.|++|+||||+||+++.+ .++|+|||.+....... .....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY  160 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence            99999998887666679999999999999999999999999999999999999876 89999999998765443 23345


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+....+....+.....................+
T Consensus       161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07847         161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP  240 (286)
T ss_pred             ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence            68899999999876556889999999999999999999999988877776666554433222110000000000000011


Q ss_pred             CC-CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QL-VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .. ...+.....+.++..+.++|.+||+.||++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            10 0011112235678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-48  Score=340.00  Aligned_cols=256  Identities=27%  Similarity=0.391  Sum_probs=211.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .|++.+.||+|+||.||++.+..+|+.||+|++........  .....+|+.+++.++||||+.+++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999876433221  2234579999999999999999999999999999999


Q ss_pred             ecCCCHHHH-Hhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           81 YMECNLYQL-MKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        81 ~~~~~l~~~-~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |++++.+.. +... ...+++..+..++.|++.||.|||++|++||||||+||+++++ .++|+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            999765544 3332 3458999999999999999999999999999999999999876 899999999987654444455


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+|++.|+|||++.+. .++.++||||+||++|+|++|..||.+.......+.+........                  
T Consensus       161 ~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------  221 (285)
T cd05605         161 RVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ------------------  221 (285)
T ss_pred             ccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc------------------
Confidence            6899999999998765 678999999999999999999999988765444433332211100                  


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                              ....+.++..+.++|.+||..||.+||     +++++++||||..
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         222 --------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             --------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence                    011245788999999999999999999     9999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-48  Score=335.61  Aligned_cols=255  Identities=30%  Similarity=0.462  Sum_probs=217.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH--hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE--CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +.|++++.||.|.-|+||+|..+.++..+|+|++.+.......  .+...|-.+|..++||.++.+|..|+.+...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            4678899999999999999999999999999999987655322  33356999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-----
Q 038835           80 EYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-----  151 (337)
Q Consensus        80 e~~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-----  151 (337)
                      |||.|+.+..+..+  ++.++++.++.++..++.||+|||-.|||+|||||+||||-++ .+-|+||.++.....     
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~  236 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV  236 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence            99998766655543  5679999999999999999999999999999999999999876 999999998743210     


Q ss_pred             ------------------------------C----------------------CCCccccccccccCchhhcCcCCCCCc
Q 038835          152 ------------------------------R----------------------PPFTEYVSTRWYRAPEVLLQSYLYSSK  179 (337)
Q Consensus       152 ------------------------------~----------------------~~~~~~~gt~~~~aPE~~~~~~~~~~~  179 (337)
                                                    .                      ....+++||--|.|||++.+. .-+.+
T Consensus       237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgsA  315 (459)
T KOG0610|consen  237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGSA  315 (459)
T ss_pred             ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCch
Confidence                                          0                      001246799999999999876 67899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHH
Q 038835          180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSL  259 (337)
Q Consensus       180 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  259 (337)
                      +|.|+||+++|||+.|..||.|.+..+.+.+|...                   ..+||.         .+.++.+++||
T Consensus       316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-------------------~l~Fp~---------~~~vs~~akDL  367 (459)
T KOG0610|consen  316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-------------------PLKFPE---------EPEVSSAAKDL  367 (459)
T ss_pred             hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-------------------CCcCCC---------CCcchhHHHHH
Confidence            99999999999999999999999999988877543                   112222         13678999999


Q ss_pred             HHHhcCCCCCCCCC----HHHHhcCcCccc
Q 038835          260 IASLCSWDPSKRPT----AAEALQHPFSRV  285 (337)
Q Consensus       260 i~~~L~~dP~~Rpt----~~ell~hp~~~~  285 (337)
                      |+++|.+||.+|..    |.||.+||||+.
T Consensus       368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEG  397 (459)
T ss_pred             HHHHhccChhhhhccccchHHhhcCccccC
Confidence            99999999999997    999999999986

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-48  Score=352.14  Aligned_cols=255  Identities=27%  Similarity=0.427  Sum_probs=205.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++...........+.+|+.+++.++|+||+++++++..++.+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            46888999999999999999999999999999987654333344557899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      ++++.+..    ....++..+..++.||+.||.|||++|++||||||+|||++.+ .+||+|||++...... .......
T Consensus       154 ~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~  229 (353)
T PLN00034        154 MDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV  229 (353)
T ss_pred             CCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccc
Confidence            99876643    2235788899999999999999999999999999999999876 8999999998865433 2234568


Q ss_pred             ccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          160 STRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       160 gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ||..|+|||.+..    +...+.++|||||||++|+|++|+.||......+....+....                   .
T Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-------------------~  290 (353)
T PLN00034        230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-------------------M  290 (353)
T ss_pred             cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-------------------c
Confidence            9999999998743    2234568999999999999999999997443322211111110                   0


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ..       ........+.++++||.+||+.||++|||+.|+++||||...
T Consensus       291 ~~-------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        291 SQ-------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             cC-------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            00       011124568899999999999999999999999999999864

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.2e-48  Score=347.96  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=204.7

Q ss_pred             CceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCCh---HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSW---EECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      +|++++.||+|+||.||++.+.   .+|+.||+|++.+.....   .......|+.+++.+ .||||+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5999999999999999998764   578999999987543211   122345799999999 599999999999999999


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-  153 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-  153 (337)
                      ++||||++++.+.........+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++....... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            9999999986554444445569999999999999999999999999999999999999876 99999999987653322 


Q ss_pred             -CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          154 -PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       154 -~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                       .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+....                 
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-----------------  223 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-----------------  223 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-----------------
Confidence             22346799999999998766567889999999999999999999997543321111111110                 


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                      ....         ....+.+++.+.++|.+||+.||++||     +++++++||||+.
T Consensus       224 ~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         224 LKCD---------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             hcCC---------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            0000         011245789999999999999999999     8899999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-47  Score=348.36  Aligned_cols=275  Identities=24%  Similarity=0.384  Sum_probs=210.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      .|++++.||+|+||.||+|.+..+++.||+|+.....       ...|+.++++++||||+++++++......++|||++
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            6999999999999999999999999999999854332       246899999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST  161 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt  161 (337)
                      .+++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||.+.............||
T Consensus       140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt  219 (357)
T PHA03209        140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT  219 (357)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccccc
Confidence            999999888777779999999999999999999999999999999999999876 8999999999765444444556799


Q ss_pred             ccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCc---------HHHHHHHHHHhCCCCccch--hhhhhh
Q 038835          162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSE---------ADEIYKICSVIGTPTQDSW--ADGLLL  229 (337)
Q Consensus       162 ~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~--~~~~~~  229 (337)
                      +.|+|||++.+. .++.++|||||||++|+|+++ .++|.....         ...+..+....+..+....  ......
T Consensus       220 ~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  298 (357)
T PHA03209        220 VETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV  298 (357)
T ss_pred             ccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHH
Confidence            999999998765 689999999999999999985 455554322         1223333333332222111  011111


Q ss_pred             HHhhhccCCCCCCC-c-ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          230 ARAINYKFPQLVGV-P-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       230 ~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .............. . ........+.++.++|.+||+.||.+|||+.|+|+||||++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        299 RGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            11111110000000 0 00011356788899999999999999999999999999974

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-48  Score=344.95  Aligned_cols=247  Identities=27%  Similarity=0.429  Sum_probs=202.5

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhc-CCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRK-MSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+|+.||+|++.....  .........|..++.. ++||||+++++++.+++..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999999999999999976532  1222333567777765 4899999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..+..++.||+.||+|||++|++||||||+|||++.+ .++|+|||++..... .......+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            6555444445568999999999999999999999999999999999999876 999999999875322 22234568999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...                      .+    
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~----------------------~~----  213 (316)
T cd05620         161 DYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD----------------------TP----  213 (316)
T ss_pred             CccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------------------CC----
Confidence            99999998765 6899999999999999999999999887766555444221                      00    


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCH-HHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTA-AEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~hp~~~~  285 (337)
                          ......+.+++++|.+||+.||.+||++ +++++||||..
T Consensus       214 ----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         214 ----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence                0113467899999999999999999998 58889999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-49  Score=327.87  Aligned_cols=270  Identities=30%  Similarity=0.473  Sum_probs=215.1

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      .+.||+|+|+.|..|+...||..||+|++.+.... ...+..+|++++.+. .|+||+.++++|+++..+|+|||-|.|+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH-sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH-SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCch-HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            35689999999999999999999999999987443 344556999999998 7999999999999999999999999975


Q ss_pred             -HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCC--------CC
Q 038835           86 -LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREIN--------SR  152 (337)
Q Consensus        86 -l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~--------~~  152 (337)
                       ++..+.++ ..++|.++.++++.|+.||.|||.+||.|||+||+|||....    -||||||.+.....        ..
T Consensus       162 plLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  162 PLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             hHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence             56666554 559999999999999999999999999999999999998653    79999999875432        12


Q ss_pred             CCCccccccccccCchhhc----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh---
Q 038835          153 PPFTEYVSTRWYRAPEVLL----QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD---  225 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---  225 (337)
                      +.+.+.+|+..|||||+..    +...|+.++|.||||||+|.||+|++||.|....+-        |+...+....   
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCRVCQN  312 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccHHHHH
Confidence            3345678999999999964    335789999999999999999999999988765211        1111111110   


Q ss_pred             -hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCCCC
Q 038835          226 -GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLS  293 (337)
Q Consensus       226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~  293 (337)
                       -........++||+       ..|..+|.+++|+|+.+|..|+.+|.++.++++|||++.-.....++
T Consensus       313 ~LFesIQEGkYeFPd-------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp  374 (463)
T KOG0607|consen  313 KLFESIQEGKYEFPD-------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP  374 (463)
T ss_pred             HHHHHHhccCCcCCh-------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence             11122233445554       34668999999999999999999999999999999998654443333

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-47  Score=336.76  Aligned_cols=280  Identities=39%  Similarity=0.732  Sum_probs=227.9

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++++.||.|++|.||+|.++.+|+.||+|.+....... ......+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4899999999999999999999999999999987543322 223456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           82 MECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      +.+++.+.+... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ .++|+|||.+...... ......
T Consensus        81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (284)
T cd07860          81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE  160 (284)
T ss_pred             cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence            988777766543 3568999999999999999999999999999999999999876 9999999998765432 223445


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+...++....+.+....|......... ...++
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  239 (284)
T cd07860         161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY-KPSFP  239 (284)
T ss_pred             cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH-Hhhcc
Confidence            67889999998876656788999999999999999999999998888888888887777766555433222111 11233


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ...........+.++++++++|.+||+.||.+|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            222222233345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.7e-48  Score=345.98  Aligned_cols=247  Identities=31%  Similarity=0.448  Sum_probs=205.8

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+|+.||+|++......  ........|..+++.+ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999765322  1222335688888766 899999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++..... ........||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            6665555555669999999999999999999999999999999999999876 999999999875432 22234567999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+....                   ..      
T Consensus       161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-------------------~~------  214 (321)
T cd05591         161 DYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-------------------VL------  214 (321)
T ss_pred             cccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------CC------
Confidence            99999998655 68999999999999999999999999888777666554310                   00      


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCC-------CHHHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRP-------TAAEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-------t~~ell~hp~~~~  285 (337)
                           .+...+.++.++|.+||+.||++||       +++++++||||..
T Consensus       215 -----~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         215 -----YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             -----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence                 1134678999999999999999999       9999999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-47  Score=338.21  Aligned_cols=284  Identities=39%  Similarity=0.705  Sum_probs=231.0

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC---h-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS---W-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +|++++.||.|++|.||+|.++.+|+.||+|.+......   . .......|+.++++++|+||+++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            699999999999999999999999999999999765433   1 122335799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~  156 (337)
                      |||+.+++.+.+......+++..++.++.||++||.|||++|++|+||+|+||+++.+ .++|+|||.+...... ....
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT  160 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence            9999666666665544369999999999999999999999999999999999999876 8999999999876543 2334


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ...+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.++.+...++....+.+....|...........  
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (298)
T cd07841         161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE--  238 (298)
T ss_pred             ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc--
Confidence            456788999999987665678999999999999999999999999888888888877777776666654332222111  


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .......+.....+..+.++.++|.+||+.||++|||+.|++.||||++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence            1111122223344567889999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.4e-48  Score=353.24  Aligned_cols=256  Identities=26%  Similarity=0.420  Sum_probs=209.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......  .......+|+.++..++||||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5799999999999999999999999999999999754322  12233457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----  153 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----  153 (337)
                      ||++|+.+..+......+++..++.++.|++.||+|||++||+||||||+|||++.+ .++|+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999986665555555669999999999999999999999999999999999999876 99999999986442110     


Q ss_pred             -------------------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 038835          154 -------------------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGT  202 (337)
Q Consensus       154 -------------------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  202 (337)
                                                     .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCCCC
Confidence                                           01245799999999998765 6899999999999999999999999988


Q ss_pred             CcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhc
Q 038835          203 SEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP---TAAEALQ  279 (337)
Q Consensus       203 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~  279 (337)
                      +..+....+.....                 ...++.         ...++++++++|.+|+. ||.+|+   +++++++
T Consensus       240 ~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         240 TPQETYRKVMNWKE-----------------TLVFPP---------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CHHHHHHHHHcCCC-----------------ceecCC---------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            77666555542100                 001111         12367899999999875 999998   5899999


Q ss_pred             CcCccc
Q 038835          280 HPFSRV  285 (337)
Q Consensus       280 hp~~~~  285 (337)
                      ||||+.
T Consensus       293 hp~f~~  298 (360)
T cd05627         293 HPFFEG  298 (360)
T ss_pred             CCCCCC
Confidence            999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-47  Score=346.50  Aligned_cols=291  Identities=34%  Similarity=0.546  Sum_probs=227.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   74 (337)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|.+.+..... ......+|+.++++++||||+++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            58999999999999999999999999999999987543332 223445799999999999999999988543      35


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .|+||||+++++...+...   +++..+..++.|++.||+|||++|++||||||+||+++.+ .+||+|||.+.......
T Consensus        96 ~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  172 (353)
T cd07850          96 VYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  172 (353)
T ss_pred             EEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence            7999999999888776543   8999999999999999999999999999999999999876 89999999998766544


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+..+....+....+.+....+..........
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (353)
T cd07850         173 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY  251 (353)
T ss_pred             CCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence            44556789999999998765 68999999999999999999999999888888888887777776654333221111111


Q ss_pred             hccCCCCCCCc-------------ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCCCCCCh
Q 038835          234 NYKFPQLVGVP-------------LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPE  296 (337)
Q Consensus       234 ~~~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~  296 (337)
                      ...-+.....+             ........+..++++|.+||+.||++|||+.|+|.||||+..+.......|.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~  327 (353)
T cd07850         252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPP  327 (353)
T ss_pred             hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCCCC
Confidence            00001000000             0111234567799999999999999999999999999998655554444443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.6e-48  Score=344.94  Aligned_cols=252  Identities=28%  Similarity=0.436  Sum_probs=209.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +|.+++.||+|+||.||+|.++.+++.||+|++.+.....  .......|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999998653321  222335677777777 5899999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~  157 (337)
                      ||++++.+.........+++..+..++.||+.||+|||++|++||||||+|||++.+ .+||+|||++..... ......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            999876555444455569999999999999999999999999999999999999877 899999999875432 222345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+....                   ..+
T Consensus       161 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------~~~  220 (323)
T cd05616         161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------------------VAY  220 (323)
T ss_pred             CCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------CCC
Confidence            6799999999998765 68999999999999999999999999887776666554321                   011


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA-----AEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  285 (337)
                                 +...+.++.+++.+||+.||.+|+++     .++++||||+.
T Consensus       221 -----------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         221 -----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             -----------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence                       23578999999999999999999974     89999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-47  Score=336.46  Aligned_cols=280  Identities=68%  Similarity=1.163  Sum_probs=241.0

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEEeec
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      |.+.+.||.|++|.||+|....+++.|++|.+.............+|+..+++++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7899999999999999999999999999999876544433444457999999998 999999999999999999999999


Q ss_pred             CCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccc
Q 038835           83 ECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~g  160 (337)
                      ++++.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++++ .++|+|||.+.............+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  160 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS  160 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCC
Confidence            888888776654 468999999999999999999999999999999999999986 999999999987766555556788


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      +..|+|||++.+...++.++|+||||+++++|++|++||.+....+...++....+.+....|.+...........++..
T Consensus       161 ~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd07830         161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF  240 (283)
T ss_pred             cccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccc
Confidence            99999999987665689999999999999999999999999999999999999888888888887766655555555544


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .........+..+.++.++|++||+.||++|||++|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            4333333344558899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.5e-47  Score=342.85  Aligned_cols=277  Identities=22%  Similarity=0.345  Sum_probs=211.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|+||.||++.++.+|..+|+|.+.............+|+++++.++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            68999999999999999999999999999999987654333334557899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      +.++.+..+......+++..+..++.|++.||.|||+. +++||||||+|||++.+ .+||+|||++...... ......
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~  163 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV  163 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCC
Confidence            98866665555556689999999999999999999985 79999999999999876 8999999998765332 123457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCccchh--------------
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV-IGTPTQDSWA--------------  224 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~--------------  224 (337)
                      |++.|+|||++.+. .++.++|+||+||++|+|++|+.||......+....+... .+.+......              
T Consensus       164 ~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (333)
T cd06650         164 GTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG  242 (333)
T ss_pred             CCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence            89999999998665 6789999999999999999999999876553332211100 0000000000              


Q ss_pred             -------hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          225 -------DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       225 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                             .............      .........+.++++||.+||+.||++|||++|++.||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         243 PDSRPPMAIFELLDYIVNEP------PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccccccccHHHHHHHHhcCC------CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                   0000000000000      0000112467889999999999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9e-48  Score=342.39  Aligned_cols=246  Identities=28%  Similarity=0.415  Sum_probs=206.6

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcE-EEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCC-EEEEEEe
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEV-VAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIREND-ILYFVFE   80 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~-vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e   80 (337)
                      ..+.+.||.|+||+||++...  |+. ||+|++........ ...+.+|+.+|.+++|||||++++++.+.. .++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            345667999999999999876  666 99999987654433 345578999999999999999999998877 7999999


Q ss_pred             ecCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCCeeeeCC--cEEEeeCCCcccCCCC-CC
Q 038835           81 YMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRG-YFHRDLKPENLLVSKD--TIKIADFGLAREINSR-PP  154 (337)
Q Consensus        81 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~-i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~-~~  154 (337)
                      |+++|.+..+...  ...++...+..|+.||+.|+.|||+++ ||||||||+|||++.+  ++||+|||+++..... ..
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~  200 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS  200 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence            9998877766644  677999999999999999999999999 9999999999999986  8999999999876543 33


Q ss_pred             CccccccccccCchhhcC-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 FTEYVSTRWYRAPEVLLQ-SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .+...||+.|||||++.+ ...|+.++||||||+++|||++|..||.+....+....+......|.              
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~--------------  266 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP--------------  266 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--------------
Confidence            455799999999999985 35799999999999999999999999999988666555543322211              


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                    ++...++.+.+++..||..||..||+..+++.
T Consensus       267 --------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 --------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                          11236788999999999999999999999864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.9e-48  Score=343.67  Aligned_cols=247  Identities=31%  Similarity=0.476  Sum_probs=202.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhc-CCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRK-MSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.+..+++.||+|++.......  .......|..++.. .+||||+++++++..++..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997653221  22223456666665 4899999999999999999999999988


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++...... ......+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            7665555555569999999999999999999999999999999999999876 8999999998764322 2334568999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||.+.+. .++.++||||+||++|+|++|..||.+.+..+....+....                      +    
T Consensus       161 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------------------~----  213 (316)
T cd05592         161 DYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR----------------------P----  213 (316)
T ss_pred             cccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------------C----
Confidence            99999998765 68999999999999999999999999887766555443210                      0    


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCH-HHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTA-AEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-~ell~hp~~~~  285 (337)
                          .....++.++.++|.+||+.||.+||++ .++++||||..
T Consensus       214 ----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         214 ----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence                1123567899999999999999999986 58889999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8e-48  Score=345.51  Aligned_cols=256  Identities=26%  Similarity=0.399  Sum_probs=200.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+|+.||+|++++......  ......|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            479999999999999999999999999986543322  23345789999888 799999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.... ........+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            6555444445669999999999999999999999999999999999999876 89999999987532 223334568999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++|+||+||++|+|++|+.||......+.          +..   ...............    
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------~~~---~~~~~~~~~~~~~~~----  222 (329)
T cd05588         161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----------PDQ---NTEDYLFQVILEKQI----  222 (329)
T ss_pred             cccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCccccccccc----------ccc---cchHHHHHHHHcCCC----
Confidence            99999998765 679999999999999999999999964221100          000   000000000000000    


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPT------AAEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~~~~  285 (337)
                          ..+..++.++.++|.+||+.||.+|+|      ++++++||||..
T Consensus       223 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         223 ----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             ----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence                112457889999999999999999987      789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.8e-47  Score=336.94  Aligned_cols=281  Identities=37%  Similarity=0.676  Sum_probs=227.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCC-CCCcccceeEEeeCCE-----
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMS-HPNIVKLKEVIRENDI-----   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----   74 (337)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+....... ......+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            58999999999999999999999999999999987643322 1234467999999995 6999999999876555     


Q ss_pred             EEEEEeecCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-C-cEEEeeCCCccc
Q 038835           75 LYFVFEYMECNLYQLMKDR----EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-D-TIKIADFGLARE  148 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-~-~~kL~Dfg~a~~  148 (337)
                      .|+||||+++++.+.+...    ...+++..++.++.||+.||.|||++|++||||+|+||+++. + .++|+|||.+..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            8999999999887776543    235899999999999999999999999999999999999997 4 899999999876


Q ss_pred             CCCC-CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh
Q 038835          149 INSR-PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL  227 (337)
Q Consensus       149 ~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  227 (337)
                      .... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.++.+....+....+.+....|....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            5432 222345678899999998766567999999999999999999999999988888888888777777766665433


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                      .......  ++...........+.++.++.++|.+||..||.+|||++|++.||||+
T Consensus       241 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHE--FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhh--cCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            3222221  222222223333456889999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.6e-49  Score=327.46  Aligned_cols=287  Identities=35%  Similarity=0.618  Sum_probs=231.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc----EEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee-CCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE-NDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   75 (337)
                      ..|++++.||+|.||.||+|..+.++.    .+|+|.++.+.... -.....+|+.+++.++||||+.+..+|-+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            469999999999999999997766543    68999998663321 22334689999999999999999999876 7889


Q ss_pred             EEEEeecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-----CcEEEeeCCCc
Q 038835           76 YFVFEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-----DTIKIADFGLA  146 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-----~~~kL~Dfg~a  146 (337)
                      |+++||++.+++..+..    ....++...++.+++||+.|+.|||++=|+||||||.|||+..     +.|||+|||+|
T Consensus       104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla  183 (438)
T KOG0666|consen  104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA  183 (438)
T ss_pred             EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence            99999999999998863    2356899999999999999999999999999999999999963     38999999999


Q ss_pred             ccCCCCC----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHH
Q 038835          147 REINSRP----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---------ADEIYKICS  213 (337)
Q Consensus       147 ~~~~~~~----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~  213 (337)
                      +.+.+.-    .....+-|.+|+|||++.+..-|+.+.|+|++|||+.||++..|.|.+...         .+++.+|.+
T Consensus       184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~  263 (438)
T KOG0666|consen  184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE  263 (438)
T ss_pred             HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence            9775432    224567899999999999998999999999999999999999999976442         478999999


Q ss_pred             HhCCCCccchhhhhhhHHhhhc--cCC-----CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          214 VIGTPTQDSWADGLLLARAINY--KFP-----QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .+|.|.+..|.+-.......+.  .++     ...-..+-.....-++.+.+|+.+||..||.+|.|++++|+|+||...
T Consensus       264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence            9999999999875543332110  111     100000111223345669999999999999999999999999999976


Q ss_pred             cc
Q 038835          287 FM  288 (337)
Q Consensus       287 ~~  288 (337)
                      ..
T Consensus       344 ~l  345 (438)
T KOG0666|consen  344 PL  345 (438)
T ss_pred             CC
Confidence            43

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.9e-48  Score=344.13  Aligned_cols=248  Identities=31%  Similarity=0.478  Sum_probs=205.5

Q ss_pred             eeeecccCceEEEEEEEC---CCCcEEEEEEcccccCC---hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            7 IKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYS---WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++.||+|+||.||++.+.   .+|+.||+|++......   .......+|+.+++.++||||+++++.+..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   57889999998764321   122234579999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      |++++.+.....+...+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++...... ......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99987666555556668999999999999999999999999999999999999876 9999999998754322 223446


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+....                   .   
T Consensus       161 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------------~---  217 (323)
T cd05584         161 CGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------------L---  217 (323)
T ss_pred             CCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------C---
Confidence            799999999998665 67899999999999999999999998877666555543210                   0   


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                              ..++..++++.++|.+||+.||++||     +++++++||||..
T Consensus       218 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         218 --------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             --------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence                    11245678999999999999999999     8999999999975

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.1e-48  Score=345.56  Aligned_cols=247  Identities=31%  Similarity=0.463  Sum_probs=203.0

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHH-HHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVK-SLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+|+.||+|++.......  .......|.. +++.++||||+++++.+.+++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999997643221  1222334444 56789999999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++..... .......+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            7665555556679999999999999999999999999999999999999876 999999999875432 22234567999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....                           
T Consensus       161 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------------------  212 (323)
T cd05575         161 EYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP---------------------------  212 (323)
T ss_pred             hhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------------------------
Confidence            99999998765 68999999999999999999999998877666555443210                           


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTA----AEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~~~~  285 (337)
                         ....+.++.++.++|.+||+.||.+||++    .+++.||||..
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         213 ---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence               01124568999999999999999999988    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.4e-48  Score=343.55  Aligned_cols=247  Identities=30%  Similarity=0.477  Sum_probs=205.3

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+++.||+|++.+....  ........|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999865322  1223335788888877 799999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.....+...+++..+..++.||+.||.|||++|++||||||+||+++.+ .+||+|||++..... .......+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            7665555555569999999999999999999999999999999999999876 999999999875322 22234467999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...                   ...      
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-------------------~~~------  214 (318)
T cd05570         161 DYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-------------------EVR------  214 (318)
T ss_pred             cccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------------------CCC------
Confidence            99999998765 6899999999999999999999999887765555444221                   000      


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTA-----AEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  285 (337)
                           .+...+.++.++|.+||+.||.+|||+     .++++||||..
T Consensus       215 -----~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         215 -----YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             -----CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence                 123567899999999999999999999     99999999976

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-47  Score=342.99  Aligned_cols=285  Identities=38%  Similarity=0.660  Sum_probs=225.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN-----DILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (337)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|.+.............+|+.+++.++||||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            58999999999999999999999999999999986533333333446799999999999999999886543     4589


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      +++||+++++...+..  ..+++..++.++.|++.||.|||+.|++||||||+||+++.+ .++|+|||++.......  
T Consensus        85 lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  162 (336)
T cd07849          85 IVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH  162 (336)
T ss_pred             EEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence            9999999888776643  358999999999999999999999999999999999999886 89999999987654322  


Q ss_pred             --CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          154 --PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       154 --~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        ......|++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+....+.+..+.+........
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (336)
T cd07849         163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA  242 (336)
T ss_pred             cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence              123457899999999876655689999999999999999999999998887777777777777766655543221111


Q ss_pred             h-hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          232 A-INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       232 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      . .....+.....+.....+..+.++.++|.+||+.||.+|||+.|+++||||.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            0 00111111122222233567899999999999999999999999999999987554

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-47  Score=336.18  Aligned_cols=249  Identities=28%  Similarity=0.364  Sum_probs=201.4

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      ||+|+||+||++.++.+|+.+|+|.+........  ......|+.+++.++||||+++.+++..++..++||||++++.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999876433221  12335799999999999999999999999999999999998665


Q ss_pred             HHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcccccc
Q 038835           88 QLMK----DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVST  161 (337)
Q Consensus        88 ~~~~----~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~gt  161 (337)
                      ....    ..+..+++..++.++.||+.||.|||++|++||||||+||+++.+ .++|+|||.+....... ......||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            4333    234568999999999999999999999999999999999999876 89999999987654332 23446799


Q ss_pred             ccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCC
Q 038835          162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV  241 (337)
Q Consensus       162 ~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
                      +.|+|||.+.+. .++.++|+||+||++|+|++|+.||...........+.......                       
T Consensus       161 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------  216 (280)
T cd05608         161 PGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-----------------------  216 (280)
T ss_pred             cCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-----------------------
Confidence            999999998765 67899999999999999999999997654332222211110000                       


Q ss_pred             CCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       242 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                         .....+.++.++.+++.+||+.||++||     |++++++||||+.
T Consensus       217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         217 ---SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             ---CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence               0012245789999999999999999999     8899999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.5e-47  Score=341.88  Aligned_cols=247  Identities=28%  Similarity=0.457  Sum_probs=202.8

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhc-CCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRK-MSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+++.||+|++.....  .........|..++.. ++||||+++++++.+++.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999976532  1222333467777775 4999999999999999999999999987


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..+..++.|++.||.|||++|++||||||+|||++.+ .+||+|||++..... ........||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            6655555555568999999999999999999999999999999999999876 899999999875422 22334567999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...                      .+    
T Consensus       161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~----------------------~~----  213 (316)
T cd05619         161 DYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD----------------------NP----  213 (316)
T ss_pred             cccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------------------CC----
Confidence            99999998765 6899999999999999999999999887766555443221                      00    


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA-EALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~~~~  285 (337)
                          ......+.++.++|.+||+.||.+||++. ++++||||..
T Consensus       214 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         214 ----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             ----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence                01134678899999999999999999996 8999999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-50  Score=334.87  Aligned_cols=254  Identities=27%  Similarity=0.435  Sum_probs=215.3

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      |.++++||+|+||.||+|.++++|+.+|||.+.-+.   ......+|+.++++++.|+||++|+.|..+..+|||||||+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            678899999999999999999999999999987643   34456799999999999999999999999999999999999


Q ss_pred             CCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccccc
Q 038835           84 CNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVS  160 (337)
Q Consensus        84 ~~l~~-~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~g  160 (337)
                      .+..+ .+..++++++|+++..+++.-+.||+|||...-+|||||..|||++.+ .+||+|||.|.+..+. ....+.+|
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcccc
Confidence            66554 555678899999999999999999999999999999999999999876 9999999999887643 44577899


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      ||.|||||++..- .|++.+||||||++..||..|+|||.+-.+...   |..                       .|..
T Consensus       192 TPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFM-----------------------IPT~  244 (502)
T KOG0574|consen  192 TPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFM-----------------------IPTK  244 (502)
T ss_pred             CcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccce---eEe-----------------------ccCC
Confidence            9999999998654 789999999999999999999999987655321   111                       1111


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .++.. ..+..+|.++.|||++||.+.|++|.|+-++++|||+++++.
T Consensus       245 PPPTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  245 PPPTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             CCCCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            11111 112467889999999999999999999999999999987653

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-47  Score=348.85  Aligned_cols=257  Identities=27%  Similarity=0.390  Sum_probs=209.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||+|.++.+++.+|+|++.+.....  ......+|+.+++.++||||+++++.+.+++..|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999987533221  2223457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ||++|+.+..+.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.......  ...
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~  201 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD  201 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccccc
Confidence            999987665555443 48999999999999999999999999999999999999876 99999999998764332  224


Q ss_pred             cccccccccCchhhcCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          157 EYVSTRWYRAPEVLLQS---YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ..+||+.|+|||++...   ..++.++||||+||++|+|++|.+||.+.+.......+......                
T Consensus       202 ~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------------  265 (371)
T cd05622         202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS----------------  265 (371)
T ss_pred             CcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc----------------
Confidence            56899999999998643   23788999999999999999999999988776665555432100                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK--RPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~~~~  285 (337)
                       ..++.         ...++.+++++|.+||..++.+  |++++++++||||..
T Consensus       266 -~~~~~---------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         266 -LTFPD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             -ccCCC---------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence             01111         1357899999999999844433  789999999999976

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.4e-47  Score=339.75  Aligned_cols=283  Identities=35%  Similarity=0.655  Sum_probs=227.2

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee--------
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE--------   71 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------   71 (337)
                      +++|++.+.||.|++|.||+|.++.+|+.+|+|.+....... ......+|+.+++.++||||+++++++..        
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999999999999999986543322 12234589999999999999999998743        


Q ss_pred             CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835           72 NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      ...+++|+||+++++...+......+++..++.++.|+++||.|||++|++|+||||+||+++++ .++|+|||++....
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            23579999999999888877666679999999999999999999999999999999999999887 99999999987554


Q ss_pred             CCCC------------CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 038835          151 SRPP------------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP  218 (337)
Q Consensus       151 ~~~~------------~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  218 (337)
                      ....            .....+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+....+....+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP  246 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            3211            1234678899999998766568899999999999999999999999999988888888887777


Q ss_pred             CccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ....|.............................++.+.++|.+||+.||.+|||+.|++.||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77666543322222111111111111222234566889999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.9e-47  Score=339.47  Aligned_cols=274  Identities=33%  Similarity=0.596  Sum_probs=210.4

Q ss_pred             eeeecccCceEEEEEEECC--CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe--eCCEEEEEEeec
Q 038835            7 IKEVGDGTFGSVWRAISKQ--SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR--ENDILYFVFEYM   82 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~   82 (337)
                      +.+||+|+||.||+|.++.  ++..||+|.+......   ....+|+.+++.++||||+++++++.  .+...++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS---MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc---HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            5689999999999999764  5688999998754322   23458999999999999999999884  456789999999


Q ss_pred             CCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee----C-CcEEEeeCCCcccC
Q 038835           83 ECNLYQLMKDR--------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS----K-DTIKIADFGLAREI  149 (337)
Q Consensus        83 ~~~l~~~~~~~--------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~----~-~~~kL~Dfg~a~~~  149 (337)
                      ++++.+.+...        ...+++..++.++.||+.||.|||++|++||||||+||++.    . +.+||+|||++...
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            99888776421        23488999999999999999999999999999999999994    2 28999999999865


Q ss_pred             CCCC----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHhC
Q 038835          150 NSRP----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---------ADEIYKICSVIG  216 (337)
Q Consensus       150 ~~~~----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~~~~  216 (337)
                      ....    ......||+.|+|||.+.+...++.++||||+||++|+|++|.+||.....         ...+..+....+
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG  242 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence            4322    224467899999999987765689999999999999999999999975432         345666777777


Q ss_pred             CCCccchhhhhhhHHhhhcc--C--CCCCCC----cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          217 TPTQDSWADGLLLARAINYK--F--PQLVGV----PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~--~--~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .+....|.............  +  ......    .........+..+.++|.+||+.||.+|||++|+|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            77777776543221111100  0  000000    0111123456779999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.3e-48  Score=334.62  Aligned_cols=257  Identities=36%  Similarity=0.647  Sum_probs=209.2

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHh-HHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEEC-VNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      |++++.||+|+||+||++.++.+++.+|+|++.......... ...+|+.++++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            899999999999999999999999999999998765443332 2246999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC-CCCCCCccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~-~~~~~~~~~~g  160 (337)
                      +++.+..+......+++..++.++.||+.||++||++|++|+||||+||+++.+ .++|+|||.+... ..........+
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  160 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG  160 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            995444444445568999999999999999999999999999999999999965 8999999998763 23334456789


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      ++.|+|||++.....++.++|+||+|+++|+|++|..||......+....+..........              .... 
T Consensus       161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~-  225 (260)
T PF00069_consen  161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------------SSQQ-  225 (260)
T ss_dssp             SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------------HTTS-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------------cccc-
Confidence            9999999998734578999999999999999999999999875444444443322111000              0000 


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                              ....+.++.++|.+||+.||++|||+.++++||||
T Consensus       226 --------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  226 --------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             --------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             --------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                    01123789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-49  Score=355.00  Aligned_cols=258  Identities=28%  Similarity=0.497  Sum_probs=220.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      -|.|+..||.|+||+||+|.++.++-..|.|+|..... .....++-|+.+|..++||+||++++.|...+.+||..|||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse-EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE-EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch-hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            46788999999999999999999999899999875432 23334467999999999999999999999999999999999


Q ss_pred             CCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC-CCCCCCcccc
Q 038835           83 ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYV  159 (337)
Q Consensus        83 ~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~-~~~~~~~~~~  159 (337)
                      +||-.+.+. .-+.++++++|.-+++|++.||.|||+++|||||||..|||++.+ .++|+|||.+... .......+++
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI  191 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI  191 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence            999877665 457789999999999999999999999999999999999999865 9999999976543 3445567899


Q ss_pred             ccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          160 STRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       160 gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      |||+|||||+..+    +.+|++++||||||+++.+|..+.||-...+....+-+|..-                     
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---------------------  250 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---------------------  250 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---------------------
Confidence            9999999999864    458999999999999999999999999988887776666432                     


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      ..|.+      ..+..++..+.||+.+||.+||..||++++||+||||++...
T Consensus       251 ePPTL------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  251 EPPTL------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             CCCcc------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            11111      223577899999999999999999999999999999997543

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.7e-47  Score=336.74  Aligned_cols=283  Identities=34%  Similarity=0.568  Sum_probs=221.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC-------
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN-------   72 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------   72 (337)
                      +++|++.+.||.|++|.||+|.++.+|+.||+|.+....... ......+|+.++++++||||+++++++...       
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            478999999999999999999999999999999886543222 122335799999999999999999987644       


Q ss_pred             -CEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835           73 -DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus        73 -~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                       ...++||||+++++.+.+......+++..++.++.||+.||.|||++|++|+||||+||+++.+ .+||+|||.+....
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence             3569999999998888887766679999999999999999999999999999999999999876 89999999987654


Q ss_pred             CCC-----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          151 SRP-----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       151 ~~~-----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      ...     ......++..|+|||.+.+...++.++||||+|+++|+|++|.+||.+.+.......+....+..+...|..
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (310)
T cd07865         171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG  250 (310)
T ss_pred             CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            321     123356788999999887665578899999999999999999999999888777777777766665555443


Q ss_pred             hhhhHHhhhccCCCCCCC--cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          226 GLLLARAINYKFPQLVGV--PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ............+.....  .........+..+.++|.+||..||.+|||++++++||||
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            321111111111111000  0000011245778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-47  Score=334.25  Aligned_cols=280  Identities=47%  Similarity=0.885  Sum_probs=239.0

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+...... .......+|+.++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            78899999999999999999999999999998765443 22334468999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~g  160 (337)
                      ++++.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+....... ......+
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV  160 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence            998888887766679999999999999999999999999999999999999976 89999999988765543 3344678


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      +..|+|||.+.+...++.++|+||+|+++|+|++|++||.+.+..+....+....+.+....|.............++..
T Consensus       161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05118         161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK  240 (283)
T ss_pred             cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence            89999999987665789999999999999999999999999998888888888877777776666555444444455544


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .........+..+.++.++|.+||+.||.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            4444445556789999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.3e-47  Score=339.36  Aligned_cols=252  Identities=29%  Similarity=0.452  Sum_probs=208.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +|++.+.||+|+||.||+|.++.+|+.||+|++.+....  ........|..+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            588999999999999999999999999999999764322  12233457888888885 577888999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||++|+.+.........+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++...... .....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            999986665555555669999999999999999999999999999999999999876 8999999998764322 22244


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+....                   ..+
T Consensus       161 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-------------------~~~  220 (323)
T cd05615         161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-------------------VSY  220 (323)
T ss_pred             ccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------CCC
Confidence            6799999999998765 68999999999999999999999999887766655554321                   011


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                                 +...+.++.+++.+||+.||.+|++     .+++++||||+.
T Consensus       221 -----------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         221 -----------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             -----------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence                       1356789999999999999999997     579999999986

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-47  Score=340.19  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=207.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||++.++.+++.||+|++.+....  .......+|+.+++.++|+||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            5899999999999999999999999999999998753221  12233457899999999999999999999999999999


Q ss_pred             eecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--C
Q 038835           80 EYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--F  155 (337)
Q Consensus        80 e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~  155 (337)
                      ||+.|+.+ +.+.+....+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||.+........  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99987544 4554445669999999999999999999999999999999999999876 899999999876543322  1


Q ss_pred             ccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 TEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ...+||+.|+|||++..    ...++.++||||+||++|+|++|+.||.+.+..+....+......              
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------------  226 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH--------------  226 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc--------------
Confidence            23579999999999863    235788999999999999999999999887766655554321100              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCC--CCCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPS--KRPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~--~Rpt~~ell~hp~~~~  285 (337)
                         ..+        ....+.++.+++++|++||..++.  .|++++++++||||..
T Consensus       227 ---~~~--------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         227 ---FQF--------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             ---ccC--------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence               001        111235789999999999865443  3789999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.9e-47  Score=341.86  Aligned_cols=251  Identities=27%  Similarity=0.405  Sum_probs=199.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+++.+|+|++.+.....  .......|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998654322  222345788888776 899999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.... ........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            7665555555669999999999999999999999999999999999999876 99999999987532 222334568999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA-----DEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .|+|||++.+. .++.++|||||||++|+|++|..||......     .....+..                  ......
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------------------~i~~~~  221 (329)
T cd05618         161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ------------------VILEKQ  221 (329)
T ss_pred             cccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH------------------HHhcCC
Confidence            99999998765 6799999999999999999999999532110     00000000                  000000


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT------AAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~~~~  285 (337)
                              ...+...+.++.++|.+||+.||.+|||      +.++++||||+.
T Consensus       222 --------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         222 --------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence                    0122467889999999999999999998      589999999976

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-49  Score=321.22  Aligned_cols=286  Identities=34%  Similarity=0.581  Sum_probs=236.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEee--------C
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIRE--------N   72 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~   72 (337)
                      ..|.-..+||+|.||.||+|..+.+|+.||+|++.-+... .-....++|+++|..|+|+|++.+++++..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4677788999999999999999999999999877542211 112234799999999999999999988642        3


Q ss_pred             CEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC
Q 038835           73 DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS  151 (337)
Q Consensus        73 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~  151 (337)
                      ..+|+||.+|+.++...+.+....++..+|+.++.+++.||.|+|+..|+|||+|++|+||+.+ .+||+|||+++..+.
T Consensus        97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~  176 (376)
T KOG0669|consen   97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST  176 (376)
T ss_pred             ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence            4689999999999999888877779999999999999999999999999999999999999985 999999999976543


Q ss_pred             C-----CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          152 R-----PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       152 ~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      .     +.++..+.|.+|++||.+.+...|+++.|||..||++.+|+++.+.+.+.++...+..|...+|....+.|...
T Consensus       177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            2     23466778999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             hhhHHhhhccCCCCCCCcccccC-----CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLM-----PSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      ....-....+.+.+.........     -.-.+++.||+.++|..||.+|++++++|.|.||-...
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            54433333332322221111111     12246899999999999999999999999999997643

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-47  Score=332.66  Aligned_cols=282  Identities=40%  Similarity=0.683  Sum_probs=225.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++.+.||.|++|.||+|.++.+++.||+|.+....... ......+|+++++.++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            57999999999999999999999999999999987643322 23345689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCcc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTE  157 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~  157 (337)
                      |++++++..+..+...+++..++.++.||+.||.|||++|++|+||+|+||+++.+ .++|+|||.+.......  ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD  160 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence            99999988877766679999999999999999999999999999999999999876 99999999988765543  3345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+.+..+....+......+.............+
T Consensus       161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07833         161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF  240 (288)
T ss_pred             cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence            67899999999987665788999999999999999999999998888777777666555444322221110000000011


Q ss_pred             CCCCCC-ccc-ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGV-PLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~-~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +..... ... .....++.++.++|++||..||++|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            111100 000 1223458999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.2e-47  Score=332.12  Aligned_cols=282  Identities=33%  Similarity=0.647  Sum_probs=222.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++.+.||+|++|.||+|.++.+|+.+|+|.+....... ......+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            58999999999999999999999999999999986543332 23344689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      |+++++++.+......+++..++.++.||+.||+|||+.|++|+||+|+||+++++ .++|+|||++...... ......
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY  160 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence            99999888777666669999999999999999999999999999999999999876 8999999998765432 223446


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .++..|+|||.+.+...++.++||||+|+++|+|++|++||.+....+....+....+.....................+
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07846         161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP  240 (286)
T ss_pred             cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence            78899999999876556788999999999999999999999887777766666655443322110000000000011111


Q ss_pred             CCCC-CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QLVG-VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +... .......+.++..+.+++.+||..||++|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            1110 11112245778999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-48  Score=344.10  Aligned_cols=248  Identities=27%  Similarity=0.443  Sum_probs=205.6

Q ss_pred             eeeecccCceEEEEEEE---CCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            7 IKEVGDGTFGSVWRAIS---KQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~---~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      ++.||+|+||.||++.+   +.+|+.+|+|++....... .......|+.++++++||||+++++++..++..|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999976   4678999999997654322 2233457999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~g  160 (337)
                      +++.+.....+...+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+...... .......|
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            876554444555669999999999999999999999999999999999999876 9999999998765443 23345689


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      |+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+....                   .     
T Consensus       161 ~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-------------------~-----  215 (318)
T cd05582         161 TVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-------------------L-----  215 (318)
T ss_pred             ChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-------------------C-----
Confidence            9999999998664 67899999999999999999999998877666655543210                   0     


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                            ...+.+++++.++|++||+.||.+|||     +++++.||||+.
T Consensus       216 ------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         216 ------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence                  112356889999999999999999999     788999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-47  Score=342.80  Aligned_cols=247  Identities=31%  Similarity=0.473  Sum_probs=202.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHH-HHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVK-SLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+|+.+|+|++.......  .......|.. +++.++||||+++++.+..++..|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999997643221  2222334444 56778999999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++..... .......+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            7665555556679999999999999999999999999999999999999876 899999999875432 22334567999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+....                           
T Consensus       161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~---------------------------  212 (325)
T cd05604         161 EYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP---------------------------  212 (325)
T ss_pred             hhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC---------------------------
Confidence            99999998765 67899999999999999999999998877665554443210                           


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTA----AEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~~~~  285 (337)
                         ....+..+.++.++|++||+.||.+||++    .+++.||||..
T Consensus       213 ---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         213 ---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             ---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence               01124578899999999999999999977    59999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-46  Score=339.03  Aligned_cols=285  Identities=36%  Similarity=0.661  Sum_probs=227.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIREN-----DIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (337)
                      ++|.+.+.||+|++|.||++.+..+|+.||+|.+...... .......+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            5899999999999999999999999999999998754322 1233446799999999999999999987543     358


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-C
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-P  153 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~  153 (337)
                      ++|+||+++++.+.+.. ...+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||++...... .
T Consensus        85 ~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  163 (337)
T cd07858          85 YIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD  163 (337)
T ss_pred             EEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence            99999999888777654 4569999999999999999999999999999999999999876 8999999999866443 2


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh--hhHH
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL--LLAR  231 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~  231 (337)
                      ......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....+....+.+....+....  ...+
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07858         164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR  243 (337)
T ss_pred             cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence            23445788999999998765468899999999999999999999999888777777777777776665542111  0011


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .. ...+...........+.+++++.++|.+||+.||.+|||++++++||||.....
T Consensus       244 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         244 YI-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             HH-HhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            11 011222222223334678999999999999999999999999999999986443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-48  Score=345.71  Aligned_cols=247  Identities=28%  Similarity=0.423  Sum_probs=201.7

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcC---CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKM---SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      ||+|+||.||+|.++.+|+.||+|++.+.....  .......|..++..+   +||||+.+++.+...+..|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999987543221  112224566666655   799999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .++|+|||++..... .......+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            6555444555669999999999999999999999999999999999999876 999999999875432 22334568999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+....                   ..++    
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~~----  217 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK-------------------VRFP----  217 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC-------------------CCCC----
Confidence            99999998766568999999999999999999999998877666555443210                   0111    


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCC----CHHHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRP----TAAEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----t~~ell~hp~~~~  285 (337)
                            ...+++++.++|.+||..||.+||    ++.++++||||..
T Consensus       218 ------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         218 ------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             ------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence                  124678999999999999999998    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.2e-47  Score=341.23  Aligned_cols=247  Identities=32%  Similarity=0.466  Sum_probs=203.2

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHH-HHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREV-KSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+++.||+|++.......  .......|. .+++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999997643211  122223343 456788999999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..... .......+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            7666555555668999999999999999999999999999999999999876 999999999875432 22334568999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+....                           
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------------------------  212 (325)
T cd05602         161 EYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------------------------  212 (325)
T ss_pred             cccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------------------------
Confidence            99999998765 68999999999999999999999999887766655543210                           


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCHH----HHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA----EALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~~~~  285 (337)
                         ....+.++..+.++|.+||+.||.+|+++.    ++++|+||..
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         213 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             ---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence               011246789999999999999999999876    8999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.9e-47  Score=339.33  Aligned_cols=285  Identities=38%  Similarity=0.696  Sum_probs=230.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEe----eCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIR----ENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~   76 (337)
                      ++|++.+.||.|++|.||++.++.+|+.||+|++...... .......+|+.++++++||||+++++++.    .....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5799999999999999999999999999999998764332 22334467999999999999999999875    345789


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      +||||+++++.+.+.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+.......  
T Consensus        85 lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          85 VVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            9999998877666544 4559999999999999999999999999999999999999887 89999999987653321  


Q ss_pred             ---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 ---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 ---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                         ......|+..|+|||.+.+...++.++||||+||++|+|++|++||.+.+....+..+....+.++...+.......
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~  243 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR  243 (334)
T ss_pred             CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence               11345789999999998765568999999999999999999999999988888888888888877766554322111


Q ss_pred             -HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          231 -RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                       ......++......+....+..+.++.++|.+||+.||.+|||+++++.||||....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence             111112333333444445567899999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=330.51  Aligned_cols=279  Identities=39%  Similarity=0.770  Sum_probs=227.5

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      |++.+.||.|++|.||+|.++.+|+.||+|++........ .....+|+..++.++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            7889999999999999999999999999999876533221 233467999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           83 ECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        83 ~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      ++++.+.+.... ..+++..++.++.|++.||.|||+++++||||+|+||+++++ .++|+|||.+...... .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  160 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV  160 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence            887777665543 358999999999999999999999999999999999999876 9999999998765432 2223446


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      +++.|+|||.+.+...++.++|+||+|+++|+|++|++||.+.++.+...++....+.+....|......... ...++.
T Consensus       161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  239 (283)
T cd07835         161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY-KPTFPK  239 (283)
T ss_pred             cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh-hhhccc
Confidence            7889999998876556788999999999999999999999998888777777777777766665443222211 112232


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ..........+.++.++.++|.+||+.||.+|||++|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            22223334456788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1e-46  Score=334.51  Aligned_cols=283  Identities=36%  Similarity=0.652  Sum_probs=227.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCC------
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREND------   73 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------   73 (337)
                      +++|++.+.||.|++|.||+|.++.+|+.||+|.+....... ......+|+.++++++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            468999999999999999999999999999999987543221 2233457999999999999999999986544      


Q ss_pred             ----EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCccc
Q 038835           74 ----ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLARE  148 (337)
Q Consensus        74 ----~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~  148 (337)
                          .+++|+||+++++...+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.+ .+||+|||.+..
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  165 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL  165 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence                799999999998888777665569999999999999999999999999999999999999886 899999999876


Q ss_pred             CCCCC--CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          149 INSRP--PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       149 ~~~~~--~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      .....  ......++..|+|||.+.+...++.++||||+||++++|++|++||...+..+.+..+....+.+....|...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (302)
T cd07864         166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV  245 (302)
T ss_pred             ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence            54332  2233456888999998876556789999999999999999999999998888888888888777776666543


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .........................++..+.++|.+||+.||.+|||+++++.||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            221111111111100011112234568999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=347.84  Aligned_cols=251  Identities=31%  Similarity=0.482  Sum_probs=220.5

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      |.-++.||.|+||.||.|.+..|.+.||||++.-...  ...+..+++|+..|++++|||++.+.++|-.....|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            4556789999999999999999999999999865432  23455668999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS  160 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~g  160 (337)
                      |-|+-.+.+.-..+++.|..|+.|..+.+.||+|||+.+.||||||..|||+++. .|||+|||.|....+.   .+++|
T Consensus       108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsFvG  184 (948)
T KOG0577|consen  108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSFVG  184 (948)
T ss_pred             HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hcccC
Confidence            9998777777667789999999999999999999999999999999999999886 9999999999877654   67899


Q ss_pred             cccccCchhhc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          161 TRWYRAPEVLL--QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       161 t~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      ||+|||||++.  +...|+-++||||||++..+|...+||+..++....++.|...-.+                     
T Consensus       185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP---------------------  243 (948)
T KOG0577|consen  185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------------------  243 (948)
T ss_pred             CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC---------------------
Confidence            99999999986  3347899999999999999999999999999999999888664211                     


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+.       .+.+|..++.||..||++-|.+|||.+++|.|+|+.-
T Consensus       244 tLq-------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  244 TLQ-------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             CCC-------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            111       2567789999999999999999999999999999863

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-46  Score=345.99  Aligned_cols=276  Identities=22%  Similarity=0.370  Sum_probs=212.9

Q ss_pred             CceEeeeecccCceEEEEEEEC--CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +|.+++.||.|+||.||+|...  .+++.||+|.+....      ...+|+.+++.++||||+++++++......+++||
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            6999999999999999999754  456789999886532      22479999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC---CCc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP---PFT  156 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~---~~~  156 (337)
                      ++.+++.+.+ .....+++..++.++.||+.||.|||++||+||||||+|||++.+ .++|+|||++.......   ...
T Consensus       167 ~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~  245 (392)
T PHA03207        167 KYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY  245 (392)
T ss_pred             hcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence            9999888877 444569999999999999999999999999999999999999876 99999999987654332   123


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCccchhhh--hhhHH
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---ADEIYKICSVIGTPTQDSWADG--LLLAR  231 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~--~~~~~  231 (337)
                      ...||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+...   ...+..+....+..+.......  .....
T Consensus       246 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  324 (392)
T PHA03207        246 GWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH  324 (392)
T ss_pred             ccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence            46799999999998765 689999999999999999999999977543   3455555555444332211110  00011


Q ss_pred             hhhccCCCCCCCcccc--cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSV--LMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ...+..........+.  ....++.++.++|.+||..||++|||+.|+|.||||...
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            1111111100001110  112467789999999999999999999999999999864

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-47  Score=339.93  Aligned_cols=284  Identities=39%  Similarity=0.692  Sum_probs=233.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC-ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC-----EEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMSHPNIVKLKEVIREND-----ILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~   76 (337)
                      +|++.+.||.|++|.||+|.+..+|+.+|+|.+..... ........+|+..++.++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            69999999999999999999999999999999876542 223344568999999999999999999987664     789


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      ++|||+++++.+.+.+ ...+++..++.++.||+.||+|||++|++||||||+||+++.+ .++|+|||.+.......  
T Consensus        81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            9999999877666654 3469999999999999999999999999999999999999977 99999999998765443  


Q ss_pred             --CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh--hhh
Q 038835          154 --PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG--LLL  229 (337)
Q Consensus       154 --~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~  229 (337)
                        ......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+....+....+.+....+...  ...
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA  239 (330)
T ss_pred             cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence              2345678999999999877657899999999999999999999999999998888888888887776665421  111


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      ... ....+......+....+..+.++.++|.+||+.||.+|||++++++||||+....
T Consensus       240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         240 RNY-LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhH-HhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            111 1112233333344445668899999999999999999999999999999986444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.4e-47  Score=339.75  Aligned_cols=247  Identities=30%  Similarity=0.463  Sum_probs=201.0

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHH-HHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREV-KSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+|+.||+|++.+.....  .......|. .+++.++||||+++++.+.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987643221  122233444 467889999999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++..... .......+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            6665544555668999999999999999999999999999999999999876 999999999875322 22234567999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+...   +                        
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------------------  212 (321)
T cd05603         161 EYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P------------------------  212 (321)
T ss_pred             ccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C------------------------
Confidence            99999998665 6899999999999999999999999887765554443221   0                        


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTA----AEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~~~~  285 (337)
                         ....+..+.++.++|.+||+.||.+||++    .++++||||..
T Consensus       213 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         213 ---LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence               01124567889999999999999999976    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-46  Score=346.60  Aligned_cols=274  Identities=23%  Similarity=0.340  Sum_probs=208.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.....       ...+|++++++++|+||+++++++..++..++|||++
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-------~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-------SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-------CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            699999999999999999999999999999964321       2358999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC---CCccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP---PFTEY  158 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~---~~~~~  158 (337)
                      .+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .++|+|||++.......   .....
T Consensus       243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  322 (461)
T PHA03211        243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI  322 (461)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence            999988887766679999999999999999999999999999999999999876 89999999987654321   12345


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCC-CCCC------cHHHHHHHHHHhCCCCcc--chhhhhhh
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF-PGTS------EADEIYKICSVIGTPTQD--SWADGLLL  229 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~------~~~~~~~i~~~~~~~~~~--~~~~~~~~  229 (337)
                      .||+.|+|||++.+. .++.++|||||||++|+|++|..|+ ....      ....+.++..........  ........
T Consensus       323 ~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~  401 (461)
T PHA03211        323 AGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV  401 (461)
T ss_pred             CCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence            799999999998765 6899999999999999999987554 3221      123344444332221111  00000000


Q ss_pred             HHhh----hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          230 ARAI----NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       230 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ....    ....+......+.. ...++.++.+||++||+.||.+|||+.|+|+||||+.
T Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        402 SQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            0000    00111111111111 1245678999999999999999999999999999974

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-46  Score=331.57  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=207.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .|++.+.||+|+||.||++.++.+++.+|+|.+........  .....+|+.++++++|++|+.+++.+..++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            48899999999999999999999999999999876433322  2334579999999999999999999999999999999


Q ss_pred             ecCCCHHHHHh-hc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           81 YMECNLYQLMK-DR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        81 ~~~~~l~~~~~-~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |+.|+.+.... .. ...+++..+..++.|++.||.|||+.|++||||||+||+++.+ .++|+|||.+...........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99876554443 32 2358999999999999999999999999999999999999876 899999999876654444445


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|++.|+|||++.+. .++.++||||+||++|+|++|++||.+................               ..   
T Consensus       161 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---------------~~---  221 (285)
T cd05630         161 RVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---------------VQ---  221 (285)
T ss_pred             CCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------------hh---
Confidence            6899999999998765 6899999999999999999999999865432111111110000               00   


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                              .......++++.+++.+||+.||.+|||     ++|+++||||..
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         222 --------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             --------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence                    0112456789999999999999999999     999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-46  Score=338.52  Aligned_cols=259  Identities=26%  Similarity=0.376  Sum_probs=208.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||++.++.+++.+|+|++.+....  .......+|+.++..++|++|+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999998653221  12223457889999999999999999999999999999


Q ss_pred             eecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--C
Q 038835           80 EYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--F  155 (337)
Q Consensus        80 e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~  155 (337)
                      ||+.++.+ +.+.+....+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++........  .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99987544 5554445668999999999999999999999999999999999999876 999999999876533221  2


Q ss_pred             ccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 TEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ...+||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+..+....+......              
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------  226 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--------------  226 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc--------------
Confidence            34579999999999862    335788999999999999999999999988776666555421100              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK--RPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~~~~  285 (337)
                         ..++        .....++.+++++|++||..+|.+  |++++|+++||||+.
T Consensus       227 ---~~~p--------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         227 ---FQFP--------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             ---ccCC--------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence               0011        112457899999999999765544  689999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-47  Score=339.49  Aligned_cols=256  Identities=26%  Similarity=0.445  Sum_probs=204.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcc-cccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .|+++++||.||.+.||++.....+ .+|+|.+. ..........+..|+..|.+| .|.+|++++++-..++.+|+|||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            6999999999999999999865444 45665554 444444555667999999999 69999999999989999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCC---CCcc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRP---PFTE  157 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~---~~~~  157 (337)
                      |-+.+|...+.++....+.-.++.+..|++.|+.++|+.||||.||||.|+|+-++.+||+|||.|.....+.   ...+
T Consensus       441 ~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kds  520 (677)
T KOG0596|consen  441 CGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDS  520 (677)
T ss_pred             cccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeecc
Confidence            9999999988877665665689999999999999999999999999999999999999999999998876543   2367


Q ss_pred             ccccccccCchhhcCcC----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh
Q 038835          158 YVSTRWYRAPEVLLQSY----------LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL  227 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  227 (337)
                      .+||+.|||||++....          ..+.++||||||||+|+|+.|++||....+  ...++.....+..        
T Consensus       521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI~~P~~--------  590 (677)
T KOG0596|consen  521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAITDPNH--------  590 (677)
T ss_pred             ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhhcCCCc--------
Confidence            89999999999997431          246799999999999999999999965332  2222222111100        


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                            ...||...          -..++.++++.||.+||.+|||+.++|+|||++.
T Consensus       591 ------~Iefp~~~----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  591 ------EIEFPDIP----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ------cccccCCC----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence                  11233222          1234999999999999999999999999999875

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-46  Score=329.79  Aligned_cols=280  Identities=38%  Similarity=0.697  Sum_probs=226.6

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeC--CEEEEEEe
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIREN--DILYFVFE   80 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e   80 (337)
                      |++.+.||.|++|.||+|.+..+|+.+|+|.+...... .......+|+.+++.++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            78999999999999999999999999999999875422 1223346899999999999999999999887  89999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCcc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTE  157 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~  157 (337)
                      |+++++.+.+......+++..++.++.||+.||+|||+.|++|+||+|+||+++++ .++|+|||.+.......  ....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN  160 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence            99988877776665679999999999999999999999999999999999999976 99999999998765443  2344


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..++..|+|||.+.+...++.++||||||+++|+|++|++||.+.+..+....+....+.+....|..............
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd07840         161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP  240 (287)
T ss_pred             cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence            56788999999877655678999999999999999999999999888888888888777777666654332211111111


Q ss_pred             CCCCCCcccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPS-ANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .............. .+.++.++|++||+.||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            11111111111122 48899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-46  Score=329.24  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=200.1

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      ||+|+||.||++.++.+|+.+|+|.+.......  .......|+++++.++||||+++++.++++...++||||++|+.+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999999999999987543321  222335699999999999999999999999999999999987655


Q ss_pred             H-HHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccc
Q 038835           88 Q-LMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWY  164 (337)
Q Consensus        88 ~-~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~  164 (337)
                      . .+... ...+++..+..++.||+.||+|||+.|++||||||+||+++.+ .++|+|||++.............|++.|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            4 44332 3358999999999999999999999999999999999999876 8999999998876554444456789999


Q ss_pred             cCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCc
Q 038835          165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVP  244 (337)
Q Consensus       165 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
                      +|||++.+. .++.++||||+||++|+|++|+.||.+.........+.....                 ....+      
T Consensus       161 ~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~~------  216 (277)
T cd05607         161 MAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-----------------EDEVK------  216 (277)
T ss_pred             cCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-----------------ccccc------
Confidence            999998766 589999999999999999999999976543222112111100                 00000      


Q ss_pred             ccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCcCccc
Q 038835          245 LSVLMPSANKDAVSLIASLCSWDPSKRPTA----AEALQHPFSRV  285 (337)
Q Consensus       245 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~~~~  285 (337)
                        .....++.+++++|.+||+.||.+|||+    ++++.||||+.
T Consensus       217 --~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         217 --FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             --cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence              0113568899999999999999999999    67889999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-46  Score=324.34  Aligned_cols=253  Identities=25%  Similarity=0.418  Sum_probs=208.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh----HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW----EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +.|++.+.||.|++|.||.|.+..+|+.+|+|.+.......    ......+|+.++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999999999999999987543322    12234579999999999999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-  155 (337)
                      |+||++++.+.........+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+......... 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999986665555555568999999999999999999999999999999999999886 9999999998765432111 


Q ss_pred             ---ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          156 ---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       156 ---~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                         ....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||.+.+..+....+....                 
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------------  223 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-----------------  223 (263)
T ss_pred             ccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-----------------
Confidence               335688899999998765 57899999999999999999999998765544433322110                 


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                                 .........+.++.++|.+||..+|.+|||+.++++||||
T Consensus       224 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 -----------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             -----------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                       0011224578899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-46  Score=337.09  Aligned_cols=281  Identities=20%  Similarity=0.256  Sum_probs=204.6

Q ss_pred             eEeeeeccc--CceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            5 KLIKEVGDG--TFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         5 ~~~~~ig~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +++++||+|  ++++||++.++.+|+.||+|.+........ .....+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            357889999  678999999999999999999976644332 23445799999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----
Q 038835           82 MECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----  153 (337)
Q Consensus        82 ~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----  153 (337)
                      ++++.+..+...  ...+++..++.++.|++.||+|||++|++||||||+|||++.+ .++++||+.+.......     
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            998666554432  3458999999999999999999999999999999999999876 89999998654332110     


Q ss_pred             ---CCccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCcc--------
Q 038835          154 ---PFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD--------  221 (337)
Q Consensus       154 ---~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------  221 (337)
                         ......++..|+|||++.+. ..++.++||||+||++|+|++|+.||.+...................+        
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               01223567789999998754 358899999999999999999999998766544433322211000000        


Q ss_pred             --------chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          222 --------SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       222 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                              .+..............+.............+++++.++|.+||+.||++|||++|+++||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                    0000000000000000000000111123356789999999999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.5e-46  Score=328.40  Aligned_cols=255  Identities=22%  Similarity=0.359  Sum_probs=207.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|++|.||+|.+..+++.||+|.+.............+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            57999999999999999999999999999999987654333344556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS  160 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~g  160 (337)
                      ++++.+....    .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ .++|+|||.+....... ....+|
T Consensus        81 ~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~  155 (279)
T cd06619          81 MDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKTYVG  155 (279)
T ss_pred             CCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-ccCCCC
Confidence            9998776542    37899999999999999999999999999999999999887 99999999987654332 244689


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE---IYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      +..|+|||.+.+. .++.++|+||+||++|+|++|..||......+.   .........                 +...
T Consensus       156 ~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------~~~~  217 (279)
T cd06619         156 TNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-----------------DEDP  217 (279)
T ss_pred             ChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-----------------ccCC
Confidence            9999999998765 679999999999999999999999965332110   000000000                 0000


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      +.       ......+++++++|.+||+.||++||+++|+++||||+..
T Consensus       218 ~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         218 PV-------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             CC-------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            00       0123467899999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.2e-46  Score=328.71  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=211.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .|+..+.||+|+||+||++.+..+|+.+|+|.+........  .....+|+.+++.++|+||+.+.+.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            48889999999999999999999999999999876433222  2234679999999999999999999999999999999


Q ss_pred             ecCCCHHH-HHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           81 YMECNLYQ-LMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        81 ~~~~~l~~-~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |+.++.+. .+... ...+++..+..++.|++.||.|||++||+||||||+||+++++ .++|+|||.+...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99986554 33332 3469999999999999999999999999999999999999876 899999999876654444455


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+........                  
T Consensus       161 ~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------------------  221 (285)
T cd05632         161 RVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE------------------  221 (285)
T ss_pred             CCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc------------------
Confidence            6899999999998665 689999999999999999999999987766544444332211110                  


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~~  286 (337)
                              ....+..+.++.+++..||+.||++|||     +.+++.||||+..
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         222 --------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             --------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence                    0112456788999999999999999999     8999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-46  Score=336.96  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=200.8

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.++.+++.||+|++.+.....  ......+|+.++.++ +||||+.+++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998754332  223345788888888 699999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~~~~~gt~  162 (337)
                      +.+.........+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++.... ........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            7665555555569999999999999999999999999999999999999876 99999999987532 223334578999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE------ADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      .|+|||++.+. .++.++|||||||++|+|++|..||.....      .+........                     .
T Consensus       161 ~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------~  218 (327)
T cd05617         161 NYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------------------K  218 (327)
T ss_pred             ccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------------------C
Confidence            99999998765 789999999999999999999999964322      1111111100                     0


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC------HHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT------AAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------~~ell~hp~~~~  285 (337)
                      .        ...+..++..+.++|.+||..||.+|++      ++++++||||..
T Consensus       219 ~--------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         219 P--------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            0        0112456789999999999999999998      579999999976

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.4e-46  Score=336.06  Aligned_cols=283  Identities=37%  Similarity=0.629  Sum_probs=229.1

Q ss_pred             cCceE-eeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-------------HhHHHHHHHHHhcCCCCCccccee
Q 038835            2 ERYKL-IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-------------ECVNLREVKSLRKMSHPNIVKLKE   67 (337)
Q Consensus         2 ~~y~~-~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------------~~~~~~e~~~l~~l~h~~iv~~~~   67 (337)
                      ++|.. .+.||.|++|.||+|.++.+|+.||+|++........             .....+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            46765 5679999999999999999999999999865433220             113468999999999999999999


Q ss_pred             EEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           68 VIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        68 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      ++..++..++||||+++++.+.+.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999999888777654 3458999999999999999999999999999999999999876 8999999988


Q ss_pred             ccCCC---------------CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 038835          147 REINS---------------RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI  211 (337)
Q Consensus       147 ~~~~~---------------~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  211 (337)
                      .....               ........+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.++.+.+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            76541               111233457889999999876656789999999999999999999999999998889889


Q ss_pred             HHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          212 CSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      ....+.+....|...........  +....+.......+..+.++.++|.+||+.||++|||++|++.||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTE--FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccc--cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            88888888777765432221111  111111122233356688999999999999999999999999999998643

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.6e-46  Score=337.31  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=208.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+....  .......+|..+++.++|+||+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999998753221  12223457889999999999999999999999999999


Q ss_pred             eecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--
Q 038835           80 EYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--  155 (337)
Q Consensus        80 e~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--  155 (337)
                      ||+.|+.+..+. .....+++..++.++.|++.||+|||++||+||||||+|||++.+ .+||+|||++.........  
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            999876555444 435678999999999999999999999999999999999999876 8999999998766543222  


Q ss_pred             ccccccccccCchhhcCc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 TEYVSTRWYRAPEVLLQS----YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ...+||+.|+|||++.+.    ..++.++|+||+||++|+|++|+.||.+.+..+....+......              
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------  226 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER--------------  226 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc--------------
Confidence            235799999999998642    35788999999999999999999999887766655554321100              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK--RPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~~~~  285 (337)
                         ..+        +.....++.+++++|.+||..++.+  |++++++++||||+.
T Consensus       227 ---~~~--------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         227 ---FQF--------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             ---ccC--------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence               001        1112356899999999999876654  469999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-46  Score=351.71  Aligned_cols=254  Identities=28%  Similarity=0.460  Sum_probs=209.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCC-------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREND-------   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------   73 (337)
                      ++|.+.+.||+|+||.||+|.++.+|+.||+|++....... ......+|+..+..++|+|++++++.+...+       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            68999999999999999999999999999999997655443 2334468999999999999999988764322       


Q ss_pred             -EEEEEEeecCCC-HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           74 -ILYFVFEYMECN-LYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        74 -~~~lv~e~~~~~-l~~~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                       .+++||||++++ +.+.+..+   ...+++..++.++.|++.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence             368999999975 44444332   3468999999999999999999999999999999999999876 89999999987


Q ss_pred             cCCCC---CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchh
Q 038835          148 EINSR---PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       148 ~~~~~---~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  224 (337)
                      .....   ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....         
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~---------  261 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR---------  261 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC---------
Confidence            65432   222456899999999998765 68999999999999999999999998877665555443211         


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                  .+        ...+..++++.+++.+||+.||.+|||+.++++|||++.
T Consensus       262 ------------~~--------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        262 ------------YD--------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             ------------CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence                        00        112467899999999999999999999999999999864

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-46  Score=350.31  Aligned_cols=252  Identities=27%  Similarity=0.386  Sum_probs=208.8

Q ss_pred             CceEeeeecccCceEEEEEEECCC-CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQS-GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .|.+.+.||+|++|.||+|.+..+ ++.||+|.+.... ........+|+.+++.++||||+++++++..++..|+||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            499999999999999999998887 7889999775432 22233446799999999999999999999999999999999


Q ss_pred             cCCCHHH-HHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC---
Q 038835           82 MECNLYQ-LMKD---REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP---  153 (337)
Q Consensus        82 ~~~~l~~-~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~---  153 (337)
                      ++|+.+. .+..   ...++++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.......   
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            9876554 3322   24568999999999999999999999999999999999999876 89999999998765432   


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+......                
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----------------  289 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----------------  289 (478)
T ss_pred             cccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence            13456799999999998665 6899999999999999999999999887776665554432110                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                   .....++.++.++|.+||..||++|||+++++.|||++.
T Consensus       290 -------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        290 -------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             -------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence                         011356789999999999999999999999999999864

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-46  Score=327.20  Aligned_cols=279  Identities=41%  Similarity=0.765  Sum_probs=233.5

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      |++.+.||+|.+|.||+|.+..+++.+|+|++....... .......|+.+++.++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            778899999999999999999999999999998654221 2233457999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~g  160 (337)
                      ++++.+.+.+....+++..+..++.|++.||.|||++|++||||+|+||+++.+ .++|+|||.+....... ......+
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV  160 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence            988877777654569999999999999999999999999999999999999886 99999999987664432 3344567


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      +..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+.++....+.+....|....... .....++..
T Consensus       161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  239 (282)
T cd07829         161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTFPKF  239 (282)
T ss_pred             CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-ccccccccc
Confidence            8889999998766578999999999999999999999999999888888888888888877776554332 223333433


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .........+..+.++.++|++||..||++||++++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            3333334445668899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-46  Score=336.22  Aligned_cols=284  Identities=37%  Similarity=0.644  Sum_probs=223.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCE------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDI------   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------   74 (337)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++....... ......+|+.+++.++|||++++++++...+.      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            57999999999999999999999999999999987543222 22334579999999999999999998765544      


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .++|+||+++++.+.+..  ..+++..++.++.|++.||.|||++|++||||+|+||+++.+ .++|+|||.+...... 
T Consensus        95 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-  171 (343)
T cd07851          95 VYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-  171 (343)
T ss_pred             EEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence            899999998777666543  358999999999999999999999999999999999999876 8999999999876443 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh-hHHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL-LARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~  232 (337)
                       .....++..|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+++..+..... ....
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07851         172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN  250 (343)
T ss_pred             -ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence             34557889999999987655678999999999999999999999999888888888777766555433221110 0000


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF  289 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  289 (337)
                      .....+..............+.++.++|.+||..||.+|||+.++++||||+.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            101111111112222334568999999999999999999999999999999875443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.6e-46  Score=330.71  Aligned_cols=278  Identities=21%  Similarity=0.349  Sum_probs=211.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||++.+..+|..+|+|.+.............+|++++++++||||+++++++..++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            57999999999999999999999999999999987653333334456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      ++++.+..+......+++..+..++.|+++||.|||+ .+++|+||||+||+++.+ .++|+|||.+...... ......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~  159 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV  159 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCC
Confidence            9986666665555669999999999999999999997 599999999999999876 8999999988765332 224567


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC-CCccch-----------hhhh
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGT-PTQDSW-----------ADGL  227 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~-----------~~~~  227 (337)
                      |++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..... ........ ......           ....
T Consensus       160 ~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         160 GTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccchh
Confidence            89999999988654 6789999999999999999999999766543322 22211100 000000           0000


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .............   ........++.+++++|.+||..||++|||+.++++||||..
T Consensus       238 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         238 AIFELLDYIVNEP---PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             hHHHHHHHHhcCC---CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence            0000000000000   001111246788999999999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.2e-46  Score=334.70  Aligned_cols=281  Identities=33%  Similarity=0.586  Sum_probs=215.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC---------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN---------   72 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------   72 (337)
                      .+|.+.+.||.|++|.||+|.++.+|+.||+|.+...... ......+|+.+++.++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~-~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ-SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc-hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            5899999999999999999999999999999998665432 233456899999999999999999876543         


Q ss_pred             -----CEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCC
Q 038835           73 -----DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGL  145 (337)
Q Consensus        73 -----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~  145 (337)
                           ...++||||+++++.+.+..  ..+++..++.++.||++||.|||+.|++||||||+||+++..  .++|+|||.
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             cccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence                 35799999999876665543  348999999999999999999999999999999999999753  789999999


Q ss_pred             cccCCCCC----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSRP----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~~----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +.......    ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+......+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            87653221    11334678899999987665578899999999999999999999999888777666665543332222


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+....................+.....+..+.++.++|.+||+.||.+|||+++++.||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            2111100000000000011111222334568899999999999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.5e-46  Score=322.82  Aligned_cols=258  Identities=29%  Similarity=0.423  Sum_probs=212.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||.|++|.||++.+..++..+|+|++.............+|+..++.++|+||+++++.+..++..+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            58999999999999999999999999999999997665544455567899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---
Q 038835           82 MECNLYQLMKDRE---KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---  154 (337)
Q Consensus        82 ~~~~l~~~~~~~~---~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---  154 (337)
                      ++++.+..+....   ..+++..++.++.|++.||.|||+.|++|+||+|+||+++++ .++|+|||.+........   
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            9986655554332   358999999999999999999999999999999999999876 999999999876554321   


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                        .....|+..|+|||.+.....++.++|+||+||++++|++|+.||...+..+........   ..             
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~-------------  224 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP-------------  224 (267)
T ss_pred             cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC-------------
Confidence              134578999999999876656789999999999999999999999877665444333221   00             


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                           +   ..........+++++.+++.+||..||++|||+.+++.||||
T Consensus       225 -----~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 -----P---SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -----C---CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                 0   000001124678899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6e-48  Score=340.63  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=221.2

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      .++||+|.||+||-++++.+|+.||+|+|.+..... .+...++|+.+|+++.||.||.+..+|+..+..++|||-+.|+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            467999999999999999999999999998765543 3455578999999999999999999999999999999999999


Q ss_pred             HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCCCCccccc
Q 038835           86 LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVS  160 (337)
Q Consensus        86 l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~~~~~~~g  160 (337)
                      .++.+.+. .+.+++...+.++.||+.||+|||.+||+|+||||+|||+.+.    .+||||||+|+..+......+.+|
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence            99998865 4569999999999999999999999999999999999999764    899999999999998888889999


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      ||.|+|||++.+. .|+.+-|+||+|||+|--++|..||...++  ...+|.+.-..                   +|  
T Consensus       729 TPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFM-------------------yP--  784 (888)
T KOG4236|consen  729 TPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFM-------------------YP--  784 (888)
T ss_pred             CccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccc-------------------cC--
Confidence            9999999999765 789999999999999999999999976544  34444443222                   22  


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                           +..|.+++.++.|||..+|+..-.+|.|++..|.|||+++..
T Consensus       785 -----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  785 -----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             -----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence                 133567899999999999999999999999999999998743

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-45  Score=333.70  Aligned_cols=282  Identities=39%  Similarity=0.677  Sum_probs=220.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCC------E
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREND------I   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~   74 (337)
                      ++|++++.||+|++|.||++.+..+|+.||+|.+....... ......+|+.+++.++||||+++++++....      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            68999999999999999999999999999999986543222 2234468999999999999999999986543      4


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .++||||+++++...+..  ..+++..++.++.||+.||+|||+.|++||||||+||+++.+ .++|+|||.+...... 
T Consensus        95 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-  171 (343)
T cd07880          95 FYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-  171 (343)
T ss_pred             EEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence            689999996666555443  348999999999999999999999999999999999999876 8999999998865432 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH--H
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA--R  231 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~  231 (337)
                       .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+.......+......++.. |.......  .
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  249 (343)
T cd07880         172 -MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQSEDAK  249 (343)
T ss_pred             -ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-HHHhhcchhHH
Confidence             2345678999999998764457899999999999999999999999888777777766654443322 22111111  0


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      ......+...........+..+.++.++|.+||..||.+|||+.+++.||||+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence            111112222222233344678899999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.4e-46  Score=325.51  Aligned_cols=257  Identities=23%  Similarity=0.396  Sum_probs=206.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHH-HhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS-LRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++.+.||+|+||.||++.++.+|+.||+|.+..............|+.. ++.++||||+++++++..++..|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            5799999999999999999999999999999998765444444444556665 566799999999999999999999999


Q ss_pred             ecCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC
Q 038835           81 YMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        81 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~  155 (337)
                      |+++++.+.+..   ....+++..++.++.||+.||+|||++ +++||||||+||+++.+ .+||+|||.+.........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (283)
T cd06617          81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK  160 (283)
T ss_pred             hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999877665543   335689999999999999999999997 99999999999999876 8999999998866443333


Q ss_pred             ccccccccccCchhhcCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 TEYVSTRWYRAPEVLLQS---YLYSSKVDMWAMGAIMAELITLRPLFPGTS-EADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ....|+..|+|||.+.+.   ..++.++|+||+||++|+|++|..||.... ..+.+......                 
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  223 (283)
T cd06617         161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-----------------  223 (283)
T ss_pred             ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-----------------
Confidence            345788999999987542   346889999999999999999999996532 22222222111                 


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                          ..+.       .....+|.++.++|.+||..+|.+|||+.++++||||...
T Consensus       224 ----~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         224 ----PSPQ-------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             ----CCCC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence                0000       0012467899999999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-48  Score=321.70  Aligned_cols=254  Identities=35%  Similarity=0.513  Sum_probs=222.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHH--HHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      |++|+.+++||+|.||+|-+|+.+.+|+.+|+|+++++..-......  +.|-++|+..+||.+..+...|..++.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            68899999999999999999999999999999999987654433333  5799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~~  156 (337)
                      |||+.|+-+-...++...++|...+.+-..|+.||.|||+++||+||+|.+|+|+|++ .+||+|||+++..- ......
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k  326 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK  326 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence            9999987555555556669999999999999999999999999999999999999987 99999999998643 334557


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ++||||.|+|||++... -|+.++|.|.+||++|||++|+.||...+.....+.|...                   ..+
T Consensus       327 TFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------------------d~k  386 (516)
T KOG0690|consen  327 TFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------------------DLK  386 (516)
T ss_pred             cccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------------hcc
Confidence            89999999999999665 7999999999999999999999999988877776666542                   223


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                      ||           ..++++++.|+..+|.+||.+|.     .+.|+.+|+||..
T Consensus       387 FP-----------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  387 FP-----------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             CC-----------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            33           57899999999999999999997     6899999999975

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-46  Score=324.29  Aligned_cols=255  Identities=29%  Similarity=0.448  Sum_probs=212.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|++|.||++.+..+|+.+|+|.+.............+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            58999999999999999999999999999999987654333444556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      ++++.+....... ++++..++.++.|++.||.|||+++++|+||+|+||+++++ .++|+|||.+...... .......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV  159 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence            9986555554444 68999999999999999999999999999999999999876 9999999999876543 2334567


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      +++.|+|||.+.+. .++.++|+||+||++|+|++|.+||...+..+....+....                     .+.
T Consensus       160 ~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------------------~~~  217 (274)
T cd06609         160 GTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---------------------PPS  217 (274)
T ss_pred             CCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC---------------------CCC
Confidence            88999999998766 58999999999999999999999998766444333322110                     000


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ..       ...++.++.+++.+||..||++|||++++++||||+..
T Consensus       218 ~~-------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         218 LE-------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             Cc-------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            00       01267889999999999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.9e-45  Score=325.40  Aligned_cols=257  Identities=27%  Similarity=0.498  Sum_probs=213.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .+|++++.||.|++|.||++.+..+|+.||+|.+...... ......+|+..++.++||||+++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4799999999999999999999999999999998754333 233456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Ccccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~~~  159 (337)
                      +.++.+..+.... .+++.++..++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||++........ .....
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  176 (296)
T cd06655          98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV  176 (296)
T ss_pred             cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcC
Confidence            9987777666544 48999999999999999999999999999999999999876 999999999876544322 23457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      +++.|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+..+....+.... .+                     
T Consensus       177 ~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~---------------------  233 (296)
T cd06655         177 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TP---------------------  233 (296)
T ss_pred             CCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Cc---------------------
Confidence            88999999988655 67899999999999999999999998876654433332110 00                     


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                           .......+++.+.++|.+||..||.+|||+.+++.||||+....
T Consensus       234 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         234 -----ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             -----ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                 00112356789999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-46  Score=330.16  Aligned_cols=281  Identities=36%  Similarity=0.627  Sum_probs=217.6

Q ss_pred             CceEeeeecccCceEEEEEEECC--CCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeC--CEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQ--SGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIREN--DILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~   76 (337)
                      +|++.+.||+|++|.||+|.++.  +|+.||+|.+......  .......+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            69999999999999999999988  8999999999874311  1122345799999999999999999999887  8899


Q ss_pred             EEEeecCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC----C-cEEEeeCCCcc
Q 038835           77 FVFEYMECNLYQLMKDR----EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK----D-TIKIADFGLAR  147 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~----~-~~kL~Dfg~a~  147 (337)
                      +||||+++++.+.+...    ...+++..++.++.||+.||.|||++|++||||||+||+++.    + .+||+|||.+.
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~  160 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR  160 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence            99999999888766432    236899999999999999999999999999999999999987    4 89999999988


Q ss_pred             cCCCCCC----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------HHHHHHHHH
Q 038835          148 EINSRPP----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA---------DEIYKICSV  214 (337)
Q Consensus       148 ~~~~~~~----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~  214 (337)
                      .......    .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+....         ..+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd07842         161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV  240 (316)
T ss_pred             ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence            6543221    234577899999999877656889999999999999999999999866543         345566666


Q ss_pred             hCCCCccchhhhhhhHHhhhc-------cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          215 IGTPTQDSWADGLLLARAINY-------KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .+.+....|............       .++..............+.++.++|.+||+.||++|||+.|++.||||
T Consensus       241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            666655555432221111110       000000000001112677889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.9e-46  Score=360.18  Aligned_cols=257  Identities=28%  Similarity=0.459  Sum_probs=208.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee--CCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE--NDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l   77 (337)
                      +++|++++.||.|+||.||+|.++.++..+|+|++....... ....+..|+.+++.|+||||++++++|..  ...+||
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            478999999999999999999999999999999987654433 33445689999999999999999998854  467999


Q ss_pred             EEeecCCCHH-HHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHc-------CccccCCCCCCeeeeCC----------
Q 038835           78 VFEYMECNLY-QLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQR-------GYFHRDLKPENLLVSKD----------  136 (337)
Q Consensus        78 v~e~~~~~l~-~~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~-------~i~H~dikp~Nili~~~----------  136 (337)
                      ||||++++.+ +.+..   ....+++..++.|+.||+.||.|||+.       +|+||||||+|||++.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999997544 44433   235699999999999999999999985       49999999999999642          


Q ss_pred             --------cEEEeeCCCcccCCCCCCCccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 038835          137 --------TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE  207 (337)
Q Consensus       137 --------~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  207 (337)
                              .+||+|||++............+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||...+....
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence                    4899999999877655444566899999999998643 3578999999999999999999999987665443


Q ss_pred             HHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       208 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      +......                      .+.       ...+..+.++.+||..||..+|.+|||+.|+|.|||+...
T Consensus       252 li~~lk~----------------------~p~-------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        252 LISELKR----------------------GPD-------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHHHhc----------------------CCC-------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            3222111                      000       0013457899999999999999999999999999999754

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-45  Score=332.44  Aligned_cols=282  Identities=40%  Similarity=0.635  Sum_probs=220.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   74 (337)
                      ++|.+.+.||+|++|.||+|.++.+|+.||+|++....... ......+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            68999999999999999999999999999999987643222 123346899999999999999999998654      35


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .++|+||+..++....   +..+++..+..++.|++.||+|||++|++||||||+||+++.+ .++|+|||.+...... 
T Consensus        95 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-  170 (342)
T cd07879          95 FYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-  170 (342)
T ss_pred             EEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence            6999999987655433   2358999999999999999999999999999999999999876 9999999998765332 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh-
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA-  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  232 (337)
                       .....+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+....+..+....+.+....+......... 
T Consensus       171 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (342)
T cd07879         171 -MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS  249 (342)
T ss_pred             -CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence             234578899999999876556789999999999999999999999988877777777776665544333222111000 


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .....+...........+..+.++.++|.+||+.||.+|||+++++.||||.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            00111222222222334567889999999999999999999999999999987544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.4e-46  Score=334.24  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=195.0

Q ss_pred             cCceEeeeecccCceEEEEEEE-----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEee-CCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRE-NDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~   74 (337)
                      ++|++++.||+|+||.||+|.+     ..+++.||+|++.............+|+.+++.+ +||||+++++++.. ++.
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            5899999999999999999975     3456789999997654433444567899999999 89999999998765 456


Q ss_pred             EEEEEeecCCCHHHHHhhc-------------------------------------------------------------
Q 038835           75 LYFVFEYMECNLYQLMKDR-------------------------------------------------------------   93 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~-------------------------------------------------------------   93 (337)
                      +++||||++++.+..+...                                                             
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            8999999997655443321                                                             


Q ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---CccccccccccCch
Q 038835           94 -EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPE  168 (337)
Q Consensus        94 -~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE  168 (337)
                       ..++++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||++........   .....+++.|+|||
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  246 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE  246 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence             1247888999999999999999999999999999999999876 899999999976533221   12345667899999


Q ss_pred             hhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccc
Q 038835          169 VLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSV  247 (337)
Q Consensus       169 ~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (337)
                      ++.+. .++.++|||||||++|+|++ |.+||.+....+.........                    ..+        .
T Consensus       247 ~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--------------------~~~--------~  297 (338)
T cd05102         247 SIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG--------------------TRM--------R  297 (338)
T ss_pred             HhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC--------------------CCC--------C
Confidence            98765 68999999999999999997 999998765433322221100                    000        0


Q ss_pred             cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          248 LMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       248 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .....++++.+++.+||+.||.+|||+.|+++
T Consensus       298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         298 APENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            12356788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-46  Score=325.24  Aligned_cols=256  Identities=29%  Similarity=0.473  Sum_probs=210.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|++|.||++.+..+++.+|+|.+..... .......+|+.++++++||||+++++.+..+...|+||||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            579999999999999999999998999999999865422 2233446799999999999999999999999999999999


Q ss_pred             cCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           82 MECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      ++++.+..+. +.+..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+...... ......
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  163 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF  163 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccccee
Confidence            9987665554 445679999999999999999999999999999999999999876 9999999988765432 222445


Q ss_pred             cccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          159 VSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       159 ~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      .|++.|+|||.+..    ...++.++|+||+||++|+|++|++||.+.+..+....+....                   
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------  224 (280)
T cd06611         164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-------------------  224 (280)
T ss_pred             ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC-------------------
Confidence            78999999999752    2356789999999999999999999998876554443332110                   


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                        .+.      ......++.++.++|.+||+.||.+|||+.++++||||..
T Consensus       225 --~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         225 --PPT------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             --CCC------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence              000      0112356789999999999999999999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-45  Score=324.14  Aligned_cols=251  Identities=31%  Similarity=0.441  Sum_probs=210.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|++|.||++.+..+++.+|+|++.......  ......+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            57999999999999999999999999999999987543221  2334468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||++++.+.........+++..+..++.||+.||.|||++|++|+||+|.||+++.+ .+||+|||++......  ....
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~  158 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL  158 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence            999765554444445669999999999999999999999999999999999999876 8999999998876544  2445


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+...  .                 .   
T Consensus       159 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------------~---  215 (290)
T cd05580         159 CGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K-----------------V---  215 (290)
T ss_pred             CCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------------c---
Confidence            789999999988665 6788999999999999999999999877754444443311  0                 0   


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                              ......+..+.++|.+||..||.+|+     +++|+++||||+.
T Consensus       216 --------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         216 --------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             --------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence                    01134578999999999999999999     9999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.5e-45  Score=316.32  Aligned_cols=251  Identities=29%  Similarity=0.558  Sum_probs=205.6

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee-CCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE-NDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   80 (337)
                      .|++++.||+|++|.||++.++.+++.+|+|.+....... ......+|+.++++++|+|++++++.+.. +..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5999999999999999999999999999999987654332 23345679999999999999999998764 456899999


Q ss_pred             ecCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCc
Q 038835           81 YMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFT  156 (337)
Q Consensus        81 ~~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~  156 (337)
                      |++++ +.+.+... ...+++.+++.++.|++.||.+||++|++|+||||+||+++.+ .++|+|||.+...... ....
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            99875 44455442 4458999999999999999999999999999999999999876 8999999998765432 2234


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ...+++.|+|||++.+. .++.++|+||+||++++|++|..||...+.......+....                     
T Consensus       161 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~---------------------  218 (257)
T cd08223         161 TLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK---------------------  218 (257)
T ss_pred             cccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------------------
Confidence            45789999999988665 67889999999999999999999998766554443332210                     


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .+        ......++++.++|.+||+.||.+|||+.++++||||
T Consensus       219 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 LP--------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CC--------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00        1124577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-45  Score=324.72  Aligned_cols=255  Identities=27%  Similarity=0.508  Sum_probs=209.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .+|++++.||.|++|.||++.++.+|+.+++|.+....... .....+|+.+++.++||||+++++.+..+...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            58999999999999999999999999999999987654432 33456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~  159 (337)
                      ++++.+..+.... .+++.++..++.|++.||.|||++|++||||||+||+++.+ .++|+|||.+....... ......
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~  177 (296)
T cd06654          99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  177 (296)
T ss_pred             cCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCccc
Confidence            9986665555433 48999999999999999999999999999999999999876 89999999887654332 223457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      |++.|+|||.+.+. .++.++||||+||++|+|++|++||...........+... ..                    +.
T Consensus       178 ~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~--------------------~~  235 (296)
T cd06654         178 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT--------------------PE  235 (296)
T ss_pred             CCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC--------------------CC
Confidence            89999999988654 6789999999999999999999999876654332222110 00                    00


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                            ....+.++..+.++|.+||..||++|||+.++++||||...
T Consensus       236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         236 ------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             ------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                  01123567889999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-45  Score=324.48  Aligned_cols=258  Identities=23%  Similarity=0.434  Sum_probs=209.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||++.+..+|+.+|+|.+.............+|+.++++++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            57999999999999999999999999999999887543333334556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           82 MECNLYQLMKDRE---KCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        82 ~~~~l~~~~~~~~---~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ++++.+..+....   ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.+ .++|+|||.+...... ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~  159 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAK  159 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccc
Confidence            9987666655442   368999999999999999999997 599999999999999876 8999999998765332 223


Q ss_pred             cccccccccCchhhcCcC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          157 EYVSTRWYRAPEVLLQSY-----LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ...+++.|+|||.+.+..     .++.++|+||+||++|+|++|+.||...........+.......             
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  226 (286)
T cd06622         160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-------------  226 (286)
T ss_pred             cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-------------
Confidence            456888999999875432     35789999999999999999999997655443333222211110             


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                           .        ...++.++.++.++|.+||+.+|.+||+++++++||||...
T Consensus       227 -----~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         227 -----P--------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             -----C--------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence                 0        11224578999999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-45  Score=321.56  Aligned_cols=255  Identities=28%  Similarity=0.473  Sum_probs=205.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.++||||+++++.+..++..++||||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            5789999999999999999999999999999998754322 223346799999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      ++++.+..+......+++.+++.++.|++.||.|||++|++|+||||+||+++.+ .++|+|||.+...... .......
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  167 (267)
T cd06645          88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI  167 (267)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccccc
Confidence            9986666555555669999999999999999999999999999999999999876 8999999998765432 2224467


Q ss_pred             ccccccCchhhc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          160 STRWYRAPEVLL--QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       160 gt~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      |++.|+|||.+.  ....++.++|+||+||++|+|++|.+||................                   ...
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-------------------~~~  228 (267)
T cd06645         168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-------------------FQP  228 (267)
T ss_pred             CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-------------------CCC
Confidence            999999999874  23357889999999999999999999997655433322211110                   000


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                      +..      .....++..+.++|.+||+.||++|||++++++|||
T Consensus       229 ~~~------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         229 PKL------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             Ccc------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            000      001246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.8e-45  Score=323.82  Aligned_cols=257  Identities=27%  Similarity=0.473  Sum_probs=208.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +.|+++++||.|++|.||++.+..+|+.+++|.+..... .......+|+.+++.++||||+++++.+..++..++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            469999999999999999999999999999999875422 2233446799999999999999999999999999999999


Q ss_pred             cCCCHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           82 MECNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~-~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      ++++.+..+ .+....+++..++.++.|++.||.|||++|++||||||+||+++.+ .++|+|||.+...... ......
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  170 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF  170 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccccee
Confidence            998766554 3445568999999999999999999999999999999999999865 8999999988754332 222445


Q ss_pred             cccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          159 VSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       159 ~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      .+++.|+|||.+..    ...++.++|+|||||++|+|++|.+||...+..+...++...                    
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------------------  230 (292)
T cd06644         171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--------------------  230 (292)
T ss_pred             cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--------------------
Confidence            78899999998852    234688999999999999999999999876654433332111                    


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                       ..+.      ......++.++.++|.+||..||++||+++++++||||...
T Consensus       231 -~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         231 -EPPT------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             -CCcc------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence             0000      01123567889999999999999999999999999999753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=326.62  Aligned_cols=256  Identities=32%  Similarity=0.489  Sum_probs=210.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||.|++|.||+|.+..+|+.+|+|.+.......  ......+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            58999999999999999999999999999999998764442  3334568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           80 EYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        80 e~~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      ||+.++.+..+...  +..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ .++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            99988555444433  3568999999999999999999999999999999999999876 999999998875432111  


Q ss_pred             ----------------------------CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 038835          155 ----------------------------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD  206 (337)
Q Consensus       155 ----------------------------~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  206 (337)
                                                  .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                        1234688999999998765 67899999999999999999999998877665


Q ss_pred             HHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC----HHHHhcCcC
Q 038835          207 EIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT----AAEALQHPF  282 (337)
Q Consensus       207 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~  282 (337)
                      ....+....                   ..++.         ....+.++.++|.+||..||++|||    ++++++|||
T Consensus       240 ~~~~~~~~~-------------------~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~  291 (316)
T cd05574         240 TFSNILKKE-------------------VTFPG---------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF  291 (316)
T ss_pred             HHHHHhcCC-------------------ccCCC---------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence            554443110                   00110         1226789999999999999999999    999999999


Q ss_pred             cccc
Q 038835          283 SRVA  286 (337)
Q Consensus       283 ~~~~  286 (337)
                      |++.
T Consensus       292 ~~~~  295 (316)
T cd05574         292 FRGV  295 (316)
T ss_pred             hhcC
Confidence            9864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.6e-45  Score=315.97  Aligned_cols=251  Identities=29%  Similarity=0.486  Sum_probs=209.9

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++.+.||+|++|.||++.++.+++.+|+|.+....... ......+|+.++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            6999999999999999999999999999999987654332 334456899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCCCcc
Q 038835           82 MECNLY-QLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        82 ~~~~l~-~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ++++.+ +.+... +..+++..++.++.|++.||+|||++|++|+||+|+||+++.+  .++|+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT  160 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence            987544 444433 3458999999999999999999999999999999999999854  689999999987765544455


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.......+.....                     
T Consensus       161 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~---------------------  218 (256)
T cd08220         161 VVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF---------------------  218 (256)
T ss_pred             cccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC---------------------
Confidence            6789999999998655 678899999999999999999999987766554443322110                     


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .        ......+.++.++|.+||+.||.+|||+.|+++||||
T Consensus       219 ~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 A--------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             C--------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            0        1123467899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-45  Score=321.31  Aligned_cols=255  Identities=28%  Similarity=0.460  Sum_probs=204.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.+|+|++...... ......+|+.++++++||||+++++.+..++..++||||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            5799999999999999999999999999999998754322 223446899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~  159 (337)
                      ++++.+..+......+++..+..++.|++.||.|||+.|++||||+|+||+++.+ .++|+|||++....... ......
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  167 (267)
T cd06646          88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI  167 (267)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccc
Confidence            9987665555555568999999999999999999999999999999999999876 89999999988654322 223457


Q ss_pred             ccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          160 STRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       160 gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      |++.|+|||.+..  ...++.++|+||+||++|+|++|.+||......+....+...                   ....
T Consensus       168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~  228 (267)
T cd06646         168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------------NFQP  228 (267)
T ss_pred             cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------------CCCC
Confidence            8899999998742  334678999999999999999999999655433221111000                   0000


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                      +.      ......++..+.++|++||..||++|||++++++|+|
T Consensus       229 ~~------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         229 PK------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CC------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            00      0011346789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.2e-45  Score=325.17  Aligned_cols=257  Identities=28%  Similarity=0.501  Sum_probs=210.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .+|++++.||.|++|.||++.++.+|+.||+|.+....... .....+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            58999999999999999999999999999999987544332 33456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~  159 (337)
                      ++++.+..+... ..+++.++..++.|++.||.|||+.|++||||||+||+++.+ .++|+|||.+....... ......
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  176 (297)
T cd06656          98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  176 (297)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCccc
Confidence            998766655543 348999999999999999999999999999999999999876 89999999987654332 223457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      +++.|+|||.+.+. .++.++|+||+||++|+|++|.+||.+.+.......+... +.                      
T Consensus       177 ~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~----------------------  232 (297)
T cd06656         177 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT----------------------  232 (297)
T ss_pred             CCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CC----------------------
Confidence            89999999998664 6789999999999999999999999776543322111100 00                      


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                          +.......++..+.++|.+||..||.+|||++++++||||+....
T Consensus       233 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         233 ----PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             ----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence                000112356788999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-45  Score=319.14  Aligned_cols=251  Identities=31%  Similarity=0.556  Sum_probs=206.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--------HhHHHHHHHHHhcCCCCCcccceeEEeeCCE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--------ECVNLREVKSLRKMSHPNIVKLKEVIRENDI   74 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   74 (337)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+........        .....+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            58899999999999999999999999999998865433211        1234579999999999999999999999999


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .+++|||++++.+..+......+++..+..++.|++.||.|||++|++||||+|+||+++++ .++|+|||.+.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999987666555555668999999999999999999999999999999999999876 89999999987664221


Q ss_pred             -------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          154 -------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       154 -------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                             ......|+..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+.......+...            
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------  227 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN------------  227 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc------------
Confidence                   11234688899999988665 6788999999999999999999999876554333322111            


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                               ..+        ......+.++.++|.+||+.||.+|||+.++++||||
T Consensus       228 ---------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ---------ASP--------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ---------CCC--------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                     001        1123567899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.4e-45  Score=321.65  Aligned_cols=256  Identities=28%  Similarity=0.465  Sum_probs=208.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      -|++.+.||.|+||.||++.+..++..+++|.+..... .......+|+.+++.++||||+++++++..++..++|+||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            47889999999999999999999999999999865422 22334467999999999999999999999999999999999


Q ss_pred             CCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           83 ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        83 ~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      +++.+..+. +...++++..+..++.|++.||.|||+.|++||||||+||+++.+ .++|+|||++...... .......
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  164 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI  164 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence            987766544 445569999999999999999999999999999999999999876 8999999998765332 2224457


Q ss_pred             ccccccCchhhc----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          160 STRWYRAPEVLL----QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       160 gt~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      +++.|+|||++.    ....++.++|+||+||++|+|++|.+||...+..+....+.....                   
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-------------------  225 (282)
T cd06643         165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-------------------  225 (282)
T ss_pred             ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC-------------------
Confidence            899999999874    233567899999999999999999999988766554444322110                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                        +.      ......++.++.++|.+||+.||.+|||+.++++||||...
T Consensus       226 --~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         226 --PT------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             --CC------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence              00      00123467899999999999999999999999999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.2e-45  Score=314.77  Aligned_cols=251  Identities=26%  Similarity=0.463  Sum_probs=208.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|.+.+.||+|++|.||+|.++.+|+.|++|.+...... .......+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            589999999999999999999999999999998754433 2334456899999999999999999999999999999999


Q ss_pred             cCCCHHH-HHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Ccc
Q 038835           82 MECNLYQ-LMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTE  157 (337)
Q Consensus        82 ~~~~l~~-~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~  157 (337)
                      ++++.+. .+... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+........ ...
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            9875544 44443 4568999999999999999999999999999999999999986 999999999886654332 234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|++.|+|||.+.+. .++.++|+|||||++++|++|+.||...+..+....+....                     .
T Consensus       161 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~  218 (256)
T cd08529         161 IVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV---------------------F  218 (256)
T ss_pred             cccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------------C
Confidence            5788999999998765 57899999999999999999999998877555444432210                     1


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +.        ....++.++.++|.+||+.+|++||++.++++|||+
T Consensus       219 ~~--------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 PP--------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CC--------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            11        112467889999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-45  Score=315.53  Aligned_cols=255  Identities=32%  Similarity=0.507  Sum_probs=209.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|++|.||+|.++.+++.+++|++...... ......+|+.++++++||||+++++++.+++.+|++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            6899999999999999999999999999999998765333 334556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccc
Q 038835           82 MECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~  158 (337)
                      ++++.+..+.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+....... .....
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  161 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF  161 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence            9987666555443 679999999999999999999999999999999999999976 89999999987665432 22445


Q ss_pred             cccccccCchhhcCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          159 VSTRWYRAPEVLLQS--YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      .++..|+|||.+.+.  ..++.++|+||+||++|+|++|.+||.+....+....+......+                  
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~------------------  223 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP------------------  223 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------------------
Confidence            788999999987543  256889999999999999999999998776554433322210000                  


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                             .........+.++.+++.+||..||.+|||+.+++.|||
T Consensus       224 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         224 -------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                   000111345678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-46  Score=334.18  Aligned_cols=256  Identities=28%  Similarity=0.440  Sum_probs=221.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH-hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE-CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .-|.+...||+|.|++|.++.+..||..||||.+.+....... ....+|+++|+.|+|||||+++.+.+....+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            4689999999999999999999999999999999887665432 224689999999999999999999999999999999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      |+.++ +.+.+.+ .+...+..++.+++|++.|++|||+++|+|||||.+|||++.+ ++||+|||++..+.......++
T Consensus       136 ya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~  214 (596)
T KOG0586|consen  136 YASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTF  214 (596)
T ss_pred             eccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccccc
Confidence            99875 5555555 4447789999999999999999999999999999999999999 7999999999999888888999


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      ||++.|.|||++.+....++++|+||+|+++|-|++|..||.+.+-.+.-.+...                   .++..|
T Consensus       215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-------------------gk~rIp  275 (596)
T KOG0586|consen  215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-------------------GKYRIP  275 (596)
T ss_pred             CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-------------------eeeccc
Confidence            9999999999998887788999999999999999999999998765443322211                   112222


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                                 -.++.+..++|+++|..+|.+|+++++++.|.|......
T Consensus       276 -----------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  276 -----------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             -----------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence                       346789999999999999999999999999999876443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-44  Score=327.47  Aligned_cols=283  Identities=37%  Similarity=0.608  Sum_probs=219.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   74 (337)
                      ++|.+.+.||+|+||.||++.+..+|+.||+|++....... ......+|+.++++++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            68999999999999999999999999999999987643222 233446799999999999999999987543      34


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .+++++++++++.+.+. .. .+++..++.++.|++.||+|||++|++||||||+||+++.+ .++|+|||.+...... 
T Consensus        97 ~~lv~~~~~~~L~~~~~-~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-  173 (345)
T cd07877          97 VYLVTHLMGADLNNIVK-CQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-  173 (345)
T ss_pred             EEEEehhcccCHHHHHh-cC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence            78999998776655443 33 48999999999999999999999999999999999999876 9999999998865432 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh-HHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL-ARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~  232 (337)
                       .....+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+....+.+....+...... ...
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T cd07877         174 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  252 (345)
T ss_pred             -ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence             234578999999999876556789999999999999999999999888777777777666655544333211110 000


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .....+..............++++.++|.+||+.||.+|||+.++++||||+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence            00011111111122222356889999999999999999999999999999986444

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-45  Score=317.68  Aligned_cols=256  Identities=23%  Similarity=0.427  Sum_probs=207.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +|+..+.||+|++|.||++.++.+|+.+|+|++.......     ....+.+|++.++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5899999999999999999999999999999987543211     12344689999999999999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCC--
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRP--  153 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~--  153 (337)
                      |+||+.++.+..+.....++++..++.++.||+.||.|||++|++|+||+|+||+++.+  .++|+|||.+.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            99999987776666555679999999999999999999999999999999999999765  69999999987664321  


Q ss_pred             ---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 ---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 ---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                         ......|+..|+|||.+.+. .++.++|+||+||++|+|++|..||...........+......             
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  226 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA-------------  226 (268)
T ss_pred             CCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-------------
Confidence               11234688899999998654 6789999999999999999999999765443322222111000             


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                          .        ......+..++++.+++.+||..||.+|||+.++++||||+
T Consensus       227 ----~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ----T--------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ----C--------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                0        00112245678999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=324.24  Aligned_cols=279  Identities=28%  Similarity=0.470  Sum_probs=222.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCC--CC----cccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH--PN----IVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~----iv~~~~~~~~~~~~   75 (337)
                      +||+++..+|+|.||.|-.+.+.+++..||+|+++....  -....+-|++++.++.+  |+    ++.+.++|+..++.
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            589999999999999999999999999999999976422  12233468999999832  22    67778889999999


Q ss_pred             EEEEeecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC------------------
Q 038835           76 YFVFEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD------------------  136 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~------------------  136 (337)
                      +||+|.++-++.+.+.+. ..+++...++.+.+|++++++|||+.+++|.||||+|||+.+.                  
T Consensus       167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence            999999998899988764 4679999999999999999999999999999999999998321                  


Q ss_pred             ---cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 038835          137 ---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS  213 (337)
Q Consensus       137 ---~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  213 (337)
                         .++++|||.|+......  ++.+.|..|+|||++.+- .|+.++||||+||||+|+.+|...|.+.++.+.+..+..
T Consensus       247 ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer  323 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER  323 (415)
T ss_pred             CCcceEEEecCCcceeccCc--ceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence               48999999998754433  667899999999999876 899999999999999999999999999999999988888


Q ss_pred             HhCCCCccchhhhhhhHHh--hhccCCCCCCC-----------ccc---ccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 038835          214 VIGTPTQDSWADGLLLARA--INYKFPQLVGV-----------PLS---VLMPSANKDAVSLIASLCSWDPSKRPTAAEA  277 (337)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  277 (337)
                      .+|+.+...........-+  ....+++....           +..   ...+..-.++.|||++||..||.+|+|+.|+
T Consensus       324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence            8887776655443210000  01122211100           000   1112233558999999999999999999999


Q ss_pred             hcCcCccc
Q 038835          278 LQHPFSRV  285 (337)
Q Consensus       278 l~hp~~~~  285 (337)
                      |.||||..
T Consensus       404 L~HpFF~~  411 (415)
T KOG0671|consen  404 LSHPFFAR  411 (415)
T ss_pred             hcCHHhhc
Confidence            99999984

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.3e-44  Score=325.38  Aligned_cols=283  Identities=38%  Similarity=0.660  Sum_probs=223.4

Q ss_pred             CceEeeeecccCceEEEEEEECCC--CcEEEEEEcccccCCh-HHhHHHHHHHHHhcC-CCCCcccceeEEee----CCE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQS--GEVVAIKKMKKKYYSW-EECVNLREVKSLRKM-SHPNIVKLKEVIRE----NDI   74 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~   74 (337)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+....... ......+|+.+++++ +||||+++++....    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999988  8999999987543222 233446799999999 59999999987532    256


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .++++||+++++.+.+.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .++|+|||.+.......
T Consensus        81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            799999999888777654 4558999999999999999999999999999999999999876 89999999997654321


Q ss_pred             -----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          154 -----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       154 -----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                           ......|++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+.+....+.....
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS  239 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence                 123457899999999887655689999999999999999999999999888888888888887766544332211


Q ss_pred             hH-HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          229 LA-RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       229 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .. ...................+..+.++.+++.+||+.||.+|||+.+++.|||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            00 00011111111222333445678999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-46  Score=330.24  Aligned_cols=241  Identities=32%  Similarity=0.532  Sum_probs=204.3

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      +++++.||+|.||.||.|.... ...||+|.+....+.  ...+.+|+++|++|+|+|||++++++..++.+|||||||.
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            4567889999999999998863 236999999877554  3344689999999999999999999999889999999999


Q ss_pred             C-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccc
Q 038835           84 C-NLYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS  160 (337)
Q Consensus        84 ~-~l~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~g  160 (337)
                      . +|++.+.. .+..+...+...++.||++|++||+++++|||||-..||||+++ .+||+|||+|+...+.. +....|
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~  363 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEG  363 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCC
Confidence            5 56666665 45678999999999999999999999999999999999999988 89999999999544332 222222


Q ss_pred             ---cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          161 ---TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       161 ---t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                         ...|.|||++..+ .++.+||||||||+|+||+| |+.||.+.+..+.++.+..+..-|-+                
T Consensus       364 ~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P----------------  426 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP----------------  426 (468)
T ss_pred             CCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC----------------
Confidence               3569999999877 78999999999999999999 99999999999999988776433322                


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL  278 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  278 (337)
                                   +..|+++.+++..||..+|++|||.+.+.
T Consensus       427 -------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  427 -------------EGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -------------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                         45678999999999999999999999664

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-45  Score=319.49  Aligned_cols=276  Identities=39%  Similarity=0.697  Sum_probs=219.4

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcC---CCCCcccceeEEeeCCE-----
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKM---SHPNIVKLKEVIRENDI-----   74 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----   74 (337)
                      |++.+.||.|++|.||+|.++.+|+.+|+|.+........ .....+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7899999999999999999998999999999975433221 22234677766655   69999999999987766     


Q ss_pred             EEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      .+++|||+.+++.+.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            99999999988777665533 358999999999999999999999999999999999999987 8999999999877655


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .......++..|+|||.+.+. .++.++|+||+||++|+|++|.+||.+.+..+...++......+....|........ 
T Consensus       161 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  238 (287)
T cd07838         161 MALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR-  238 (287)
T ss_pred             cccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch-
Confidence            444556688999999998765 678999999999999999999999999988888888877655544443332211000 


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                        ..++...........+..++.+.++|.+||+.||.+||+++++++||||
T Consensus       239 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 --SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             --hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence              0111111122233335667889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.8e-45  Score=328.24  Aligned_cols=283  Identities=40%  Similarity=0.735  Sum_probs=224.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcC-CCCCcccceeEEee--CCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKM-SHPNIVKLKEVIRE--NDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~l   77 (337)
                      ++|++.+.||.|++|.||+|.+..+|+.+|+|.+....... ......+|+.+++++ +||||+++++++..  ....++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            57999999999999999999999999999999886532221 223345799999999 99999999998754  346899


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC---
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP---  153 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~---  153 (337)
                      ||||+++++...+...  .+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+.......   
T Consensus        87 v~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~  164 (337)
T cd07852          87 VFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP  164 (337)
T ss_pred             EecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence            9999998777666543  58999999999999999999999999999999999999887 89999999987654321   


Q ss_pred             ---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 ---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 ---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                         ......|++.|+|||.+.+...++.++|+||+|+++|+|++|++||.+....+...++....+.+....+.......
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
T cd07852         165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF  244 (337)
T ss_pred             cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence               22345789999999988766667899999999999999999999999988888888888777766654444321110


Q ss_pred             Hh-hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          231 RA-INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       231 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .. .-...............+..+.++.++|.+||+.||.+|||+.++++|||++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            00 000111112222233345578999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.4e-45  Score=316.21  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=205.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +|++.+.||.|+||.||+|.+ .+|+.+|+|.+.......     ......+|+..++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            589999999999999999986 478899999887543221     12234679999999999999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-----
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-----  151 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-----  151 (337)
                      ++||++++.+..+..+..++++..++.++.|++.||+|||+.|++|+||+|+||+++++ .++|+|||.+.....     
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999987776666555668999999999999999999999999999999999999876 999999998875421     


Q ss_pred             --CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          152 --RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       152 --~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                        ........|+..|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+......            
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------  226 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL------------  226 (265)
T ss_pred             cccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC------------
Confidence              1112345789999999998655 6789999999999999999999999876554433322211000            


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                             .        ....+.++.++.++|++||+.+|.+|||+.++++||||
T Consensus       227 -------~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 -------M--------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -------C--------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                   0        11224578899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-44  Score=321.56  Aligned_cols=256  Identities=28%  Similarity=0.353  Sum_probs=209.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||++.++.+++.||+|.+......  .......+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4799999999999999999999999999999998765332  12234457999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC------
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR------  152 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~------  152 (337)
                      ||++|+.+..+......+++..+..++.|++.||.|||++|++||||||+||+++.+ .++|+|||.+......      
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            999987666666555679999999999999999999999999999999999999876 9999999988632100      


Q ss_pred             ----------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccc
Q 038835          153 ----------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS  222 (337)
Q Consensus       153 ----------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  222 (337)
                                .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+....+....+.....      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~------  233 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI------  233 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------
Confidence                      001124678899999998765 679999999999999999999999988776655554433210      


Q ss_pred             hhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCcCccc
Q 038835          223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT---AAEALQHPFSRV  285 (337)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~  285 (337)
                                   ..+        ......+.++.++|.+||+.||++|||   +.++++||||..
T Consensus       234 -------------~~~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         234 -------------EWP--------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             -------------CCC--------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence                         011        011246788999999999999999997   899999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.3e-45  Score=321.93  Aligned_cols=260  Identities=26%  Similarity=0.395  Sum_probs=207.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|+..+.||+|+||.||++.+..+|+.+|+|.+.............+|+.++.++. ||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            467888999999999999999999999999999886554444555578999999995 9999999999998899999999


Q ss_pred             ecCCCHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           81 YMECNLYQLMK----DREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        81 ~~~~~l~~~~~----~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      |+++++.+...    .....+++..+..++.|++.||+|||+. |++||||||+||+++++ .++|+|||++........
T Consensus        84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence            99876544322    2235689999999999999999999975 99999999999999876 899999999876554433


Q ss_pred             CccccccccccCchhhcCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          155 FTEYVSTRWYRAPEVLLQS--YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .....|++.|+|||.+.+.  ..++.++||||+||++|+|++|++||.....  ....+.......              
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~--------------  227 (288)
T cd06616         164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD--------------  227 (288)
T ss_pred             cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC--------------
Confidence            3445789999999998765  3688999999999999999999999976542  222221111100              


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                          .+..    .......++.++.+||.+||+.||.+|||++++++||||+.
T Consensus       228 ----~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         228 ----PPIL----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             ----CCcC----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence                0000    00111357889999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.3e-45  Score=316.80  Aligned_cols=253  Identities=26%  Similarity=0.450  Sum_probs=210.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +|++.+.||.|+||.||+|.++.+|+.+|+|++......  .......+|++.+++++||||+++++.+.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            589999999999999999999999999999999765432  223445689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      |+.|+.+........++++..+..++.||++||.|||++|++|+||+|+||+++++ .++|+|||.+.............
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  160 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS  160 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence            99987666665555679999999999999999999999999999999999999876 99999999988766554445567


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      |+..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.... ..+......                      
T Consensus       161 ~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~----------------------  216 (258)
T cd05578         161 GTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQET----------------------  216 (258)
T ss_pred             CChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHHHhcc----------------------
Confidence            88999999998665 579999999999999999999999987664211 111111000                      


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH--HHHhcCcCc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA--AEALQHPFS  283 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~~  283 (337)
                          .....++..+.++.++|.+||+.||.+||++  +|+++||||
T Consensus       217 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                0011124567899999999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.6e-45  Score=316.43  Aligned_cols=248  Identities=23%  Similarity=0.319  Sum_probs=202.4

Q ss_pred             cCceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.++   .++..||+|.++............+|+..+++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            47999999999999999999765   456789999998764444444567899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           79 FEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      |||+++++++.+... ...+++..++.++.||+.||+|||++|++||||||+||+++.+ .++++|||.+..........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~  164 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT  164 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhc
Confidence            999998777655543 4568999999999999999999999999999999999999887 89999999876543322111


Q ss_pred             --cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          157 --EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       157 --~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                        ...++..|+|||.+.+. .++.++||||+||++|++++ |.+||.+.+..+....+......                
T Consensus       165 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------------  227 (266)
T cd05064         165 TMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL----------------  227 (266)
T ss_pred             ccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC----------------
Confidence              23456789999988665 68999999999999999775 99999888776655544321100                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                   ..++..+..+.+++.+||+.+|.+|||+++|++
T Consensus       228 -------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 -------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                         012356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-44  Score=322.23  Aligned_cols=254  Identities=30%  Similarity=0.492  Sum_probs=211.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|++|.||++.+..+|+.||+|.+.......  ......+|+.+++.++||||+++++++.+++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            47899999999999999999999999999999986543222  2234568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||+.|++.+.+......+++..+..++.|++.||.|||+.|++||||+|+||+++.+ .++|+|||++......   ...
T Consensus        95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~  171 (307)
T cd06607          95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSF  171 (307)
T ss_pred             HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CCc
Confidence            999999888877656679999999999999999999999999999999999999876 9999999988765433   345


Q ss_pred             cccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          159 VSTRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       159 ~gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      .+++.|+|||++.+  ...++.++||||+|+++|+|++|.+||.+.+.......+...                     .
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~---------------------~  230 (307)
T cd06607         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------------------D  230 (307)
T ss_pred             cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---------------------C
Confidence            78889999998742  345788999999999999999999999877665543332211                     0


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .+.       ......+.++.++|.+||..||++|||+.+++.||||...
T Consensus       231 ~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         231 SPT-------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             CCC-------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            000       0012356889999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.8e-45  Score=318.20  Aligned_cols=257  Identities=27%  Similarity=0.454  Sum_probs=208.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|++|.||++.++.+++.+|+|.+.............+|++++++++||||+++++.+..++.+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47899999999999999999999999999999988765444445567899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           82 MECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ++++.+..+... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.+ .++|+|||.+........ ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~  159 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KTF  159 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hcc
Confidence            997555555443 3679999999999999999999999 999999999999999986 899999998876543221 226


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE--ADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      .++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.....  ......+.......                  
T Consensus       160 ~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------  220 (265)
T cd06605         160 VGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------------------  220 (265)
T ss_pred             cCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------------------
Confidence            788999999998665 789999999999999999999999976531  11111111111100                  


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+..       ....++.+++++|.+||..||++|||+.+++.||||+.
T Consensus       221 ~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         221 PPRL-------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             CCCC-------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            0000       00126789999999999999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.1e-45  Score=314.47  Aligned_cols=251  Identities=28%  Similarity=0.490  Sum_probs=207.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|++|.||++.++.+++.+++|.+.....   .....+|+.++++++||||+++++.+..+...|+++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            589999999999999999999998899999999875422   34556899999999999999999999999999999999


Q ss_pred             cCCCHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccc
Q 038835           82 MECNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~-~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~  158 (337)
                      ++++.+..+ ......+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+....... .....
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence            998655544 4445678999999999999999999999999999999999999876 89999999988765433 22345


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .|+..|+|||.+.+. .++.++||||+|+++|+|++|++||......+....+...    .                 . 
T Consensus       160 ~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----~-----------------~-  216 (256)
T cd06612         160 IGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----P-----------------P-  216 (256)
T ss_pred             cCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----C-----------------C-
Confidence            688999999998655 6789999999999999999999999876554332221110    0                 0 


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                           ........++.++.++|.+||+.||.+|||+.|+++||||
T Consensus       217 -----~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         217 -----PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -----CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                 0001123467889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-44  Score=312.37  Aligned_cols=253  Identities=30%  Similarity=0.498  Sum_probs=209.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC----hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS----WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +|+..+.||+|++|.||+|.++.+++.|++|.+......    .......+|+.+++.++|+||+++++++.++..++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            688999999999999999999989999999998654321    1233456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      +||++++.+..+..+...+++..+..++.||+.||+|||+.|++|+||+|+||+++.+ .+||+|||.+...........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            9999986666665555668999999999999999999999999999999999999876 999999999887654443355


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|++.|+|||.+.....++.++|+||+||++|+|++|.+||......+....+....                      
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------------------  218 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK----------------------  218 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc----------------------
Confidence            6789999999998655347899999999999999999999997766443333221100                      


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                            .....++.+++++.+++.+||+.+|.+|||+.+++.|||+
T Consensus       219 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 ------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                  0011224567899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-44  Score=314.64  Aligned_cols=253  Identities=25%  Similarity=0.450  Sum_probs=201.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh----HHhHHHHHHHHHhcCCCCCcccceeEEee--CCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW----EECVNLREVKSLRKMSHPNIVKLKEVIRE--NDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   75 (337)
                      .+|++.+.||+|++|.||++.+..+|..||+|.+.......    ......+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36899999999999999999999999999999887543221    22334679999999999999999999865  4678


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC--
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR--  152 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~--  152 (337)
                      ++++||++++.+.........+++..++.++.|++.||.|||++|++||||+|+||+++.+ .++|+|||.+......  
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            9999999976555554445568999999999999999999999999999999999999876 8999999998755321  


Q ss_pred             --CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          153 --PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       153 --~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                        .......++..|+|||.+.+. .++.++|+||+||++|+|++|++||......+....+...   +.           
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~-----------  226 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT-----------  226 (266)
T ss_pred             cCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC-----------
Confidence              112234688899999998664 6789999999999999999999999876544333222110   00           


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                    ........++.++++| +||..+|++|||++|+++||||+
T Consensus       227 --------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 --------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             --------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                          0111234578889999 56668999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.5e-44  Score=310.63  Aligned_cols=251  Identities=29%  Similarity=0.486  Sum_probs=209.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++++.||.|+||.||.+.+..+|+.+++|.+....... ......+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            6999999999999999999999999999999987654332 233446899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcc
Q 038835           82 MECNLY-QLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTE  157 (337)
Q Consensus        82 ~~~~l~-~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~  157 (337)
                      ++++.+ +.+.+. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ .+||+|||.+....... ....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            987544 444443 3568999999999999999999999999999999999999876 89999999987664433 2344


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+....+....                     +
T Consensus       161 ~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~---------------------~  218 (256)
T cd08221         161 VVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN---------------------Y  218 (256)
T ss_pred             cCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---------------------C
Confidence            6789999999988665 57889999999999999999999998876665555443210                     0


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +        ...+..+.++.++|.+||..||.+|||+.++++|||+
T Consensus       219 ~--------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 T--------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             C--------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            0        0114567899999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.6e-45  Score=321.85  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=208.9

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      .|.....||.|+||.||++.+..++..||+|.+..... .......+|+..++.++||||+++++.+..++..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            45667789999999999999999999999999865332 22334568999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~g  160 (337)
                      +++++..+.... .+++..++.++.||+.||.|||++|++||||||+||+++.+ .++|+|||++...... .......|
T Consensus       102 ~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  180 (292)
T cd06658         102 EGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG  180 (292)
T ss_pred             CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeec
Confidence            987776665443 48999999999999999999999999999999999999876 9999999988755332 22244678


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      ++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+..+....+.......                  .+  
T Consensus       181 ~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~--  239 (292)
T cd06658         181 TPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------------VK--  239 (292)
T ss_pred             CccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc------------------cc--
Confidence            9999999988654 67899999999999999999999998776655444332211000                  00  


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                             .....+..+.+++.+||..||.+|||++++++||||.....
T Consensus       240 -------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         240 -------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             -------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence                   01246788999999999999999999999999999986443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-44  Score=315.99  Aligned_cols=252  Identities=25%  Similarity=0.442  Sum_probs=201.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~   74 (337)
                      .+|++.+.||+|+||.||+|.++.+++.+|+|.+......  ......|+.+++++ +||||+++++++...      ..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            3688999999999999999999999999999998754322  33456789999998 799999999998642      46


Q ss_pred             EEEEEeecCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC
Q 038835           75 LYFVFEYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS  151 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~  151 (337)
                      .|++|||++++.+..+...  ...+++..++.++.|++.||+|||+++++|+||||+||+++.+ .++|+|||++.....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence            8999999997655544332  3468999999999999999999999999999999999999877 899999999876543


Q ss_pred             C-CCCccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          152 R-PPFTEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       152 ~-~~~~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      . .......|++.|+|||++.+    ...++.++|+||+||++|+|++|..||...........+...            
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~------------  231 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------------  231 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC------------
Confidence            2 22345678999999999863    235788999999999999999999999765543332221110            


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                               ..+       .......+.++.+++.+||..||.+|||+.+++.||||
T Consensus       232 ---------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 ---------PAP-------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ---------CCC-------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                     000       01123467899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.9e-45  Score=318.20  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=209.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ..|+.++.||.|++|.||+|.++.+++.+|+|.+.............+|+.+++.++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35888999999999999999999999999999987654444444556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~  159 (337)
                      ++++.+......+ ++++..+..++.|++.||+|||+++++|+||+|+||+++.+ .++|+|||.+....... ......
T Consensus        84 ~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06640          84 LGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccccc
Confidence            9986655555443 48999999999999999999999999999999999999876 89999999987654432 223356


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      ++..|+|||.+.+. ..+.++|+|||||++|+|++|.+||.+.+.......+...                     ..  
T Consensus       163 ~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------------~~--  218 (277)
T cd06640         163 GTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN---------------------NP--  218 (277)
T ss_pred             CcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC---------------------CC--
Confidence            88899999998655 5789999999999999999999999876654433322110                     00  


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                            .......+.++.++|.+||+.+|++|||+.++++||||...
T Consensus       219 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         219 ------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             ------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence                  01123456889999999999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-44  Score=315.36  Aligned_cols=257  Identities=28%  Similarity=0.442  Sum_probs=205.0

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh---------HHhHHHHHHHHHhcCCCCCcccceeEEeeCC
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW---------EECVNLREVKSLRKMSHPNIVKLKEVIREND   73 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   73 (337)
                      +|.+.+.||.|++|.||+|.++.+|+.+|+|.+.......         ......+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            6899999999999999999999999999999886432111         0123357999999999999999999999999


Q ss_pred             EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           74 ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ..++||||+.++.+.........+++..++.++.||+.||.|||++|++|+||+|+||+++.+ .++|+|||.+......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            999999999887665555555679999999999999999999999999999999999999876 8999999998765432


Q ss_pred             C---CCccccccccccCchhhcCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          153 P---PFTEYVSTRWYRAPEVLLQSY-LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       153 ~---~~~~~~gt~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      .   ......|+..|+|||.+.... .++.++|+||+|+++|++++|..||......+....+......           
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  230 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA-----------  230 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC-----------
Confidence            1   123346888999999987553 4788999999999999999999999765543332221110000           


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                                   ........+.++.++.++|.+||..||.+|||++++++||||
T Consensus       231 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 -------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                         000111234578999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.3e-44  Score=321.13  Aligned_cols=281  Identities=36%  Similarity=0.621  Sum_probs=221.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee-CCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE-NDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (337)
                      ++|++.+.||.|+||.||++.++.+|+.||+|.+....... ......+|+.+++.++||||+++.+++.. .+..++++
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            58999999999999999999999999999999886543222 23344589999999999999999999865 56789999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||+++++...+..  .++++..+..++.|+++||.|||++|++||||+|+||+++.+ .++|+|||.+......  ....
T Consensus        90 e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~  165 (328)
T cd07856          90 ELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGY  165 (328)
T ss_pred             ehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cCCC
Confidence            9998776655442  347899999999999999999999999999999999999876 8999999998755332  2345


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH-hhhccC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR-AINYKF  237 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~  237 (337)
                      .+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.........+.+..+.++.+.+........ ..-...
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (328)
T cd07856         166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL  245 (328)
T ss_pred             cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence            7788999999886655789999999999999999999999998887777777777766665444332111000 000011


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      +.....+.....+..+.++.++|.+||+.+|++|||+++++.||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence            2222223333445678999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.2e-44  Score=311.86  Aligned_cols=251  Identities=32%  Similarity=0.577  Sum_probs=208.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++.+.||+|+||.+|++.+..+|+.+|+|.+....... ......+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6999999999999999999999999999999987543332 233456899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Ccc
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTE  157 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~  157 (337)
                      +.++ +.+.+... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+........ ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            9874 55555443 3358999999999999999999999999999999999999876 999999999876644322 233


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|++.|+|||.+.+. .++.++|+||+||++++|++|..||...+..+....+....                     .
T Consensus       161 ~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~---------------------~  218 (256)
T cd08218         161 CIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS---------------------Y  218 (256)
T ss_pred             ccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC---------------------C
Confidence            5688899999998665 67889999999999999999999998776665554443211                     0


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +        ......+.++.++|.+||+.+|.+||++.++++||||
T Consensus       219 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 P--------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             C--------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            1        1123567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-44  Score=316.46  Aligned_cols=249  Identities=29%  Similarity=0.400  Sum_probs=196.9

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHH---hcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            9 EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSL---RKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      .||+|+||.||++.+..+|+.+|+|.+.+......  .....+|..++   ...+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999999876543221  22223444333   34479999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccc
Q 038835           84 CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTR  162 (337)
Q Consensus        84 ~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~  162 (337)
                      ++.+.........+++..+..++.|++.||.|||++|++||||||+||+++.+ .++|+|||++....... .....|++
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  159 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence            87666555555669999999999999999999999999999999999999876 89999999987654332 23457999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||.+.++..++.++|+||+||++|+|++|..||.......... +....                   ...+    
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~-------------------~~~~----  215 (279)
T cd05633         160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMT-------------------LTVN----  215 (279)
T ss_pred             CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHh-------------------hcCC----
Confidence            99999998655567899999999999999999999997654321111 11100                   0000    


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                         ...++..+.++.++|.+||..||.+||     |+.++++||||+.
T Consensus       216 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         216 ---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             ---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence               012245789999999999999999999     6999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.7e-44  Score=311.56  Aligned_cols=254  Identities=25%  Similarity=0.446  Sum_probs=203.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC----hHHhHHHHHHHHHhcCCCCCcccceeEEee--CCE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS----WEECVNLREVKSLRKMSHPNIVKLKEVIRE--NDI   74 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   74 (337)
                      +++|++.+.||+|+||.||++.++.+|+.||+|.+......    .......+|+.++++++||||+++++++.+  ...
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            46899999999999999999999999999999988643221    112344679999999999999999999865  357


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-  152 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-  152 (337)
                      ++++|||++++.+.....+...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+...... 
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            88999999986655555444568999999999999999999999999999999999999876 8999999988754321 


Q ss_pred             ---CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          153 ---PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       153 ---~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                         .......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.........+.   ..+.          
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~----------  226 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPT----------  226 (265)
T ss_pred             ccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCC----------
Confidence               112345688999999998764 67899999999999999999999997765443332221   1110          


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                     ....++.++..+.++|.+|+. +|++|||++|+++|||+.
T Consensus       227 ---------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ---------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                           011124567889999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-46  Score=303.45  Aligned_cols=257  Identities=24%  Similarity=0.392  Sum_probs=214.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++.+.+..||.|..|.|+++..+.+|...|+|.+.+..-.++..+++..++++... ++|.||+++++|..+..++|.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            34566778999999999999999999999999998876555666666677766555 69999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      .|..-....+++-..+++|..+-.+...++.||.||.++ ||+|||+||+|||+|.. ++||||||.+....+....+..
T Consensus       172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrs  251 (391)
T KOG0983|consen  172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRS  251 (391)
T ss_pred             HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccc
Confidence            998655555555567799999999999999999999965 89999999999999875 9999999999887766666778


Q ss_pred             cccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          159 VSTRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSE-ADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       159 ~gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      .|.+.|||||-+.-  ...|+..+||||||++++||.||..||.+.+. -+.+-++.+.  .                  
T Consensus       252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--e------------------  311 (391)
T KOG0983|consen  252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--E------------------  311 (391)
T ss_pred             cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--C------------------
Confidence            89999999999862  45689999999999999999999999988543 4555555441  1                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                       .|.      ......+|+++.+|+..||++|+.+||...++|+|||+..
T Consensus       312 -PP~------L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  312 -PPL------LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             -CCC------CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence             111      1112358999999999999999999999999999999874

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.5e-44  Score=315.90  Aligned_cols=254  Identities=24%  Similarity=0.417  Sum_probs=203.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeC-----CEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREN-----DIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~   75 (337)
                      ++|.+.+.||+|+||.||++.++.+|+.+|+|.+.....  ......+|+.+++++ +|||++++++++...     +..
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            579999999999999999999999999999999865322  223345789999998 899999999998643     468


Q ss_pred             EEEEeecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835           76 YFVFEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      ++||||++++.+..+..    ....+++..++.++.|++.||+|||+.|++|+||||+||+++.+ .++|+|||.+....
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            99999998865544432    34568999999999999999999999999999999999999876 89999999987654


Q ss_pred             CCC-CCccccccccccCchhhcCcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          151 SRP-PFTEYVSTRWYRAPEVLLQSY----LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       151 ~~~-~~~~~~gt~~~~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      ... ......|+..|+|||.+....    .++.++||||+||++|+|++|++||...+..+....+....   .      
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~------  250 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---P------  250 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---C------
Confidence            322 123457889999999875432    35789999999999999999999998776554443332110   0      


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                  +..      ......+.++.++|.+||+.||++|||+.|+++||||+
T Consensus       251 ------------~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 ------------PTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ------------CCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                        000      01134567899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-46  Score=324.01  Aligned_cols=258  Identities=29%  Similarity=0.420  Sum_probs=219.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++.|...++||+|+||.||-|..+.||+.+|+|.+.+......  +...+.|-.+|.+++.+.||.+-..|+.++.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            4578889999999999999999999999999999876544332  33446899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC
Q 038835           79 FEYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~  155 (337)
                      +..|+||.+...+..  ++.++|+.+..++.+|+.||++||+.+||+||+||+|||+|+. ++.|+|+|+|.......+.
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~  343 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI  343 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence            999999877655443  3479999999999999999999999999999999999999986 9999999999999888877


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||.+|||||++.+. .|+.+.|.|||||++|+|+.|+.||.........+++-...-.                  
T Consensus       344 ~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------------------  404 (591)
T KOG0986|consen  344 RGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------------------  404 (591)
T ss_pred             ccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------------------
Confidence            888999999999999877 5999999999999999999999999776554333333221110                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                              ...++.+.+|++++++.+.+|++||.+|.     +++++.+||||++
T Consensus       405 --------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  405 --------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             --------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence                    11122357899999999999999999997     6789999999986

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-44  Score=311.39  Aligned_cols=248  Identities=32%  Similarity=0.530  Sum_probs=205.6

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      +|++.+.||.|+||.||++.++.+++.+|+|.+.............+|+.+++.++||||+++++.+..++.+|++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            69999999999999999999999999999999865443333445568999999999999999999999999999999999


Q ss_pred             CCC-HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Cccc
Q 038835           83 ECN-LYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTEY  158 (337)
Q Consensus        83 ~~~-l~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~~  158 (337)
                      +++ +.+.+.. .+..++++.++.++.||+.||.|||++|++|+||||+||+++++ .++|+|||.+........ ....
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY  160 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence            875 5555543 34558999999999999999999999999999999999999876 999999999876644322 2346


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .|++.|+|||++.+. .++.++|+||+|+++|+|++|..||...+.......+......                     
T Consensus       161 ~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------  218 (255)
T cd08219         161 VGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK---------------------  218 (255)
T ss_pred             cCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC---------------------
Confidence            789999999998655 6789999999999999999999999877655554443321100                     


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                              ......+..+.++|.+||+.||.+|||+.++++-
T Consensus       219 --------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 --------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                    0123467889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-44  Score=317.39  Aligned_cols=263  Identities=25%  Similarity=0.369  Sum_probs=209.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|++|.||++.+..+|+.+|+|++.............+|+++++.++||||+++++.+...+.+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57999999999999999999999999999999887654433344557899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      ++++.+..+....+.+++..+..++.|++.||.|||+ .+++||||+|+||+++.+ .++|+|||++....... .....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~~~~  163 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-ADTFV  163 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cCccc
Confidence            9987776666656679999999999999999999997 599999999999999876 89999999886543221 23457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE----IYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      |+..|+|||++.+. .++.++|+||+||++|+|++|..||......+.    ...+...              .......
T Consensus       164 ~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~  228 (284)
T cd06620         164 GTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------------LQQIVQE  228 (284)
T ss_pred             cCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH--------------HHHHhhc
Confidence            89999999998665 678999999999999999999999987554311    0000000              0000000


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      ..+..       .....+.++.++|.+||+.||.+|||+.|+++||||....
T Consensus       229 ~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         229 PPPRL-------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             cCCCC-------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            00000       0123678899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.3e-44  Score=312.87  Aligned_cols=247  Identities=29%  Similarity=0.417  Sum_probs=203.9

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      ||.|++|.||+|.+..+++.+|+|++......  .......+|+.+++.++||||+++++.+.+++..++++||++++.+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999999999999999999765432  2334456899999999999999999999999999999999987666


Q ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccccC
Q 038835           88 QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRA  166 (337)
Q Consensus        88 ~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~a  166 (337)
                      ..+..+...+++..+..++.||+.||+|||++|++|+||+|+||+++.+ .++|+|||.+.............|++.|+|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  160 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA  160 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence            5555555568999999999999999999999999999999999999876 999999999987765433345678999999


Q ss_pred             chhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCc
Q 038835          167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS--EADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVP  244 (337)
Q Consensus       167 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
                      ||.+.+. .++.++|+||+|+++|+|++|..||....  ..+....+.....                            
T Consensus       161 PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------  211 (262)
T cd05572         161 PEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG----------------------------  211 (262)
T ss_pred             hhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC----------------------------
Confidence            9987654 67899999999999999999999998776  3233322221000                            


Q ss_pred             ccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          245 LSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       245 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                      ....++..++++.++|.+||+.||.+|||     ++|+++||||.+
T Consensus       212 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         212 KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence            00112344789999999999999999999     999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.2e-44  Score=318.83  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=198.1

Q ss_pred             cCceEeeeecccCceEEEEEEECC----------------CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccc
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ----------------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL   65 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   65 (337)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|.+...........+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            479999999999999999997532                3457999998765443344456789999999999999999


Q ss_pred             eeEEeeCCEEEEEEeecCCCHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCC
Q 038835           66 KEVIRENDILYFVFEYMECNLYQLMKDRE-------------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL  126 (337)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-------------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~di  126 (337)
                      ++++.+.+..++||||++++.+..+....                   ..+++..+..++.||+.||.|||++|++||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            99999999999999999875544433221                   23677889999999999999999999999999


Q ss_pred             CCCCeeeeCC-cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh--CCCCCC
Q 038835          127 KPENLLVSKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFP  200 (337)
Q Consensus       127 kp~Nili~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~  200 (337)
                      ||+|||++.+ .+||+|||.+........   .....++..|+|||++.+. .++.++|||||||++|+|++  +..||.
T Consensus       165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            9999999987 899999999876543321   1234557889999998765 68999999999999999986  568898


Q ss_pred             CCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          201 GTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       201 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      +.+..+....+..........                      ......+..+..+.+++.+||+.||.+|||+.++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         244 ELTDEQVIENAGEFFRDQGRQ----------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             cCCHHHHHHHHHHHhhhcccc----------------------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            877665554433221110000                      000112456788999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-44  Score=314.10  Aligned_cols=253  Identities=28%  Similarity=0.445  Sum_probs=203.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~   74 (337)
                      ++|++.+.||.|++|.||+|.++.+++.+++|++.....  ......+|+.+++++ .|+||+++++++...      ..
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            689999999999999999999999999999999876533  234456899999999 799999999998654      45


Q ss_pred             EEEEEeecCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           75 LYFVFEYMECNLYQLMKDR----EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      +++||||++++.+..+...    +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+...
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            8999999998655544332    4568999999999999999999999999999999999999876 8999999988765


Q ss_pred             CCC-CCCccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchh
Q 038835          150 NSR-PPFTEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       150 ~~~-~~~~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  224 (337)
                      ... .......|++.|+|||.+..    ...++.++||||+||++|+|++|++||.+.........+....         
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------  234 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---------  234 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---------
Confidence            432 22244678999999998753    2346789999999999999999999998765544443332110         


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                                  .+.      .......+.++.++|.+||..||.+|||+.++++|||+
T Consensus       235 ------------~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 ------------PPT------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ------------CCC------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                        000      00012367889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=315.76  Aligned_cols=255  Identities=26%  Similarity=0.422  Sum_probs=209.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC---CCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS---HPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      .|++.+.||.|++|.||+|.+..+|+.+|+|.+.............+|+.+++++.   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            58899999999999999999999999999999876544444445567999999886   999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~  157 (337)
                      ||++++.+..+...+ .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+....... ....
T Consensus        82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06917          82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST  160 (277)
T ss_pred             ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence            999987666655544 58999999999999999999999999999999999999876 99999999987665432 2234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..|+..|+|||.+.++..++.++|+||+||++|+|++|.+||.+.........+...                     ..
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---------------------~~  219 (277)
T cd06917         161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---------------------KP  219 (277)
T ss_pred             ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---------------------CC
Confidence            578999999999876656789999999999999999999999876543322111000                     00


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      +.       ......+.++.+++.+||+.||++|||+.+++.||||+..
T Consensus       220 ~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         220 PR-------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             CC-------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            00       0012367899999999999999999999999999999763

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.2e-44  Score=311.25  Aligned_cols=251  Identities=31%  Similarity=0.524  Sum_probs=206.9

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEe--eCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIR--ENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   79 (337)
                      +|++.+.||.|++|.||++.+..+|+.+|+|.+....... ......+|+.+++.++||||+++++++.  .+...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            6999999999999999999999999999999987654433 2334567999999999999999999775  456789999


Q ss_pred             eecCCCHH-HHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH-----HcCccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           80 EYMECNLY-QLMKDR---EKCFSEAEVRNWCFQVFQGLAYMH-----QRGYFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        80 e~~~~~l~-~~~~~~---~~~l~~~~~~~~~~qil~al~~LH-----~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      ||++++.+ +.+...   +..+++..++.++.||+.||.|||     +.+++|+||+|+||+++.+ .++|+|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99987544 444332   456899999999999999999999     9999999999999999876 9999999999877


Q ss_pred             CCCCC-CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          150 NSRPP-FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       150 ~~~~~-~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      ..... .....|++.|+|||.+.+. .++.++|+||||+++++|++|+.||...+..+....+...              
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------  225 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--------------  225 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--------------
Confidence            65443 3456789999999998665 5789999999999999999999999887654443333211              


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                             ..+        ......+.++.+++.+||+.+|.+|||+.++++|||+
T Consensus       226 -------~~~--------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 -------KFR--------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -------CCC--------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                   011        1124567899999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.7e-44  Score=309.40  Aligned_cols=255  Identities=28%  Similarity=0.490  Sum_probs=207.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++.+.||+|++|.||++.+..+++.+++|.+...... .......+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            699999999999999999999999999999998766543 2344556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-----C
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-----F  155 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-----~  155 (337)
                      ++++.+..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .+||+|||.+........     .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~  160 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV  160 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence            9987776666666668999999999999999999999999999999999999876 899999999887654322     1


Q ss_pred             ccccccccccCchhhcCcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          156 TEYVSTRWYRAPEVLLQSY--LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ....+++.|+|||.+.+..  ..+.++||||+|++++++++|..||..................+               
T Consensus       161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------  225 (264)
T cd06626         161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP---------------  225 (264)
T ss_pred             cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC---------------
Confidence            2356788999999987552  27889999999999999999999997654322221111100000               


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                        .++         .....+..+.++|.+||+.||.+|||+.+++.|||+
T Consensus       226 --~~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 --PIP---------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             --CCC---------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              000         012347889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-44  Score=340.51  Aligned_cols=282  Identities=22%  Similarity=0.349  Sum_probs=199.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC-cEEEEEE--------------ccccc--CChHHhHHHHHHHHHhcCCCCCccc
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG-EVVAIKK--------------MKKKY--YSWEECVNLREVKSLRKMSHPNIVK   64 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~-~~vaiK~--------------~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~   64 (337)
                      ++|++++.||+|+||.||+|..+... ...+.|.              +.+..  .......+.+|+.++++++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            57999999999999999998765332 2222221              11110  0112233468999999999999999


Q ss_pred             ceeEEeeCCEEEEEEeecCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEE
Q 038835           65 LKEVIRENDILYFVFEYMECNLYQLMKDRE----KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIK  139 (337)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~----~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~k  139 (337)
                      +++++...+..|+|+|++.++++..+....    .......++.++.||+.||+|||++||+||||||+|||++.+ .+|
T Consensus       228 l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vk  307 (501)
T PHA03210        228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV  307 (501)
T ss_pred             EeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence            999999999999999999998888765432    223467788999999999999999999999999999999876 999


Q ss_pred             EeeCCCcccCCCCCC--CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCC-CCCCC--CcHHHHHHHHHH
Q 038835          140 IADFGLAREINSRPP--FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRP-LFPGT--SEADEIYKICSV  214 (337)
Q Consensus       140 L~Dfg~a~~~~~~~~--~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~--~~~~~~~~i~~~  214 (337)
                      |+|||++........  ....+||+.|+|||++.+. .++.++|||||||++|+|++|.. ||.+.  .....+.++...
T Consensus       308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~  386 (501)
T PHA03210        308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS  386 (501)
T ss_pred             EEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence            999999987654322  2346899999999998765 68999999999999999999874 45432  233444444443


Q ss_pred             hCCCCccchhhh-hhhHHhhh-ccCCCCCCC-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          215 IGTPTQDSWADG-LLLARAIN-YKFPQLVGV-PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       215 ~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+....+ +.+. ......+. ..+...... +.......++.++.++|.+||+.||.+|||+.|+|+||||..
T Consensus       387 ~~~~~~~-~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~  459 (501)
T PHA03210        387 LSVCDEE-FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA  459 (501)
T ss_pred             cccChhh-cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence            3322211 1111 01111110 001100000 000011246778999999999999999999999999999975

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.6e-44  Score=315.98  Aligned_cols=252  Identities=24%  Similarity=0.432  Sum_probs=200.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEe------eCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIR------ENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------~~~~   74 (337)
                      .+|++.+.||.|+||.||+|.++.+++.+|+|++....  ........|+.+++++ +|+||+++++++.      ..+.
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            46899999999999999999999999999999986542  2233445788888888 7999999999984      3567


Q ss_pred             EEEEEeecCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC
Q 038835           75 LYFVFEYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS  151 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~  151 (337)
                      .+++|||++++.+..+...  ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.+ .++|+|||.+.....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~  173 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence            8999999998655444432  3458899999999999999999999999999999999999876 899999999876542


Q ss_pred             C-CCCccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          152 R-PPFTEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       152 ~-~~~~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      . .......|++.|+|||.+..    ...++.++|+|||||++|+|++|.+||......+....+...            
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------  241 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------------  241 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC------------
Confidence            2 22345678999999998753    235788999999999999999999999766543332221110            


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                               ..+       ......++.++.++|.+||+.||.+|||+.|+++||||
T Consensus       242 ---------~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         242 ---------PPP-------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ---------CCC-------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                     000       01113567899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.7e-45  Score=318.93  Aligned_cols=253  Identities=27%  Similarity=0.411  Sum_probs=207.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +.|++.+.||.|++|.||+|.+..+|+.||+|.+.............+|+.+++.++||||+++++.+..++..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            35788899999999999999999999999999987654444444556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Ccccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~~~  159 (337)
                      ++++.+...... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||++........ .....
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence            998766555543 458999999999999999999999999999999999999876 899999999876554321 23346


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      |+..|+|||.+.+. .++.++|+|||||++|+|++|.+||...........+...                     ..  
T Consensus       163 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------------~~--  218 (277)
T cd06642         163 GTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------------SP--  218 (277)
T ss_pred             CcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------------CC--
Confidence            88999999998665 6789999999999999999999999765543332211100                     00  


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                            .......+.++.++|.+||+.+|++|||+.++++||||..
T Consensus       219 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         219 ------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             ------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence                  0112346788999999999999999999999999999874

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=335.39  Aligned_cols=250  Identities=28%  Similarity=0.437  Sum_probs=208.7

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHHH
Q 038835            9 EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQ   88 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~   88 (337)
                      +||+|.||+||-|+|..|...+|||.+...... .......|+.+.++|+|.|||+++|.+..++.+-|.||-++||.++
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            589999999999999999999999999765433 2333457999999999999999999999999999999999998776


Q ss_pred             HHhh-ccCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC--CcEEEeeCCCcccCCCCCCC-ccccccc
Q 038835           89 LMKD-REKCF--SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK--DTIKIADFGLAREINSRPPF-TEYVSTR  162 (337)
Q Consensus        89 ~~~~-~~~~l--~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~--~~~kL~Dfg~a~~~~~~~~~-~~~~gt~  162 (337)
                      .+.+ ..+++  .|+++..+.+||++||+|||++.|||||||-+|+||+.  +.+||+|||-++....-.+. .++.||.
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence            6554 46778  89999999999999999999999999999999999985  59999999999887665443 5689999


Q ss_pred             cccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCC
Q 038835          163 WYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV  241 (337)
Q Consensus       163 ~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
                      .|||||++..+ ..|+.++|||||||++.||.||+|||..........  ...                ++  ++.    
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--FkV----------------Gm--yKv----  796 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--FKV----------------GM--YKV----  796 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--hhh----------------cc--eec----
Confidence            99999999765 459999999999999999999999997654432211  100                00  110    


Q ss_pred             CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       242 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                         -+.++..+|.+++.||.+|+.+||.+||+|.++|.+||++..
T Consensus       797 ---HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  797 ---HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             ---CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence               112335788999999999999999999999999999999865

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-44  Score=316.63  Aligned_cols=250  Identities=23%  Similarity=0.386  Sum_probs=203.5

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCC-----cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSG-----EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   75 (337)
                      +++|++.+.||+|++|.||+|.+...+     ..+|+|.+.............+|+..++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            367999999999999999999876555     679999987654433344556899999999999999999999998999


Q ss_pred             EEEEeecCCCHH-HHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cE
Q 038835           76 YFVFEYMECNLY-QLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TI  138 (337)
Q Consensus        76 ~lv~e~~~~~l~-~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~  138 (337)
                      +++|||++++.+ +.+....               ..+++..+..++.|++.||.|||++|++|+||||+||+++++ .+
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence            999999987544 4443321               457889999999999999999999999999999999999887 89


Q ss_pred             EEeeCCCcccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 038835          139 KIADFGLAREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSV  214 (337)
Q Consensus       139 kL~Dfg~a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  214 (337)
                      +|+|||++.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR  242 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999987653322   12345678899999988665 67999999999999999998 99999888776655544321


Q ss_pred             hCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          215 IGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...                             ......+.++.+++.+||+.||.+|||+.|++++
T Consensus       243 ~~~-----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         243 QLL-----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CcC-----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            100                             1124578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.4e-44  Score=310.63  Aligned_cols=254  Identities=30%  Similarity=0.463  Sum_probs=211.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|++|.||+|.++.+|+.+++|++.............+|+..+.+++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            47999999999999999999999999999999987765433345557899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-ccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-TEY  158 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-~~~  158 (337)
                      ++++.+..+......+++..++.++.|++.||.|||+ +|++|+||+|+||+++.+ .++|+|||.+......... ...
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  160 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF  160 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence            9976666555555679999999999999999999999 999999999999999876 8999999998876544332 255


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---ADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....   .+....+...   .                 
T Consensus       161 ~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~-----------------  219 (264)
T cd06623         161 VGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---P-----------------  219 (264)
T ss_pred             eecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---C-----------------
Confidence            788999999988665 778999999999999999999999977642   2222222110   0                 


Q ss_pred             cCCCCCCCcccccCCC-CChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPS-ANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                       .+        ..... ++..+.++|.+||..+|++|||+.++++|||++.
T Consensus       220 -~~--------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         220 -PP--------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             -CC--------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence             00        01123 6789999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.8e-44  Score=318.13  Aligned_cols=254  Identities=25%  Similarity=0.452  Sum_probs=208.6

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      |+....||.|+||.||++.++.+++.||+|.+...... ......+|+..++.++||||+++++.+..++..++++||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            55567899999999999999999999999998654332 23345689999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcccccc
Q 038835           84 CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVST  161 (337)
Q Consensus        84 ~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~gt  161 (337)
                      ++.+..+... ..+++..++.++.|++.||.|||++|++||||+|+||+++.+ .++|+|||.+....... ......|+
T Consensus       102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  180 (297)
T cd06659         102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  180 (297)
T ss_pred             CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence            8776666544 348999999999999999999999999999999999999876 99999999987554322 22446789


Q ss_pred             ccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCC
Q 038835          162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV  241 (337)
Q Consensus       162 ~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
                      ..|+|||.+.+. .++.++|+||+||++|+|++|+.||......+....+...    ..                     
T Consensus       181 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~---------------------  234 (297)
T cd06659         181 PYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PP---------------------  234 (297)
T ss_pred             ccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----CC---------------------
Confidence            999999998665 6789999999999999999999999876655544433211    00                     


Q ss_pred             CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       242 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                        .........+.++.++|.+||+.+|.+|||++++++||||....
T Consensus       235 --~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         235 --PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             --CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence              00111235678899999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3e-44  Score=327.63  Aligned_cols=250  Identities=25%  Similarity=0.432  Sum_probs=197.7

Q ss_pred             cCceEeeeecccCceEEEEEEE-----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|++++.||+|+||.||+|.+     ..++..||+|++.............+|+.+++.+ +||||+++++++..++..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999964     3567789999997654444445567899999999 899999999999999999


Q ss_pred             EEEEeecCCC-HHHHHhhcc------------------------------------------------------------
Q 038835           76 YFVFEYMECN-LYQLMKDRE------------------------------------------------------------   94 (337)
Q Consensus        76 ~lv~e~~~~~-l~~~~~~~~------------------------------------------------------------   94 (337)
                      ++||||++++ +.+.+....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            9999999975 444443211                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC---c
Q 038835           95 --------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF---T  156 (337)
Q Consensus        95 --------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~---~  156 (337)
                                    ..+++..+..++.||+.||.|||++|++||||||+|||++.+ .+||+|||++.........   .
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  274 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG  274 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence                          247888999999999999999999999999999999999977 8999999999866443221   1


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||++.+. .++.++|||||||++|+|++ |.+||.+........+.....                    
T Consensus       275 ~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~--------------------  333 (375)
T cd05104         275 NARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG--------------------  333 (375)
T ss_pred             CCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC--------------------
Confidence            23445679999998765 68999999999999999997 899998765543333322210                    


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                       ...       ..+...+.++.++|.+||+.||++|||+.|+++.
T Consensus       334 -~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 -YRM-------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -ccC-------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence             000       0012346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-44  Score=313.85  Aligned_cols=249  Identities=31%  Similarity=0.392  Sum_probs=200.8

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      ||+|+||.||+|.++.+|+.+|+|.+......  .......+|+.++++++||||+++++.++..+..|+||||++++.+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999998754322  1223335799999999999999999999999999999999997655


Q ss_pred             H-HHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccc
Q 038835           88 Q-LMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWY  164 (337)
Q Consensus        88 ~-~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~  164 (337)
                      . .+.+.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ .++|+|||.+.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            4 443333 368999999999999999999999999999999999999886 8999999998766544444456788899


Q ss_pred             cCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCc
Q 038835          165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVP  244 (337)
Q Consensus       165 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
                      +|||.+.+. .++.++|+||+||++|+|++|+.||...........+.....                   .       .
T Consensus       161 ~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~-------~  213 (277)
T cd05577         161 MAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-------------------E-------M  213 (277)
T ss_pred             CCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-------------------c-------c
Confidence            999998765 588999999999999999999999977654222222111100                   0       0


Q ss_pred             ccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          245 LSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       245 ~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                      .....+..++.+.++|.+||+.||.+||     ++.++++||||..
T Consensus       214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence            0011245689999999999999999999     8999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.4e-44  Score=314.08  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=200.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEe-----eCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIR-----ENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~   75 (337)
                      ++|++.+.||+|++|.||++.++.+|+.+|+|++.....  ......+|+.+++.+ +||||+++++++.     .++..
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            689999999999999999999999999999998765322  223345789999999 7999999999873     45678


Q ss_pred             EEEEeecCCCHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835           76 YFVFEYMECNLYQLMK----DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~----~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      ++||||++++.+..+.    .....+++..++.++.|++.||.|||+.+++||||||+||+++.+ .++|+|||++....
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            9999999986655443    234568999999999999999999999999999999999999876 89999999987654


Q ss_pred             CCC-CCccccccccccCchhhcCc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          151 SRP-PFTEYVSTRWYRAPEVLLQS----YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       151 ~~~-~~~~~~gt~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      ... ......|++.|+|||.+...    ..++.++||||+||++|+|++|..||...........+...           
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-----------  244 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-----------  244 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc-----------
Confidence            322 22345789999999987532    34788999999999999999999999776543332221100           


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                                ..+.      .......+.++.++|.+||+.||++|||+.|+++||||
T Consensus       245 ----------~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 ----------PPPT------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ----------CCCc------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                      0000      00112356789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.8e-44  Score=327.60  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=196.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-----CcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-----GEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|++++.||+|+||.||+|.+..+     +..||+|++.............+|+.+++.+ +|+||+++++.+...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4699999999999999999986544     3579999998655444444557899999999 899999999999999999


Q ss_pred             EEEEeecCCCHH-HHHhhc-------------------------------------------------------------
Q 038835           76 YFVFEYMECNLY-QLMKDR-------------------------------------------------------------   93 (337)
Q Consensus        76 ~lv~e~~~~~l~-~~~~~~-------------------------------------------------------------   93 (337)
                      ++||||+.++.+ +.+...                                                             
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999987544 443221                                                             


Q ss_pred             --------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC---cccccc
Q 038835           94 --------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF---TEYVST  161 (337)
Q Consensus        94 --------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~---~~~~gt  161 (337)
                              ..++++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.........   ....++
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~  277 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP  277 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence                    1247888999999999999999999999999999999999876 8999999998765433211   123355


Q ss_pred             ccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       162 ~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      ..|+|||++.+. .++.++||||+||++|+|++ |+.||..................+                      
T Consensus       278 ~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~----------------------  334 (374)
T cd05106         278 VKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM----------------------  334 (374)
T ss_pred             cceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc----------------------
Confidence            679999998655 68999999999999999997 999998765443333322210000                      


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                            ......++++.++|.+||+.||.+|||+.++++
T Consensus       335 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 ------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  011245789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-46  Score=351.36  Aligned_cols=256  Identities=28%  Similarity=0.410  Sum_probs=216.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|.|+++||+|+||.|.+++++.|++.||+|++++-.+-  .....+..|-.+|.--+.+=|++++..|.++.++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            5799999999999999999999999999999999874332  12333456778888778888999999999999999999


Q ss_pred             eecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC--CCC
Q 038835           80 EYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR--PPF  155 (337)
Q Consensus        80 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~--~~~  155 (337)
                      |||+|| ++..+.+.+ +++|..++.|+..|+.||.-||+.|+|||||||+|||+|.. .+||+|||.+...+..  ...
T Consensus       155 dY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s  233 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS  233 (1317)
T ss_pred             ecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence            999975 555554444 79999999999999999999999999999999999999986 9999999988776533  234


Q ss_pred             ccccccccccCchhhc---Cc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 TEYVSTRWYRAPEVLL---QS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~---~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ...+|||.|.|||++.   ++ ..|+..+|.||+||++|||+.|..||...+-.+.+.+|.+.-                
T Consensus       234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----------------  297 (1317)
T KOG0612|consen  234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----------------  297 (1317)
T ss_pred             ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----------------
Confidence            6689999999999986   22 468999999999999999999999999999888888887641                


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT---AAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~  285 (337)
                       -.+.||.         ...+|.++++||++++. +|+.|..   ++++..||||.+
T Consensus       298 -~~l~FP~---------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  298 -ESLSFPD---------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             -hhcCCCc---------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence             0122331         13589999999999997 7999998   999999999976

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8e-44  Score=312.95  Aligned_cols=240  Identities=21%  Similarity=0.267  Sum_probs=196.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEee----CCEEEEEEee
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRE----NDILYFVFEY   81 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~   81 (337)
                      ..||+|++|.||+|..  +|+.||+|.+........  .....+|+.++++++||||+++++++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5689999999999976  689999999976543321  2334589999999999999999999866    4578999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      ++++.+..+......+++.....++.|++.||.|||+. +++||||||+||+++.+ .+||+|||++.......  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~  181 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNV  181 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cccc
Confidence            99876666666566789999999999999999999984 99999999999999976 99999999988654332  3457


Q ss_pred             ccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          160 STRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       160 gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      |++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+.                   
T Consensus       182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------  242 (283)
T PHA02988        182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK-------------------  242 (283)
T ss_pred             CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------------------
Confidence            89999999998652 3689999999999999999999999998876665554432211100                   


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                               .+...++++.+++.+||+.||.+|||++++++
T Consensus       243 ---------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 ---------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ---------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                     11245789999999999999999999999986

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.3e-44  Score=308.32  Aligned_cols=251  Identities=34%  Similarity=0.612  Sum_probs=206.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|.+.+.||.|++|.||++.++.+|..+|+|.+....... ......+|+.+++.++|+||+++++.+..++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            6899999999999999999999999999999987653322 233446899999999999999999999999999999999


Q ss_pred             cCCCH-HHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCC-Cc
Q 038835           82 MECNL-YQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPP-FT  156 (337)
Q Consensus        82 ~~~~l-~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~-~~  156 (337)
                      +.++. .+.+... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++++  .++|+|||.+........ ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            98754 4444433 2357999999999999999999999999999999999999876  579999999876654322 23


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ...|++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+....+....                     
T Consensus       161 ~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  218 (257)
T cd08225         161 TCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY---------------------  218 (257)
T ss_pred             ccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc---------------------
Confidence            34689999999988655 67899999999999999999999998766554443332110                     


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      .        ....+..+.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 F--------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            0        01124567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.7e-44  Score=311.77  Aligned_cols=249  Identities=29%  Similarity=0.411  Sum_probs=197.8

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHH---HHHHhcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            9 EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLRE---VKSLRKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      .||+|+||.||+|.+..+|+.||+|.+........  ......|   +..++...||+|+.+++.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999876533211  1112233   344455689999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccc
Q 038835           84 CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTR  162 (337)
Q Consensus        84 ~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~  162 (337)
                      |+.+.........+++..++.++.|++.||.|||+.+++||||||+||+++.+ .++|+|||.+....... .....|+.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence            87776666556679999999999999999999999999999999999999876 99999999987654332 23457999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||.+.++..++.++||||+||++|+|++|+.||.+.............. .                         
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~-------------------------  213 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-T-------------------------  213 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-c-------------------------
Confidence            99999998766568899999999999999999999997763322111100000 0                         


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                       .....+...+.++.++|.+||..||.+||     ++.++++||||..
T Consensus       214 -~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         214 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             -cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence             00011234688999999999999999999     9999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-43  Score=314.10  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=206.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++|++.+.||+|++|.||+|.++.+|+.||+|.+..............|+.++..+ +||||+++++++..+...+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            368999999999999999999999999999999997654443444445677666666 5999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ||+++.+.+.+......+++..+..++.|++.||.|||+ .|++||||+|+||+++.+ .++|+|||.+...........
T Consensus        94 e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~  173 (296)
T cd06618          94 ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR  173 (296)
T ss_pred             eccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccC
Confidence            999887776666655679999999999999999999997 599999999999999876 899999999876654433344


Q ss_pred             ccccccccCchhhcCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          158 YVSTRWYRAPEVLLQS---YLYSSKVDMWAMGAIMAELITLRPLFPGTSE-ADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ..+++.|+|||.+.+.   ..++.++||||||+++|+|++|+.||..... .+.+..+...                   
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------  234 (296)
T cd06618         174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-------------------  234 (296)
T ss_pred             CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-------------------
Confidence            5678899999998644   2468899999999999999999999965432 2222222111                   


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                        ..+..      ......+.++.++|.+||..||.+|||++++++||||+.
T Consensus       235 --~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         235 --EPPSL------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             --CCCCC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence              00000      001246788999999999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.8e-44  Score=315.55  Aligned_cols=260  Identities=28%  Similarity=0.511  Sum_probs=210.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|+||.||++.+..+++.+|+|.+...... ......+|+.+++.++||||+++++.+...+..|+|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            5899999999999999999999989999999998654322 233456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~  159 (337)
                      ++++.+..+..+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+....... ......
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~  176 (293)
T cd06647          98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  176 (293)
T ss_pred             CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccccc
Confidence            9986666555443 37899999999999999999999999999999999999876 89999999887654332 223457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      |++.|+|||.+... .++.++|+||+||++|++++|..||...+..+....+... +.                    + 
T Consensus       177 ~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~--------------------~-  233 (293)
T cd06647         177 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT--------------------P-  233 (293)
T ss_pred             CChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CC--------------------C-
Confidence            88999999988655 6789999999999999999999999776543322211100 00                    0 


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCC
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH  291 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  291 (337)
                           .......++..++++|++||..+|++||++.+++.||||+.......
T Consensus       234 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~  280 (293)
T cd06647         234 -----ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS  280 (293)
T ss_pred             -----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence                 00112346788999999999999999999999999999997654443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.3e-43  Score=314.52  Aligned_cols=253  Identities=30%  Similarity=0.481  Sum_probs=210.1

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .|...+.||.|++|.||+|.+..+|+.+++|.+.......  ......+|+.+++.++|||++++++++.+.+..|+|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            3566788999999999999999999999999987543322  22344679999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      |+.+++.+.+.....++++.+++.++.||+.||.|||++|++|+||+|+||+++.+ .++|+|||.+......   ....
T Consensus       102 ~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---~~~~  178 (313)
T cd06633         102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---NSFV  178 (313)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC---CCcc
Confidence            99999888887766679999999999999999999999999999999999999876 8999999988654322   3457


Q ss_pred             ccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          160 STRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       160 gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      |+..|+|||.+..  ...++.++||||+||++|+|++|.+||.+.+.......+....                     .
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---------------------~  237 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---------------------S  237 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---------------------C
Confidence            8899999999742  3357889999999999999999999998876655544432210                     0


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      +.       ...+.++..+.+++.+||+.+|.+|||+.+++.||||+..
T Consensus       238 ~~-------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         238 PT-------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             CC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            10       0113456789999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.9e-44  Score=311.85  Aligned_cols=253  Identities=27%  Similarity=0.435  Sum_probs=208.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      -|++.+.||.|+||.||++.+..+++.+|+|.+.............+|+..+++++||||+++++.+..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            47889999999999999999999999999998865443333445568999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~g  160 (337)
                      +++.+....... .+++..+..++.|++.|+.+||++|++|+||+|+||+++.+ .++|+|||.+....... ......+
T Consensus        85 ~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  163 (277)
T cd06641          85 GGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG  163 (277)
T ss_pred             CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccC
Confidence            987666555443 48999999999999999999999999999999999999876 89999999887654332 1233568


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      +..|+|||.+.+. ..+.++|+||+||++|+|++|..||...........+...                     ..+  
T Consensus       164 ~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~--  219 (277)
T cd06641         164 TPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN---------------------NPP--  219 (277)
T ss_pred             CccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC---------------------CCC--
Confidence            8899999988654 6788999999999999999999999876554433332110                     000  


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                            ......+.++.++|.+||+.+|.+||++.++++||||...
T Consensus       220 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         220 ------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                  1123567889999999999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-43  Score=311.38  Aligned_cols=254  Identities=27%  Similarity=0.499  Sum_probs=207.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      +|...+.||+|++|.||++.++.+++.+++|.+...... ......+|+.+++.++||||+++++++..++..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            456678999999999999999999999999988643222 2334568999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~g  160 (337)
                      .++.+...... ..+++..+..++.|++.||+|||++|++||||+|+||+++.+ .++|+|||.+....... ......|
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  177 (285)
T cd06648          99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG  177 (285)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence            88666655554 458999999999999999999999999999999999999876 99999999877554322 2234578


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      ++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+..+....+.... .                    +  
T Consensus       178 ~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~--------------------~--  233 (285)
T cd06648         178 TPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-P--------------------P--  233 (285)
T ss_pred             CccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-C--------------------C--
Confidence            9999999998665 67899999999999999999999998766554444332210 0                    0  


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                          ........+..+.++|.+||+.||++|||+.++++||||+..
T Consensus       234 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         234 ----KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             ----CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence                000112367889999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-43  Score=308.77  Aligned_cols=247  Identities=24%  Similarity=0.366  Sum_probs=195.8

Q ss_pred             cCceEeeee--cccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEV--GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~i--g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.+  |+|+||.||++.++.+|..+|+|.+.......      .|+.....+ +||||+++++.+..++..++|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            467777777  99999999999999999999999987643321      122222222 799999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      |||++++.+..+......+++..++.++.|++.||.|||+.|++||||||+||+++.+  .++|+|||.+......   .
T Consensus        88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~  164 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---S  164 (267)
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---c
Confidence            9999875554444444479999999999999999999999999999999999999876  6999999998766433   2


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE-IYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...|+..|+|||++.+. .++.++|+||+|+++|+|++|..||......+. .........                   
T Consensus       165 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  224 (267)
T PHA03390        165 CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-------------------  224 (267)
T ss_pred             cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-------------------
Confidence            34688999999998765 678999999999999999999999986544321 111111100                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-AAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell~hp~~~~  285 (337)
                              ......+..++.+.++|.+||+.||.+||+ ++++|+||||.+
T Consensus       225 --------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        225 --------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                    000112357899999999999999999996 699999999963

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.3e-43  Score=304.29  Aligned_cols=251  Identities=33%  Similarity=0.606  Sum_probs=210.0

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|.+.+.||.|++|.||++.+..+++.+|+|++...... .......+|++.++.++|||++++.+.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            699999999999999999999999999999999875543 2344456899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CC
Q 038835           82 MECN-LYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PF  155 (337)
Q Consensus        82 ~~~~-l~~~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~  155 (337)
                      ++++ +.+.+...   +..+++..+..++.|++.||.+||++|++|+||+|+||+++.+ .++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            9975 54555443   3679999999999999999999999999999999999999975 99999999998765543 22


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....|++.|+|||.+... .++.++|+||+|+++++|++|..||...+..+.........                    
T Consensus       161 ~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------  219 (258)
T cd08215         161 KTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--------------------  219 (258)
T ss_pred             cceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--------------------
Confidence            445789999999987655 57899999999999999999999998776544443332110                    


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                       .+        ......+.++.+++..||..+|++|||+.++|+||||
T Consensus       220 -~~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 -YP--------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             -CC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence             01        1123567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-43  Score=313.14  Aligned_cols=252  Identities=30%  Similarity=0.465  Sum_probs=209.6

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .|...+.||+|+||.||++.+..+|..+|+|.+.......  ......+|+.+++.++|||++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4778889999999999999999999999999987543222  22345689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      |+.|++++.+.....++++..+..++.|++.||.|||++|++||||+|+||+++.+ .++|+|||.+......   ....
T Consensus       106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~  182 (317)
T cd06635         106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFV  182 (317)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---cccc
Confidence            99998888776666679999999999999999999999999999999999999876 8999999988755432   3457


Q ss_pred             ccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          160 STRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       160 gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      |++.|+|||.+..  ...++.++|+||+||++|+|++|++||.+.........+......                    
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  242 (317)
T cd06635         183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------------------  242 (317)
T ss_pred             CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--------------------
Confidence            8899999998742  235788999999999999999999999877655554444321100                    


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                       .       ......++.++++|.+||+.+|.+|||+.++++|||+..
T Consensus       243 -~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         243 -T-------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -C-------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence             0       011346788999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=295.90  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=198.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee-----CCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE-----NDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (337)
                      +||++.+.+|+|+|+.||+++...+++.+|+|++.... .......++|++..++++||||++++++...     ....|
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            68999999999999999999999999999999998765 3345556799999999999999999887532     34589


Q ss_pred             EEEeecCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeC-CcEEEeeCCCcccC
Q 038835           77 FVFEYMEC-NLYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSK-DTIKIADFGLAREI  149 (337)
Q Consensus        77 lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~-~~~kL~Dfg~a~~~  149 (337)
                      ++++|... ++++.+...   +..++|.++..|+.+|++||++||+..  ++||||||.|||+++ +.++|.|||++...
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA  179 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence            99999875 577776543   447999999999999999999999999  999999999999988 49999999998765


Q ss_pred             CCCC----------CCccccccccccCchhhcCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 038835          150 NSRP----------PFTEYVSTRWYRAPEVLLQS--YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGT  217 (337)
Q Consensus       150 ~~~~----------~~~~~~gt~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  217 (337)
                      .-..          .......|..|+|||.+...  ...+.++|||||||++|.|+.|..||......         .+.
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------GgS  250 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------GGS  250 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------CCe
Confidence            3211          11234568889999998643  24578999999999999999999999432110         000


Q ss_pred             CCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          218 PTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..        .......+.+|..         ..+|..+.++|+.||++||.+||++.+++.+
T Consensus       251 la--------LAv~n~q~s~P~~---------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LA--------LAVQNAQISIPNS---------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EE--------EeeeccccccCCC---------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            00        0000112233332         2478999999999999999999999999874

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=307.30  Aligned_cols=248  Identities=30%  Similarity=0.445  Sum_probs=199.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHH-HhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKS-LRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||.|++|.||+|.+..+|+.||+|.+........  ......|... ....+|+|+++++++++.++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            579999999999999999999999999875432211  1122334443 4455899999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW  163 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~  163 (337)
                      +.+..+.....++++..+..++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+......   ....|++.
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~  158 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGTPD  158 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc---ccCCCCcC
Confidence            7776666666679999999999999999999999999999999999999876 9999999988765432   34568889


Q ss_pred             ccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCC
Q 038835          164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV  243 (337)
Q Consensus       164 ~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
                      |+|||.+.+. .++.++||||+|+++|+|++|.+||...+..+....+....                   ..++.    
T Consensus       159 y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~----  214 (260)
T cd05611         159 YLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-------------------INWPE----  214 (260)
T ss_pred             ccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-------------------cCCCC----
Confidence            9999998766 47899999999999999999999998877655544432210                   00110    


Q ss_pred             cccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCcCccc
Q 038835          244 PLSVLMPSANKDAVSLIASLCSWDPSKRP---TAAEALQHPFSRV  285 (337)
Q Consensus       244 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~  285 (337)
                         .....+++++.++|.+||+.||++||   +++|++.||||..
T Consensus       215 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         215 ---EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             ---cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence               11135688999999999999999999   5579999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-43  Score=315.02  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=196.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcE--EEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++.+.||+|+||.||+|.++.+|..  +++|.+.............+|+.++.++ +||||+++++++..++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            36899999999999999999999887765  5777665433333344556799999999 89999999999999999999


Q ss_pred             EEeecCCC-HHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEE
Q 038835           78 VFEYMECN-LYQLMKDR---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKI  140 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL  140 (337)
                      ||||++++ +.+.+...               ...+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence            99999875 44444322               1257899999999999999999999999999999999999876 9999


Q ss_pred             eeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 038835          141 ADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPT  219 (337)
Q Consensus       141 ~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~  219 (337)
                      +|||++.............++..|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+....    
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----  240 (303)
T cd05088         166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----  240 (303)
T ss_pred             CccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC----
Confidence            999998643322111223346679999988655 67899999999999999998 999998776654443321100    


Q ss_pred             ccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                      ..         ..+...++++.++|.+||+.+|++|||+++++++
T Consensus       241 ----------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 ----------------RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ----------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            00         0112457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-43  Score=308.94  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=203.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee--CCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE--NDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   79 (337)
                      ++|+..+.||.|++|.||++.++.+++.+|+|.+.............+|++++++++||||+++++++..  .+.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            5799999999999999999999999999999998765444444556789999999999999999998754  45789999


Q ss_pred             eecCCCHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           80 EYMECNLYQLMK----DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        80 e~~~~~l~~~~~----~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      ||++++.+..+.    .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.+ .++|+|||.+........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            999876554332    234558999999999999999999999999999999999999876 899999999876543221


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE--ADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                       ....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.....  ....+.......                
T Consensus       161 -~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------  222 (287)
T cd06621         161 -GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----------------  222 (287)
T ss_pred             -ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----------------
Confidence             345678899999988655 678999999999999999999999976532  111111110000                


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                        ...+....  ........++++.++|.+||..||.+|||+.|+++||||..
T Consensus       223 --~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~  271 (287)
T cd06621         223 --MPNPELKD--EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA  271 (287)
T ss_pred             --CCchhhcc--CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence              00000000  00001134678999999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.6e-43  Score=310.50  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=201.9

Q ss_pred             cCceEeeeecccCceEEEEEEECC-----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|.+.+.||+|+||.||+|.+..     +++.||+|.+.............+|+++++.++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            578999999999999999998753     467899999876544434455678999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEe
Q 038835           77 FVFEYMECNLYQLMKDRE--------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIA  141 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~--------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~  141 (337)
                      +||||++++.+.......              ..+++..+..++.|++.||.|||++|++||||||+||+++.+ .++|+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~  164 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG  164 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence            999999976555444321              347899999999999999999999999999999999999876 99999


Q ss_pred             eCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 038835          142 DFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGT  217 (337)
Q Consensus       142 Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~  217 (337)
                      |||.+........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..... 
T Consensus       165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~-  242 (280)
T cd05049         165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL-  242 (280)
T ss_pred             CcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc-
Confidence            9999875432221   1234567889999998765 68999999999999999998 9999988776665544432100 


Q ss_pred             CCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          218 PTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                                  .......+.++.+++.+||+.||.+|||+.|+++
T Consensus       243 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         243 ----------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                        0111356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.4e-43  Score=309.18  Aligned_cols=249  Identities=22%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             cCceEeeeecccCceEEEEEEECC-----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|.+.+.||+|++|.||+|.++.     ++..||+|.+.............+|+.+++.++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            468999999999999999999987     778899998876544444455678999999999999999999998888999


Q ss_pred             EEEeecCCCHHHH-Hhhcc------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCC
Q 038835           77 FVFEYMECNLYQL-MKDRE------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGL  145 (337)
Q Consensus        77 lv~e~~~~~l~~~-~~~~~------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~  145 (337)
                      +||||+.++.+.. +....      ..+++..+..++.||+.||.|||+++++||||||+||+++.+    .+||+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999998755544 43322      248999999999999999999999999999999999999864    599999999


Q ss_pred             cccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +........   .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.... .    
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~----  239 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R----  239 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c----
Confidence            886533221   1122345679999998765 68999999999999999997 999998877655443332110 0    


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                              .......+.++.+++.+||+.||++|||+.++++|
T Consensus       240 ------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 ------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    00124567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-43  Score=310.75  Aligned_cols=254  Identities=26%  Similarity=0.464  Sum_probs=207.2

Q ss_pred             eEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            5 KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +....||+|++|.||++.++.+|+.+|+|.+..... .......+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            334679999999999999999999999998864322 2334456899999999999999999999999999999999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~gt~  162 (337)
                      +.+..+.... .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ .++|+|||.+....... ......|++
T Consensus       102 ~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  180 (292)
T cd06657         102 GALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP  180 (292)
T ss_pred             CcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence            7776665543 48999999999999999999999999999999999999876 89999999887654332 223457899


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||.+.+. .++.++|+||+|+++|+|++|.+||.+....+....+....                      +..  
T Consensus       181 ~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~----------------------~~~--  235 (292)
T cd06657         181 YWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL----------------------PPK--  235 (292)
T ss_pred             cccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC----------------------Ccc--
Confidence            99999987654 67899999999999999999999998766654443332211                      000  


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                         .......+..+.+++.+||+.||.+||++.++++||||.....
T Consensus       236 ---~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         236 ---LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             ---cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence               0011346788999999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-43  Score=303.91  Aligned_cols=252  Identities=26%  Similarity=0.447  Sum_probs=203.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC----ChHHhHHHHHHHHHhcCCCCCcccceeEEeeC--CEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY----SWEECVNLREVKSLRKMSHPNIVKLKEVIREN--DIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~   75 (337)
                      ++|.+.+.||+|++|.||+|.++.+|+.+|+|.+.....    ......+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            579999999999999999999999999999998754321    12233446799999999999999999998654  568


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC--
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR--  152 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~--  152 (337)
                      ++++||++++.+.........+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+......  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            9999999876555444444558999999999999999999999999999999999999876 8999999998765321  


Q ss_pred             --CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          153 --PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       153 --~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                        .......|+..|+|||.+.+. .++.++|+|||||++|+|++|++||.+....+....+.   ..+.           
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~-----------  226 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT-----------  226 (264)
T ss_pred             cCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC-----------
Confidence              112345689999999988765 57899999999999999999999998765444333221   1110           


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                                    ....++.+++++.++|.+||+ +|..|||+.+++.|||.
T Consensus       227 --------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 --------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             --------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                          011235678999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.2e-43  Score=309.32  Aligned_cols=254  Identities=23%  Similarity=0.397  Sum_probs=200.4

Q ss_pred             cCceEeeeecccCceEEEEEEECC-----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++.+.||+|+||.||+|.++.     .+..||+|.+.............+|+..++.++||||+++++++..++..+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            589999999999999999997652     355799998875543333344568999999999999999999999889999


Q ss_pred             EEEeecCCCHHH-HHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           77 FVFEYMECNLYQ-LMKDR---------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        77 lv~e~~~~~l~~-~~~~~---------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                      +||||+.++.+. .+...         ....+...+..++.|++.||.|||++|++||||||+||+++.+ .++|+|||.
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~  165 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM  165 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCc
Confidence            999999875544 44321         1235677889999999999999999999999999999999876 899999999


Q ss_pred             cccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +........   .....++..|+|||.+.++ .++.++|+||+||++|+|++ |.+||.+....+....+....      
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~------  238 (288)
T cd05061         166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG------  238 (288)
T ss_pred             cccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            875433221   1223456789999998765 67899999999999999998 789998876655444332110      


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc------CcCccc
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ------HPFSRV  285 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~~~~  285 (337)
                                     .+.        .....++.+.+++.+||+.||++|||+.++++      ||||+.
T Consensus       239 ---------------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         239 ---------------YLD--------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             ---------------CCC--------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence                           000        11245688999999999999999999999986      888875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-43  Score=309.26  Aligned_cols=250  Identities=22%  Similarity=0.383  Sum_probs=200.3

Q ss_pred             CcCceEeeeecccCceEEEEEEE----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAIS----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      +++|++.+.||+|+||.||+|..    ..++..+++|.+...........+.+|+.+++.++||||+++++++..++..|
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            46799999999999999999985    34567899999976443333345568999999999999999999999999999


Q ss_pred             EEEeecCCCHH-HHHhhc----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cE
Q 038835           77 FVFEYMECNLY-QLMKDR----------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TI  138 (337)
Q Consensus        77 lv~e~~~~~l~-~~~~~~----------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~  138 (337)
                      +||||++++.+ +.+...                ...+++..+..++.|++.||.|||++|++||||||+||+++++ .+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence            99999997544 444321                1237889999999999999999999999999999999999877 89


Q ss_pred             EEeeCCCcccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 038835          139 KIADFGLAREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSV  214 (337)
Q Consensus       139 kL~Dfg~a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  214 (337)
                      ||+|||++.......   ......++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+..+.+...
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  242 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR  242 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999997653321   12334566789999988655 67999999999999999998 99999887665554443221


Q ss_pred             hCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          215 IGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..                             ...+...++.+.+++.+||+.||.+||++.+++++
T Consensus       243 ~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         243 QL-----------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             Cc-----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            00                             01123467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8e-43  Score=300.69  Aligned_cols=251  Identities=29%  Similarity=0.532  Sum_probs=207.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      +|.+.+.||+|++|.||++.+..+|+.+++|++..... .......+|+..++.++|+|++++++++..++..++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            58999999999999999999999999999999977544 23345568999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccc
Q 038835           83 ECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS  160 (337)
Q Consensus        83 ~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~g  160 (337)
                      +++.+..+... ...+++..+..++.|++.||.+||++|++|+||+|+||+++.+ .++|+|||.+.............+
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  159 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG  159 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence            97655555443 3579999999999999999999999999999999999999876 899999999887765432345678


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL  240 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
                      +..|+|||.+... .++.++|+||+|+++|+|++|..||...+..+....+....                     .+..
T Consensus       160 ~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~~~~  217 (253)
T cd05122         160 TPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG---------------------PPGL  217 (253)
T ss_pred             CCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC---------------------CCCc
Confidence            8999999998765 57889999999999999999999998775544433322110                     0000


Q ss_pred             CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          241 VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                      .      ....++..+.++|.+||+.||++|||+.++++|||
T Consensus       218 ~------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 R------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             C------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            0      01124788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.8e-43  Score=313.37  Aligned_cols=253  Identities=29%  Similarity=0.462  Sum_probs=209.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +.|+..+.||.|++|.||++.++.+++.+|+|.+......  .......+|+.+++.++|+|++++++++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3577888999999999999999999999999998643222  22334468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||+.+++.+.+.....++++..+..++.|++.||.|||+++++||||+|+||+++.+ .++|+|||.+......   ...
T Consensus        95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~  171 (308)
T cd06634          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXF  171 (308)
T ss_pred             EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccc
Confidence            999988887776666678999999999999999999999999999999999999876 8999999988765433   345


Q ss_pred             cccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          159 VSTRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       159 ~gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      .|++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+....                     
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---------------------  230 (308)
T cd06634         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---------------------  230 (308)
T ss_pred             cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC---------------------
Confidence            78899999999752  2356889999999999999999999997765544443332210                     


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+.       ......+..+.++|.+||..+|.+|||+++++.|||+..
T Consensus       231 ~~~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         231 SPA-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             CCC-------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            000       011356788999999999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.6e-43  Score=311.10  Aligned_cols=249  Identities=26%  Similarity=0.388  Sum_probs=197.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc--EEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE--VVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.++.+|.  .+++|.+.............+|+.+++++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            689999999999999999999887775  46888876433333334456899999999 799999999999999999999


Q ss_pred             EeecCCC-HHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEe
Q 038835           79 FEYMECN-LYQLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIA  141 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~  141 (337)
                      +||++++ +.+.+....               ..+++..++.++.|++.||+|||++|++||||||+||+++.+ .+||+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence            9999865 444443321               248899999999999999999999999999999999999877 89999


Q ss_pred             eCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCc
Q 038835          142 DFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQ  220 (337)
Q Consensus       142 Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~  220 (337)
                      |||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |.+||.+....+....+.....    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~----  236 (297)
T cd05089         162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR----  236 (297)
T ss_pred             CcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----
Confidence            99998654322111222335579999988655 67999999999999999997 9999988776655444322100    


Q ss_pred             cchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                               .......+.++.++|.+||+.||.+|||++++++.
T Consensus       237 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 -------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     01123567899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.3e-43  Score=308.23  Aligned_cols=249  Identities=22%  Similarity=0.359  Sum_probs=198.1

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++.+.||+|++|.||+|.++     .++..||+|.+.............+|+.+++.++||||+++++++..++..+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            57999999999999999999864     2456799999865433333344568999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhc-c---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           77 FVFEYMECNLYQLMKDR-E---------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~-~---------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                      +||||++++.+..+... .         ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ .++|+|||+
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~  165 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCC
Confidence            99999997655544332 1         235778899999999999999999999999999999999976 899999999


Q ss_pred             cccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+....      
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~------  238 (277)
T cd05062         166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG------  238 (277)
T ss_pred             ccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC------
Confidence            875533221   1223557889999998765 67999999999999999998 789998877665554432210      


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                     .+        ......+..+.+++.+||+.||++|||+.|++++
T Consensus       239 ---------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 ---------------LL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             ---------------cC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           00        0113457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4e-43  Score=303.35  Aligned_cols=242  Identities=24%  Similarity=0.373  Sum_probs=193.9

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      +.||+|+||.||+|.++.+|+.+|+|.+.............+|+++++.++||||+++++++...+..++||||++++.+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999999999999999887554433444567899999999999999999999999999999999987555


Q ss_pred             H-HHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc---cccccc
Q 038835           88 Q-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT---EYVSTR  162 (337)
Q Consensus        88 ~-~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~---~~~gt~  162 (337)
                      . .+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+..........   ...++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  160 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV  160 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence            4 444445568999999999999999999999999999999999999876 89999999987654321111   112245


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV  241 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
                      .|+|||.+.++ .++.++|||||||++|+|++ |.+||......+....+......                        
T Consensus       161 ~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------------  215 (252)
T cd05084         161 KWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL------------------------  215 (252)
T ss_pred             eecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC------------------------
Confidence            69999988665 57899999999999999997 89999776654433322211000                        


Q ss_pred             CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       242 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                           ......+..+.+++.+||+.||++|||+.++++
T Consensus       216 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 -----PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 112345788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.7e-43  Score=314.33  Aligned_cols=273  Identities=19%  Similarity=0.226  Sum_probs=196.1

Q ss_pred             CceEEEEEEECCCCcEEEEEEcccccC-ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHHHHHhh
Q 038835           14 TFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKD   92 (337)
Q Consensus        14 ~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~   92 (337)
                      ++|.||.+.++.+|+.||+|++..... ........+|+.++++++||||+++++++.+++..+++|||++++.+..+..
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            445666666677999999999986532 2334455789999999999999999999999999999999999766655543


Q ss_pred             c--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--------CCcccccc
Q 038835           93 R--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--------PFTEYVST  161 (337)
Q Consensus        93 ~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--------~~~~~~gt  161 (337)
                      .  ...+++..++.++.|++.||.|||++||+||||||+||+++.+ .++|+|||.+.......        ......++
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN  171 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence            2  3458999999999999999999999999999999999999875 99999999886543211        11334577


Q ss_pred             ccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccc--hhhhhhhHHhh--hcc
Q 038835          162 RWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS--WADGLLLARAI--NYK  236 (337)
Q Consensus       162 ~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~--~~~  236 (337)
                      ..|+|||++... ..++.++|+||+||++|+|++|..||.......................  +..........  ...
T Consensus       172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
T cd08216         172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE  251 (314)
T ss_pred             ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence            889999998653 3578899999999999999999999987665544332222111100000  00000000000  000


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .+.............++.++.+++..||..||++|||++++|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence            00000001111123456789999999999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.6e-43  Score=304.41  Aligned_cols=250  Identities=25%  Similarity=0.361  Sum_probs=198.1

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      ....||+|+||.||++.+..++..||+|.+...... ......+|+.+++.++|+||+++++++..++..++|+||++++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            456799999999999999999999999988754322 2334568999999999999999999999999999999999976


Q ss_pred             HHHH-HhhccCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC--CcEEEeeCCCcccCCCCC-CCcccc
Q 038835           86 LYQL-MKDREKCF--SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK--DTIKIADFGLAREINSRP-PFTEYV  159 (337)
Q Consensus        86 l~~~-~~~~~~~l--~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~--~~~kL~Dfg~a~~~~~~~-~~~~~~  159 (337)
                      .+.. +......+  ++..+..++.||+.||.|||++|++||||||+||+++.  +.++|+|||.+....... ......
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  170 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT  170 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence            5554 44433445  88999999999999999999999999999999999975  389999999987654322 223456


Q ss_pred             ccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          160 STRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       160 gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      |++.|+|||.+... ..++.++|+||+|+++|+|++|.+||...............                   . .  
T Consensus       171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~-~--  228 (268)
T cd06624         171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-------------------F-K--  228 (268)
T ss_pred             CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-------------------h-c--
Confidence            88999999998654 24788999999999999999999999754332111100000                   0 0  


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                           .....+...++++.+++.+||+.+|.+|||+.|++.||||
T Consensus       229 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 -----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                 0011224567899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.5e-43  Score=339.66  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=198.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      |++|+++++||+|+||.||+|.++.+|+.||+|++.......  ......+|+.+++.++||||+++++++.+++..++|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            689999999999999999999999999999999997643322  233456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           79 FEYMECNLYQLMKDR-----------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~-----------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      |||++|+.+..+..+           ....+...+..++.||+.||+|||++||+||||||+||+++.+ .++|+|||.+
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            999998655544321           1235667789999999999999999999999999999999876 9999999998


Q ss_pred             ccCCCC-------------------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 038835          147 REINSR-------------------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE  207 (337)
Q Consensus       147 ~~~~~~-------------------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  207 (337)
                      ......                   ......+||+.|+|||.+.+. .++.++||||+||++|+|++|.+||.+....+.
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            765210                   011235799999999998765 679999999999999999999999977544332


Q ss_pred             HHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       208 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ....  ....                    +.     .......+++.+.+++.+||..||++|++..+.+.+
T Consensus       240 ~~~~--~i~~--------------------P~-----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        240 SYRD--VILS--------------------PI-----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhh--hccC--------------------hh-----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2110  0000                    00     000113577899999999999999999876665543

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.8e-43  Score=303.73  Aligned_cols=251  Identities=25%  Similarity=0.438  Sum_probs=200.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++.+.||+|+||.||+|.++.+|+.||+|.+......  .......+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            47899999999999999999999999999999988653222  2233446799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           79 FEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        79 ~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      +||++++.+..+..    ....+++..+..++.|++.||.|||++|++|+||||+||+++.+ .++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            99999765544332    33458999999999999999999999999999999999999876 89999999988765432


Q ss_pred             C-CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 P-FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE--ADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 ~-~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      . .....|++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.....  .+....+ ....              
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~--------------  224 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCD--------------  224 (267)
T ss_pred             HHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCC--------------
Confidence            2 2345788999999988665 578899999999999999999999865432  1222111 1100              


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                            .+.       ......+..+.++|.+||..+|++|||+.++++.
T Consensus       225 ------~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         225 ------YPP-------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             ------CCC-------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                  110       0112456889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=324.55  Aligned_cols=241  Identities=28%  Similarity=0.471  Sum_probs=201.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +.|.+...+|.|+|+.|-.+.++.+++..++|++.+...+.     .+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~-----~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN-----QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheecccccccc-----ccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            57889999999999999999999999999999998763221     3566555554 89999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee-C-CcEEEeeCCCcccCCCCCCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-K-DTIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~-~-~~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      .+.|+.+-..+...+.+. ..+..|+.+|+.|+.|||++|++|||+||+|||++ . ++++|+|||.+......  ..+.
T Consensus       397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp  473 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTP  473 (612)
T ss_pred             hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hccc
Confidence            999865444433333233 78889999999999999999999999999999994 4 38999999999987665  4455


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      +-|..|.|||++. ...|++++|+||||+++|+||+|+.||...... +.+.++    +.+.                  
T Consensus       474 ~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~------------------  530 (612)
T KOG0603|consen  474 ALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPK------------------  530 (612)
T ss_pred             chhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCc------------------
Confidence            7789999999987 448999999999999999999999999887766 332222    1111                  


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                                +...+|.++++||++||+.||.+|+++.+++.||||
T Consensus       531 ----------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 ----------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                      114689999999999999999999999999999999

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3e-43  Score=316.64  Aligned_cols=250  Identities=26%  Similarity=0.404  Sum_probs=195.7

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEe-eCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIR-ENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~   74 (337)
                      ++|++.+.||.|+||.||+|.+.     .+++.||+|++.............+|+.+++++ +|+||+++++++. .+..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            48999999999999999999743     345789999987654333344456899999999 8999999999875 4467


Q ss_pred             EEEEEeecCCCHHHHHhhc-------------------------------------------------------------
Q 038835           75 LYFVFEYMECNLYQLMKDR-------------------------------------------------------------   93 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~-------------------------------------------------------------   93 (337)
                      ++++|||++++.+..+...                                                             
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            8999999998655443321                                                             


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---CccccccccccCchh
Q 038835           94 EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEV  169 (337)
Q Consensus        94 ~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~  169 (337)
                      ..++++..+..++.||+.||+|||++||+||||||+||+++.+ .++|+|||++........   .....++..|+|||+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            1257899999999999999999999999999999999999976 899999999986543221   123455678999999


Q ss_pred             hcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCccccc
Q 038835          170 LLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVL  248 (337)
Q Consensus       170 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (337)
                      +.+. .++.++||||+||++|+|++ |.+||.+....+..........                    .+        ..
T Consensus       247 ~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------------~~--------~~  297 (337)
T cd05054         247 IFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--------------------RM--------RA  297 (337)
T ss_pred             hcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--------------------CC--------CC
Confidence            8765 78999999999999999998 9999987554333322221100                    00        01


Q ss_pred             CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          249 MPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       249 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ....++++.+++.+||+.+|++|||+.|+++|
T Consensus       298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            13457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.7e-43  Score=301.65  Aligned_cols=250  Identities=29%  Similarity=0.505  Sum_probs=207.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++.+.||.|++|.||++.++.+|+.+|+|.+....... ......+|+.+++.++|+||+++++++..+...++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            6899999999999999999999999999999987654332 233446899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           82 MECNLYQLMKDR----EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        82 ~~~~l~~~~~~~----~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ++++.+.....+    +..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .+||+|||.+...... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~  159 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK  159 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence            987655443322    3568999999999999999999999999999999999999876 8999999999876554 233


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ...+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+....+...                     .
T Consensus       160 ~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~  217 (256)
T cd08530         160 TQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------------K  217 (256)
T ss_pred             cccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------------C
Confidence            46789999999998654 6788999999999999999999999877655443332211                     1


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ++.        .....+.++++++.+||+.+|.+|||+.++++||++
T Consensus       218 ~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 YPP--------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCC--------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            111        113567889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=299.26  Aligned_cols=251  Identities=32%  Similarity=0.562  Sum_probs=209.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|++.+.||+|++|.||++.++.+++.+++|.+....... ......+|++++++++|||++++++++.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            6899999999999999999999999999999998765432 233456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Ccccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~~~  159 (337)
                      ++++.+..+......+++..++.++.|++.||.+||++|++||||+|+||+++.+ .++|+|||.+........ .....
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  160 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV  160 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence            9986666555555679999999999999999999999999999999999999876 899999999987654432 23457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      ++..|+|||...+. ..+.++|+||+|+++|+|++|.+||...........+...                     ..+ 
T Consensus       161 ~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~-  217 (254)
T cd06627         161 GTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---------------------DHP-  217 (254)
T ss_pred             cchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---------------------CCC-
Confidence            88999999988655 4789999999999999999999999776543333222110                     011 


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                             ...+..+..+.++|.+||..+|++|||+.+++.||||
T Consensus       218 -------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         218 -------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                   1124567899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.1e-43  Score=309.33  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             cCceEeeeecccCceEEEEEEECC-----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      .+|.+.+.||.|+||.||+|.+..     +++.||+|++.............+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            578899999999999999998754     357899999986543333344568999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhh-c---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEE
Q 038835           77 FVFEYMECNLYQLMKD-R---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIK  139 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~-~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~k  139 (337)
                      +++||+.++.+..+.. .               ...+++..+..++.|++.||.|||++|++||||||+||+++.+ .+|
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k  164 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK  164 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence            9999998765544432 1               2347888999999999999999999999999999999999876 899


Q ss_pred             EeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 038835          140 IADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVI  215 (337)
Q Consensus       140 L~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~  215 (337)
                      |+|||++........   .....+++.|+|||.+.++ .++.++||||+||++|+|++ |.+||.+....+....+....
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~  243 (283)
T cd05091         165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ  243 (283)
T ss_pred             ecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999876543221   2334567889999998765 57899999999999999998 889998877766555543321


Q ss_pred             CCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..                             ......+..+.+++..||+.+|.+||++.++++.
T Consensus       244 ~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         244 VL-----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             cC-----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            00                             1124567889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.2e-43  Score=307.63  Aligned_cols=251  Identities=33%  Similarity=0.538  Sum_probs=207.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|.+.+.||.|++|.||++.+..+|+.+|+|++......  .......+|+.+++++. ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            5899999999999999999999999999999998764322  22334467999999998 99999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---  154 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---  154 (337)
                      ||+++++.+.........+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ .++|+|||.+........   
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999765554444455569999999999999999999999999999999999999876 999999999876543221   


Q ss_pred             ------------------CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 038835          155 ------------------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG  216 (337)
Q Consensus       155 ------------------~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  216 (337)
                                        .....++..|+|||.+... .++.++|+||+|++++++++|..||...........+...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--  237 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL--  237 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc--
Confidence                              1234678899999988655 5788999999999999999999999887654444433211  


Q ss_pred             CCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCcCc
Q 038835          217 TPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA----AEALQHPFS  283 (337)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~~  283 (337)
                                       ...           ....+++.+.++|.+||+.||.+|||+    +++++||||
T Consensus       238 -----------------~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 -----------------EYS-----------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -----------------CCC-----------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                             001           113567899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-42  Score=301.20  Aligned_cols=245  Identities=30%  Similarity=0.430  Sum_probs=199.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||++..+. +..+|+|.+......  .....+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            579999999999999999998764 567999988754333  33456899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--cc
Q 038835           82 MECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--TE  157 (337)
Q Consensus        82 ~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--~~  157 (337)
                      ++++ +.+.+......+++..++.++.|++.||+|||++|++||||||+||+++.+ .++|+|||.+.........  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence            9865 445554444568999999999999999999999999999999999999876 8999999988765432221  22


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..++..|+|||.+.+. .++.++|+||+|+++|+|++ |++||...+..+....+......                   
T Consensus       161 ~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-------------------  220 (256)
T cd05114         161 AKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-------------------  220 (256)
T ss_pred             CCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-------------------
Confidence            3455679999998654 67899999999999999999 99999888776666555332100                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                ......+.++.+++.+||+.||++|||++++++
T Consensus       221 ----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 ----------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                      001235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.7e-43  Score=304.31  Aligned_cols=251  Identities=33%  Similarity=0.536  Sum_probs=202.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC----ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY----SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ||.+.+.||+|++|.||++.+..++..+++|+++....    .........|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            69999999999999999999988777777776654221    11223345789999999999999999999988999999


Q ss_pred             EeecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCC-
Q 038835           79 FEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRP-  153 (337)
Q Consensus        79 ~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~-  153 (337)
                      +||++++.+..+..    ....+++..++.++.|++.||.|||++|++|+||+|+||+++.+.++|+|||.+....... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcc
Confidence            99999865554332    3456899999999999999999999999999999999999998899999999887654332 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ......|++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+....+....+...                   
T Consensus       161 ~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-------------------  220 (260)
T cd08222         161 LATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-------------------  220 (260)
T ss_pred             cccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------------------
Confidence            22345688999999987554 6788999999999999999999999766554433332211                   


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                        ..+        ......+.++.++|.+||..||++||++.++++||||
T Consensus       221 --~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         221 --PTP--------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             --CCC--------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence              001        1123567899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-42  Score=302.36  Aligned_cols=246  Identities=24%  Similarity=0.408  Sum_probs=199.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .+|.+.+.||+|++|.||+|.++.+++.+|+|.+.....  ......+|++.++.++||||+++++++..++..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            368899999999999999999999999999999875422  233456899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--c
Q 038835           82 MECNLY-QLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--T  156 (337)
Q Consensus        82 ~~~~l~-~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--~  156 (337)
                      ++++.+ +.+... ...+++..++.++.|++.||.|||++|++||||||+||+++++ .+||+|||.+.........  .
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence            987554 444433 3458999999999999999999999999999999999999876 8999999998876543221  1


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....                    
T Consensus       164 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------------------  222 (263)
T cd05052         164 GAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------------------  222 (263)
T ss_pred             CCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------------------
Confidence            22345679999988655 67899999999999999998 999998776554443332110                    


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                        .       .......+.++.++|.+||+.||++|||+.++++
T Consensus       223 --~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 --R-------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             --C-------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence              0       0112456789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-42  Score=299.69  Aligned_cols=253  Identities=30%  Similarity=0.484  Sum_probs=208.6

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeC--CEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIREN--DILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~   79 (337)
                      +|.+.+.||+|++|.||+|.+..+|+.+++|++...... .......+|+..+++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            589999999999999999999999999999998765432 2234456899999999999999999999888  8999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---C
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---F  155 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---~  155 (337)
                      ||++++.+..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+........   .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT  160 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence            999876665555555579999999999999999999999999999999999999986 999999999987765543   3


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....++..|+|||.+.+. ..+.++|+||+|+++|+|++|..||....+...  ......                    
T Consensus       161 ~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~--------------------  217 (260)
T cd06606         161 GSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIG--------------------  217 (260)
T ss_pred             cCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhcc--------------------
Confidence            456788999999988665 578999999999999999999999987662211  111100                    


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                       .    ...........+..+.++|.+||+.||.+|||+.++++||||
T Consensus       218 -~----~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         218 -S----SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -c----cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence             0    001111224568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=302.87  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=202.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCC---CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.++.+   ...||+|.+.............+|+.+++.++||||+++++.+..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5799999999999999999988754   4579999987665544455567899999999999999999999999999999


Q ss_pred             EeecCCCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCC
Q 038835           79 FEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPF  155 (337)
Q Consensus        79 ~e~~~~~l~~-~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~  155 (337)
                      |||++++.+. .+......+++..+..++.|++.||.|||++|++|+||||+||+++.+ .++|+|||.+...... ...
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY  163 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence            9999875554 444445568999999999999999999999999999999999999876 8999999999876421 111


Q ss_pred             --ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          156 --TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       156 --~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                        ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+......               
T Consensus       164 ~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------  227 (266)
T cd05033         164 TTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---------------  227 (266)
T ss_pred             eccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence              123345789999988655 67899999999999999997 99999877665554444221100               


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                           +         .....+..+.+++.+||+.+|++||++.+++++
T Consensus       228 -----~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 -----P---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -----C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                 0         012457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.4e-43  Score=315.51  Aligned_cols=279  Identities=23%  Similarity=0.279  Sum_probs=199.4

Q ss_pred             eeeccc--CceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDG--TFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      ..||.|  ++|+||++.++.+|+.||+|++........ ...+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            457776  999999999999999999999876544332 23446789999999999999999999999999999999997


Q ss_pred             CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-------
Q 038835           85 NLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-------  154 (337)
Q Consensus        85 ~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-------  154 (337)
                      +.+..+..+  ...+++..++.++.|++.||.|||++|++||||||+||+++.+ .++++||+.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            554444433  2358999999999999999999999999999999999999876 899999985533211100       


Q ss_pred             -CccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          155 -FTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       155 -~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                       .....++..|+|||++.+. ..++.++||||+||++|+|++|.+||.+.................+.............
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM  243 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence             0112345679999998654 34789999999999999999999999887665544333322111111000000000000


Q ss_pred             hhc--cCC--------------CCCCC-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INY--KFP--------------QLVGV-PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~--~~~--------------~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .+.  ...              ..... .........++++.+||++||+.||++|||++|+++||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence            000  000              00000 0001123467889999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.7e-43  Score=304.09  Aligned_cols=247  Identities=31%  Similarity=0.469  Sum_probs=202.6

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      ||.|++|.||++.+..+|+.+++|.+......  .......+|++++++++||||+++++.+..+...|+++||+.++.+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999998765432  2233446799999999999999999999999999999999988666


Q ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC---------CCcc
Q 038835           88 QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP---------PFTE  157 (337)
Q Consensus        88 ~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~---------~~~~  157 (337)
                      ..+..+...+++..++.++.||+.||.|||++|++|+||+|+||+++.+ .++|+|||++.......         ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            5555554569999999999999999999999999999999999999876 99999999887654321         1234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..++..|+|||..... .++.++|+||||+++|++++|..||......+....+....                   ..+
T Consensus       161 ~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~  220 (265)
T cd05579         161 IVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-------------------IEW  220 (265)
T ss_pred             cccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------------cCC
Confidence            5688899999998765 57889999999999999999999998777655544432210                   001


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA---AEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~~~~  285 (337)
                      +.         ....+..+.+++.+||+.+|.+|||+   .++|+||||.+
T Consensus       221 ~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         221 PE---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             Cc---------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            10         01247899999999999999999999   99999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=326.06  Aligned_cols=249  Identities=27%  Similarity=0.462  Sum_probs=205.1

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh---HHhHHHHHHHHHhcCCCCCcccceeEEeeCC--EEEEEEe
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW---EECVNLREVKSLRKMSHPNIVKLKEVIREND--ILYFVFE   80 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e   80 (337)
                      ...+||+|+|-+||+|.|..+|..||.-.++......   ....+..|+.+|+.|+||||+++++.+.+..  .+.+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3567999999999999999999999976655433222   2245568999999999999999999997654  5899999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCCCc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ++.+|.+....++.+.++...++.|++||++||.|||++.  |+|||||.+||+|+.+  .|||+|+|+|+...... ..
T Consensus       124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-ak  202 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AK  202 (632)
T ss_pred             cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-cc
Confidence            9998777766666666999999999999999999999985  9999999999999876  99999999999875443 24


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ..+|||-|||||++..  .|+..+||||||+.++||+|+..||.......+++ ++..+..+.                 
T Consensus       203 svIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~-----------------  263 (632)
T KOG0584|consen  203 SVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA-----------------  263 (632)
T ss_pred             eeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH-----------------
Confidence            4799999999998863  68999999999999999999999998876655444 443332111                 


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                 .+..--.+++++||.+||.. ..+|+|+.|||.||||+..
T Consensus       264 -----------sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  264 -----------ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -----------HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                       00122358899999999998 9999999999999999975

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-42  Score=307.67  Aligned_cols=255  Identities=26%  Similarity=0.354  Sum_probs=201.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC----------------cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccc
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG----------------EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL   65 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   65 (337)
                      ++|++++.||+|+||.||+|.+..++                ..||+|.+.............+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            58999999999999999999876544                45799998765444344455689999999999999999


Q ss_pred             eeEEeeCCEEEEEEeecCCCHHHHHhhccC-----------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee
Q 038835           66 KEVIRENDILYFVFEYMECNLYQLMKDREK-----------CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS  134 (337)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-----------~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~  134 (337)
                      ++++..++..+++||++.++.+..+.....           .+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            999999999999999998765554443332           589999999999999999999999999999999999998


Q ss_pred             CC-cEEEeeCCCcccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHH
Q 038835          135 KD-TIKIADFGLAREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEI  208 (337)
Q Consensus       135 ~~-~~kL~Dfg~a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~  208 (337)
                      .+ .++|+|||.+.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++  |..||...+..+.+
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05051         165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI  243 (296)
T ss_pred             CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence            86 99999999987653322   12334567789999998765 67999999999999999998  77899877766555


Q ss_pred             HHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          209 YKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       209 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ...........                      ........+..+.++.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         244 ENAGHFFRDDG----------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHhcccccc----------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            44432211000                      00000112356789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.1e-44  Score=289.56  Aligned_cols=275  Identities=26%  Similarity=0.556  Sum_probs=223.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeC--CEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIREN--DILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv   78 (337)
                      ++|++++++|+|.++.||.|.+..+++.++||+++.-    ..+...+|+++|+.|. +|||++++++..+.  ....+|
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            6899999999999999999999999999999999764    2444568999999995 99999999998654  457899


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      |||++......+-   +.++.-.|+.++.+++.||.|||++||.|||+||.|++|+..  .++|+|+|+|-.+-+...+.
T Consensus       114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence            9999987665543   348899999999999999999999999999999999999975  89999999999888887777


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ..+.+.+|--||++..-..|+.+-|+|||||++..|++.+-| |.|.++.+++-+|...+|......+.......  .+.
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~--Ldp  268 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID--LDP  268 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC--CCh
Confidence            888999999999998888899999999999999999997655 67888999999999987764433222111000  000


Q ss_pred             cCCC----CCCCccc-----ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          236 KFPQ----LVGVPLS-----VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~----~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+..    ...-++.     ....-.++++.||+.++|..|..+|+||.|++.||||..
T Consensus       269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence            0000    0001111     112235699999999999999999999999999999975

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1e-42  Score=306.50  Aligned_cols=254  Identities=31%  Similarity=0.534  Sum_probs=208.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +.|++.+.||.|++|.||++.+..++..+++|++.....  ......+|+..++.++|+|++++++.+...+..|+++||
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            468888999999999999999998999999999876433  334456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCccc
Q 038835           82 MECNLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~~~~~~-~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~  158 (337)
                      ++++.+..+..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+....... .....
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence            99755554444433 69999999999999999999999999999999999999876 99999999887554321 22344


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......+.... .                    +
T Consensus       177 ~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~--------------------~  234 (286)
T cd06614         177 VGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-I--------------------P  234 (286)
T ss_pred             cCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-C--------------------C
Confidence            678899999988655 67999999999999999999999998776654443332210 0                    0


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .      ......++.++.++|.+||+.+|.+|||+.+++.||||..
T Consensus       235 ~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         235 P------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             C------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            0      0011236788999999999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=300.78  Aligned_cols=243  Identities=30%  Similarity=0.508  Sum_probs=201.7

Q ss_pred             eeecccCceEEEEEEECCC---CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.+...   +..+++|.+.............+|+..++.++|+||+++++++..+...+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   8899999998765544345557899999999999999999999999999999999976


Q ss_pred             C-HHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-
Q 038835           85 N-LYQLMKDR--------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-  153 (337)
Q Consensus        85 ~-l~~~~~~~--------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-  153 (337)
                      + +.+.+...        ...+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||.+....... 
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  160 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY  160 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence            5 54554443        3679999999999999999999999999999999999999986 99999999998765432 


Q ss_pred             --CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 --PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 --~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                        ......+++.|+|||.+... .++.++||||+||++|+|++ |..||.+....+....+....               
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------  224 (262)
T cd00192         161 YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---------------  224 (262)
T ss_pred             cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------
Confidence              22345678899999988765 68999999999999999999 699998886665555443210               


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                    ........+.++.+++.+||+.||.+|||+.|++++
T Consensus       225 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                          001123557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=331.19  Aligned_cols=245  Identities=29%  Similarity=0.435  Sum_probs=198.6

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCccccee-EEee---C---CE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKE-VIRE---N---DI   74 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~-~~~~---~---~~   74 (337)
                      +++|.+.|.+|||+.||+|.+...|..||+|++... .........+|+.+|++|+ |+|||.+++ ....   +   -.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            568899999999999999999988899999988765 3334445578999999995 999999999 3321   1   24


Q ss_pred             EEEEEeecC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           75 LYFVFEYME-CNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        75 ~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      +.|.||||. |++.+.+..+ ...|+|.++++|+.|+++||.+||...  |||||||-+||||+.+ ..||||||.|...
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            789999999 5888888754 234999999999999999999999998  9999999999999876 8999999998754


Q ss_pred             CCCCCC----------ccccccccccCchhhc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 038835          150 NSRPPF----------TEYVSTRWYRAPEVLL--QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGT  217 (337)
Q Consensus       150 ~~~~~~----------~~~~gt~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  217 (337)
                      -.....          -....|+.|+|||.+.  .+...++|+|||+|||+||.|+....||.+.....++         
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl---------  267 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL---------  267 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE---------
Confidence            322211          1235799999999974  4456799999999999999999999999876432221         


Q ss_pred             CCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          218 PTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                    ..+|.+|..         +.++..+.+||+.||+.||.+||++-+++.+
T Consensus       268 --------------ng~Y~~P~~---------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  268 --------------NGNYSFPPF---------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             --------------eccccCCCC---------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                          114455542         4678999999999999999999999998765

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.8e-42  Score=305.36  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=197.9

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      .+|.+.+.||+|+||.||++.+.     .++..+|+|.+.... ........+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            36899999999999999999853     345679999887542 222334568999999999999999999999999999


Q ss_pred             EEEeecCCCHHH-HHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEee
Q 038835           77 FVFEYMECNLYQ-LMKDRE------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIAD  142 (337)
Q Consensus        77 lv~e~~~~~l~~-~~~~~~------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~D  142 (337)
                      +||||++++.+. .+....            ..+++..++.++.|++.||+|||++|++||||||+||+++++ .++|+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence            999999875554 443222            248999999999999999999999999999999999999876 899999


Q ss_pred             CCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 038835          143 FGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTP  218 (337)
Q Consensus       143 fg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~  218 (337)
                      ||.+........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||......+....+.....  
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~--  240 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV--  240 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc--
Confidence            999876543221   1233457789999988655 67999999999999999998 9999988776665555433210  


Q ss_pred             CccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                         +        ......+.++.+++.+||+.||.+|||+.++++
T Consensus       241 -------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 -------------------L--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             -------------------C--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                               0        011346788999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=304.11  Aligned_cols=248  Identities=25%  Similarity=0.419  Sum_probs=199.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-----CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-----GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|.+.+.||+|+||.||++.++..     +..||+|.+.............+|+.+++.++||||+++++++..+...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            6899999999999999999987643     47899999876543333445568999999999999999999999999999


Q ss_pred             EEEeecCCCHH-HHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           77 FVFEYMECNLY-QLMKDR---------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        77 lv~e~~~~~l~-~~~~~~---------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                      +||||++++.+ +.+...         ...+++..+..++.|++.||.|||++|++||||||+||+++.+ .+||+|||.
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~  165 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence            99999986544 444322         1236888999999999999999999999999999999999986 999999999


Q ss_pred             cccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +.......   ......++..|+|||.+.+. .++.++|||||||++|++++ |.+||.+.+..+....+... .     
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~-----  238 (277)
T cd05032         166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-G-----  238 (277)
T ss_pred             chhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-C-----
Confidence            87654322   12344567889999988665 57899999999999999998 99999887765554443211 0     


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                     .+        ......+.++.++|.+||+.+|++|||+.++++
T Consensus       239 ---------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 ---------------HL--------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ---------------CC--------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                           00        011345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.1e-42  Score=299.74  Aligned_cols=246  Identities=28%  Similarity=0.420  Sum_probs=198.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|++|.||++.+.. +..+|+|.+......  .....+|+.+++.++||||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            579999999999999999998764 446999998755433  33456899999999999999999999988899999999


Q ss_pred             cCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--cc
Q 038835           82 MECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--TE  157 (337)
Q Consensus        82 ~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--~~  157 (337)
                      +.++.+ +.+......+++..++.++.||+.||.|||+.|++|+||||+||+++.+ .+||+|||.+.........  ..
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence            987644 4444434468999999999999999999999999999999999999876 8999999988765433211  12


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......+                  
T Consensus       161 ~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------  221 (256)
T cd05113         161 SKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY------------------  221 (256)
T ss_pred             CccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC------------------
Confidence            3355679999998655 57899999999999999998 999998877665555443321100                  


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                 .....+..+.+++.+||+.||.+|||+.+++.+
T Consensus       222 -----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         222 -----------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                       012356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-43  Score=338.67  Aligned_cols=254  Identities=34%  Similarity=0.521  Sum_probs=202.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee----------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE----------   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------   71 (337)
                      .+|+.++.||+||||.||+++++-+|+.||||+|.............+|+..+.+|+|||||+++..+..          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            4678889999999999999999999999999999887644444555789999999999999998765411          


Q ss_pred             --------------------------------------------------------------------------------
Q 038835           72 --------------------------------------------------------------------------------   71 (337)
Q Consensus        72 --------------------------------------------------------------------------------   71 (337)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ---------------------C--------CEEEEEEeecCCCHHHHHhhccCCC-CHHHHHHHHHHHHHHHHHHHHcCc
Q 038835           72 ---------------------N--------DILYFVFEYMECNLYQLMKDREKCF-SEAEVRNWCFQVFQGLAYMHQRGY  121 (337)
Q Consensus        72 ---------------------~--------~~~~lv~e~~~~~l~~~~~~~~~~l-~~~~~~~~~~qil~al~~LH~~~i  121 (337)
                                           +        ..+||-||||+..++..+.+++... .....++++++|++||.|+|++||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                 0        1268999999999999999887754 478899999999999999999999


Q ss_pred             cccCCCCCCeeeeCC-cEEEeeCCCcccC------------------C-CCCCCccccccccccCchhhcCcC--CCCCc
Q 038835          122 FHRDLKPENLLVSKD-TIKIADFGLAREI------------------N-SRPPFTEYVSTRWYRAPEVLLQSY--LYSSK  179 (337)
Q Consensus       122 ~H~dikp~Nili~~~-~~kL~Dfg~a~~~------------------~-~~~~~~~~~gt~~~~aPE~~~~~~--~~~~~  179 (337)
                      |||||||.||+++.+ .|||+|||+|+..                  + +....+..+||..|+|||++.+..  .|+.+
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            999999999999976 9999999999861                  1 111346789999999999997665  69999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHH
Q 038835          180 VDMWAMGAIMAELITLRPLFPG-TSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVS  258 (337)
Q Consensus       180 ~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (337)
                      +|+||||++++||+.   ||.. ++....+..+..+                     .+|..     ..++...-+.-..
T Consensus       799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g---------------------~iP~~-----~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLY---PFGTSMERASILTNLRKG---------------------SIPEP-----ADFFDPEHPEEAS  849 (1351)
T ss_pred             hhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccC---------------------CCCCC-----cccccccchHHHH
Confidence            999999999999995   4643 3333333333211                     11111     1112223355678


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          259 LIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       259 li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                      +|+.||+.||.+||||.|+|++.||.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhhccCCC
Confidence            99999999999999999999999876

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-42  Score=317.16  Aligned_cols=249  Identities=23%  Similarity=0.381  Sum_probs=195.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-----CcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-----GEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   75 (337)
                      ++|.+++.||+|+||.||+|.+...     +..||+|++.............+|+.++++++ ||||+++++++...+..
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            4688999999999999999986432     45699999976544444445678999999996 99999999999999999


Q ss_pred             EEEEeecCCCHHH-HHhhc-------------------------------------------------------------
Q 038835           76 YFVFEYMECNLYQ-LMKDR-------------------------------------------------------------   93 (337)
Q Consensus        76 ~lv~e~~~~~l~~-~~~~~-------------------------------------------------------------   93 (337)
                      |+||||++++.+. .+...                                                             
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999875443 33221                                                             


Q ss_pred             ----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cE
Q 038835           94 ----------------------------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TI  138 (337)
Q Consensus        94 ----------------------------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~  138 (337)
                                                        ...+++..+..++.||+.||+|||++|++||||||+|||++.+ .+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~  276 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV  276 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence                                              1247888899999999999999999999999999999999987 89


Q ss_pred             EEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 038835          139 KIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSV  214 (337)
Q Consensus       139 kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  214 (337)
                      ||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+........
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~  355 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS  355 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence            9999999876543221   1234567889999998665 67999999999999999997 99999775443332222111


Q ss_pred             hCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          215 IGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ..                   ..         ......+.++.+++.+||+.||++|||+.++.+
T Consensus       356 ~~-------------------~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         356 GY-------------------RM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CC-------------------CC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            00                   00         011356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-42  Score=306.87  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=199.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-----CcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-----GEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|++.+.||+|++|.||++.++..     ...+|+|.+.............+|+.+++++ +|+||+++++++..++.+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            5799999999999999999987643     3679999987654433344456899999999 899999999999999999


Q ss_pred             EEEEeecCCCHHHHHhh----------------ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cE
Q 038835           76 YFVFEYMECNLYQLMKD----------------REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TI  138 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~----------------~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~  138 (337)
                      +++|||+.++.+..+..                ....+++..+..++.|++.||.|||++|++||||||+||+++.+ .+
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~  171 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM  171 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeE
Confidence            99999998765544432                23458999999999999999999999999999999999999876 89


Q ss_pred             EEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 038835          139 KIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSV  214 (337)
Q Consensus       139 kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  214 (337)
                      ||+|||.+........   .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  250 (293)
T cd05053         172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG  250 (293)
T ss_pred             EeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999886543321   1223345679999988655 67999999999999999997 99999887765554433221


Q ss_pred             hCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          215 IGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..                    .         ......+.++.+++.+||..||.+|||+.+++++
T Consensus       251 ~~--------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         251 YR--------------------M---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             Cc--------------------C---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            00                    0         0113457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-42  Score=309.41  Aligned_cols=248  Identities=24%  Similarity=0.428  Sum_probs=197.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcE----EEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEV----VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      .+|++.+.||+|+||.||+|.+..+|+.    ||+|.+.............+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            5799999999999999999998766664    8999987544433444556899999999999999999998764 5678


Q ss_pred             EEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC
Q 038835           78 VFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~  155 (337)
                      ++||+.++ +.+.+......+++..+..++.||+.||+|||++|++||||||+||+++.+ .+||+|||.+.........
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  165 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE  165 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence            99999865 556665555568999999999999999999999999999999999999876 8999999999876543221


Q ss_pred             ---ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 ---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ---~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                         ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+... +.....               
T Consensus       166 ~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~---------------  228 (316)
T cd05108         166 YHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGE---------------  228 (316)
T ss_pred             eeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCC---------------
Confidence               223346679999998665 67999999999999999997 999998766544322 221100               


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                          ..+         ..+..+.++.+++.+||..||.+|||+.+++.+
T Consensus       229 ----~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 ----RLP---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ----CCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                000         013456789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.9e-42  Score=302.58  Aligned_cols=247  Identities=23%  Similarity=0.367  Sum_probs=197.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcE----EEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEV----VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||.|+||.||+|.+..+|+.    ||+|.+.............+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            5789999999999999999998877764    799998765544445556789999999999999999999865 44679


Q ss_pred             EEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC
Q 038835           78 VFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        78 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~  155 (337)
                      ++||+++ ++.+.+......+++..+..++.|++.||+|||++|++||||||+|||++.+ .+||+|||++.........
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~  165 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE  165 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence            9999986 4555555545568999999999999999999999999999999999999775 8999999998866432211


Q ss_pred             ---ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 ---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ---~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                         ....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+....+.... .              
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--------------  229 (279)
T cd05109         166 YHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-R--------------  229 (279)
T ss_pred             eecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-c--------------
Confidence               123346789999998665 67899999999999999998 999997766544333222110 0              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                            +        ...+..+.++.++|.+||..||++|||+.+++.
T Consensus       230 ------~--------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         230 ------L--------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ------C--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  0        011346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.1e-42  Score=305.80  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=198.7

Q ss_pred             cCceEeeeecccCceEEEEEEE-----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|.+.+.||+|+||.||++.+     ..++..+|+|.+.............+|+.+++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4789999999999999999975     3456689999987654433344557899999999 799999999999999999


Q ss_pred             EEEEeecCCCHH-HHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           76 YFVFEYMECNLY-QLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        76 ~lv~e~~~~~l~-~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      +++|||+.++.+ +.+... ...+++.++..++.|++.||.|||++|++|+||||+||+++.+ .++|+|||.+......
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  194 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND  194 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence            999999986544 444432 2348999999999999999999999999999999999999876 8999999998865433


Q ss_pred             CC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          153 PP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       153 ~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      ..   .....++..|+|||.+.+. .++.++||||+||++|+|++ |.+||.+....+.........             
T Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  260 (302)
T cd05055         195 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-------------  260 (302)
T ss_pred             CceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-------------
Confidence            21   1223457789999988765 67899999999999999998 999998776554443332210             


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                              .+       .......++++.+++.+||..+|++|||+.|+++
T Consensus       261 --------~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 --------YR-------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             --------Cc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                    00       0011345789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.1e-42  Score=300.47  Aligned_cols=248  Identities=26%  Similarity=0.409  Sum_probs=200.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc---EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.++.++.   .+|+|.+...........+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            579999999999999999998875544   69999987654444444557899999999999999999999999999999


Q ss_pred             EeecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-
Q 038835           79 FEYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-  155 (337)
Q Consensus        79 ~e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-  155 (337)
                      |||++++.+ +.+......+++.++..++.|++.||.|||++|++||||||+||+++.+ .++|+|||.+......... 
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  163 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence            999987554 4544444568999999999999999999999999999999999999876 8999999998866443211 


Q ss_pred             ---ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 ---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ---~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                         ....++..|+|||.+.+. .++.++|+|||||++|++++ |..||.+....+....+.....               
T Consensus       164 ~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---------------  227 (267)
T cd05066         164 YTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---------------  227 (267)
T ss_pred             eecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---------------
Confidence               112235679999998665 67999999999999999886 9999988766555444432110               


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                           .+         .....+..+.+++.+||+.+|.+|||+.++++
T Consensus       228 -----~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 -----LP---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -----CC---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                 00         01345788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.8e-42  Score=299.67  Aligned_cols=245  Identities=27%  Similarity=0.469  Sum_probs=198.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|+++++||+|++|.||+|.+. ++..||+|.+.....  ......+|+.+++.++|+||+++++.+...+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            68999999999999999999865 566799998865432  234456899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--Cc
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FT  156 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~~  156 (337)
                      +.++ +.+.+... ...+++..+..++.|++.||+|||++|++||||||+||+++.+ .++|+|||.+........  ..
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence            9865 44444432 3558899999999999999999999999999999999999887 899999999987643321  12


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||.+... .++.++|||||||++|+|++ |..||.+....+....+.....                   
T Consensus       163 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------------------  222 (261)
T cd05072         163 GAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-------------------  222 (261)
T ss_pred             CCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            23456789999988655 67889999999999999998 9999988776655544432110                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                       .+         .....+.++.+++.+||..+|++|||++++++
T Consensus       223 -~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 -MP---------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -CC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             00         11346788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-42  Score=301.12  Aligned_cols=248  Identities=25%  Similarity=0.404  Sum_probs=199.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc---EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      .+|++.+.||+|+||.||+|.++.+|+   .||+|.+...........+..|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            579999999999999999999887765   59999987654333344567899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |||++++.+..+. ...+.+++.+++.++.|++.||.|||++|++|+||||+||+++.+ .++|+|||.+........  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  163 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  163 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence            9999986555444 445568999999999999999999999999999999999999876 999999998875543221  


Q ss_pred             -Ccccc---ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          155 -FTEYV---STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       155 -~~~~~---gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                       .....   .+..|+|||.+.+. .++.++||||+||++|+|++ |..||.+.+..+....+.....             
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~-------------  229 (269)
T cd05065         164 TYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR-------------  229 (269)
T ss_pred             ccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence             11111   24579999998655 67999999999999999886 9999988776655444421100             


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                             .+         .....+..+.+++.+||+.+|.+||++.+++.
T Consensus       230 -------~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         230 -------LP---------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -------CC---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   00         01345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-42  Score=300.75  Aligned_cols=246  Identities=26%  Similarity=0.446  Sum_probs=201.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|+++++||.|++|.||+|.++. ++.+|+|.+...... ......+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            478999999999999999999987 888999998765432 233456899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Ccc
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTE  157 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~  157 (337)
                      ++++ +.+.+.+. +..+++..+..++.||+.||.|||++|++|+||+|+||+++.+ .+||+|||.+........ ...
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~  163 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD  163 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence            9875 55555442 3458999999999999999999999999999999999999877 999999999876643321 123


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..++..|+|||.+... .++.++||||||+++|+|++ |..||.+.+..+....+......                   
T Consensus       164 ~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  223 (261)
T cd05148         164 KKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-------------------  223 (261)
T ss_pred             CCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-------------------
Confidence            3456789999998665 67899999999999999998 89999887766655554321100                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                ......++++.++|.+||+.||.+|||+.++++
T Consensus       224 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                      012456789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-42  Score=298.79  Aligned_cols=246  Identities=27%  Similarity=0.422  Sum_probs=198.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .+|++.+.||+|++|.||++.++ ++..+|+|.+......  .....+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            46899999999999999999886 4667999998754433  23456799999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc--c
Q 038835           82 MECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT--E  157 (337)
Q Consensus        82 ~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~--~  157 (337)
                      ++++ +.+.+......+++..+..++.|++.||+|||++|++||||||+||+++.+ .+||+|||.+..........  .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence            9875 555555445568999999999999999999999999999999999999876 89999999987654322111  1


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.++.+....+......                   
T Consensus       161 ~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  220 (256)
T cd05059         161 TKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-------------------  220 (256)
T ss_pred             CCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-------------------
Confidence            2234579999988765 67899999999999999998 89999877665554443221100                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                ......+.++.+++.+||..+|++|||+.|+++.
T Consensus       221 ----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         221 ----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                      1113467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-43  Score=305.10  Aligned_cols=281  Identities=33%  Similarity=0.508  Sum_probs=219.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-----C---CCcccceeEEe---
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-----H---PNIVKLKEVIR---   70 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~---   70 (337)
                      .||.+.++||.|-|++||+|.|..+.+.||+|+.+....  -....++||++|++++     +   .+||++++.|.   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            489999999999999999999999999999999976421  1233468999999882     2   46999999986   


Q ss_pred             -eCCEEEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCCc----------
Q 038835           71 -ENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKDT----------  137 (337)
Q Consensus        71 -~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~~----------  137 (337)
                       ++.++++|||+++.+|+..++..+ ..++...++.|++||+.||.|||.. ||||.||||+|||+..+.          
T Consensus       156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a  235 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREA  235 (590)
T ss_pred             CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhh
Confidence             457899999999999999998764 5699999999999999999999965 999999999999984320          


Q ss_pred             --------------------------------------------------------------------------------
Q 038835          138 --------------------------------------------------------------------------------  137 (337)
Q Consensus       138 --------------------------------------------------------------------------------  137 (337)
                                                                                                      
T Consensus       236 ~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~  315 (590)
T KOG1290|consen  236 GEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNEST  315 (590)
T ss_pred             ccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------------------EEE
Q 038835          138 -----------------------------------------------------------------------------IKI  140 (337)
Q Consensus       138 -----------------------------------------------------------------------------~kL  140 (337)
                                                                                                   +||
T Consensus       316 v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKI  395 (590)
T KOG1290|consen  316 VERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKI  395 (590)
T ss_pred             hhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEE
Confidence                                                                                         455


Q ss_pred             eeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCC------CCcHHHHHHHHHH
Q 038835          141 ADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG------TSEADEIYKICSV  214 (337)
Q Consensus       141 ~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~------~~~~~~~~~i~~~  214 (337)
                      +|||.|.....  .++..+.|..|+|||++.+. .|++.+||||++|++|||+||...|..      ..+++.+..|++.
T Consensus       396 aDlGNACW~~k--hFT~DIQTRQYRapEVllGs-gY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~EL  472 (590)
T KOG1290|consen  396 ADLGNACWVHK--HFTEDIQTRQYRAPEVLLGS-GYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMEL  472 (590)
T ss_pred             eeccchhhhhh--hhchhhhhhhccCcceeecC-CCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHH
Confidence            55555544322  23456778899999999987 899999999999999999999998864      3367889999999


Q ss_pred             hCCCCccchhhhhhhHHhhhcc-----CCCCCCCccc-------ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          215 IGTPTQDSWADGLLLARAINYK-----FPQLVGVPLS-------VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                      ++..+......+.....+++..     ...+..-++.       .+......++.+|+.-||+.+|++||||.++|+|||
T Consensus       473 LG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPw  552 (590)
T KOG1290|consen  473 LGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPW  552 (590)
T ss_pred             HhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcc
Confidence            9988776655555544454431     0111100000       111234467899999999999999999999999999


Q ss_pred             ccccc
Q 038835          283 SRVAF  287 (337)
Q Consensus       283 ~~~~~  287 (337)
                      +....
T Consensus       553 Ln~~~  557 (590)
T KOG1290|consen  553 LNPVA  557 (590)
T ss_pred             ccCCC
Confidence            98643

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-42  Score=304.52  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=197.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC--------------cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCccccee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG--------------EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKE   67 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   67 (337)
                      ++|++.+.||+|+||.||+|.+..++              ..||+|.+.............+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            48999999999999999999875432              3589999876544333445568999999999999999999


Q ss_pred             EEeeCCEEEEEEeecCCCHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC
Q 038835           68 VIRENDILYFVFEYMECNLYQLMKDRE------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK  135 (337)
Q Consensus        68 ~~~~~~~~~lv~e~~~~~l~~~~~~~~------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~  135 (337)
                      ++...+..++||||+.++.+..+....            ..+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            999999999999999976554443221            23688999999999999999999999999999999999987


Q ss_pred             C-cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHHH
Q 038835          136 D-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIY  209 (337)
Q Consensus       136 ~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~  209 (337)
                      + .+||+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++  |..||...+..+...
T Consensus       165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~  243 (295)
T cd05097         165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE  243 (295)
T ss_pred             CCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence            7 899999999875433221   1223456789999988765 57999999999999999988  678998877665554


Q ss_pred             HHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          210 KICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       210 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .+.........              ..+        ....+..++.+.+++.+||+.||.+|||++++++
T Consensus       244 ~~~~~~~~~~~--------------~~~--------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         244 NTGEFFRNQGR--------------QIY--------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHhhhhccc--------------ccc--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            43321100000              000        0112346789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.8e-42  Score=302.83  Aligned_cols=258  Identities=26%  Similarity=0.382  Sum_probs=203.8

Q ss_pred             CceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCCh---HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSW---EECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      .|++.+.||.|+||.||++.+.   .+|+.||+|++.......   ......+|+++++++ +|+||+.+++.++.+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999875   478999999987543211   123345799999999 699999999999999999


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-  153 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-  153 (337)
                      ++||||++++.+........++++..+..++.|++.||.|||+.|++||||+|+||+++.+ .++|+|||.+....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999976555444445568999999999999999999999999999999999999876 89999999987654432 


Q ss_pred             -CCccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          154 -PFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       154 -~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                       ......|+..|+|||.+... ..++.++||||+|+++|+|++|..||...........+.......             
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------  227 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------------  227 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-------------
Confidence             22345789999999998643 246789999999999999999999997543322222222111000             


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~  286 (337)
                           .+        ...+.+++.+.+++.+||+.||++||     ++++++.||||+..
T Consensus       228 -----~~--------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         228 -----EP--------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             -----CC--------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence                 00        01235678899999999999999997     89999999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.9e-42  Score=297.49  Aligned_cols=240  Identities=24%  Similarity=0.362  Sum_probs=192.1

Q ss_pred             eecccCceEEEEEEE--CCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            9 EVGDGTFGSVWRAIS--KQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      .||+|+||.||+|.+  +.++..+|+|++....... ......+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999964  4678899999987554332 2334468999999999999999999875 45678999999987


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC----ccccc
Q 038835           86 LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF----TEYVS  160 (337)
Q Consensus        86 l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~----~~~~g  160 (337)
                      .+..+......+++..+..++.|++.||+|||++|++||||||.||+++.+ .++|+|||.+.........    ....+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW  160 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence            665555555569999999999999999999999999999999999999887 8999999998766443221    22334


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      +..|+|||.+... .++.++|+|||||++|+|++ |.+||.+....+....+.....                     + 
T Consensus       161 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---------------------~-  217 (257)
T cd05116         161 PVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---------------------M-  217 (257)
T ss_pred             CccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---------------------C-
Confidence            5789999988654 67889999999999999997 9999988776655554432110                     0 


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                             ..++..++++.++|.+||+.||++|||+++|..
T Consensus       218 -------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         218 -------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                   012357889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.7e-42  Score=306.06  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=197.5

Q ss_pred             cCceEeeeecccCceEEEEEEECC-------CCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|.+++.||+|+||.||++.+..       ++..+|+|.+.............+|+.+++.+ +||||+++++++..++
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            579999999999999999998643       23569999998654333344556899999999 8999999999999999


Q ss_pred             EEEEEEeecCCC-HHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           74 ILYFVFEYMECN-LYQLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~-l~~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ..|+||||++++ +.+.+....               ..+++.++..++.|++.||+|||++|++||||||+||+++.+ 
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            999999999875 445554321               247889999999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCCCC---ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRPPF---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .++|+|||.+.........   ....+++.|+|||.+.+. .++.++|+||+||++|+|++ |.+||.+.+..+....+.
T Consensus       178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~  256 (307)
T cd05098         178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  256 (307)
T ss_pred             cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence            8999999998765432211   122345689999988665 67899999999999999998 899998766544444332


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...                             ........+.++.++|.+||..+|.+|||+.+++++
T Consensus       257 ~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         257 EGH-----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             cCC-----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            110                             001123567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=293.37  Aligned_cols=279  Identities=34%  Similarity=0.530  Sum_probs=232.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   74 (337)
                      .||.-++.+|.|+- .|.-|.|.-+++.||+|+...+.... ......+|...+..+.|+||++++.+|.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            47888889999999 88889999999999999987764332 234456899999999999999999998643      35


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .|+|||+|..++-..+.-.   ++-..+..++.|++.|++|||+.||+||||||+||++..+ .+|+.|||+|...+...
T Consensus        96 ~y~v~e~m~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~  172 (369)
T KOG0665|consen   96 VYLVMELMDANLCQVILME---LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF  172 (369)
T ss_pred             HHHHHHhhhhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccc
Confidence            7999999999988877632   6788999999999999999999999999999999999887 99999999999887776


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ..+.++.|..|+|||++.+- .|...+||||+||++.||+.|+..|.|.+..++..++....|.|.+..........+..
T Consensus       173 ~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y  251 (369)
T KOG0665|consen  173 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY  251 (369)
T ss_pred             ccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence            67889999999999999877 48999999999999999999999999999999999999999998887665443333222


Q ss_pred             hc--------c----CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          234 NY--------K----FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~--------~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      -.        .    +|.........-.+.-+..+++++.+||..||++|.|++++|+|||++.
T Consensus       252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v  315 (369)
T KOG0665|consen  252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV  315 (369)
T ss_pred             hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence            11        1    2222222222222345677999999999999999999999999999984

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.5e-42  Score=299.98  Aligned_cols=250  Identities=26%  Similarity=0.459  Sum_probs=200.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|.+.+.||.|++|.||++.++.+|+.+|+|.+.......  ......+|+.+++.++||||+++++++..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            478999999999999999999999999999999886543222  223446899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           79 FEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        79 ~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      |||++++.+..+..    ....+++..++.++.||+.||.|||++|++|+||||+||+++.+ .++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            99999765544432    24458999999999999999999999999999999999999876 89999999987665432


Q ss_pred             C-CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 P-FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA--DEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 ~-~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      . .....|+..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+....  +....+..                 
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  222 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-----------------  222 (267)
T ss_pred             cccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-----------------
Confidence            2 2345789999999998655 6788999999999999999999999765432  11111110                 


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                          ..++.       ......+.++.++|.+||..||.+|||+.++++
T Consensus       223 ----~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         223 ----CDYPP-------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ----CCCCC-------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                00110       011346789999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-45  Score=350.39  Aligned_cols=254  Identities=27%  Similarity=0.469  Sum_probs=214.6

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      |+.-+..||.|.||.||.|.+..||+..|+|-+.-..... ......+|.+++..++|||+|+++++-.+.+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            4666788999999999999999999999999887654331 222335899999999999999999999899999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----CC
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----PF  155 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----~~  155 (337)
                      |+||.+..+.+.+...+|...+.+..|++.|+.|||+.|||||||||+||+++.+ .+|++|||.|....+..     ..
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence            9999999999888878999999999999999999999999999999999999876 99999999998775542     23


Q ss_pred             ccccccccccCchhhcCcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          156 TEYVSTRWYRAPEVLLQSY--LYSSKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ....||+.|||||++.+.+  .-..++|||||||++.||+||+.||...+.+ ..++....+..                
T Consensus      1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~---------------- 1459 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK---------------- 1459 (1509)
T ss_pred             HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC----------------
Confidence            4578999999999998653  3467899999999999999999999876543 44444433211                


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                           |        ..+..+|++.++||..||+.||++|+++.||++|.|-+.
T Consensus      1460 -----P--------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1460 -----P--------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             -----C--------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                 1        122458899999999999999999999999999998765

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-42  Score=302.11  Aligned_cols=245  Identities=35%  Similarity=0.518  Sum_probs=194.1

Q ss_pred             eEeeeecccCceEEEEEEEC----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            5 KLIKEVGDGTFGSVWRAISK----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .+.+.||.|+||.||+|..+    ..+..|++|.+.............+|++.+++++||||+++++++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            56889999999999999887    45677999999664333345566789999999999999999999998888999999


Q ss_pred             ecCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---
Q 038835           81 YMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---  154 (337)
Q Consensus        81 ~~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---  154 (337)
                      |+.++ +.+.+... ...+++..+..++.||+.||.|||+++++|+||+++||+++.+ .+||+|||++........   
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~  161 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN  161 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99864 55565554 4669999999999999999999999999999999999999976 999999999987633222   


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+...|+|||.+.+. .++.++||||||+++||+++ |+.||.+.+..+....+.....                 
T Consensus       162 ~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-----------------  223 (259)
T PF07714_consen  162 DSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-----------------  223 (259)
T ss_dssp             STTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-----------------
T ss_pred             ccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-----------------
Confidence            1334567789999998766 57999999999999999999 7899988877666655532211                 


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                  ....+..+..+.++|..||..||.+|||+.++++
T Consensus       224 ------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 ------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                        0112456788999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.6e-42  Score=297.21  Aligned_cols=244  Identities=30%  Similarity=0.482  Sum_probs=195.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.++||+|++|.||+|.+..++ .||+|++......  .....+|+.+++.++||||+++++.+.. +..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            57999999999999999999887654 5999999864433  2345689999999999999999998754 557999999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--c
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--T  156 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--~  156 (337)
                      ++++ +.+.+.+. ...+++..+..++.|++.||.|||++|++||||||+||+++++ .++|+|||.+.........  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence            9975 44555432 3457999999999999999999999999999999999999887 8999999999765433211  2


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||...+. .++.++|+|||||++|+|++ |.+||.+....+....+.....                   
T Consensus       162 ~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------  221 (262)
T cd05071         162 GAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------------------  221 (262)
T ss_pred             CCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-------------------
Confidence            33456789999987655 67999999999999999999 8899988766555444322100                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                       .+         .....+..+.++|.+||+.||++|||+.++++
T Consensus       222 -~~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         222 -MP---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -CC---------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence             00         11346788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-42  Score=296.56  Aligned_cols=245  Identities=27%  Similarity=0.469  Sum_probs=197.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|++|.||+|.+. +++.||+|.+......  .....+|+.++++++||||+++++++...+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc--HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            57899999999999999999875 4578999998765432  33456899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--c
Q 038835           82 MECN-LYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--T  156 (337)
Q Consensus        82 ~~~~-l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--~  156 (337)
                      ++++ +.+.+.... ..+++..+..++.|++.||.+||++|++||||||+||+++++ .++|+|||.+.........  .
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence            9765 555544432 468999999999999999999999999999999999999876 8999999999876532211  1


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+..+....+.....                   
T Consensus       163 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------  222 (261)
T cd05068         163 GAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-------------------  222 (261)
T ss_pred             CCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            11223579999988655 67899999999999999999 9999988776555544322100                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                       .         ......+.++.+++.+||+.||.+||++.++++
T Consensus       223 -~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         223 -M---------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -C---------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence             0         011346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.9e-42  Score=332.39  Aligned_cols=147  Identities=29%  Similarity=0.474  Sum_probs=128.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      |++|.+++.||+|+||.||+|.+..+++.||+|++.......  .......|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999997643322  123446799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      |||+.|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999876555555555568999999999999999999999999999999999999876 99999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-41  Score=299.17  Aligned_cols=247  Identities=21%  Similarity=0.346  Sum_probs=193.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcE----EEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEV----VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.+..+|+.    +++|.+..............|+..++.++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            5799999999999999999999877764    67777654322222334456888899999999999999875 455788


Q ss_pred             EEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           78 VFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        78 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      ++||+.+ ++.+.+......+++..+..++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+.......  
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            9999986 5555655556678999999999999999999999999999999999999877 89999999997654322  


Q ss_pred             -CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          154 -PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       154 -~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                       ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+... ..+.            
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~------------  231 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERLA------------  231 (279)
T ss_pred             cccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCC------------
Confidence             12334567789999998765 68999999999999999998 99999887654433322111 0000            


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                      .....+.++.+++.+||..||.+|||+.|+++
T Consensus       232 ----------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 ----------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                            01224567899999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.4e-42  Score=296.85  Aligned_cols=244  Identities=30%  Similarity=0.481  Sum_probs=195.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|++|.||+|.+. ++..+|+|.+......  .....+|+.++++++|+|++++++++.. +..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence            68999999999999999999876 5667999998765443  2345689999999999999999998754 567899999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--c
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--T  156 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--~  156 (337)
                      ++++ +.+.+... ...+++..++.++.|++.||.|||++|++||||||+||+++++ .++|+|||.+.........  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence            9875 44444432 3458999999999999999999999999999999999999887 8999999999765433211  2


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+.....                   
T Consensus       162 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------------  221 (260)
T cd05070         162 GAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-------------------  221 (260)
T ss_pred             CCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            23455679999988655 67899999999999999999 8999988776665554432100                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                       .         ......+.++.+++.+||..||++|||+.++.+
T Consensus       222 -~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         222 -M---------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             -C---------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence             0         011356788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.9e-42  Score=301.85  Aligned_cols=247  Identities=24%  Similarity=0.424  Sum_probs=196.4

Q ss_pred             CceEeeeecccCceEEEEEEECC-----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQ-----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+.............+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998753     2356888888765443334455689999999999999999999999999999


Q ss_pred             EEeecCCCHHHHHhhc------------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee
Q 038835           78 VFEYMECNLYQLMKDR------------------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV  133 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~------------------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili  133 (337)
                      ++||+.++.+..+...                        ...+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            9999997655544321                        1247889999999999999999999999999999999999


Q ss_pred             eCC-cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 038835          134 SKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEI  208 (337)
Q Consensus       134 ~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  208 (337)
                      +++ .++|+|||.+........   .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+..
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            876 899999999876533221   1233456789999988655 67999999999999999998 99999887665544


Q ss_pred             HHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          209 YKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       209 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      +.+....                    ..         ......+.++.+++..||+.||.+|||+.++++
T Consensus       240 ~~~~~~~--------------------~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         240 NLLKTGY--------------------RM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHhCCC--------------------CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            3322110                    00         011356789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-42  Score=294.50  Aligned_cols=243  Identities=35%  Similarity=0.523  Sum_probs=200.8

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      ||.|++|.||++.+..+|+.+|+|.+.......  ......+|+.++++++||||+++++.++.++..++||||++++.+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999999899999999987654322  233446799999999999999999999999999999999976555


Q ss_pred             HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccccccccc
Q 038835           88 QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYR  165 (337)
Q Consensus        88 ~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~gt~~~~  165 (337)
                      .........+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ .++|+|||.+...... .......++..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            4444444568999999999999999999999999999999999999876 8999999998776543 2234567888999


Q ss_pred             CchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcc
Q 038835          166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPL  245 (337)
Q Consensus       166 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (337)
                      |||...+. ..+.++|+||||+++|++++|..||...+..+....+...                   ..          
T Consensus       161 ~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~----------  210 (250)
T cd05123         161 APEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-------------------PL----------  210 (250)
T ss_pred             ChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-------------------CC----------
Confidence            99988655 5788999999999999999999999776654443333210                   00          


Q ss_pred             cccCCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcCcCc
Q 038835          246 SVLMPSANKDAVSLIASLCSWDPSKRPTA---AEALQHPFS  283 (337)
Q Consensus       246 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~---~ell~hp~~  283 (337)
                       ......+..+.++|.+||..||++|||+   +++++||||
T Consensus       211 -~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         211 -RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence             1123457889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-41  Score=296.54  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=200.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc---EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|+..+.||+|++|.||+|.++.++.   .+|+|.+..............|+.+++.++|||++++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            468999999999999999999887665   69999987654333444556899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-
Q 038835           79 FEYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-  155 (337)
                      |||++++.+.... .....+++..+..++.|++.||+|||+.|++|+||||+||+++.+ .++|+|||.+......... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  164 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT  164 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence            9999986665444 444568999999999999999999999999999999999999876 8999999998765432211 


Q ss_pred             -c--cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 -T--EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 -~--~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                       .  ....+..|+|||.+.+. .++.++||||+||++|+|++ |..||...+..+....+......              
T Consensus       165 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~--------------  229 (268)
T cd05063         165 YTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL--------------  229 (268)
T ss_pred             eeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC--------------
Confidence             1  12234579999988665 67899999999999999997 99999877766555544321100              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                            +.         ....+.++.+++.+||+.||.+||++.++++
T Consensus       230 ------~~---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         230 ------PA---------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ------CC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                  00         1245688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-42  Score=298.64  Aligned_cols=247  Identities=26%  Similarity=0.337  Sum_probs=194.5

Q ss_pred             ceEeeeecccCceEEEEEEECCC---CcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCE-----
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDI-----   74 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----   74 (337)
                      |++++.||+|+||.||+|....+   +..||+|.+........ .....+|+..++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999987653   47899999876544332 3345689999999999999999998755443     


Q ss_pred             -EEEEEeecCCCHHHHHh-hc-----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           75 -LYFVFEYMECNLYQLMK-DR-----EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        75 -~~lv~e~~~~~l~~~~~-~~-----~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                       .+++|||+.++.+.... ..     ...+++..++.++.|++.||.|||++|++||||||+||+++++ .+||+|||.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             79999999976554333 21     2358999999999999999999999999999999999999887 9999999998


Q ss_pred             ccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccc
Q 038835          147 REINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDS  222 (337)
Q Consensus       147 ~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  222 (337)
                      ........   .....++..|+|||.+.+. .++.++||||+||++|+|++ |.+||.+....+..+.+....       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------  232 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-------  232 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            76543321   1123346789999987554 67999999999999999999 899998876655444332210       


Q ss_pred             hhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                    .        .......+.++.+++.+||+.||.+|||+.|++++
T Consensus       233 --------------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 --------------R--------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --------------C--------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                          0        01123567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.1e-42  Score=303.13  Aligned_cols=249  Identities=25%  Similarity=0.406  Sum_probs=198.8

Q ss_pred             cCceEeeeecccCceEEEEEEEC-------CCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-------QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|.+.+.||+|+||.||+|.+.       .++..+|+|.+.............+|+.+++.+ +||||+++++++....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            57899999999999999999742       235579999987654333444557899999999 8999999999999999


Q ss_pred             EEEEEEeecCCCHHH-HHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           74 ILYFVFEYMECNLYQ-LMKDR---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~-~~~~~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ..+++|||+.++.+. .+.+.               ...++...+..++.||+.||.|||++|++||||||+||+++.+ 
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            999999999875554 44332               1247788899999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||.+........   .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus       175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  253 (304)
T cd05101         175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  253 (304)
T ss_pred             cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            899999999986643221   1233456789999988665 67899999999999999998 889998877666555442


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .....                             ......+.++.++|.+||..+|.+|||+.++++.
T Consensus       254 ~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         254 EGHRM-----------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             cCCcC-----------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            21000                             0113467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1e-41  Score=304.12  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=197.2

Q ss_pred             cCceEeeeecccCceEEEEEEECC-------CCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|.+++.||+|+||.||++.+..       .+..+|+|.+.............+|+.+++.+ +||||+++++++..++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            478999999999999999997632       34569999987654443444556899999999 6999999999999889


Q ss_pred             EEEEEEeecCCCHHH-HHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           74 ILYFVFEYMECNLYQ-LMKDR---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~-~~~~~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ..+++|||+.++.+. .+...               ...+++..+..++.||+.||.|||++|++||||||+||+++.+ 
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            999999999876554 44332               1348889999999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||.+........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~  250 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR  250 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            899999999986543221   1222345679999998765 67999999999999999999 899998877655554432


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ....                             .......+.++.++|.+||..||.+|||+.++++
T Consensus       251 ~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         251 EGHR-----------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             cCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2100                             0011345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=295.18  Aligned_cols=242  Identities=28%  Similarity=0.467  Sum_probs=197.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||.|++|.||+|...  |+.||+|.+.....  ......+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            57999999999999999999765  88999999976543  344557899999999999999999999989999999999


Q ss_pred             cCCC-HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           82 MECN-LYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        82 ~~~~-l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ++++ +.+.+.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ .++|+|||.+.......  ...
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~~~  159 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--DSG  159 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--ccC
Confidence            9975 444444333 268999999999999999999999999999999999999876 89999999988764322  233


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .++..|+|||.+.++ .++.++|+||||+++|+|++ |..||...+..+....+...                      +
T Consensus       160 ~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------------~  216 (256)
T cd05039         160 KLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------------------Y  216 (256)
T ss_pred             CCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------------C
Confidence            456679999988655 67889999999999999997 99999877655544333211                      0


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      +       .......++++.++|.+||..+|++|||++++++
T Consensus       217 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 R-------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             C-------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            0       0111346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=8.7e-44  Score=313.73  Aligned_cols=280  Identities=28%  Similarity=0.468  Sum_probs=231.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCC------CCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH------PNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~   75 (337)
                      .+|.+..-.|+|-|++|..|.+...|..||||+|.....-  ...-++|+.+|+.|..      -|+++++-.|...+++
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            4799999999999999999999999999999999864221  1122689999999953      4799999999999999


Q ss_pred             EEEEeecCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCC
Q 038835           76 YFVFEYMECNLYQLMKDRE--KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINS  151 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~--~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~  151 (337)
                      |+|||-+..+|.+.+.+.+  ..|....++.++.|++.||..|.+.||+|.||||+|||++.+  .+||||||.|...+.
T Consensus       510 ClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e  589 (752)
T KOG0670|consen  510 CLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE  589 (752)
T ss_pred             EEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence            9999999999999888754  458889999999999999999999999999999999999876  899999999988765


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      +. .+.+..+..|+|||++.+- .|+...|+||+||+||||.+|+..|.|.++.+++...+..-|+.+-.....+.....
T Consensus       590 ne-itPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq  667 (752)
T KOG0670|consen  590 NE-ITPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ  667 (752)
T ss_pred             cc-ccHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence            54 4667888999999999876 899999999999999999999999999999999999999888877766555544444


Q ss_pred             hhhccCCC------------------CCCC------------cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 038835          232 AINYKFPQ------------------LVGV------------PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP  281 (337)
Q Consensus       232 ~~~~~~~~------------------~~~~------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  281 (337)
                      .++..+.-                  ..++            .++...+.+-.++++|+.+||..||++|.|+.++|+||
T Consensus       668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence            43322110                  0000            01111123336789999999999999999999999999


Q ss_pred             Cccc
Q 038835          282 FSRV  285 (337)
Q Consensus       282 ~~~~  285 (337)
                      ||+.
T Consensus       748 Fi~~  751 (752)
T KOG0670|consen  748 FITE  751 (752)
T ss_pred             cccC
Confidence            9974

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.7e-42  Score=299.43  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=196.4

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|.+.++||+|+||.||++...     .++..+|+|.+.... ......+.+|+++++.++|+||+++++++..++..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            46889999999999999999643     356789999876532 222334568999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEE
Q 038835           77 FVFEYMECNLYQLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKI  140 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL  140 (337)
                      ++|||++++.+..+....               ..+++..++.++.||+.||+|||++|++||||||+||+++++ .++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence            999999875554443321               247899999999999999999999999999999999999876 8999


Q ss_pred             eeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 038835          141 ADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIG  216 (337)
Q Consensus       141 ~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~  216 (337)
                      +|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+....+.....
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  242 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE  242 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence            99999875533221   1233456789999988765 67999999999999999998 9999987766555444322100


Q ss_pred             CCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          217 TPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .                             ......++.+.++|.+||+.||.+||++.++++
T Consensus       243 ~-----------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         243 L-----------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             C-----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0                             011346788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=294.91  Aligned_cols=241  Identities=25%  Similarity=0.375  Sum_probs=192.6

Q ss_pred             eeecccCceEEEEEEECCCC---cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSG---EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      ++||+|+||.||+|....++   ..+|+|.+.............+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876554   7899999987655444455678999999999999999999876 4568999999987


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-c---ccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-T---EYV  159 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-~---~~~  159 (337)
                      +.+.........+++..+..++.|++.||+|||+.|++|+||||+||+++.+ .+||+|||.+......... .   ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR  159 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence            5554444444568999999999999999999999999999999999999876 8999999998866433221 1   122


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      ++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+.....                      
T Consensus       160 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------  216 (257)
T cd05060         160 WPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER----------------------  216 (257)
T ss_pred             ccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc----------------------
Confidence            34579999988655 68999999999999999997 9999988776555444322100                      


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                             .......+..+.++|.+||..||.+|||+.++++
T Consensus       217 -------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                   0112356788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-41  Score=301.12  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=195.7

Q ss_pred             cCceEeeeecccCceEEEEEEECC----------------CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccc
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ----------------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL   65 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   65 (337)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|.+...........+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            479999999999999999985432                3457999998765433334455689999999999999999


Q ss_pred             eeEEeeCCEEEEEEeecCCCHH-HHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee
Q 038835           66 KEVIRENDILYFVFEYMECNLY-QLMKDRE----------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS  134 (337)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~----------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~  134 (337)
                      ++++..++..+++|||++++.+ +.+....          ..+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            9999999999999999987544 4443321          2367789999999999999999999999999999999998


Q ss_pred             CC-cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHH
Q 038835          135 KD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEI  208 (337)
Q Consensus       135 ~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~  208 (337)
                      .+ .++|+|||.+........   .....+++.|+|||...++ .++.++|+|||||++|+|++  |..||...+..+..
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05095         165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI  243 (296)
T ss_pred             CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence            76 899999999876543221   1223446789999987665 68999999999999999998  77999877665544


Q ss_pred             HHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          209 YKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       209 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ..........             ......+         .....++.+.+++..||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~-------------~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         244 ENTGEFFRDQ-------------GRQVYLP---------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHhhc-------------cccccCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3322110000             0000000         11345688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-41  Score=297.71  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=193.4

Q ss_pred             ceEeeeecccCceEEEEEEECCCCc--EEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee------CCE
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGE--VVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE------NDI   74 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~--~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~   74 (337)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.+....... ......+|+.+++.++||||+++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999887775  58999887654333 23344679999999999999999987632      135


Q ss_pred             EEEEEeecCCCHHHHHh-h-----ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           75 LYFVFEYMECNLYQLMK-D-----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~-~-----~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      .+++|||+.++.+.... .     ....+++..+..++.|++.||+|||++|++||||||+|||++.+ .++|+|||.+.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            68999999975544332 1     22348999999999999999999999999999999999999876 89999999998


Q ss_pred             cCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccch
Q 038835          148 EINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSW  223 (337)
Q Consensus       148 ~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  223 (337)
                      .......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+....+....+.....       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------  232 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-------  232 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence            7643321   1223456789999988655 67999999999999999999 8999988766554444322100       


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                            ....+..+..+.++|.+||+.||++|||+.+++++
T Consensus       233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 ----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                  00123567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-41  Score=299.52  Aligned_cols=262  Identities=25%  Similarity=0.358  Sum_probs=195.5

Q ss_pred             cCc-eEeeeecccCceEEEEEE----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee--CCE
Q 038835            2 ERY-KLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE--NDI   74 (337)
Q Consensus         2 ~~y-~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   74 (337)
                      +|| ++.+.||+|+||+||++.    ...++..||+|.+.............+|+.+++.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            567 999999999999998764    3457889999999765433334455689999999999999999998754  346


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .+++|||++++.+....... .+++..++.++.|++.||+|||++|++||||||+||+++.+ .++|+|||.+.......
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            89999999987666555443 48999999999999999999999999999999999999876 89999999988664332


Q ss_pred             C----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          154 P----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       154 ~----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      .    .....++..|+|||.+.+. .++.++||||||+++|+|++|..||......  .......    ....+.... .
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~----~~~~~~~~~-~  233 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGP----KQGQMTVVR-L  233 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcc----cccccchhh-h
Confidence            1    1223456779999988655 6789999999999999999999998654321  1111100    000000000 0


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .......       .........+.++.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         234 IELLERG-------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhcC-------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000000       000112456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-41  Score=294.46  Aligned_cols=246  Identities=29%  Similarity=0.456  Sum_probs=201.3

Q ss_pred             ceEeeeecccCceEEEEEEECCCC----cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSG----EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++++.||.|+||.||++.+..++    ..+|+|.+..............|+..++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999998766    8899999976654434555678999999999999999999999999999999


Q ss_pred             eecCCCHHHHHh-hccCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           80 EYMECNLYQLMK-DREKC-FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        80 e~~~~~l~~~~~-~~~~~-l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ||++++.+..+. ..... +++..+..++.|++.||.+||+.|++|+||+|+||+++.+ .++|+|||.+..........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            999876554444 33333 8999999999999999999999999999999999999987 89999999987665442222


Q ss_pred             --cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          157 --EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       157 --~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                        ...+++.|+|||.+.+. .++.++|+||+|+++|+|++ |.+||.+.+..+..+.+.....                 
T Consensus       161 ~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------------  222 (258)
T smart00219      161 KKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-----------------  222 (258)
T ss_pred             cccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----------------
Confidence              13367889999988544 67999999999999999998 8999988766655554432110                 


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                          +        ......+.++.+++.+||..||.+|||+.|+++
T Consensus       223 ----~--------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 ----L--------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ----C--------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                0        011346789999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.7e-42  Score=301.36  Aligned_cols=247  Identities=24%  Similarity=0.359  Sum_probs=197.7

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      .+|.+.+.||+|+||.||++.+.     .++..+++|.+...... ....+.+|+..+++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            47899999999999999999854     34566889988654322 2334568999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEE
Q 038835           77 FVFEYMECNLYQLMKDRE----------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIK  139 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~----------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~k  139 (337)
                      +||||++++.+..+....                ..+++..++.++.||+.||+|||++|++||||||+||+++.+ .++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~  163 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK  163 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            999999876555444321                237899999999999999999999999999999999999876 899


Q ss_pred             EeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 038835          140 IADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVI  215 (337)
Q Consensus       140 L~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~  215 (337)
                      |+|||.+........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus       164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  242 (291)
T cd05094         164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR  242 (291)
T ss_pred             ECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence            999999876543221   2334567889999988765 67899999999999999998 999998877665544332110


Q ss_pred             CCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                           .+        ......+..+.+++.+||+.||.+|||+.++++
T Consensus       243 ---------------------~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         243 ---------------------VL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             ---------------------CC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                                 00        011345788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-41  Score=294.83  Aligned_cols=250  Identities=28%  Similarity=0.495  Sum_probs=200.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      .++|++.+.||.|++|.||+|.+..+|+.||+|.++.....  .......+|++++++++|+|++++++.+..++..++|
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            36899999999999999999999999999999988753322  2234456899999999999999999999999999999


Q ss_pred             EeecCCCHHH-HHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           79 FEYMECNLYQ-LMKD---REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        79 ~e~~~~~l~~-~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      |||++++.+. .+..   ....+++..++.++.|++.||.|||+.|++||||+|+||+++.+ .++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            9999975444 4332   23458999999999999999999999999999999999999876 89999999987654332


Q ss_pred             -CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 -PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA--DEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 -~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                       ......+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||......  +....+...                
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  223 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----------------  223 (267)
T ss_pred             cccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------------
Confidence             22345788999999988654 6789999999999999999999999654321  111111110                


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                           .++.       ...+..+.++.++|.+||..+|++|||+.++++
T Consensus       224 -----~~~~-------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 -----DYPP-------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -----CCCC-------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                 0110       011256788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.5e-42  Score=308.57  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=193.2

Q ss_pred             cCceEeeeecccCceEEEEEEE-----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEee-CCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRE-NDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~   74 (337)
                      ++|++++.||+|+||.||+|.+     ..+++.||+|++.............+|+.++.++ +||||+++++++.. +..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5899999999999999999984     3567899999997654444444567899999999 68999999998754 456


Q ss_pred             EEEEEeecCCCHHHHHhhc-c-----------------------------------------------------------
Q 038835           75 LYFVFEYMECNLYQLMKDR-E-----------------------------------------------------------   94 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~-~-----------------------------------------------------------   94 (337)
                      .+++|||++++.+..+... .                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            8999999997655444321 1                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---Ccccccccc
Q 038835           95 -------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---FTEYVSTRW  163 (337)
Q Consensus        95 -------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~  163 (337)
                             ..+++..+..++.||+.||+|||++|++||||||+||+++.+ .+||+|||++........   .....++..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  246 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence                   236788889999999999999999999999999999999876 999999999876533221   122345677


Q ss_pred             ccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       164 ~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      |+|||.+.+. .++.++||||||+++|+|++ |..||.+................                    +    
T Consensus       247 y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~----  301 (343)
T cd05103         247 WMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--------------------M----  301 (343)
T ss_pred             eECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC--------------------C----
Confidence            9999998665 67999999999999999997 99999775443222221110000                    0    


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                          ......++++.+++..||+.||.+|||+.++++|
T Consensus       302 ----~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         302 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                0012346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.8e-42  Score=300.55  Aligned_cols=248  Identities=28%  Similarity=0.414  Sum_probs=198.0

Q ss_pred             cCceEeeeecccCceEEEEEEECC-----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++.+.||.|+||.||+|.++.     ++..+|+|.+.............+|+.+++.++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            579999999999999999998753     678899999876544333445568999999999999999999999999999


Q ss_pred             EEEeecCCC-HHHHHhhc---------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee
Q 038835           77 FVFEYMECN-LYQLMKDR---------------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS  134 (337)
Q Consensus        77 lv~e~~~~~-l~~~~~~~---------------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~  134 (337)
                      ++|||++++ +.+.+...                     ...+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            999999975 44444321                     12478889999999999999999999999999999999998


Q ss_pred             CC-cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 038835          135 KD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIY  209 (337)
Q Consensus       135 ~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  209 (337)
                      .+ .++|+|||.+........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~  243 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY  243 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            76 899999999875533221   1223456679999988665 68999999999999999997 888998776655544


Q ss_pred             HHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          210 KICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       210 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .+....                     ..        ...+..+.++.++|.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~---------------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         244 YVRDGN---------------------VL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHhcCC---------------------CC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            332210                     00        011346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2e-41  Score=293.79  Aligned_cols=240  Identities=22%  Similarity=0.335  Sum_probs=190.5

Q ss_pred             eecccCceEEEEEEEC--CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCH
Q 038835            9 EVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNL   86 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l   86 (337)
                      .||+|+||.||+|.+.  .++..||+|++.............+|+.++++++||||++++++++ ....++||||++++.
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999765  4566799999876544333445568999999999999999999875 457899999998765


Q ss_pred             HH-HHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC----ccccc
Q 038835           87 YQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF----TEYVS  160 (337)
Q Consensus        87 ~~-~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~----~~~~g  160 (337)
                      +. .+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+.........    ....+
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW  160 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence            54 444445568999999999999999999999999999999999999876 8999999998755433211    11233


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      +..|+|||.+... .++.++|||||||++|++++ |.+||.+....+....+.....                       
T Consensus       161 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------  216 (257)
T cd05115         161 PLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-----------------------  216 (257)
T ss_pred             CcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-----------------------
Confidence            5689999988655 57899999999999999996 9999988776655443322100                       


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                            ....+..++++.++|.+||..||++||++.++.+
T Consensus       217 ------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  0112356789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=297.20  Aligned_cols=242  Identities=27%  Similarity=0.407  Sum_probs=189.8

Q ss_pred             eeecccCceEEEEEEECCCCcE--EEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||++.++.+|..  +++|.+.............+|+.+++++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            4689999999999999888764  6888887543333344556899999999 899999999999999999999999986


Q ss_pred             C-HHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           85 N-LYQLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        85 ~-l~~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      + +.+.+....               ..+++.+++.++.|++.||+|||++|++||||||+||+++.+ .+||+|||++.
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            5 444443321               247899999999999999999999999999999999999876 99999999986


Q ss_pred             cCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          148 EINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       148 ~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      .............+..|+|||.+... .++.++|||||||++|+|++ |..||.+.+..+....+....           
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----------  228 (270)
T cd05047         161 GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----------  228 (270)
T ss_pred             ccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----------
Confidence            43322111223345679999988654 67999999999999999997 999998776555444332110           


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                               . .        ......+.++.+++.+||..||.+|||+.++++
T Consensus       229 ---------~-~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 ---------R-L--------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ---------C-C--------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                     0 0        011245688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=314.25  Aligned_cols=235  Identities=26%  Similarity=0.457  Sum_probs=196.8

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCH
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNL   86 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l   86 (337)
                      ++=||.|+.|.||+++.+  ++.||||+++.-        ...+|+-|+.|+||||+.+.+++...-.++||||||..+-
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            455899999999999765  889999988642        1358899999999999999999999999999999999766


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccccccccc
Q 038835           87 YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYR  165 (337)
Q Consensus        87 ~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~  165 (337)
                      +..+.+.+.+++......|..+|+.|+.|||.+.|||||||.-||||+.+ .|||+|||-++........-+++||..||
T Consensus       199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWM  278 (904)
T KOG4721|consen  199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWM  278 (904)
T ss_pred             HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhh
Confidence            65556666679999999999999999999999999999999999999876 89999999999887765556789999999


Q ss_pred             CchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcc
Q 038835          166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPL  245 (337)
Q Consensus       166 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (337)
                      |||++.+. +.+.++|||||||+|||||||..||.+.+...++-    +++...                        .-
T Consensus       279 APEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVGsNs------------------------L~  329 (904)
T KOG4721|consen  279 APEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVGSNS------------------------LH  329 (904)
T ss_pred             CHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEE----eccCCc------------------------cc
Confidence            99999876 78999999999999999999999997655422211    111100                        00


Q ss_pred             cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          246 SVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       246 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...+...+..++=||+.||+-.|..||+..++|.|
T Consensus       330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            11124567889999999999999999999999999

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-41  Score=293.71  Aligned_cols=245  Identities=30%  Similarity=0.475  Sum_probs=199.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|.+.++||.|++|.||+|.+. +++.+|+|.+......  .....+|+.+++.++|+||+++++++......+++|||
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            68999999999999999999876 4577999998765443  33456899999999999999999999988999999999


Q ss_pred             cCCC-HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--Cc
Q 038835           82 MECN-LYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FT  156 (337)
Q Consensus        82 ~~~~-l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~~  156 (337)
                      ++++ +.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++++ .++|+|||.+........  ..
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE  162 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence            9875 444544432 468999999999999999999999999999999999999876 999999999876643211  11


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.||.+....+....+......                  
T Consensus       163 ~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------------------  223 (261)
T cd05034         163 GAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM------------------  223 (261)
T ss_pred             ccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence            22345679999988755 67899999999999999998 99999887766665554322110                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 ......+.++.+++.+||+.+|.+|||++++.+
T Consensus       224 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 -----------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       011334788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=296.43  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=198.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc----EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      .+|++++.||+|+||.||+|.++.+|+    .+|+|...............+|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            579999999999999999999887765    5899988766543344455689999999999999999999877 78899


Q ss_pred             EEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC
Q 038835           78 VFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~  155 (337)
                      ||||++++ +.+.+.+....+++..+..++.|++.||+|||++|++||||||+||+++.+ .+||+|||.+.........
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  165 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE  165 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence            99999865 555555545568999999999999999999999999999999999999875 8999999999866533221


Q ss_pred             c---cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 T---EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~---~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      .   ...++..|+|||.+... .++.++|+||+||++|++++ |.+||.+....+....+......              
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------  230 (279)
T cd05057         166 YHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL--------------  230 (279)
T ss_pred             eecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC--------------
Confidence            1   12235679999988654 67899999999999999998 99999887765554444321000              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                     ......+.++.+++.+||..||.+|||+.++++
T Consensus       231 ---------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 ---------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                           001235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-41  Score=291.05  Aligned_cols=241  Identities=24%  Similarity=0.400  Sum_probs=193.5

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHH
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      +.||.|++|.||++... ++..+|+|.+.............+|+.+++.++||||+++++++...+..++||||++++.+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46899999999999865 68889999987654433344556899999999999999999999999999999999987544


Q ss_pred             -HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--cccccccc
Q 038835           88 -QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--TEYVSTRW  163 (337)
Q Consensus        88 -~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--~~~~gt~~  163 (337)
                       +.+......+++..+..++.|++.||.|||++|++||||+|+||+++.+ .++|+|||++.........  ....++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence             4444445568999999999999999999999999999999999999876 8999999998754432211  12234567


Q ss_pred             ccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       164 ~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      |+|||.+.+. .++.++||||+|+++|++++ |..||.+.........+....                           
T Consensus       160 y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---------------------------  211 (250)
T cd05085         160 WTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---------------------------  211 (250)
T ss_pred             ccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---------------------------
Confidence            9999988655 67889999999999999998 999998776655444332110                           


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                        ........+.++.+++.+||..+|++|||+.++++
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 --RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence              00112356789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=291.65  Aligned_cols=241  Identities=25%  Similarity=0.425  Sum_probs=195.1

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC-H
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN-L   86 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-l   86 (337)
                      ++||.|++|.||++.+.. |+.||+|.+.............+|++++++++|+||+++++++...+..++||||++++ +
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999887 99999999877654434445678999999999999999999999999999999999875 4


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC---ccccccc
Q 038835           87 YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF---TEYVSTR  162 (337)
Q Consensus        87 ~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~---~~~~gt~  162 (337)
                      .+.+......+++..+..++.|++.||.|||++|++||||+|+||+++.+ .++|+|||.+.........   ....++.
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            44554445568999999999999999999999999999999999999876 8999999998765422111   1123356


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV  241 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
                      .|+|||.+.++ .++.++|+|||||++|+|++ |..||.+.........+.....                    .    
T Consensus       160 ~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------------------~----  214 (251)
T cd05041         160 KWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------------M----  214 (251)
T ss_pred             ccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC--------------------C----
Confidence            79999988665 67999999999999999998 8999987765544433321100                    0    


Q ss_pred             CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       242 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                           ......+.++.+++.+||..+|.+|||+.|+++
T Consensus       215 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 -----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                 011356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-41  Score=304.97  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=197.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-------CcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-------GEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      .+|++++.||+|+||.||+|.+...       +..+|+|.+.............+|+.+++++ +||||+++++++..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            3699999999999999999986432       2368999887654343444557899999999 8999999999999999


Q ss_pred             EEEEEEeecCCCHH-HHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           74 ILYFVFEYMECNLY-QLMKDR---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~l~-~~~~~~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ..++++||++++.+ +.+...               ...++...+..++.|++.||.|||++|++||||||+||+++.+ 
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            99999999987544 444332               1247788899999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||.+........   .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  250 (334)
T cd05100         172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  250 (334)
T ss_pred             cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            899999999876543221   1223345679999998665 67899999999999999998 899998877665544432


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .....                             ......+.++.+++.+||+.+|.+|||+.+++++
T Consensus       251 ~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         251 EGHRM-----------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             cCCCC-----------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            21000                             0113457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3e-41  Score=292.34  Aligned_cols=242  Identities=26%  Similarity=0.434  Sum_probs=194.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEE-eeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI-RENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~   79 (337)
                      +++|++.+.||+|++|.||++...  |..+|+|.+....   ......+|+.++++++|+|++++++++ ..++..+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            468999999999999999999664  7889999886532   233456899999999999999999875 4556789999


Q ss_pred             eecCCC-HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           80 EYMECN-LYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        80 e~~~~~-l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ||++++ +.+.+.... ..+++..+..++.|++.||+|||++|++||||||+||+++.+ .+||+|||++.......  .
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--C
Confidence            999874 555554433 348899999999999999999999999999999999999876 89999999987654322  2


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||.+... .++.++||||+||++|+|++ |++||...+..+....+....                    
T Consensus       158 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------------  216 (256)
T cd05082         158 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------------  216 (256)
T ss_pred             CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------------------
Confidence            33456789999988655 67889999999999999997 999998766554443332110                    


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                        +       ....+..++.+.+++.+||+.||++|||+.++++
T Consensus       217 --~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 --K-------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             --C-------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              0       0112456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-43  Score=313.85  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH-hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE-CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++..++..||+|.||+||+|.+..   .||||+++-.....+. ..+.+|+.++++-+|.||+-+.|++.+... .||+.
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            345788999999999999998863   5999999987766543 344689999999999999999999988777 99999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC---CCCCC
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN---SRPPF  155 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~---~~~~~  155 (337)
                      +|+|. |+..+......|.......|++||++|+.|||.++|||||||..|||+.++ +|||+|||++....   ....+
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~  547 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL  547 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence            99995 555665556669999999999999999999999999999999999999885 99999999987543   23334


Q ss_pred             ccccccccccCchhhc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          156 TEYVSTRWYRAPEVLL--QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ....|...|||||++.  +.++|++.+|||||||++|||++|..||...+....+-.+-.+...+               
T Consensus       548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p---------------  612 (678)
T KOG0193|consen  548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP---------------  612 (678)
T ss_pred             CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc---------------
Confidence            5567888999999987  34689999999999999999999999999555443332221111111               


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                ........-+.++++|+..||..++++||+..+||.
T Consensus       613 ----------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  613 ----------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ----------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                      011111234568999999999999999999999987

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.1e-41  Score=292.95  Aligned_cols=244  Identities=29%  Similarity=0.475  Sum_probs=196.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|+++++||+|+||.||+|..+ +++.+|+|.+......  .....+|+.++++++||||+++++++. .+..+++|||
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            57999999999999999999865 5778999998765443  334568999999999999999999875 4568999999


Q ss_pred             cCCC-HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--Cc
Q 038835           82 MECN-LYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FT  156 (337)
Q Consensus        82 ~~~~-l~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~~  156 (337)
                      +.++ +.+.+.. .+..+++.++..++.|++.||+|||+.|++||||||+||+++++ .++|+|||.+........  ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE  161 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence            9865 5555443 23468999999999999999999999999999999999999887 899999999876542221  12


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||.+... .++.++||||||+++|++++ |++||.+.+..+....+......                  
T Consensus       162 ~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  222 (260)
T cd05067         162 GAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM------------------  222 (260)
T ss_pred             CCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC------------------
Confidence            33456789999988655 57899999999999999998 99999887766555544221100                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 ......+.++.++|.+||..+|++|||+++++.
T Consensus       223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 -----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                       011345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.4e-42  Score=296.99  Aligned_cols=238  Identities=17%  Similarity=0.260  Sum_probs=187.4

Q ss_pred             eeecccCceEEEEEEECCCCcE-------EEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            8 KEVGDGTFGSVWRAISKQSGEV-------VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~-------vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +.||.|+||.||+|.++.++..       +|+|.+..... .......+|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhH-HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            4799999999999998765543       88887754322 122344579999999999999999999999889999999


Q ss_pred             ecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-c--------EEEeeCCCcccCC
Q 038835           81 YMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-T--------IKIADFGLAREIN  150 (337)
Q Consensus        81 ~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~--------~kL~Dfg~a~~~~  150 (337)
                      |++++.+..+. .....+++..++.++.||+.||+|||++|++||||||+||+++.+ .        ++++|||.+....
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            99987655544 444568999999999999999999999999999999999999765 2        7999999887654


Q ss_pred             CCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          151 SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       151 ~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      ..   ....+++.|+|||.+.+...++.++||||+||++|+|++| .+||...+........ ..               
T Consensus       160 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~---------------  220 (258)
T cd05078         160 PK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED---------------  220 (258)
T ss_pred             Cc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc---------------
Confidence            32   3356888999999987655678999999999999999998 4677655443322111 00               


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                          ...           .+...+.++.++|.+||+.||++|||++++++.
T Consensus       221 ----~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----RHQ-----------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----ccc-----------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                000           113456789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4e-41  Score=292.27  Aligned_cols=244  Identities=29%  Similarity=0.455  Sum_probs=195.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|.+.+.||+|++|.||++.+..++ .+|+|.+......  .....+|+.+++.++|||++++++++.. +..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc--HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            57999999999999999999887554 5899988654332  2345679999999999999999998754 567899999


Q ss_pred             cCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           82 MEC-NLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        82 ~~~-~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      +.+ ++.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||+++++ .++|+|||.+.......  ...
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence            987 455555443 3457899999999999999999999999999999999999876 89999999987654322  112


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||...+. .++.++||||||+++|+|++ |.+||.+....+....+......                  
T Consensus       162 ~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------  222 (260)
T cd05069         162 GAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM------------------  222 (260)
T ss_pred             CCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence            23456789999988655 67899999999999999999 99999887766655444321000                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 ......+..+.+++++||.+||.+|||++++++
T Consensus       223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 -----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       011346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.6e-41  Score=294.92  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=199.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-----CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-----GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||.|+||.||+|..+.+     .+.+++|.+.............+|+.++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            5799999999999999999997643     46799998865443323345578999999999999999999999989999


Q ss_pred             EEEeecCCCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           77 FVFEYMECNLYQLMKDREK---------CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~---------~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      +||||++++.+..+.....         .+++..+..++.|++.||+|||++|++||||||+||+++.+ .++++|||++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence            9999999765554443322         58999999999999999999999999999999999999876 8999999988


Q ss_pred             ccCCCC--CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccch
Q 038835          147 REINSR--PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSW  223 (337)
Q Consensus       147 ~~~~~~--~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  223 (337)
                      ......  .......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+....+....        
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~--------  235 (275)
T cd05046         165 KDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--------  235 (275)
T ss_pred             cccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC--------
Confidence            654322  122344667889999988655 56889999999999999998 889998766555444332110        


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                 ..++         .....+..+.+++.+||+.||.+|||+.++++.
T Consensus       236 -----------~~~~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 -----------LELP---------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             -----------cCCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                       0000         113567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-41  Score=309.12  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=197.6

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   75 (337)
                      ++|.+++.||+|+||.||+|.+.     .+++.||+|++.............+|+.++.++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46788899999999999999854     3567899999986544443445568999999997 99999999999998999


Q ss_pred             EEEEeecCCCHH-HHHhhcc------------------------------------------------------------
Q 038835           76 YFVFEYMECNLY-QLMKDRE------------------------------------------------------------   94 (337)
Q Consensus        76 ~lv~e~~~~~l~-~~~~~~~------------------------------------------------------------   94 (337)
                      ++||||+.++.+ +.+....                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999997544 4442211                                                            


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           95 -------------------------------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        95 -------------------------------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                                                           ..+++..+..++.||+.||+|||+++++||||||+|||++.+ 
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                                 236777889999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||++.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......+......
T Consensus       277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~  355 (401)
T cd05107         277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI  355 (401)
T ss_pred             EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence            89999999987643221   11234677889999998765 67899999999999999998 899998766555433322


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .....                            ...+...+.++.+++.+||..+|.+||+++++++.
T Consensus       356 ~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         356 KRGYR----------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            21000                            01123467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.8e-41  Score=290.06  Aligned_cols=246  Identities=28%  Similarity=0.446  Sum_probs=199.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .+|++.+.||.|++|.||++.+. ++..+|+|.+......  .....+|++++++++|||++++++++......+++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            57899999999999999999876 4678999998765443  23456899999999999999999999999999999999


Q ss_pred             cCCCHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--Ccc
Q 038835           82 MECNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FTE  157 (337)
Q Consensus        82 ~~~~l~~~~-~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~~~  157 (337)
                      +.++.+... ......+++..++.++.|++.||++||+.|++|+||||+||+++.+ .++|+|||.+........  ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence            998655544 4444568999999999999999999999999999999999999876 899999999876543221  112


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..++..|+|||.+.++ .++.++|+||+|+++|+|++ |.+||......+....+......                   
T Consensus       161 ~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  220 (256)
T cd05112         161 TKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL-------------------  220 (256)
T ss_pred             CccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC-------------------
Confidence            3345689999988655 67899999999999999998 99999887766555444221000                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                ......+.++.+++.+||+.+|++|||+.++++.
T Consensus       221 ----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         221 ----------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                      0012357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-41  Score=293.90  Aligned_cols=238  Identities=20%  Similarity=0.282  Sum_probs=186.6

Q ss_pred             eeecccCceEEEEEEECC------------CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEE
Q 038835            8 KEVGDGTFGSVWRAISKQ------------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   75 (337)
                      +.||+|+||.||+|....            ....+++|.+...... ......+|+.+++.++||||+++++++..+...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD-ISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh-HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999997432            2335888887654322 233446788999999999999999999988889


Q ss_pred             EEEEeecCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--------cEEEeeCCCc
Q 038835           76 YFVFEYMECNLYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--------TIKIADFGLA  146 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--------~~kL~Dfg~a  146 (337)
                      ++||||++++.++.+.. ....+++..++.++.||+.||+|||++|++||||||+|||++.+        .++++|||.+
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            99999999877666554 34568999999999999999999999999999999999999754        2899999988


Q ss_pred             ccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          147 REINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELI-TLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       147 ~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      ......   ....++..|+|||.+.....++.++|||||||++|+|+ .|..||.+....+... ....           
T Consensus       160 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~-----------  224 (262)
T cd05077         160 ITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG-----------  224 (262)
T ss_pred             ccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc-----------
Confidence            765432   23567888999998875557899999999999999998 5888887654332211 1100           


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                ...         .....+.++.++|.+||+.||.+||++.+|+++
T Consensus       225 ----------~~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 ----------QCM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ----------Ccc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                      000         012235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-43  Score=299.93  Aligned_cols=253  Identities=30%  Similarity=0.486  Sum_probs=216.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhH--HHHHHHHHhcC-CCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKM-SHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~--~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      .+|..+.+||+|+||+|-++..+.|.+.+|||+++++..-.....  ...|-++|... +-|.++.++.+|..-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467889999999999999999999999999999988754332221  14577777777 567899999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~~  156 (337)
                      |||+.|+.+-..+.+-+.+.|+.+..++..|+.||-|||++||++||||.+||+++.. .+||+|||++...- +.....
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTk  508 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTK  508 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCccee
Confidence            9999987665555555669999999999999999999999999999999999999976 99999999998653 233346


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ++||||.|+|||++... +|+.++|.||+||++|||+.|++||.+.+..+..+.|...                   +..
T Consensus       509 TFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------------------nvs  568 (683)
T KOG0696|consen  509 TFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------------------NVS  568 (683)
T ss_pred             eecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------------cCc
Confidence            78999999999998776 8999999999999999999999999999999988888653                   333


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA-----AEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  285 (337)
                      +|           +.+|.++.++....|.+.|.+|..+     .++-.||||+.
T Consensus       569 yP-----------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  569 YP-----------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             Cc-----------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            33           6789999999999999999999743     67889999975

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.8e-41  Score=289.84  Aligned_cols=242  Identities=26%  Similarity=0.390  Sum_probs=195.3

Q ss_pred             eeecccCceEEEEEEECC-CCc--EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISKQ-SGE--VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|++|.||+|.+.. +++  .+|+|.+.............+|+..+++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998865 333  5899999876654334455689999999999999999999988 889999999986


Q ss_pred             -CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC----Ccc
Q 038835           85 -NLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP----FTE  157 (337)
Q Consensus        85 -~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~----~~~  157 (337)
                       ++.+.+.+.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .+||+|||.+........    ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  159 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH  159 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence             4555555544 468999999999999999999999999999999999999876 899999999887644221    123


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+......                   
T Consensus       160 ~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------  219 (257)
T cd05040         160 LKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-------------------  219 (257)
T ss_pred             CCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-------------------
Confidence            4567889999987655 67899999999999999998 99999877776655554321000                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .         ......+..+.+++.+||+.+|++|||+.++++
T Consensus       220 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 L---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             C---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            0         011345788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-41  Score=295.50  Aligned_cols=237  Identities=18%  Similarity=0.234  Sum_probs=186.1

Q ss_pred             eecccCceEEEEEEECCC------------------------CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCccc
Q 038835            9 EVGDGTFGSVWRAISKQS------------------------GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK   64 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   64 (337)
                      .||+|+||.||++....+                        ...|++|++..... .......+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            699999999999974322                        23588888865422 12233457889999999999999


Q ss_pred             ceeEEeeCCEEEEEEeecCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-------
Q 038835           65 LKEVIRENDILYFVFEYMECNLYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-------  136 (337)
Q Consensus        65 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-------  136 (337)
                      +++++..+...++||||++++.++.+.. ....+++..+..++.||+.||+|||++|++||||||+||+++..       
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            9999999999999999999887766654 35568999999999999999999999999999999999999752       


Q ss_pred             -cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHH
Q 038835          137 -TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELI-TLRPLFPGTSEADEIYKICSV  214 (337)
Q Consensus       137 -~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~  214 (337)
                       .++++|||.+......   ....++..|+|||.+.+...++.++|||||||++|+|+ +|.+||.+....+........
T Consensus       161 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  237 (274)
T cd05076         161 PFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK  237 (274)
T ss_pred             ceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhc
Confidence             4899999987654322   23467788999998876556899999999999999985 699999876554332211100


Q ss_pred             hCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          215 IGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                          ...+           ...++++.++|.+||+.+|++|||+.+++++
T Consensus       238 --------------------~~~~-----------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         238 --------------------HRLP-----------EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             --------------------cCCC-----------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence                                0011           2235679999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.2e-41  Score=295.93  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             CceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCCh---HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSW---EECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      +|++.+.||+|++|.||++.+.   .+++.+|+|.+.......   ......+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999854   467889999987543211   122345799999999 699999999999999999


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      ++||||+.++.+.........+++..++.++.|++.||.|||+.|++||||+|.||+++.+ .++|+|||.+........
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            9999999976555444444568999999999999999999999999999999999999876 899999999876543322


Q ss_pred             --CccccccccccCchhhcCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSY-LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....|+..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...........+....                
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~----------------  224 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI----------------  224 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH----------------
Confidence              12346889999999976542 36789999999999999999999996433221111111110                


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC---HHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT---AAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~  285 (337)
                       ... .+        .....++.++.++|.+||+.||++|||   +.++|+||||+.
T Consensus       225 -~~~-~~--------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~  271 (288)
T cd05583         225 -LKS-KP--------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG  271 (288)
T ss_pred             -Hcc-CC--------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence             000 00        112346788999999999999999998   567799999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.6e-41  Score=294.52  Aligned_cols=248  Identities=22%  Similarity=0.367  Sum_probs=196.2

Q ss_pred             cCceEeeeecccCceEEEEEEECC----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee-CCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE-NDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   76 (337)
                      ++|++.+.||+|+||.||+|.++.    ++..|++|.+.............+|+.+++.++||||+++++++.. +...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            579999999999999999999876    3578999988755444444555789999999999999999998654 57789


Q ss_pred             EEEeecCCCHHH-HHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           77 FVFEYMECNLYQ-LMKDRE-------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        77 lv~e~~~~~l~~-~~~~~~-------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      +++||++++.+. .+....       ..+++..++.++.|++.||+|||+++++||||||+||+++.+ .+||+|||+++
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~  165 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR  165 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence            999999865554 443321       458999999999999999999999999999999999999876 89999999997


Q ss_pred             cCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccch
Q 038835          148 EINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSW  223 (337)
Q Consensus       148 ~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  223 (337)
                      .......   .....++..|+|||.+.+. .++.++|||||||++|++++ |.+||...+..+....+....        
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------  236 (280)
T cd05043         166 DLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY--------  236 (280)
T ss_pred             cccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC--------
Confidence            6533211   1223456779999998655 67999999999999999998 999998776554333222110        


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                  ..+         .....++++.+++.+||..||++|||+.++++
T Consensus       237 ------------~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 ------------RLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ------------CCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                        000         01245688999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6e-41  Score=292.76  Aligned_cols=248  Identities=27%  Similarity=0.410  Sum_probs=197.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCC---CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|.+.+.||.|++|.||+|.+..+   ...+|+|...............+|+.+++.++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4689999999999999999987644   346899988765433334455689999999999999999998875 457899


Q ss_pred             EeecCCCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-
Q 038835           79 FEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-  155 (337)
Q Consensus        79 ~e~~~~~l~~-~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-  155 (337)
                      |||++++.+. .+......+++..++.++.|++.||+|||+.|++|+||||+||+++.+ .++|+|||.+......... 
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  164 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK  164 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence            9999875554 444434458999999999999999999999999999999999999876 8999999998765443221 


Q ss_pred             -ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          156 -TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       156 -~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                       ....++..|+|||.+... .++.++||||||+++|++++ |.+||.+....+....+.....                 
T Consensus       165 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-----------------  226 (270)
T cd05056         165 ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-----------------  226 (270)
T ss_pred             cCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc-----------------
Confidence             122345679999987654 67899999999999999986 9999988876655544422100                 


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                          .        ...+..+.++.++|.+|+..+|.+|||+.+++..
T Consensus       227 ----~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         227 ----L--------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             ----C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                0        1124567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-43  Score=318.38  Aligned_cols=201  Identities=29%  Similarity=0.487  Sum_probs=176.2

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC------CEEEE
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN------DILYF   77 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~l   77 (337)
                      +..-+.||+||||.||+++++.||+.||+|..+...........-+|+++|++|+|||||++.++-+..      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            445678999999999999999999999999998866555555667999999999999999999986543      35689


Q ss_pred             EEeecCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccC
Q 038835           78 VFEYMECNLYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREI  149 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~  149 (337)
                      |||||.||.+....++   ..+++|.++..++..+..||.|||++||+||||||.||++..+     ..||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            9999998777666543   2469999999999999999999999999999999999998543     5799999999999


Q ss_pred             CCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 038835          150 NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE  204 (337)
Q Consensus       150 ~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  204 (337)
                      +.+....+.+||+.|.+||++.....|+..+|.|||||++|+++||..||.....
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            9999999999999999999997656899999999999999999999999965433

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6e-41  Score=292.60  Aligned_cols=247  Identities=23%  Similarity=0.339  Sum_probs=188.3

Q ss_pred             eeecccCceEEEEEEECC--CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGSVWRAISKQ--SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.||+|+||.||+|....  ....+|+|.+...........+.+|+..++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999996533  345688888765443333445568999999999999999999999999999999999976


Q ss_pred             HHHHHhhc-c----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---Cc
Q 038835           86 LYQLMKDR-E----KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---FT  156 (337)
Q Consensus        86 l~~~~~~~-~----~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---~~  156 (337)
                      .+..+... .    ...++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||.+........   ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD  160 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence            55544432 2    224678889999999999999999999999999999999887 999999999865432211   12


Q ss_pred             cccccccccCchhhcC------cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          157 EYVSTRWYRAPEVLLQ------SYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      ...+++.|+|||++..      ...++.++||||+||++|+|++ |.+||....+.+.+..........           
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-----------  229 (269)
T cd05042         161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK-----------  229 (269)
T ss_pred             CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc-----------
Confidence            3345677999998753      2346789999999999999999 789998877665544443221110           


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                             .      +.+......+..+.+++..|+ .||++|||++++++
T Consensus       230 -------~------~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 -------L------PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -------C------CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                   0      111223457788899999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.4e-41  Score=291.74  Aligned_cols=247  Identities=20%  Similarity=0.282  Sum_probs=188.2

Q ss_pred             eeecccCceEEEEEEEC--CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.||+|+||.||+|...  .++..+|+|.+.............+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46899999999999764  3556799999876654444445678999999999999999999999888999999999976


Q ss_pred             HHH-HHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---Cc
Q 038835           86 LYQ-LMKDR----EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---FT  156 (337)
Q Consensus        86 l~~-~~~~~----~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---~~  156 (337)
                      .+. .+...    ....++..+..++.|++.||+|||++|++|+||||+||+++.+ +++|+|||.+........   ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD  160 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence            554 44322    1245677888999999999999999999999999999999887 899999999875433221   12


Q ss_pred             cccccccccCchhhcCc------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          157 EYVSTRWYRAPEVLLQS------YLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      ...++..|+|||++.+.      ..++.++|+||+||++|+|++ |.+||......+...........            
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------  228 (269)
T cd05087         161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL------------  228 (269)
T ss_pred             CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC------------
Confidence            34577889999988532      135789999999999999996 99999876655443322111000            


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                            ..      ..+......+..+.+++..|+ .+|++|||++||+.
T Consensus       229 ------~~------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 ------KL------PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ------CC------CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                  00      001111345778999999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4e-42  Score=320.55  Aligned_cols=246  Identities=29%  Similarity=0.471  Sum_probs=207.2

Q ss_pred             CceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +-+..+.||+|+||+||+|.-.     .....||||.++..........+.+|+.++..|+|||||+++|++..++..++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3456788999999999999643     23456999999988776677777899999999999999999999999999999


Q ss_pred             EEeecCCC-HHHHHhhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEee
Q 038835           78 VFEYMECN-LYQLMKDRE-------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIAD  142 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~~~-------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~D  142 (337)
                      |||||..| |.+.++.+.             ++++..+...++.||+.|++||-++.+|||||-..|+||+++ .|||+|
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsD  646 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISD  646 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecc
Confidence            99999965 444444221             238899999999999999999999999999999999999999 999999


Q ss_pred             CCCcccCCCCCCCcc---ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 038835          143 FGLAREINSRPPFTE---YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTP  218 (337)
Q Consensus       143 fg~a~~~~~~~~~~~---~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~  218 (337)
                      ||+++..-+.+.+..   ..-...|||||.+..+ .++++|||||+||++||+++ |..||.+..+.+.++.+.++.   
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~---  722 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ---  722 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC---
Confidence            999987655443322   2234679999999887 78999999999999999998 999999999999998886541   


Q ss_pred             CccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 038835          219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL  278 (337)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  278 (337)
                                                ....+..-+.++.+|+..||+.+|.+||+++||-
T Consensus       723 --------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  723 --------------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             --------------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence                                      1122356789999999999999999999999984

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.8e-41  Score=294.65  Aligned_cols=263  Identities=25%  Similarity=0.404  Sum_probs=195.9

Q ss_pred             CceEeeeecccCceEEEEEEE----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC--CEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAIS----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN--DILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~   76 (337)
                      -|++++.||+|+||.||+|..    +.++..||+|.+.............+|+.+++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            368999999999999999974    4678899999987654333344557899999999999999999998764  6789


Q ss_pred             EEEeecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           77 FVFEYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        77 lv~e~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      +||||++|+.+..+. +....+++..+..++.|++.||+|||++|++||||||+||+++.+ .++|+|||.+........
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~  164 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE  164 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence            999999876655554 434458999999999999999999999999999999999999876 899999999886644322


Q ss_pred             ----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          155 ----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       155 ----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                          .....++..|+|||.+.+. .++.++|||||||++|+|+++..|+.....  .   .....+...........  .
T Consensus       165 ~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~--~  236 (284)
T cd05079         165 YYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--L---FLKMIGPTHGQMTVTRL--V  236 (284)
T ss_pred             ceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--h---hhhhcccccccccHHHH--H
Confidence                1234567789999988765 678999999999999999998776533211  0   01111111111100000  0


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ......       .....+...+.++.+++.+||+.||.+|||++++++.
T Consensus       237 ~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         237 RVLEEG-------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHcC-------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            000000       0011234578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-41  Score=290.02  Aligned_cols=228  Identities=24%  Similarity=0.345  Sum_probs=183.1

Q ss_pred             cCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHHHHHhh
Q 038835           13 GTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKD   92 (337)
Q Consensus        13 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~   92 (337)
                      |.+|.||++.++.+|+.+|+|.+.....      ..+|...+....||||+++++++...+..++||||++|+.+.....
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            8999999999999999999999976421      1234455555679999999999999999999999999765544433


Q ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccccCchhhc
Q 038835           93 REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL  171 (337)
Q Consensus        93 ~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~  171 (337)
                      +...+++..+..++.|++.||.|||++|++||||||+||+++.+ .++|+|||.+......  .....++..|+|||.+.
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccC
Confidence            44459999999999999999999999999999999999999876 8999999987665433  23445678899999875


Q ss_pred             CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCC
Q 038835          172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPS  251 (337)
Q Consensus       172 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (337)
                      .. .++.++|+||+|+++|+|++|..||........                 .      ...           ...++.
T Consensus       156 ~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~------~~~-----------~~~~~~  200 (237)
T cd05576         156 IS-EETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------T------HTT-----------LNIPEW  200 (237)
T ss_pred             CC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------c------ccc-----------cCCccc
Confidence            54 578899999999999999999988754321100                 0      000           011245


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCH-----HHHhcCcCc
Q 038835          252 ANKDAVSLIASLCSWDPSKRPTA-----AEALQHPFS  283 (337)
Q Consensus       252 ~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~  283 (337)
                      +++.+.++|.+||+.||++|||+     +++++||||
T Consensus       201 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         201 VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            68899999999999999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-40  Score=296.26  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=195.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc----EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++.+.||+|+||.||++.+..+|.    .+|+|.+.............+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            478899999999999999999887776    46888887654433333456899999999999999999998654 4678


Q ss_pred             EEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-
Q 038835           78 VFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-  154 (337)
Q Consensus        78 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-  154 (337)
                      ++||+++ ++.+.+......+++..+..++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+........ 
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence            9999986 4556655555568999999999999999999999999999999999999875 899999999986543322 


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+ ....               
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~---------------  228 (303)
T cd05110         166 YNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGE---------------  228 (303)
T ss_pred             cccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCC---------------
Confidence              1223456789999988655 67999999999999999997 99999876544332222 1100               


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                          ..+         ..+..+..+.+++..||..||++||+++++++.
T Consensus       229 ----~~~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         229 ----RLP---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ----CCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                000         013456789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-40  Score=288.18  Aligned_cols=245  Identities=29%  Similarity=0.449  Sum_probs=195.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .++|++.+.||+|+||.||++.+. .+..+|+|.+.....  ......+|+.+++.++|+||+++++++.. ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            468999999999999999999865 456699998875422  23345689999999999999999999877 77899999


Q ss_pred             ecCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--C
Q 038835           81 YMEC-NLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--F  155 (337)
Q Consensus        81 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~  155 (337)
                      |+++ ++.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ .++|+|||.+........  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence            9986 555555442 3457889999999999999999999999999999999999877 999999999876543221  1


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      ....++..|+|||.+... .++.++|+|||||++|++++ |.+||.+.+..+....+......                 
T Consensus       161 ~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------  222 (260)
T cd05073         161 EGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-----------------  222 (260)
T ss_pred             cCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------------
Confidence            223456679999998655 67889999999999999998 99999887765554443221000                 


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                  ...+..+.++.+++.+||+.||++||++.++++
T Consensus       223 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         223 ------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                        011456789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=287.99  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=209.4

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      -++.||.|+||+|+++.++.+|+..|+|.++......+..+++.|.+...+- ++||||++++....++..||-||+|+-
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~  147 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI  147 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence            3567999999999999999999999999999877766666777777766554 899999999999899999999999997


Q ss_pred             CHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           85 NLYQLMK----DREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        85 ~l~~~~~----~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ++-...+    .....++|+.+..+..-.+.||.||... +|+|||+||+|||+++. .+||||||.+.+..+.-..+..
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~d  227 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVD  227 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhc
Confidence            6543332    2344589999999999999999999865 89999999999999986 9999999999887665555667


Q ss_pred             cccccccCchhhcCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          159 VSTRWYRAPEVLLQSY-LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .|...|||||-+.... .|+.+||+||||+++||+++|..|+.+-+.  ..++++......+..-               
T Consensus       228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l---------------  290 (361)
T KOG1006|consen  228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL---------------  290 (361)
T ss_pred             cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee---------------
Confidence            8999999999987543 489999999999999999999999976544  4444444322211110               


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                            ......-+++..+..+|.-||.+|-.+||...+++.+||++..
T Consensus       291 ------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  291 ------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             ------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence                  1111123578999999999999999999999999999998863

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=303.65  Aligned_cols=260  Identities=28%  Similarity=0.421  Sum_probs=193.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC-EEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND-ILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~   81 (337)
                      .|.-...||+|+||.||+|.-.. |..||||.+....... ...+.+|+.++.+++|||+|+++|++.+.+ ...+|+||
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             CCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            45666899999999999998654 4889999887654432 344789999999999999999999999888 59999999


Q ss_pred             cCCCHH-HHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCC
Q 038835           82 MECNLY-QLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRG---YFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPP  154 (337)
Q Consensus        82 ~~~~l~-~~~~~~~~-~l~~~~~~~~~~qil~al~~LH~~~---i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~  154 (337)
                      |+.|.+ +.+..... +++|.....|+.+++.||+|||...   |+||||||+|||+|.+ ++||+|||+|..... ...
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~  233 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS  233 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc
Confidence            996555 55554444 7999999999999999999999864   9999999999999988 999999999966544 332


Q ss_pred             Cccc-cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 FTEY-VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 ~~~~-~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .... .||.+|+|||.+..+ ..+.++||||||+++.|+++|+.|...........          ...|......    
T Consensus       234 ~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~----------l~~w~~~~~~----  298 (361)
T KOG1187|consen  234 VSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS----------LVEWAKPLLE----  298 (361)
T ss_pred             eeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCccccc----------HHHHHHHHHH----
Confidence            2333 899999999988765 67999999999999999999998886543111100          0111100000    


Q ss_pred             hccCCCCCCCccc-ccCC--CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          234 NYKFPQLVGVPLS-VLMP--SANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       234 ~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      +....+..+..+. ...+  ..-..+..+...|++.+|.+||++.|+++
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            0012222222211 0001  11233678889999999999999999754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=316.39  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=213.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEe-----eCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIR-----ENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~   75 (337)
                      +.|++++.||.|.+|.||+++++.+|+..|+|+.......+++  ...|.++++.+ .|||++.++++|.     .++.+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deE--iE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEE--IELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHH--HHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            4588999999999999999999999999999998876554333  34588888887 7999999999984     45789


Q ss_pred             EEEEeecCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-
Q 038835           76 YFVFEYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-  151 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-  151 (337)
                      |+|||||+||+..++.+.  +..+.|..|..|++.++.||.+||.+.++|||||-.|||++.+ .|||+|||.+.+.+. 
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST  176 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence            999999998876666543  5568999999999999999999999999999999999999987 999999999887764 


Q ss_pred             CCCCccccccccccCchhhcCc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQS----YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL  227 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  227 (337)
                      .....+.+|||+|||||++.+.    ..|+..+|+||||++..||.-|.||+-++.+.-.+-.|-   ..          
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RN----------  243 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RN----------  243 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CC----------
Confidence            3455788999999999999754    246778999999999999999999998877654432221   11          


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                    +++-..-+..++.++.+||..||.+|-.+||+..++|+|||...
T Consensus       244 --------------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  244 --------------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             --------------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence                          11222334677899999999999999999999999999999874

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-40  Score=288.62  Aligned_cols=235  Identities=22%  Similarity=0.327  Sum_probs=185.7

Q ss_pred             eeecccCceEEEEEEECCCC----------cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            8 KEVGDGTFGSVWRAISKQSG----------EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +.||+|+||.||++.++.++          ..+++|.+......  .....+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46999999999999998777          35788877654322  3445689999999999999999999877 77899


Q ss_pred             EEeecCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--------cEEEeeCCCccc
Q 038835           78 VFEYMECNLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--------TIKIADFGLARE  148 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~-~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--------~~kL~Dfg~a~~  148 (337)
                      ||||++++.++.+..... .+++..+..++.||+.||+|||++|++||||||+||+++.+        .+||+|||.+..
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~  157 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT  157 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence            999999877665554433 68999999999999999999999999999999999999865        499999999887


Q ss_pred             CCCCCCCccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          149 INSRPPFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       149 ~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      ....   ....++..|+|||.+.+. ..++.++||||+||++|+|++ |..||...+..+.......             
T Consensus       158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-------------  221 (259)
T cd05037         158 VLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-------------  221 (259)
T ss_pred             cccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-------------
Confidence            6442   234567789999998755 467899999999999999999 5788876643222111100             


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                             ....+           .....++.++|.+||..+|.+|||+.++++
T Consensus       222 -------~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 -------QHRLP-----------MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -------CCCCC-----------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                   00000           112378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-40  Score=289.63  Aligned_cols=249  Identities=29%  Similarity=0.508  Sum_probs=199.7

Q ss_pred             CceEeeeecccCceEEEEEEECC-CCcEEEEEEcccccC---------ChHHhHHHHHHHHHhc-CCCCCcccceeEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQ-SGEVVAIKKMKKKYY---------SWEECVNLREVKSLRK-MSHPNIVKLKEVIRE   71 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~   71 (337)
                      .|++.+.||+|+||.||++.++. +++.+|+|.+.....         .........|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 688899998764321         1122233568887765 799999999999999


Q ss_pred             CCEEEEEEeecCCCHHH-HH---hhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           72 NDILYFVFEYMECNLYQ-LM---KDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~-~~---~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                      ++..+++|||++++.+. .+   ......+++..++.++.|++.||.|||+ .|++|+||+|.||+++.+ .++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            99999999999875443 33   2334568999999999999999999996 789999999999999877 899999999


Q ss_pred             cccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          146 AREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       146 a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      +.............|+..|+|||.+.+. .++.++|+||||+++|+|++|++||...+.......+......+       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  232 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-------  232 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-------
Confidence            9876655444566789999999998765 57999999999999999999999998766554444433211110       


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                           ......+.++.++|.+||+.||++|||+.|+.++
T Consensus       233 ---------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 ---------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                 0012467899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-40  Score=287.45  Aligned_cols=240  Identities=29%  Similarity=0.431  Sum_probs=192.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||++.  .+++.+|+|.+....   ......+|+.+++.++|||++++++++..+ ..+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            579999999999999999985  568899999986542   233456899999999999999999998654 47999999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      +.++ +.+.+... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ .++|+|||.+......  ....
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~  157 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNS  157 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCC
Confidence            9874 55555433 2358999999999999999999999999999999999999876 8999999998764322  1233


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..+..|+|||.+.+. .++.++|+||+||++|+|++ |++||.+.+..+....+.....                     
T Consensus       158 ~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------  215 (254)
T cd05083         158 KLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---------------------  215 (254)
T ss_pred             CCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---------------------
Confidence            456789999988655 67899999999999999997 9999987766554433321100                     


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      +        ...+..+..+.+++.+||+.+|.+|||+++++.
T Consensus       216 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 M--------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             C--------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0        011356789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-40  Score=290.60  Aligned_cols=242  Identities=29%  Similarity=0.456  Sum_probs=191.9

Q ss_pred             eeecccCceEEEEEEECCCC------cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            8 KEVGDGTFGSVWRAISKQSG------EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +.||.|++|.||++.++..+      +.+|+|.+.............+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999886544      679999887654333444557899999999999999999999998999999999


Q ss_pred             cCCC-HHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC------cEEEeeCCCccc
Q 038835           82 MECN-LYQLMKD------REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD------TIKIADFGLARE  148 (337)
Q Consensus        82 ~~~~-l~~~~~~------~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~------~~kL~Dfg~a~~  148 (337)
                      ++++ +.+.+.+      ....+++..+..++.|++.||+|||+++++|+||+|+||+++.+      .++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9875 4444443      12347889999999999999999999999999999999999864      599999999875


Q ss_pred             CCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchh
Q 038835          149 INSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       149 ~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  224 (337)
                      ......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+....         
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---------  230 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---------  230 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---------
Confidence            533221   1233556789999998765 67999999999999999998 999998776655444332110         


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 .         .......+..+.++|.+||..+|.+|||++++++
T Consensus       231 -----------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -----------R---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -----------c---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                       0         0112356788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.9e-40  Score=287.08  Aligned_cols=243  Identities=23%  Similarity=0.358  Sum_probs=186.3

Q ss_pred             eeecccCceEEEEEEECC---CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe-eCCEEEEEEeecC
Q 038835            8 KEVGDGTFGSVWRAISKQ---SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR-ENDILYFVFEYME   83 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~   83 (337)
                      +.||+|+||.||+|.+..   ++..+|+|.+.............+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998653   345799998865333333344568999999999999999999764 4566899999998


Q ss_pred             CCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----CCc
Q 038835           84 CNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----PFT  156 (337)
Q Consensus        84 ~~l~~-~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----~~~  156 (337)
                      ++.+. .+......+++..+..++.|++.||.|||+.+++||||||+|||++.+ .+||+|||.+.......     ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  160 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT  160 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence            75554 444434456788889999999999999999999999999999999876 89999999987543221     112


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+....                    
T Consensus       161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--------------------  219 (262)
T cd05058         161 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--------------------  219 (262)
T ss_pred             cCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--------------------
Confidence            33457789999988655 67899999999999999999 577887665544433322110                    


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                       .+        ......+..+.+++.+||..+|++||++.++++.
T Consensus       220 -~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         220 -RL--------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -CC--------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence             00        0012456889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-43  Score=285.70  Aligned_cols=282  Identities=32%  Similarity=0.565  Sum_probs=227.9

Q ss_pred             eEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEEEEE
Q 038835            5 KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN-----DILYFV   78 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv   78 (337)
                      +-.+.||-|+||+||.+.|..+|+.||+|++..-.... ..+...+|+++|.-++|.|++..+++....     ..+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34578999999999999999999999999887644332 234446899999999999999999886543     246889


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CC
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PF  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~  155 (337)
                      +|+|..++...+.+ ..+++.+.++-+++||+.||+|||+.||.||||||.|+|+++| .+||||||+|+....+.  ..
T Consensus       136 TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  136 TELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence            99998777766554 4569999999999999999999999999999999999999999 89999999998765443  33


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      +..+-|-+|+|||++.+...|+.+.||||+||++.|++..+..|...++.++++.|...+|.|+.+.+.....-.+..-.
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L  294 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL  294 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence            55678999999999999989999999999999999999999999999999999999999999998877654332222211


Q ss_pred             c----CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          236 K----FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       236 ~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      .    -|++...--..-......+..+++..+|..||++|.+..+.+.|++.....
T Consensus       295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            1    111111000011234456789999999999999999999999999976543

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.6e-40  Score=290.75  Aligned_cols=254  Identities=17%  Similarity=0.249  Sum_probs=185.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCC---CcEEEEEEcccccCChHH----------hHHHHHHHHHhcCCCCCcccceeE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEE----------CVNLREVKSLRKMSHPNIVKLKEV   68 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~   68 (337)
                      ++|++.+.||+|+||.||+|.+..+   +..+|+|+..........          .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5899999999999999999998877   667888865433221100          011233445567799999999987


Q ss_pred             EeeCC----EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeC
Q 038835           69 IREND----ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADF  143 (337)
Q Consensus        69 ~~~~~----~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Df  143 (337)
                      .....    ..++++|++..++.+.+.. ....++..++.++.|++.||.|||+++++||||||+|||++.+ .++|+||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF  170 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY  170 (294)
T ss_pred             eeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence            65433    4578888887776655543 3346889999999999999999999999999999999999876 9999999


Q ss_pred             CCcccCCCCC--------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 038835          144 GLAREINSRP--------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI  215 (337)
Q Consensus       144 g~a~~~~~~~--------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  215 (337)
                      |+|.......        ......||+.|+|||+..+. .++.++||||+||++|+|++|.+||.+............. 
T Consensus       171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~-  248 (294)
T PHA02882        171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC-  248 (294)
T ss_pred             CCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH-
Confidence            9987653211        11235799999999988655 6899999999999999999999999887433222111110 


Q ss_pred             CCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                  .....+.  ...       ...+..+.++.+++..|+..+|++||+..++++
T Consensus       249 ------------~~~~~~~--~~~-------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 ------------DFIKRLH--EGK-------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             ------------HHHHHhh--hhh-------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                        0000000  000       001344688999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=305.64  Aligned_cols=254  Identities=29%  Similarity=0.446  Sum_probs=221.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH--hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE--CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++.+++..||-|+||.|=++..+.....+|+|++++...-+..  .-...|-++|...+.|.||++|-.|.++..+|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4567788899999999999987766666999999887654432  23357999999999999999999999999999999


Q ss_pred             eecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           80 EYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        80 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |-|-|+ +...+.+ .+.+++...+.++..+++|++|||++|||+|||||+|++++.+ -+||.|||+|+..+......+
T Consensus       500 EaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT  578 (732)
T KOG0614|consen  500 EACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT  578 (732)
T ss_pred             HhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceee
Confidence            998765 5555555 4559999999999999999999999999999999999999986 899999999999999888899


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      +||||-|.|||++.+. ..+.++|.||||+++|||++|.|||.+.+....+..|.+++...                 .+
T Consensus       579 FcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-----------------~~  640 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-----------------EF  640 (732)
T ss_pred             ecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----------------hc
Confidence            9999999999999876 67899999999999999999999999999999999888764221                 22


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                      |           ..++..+.+||++++..+|.+|..     +.||-.|.||..
T Consensus       641 P-----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  641 P-----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             c-----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            2           467889999999999999999984     899999999975

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.4e-40  Score=289.42  Aligned_cols=262  Identities=27%  Similarity=0.418  Sum_probs=192.3

Q ss_pred             cCceEeeeecccCceEEEEEE----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe--eCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR--ENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~   75 (337)
                      ++|++++.||+|+||.||++.    +..+++.||+|.+..... .....+.+|+++++.++||||+++++++.  +....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            478999999999999999997    456788999999865422 22334568999999999999999999864  34568


Q ss_pred             EEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           76 YFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        76 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      ++||||++++ +.+.+.+....+++..++.++.|++.||.|||++|++||||||+||+++.+ .++|+|||++.......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            9999999865 445554545568999999999999999999999999999999999999876 89999999988654332


Q ss_pred             CC----ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCc-cchhhhhh
Q 038835          154 PF----TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ-DSWADGLL  228 (337)
Q Consensus       154 ~~----~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~  228 (337)
                      ..    ....++..|+|||.+.+. .++.++||||+||++|+|++|..|+..... .....+    +.... .....  .
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~--~  234 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMM----GNDKQGQMIVY--H  234 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhc----ccccccccchH--H
Confidence            11    112334569999998655 678999999999999999999877644322 111111    11000 00000  0


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .........       .....+..+.++.++|.+||..+|++|||+.|+++
T Consensus       235 ~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         235 LIELLKNNG-------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHhcCC-------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            000000000       00112457789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=303.67  Aligned_cols=247  Identities=27%  Similarity=0.433  Sum_probs=201.1

Q ss_pred             CceEeeeecccCceEEEEEEECCCCc---E-EEEEEccccc--CChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGE---V-VAIKKMKKKY--YSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~---~-vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      +-.+.++||+|+||.||+|.-+..+.   . ||+|......  .......+.+|+++|++++|||||+++|+......++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            44567899999999999998765433   3 8999888522  2334455579999999999999999999999999999


Q ss_pred             EEEeecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           77 FVFEYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        77 lv~e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      +|||+|.||.+ +.+.+....++..+...++.+.+.||+|||+++++||||-..|+|++.+ .+||+|||++........
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~  317 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM  317 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence            99999998655 5555544469999999999999999999999999999999999999996 669999999887642211


Q ss_pred             Cc-cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH-HhCCCCccchhhhhhhHH
Q 038835          155 FT-EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICS-VIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 ~~-~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~  231 (337)
                      .. ..--...|+|||.+... .|+.++||||+||++||+.+ |..||.+....+....+.. ....+.            
T Consensus       318 ~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~------------  384 (474)
T KOG0194|consen  318 KKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI------------  384 (474)
T ss_pred             ccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC------------
Confidence            11 11234679999999877 89999999999999999999 8899999999888887743 221111            


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                       ++..+.++..++..|+..||++|||+.++.+
T Consensus       385 -----------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  385 -----------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             -----------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                             1245688899999999999999999999865

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.9e-39  Score=283.04  Aligned_cols=247  Identities=21%  Similarity=0.291  Sum_probs=186.3

Q ss_pred             eeecccCceEEEEEEECCC--CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGSVWRAISKQS--GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.||+|+||.||++....+  ...+++|.+.............+|+..++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433  33466777665443334455678999999999999999999999999999999999975


Q ss_pred             HHH-HHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC---CCcc
Q 038835           86 LYQ-LMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP---PFTE  157 (337)
Q Consensus        86 l~~-~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~---~~~~  157 (337)
                      .+. .+.+.   ....++..++.++.||+.||+|||+++++||||||+|||++.+ .++|+|||.+.......   ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            554 44432   2346778889999999999999999999999999999999876 89999999876432211   1234


Q ss_pred             ccccccccCchhhcCc------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          158 YVSTRWYRAPEVLLQS------YLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      ..++..|+|||++...      ..++.++|||||||++|+|++ |.+||...+..+....+......             
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-------------  227 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV-------------  227 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-------------
Confidence            5688899999987531      235779999999999999997 57899877766655544322100             


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                           ..      ..+.....+++.+.+++..|+ .+|++|||++++++
T Consensus       228 -----~~------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 -----KL------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -----cc------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                 00      001112346788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.7e-40  Score=285.47  Aligned_cols=247  Identities=24%  Similarity=0.369  Sum_probs=192.4

Q ss_pred             ceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCC------
Q 038835            4 YKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREND------   73 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------   73 (337)
                      |++.+.||+|+||.||+|.++   .+|+.+|+|++....... ......+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            778999999999999999865   357889999997654433 3334568999999999999999999875432      


Q ss_pred             EEEEEEeecCCCHHHHH-hhc-----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           74 ILYFVFEYMECNLYQLM-KDR-----EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~-~~~-----~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      ..++++||+.++.+..+ ...     ...+++..++.++.|++.||+|||++|++||||||+||+++.+ .+||+|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            34788999987655433 211     1247899999999999999999999999999999999999876 9999999998


Q ss_pred             ccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccc
Q 038835          147 REINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDS  222 (337)
Q Consensus       147 ~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  222 (337)
                      .......   ......+++.|++||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+....       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------  232 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-------  232 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            8654322   11233456789999988655 67889999999999999999 899998776654433332110       


Q ss_pred             hhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                    .        ....+..+..+.+++.+||+.+|++|||+.++++.
T Consensus       233 --------------~--------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 --------------R--------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             --------------c--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                          0        00113467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-41  Score=301.22  Aligned_cols=253  Identities=28%  Similarity=0.501  Sum_probs=205.7

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHH--HHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      |..++.||-|+||.|.++....|...||+|.+.+...-......  ..|-++|..-+++=||+++..|.+++.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            66788999999999999999999999999999875443322222  4688999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC---------
Q 038835           82 MECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN---------  150 (337)
Q Consensus        82 ~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~---------  150 (337)
                      .+|| +...+++.+. |+|..++.++..+..|+++.|+.|+|||||||+|||||.+ .+||+|||+++...         
T Consensus       711 IPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq  789 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  789 (1034)
T ss_pred             cCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence            9975 5566666554 9999999999999999999999999999999999999987 99999999986330         


Q ss_pred             CCC----------------------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCC
Q 038835          151 SRP----------------------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLR  196 (337)
Q Consensus       151 ~~~----------------------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  196 (337)
                      ...                                  ..-..+||+.|+|||++... .|+..+|.||.|||||+|+.|+
T Consensus       790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhhCC
Confidence            000                                  01145799999999999765 7899999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC---C
Q 038835          197 PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP---T  273 (337)
Q Consensus       197 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t  273 (337)
                      +||......+...++.+         |..              ....   ...-.+|.++.++|.+++. +++.|.   .
T Consensus       869 ~pf~~~tp~~tq~kv~n---------w~~--------------~l~~---~~~~~ls~e~~~li~kLc~-sad~RLGkng  921 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVIN---------WRN--------------FLHI---PYQGNLSKEALDLIQKLCC-SADSRLGKNG  921 (1034)
T ss_pred             CCccCCCCCcceeeeee---------hhh--------------cccc---ccccccCHHHHHHHHHHhc-Chhhhhcccc
Confidence            99998887665544432         222              1111   1124689999999999876 788887   5


Q ss_pred             HHHHhcCcCccc
Q 038835          274 AAEALQHPFSRV  285 (337)
Q Consensus       274 ~~ell~hp~~~~  285 (337)
                      ++|+..||||+.
T Consensus       922 ~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  922 ADQVKAHPFFKG  933 (1034)
T ss_pred             hhhhhcCccccc
Confidence            778999999975

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-40  Score=315.84  Aligned_cols=246  Identities=25%  Similarity=0.445  Sum_probs=206.5

Q ss_pred             ceEeeeecccCceEEEEEEECCCCc-----EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      -+..+.||+|+||.||.|.-.....     .||+|.+.+.....+...+++|+.+|+.++|||||+++++.-+....+|+
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            4567889999999999998654322     39999999887777777788999999999999999999999999999999


Q ss_pred             EeecCC-CHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835           79 FEYMEC-NLYQLMKDR------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus        79 ~e~~~~-~l~~~~~~~------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      +|||+| +|+..+.+.      ...++..+...++.||+.|+.||+++++|||||-..|+|++.. .|||+|||+|+..-
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy  853 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIY  853 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence            999996 566777765      4568999999999999999999999999999999999999987 99999999999554


Q ss_pred             CCCCCccc---cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          151 SRPPFTEY---VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       151 ~~~~~~~~---~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      ....+...   .-...|||||.+..+ .++.++|||||||++||+++ |..||.+.++.+.+........-         
T Consensus       854 ~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL---------  923 (1025)
T KOG1095|consen  854 DKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL---------  923 (1025)
T ss_pred             hchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc---------
Confidence            43322211   113579999999876 89999999999999999999 99999999998887655443111         


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                          ..++..+..+.+++..||+.+|++||+...|++
T Consensus       924 --------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 --------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             --------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                112456778899999999999999999999986

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-39  Score=285.48  Aligned_cols=263  Identities=27%  Similarity=0.403  Sum_probs=195.4

Q ss_pred             cCceEeeeecccCceEEEEEEEC----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee--CCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE--NDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   75 (337)
                      ++|++.+.||+|+||.||++...    .+++.+|+|.+...........+.+|++.++.++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46888999999999999999854    35889999999865443234455789999999999999999999876  5678


Q ss_pred             EEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           76 YFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        76 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      +++|||++++ +.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++.+ .++|+|||.+.......
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK  163 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence            9999999875 555554444468999999999999999999999999999999999999887 89999999998765322


Q ss_pred             CC----ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          154 PF----TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       154 ~~----~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      ..    ....++..|+|||.+.+. .++.++||||||+++++|++|..||........ .    ..+.........  ..
T Consensus       164 ~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~----~~~~~~~~~~~~--~~  235 (284)
T cd05038         164 DYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-R----MIGIAQGQMIVT--RL  235 (284)
T ss_pred             cceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhc-c----ccccccccccHH--HH
Confidence            11    123445679999988665 678999999999999999999999865432210 0    000000000000  00


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .........       .......+.++.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         236 LELLKEGER-------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHcCCc-------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000000       0011345688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.6e-39  Score=308.34  Aligned_cols=272  Identities=20%  Similarity=0.273  Sum_probs=177.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCC----CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeE------Ee
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQS----GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV------IR   70 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~   70 (337)
                      .++|.+.+.||+|+||.||+|.+..+    +..||+|.+......  + ....  ..++...+.++..+...      ..
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e-~~~~--e~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--E-IWMN--ERVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--H-HHHH--HHHHhhchhhHHHHHHhhhcccccc
Confidence            36899999999999999999999988    999999987643211  1 0111  11222222223322221      23


Q ss_pred             eCCEEEEEEeecCCCHHH-HHhhccC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCC
Q 038835           71 ENDILYFVFEYMECNLYQ-LMKDREK-------------------CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPEN  130 (337)
Q Consensus        71 ~~~~~~lv~e~~~~~l~~-~~~~~~~-------------------~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~N  130 (337)
                      .+...++|+||++++.+. .+.....                   ...+..+..++.||+.||+|||++||+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            556789999999976554 4332211                   11234577899999999999999999999999999


Q ss_pred             eeeeCC--cEEEeeCCCcccCCCC--CCCccccccccccCchhhcCcC---------------------CCCCcchHHHH
Q 038835          131 LLVSKD--TIKIADFGLAREINSR--PPFTEYVSTRWYRAPEVLLQSY---------------------LYSSKVDMWAM  185 (337)
Q Consensus       131 ili~~~--~~kL~Dfg~a~~~~~~--~~~~~~~gt~~~~aPE~~~~~~---------------------~~~~~~Diwsl  185 (337)
                      ||++.+  .+||+|||+|......  ......++++.|+|||.+....                     .++.++||||+
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            999853  8999999999765322  2235678999999999764321                     13446799999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcC
Q 038835          186 GAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCS  265 (337)
Q Consensus       186 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  265 (337)
                      ||++|+|+++..|+  .+.......+....+.. ...|.......     ..++..  ......+..+....+||.+||+
T Consensus       366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~-~~~~~~~~~~~-----~~~~~~--~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYD-LVAWRKLVEPR-----ASPDLR--RGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCc-HHHHHHhhccc-----cchhhh--hhhhhccccchHHHHHHHHHcc
Confidence            99999999866554  23333333333322211 11221111000     000000  0001112334567799999999


Q ss_pred             CCCCCCCCHHHHhcCcCccccc
Q 038835          266 WDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       266 ~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      .||.+|||+.++|+||||+...
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCCCC
Confidence            9999999999999999998643

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=291.28  Aligned_cols=259  Identities=27%  Similarity=0.455  Sum_probs=212.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcc--cccCChHHhHH----HHHHHHHhcCCCCCcccceeEEe-eCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK--KKYYSWEECVN----LREVKSLRKMSHPNIVKLKEVIR-ENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~----~~e~~~l~~l~h~~iv~~~~~~~-~~~~   74 (337)
                      +||-++..||+|+|+.||+|.+....+.||+|+-.  +.+.++...+.    .+|-++.+.|+||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            57888999999999999999999999999999754  33333322222    47999999999999999999985 6678


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc--CccccCCCCCCeeeeCC----cEEEeeCCCccc
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR--GYFHRDLKPENLLVSKD----TIKIADFGLARE  148 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~--~i~H~dikp~Nili~~~----~~kL~Dfg~a~~  148 (337)
                      ++-|+|||+|+.++...+....++|.+++.|+.||+.||.||.+.  -|||-||||.|||+-.+    .+||+|||+++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            999999999999999988888899999999999999999999977  59999999999999764    799999999987


Q ss_pred             CCCCCC--------CccccccccccCchhhcCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhC
Q 038835          149 INSRPP--------FTEYVSTRWYRAPEVLLQS---YLYSSKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIG  216 (337)
Q Consensus       149 ~~~~~~--------~~~~~gt~~~~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~  216 (337)
                      .++...        .+...||.||+|||.+.-+   +..++++||||+|||+|.++.|+.||...-.. +.++...    
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT----  698 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT----  698 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc----
Confidence            754432        2346899999999998643   45789999999999999999999999765433 2222111    


Q ss_pred             CCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          217 TPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                  ..++..+.||..         |.+++++++||++||+..-++|..+.++..||+|..
T Consensus       699 ------------IlkAtEVqFP~K---------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  699 ------------ILKATEVQFPPK---------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ------------hhcceeccCCCC---------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence                        111222334432         578899999999999999999999999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.4e-38  Score=270.03  Aligned_cols=243  Identities=41%  Similarity=0.643  Sum_probs=197.8

Q ss_pred             CceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHHHHHhhc
Q 038835           14 TFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDR   93 (337)
Q Consensus        14 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   93 (337)
                      +||.||+|.+..+|+.+|+|++.............+|++.+++++|+|++++++.+......++++|+++++.+..+...
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999999999999998765443244556899999999999999999999999999999999998544444443


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccccCchhhcC
Q 038835           94 EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ  172 (337)
Q Consensus        94 ~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~  172 (337)
                      ...+++..++.++.+++.++.+||+.|++|+||+|.||+++.+ .++|+|||.+.............++..|+|||.+..
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~  160 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG  160 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc
Confidence            4448999999999999999999999999999999999999886 999999999988766544566778999999998865


Q ss_pred             cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCC
Q 038835          173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSA  252 (337)
Q Consensus       173 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (337)
                      . .++.++||||+|++++++++|..||......+............                          .......+
T Consensus       161 ~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~  213 (244)
T smart00220      161 K-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP--------------------------FPPPEWKI  213 (244)
T ss_pred             C-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC--------------------------CccccccC
Confidence            4 56889999999999999999999998744333322222110000                          00001126


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          253 NKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       253 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      +.++.+++.+||..+|.+||++.++++||||
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            7889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=271.74  Aligned_cols=255  Identities=24%  Similarity=0.446  Sum_probs=206.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHH--HHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|+++++||+|+|++|.++..++|.+.+|+|+++++-..+.+...  ..|-.+..+- +||.+|-++.+|..++.+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46899999999999999999999999999999999987655433211  3455555554 79999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC-CCCCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~-~~~~~~  155 (337)
                      |.||++|+.+-....+...++|+.++.+...|+.||.|||++||++||+|.+|+|++.. .+||+|+|+.+.. .+....
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t  408 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT  408 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence            99999986554333444459999999999999999999999999999999999999975 9999999999864 344556


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCC-------CCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG-------TSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      +++||||.|.|||++.+. .|+.++|.|+||++++||+.|+.||.-       .+.++.+-++.-.              
T Consensus       409 stfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------------  473 (593)
T KOG0695|consen  409 STFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------------  473 (593)
T ss_pred             ccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------------
Confidence            789999999999999876 799999999999999999999999952       2222222222110              


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC------CHHHHhcCcCccc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP------TAAEALQHPFSRV  285 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ell~hp~~~~  285 (337)
                          .....           +..+|..+..+++.-|.+||.+|.      ..+++-.||||+.
T Consensus       474 ----kqiri-----------prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  474 ----KQIRI-----------PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             ----hcccc-----------cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence                01111           245677788999999999999996      5689999999975

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.7e-39  Score=279.56  Aligned_cols=278  Identities=27%  Similarity=0.473  Sum_probs=213.6

Q ss_pred             cCceEeeeecccCceEEEEEEECC---CCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ---SGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +.|.++.+||+|.|++||++.+..   .++.||+|.+.....   ......|++.|..+ .+.||+++.+++.++++..+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            468899999999999999999887   788999999876432   33456899999999 69999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCC----
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINS----  151 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~----  151 (337)
                      |+||++......+...   ++...++.+++.++.||.++|++|||||||||+|+|.+..  .-.|.|||+|.....    
T Consensus       113 vlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             EecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence            9999998777666553   6789999999999999999999999999999999999975  789999999872100    


Q ss_pred             ------------C-----------------------------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHH
Q 038835          152 ------------R-----------------------------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMA  190 (337)
Q Consensus       152 ------------~-----------------------------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~  190 (337)
                                  .                             .......||++|+|||++..-...++++||||.|+++.
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L  269 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL  269 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence                        0                             00123569999999999987667799999999999999


Q ss_pred             HHHhCCCCCC-CCCcHHHHHHHHHHhCCCCcc----------chh-hhhhhHHhhhccCCCCC-CC--------ccccc-
Q 038835          191 ELITLRPLFP-GTSEADEIYKICSVIGTPTQD----------SWA-DGLLLARAINYKFPQLV-GV--------PLSVL-  248 (337)
Q Consensus       191 ~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~----------~~~-~~~~~~~~~~~~~~~~~-~~--------~~~~~-  248 (337)
                      .++++..||. ..++.+.+.++....|...-.          .|. ............|.... ..        ..... 
T Consensus       270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~  349 (418)
T KOG1167|consen  270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG  349 (418)
T ss_pred             hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence            9999998864 455667777777665543222          222 11111111111222221 00        11112 


Q ss_pred             CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          249 MPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       249 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+..+..+.+|+.+||..||.+|.|++++|.||||..
T Consensus       350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence            2345568999999999999999999999999999984

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=288.22  Aligned_cols=244  Identities=27%  Similarity=0.472  Sum_probs=202.6

Q ss_pred             eEeeeecccCceEEEEEEECC--CCc--EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            5 KLIKEVGDGTFGSVWRAISKQ--SGE--VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~--~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ...+.||.|.||.||+|....  .|+  .||||.-+.+...+....++.|+.+|+.++||||++++|++.+ ...|||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            345679999999999997532  233  4899998886666666677899999999999999999999865 56799999


Q ss_pred             ecC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           81 YME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        81 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      +++ |.+...+......++......++.||+.||.|||++++|||||-..|||+.+. -|||+|||+++.......+...
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS  550 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS  550 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence            998 56777777767779999999999999999999999999999999999999987 8999999999998877666554


Q ss_pred             cc--cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          159 VS--TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       159 ~g--t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      .|  ..-|||||-+..+ .++.++|||.|||.+||++. |..||.+..+.+.+-.+.++-..                  
T Consensus       551 ~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl------------------  611 (974)
T KOG4257|consen  551 RGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL------------------  611 (974)
T ss_pred             ccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC------------------
Confidence            44  3469999998665 78999999999999999887 99999998877665555443221                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 ..++.-++.+..++.+||..||.+||+..+|..
T Consensus       612 -----------P~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  612 -----------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             -----------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence                       123567789999999999999999998877643

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=295.95  Aligned_cols=247  Identities=26%  Similarity=0.423  Sum_probs=214.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCc---EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ..+|.++||.|.||.|+++.-+..|+   .||||.++......+...++.|+.+|-+++||||+++.++........||+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            35688999999999999999887664   499999998877777777889999999999999999999999999999999


Q ss_pred             eecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--C
Q 038835           80 EYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--F  155 (337)
Q Consensus        80 e~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~  155 (337)
                      |||+.+.++.+. .+++.|+.-++.-+++.|+.|++||-+.|+|||||-..|||++.+ ..|++|||+++...+++.  +
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y  789 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY  789 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence            999987776554 456779999999999999999999999999999999999999999 999999999998765542  2


Q ss_pred             ccccc--cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          156 TEYVS--TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       156 ~~~~g--t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ++..|  ...|.|||++..+ +++.+|||||+|+++||.++ |..||.+.++.+.++.|......|++            
T Consensus       790 tt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP------------  856 (996)
T KOG0196|consen  790 TTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP------------  856 (996)
T ss_pred             cccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC------------
Confidence            22222  3679999999876 78999999999999999776 99999999999999998776544432            


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                       .+-+..+.+|+..||++|-.+||...+|+.
T Consensus       857 -----------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  857 -----------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             -----------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                             245688999999999999999999999875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=286.28  Aligned_cols=267  Identities=21%  Similarity=0.305  Sum_probs=182.6

Q ss_pred             cCceEeeeecccCceEEEEEEEC----------------CCCcEEEEEEcccccCChH-------------HhHHHHHHH
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK----------------QSGEVVAIKKMKKKYYSWE-------------ECVNLREVK   52 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~----------------~~~~~vaiK~~~~~~~~~~-------------~~~~~~e~~   52 (337)
                      ++|++.++||+|+||+||+|...                ..++.||+|.+........             ......|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            68999999999999999999642                3456799999865322111             111134677


Q ss_pred             HHhcCCCCCc-----ccceeEEee--------CCEEEEEEeecCCCHHHHHhhc-c-----------------------C
Q 038835           53 SLRKMSHPNI-----VKLKEVIRE--------NDILYFVFEYMECNLYQLMKDR-E-----------------------K   95 (337)
Q Consensus        53 ~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~l~~~~~~~-~-----------------------~   95 (337)
                      ++.+++|.++     +++++++..        ++..++|+||++++.+..+... .                       .
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            7777766554     666676542        3568999999997655443321 1                       1


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc--ccccccccCchhhcC
Q 038835           96 CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE--YVSTRWYRAPEVLLQ  172 (337)
Q Consensus        96 ~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~--~~gt~~~~aPE~~~~  172 (337)
                      .+++..++.++.|++.||.|||+++++||||||+||+++.+ .+||+|||++...........  ..+|+.|+|||.+..
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~  384 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM  384 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence            24567889999999999999999999999999999999876 899999999976543322222  345899999999753


Q ss_pred             cCC-------------------CC--CcchHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          173 SYL-------------------YS--SKVDMWAMGAIMAELITLRP-LFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       173 ~~~-------------------~~--~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      ...                   ++  .+.|+||+||++|+|++|.. ||.+...........    ......|...    
T Consensus       385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~----~~~~~~~r~~----  456 (507)
T PLN03224        385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY----DNDLNRWRMY----  456 (507)
T ss_pred             CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc----cchHHHHHhh----
Confidence            211                   11  24799999999999999875 775432211100000    0000011100    


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCC---CCCCCHHHHhcCcCccc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDP---SKRPTAAEALQHPFSRV  285 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rpt~~ell~hp~~~~  285 (337)
                      ....+.+         ..++..++...||+.+||..+|   .+|+|++|+|+||||..
T Consensus       457 ~~~~~~~---------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        457 KGQKYDF---------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cccCCCc---------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            0001111         1245678999999999999876   68999999999999964

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=277.61  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=207.1

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      +..++++||+|.||.|.+|.-. .+..||+|.++.+........+.+|+++|.+|+||||+++++++..++.+++|+|||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3467899999999999999754 368999999998776666677789999999999999999999999999999999999


Q ss_pred             CCCHHH-HHhhccCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC---c
Q 038835           83 ECNLYQ-LMKDREKC-FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF---T  156 (337)
Q Consensus        83 ~~~l~~-~~~~~~~~-l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~---~  156 (337)
                      +.|.+. .+.....+ +......+++.||+.|++||.+.++|||||-+.|+|++.+ ++||+|||+++..-..+.+   .
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg  697 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG  697 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence            976554 44444322 3455567799999999999999999999999999999988 9999999999976554433   2


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      ..+-...|||||.+..+ .++.++|+|+||+++||+++  ...||....+++..+........+...             
T Consensus       698 r~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~-------------  763 (807)
T KOG1094|consen  698 RAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ-------------  763 (807)
T ss_pred             ceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc-------------
Confidence            23446789999999877 78999999999999999765  689999998888877766554333222             


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                               .....++..+..+.+++..|+..|-.+|||.+++-.
T Consensus       764 ---------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  764 ---------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             ---------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                     222334567788999999999999999999999854

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=291.08  Aligned_cols=259  Identities=30%  Similarity=0.465  Sum_probs=220.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|+.+.++|.|.||.||+++++.+|+..|+|+++...... -.....|+-+++..+||||+.+++.+-....+|+.|||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            58999999999999999999999999999999998765432 33345799999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      |+|+.++.+-.--++++|.++..+.+..+++|+|||++|-+|||||-.|||+++. .+||.|||.+.+++.. ....+++
T Consensus        94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksfi  173 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFI  173 (829)
T ss_pred             cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhccc
Confidence            9999888887767779999999999999999999999999999999999999875 9999999998877644 4457789


Q ss_pred             ccccccCchhhc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          160 STRWYRAPEVLL--QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       160 gt~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      |||+|||||+..  ....|+..+|||++|+...|+-.-++|-.+......+..+..-..+|                   
T Consensus       174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp-------------------  234 (829)
T KOG0576|consen  174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP-------------------  234 (829)
T ss_pred             CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC-------------------
Confidence            999999999965  22358899999999999999999999987766655554443322111                   


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                            +-.......++.+.+|++.+|.++|++|||++.+|+|||....
T Consensus       235 ------p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  235 ------PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             ------CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                  1112235677889999999999999999999999999998753

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=285.19  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=208.9

Q ss_pred             CceEeeeecccCceEEEEEEECCC-Cc--EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQS-GE--VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +.++.+.||+|.||+|++|.++.. |+  .||||++..+........+++|+.+|.+|+|+|++++|++..+ ....+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            456778999999999999988743 33  4999999988777666677899999999999999999999877 6678999


Q ss_pred             eecCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           80 EYMEC-NLYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        80 e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      |++++ +|++.+.+ ....|.......|+.||+.|+.||.++++|||||-..|+|+.+. .|||+|||+.+.++.....+
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            99996 56677766 45668899999999999999999999999999999999999765 99999999999887665544


Q ss_pred             cccc----cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          157 EYVS----TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       157 ~~~g----t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ...+    ...|+|||.+... .++-++|+|++||++|||++ |..||.|....+++++|-..-.               
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er---------------  333 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER---------------  333 (1039)
T ss_pred             EecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc---------------
Confidence            3322    3569999999776 78999999999999999998 7899999999988888753210               


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                           .+         -++.-+.++.+++..||..+|.+|||...|.+.-+.
T Consensus       334 -----Lp---------RPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  334 -----LP---------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             -----CC---------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence                 11         124567889999999999999999999998655443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=295.14  Aligned_cols=241  Identities=29%  Similarity=0.489  Sum_probs=189.0

Q ss_pred             eeecccCceE-EEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGS-VWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~-v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.+|.|+.|+ ||+|..  .|+.||||.+-.+.    ...+.+|+..|+.- .||||+++++.-.+....||..|.|..+
T Consensus       515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~s  588 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY--EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACS  588 (903)
T ss_pred             HHcccCCCCcEEEEEee--CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhh
Confidence            4578999985 599965  58899999886543    23446899999988 7999999999999999999999999999


Q ss_pred             HHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC---C---cEEEeeCCCcccCCCCC---
Q 038835           86 LYQLMKDREK---CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK---D---TIKIADFGLAREINSRP---  153 (337)
Q Consensus        86 l~~~~~~~~~---~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~---~---~~kL~Dfg~a~~~~~~~---  153 (337)
                      |.+.+.....   ....-..+..+.|++.||++||+.+||||||||.||||+.   +   .++|+|||+++......   
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence            9998876311   1111345788999999999999999999999999999976   2   79999999998876543   


Q ss_pred             -CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          154 -PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       154 -~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                       ......||.+|+|||++.... -+.++||||+||++|+.++| ..||.+.-..+.  .|...                 
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~-----------------  728 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTG-----------------  728 (903)
T ss_pred             hcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcC-----------------
Confidence             235578999999999998764 46799999999999998885 899987544322  11111                 


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                        ++....+        .+....++.|||.+|+.+||..||+|.++|.||||=
T Consensus       729 --~~~L~~L--------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  729 --NYTLVHL--------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             --ccceeee--------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence              0011111        111122899999999999999999999999999983

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=272.94  Aligned_cols=242  Identities=25%  Similarity=0.441  Sum_probs=202.8

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      .....+||.|.||.||.+.++.-.-.||+|.++.+.+.  ...+++|+.+|+.++|||+|++++++..+..+|||+|||.
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            34567899999999999999999999999999887654  4456799999999999999999999999999999999987


Q ss_pred             -CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccc
Q 038835           84 -CNLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS  160 (337)
Q Consensus        84 -~~l~~~~~~~~~-~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~g  160 (337)
                       |+|++++.+++. -++.-....++-||..|+.||.++++|||||-..|+|+..+ .||++|||+++....+. ++...|
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAG  425 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAG  425 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccC
Confidence             689999988764 35666677889999999999999999999999999999998 89999999999875543 233344


Q ss_pred             ---cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          161 ---TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       161 ---t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                         ..-|.|||-+..+ .++.++|||+|||++||+.+ |-.||.+.+--..+..+.+....                  +
T Consensus       426 AKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM------------------~  486 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM------------------D  486 (1157)
T ss_pred             ccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc------------------c
Confidence               3569999998765 67999999999999999998 88999998766555544432111                  1


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL  278 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  278 (337)
                      -           +.+.++.+.+|++.||+++|.+||+..|+-
T Consensus       487 ~-----------PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  487 G-----------PEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             C-----------CCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            1           145678899999999999999999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=241.43  Aligned_cols=209  Identities=24%  Similarity=0.405  Sum_probs=176.5

Q ss_pred             eEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEeecC
Q 038835            5 KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      ..+..||+|++|.|=+.++..+|...|+|.+....-.......+.|+++..+. .||.+|.+++........||.||.|+
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~  128 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD  128 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence            34567999999999999999999999999998766666667777899887765 89999999999999999999999998


Q ss_pred             CCHHH---HHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           84 CNLYQ---LMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        84 ~~l~~---~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      .++-.   ...+.+..++|..+-+++..++.||.|||++ .++|||+||+||||+.+ .||+||||.+....+....+..
T Consensus       129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d  208 (282)
T KOG0984|consen  129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD  208 (282)
T ss_pred             hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh
Confidence            65433   3345678899999999999999999999976 89999999999999986 9999999999887665444556


Q ss_pred             cccccccCchhhcC---cCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHH
Q 038835          159 VSTRWYRAPEVLLQ---SYLYSSKVDMWAMGAIMAELITLRPLFPG-TSEADEIYKICS  213 (337)
Q Consensus       159 ~gt~~~~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~  213 (337)
                      .|.-.|+|||.+..   +..|+.++||||||+++.||.+++.||.. .++-+++.++.+
T Consensus       209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            78888999999863   34689999999999999999999999964 444455555543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-36  Score=306.46  Aligned_cols=251  Identities=21%  Similarity=0.328  Sum_probs=183.0

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      .|.....||+|+||.||+|.++.+|..||+|.+......     ...|+..+++++||||+++++++.+.+..++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            456677899999999999999999999999998653221     135688999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH---QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH---~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      +++.+..+...   +++..+..++.|++.||+|||   +.+++||||||+||+++.+ ..++. |+.+......   ...
T Consensus       766 ~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~~~  838 (968)
T PLN00113        766 EGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---TKC  838 (968)
T ss_pred             CCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---CCc
Confidence            98766655542   789999999999999999999   6799999999999999876 55544 5544332211   234


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH-hCCCCccchhhhhhhHHhhhcc
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSV-IGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      .||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ....+.... ........|.+           
T Consensus       839 ~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  906 (968)
T PLN00113        839 FISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID-----------  906 (968)
T ss_pred             cccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC-----------
Confidence            788999999998665 6899999999999999999999999543221 001110000 00000000000           


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                       +.... . .........++.+++.+||+.||++|||++|+++.
T Consensus       907 -~~~~~-~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        907 -PSIRG-D-VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             -ccccC-C-CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence             00000 0 00001122457899999999999999999999874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-36  Score=266.47  Aligned_cols=198  Identities=29%  Similarity=0.458  Sum_probs=172.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhH------HHHHHHHHhcCC---CCCcccceeEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECV------NLREVKSLRKMS---HPNIVKLKEVIRE   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~------~~~e~~~l~~l~---h~~iv~~~~~~~~   71 (337)
                      .+|..++.+|.|+||.|++|.++++...|++|.|.++..-.. ..+      .--|+.+|..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            469999999999999999999999999999999987654321 111      135999999996   9999999999999


Q ss_pred             CCEEEEEEeecCC--CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCccc
Q 038835           72 NDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLARE  148 (337)
Q Consensus        72 ~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~  148 (337)
                      ++.+||+||--+-  +|++. ++..+.++|.+++.|++|++.|+++||+.||||||||-+|+.++.+ -+||+|||.|..
T Consensus       641 dd~yyl~te~hg~gIDLFd~-IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDF-IEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             CCeeEEEecCCCCCcchhhh-hhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            9999999998764  35554 4556669999999999999999999999999999999999999987 899999999886


Q ss_pred             CCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 038835          149 INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG  201 (337)
Q Consensus       149 ~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (337)
                      ..+ .++..++||..|.|||++.+.+..+.+-|||++|+++|.++....||..
T Consensus       720 ~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            644 4568899999999999999888889999999999999999998888853

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=272.35  Aligned_cols=245  Identities=29%  Similarity=0.486  Sum_probs=199.1

Q ss_pred             eEeeeecccCceEEEEEEEC----C---CCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEE
Q 038835            5 KLIKEVGDGTFGSVWRAISK----Q---SGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   76 (337)
                      .+.+.||+|+||.|++|.-+    .   ....||+|.++......+......|+++|+.+ .|+||+.+++.+..++..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            56679999999999999633    1   14569999999877776666778999999999 6999999999999899999


Q ss_pred             EEEeecCC-CHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEE
Q 038835           77 FVFEYMEC-NLYQLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIK  139 (337)
Q Consensus        77 lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~k  139 (337)
                      +|+||+.. +++..+..+.               ..++..+...+++||+.|++||++++++||||-..|||+..+ .+|
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k  458 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK  458 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence            99999985 6666666555               348999999999999999999999999999999999999998 999


Q ss_pred             EeeCCCcccCCCCCCCcc--ccc--cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC-cHHHHHHHHH
Q 038835          140 IADFGLAREINSRPPFTE--YVS--TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTS-EADEIYKICS  213 (337)
Q Consensus       140 L~Dfg~a~~~~~~~~~~~--~~g--t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~~~~~~~i~~  213 (337)
                      ++|||+|+...+...+..  ..|  ...|||||.+.. ..|+.++||||+|+++||+.+ |..||.+.. ..+..+.+..
T Consensus       459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~  537 (609)
T KOG0200|consen  459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE  537 (609)
T ss_pred             EccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc
Confidence            999999997655444321  222  235999999977 589999999999999999998 889998865 3444333332


Q ss_pred             HhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      +...                             ..+..-++++.++++.||..+|++||+..++..
T Consensus       538 G~r~-----------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  538 GNRM-----------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCC-----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            2110                             111345789999999999999999999999876

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=263.93  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=203.2

Q ss_pred             eEeeeecccCceEEEEEEECCCCc----EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            5 KLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +..++||.|+||+||++.+.-.|+    +||+|++...........+++|+.+|.+|+|||+++++++..... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            446789999999999998765555    488888887766666677789999999999999999999987655 889999


Q ss_pred             ecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-cc
Q 038835           81 YMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-TE  157 (337)
Q Consensus        81 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-~~  157 (337)
                      ||++ .|++.+......+.......|..||++|+.|||+++++||||-..|||+.+. .+|+.|||+|+...+.... ..
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~  857 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA  857 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence            9995 5778888777779999999999999999999999999999999999999874 9999999999988765432 22


Q ss_pred             ccc--cccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          158 YVS--TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       158 ~~g--t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      ..|  .+-|+|-|.+... .|+.++||||+||++||++| |..|+.+....+....+..+.                   
T Consensus       858 ~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-------------------  917 (1177)
T KOG1025|consen  858 PGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-------------------  917 (1177)
T ss_pred             cccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-------------------
Confidence            222  4569999988766 78999999999999999998 999999988877655543321                   


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                ....++.-+-++.-++.+||..|+..||+++++..
T Consensus       918 ----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  918 ----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                      11223566788999999999999999999998743

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=237.40  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=191.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeE-EeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEV-IRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~   79 (337)
                      +.|.|.+.+|+|-||.+-+|.|+.+...+|+|.+.++...  ...+.+|..---.| .|.||+.-|++ |+..+.+++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            5799999999999999999999999999999999876443  33344565554445 58999998876 77888999999


Q ss_pred             eecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC---cEEEeeCCCcccCCCCCCC
Q 038835           80 EYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD---TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        80 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~---~~kL~Dfg~a~~~~~~~~~  155 (337)
                      ||++. +|.+.+...  ++.|...+.++.|+++|+.|+|++++||||||.+||||.+.   .+||||||.++..+..-..
T Consensus       102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~  179 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY  179 (378)
T ss_pred             ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence            99995 455555443  38999999999999999999999999999999999999653   8999999998876644322


Q ss_pred             ccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 TEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      -  --+..|.+||+...    .-..++.+|||.||+++|.+++|++||......+.-+           ..|   ....+
T Consensus       180 ~--~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y-----------~~~---~~w~~  243 (378)
T KOG1345|consen  180 L--EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY-----------WEW---EQWLK  243 (378)
T ss_pred             h--hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH-----------HHH---HHHhc
Confidence            1  23445889998652    2345778999999999999999999997433222111           111   11122


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHhcCcCcc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR---PTAAEALQHPFSR  284 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~ell~hp~~~  284 (337)
                      ..+...|..        ...+++.+..+.++-|..+|++|   .++..-...-|..
T Consensus       244 rk~~~~P~~--------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  244 RKNPALPKK--------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             ccCccCchh--------hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            223333332        24578999999999999999999   5666666666643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.8e-32  Score=227.98  Aligned_cols=211  Identities=42%  Similarity=0.659  Sum_probs=179.8

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCCHHHH
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQL   89 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~   89 (337)
                      ||+|.+|.||++.+..+|+.+++|++.............+|+..++.+.|++++++++++......++++|+++|..+..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999888999999999876543223455789999999999999999999999899999999999655544


Q ss_pred             Hhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC--CcEEEeeCCCcccCCCCC-CCcccccccccc
Q 038835           90 MKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK--DTIKIADFGLAREINSRP-PFTEYVSTRWYR  165 (337)
Q Consensus        90 ~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~--~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~~~  165 (337)
                      +.... ..+++..++.++.+++.++.+||++|++|+||+|.||+++.  +.++|+|||.+....... ......+...|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM  160 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence            44433 46899999999999999999999999999999999999998  499999999988665432 123456888899


Q ss_pred             CchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcc
Q 038835          166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPL  245 (337)
Q Consensus       166 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (337)
                      +||.+......+.++|+|++|++++++                                                     
T Consensus       161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------------  187 (215)
T cd00180         161 APEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------------  187 (215)
T ss_pred             ChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------------
Confidence            999886543678899999999999999                                                     


Q ss_pred             cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 038835          246 SVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP  281 (337)
Q Consensus       246 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  281 (337)
                              ..+.+++..|++.||.+||++.++++++
T Consensus       188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                    1357899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=245.68  Aligned_cols=259  Identities=25%  Similarity=0.305  Sum_probs=180.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHh--cCCCCCcccceeEEeeCC----EEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR--KMSHPNIVKLKEVIREND----ILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~----~~~   76 (337)
                      ..++.+.||+|.||.||+|.  -+++.||||++...    +...+..|-++..  .++|+||+++++.-+...    .++
T Consensus       211 pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhh--ccCceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            44667889999999999995  45799999999754    2333345555555  468999999999976555    799


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR---------GYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~---------~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      ||++|.+.+.+......+. +++....+++..++.||+|||+-         .|+|||||..|||+..+ +..|+|||+|
T Consensus       285 LVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            9999998665555554443 89999999999999999999953         69999999999999888 9999999999


Q ss_pred             ccCCCCCC---CccccccccccCchhhcCcCCCC-----CcchHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCC
Q 038835          147 REINSRPP---FTEYVSTRWYRAPEVLLQSYLYS-----SKVDMWAMGAIMAELITLRPLFP-GTSEADEIYKICSVIGT  217 (337)
Q Consensus       147 ~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~  217 (337)
                      ..+.+...   ....+||..|||||++.+...+.     ...||||+|.+++||++...-+. +..+.=++---.+....
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            88764432   34479999999999997653333     25899999999999998654332 21111111111111122


Q ss_pred             CCccchhhhhhhHHhhhccCCCCCCCcccccCC--CCChhHHHHHHHhcCCCCCCCCCHHHH
Q 038835          218 PTQDSWADGLLLARAINYKFPQLVGVPLSVLMP--SANKDAVSLIASLCSWDPSKRPTAAEA  277 (337)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~el  277 (337)
                      |..+.+.+.-         ......+.++..|.  ..-..+.+.+..||..||+-|.|+.=+
T Consensus       444 Pt~e~mq~~V---------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  444 PTLEEMQELV---------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCHHHHHHHH---------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            2222221111         11111111111121  123558899999999999999998533

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=5.6e-32  Score=229.08  Aligned_cols=209  Identities=39%  Similarity=0.576  Sum_probs=174.0

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.............+|+..++.++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            67889999999999999999988999999999875443234455689999999999999999999998899999999999


Q ss_pred             CCHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCcccc
Q 038835           84 CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTEYV  159 (337)
Q Consensus        84 ~~l~~~~~~~~~~-l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~~~  159 (337)
                      ++.+..+...... +++..+..++.+++.++.+||+.+++|+|++|.||+++.+ .++|+|||.+.......  ......
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK  160 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence            8444444443333 8999999999999999999999999999999999999976 99999999988765442  334567


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcH-HHHHHHH
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG-TSEA-DEIYKIC  212 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~-~~~~~i~  212 (337)
                      ++..|++||.+.....++.++|+|+||+++++|++|+.||.. .++. +..+.+.
T Consensus       161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            888999999874444678899999999999999999999977 4444 4444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-32  Score=237.88  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=181.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhc--CCCCCcccceeEEeeC----CEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK--MSHPNIVKLKEVIREN----DILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~   76 (337)
                      +..+.+.||+|.||.||+|.+.  |+.||||++...    ++....+|.++.+.  |+|+||+.+++.-..+    .++|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            5678999999999999999876  999999998753    34445667777665  5999999999885433    4689


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR--------GYFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~--------~i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      +|++|-+.|++.++..+ ..++.....+++..++.||+|||-.        .|.|||||..|||+.++ +..|+|+|+|.
T Consensus       286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            99999996655555554 4489999999999999999999943        59999999999999987 99999999998


Q ss_pred             cCCCC-----CCCccccccccccCchhhcCcCCC----C-CcchHHHHHHHHHHHHh-----C-----CCCCCCCCc---
Q 038835          148 EINSR-----PPFTEYVSTRWYRAPEVLLQSYLY----S-SKVDMWAMGAIMAELIT-----L-----RPLFPGTSE---  204 (337)
Q Consensus       148 ~~~~~-----~~~~~~~gt~~~~aPE~~~~~~~~----~-~~~DiwslG~il~~ll~-----g-----~~pf~~~~~---  204 (337)
                      .....     ......+||-.|||||++...-..    + ..+||||||.++||++.     |     .+||.+..+   
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            66543     223567999999999998654211    1 25899999999999885     2     578865332   


Q ss_pred             -HHHHHHHHH--HhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          205 -ADEIYKICS--VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       205 -~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                       .+.+.+...  .+.+..+..|.....                        =..+..+++.||..||.-|.|+-.+-+
T Consensus       445 s~eeMrkVVCv~~~RP~ipnrW~s~~~------------------------l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  445 SFEEMRKVVCVQKLRPNIPNRWKSDPA------------------------LRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CHHHHhcceeecccCCCCCcccccCHH------------------------HHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence             122222211  122222223332111                        133568899999999999999876644

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=2.2e-33  Score=278.66  Aligned_cols=199  Identities=20%  Similarity=0.258  Sum_probs=147.7

Q ss_pred             hcCCC-CCcccceeEE-------eeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC
Q 038835           55 RKMSH-PNIVKLKEVI-------RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL  126 (337)
Q Consensus        55 ~~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~di  126 (337)
                      +.++| +||+++++.+       .....++++||+++++|.+.+......+++..++.+++||+.||+|||++||+||||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            34455 5777788876       233567888999998888888665566999999999999999999999999999999


Q ss_pred             CCCCeeeeC-------------------C-cEEEeeCCCcccCCCCC-----------------CCccccccccccCchh
Q 038835          127 KPENLLVSK-------------------D-TIKIADFGLAREINSRP-----------------PFTEYVSTRWYRAPEV  169 (337)
Q Consensus       127 kp~Nili~~-------------------~-~~kL~Dfg~a~~~~~~~-----------------~~~~~~gt~~~~aPE~  169 (337)
                      ||+|||++.                   + .+|++|||++.......                 .....+||++|+|||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999953                   1 56777777765421100                 0112468999999999


Q ss_pred             hcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccC
Q 038835          170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLM  249 (337)
Q Consensus       170 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (337)
                      +.+. .++.++|||||||++|||++|.+|+.....  ....+....                     .+..        .
T Consensus       187 ~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~---------------------~~~~--------~  234 (793)
T PLN00181        187 DNGS-SSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV---------------------LPPQ--------I  234 (793)
T ss_pred             hccC-CCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh---------------------cChh--------h
Confidence            8766 679999999999999999999988753211  111111110                     0000        0


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          250 PSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       250 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ....+...+++..||++||.+|||+.|+++||||..
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence            012355678999999999999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.1e-30  Score=210.62  Aligned_cols=165  Identities=19%  Similarity=0.290  Sum_probs=125.8

Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccc
Q 038835           84 CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTR  162 (337)
Q Consensus        84 ~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~  162 (337)
                      |++.+.+.+++.++++..++.++.||+.||.|||+++      ||+|||++.+ .+++  ||.+......    ...||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            4566666665667999999999999999999999999      9999999877 7888  9988765443    236899


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV  241 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
                      .|+|||++.+. .++.++||||+||++|+|++|.+||...... .....+...........                   
T Consensus        69 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  128 (176)
T smart00750       69 YFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-------------------  128 (176)
T ss_pred             cccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------------
Confidence            99999999765 6899999999999999999999999765443 22222222111100000                   


Q ss_pred             CCcccccCCCCCh--hHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          242 GVPLSVLMPSANK--DAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       242 ~~~~~~~~~~~~~--~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                          ......++.  ++.++|.+||..||.+|||+.++++|+|+.
T Consensus       129 ----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      129 ----RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ----cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                000012223  689999999999999999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=9.5e-29  Score=212.22  Aligned_cols=247  Identities=19%  Similarity=0.298  Sum_probs=192.9

Q ss_pred             CceEeeeecccCceEEEEEEECCC-----CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEE-eeCCEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQS-----GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI-RENDILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~   76 (337)
                      |++..-.+-+|.||.||.|.+.+.     .+.|-+|.++......+-..++.|.-.+..+.|||+..+.++. ++....+
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~  364 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF  364 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence            456666788999999999965432     3346677777666555556667899999999999999999986 4567788


Q ss_pred             EEEeecCCC-HHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           77 FVFEYMECN-LYQLMKD-------REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        77 lv~e~~~~~-l~~~~~~-------~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      +++.+++-+ +...+..       ....++..++..++.|++.|++|||+.|++|.||-..|.+|++. .|||+|=.+++
T Consensus       365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSR  444 (563)
T KOG1024|consen  365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSR  444 (563)
T ss_pred             EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhcc
Confidence            899999854 4444441       12347778888999999999999999999999999999999998 99999999998


Q ss_pred             cCCCCCCC---ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccch
Q 038835          148 EINSRPPF---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSW  223 (337)
Q Consensus       148 ~~~~~~~~---~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  223 (337)
                      ..-+....   ........|||||.+.+. .|+.++|+||||+++|||++ |+.|+..-++.|+..-+..+.        
T Consensus       445 DLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy--------  515 (563)
T KOG1024|consen  445 DLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY--------  515 (563)
T ss_pred             ccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc--------
Confidence            76543321   223345679999999765 88999999999999999998 899999888877655443321        


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                  +..+         +-.-++++..++..||..+|++||+.+|+..
T Consensus       516 ------------RlaQ---------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 ------------RLAQ---------PFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ------------eecC---------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                        1111         1245789999999999999999999999854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.2e-29  Score=240.32  Aligned_cols=261  Identities=26%  Similarity=0.339  Sum_probs=192.6

Q ss_pred             eEeeeecccCceEEEEEEECCCCcEEEEEEcccc---cCChHH--hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            5 KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKK---YYSWEE--CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ...+.+|.|++|.|+.+......+.++.|.....   ......  .....|.-+-..|.|||++.......+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3467899999998888887776766666655421   111111  11245777778889999988877766555555559


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-----C
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-----P  153 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-----~  153 (337)
                      |||++++...+.+ ...++...+..+++|++.||+|+|+.|+.|||+||+|+++..+ .+|++|||.+......     .
T Consensus       401 E~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            9999955555554 4458999999999999999999999999999999999999988 9999999988765422     2


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+|+..|+|||++.+........||||.|++++.|.+|+.||.-....+....-...      ..|.         
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~------~~~~---------  544 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY------SDQR---------  544 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc------cccc---------
Confidence            2356789999999999987755556799999999999999999999655443322100000      0000         


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                            .........+..++...+.+|.+||+.||.+|.|+++|++++||+...
T Consensus       545 ------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  545 ------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             ------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence                  000111122345678889999999999999999999999999998743

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=193.34  Aligned_cols=246  Identities=24%  Similarity=0.327  Sum_probs=192.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .+|+++++||+|+||.+|++....+|+.||||+-......   .....|.++.+.|+ ...|..+..++.+...-.+||+
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            5799999999999999999999999999999987664332   23457999999995 5788999999988899999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCC---
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRP---  153 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~---  153 (337)
                      .++-++.+.+.-+...++..++.-.+-|++.-++|+|.++++||||||+|+|..-+    .+.|+|||+|+.+.+..   
T Consensus        92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen   92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            99999988888777779999999999999999999999999999999999998654    89999999998664321   


Q ss_pred             -----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          154 -----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       154 -----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                           .-....||..|.+--+..+- .-+...|+=|+|.++.++.-|..||.+.......++........          
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK----------  240 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK----------  240 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh----------
Confidence                 12456899999988776544 45788999999999999999999999977654443333221110          


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT  273 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  273 (337)
                                  ...+......++|.++.-.+.-|-..--++-|.
T Consensus       241 ------------~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  241 ------------MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             ------------cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence                        011222333566777777777776555555553

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-26  Score=207.31  Aligned_cols=251  Identities=25%  Similarity=0.311  Sum_probs=191.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCC-cEEEEEEcccccCChHHhHHHHHHHHHhcCC----CCCcccceeEE-eeCCEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRKMS----HPNIVKLKEVI-RENDILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~   76 (337)
                      +|++.+.||+|+||.||.+.+..++ ..+|+|........... ....|..++..+.    .+++..+++.+ ..+...|
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            7999999999999999999988775 67888887764333222 4456888888885    36899999999 5778899


Q ss_pred             EEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC------cEEEeeCCCcc--
Q 038835           77 FVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD------TIKIADFGLAR--  147 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~------~~kL~Dfg~a~--  147 (337)
                      +||+.++.++.+...... ..++..++..++.|++.+|+++|+.|++||||||+|+.+...      .+.|.|||+|+  
T Consensus        98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            999999988888775544 679999999999999999999999999999999999999742      69999999998  


Q ss_pred             cCC-CC-----CC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 038835          148 EIN-SR-----PP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP  218 (337)
Q Consensus       148 ~~~-~~-----~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  218 (337)
                      ... ..     ..   .....||..|.|+.+-.+. ..+...|+||++.++.++..|..||.+........+........
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence            321 11     11   1335699999999987655 67999999999999999999999997766543333332211100


Q ss_pred             CccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..                 ..        .....+.++.++...+-..+...+|....+...
T Consensus       257 ~~-----------------~~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  257 LT-----------------DR--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             cc-----------------cc--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            00                 00        112345667777777777888999987776553

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=7.6e-28  Score=214.71  Aligned_cols=161  Identities=20%  Similarity=0.284  Sum_probs=125.5

Q ss_pred             CcCceEeeeecccCceEEEEEEECC-CCcEEEEEEcccccC----ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQ-SGEVVAIKKMKKKYY----SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   75 (337)
                      +++|.+.+.||+|+||+||+|.++. +|+.+|+|++.....    ......+.+|+++|++++|+|++..+..+   +..
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~   93 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKD   93 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCc
Confidence            4689999999999999999998876 688889998753311    11233456899999999999998533222   457


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL-KPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~di-kp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      |+||||++|+.+.....    ..   ...++.|+++||.|||++||+|||| ||+|||++.+ .+||+|||+|.......
T Consensus        94 ~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~  166 (365)
T PRK09188         94 GLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG  166 (365)
T ss_pred             EEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence            99999999876653211    11   1568899999999999999999999 9999999765 89999999998665432


Q ss_pred             C---------CccccccccccCchhhc
Q 038835          154 P---------FTEYVSTRWYRAPEVLL  171 (337)
Q Consensus       154 ~---------~~~~~gt~~~~aPE~~~  171 (337)
                      .         .....+++.|+|||.+.
T Consensus       167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        167 ALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             chhhhhhhhhhhhhhccCccCCcccCC
Confidence            1         13456788899999886

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=6e-26  Score=202.53  Aligned_cols=258  Identities=33%  Similarity=0.525  Sum_probs=202.0

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCC-CcccceeEEeeCCEEEEEEe
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHP-NIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e   80 (337)
                      |.+.+.||.|+||.||++.+.   ..+++|.+........  .....+|+.+++.+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999887   7789999987665543  44557899999999988 79999999988888899999


Q ss_pred             ecCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCC--
Q 038835           81 YMECNLYQLMKDREK---CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRP--  153 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~--  153 (337)
                      ++.++.+..+.....   .+++..+..++.|++.++.++|+.+++|||+||+||+++..  .++++|||.+.......  
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999876665554443   68999999999999999999999999999999999999976  59999999987554332  


Q ss_pred             -----CCccccccccccCchhhcCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCC-Cccc
Q 038835          154 -----PFTEYVSTRWYRAPEVLLQS--YLYSSKVDMWAMGAIMAELITLRPLFPGTSE---ADEIYKICSVIGTP-TQDS  222 (337)
Q Consensus       154 -----~~~~~~gt~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~-~~~~  222 (337)
                           ......||..|+|||.+.+.  ..++...|+|++|+++++++.|..||.....   .............+ ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 34677999999999998763  4678899999999999999999999877764   22222222221111 0000


Q ss_pred             hhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                    ..       ..........+.+++..++..+|..|.+..+...+++...
T Consensus       239 --------------~~-------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         239 --------------LS-------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             --------------cC-------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence                          00       0000112357899999999999999999999998876654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8e-27  Score=196.69  Aligned_cols=207  Identities=23%  Similarity=0.326  Sum_probs=176.1

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .|+++++||+|.||.++.+++..+++.||||.-.....   ...+..|-...+.| ..++|..++.+...+.+-.+|+|+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            59999999999999999999999999999998765432   23345788899888 689999999999888888999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC------CcEEEeeCCCcccCCCCC--
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK------DTIKIADFGLAREINSRP--  153 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~------~~~kL~Dfg~a~~~~~~~--  153 (337)
                      ++-+|.+.+--++..|+..+++.++.|++.-++++|++.+|+|||||+|+||.+      +.+.++|||+|+.+.+..  
T Consensus       106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk  185 (449)
T KOG1165|consen  106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK  185 (449)
T ss_pred             hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence            999998888888888999999999999999999999999999999999999965      278999999999875432  


Q ss_pred             ------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHH
Q 038835          154 ------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---ADEIYKICS  213 (337)
Q Consensus       154 ------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~  213 (337)
                            ...+..||..||+--.-.+. .-+...|.=|||-++++.|-|..||.|...   .+-.++|-.
T Consensus       186 qHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  186 QHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             ccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence                  23567899999998766555 558899999999999999999999988554   344444433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.7e-26  Score=197.02  Aligned_cols=193  Identities=27%  Similarity=0.355  Sum_probs=144.1

Q ss_pred             CCCCcccceeEEee---------------------------CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHH
Q 038835           58 SHPNIVKLKEVIRE---------------------------NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVF  110 (337)
Q Consensus        58 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil  110 (337)
                      +|||||++...|.+                           +..+|+||..++.++.+.+..+.  .+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence            69999999887643                           34689999999999998887654  57788888999999


Q ss_pred             HHHHHHHHcCccccCCCCCCeeee--CC---cEEEeeCCCcccCCCC-------CCCccccccccccCchhhcCcCC---
Q 038835          111 QGLAYMHQRGYFHRDLKPENLLVS--KD---TIKIADFGLAREINSR-------PPFTEYVSTRWYRAPEVLLQSYL---  175 (337)
Q Consensus       111 ~al~~LH~~~i~H~dikp~Nili~--~~---~~kL~Dfg~a~~~~~~-------~~~~~~~gt~~~~aPE~~~~~~~---  175 (337)
                      +|+.|||++|+.|||+|.+|||+.  ++   .+.++|||++-.....       +......|....||||+....+.   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999984  33   7899999987544331       11123467888999999864321   


Q ss_pred             --CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCC
Q 038835          176 --YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSAN  253 (337)
Q Consensus       176 --~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (337)
                        .-.++|.|+.|.+.||+++...||.+......  .         ..            ++.     ...++..++..+
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--~---------~r------------~Yq-----e~qLPalp~~vp  483 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--D---------TR------------TYQ-----ESQLPALPSRVP  483 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchhee--c---------hh------------hhh-----hhhCCCCcccCC
Confidence              12389999999999999999999977332110  0         00            011     112223346788


Q ss_pred             hhHHHHHHHhcCCCCCCCCCH---HHHhcC
Q 038835          254 KDAVSLIASLCSWDPSKRPTA---AEALQH  280 (337)
Q Consensus       254 ~~~~~li~~~L~~dP~~Rpt~---~ell~h  280 (337)
                      +.+++++..+|+.||.+|+++   ..+++-
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence            999999999999999999975   344543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=1.3e-25  Score=184.62  Aligned_cols=141  Identities=21%  Similarity=0.293  Sum_probs=110.8

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH-------------------------hHHHHHHHHHhcCCCCC
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE-------------------------CVNLREVKSLRKMSHPN   61 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------~~~~~e~~~l~~l~h~~   61 (337)
                      ...||+|++|.||+|.+. +|+.||+|+++........                         .....|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            578999999999999987 8999999999764321100                         11134999999998888


Q ss_pred             cccceeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCCeeeeCCcEEE
Q 038835           62 IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM-HQRGYFHRDLKPENLLVSKDTIKI  140 (337)
Q Consensus        62 iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~L-H~~~i~H~dikp~Nili~~~~~kL  140 (337)
                      +.....+....  .+|||||++|+.+........++++..+..++.|++.+|.++ |+.||+||||||+||+++.+.++|
T Consensus        81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~L  158 (190)
T cd05147          81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLYI  158 (190)
T ss_pred             CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEEE
Confidence            75544433222  389999999865543322345689999999999999999999 799999999999999999889999


Q ss_pred             eeCCCcccCC
Q 038835          141 ADFGLAREIN  150 (337)
Q Consensus       141 ~Dfg~a~~~~  150 (337)
                      +|||+|...+
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05147         159 IDVSQSVEHD  168 (190)
T ss_pred             EEccccccCC
Confidence            9999988653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=3.1e-25  Score=189.95  Aligned_cols=232  Identities=20%  Similarity=0.262  Sum_probs=148.1

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCC----------CCcccceeEEe-
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSH----------PNIVKLKEVIR-   70 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h----------~~iv~~~~~~~-   70 (337)
                      +..++.||.|+++.||.+.+.+||+.+|+|+........  ......+|.-....+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            467888999999999999999999999999886554221  22233344444444322          12333333321 


Q ss_pred             --------eC---C-----EEEEEEeecCCCHHHHHh---hccC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC
Q 038835           71 --------EN---D-----ILYFVFEYMECNLYQLMK---DREK---CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP  128 (337)
Q Consensus        71 --------~~---~-----~~~lv~e~~~~~l~~~~~---~~~~---~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp  128 (337)
                              ..   +     +.+++|+-+.+++...+.   ....   .+.......+..|++..+++||+.|++|+||+|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~  173 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP  173 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence                    11   1     236788888888766543   2221   122233345568999999999999999999999


Q ss_pred             CCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccccCchhhcCc-------CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 038835          129 ENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS-------YLYSSKVDMWAMGAIMAELITLRPLFP  200 (337)
Q Consensus       129 ~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~  200 (337)
                      +|++++.+ .+.|+||+.....+.....  ...+..|.|||.....       ..++.+.|.|+||+++|.|+||..||.
T Consensus       174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~  251 (288)
T PF14531_consen  174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG  251 (288)
T ss_dssp             GGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred             eeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence            99999987 9999999988876654322  3455789999987542       246889999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCC
Q 038835          201 GTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR  271 (337)
Q Consensus       201 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  271 (337)
                      ........             .|                    .+... ..+++.+++||+++|+.||.+|
T Consensus       252 ~~~~~~~~-------------~~--------------------~f~~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  252 LSSPEADP-------------EW--------------------DFSRC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CCGGGSTS-------------GG--------------------GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCccccc-------------cc--------------------cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence            66432110             00                    11112 2678999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-26  Score=208.99  Aligned_cols=238  Identities=27%  Similarity=0.379  Sum_probs=192.2

Q ss_pred             eecccCceEEEEEE---ECCCCcEEEEEEcccccCChHHhH-HHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEEeecC
Q 038835            9 EVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMS-HPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         9 ~ig~G~~g~v~~~~---~~~~~~~vaiK~~~~~~~~~~~~~-~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      .+|.|+||.|+++.   -...|..+|+|+.++......... ...|..++...+ ||.+++++..++.+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999998774   234577899999887654432222 235778888885 9999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccc
Q 038835           84 CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTR  162 (337)
Q Consensus        84 ~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~  162 (337)
                      |+.+-........+++...+.+...++.|++++|+.+++|||+|++||+++.+ .+++.|||.++..-...   ..|||.
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---~~cgt~  157 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---IACGTY  157 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh---hcccch
Confidence            86544444445558999999999999999999999999999999999999986 79999999998765443   239999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      -|||||++.   .....+|.||+|+++++|++|..||.+    +....|....                           
T Consensus       158 eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~---------------------------  203 (612)
T KOG0603|consen  158 EYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE---------------------------  203 (612)
T ss_pred             hhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc---------------------------
Confidence            999999986   347789999999999999999999988    4444443310                           


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCcccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRVA  286 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~  286 (337)
                         ..++...+..+++++..++..+|..|.     -+.|+++|+||+..
T Consensus       204 ---~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  204 ---LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             ---cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence               112246678899999999999999997     45899999999863

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=8.6e-25  Score=181.93  Aligned_cols=171  Identities=17%  Similarity=0.130  Sum_probs=131.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHh--H------HHHHHHHHhcCCCCCcccceeEEeeC-
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEEC--V------NLREVKSLRKMSHPNIVKLKEVIREN-   72 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~--~------~~~e~~~l~~l~h~~iv~~~~~~~~~-   72 (337)
                      .+|++++.+|.|+||.||++..  ++..+|+|++..........  .      ..+|++.+.++.|++|..+.+++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            4899999999999999999755  46689999997654433221  1      35799999999999999999886543 


Q ss_pred             -------CEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCC
Q 038835           73 -------DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGL  145 (337)
Q Consensus        73 -------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~  145 (337)
                             +..+++|||++|..+..+..    +++.    ...+++.+|..||+.|++|||++|+||+++.+.++|+|||.
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg~  180 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLSG  180 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECCC
Confidence                   35799999999976655422    3432    45699999999999999999999999999877799999998


Q ss_pred             cccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh
Q 038835          146 AREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT  194 (337)
Q Consensus       146 a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  194 (337)
                      +........            -+.+.-...++.++|+|+||+++..+..
T Consensus       181 ~~~~~e~~a------------~d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        181 KRCTAQRKA------------KDRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             cccccchhh------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence            876532211            1112222356789999999999877654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=8.2e-26  Score=215.74  Aligned_cols=245  Identities=27%  Similarity=0.404  Sum_probs=180.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH---hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE---CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +|...+.||++.|=+|.+|++.+ |. |++|++-+.......   .+.+.|++ ...+++||++.+.-+...+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            46778999999999999998764 44 889988765433222   22245666 66779999999998888888889999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-CcEEEeeCCCcccC--CCCC--C
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREI--NSRP--P  154 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-~~~kL~Dfg~a~~~--~~~~--~  154 (337)
                      +|+..+|.+++.-+ +.+..-+.+.++.||+.||.-||+.||+|||||.+||||++ |=+.|+||..-+..  ..++  .
T Consensus       101 qyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99999999988654 55889999999999999999999999999999999999988 57899999865422  1111  1


Q ss_pred             C----ccccccccccCchhhcCc----------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 038835          155 F----TEYVSTRWYRAPEVLLQS----------YLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPT  219 (337)
Q Consensus       155 ~----~~~~gt~~~~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~  219 (337)
                      +    .+...-.+|.|||-+...          ...+++-||||+||+++||++ |+|||.-       .+....-... 
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~~-  251 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSGN-  251 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhccC-
Confidence            1    222334579999998641          125778999999999999988 7999941       1111110000 


Q ss_pred             ccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...   .    ..              ....-.+..++.+|..|++.||.+|.+|++.|+-
T Consensus       252 ~~~---~----e~--------------~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADD---P----EQ--------------LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccC---H----HH--------------HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            000   0    00              0001223578999999999999999999999986

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=9.6e-25  Score=208.13  Aligned_cols=218  Identities=30%  Similarity=0.428  Sum_probs=165.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|..++.|..|+||.||.+.|+.+.+.+|+| ++++..-      ++  +++..-.+|.+|                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li------lR--nilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI------LR--NILTFAGNPFVV------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh------hh--ccccccCCccee------------------
Confidence            46889999999999999999999999999994 4433110      11  022223444444                  


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-CcEEEeeCCCcccCCCC--------
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSR--------  152 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-~~~kL~Dfg~a~~~~~~--------  152 (337)
                        |+....+..- ++++...        +.|++|||+.||+|||+||+|.+|.. +.+|++|||++......        
T Consensus       136 --gDc~tllk~~-g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 --GDCATLLKNI-GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             --chhhhhcccC-CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence              4444444332 3355433        88999999999999999999999986 59999999998643110        


Q ss_pred             -------CC-CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchh
Q 038835          153 -------PP-FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       153 -------~~-~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  224 (337)
                             .. -...+|||.|.|||++... .|+..+|.|++|+|+|+.+-|+.||.+.+.++.+........        
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i--------  275 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI--------  275 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc--------
Confidence                   01 1345899999999998755 789999999999999999999999999999988877665321        


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcCcCccc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP---TAAEALQHPFSRV  285 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~  285 (337)
                                 .|++        -....+++++++|..+|+.+|..|.   .+-++.+|+||+.
T Consensus       276 -----------~wpE--------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  276 -----------EWPE--------EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             -----------cccc--------cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence                       1221        1245789999999999999999995   6788889999985

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=9.6e-24  Score=174.13  Aligned_cols=142  Identities=20%  Similarity=0.247  Sum_probs=112.2

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-------------------------HhHHHHHHHHHhcCCCC
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-------------------------ECVNLREVKSLRKMSHP   60 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------------------------~~~~~~e~~~l~~l~h~   60 (337)
                      +.+.||+|++|.||+|.+. +|+.||+|+++.......                         .....+|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999876532100                         11124688999999999


Q ss_pred             CcccceeEEeeCCEEEEEEeecCCCH-HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCCcE
Q 038835           61 NIVKLKEVIRENDILYFVFEYMECNL-YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKDTI  138 (337)
Q Consensus        61 ~iv~~~~~~~~~~~~~lv~e~~~~~l-~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~~~  138 (337)
                      ++.....+....  .++||||++|+. ...... ...+++..+..++.|++.++.++|+ .|++||||||+||+++.+.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCCE
Confidence            886655554333  389999999863 333233 3457889999999999999999999 99999999999999996799


Q ss_pred             EEeeCCCcccCCC
Q 038835          139 KIADFGLAREINS  151 (337)
Q Consensus       139 kL~Dfg~a~~~~~  151 (337)
                      +|+|||+|...+.
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.7e-22  Score=162.73  Aligned_cols=187  Identities=19%  Similarity=0.140  Sum_probs=137.6

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH---HhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEE
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---ECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ..+...|++|+||+|+.+..  .+..++.+.+.....-..   ...+.+|+++|++|. ++++++++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45678999999999997754  577788776655433111   123468999999995 5889999886    3468999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCCeeeeCC-cEEEeeCCCcccCCCCCCC--
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL-KPENLLVSKD-TIKIADFGLAREINSRPPF--  155 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~di-kp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--  155 (337)
                      ||+.|..+.....      .. ...++.|++.+|+++|++||+|||| ||+|||++.+ .++|+|||+|.........  
T Consensus        78 eyI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            9999976643321      11 2357889999999999999999999 7999999865 8999999999866544321  


Q ss_pred             --c----------cccccccccCchhhcCcCCCC-CcchHHHHHHHHHHHHhCCCCCCCCC
Q 038835          156 --T----------EYVSTRWYRAPEVLLQSYLYS-SKVDMWAMGAIMAELITLRPLFPGTS  203 (337)
Q Consensus       156 --~----------~~~gt~~~~aPE~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~  203 (337)
                        .          -...++.+++|+.-.--...+ ...+.++.|+-+|.++|+..|+.+.+
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence              0          112577788887643221223 45688899999999999998876554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2e-22  Score=195.39  Aligned_cols=189  Identities=21%  Similarity=0.346  Sum_probs=151.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC---CCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS---HPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|.|-+.||+|+||.||+|.+.. |+.||+|+-+....-+--.    =.+++.+|+   -+.|..+...+...+..++|
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI----~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI----CLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee----hHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            478999999999999999999876 9999999876653321111    113344444   35567777766667778899


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--------cEEEeeCCCcccCC
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--------TIKIADFGLAREIN  150 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--------~~kL~Dfg~a~~~~  150 (337)
                      +||.+.|++-.+.+..+.+++..+..+..|++..|++||..+|||+||||+|+||...        .++|+|||.|....
T Consensus       773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            9999965444444466779999999999999999999999999999999999999532        79999999998664


Q ss_pred             ---CCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCC
Q 038835          151 ---SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLR  196 (337)
Q Consensus       151 ---~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  196 (337)
                         +...+...++|-.+-.+|...+. .|+..+|.|.++-+++.||+|+
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence               33455677899999999987665 8999999999999999999987

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.88  E-value=2.1e-23  Score=186.54  Aligned_cols=174  Identities=30%  Similarity=0.446  Sum_probs=127.6

Q ss_pred             EEEEEEeecCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           74 ILYFVFEYMECNLYQLMKDRE---KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~---~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      ++||.|++|.-+.+...+.+.   ...+....+.++.|+..|++|   ++.+|+|+||.||+...+ .+||+|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            467888888866665555432   235677889999999999999   999999999999999877 7999999999877


Q ss_pred             CCCC-------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          150 NSRP-------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       150 ~~~~-------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      ....       ..+..+||.+||+||.+.++ .|+.++|||+||.+++|++.- ..+|   .....+..+..+       
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g-------  475 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDG-------  475 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcC-------
Confidence            6555       45678999999999999876 789999999999999999971 1111   111111111110       


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                                    .+|..       + ..--++-.+|+..||.+.|.+||++.+.-.|+|.
T Consensus       476 --------------~ip~~-------~-~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 --------------IIPPE-------F-LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             --------------CCChH-------H-hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                          11100       0 0112445689999999999999988887777764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.4e-22  Score=164.67  Aligned_cols=240  Identities=19%  Similarity=0.275  Sum_probs=182.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH-hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE-CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ...++.+|.+...|..|++++.  |..+++|++.-....... ..+..|.-.|+-+.||||+.+++.+....++.++..|
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            3456677889999999999876  556778888654433322 2234688888999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeCC---cEEEeeCCCcccCCCCCC
Q 038835           82 MECNLY-QLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSKD---TIKIADFGLAREINSRPP  154 (337)
Q Consensus        82 ~~~~l~-~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~~---~~kL~Dfg~a~~~~~~~~  154 (337)
                      |+.+++ ..+... +-.++..++.+++.+++.|++|||+..  |.---++...++||++   .+..+|--++.+..+   
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~g---  345 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVG---  345 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeeccc---
Confidence            996555 444432 234678899999999999999999875  3344588889999987   555667666665432   


Q ss_pred             CccccccccccCchhhcCcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYL--YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                         ..-+|.|++||.+...+.  .-.++|+|||+++++||.+...||.+.++.+.-.++.-.                  
T Consensus       346 ---r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale------------------  404 (448)
T KOG0195|consen  346 ---RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE------------------  404 (448)
T ss_pred             ---cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc------------------
Confidence               345788999999875433  234799999999999999999999998887765554321                  


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL  278 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  278 (337)
                                .....++|+++.....|+.-|+..||.+||..+.+.
T Consensus       405 ----------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  405 ----------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ----------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                      011234578899999999999999999999877653

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=9.7e-22  Score=167.06  Aligned_cols=145  Identities=17%  Similarity=0.216  Sum_probs=110.5

Q ss_pred             ceEeeeecccCceEEEEEE-ECCCCcEEEEEEcccccCCh-----------------------HHhHHHHHHHHHhcCCC
Q 038835            4 YKLIKEVGDGTFGSVWRAI-SKQSGEVVAIKKMKKKYYSW-----------------------EECVNLREVKSLRKMSH   59 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~-~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h   59 (337)
                      |.+.+.||+|++|.||+|. +..+|+.||+|++.......                       ......+|+..++++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7788999999999999998 77789999999987542110                       01123479999999965


Q ss_pred             CCcccceeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCCeeeeCCcE
Q 038835           60 PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG-YFHRDLKPENLLVSKDTI  138 (337)
Q Consensus        60 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~-i~H~dikp~Nili~~~~~  138 (337)
                      .+ +.+..++... ..++||||++|+.+.........+....+..++.|++.+|.+||+.| ++||||||+||+++.+.+
T Consensus       110 ~~-i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~i  187 (237)
T smart00090      110 AG-VPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDGKV  187 (237)
T ss_pred             cC-CCCCeeeEec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCCE
Confidence            33 2222222222 34899999999765444333344677778899999999999999999 999999999999996699


Q ss_pred             EEeeCCCcccCC
Q 038835          139 KIADFGLAREIN  150 (337)
Q Consensus       139 kL~Dfg~a~~~~  150 (337)
                      +|+|||.|...+
T Consensus       188 ~LiDFg~a~~~~  199 (237)
T smart00090      188 VIIDVSQSVELD  199 (237)
T ss_pred             EEEEChhhhccC
Confidence            999999887543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=5.3e-21  Score=158.74  Aligned_cols=137  Identities=13%  Similarity=0.142  Sum_probs=104.5

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-----CCCCcccceeEEeeCC---E-
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-----SHPNIVKLKEVIREND---I-   74 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-   74 (337)
                      +.-.+.||+|++|.||.  ++.++.. +||++...... ......+|+..++.+     +||||++++++++++.   . 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            34467899999999995  7777766 69988764332 234557899999999     5799999999998763   3 


Q ss_pred             EEEEEeecC--CCHHHHHhhccCCCCHHHHHHHHHHHHHHH-HHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCc
Q 038835           75 LYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGL-AYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLA  146 (337)
Q Consensus        75 ~~lv~e~~~--~~l~~~~~~~~~~l~~~~~~~~~~qil~al-~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a  146 (337)
                      +.+|+||.+  ++.+..+.++. .+++.  ..++.|++.++ +|||+++|+||||||+||++++.     .++|+||+.+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            347899954  54554444443 36666  46788888888 89999999999999999999742     7999995544


Q ss_pred             c
Q 038835          147 R  147 (337)
Q Consensus       147 ~  147 (337)
                      .
T Consensus       157 ~  157 (210)
T PRK10345        157 S  157 (210)
T ss_pred             c
Confidence            3

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=8e-20  Score=153.55  Aligned_cols=136  Identities=20%  Similarity=0.230  Sum_probs=111.2

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChH-------HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-------ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +.||+|++|.||+|.+  +|..+++|+.........       .....+|+.++..+.|+++.....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999976  677899998664332211       1233579999999999999888888777788899999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccC
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREI  149 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~  149 (337)
                      |++|..+..+.....   . ....++.+++.+|.++|+.|++|+|++|.||+++.+.++|+|||.+...
T Consensus        80 ~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~~  144 (211)
T PRK14879         80 YIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEFS  144 (211)
T ss_pred             EeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccCC
Confidence            999876655554332   2 7889999999999999999999999999999999779999999988764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.2e-21  Score=186.07  Aligned_cols=259  Identities=24%  Similarity=0.309  Sum_probs=201.2

Q ss_pred             cCceEeeeecccCceEEEEEEECC-CCcEEEEEEcccccC-ChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-SGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ..|.+.+.||+|+++.|-.+.... +...+|.|.+..... .........|..+-+.+. |+|++..++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            468899999999999998887643 344567776655431 112222235778888886 99999999999999999999


Q ss_pred             EeecCCCHHHHHh-hccC-CCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCC-C
Q 038835           79 FEYMECNLYQLMK-DREK-CFSEAEVRNWCFQVFQGLAYMH-QRGYFHRDLKPENLLVSKD--TIKIADFGLAREINS-R  152 (337)
Q Consensus        79 ~e~~~~~l~~~~~-~~~~-~l~~~~~~~~~~qil~al~~LH-~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~-~  152 (337)
                      ++|..|+.+.... ..+. ..+......++.|+..++.|+| ..++.|+|+||+|.+++..  .+++.|||+|..... .
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            9998876544433 3333 5788899999999999999999 9999999999999999864  699999999987755 2


Q ss_pred             ---CCCccccc-cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          153 ---PPFTEYVS-TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       153 ---~~~~~~~g-t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                         ......+| ++.|+|||...+.....+..|+||+|+++.-+++|..|+......+...                   
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------------------  240 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------------------  240 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-------------------
Confidence               22344678 9999999998875567889999999999999999999996654432100                   


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                            ..+.+.........|..++..+.+++.+++..+|..|.+.+++-.+||+..
T Consensus       241 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 ------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ------eeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                  011111122233456788899999999999999999999999999999986

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=5.1e-19  Score=147.26  Aligned_cols=133  Identities=19%  Similarity=0.231  Sum_probs=104.4

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccCCh-------HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            9 EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-------EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .||+|++|.||++..  +|..+++|.........       ......+|+++++.+.++++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999974  57889999865432211       113335799999999988876666666666777899999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCC
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREIN  150 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~  150 (337)
                      ++|..+.........       .++.|++.+|.+||+.|++|+|++|.||+++.+.++++|||.+....
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKYSD  140 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcCCC
Confidence            998766555433211       78999999999999999999999999999997799999999887643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=3.5e-19  Score=162.23  Aligned_cols=207  Identities=20%  Similarity=0.316  Sum_probs=151.4

Q ss_pred             HhcCCCCCcccceeEEeeCCEEEEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCc-cccCCCCCCe
Q 038835           54 LRKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY-FHRDLKPENL  131 (337)
Q Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i-~H~dikp~Ni  131 (337)
                      |+.+.|.|+.++++...++...++|.+||..+ +.+.+......++.-....+++.|+.||.|+|+-.| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999965 455555546678888999999999999999998866 9999999999


Q ss_pred             eeeCC-cEEEeeCCCcccCCCC---CCCccccccccccCchhhcCcCC------CCCcchHHHHHHHHHHHHhCCCCCCC
Q 038835          132 LVSKD-TIKIADFGLAREINSR---PPFTEYVSTRWYRAPEVLLQSYL------YSSKVDMWAMGAIMAELITLRPLFPG  201 (337)
Q Consensus       132 li~~~-~~kL~Dfg~a~~~~~~---~~~~~~~gt~~~~aPE~~~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~  201 (337)
                      +++.. .+||+|||+.......   .......-...|.|||.+.+...      .+.+.||||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            99999 9999999988766421   11122234456999999876311      36679999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          202 TSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       202 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ........++...+...                  ......+.... .....+++..+++.||..+|.+||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~------------------~~~~~rP~i~~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKG------------------GSNPFRPSIEL-LNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhc------------------CCCCcCcchhh-hhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            43322212222211110                  00000000000 0144568999999999999999999998854

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=4.8e-19  Score=147.23  Aligned_cols=137  Identities=20%  Similarity=0.240  Sum_probs=104.9

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh---------------------HHhHHHHHHHHHhcCCCCC-
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW---------------------EECVNLREVKSLRKMSHPN-   61 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---------------------~~~~~~~e~~~l~~l~h~~-   61 (337)
                      |.+.+.||.|++|.||++... +|+.+|+|++.......                     ......+|...+..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 79999999876432110                     0112346888888887774 


Q ss_pred             -cccceeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEE
Q 038835           62 -IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIK  139 (337)
Q Consensus        62 -iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~k  139 (337)
                       +...++    ....++||||++|..+..+..      ......++.+++.++.++|+.|++||||+|+||+++.+ .++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             333333    234589999999976654432      13456788999999999999999999999999999865 899


Q ss_pred             EeeCCCcccCCC
Q 038835          140 IADFGLAREINS  151 (337)
Q Consensus       140 L~Dfg~a~~~~~  151 (337)
                      |+|||.+.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2.6e-18  Score=163.63  Aligned_cols=136  Identities=18%  Similarity=0.173  Sum_probs=106.3

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-------hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-------WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      |...+.||+|+||.||++....  ..+++|+.......       .......+|+++++.++|++++....+.......+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            4567889999999999997653  34444433221111       11233468999999999999988877777777789


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREI  149 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~  149 (337)
                      +||||++|+.+.....        ....++.|++.+|.+||+.|++||||||+|||++.+.++|+|||++...
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCcccccC
Confidence            9999999876655443        3567899999999999999999999999999997779999999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=4.3e-18  Score=140.21  Aligned_cols=135  Identities=21%  Similarity=0.317  Sum_probs=97.9

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhH-----------------------HHHHHHHHhcCCCCC-
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-----------------------NLREVKSLRKMSHPN-   61 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~-----------------------~~~e~~~l~~l~h~~-   61 (337)
                      +++.||+|++|.||+|.+. +|+.||+|++...........                       ...|...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999887 799999999875432211100                       024555555554332 


Q ss_pred             -cccceeEEeeCCEEEEEEeecCCC-----HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeee
Q 038835           62 -IVKLKEVIRENDILYFVFEYMECN-----LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVS  134 (337)
Q Consensus        62 -iv~~~~~~~~~~~~~lv~e~~~~~-----l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~  134 (337)
                       +.++++.    ...++||||++++     .+....     . ...++.++.+++.++.++|+ .|++|+||||+||+++
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence             3444433    2358999999983     222221     1 16788999999999999999 9999999999999999


Q ss_pred             CCcEEEeeCCCcccCCC
Q 038835          135 KDTIKIADFGLAREINS  151 (337)
Q Consensus       135 ~~~~kL~Dfg~a~~~~~  151 (337)
                      .+.++|+|||.+.....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            66999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.7e-16  Score=135.27  Aligned_cols=135  Identities=18%  Similarity=0.233  Sum_probs=98.8

Q ss_pred             eeec-ccCceEEEEEEECCCCcEEEEEEcccccC------------ChHHhHHHHHHHHHhcCCCCCc--ccceeEEeeC
Q 038835            8 KEVG-DGTFGSVWRAISKQSGEVVAIKKMKKKYY------------SWEECVNLREVKSLRKMSHPNI--VKLKEVIREN   72 (337)
Q Consensus         8 ~~ig-~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~   72 (337)
                      ..|| .|+.|+||.+...  +..+++|.+.....            ........+|+.++..|.|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7888888888653  77899998754211            1122344689999999988875  6666664332


Q ss_pred             -C---EEEEEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           73 -D---ILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        73 -~---~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                       .   ..++|||+++| ..+..+.... .+++..    +.||+.+|.+||++||+||||||.|||++.+ .++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             2   23599999997 4554444433 356543    5789999999999999999999999999875 8999999987


Q ss_pred             ccC
Q 038835          147 REI  149 (337)
Q Consensus       147 ~~~  149 (337)
                      ...
T Consensus       190 ~~~  192 (239)
T PRK01723        190 ELR  192 (239)
T ss_pred             ccC
Confidence            753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=5e-17  Score=128.70  Aligned_cols=132  Identities=25%  Similarity=0.246  Sum_probs=109.2

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCC--CCcccceeEEeeCCEEEEEEeecC
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH--PNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      +++.||.|.++.||++...  +..+++|.......   .....+|+..++.+.+  .++++++......+..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            5678999999999999875  36799999866533   2345689999999976  588999988888788999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCCeeeeC-CcEEEeeCCCcccC
Q 038835           84 CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR---GYFHRDLKPENLLVSK-DTIKIADFGLAREI  149 (337)
Q Consensus        84 ~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~---~i~H~dikp~Nili~~-~~~kL~Dfg~a~~~  149 (337)
                      |..+..+       +......++.+++.+|+.+|..   +++|+|++|+||+++. +.+++.|||.+...
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            8655433       5566778899999999999985   7999999999999998 59999999987643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=7.9e-17  Score=147.12  Aligned_cols=250  Identities=24%  Similarity=0.280  Sum_probs=196.2

Q ss_pred             CceEeeeecc--cCceEEEEEEE--CCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEE
Q 038835            3 RYKLIKEVGD--GTFGSVWRAIS--KQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKM-SHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         3 ~y~~~~~ig~--G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   76 (337)
                      .+.+...+|.  |.+|.||.+..  ..++..+|+|.-+...... ......+|+...+.+ .|+|.++.+..++..+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3456677899  99999999988  8899999999855443321 222235788888888 5899999999999999999


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHH----HHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQ----GLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREIN  150 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~----al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~  150 (337)
                      +-+|+++..+..........+++..++..+.+..+    ||.++|+.+++|-|+||+||+...+  ..+++|||.....+
T Consensus       195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~  274 (524)
T KOG0601|consen  195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS  274 (524)
T ss_pred             eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence            99999998888888887777999999999999999    9999999999999999999999877  78999999988776


Q ss_pred             CCCCC------ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCccch
Q 038835          151 SRPPF------TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGT-SEADEIYKICSVIGTPTQDSW  223 (337)
Q Consensus       151 ~~~~~------~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~  223 (337)
                      +....      ...-|...|++||+..+  .++..+||+++|.++.+..+|..++... +.                 .|
T Consensus       275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----------------~W  335 (524)
T KOG0601|consen  275 DGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNS-----------------SW  335 (524)
T ss_pred             CCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCC-----------------Cc
Confidence            65421      11256778999998743  5799999999999999999987555332 11                 01


Q ss_pred             hhhhhhHHhhhccCCCCCC-CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          224 ADGLLLARAINYKFPQLVG-VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ..              ... ....++....+.++...+..|++.+|..|+++..+++|++...
T Consensus       336 ~~--------------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  336 SQ--------------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             cc--------------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            10              000 0011222355677777999999999999999999999999774

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.60  E-value=1.6e-14  Score=117.89  Aligned_cols=140  Identities=16%  Similarity=0.157  Sum_probs=102.3

Q ss_pred             eeeecccCceEEEEEEECC------CCcEEEEEEcccccC---------------------ChHHhHH----HHHHHHHh
Q 038835            7 IKEVGDGTFGSVWRAISKQ------SGEVVAIKKMKKKYY---------------------SWEECVN----LREVKSLR   55 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~---------------------~~~~~~~----~~e~~~l~   55 (337)
                      ...||.|--+.||.|....      .+..+|+|+.+....                     .......    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4689999999999997543      357899998742110                     0011111    37999999


Q ss_pred             cCCC--CCcccceeEEeeCCEEEEEEeecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCCe
Q 038835           56 KMSH--PNIVKLKEVIRENDILYFVFEYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYM-HQRGYFHRDLKPENL  131 (337)
Q Consensus        56 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~L-H~~~i~H~dikp~Ni  131 (337)
                      ++..  -++.+++++    ..-+|||||++++.+ ....+ ...+++.....+..+++.+|..+ |+.|++|+||++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            9854  445556654    344799999987422 21122 22356677788899999999999 899999999999999


Q ss_pred             eeeCCcEEEeeCCCcccCCC
Q 038835          132 LVSKDTIKIADFGLAREINS  151 (337)
Q Consensus       132 li~~~~~kL~Dfg~a~~~~~  151 (337)
                      +++.+.+.|+|||.|...+.
T Consensus       157 L~~~~~v~iIDF~qav~~~h  176 (197)
T cd05146         157 LWHDGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEECCcEEEEECCCceeCCC
Confidence            99988999999998887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.58  E-value=3.6e-14  Score=131.22  Aligned_cols=182  Identities=21%  Similarity=0.325  Sum_probs=133.8

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      |++ ....-+..+....|..+.++.+|.+........ .......+-++.|+.++||||+++++.++..+..|||+|.+.
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~   92 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR   92 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc
Confidence            444 334444444333577788999999988876544 222334567889999999999999999999999999999885


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-Cccccc
Q 038835           84 CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH-QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTEYVS  160 (337)
Q Consensus        84 ~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH-~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-~~~~~g  160 (337)
                      - +-..+.+    ++...+..-++||+.||.||| +.+++|++|.-+.|+++.. ..||++|..+........ .....-
T Consensus        93 P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~  167 (690)
T KOG1243|consen   93 P-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYL  167 (690)
T ss_pred             c-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchh
Confidence            2 2223333    347778888999999999997 6789999999999999976 999999998765543321 111222


Q ss_pred             cccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC
Q 038835          161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL  195 (337)
Q Consensus       161 t~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  195 (337)
                      --.|..|+.+...   +...|.|.|||++++++.|
T Consensus       168 ~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  168 IESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            2346777755322   3567999999999999998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.55  E-value=1.6e-15  Score=145.80  Aligned_cols=256  Identities=24%  Similarity=0.273  Sum_probs=183.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +.+.+.+-+.+|+++.++.+.-..+|...++|+......-..  ......+-+++-...+|.++....-+.-....++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            456677788899999999998777786666665543211100  001111222222234466665555555567789999


Q ss_pred             eecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC------
Q 038835           80 EYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS------  151 (337)
Q Consensus        80 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~------  151 (337)
                      +|++++ +...+.+ .++.+++-.+.+...+..++++||...+.|+|++|.|+++..+ ..+++||+.....+-      
T Consensus       884 ~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             HHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            999874 4444444 3457777888888899999999999999999999999999776 888888873221100      


Q ss_pred             ------------------------C--CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 038835          152 ------------------------R--PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA  205 (337)
Q Consensus       152 ------------------------~--~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  205 (337)
                                              .  .......||+.|.+||...+. .-+..+|.|+.|+++++.++|.+||......
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence                                    0  001235789999999998776 5688899999999999999999999998887


Q ss_pred             HHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH---HHhcCcC
Q 038835          206 DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA---EALQHPF  282 (337)
Q Consensus       206 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~---ell~hp~  282 (337)
                      ...+.|.+..                           .+++.-....+.++++++..+|..+|.+|..+.   ++-.|||
T Consensus      1042 ~~f~ni~~~~---------------------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1042 QIFENILNRD---------------------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred             hhhhccccCC---------------------------CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence            7765554431                           122222346788999999999999999999887   8899999


Q ss_pred             cccc
Q 038835          283 SRVA  286 (337)
Q Consensus       283 ~~~~  286 (337)
                      |+..
T Consensus      1095 ~~~~ 1098 (1205)
T KOG0606|consen 1095 FQDV 1098 (1205)
T ss_pred             cCCC
Confidence            9863

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=2.8e-15  Score=137.09  Aligned_cols=246  Identities=24%  Similarity=0.324  Sum_probs=183.5

Q ss_pred             CceEeeeecccCceEEEEEEEC-CCCcEEEEEEcccccCChHHhH-HHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISK-QSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKM-SHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~-~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +|..+..||.|.|+.|+.+... .++..|++|.+.+......... .+.|+.+...+ .|.+++.+...+......|+--
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            5778899999999999987654 6788899998877655543322 25677777777 6899999988888888888999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ||++++...........+.+...++...|++.++.++|++.++|+|++|+||++..+  ..+++|||.++...-.  ...
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~~  423 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SGV  423 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--ccc
Confidence            999887665554444457889999999999999999999999999999999999883  7899999988753211  122


Q ss_pred             ccccccccC-chhhcCcCCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          158 YVSTRWYRA-PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF-PGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       158 ~~gt~~~~a-PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ..+..++.| +|++.....+..+.|++|||..+.+.++|.+.- .+...    ..+..                     .
T Consensus       424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----~~i~~---------------------~  478 (524)
T KOG0601|consen  424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----LTIRS---------------------G  478 (524)
T ss_pred             ccccccccccchhhccccccccccccccccccccccccCcccCcccccc----eeeec---------------------c
Confidence            344445553 666666667888999999999999999986432 21111    00000                     0


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                      .++         ..+..+.++..+...+...++..||.+.++..|+=|.
T Consensus       479 ~~p---------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  479 DTP---------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ccc---------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            011         1134457788999999999999999999998886543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.53  E-value=5.6e-14  Score=113.72  Aligned_cols=128  Identities=15%  Similarity=0.114  Sum_probs=95.3

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc-ccceeEEeeCCEEEEEEeecCCC
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI-VKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      ++.|+.|.++.||++...  |..+++|........  .....+|+..++.+...++ .+++....  +..++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence            567899999999999764  778999998654321  1223578899988865554 44554432  3347999999996


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCc-----cccCCCCCCeeeeCCcEEEeeCCCccc
Q 038835           86 LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY-----FHRDLKPENLLVSKDTIKIADFGLARE  148 (337)
Q Consensus        86 l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i-----~H~dikp~Nili~~~~~kL~Dfg~a~~  148 (337)
                      .+...        .......+.+++.+|+.||+.++     +|+|++|.||+++.+.++++||+.+..
T Consensus        77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEecccccC
Confidence            55432        01123457899999999999985     999999999999977999999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.50  E-value=2.1e-14  Score=134.29  Aligned_cols=141  Identities=23%  Similarity=0.340  Sum_probs=94.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC---------------------------------hHHhHH--
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS---------------------------------WEECVN--   47 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------------------------~~~~~~--   47 (337)
                      .|+. +.||+|++|.||+|..+.+|+.||||+.+.....                                 +-....  
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4565 7899999999999999988999999999754210                                 000111  


Q ss_pred             ----HHHHHHHhcC----CCCCcccceeEEe-eCCEEEEEEeecCCCHHHHH---hhccC---CCCHHHHHHHHHHHHHH
Q 038835           48 ----LREVKSLRKM----SHPNIVKLKEVIR-ENDILYFVFEYMECNLYQLM---KDREK---CFSEAEVRNWCFQVFQG  112 (337)
Q Consensus        48 ----~~e~~~l~~l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~l~~~~---~~~~~---~l~~~~~~~~~~qil~a  112 (337)
                          .+|+..+.++    .+.+.+.+-.++. -.+..++||||++|..++.+   ...+.   .+.+..+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence                2344444443    2333344444432 24556899999999665443   22221   245555666666665  


Q ss_pred             HHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccCCC
Q 038835          113 LAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINS  151 (337)
Q Consensus       113 l~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~~~  151 (337)
                           ..|++|+|++|.||+++.+     .+++.|||++...+.
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 5899999999999999864     799999999987754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=1.8e-13  Score=126.50  Aligned_cols=139  Identities=21%  Similarity=0.274  Sum_probs=92.1

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChH---------------------------------------HhHHH
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---------------------------------------ECVNL   48 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------------~~~~~   48 (337)
                      +.||.|++|.||+|+.+ +|+.||||+.+......-                                       +..+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            56999999999999865 799999999865321100                                       00112


Q ss_pred             HHHHHHhcC----C-CCCcccceeEEeeCCEEEEEEeecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHH-HHHHHHHcCc
Q 038835           49 REVKSLRKM----S-HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQ-GLAYMHQRGY  121 (337)
Q Consensus        49 ~e~~~l~~l----~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~-al~~LH~~~i  121 (337)
                      +|+..+.++    . ++++.-..-+.+..+..++||||++|..+..+... ....+   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            355555554    2 23332222222334556899999998765544321 11122   3345555555 4788999999


Q ss_pred             cccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835          122 FHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus       122 ~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      +|+|++|.||+++.+ .++|+|||++...+
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999766 89999999987764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=1.7e-13  Score=116.63  Aligned_cols=200  Identities=19%  Similarity=0.273  Sum_probs=135.8

Q ss_pred             HHHHhcCCCCCcccceeEEeeC-----CEEEEEEeecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHcC-
Q 038835           51 VKSLRKMSHPNIVKLKEVIREN-----DILYFVFEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQRG-  120 (337)
Q Consensus        51 ~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~~-  120 (337)
                      ...+-++.|.|+++++.++.+.     ....+++|||..+.+..+.+    ....+....-++|+-||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3455566899999999998644     45789999999765544432    3445788888999999999999999884 


Q ss_pred             -ccccCCCCCCeeeeCCcEEEeeCC-CcccC-----CCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHH
Q 038835          121 -YFHRDLKPENLLVSKDTIKIADFG-LAREI-----NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELI  193 (337)
Q Consensus       121 -i~H~dikp~Nili~~~~~kL~Dfg-~a~~~-----~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll  193 (337)
                       |+|+++..+.|++..+.+.-+|-+ .....     ..........+.++|.+||.=... ..+.++|||++|+.+.+|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHH
Confidence             999999999999997744333332 11110     000111234567889999953322 3467899999999999999


Q ss_pred             hCCCC-CCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCC-hhHHHHHHHhcCCCCCCC
Q 038835          194 TLRPL-FPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSAN-KDAVSLIASLCSWDPSKR  271 (337)
Q Consensus       194 ~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dP~~R  271 (337)
                      -|..- =.+....+.-..+.+...                                  ..+ .--+++|.+||+-.|..|
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~----------------------------------~len~lqr~~i~kcl~~eP~~r  322 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVII----------------------------------GLENGLQRGSITKCLEGEPNGR  322 (458)
T ss_pred             HheeccCCCcceeehhhhhhhhee----------------------------------eccCccccCcCcccccCCCCCC
Confidence            87633 222222222222211100                                  011 123579999999999999


Q ss_pred             CCHHHHhcCcCccc
Q 038835          272 PTAAEALQHPFSRV  285 (337)
Q Consensus       272 pt~~ell~hp~~~~  285 (337)
                      |++.+++.||..-+
T Consensus       323 p~ar~llfHpllfe  336 (458)
T KOG1266|consen  323 PDARLLLFHPLLFE  336 (458)
T ss_pred             cchhhhhcCceeee
Confidence            99999999998543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=1.9e-12  Score=102.38  Aligned_cols=133  Identities=22%  Similarity=0.206  Sum_probs=101.2

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccC-ChHH------hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEE------CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ..+++|+-+.++.+...  |..+++|.=.+..+ ..+.      ....+|+.++..+.--.|....=+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35789999999999664  55566764333222 2211      122579999999877677766666667777789999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccC
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREI  149 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~  149 (337)
                      |.+|.++.......       ...+++.+=.-+.-||+.||+|+|+.++||+++.+.+.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCccccc
Confidence            99999887665543       245777788888999999999999999999999999999999998753

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.42  E-value=3.8e-12  Score=100.25  Aligned_cols=142  Identities=21%  Similarity=0.226  Sum_probs=106.5

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-----h--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-----W--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ....|-+|+-+.|+++.+  .|+..+||.=....+.     .  ...+...|++.+.++.--.|....-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            466788999999999965  5888888865433322     1  122235799999988766776666667666667799


Q ss_pred             EeecCC--CHHHHHhhccCCCCHHH-HHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccC
Q 038835           79 FEYMEC--NLYQLMKDREKCFSEAE-VRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREI  149 (337)
Q Consensus        79 ~e~~~~--~l~~~~~~~~~~l~~~~-~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~  149 (337)
                      |||++|  ++.+.+......-.++. ...++++|=+.+.-||.++++|+||..+||++.++    ++.|+|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999998  55666665433333333 37899999999999999999999999999999764    5699999988754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.37  E-value=2.7e-11  Score=109.31  Aligned_cols=211  Identities=19%  Similarity=0.275  Sum_probs=156.5

Q ss_pred             CceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe----eCCEEEEEEeecCC--CHH
Q 038835           14 TFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR----ENDILYFVFEYMEC--NLY   87 (337)
Q Consensus        14 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~--~l~   87 (337)
                      ...+.|++....+|..|++|.++....... .....-++.++++.|+|||++.++|.    .+..+++|++|.++  +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            346789999999999999999954322211 11235688999999999999999985    45678999999986  455


Q ss_pred             HHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           88 QLMKD--------------REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        88 ~~~~~--------------~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      +..-.              .+...+|..+|.++.|+..||.++|+.|+..+-|.|.+||++.+ +++|...|.......+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            44321              23357899999999999999999999999999999999999988 9999999877665544


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHH-HHHHHHHhCCCCccchhhhhhhH
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADE-IYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      +           .  |.+.+.    .+-|.=.||.+++.|.+|..- +......+. +..|                   
T Consensus       447 ~-----------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------------------  490 (655)
T KOG3741|consen  447 P-----------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------------------  490 (655)
T ss_pred             C-----------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------------------
Confidence            2           0  112222    256999999999999998622 111112111 1111                   


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                        .+.++.+++++|.-+...++++ -++.+++.+
T Consensus       491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                              2467889999999999999877 788898875

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.34  E-value=7.1e-11  Score=104.22  Aligned_cols=249  Identities=14%  Similarity=0.120  Sum_probs=160.3

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeE------E-eeCCEEEE
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEV------I-RENDILYF   77 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~------~-~~~~~~~l   77 (337)
                      .++.||+|+-+.+|-.-..  +. .+.|++........    .+.+..|... .||-+-.-+.+      . ..+....+
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCccccCCccceeeecchh--hc-hhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            3567899999999977332  22 35688876543321    1233444444 56655441211      1 12233678


Q ss_pred             EEeecCCC--HHHHH-----hhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           78 VFEYMECN--LYQLM-----KDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        78 v~e~~~~~--l~~~~-----~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      .|+.+.|.  ....+     ..+.+...++...++.+.++.+-+.||..|.+-+|++++|+|++++ .|.|.|=..-...
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence            88988863  21111     1234557889999999999999999999999999999999999887 8899887654444


Q ss_pred             CCCCCCccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcH----HHHH-HHHHHhCCCC
Q 038835          150 NSRPPFTEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEA----DEIY-KICSVIGTPT  219 (337)
Q Consensus       150 ~~~~~~~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~----~~~~-~i~~~~~~~~  219 (337)
                      .+...+...+|.+.|.+||.-.-    +-..+...|.|.||+++++++.| +.||.|..-.    ..++ .|..+.....
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya  247 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA  247 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence            44444566789999999997541    12346789999999999999986 9999874321    1111 1111100000


Q ss_pred             ccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCC--CCCCCCCHH
Q 038835          220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAA  275 (337)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~Rpt~~  275 (337)
                      .             + .-+.....+..-.+..+++++..++.+|+..  ++.-|||++
T Consensus       248 ~-------------~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         248 S-------------D-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             h-------------h-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            0             0 1112222333344567889999999999953  466899875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=2.2e-11  Score=102.79  Aligned_cols=141  Identities=17%  Similarity=0.222  Sum_probs=102.3

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCC--CcccceeEEeeC---CEEEEEEee
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP--NIVKLKEVIREN---DILYFVFEY   81 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~   81 (337)
                      .+.||.|..+.+|++.... |+.+++|................|+.+++.+.+.  ++.+++.+...+   +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            3678999999999998643 6789999987643321233446899999999653  456677776553   356899999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-------------------------------------------  118 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-------------------------------------------  118 (337)
                      ++|..+...... ..+++.....++.+++.+|..||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            998655433221 236677777777777777777773                                           


Q ss_pred             -------------cCccccCCCCCCeeeeC--C-cEEEeeCCCcccC
Q 038835          119 -------------RGYFHRDLKPENLLVSK--D-TIKIADFGLAREI  149 (337)
Q Consensus       119 -------------~~i~H~dikp~Nili~~--~-~~kL~Dfg~a~~~  149 (337)
                                   ..++|+|++|.||+++.  + .+.|+||+.+...
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                         24699999999999988  4 5789999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.22  E-value=1.5e-10  Score=94.32  Aligned_cols=127  Identities=24%  Similarity=0.354  Sum_probs=84.0

Q ss_pred             EEEEEEECCCCcEEEEEEcccccC-----------------------C--hHHhHHHHHHHHHhcCCCC--CcccceeEE
Q 038835           17 SVWRAISKQSGEVVAIKKMKKKYY-----------------------S--WEECVNLREVKSLRKMSHP--NIVKLKEVI   69 (337)
Q Consensus        17 ~v~~~~~~~~~~~vaiK~~~~~~~-----------------------~--~~~~~~~~e~~~l~~l~h~--~iv~~~~~~   69 (337)
                      .||.|... +|..+|+|+.+....                       .  .......+|.+.|.++...  ++.+++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48888764 577999997743110                       0  0111225799999999765  456666552


Q ss_pred             eeCCEEEEEEeecC--CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHH-HHHcCccccCCCCCCeeeeCCcEEEeeCCCc
Q 038835           70 RENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY-MHQRGYFHRDLKPENLLVSKDTIKIADFGLA  146 (337)
Q Consensus        70 ~~~~~~~lv~e~~~--~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~-LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a  146 (337)
                        ++  +|||||++  |..+..+....  ++......++.+++..+.. +|+.|++|+|+.+.||+++.+.+.++|||.+
T Consensus        80 --~~--~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf~qa  153 (188)
T PF01163_consen   80 --RN--VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDFGQA  153 (188)
T ss_dssp             --TT--EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--GTTE
T ss_pred             --CC--EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEecCcc
Confidence              22  69999999  76555554433  2245567788888885555 5799999999999999999999999999988


Q ss_pred             ccCC
Q 038835          147 REIN  150 (337)
Q Consensus       147 ~~~~  150 (337)
                      ....
T Consensus       154 v~~~  157 (188)
T PF01163_consen  154 VDSS  157 (188)
T ss_dssp             EETT
T ss_pred             eecC
Confidence            8754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=2.2e-11  Score=113.43  Aligned_cols=152  Identities=18%  Similarity=0.267  Sum_probs=112.1

Q ss_pred             HHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-----c-----cccccccccCchhhcCcCCC
Q 038835          109 VFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-----T-----EYVSTRWYRAPEVLLQSYLY  176 (337)
Q Consensus       109 il~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-----~-----~~~gt~~~~aPE~~~~~~~~  176 (337)
                      ...|+.|+|. .++||++|.|++|.++.+ ..||+.|+++....+...+     +     .......|.|||.+... ..
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~~  186 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-TN  186 (700)
T ss_pred             ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-cc
Confidence            3389999995 589999999999999987 8999999988765542111     1     12345679999998764 67


Q ss_pred             CCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChh
Q 038835          177 SSKVDMWAMGAIMAELI-TLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKD  255 (337)
Q Consensus       177 ~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (337)
                      +.++|++|+||++|.+. .|+..+...........-....                          ..........++++
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~--------------------------~~~~~~~s~~~p~e  240 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL--------------------------NAGAFGYSNNLPSE  240 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc--------------------------ccccccccccCcHH
Confidence            89999999999999999 5666665544322221111100                          01111222578899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          256 AVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       256 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      +++=+.++|..++.-||++.+++..|||++..
T Consensus       241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            99999999999999999999999999998743

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.16  E-value=2.5e-10  Score=95.76  Aligned_cols=137  Identities=22%  Similarity=0.275  Sum_probs=102.6

Q ss_pred             eEeeeecccCceEEEEEEECCCCcEEEEEEcccc---------------------cCChHHhHHHHHHHHHhcCCCC--C
Q 038835            5 KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKK---------------------YYSWEECVNLREVKSLRKMSHP--N   61 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~---------------------~~~~~~~~~~~e~~~l~~l~h~--~   61 (337)
                      .++..||.|--|.||.|.+. .|..+|+|.=+..                     ........+.+|.++|.+|.-.  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            46789999999999999887 5888999953211                     1111223336899999999544  6


Q ss_pred             cccceeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEE
Q 038835           62 IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKI  140 (337)
Q Consensus        62 iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL  140 (337)
                      |.+.+++    +.-.+|||+.+|..+....     ++......++..|++-+..+-..|+||+|+++-||+++.+ .+.+
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            7777776    4557999999996554432     2345556677777777777779999999999999999987 9999


Q ss_pred             eeCCCcccCCC
Q 038835          141 ADFGLAREINS  151 (337)
Q Consensus       141 ~Dfg~a~~~~~  151 (337)
                      +||--+...+.
T Consensus       244 IDwPQ~v~~~h  254 (304)
T COG0478         244 IDWPQAVPISH  254 (304)
T ss_pred             EeCcccccCCC
Confidence            99998776543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=1.4e-09  Score=93.82  Aligned_cols=130  Identities=14%  Similarity=0.046  Sum_probs=89.7

Q ss_pred             EEEEEEECCCCcEEEEEEcccccCCh----------HHhHHHHHHHHHhcCCCCCcc--cceeEEee-----CCEEEEEE
Q 038835           17 SVWRAISKQSGEVVAIKKMKKKYYSW----------EECVNLREVKSLRKMSHPNIV--KLKEVIRE-----NDILYFVF   79 (337)
Q Consensus        17 ~v~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv--~~~~~~~~-----~~~~~lv~   79 (337)
                      .|.++..  .|+.+.+|.........          ......+|...+.+|...+|.  .++++++.     ....++||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555533  57789999664322110          011245788888888544443  34555543     23578999


Q ss_pred             eecCCC-HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-------C-cEEEeeCCCccc
Q 038835           80 EYMECN-LYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-------D-TIKIADFGLARE  148 (337)
Q Consensus        80 e~~~~~-l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-------~-~~kL~Dfg~a~~  148 (337)
                      |++++. .+..+...  ..+.++.....++.+++..+.-||+.|++|+|+++.|||++.       + .+.|+||+.+..
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999984 44444321  233567788899999999999999999999999999999974       2 799999997753

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.99  E-value=8.1e-09  Score=85.94  Aligned_cols=140  Identities=17%  Similarity=0.202  Sum_probs=98.7

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH------------------hHH-----HHHHHHHhcCCCC--C
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE------------------CVN-----LREVKSLRKMSHP--N   61 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------------------~~~-----~~e~~~l~~l~h~--~   61 (337)
                      ...|+.|--++||+|.. .++..+|+|+..........                  ...     .+|...|+++...  .
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            44788889999999975 45889999988643221111                  000     4688888888443  4


Q ss_pred             cccceeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCCcEEE
Q 038835           62 IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKDTIKI  140 (337)
Q Consensus        62 iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~~~kL  140 (337)
                      +.+.+.+..    -.+||||++....-.-.-+..+++..+...+..++++.+.-|-. .|+||+||+.-|||+..+.+.+
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~i  207 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPYI  207 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEEE
Confidence            455555532    26999999865211111112224444778888999999998887 8999999999999999889999


Q ss_pred             eeCCCcccCCC
Q 038835          141 ADFGLAREINS  151 (337)
Q Consensus       141 ~Dfg~a~~~~~  151 (337)
                      +|||-|.....
T Consensus       208 ID~~QaV~~~h  218 (268)
T COG1718         208 IDVSQAVTIDH  218 (268)
T ss_pred             EECccccccCC
Confidence            99999887653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.98  E-value=1.9e-08  Score=82.87  Aligned_cols=137  Identities=20%  Similarity=0.288  Sum_probs=90.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHH--------HHHHHHHhcC---CCCCcccceeEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--------LREVKSLRKM---SHPNIVKLKEVIR   70 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--------~~e~~~l~~l---~h~~iv~~~~~~~   70 (337)
                      .+|.+.+.+-......|.+..  -+|+.+++|.........+....        .+.+..+.++   .......++.+.+
T Consensus        31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            367777888777777776663  45788999988765432211111        2333333333   3334444444433


Q ss_pred             e-----CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCC
Q 038835           71 E-----NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGL  145 (337)
Q Consensus        71 ~-----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~  145 (337)
                      .     ....+++|||++|..+..+..    +++    .+...+.+++.-+|+.|+.|+|.+|.|++++.+.++++||+.
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~  180 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQG  180 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECcc
Confidence            2     245578999999965543322    333    244567788999999999999999999999999999999986


Q ss_pred             ccc
Q 038835          146 ARE  148 (337)
Q Consensus       146 a~~  148 (337)
                      ...
T Consensus       181 k~~  183 (229)
T PF06176_consen  181 KRM  183 (229)
T ss_pred             ccc
Confidence            553

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=1.1e-08  Score=85.26  Aligned_cols=104  Identities=18%  Similarity=0.225  Sum_probs=79.3

Q ss_pred             HHHHHHHHHhcCCCCC--cccceeEEeeC----CEEEEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Q 038835           46 VNLREVKSLRKMSHPN--IVKLKEVIREN----DILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ  118 (337)
Q Consensus        46 ~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~  118 (337)
                      ...+|...+..|...+  +.+.+++.+..    ...++|+|++++. .+..+.......+......++.++...++-||+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            3457888888875444  45556665542    2458999999973 455554443336778889999999999999999


Q ss_pred             cCccccCCCCCCeeeeCC----cEEEeeCCCcccC
Q 038835          119 RGYFHRDLKPENLLVSKD----TIKIADFGLAREI  149 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~  149 (337)
                      +|++|+|+++.|||++.+    .+.|+||+.+...
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999876    4999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.89  E-value=3.3e-10  Score=104.79  Aligned_cols=184  Identities=16%  Similarity=0.147  Sum_probs=142.6

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC-cccceeEEeeCCEEEEEEeecCC
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN-IVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      ....+++|+++++++.+...+...+ .+.+...      ....-++++|.+++||| .+..++-++.+...+++++++.+
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3445788999999999776655444 5555443      12235889999999999 77777777778899999999987


Q ss_pred             C--HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCCCCccccccc
Q 038835           85 N--LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTR  162 (337)
Q Consensus        85 ~--l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~  162 (337)
                      +  ...........+.+-++....+.-.++++++|+.-=+|+|    ||+..++..+++||+....+.......+..+++
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~  394 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTP  394 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCCCCC
Confidence            6  2222222233355566667777778899999998878998    999988999999999998887776667889999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG  201 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  201 (337)
                      .++|||+...+ .+....|.|++|+-..+|.-|-+|-..
T Consensus       395 ~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  395 EPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCC
Confidence            99999988665 678889999999988888888877644

>PRK09902 hypothetical protein; Provisional

Probab=98.71  E-value=4.3e-07  Score=74.67  Aligned_cols=136  Identities=14%  Similarity=0.125  Sum_probs=93.6

Q ss_pred             cccCceEEEEEEECCCCcEEEEEEcccccC-----ChHHhHHHHHHHHHhcCCCCC--cccceeEEee----CCEEEEEE
Q 038835           11 GDGTFGSVWRAISKQSGEVVAIKKMKKKYY-----SWEECVNLREVKSLRKMSHPN--IVKLKEVIRE----NDILYFVF   79 (337)
Q Consensus        11 g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~----~~~~~lv~   79 (337)
                      |+|+-+.|+.....  |+.+-+|.-..-..     ......+.+|+..+++|..-+  +.++......    .-..+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56888889987543  44677786541110     112334468999998884333  4444422111    12468999


Q ss_pred             eecCC--CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-C--cEEEeeCCCccc
Q 038835           80 EYMEC--NLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-D--TIKIADFGLARE  148 (337)
Q Consensus        80 e~~~~--~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-~--~~kL~Dfg~a~~  148 (337)
                      |-++|  ++.+.+.+. -.+.++.....++.+|..+++-||+.|+.|+|+.+.||+++. +  .++++||.-+..
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98885  444444332 224577888899999999999999999999999999999974 3  599999997654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=2.9e-07  Score=77.79  Aligned_cols=134  Identities=13%  Similarity=0.151  Sum_probs=83.2

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC--cccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN--IVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      ..||.|..+.||+.    .|..+++|.......   .....+|.++++.+..-+  +.+++++.+..+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            57899999999984    245678888765331   223468999999885433  577788887788889999999985


Q ss_pred             H-HHHHh---------------h------c-c-CCCCHHH-HHHHHHHH----------HH-HHHHHH----HcCccccC
Q 038835           86 L-YQLMK---------------D------R-E-KCFSEAE-VRNWCFQV----------FQ-GLAYMH----QRGYFHRD  125 (337)
Q Consensus        86 l-~~~~~---------------~------~-~-~~l~~~~-~~~~~~qi----------l~-al~~LH----~~~i~H~d  125 (337)
                      . .....               +      . . ...+... ...+..++          .. ...+|.    ...++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            1 11000               0      0 0 0011111 11111111          11 111222    12478999


Q ss_pred             CCCCCeeeeCCcEEEeeCCCccc
Q 038835          126 LKPENLLVSKDTIKIADFGLARE  148 (337)
Q Consensus       126 ikp~Nili~~~~~kL~Dfg~a~~  148 (337)
                      +.|.||+++.+.+.++||+.+..
T Consensus       160 ~~~~Nii~~~~~~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKGTYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCCcEEEechhcCc
Confidence            99999999987799999997764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.54  E-value=1.3e-06  Score=86.71  Aligned_cols=196  Identities=19%  Similarity=0.224  Sum_probs=133.2

Q ss_pred             HHHHHHhcCCCCCcccceeEEeeCCE----EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 038835           49 REVKSLRKMSHPNIVKLKEVIRENDI----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR  124 (337)
Q Consensus        49 ~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~  124 (337)
                      .|...+....|+|++.++.+.-....    ..+..+++....+......-..++....+.+..++++||+++|+....|.
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v  310 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHV  310 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcccee
Confidence            46777778899999999988643322    22445666664444444444558999999999999999999999965555


Q ss_pred             CCCCCC---eeeeCC-cEEEe--eCCCcccCCCCCCCccccccccccCchhhcCcCCCC--CcchHHHHHHHHHHHHhCC
Q 038835          125 DLKPEN---LLVSKD-TIKIA--DFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS--SKVDMWAMGAIMAELITLR  196 (337)
Q Consensus       125 dikp~N---ili~~~-~~kL~--Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~--~~~DiwslG~il~~ll~g~  196 (337)
                      -+...-   --.+.. .+..+  ||+.+.............-+..+.+||....+ .+.  ...|+|++|.....+..|.
T Consensus       311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll~~~~~~~~  389 (1351)
T KOG1035|consen  311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLLLLQLSQGE  389 (1351)
T ss_pred             EEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccc-cchhhhhhHHHHHHHHHhhhhhcC
Confidence            444331   112222 45555  89988877665555556667778888877544 333  3479999999999999876


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCCh-hHHHHHHHhcCCCCCCCCCHH
Q 038835          197 PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANK-DAVSLIASLCSWDPSKRPTAA  275 (337)
Q Consensus       197 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~~L~~dP~~Rpt~~  275 (337)
                      .+-.......                                        ...+..+. +..+.+.+|+.-++++|+++.
T Consensus       390 ~i~~~~~~~~----------------------------------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  390 DISEKSAVPV----------------------------------------SLLDVLSTSELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             cccccccchh----------------------------------------hhhccccchhhhhhhhhhcchhhhhccchh
Confidence            4432111100                                        00011122 678999999999999999999


Q ss_pred             HHhcCcCccc
Q 038835          276 EALQHPFSRV  285 (337)
Q Consensus       276 ell~hp~~~~  285 (337)
                      +++.|||.+.
T Consensus       430 ~ll~~~f~~~  439 (1351)
T KOG1035|consen  430 ELLTHPFLRF  439 (1351)
T ss_pred             hhhhchhccc
Confidence            9999999764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=5.3e-07  Score=84.45  Aligned_cols=142  Identities=23%  Similarity=0.367  Sum_probs=87.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCC---------------------------h------------HHhHHH
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS---------------------------W------------EECVNL   48 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------------------~------------~~~~~~   48 (337)
                      ..|+.++-|.||+|+-+. |+.||||+.+.....                           .            .+....
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            457889999999999765 999999987542110                           0            001113


Q ss_pred             HHHHHHhcC-----CCCCcccceeEEeeCCEEEEEEeecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 038835           49 REVKSLRKM-----SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYF  122 (337)
Q Consensus        49 ~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~  122 (337)
                      +|+..+.++     +.|++.-..=+++-.+.-.++|||++|--.+.+. -....++...+.....++.  +.-+=..|+.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            455555554     1233333333334456668999999995433332 1112345333333222221  2222347999


Q ss_pred             ccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835          123 HRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus       123 H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      |+|..|.||+++.+ .+.+.|||+....++.
T Consensus       288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         288 HADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            99999999999987 9999999998877553

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.50  E-value=3.1e-06  Score=71.79  Aligned_cols=78  Identities=17%  Similarity=0.206  Sum_probs=53.2

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCC--CcccceeEE---eeCCEEEEEEee
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP--NIVKLKEVI---RENDILYFVFEY   81 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv~e~   81 (337)
                      ++.|+.|..+.||++....  ..+++|.....   .......+|..+++.|...  .+.+++...   ......+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            5789999999999998764  48899987654   2334445788888887433  355666543   233457999999


Q ss_pred             cCCCHHHH
Q 038835           82 MECNLYQL   89 (337)
Q Consensus        82 ~~~~l~~~   89 (337)
                      ++|..+..
T Consensus        77 i~g~~~~~   84 (239)
T PF01636_consen   77 IPGRPLDD   84 (239)
T ss_dssp             ESSEEHHH
T ss_pred             eccccccc
Confidence            99864433

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.45  E-value=3.1e-06  Score=72.56  Aligned_cols=75  Identities=13%  Similarity=0.100  Sum_probs=51.4

Q ss_pred             eeecccCc-eEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEEeecCCC
Q 038835            8 KEVGDGTF-GSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         8 ~~ig~G~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      +.|..|.+ +.||++...  +..+++|......    .....+|+.+++.+. +--+.+++++...++..++|||+++|.
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            34556666 788999643  4678888876542    122357888888873 444667777777666789999999986


Q ss_pred             HHH
Q 038835           86 LYQ   88 (337)
Q Consensus        86 l~~   88 (337)
                      .+.
T Consensus        78 ~l~   80 (244)
T cd05150          78 PAA   80 (244)
T ss_pred             cHh
Confidence            443

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.44  E-value=3e-06  Score=85.16  Aligned_cols=145  Identities=18%  Similarity=0.380  Sum_probs=90.6

Q ss_pred             eeeecccCceEEEEEEECCCC--cEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCc--ccceeEEeeC---CEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSG--EVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNI--VKLKEVIREN---DILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv   78 (337)
                      ++.++.|.++.+|+......+  ..+++|+..............+|+.+++.+. |+++  .+++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            677899999999998765432  4677887654332222334568999999995 6665  6667766553   467899


Q ss_pred             EeecCCCHHH------------------------HHhhcc----------CC--CCHHHHHHHHHH--------------
Q 038835           79 FEYMECNLYQ------------------------LMKDRE----------KC--FSEAEVRNWCFQ--------------  108 (337)
Q Consensus        79 ~e~~~~~l~~------------------------~~~~~~----------~~--l~~~~~~~~~~q--------------  108 (337)
                      |||++|..+.                        .+..-.          .+  ....++..|..+              
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            9999985311                        000100          00  112234333332              


Q ss_pred             -HHHHHHHHHH-----------cCccccCCCCCCeeeeCC---cEEEeeCCCcccCCC
Q 038835          109 -VFQGLAYMHQ-----------RGYFHRDLKPENLLVSKD---TIKIADFGLAREINS  151 (337)
Q Consensus       109 -il~al~~LH~-----------~~i~H~dikp~Nili~~~---~~kL~Dfg~a~~~~~  151 (337)
                       +...+++|..           ..+||+|+++.||+++.+   .+-+.||+++...++
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP  260 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ  260 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence             2233456632           249999999999999753   357999999876543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.35  E-value=2.6e-06  Score=67.39  Aligned_cols=129  Identities=20%  Similarity=0.244  Sum_probs=91.2

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcc-cceeEEeeCCEEEEEEeecCC
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV-KLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.+.|++|.+|.||++...  |..+|+|+-+.+..   ...+..|+++|..+.-.++. +++.+.++    .+.|||..|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G   96 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG   96 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence            4567999999999999765  67899998776533   34456899999888665554 44444332    355999999


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC--CCeeeeCCcEEEeeCCCcccCC
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP--ENLLVSKDTIKIADFGLAREIN  150 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp--~Nili~~~~~kL~Dfg~a~~~~  150 (337)
                      -.+.......   +    +.-+..++++-.-|-..||-|..|.-  .||++.++.+.|+||..|+...
T Consensus        97 ~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112          97 RPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             cchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            5554433211   2    23334567776677888999999875  4777777799999999998543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.30  E-value=5.1e-06  Score=73.16  Aligned_cols=144  Identities=19%  Similarity=0.246  Sum_probs=105.2

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCC---------------------hHHhHH----HHHHHHHhcCCCC
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS---------------------WEECVN----LREVKSLRKMSHP   60 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~~----~~e~~~l~~l~h~   60 (337)
                      +-.+|..|--+.||.|.. .+|..+|||+++.....                     ......    .+|+..|++|...
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            446788999999999975 46888999987532110                     001111    4688889988777


Q ss_pred             CcccceeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCCeeeeCCcEE
Q 038835           61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH-QRGYFHRDLKPENLLVSKDTIK  139 (337)
Q Consensus        61 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH-~~~i~H~dikp~Nili~~~~~k  139 (337)
                      .|...--+.-.+  -+|||++++++..-.-.-++..++...+..+-.|++.-+.-|- ..++||.||.--|+|+-.+.+.
T Consensus       227 GIP~PePIlLk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~ly  304 (520)
T KOG2270|consen  227 GIPCPEPILLKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKLY  304 (520)
T ss_pred             CCCCCCceeeec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCEEE
Confidence            755443333322  3699999997544443344555888889999999999888876 4589999999999999999999


Q ss_pred             EeeCCCcccCCCC
Q 038835          140 IADFGLAREINSR  152 (337)
Q Consensus       140 L~Dfg~a~~~~~~  152 (337)
                      ++|.+-+...+..
T Consensus       305 iIDVSQSVE~DHP  317 (520)
T KOG2270|consen  305 IIDVSQSVEHDHP  317 (520)
T ss_pred             EEEccccccCCCh
Confidence            9999988876543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.19  E-value=4e-05  Score=62.64  Aligned_cols=126  Identities=19%  Similarity=0.294  Sum_probs=86.2

Q ss_pred             cCceEeeeecccCc-eEEEEEEECCCCcEEEEEEccc---cc-------CCh----------HHhHHHHHHHHHhcC---
Q 038835            2 ERYKLIKEVGDGTF-GSVWRAISKQSGEVVAIKKMKK---KY-------YSW----------EECVNLREVKSLRKM---   57 (337)
Q Consensus         2 ~~y~~~~~ig~G~~-g~v~~~~~~~~~~~vaiK~~~~---~~-------~~~----------~~~~~~~e~~~l~~l---   57 (337)
                      .+++.++.||.|.- |.||++.-  +|+.+|+|+...   ..       ...          ....+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            36788999999999 99999965  588999999221   00       000          011123577766666   


Q ss_pred             CCCCc--ccceeEEeeC------------------CEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Q 038835           58 SHPNI--VKLKEVIREN------------------DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH  117 (337)
Q Consensus        58 ~h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH  117 (337)
                      .+.++  |+++++..=.                  ....||.||+....         .++...    +.+|++-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            45556  8888886211                  12467788776544         233333    456777889999


Q ss_pred             HcCccccCCCCCCeeeeCCcEEEeeCCCc
Q 038835          118 QRGYFHRDLKPENLLVSKDTIKIADFGLA  146 (337)
Q Consensus       118 ~~~i~H~dikp~Nili~~~~~kL~Dfg~a  146 (337)
                      +.||+-+|+++.|..    .-+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc----CCEEEecccC
Confidence            999999999999886    4589999965

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.18  E-value=6e-05  Score=62.05  Aligned_cols=128  Identities=19%  Similarity=0.222  Sum_probs=88.1

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccC---------------ChHHhHHHHHHHHHhcCC------CCCcccc
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY---------------SWEECVNLREVKSLRKMS------HPNIVKL   65 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~~~e~~~l~~l~------h~~iv~~   65 (337)
                      ...||.|+.-.||.-  .. ....+||+......               ........+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356899999999975  33 34467899877650               011223345666655554      7889999


Q ss_pred             eeEEeeCCEEEEEEeecC---CC---HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC---
Q 038835           66 KEVIRENDILYFVFEYME---CN---LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD---  136 (337)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~---~~---l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~---  136 (337)
                      +|+.+.+....+|+|...   |+   ++..+...+. +++ .+   ...+-+-.++|-+.+|+.+|++|.||++..+   
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999999999999999874   22   3444444333 665 33   3334455668889999999999999999653   


Q ss_pred             --cEEEee
Q 038835          137 --TIKIAD  142 (337)
Q Consensus       137 --~~kL~D  142 (337)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.11  E-value=1.8e-05  Score=67.43  Aligned_cols=71  Identities=13%  Similarity=0.154  Sum_probs=42.8

Q ss_pred             eeeecccCce-EEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCC---CcccceeEEeeC---CEEEEEE
Q 038835            7 IKEVGDGTFG-SVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP---NIVKLKEVIREN---DILYFVF   79 (337)
Q Consensus         7 ~~~ig~G~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~   79 (337)
                      ++.|+.|+.. .||+.     +..+++|......   ......+|..+++.+...   .+.++++.....   ...+++|
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence            3567766666 58986     2357788765422   223456799999888532   234444433322   2458899


Q ss_pred             eecCCC
Q 038835           80 EYMECN   85 (337)
Q Consensus        80 e~~~~~   85 (337)
                      ++++|.
T Consensus        74 ~~i~G~   79 (235)
T cd05155          74 RWLEGE   79 (235)
T ss_pred             EeecCC
Confidence            999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.08  E-value=2.6e-05  Score=67.43  Aligned_cols=135  Identities=18%  Similarity=0.264  Sum_probs=78.4

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc-ccceeEEeeCCEEEEEEeecCCCHH
Q 038835            9 EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI-VKLKEVIRENDILYFVFEYMECNLY   87 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~l~   87 (337)
                      .+..|-.+.+|++.  .+|+.+++|......... .....+|..+++.+...++ .+++...  .  -++|+||++|..+
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI   75 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence            45678889999986  457788898765432211 0123478888888854333 3444443  2  2689999998432


Q ss_pred             HH-----------Hh-------hc---cCCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCccccCCCC
Q 038835           88 QL-----------MK-------DR---EKCFSE-AEVRNWCFQV---------FQGLAYMHQ--------RGYFHRDLKP  128 (337)
Q Consensus        88 ~~-----------~~-------~~---~~~l~~-~~~~~~~~qi---------l~al~~LH~--------~~i~H~dikp  128 (337)
                      +.           +.       ..   +.+++. ..+..+..++         ...++.+-+        ..++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            21           10       11   111111 1222222122         111222222        2589999999


Q ss_pred             CCeeeeCCcEEEeeCCCcccCC
Q 038835          129 ENLLVSKDTIKIADFGLAREIN  150 (337)
Q Consensus       129 ~Nili~~~~~kL~Dfg~a~~~~  150 (337)
                      .||+++.+.+.|+||+.|....
T Consensus       156 ~Nil~~~~~~~lIDwE~a~~gd  177 (256)
T TIGR02721       156 YNLVVTPQGLKLIDWEYASDGD  177 (256)
T ss_pred             CcEEEeCCCCEEEeccccCcCC
Confidence            9999998888999999887543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.06  E-value=8.3e-05  Score=69.81  Aligned_cols=140  Identities=24%  Similarity=0.355  Sum_probs=86.8

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCCh------------------------------------HHhHHHHHH
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW------------------------------------EECVNLREV   51 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------~~~~~~~e~   51 (337)
                      +.||.-+.|.||+|+-+. |+.||+|+-+..-...                                    .+-.+.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            568889999999999776 9999999865421110                                    000012344


Q ss_pred             HHHhcC----CCCCc---ccceeEE-eeCCEEEEEEeecCC---CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 038835           52 KSLRKM----SHPNI---VKLKEVI-RENDILYFVFEYMEC---NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG  120 (337)
Q Consensus        52 ~~l~~l----~h~~i---v~~~~~~-~~~~~~~lv~e~~~~---~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~  120 (337)
                      +...++    .|-+.   |.+-.++ .-.....++||||+|   +.++.+.+.+  ++...+..-+.+...-  -+=..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~~--qIf~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYLE--QIFKTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHHH--HHHhcC
Confidence            333332    33331   1222232 223456899999998   3455555544  5666554444333222  223468


Q ss_pred             ccccCCCCCCeeeeC----C-cEEEeeCCCcccCCCC
Q 038835          121 YFHRDLKPENLLVSK----D-TIKIADFGLAREINSR  152 (337)
Q Consensus       121 i~H~dikp~Nili~~----~-~~kL~Dfg~a~~~~~~  152 (337)
                      ++|+|=.|.||++.+    + .+.+-|||+....+..
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            999999999999983    2 8999999998876543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.03  E-value=9.2e-05  Score=63.02  Aligned_cols=73  Identities=15%  Similarity=0.216  Sum_probs=46.4

Q ss_pred             eeeecccCceEEEEEEECC-CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC-cccceeEEeeCCEEEEEEeecCC
Q 038835            7 IKEVGDGTFGSVWRAISKQ-SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN-IVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      ++.|+.|-.+.+|++.... +++.|++|+.......  .....+|+.+++.+...+ .+++++...  +  .++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence            5678889999999996543 3567889976543221  112236888888885433 344444332  2  379999987


Q ss_pred             C
Q 038835           85 N   85 (337)
Q Consensus        85 ~   85 (337)
                      .
T Consensus        77 ~   77 (235)
T cd05157          77 R   77 (235)
T ss_pred             C
Confidence            4

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.01  E-value=5.1e-07  Score=91.54  Aligned_cols=195  Identities=13%  Similarity=0.021  Sum_probs=127.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccc---cCChHH-hHHHHHHHHHhcCCCCCcccceeEEee--CCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKK---YYSWEE-CVNLREVKSLRKMSHPNIVKLKEVIRE--NDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   75 (337)
                      +.|++.--+|.|.++..-....+.++  +.+|+.+.-   ...+.. .....|.+.++...|+++.....-...  ....
T Consensus      1229 e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee 1306 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEE 1306 (2724)
T ss_pred             hhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHH
Confidence            44555555666665554333333333  234444322   112211 122345556666789988877665543  3345


Q ss_pred             EEEEeecCCC-HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           76 YFVFEYMECN-LYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRG-----YFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        76 ~lv~e~~~~~-l~~~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~-----i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                      |.+++|+.++ +.+.+.+.   .+++.+.-+.....+.+.+..-+|+..     -+|+++|+.|.+|..+ +++++++|+
T Consensus      1307 ~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gL 1386 (2724)
T KOG1826|consen 1307 YIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGL 1386 (2724)
T ss_pred             HHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccc
Confidence            8889998865 55555543   233444445444455577777777652     6899999999999887 899999999


Q ss_pred             cccCCC-CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 038835          146 AREINS-RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF  199 (337)
Q Consensus       146 a~~~~~-~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (337)
                      .+...+ ........+++.|++|++... -.++.++|+|..|+.+|..-.|..+|
T Consensus      1387 dKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1387 DKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             ccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            994433 344466788999999997643 35677799999999999999888877

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00035  Score=63.81  Aligned_cols=76  Identities=18%  Similarity=0.215  Sum_probs=51.3

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccC------ChHHhHHHHHHHHHhcCC---CCCcccceeEEeeCCEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY------SWEECVNLREVKSLRKMS---HPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l   77 (337)
                      .+.||.|..+.||++.....++.+++|.......      .....+...|...|+.+.   -.++++++.+.  .+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            4678999999999999865446899998542110      112233456888888762   24567777773  355689


Q ss_pred             EEeecCC
Q 038835           78 VFEYMEC   84 (337)
Q Consensus        78 v~e~~~~   84 (337)
                      |||++++
T Consensus       109 VME~L~~  115 (401)
T PRK09550        109 VMEDLSD  115 (401)
T ss_pred             EEecCCC
Confidence            9999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.72  E-value=0.00063  Score=60.49  Aligned_cols=137  Identities=18%  Similarity=0.193  Sum_probs=76.7

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC--cccceeE------EeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN--IVKLKEV------IRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv   78 (337)
                      ++.++.|..+.+|++.. .+| .+++|+......   ......|..++..|...+  +.+++..      ...++..+++
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             ccccCCccccceEEEEe-CCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            55677788889998864 234 577887654211   112235666676663222  3344332      1234567899


Q ss_pred             EeecCCCHH-----H----------HHhhccCCCCH-------HHHH----------------HHHHHHHHHHHHHHH--
Q 038835           79 FEYMECNLY-----Q----------LMKDREKCFSE-------AEVR----------------NWCFQVFQGLAYMHQ--  118 (337)
Q Consensus        79 ~e~~~~~l~-----~----------~~~~~~~~l~~-------~~~~----------------~~~~qil~al~~LH~--  118 (337)
                      +||++|...     .          .+......++.       ...+                .....+...++++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            999987321     1          11111010100       0000                001122334555542  


Q ss_pred             -----cCccccCCCCCCeeeeCCc-EEEeeCCCccc
Q 038835          119 -----RGYFHRDLKPENLLVSKDT-IKIADFGLARE  148 (337)
Q Consensus       119 -----~~i~H~dikp~Nili~~~~-~kL~Dfg~a~~  148 (337)
                           .+++|+|+.+.||+++.+. +.++||+.+..
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                 5899999999999999885 58999997653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.69  E-value=5.4e-05  Score=65.86  Aligned_cols=136  Identities=13%  Similarity=0.186  Sum_probs=92.2

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEccccc---------------------CChHHhHHHHHHHHHhcCCCC--
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY---------------------YSWEECVNLREVKSLRKMSHP--   60 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h~--   60 (337)
                      |.++.+||-|.-+.+|.+.+. .|+..++|.=+...                     .-...-...+|...|+.|.-.  
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            567899999999999999875 47888888432110                     001112225788888888332  


Q ss_pred             CcccceeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEE
Q 038835           61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIK  139 (337)
Q Consensus        61 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~k  139 (337)
                      -|.+.+++    +.-++|||++.|=.+..+..      ...+..+...+..-+.-|-..|+||+|++-=||++.++ .++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            24455554    45579999998754433321      11223444556666777889999999999999999865 899


Q ss_pred             EeeCCCcccCC
Q 038835          140 IADFGLAREIN  150 (337)
Q Consensus       140 L~Dfg~a~~~~  150 (337)
                      ++||--....+
T Consensus       243 vIDFPQmvS~s  253 (465)
T KOG2268|consen  243 VIDFPQMVSTS  253 (465)
T ss_pred             EeechHhhccC
Confidence            99999665544

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.63  E-value=0.00086  Score=59.20  Aligned_cols=136  Identities=15%  Similarity=0.112  Sum_probs=78.9

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC--cccceeE------EeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN--IVKLKEV------IRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv   78 (337)
                      ++.|..|....+|++..  ++..+++|+....  .  ......|+.+++.|...+  +.+++..      ...++..++|
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~--~--~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV--S--AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC--C--hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            55677788889999854  3456888987641  1  223346777777774332  4444332      2334567899


Q ss_pred             EeecCCCHHH---------------HHhhccCCCC--------HHHHHH------------HHHHHHHHHHHHHH-----
Q 038835           79 FEYMECNLYQ---------------LMKDREKCFS--------EAEVRN------------WCFQVFQGLAYMHQ-----  118 (337)
Q Consensus        79 ~e~~~~~l~~---------------~~~~~~~~l~--------~~~~~~------------~~~qil~al~~LH~-----  118 (337)
                      +++++|....               .+......+.        ......            ....+..++.++.+     
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            9999874321               1111000000        000000            11112334445543     


Q ss_pred             --cCccccCCCCCCeeeeCCc-EEEeeCCCccc
Q 038835          119 --RGYFHRDLKPENLLVSKDT-IKIADFGLARE  148 (337)
Q Consensus       119 --~~i~H~dikp~Nili~~~~-~kL~Dfg~a~~  148 (337)
                        .+++|+|+.|.||+++.+. +.|.||+.+..
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence              4799999999999999885 47999997664

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.62  E-value=0.0021  Score=57.42  Aligned_cols=30  Identities=37%  Similarity=0.554  Sum_probs=26.0

Q ss_pred             cCccccCCCCCCeeeeCCcE-EEeeCCCccc
Q 038835          119 RGYFHRDLKPENLLVSKDTI-KIADFGLARE  148 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~~~~-kL~Dfg~a~~  148 (337)
                      .++||+|+.|.||+++.+.+ -++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            38999999999999998765 7999997764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.61  E-value=0.0005  Score=60.95  Aligned_cols=73  Identities=14%  Similarity=0.151  Sum_probs=46.3

Q ss_pred             eeeecccCceEEEEEEECC------CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC-cccceeEEeeCCEEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQ------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN-IVKLKEVIRENDILYFVF   79 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~   79 (337)
                      ++.+..|-...+|++....      +++.+++|+.......  .....+|..+++.+...+ ..++++.+..    .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL--LIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc--eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            4667778888999997543      2578999986553211  122347888888874333 3445555432    3588


Q ss_pred             eecCCC
Q 038835           80 EYMECN   85 (337)
Q Consensus        80 e~~~~~   85 (337)
                      ||++|.
T Consensus        77 e~i~G~   82 (302)
T cd05156          77 EFIPSR   82 (302)
T ss_pred             heeCCC
Confidence            998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.57  E-value=0.00098  Score=59.69  Aligned_cols=74  Identities=16%  Similarity=0.242  Sum_probs=47.2

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccc------cCChHHhHHHHHHHHHhcCC--CC-CcccceeEEeeCCEEEEEE
Q 038835            9 EVGDGTFGSVWRAISKQSGEVVAIKKMKKK------YYSWEECVNLREVKSLRKMS--HP-NIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         9 ~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~   79 (337)
                      .||.|....||++.+..+++.++||.-..-      .......+..-|...|+...  .| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999998644468999965321      11122333346778887763  35 34444444  445556999


Q ss_pred             eecCC
Q 038835           80 EYMEC   84 (337)
Q Consensus        80 e~~~~   84 (337)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99853

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.49  E-value=0.00043  Score=56.69  Aligned_cols=98  Identities=18%  Similarity=0.240  Sum_probs=75.9

Q ss_pred             HHHHHHhcCCC-CCcccceeEEeeCCEEEEEEeecCCC-HHHHH--hhccCCCCHHHHHHHHHHHHHHHHHHHH---cCc
Q 038835           49 REVKSLRKMSH-PNIVKLKEVIRENDILYFVFEYMECN-LYQLM--KDREKCFSEAEVRNWCFQVFQGLAYMHQ---RGY  121 (337)
Q Consensus        49 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~-l~~~~--~~~~~~l~~~~~~~~~~qil~al~~LH~---~~i  121 (337)
                      .|.-+++.+.+ +++++++|.+..    .+|.||.+.+ +.+..  .......++..+..++.++++.+.+++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888888865 699999999733    5789999854 32110  0111225899999999999999999997   358


Q ss_pred             cccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835          122 FHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus       122 ~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      .-.|++|+|+-++++ ++|++|.+.+....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            889999999999876 99999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.48  E-value=0.00078  Score=62.25  Aligned_cols=174  Identities=18%  Similarity=0.194  Sum_probs=109.7

Q ss_pred             HhHHHHHHHHHhcCCCCCcccceeEEee-CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 038835           44 ECVNLREVKSLRKMSHPNIVKLKEVIRE-NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF  122 (337)
Q Consensus        44 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~  122 (337)
                      ....+-..+.++.+.|+|...++++... .....+|+|+++.++.+....++  +-.....                  .
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~------------------~   85 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL------------------A   85 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc------------------c
Confidence            3444567888999999999999998753 35588999999998888776554  2211111                  2


Q ss_pred             ccCCCCCCeeeeCCcEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 038835          123 HRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGT  202 (337)
Q Consensus       123 H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  202 (337)
                      |+-+ +-|+      ++.+| -++...                 |-      ...+++||||+|.++.++.-|...+...
T Consensus        86 ~~~~-~~~~------~~~td-~~~t~~-----------------~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   86 HGVL-HLNI------IYITD-HFLTKY-----------------PS------PIGPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             cccc-eehh------hhccc-cccccC-----------------CC------CCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence            2211 1122      22223 111100                 10      1124999999999999999999888777


Q ss_pred             CcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          203 SEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       203 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                      ...+....+......+....-.....     ..             .-..+.-+.++..+|+-..|..||...++.+++-
T Consensus       135 ~~s~~l~~i~k~~~~d~~~~~~a~e~-----~~-------------~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i  196 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQELLSTAMEH-----LI-------------QLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCS  196 (725)
T ss_pred             HHHHHHHHHHHhccCchhHHHHHHHH-----HH-------------HHhhhHhHHHHhccCCccccccccchhHHhcCcc
Confidence            66666665555432222111111110     00             0123456788999999999999999999999998


Q ss_pred             cccc
Q 038835          283 SRVA  286 (337)
Q Consensus       283 ~~~~  286 (337)
                      |...
T Consensus       197 ~~ev  200 (725)
T KOG1093|consen  197 FTEV  200 (725)
T ss_pred             HHHH
Confidence            8764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.44  E-value=0.0025  Score=56.26  Aligned_cols=146  Identities=14%  Similarity=0.232  Sum_probs=82.6

Q ss_pred             eEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC--cccceeEEeeCC--EEEEEEe
Q 038835            5 KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN--IVKLKEVIREND--ILYFVFE   80 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~--~~~lv~e   80 (337)
                      .+++.+..|....+|.....  ++.+++..-.............+|..+++.+.---  +...++++.++.  ..+.||+
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            35566655666666777544  78888882222222223333346888888774322  333444444444  6799999


Q ss_pred             ecCCCH---------HH--HHh-----------h---cc-C------CCCHHHHHHHHHHH--------------HHHHH
Q 038835           81 YMECNL---------YQ--LMK-----------D---RE-K------CFSEAEVRNWCFQV--------------FQGLA  114 (337)
Q Consensus        81 ~~~~~l---------~~--~~~-----------~---~~-~------~l~~~~~~~~~~qi--------------l~al~  114 (337)
                      |++|..         ..  ...           +   .+ .      .....++..+..+.              ..-..
T Consensus       106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~  185 (321)
T COG3173         106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK  185 (321)
T ss_pred             EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence            998731         11  000           0   00 0      01112222332222              12334


Q ss_pred             HHHHc--------CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835          115 YMHQR--------GYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus       115 ~LH~~--------~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      +++.+        .++|+|+.+.|++++.+ -+-+.||+.+...++.
T Consensus       186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence            45443        48999999999999887 6889999998876544

>PLN02236 choline kinase

Probab=97.37  E-value=0.0016  Score=58.72  Aligned_cols=136  Identities=15%  Similarity=0.226  Sum_probs=79.1

Q ss_pred             eeeecccCceEEEEEEECC----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc-ccceeEEeeCCEEEEEEee
Q 038835            7 IKEVGDGTFGSVWRAISKQ----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI-VKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~   81 (337)
                      ++.+..|-...+|++....    +++.+++|+......  .......|..+++.+...++ .++++.+.++    .|.+|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef  114 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF  114 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence            4566668899999986432    346788998765421  11122468888888854443 4556665432    57899


Q ss_pred             cCCCHHHH-----------H-------hhccC-----CCCHHHHHHHHHHHH-----------------HHHHHH----H
Q 038835           82 MECNLYQL-----------M-------KDREK-----CFSEAEVRNWCFQVF-----------------QGLAYM----H  117 (337)
Q Consensus        82 ~~~~l~~~-----------~-------~~~~~-----~l~~~~~~~~~~qil-----------------~al~~L----H  117 (337)
                      ++|..++.           +       .....     +.....+..++.++.                 ..+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            87633211           1       01110     111233334432221                 111112    1


Q ss_pred             ----HcCccccCCCCCCeeeeCC--cEEEeeCCCccc
Q 038835          118 ----QRGYFHRDLKPENLLVSKD--TIKIADFGLARE  148 (337)
Q Consensus       118 ----~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~  148 (337)
                          ...++|+|+++.||+++..  .+.++||..|..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                2258999999999999863  699999998764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.27  E-value=0.0026  Score=57.13  Aligned_cols=137  Identities=12%  Similarity=0.177  Sum_probs=77.9

Q ss_pred             eeeecccCceEEEEEEECCC---CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc-ccceeEEeeCCEEEEEEeec
Q 038835            7 IKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI-VKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~   82 (337)
                      ++.|..|-...+|++.....   +..|++|+......  ......+|..+++.+..-++ .++++++.+ +   +|.+|+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi   92 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFI   92 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehhh
Confidence            45566688889999865432   33788887754322  11122478888888865444 455666532 2   578888


Q ss_pred             CCCHHH-----------HH-------hhccC-----CCCHHHHHHHHHHH----------------------HHHHHHHH
Q 038835           83 ECNLYQ-----------LM-------KDREK-----CFSEAEVRNWCFQV----------------------FQGLAYMH  117 (337)
Q Consensus        83 ~~~l~~-----------~~-------~~~~~-----~l~~~~~~~~~~qi----------------------l~al~~LH  117 (337)
                      +|..++           .+       .....     +-....+..+..++                      ..-+..+.
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            764321           11       11110     11123333333222                      11122221


Q ss_pred             ----Hc----CccccCCCCCCeeeeC--CcEEEeeCCCcccC
Q 038835          118 ----QR----GYFHRDLKPENLLVSK--DTIKIADFGLAREI  149 (337)
Q Consensus       118 ----~~----~i~H~dikp~Nili~~--~~~kL~Dfg~a~~~  149 (337)
                          ..    -++|.|+.+.||++++  +.++++||..|...
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence                11    2799999999999974  37999999987753

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.22  E-value=0.0061  Score=54.19  Aligned_cols=29  Identities=28%  Similarity=0.635  Sum_probs=25.9

Q ss_pred             cCccccCCCCCCeeeeCCcEEEeeCCCcc
Q 038835          119 RGYFHRDLKPENLLVSKDTIKIADFGLAR  147 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~~~~kL~Dfg~a~  147 (337)
                      .+++|+|+.+.||+++.+.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKDNEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeCCcEEEEECcccc
Confidence            47899999999999998888999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.21  E-value=0.0037  Score=56.76  Aligned_cols=75  Identities=21%  Similarity=0.263  Sum_probs=48.6

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccc-----cCChHHhHHHHHHHHHhcCC--CCC-cccceeEEeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKK-----YYSWEECVNLREVKSLRKMS--HPN-IVKLKEVIRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv   78 (337)
                      .+.||.|.-+.||++.+...++.++||.-..-     .......+..-|...|+.+.  .|. +.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            56789999999999988544567999965321     11122334456888888763  453 4455554  34455688


Q ss_pred             EeecC
Q 038835           79 FEYME   83 (337)
Q Consensus        79 ~e~~~   83 (337)
                      ||+++
T Consensus       112 MEdL~  116 (409)
T PRK12396        112 MEDLS  116 (409)
T ss_pred             HHhCc
Confidence            88885

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.19  E-value=0.0028  Score=55.32  Aligned_cols=30  Identities=23%  Similarity=0.375  Sum_probs=25.1

Q ss_pred             CccccCCCCCCeeeeC-Cc-EEEeeCCCcccC
Q 038835          120 GYFHRDLKPENLLVSK-DT-IKIADFGLAREI  149 (337)
Q Consensus       120 ~i~H~dikp~Nili~~-~~-~kL~Dfg~a~~~  149 (337)
                      .++|+|++|.||+++. +. .-|.||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997 54 569999987753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.92  E-value=0.025  Score=51.79  Aligned_cols=75  Identities=23%  Similarity=0.274  Sum_probs=49.6

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccC--C----hHHhHHHHHHHHHhcCC---CCCcccceeEEeeCCEEE
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--S----WEECVNLREVKSLRKMS---HPNIVKLKEVIRENDILY   76 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~----~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~   76 (337)
                      ..+.||.|....||+..+.  +..++||.-.....  .    ....+...|+..|+.+.   -.++.+++.+.+  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3567899999999999863  45688997652211  0    12223345677776663   246777888766  4457


Q ss_pred             EEEeecCC
Q 038835           77 FVFEYMEC   84 (337)
Q Consensus        77 lv~e~~~~   84 (337)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999976

>PTZ00384 choline kinase; Provisional

Probab=96.91  E-value=0.0051  Score=56.20  Aligned_cols=30  Identities=30%  Similarity=0.275  Sum_probs=26.5

Q ss_pred             cCccccCCCCCCeeeeCCcEEEeeCCCccc
Q 038835          119 RGYFHRDLKPENLLVSKDTIKIADFGLARE  148 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~~~~kL~Dfg~a~~  148 (337)
                      ..++|.|+-+.||+.+.+.+.++||..|..
T Consensus       227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecCCCEEEEEeccccC
Confidence            468999999999999888999999997763

>PRK10593 hypothetical protein; Provisional

Probab=96.71  E-value=0.011  Score=52.18  Aligned_cols=104  Identities=11%  Similarity=0.102  Sum_probs=71.4

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCC---CCcccceeEEee---CCEEEEEE
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH---PNIVKLKEVIRE---NDILYFVF   79 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~   79 (337)
                      -.+.||.|..+.||..... +| .+++|..+...   .......|+..++.|.-   -.+.++++++..   .+..++||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         18 RVECISEQPYAALWALYDS-QG-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             eeeecCCccceeEEEEEcC-CC-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            3567999999999998543 23 46677743211   12345689999988843   357778877654   36689999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR  119 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~  119 (337)
                      |+++|......     ..+......+..+++.+|+-||+.
T Consensus        93 E~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         93 ERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             eccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            99998654331     134455667778889999999975

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.42  E-value=0.073  Score=47.32  Aligned_cols=29  Identities=17%  Similarity=0.108  Sum_probs=25.9

Q ss_pred             CccccCCCCCCeeeeCC-cEEEeeCCCccc
Q 038835          120 GYFHRDLKPENLLVSKD-TIKIADFGLARE  148 (337)
Q Consensus       120 ~i~H~dikp~Nili~~~-~~kL~Dfg~a~~  148 (337)
                      +++|+|+.+.|++++.+ .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            79999999999999776 889999997764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PHA03111 Ser/Thr kinase; Provisional

Probab=96.33  E-value=0.0085  Score=52.59  Aligned_cols=75  Identities=16%  Similarity=0.221  Sum_probs=46.6

Q ss_pred             EEEEEeecCCCH----HHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HcCccccCCCCCCeeeeCC----------
Q 038835           75 LYFVFEYMECNL----YQLMKDREKCFSEAEVRNWCFQVFQGLAYMH----QRGYFHRDLKPENLLVSKD----------  136 (337)
Q Consensus        75 ~~lv~e~~~~~l----~~~~~~~~~~l~~~~~~~~~~qil~al~~LH----~~~i~H~dikp~Nili~~~----------  136 (337)
                      -.|||+++.++.    .....+.+-.--.+-++.++.||+.-.-.+-    ..+++|-||||+|||+.+.          
T Consensus       250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~  329 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKD  329 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECC
Confidence            468888876532    2223333322234557778888866553342    3479999999999998532          


Q ss_pred             ---------cEEEeeCCCcccC
Q 038835          137 ---------TIKIADFGLAREI  149 (337)
Q Consensus       137 ---------~~kL~Dfg~a~~~  149 (337)
                               .++|.||.+|...
T Consensus       330 ~~~vF~Epi~~~LnDFDfSqv~  351 (444)
T PHA03111        330 ATYVFNEPIKACLNDFDFSQVA  351 (444)
T ss_pred             eEEEeccchhhhhcccCHHHHc
Confidence                     2567777776654

>PTZ00296 choline kinase; Provisional

Probab=96.32  E-value=0.048  Score=50.91  Aligned_cols=74  Identities=14%  Similarity=0.147  Sum_probs=46.1

Q ss_pred             EeeeecccCceEEEEEEECCC--------CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcc-cceeEEeeCCEEE
Q 038835            6 LIKEVGDGTFGSVWRAISKQS--------GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV-KLKEVIRENDILY   76 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~   76 (337)
                      -++.|..|-...+|++.....        ++.|++++.-......  .....|..+++.+...+|. ++++.+. +   +
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l--IdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g  182 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL--YNPISEFEVYKTMSKYRIAPQLLNTFS-G---G  182 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce--eCHHHHHHHHHHHHHCCCCCceEEEeC-C---C
Confidence            456777788899999975421        5678888875543221  1224688888877544443 4555543 2   3


Q ss_pred             EEEeecCCC
Q 038835           77 FVFEYMECN   85 (337)
Q Consensus        77 lv~e~~~~~   85 (337)
                      .|.||++|.
T Consensus       183 ~I~efi~g~  191 (442)
T PTZ00296        183 RIEEWLYGD  191 (442)
T ss_pred             EEEEeeCCc
Confidence            578898864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.29  E-value=0.016  Score=51.67  Aligned_cols=75  Identities=21%  Similarity=0.370  Sum_probs=59.0

Q ss_pred             CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCCcEEEeeCCCcccCC
Q 038835           72 NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKDTIKIADFGLAREIN  150 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~  150 (337)
                      ..+.|++|++-++.+. .+..    -..+++..++++++..++-+.++ .+-|||+...||||+.++|.|+||-+++...
T Consensus       298 ~~y~yl~~kdhgt~is-~ik~----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsRl~~  372 (488)
T COG5072         298 TLYLYLHFKDHGTPIS-IIKA----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSRLSY  372 (488)
T ss_pred             ceEEEEEEecCCceee-eeec----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeeeccc
Confidence            4566788887655443 2322    35788899999999999888866 6899999999999998899999999998543


Q ss_pred             C
Q 038835          151 S  151 (337)
Q Consensus       151 ~  151 (337)
                      +
T Consensus       373 ~  373 (488)
T COG5072         373 S  373 (488)
T ss_pred             C
Confidence            3

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.11  E-value=0.19  Score=44.03  Aligned_cols=74  Identities=16%  Similarity=0.210  Sum_probs=46.4

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC---CCCCcccceeEEeeCCEEEEEEeec
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM---SHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      -.+.++.|..+.+|...  .+++.+.+|+-....    ...+..|+.-|+.|   .--.+.+++++...++..++||||+
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            45678889999999986  678889999876332    22345677777777   3445778888888777779999998


Q ss_pred             CCC
Q 038835           83 ECN   85 (337)
Q Consensus        83 ~~~   85 (337)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            744

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=96.01  E-value=0.011  Score=52.17  Aligned_cols=76  Identities=18%  Similarity=0.245  Sum_probs=46.6

Q ss_pred             EEEEEeecCCCHH----HHHhhccCCCCHHHHHHHHHHHHHHHHHH---H-HcCccccCCCCCCeeeeCC----------
Q 038835           75 LYFVFEYMECNLY----QLMKDREKCFSEAEVRNWCFQVFQGLAYM---H-QRGYFHRDLKPENLLVSKD----------  136 (337)
Q Consensus        75 ~~lv~e~~~~~l~----~~~~~~~~~l~~~~~~~~~~qil~al~~L---H-~~~i~H~dikp~Nili~~~----------  136 (337)
                      -.|||+++.++.-    ....+.+-..-.+-++.++.||+.-.--+   - ..+++|-||||+|||+.+.          
T Consensus       246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~  325 (434)
T PF05445_consen  246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN  325 (434)
T ss_pred             cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence            3588998875422    22222222223345667777775433212   1 3479999999999998432          


Q ss_pred             ---------cEEEeeCCCcccCC
Q 038835          137 ---------TIKIADFGLAREIN  150 (337)
Q Consensus       137 ---------~~kL~Dfg~a~~~~  150 (337)
                               .++|.||.+|...+
T Consensus       326 ~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  326 RNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             eEEEecccceeeecccCHHHhcc
Confidence                     26788888887643

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.72  E-value=0.43  Score=42.78  Aligned_cols=28  Identities=32%  Similarity=0.354  Sum_probs=24.0

Q ss_pred             cCccccCCCCCCeeeeCCcEEEeeCCCcc
Q 038835          119 RGYFHRDLKPENLLVSKDTIKIADFGLAR  147 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~~~~kL~Dfg~a~  147 (337)
                      .++||+|+.+.|||++ +.+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-DGPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-CCcEEEeCCCCC
Confidence            3689999999999995 478899999665

>PRK06148 hypothetical protein; Provisional

Probab=95.25  E-value=0.57  Score=48.71  Aligned_cols=30  Identities=37%  Similarity=0.504  Sum_probs=25.3

Q ss_pred             cCccccCCCCCCeeeeCC---cEE-EeeCCCccc
Q 038835          119 RGYFHRDLKPENLLVSKD---TIK-IADFGLARE  148 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~~---~~k-L~Dfg~a~~  148 (337)
                      .++||+|+++.|||++.+   .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            479999999999999876   454 999998764

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.91  E-value=0.025  Score=46.01  Aligned_cols=32  Identities=22%  Similarity=0.357  Sum_probs=27.9

Q ss_pred             CccccCCCCCCeeeeCCcEEEeeCCCcccCCC
Q 038835          120 GYFHRDLKPENLLVSKDTIKIADFGLAREINS  151 (337)
Q Consensus       120 ~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~  151 (337)
                      -.+|+|+.|.||+++.+.++|+||+.|...++
T Consensus        78 ~p~H~D~~~~N~~~~~~~~~lIDwe~a~~gDp  109 (188)
T PRK10271         78 APLHMDVHAGNLVHSASGLRLIDWEYAGDGDI  109 (188)
T ss_pred             eeecCCCCCccEEEECCCEEEEeCCcccCCCH
Confidence            46999999999999988899999998876543

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.54  E-value=0.2  Score=45.68  Aligned_cols=60  Identities=23%  Similarity=0.197  Sum_probs=38.4

Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCCeeeeC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH-QRGYFHRDLKPENLLVSK  135 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH-~~~i~H~dikp~Nili~~  135 (337)
                      ..++=+|..|-....+.+... .+|...+.++.-...|+.-+- --+++|.|+.|.||++-.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            345556666744444444322 466666666666666655433 458999999999999953

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	337
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-56
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-56
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-56
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-56
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-56
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-56
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-56
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-56
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-56
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-56
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-56
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-56
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-55
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-55
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-55
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-55
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-55
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-55
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-55
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-55
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-55
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-55
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-55
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-55
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-55
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-55
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-55
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-55
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-55
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-55
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-55
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-55
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-55
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-55
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-55
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-54
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-54
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-54
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-52
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-50
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-50
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-50
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-49
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-49
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-49
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-48
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-48
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-47
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-47
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-47
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-47
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-47
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-47
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-47
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-47
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-47
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-47
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-47
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-47
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-47
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-47
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-47
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-47
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-47
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-47
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-47
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-47
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-47
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-47
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-46
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-46
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-46
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-46
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-46
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-46
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-46
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-45
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-45
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-45
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-45
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-45
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-45
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-45
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-45
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-44
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-44
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-44
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-44
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-44
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-44
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-44
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-44
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-44
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-44
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-44
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-44
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-44
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-44
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-44
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-44
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-44
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-44
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-44
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-44
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-44
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-44
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-44
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-44
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-44
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-44
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-44
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-44
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-44
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-44
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-44
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-44
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-44
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-44
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-44
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-44
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-44
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-44
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-44
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-44
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-44
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-44
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-44
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-44
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-44
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-44
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-43
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-43
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-43
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-43
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-43
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-43
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-43
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-43
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-43
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-43
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-43
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-43
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-43
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-43
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-43
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-43
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-43
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-43
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-43
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-43
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-43
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-43
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-43
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-43
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-43
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-43
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-43
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-43
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-42
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-42
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-42
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-42
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-42
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-42
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-42
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-42
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-42
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-42
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-42
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-42
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-42
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-42
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-39
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-39
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		9e-39
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-38
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-37
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-37
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-36
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-36
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-36
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-36
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-36
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-36
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-36
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-36
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-36
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-36
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-36
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-35
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-35
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-35
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-35
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-35
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-35
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-35
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-35
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-35
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-35
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-35
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-35
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-35
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-35
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-35
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-35
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-35
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-35
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-35
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-35
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-35
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-34
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-34
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-33
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-32
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-32
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-32
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-31
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-31
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-31
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-31
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-31
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-30
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-30
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-30
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-29
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-29
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-29
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-29
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-29
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-29
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-29
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-29
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-28
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-28
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-28
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-28
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-28
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-28
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-27
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-27
3soa_A	444	Full-Length Human Camkii Length = 444		6e-27
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-26
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-26
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-26
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-26
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-26
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-26
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-25
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-25
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-25
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-25
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-25
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		7e-25
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-25
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-24
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-24
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-24
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-24
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-24
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-24
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-24
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		6e-24
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-24
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-24
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-24
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		6e-24
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-24
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-24
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-24
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-24
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-24
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-24
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-24
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-23
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-23
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-23
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-23
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-23
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-23
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-23
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-23
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-23
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-23
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-23
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-23
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-23
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-23
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-23
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-23
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-23
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-23
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-23
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-23
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-23
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-23
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-23
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-23
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-23
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-23
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-23
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-23
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-23
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-23
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-23
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-23
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-23
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-23
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-23
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-22
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-22
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-22
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-22
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-22
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-22
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-22
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-22
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-22
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-22
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-22
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-22
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-22
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-22
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-22
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-22
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-22
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-21
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-21
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-21
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-21
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-21
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-21
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-21
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-21
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-21
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-21
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-21
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-21
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-21
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-21
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-21
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-21
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-21
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-21
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-21
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-21
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-21
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-21
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-21
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-21
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-21
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-21
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-21
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-21
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-21
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-21
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-21
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-21
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-21
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-21
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-21
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-21
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-21
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-21
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-20
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-20
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-20
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-20
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-20
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-20
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-20
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-20
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-20
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-20
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-20
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-20
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-20
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-20
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-20
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-20
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-20
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-20
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-20
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-20
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-20
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-20
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-20
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-20
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-20
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-20
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-20
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-20
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-20
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-20
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-20
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-20
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-20
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-20
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-20
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-20
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-20
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-20
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-20
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-20
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-20
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-20
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-20
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-20
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-20
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-19
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-19
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-19
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-19
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-19
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-19
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-19
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-19
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-19
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-19
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-19
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-19
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-19
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-19
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-19
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-19
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-19
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-19
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-19
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-19
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-19
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-19
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-19
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-19
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-19
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-19
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-19
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-19
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-19
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		8e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-19
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		8e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-19
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-19
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-19
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		9e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-18
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-18
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-18
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-18
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-18
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-18
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-18
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-18
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-18
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-18
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-18
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-18
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-18
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-18
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-18
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-18
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-17
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-17
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-17
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-17
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-17
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-17
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-16
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-16
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-16
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-16
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-15
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-15
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-15
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-15
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-15
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-14
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-14
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-14
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-14
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-14
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-14
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-13
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-13
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-13
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-13
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-13
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-13
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-13
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-13
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-13
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-13
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-13
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-13
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-13
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-12
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-12
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-11
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-11
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		3e-11

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  214 bits (545), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 178/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W     +    +YK
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG---VTSMPDYK 238
Query: 237 --FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  214 bits (545), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 112/286 (39%), Positives = 176/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 247
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  214 bits (545), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 114/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKPENLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 180
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 239
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  214 bits (545), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 114/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKPENLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 182
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 241
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  214 bits (544), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 114/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKPENLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 180
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 239
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  214 bits (544), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 112/286 (39%), Positives = 176/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 241
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  214 bits (544), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 114/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKPENLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 240
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  214 bits (544), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 112/286 (39%), Positives = 176/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 244
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  214 bits (544), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 112/286 (39%), Positives = 176/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 240
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  214 bits (544), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 112/286 (39%), Positives = 176/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 239
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  214 bits (544), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 112/286 (39%), Positives = 176/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 247
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  214 bits (544), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 178/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W     +    +YK
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG---VTSMPDYK 238
Query: 237 --FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  213 bits (543), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 114/288 (39%), Positives = 175/288 (60%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L   M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKPENLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 179
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 238
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 175/288 (60%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L   M            ++++ FQ+ QGLA+ H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 182
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 241
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 182
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 241
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 175/288 (60%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L   M            ++++ FQ+ QGLA+ H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 240
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 178
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 237
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 111/286 (38%), Positives = 176/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGL++ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 240
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 178
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 237
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 179
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 238
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 179
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 238
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 179
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 238
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 178/290 (61%), Gaps = 13/290 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 183
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W     +    +
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG---VTSMPD 240
Query: 235 YK--FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           YK  FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 179
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 238
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 114/290 (39%), Positives = 178/290 (61%), Gaps = 13/290 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 180
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W     +    +
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG---VTSMPD 237
Query: 235 YK--FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           YK  FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 182
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 241
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 240
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 112/286 (39%), Positives = 175/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L   M            ++++ FQ+ QGLA+ H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 239
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 180
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 239
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 287

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  212 bits (540), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 176/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 240
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 288

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  212 bits (540), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 177/288 (61%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE+++ +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 182
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 241
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  212 bits (539), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 113/288 (39%), Positives = 175/288 (60%), Gaps = 9/288 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L   M            ++++ FQ+ QGLA+ H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLLQSY 174
               HRDLKP+NLL++ +  IK+ADFGLAR      P   Y   V T WYRAPE+LL   
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYXHEVVTLWYRAPEILLGCK 182
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            YS+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+       
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYK 241
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  212 bits (539), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 111/286 (38%), Positives = 175/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+ K++            +RE+  L++++H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 240
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  212 bits (539), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 111/286 (38%), Positives = 175/286 (61%), Gaps = 5/286 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+ K++            +RE+  L++++H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPS 239
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  211 bits (538), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 111/285 (38%), Positives = 175/285 (61%), Gaps = 5/285 (1%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHP 60
           E ++ ++++G+GT+G V++A +K +GEVVA+KK++            +RE+  L++++HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    YS
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           + VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         F
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPSF 240
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           P+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 106/287 (36%), Positives = 182/287 (63%), Gaps = 8/287 (2%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM 57
           ME+Y+ +++VG+GT+G V++A   Q G +VA+K+++    + +E +    +RE+  L+++
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLD--AEDEGIPSTAIREISLLKEL 76
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            HPNIV L +VI     L  VFE+ME +L +++ + +    +++++ + +Q+ +G+A+ H
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYL 175
           Q    HRDLKP+NLL++ D  +K+ADFGLAR        +T  V T WYRAP+VL+ S  
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS+ VD+W++G I AE+IT +PLFPG ++ D++ KI S++GTP    W     L      
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            F      P S ++P   ++ + L++++  +DP+KR +A +A+ HP+
Sbjct: 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  209 bits (531), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 106/287 (36%), Positives = 182/287 (63%), Gaps = 8/287 (2%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM 57
           ME+Y+ +++VG+GT+G V++A   Q G +VA+K+++    + +E +    +RE+  L+++
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLD--AEDEGIPSTAIREISLLKEL 76
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            HPNIV L +VI     L  VFE+ME +L +++ + +    +++++ + +Q+ +G+A+ H
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYL 175
           Q    HRDLKP+NLL++ D  +K+ADFGLAR        +T  V T WYRAP+VL+ S  
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS+ VD+W++G I AE+IT +PLFPG ++ D++ KI S++GTP    W     L      
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            F      P S ++P   ++ + L++++  +DP+KR +A +A+ HP+
Sbjct: 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  207 bits (527), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 108/285 (37%), Positives = 172/285 (60%), Gaps = 10/285 (3%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVN---LREVKSLRKM 57
           +RY+ +  +G+G F +V++A  K + ++VAIKK+K  + S  ++ +N   LRE+K L+++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           SHPNI+ L +       +  VF++ME +L  ++KD     + + ++ +     QGL Y+H
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 118 QRGYFHRDLKPENLLVSKDTI-KIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYL 175
           Q    HRDLKP NLL+ ++ + K+ADFGLA+   S    +   V TRWYRAPE+L  + +
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARM 189
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y   VDMWA+G I+AEL+   P  PG S+ D++ +I   +GTPT++ W D   L   + +
Sbjct: 190 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 249
Query: 236 K-FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           K FP   G+PL  +  +A  D + LI  L  ++P  R TA +AL+
Sbjct: 250 KSFP---GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 102/285 (35%), Positives = 169/285 (59%), Gaps = 4/285 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           ME Y  + ++G+GT+ +V++  SK +  +VA+K+++ ++     C  +REV  L+ + H 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NIV L ++I     L  VFEY++ +L Q + D     +   V+ + FQ+ +GLAY H++ 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 121 YFHRDLKPENLLVS-KDTIKIADFGLAREINSRP--PFTEYVSTRWYRAPEVLLQSYLYS 177
             HRDLKP+NLL++ +  +K+ADFGLAR   S P   +   V T WYR P++LL S  YS
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           +++DMW +G I  E+ T RPLFPG++  ++++ I  ++GTPT+++W   L       Y +
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           P+     L    P  + D   L+  L  ++   R +A +A++HPF
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  196 bits (498), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 102/285 (35%), Positives = 170/285 (59%), Gaps = 5/285 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME+Y  ++++G+GT+G V++A     GE  A+KK++ +K         +RE+  L+++ H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIVKL +VI     L  VFE+++ +L +L+   E        +++  Q+  G+AY H R
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRDLKP+NLL++++  +KIADFGLAR        +T  V T WYRAP+VL+ S  YS
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           + +D+W++G I AE++   PLFPG SEAD++ +I  ++GTP   +W +   L +  +  F
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF 238
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                +P    +   ++  + L++ +   DP++R TA +AL+H +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 102/285 (35%), Positives = 170/285 (59%), Gaps = 5/285 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME+Y  ++++G+GT+G V++A     GE  A+KK++ +K         +RE+  L+++ H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIVKL +VI     L  VFE+++ +L +L+   E        +++  Q+  G+AY H R
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRDLKP+NLL++++  +KIADFGLAR        +T  V T WYRAP+VL+ S  YS
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           + +D+W++G I AE++   PLFPG SEAD++ +I  ++GTP   +W +   L +  +  F
Sbjct: 180 TTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF 238
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                +P    +   ++  + L++ +   DP++R TA +AL+H +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 101/285 (35%), Positives = 170/285 (59%), Gaps = 5/285 (1%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME+Y  ++++G+GT+G V++A     GE  A+KK++ +K         +RE+  L+++ H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIVKL +VI     L  VFE+++ +L +L+   E        +++  Q+  G+AY H R
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRDLKP+NLL++++  +KIADFGLAR        +T  + T WYRAP+VL+ S  YS
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           + +D+W++G I AE++   PLFPG SEAD++ +I  ++GTP   +W +   L +  +  F
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF 238
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                +P    +   ++  + L++ +   DP++R TA +AL+H +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 108/295 (36%), Positives = 171/295 (57%), Gaps = 15/295 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           + Y++I+ +G+G +G V  A  + +G+ VAIKK+   +         LRE+K L+   H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 61  NIVKLKEVIR------ENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           NI+ +K+++R      E   +Y V + ME +L+Q++   +    E  VR + +Q+ +GL 
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE-HVRYFLYQLLRGLK 172
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-----FTEYVSTRWYRAPE 168
           YMH     HRDLKP NLLV+++  +KI DFG+AR + + P       TEYV+TRWYRAPE
Sbjct: 173 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS-WADGL 227
           ++L  + Y+  +D+W++G I  E++  R LFPG +   ++  I  V+GTP+     A G 
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              RA     P    VP   + P A++ A+SL+  +  ++PS R +AA AL+HPF
Sbjct: 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  192 bits (487), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 108/295 (36%), Positives = 171/295 (57%), Gaps = 15/295 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           + Y++I+ +G+G +G V  A  + +G+ VAIKK+   +         LRE+K L+   H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 61  NIVKLKEVIR------ENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           NI+ +K+++R      E   +Y V + ME +L+Q++   +    E  VR + +Q+ +GL 
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE-HVRYFLYQLLRGLK 173
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPP-----FTEYVSTRWYRAPE 168
           YMH     HRDLKP NLLV+++  +KI DFG+AR + + P       TEYV+TRWYRAPE
Sbjct: 174 YMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS-WADGL 227
           ++L  + Y+  +D+W++G I  E++  R LFPG +   ++  I  V+GTP+     A G 
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              RA     P    VP   + P A++ A+SL+  +  ++PS R +AA AL+HPF
Sbjct: 294 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 348

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  191 bits (485), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 172/293 (58%), Gaps = 15/293 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM 57
           ++RY+ I ++G+GT+G V++AI   + E VAIK+++ ++   EE V    +REV  L+++
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKEL 90
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            H NI++LK VI  N  L+ +FEY E +L + M D+    S   ++++ +Q+  G+ + H
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 118 QRGYFHRDLKPENLLVS------KDTIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVL 170
            R   HRDLKP+NLL+S         +KI DFGLAR        FT  + T WYR PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           L S  YS+ VD+W++  I AE++   PLFPG SE D+++KI  V+G P   +W  G+   
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP-GVTAL 268
Query: 231 RAINYKFPQLVGVPLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                 FP+  G  L  VL    + + + L+ ++   DP KR +A  AL+HP+
Sbjct: 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 105/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L    H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 143
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++  + +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 144 SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+    G+ L +A
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINL-KA 262
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 314

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  187 bits (475), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 145
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL+ +   +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 264
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 141
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL+ +   +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NXIINLKA 260
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 143
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 262
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 314

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 141
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL+ +   +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NXIINLKA 260
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 141
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL+ +   +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 260
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 141
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 260
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 161
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 162 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 280
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 332

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 145
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL+ +   +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 264
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 149
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 268
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 269 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 320

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 141
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 260
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 139
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 258
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 310

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 146
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 265
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 317

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 147
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 266
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 267 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 318

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 138
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 257
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 258 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 309

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 145
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 264
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 177/291 (60%), Gaps = 15/291 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM 57
           M++Y+ ++++G+GT+G+V++A ++++ E+VA+K+++      +E V    LRE+  L+++
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKEL 58
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            H NIV+L +V+  +  L  VFE+ + +L +             V+++ FQ+ +GL + H
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSY 174
            R   HRDLKP+NLL++++  +K+ADFGLAR   I  R  ++  V T WYR P+VL  + 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAK 177
Query: 175 LYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
           LYS+ +DMW+ G I AEL    RPLFPG    D++ +I  ++GTPT++ W     + +  
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPS---MTKLP 234
Query: 234 NYK-FPQL-VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +YK +P       L  ++P  N     L+ +L   +P +R +A EALQHP+
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 167/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L    H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 143
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 262
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 314

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAI+K+    +       LRE+K L +  H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 145
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 264
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 167/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 139
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P Q+   + ++  +A
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDL-NCIINLKA 258
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 310

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH--LSNDHICYFLYQILRGLKYIH 145
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 264
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  184 bits (467), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 105/298 (35%), Positives = 162/298 (54%), Gaps = 21/298 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           ++L   +G+G +G V  A  K +GE+VAIKK++           LRE+K L+   H NI+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 64  KLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            +  + R +       +Y + E M+ +L++++    +  S+  ++ + +Q  + +  +H 
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREI------NSRPP-----FTEYVSTRWYRA 166
               HRDLKP NLL++ +  +K+ DFGLAR I      NS P       TEYV+TRWYRA
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEV+L S  YS  +D+W+ G I+AEL   RP+FPG     ++  I  +IGTP  D+    
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 227 LLLARAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   RA  Y    P     PL  + P  N   + L+  +  +DP+KR TA EAL+HP+
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  184 bits (466), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 166/292 (56%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V   M  +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 161
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL+ +   +KI DFGLAR    + +     TEYV+TRWYRAPE++L 
Sbjct: 162 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 280
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 332

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  184 bits (466), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 101/290 (34%), Positives = 175/290 (60%), Gaps = 13/290 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM 57
           M++Y+ ++++G+GT+G+V++A ++++ E+VA+K+++      +E V    LRE+  L+++
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKEL 58
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            H NIV+L +V+  +  L  VFE+ + +L +             V+++ FQ+ +GL + H
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYL 175
            R   HRDLKP+NLL++++  +K+A+FGLAR        ++  V T WYR P+VL  + L
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 176 YSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           YS+ +DMW+ G I AEL    RPLFPG    D++ +I  ++GTPT++ W     + +  +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS---MTKLPD 235
Query: 235 YK-FPQL-VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           YK +P       L  ++P  N     L+ +L   +P +R +A EALQHP+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 99/292 (33%), Positives = 170/292 (58%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  ++ +G+G +G V  A        VAIKK+    +       LRE++ L +  H N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + +++++R + +     +Y V + ME +LY+L+K ++   S   +  + +Q+ +GL Y+H
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ--LSNDHICYFLYQILRGLKYIH 161
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR    E +     TE V+TRWYRAPE++L 
Sbjct: 162 SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINMKA 280
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    V  + L P ++  A+ L+  + +++P+KR T  EAL HP+
Sbjct: 281 RNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPY 332

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 111/339 (32%), Positives = 190/339 (56%), Gaps = 57/339 (16%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMS- 58
           + +Y+L+K++G G +G VW++I +++GEVVA+KK+   +  S +     RE+  L ++S 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 59  HPNIVKLKEVIR-END-ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           H NIV L  V+R +ND  +Y VF+YME +L+ ++  R         +   +Q+ + + Y+
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI--RANILEPVHKQYVVYQLIKVIKYL 125
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREI----------------------NSRP 153
           H  G  HRD+KP N+L++ +  +K+ADFGL+R                        + +P
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS 213
             T+YV+TRWYRAPE+LL S  Y+  +DMW++G I+ E++  +P+FPG+S  +++ +I  
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 214 VIGTPT-------QDSWADGLLLA------------RAINYKFPQLVGVPLSVLMPSA-- 252
           VI  P+       Q  +A  ++ +            R I  K+  L    L  + P A  
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL----LLKINPKADC 301
Query: 253 NKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH 291
           N++A+ L+  L  ++P+KR +A +AL+HPF  +   FH+
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSI---FHN 337

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 166/292 (56%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 145
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT----EYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR  +     T    E V+TRWYRAPE++L 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 264
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 166/292 (56%), Gaps = 15/292 (5%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 63  VKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           + + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +GL Y+H
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 146
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT----EYVSTRWYRAPEVLLQ 172
                HRDLKP NLL++    +KI DFGLAR  +     T    E V+TRWYRAPE++L 
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + ++  +A
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIINLKA 265
Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 317

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 103/309 (33%), Positives = 179/309 (57%), Gaps = 25/309 (8%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           ++K ++++G+GT+ +V++ ++K +G  VA+K++K           +RE+  ++++ H NI
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDRE-----KCFSEAEVRNWCFQVFQGLAYMH 117
           V+L +VI   + L  VFE+M+ +L + M  R      +      V+ + +Q+ QGLA+ H
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 118 QRGYFHRDLKPENLLVSK-DTIKIADFGLARE----INSRPPFTEYVSTRWYRAPEVLLQ 172
           +    HRDLKP+NLL++K   +K+ DFGLAR     +N+   F+  V T WYRAP+VL+ 
Sbjct: 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT---FSSEVVTLWYRAPDVLMG 182
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR- 231
           S  YS+ +D+W+ G I+AE+IT +PLFPGT++ +++  I  ++GTP +  W     L + 
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 232 --AINYKFPQLVGVPLSVLMPSA----NKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
              I  + P+ +     VL P      + + +  +  L   +P  R +A +AL HP+   
Sbjct: 243 NPNIQQRPPRDL---RQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW--F 297
Query: 286 AFMFHHLSV 294
           A  +HH S+
Sbjct: 298 AEYYHHASM 306

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 21/298 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           ++L   +G+G +G V  A  K +GE+VAIKK++           LRE+K L+   H NI+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 64  KLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            +  + R +       +Y + E M+ +L++++    +  S+  ++ + +Q  + +  +H 
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREI------NSRPP-----FTEYVSTRWYRA 166
               HRDLKP NLL++ +  +K+ DFGLAR I      NS P       TE V+TRWYRA
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEV+L S  YS  +D+W+ G I+AEL   RP+FPG     ++  I  +IGTP  D+    
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 227 LLLARAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   RA  Y    P     PL  + P  N   + L+  +  +DP+KR TA EAL+HP+
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 161/298 (54%), Gaps = 21/298 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           ++L   +G+G +G V  A  K +GE+VAIKK++           LRE+K L+   H NI+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 64  KLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            +  + R +       +Y + E M+ +L++++    +  S+  ++ + +Q  + +  +H 
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREI------NSRPP-----FTEYVSTRWYRA 166
               HRDLKP NLL++ +  +K+ DFGLAR I      NS P        E+V+TRWYRA
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEV+L S  YS  +D+W+ G I+AEL   RP+FPG     ++  I  +IGTP  D+    
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 227 LLLARAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   RA  Y    P     PL  + P  N   + L+  +  +DP+KR TA EAL+HP+
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 111/283 (39%), Positives = 159/283 (56%), Gaps = 16/283 (5%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIVKLKEV 68
           VG G +GSV  AI K+SGE VAIKK+ + + S        RE+  L+ M H N++ L +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 69  ------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
                 +R     Y V  +M+ +L ++M  +   FSE +++   +Q+ +GL Y+H  G  
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           HRDLKP NL V++D  +KI DFGLAR  ++    T YV TRWYRAPEV+L    Y+  VD
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVD 206
Query: 182 MWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY--KFPQ 239
           +W++G IMAE++T + LF G    D++ +I  V G P  + +   L    A +Y    PQ
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE-FVQKLNDKAAKSYIQSLPQ 265
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                 + L P A+  A  L+  +   D  KR TAA+AL HPF
Sbjct: 266 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 111/283 (39%), Positives = 158/283 (55%), Gaps = 16/283 (5%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIVKLKEV 68
           VG G +GSV  AI K+SGE VAIKK+ + + S        RE+  L+ M H N++ L +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 69  ------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
                 +R     Y V  +M+ +L ++M      FSE +++   +Q+ +GL Y+H  G  
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGME---FSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           HRDLKP NL V++D  +KI DFGLAR  ++    T YV TRWYRAPEV+L    Y+  VD
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVD 224
Query: 182 MWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY--KFPQ 239
           +W++G IMAE++T + LF G    D++ +I  V G P  + +   L    A +Y    PQ
Sbjct: 225 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE-FVQKLNDKAAKSYIQSLPQ 283
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                 + L P A+  A  L+  +   D  KR TAA+AL HPF
Sbjct: 284 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 108/293 (36%), Positives = 166/293 (56%), Gaps = 19/293 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKMS- 58
           RY+ + E+G G +G+V++A    SG  VA+K ++    + EE +    +REV  LR++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEA 62
Query: 59  --HPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAE-VRNWCFQVF 110
             HPN+V+L +V   +       +  VFE+++ +L   +         AE +++   Q  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 111 QGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
           +GL ++H     HRDLKPEN+LV S  T+K+ADFGLAR  + +      V T WYRAPEV
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           LLQS  Y++ VDMW++G I AE+   +PLF G SEAD++ KI  +IG P +D W   + L
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            R     FP     P+  ++P   +    L+  + +++P KR +A  ALQH +
Sbjct: 242 PRG---AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 291

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  178 bits (451), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 108/293 (36%), Positives = 166/293 (56%), Gaps = 19/293 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKMS- 58
           RY+ + E+G G +G+V++A    SG  VA+K ++    + EE +    +REV  LR++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEA 62
Query: 59  --HPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAE-VRNWCFQVF 110
             HPN+V+L +V   +       +  VFE+++ +L   +         AE +++   Q  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 111 QGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
           +GL ++H     HRDLKPEN+LV S  T+K+ADFGLAR  + +      V T WYRAPEV
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           LLQS  Y++ VDMW++G I AE+   +PLF G SEAD++ KI  +IG P +D W   + L
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            R     FP     P+  ++P   +    L+  + +++P KR +A  ALQH +
Sbjct: 242 PRG---AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 291

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 107/294 (36%), Positives = 163/294 (55%), Gaps = 18/294 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV----NLREVKSLRKMS 58
           RY+ + E+G G +G+V++A    SG  VA+K ++               +REV  LR++ 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 59  ---HPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAE-VRNWCFQV 109
              HPN+V+L +V   +       +  VFE+++ +L   +         AE +++   Q 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
            +GL ++H     HRDLKPEN+LV S  T+K+ADFGLAR  + +   T  V T WYRAPE
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPE 189
Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           VLLQS  Y++ VDMW++G I AE+   +PLF G SEAD++ KI  +IG P +D W   + 
Sbjct: 190 VLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 248
Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           L R     FP     P+  ++P   +    L+  + +++P KR +A  ALQH +
Sbjct: 249 LPRG---AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 108/293 (36%), Positives = 166/293 (56%), Gaps = 19/293 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKMS- 58
           RY+ + E+G G +G+V++A    SG  VA+K ++    + EE +    +REV  LR++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEA 62
Query: 59  --HPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAE-VRNWCFQVF 110
             HPN+V+L +V   +       +  VFE+++ +L   +         AE +++   Q  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 111 QGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
           +GL ++H     HRDLKPEN+LV S  T+K+ADFGLAR  + +      V T WYRAPEV
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           LLQS  Y++ VDMW++G I AE+   +PLF G SEAD++ KI  +IG P +D W   + L
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            R     FP     P+  ++P   +    L+  + +++P KR +A  ALQH +
Sbjct: 242 PRG---AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 291

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 107/291 (36%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  +   +SG  +A+KK+ + + S        RE++ L+ M H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 168
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 169 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 226
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   +++ +I  + GTP   S    +    A 
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPA-SVISRMPSHEAR 285
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY    PQ+     + +   AN  AV L+  +   D  KR TA+EAL HP+
Sbjct: 286 NYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPY 336

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  177 bits (448), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L +
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNA 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 159
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 217
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 276
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 277 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 327

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 145
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 203
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 262
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 263 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 158
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 159 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 216
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 275
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 276 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 326

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 135
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 193
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 252
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 253 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 141
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D+ +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 199
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 258
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 259 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 149
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 150 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 207
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 266
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 267 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 317

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 145
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D+ +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 203
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 262
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 263 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 107/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ K + S        RE++ L+ M H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 151
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 268
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 269 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 106/289 (36%), Positives = 164/289 (56%), Gaps = 15/289 (5%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+ ++ VG G +G+V  A+  ++G  VAIKK+ + + S        RE++ L+ M H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 63  VKLKEVIRENDIL------YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           + L +V   ++ L      Y V  +M  +L +LMK  +    E  ++   +Q+ +GL Y+
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYI 144
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H  G  HRDLKP NL V++D  +KI DFGLAR+ +S       V TRWYRAPEV+L    
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MXGXVVTRWYRAPEVILNWMR 202
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y+  VD+W++G IMAE+IT + LF G+   D++ +I  V GTP  + +   L    A NY
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE-FVQRLQSDEAKNY 261
Query: 236 --KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               P+L     + ++ +A+  AV+L+  +   D  +R TA EAL HP+
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 107/293 (36%), Positives = 161/293 (54%), Gaps = 19/293 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKC--FSEAEVRNWCFQVFQG 112
           N++ L +V      + E + +Y V   M  +L  ++K    C   ++  V+   +Q+ +G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CAKLTDDHVQFLIYQILRG 133
Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
           L Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIML 191
Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
               Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSES 250
Query: 232 AINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           A NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D+ +KI DFGL R  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 144
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 202
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 261
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 262 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  175 bits (443), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 144
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 202
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 261
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 262 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 162
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 163 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 220
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 279
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 280 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 330

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 137
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 138 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 195
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 254
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 255 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 305

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 145
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 203
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 262
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 263 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 158
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 159 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 216
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 275
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 276 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 326

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 145
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 203
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 262
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 263 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 150
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 151 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 208
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 267
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 268 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 318

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 159
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 217
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 276
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 277 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 327

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 146
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 204
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 263
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 141
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 199
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 258
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 259 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 135
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 193
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 252
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 150
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 151 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 208
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 267
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 268 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 318

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 151
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 268
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 269 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 151
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 268
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 269 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 137 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 194
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 253
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 254 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 304

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 141
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 199
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 258
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 259 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  174 bits (442), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 137 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 194
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 253
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 254 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 304

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 141
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 199
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 258
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 259 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  +G G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 144
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 202
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 261
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 262 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 144
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 202
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 261
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 262 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 138
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 139 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNW 196
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 255
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 256 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 306

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 146
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  ++    T YV+TRWYRAPE++L  
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNW 204
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 263
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 146
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  ++    T YV+TRWYRAPE++L  
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNW 204
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 263
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 146
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  ++    T YV+TRWYRAPE++L  
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNW 204
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 263
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 165/287 (57%), Gaps = 6/287 (2%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK-MKKKYYSWEECVNLREVKSLRKMSH 59
           ME+Y+ I ++G+G++G V++  ++ +G++VAIKK ++ +     + + LRE++ L+++ H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           PN+V L EV R    L+ VFEY +  +   +   ++   E  V++  +Q  Q + + H+ 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 120 GYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPP-FTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KPEN+L++K + IK+ DFG AR +      + + V+TRWYR+PE+L+    Y 
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGT--PTQDSWADGLLLARAINY 235
             VD+WA+G + AEL++  PL+PG S+ D++Y I   +G   P              +  
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             P+ +  PL +  P+ +  A+ L+      DP++R T  + L HP+
Sbjct: 242 PDPEDME-PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 162/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI D+GLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 167/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +      +    RE++ +RK+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIV 76
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRAPE++  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 254
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 168/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRAPE++  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 254
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 162
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +       YV+TRWYRAPE++L  
Sbjct: 163 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXGYVATRWYRAPEIMLNW 220
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 279
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 280 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 330

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 135
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +       +V+TRWYRAPE++L  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MAGFVATRWYRAPEIMLNW 193
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 252
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 253 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +       +V+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MAGFVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +       +V+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MAGFVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 168/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 89
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRAPE++  
Sbjct: 150 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 209
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 267
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 268 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 318

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 168/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 81
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRAPE++  
Sbjct: 142 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 201
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 202 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 259
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 260 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 310

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 172/297 (57%), Gaps = 24/297 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-KQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM 57
           ++Y+ + E+G+G +G V++A   K  G  VA+K+++ +  + EE +    +REV  LR +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHL 68
Query: 58  S---HPNIVKLKEVI------RENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCF 107
               HPN+V+L +V       RE   L  VFE+++ +L   L K  E       +++  F
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRA 166
           Q+ +GL ++H     HRDLKP+N+LV S   IK+ADFGLAR  + +   T  V T WYRA
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEVLLQS  Y++ VD+W++G I AE+   +PLF G+S+ D++ KI  VIG P ++ W   
Sbjct: 188 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 227 LLLAR-AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + L R A + K  Q    P+   +   ++    L+    +++P+KR +A  AL HP+
Sbjct: 247 VALPRQAFHSKSAQ----PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DF LAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 100/297 (33%), Positives = 171/297 (57%), Gaps = 31/297 (10%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHPN 61
           Y   K +G+G+FG V++A    SGE+VAIKK+   K++ +       RE++ +RK+ H N
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 102
Query: 62  IVKLKEVI------RENDILYFVFEYMECNLYQLMKDREKCFSEAE-------VRNWCFQ 108
           IV+L+         ++   L  V +Y+   +Y++ +     +S A+       V+ + +Q
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQ 158
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRA 166
           +F+ LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRA
Sbjct: 159 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 218
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE++  +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   + 
Sbjct: 219 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE- 277
Query: 227 LLLARAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +      +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 278 -MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 333

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 100/297 (33%), Positives = 171/297 (57%), Gaps = 31/297 (10%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHPN 61
           Y   K +G+G+FG V++A    SGE+VAIKK+   K++ +       RE++ +RK+ H N
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 110
Query: 62  IVKLKEVI------RENDILYFVFEYMECNLYQLMKDREKCFSEAE-------VRNWCFQ 108
           IV+L+         ++   L  V +Y+   +Y++ +     +S A+       V+ + +Q
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQ 166
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRA 166
           +F+ LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRA
Sbjct: 167 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 226
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE++  +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   + 
Sbjct: 227 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE- 285
Query: 227 LLLARAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +      +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 286 -MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 341

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 99/295 (33%), Positives = 170/295 (57%), Gaps = 27/295 (9%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 155
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKDREKCFSEAE-------VRNWCFQVF 110
           +L+         ++   L  V +Y+   +Y++ +     +S A+       V+ + +Q+F
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQLF 211
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
           + LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRAPE
Sbjct: 212 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 271
Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           ++  +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--M 329
Query: 229 LARAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                 +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 330 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 384

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 100/297 (33%), Positives = 171/297 (57%), Gaps = 31/297 (10%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHPN 61
           Y   K +G+G+FG V++A    SGE+VAIKK+   K++ +       RE++ +RK+ H N
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 112
Query: 62  IVKLKEVI------RENDILYFVFEYMECNLYQLMKDREKCFSEAE-------VRNWCFQ 108
           IV+L+         ++   L  V +Y+   +Y++ +     +S A+       V+ + +Q
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQ 168
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRA 166
           +F+ LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRA
Sbjct: 169 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 228
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE++  +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   + 
Sbjct: 229 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE- 287
Query: 227 LLLARAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +      +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 288 -MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 343

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 172/297 (57%), Gaps = 24/297 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-KQSGEVVAIKKMKKKYYSWEECVNL---REVKSLRKM 57
           ++Y+ + E+G+G +G V++A   K  G  VA+K+++ +  + EE + L   REV  LR +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHL 68
Query: 58  S---HPNIVKLKEVI------RENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCF 107
               HPN+V+L +V       RE   L  VFE+++ +L   L K  E       +++  F
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRA 166
           Q+ +GL ++H     HRDLKP+N+LV S   IK+ADFGLAR  + +   T  V T WYRA
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEVLLQS  Y++ VD+W++G I AE+   +PLF G+S+ D++ KI  VIG P ++ W   
Sbjct: 188 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 227 LLLAR-AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + L R A + K  Q    P+   +   ++    L+    +++P+KR +A  AL HP+
Sbjct: 247 VALPRQAFHSKSAQ----PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI  FGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 172/297 (57%), Gaps = 24/297 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-KQSGEVVAIKKMKKKYYSWEECV---NLREVKSLRKM 57
           ++Y+ + E+G+G +G V++A   K  G  VA+K+++ +  + EE +    +REV  LR +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHL 68
Query: 58  S---HPNIVKLKEVI------RENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCF 107
               HPN+V+L +V       RE   L  VFE+++ +L   L K  E       +++  F
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRA 166
           Q+ +GL ++H     HRDLKP+N+LV S   IK+ADFGLAR  + +   T  V T WYRA
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEVLLQS  Y++ VD+W++G I AE+   +PLF G+S+ D++ KI  VIG P ++ W   
Sbjct: 188 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 227 LLLAR-AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + L R A + K  Q    P+   +   ++    L+    +++P+KR +A  AL HP+
Sbjct: 247 VALPRQAFHSKSAQ----PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 100/297 (33%), Positives = 171/297 (57%), Gaps = 31/297 (10%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHPN 61
           Y   K +G+G+FG V++A    SGE+VAIKK+   K++ +       RE++ +RK+ H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 108
Query: 62  IVKLKEVI------RENDILYFVFEYMECNLYQLMKDREKCFSEAE-------VRNWCFQ 108
           IV+L+         ++   L  V +Y+   +Y++ +     +S A+       V+ + +Q
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQ 164
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRA 166
           +F+ LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRA
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 224
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE++  +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   + 
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE- 283
Query: 227 LLLARAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +      +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 284 -MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 169/291 (58%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 64  KLKEVI----RENDILYF--VFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+        + D++Y   V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 254
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T  V+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGXVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI D GLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI D GLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 139
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI D GLAR  +     T YV+TRWYRAPE++L  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE--MTGYVATRWYRAPEIMLNW 197
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 256
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 160/291 (54%), Gaps = 15/291 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      + E + +Y V   M  +L  ++K ++   ++  V+   +Q+ +GL 
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLK 159
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +        V+TRWYRAPE++L  
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXGXVATRWYRAPEIMLNW 217
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A 
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-LLKKISSESAR 276
Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 277 NYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 327

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/290 (34%), Positives = 162/290 (55%), Gaps = 13/290 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           +R + ++ VG G +GSV  A   +  + VA+KK+ + + S        RE++ L+ + H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      I +   +Y V   M  +L  ++K   +  S+  V+   +Q+ +GL 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS--QALSDEHVQFLVYQLLRGLK 145
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP N+ V++D+ ++I DFGLAR+ +     T YV+TRWYRAPE++L  
Sbjct: 146 YIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNW 203
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD-GLLLARA 232
             Y+  VD+W++G IMAEL+  + LFPG+   D++ +I  V+GTP+ +  A      AR 
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 263
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                P +    LS +   AN  A+ L+  +   D  +R +AAEAL H +
Sbjct: 264 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAY 313

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 166/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +      +    RE++ +RK+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIV 76
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRAPE++  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 254
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             + FPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 255 TEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 167/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 254
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 167/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 77
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++  
Sbjct: 138 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 197
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 255
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 256 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 306

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 167/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 254
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 161/291 (55%), Gaps = 20/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A   +S EV   K ++ K +        RE++ +R + HPN+V
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPNVV 95
Query: 64  KLKEVIREND------ILYFVFEYMECNLYQLMKDREKCFSEAE---VRNWCFQVFQGLA 114
            LK     N        L  V EY+   +Y+  +   K         ++ + +Q+ + LA
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+   +  +K+ DFG A+ + +  P    + +R+YRAPE++  
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFG 215
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y++ +D+W+ G +MAEL+  +PLFPG S  D++ +I  V+GTP+++      +    
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT--MNPNY 273
Query: 233 INYKFPQLVGVPLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + +KFPQ+   P S V  P    DA+ LI+ L  + PS R TA EAL HPF
Sbjct: 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 167/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 88
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++  
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 266
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 267 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/297 (33%), Positives = 170/297 (57%), Gaps = 31/297 (10%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHPN 61
           Y   K +G+G+FG V++A    SGE+VAIKK+   K++ +       RE++ +RK+ H N
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 86
Query: 62  IVKLKEVI------RENDILYFVFEYMECNLYQLMKDREKCFSEAE-------VRNWCFQ 108
           IV+L+         ++   L  V +Y+   +Y++ +     +S A+       V+ + +Q
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQ 142
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRA 166
           +F+ LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRA
Sbjct: 143 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 202
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE++  +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   + 
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE- 261
Query: 227 LLLARAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +      +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 262 -MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 97/293 (33%), Positives = 168/293 (57%), Gaps = 23/293 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHPN 61
           Y   K +G+G+FG V++A    SGE+VAIKK+   K++ +       RE++ +RK+ H N
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 93
Query: 62  IVKLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQG 112
           IV+L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ 
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 213
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
             +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +  
Sbjct: 214 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNP 271
Query: 231 RAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 272 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 324

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 100/290 (34%), Positives = 162/290 (55%), Gaps = 13/290 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           +R + ++ VG G +GSV  A   +  + VA+KK+ + + S        RE++ L+ + H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      I +   +Y V   M  +L  ++K   +  S+  V+   +Q+ +GL 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQLLRGLK 145
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP N+ V++D+ ++I DFGLAR+ +     T YV+TRWYRAPE++L  
Sbjct: 146 YIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNW 203
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD-GLLLARA 232
             Y+  VD+W++G IMAEL+  + LFPG+   D++ +I  V+GTP+ +  A      AR 
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 263
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                P +    LS +   AN  A+ L+  +   D  +R +AAEAL H +
Sbjct: 264 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAY 313

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 95/291 (32%), Positives = 165/291 (56%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +      +    RE++ +RK+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNIV 76
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 254
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             + FPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 255 TEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/297 (33%), Positives = 170/297 (57%), Gaps = 31/297 (10%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHPN 61
           Y   K +G+G+FG V++A    SGE+VAIKK+   K++ +       RE++ +RK+ H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 108
Query: 62  IVKLKEVI------RENDILYFVFEYMECNLYQLMKDREKCFSEAE-------VRNWCFQ 108
           IV+L+         ++   L  V +Y+   +Y++ +     +S A+       V+ + +Q
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQ 164
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRA 166
           +F+ LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRA
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRA 224
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE++  +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   + 
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE- 283
Query: 227 LLLARAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +      +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 284 -MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 167/291 (57%), Gaps = 19/291 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NIV
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 80
Query: 64  KLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           +L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ LA
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 115 YMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           Y+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++  
Sbjct: 141 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 200
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +    
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPNY 258
Query: 233 INYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 259 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 309

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 97/293 (33%), Positives = 168/293 (57%), Gaps = 23/293 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSHPN 61
           Y   K +G+G+FG V++A    SGE+VAIKK+   K++ +       RE++ +RK+ H N
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 82
Query: 62  IVKLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQG 112
           IV+L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ 
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P    + +R+YRAPE++
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 202
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
             +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +  
Sbjct: 203 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNP 260
Query: 231 RAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               +KFPQ+   P   V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 261 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 313

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 100/290 (34%), Positives = 161/290 (55%), Gaps = 13/290 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           +R + ++ VG G +GSV  A   +  + VA+KK+ + + S        RE++ L+ + H 
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 79
Query: 61  NIVKLKEV------IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V      I +   +Y V   M  +L  ++K   +  S+  V+   +Q+ +GL 
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQLLRGLK 137
Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP N+ V++D  ++I DFGLAR+ +     T YV+TRWYRAPE++L  
Sbjct: 138 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNW 195
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD-GLLLARA 232
             Y+  VD+W++G IMAEL+  + LFPG+   D++ +I  V+GTP+ +  A      AR 
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 255
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                P +    LS +   AN  A+ L+  +   D  +R +AAEAL H +
Sbjct: 256 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAY 305

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 156/296 (52%), Gaps = 24/296 (8%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK-MKKKYYSWEECVNLREVKSLRKMSH 59
           ME+Y+ +  VG+G++G V +  +K +G +VAIKK ++       + + +RE+K L+++ H
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            N+V L EV ++    Y VFE+++  +   ++          V+ + FQ+  G+ + H  
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-FTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KPEN+LVS+   +K+ DFG AR + +    + + V+TRWYRAPE+L+    Y 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR--AINY 235
             VD+WA+G ++ E+    PLFPG S+ D++Y I   +G           L+ R   +  
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN----------LIPRHQELFN 253
Query: 236 KFPQLVGV---------PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           K P   GV         PL    P  ++  + L       DP KRP  AE L H F
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 101/333 (30%), Positives = 166/333 (49%), Gaps = 62/333 (18%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIVKLKEV 68
           +G G++G V+ A  K + + VAIKK+ + +    +C   LRE+  L ++    I++L ++
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 69  IRENDIL-----YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           I  +D+L     Y V E  + +L +L K      +E  ++   + +  G  ++H+ G  H
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 124 RDLKPENLLVSKD-TIKIADFGLAREINS-----------------------RPPFTEYV 159
           RDLKP N L+++D ++K+ DFGLAR INS                       +   T +V
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLR-----------PLFPGT------ 202
            TRWYRAPE++L    Y+  +D+W+ G I AEL+ +            PLFPG+      
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLS 272
Query: 203 -----------SEADEIYKICSVIGTPTQDSWADGLLLARAINY--KFPQLVGVPLSVLM 249
                      S  D++  I ++IGTPT+D   + +     I Y   FP    + L    
Sbjct: 273 PDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN-INKPEVIKYIKLFPHRKPINLKQKY 331
Query: 250 PSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           PS + D ++L+ S+  ++P+KR T  +AL HP+
Sbjct: 332 PSISDDGINLLESMLKFNPNKRITIDQALDHPY 364

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 95/301 (31%), Positives = 163/301 (54%), Gaps = 27/301 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----------LREVK 52
           Y + + +  G++G+V   +  + G  VAIK++     S    VN           LRE++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTV-SDGRTVNILSDSFLCKRVLREIR 81
Query: 53  SLRKMSHPNIVKLKEVIREND-----ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCF 107
            L    HPNI+ L+++    +      LY V E M  +L Q++ D+    S   ++ + +
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRA 166
            +  GL  +H+ G  HRDL P N+L++ +  I I DF LARE  +    T YV+ RWYRA
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRA 201
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE+++Q   ++  VDMW+ G +MAE+   + LF G++  +++ KI  V+GTP  +   D 
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE---DV 258
Query: 227 LLLA--RAINYKFPQLVGVPL---SVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           ++ +   A +Y    L  VP    + ++P+A+  A+ LIA +  ++P +R +  +AL+HP
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 282 F 282
           +
Sbjct: 319 Y 319

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  157 bits (396), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 95/301 (31%), Positives = 163/301 (54%), Gaps = 27/301 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----------LREVK 52
           Y + + +  G++G+V   +  + G  VAIK++     S    VN           LRE++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTV-SDGRTVNILSDSFLCKRVLREIR 81
Query: 53  SLRKMSHPNIVKLKEVIREND-----ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCF 107
            L    HPNI+ L+++    +      LY V E M  +L Q++ D+    S   ++ + +
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRA 166
            +  GL  +H+ G  HRDL P N+L++ +  I I DF LARE  +    T YV+ RWYRA
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRA 201
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE+++Q   ++  VDMW+ G +MAE+   + LF G++  +++ KI  V+GTP  +   D 
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE---DV 258
Query: 227 LLLA--RAINYKFPQLVGVPL---SVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           ++ +   A +Y    L  VP    + ++P+A+  A+ LIA +  ++P +R +  +AL+HP
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 282 F 282
           +
Sbjct: 319 Y 319

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 103/349 (29%), Positives = 173/349 (49%), Gaps = 70/349 (20%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           +RY++   +G G++G V  A  K    VVAIKK+ + +    +C   LRE+  L +++H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 61  NIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           ++VK+ +++   D+     LY V E  + +  +L +      +E  ++   + +  G+ Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKY 171
Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI------NSRPP-------------- 154
           +H  G  HRDLKP N LV++D ++K+ DFGLAR +      NS+ P              
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 155 --------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL----------- 195
                    T +V TRWYRAPE++L    Y+  +D+W++G I AEL+ +           
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 196 RPLFPGTS--------------------EADEIYKICSVIGTPTQDSWADGLLLARAINY 235
            PLFPG+S                      D++  I +++GTP+++   + L    A  Y
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED-IEALEKEDAKRY 350
Query: 236 --KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              FP+  G  L+   P+++ DA+ L+  +  ++P+KR T  E L HPF
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 103/344 (29%), Positives = 167/344 (48%), Gaps = 65/344 (18%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           + Y++   +G G++G V+ A  K + + VAIKK+ + +    +C   LRE+  L ++   
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 61  NIVKLKEVIRENDIL-----YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
            I++L ++I   D+L     Y V E  + +L +L K      +E  V+   + +  G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEQHVKTILYNLLLGEKF 146
Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----------------------- 151
           +H+ G  HRDLKP N L+++D ++KI DFGLAR INS                       
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 152 ---RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLR-----------P 197
              +   T +V TRWYRAPE++L    Y++ +D+W+ G I AEL+ +            P
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 198 LFPGT-----------------SEADEIYKICSVIGTPTQDSWADGLLLARAINY--KFP 238
           LFPG+                 S  D++  I +VIGTP ++     +     I Y   FP
Sbjct: 267 LFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLK-CITKQEVIKYIKLFP 325
Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              G+ LS    S +K+ + L+ S+  ++  KR T  +AL HP+
Sbjct: 326 TRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPY 369

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 96/305 (31%), Positives = 158/305 (51%), Gaps = 27/305 (8%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP 60
           RY  +K +G G  G V+ A+     + VAIKK+     +  + V   LRE+K +R++ H 
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLDHD 68
Query: 61  NIVKLKEVI--------------RENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWC 106
           NIVK+ E++               E + +Y V EYME +L  +++  +    E   R + 
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFM 126
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREIN----SRPPFTEYVS 160
           +Q+ +GL Y+H     HRDLKP NL ++ +   +KI DFGLAR ++     +   +E + 
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
           T+WYR+P +LL    Y+  +DMWA G I AE++T + LF G  E +++  I   I    +
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           +   + L +              PL+ L+P  +++AV  +  + ++ P  R TA EAL H
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306
Query: 281 PFSRV 285
           P+  +
Sbjct: 307 PYMSI 311

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP+ +        
Sbjct: 197 IL-GMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHER------MSYLLYQML 129
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 190 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 309 LQHPYINV 316

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A     G  VA+KK+ + + +        RE+  L+ ++H
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 80
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q++    D E+      +    +Q+ 
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHER------MSYLLYQML 134
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR  ++    T YV TR+YRAPEV
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEV 194
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM EL+    +F GT   D+  K+   +GTP+ +  A     
Sbjct: 195 IL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 253
Query: 230 ARAINYKFPQLVGVPLSVLMPS------ANKDAV------SLIASLCSWDPSKRPTAAEA 277
            R      P   G+    L P       + +D +       L++ +   DP KR +  EA
Sbjct: 254 VRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 278 LQHPFSRV 285
           L+HP+  V
Sbjct: 314 LRHPYITV 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP+ +        
Sbjct: 197 IL-GMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP+ +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP+ +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 157/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A     G  VA+KK+ + + +        RE+  L+ ++H
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 82
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q++    D E+      +    +Q+ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y++ VD+W++G IM EL+    +F GT   D+  K+   +GTP+ +  A     
Sbjct: 197 IL-GMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPS------ANKDAV------SLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P       + +D +       L++ +   DP KR +  EA
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 278 LQHPFSRV 285
           L+HP+  V
Sbjct: 316 LRHPYITV 323

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP+ +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP+ +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP+ +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 137
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 198 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 317 LQHPYINV 324

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 81
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 135
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 136 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 195
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 196 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 254
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 255 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 314
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 315 LQHPYINV 322

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 174
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 235 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 354 LQHPYINV 361

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 137
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 198 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 317 LQHPYINV 324

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 129
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 190 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 309 LQHPYINV 316

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 174
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 235 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 354 LQHPYINV 361

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 130
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 191 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 249
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 250 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 310 LQHPYINV 317

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 155/308 (50%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 60  PNIVKL------KEVIRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L      ++ + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQML 130
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 191 IL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 249
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G+    L P +        NK     A  L++ +   DP+KR +  +A
Sbjct: 250 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 310 LQHPYINV 317

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 151/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 151/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 137
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP  +        
Sbjct: 198 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 317 LQHPYINV 324

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 94/299 (31%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK-MKKKYYSWEECVNLREVKSLRKMSH 59
           + +Y+ + ++G GTFG V++A  +++G+ VA+KK + +          LRE+K L+ + H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 60  PNIVKLKEVIREN--------DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQ 111
            N+V L E+ R            +Y VF++ E +L  L+ +    F+ +E++     +  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREI----NSRPP-FTEYVSTRWYR 165
           GL Y+H+    HRD+K  N+L+++D + K+ADFGLAR      NS+P  +   V T WYR
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW-- 223
            PE+LL    Y   +D+W  G IMAE+ T  P+  G +E  ++  I  + G+ T + W  
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            D   L   +     Q   V   +     +  A+ LI  L   DP++R  + +AL H F
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 94/299 (31%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK-MKKKYYSWEECVNLREVKSLRKMSH 59
           + +Y+ + ++G GTFG V++A  +++G+ VA+KK + +          LRE+K L+ + H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 60  PNIVKLKEVIREN--------DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQ 111
            N+V L E+ R            +Y VF++ E +L  L+ +    F+ +E++     +  
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREI----NSRPP-FTEYVSTRWYR 165
           GL Y+H+    HRD+K  N+L+++D + K+ADFGLAR      NS+P  +   V T WYR
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW-- 223
            PE+LL    Y   +D+W  G IMAE+ T  P+  G +E  ++  I  + G+ T + W  
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255
Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            D   L   +     Q   V   +     +  A+ LI  L   DP++R  + +AL H F
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 95/300 (31%), Positives = 157/300 (52%), Gaps = 19/300 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK--MKKKYYSWEECVNLREVKSLRKMS 58
           + +Y+ + ++G GTFG V++A  +++G+ VA+KK  M+ +   +     LRE+K L+ + 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLK 75
Query: 59  HPNIVKLKEVIREN--------DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVF 110
           H N+V L E+ R            +Y VF++ E +L  L+ +    F+ +E++     + 
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREI----NSRPP-FTEYVSTRWY 164
            GL Y+H+    HRD+K  N+L+++D + K+ADFGLAR      NS+P  +   V T WY
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW- 223
           R PE+LL    Y   +D+W  G IMAE+ T  P+  G +E  ++  I  + G+ T + W 
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 224 -ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             D   L   +     Q   V   +     +  A+ LI  L   DP++R  + +AL H F
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 94/299 (31%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK-MKKKYYSWEECVNLREVKSLRKMSH 59
           + +Y+ + ++G GTFG V++A  +++G+ VA+KK + +          LRE+K L+ + H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 60  PNIVKLKEVIRENDI--------LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQ 111
            N+V L E+ R            +Y VF++ E +L  L+ +    F+ +E++     +  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREI----NSRPP-FTEYVSTRWYR 165
           GL Y+H+    HRD+K  N+L+++D + K+ADFGLAR      NS+P  +   V T WYR
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW-- 223
            PE+LL    Y   +D+W  G IMAE+ T  P+  G +E  ++  I  + G+ T + W  
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            D   L   +     Q   V   +     +  A+ LI  L   DP++R  + +AL H F
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 315

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  144 bits (362), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 151/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 130
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 191 IL-GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 249
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 250 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 310 LQHPYINV 317

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 151/308 (49%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 87
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 141
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV
Sbjct: 142 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 201
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 202 IL-GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 260
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 261 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 321 LQHPYINV 328

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 150/308 (48%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 138
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +      +V TR+YRAPEV
Sbjct: 139 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEV 198
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP  +        
Sbjct: 199 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 257
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 258 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 318 LQHPYINV 325

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 148/308 (48%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T  V TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA------------NKDAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P                 A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 149/308 (48%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +       V TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +        
Sbjct: 197 IL-GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 93/337 (27%), Positives = 162/337 (48%), Gaps = 61/337 (18%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMSH 59
           ++Y L K +G G+FG V      +SG+  A+KK+    +Y +       RE+  ++ + H
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-------RELDIMKVLDH 59
Query: 60  PNIVKL-----------------------------------KEVI---RENDILYFVFEY 81
            NI+KL                                   K VI    +N  L  + EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 82  MECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV-SKD- 136
           +   L++++K      +      +  + +Q+F+ + ++H  G  HRD+KP+NLLV SKD 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 137 TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLR 196
           T+K+ DFG A+++    P    + +R+YRAPE++L +  Y+  +D+W++G +  ELI  +
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 197 PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKD- 255
           PLF G +  D++ +I  ++GTPT++      +       +FP L       ++P      
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIR--MNPHYTEVRFPTLKAKDWRKILPEGTPSL 297
Query: 256 AVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHL 292
           A+ L+  +  ++P  R    EA+ HPF      F HL
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPF------FDHL 328

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 148/308 (48%), Gaps = 30/308 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60  PNIVKLKEV------IRENDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVF 110
            NI+ L  V      + E   +Y V E M+ NL Q+++   D E+      +    +Q+ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 136
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            G+ ++H  G  HRDLKP N++V  D T+KI DFGLAR   +       V TR+YRAPEV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +L    Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP           
Sbjct: 197 IL-GMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPT 255
Query: 230 ARAINYKFPQLVGVPLSVLMPSA--------NK----DAVSLIASLCSWDPSKRPTAAEA 277
            R      P+  G     L P          NK     A  L++ +   D SKR +  EA
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 278 LQHPFSRV 285
           LQHP+  V
Sbjct: 316 LQHPYINV 323

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 163/302 (53%), Gaps = 26/302 (8%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMS 58
           M+R+++ +  G GTFG+V     K +G  VAIKK+    ++ + E    L+ ++ L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77
Query: 59  HPNIVKLK-------EVIRENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQ 108
           HPNIV+L+       E  R +  L  V EY+   L++  ++   R+       ++ + FQ
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 109 VFQGLAYMH--QRGYFHRDLKPENLLVSK--DTIKIADFGLAREINSRPPFTEYVSTRWY 164
           + + +  +H       HRD+KP N+LV++   T+K+ DFG A++++   P   Y+ +R+Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
           RAPE++  +  Y++ VD+W++G I AE++   P+F G + A ++++I  V+G P+++   
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257
Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSAN----KDAVSLIASLCSWDPSKRPTAAEALQH 280
              L     +       G+P S +    +    K+A  L+++L  + P +R    EAL H
Sbjct: 258 K--LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315
Query: 281 PF 282
           P+
Sbjct: 316 PY 317

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 159/319 (49%), Gaps = 40/319 (12%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHPN 61
           RY+++K +G G+FG V +A   +  + VA+K ++ +K +  +    +R ++ LRK    N
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 62  ---IVKLKEVIRENDILYFVFEYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMH 117
              ++ + E     + +   FE +  NLY+L+K ++ + FS   VR +   + Q L  +H
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 118 QRGYFHRDLKPENLLV---SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           +    H DLKPEN+L+    +  IK+ DFG +   + R      + +R+YRAPEV+L + 
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTXIQSRFYRAPEVILGAR 275
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD------------- 221
            Y   +DMW++G I+AEL+T  PL PG  E D++  +  ++G P+Q              
Sbjct: 276 -YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334
Query: 222 -----------SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDA-----VSLIASLCS 265
                      + +DG ++      +  +L G P S    +A K       +  +     
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 266 WDPSKRPTAAEALQHPFSR 284
           WDP+ R T  +AL+HP+ R
Sbjct: 395 WDPAVRMTPGQALRHPWLR 413

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 159/319 (49%), Gaps = 40/319 (12%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHPN 61
           RY+++K +G G+FG V +A   +  + VA+K ++ +K +  +    +R ++ LRK    N
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 62  ---IVKLKEVIRENDILYFVFEYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMH 117
              ++ + E     + +   FE +  NLY+L+K ++ + FS   VR +   + Q L  +H
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 118 QRGYFHRDLKPENLLV---SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           +    H DLKPEN+L+    +  IK+ DFG +   + R      + +R+YRAPEV+L + 
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTXIQSRFYRAPEVILGAR 275
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD------------- 221
            Y   +DMW++G I+AEL+T  PL PG  E D++  +  ++G P+Q              
Sbjct: 276 -YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334
Query: 222 -----------SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDA-----VSLIASLCS 265
                      + +DG ++      +  +L G P S    +A K       +  +     
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 266 WDPSKRPTAAEALQHPFSR 284
           WDP+ R T  +AL+HP+ R
Sbjct: 395 WDPAVRMTPGQALRHPWLR 413

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 94/286 (32%), Positives = 144/286 (50%), Gaps = 35/286 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           ERY ++  +G G+FG V +   + + +  A+K + K     ++    LREV+ L+K+ HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 61  NIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NI+KL E++ ++   Y V E Y    L+  +  R++ FSE +      QVF G+ YMH+ 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH 140
Query: 120 GYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
              HRDLKPEN+L+    KD  IKI DFGL+          + + T +Y APEVL  +  
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-- 198
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y  K D+W+ G I+  L++  P F G +E    Y I   + T     +A          +
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETG---KYA----------F 241
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
             PQ   +         + DA  LI  + ++ PS R TA + L+HP
Sbjct: 242 DLPQWRTI---------SDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 95/288 (32%), Positives = 144/288 (50%), Gaps = 39/288 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRA---ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ERY ++  +G G+FG V +    I++Q   V  I K   K  + +    LREV+ L+K+ 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLD 79
Query: 59  HPNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI+KL E++ ++   Y V E Y    L+  +  R++ FSE +      QVF G+ YMH
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH 138
Query: 118 QRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPEN+L+    KD  IKI DFGL+          + + T +Y APEVL  +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W+ G I+  L++  P F G +E D + ++           +A         
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------ETGKYA--------- 240
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            +  PQ   +         + DA  LI  + ++ PS R TA + L+HP
Sbjct: 241 -FDLPQWRTI---------SDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 95/288 (32%), Positives = 144/288 (50%), Gaps = 39/288 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRA---ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ERY ++  +G G+FG V +    I++Q   V  I K   K  + +    LREV+ L+K+ 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLD 79
Query: 59  HPNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI+KL E++ ++   Y V E Y    L+  +  R++ FSE +      QVF G+ YMH
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH 138
Query: 118 QRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPEN+L+    KD  IKI DFGL+          + + T +Y APEVL  +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W+ G I+  L++  P F G +E D + ++           +A         
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------ETGKYA--------- 240
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            +  PQ   +         + DA  LI  + ++ PS R TA + L+HP
Sbjct: 241 -FDLPQWRTI---------SDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 157/319 (49%), Gaps = 40/319 (12%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHPN 61
           RY+++K +G G FG V +A   +  + VA+K ++ +K +  +    +R ++ LRK    N
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 62  ---IVKLKEVIRENDILYFVFEYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMH 117
              ++ + E     + +   FE +  NLY+L+K ++ + FS   VR +   + Q L  +H
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 118 QRGYFHRDLKPENLLV---SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           +    H DLKPEN+L+    +  IK+ DFG +   + R      + +R+YRAPEV+L + 
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYXXIQSRFYRAPEVILGAR 275
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD------------- 221
            Y   +DMW++G I+AEL+T  PL PG  E D++  +  ++G P Q              
Sbjct: 276 -YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVS 334
Query: 222 -----------SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDA-----VSLIASLCS 265
                      + +DG ++      +  +L G P S    +A K       +  +     
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 266 WDPSKRPTAAEALQHPFSR 284
           WDP+ R T  +AL+HP+ R
Sbjct: 395 WDPAVRMTPGQALRHPWLR 413

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 154/313 (49%), Gaps = 43/313 (13%)
Query: 9   EVGDGTFGSVWRAISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +VG GT+G V++A  K   +    A+K+++    S   C   RE+  LR++ HPN++ L+
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC---REIALLRELKHPNVISLQ 84
Query: 67  EVI--RENDILYFVFEYMECNLYQLMK--------DREKCFSEAEVRNWCFQVFQGLAYM 116
           +V     +  ++ +F+Y E +L+ ++K         +        V++  +Q+  G+ Y+
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 117 HQRGYFHRDLKPENLLV-----SKDTIKIADFGLAREINS--RP--PFTEYVSTRWYRAP 167
           H     HRDLKP N+LV      +  +KIAD G AR  NS  +P       V T WYRAP
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA---------DEIYKICSVIGTP 218
           E+LL +  Y+  +D+WA+G I AEL+T  P+F    E          D++ +I +V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 219 TQDSWAD-------GLLLA--RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPS 269
               W D         L+   R   Y    L+   +       +  A  L+  L + DP 
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKY-MEKHKVKPDSKAFHLLQKLLTMDPI 323
Query: 270 KRPTAAEALQHPF 282
           KR T+ +A+Q P+
Sbjct: 324 KRITSEQAMQDPY 336

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 145/287 (50%), Gaps = 35/287 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME+Y  ++++G+G+FG      S + G    IK++   +  S E   + REV  L  M H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 60  PNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMH 117
           PNIV+ +E   EN  LY V +Y E  +L++ +  ++   F E ++ +W  Q+   L ++H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY-VSTRWYRAPEVLLQSYL 175
            R   HRD+K +N+ ++KD T+++ DFG+AR +NS        + T +Y +PE+  ++  
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI-CENKP 201
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y++K D+WA+G ++ EL TL+  F   S  + + KI S    P             +++Y
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV------------SLHY 249
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +                 D  SL++ L   +P  RP+    L+  F
Sbjct: 250 SY-----------------DLRSLVSQLFKRNPRDRPSVNSILEKGF 279

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 97/299 (32%), Positives = 147/299 (49%), Gaps = 38/299 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y + +E+G G F  V R + K +G   A K +  K  S  +   L RE +  RK+ HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I+E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + +AY H  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN 124
Query: 120 GYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           G  HR+LKPENLL++       +K+ADFGLA E+N    +  +  T  Y +PEVL +   
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-P 183
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS  VD+WA G I+  L+   P F    +   +Y                  + A A +Y
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPF-WDEDQHRLY----------------AQIKAGAYDY 226
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
             P+           +   +A SLI S+ + +P KR TA +AL+ P+     RVA   H
Sbjct: 227 PSPE---------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH 276

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 98/299 (32%), Positives = 147/299 (49%), Gaps = 38/299 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y + +E+G G F  V R + K +G   A K +  K  S  +   L RE +  RK+ HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I+E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + +AY H  
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN 147
Query: 120 GYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           G  HR+LKPENLL++       +K+ADFGLA E+N    +  +  T  Y +PEVL +   
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-P 206
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS  VD+WA G I+  L+   P F    +   +Y                  + A A +Y
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPF-WDEDQHRLY----------------AQIKAGAYDY 249
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
             P+   V           +A SLI S+ + +P KR TA +AL+ P+     RVA   H
Sbjct: 250 PSPEWDTV---------TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH 299

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 97/299 (32%), Positives = 147/299 (49%), Gaps = 38/299 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y + +E+G G F  V R + K +G   A K +  K  S  +   L RE +  RK+ HP
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 64
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I+E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + +AY H  
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN 123
Query: 120 GYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           G  HR+LKPENLL++       +K+ADFGLA E+N    +  +  T  Y +PEVL +   
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-P 182
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS  VD+WA G I+  L+   P F    +   +Y                  + A A +Y
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPF-WDEDQHRLY----------------AQIKAGAYDY 225
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
             P+           +   +A SLI S+ + +P KR TA +AL+ P+     RVA   H
Sbjct: 226 PSPE---------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH 275

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 144/287 (50%), Gaps = 38/287 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK---KYYSWEECVNLREVKSLRKMS 58
           +RYK  + +G G+FG V     K +G+  A+K + K   K  + +E + LREV+ L+++ 
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL-LREVQLLKQLD 84
Query: 59  HPNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI+KL E   +    Y V E Y    L+  +  R++ FSE +      QV  G+ YMH
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH 143
Query: 118 QRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPENLL+   SKD  I+I DFGL+    +     + + T +Y APEVL  +
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT 203
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W+ G I+  L++  P F G +E D + K+    G  T              
Sbjct: 204 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYT-------------- 245
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            ++ PQ   V  S         A  LI  + ++ PS R +A +AL H
Sbjct: 246 -FELPQWKKVSES---------AKDLIRKMLTYVPSMRISARDALDH 282

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 144/287 (50%), Gaps = 38/287 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK---KYYSWEECVNLREVKSLRKMS 58
           +RYK  + +G G+FG V     K +G+  A+K + K   K  + +E + LREV+ L+++ 
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL-LREVQLLKQLD 108
Query: 59  HPNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI+KL E   +    Y V E Y    L+  +  R++ FSE +      QV  G+ YMH
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH 167
Query: 118 QRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPENLL+   SKD  I+I DFGL+    +     + + T +Y APEVL  +
Sbjct: 168 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT 227
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W+ G I+  L++  P F G +E D + K+    G  T              
Sbjct: 228 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYT-------------- 269
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            ++ PQ   V  S         A  LI  + ++ PS R +A +AL H
Sbjct: 270 -FELPQWKKVSES---------AKDLIRKMLTYVPSMRISARDALDH 306

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 144/287 (50%), Gaps = 38/287 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK---KYYSWEECVNLREVKSLRKMS 58
           +RYK  + +G G+FG V     K +G+  A+K + K   K  + +E + LREV+ L+++ 
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL-LREVQLLKQLD 107
Query: 59  HPNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI+KL E   +    Y V E Y    L+  +  R++ FSE +      QV  G+ YMH
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH 166
Query: 118 QRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPENLL+   SKD  I+I DFGL+    +     + + T +Y APEVL  +
Sbjct: 167 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT 226
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W+ G I+  L++  P F G +E D + K+    G  T              
Sbjct: 227 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYT-------------- 268
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            ++ PQ   V  S         A  LI  + ++ PS R +A +AL H
Sbjct: 269 -FELPQWKKVSES---------AKDLIRKMLTYVPSMRISARDALDH 305

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 143/287 (49%), Gaps = 34/287 (11%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y + +E+G G F  V R + K +G   A K +  K  S  +   L RE +  RK+ HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I+E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + +AY H  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN 124
Query: 120 GYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           G  HR+LKPENLL++       +K+ADFGLA E+N    +  +  T  Y +PEVL +   
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-P 183
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS  VD+WA G I+  L+   P F    +   +Y                  + A A +Y
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPF-WDEDQHRLY----------------AQIKAGAYDY 226
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             P+           +   +A SLI S+ + +P KR TA +AL+ P+
Sbjct: 227 PSPE---------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 97/287 (33%), Positives = 144/287 (50%), Gaps = 38/287 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK---KYYSWEECVNLREVKSLRKMS 58
           +RYK  + +G G+FG V     K +G+  A+K + K   K  + +E + LREV+ L+++ 
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL-LREVQLLKQLD 90
Query: 59  HPNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI+KL E   +    Y V E Y    L+  +  R++ FSE +      QV  G+ YMH
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH 149
Query: 118 QRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPENLL+   SKD  I+I DFGL+    +     + + T +Y APEVL  +
Sbjct: 150 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W+ G I+  L++  P F G +E D + K+    G  T              
Sbjct: 210 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYT-------------- 251
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            ++ PQ   V  S         A  LI  + ++ PS R +A +AL H
Sbjct: 252 -FELPQWKKVSES---------AKDLIRKMLTYVPSMRISARDALDH 288

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 95/291 (32%), Positives = 137/291 (47%), Gaps = 44/291 (15%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           +RY+ +K++G G +G V     K +G   AIK +KK   +        L EV  L+++ H
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 60  PNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNI+KL E   +    Y V E Y    L+  +  R+K FSE +      QV  G  Y+H+
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLSGTTYLHK 139
Query: 119 RGYFHRDLKPENLLV---SKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
               HRDLKPENLL+   S+D  IKI DFGL+          E + T +Y APEVL +  
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK- 198
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y  K D+W+ G I+  L+   P F G ++ +                     +L R   
Sbjct: 199 -YDEKCDVWSCGVILYILLCGYPPFGGQTDQE---------------------ILKRVEK 236
Query: 235 YKF----PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            KF    P    V         + +A  L+  + +++PSKR +A EAL HP
Sbjct: 237 GKFSFDPPDWTQV---------SDEAKQLVKLMLTYEPSKRISAEEALNHP 278

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 95/291 (32%), Positives = 137/291 (47%), Gaps = 44/291 (15%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           +RY+ +K++G G +G V     K +G   AIK +KK   +        L EV  L+++ H
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 60  PNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNI+KL E   +    Y V E Y    L+  +  R+K FSE +      QV  G  Y+H+
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLSGTTYLHK 122
Query: 119 RGYFHRDLKPENLLV---SKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
               HRDLKPENLL+   S+D  IKI DFGL+          E + T +Y APEVL +  
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK- 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y  K D+W+ G I+  L+   P F G ++ +                     +L R   
Sbjct: 182 -YDEKCDVWSCGVILYILLCGYPPFGGQTDQE---------------------ILKRVEK 219
Query: 235 YKF----PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            KF    P    V         + +A  L+  + +++PSKR +A EAL HP
Sbjct: 220 GKFSFDPPDWTQV---------SDEAKQLVKLMLTYEPSKRISAEEALNHP 261

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 146/300 (48%), Gaps = 39/300 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y+L +E+G G F  V R +   +G+  A K +  K  S  +   L RE +  R + HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + + + H  
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQILESVNHCHLN 122
Query: 120 GYFHRDLKPENLLVSKDT----IKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSY 174
           G  HRDLKPENLL++  +    +K+ADFGLA E+   +  +  +  T  Y +PEVL +  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD- 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y   VDMWA G I+  L+   P F    +     +I                   +A  
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI-------------------KAGA 222
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
           Y FP       S    +   +A  LI  + + +P+KR TA+EAL+HP+    S VA M H
Sbjct: 223 YDFP-------SPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMH 275

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 96/300 (32%), Positives = 146/300 (48%), Gaps = 39/300 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y+L +E+G G F  V R +   +G+  A K +  K  S  +   L RE +  R + HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + + + H  
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQILESVNHCHLN 122
Query: 120 GYFHRDLKPENLLVSKDT----IKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSY 174
           G  HRDLKPENLL++  +    +K+ADFGLA E+   +  +  +  T  Y +PEVL +  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD- 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y   VDMWA G I+  L+   P F    +     +I                   +A  
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI-------------------KAGA 222
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
           Y FP       S    +   +A  LI  + + +P+KR TA+EAL+HP+    S VA M H
Sbjct: 223 YDFP-------SPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMH 275

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 96/287 (33%), Positives = 141/287 (49%), Gaps = 38/287 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK---KYYSWEECVNLREVKSLRKMS 58
           +RYK  + +G G+FG V     K +G+  A+K + K   K  + +E + LREV+ L+++ 
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL-LREVQLLKQLD 84
Query: 59  HPNIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI KL E   +    Y V E Y    L+  +  R++ FSE +      QV  G+ Y H
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYXH 143
Query: 118 QRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPENLL+   SKD  I+I DFGL+    +     + + T +Y APEVL  +
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT 203
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W+ G I+  L++  P F G +E D + K+    G  T              
Sbjct: 204 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYT-------------- 245
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            ++ PQ   V  S         A  LI    ++ PS R +A +AL H
Sbjct: 246 -FELPQWKKVSES---------AKDLIRKXLTYVPSXRISARDALDH 282

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 144/298 (48%), Gaps = 39/298 (13%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L +E+G G F  V R +   +G+  A K +  K  S  +   L RE +  R + HPNI
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 63  VKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           V+L + I E    Y +F+ +    L++ +  RE  +SEA+  +   Q+ + + + HQ G 
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQMGV 142
Query: 122 FHRDLKPENLLVSKD----TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            HRDLKPENLL++       +K+ADFGLA E+   +  +  +  T  Y +PEVL +   Y
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PY 201
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
              VD+WA G I+  L+   P F    +     +I                   +A  Y 
Sbjct: 202 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-------------------KAGAYD 242
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
           FP       S    +   +A  LI  + + +PSKR TAAEAL+HP+    S VA   H
Sbjct: 243 FP-------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMH 293

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 145/300 (48%), Gaps = 39/300 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y+L +E+G G F  V R + K   +  A K +  K  S  +   L RE +  R + HP
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + + ++HQ 
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIHQILESVNHIHQH 149
Query: 120 GYFHRDLKPENLLVSKD----TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSY 174
              HRDLKPENLL++       +K+ADFGLA E+   +  +  +  T  Y +PEVL +  
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD- 208
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y   VD+WA G I+  L+   P F    +     +I                   +A  
Sbjct: 209 PYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI-------------------KAGA 249
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
           Y FP       S    +   +A +LI  + + +P+KR TA +AL+HP+    S VA M H
Sbjct: 250 YDFP-------SPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMH 302

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 144/300 (48%), Gaps = 39/300 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y+L +++G G F  V R +   +G   A K +  K  S  +   L RE +  R + H 
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + + + HQ 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQM 122
Query: 120 GYFHRDLKPENLLVSKD----TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSY 174
           G  HRDLKPENLL++       +K+ADFGLA E+   +  +  +  T  Y +PEVL +  
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE- 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y   VD+WA G I+  L+   P F    +     +I                   +A  
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI-------------------KAGA 222
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
           Y FP       S    +   +A +LI  + + +P+KR TA EAL+HP+    S VA M H
Sbjct: 223 YDFP-------SPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMH 275

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 95/300 (31%), Positives = 144/300 (48%), Gaps = 39/300 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           E Y+L +E+G G F  V R +   +G+  A   +  K  S  +   L RE +  R + HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I E    Y +F+ +    L++ +  RE  +SEA+  +   Q+ + + + HQ 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQM 129
Query: 120 GYFHRDLKPENLLVSKD----TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSY 174
           G  HR+LKPENLL++       +K+ADFGLA E+   +  +  +  T  Y +PEVL +  
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD- 188
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y   VD+WA G I+  L+   P F    +     +I                   +A  
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-------------------KAGA 229
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFH 290
           Y FP       S    +   +A  LI  + + +PSKR TAAEAL+HP+    S VA   H
Sbjct: 230 YDFP-------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMH 282

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 156/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+L++++G G +  V+ AI+  + E V +K +K      ++    RE+K L  +   P
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKNKIKREIKILENLRGGP 92
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NI+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS 149
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 209
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ 
Sbjct: 210 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDP 267
Query: 236 KFPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 142/290 (48%), Gaps = 42/290 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +E +K+   +G G+F  V+RA S  +G  VAIK + KK       V     EVK   ++ 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+I++L     +++ +Y V E     E N Y  +K+R K FSE E R++  Q+  G+ Y
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRY--LKNRVKPFSENEARHFMHQIITGMLY 127
Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV--STRWYRAPEVLLQ 172
           +H  G  HRDL   NLL++++  IKIADFGLA ++   P    Y    T  Y +PE+  +
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLCGTPNYISPEIATR 186
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
           S  +  + D+W++G +   L+  RP F                 T T  +  + ++LA  
Sbjct: 187 S-AHGLESDVWSLGCMFYTLLIGRPPFD----------------TDTVKNTLNKVVLA-- 227
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +Y+ P  + +           +A  LI  L   +P+ R + +  L HPF
Sbjct: 228 -DYEMPSFLSI-----------EAKDLIHQLLRRNPADRLSLSSVLDHPF 265

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 4/204 (1%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSHP 60
            Y+++K +G+G+FG V  A    +G+ VA+K + KK  +  +      RE+  LR + HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +I+KL +VI+  D +  V EY    L+  +  R+K  SE E R +  Q+   + Y H+  
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCHRHK 127
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             HRDLKPENLL+ +   +KIADFGL+  +           +  Y APEV+        +
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 180 VDMWAMGAIMAELITLRPLFPGTS 203
           VD+W+ G I+  ++  R  F   S
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 4/204 (1%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSHP 60
            Y+++K +G+G+FG V  A    +G+ VA+K + KK  +  +      RE+  LR + HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +I+KL +VI+  D +  V EY    L+  +  R+K  SE E R +  Q+   + Y H+  
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCHRHK 133
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             HRDLKPENLL+ +   +KIADFGL+  +           +  Y APEV+        +
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 193
Query: 180 VDMWAMGAIMAELITLRPLFPGTS 203
           VD+W+ G I+  ++  R  F   S
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 4/204 (1%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSHP 60
            Y+++K +G+G+FG V  A    +G+ VA+K + KK  +  +      RE+  LR + HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +I+KL +VI+  D +  V EY    L+  +  R+K  SE E R +  Q+   + Y H+  
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCHRHK 132
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             HRDLKPENLL+ +   +KIADFGL+  +           +  Y APEV+        +
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192
Query: 180 VDMWAMGAIMAELITLRPLFPGTS 203
           VD+W+ G I+  ++  R  F   S
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 108/203 (53%), Gaps = 4/203 (1%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSHPN 61
           Y+++K +G+G+FG V  A    +G+ VA+K + KK  +  +      RE+  LR + HP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I+KL +VI+  D +  V EY    L+  +  R+K  SE E R +  Q+   + Y H+   
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCHRHKI 124
Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
            HRDLKPENLL+ +   +KIADFGL+  +           +  Y APEV+        +V
Sbjct: 125 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 184
Query: 181 DMWAMGAIMAELITLRPLFPGTS 203
           D+W+ G I+  ++  R  F   S
Sbjct: 185 DVWSCGVILYVMLCRRLPFDDES 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/286 (31%), Positives = 137/286 (47%), Gaps = 35/286 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           E Y+ +K++G G +G V     K +    AIK ++K   S      L  EV  L+ + HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 61  NIVKLKEVIRENDILYFVFE-YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NI+KL +   +    Y V E Y    L+  +  R K F+E +      QV  G+ Y+H+ 
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKH 155
Query: 120 GYFHRDLKPENLLV---SKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
              HRDLKPENLL+    KD  IKI DFGL+    ++    E + T +Y APEVL +   
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-- 213
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y  K D+W++G I+  L+   P F G ++ + + K+    G  T DS             
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDS------------- 258
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
             P+   V         ++ A  LI  +  +D  +R +A +AL+HP
Sbjct: 259 --PEWKNV---------SEGAKDLIKQMLQFDSQRRISAQQALEHP 293

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKM----KKKYYSWEECVNLREVKSLRKMSHPNI 62
           ++E+G G+FG+V+ A   ++ EVVAIKKM    K+    W++ +  +EV+ L+K+ HPN 
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQKLRHPNT 116
Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           ++ +         + V EY   +   L++  +K   E E+        QGLAY+H     
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 123 HRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL--QSYLYSSK 179
           HRD+K  N+L+S+   +K+ DFG A  +    P   +V T ++ APEV+L      Y  K
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKIC 212
           VD+W++G    EL   +P     +    +Y I 
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIA 266

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKM----KKKYYSWEECVNLREVKSLRKMSHPNI 62
           ++E+G G+FG+V+ A   ++ EVVAIKKM    K+    W++ +  +EV+ L+K+ HPN 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQKLRHPNT 77
Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           ++ +         + V EY   +   L++  +K   E E+        QGLAY+H     
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 123 HRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL--QSYLYSSK 179
           HRD+K  N+L+S+   +K+ DFG A  +    P   +V T ++ APEV+L      Y  K
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKIC 212
           VD+W++G    EL   +P     +    +Y I 
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 133/297 (44%), Gaps = 50/297 (16%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--------------WEECVN 47
           E Y  ++++G G +G V     K      AIK +KK  +                EE  N
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 48  LREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWC 106
             E+  L+ + HPNI+KL +V  +    Y V E+ E   L++ + +R K F E +  N  
Sbjct: 96  --EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIM 152
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTR 162
            Q+  G+ Y+H+    HRD+KPEN+L+        IKI DFGL+   +      + + T 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS 222
           +Y APEVL +   Y+ K D+W+ G IM  L+   P F G ++ D I K+         + 
Sbjct: 213 YYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           W                           + + +A  LI  + ++D +KR TA EAL 
Sbjct: 271 W--------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALN 301

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 77/228 (33%), Positives = 123/228 (53%), Gaps = 13/228 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           M+RY++   +G G+FG V +A  +   E VAIK +K KK +  +  + +R ++ + K   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 60  PN---IVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAY 115
                IV LK      + L  VFE +  NLY L+++   +  S    R +  Q+   L +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 116 MH--QRGYFHRDLKPENLLV---SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +   +    H DLKPEN+L+    +  IKI DFG + ++  R    + + +R+YR+PEVL
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQXIQSRFYRSPEVL 230
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           L    Y   +DMW++G I+ E+ T  PLF G +E D++ KI  V+G P
Sbjct: 231 L-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 77/228 (33%), Positives = 123/228 (53%), Gaps = 13/228 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           M+RY++   +G G+FG V +A  +   E VAIK +K KK +  +  + +R ++ + K   
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 93
Query: 60  PN---IVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAY 115
                IV LK      + L  VFE +  NLY L+++   +  S    R +  Q+   L +
Sbjct: 94  EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 153
Query: 116 MH--QRGYFHRDLKPENLLV---SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +   +    H DLKPEN+L+    +  IKI DFG + ++  R    + + +R+YR+PEVL
Sbjct: 154 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQXIQSRFYRSPEVL 211
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           L    Y   +DMW++G I+ E+ T  PLF G +E D++ KI  V+G P
Sbjct: 212 L-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 258

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 77/228 (33%), Positives = 123/228 (53%), Gaps = 13/228 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           M+RY++   +G G+FG V +A  +   E VAIK +K KK +  +  + +R ++ + K   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 60  PN---IVKLKEVIRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAY 115
                IV LK      + L  VFE +  NLY L+++   +  S    R +  Q+   L +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 116 MH--QRGYFHRDLKPENLLV---SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +   +    H DLKPEN+L+    +  IKI DFG + ++  R    + + +R+YR+PEVL
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQR--IYQXIQSRFYRSPEVL 230
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           L    Y   +DMW++G I+ E+ T  PLF G +E D++ KI  V+G P
Sbjct: 231 L-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 157/295 (53%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E VA+K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+L+  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 155/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+++++VG G +  V+  I+  + E   IK +K      +    ++ +++L  M  PN
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKK-KIKREIKILQNL--MGGPN 87
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           IVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H +
Sbjct: 88  IVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ 144
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y 
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 204
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ +
Sbjct: 205 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDPQ 262
Query: 237 FPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
              LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 156/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 52  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 107
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 164
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 165 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 224
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   +++ +   +   ++ 
Sbjct: 225 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRI--ELDP 282
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 283 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 338

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 104/205 (50%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G+ VA++ + K   +      L REV+ ++ ++HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY V EY    E   Y +   R K   E E R    Q+   + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK---EKEARAKFRQIVSAVQYCHQK 132
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E        E+  +  Y APE+         
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGP 192
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G  VAIK + K   +      L REV+ ++ ++HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY + EY    E   Y +   R K   E E R+   Q+   + Y HQ+
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK---EKEARSKFRQIVSAVQYCHQK 130
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E         +  +  Y APE+         
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGP 190
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 127/282 (45%), Gaps = 43/282 (15%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G F  V  A  K++ ++VAIK + KK    +E     E+  L K+ HPNIV L ++ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 70  RENDILYFVFEYMECNLYQLMKDR--EKCF-SEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
                LY + + +       + DR  EK F +E +     FQV   + Y+H  G  HRDL
Sbjct: 86  ESGGHLYLIMQLVSGG---ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 127 KPENLL---VSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           KPENLL   + +D+ I I+DFGL++  +     +    T  Y APEVL Q   YS  VD 
Sbjct: 143 KPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDC 201
Query: 183 WAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           W++G I   L+   P F   ++A   ++I K      +P  D  +D              
Sbjct: 202 WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS------------- 248
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                           A   I  L   DP KR T  +ALQHP
Sbjct: 249 ----------------AKDFIRHLMEKDPEKRFTCEQALQHP 274

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 102/205 (49%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G  VAIK + K   +      L REV+ ++ ++HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY + EY    E   Y +   R K   E E R+   Q+   + Y HQ+
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK---EKEARSKFRQIVSAVQYCHQK 133
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E         +     Y APE+         
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 155/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 143
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 203
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ 
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDP 261
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 157/295 (53%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ ++   +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLR---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 155/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 33  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 88
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 145
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 146 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 205
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ 
Sbjct: 206 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDP 263
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 264 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 319

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G+ VA+K + K   +      L REV+ ++ ++HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY V EY    E   Y +   R K   E E R    Q+   + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK---EKEARAKFRQIVSAVQYCHQK 132
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E         +  +  Y APE+         
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G+ VA+K + K   +      L REV+ ++ ++HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY V EY    E   Y +   R K   E E R    Q+   + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK---EKEARAKFRQIVSAVQYCHQK 132
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E         +  +  Y APE+         
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 155/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 143
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 203
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ 
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDP 261
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 155/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 32  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 87
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 144
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 204
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ 
Sbjct: 205 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDP 262
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 318

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 155/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 86
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 143
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 203
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ 
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDP 261
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 155/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 32  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 87
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 144
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 204
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ 
Sbjct: 205 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDP 262
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 318

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 155/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 86
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 143
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 203
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ 
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDP 261
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 155/296 (52%), Gaps = 24/296 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHP 60
           + Y+++++VG G +  V+  I+  + E    K + K     ++    RE+K L+ +   P
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 61  NIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           NIVKL +++R+  +     +FEY+    ++++       ++ ++R + +++ + L Y H 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS 143
Query: 119 RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+    Y
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 203
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              +DMW++G + A +I  + P F G    D++ KI  V+GT   + + +   +   ++ 
Sbjct: 204 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI--ELDP 261
Query: 236 KFPQLVG----VPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +   LVG     P    M + N+     +A+  +  L  +D  +R TA EA+ HP+
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 124/284 (43%), Gaps = 43/284 (15%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKE 67
           +++G G FG V     + SG    IK + K            E++ L+ + HPNI+K+ E
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 68  VIRENDILYFVFEYMECNLYQLM------KDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           V  +   +Y V E   C   +L+      + R K  SE  V     Q+   LAY H +  
Sbjct: 88  VFEDYHNMYIVMET--CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 122 FHRDLKPENLLVSKDT-----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            H+DLKPEN+L  +DT     IKI DFGLA    S    T    T  Y APEV  +   +
Sbjct: 146 VHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTF 204
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             K D+W+ G +M  L+T    F GTS  +                      + +   YK
Sbjct: 205 --KCDIWSAGVVMYFLLTGCLPFTGTSLEE----------------------VQQKATYK 240
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            P    V    L P     AV L+  + + DP +RP+AA+ L H
Sbjct: 241 EPNY-AVECRPLTPQ----AVDLLKQMLTKDPERRPSAAQVLHH 279

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 127/282 (45%), Gaps = 43/282 (15%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G F  V  A  K++ ++VAIK + K+    +E     E+  L K+ HPNIV L ++ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 70  RENDILYFVFEYMECNLYQLMKDR--EKCF-SEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
                LY + + +       + DR  EK F +E +     FQV   + Y+H  G  HRDL
Sbjct: 86  ESGGHLYLIMQLVSGG---ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 127 KPENLL---VSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           KPENLL   + +D+ I I+DFGL++  +     +    T  Y APEVL Q   YS  VD 
Sbjct: 143 KPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDC 201
Query: 183 WAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           W++G I   L+   P F   ++A   ++I K      +P  D  +D              
Sbjct: 202 WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS------------- 248
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                           A   I  L   DP KR T  +ALQHP
Sbjct: 249 ----------------AKDFIRHLMEKDPEKRFTCEQALQHP 274

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 102/205 (49%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G+ VA+K + K   +      L REV+ ++ ++HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY V EY    E   Y +   R K   E E R    Q+   + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK---EKEARAKFRQIVSAVQYCHQK 132
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E         +     Y APE+         
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 127/282 (45%), Gaps = 43/282 (15%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G F  V  A  K++ ++VAIK + K+    +E     E+  L K+ HPNIV L ++ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 70  RENDILYFVFEYMECNLYQLMKDR--EKCF-SEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
                LY + + +       + DR  EK F +E +     FQV   + Y+H  G  HRDL
Sbjct: 86  ESGGHLYLIMQLVSGG---ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 127 KPENLL---VSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           KPENLL   + +D+ I I+DFGL++  +     +    T  Y APEVL Q   YS  VD 
Sbjct: 143 KPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDC 201
Query: 183 WAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           W++G I   L+   P F   ++A   ++I K      +P  D  +D              
Sbjct: 202 WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS------------- 248
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                           A   I  L   DP KR T  +ALQHP
Sbjct: 249 ----------------AKDFIRHLMEKDPEKRFTCEQALQHP 274

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 127/282 (45%), Gaps = 43/282 (15%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G F  V  A  K++ ++VAIK + K+    +E     E+  L K+ HPNIV L ++ 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 70  RENDILYFVFEYMECNLYQLMKDR--EKCF-SEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
                LY + + +       + DR  EK F +E +     FQV   + Y+H  G  HRDL
Sbjct: 86  ESGGHLYLIMQLVSGG---ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 127 KPENLL---VSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
           KPENLL   + +D+ I I+DFGL++  +     +    T  Y APEVL Q   YS  VD 
Sbjct: 143 KPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDC 201
Query: 183 WAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           W++G I   L+   P F   ++A   ++I K      +P  D  +D              
Sbjct: 202 WSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS------------- 248
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                           A   I  L   DP KR T  +ALQHP
Sbjct: 249 ----------------AKDFIRHLMEKDPEKRFTCEQALQHP 274

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  +  +K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP +  LK   + +D L FV EY           RE+ F+E   R +  ++   L Y+H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           R   +RD+K ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-LEDNDY 182
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              VD W +G +M E++  R P +    + + +++                L+L   I  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE----------------LILMEEI-- 222
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           +FP+        L P A     SL+A L   DP +R       A E ++H F
Sbjct: 223 RFPR-------TLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 157/299 (52%), Gaps = 30/299 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR  +  N
Sbjct: 43  DDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKK-KIKREVKILENLRGGT--N 99
Query: 62  IVKLKEVIRE--NDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           I+KL + +++  +     VFEY+       LYQ++ D        ++R + +++ + L Y
Sbjct: 100 IIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTD-------FDIRFYMYELLKALDY 152
Query: 116 MHQRGYFHRDLKPENLLVS--KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
            H +G  HRD+KP N+++   +  +++ D+GLA   +    +   V++R+++ PE+L+  
Sbjct: 153 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 212
Query: 174 YLYSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
            +Y   +DMW++G ++A +I  R P F G    D++ +I  V+GT     +     +   
Sbjct: 213 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI--D 270
Query: 233 INYKFPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           ++  F  ++G          + S N+     +A+ L+  L  +D  +R TA EA++HP+
Sbjct: 271 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 157/299 (52%), Gaps = 30/299 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR  +  N
Sbjct: 38  DDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKK-KIKREVKILENLRGGT--N 94
Query: 62  IVKLKEVIRE--NDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           I+KL + +++  +     VFEY+       LYQ++ D        ++R + +++ + L Y
Sbjct: 95  IIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTD-------FDIRFYMYELLKALDY 147
Query: 116 MHQRGYFHRDLKPENLLVS--KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
            H +G  HRD+KP N+++   +  +++ D+GLA   +    +   V++R+++ PE+L+  
Sbjct: 148 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 207
Query: 174 YLYSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
            +Y   +DMW++G ++A +I  R P F G    D++ +I  V+GT     +     +   
Sbjct: 208 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI--D 265
Query: 233 INYKFPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           ++  F  ++G          + S N+     +A+ L+  L  +D  +R TA EA++HP+
Sbjct: 266 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  +  +K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP +  LK   + +D L FV EY           RE+ F+E   R +  ++   L Y+H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           R   +RD+K ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV-LEDNDY 182
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              VD W +G +M E++  R P +    + + +++                L+L   I  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE----------------LILMEEI-- 222
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           +FP+        L P A     SL+A L   DP +R       A E ++H F
Sbjct: 223 RFPR-------TLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G+ VA++ + K   +      L REV+ ++ ++HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY V EY    E   Y +   R K   E E R    Q+   + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK---EKEARAKFRQIVSAVQYCHQK 132
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E         +  +  Y APE+         
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  +  +K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP +  LK   + +D L FV EY           RE+ F+E   R +  ++   L Y+H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           R   +RD+K ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV-LEDNDY 182
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              VD W +G +M E++  R P +    + + +++                L+L   I  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE----------------LILMEEI-- 222
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           +FP+        L P A     SL+A L   DP +R       A E ++H F
Sbjct: 223 RFPR-------TLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 39/285 (13%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           +++  E+G G    V+R   K + +  A+K +KK   + ++ +   E+  L ++SHPNI+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLSHPNII 111
Query: 64  KLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           KLKE+      +  V E +    L+  + ++   +SE +  +   Q+ + +AY+H+ G  
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 123 HRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
           HRDLKPENLL +       +KIADFGL++ +  +        T  Y APE+ L+   Y  
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI-LRGCAYGP 229
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN--YK 236
           +VDMW++G I   L                  +C     P  D   D  +  R +N  Y 
Sbjct: 230 EVDMWSVGIITYIL------------------LCGF--EPFYDERGDQFMFRRILNCEYY 269
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           F       +S      + +A  L+  L   DP KR T  +ALQHP
Sbjct: 270 F-------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  +  +K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP +  LK   + +D L FV EY           RE+ F+E   R +  ++   L Y+H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           R   +RD+K ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-LEDNDY 182
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              VD W +G +M E++  R P +    + + +++                L+L   I  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE----------------LILMEEI-- 222
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           +FP+        L P A     SL+A L   DP +R       A E ++H F
Sbjct: 223 RFPR-------TLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  +  +K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   
Sbjct: 7   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP +  LK   + +D L FV EY           RE+ F+E   R +  ++   L Y+H 
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 126
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           R   +RD+K ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y
Sbjct: 127 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-LEDNDY 185
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              VD W +G +M E++  R P +    + + +++                L+L   I  
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE----------------LILMEEI-- 225
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           +FP+        L P A     SL+A L   DP +R       A E ++H F
Sbjct: 226 RFPR-------TLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 266

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  +  +K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP +  LK   + +D L FV EY           RE+ F+E   R +  ++   L Y+H 
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 128
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           R   +RD+K ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV-LEDNDY 187
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              VD W +G +M E++  R P +    + + +++                L+L   I  
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE----------------LILMEEI-- 227
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           +FP+        L P A     SL+A L   DP +R       A E ++H F
Sbjct: 228 RFPR-------TLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 268

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  +  +K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP +  LK   + +D L FV EY           RE+ F+E   R +  ++   L Y+H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           R   +RD+K ENL++ KD  IKI DFGL +E I+       +  T  Y APEV L+   Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV-LEDNDY 182
Query: 177 SSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
              VD W +G +M E++  R P +    + + +++                L+L   I  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE----------------LILMEEI-- 222
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           +FP+        L P A     SL+A L   DP +R       A E ++H F
Sbjct: 223 RFPR-------TLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 137/293 (46%), Gaps = 43/293 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  ++ +K +G GTFG V     K +G   A+K +KK+    ++ V   L E + L+   
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH- 117
           HP +  LK   + +D L FV EY           RE+ FSE   R +  ++   L Y+H 
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 126
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYL 175
           ++   +RDLK ENL++ KD  IKI DFGL +E I        +  T  Y APEV L+   
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV-LEDND 185
Query: 176 YSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y   VD W +G +M E++  R P +    + +++++                L+L   I 
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE----------------LILMEEI- 226
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
            +FP+ +G            +A SL++ L   DP +R       A E +QH F
Sbjct: 227 -RFPRTLG-----------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 267

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           +++ + +G G FG V R I + +GE VAIK+ +++           E++ ++K++HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 64  KLKEV------IRENDILYFVFEYMEC-NLYQLMKDREKC--FSEAEVRNWCFQVFQGLA 114
             +EV      +  ND+     EY E  +L + +   E C    E  +R     +   L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 115 YMHQRGYFHRDLKPENLLVSKDTI----KIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           Y+H+    HRDLKPEN+++         KI D G A+E++     TE+V T  Y APE+L
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT-LRPLFPG 201
            Q   Y+  VD W+ G +  E IT  RP  P 
Sbjct: 196 EQKK-YTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 92
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 209
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 210 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 267
Query: 237 FPQLVGVP----LSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           +++ + +G G FG V R I + +GE VAIK+ +++           E++ ++K++HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 64  KLKEV------IRENDILYFVFEYMEC-NLYQLMKDREKC--FSEAEVRNWCFQVFQGLA 114
             +EV      +  ND+     EY E  +L + +   E C    E  +R     +   L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 115 YMHQRGYFHRDLKPENLLVSKDTI----KIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           Y+H+    HRDLKPEN+++         KI D G A+E++     TE+V T  Y APE+L
Sbjct: 137 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 196
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT-LRPLFPG 201
            Q   Y+  VD W+ G +  E IT  RP  P 
Sbjct: 197 EQKK-YTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 137/293 (46%), Gaps = 43/293 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  ++ +K +G GTFG V     K +G   A+K +KK+    ++ V   L E + L+   
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH- 117
           HP +  LK   + +D L FV EY           RE+ FSE   R +  ++   L Y+H 
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 127
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYL 175
           ++   +RDLK ENL++ KD  IKI DFGL +E I        +  T  Y APEV L+   
Sbjct: 128 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV-LEDND 186
Query: 176 YSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y   VD W +G +M E++  R P +    + +++++                L+L   I 
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE----------------LILMEEI- 227
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
            +FP+ +G            +A SL++ L   DP +R       A E +QH F
Sbjct: 228 -RFPRTLG-----------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 268

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVP----LSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 137/293 (46%), Gaps = 43/293 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  ++ +K +G GTFG V     K +G   A+K +KK+    ++ V   L E + L+   
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH- 117
           HP +  LK   + +D L FV EY           RE+ FSE   R +  ++   L Y+H 
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 128
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYL 175
           ++   +RDLK ENL++ KD  IKI DFGL +E I        +  T  Y APEV L+   
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV-LEDND 187
Query: 176 YSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y   VD W +G +M E++  R P +    + +++++                L+L   I 
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE----------------LILMEEI- 228
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
            +FP+ +G            +A SL++ L   DP +R       A E +QH F
Sbjct: 229 -RFPRTLG-----------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 269

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 92
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 209
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 210 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 267
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVP----LSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 91
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 266
Query: 237 FPQLVGVP----LSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 42  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 98
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 99  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 155
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 156 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 215
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 216 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 273
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 274 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 101/205 (49%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G+ VA+K + K   +      L REV+  + ++HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY V EY    E   Y +   R K   E E R    Q+   + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK---EKEARAKFRQIVSAVQYCHQK 132
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E         +     Y APE+         
Sbjct: 133 FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 156/295 (52%), Gaps = 22/295 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L++++G G +  V+ AI+  + E V +K +K      +    ++ +++LR    PN
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLR--GGPN 93
Query: 62  IVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           I+ L +++++  +     VFE++    ++ +    +  ++ ++R + +++ + L Y H  
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +Y 
Sbjct: 151 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +   ++ +
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI--ELDPR 268
Query: 237 FPQLVGVPL----SVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
           F  ++G          + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 140/299 (46%), Gaps = 36/299 (12%)
Query: 4   YKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK-MSHPN 61
           YKL  E+ G+G +  V  A+S Q+G+  A+K ++K+       V  REV++L +   + N
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV-FREVETLYQCQGNKN 72
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I++L E   ++   Y VFE ++         ++K F+E E       V   L ++H +G 
Sbjct: 73  ILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGI 132
Query: 122 FHRDLKPENLLVSK----DTIKIADFGLAREIN--------SRPPFTEYVSTRWYRAPEV 169
            HRDLKPEN+L         +KI DF L   +         + P  T    +  Y APEV
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 170 LL----QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD---EIYKICSVIGTPTQDS 222
           +     Q+  Y  + D+W++G ++  +++  P F G   AD   +  ++C V      +S
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 252
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
             +G        Y+FP      +S        +A  LI+ L   D  +R +AA+ LQHP
Sbjct: 253 IQEG-------KYEFPDKDWAHIS-------SEAKDLISKLLVRDAKQRLSAAQVLQHP 297

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 137/293 (46%), Gaps = 43/293 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  ++ +K +G GTFG V     K +G   A+K +KK+    ++ V   L E + L+   
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH- 117
           HP +  LK   + +D L FV EY           RE+ FSE   R +  ++   L Y+H 
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYL 175
           ++   +RDLK ENL++ KD  IKI DFGL +E I        +  T  Y APEV L+   
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV-LEDND 325
Query: 176 YSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y   VD W +G +M E++  R P +    + +++++                L+L   I 
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE----------------LILMEEI- 366
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
            +FP+ +G            +A SL++ L   DP +R       A E +QH F
Sbjct: 367 -RFPRTLG-----------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 137/293 (46%), Gaps = 43/293 (14%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMS 58
           M  ++ +K +G GTFG V     K +G   A+K +KK+    ++ V   L E + L+   
Sbjct: 150 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH- 117
           HP +  LK   + +D L FV EY           RE+ FSE   R +  ++   L Y+H 
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 269
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYL 175
           ++   +RDLK ENL++ KD  IKI DFGL +E I        +  T  Y APEV L+   
Sbjct: 270 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV-LEDND 328
Query: 176 YSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y   VD W +G +M E++  R P +    + +++++                L+L   I 
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE----------------LILMEEI- 369
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
            +FP+ +G            +A SL++ L   DP +R       A E +QH F
Sbjct: 370 -RFPRTLG-----------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 410

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 101/205 (49%), Gaps = 8/205 (3%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L K +G G F  V  A    +G  VA+K + K   +      L REV+ ++ ++HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 63  VKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           VKL EVI     LY V EY    E   Y +   R K   E E R    Q+   + Y HQ+
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK---EKEARAKFRQIVSAVQYCHQK 133
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLK ENLL+  D  IKIADFG + E         +  +  Y APE+         
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGP 193
Query: 179 KVDMWAMGAIMAELITLRPLFPGTS 203
           +VD+W++G I+  L++    F G +
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    TE   T  Y  PE +++  ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTELCGTLDYLPPE-MIEGRMH 183
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 224
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 258

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 98/202 (48%), Gaps = 2/202 (0%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
           Y+L+K +G G F  V  A    +G+ VA+K + K   +      L REV+ ++ ++HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 63  VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           VKL EVI     LY V EY                 E E R    Q+   + Y HQ+   
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           HRDLK ENLL+  D  IKIADFG + E         +  +  Y APE+         +VD
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 188
Query: 182 MWAMGAIMAELITLRPLFPGTS 203
           +W++G I+  L++    F G +
Sbjct: 189 VWSLGVILYTLVSGSLPFDGQN 210

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 118/220 (53%), Gaps = 8/220 (3%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ A+   +G+ VAI++M  +    +E + + E+  +R+  +PN
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 78
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+  D ++K+ DFG   +I   +   +E V T ++ APEV+ +   Y  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA-YGP 195
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           KVD+W++G +  E+I   P +   +    +Y I +  GTP
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP 234

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T+   T  Y  PE +++  ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE-MIEGRMH 183
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 224
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 258

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T+   T  Y  PE +++  ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE-MIEGRMH 183
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 224
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 258

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 130
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T+   T  Y  PE +++  ++
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE-MIEGRMH 188
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 229
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 230 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 263

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 32/286 (11%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           ++ Y + +E+G G FG V R   + +G   A K +   + S +E V  +E++++  + HP
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-KEIQTMSVLRHP 108
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            +V L +   +++ +  ++E+M    L++ + D     SE E   +  QV +GL +MH+ 
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 120 GYFHRDLKPENLLVS---KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            Y H DLKPEN++ +    + +K+ DFGL   ++ +        T  + APEV  +    
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKPV 227
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
               DMW++G +   L++    F G ++ DE  +          DS   G+         
Sbjct: 228 GYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWNMDDSAFSGI--------- 277
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                           ++D    I  L   DP+ R T  +AL+HP+
Sbjct: 278 ----------------SEDGKDFIRKLLLADPNTRMTIHQALEHPW 307

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 126
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T+   T  Y  PE +++  ++
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE-MIEGRMH 184
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 225
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 226 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 259

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 32/286 (11%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           ++ Y + +E+G G FG V R   + +G   A K +   + S +E V  +E++++  + HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-KEIQTMSVLRHP 214
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            +V L +   +++ +  ++E+M    L++ + D     SE E   +  QV +GL +MH+ 
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 120 GYFHRDLKPENLLVS---KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            Y H DLKPEN++ +    + +K+ DFGL   ++ +        T  + APEV  +    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKPV 333
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
               DMW++G +   L++    F G ++ + +  + S         W          N  
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-------DW----------NMD 376
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                G+         ++D    I  L   DP+ R T  +AL+HP+
Sbjct: 377 DSAFSGI---------SEDGKDFIRKLLLADPNTRMTIHQALEHPW 413

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TXLCGTLDYLPPE-MIEGRMH 183
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 224
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 258

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 129
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPE-MIEGRMH 187
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 228
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 229 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 262

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 124
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPE-MIEGRMH 182
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 223
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 224 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 257

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 128
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPE-MIEGRMH 186
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 227
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 228 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 261

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK---KKYYSWEECVNLRE-----VKS 53
           E Y+  + +G G    V R I K + +  A+K +       +S EE   LRE     V  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 54  LRKMS-HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQ 111
           LRK+S HPNI++LK+    N   + VF+ M+   L+  + ++    SE E R     + +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLE 135
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
            +  +H+    HRDLKPEN+L+  D  IK+ DFG + +++      E   T  Y APE++
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195
Query: 171 LQSYL-----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS---VIGTPTQDS 222
             S       Y  +VDMW+ G IM  L+   P F    +   +  I S     G+P  D 
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           ++D +                          KD   L++      P KR TA EAL HPF
Sbjct: 256 YSDTV--------------------------KD---LVSRFLVVQPQKRYTAEEALAHPF 286

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK---KKYYSWEECVNLRE-----VKS 53
           E Y+  + +G G    V R I K + +  A+K +       +S EE   LRE     V  
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 54  LRKMS-HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQ 111
           LRK+S HPNI++LK+    N   + VF+ M+   L+  + ++    SE E R     + +
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLE 122
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
            +  +H+    HRDLKPEN+L+  D  IK+ DFG + +++      E   T  Y APE++
Sbjct: 123 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 182
Query: 171 LQSYL-----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS---VIGTPTQDS 222
             S       Y  +VDMW+ G IM  L+   P F    +   +  I S     G+P  D 
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 242
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           ++D +                          KD   L++      P KR TA EAL HPF
Sbjct: 243 YSDTV--------------------------KD---LVSRFLVVQPQKRYTAEEALAHPF 273

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE-MIEGRMH 183
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 224
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 130
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE-MIEGRMH 188
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 229
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 230 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 263

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 59  HPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCH 130
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE-MIEGRMH 188
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 229
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 230 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 263

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 128
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE-MIEGRMH 186
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 227
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 228 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 261

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 115/218 (52%), Gaps = 9/218 (4%)
Query: 2   ERYKLIKEVGDGTFGSVW---RAISKQSGEVVAIKKMKKKYY---SWEECVNLREVKSLR 55
           E ++L++ +G G +G V+   +     +G++ A+K +KK      + +      E   L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           ++ HP IV L    +    LY + EY+      +  +RE  F E     +  ++   L +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQS 173
           +HQ+G  +RDLKPEN++++ +  +K+ DFGL +E I+       +  T  Y APE+L++S
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
             ++  VD W++GA+M +++T  P F G +    I KI
Sbjct: 197 G-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +RY+L+K++G G FG       KQS E+VA+K +++     +E V  RE+ + R + HPN
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG-EKIDENVK-REIINHRSLRHPN 75
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV+ KEVI     L  V EY     L++ + +  + FSE E R +  Q+  G++Y H   
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 134
Query: 121 YFHRDLKPENLLVSKDT---IKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSYL 175
             HRDLK EN L+       +KI DFG ++   ++S+P  T  V T  Y APEVLL+   
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 192
Query: 176 YSSKVDMWAMGAIM 189
                D+W+ G  +
Sbjct: 193 DGKVADVWSCGVTL 206

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 128
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S     +   T  Y  PE +++  ++
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRDDLCGTLDYLPPE-MIEGRMH 186
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 227
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 228 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 261

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 117/220 (53%), Gaps = 8/220 (3%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ A+   +G+ VAI++M  +    +E + + E+  +R+  +PN
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 78
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGP 195
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           KVD+W++G +  E+I   P +   +    +Y I +  GTP
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP 234

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 117/220 (53%), Gaps = 8/220 (3%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ A+   +G+ VAI++M  +    +E + + E+  +R+  +PN
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 78
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YGP 195
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           KVD+W++G +  E+I   P +   +    +Y I +  GTP
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP 234

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 117/220 (53%), Gaps = 8/220 (3%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ A+   +G+ VAI++M  +    +E + + E+  +R+  +PN
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 79
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H   
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YGP 196
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           KVD+W++G +  E+I   P +   +    +Y I +  GTP
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP 235

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 115/218 (52%), Gaps = 9/218 (4%)
Query: 2   ERYKLIKEVGDGTFGSVW---RAISKQSGEVVAIKKMKKKYY---SWEECVNLREVKSLR 55
           E ++L++ +G G +G V+   +     +G++ A+K +KK      + +      E   L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           ++ HP IV L    +    LY + EY+      +  +RE  F E     +  ++   L +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQS 173
           +HQ+G  +RDLKPEN++++ +  +K+ DFGL +E I+       +  T  Y APE+L++S
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
             ++  VD W++GA+M +++T  P F G +    I KI
Sbjct: 197 G-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 39/286 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 126
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLA-REINSRPPFTEYVSTRWYRAPEVLLQSYL 175
            +   HRD+KPENLL+ S   +KIADFG +    +SR   T    T  Y  PE +++  +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR--TTLSGTLDYLPPE-MIEGRM 183
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           +  KVD+W++G +  E +  +P F   +   E YK  S                   + +
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEF 224
Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 TFPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 259

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 131/285 (45%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  K S  ++A+K + K     +  E    REV+    + 
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     ++  +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S         T  Y  PE +++  ++
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-AALCGTLDYLPPE-MIEGRMH 183
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +  D   +I  V                    + 
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-------------------EFT 224
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 126
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-LCGTLDYLPPE-MIEGRMH 184
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 225
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 226 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 259

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 151
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPE-MIEGRMH 209
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 250
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 251 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 284

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQ   ++A+K + K     +  E    REV+    + 
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 122
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPE-MIEGRMH 180
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 221
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 222 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 255

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 24  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 83
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 142
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++
Sbjct: 143 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE-MIEGRMH 200
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 241
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 242 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 275

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S         T  Y  PE +++  ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-AALCGTLDYLPPE-MIEGRMH 183
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 224
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S         T  Y  PE +++  ++
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-XXLCGTLDYLPPE-MIEGRMH 183
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 224
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 225 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 258

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 128
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIA+FG +    S    T    T  Y  PE +++  ++
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPE-MIEGRMH 186
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 227
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 228 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 261

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 133/300 (44%), Gaps = 49/300 (16%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK---KKYYSWEECVNLRE-----VKS 53
           E Y+  + +G G    V R I K + +  A+K +       +S EE   LRE     V  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 54  LRKMS-HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQ 111
           LRK+S HPNI++LK+    N   + VF+ M+   L+  + ++    SE E R     + +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLE 135
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
            +  +H+    HRDLKPEN+L+  D  IK+ DFG + +++          T  Y APE++
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEII 195
Query: 171 LQSYL-----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS---VIGTPTQDS 222
             S       Y  +VDMW+ G IM  L+   P F    +   +  I S     G+P  D 
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           ++D +                          KD   L++      P KR TA EAL HPF
Sbjct: 256 YSDTV--------------------------KD---LVSRFLVVQPQKRYTAEEALAHPF 286

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 128
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S         T  Y  PE +++  ++
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-XXLCGTLDYLPPE-MIEGRMH 186
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 227
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 228 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 261

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 128
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S         T  Y  PE +++  ++
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPE-MIEGRMH 186
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 227
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 228 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 261

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 106/195 (54%), Gaps = 13/195 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           +RY+L+K++G G FG       KQS E+VA+K +++     +   N+ RE+ + R + HP
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER---GEKIAANVKREIINHRSLRHP 75
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+ KEVI     L  V EY     L++ + +  + FSE E R +  Q+  G++Y H  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 134
Query: 120 GYFHRDLKPENLLVSKDT---IKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSY 174
              HRDLK EN L+       +KI DFG ++   ++S+P  T  V T  Y APEVLL+  
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 192
Query: 175 LYSSKVDMWAMGAIM 189
                 D+W+ G  +
Sbjct: 193 YDGKVADVWSCGVTL 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 127
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIA+FG +    S    T    T  Y  PE +++  ++
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPE-MIEGRMH 185
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 226
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 227 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 260

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 139/294 (47%), Gaps = 41/294 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS------WEECVNLR-EVKSL 54
           + Y + K +G G  G V  A  +++ + VAIK + K+ ++       +  +N+  E++ L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +K++HP I+K+K      D  Y V E ME   L+  +   ++   EA  + + +Q+   +
Sbjct: 76  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 133
Query: 114 AYMHQRGYFHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H+ G  HRDLKPEN+L+S       IKI DFG ++ +           T  Y APEV
Sbjct: 134 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 193
Query: 170 LLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           L+   +  Y+  VD W++G I+   ++  P F   SE              TQ S  D +
Sbjct: 194 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF---SEHR------------TQVSLKDQI 238
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +   Y F   V   +S       + A+ L+  L   DP  R T  EAL+HP
Sbjct: 239 TSGK---YNFIPEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRHP 282

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 112/212 (52%), Gaps = 8/212 (3%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRK 56
           ++ ++ I+ +G G+FG V  A  K++G++ A+K +KK     ++ V      + + SL +
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
            +HP + +L    +  D L+FV E++          + + F EA  R +  ++   L ++
Sbjct: 82  -NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSY 174
           H +G  +RDLK +N+L+  +   K+ADFG+ +E I +      +  T  Y APE+ LQ  
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI-LQEM 199
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEAD 206
           LY   VD WAMG ++ E++     F   +E D
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 139/294 (47%), Gaps = 41/294 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS------WEECVNLR-EVKSL 54
           + Y + K +G G  G V  A  +++ + VAIK + K+ ++       +  +N+  E++ L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +K++HP I+K+K      D  Y V E ME   L+  +   ++   EA  + + +Q+   +
Sbjct: 70  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 127
Query: 114 AYMHQRGYFHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H+ G  HRDLKPEN+L+S       IKI DFG ++ +           T  Y APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 170 LLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           L+   +  Y+  VD W++G I+   ++  P F   SE              TQ S  D +
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF---SEHR------------TQVSLKDQI 232
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +   Y F   V   +S       + A+ L+  L   DP  R T  EAL+HP
Sbjct: 233 TSGK---YNFIPEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRHP 276

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 142/289 (49%), Gaps = 37/289 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           E ++++ E+GDG FG V++A +K++G + A K ++ K  S EE  + + E++ L    HP
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHP 68
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            IVKL      +  L+ + E+        +M + ++  +E +++  C Q+ + L ++H +
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 120 GYFHRDLKPENLLVS-KDTIKIADFGL-AREINSRPPFTEYVSTRWYRAPEVLLQSYL-- 175
              HRDLK  N+L++ +  I++ADFG+ A+ + +      ++ T ++ APEV++   +  
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 176 --YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W++G  + E+  + P     +    + KI      PT       LL     
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPT-------LLTPSKW 240
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + +F   + + L                     +P  RP+AA+ L+HPF
Sbjct: 241 SVEFRDFLKIALDK-------------------NPETRPSAAQLLEHPF 270

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 151
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S     +   T  Y  PE +++  ++
Sbjct: 152 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRDDLCGTLDYLPPE-MIEGRMH 209
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 250
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 251 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 284

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 41/294 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS------WEECVNLR-EVKSL 54
           + Y + K +G G  G V  A  +++ + VAIK + K+ ++       +  +N+  E++ L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +K++HP I+K+K      D  Y V E ME   L+  +   ++   EA  + + +Q+   +
Sbjct: 70  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 127
Query: 114 AYMHQRGYFHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H+ G  HRDLKPEN+L+S       IKI DFG ++ +           T  Y APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 170 LLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           L+   +  Y+  VD W++G I+   ++  P F                   TQ S  D +
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---------------TQVSLKDQI 232
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +   Y F   V   +S       + A+ L+  L   DP  R T  EAL+HP
Sbjct: 233 TSGK---YNFIPEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRHP 276

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 130
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE  ++   +
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEX-IEGRXH 188
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 229
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 230 FPDFV-----------TEGARDLISRLLKHNPSQRPXLREVLEHP 263

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +RY+L+K++G G FG       KQ+ E+VA+K +++     +E V  RE+ + R + HPN
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG-EKIDENVK-REIINHRSLRHPN 76
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV+ KEVI     L  V EY     L++ + +  + FSE E R +  Q+  G++Y H   
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYAHAMQ 135
Query: 121 YFHRDLKPENLLVSKDT---IKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSYL 175
             HRDLK EN L+       +KIADFG ++   ++S+P     V T  Y APEVLL+   
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP--KSAVGTPAYIAPEVLLKKEY 193
Query: 176 YSSKVDMWAMGAIM 189
                D+W+ G  +
Sbjct: 194 DGKVADVWSCGVTL 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 127
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S         T  Y  PE +++  ++
Sbjct: 128 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE-MIEGRMH 185
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 226
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 227 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 260

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 41/294 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS------WEECVNLR-EVKSL 54
           + Y + K +G G  G V  A  +++ + VAIK + K+ ++       +  +N+  E++ L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +K++HP I+K+K      D  Y V E ME   L+  +   ++   EA  + + +Q+   +
Sbjct: 69  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 126
Query: 114 AYMHQRGYFHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H+ G  HRDLKPEN+L+S       IKI DFG ++ +           T  Y APEV
Sbjct: 127 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 186
Query: 170 LLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           L+   +  Y+  VD W++G I+   ++  P F                   TQ S  D +
Sbjct: 187 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---------------TQVSLKDQI 231
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +   Y F   V   +S       + A+ L+  L   DP  R T  EAL+HP
Sbjct: 232 TSGK---YNFIPEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRHP 275

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNI 62
           +++I E+GDG FG V++A +K++  + A K +  K  S EE  + + E+  L    HPNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNI 96
Query: 63  VKLKEVIRENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           VKL +     + L+ + E+        +M + E+  +E++++  C Q    L Y+H    
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 122 FHRDLKPENLLVSKD-TIKIADFGLA----REINSRPPFTEYVSTRWYRAPEVLL----Q 172
            HRDLK  N+L + D  IK+ADFG++    R I  R  F   + T ++ APEV++    +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF---IGTPYWMAPEVVMCETSK 213
Query: 173 SYLYSSKVDMWAMGAIMAELITLRP 197
              Y  K D+W++G  + E+  + P
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNI 62
           +++I E+GDG FG V++A +K++  + A K +  K  S EE  + + E+  L    HPNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNI 96
Query: 63  VKLKEVIRENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           VKL +     + L+ + E+        +M + E+  +E++++  C Q    L Y+H    
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 122 FHRDLKPENLLVSKD-TIKIADFGLA----REINSRPPFTEYVSTRWYRAPEVLL----Q 172
            HRDLK  N+L + D  IK+ADFG++    R I  R  F   + T ++ APEV++    +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF---IGTPYWMAPEVVMCETSK 213
Query: 173 SYLYSSKVDMWAMGAIMAELITLRP 197
              Y  K D+W++G  + E+  + P
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  + SG++VA+KKM  +     E +   EV  +R   H N+V++   
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNS 89
Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V Q L+ +H +G  HRD+K 
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 148
Query: 129 ENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +++   P  +  V T ++ APE L+    Y  +VD+W++G
Sbjct: 149 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLG 207
Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P +        +  I        +D+    L   + ++   P L G    
Sbjct: 208 IMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL---KNLHKVSPSLKG---- 252
Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                        +  L   DP++R TAAE L+HPF
Sbjct: 253 ------------FLDRLLVRDPAQRATAAELLKHPF 276

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K     +  E    REV+    + 
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 59  HPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     +Y+ ++   K F E     +  ++   L+Y H
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCH 130
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+ S   +KIADFG +    S         T  Y  PE +++  ++
Sbjct: 131 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLXGTLDYLPPE-MIEGRMH 188
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G +  E +  +P F   +   E YK  S                   + + 
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS------------------RVEFT 229
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           FP  V            + A  LI+ L   +PS+RP   E L+HP
Sbjct: 230 FPDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHP 263

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 117/220 (53%), Gaps = 8/220 (3%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ A+   +G+ VAI++M  +    +E + + E+  +R+  +PN
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 79
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H   
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HR++K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGP 196
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           KVD+W++G +  E+I   P +   +    +Y I +  GTP
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP 235

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 41/294 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS------WEECVNLR-EVKSL 54
           + Y + K +G G  G V  A  +++ + VAIK + K+ ++       +  +N+  E++ L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +K++HP I+K+K      D  Y V E ME   L+  +   ++   EA  + + +Q+   +
Sbjct: 70  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 127
Query: 114 AYMHQRGYFHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H+ G  HRDLKPEN+L+S       IKI DFG ++ +           T  Y APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 170 LLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           L+   +  Y+  VD W++G I+   ++  P F                   TQ S  D +
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---------------TQVSLKDQI 232
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +   Y F   V   +S       + A+ L+  L   DP  R T  EAL+HP
Sbjct: 233 TSGK---YNFIPEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRHP 276

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 32/280 (11%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  K +G+ VA+KKM  +     E +   EV  +R   H N+V +   
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL-FNEVVIMRDYHHDNVVDMYSS 110
Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V + L+Y+H +G  HRD+K 
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 129 ENLLVSKDT-IKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  IK++DFG   +++   P     V T ++ APEV +    Y ++VD+W++G
Sbjct: 170 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV-ISRLPYGTEVDIWSLG 228
Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E+I   P +        + +I   +    +D     L    ++   F  L+ V   
Sbjct: 229 IMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKD-----LHKVSSVLRGFLDLMLV--- 280
Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
                               +PS+R TA E L HPF ++A
Sbjct: 281 -------------------REPSQRATAQELLGHPFLKLA 301

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNI 62
           +++I E+GDG FG V++A +K++  + A K +  K  S EE  + + E+  L    HPNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNI 96
Query: 63  VKLKEVIRENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           VKL +     + L+ + E+        +M + E+  +E++++  C Q    L Y+H    
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 122 FHRDLKPENLLVSKD-TIKIADFGLA----REINSRPPFTEYVSTRWYRAPEVLL----Q 172
            HRDLK  N+L + D  IK+ADFG++    R I  R  F   + T ++ APEV++    +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXF---IGTPYWMAPEVVMCETSK 213
Query: 173 SYLYSSKVDMWAMGAIMAELITLRP 197
              Y  K D+W++G  + E+  + P
Sbjct: 214 DRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 142/289 (49%), Gaps = 37/289 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           E ++++ E+GDG FG V++A +K++G + A K ++ K  S EE  + + E++ L    HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHP 76
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            IVKL      +  L+ + E+        +M + ++  +E +++  C Q+ + L ++H +
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 120 GYFHRDLKPENLLVS-KDTIKIADFGL-AREINSRPPFTEYVSTRWYRAPEVLLQSYL-- 175
              HRDLK  N+L++ +  I++ADFG+ A+ + +      ++ T ++ APEV++   +  
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 176 --YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W++G  + E+  + P     +    + KI      PT       LL     
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPT-------LLTPSKW 248
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + +F   + + L                     +P  RP+AA+ L+HPF
Sbjct: 249 SVEFRDFLKIALDK-------------------NPETRPSAAQLLEHPF 278

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  + SG++VA+KKM  +     E +   EV  +R   H N+V++   
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNS 85
Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V Q L+ +H +G  HRD+K 
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 144
Query: 129 ENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +++   P  +  V T ++ APE L+    Y  +VD+W++G
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLG 203
Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P +        +  I        +D+    L   + ++   P L G    
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL---KNLHKVSPSLKG---- 248
Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                        +  L   DP++R TAAE L+HPF
Sbjct: 249 ------------FLDRLLVRDPAQRATAAELLKHPF 272

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  + SG++VA+KKM  +     E +   EV  +R   H N+V++   
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNS 96
Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V Q L+ +H +G  HRD+K 
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 155
Query: 129 ENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +++   P  +  V T ++ APE L+    Y  +VD+W++G
Sbjct: 156 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLG 214
Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P +        +  I        +D+    L   + ++   P L G    
Sbjct: 215 IMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL---KNLHKVSPSLKG---- 259
Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                        +  L   DP++R TAAE L+HPF
Sbjct: 260 ------------FLDRLLVRDPAQRATAAELLKHPF 283

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  + SG++VA+KKM  +     E +   EV  +R   H N+V++   
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNS 94
Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V Q L+ +H +G  HRD+K 
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 153
Query: 129 ENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +++   P  +  V T ++ APE L+    Y  +VD+W++G
Sbjct: 154 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLG 212
Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P +        +  I        +D+    L   + ++   P L G    
Sbjct: 213 IMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL---KNLHKVSPSLKG---- 257
Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                        +  L   DP++R TAAE L+HPF
Sbjct: 258 ------------FLDRLLVRDPAQRATAAELLKHPF 281

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 128/282 (45%), Gaps = 32/282 (11%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y +++E+G G FG V R + K +G V  + K     Y  ++     E+  + ++ HP ++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVF-VAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 111
Query: 64  KLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
            L +   +   +  + E++    L+  +   +   SEAEV N+  Q  +GL +MH+    
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 123 HRDLKPENLLVSK---DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           H D+KPEN++       ++KI DFGLA ++N         +T  + APE++ +  +    
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFY 230
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
            DMWA+G +   L++    F G  + + +  +        +D+++               
Sbjct: 231 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS--------------- 275
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                      S + +A   I +L   +P KR T  +AL+HP
Sbjct: 276 -----------SVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           ++  + +G G F  V  A  K +G++ A+K + KK    +E     E+  LRK+ H NIV
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKDR--EKCF-SEAEVRNWCFQVFQGLAYMHQRG 120
            L+++    + LY V + +       + DR  EK F +E +      QV   + Y+H+ G
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGG---ELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMG 140
Query: 121 YFHRDLKPENLL-VSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
             HRDLKPENLL  S+D    I I+DFGL++        +    T  Y APEVL Q   Y
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQK-PY 199
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSWADGLLLARAI 233
           S  VD W++G I   L+   P F   +++   ++I K      +P  D  +D        
Sbjct: 200 SKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDS------- 252
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                                 A   I +L   DP+KR T  +A +HP
Sbjct: 253 ----------------------AKDFIRNLMEKDPNKRYTCEQAARHP 278

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++      G S           +G   Q++ A+     
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLS------GAS---------PFLGDTKQETLAN----V 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++      G S           +G   Q++ A+     
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLS------GAS---------PFLGDTKQETLAN----V 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 43/292 (14%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-------WEECVNLREVKSL 54
           + Y++ +E+G G F  V +   K +G+  A K +KK+  S        EE    REV  L
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE--REVNIL 62
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           R++ HPNI+ L ++      +  + E +    L+  + ++E   +E E   +  Q+  G+
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGV 121
Query: 114 AYMHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
            Y+H +   H DLKPEN++     V    IK+ DFG+A +I +   F     T  + APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           ++    L   + DMW++G I   L++    F G ++ + +  I                 
Sbjct: 182 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNIS---------------- 224
Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
              A+NY F +      S L       A   I  L   DP +R T A++L+H
Sbjct: 225 ---AVNYDFDEEYFSNTSEL-------AKDFIRRLLVKDPKRRMTIAQSLEH 266

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++      G S           +G   Q++ A+     
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLS------GAS---------PFLGDTKQETLAN----V 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++      G S           +G   Q++ A+     
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLS------GAS---------PFLGDTKQETLAN----V 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 9/222 (4%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY---SWEECVNLREVKSLRKMSHP 60
           +  +K +G G+FG V  A  K      A+K ++KK       E+ +       L+ + HP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            +V L    +  D LYFV +Y+          RE+CF E   R +  ++   L Y+H   
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 121 YFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             +RDLKPEN+L+ S+  I + DFGL +E I      + +  T  Y APEV L    Y  
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV-LHKQPYDR 218
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
            VD W +GA++ E++   P F   + A E+Y   +++  P Q
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYD--NILNKPLQ 257

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  + SG++VA+KKM  +     E +   EV  +R   H N+V++   
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNS 139
Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V Q L+ +H +G  HRD+K 
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 198
Query: 129 ENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +++   P  +  V T ++ APE L+    Y  +VD+W++G
Sbjct: 199 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLG 257
Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P +        +  I        +D+    L   + ++   P L G    
Sbjct: 258 IMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL---KNLHKVSPSLKG---- 302
Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                        +  L   DP++R TAAE L+HPF
Sbjct: 303 ------------FLDRLLVRDPAQRATAAELLKHPF 326

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 69
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 128
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 189 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 228
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 229 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 272

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 141/289 (48%), Gaps = 36/289 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E + +++++G+G++GSV++AI K++G++VAIK++  +    E    ++E+  +++   P+
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE---IIKEISIMQQCDSPH 85
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +VK      +N  L+ V EY    ++  +++ R K  +E E+        +GL Y+H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 121 YFHRDLKPENLLVSKDT-IKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L++ +   K+ADFG+A ++ +        + T ++ APEV +Q   Y+ 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEV-IQEIGYNC 204
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
             D+W++G    E+   +P +       +I+ + ++   PT                   
Sbjct: 205 VADIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPTNP----------------- 241
Query: 239 QLVGVPLSVLMPSANKDAVSLIASLC-SWDPSKRPTAAEALQHPFSRVA 286
                P +   P    D  +     C    P +R TA + LQHPF R A
Sbjct: 242 -----PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 133/293 (45%), Gaps = 39/293 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS------WEECVNLR-EVKSL 54
           + Y + K +G G  G V  A  +++ + VAI+ + K+ ++       +  +N+  E++ L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           +K++HP I+K+K      D  Y V E ME           K   EA  + + +Q+   + 
Sbjct: 209 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 115 YMHQRGYFHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           Y+H+ G  HRDLKPEN+L+S       IKI DFG ++ +           T  Y APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 171 LQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           +   +  Y+  VD W++G I+   ++  P F                   TQ S  D + 
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---------------TQVSLKDQIT 372
Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
             +   Y F   V   +S       + A+ L+  L   DP  R T  EAL+HP
Sbjct: 373 SGK---YNFIPEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRHP 415

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F               +G   Q++ A+     
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPF---------------LGDTKQETLAN----V 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 69
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 128
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 189 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 228
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 229 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 272

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 105/194 (54%), Gaps = 11/194 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +RY+L+K++G G FG       KQS E+VA+K +++     +E V  RE+ + R + HPN
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG-EKIDENVK-REIINHRSLRHPN 76
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV+ KEVI     L  V EY     L++ + +  + FSE E R +  Q+  G++Y H   
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 135
Query: 121 YFHRDLKPENLLVSKDT---IKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSYL 175
             HRDLK EN L+       +KI  FG ++   ++S+P  T  V T  Y APEVLL+   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 193
Query: 176 YSSKVDMWAMGAIM 189
                D+W+ G  +
Sbjct: 194 DGKVADVWSCGVTL 207

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 133/293 (45%), Gaps = 39/293 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS------WEECVNLR-EVKSL 54
           + Y + K +G G  G V  A  +++ + VAI+ + K+ ++       +  +N+  E++ L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           +K++HP I+K+K      D  Y V E ME           K   EA  + + +Q+   + 
Sbjct: 195 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 115 YMHQRGYFHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           Y+H+ G  HRDLKPEN+L+S       IKI DFG ++ +           T  Y APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 171 LQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           +   +  Y+  VD W++G I+   ++  P F                   TQ S  D + 
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---------------TQVSLKDQIT 358
Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
             +   Y F   V   +S       + A+ L+  L   DP  R T  EAL+HP
Sbjct: 359 SGK---YNFIPEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRHP 401

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 130/283 (45%), Gaps = 37/283 (13%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y L   +G G++G V  A+ K +    A KK+ K Y+  +     +E++ ++ + HPNI+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKD--REKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +L E   +N  +Y V E   C   +L +    ++ F E++       V   +AY H+   
Sbjct: 87  RLYETFEDNTDIYLVMEL--CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 122 FHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
            HRDLKPEN L   D+    +K+ DFGLA            V T +Y +P+VL    LY 
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYG 202
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            + D W+ G +M  L+   P F   ++ + + KI                   R   + F
Sbjct: 203 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI-------------------REGTFTF 243
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           P+   + +S   P A     SLI  L +  P +R T+ +AL+H
Sbjct: 244 PEKDWLNVS---PQAE----SLIRRLLTKSPKQRITSLQALEH 279

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 127/282 (45%), Gaps = 37/282 (13%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLR-KMSHPNIVK 64
           KE+G G F  V + ISK +G+  A K +KK+    ++C    L E+  L    S P ++ 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVIN 93
Query: 65  LKEVIRENDILYFVFEYMECN-LYQL-MKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           L EV      +  + EY     ++ L + +  +  SE +V     Q+ +G+ Y+HQ    
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 123 HRDLKPENLLVSK----DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
           H DLKP+N+L+S       IKI DFG++R+I       E + T  Y APE+L    + ++
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI-TT 212
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
             DMW +G I   L+T    F G    +    I  V    ++++++              
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS-------------- 258
Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                       S ++ A   I SL   +P KRPTA   L H
Sbjct: 259 ------------SVSQLATDFIQSLLVKNPEKRPTAEICLSH 288

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 105/194 (54%), Gaps = 11/194 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +RY+L+K++G G FG       KQS E+VA+K +++     +E V  RE+ + R + HPN
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG-EKIDENVK-REIINHRSLRHPN 76
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV+ KEVI     L  V EY     L++ + +  + FSE E R +  Q+  G++Y H   
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 135
Query: 121 YFHRDLKPENLLVSKDT---IKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSYL 175
             HRDLK EN L+       +KI  FG ++   ++S+P  T  V T  Y APEVLL+   
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT--VGTPAYIAPEVLLKKEY 193
Query: 176 YSSKVDMWAMGAIM 189
                D+W+ G  +
Sbjct: 194 DGKVADVWSCGVTL 207

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 130/283 (45%), Gaps = 37/283 (13%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           Y L   +G G++G V  A+ K +    A KK+ K Y+  +     +E++ ++ + HPNI+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 64  KLKEVIRENDILYFVFEYMECNLYQLMKD--REKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +L E   +N  +Y V E   C   +L +    ++ F E++       V   +AY H+   
Sbjct: 70  RLYETFEDNTDIYLVMEL--CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 122 FHRDLKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
            HRDLKPEN L   D+    +K+ DFGLA            V T +Y +P+VL    LY 
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYG 185
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            + D W+ G +M  L+   P F   ++ + + KI                   R   + F
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI-------------------REGTFTF 226
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           P+   + +S   P A     SLI  L +  P +R T+ +AL+H
Sbjct: 227 PEKDWLNVS---PQAE----SLIRRLLTKSPKQRITSLQALEH 262

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 134/287 (46%), Gaps = 36/287 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y++ +++G G++    R I K +    A+K + K      E + +     LR   HPN
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL----LRYGQHPN 77
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I+ LK+V  +   +Y V E M+         R+K FSE E     F + + + Y+H +G 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 122 FHRDLKPENLLV-----SKDTIKIADFGLAREINSRPP-FTEYVSTRWYRAPEVLLQSYL 175
            HRDLKP N+L      + ++I+I DFG A+++ +          T  + APEV L+   
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV-LERQG 196
Query: 176 YSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y +  D+W++G ++  ++T   P   G  +            TP +       +LAR  +
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTPFANGPDD------------TPEE-------ILARIGS 237
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            KF    G   SV     +  A  L++ +   DP +R TAA  L+HP
Sbjct: 238 GKFSLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHP 279

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 142/333 (42%), Gaps = 79/333 (23%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS----LRKM 57
           ++Y L   +G G++G V  AI  Q+  + AIK M K         ++  +K+    ++K+
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 58  SHPNIVKLKEVIRENDILYFVFEYM---------------------------------EC 84
            HPNI +L EV  +   +  V E                                   EC
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 85  N-------LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDT 137
           N       ++   +  +    E  + N   Q+F  L Y+H +G  HRD+KPEN L S + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 138 ---IKIADFGLARE---INSRPPF--TEYVSTRWYRAPEVL-LQSYLYSSKVDMWAMGAI 188
              IK+ DFGL++E   +N+   +  T    T ++ APEVL   +  Y  K D W+ G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 189 MAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVL 248
           +  L+     FPG ++AD I ++                 L + + ++ P       +VL
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQV-----------------LNKKLCFENPN-----YNVL 303
Query: 249 MPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            P A      L+++L + +  +R  A  ALQHP
Sbjct: 304 SPLAR----DLLSNLLNRNVDERFDAMRALQHP 332

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +RY  +K++G G FG       K + E+VA+K +++   + +E V  RE+ + R + HPN
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQ-REIINHRSLRHPN 77
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV+ KEVI     L  + EY     LY+ + +  + FSE E R +  Q+  G++Y H   
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 121 YFHRDLKPENLLVSKDT---IKIADFGLARE--INSRPPFTEYVSTRWYRAPEVLLQSYL 175
             HRDLK EN L+       +KI DFG ++   ++S+P  T  V T  Y APEVLL+   
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEY 194
Query: 176 YSSKVDMWAMGAIM 189
                D+W+ G  +
Sbjct: 195 DGKIADVWSCGVTL 208

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEA 205
               S  D+WA+G I+ +L+   P F   +E 
Sbjct: 210 SAXKSS-DLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 45/304 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRKMSH 59
           Y+L + +G G F  V R I++++G+  A+K +    ++    ++     RE      + H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN--LYQLMKDREKCF--SEAEVRNWCFQVFQGLAY 115
           P+IV+L E    + +LY VFE+M+     ++++K  +  F  SEA   ++  Q+ + L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT---IKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVL 170
            H     HRD+KPEN LL SK+    +K+ DFG+A ++  S       V T  + APEV+
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
            +   Y   VD+W  G I+  L++    F GT E                    +G++  
Sbjct: 206 KRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE-----------------RLFEGIIKG 247
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVA 286
           +   YK        +S       + A  L+  +   DP++R T  EAL HP+     R A
Sbjct: 248 K---YKMNPRQWSHIS-------ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
Query: 287 FMFH 290
           +  H
Sbjct: 298 YKIH 301

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y   +E+G G F  V +   K +G   A K +KK+         S E+    REV  L++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE--REVSILKE 70
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYY 129
Query: 116 MHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN++     V K  IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G                   D+  + L   
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLG-------------------DTKQETLANV 229
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F        S L       A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 43/292 (14%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-------SWEECVNLREVKSL 54
           + Y++ +E+G G F  V +   K +G+  A K +KK+         S EE    REV  L
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE--REVNIL 83
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           R++ HPNI+ L ++      +  + E +    L+  + ++E   +E E   +  Q+  G+
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGV 142
Query: 114 AYMHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
            Y+H +   H DLKPEN++     V    IK+ DFG+A +I +   F     T  + APE
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           ++    L   + DMW++G I   L++    F G ++ + +  I                 
Sbjct: 203 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNIS---------------- 245
Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
              A+NY F +      S L       A   I  L   DP +R   A++L+H
Sbjct: 246 ---AVNYDFDEEYFSNTSEL-------AKDFIRRLLVKDPKRRMXIAQSLEH 287

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  + SG++VA+KKM  +     E +   EV  +R   H N+V++   
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNS 216
Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               D L+ V E++E      +    +  +E ++   C  V Q L+ +H +G  HRD+K 
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 275
Query: 129 ENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +++   P  +  V T ++ APE L+    Y  +VD+W++G
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLG 334
Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P +        +  I        +D+    L   + ++   P L G    
Sbjct: 335 IMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL---KNLHKVSPSLKG---- 379
Query: 247 VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                        +  L   DP++R TAAE L+HPF
Sbjct: 380 ------------FLDRLLVRDPAQRATAAELLKHPF 403

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 43/292 (14%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-------WEECVNLREVKSL 54
           + Y++ +E+G G F  V +   K +G+  A K +KK+  S        EE    REV  L
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE--REVNIL 69
Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           R++ HPNI+ L ++      +  + E +    L+  + ++E   +E E   +  Q+  G+
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGV 128
Query: 114 AYMHQRGYFHRDLKPENLL-----VSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
            Y+H +   H DLKPEN++     V    IK+ DFG+A +I +   F     T  + APE
Sbjct: 129 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           ++    L   + DMW++G I   L++    F G ++ + +  I                 
Sbjct: 189 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNIS---------------- 231
Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
              A+NY F +      S L       A   I  L   DP +R   A++L+H
Sbjct: 232 ---AVNYDFDEEYFSNTSEL-------AKDFIRRLLVKDPKRRMXIAQSLEH 273

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 134/281 (47%), Gaps = 42/281 (14%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV 68
           ++G+G+ G V  A  K SG  VA+K M  +     E +   EV  +R   H N+V++ + 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL-FNEVVIMRDYQHFNVVEMYKS 110
Query: 69  IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
               + L+ + E+++      +  + +  +E ++   C  V Q LAY+H +G  HRD+K 
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 129 ENLLVSKDT-IKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMG 186
           +++L++ D  +K++DFG   +I+   P     V T ++ APEV+ +S LY+++VD+W++G
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRS-LYATEVDIWSLG 228
Query: 187 AIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLS 246
            ++ E++   P +   S              P Q        + R  +   P+L      
Sbjct: 229 IMVIEMVDGEPPYFSDS--------------PVQ-------AMKRLRDSPPPKL------ 261
Query: 247 VLMPSANKDAVS-----LIASLCSWDPSKRPTAAEALQHPF 282
                 N   VS      +  +   DP +R TA E L HPF
Sbjct: 262 -----KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 152
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 213 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEA 205
               S  D+WA+G I+ +L+   P F   +E 
Sbjct: 210 SACKSS-DLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 7/209 (3%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P  VKL    ++++ LYF   Y +         +   F E   R +  ++   L Y+H +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 120 GYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQSYL 175
           G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L +   
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSE 204
            S   D+WA+G I+ +L+   P F   +E
Sbjct: 212 -SKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           +E + L++ +G+G +G V  A+++ + E VA+K +  K+     E +  +E+   + ++H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEIXINKMLNH 63
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAYMH 117
            N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 118 QRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLLQS 173
             G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L + 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 174 YLYSSKVDMWAMGAIMAELIT 194
             ++  VD+W+ G ++  ++ 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLA 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 60
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLA 201

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 150
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 211 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           +E + L++ +G+G +G V  A+++ + E VA+K +  K+     E +  +E+   + ++H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEIXINKMLNH 64
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAYMH 117
            N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 118 QRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLLQS 173
             G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L + 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 174 YLYSSKVDMWAMGAIMAELIT 194
             ++  VD+W+ G ++  ++ 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLA 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           +E + L++ +G+G +G V  A+++ + E VA+K +  K+     E +  +E+   + ++H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEIXINKMLNH 63
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAYMH 117
            N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 118 QRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLLQS 173
             G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L + 
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 174 YLYSSKVDMWAMGAIMAELIT 194
             ++  VD+W+ G ++  ++ 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLA 202

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 35/284 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E + + + +G G FG+V+ A  +QS  ++A+K + K     +  E    REV+    + 
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HPNI++L     +   +Y + EY           +   F E     +  ++   L+Y H 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++ 
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE-MIEGRMHD 188
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            KVD+W++G +  E +   P F   +  +   +I  V                    + F
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-------------------EFTF 229
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           P  V            + A  LI+ L   + S+R T AE L+HP
Sbjct: 230 PDFV-----------TEGARDLISRLLKHNASQRLTLAEVLEHP 262

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 210 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 208 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 210 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 208 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           E   L+KE+G G FG V   + K  G+  VA+K +K+   S +E    +E +++ K+SHP
Sbjct: 8   EEITLLKELGSGQFGVV--KLGKWKGQYDVAVKMIKEGSMSEDEF--FQEAQTMMKLSHP 63
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            +VK   V  +   +Y V EY+    L   ++   K    +++   C+ V +G+A++   
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYL 175
            + HRDL   N LV +D  +K++DFG+ R +     +   V T++   + APEV    + 
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEV-FHYFK 181
Query: 176 YSSKVDMWAMGAIMAELITL 195
           YSSK D+WA G +M E+ +L
Sbjct: 182 YSSKSDVWAFGILMWEVFSL 201

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 208 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 150
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 211 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 109/205 (53%), Gaps = 12/205 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           ++ P +VKL+   ++N  LY V EYM   +++  ++ R   FSE   R +  Q+     Y
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARFYAAQIVLTFEY 156
Query: 116 MHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           +H     +RDLKPENLL+ +   IK+ADFG A+ +  R        T  Y APE++L S 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SK 213
Query: 175 LYSSKVDMWAMGAIMAELITLRPLF 199
            Y+  VD WA+G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 210 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 207 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 109/205 (53%), Gaps = 12/205 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           ++ P +VKL+   ++N  LY V EYM   +++  ++ R   FSE   R +  Q+     Y
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARFYAAQIVLTFEY 156
Query: 116 MHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           +H     +RDLKPENLL+ +   IK+ADFG A+ +  R        T  Y APE++L S 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SK 213
Query: 175 LYSSKVDMWAMGAIMAELITLRPLF 199
            Y+  VD WA+G ++ E+    P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 131
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 192 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 19/197 (9%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLK 66
           K +G+G+F    + + K+S +  A+K + K+     E    +E+ +L+    HPNIVKL 
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLH 72
Query: 67  EVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
           EV  +    + V E +    L++ +K ++K FSE E      ++   +++MH  G  HRD
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIK-KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 126 LKPENLLVSKDT----IKIADFGLAREINSRPPFTEYVSTRW----YRAPEVLLQSYLYS 177
           LKPENLL + +     IKI DFG AR    +PP  + + T      Y APE+L Q+  Y 
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFAR---LKPPDNQPLKTPCFTLHYAAPELLNQNG-YD 187
Query: 178 SKVDMWAMGAIMAELIT 194
              D+W++G I+  +++
Sbjct: 188 ESCDLWSLGVILYTMLS 204

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 207 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 117/222 (52%), Gaps = 8/222 (3%)
Query: 4   YKLIKEVGDGTFGSVW--RAISK-QSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSH 59
           ++L+K +G G+FG V+  R +++  SG + A+K +KK      + V  + E   L  ++H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P +VKL    +    LY + +++          +E  F+E +V+ +  ++  GL ++H  
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSL 149
Query: 120 GYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  +RDLKPEN+L+ ++  IK+ DFGL++E I+       +  T  Y APEV+ +   +S
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQG-HS 208
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV-IGTP 218
              D W+ G +M E++T    F G    + +  I    +G P
Sbjct: 209 HSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 154
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 155 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 215 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 112/217 (51%), Gaps = 13/217 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +LIK +G+G FG VW   +      VAIK +K    S E    L E + ++K+ H  
Sbjct: 9   ESLQLIKRLGNGQFGEVWMG-TWNGNTKVAIKTLKPGTMSPESF--LEEAQIMKKLKHDK 65
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +KD E +      + +   QV  G+AY+ + 
Sbjct: 66  LVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSYL 175
            Y HRDL+  N+LV    I KIADFGLAR I          +    +W  APE  L    
Sbjct: 125 NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALYGR- 182
Query: 176 YSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           ++ K D+W+ G ++ EL+T  R  +PG +  + + ++
Sbjct: 183 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 219

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 35/284 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS 58
           +E + + + +G G FG+V+ A  +QS  ++A+K + K     +  E    REV+    + 
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HPNI++L     +   +Y + EY           +   F E     +  ++   L+Y H 
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           +   HRD+KPENLL+ S   +KIADFG +    S    T    T  Y  PE +++  ++ 
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-LCGTLDYLPPE-MIEGRMHD 188
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            KVD+W++G +  E +   P F   +  +   +I  V                    + F
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-------------------EFTF 229
Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           P  V            + A  LI+ L   + S+R T AE L+HP
Sbjct: 230 PDFV-----------TEGARDLISRLLKHNASQRLTLAEVLEHP 262

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 124
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 185 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-- 58
           +E ++L K +G G+FG V+ A  K++ +  AIK +KK     ++ V    V+  R +S  
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK-RVLSLA 75
Query: 59  --HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKC--FSEAEVRNWCFQVFQGLA 114
             HP +  +    +  + L+FV EY+  N   LM   + C  F  +    +  ++  GL 
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYL--NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQ 172
           ++H +G  +RDLK +N+L+ KD  IKIADFG+ +E +       E+  T  Y APE+LL 
Sbjct: 134 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
              Y+  VD W+ G ++ E++  +  F G  E +  + I
Sbjct: 194 QK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 231

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 186 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 127
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 188 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 126
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 187 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G  G V  A+++ + E VA+K   MK+     E   N+++   + KM 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLA 202

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 114/227 (50%), Gaps = 21/227 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMS 58
           E Y+++  +G G++G   +   K  G+++  K++   Y S  E      + EV  LR++ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 63
Query: 59  HPNIVKLKEVI--RENDILYFVFEYMECN-----LYQLMKDREKCFSEAEVRNWCFQVFQ 111
           HPNIV+  + I  R N  LY V EY E       + +  K+R+    E  +R    Q+  
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTL 122
Query: 112 GLAYMHQRG-----YFHRDLKPENL-LVSKDTIKIADFGLAREINSRPPFT-EYVSTRWY 164
            L   H+R        HRDLKP N+ L  K  +K+ DFGLAR +N    F  E+V T +Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYY 182
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
            +PE  +    Y+ K D+W++G ++ EL  L P F   S+ +   KI
Sbjct: 183 MSPEQ-MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 11/211 (5%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +   A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREK--CFSEAEVRNWCFQVFQGLAYMH 117
           P  VKL    ++++ LYF   Y +    +L+K   K   F E   R +  ++   L Y+H
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQS 173
            +G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L + 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSE 204
               S  D+WA+G I+ +L+   P F   +E
Sbjct: 208 SACKSS-DLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKM- 57
           +E + L++ +G+G +G V  A+++ + E VA+K   MK+     E   N+++   +  M 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINAML 62
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFS--EAEVRNWCFQVFQGLAY 115
           +H N+VK     RE +I Y   EY  C+  +L    E      E + + +  Q+  G+ Y
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLA---REINSRPPFTEYVSTRWYRAPEVLL 171
           +H  G  HRD+KPENLL+  +D +KI+DFGLA   R  N      +   T  Y APE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           +   ++  VD+W+ G ++  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 112/221 (50%), Gaps = 34/221 (15%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE---------------- 44
           + +Y L  E+G G++G V  A ++      A+K + KK    +                 
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 45  -CVNLR--------EVKSLRKMSHPNIVKLKEVIRE--NDILYFVFEYMECNLYQLMK-D 92
            C+  R        E+  L+K+ HPN+VKL EV+ +   D LY VFE +  N   +M+  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV--NQGPVMEVP 129
Query: 93  REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREI-N 150
             K  SE + R +   + +G+ Y+H +   HRD+KP NLLV +D  IKIADFG++ E   
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 151 SRPPFTEYVSTRWYRAPEVLLQSY-LYSSK-VDMWAMGAIM 189
           S    +  V T  + APE L ++  ++S K +D+WAMG  +
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 134/278 (48%), Gaps = 45/278 (16%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           VG G FG V +A  K   + VAIK+++ +    E    + E++ L +++HPNIVKL    
Sbjct: 17  VGRGAFGVVCKA--KWRAKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYMHQ---RGYFH 123
              + +  V EY E  +LY ++   E    ++ A   +WC Q  QG+AY+H    +   H
Sbjct: 72  L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 124 RDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           RDLKP NLL+      +KI DFG A +I +    T    +  + APEV   S  YS K D
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSN-YSEKCD 186
Query: 182 MWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV 241
           +++ G I+ E+IT R  F      DE       IG P     A  ++ A     + P + 
Sbjct: 187 VFSWGIILWEVITRRKPF------DE-------IGGP-----AFRIMWAVHNGTRPPLIK 228
Query: 242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
            +P         K   SL+    S DPS+RP+  E ++
Sbjct: 229 NLP---------KPIESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 134/278 (48%), Gaps = 45/278 (16%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           VG G FG V +A  K   + VAIK+++ +    E    + E++ L +++HPNIVKL    
Sbjct: 16  VGRGAFGVVCKA--KWRAKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYMHQ---RGYFH 123
              + +  V EY E  +LY ++   E    ++ A   +WC Q  QG+AY+H    +   H
Sbjct: 71  L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 124 RDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVD 181
           RDLKP NLL+      +KI DFG A +I +    T    +  + APEV   S  YS K D
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSN-YSEKCD 185
Query: 182 MWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV 241
           +++ G I+ E+IT R  F      DE       IG P     A  ++ A     + P + 
Sbjct: 186 VFSWGIILWEVITRRKPF------DE-------IGGP-----AFRIMWAVHNGTRPPLIK 227
Query: 242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
            +P         K   SL+    S DPS+RP+  E ++
Sbjct: 228 NLP---------KPIESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   IK+ADFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLAGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLXGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 36/288 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
            + Y++ +++G G++    R I K +    A+K + K      E + +     LR   HP
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEIL----LRYGQHP 76
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           NI+ LK+V  +   +Y V E  +         R+K FSE E     F + + + Y+H +G
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 121 YFHRDLKPENLLV-----SKDTIKIADFGLAREINSRPPFTEY-VSTRWYRAPEVLLQSY 174
             HRDLKP N+L      + ++I+I DFG A+++ +          T  + APEV L+  
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEV-LERQ 195
Query: 175 LYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
            Y +  D+W++G ++   +T   P   G  +            TP +       +LAR  
Sbjct: 196 GYDAACDIWSLGVLLYTXLTGYTPFANGPDD------------TPEE-------ILARIG 236
Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           + KF    G        S +  A  L++     DP +R TAA  L+HP
Sbjct: 237 SGKFSLSGG-----YWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHP 279

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPN 61
           Y L   +G GTFG V     + +G  VA+K + ++     + V    RE+++L+   HP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I+KL +VI     ++ V EY+    L+  +    +   E E R    Q+  G+ Y H+  
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCHRHM 136
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             HRDLKPEN+L+      KIADFGL+  ++          +  Y APEV+        +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPE 196
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           VD+W+ G I+  L+     F          KIC            DG+          PQ
Sbjct: 197 VDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC------------DGIFYT-------PQ 237
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            +           N   +SL+  +   DP KR T  +  +H
Sbjct: 238 YL-----------NPSVISLLKHMLQVDPMKRATIKDIREH 267

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 114/227 (50%), Gaps = 21/227 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMS 58
           E Y+++  +G G++G   +   K  G+++  K++   Y S  E      + EV  LR++ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 63
Query: 59  HPNIVKLKEVI--RENDILYFVFEYMECN-----LYQLMKDREKCFSEAEVRNWCFQVFQ 111
           HPNIV+  + I  R N  LY V EY E       + +  K+R+    E  +R    Q+  
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTL 122
Query: 112 GLAYMHQRG-----YFHRDLKPENL-LVSKDTIKIADFGLAREINSRPPFTE-YVSTRWY 164
            L   H+R        HRDLKP N+ L  K  +K+ DFGLAR +N    F + +V T +Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 182
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
            +PE  +    Y+ K D+W++G ++ EL  L P F   S+ +   KI
Sbjct: 183 MSPEQ-MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 114/227 (50%), Gaps = 21/227 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMS 58
           E Y+++  +G G++G   +   K  G+++  K++   Y S  E      + EV  LR++ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 63
Query: 59  HPNIVKLKEVI--RENDILYFVFEYMECN-----LYQLMKDREKCFSEAEVRNWCFQVFQ 111
           HPNIV+  + I  R N  LY V EY E       + +  K+R+    E  +R    Q+  
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTL 122
Query: 112 GLAYMHQRG-----YFHRDLKPENL-LVSKDTIKIADFGLAREINSRPPFTE-YVSTRWY 164
            L   H+R        HRDLKP N+ L  K  +K+ DFGLAR +N    F + +V T +Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
            +PE  +    Y+ K D+W++G ++ EL  L P F   S+ +   KI
Sbjct: 183 MSPEQ-MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 118
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 179 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 235
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 33/283 (11%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++ +G G+FG V++ I  ++ +VVAIK +  +    E     +E+  L +     
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           + K      +   L+ + EY+      L   R   F E ++     ++ +GL Y+H    
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGG-SALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 122 FHRDLKPENLLVS-KDTIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            HRD+K  N+L+S +  +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y SK
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSK 200
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
            D+W++G    EL    P                    P  D     +L     N   P 
Sbjct: 201 ADIWSLGITAIELAKGEP--------------------PNSDMHPMRVLFLIPKNNP-PT 239
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           LVG           K     I +  + DPS RPTA E L+H F
Sbjct: 240 LVG--------DFTKSFKEFIDACLNKDPSFRPTAKELLKHKF 274

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 90
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 150
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 151 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 207
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 84
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 144
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 145 HSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 201
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 202 YNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 41/299 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK--MKKKYYSWEECVNLREVKSLRKMSH 59
           + Y+L + +G G    V  A      E VAIK+  ++K   S +E   L+E++++ +  H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQCHH 67
Query: 60  PNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKD-------REKCFSEAEVRNWCFQVFQ 111
           PNIV         D L+ V + +   ++  ++K        +     E+ +     +V +
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE------YVSTRWY 164
           GL Y+H+ G  HRD+K  N+L+ +D +++IADFG++  + +    T       +V T  +
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
            APEV+ Q   Y  K D+W+ G    EL T                     G      + 
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIELAT---------------------GAAPYHKYP 226
Query: 225 DGLLLARAINYKFPQL-VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              +L   +    P L  GV    ++    K    +I+     DP KRPTAAE L+H F
Sbjct: 227 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 285

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ I+ +G G+FG V     K++G   A+K + K    K    E  +N + ++  + 
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQ--QA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY           R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   IK+ADFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 41/299 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK--MKKKYYSWEECVNLREVKSLRKMSH 59
           + Y+L + +G G    V  A      E VAIK+  ++K   S +E   L+E++++ +  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQCHH 72
Query: 60  PNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKD-------REKCFSEAEVRNWCFQVFQ 111
           PNIV         D L+ V + +   ++  ++K        +     E+ +     +V +
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE------YVSTRWY 164
           GL Y+H+ G  HRD+K  N+L+ +D +++IADFG++  + +    T       +V T  +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
            APEV+ Q   Y  K D+W+ G    EL T                     G      + 
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELAT---------------------GAAPYHKYP 231
Query: 225 DGLLLARAINYKFPQL-VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              +L   +    P L  GV    ++    K    +I+     DP KRPTAAE L+H F
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY           R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENL++ +   IK+ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 114/216 (52%), Gaps = 20/216 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL+K +G G FG VW      S +V A+K +K    S +    L E   ++ + H  
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQ--AFLEEANLMKTLQHDK 69
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+   + +Y + EYM + +L   +K  E       ++ ++  Q+ +G+AY+ ++
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LVS+  + KIADFGLAR I       EY +        +W  APE  +
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIED----NEYTAREGAKFPIKW-TAPEA-I 183
Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEAD 206
               ++ K D+W+ G ++ E++T   + +PG + AD
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNAD 219

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 141/322 (43%), Gaps = 45/322 (13%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ERY+++  +G+GTFG V + +  + G      K+ K    ++E   L E+  L K++  +
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARL-EINVLEKINEKD 91
Query: 62  ------IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQGLA 114
                  V++ +    +  +   FE +  + +  +KD     +   +VR+  FQ+ Q + 
Sbjct: 92  PDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVK 151
Query: 115 YMHQRGYFHRDLKPENLL--------------------VSKDTIKIADFGLAREINSRPP 154
           ++H     H DLKPEN+L                    V    +++ DFG A        
Sbjct: 152 FLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSA--TFDHEH 209
Query: 155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV 214
            +  VSTR YRAPEV+L+   +S   D+W++G I+ E      LF      + +  +  +
Sbjct: 210 HSTIVSTRHYRAPEVILE-LGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERI 268
Query: 215 IG---------TPTQDSWADGLL--LARAINYKFPQLVGVPLSVLMPSANKDA---VSLI 260
           +G         T  Q  +  G L         ++ +    PL   + S  ++      LI
Sbjct: 269 LGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLI 328
Query: 261 ASLCSWDPSKRPTAAEALQHPF 282
            S+  ++P+KR T  EALQHPF
Sbjct: 329 ESMLEYEPAKRLTLGEALQHPF 350

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y + +E+G G F  V +   K +G   A K +KK+           EE    REV  LR+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE--REVSILRQ 71
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPNI+ L +V      +  + E +    L+  +  +E   SE E  ++  Q+  G+ Y
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNY 130
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFGLA EI     F     T  + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G ++ + +  I                   
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANIT------------------ 231
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A++Y F +      S L       A   I  L   +  KR T  EAL+HP
Sbjct: 232 -AVSYDFDEEFFSQTSEL-------AKDFIRKLLVKETRKRLTIQEALRHP 274

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F+E   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 6/202 (2%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM-KKKYYSWEECVN-LREVKSLRKMS 58
           +++++ IK +G G+FG V      ++G   A+K + K+K    +E  + L E + L+ ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            P +VKL+   ++N  LY V EY           R   FSE   R +  Q+     Y+H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
               +RDLKPENL++ +   IK+ DFGLA+ +  R        T  Y APE++L S  Y+
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRT--WXLCGTPEYLAPEIIL-SKGYN 216
Query: 178 SKVDMWAMGAIMAELITLRPLF 199
             VD WA+G ++ E+    P F
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ ++    P F
Sbjct: 215 YNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 118
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 178
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 179 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 235
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 116/225 (51%), Gaps = 15/225 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK----KKYYSWEECVNLREVKSLRK 56
           +  +++ K++G G F  V+RA     G  VA+KK++        +  +C+  +E+  L++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQ 88
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQVFQG 112
           ++HPN++K      E++ L  V E  +      + +  K +++   E  V  +  Q+   
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 113 LAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVL 170
           L +MH R   HRD+KP N+ ++    +K+ D GL R  +S+       V T +Y +PE +
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI 215
            ++  Y+ K D+W++G ++ E+  L+  F G  +   +Y +C  I
Sbjct: 209 HENG-YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKI 250

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 12/219 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-- 58
           +E + L K +G G+FG V+ A  K++ +  AIK +KK     ++ V    V+  R +S  
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK-RVLSLA 74
Query: 59  --HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKC--FSEAEVRNWCFQVFQGLA 114
             HP +  +    +  + L+FV EY+  N   LM   + C  F  +    +  ++  GL 
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYL--NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQ 172
           ++H +G  +RDLK +N+L+ KD  IKIADFG+ +E +        +  T  Y APE+LL 
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG 192
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
              Y+  VD W+ G ++ E++  +  F G  E +  + I
Sbjct: 193 QK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENL++ +   I++ DFG A+ +  R        T  Y APE+++ S  
Sbjct: 158 HSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIII-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 39/288 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           M+RY   + +G G F   +      + EV A K + K    K +  E+     E+   + 
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKS 82
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           + +P++V       ++D +Y V E         +  R K  +E E R +  Q  QG+ Y+
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSY 174
           H     HRDLK  NL ++ D  +KI DFGLA +I        +   T  Y APEVL +  
Sbjct: 143 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            +S +VD+W++G I+  L+  +P F  TS   E Y                  +  +   
Sbjct: 203 -HSFEVDIWSLGCILYTLLVGKPPF-ETSCLKETY------------------IRIKKNE 242
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           Y  P+ +           N  A +LI  +   DP+ RP+ AE L   F
Sbjct: 243 YSVPRHI-----------NPVASALIRRMLHADPTLRPSVAELLTDEF 279

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 114/218 (52%), Gaps = 21/218 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL K++G G FG VW A   +  +V A+K MK    S E    L E   ++ + H  
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAF--LAEANVMKTLQHDK 71
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSE-AEVRNWCFQVFQGLAYMHQR 119
           +VKL  V+ +  I Y + E+M + +L   +K  E       ++ ++  Q+ +G+A++ QR
Sbjct: 72  LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 130
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LVS   + KIADFGLAR I       EY +        +W  APE  +
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKW-TAPEA-I 184
Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEI 208
               ++ K D+W+ G ++ E++T  R  +PG S  + I
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 222

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 39/288 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           M+RY   + +G G F   +      + EV A K + K    K +  E+     E+   + 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKS 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           + +P++V       ++D +Y V E         +  R K  +E E R +  Q  QG+ Y+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSY 174
           H     HRDLK  NL ++ D  +KI DFGLA +I        +   T  Y APEVL +  
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            +S +VD+W++G I+  L+  +P F  TS   E Y                  +  +   
Sbjct: 219 -HSFEVDIWSLGCILYTLLVGKPPF-ETSCLKETY------------------IRIKKNE 258
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           Y  P+ +           N  A +LI  +   DP+ RP+ AE L   F
Sbjct: 259 YSVPRHI-----------NPVASALIRRMLHADPTLRPSVAELLTDEF 295

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 92
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 152
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 153 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 209
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 210 YNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V     K++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 90
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 150
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 151 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 207
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 123/237 (51%), Gaps = 20/237 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL+K++G G FG VW      S +V A+K +K    S +    L E   ++ + H  
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAF--LEEANLMKTLQHDK 68
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ + + +Y + E+M + +L   +K  E       ++ ++  Q+ +G+AY+ ++
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LVS+  + KIADFGLAR I       EY +        +W  APE  +
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIED----NEYTAREGAKFPIKW-TAPEA-I 182
Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPTQDSWADGL 227
               ++ K ++W+ G ++ E++T   + +PG + AD +  +      P  ++  D L
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDEL 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 118
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  +        T  Y APE++L S  
Sbjct: 179 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGATWTLCGTPEYLAPEIIL-SKG 235
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           M+RY   + +G G F   +      + EV A K + K    K +  E+     E+   + 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKS 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           + +P++V       ++D +Y V E         +  R K  +E E R +  Q  QG+ Y+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSY 174
           H     HRDLK  NL ++ D  +KI DFGLA +I       + +  T  Y APEVL +  
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            +S +VD+W++G I+  L+  +P F  TS   E Y                  +  +   
Sbjct: 219 -HSFEVDIWSLGCILYTLLVGKPPF-ETSCLKETY------------------IRIKKNE 258
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           Y  P+ +           N  A +LI  +   DP+ RP+ AE L   F
Sbjct: 259 YSVPRHI-----------NPVASALIRRMLHADPTLRPSVAELLTDEF 295

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y + +E+G G F  V +   K +G   A K +KK+         S EE    REV  LR+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE--REVSILRQ 71
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + H N++ L +V      +  + E +    L+  +  +E   SE E  ++  Q+  G+ Y
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNY 130
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFGLA EI     F     T  + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G ++ + +  I SV                
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---------------- 233
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +Y F +      S L       A   I  L   +  KR T  EAL+HP
Sbjct: 234 ---SYDFDEEFFSHTSEL-------AKDFIRKLLVKETRKRLTIQEALRHP 274

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y + +E+G G F  V +   K +G   A K +KK+         S EE    REV  LR+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE--REVSILRQ 71
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + H N++ L +V      +  + E +    L+  +  +E   SE E  ++  Q+  G+ Y
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNY 130
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFGLA EI     F     T  + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G ++ + +  I SV                
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---------------- 233
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +Y F +      S L       A   I  L   +  KR T  EAL+HP
Sbjct: 234 ---SYDFDEEFFSHTSEL-------AKDFIRKLLVKETRKRLTIQEALRHP 274

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y AP ++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPAIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 6/202 (2%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM-KKKYYSWEECVN-LREVKSLRKMS 58
           +++++ IK +G G+FG V      ++G   A+K + K+K    +E  + L E + L+ ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            P +VKL+   ++N  LY V EY           R   FSE   R +  Q+     Y+H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 119 RGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
               +RDLKPENL++ +   I++ DFGLA+ +  R        T  Y APE++L S  Y+
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRT--WXLCGTPEYLAPEIIL-SKGYN 216
Query: 178 SKVDMWAMGAIMAELITLRPLF 199
             VD WA+G ++ E+    P F
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 15/199 (7%)
Query: 8   KEVGDGTFGSVWRAISKQSG---EV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           K +G G FG V++ + K S    EV VAIK +K  Y   +    L E   + + SH NI+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 64  KLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           +L+ VI +   +  + EYME   L + +++++  FS  ++      +  G+ Y+    Y 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 123 HRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-----TRWYRAPEVLLQSYL- 175
           HRDL   N+LV+ + + K++DFGL+R +   P  T   S      RW  APE +  SY  
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW-TAPEAI--SYRK 226
Query: 176 YSSKVDMWAMGAIMAELIT 194
           ++S  D+W+ G +M E++T
Sbjct: 227 FTSASDVWSFGIVMWEVMT 245

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 114/218 (52%), Gaps = 21/218 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL K++G G FG VW A   +  +V A+K MK    S E    L E   ++ + H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAF--LAEANVMKTLQHDK 244
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSE-AEVRNWCFQVFQGLAYMHQR 119
           +VKL  V+ +  I Y + E+M + +L   +K  E       ++ ++  Q+ +G+A++ QR
Sbjct: 245 LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVLL 171
            Y HRDL+  N+LVS   + KIADFGLAR I       EY +        +W  APE  +
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKW-TAPEA-I 357
Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEI 208
               ++ K D+W+ G ++ E++T  R  +PG S  + I
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           M+RY   + +G G F   +      + EV A K + K    K +  E+     E+   + 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKS 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           + +P++V       ++D +Y V E         +  R K  +E E R +  Q  QG+ Y+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSY 174
           H     HRDLK  NL ++ D  +KI DFGLA +I       + +  T  Y APEVL +  
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            +S +VD+W++G I+  L+  +P F  TS   E Y                  +  +   
Sbjct: 219 -HSFEVDIWSLGCILYTLLVGKPPF-ETSCLKETY------------------IRIKKNE 258
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           Y  P+ +           N  A +LI  +   DP+ RP+ AE L   F
Sbjct: 259 YSVPRHI-----------NPVASALIRRMLHADPTLRPSVAELLTDEF 295

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y + +E+G G F  V +   K +G   A K +KK+         S EE    REV  LR+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE--REVSILRQ 71
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + H N++ L +V      +  + E +    L+  +  +E   SE E  ++  Q+  G+ Y
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNY 130
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFGLA EI     F     T  + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G ++ + +  I                   
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANIT------------------ 231
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A++Y F +      S L       A   I  L   +  KR T  EAL+HP
Sbjct: 232 -AVSYDFDEEFFSQTSEL-------AKDFIRKLLVKETRKRLTIQEALRHP 274

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 114/211 (54%), Gaps = 17/211 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL K++G G FG VW A   +  +V A+K MK    S E    L E   ++ + H  
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAF--LAEANVMKTLQHDK 238
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSE-AEVRNWCFQVFQGLAYMHQR 119
           +VKL  V+ +  I Y + E+M + +L   +K  E       ++ ++  Q+ +G+A++ QR
Sbjct: 239 LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 297
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
            Y HRDL+  N+LVS   + KIADFGLAR + ++ P       +W  APE  +    ++ 
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGLAR-VGAKFPI------KW-TAPEA-INFGSFTI 348
Query: 179 KVDMWAMGAIMAELITL-RPLFPGTSEADEI 208
           K D+W+ G ++ E++T  R  +PG S  + I
Sbjct: 349 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 379

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y + +E+G G F  V +   K +G   A K +KK+         S EE    REV  LR+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE--REVSILRQ 71
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + H N++ L +V      +  + E +    L+  +  +E   SE E  ++  Q+  G+ Y
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNY 130
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFGLA EI     F     T  + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G ++ + +  I                   
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANIT------------------ 231
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A++Y F +      S L       A   I  L   +  KR T  EAL+HP
Sbjct: 232 -AVSYDFDEEFFSQTSEL-------AKDFIRKLLVKETRKRLTIQEALRHP 274

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 43/291 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-------YSWEECVNLREVKSLRK 56
           Y + +E+G G F  V +   K +G   A K +KK+         S EE    REV  LR+
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE--REVSILRQ 71
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + H N++ L +V      +  + E +    L+  +  +E   SE E  ++  Q+  G+ Y
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNY 130
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT----IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFGLA EI     F     T  + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               L   + DMW++G I   L++    F G ++ + +  I SV                
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---------------- 233
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +Y F +      S L       A   I  L   +  KR T  EAL+HP
Sbjct: 234 ---SYDFDEEFFSHTSEL-------AKDFIRKLLVKETRKRLTIQEALRHP 274

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 116/224 (51%), Gaps = 10/224 (4%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSG----EVVAIKKMKKKYYSWEECVNLR-EVKSLRKM 57
           +++L+K +G G+FG V+  + K SG    ++ A+K +KK      + V  + E   L ++
Sbjct: 26  QFELLKVLGQGSFGKVF-LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +HP IVKL    +    LY + +++          +E  F+E +V+ +  ++   L ++H
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 144
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYL 175
             G  +RDLKPEN+L+ ++  IK+ DFGL++E I+       +  T  Y APEV +    
Sbjct: 145 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRG 203
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV-IGTP 218
           ++   D W+ G +M E++T    F G    + +  I    +G P
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 116/224 (51%), Gaps = 10/224 (4%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSG----EVVAIKKMKKKYYSWEECVNLR-EVKSLRKM 57
           +++L+K +G G+FG V+  + K SG    ++ A+K +KK      + V  + E   L ++
Sbjct: 25  QFELLKVLGQGSFGKVF-LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +HP IVKL    +    LY + +++          +E  F+E +V+ +  ++   L ++H
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYL 175
             G  +RDLKPEN+L+ ++  IK+ DFGL++E I+       +  T  Y APEV +    
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRG 202
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV-IGTP 218
           ++   D W+ G +M E++T    F G    + +  I    +G P
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 83
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 143
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 144 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEYLAPEIIL-SKG 200
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 201 YNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 134/300 (44%), Gaps = 50/300 (16%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK--KKYYSWEECVNLREVKS-----L 54
           ++Y     +G G    V R + + +G   A+K M+   +  S E+   +RE        L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 55  RKMS-HPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
           R+++ HP+I+ L +    +  ++ VF+ M +  L+  + ++    SE E R+    + + 
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEA 212
Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
           ++++H     HRDLKPEN+L+  +  I+++DFG +  +       E   T  Y APE+L 
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 172 QSYL-----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW-AD 225
            S       Y  +VD+WA G I+  L+   P F                       W   
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPF-----------------------WHRR 309
Query: 226 GLLLARAI---NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +L+ R I    Y+F      P      S  KD   LI+ L   DP  R TA +ALQHPF
Sbjct: 310 QILMLRMIMEGQYQF----SSPEWDDRSSTVKD---LISRLLQVDPEARLTAEQALQHPF 362

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 143/330 (43%), Gaps = 61/330 (18%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ERY+++  +G+GTFG V   +    G+     K+ +    + E   L E+  L+K     
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKK----- 72
Query: 62  IVKLKEVIRENDILYFV--------------FEYMECNLYQLMKDRE-KCFSEAEVRNWC 106
              +KE  +EN  L  +              FE +  N ++ +K+   + +    VR+  
Sbjct: 73  ---IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLL--------------------VSKDTIKIADFGLA 146
           +Q+   L ++H+    H DLKPEN+L                    V   +I++ADFG A
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 147 REINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD 206
                    T  V+TR YR PEV+L+   ++   D+W++G I+ E      LF      +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 207 EIYKICSVIG---------TPTQDSWADGLLL--ARAINYKFPQLVGVPLSVLMPSANKD 255
            +  +  ++G         T  Q  +  G L+    + + ++ +    PL   M   + +
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 256 AV---SLIASLCSWDPSKRPTAAEALQHPF 282
            V    L+  +  +DP++R T AEAL HPF
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPF 336

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 143/330 (43%), Gaps = 61/330 (18%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ERY+++  +G+GTFG V   +    G+     K+ +    + E   L E+  L+K     
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKK----- 104
Query: 62  IVKLKEVIRENDILYFV--------------FEYMECNLYQLMKDRE-KCFSEAEVRNWC 106
              +KE  +EN  L  +              FE +  N ++ +K+   + +    VR+  
Sbjct: 105 ---IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMA 161
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLL--------------------VSKDTIKIADFGLA 146
           +Q+   L ++H+    H DLKPEN+L                    V   +I++ADFG A
Sbjct: 162 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 221
Query: 147 REINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD 206
                    T  V+TR YR PEV+L+   ++   D+W++G I+ E      LF      +
Sbjct: 222 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 278
Query: 207 EIYKICSVIG---------TPTQDSWADGLLL--ARAINYKFPQLVGVPLSVLMPSANKD 255
            +  +  ++G         T  Q  +  G L+    + + ++ +    PL   M   + +
Sbjct: 279 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 338
Query: 256 AV---SLIASLCSWDPSKRPTAAEALQHPF 282
            V    L+  +  +DP++R T AEAL HPF
Sbjct: 339 HVQLFDLMRRMLEFDPAQRITLAEALLHPF 368

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           ++++  IK +G G+FG V     K+SG   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T    APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEALAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 32/276 (11%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G FG V +     +G  +A K +K +    +E V   E+  + ++ H N+++L +  
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK-NEISVMNQLDHANLIQLYDAF 155
Query: 70  RENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
              + +  V EY++   L+  + D     +E +   +  Q+ +G+ +MHQ    H DLKP
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP 215
Query: 129 ENLL-VSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAM 185
           EN+L V++D   IKI DFGLAR    R        T  + APEV+   ++ S   DMW++
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSV 274
Query: 186 GAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPL 245
           G I   L++    F G ++A+ +  I +       + + D                    
Sbjct: 275 GVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD-------------------- 314
Query: 246 SVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                  +++A   I+ L   + S R +A+EAL+HP
Sbjct: 315 ------ISEEAKEFISKLLIKEKSWRISASEALKHP 344

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 116/224 (51%), Gaps = 10/224 (4%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSG----EVVAIKKMKKKYYSWEECVNLR-EVKSLRKM 57
           +++L+K +G G+FG V+  + K SG    ++ A+K +KK      + V  + E   L ++
Sbjct: 25  QFELLKVLGQGSFGKVF-LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +HP IVKL    +    LY + +++          +E  F+E +V+ +  ++   L ++H
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 118 QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYL 175
             G  +RDLKPEN+L+ ++  IK+ DFGL++E I+       +  T  Y APEV +    
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRG 202
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV-IGTP 218
           ++   D W+ G +M E++T    F G    + +  I    +G P
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 143/330 (43%), Gaps = 61/330 (18%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ERY+++  +G+GTFG V   +    G+     K+ +    + E   L E+  L+K     
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKK----- 81
Query: 62  IVKLKEVIRENDILYFV--------------FEYMECNLYQLMKDRE-KCFSEAEVRNWC 106
              +KE  +EN  L  +              FE +  N ++ +K+   + +    VR+  
Sbjct: 82  ---IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMA 138
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLL--------------------VSKDTIKIADFGLA 146
           +Q+   L ++H+    H DLKPEN+L                    V   +I++ADFG A
Sbjct: 139 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 198
Query: 147 REINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD 206
                    T  V+TR YR PEV+L+   ++   D+W++G I+ E      LF      +
Sbjct: 199 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 255
Query: 207 EIYKICSVIG---------TPTQDSWADGLLL--ARAINYKFPQLVGVPLSVLMPSANKD 255
            +  +  ++G         T  Q  +  G L+    + + ++ +    PL   M   + +
Sbjct: 256 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 315
Query: 256 AV---SLIASLCSWDPSKRPTAAEALQHPF 282
            V    L+  +  +DP++R T AEAL HPF
Sbjct: 316 HVQLFDLMRRMLEFDPAQRITLAEALLHPF 345

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY           R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENL++ +   IK+ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 15/251 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE----CVNLREVKSLRK 56
           M  + + + +G G FG V+      +G++ A+K + KK    ++     +N R + SL  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 57  MSH-PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
               P IV +       D L F+ + M          +   FSEA++R +  ++  GL +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 116 MHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           MH R   +RDLKP N+L+ +   ++I+D GLA + + + P    V T  Y APEVL +  
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 175 LYSSKVDMWAMGAIMAELITLRPLF--PGTSEADEIYKICSVIGTPTQDSWADGL----- 227
            Y S  D +++G ++ +L+     F    T +  EI ++   +     DS++  L     
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 228 -LLARAINYKF 237
            LL R +N + 
Sbjct: 427 GLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 15/251 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE----CVNLREVKSLRK 56
           M  + + + +G G FG V+      +G++ A+K + KK    ++     +N R + SL  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 57  MSH-PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
               P IV +       D L F+ + M          +   FSEA++R +  ++  GL +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 116 MHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           MH R   +RDLKP N+L+ +   ++I+D GLA + + + P    V T  Y APEVL +  
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 175 LYSSKVDMWAMGAIMAELITLRPLF--PGTSEADEIYKICSVIGTPTQDSWADGL----- 227
            Y S  D +++G ++ +L+     F    T +  EI ++   +     DS++  L     
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 228 -LLARAINYKF 237
            LL R +N + 
Sbjct: 427 GLLQRDVNRRL 437

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 15/251 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE----CVNLREVKSLRK 56
           M  + + + +G G FG V+      +G++ A+K + KK    ++     +N R + SL  
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 57  MSH-PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
               P IV +       D L F+ + M          +   FSEA++R +  ++  GL +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 116 MHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           MH R   +RDLKP N+L+ +   ++I+D GLA + + + P    V T  Y APEVL +  
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 175 LYSSKVDMWAMGAIMAELITLRPLF--PGTSEADEIYKICSVIGTPTQDSWADGL----- 227
            Y S  D +++G ++ +L+     F    T +  EI ++   +     DS++  L     
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 228 -LLARAINYKF 237
            LL R +N + 
Sbjct: 427 GLLQRDVNRRL 437

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 138/296 (46%), Gaps = 47/296 (15%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +Y +   +G+G++G V   +  ++     V  +KK K +     E    +E++ LR++ H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 60  PNIVKLKEVI--RENDILYFVFEYMECNLYQLMKD-REKCFSEAEVRNWCFQVFQGLAYM 116
            N+++L +V+   E   +Y V EY  C + +++    EK F   +   +  Q+  GL Y+
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 117 HQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRW------YRAPEV 169
           H +G  H+D+KP NLL++   T+KI+  G+A  ++   PF    + R       ++ PE+
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH---PFAADDTCRTSQGSPAFQPPEI 182
Query: 170 LLQSYLYSS-KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
                 +S  KVD+W+ G  +  + T   L+P   E D IYK+   IG  +         
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITT--GLYP--FEGDNIYKLFENIGKGS--------- 229
Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR 284
                 Y  P   G PLS            L+  +  ++P+KR +  +  QH + R
Sbjct: 230 ------YAIPGDCGPPLS-----------DLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 15/251 (5%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE----CVNLREVKSLRK 56
           M  + + + +G G FG V+      +G++ A+K + KK    ++     +N R + SL  
Sbjct: 187 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 246
Query: 57  MSH-PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
               P IV +       D L F+ + M          +   FSEA++R +  ++  GL +
Sbjct: 247 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 306
Query: 116 MHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           MH R   +RDLKP N+L+ +   ++I+D GLA + + + P    V T  Y APEVL +  
Sbjct: 307 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 365
Query: 175 LYSSKVDMWAMGAIMAELITLRPLF--PGTSEADEIYKICSVIGTPTQDSWADGL----- 227
            Y S  D +++G ++ +L+     F    T +  EI ++   +     DS++  L     
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 425
Query: 228 -LLARAINYKF 237
            LL R +N + 
Sbjct: 426 GLLQRDVNRRL 436

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRKMSHPNIVKL 65
           +G G F   +      + EV A K + K    K +  E+     E+   R ++H ++V  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGF 80
Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                +ND ++ V E         +  R K  +E E R +  Q+  G  Y+H+    HRD
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 140
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKVDMW 183
           LK  NL +++D  +KI DFGLA ++       + +  T  Y APEVL +   +S +VD+W
Sbjct: 141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVW 199
Query: 184 AMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV 243
           ++G IM  L+  +P F  TS   E Y                  L  +   Y  P+ +  
Sbjct: 200 SIGCIMYTLLVGKPPFE-TSCLKETY------------------LRIKKNEYSIPKHI-- 238
Query: 244 PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                    N  A SLI  +   DP+ RPT  E L   F
Sbjct: 239 ---------NPVAASLIQKMLQTDPTARPTINELLNDEF 268

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 35/277 (12%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G F  V+    + +G++ A+K +KK   ++ +     E+  L+K+ H NIV L+++ 
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 70  RENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
                 Y V + +    L+  + +R   ++E +      QV   + Y+H+ G  HRDLKP
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134
Query: 129 ENLLV----SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWA 184
           ENLL         I I DFGL++ +      +    T  Y APEVL Q   YS  VD W+
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQK-PYSKAVDCWS 192
Query: 185 MGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVP 244
           +G I   L+   P F   +E+    KI                   +   Y+F       
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKI-------------------KEGYYEFE------ 227
Query: 245 LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            S      ++ A   I  L   DP++R T  +AL HP
Sbjct: 228 -SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/329 (25%), Positives = 139/329 (42%), Gaps = 61/329 (18%)
Query: 3   RYKLIKEVGDGTFGSVWRAIS-KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           RY+++  +G+G FG V   I  K  G  VA+K +K      E   +  +V      + PN
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 62  ----IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYM 116
                V++ E    +  +  VFE +  + Y  +K+     F    +R   +Q+ + + ++
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 117 HQRGYFHRDLKPENLL-------------VSKD-------TIKIADFGLAREINSRPPFT 156
           H     H DLKPEN+L             + +D        IK+ DFG A   +     +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HS 192
Query: 157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG 216
             VSTR YRAPEV+L +  +S   D+W++G I+ E      +FP     + +  +  ++G
Sbjct: 193 TLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILG 251
Query: 217 TPTQD----------------SWAD----GLLLARAINYKFPQLVGVPLSVLMPSANKDA 256
              +                  W +    G  ++RA           PL   M S + + 
Sbjct: 252 PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK---------PLKEFMLSQDVEH 302
Query: 257 ---VSLIASLCSWDPSKRPTAAEALQHPF 282
                LI  +  +DP+KR T  EAL+HPF
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPF 331

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRKMSHPNIVKL 65
           +G G F   +      + EV A K + K    K +  E+     E+   R ++H ++V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGF 82
Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                +ND ++ V E         +  R K  +E E R +  Q+  G  Y+H+    HRD
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 142
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKVDMW 183
           LK  NL +++D  +KI DFGLA ++       + +  T  Y APEVL +   +S +VD+W
Sbjct: 143 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG-HSFEVDVW 201
Query: 184 AMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV 243
           ++G IM  L+  +P F  TS   E Y                  L  +   Y  P+ +  
Sbjct: 202 SIGCIMYTLLVGKPPF-ETSCLKETY------------------LRIKKNEYSIPKHI-- 240
Query: 244 PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                    N  A SLI  +   DP+ RPT  E L   F
Sbjct: 241 ---------NPVAASLIQKMLQTDPTARPTINELLNDEF 270

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRKMSHPNIVKL 65
           +G G F   +      + EV A K + K    K +  E+     E+   R ++H ++V  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGF 106
Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                +ND ++ V E         +  R K  +E E R +  Q+  G  Y+H+    HRD
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKVDMW 183
           LK  NL +++D  +KI DFGLA ++       + +  T  Y APEVL +   +S +VD+W
Sbjct: 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVW 225
Query: 184 AMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV 243
           ++G IM  L+  +P F  TS   E Y                  L  +   Y  P+ +  
Sbjct: 226 SIGCIMYTLLVGKPPF-ETSCLKETY------------------LRIKKNEYSIPKHI-- 264
Query: 244 PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                    N  A SLI  +   DP+ RPT  E L   F
Sbjct: 265 ---------NPVAASLIQKMLQTDPTARPTINELLNDEF 294

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            ++E+G G FG V    W    K     VAIK +++   S E+ +   EV  + K+SHP 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEV--MMKLSHPK 63
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  E   +  VFE+ME   L   ++ +   F+   +   C  V +G+AY+ +  
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYLY 176
             HRDL   N LV ++  IK++DFG+ R +     +T    T++   + +PEV   S  Y
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR-Y 181
Query: 177 SSKVDMWAMGAIMAELIT 194
           SSK D+W+ G +M E+ +
Sbjct: 182 SSKSDVWSFGVLMWEVFS 199

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRKMSHPNIVKL 65
           +G G F   +      + EV A K + K    K +  E+     E+   R ++H ++V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGF 82
Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                +ND ++ V E         +  R K  +E E R +  Q+  G  Y+H+    HRD
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 142
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKVDMW 183
           LK  NL +++D  +KI DFGLA ++       + +  T  Y APEVL +   +S +VD+W
Sbjct: 143 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG-HSFEVDVW 201
Query: 184 AMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV 243
           ++G IM  L+  +P F  TS   E Y                  L  +   Y  P+ +  
Sbjct: 202 SIGCIMYTLLVGKPPF-ETSCLKETY------------------LRIKKNEYSIPKHI-- 240
Query: 244 PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                    N  A SLI  +   DP+ RPT  E L   F
Sbjct: 241 ---------NPVAASLIQKMLQTDPTARPTINELLNDEF 270

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRKMSHPNIVKL 65
           +G G F   +      + EV A K + K    K +  E+     E+   R ++H ++V  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGF 104
Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                +ND ++ V E         +  R K  +E E R +  Q+  G  Y+H+    HRD
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 164
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKVDMW 183
           LK  NL +++D  +KI DFGLA ++       + +  T  Y APEVL +   +S +VD+W
Sbjct: 165 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVW 223
Query: 184 AMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV 243
           ++G IM  L+  +P F  TS   E Y                  L  +   Y  P+ +  
Sbjct: 224 SIGCIMYTLLVGKPPF-ETSCLKETY------------------LRIKKNEYSIPKHI-- 262
Query: 244 PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                    N  A SLI  +   DP+ RPT  E L   F
Sbjct: 263 ---------NPVAASLIQKMLQTDPTARPTINELLNDEF 292

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRKMSHPNIVKL 65
           +G G F   +      + EV A K + K    K +  E+     E+   R ++H ++V  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGF 86
Query: 66  KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                +ND ++ V E         +  R K  +E E R +  Q+  G  Y+H+    HRD
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRD 146
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKVDMW 183
           LK  NL +++D  +KI DFGLA ++       + +  T  Y APEVL +   +S +VD+W
Sbjct: 147 LKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKG-HSFEVDVW 205
Query: 184 AMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV 243
           ++G IM  L+  +P F  TS   E Y                  L  +   Y  P+ +  
Sbjct: 206 SIGCIMYTLLVGKPPF-ETSCLKETY------------------LRIKKNEYSIPKHI-- 244
Query: 244 PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                    N  A SLI  +   DP+ RPT  E L   F
Sbjct: 245 ---------NPVAASLIQKMLQTDPTARPTINELLNDEF 274

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 15/216 (6%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV--NLREVKSLRKMSHPN 61
           +  +  +G G+FG V  A  K + E+ AIK +KK     ++ V   + E + L  +  P 
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 62  -IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            + +L    +  D LYFV EY+          +   F E +   +  ++  GL ++H+RG
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG 140
Query: 121 YFHRDLKPENLLV-SKDTIKIADFGLARE-----INSRPPFTEYVSTRWYRAPEVLLQSY 174
             +RDLK +N+++ S+  IKIADFG+ +E     + +R    E+  T  Y APE++    
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTR----EFCGTPDYIAPEIIAYQ- 195
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
            Y   VD WA G ++ E++  +P F G  E DE+++
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQ 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 6/207 (2%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSH 59
           ERYK++ ++G G   +V+ A        VAIK +       EE +    REV +  ++SH
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIV + +V  E+D  Y V EY+E        +     S     N+  Q+  G+ + H  
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREIN--SRPPFTEYVSTRWYRAPEVLLQSYLY 176
              HRD+KP+N+L+ S  T+KI DFG+A+ ++  S       + T  Y +PE   +    
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKGEAT 189
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTS 203
               D++++G ++ E++   P F G +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 141/298 (47%), Gaps = 39/298 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL---RKM 57
           ++ + L++ +G G++  V     K++  + A+K +KK+  + +E ++  + +     +  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +HP +V L    +    L+FV EY+          R++   E   R +  ++   L Y+H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFT--EYVSTRWYRAPEVLLQSY 174
           +RG  +RDLK +N+L+ S+  IK+ D+G+ +E   RP  T   +  T  Y APE+ L+  
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEI-LRGE 181
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS--WADGLLLARA 232
            Y   VD WA+G +M E++  R  F     +D           P Q++  +   ++L + 
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYLFQVILEKQ 231
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTA--AEALQHPFSR 284
           I  + P+ + V            A S++ S  + DP +R    P    A+   HPF R
Sbjct: 232 I--RIPRSLSVK-----------AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 141/298 (47%), Gaps = 39/298 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL---RKM 57
           ++ + L++ +G G++  V     K++  + A+K +KK+  + +E ++  + +     +  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +HP +V L    +    L+FV EY+          R++   E   R +  ++   L Y+H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFT--EYVSTRWYRAPEVLLQSY 174
           +RG  +RDLK +N+L+ S+  IK+ D+G+ +E   RP  T   +  T  Y APE+ L+  
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEI-LRGE 185
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS--WADGLLLARA 232
            Y   VD WA+G +M E++  R  F     +D           P Q++  +   ++L + 
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYLFQVILEKQ 235
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTA--AEALQHPFSR 284
           I  + P+ + V            A S++ S  + DP +R    P    A+   HPF R
Sbjct: 236 I--RIPRSLSVK-----------AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 5/195 (2%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSHP 60
            Y L   +G GTFG V     + +G  VA+K + ++     + V    RE+++L+   HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +I+KL +VI      + V EY+    L+  +    +   E E R    Q+   + Y H+ 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV-EEMEARRLFQQILSAVDYCHRH 130
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLKPEN+L+      KIADFGL+  ++      +   +  Y APEV+        
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 179 KVDMWAMGAIMAELI 193
           +VD+W+ G I+  L+
Sbjct: 191 EVDIWSCGVILYALL 205

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 124/257 (48%), Gaps = 16/257 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMS 58
           ++ + +++ +G G FG+V+ A  KQ+  ++A+K + K     E  E    RE++    + 
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 59  HPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI+++     +   +Y + E+     LY+ ++   + F E     +  ++   L Y H
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH 131
Query: 118 QRGYFHRDLKPENLLVS-KDTIKIADFG---LAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +R   HRD+KPENLL+  K  +KIADFG    A  +  R        T  Y  PE +++ 
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----XMCGTLDYLPPE-MIEG 186
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV-IGTPTQDSWADGLLLARA 232
             +  KVD+W  G +  E +   P F   S  +   +I +V +  P   S     L+++ 
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKL 246
Query: 233 INYKFPQLVGVPLSVLM 249
           + Y  PQ   +PL  +M
Sbjct: 247 LRYHPPQ--RLPLKGVM 261

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 139/304 (45%), Gaps = 45/304 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRKMSH 59
           Y+L + +G G F  V R I++++G+  A+K +    ++    ++     RE      + H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN--LYQLMKDREKCF--SEAEVRNWCFQVFQGLAY 115
           P+IV+L E    + +LY VFE+M+     ++++K  +  F  SEA   ++  Q+ + L Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT---IKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVL 170
            H     HRD+KP   LL SK+    +K+  FG+A ++  S       V T  + APEV 
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV- 206
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           ++   Y   VD+W  G I+  L++    F GT E                    +G++  
Sbjct: 207 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----------------RLFEGIIKG 249
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVA 286
           +   YK        +S       + A  L+  +   DP++R T  EAL HP+     R A
Sbjct: 250 K---YKMNPRQWSHIS-------ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 299
Query: 287 FMFH 290
           +  H
Sbjct: 300 YKIH 303

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 4/196 (2%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSHPN 61
           Y + + +G+G+FG V  A   ++ + VA+K + ++     +      RE+  L+ + HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I+KL +VI     +  V EY    L+  + ++++  +E E R +  Q+   + Y H+   
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKV 180
            HRDLKPENLL+  +  +KIADFGL+  +           +  Y APEV+        +V
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189
Query: 181 DMWAMGAIMAELITLR 196
           D+W+ G ++  ++  R
Sbjct: 190 DVWSCGIVLYVMLVGR 205

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 139/304 (45%), Gaps = 45/304 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRKMSH 59
           Y+L + +G G F  V R I++++G+  A+K +    ++    ++     RE      + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN--LYQLMKDREKCF--SEAEVRNWCFQVFQGLAY 115
           P+IV+L E    + +LY VFE+M+     ++++K  +  F  SEA   ++  Q+ + L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 116 MHQRGYFHRDLKPEN-LLVSKDT---IKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVL 170
            H     HRD+KP   LL SK+    +K+  FG+A ++  S       V T  + APEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
            +   Y   VD+W  G I+  L++    F GT E                    +G++  
Sbjct: 206 KRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE-----------------RLFEGIIKG 247
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVA 286
           +   YK        +S       + A  L+  +   DP++R T  EAL HP+     R A
Sbjct: 248 K---YKMNPRQWSHIS-------ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
Query: 287 FMFH 290
           +  H
Sbjct: 298 YKIH 301

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY           R   FSE   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENL++ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 36/287 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y + + +G G++    R + K +    A+K + K      E + +     LR   HPN
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL----LRYGQHPN 82
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I+ LK+V  +   +Y V E M          R+K FSE E       + + + Y+H +G 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 122 FHRDLKPENLLVSKDT-----IKIADFGLAREINSRPP-FTEYVSTRWYRAPEVLLQSYL 175
            HRDLKP N+L   ++     ++I DFG A+++ +          T  + APEV L+   
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEV-LKRQG 201
Query: 176 YSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y    D+W++G ++  ++    P   G S+  E  +I + IG+        G       N
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGS--------GKFTLSGGN 251
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           +               + ++ A  L++ +   DP +R TA + LQHP
Sbjct: 252 WN--------------TVSETAKDLVSKMLHVDPHQRLTAKQVLQHP 284

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 35/285 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E+Y + +++G G FG V R +   S +    K +K K    ++ +  +E+  L    H N
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRN 62
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I+ L E     + L  +FE++   ++++ +       +E E+ ++  QV + L ++H   
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 121 YFHRDLKPENLLVS---KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
             H D++PEN++       TIKI +FG AR++     F    +   Y APEV  Q  + S
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-HQHDVVS 181
Query: 178 SKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           +  DMW++G ++  L++ + P    T++                    + ++ A    Y 
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQ-----------------QIIENIMNA---EYT 221
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           F +     +S+       +A+  +  L   +   R TA+EALQHP
Sbjct: 222 FDEEAFKEISI-------EAMDFVDRLLVKERKSRMTASEALQHP 259

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P + KL+   ++N  LY V EY           R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENL++ +   IK+ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 36/287 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y + + +G G++    R + K +    A+K + K      E + +     LR   HPN
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL----LRYGQHPN 82
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I+ LK+V  +   +Y V E M          R+K FSE E       + + + Y+H +G 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 122 FHRDLKPENLLVSKDT-----IKIADFGLAREINSRPP-FTEYVSTRWYRAPEVLLQSYL 175
            HRDLKP N+L   ++     ++I DFG A+++ +          T  + APEV L+   
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEV-LKRQG 201
Query: 176 YSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y    D+W++G ++  ++    P   G S+  E  +I + IG+        G       N
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGS--------GKFTLSGGN 251
Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           +               + ++ A  L++ +   DP +R TA + LQHP
Sbjct: 252 WN--------------TVSETAKDLVSKMLHVDPHQRLTAKQVLQHP 284

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P + KL+   ++N  LY V EY           R   FSE   R +  Q+     Y+
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENL++ +   IK+ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 141/298 (47%), Gaps = 39/298 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL---RKM 57
           ++ + L++ +G G++  V     K++  + A+K +KK+  + +E ++  + +     +  
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +HP +V L    +    L+FV EY+          R++   E   R +  ++   L Y+H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFT--EYVSTRWYRAPEVLLQSY 174
           +RG  +RDLK +N+L+ S+  IK+ D+G+ +E   RP  T   +  T  Y APE+ L+  
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSXFCGTPNYIAPEI-LRGE 196
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS--WADGLLLARA 232
            Y   VD WA+G +M E++  R  F     +D           P Q++  +   ++L + 
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYLFQVILEKQ 246
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTA--AEALQHPFSR 284
           I  + P+ + V            A S++ S  + DP +R    P    A+   HPF R
Sbjct: 247 I--RIPRSMSVK-----------AASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY+          R   F E   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENLL+ +   I++ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 121/265 (45%), Gaps = 31/265 (11%)
Query: 3   RYKLIKEVGDGTFGSVWRA---ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           R  + K +G G  G V      +  Q    VAIK +K  Y   +    L E   + +  H
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109
Query: 60  PNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNI++L+ V+    +   V EYME  +L   ++  +  F+  ++      V  G+ Y+  
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 119 RGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVST------RWYRAPEVLL 171
            GY HRDL   N+LV  + + K++DFGL+R +   P    Y +T      RW  APE  +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD-AAYTTTGGKIPIRWT-APEA-I 226
Query: 172 QSYLYSSKVDMWAMGAIMAELITL--RPLFPGT-----SEADEIYKICSVIGTPTQ---- 220
               +SS  D+W+ G +M E++    RP +  T     S  +E Y++ + +G P      
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQL 286
Query: 221 --DSWADGLLLARAINYKFPQLVGV 243
             D W       RA   +F Q+V V
Sbjct: 287 MLDCWHK----DRAQRPRFSQIVSV 307

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K I+++G+G FG V    +      +GE VA+K +K +          +E++ LR + H 
Sbjct: 12  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 61  NIVKLKEVIREN--DILYFVFEYMECNLYQ--LMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           NIVK K +  E+  + +  + E++     +  L K++ K   + +++ +  Q+ +G+ Y+
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICKGMDYL 130
Query: 117 HQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR-----WYRAPEVL 170
             R Y HRDL   N+LV S+  +KI DFGL + I +          R     WY APE L
Sbjct: 131 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT 194
           +QS  Y +  D+W+ G  + EL+T
Sbjct: 190 MQSKFYIAS-DVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K I+++G+G FG V    +      +GE VA+K +K +          +E++ LR + H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 61  NIVKLKEVIREN--DILYFVFEYMECNLYQ--LMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           NIVK K +  E+  + +  + E++     +  L K++ K   + +++ +  Q+ +G+ Y+
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICKGMDYL 142
Query: 117 HQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR-----WYRAPEVL 170
             R Y HRDL   N+LV S+  +KI DFGL + I +          R     WY APE L
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 201
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT 194
           +QS  Y +  D+W+ G  + EL+T
Sbjct: 202 MQSKFYIAS-DVWSFGVTLHELLT 224

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            ++E+G G FG V    W    K     VAIK +++   S E+ +   EV  + K+SHP 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEV--MMKLSHPK 63
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  E   +  VFE+ME   L   ++ +   F+   +   C  V +G+AY+ +  
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYLY 176
             HRDL   N LV ++  IK++DFG+ R +     +T    T++   + +PEV   S  Y
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR-Y 181
Query: 177 SSKVDMWAMGAIMAELIT 194
           SSK D+W+ G +M E+ +
Sbjct: 182 SSKSDVWSFGVLMWEVFS 199

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 97
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P +VKL+   ++N  LY V EY           R   F E   R +  Q+     Y+
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENL++ +   IK+ DFG A+ +  R        T  Y APE++L S  
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 214
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            ++E+G G FG V    W    K     VAIK +++   S E+ +   EV  + K+SHP 
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEV--MMKLSHPK 66
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  E   +  VFE+ME   L   ++ +   F+   +   C  V +G+AY+ +  
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYLY 176
             HRDL   N LV ++  IK++DFG+ R +     +T    T++   + +PEV   S  Y
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR-Y 184
Query: 177 SSKVDMWAMGAIMAELIT 194
           SSK D+W+ G +M E+ +
Sbjct: 185 SSKSDVWSFGVLMWEVFS 202

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            ++E+G G FG V    W    K     VAIK +K+   S ++ +   EV  + K+SHP 
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIKEGSMSEDDFIEEAEV--MMKLSHPK 83
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  E   +  VFE+ME   L   ++ +   F+   +   C  V +G+AY+ +  
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYLY 176
             HRDL   N LV ++  IK++DFG+ R +     +T    T++   + +PEV   S  Y
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR-Y 201
Query: 177 SSKVDMWAMGAIMAELIT 194
           SSK D+W+ G +M E+ +
Sbjct: 202 SSKSDVWSFGVLMWEVFS 219

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            ++E+G G FG V    W    K     VAIK +++   S E+ +   EV  + K+SHP 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEV--MMKLSHPK 61
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  E   +  VFE+ME   L   ++ +   F+   +   C  V +G+AY+ +  
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYLY 176
             HRDL   N LV ++  IK++DFG+ R +     +T    T++   + +PEV   S  Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR-Y 179
Query: 177 SSKVDMWAMGAIMAELIT 194
           SSK D+W+ G +M E+ +
Sbjct: 180 SSKSDVWSFGVLMWEVFS 197

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 132/283 (46%), Gaps = 33/283 (11%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++++G G+FG V++ I  ++ +VVAIK +  +    E     +E+  L +   P 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           + K      ++  L+ + EY+      L         E ++     ++ +GL Y+H    
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGG-SALDLLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 122 FHRDLKPENLLVSK-DTIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            HRD+K  N+L+S+   +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y SK
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSK 204
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
            D+W++G      IT   L  G     E++ +  +   P  +                P 
Sbjct: 205 ADIWSLG------ITAIELARGEPPHSELHPMKVLFLIPKNNP---------------PT 243
Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           L G        + +K     + +  + +PS RPTA E L+H F
Sbjct: 244 LEG--------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 278

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 74
Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM   C L  L  +  K     ++ +   Q+  G+AY+ + 
Sbjct: 75  LVQLYAVVSEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 189
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 190 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 95/195 (48%), Gaps = 5/195 (2%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSHP 60
            Y L   +G GTFG V     + +G  VA+K + ++     + V    RE+++L+   HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +I+KL +VI      + V EY+    L+  +    +   E E R    Q+   + Y H+ 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV-EEMEARRLFQQILSAVDYCHRH 130
Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRDLKPEN+L+      KIADFGL+  ++          +  Y APEV+        
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 179 KVDMWAMGAIMAELI 193
           +VD+W+ G I+  L+
Sbjct: 191 EVDIWSCGVILYALL 205

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 35/284 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++++G G+FG V++ I  ++ +VVAIK +  +    E     +E+  L +   P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           + K      ++  L+ + EY+   +   L++       E ++     ++ +GL Y+H   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK 124
Query: 121 YFHRDLKPENLLVSK-DTIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L+S+   +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y S
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS-AYDS 183
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           K D+W++G    EL        G     E++ +  +   P  +                P
Sbjct: 184 KADIWSLGITAIELAR------GEPPHSELHPMKVLFLIPKNNP---------------P 222
Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            L G        + +K     + +  + +PS RPTA E L+H F
Sbjct: 223 TLEG--------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 258

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 35/284 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++++G G+FG V++ I  ++ +VVAIK +  +    E     +E+  L +   P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           + K      ++  L+ + EY+   +   L++       E ++     ++ +GL Y+H   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK 124
Query: 121 YFHRDLKPENLLVSK-DTIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L+S+   +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y S
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDS 183
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           K D+W++G    EL        G     E++ +  +   P  +                P
Sbjct: 184 KADIWSLGITAIELAR------GEPPHSELHPMKVLFLIPKNNP---------------P 222
Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            L G        + +K     + +  + +PS RPTA E L+H F
Sbjct: 223 TLEG--------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 258

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 141/298 (47%), Gaps = 39/298 (13%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL---RKM 57
           ++ + L++ +G G++  V     K++  + A++ +KK+  + +E ++  + +     +  
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +HP +V L    +    L+FV EY+          R++   E   R +  ++   L Y+H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFT--EYVSTRWYRAPEVLLQSY 174
           +RG  +RDLK +N+L+ S+  IK+ D+G+ +E   RP  T   +  T  Y APE+ L+  
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEI-LRGE 228
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS--WADGLLLARA 232
            Y   VD WA+G +M E++  R  F     +D           P Q++  +   ++L + 
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYLFQVILEKQ 278
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTA--AEALQHPFSR 284
           I  + P+ + V            A S++ S  + DP +R    P    A+   HPF R
Sbjct: 279 I--RIPRSLSVK-----------AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 35/284 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++++G G+FG V++ I  ++ +VVAIK +  +    E     +E+  L +   P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           + K      ++  L+ + EY+   +   L++       E ++     ++ +GL Y+H   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK 139
Query: 121 YFHRDLKPENLLVSK-DTIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L+S+   +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y S
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS-AYDS 198
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           K D+W++G    EL        G     E++ +  +   P  +                P
Sbjct: 199 KADIWSLGITAIELAR------GEPPHSELHPMKVLFLIPKNNP---------------P 237
Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            L G        + +K     + +  + +PS RPTA E L+H F
Sbjct: 238 TLEG--------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 29/264 (10%)
Query: 3   RYKLIKEVGDGTFGSVWRA---ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           R  + K +G G  G V      +  Q    VAIK +K  Y   +    L E   + +  H
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109
Query: 60  PNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNI++L+ V+    +   V EYME  +L   ++  +  F+  ++      V  G+ Y+  
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 119 RGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVST-----RWYRAPEVLLQ 172
            GY HRDL   N+LV  + + K++DFGL+R +   P      +      RW  APE  + 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT-APEA-IA 227
Query: 173 SYLYSSKVDMWAMGAIMAELITL--RPLFPGT-----SEADEIYKICSVIGTPTQ----- 220
              +SS  D+W+ G +M E++    RP +  T     S  +E Y++ + +G P       
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM 287
Query: 221 -DSWADGLLLARAINYKFPQLVGV 243
            D W       RA   +F Q+V V
Sbjct: 288 LDCWHK----DRAQRPRFSQIVSV 307

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 74
Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM   C L  L  +  K     ++ +   Q+  G+AY+ + 
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 189
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 190 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 115/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 65
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E+   +      
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEFFKVKEPGESP 180
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 181 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 31/263 (11%)
Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           K+ + +G G FG V     K  G+    VAIK +K  Y   +    L E   + +  HPN
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V L+ V+     +  V E+ME   L   ++  +  F+  ++      +  G+ Y+   G
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMG 165
Query: 121 YFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQS 173
           Y HRDL   N+LV+ + + K++DFGL+R I   P    Y +T      RW  APE  +Q 
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV-YTTTGGKIPVRW-TAPEA-IQY 222
Query: 174 YLYSSKVDMWAMGAIMAELITL--RPLFPGTSEA-----DEIYKICSVIGTPTQ------ 220
             ++S  D+W+ G +M E+++   RP +  +++      +E Y++ + +  P        
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLML 282
Query: 221 DSWADGLLLARAINYKFPQLVGV 243
           D W       RA   KF Q+VG+
Sbjct: 283 DCWQK----ERAERPKFEQIVGI 301

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK----KYYSWEECVNLREVKSLRK 56
           +++++ IK +G G+FG V      ++G   A+K + K    K    E  +N  E + L+ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN--EKRILQA 98
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           ++ P + KL+   ++N  LY V EY           R   F E   R +  Q+     Y+
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           H     +RDLKPENL++ +   IK+ DFG A+ +  R        T  Y APE++L S  
Sbjct: 159 HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT--WXLCGTPEYLAPEIIL-SKG 215
Query: 176 YSSKVDMWAMGAIMAELITLRPLF 199
           Y+  VD WA+G ++ E+    P F
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 115/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 10  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 66
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 124
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HR+L   N+LV +++ +KI DFGL + +   P   EY   +      
Sbjct: 125 CKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVL---PQDKEYYKVKEPGESP 181
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 182 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 123/257 (47%), Gaps = 16/257 (6%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMS 58
           ++ + + + +G G FG+V+ A  KQ+  ++A+K + K     E  E    RE++    + 
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 59  HPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI+++     +   +Y + E+     LY+ ++   + F E     +  ++   L Y H
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH 132
Query: 118 QRGYFHRDLKPENLLVS-KDTIKIADFG---LAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +R   HRD+KPENLL+  K  +KIADFG    A  +  R        T  Y  PE +++ 
Sbjct: 133 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----XMCGTLDYLPPE-MIEG 187
Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV-IGTPTQDSWADGLLLARA 232
             +  KVD+W  G +  E +   P F   S  +   +I +V +  P   S     L+++ 
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKL 247
Query: 233 INYKFPQLVGVPLSVLM 249
           + Y  PQ   +PL  +M
Sbjct: 248 LRYHPPQR--LPLKGVM 262

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 116/222 (52%), Gaps = 23/222 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 64
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 65  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVL 170
            Y HRDL+  N+LVS DT+  KIADFGLAR I       EY +        +W  APE  
Sbjct: 124 NYIHRDLRAANILVS-DTLSCKIADFGLARLIED----NEYTAREGAKFPIKW-TAPEA- 176
Query: 171 LQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +    ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 218

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 36/299 (12%)
Query: 4   YKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK-MSHPN 61
           Y+L ++V G+G    V   I+  + +  A+K ++K+       V  REV+ L +   H N
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQGHRN 72
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +++L E   E D  Y VFE M          + + F+E E       V   L ++H +G 
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 122 FHRDLKPENLLVSKDT----IKIADFGLAREIN--------SRPPFTEYVSTRWYRAPEV 169
            HRDLKPEN+L         +KI DFGL   I         S P       +  Y APEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 170 L----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD---EIYKICSVIGTPTQDS 222
           +     ++ +Y  + D+W++G I+  L++  P F G   +D   +  + C        +S
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
             +G        Y+FP      +S     A KD   LI+ L   D  +R +AA+ LQHP
Sbjct: 253 IQEG-------KYEFPDKDWAHISC----AAKD---LISKLLVRDAKQRLSAAQVLQHP 297

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 27  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 83
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 198
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 199 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 27  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 83
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 198
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 199 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 40  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 96
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 211
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 212 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 14  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 70
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 71  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 128
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 129 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 185
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 186 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 12  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 68
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 126
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 183
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 184 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 16  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 72
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 73  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 130
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 131 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 187
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 188 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 13  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 69
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 127
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 128 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 184
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 185 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 116/222 (52%), Gaps = 23/222 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 75
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 76  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVL 170
            Y HRDL+  N+LVS DT+  KIADFGLAR I       EY +        +W  APE  
Sbjct: 135 NYIHRDLRAANILVS-DTLSCKIADFGLARLIED----NEYTAREGAKFPIKW-TAPEA- 187
Query: 171 LQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +    ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 229

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 116/222 (52%), Gaps = 23/222 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 69
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVL 170
            Y HRDL+  N+LVS DT+  KIADFGLAR I       EY +        +W  APE  
Sbjct: 129 NYIHRDLRAANILVS-DTLSCKIADFGLARLIED----NEYTAREGAKFPIKW-TAPEA- 181
Query: 171 LQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +    ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 15  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 71
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 72  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 129
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 130 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 186
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 187 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 65
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 180
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 181 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 8   MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 65
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   FT +   ++   + APE L  
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAPESLAY 184
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DPSQVYE-----------------LLE 224
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 225 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 262

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 74
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 75  LVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 189
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 190 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 116/222 (52%), Gaps = 23/222 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 79
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 80  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 138
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVL 170
            Y HRDL+  N+LVS DT+  KIADFGLAR I       EY +        +W  APE  
Sbjct: 139 NYIHRDLRAANILVS-DTLSCKIADFGLARLIED----NEYTAREGAKFPIKW-TAPEA- 191
Query: 171 LQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +    ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 233

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 65
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 180
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 181 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 116/222 (52%), Gaps = 23/222 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 74
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 75  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 133
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVL 170
            Y HRDL+  N+LVS DT+  KIADFGLAR I       EY +        +W  APE  
Sbjct: 134 NYIHRDLRAANILVS-DTLSCKIADFGLARLIED----NEYTAREGAKFPIKW-TAPEA- 186
Query: 171 LQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +    ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 228

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 7   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 63
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 121
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 122 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 178
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 179 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 114/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 8   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 64
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++  ++     ++  +  Q+
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 122
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 123 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 179
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 180 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 47/288 (16%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G FG   +   +++GEV+ +K++ + +    +   L+EVK +R + HPN++K   V+
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 70  RENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
            ++  L F+ EY++   L  ++K  +  +  ++  ++   +  G+AY+H     HRDL  
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNS 136
Query: 129 ENLLVSKD-TIKIADFGLAR---------------EINSRPPFTEYVSTRWYRAPEVLLQ 172
            N LV ++  + +ADFGLAR               +   R      V   ++ APE ++ 
Sbjct: 137 HNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE-MIN 195
Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y  KVD+++ G ++ E+I       G   AD  Y                   L R 
Sbjct: 196 GRSYDEKVDVFSFGIVLCEII-------GRVNADPDY-------------------LPRT 229
Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           +++    + G       P+       +    C  DP KRP+  + L+H
Sbjct: 230 MDFGL-NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVK-LEH 275

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 67
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 68  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 126
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 182
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 183 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 15  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 72
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 73  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 192 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 231
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 232 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 323
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 324 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRWYR------APEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +  +      APE  L 
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 438
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 439 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 141/302 (46%), Gaps = 52/302 (17%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 29  MERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 86
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y V EYM   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 87  HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL 146
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 147 EKKNFIHRDLAARNCLVGENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 205
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y                  LL 
Sbjct: 206 N-TFSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYD-----------------LLE 245
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF--M 288
           +   Y+  Q  G P  V           L+ +   W P+ RP+ AE  Q      AF  M
Sbjct: 246 KG--YRMEQPEGCPPKVY---------ELMRACWKWSPADRPSFAETHQ------AFETM 288
Query: 289 FH 290
           FH
Sbjct: 289 FH 290

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/329 (25%), Positives = 137/329 (41%), Gaps = 61/329 (18%)
Query: 3   RYKLIKEVGDGTFGSVWRAIS-KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           RY+++  +G+G FG V   I  K  G  VA+K +K      E   +  +V      + PN
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 62  ----IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYM 116
                V++ E    +  +  VFE +  + Y  +K+     F    +R   +Q+ + + ++
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 117 HQRGYFHRDLKPENLL-------------VSKD-------TIKIADFGLAREINSRPPFT 156
           H     H DLKPEN+L             + +D        IK+ DFG A   +     +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HS 192
Query: 157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG 216
             V  R YRAPEV+L +  +S   D+W++G I+ E      +FP     + +  +  ++G
Sbjct: 193 TLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILG 251
Query: 217 TPTQD----------------SWAD----GLLLARAINYKFPQLVGVPLSVLMPSANKDA 256
              +                  W +    G  ++RA           PL   M S + + 
Sbjct: 252 PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK---------PLKEFMLSQDVEH 302
Query: 257 ---VSLIASLCSWDPSKRPTAAEALQHPF 282
                LI  +  +DP+KR T  EAL+HPF
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPF 331

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 115/214 (53%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 12  ERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 68
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + E++   +L + ++  ++     ++  +  Q+
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQI 126
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 183
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 184 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 226
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 227 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 264

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 240
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 241 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 355
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 356 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 18/198 (9%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            ++E+G G FG V    W    K     VAIK +++   S E+ +   EV  + K+SHP 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEV--MMKLSHPK 64
Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  E   +  V E+ME   L   ++ +   F+   +   C  V +G+AY+ +  
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYLY 176
             HRDL   N LV ++  IK++DFG+ R +     +T    T++   + +PEV   S  Y
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR-Y 182
Query: 177 SSKVDMWAMGAIMAELIT 194
           SSK D+W+ G +M E+ +
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 63
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 64  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 122
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 123 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 178
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 179 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 74
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 189
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 190 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 74
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 75  LVQLYAVVSEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 189
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 190 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 226
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 227 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 264

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 116/240 (48%), Gaps = 35/240 (14%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           ++ I+ +G G FG V+ A +K      AIK+++           +REVK+L K+ HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 64  K---------LKEVIRENDILYFVFEYMECNLYQLMKD--REKCFSEAEVRNWCFQVF-- 110
           +           E ++ +    +++  M+    + +KD    +C  E   R+ C  +F  
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 111 --QGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSR----------PPF-- 155
             + + ++H +G  HRDLKP N+  +  D +K+ DFGL   ++            P +  
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 156 -TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV 214
            T  V T+ Y +PE  +    YS KVD++++G I+ EL     L+P +++ + +  +  V
Sbjct: 187 HTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTDV 240

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 71
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 72  LVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 186
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 187 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEEC---------VNLREVK 52
           ++Y  +  +G G FG VW A+ K+  + V +K +KK+    E+C         V L E+ 
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV-LEDCWIEDPKLGKVTL-EIA 81
Query: 53  SLRKMSHPNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVF 110
            L ++ H NI+K+ ++         V E      +L+  + DR     E        Q+ 
Sbjct: 82  ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQLV 140
Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
             + Y+  +   HRD+K EN+++++D TIK+ DFG A  +     F  +  T  Y APEV
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 170 LLQSYLYSSKVDMWAMGAIMAELI 193
           L+ +     +++MW++G  +  L+
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 116/222 (52%), Gaps = 23/222 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 65
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 66  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS-------TRWYRAPEVL 170
            Y HR+L+  N+LVS DT+  KIADFGLAR I       EY +        +W  APE  
Sbjct: 125 NYIHRNLRAANILVS-DTLSCKIADFGLARLIED----NEYTAREGAKFPIKW-TAPEA- 177
Query: 171 LQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +    ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 219

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 240
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 241 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 355
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 356 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 240
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 241 LVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 355
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 356 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 15/218 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 71
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 72  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSY 174
            Y HRDL+  N+LVS DT+  KIADFGLAR I          +    +W  APE  +   
Sbjct: 131 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYG 187
Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
            ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 188 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 225

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 37/289 (12%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMS 58
           ++ +++ + +G G FG+V+ A  K+S  +VA+K + K     E  E    RE++    + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 59  HPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L     +   +Y + EY     LY+ ++ +   F E        ++   L Y H
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQ-KSCTFDEQRTATIMEELADALMYCH 140
Query: 118 QRGYFHRDLKPENLLVSKDTIK-IADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            +   HRD+KPENLL+       IADFG +    S    T    T  Y  PE +++  ++
Sbjct: 141 GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-MCGTLDYLPPE-MIEGRMH 198
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           + KVD+W +G +  EL+   P F   S  +   +I  V                   + K
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-------------------DLK 239
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
           FP  V        P+  +D   LI+ L   +PS+R   A+   HP+ R 
Sbjct: 240 FPASV--------PTGAQD---LISKLLRHNPSERLPLAQVSAHPWVRA 277

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 65
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 66  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 124
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 125 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 180
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 181 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKIRHEK 74
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 189
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 190 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 15/218 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 69
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSY 174
            Y HRDL+  N+LVS DT+  KIADFGLAR I          +    +W  APE  +   
Sbjct: 129 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYG 185
Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
            ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 23  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 80
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 81  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 140
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 141 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 199
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 200 N-KFSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 239
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 240 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 277

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 187 N-KFSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 226
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 227 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 113/214 (52%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL 54
           ER+ K ++++G G FGSV    +  +   +GEVVA+KK++   +S EE +    RE++ L
Sbjct: 12  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEIL 68
Query: 55  RKMSHPNIVKLKEVI----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQV 109
           + + H NIVK K V     R N  L  + EY+   +L   ++   +     ++  +  Q+
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI 126
Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR------ 162
            +G+ Y+  + Y HRDL   N+LV +++ +KI DFGL + +   P   E    +      
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEXXKVKEPGESP 183
Query: 163 --WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L +S  +S   D+W+ G ++ EL T
Sbjct: 184 IFWY-APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 15/218 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 70
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 71  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 129
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSY 174
            Y HRDL+  N+LVS DT+  KIADFGLAR I          +    +W  APE  +   
Sbjct: 130 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYG 186
Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
            ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 187 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 224

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 15  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 72
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 192 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 231
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 232 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 15  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 72
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 192 N-KFSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 231
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 232 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 15/218 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 78
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 79  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 137
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSY 174
            Y HRDL+  N+LVS DT+  KIADFGLAR I          +    +W  APE  +   
Sbjct: 138 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYG 194
Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
            ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 195 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 232

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 15  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 72
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 192 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 231
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 232 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 71
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 131
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 191 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 230
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 231 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 268

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 12  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 130 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 189 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 228
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 229 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 266

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 74
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 75  LVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSYL 175
            Y HRDL+  N+LV ++ + K+ADFGLAR I          +    +W  APE  L    
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALYGR- 191
Query: 176 YSSKVDMWAMGAIMAELITL-RPLFPG 201
           ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 187 N-KFSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 226
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 227 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 264

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 226
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 227 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 12  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 130 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 189 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 228
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 229 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 15/218 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 75
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 76  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVST---RWYRAPEVLLQSY 174
            Y HRDL+  N+LVS DT+  KIADFGLAR I          +    +W  APE  +   
Sbjct: 135 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYG 191
Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
            ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 229

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 66
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 67  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    TE   T +Y AP
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAP 186
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 187 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 231
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 232 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 278

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 15/218 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 69
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSY 174
            Y HRDL+  N+LVS DT+  KIADFGLAR I          +    +W  APE  +   
Sbjct: 129 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYG 185
Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
            ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 67
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 187 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 226
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 227 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 15/218 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 77
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 78  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVST---RWYRAPEVLLQSY 174
            Y HRDL+  N+LVS DT+  KIADFGLAR I          +    +W  APE  +   
Sbjct: 137 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEA-INYG 193
Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
            ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 194 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 231

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +RY K I+++G+G FG V    +   +  +GE+VA+K +K+           RE++ LR 
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRT 67
Query: 57  MSHPNIVKLKEVIREND--ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           + H +IVK K    +     +  V EY+     +    R  C   A++  +  Q+ +G+A
Sbjct: 68  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMA 126
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTR--------WYR 165
           Y+H + Y HR L   N+L+  D  +KI DFGLA+ +   P   EY   R        WY 
Sbjct: 127 YLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFWY- 182
Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           APE L +   Y +  D+W+ G  + EL+T
Sbjct: 183 APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 138/289 (47%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G FG V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 8   MERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 65
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +    T +   ++   + APE L  
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DPSQVYE-----------------LLE 224
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 225 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 262

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +RY K I+++G+G FG V    +   +  +GE+VA+K +K+           RE++ LR 
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRT 66
Query: 57  MSHPNIVKLKEVIREND--ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           + H +IVK K    +     +  V EY+     +    R  C   A++  +  Q+ +G+A
Sbjct: 67  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMA 125
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTR--------WYR 165
           Y+H + Y HR L   N+L+  D  +KI DFGLA+ +   P   EY   R        WY 
Sbjct: 126 YLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFWY- 181
Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           APE L +   Y +  D+W+ G  + EL+T
Sbjct: 182 APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 74
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL   N+LV ++ + K+ADFGLAR I       EY + +       + APE  L 
Sbjct: 134 NYVHRDLAAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 189
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 190 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 35/284 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  +  +G G+FG V++ I   + EVVAIK +  +    E     +E+  L +   P 
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I +      ++  L+ + EY+   +   L+K       E  +     ++ +GL Y+H   
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSER 136
Query: 121 YFHRDLKPENLLVS-KDTIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L+S +  +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y  
Sbjct: 137 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS-AYDF 195
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           K D+W++G    EL    P                    P  D     +L     N   P
Sbjct: 196 KADIWSLGITAIELAKGEP--------------------PNSDLHPMRVLFLIPKNSP-P 234
Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            L G          +K     + +  + DP  RPTA E L+H F
Sbjct: 235 TLEG--------QHSKPFKEFVEACLNKDPRFRPTAKELLKHKF 270

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 112/201 (55%), Gaps = 16/201 (7%)
Query: 7   IKE-VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIV 63
           IKE +G G+FG+V RA  +  G  VA+K + ++ +  E  VN  LREV  ++++ HPNIV
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNIV 97
Query: 64  KLKEVIRENDILYFVFEYM-ECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQR 119
                + +   L  V EY+   +LY+L+     RE+   E    +  + V +G+ Y+H R
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR 156
Query: 120 G--YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS-TRWYRAPEVLLQSYL 175
                HRDLK  NLLV K  T+K+ DFGL+R   S    ++  + T  + APEV L+   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEV-LRDEP 215
Query: 176 YSSKVDMWAMGAIMAELITLR 196
            + K D+++ G I+ EL TL+
Sbjct: 216 SNEKSDVYSFGVILWELATLQ 236

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 138/289 (47%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 8   MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 65
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +    T +   ++   + APE L  
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 185 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DPSQVYE-----------------LLE 224
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 225 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 262

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G   +V+R   K++G++ AIK      +     V +RE + L+K++H NIVKL  + 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 70  RENDILY--FVFEYMEC-NLYQLMKDREKCFS--EAEVRNWCFQVFQGLAYMHQRGYFHR 124
            E    +   + E+  C +LY ++++    +   E+E       V  G+ ++ + G  HR
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 125 DLKPENLL--VSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL---- 175
           ++KP N++  + +D     K+ DFG ARE+     F     T  Y  P++  ++ L    
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 176 ---YSSKVDMWAMGAIMAELIT----LRPLFPGTSEADEI-YKICSVIGTPT 219
              Y + VD+W++G       T     RP F G     E+ YKI  + G P+
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRP-FEGPRRNKEVMYKI--ITGKPS 245

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 93/336 (27%), Positives = 149/336 (44%), Gaps = 49/336 (14%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY L++++G G F +VW A    +   VA+K ++      E   +  E+K L++++  + 
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED--EIKLLQRVNDADN 77
Query: 63  VKLKEVIRENDIL----------------YFVFEYMECNLYQLMKDRE-KCFSEAEVRNW 105
            K ++ +  N IL                  VFE +  NL  L+K  E +      V+  
Sbjct: 78  TK-EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 106 CFQVFQGLAYMHQR-GYFHRDLKPENLLVS-KDT------IKIADFGLAREINSRPPFTE 157
             Q+  GL YMH+R G  H D+KPEN+L+   D+      IKIAD G A   +    +T 
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTN 194
Query: 158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG------TSEADEIYKI 211
            + TR YR+PEVLL +  +    D+W+   ++ ELIT   LF        T + D I +I
Sbjct: 195 SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 212 CSVIGT-PT----QDSWADGLLLARAINYKFPQLVGVPLSVLMPSA---NKDAVSLIASL 263
             ++G  P+       +      +R +     +L   PL  ++      +KD    I+  
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 264 CS----WDPSKRPTAAEALQHPFSRVAFMFHHLSVP 295
            S     DP KR  A   + HP+ +       + VP
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 349

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 24/217 (11%)
Query: 6   LIKEVGDGTFGSVWRAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
            +KE+G G FG V     K  G+  VAIK +K+   S +E +   E K +  +SH  +V+
Sbjct: 13  FLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIE--EAKVMMNLSHEKLVQ 68
Query: 65  LKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           L  V  +   ++ + EYM   C L  L + R + F   ++   C  V + + Y+  + + 
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 123 HRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQSYL 175
           HRDL   N LV+ +  +K++DFGL+R +       EY S+R       +  PEVL+ S  
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSRGSKFPVRWSPPEVLMYSK- 182
Query: 176 YSSKVDMWAMGAIMAELITLRPL----FPGTSEADEI 208
           +SSK D+WA G +M E+ +L  +    F  +  A+ I
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 93/336 (27%), Positives = 149/336 (44%), Gaps = 49/336 (14%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY L++++G G F +VW A    +   VA+K ++      E   +  E+K L++++  + 
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED--EIKLLQRVNDADN 77
Query: 63  VKLKEVIRENDIL----------------YFVFEYMECNLYQLMKDRE-KCFSEAEVRNW 105
            K ++ +  N IL                  VFE +  NL  L+K  E +      V+  
Sbjct: 78  TK-EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 106 CFQVFQGLAYMHQR-GYFHRDLKPENLLVS-KDT------IKIADFGLAREINSRPPFTE 157
             Q+  GL YMH+R G  H D+KPEN+L+   D+      IKIAD G A   +    +T 
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTN 194
Query: 158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG------TSEADEIYKI 211
            + TR YR+PEVLL +  +    D+W+   ++ ELIT   LF        T + D I +I
Sbjct: 195 SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 212 CSVIGT-PT----QDSWADGLLLARAINYKFPQLVGVPLSVLMPSA---NKDAVSLIASL 263
             ++G  P+       +      +R +     +L   PL  ++      +KD    I+  
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 264 CS----WDPSKRPTAAEALQHPFSRVAFMFHHLSVP 295
            S     DP KR  A   + HP+ +       + VP
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 349

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 138/289 (47%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 11  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 68
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 69  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +    T +   ++   + APE L  
Sbjct: 129 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAY 187
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 188 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 227
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 228 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 265

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G   +V+R   K++G++ AIK      +     V +RE + L+K++H NIVKL  + 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 70  RENDILY--FVFEYMEC-NLYQLMKDREKCFS--EAEVRNWCFQVFQGLAYMHQRGYFHR 124
            E    +   + E+  C +LY ++++    +   E+E       V  G+ ++ + G  HR
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 125 DLKPENLL--VSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL---- 175
           ++KP N++  + +D     K+ DFG ARE+     F     T  Y  P++  ++ L    
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDH 196
Query: 176 ---YSSKVDMWAMGAIMAELIT----LRPLFPGTSEADEI-YKICSVIGTPT 219
              Y + VD+W++G       T     RP F G     E+ YKI  + G P+
Sbjct: 197 QKKYGATVDLWSIGVTFYHAATGSLPFRP-FEGPRRNKEVMYKI--ITGKPS 245

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 24/217 (11%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            +KE+G G FG V    WR         VAIK +K+   S +E +   E K +  +SH  
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-----VAIKMIKEGSMSEDEFI--EEAKVMMNLSHEK 80
Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V  +   ++ + EYM   C L  L + R + F   ++   C  V + + Y+  +
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK 139
Query: 120 GYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYL 175
            + HRDL   N LV+ +  +K++DFGL+R +     +T  V +++   +  PEVL+ S  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK- 197
Query: 176 YSSKVDMWAMGAIMAELITLRPL----FPGTSEADEI 208
           +SSK D+WA G +M E+ +L  +    F  +  A+ I
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 71
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 72  LVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYL 175
            Y HRDL+  N+LV ++ + K+ADFGLAR I     +T     ++   + APE  L    
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EWTARQGAKFPIKWTAPEAALYGR- 188
Query: 176 YSSKVDMWAMGAIMAELITL-RPLFPG 201
           ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 189 FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 112/214 (52%), Gaps = 18/214 (8%)
Query: 6   LIKEVGDGTFGSVWRAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
            +KE+G G FG V     K  G+  VAIK +K+   S +E +   E K +  +SH  +V+
Sbjct: 12  FLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIE--EAKVMMNLSHEKLVQ 67
Query: 65  LKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           L  V  +   ++ + EYM   C L  L + R + F   ++   C  V + + Y+  + + 
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 126
Query: 123 HRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYLYSS 178
           HRDL   N LV+ +  +K++DFGL+R +     +T  V +++   +  PEVL+ S  +SS
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK-FSS 184
Query: 179 KVDMWAMGAIMAELITLRPL----FPGTSEADEI 208
           K D+WA G +M E+ +L  +    F  +  A+ I
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 24/217 (11%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            +KE+G G FG V    WR         VAIK +K+   S +E +   E K +  +SH  
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYD-----VAIKMIKEGSMSEDEFIE--EAKVMMNLSHEK 71
Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V  +   ++ + EYM   C L  L + R + F   ++   C  V + + Y+  +
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK 130
Query: 120 GYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYL 175
            + HRDL   N LV+ +  +K++DFGL+R +     +T  V +++   +  PEVL+ S  
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK- 188
Query: 176 YSSKVDMWAMGAIMAELITLRPL----FPGTSEADEI 208
           +SSK D+WA G +M E+ +L  +    F  +  A+ I
Sbjct: 189 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 225

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 112/214 (52%), Gaps = 18/214 (8%)
Query: 6   LIKEVGDGTFGSVWRAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
            +KE+G G FG V     K  G+  VAIK +K+   S +E +   E K +  +SH  +V+
Sbjct: 13  FLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFI--EEAKVMMNLSHEKLVQ 68
Query: 65  LKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           L  V  +   ++ + EYM   C L  L + R + F   ++   C  V + + Y+  + + 
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 123 HRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYLYSS 178
           HRDL   N LV+ +  +K++DFGL+R +     +T  V +++   +  PEVL+ S  +SS
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK-FSS 185
Query: 179 KVDMWAMGAIMAELITLRPL----FPGTSEADEI 208
           K D+WA G +M E+ +L  +    F  +  A+ I
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 24/217 (11%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            +KE+G G FG V    WR         VAIK +K+   S +E +   E K +  +SH  
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-----VAIKMIKEGSMSEDEFIE--EAKVMMNLSHEK 60
Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V  +   ++ + EYM   C L  L + R + F   ++   C  V + + Y+  +
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK 119
Query: 120 GYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQSYL 175
            + HRDL   N LV+ +  +K++DFGL+R +     +T  V +++   +  PEVL+ S  
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK- 177
Query: 176 YSSKVDMWAMGAIMAELITLRPL----FPGTSEADEI 208
           +SSK D+WA G +M E+ +L  +    F  +  A+ I
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 36/299 (12%)
Query: 4   YKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK-MSHPN 61
           Y+L ++V G+G    V   I+  + +  A+K ++K+       V  REV+ L +   H N
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQGHRN 72
Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +++L E   E D  Y VFE M          + + F+E E       V   L ++H +G 
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 122 FHRDLKPENLLVSKDT----IKIADFGLAREIN--------SRPPFTEYVSTRWYRAPEV 169
            HRDLKPEN+L         +KI DF L   I         S P       +  Y APEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 170 L----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD---EIYKICSVIGTPTQDS 222
           +     ++ +Y  + D+W++G I+  L++  P F G   +D   +  + C        +S
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
             +G        Y+FP      +S     A KD   LI+ L   D  +R +AA+ LQHP
Sbjct: 253 IQEG-------KYEFPDKDWAHISC----AAKD---LISKLLVRDAKQRLSAAQVLQHP 297

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 12  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS---RPPFTEYVSTRWYRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R +       P       +W  APE L  
Sbjct: 130 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPESLAY 188
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 189 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 228
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 229 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 266

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 72/312 (23%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP- 60
           ++ I  +G G FG V +A +       AIKK++      EE ++  L EV  L  ++H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQY 63
Query: 61  ------------NIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCF 107
                       N VK    +++   L+   EY E   LY L+          E      
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN---------------S 151
           Q+ + L+Y+H +G  HRDLKP N+ + +   +KI DFGLA+ ++               S
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
               T  + T  Y A EVL  +  Y+ K+DM+++G I  E+I   P   G    + + K+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKL 241
Query: 212 CSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAV----SLIASLCSWD 267
                              R+++ +FP           P  + + +     +I  L   D
Sbjct: 242 -------------------RSVSIEFP-----------PDFDDNKMKVEKKIIRLLIDHD 271
Query: 268 PSKRPTAAEALQ 279
           P+KRP A   L 
Sbjct: 272 PNKRPGARTLLN 283

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 19/210 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGNMSPE--AFLQEAQVMKKLRHEK 241
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 242 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 300
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW------YRAPEVLLQ 172
            Y HRDL+  N+LV ++ + K+ADFGL R I       EY + +       + APE  L 
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFGLGRLIED----NEYTARQGAKFPIKWTAPEAALY 356
Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPG 201
              ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 357 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 11  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 68
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 69  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS---RPPFTEYVSTRWYRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R +       P       +W  APE L  
Sbjct: 129 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPESLAY 187
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 188 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 227
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 228 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 265

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 138/289 (47%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 15  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 72
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HRDL   N LV ++  +K+ADFGL+R + +    T +   ++   + APE L  
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAY 191
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 192 NK-FSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 231
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 232 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 269

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 111/203 (54%), Gaps = 20/203 (9%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS------- 53
           ++ +++++ +G G+FG V    S+ +G   A+K +KK     E  V L++V+        
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLM 59
Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQG 112
           L  ++HP I+++    ++   ++ + +Y+E   L+ L++  ++ F     + +  +V   
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLA 118
Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYV-STRWYRAPEVL 170
           L Y+H +   +RDLKPEN+L+ K+  IKI DFG A+ +   P  T  +  T  Y APEV 
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYXLCGTPDYIAPEV- 174
Query: 171 LQSYLYSSKVDMWAMGAIMAELI 193
           + +  Y+  +D W+ G ++ E++
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEML 197

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 137/289 (47%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 256 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 313
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 314 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 373
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HR+L   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 374 EKKNFIHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y++                   
Sbjct: 433 N-KFSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYELLEK---------------- 473
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
              +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 474 ---DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 510

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 72/312 (23%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP- 60
           ++ I  +G G FG V +A +       AIKK++      EE ++  L EV  L  ++H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQY 63
Query: 61  ------------NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCF 107
                       N VK    +++   L+   EY E   LY L+          E      
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN---------------S 151
           Q+ + L+Y+H +G  HRDLKP N+ + +   +KI DFGLA+ ++               S
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
               T  + T  Y A EVL  +  Y+ K+DM+++G I  E+I   P   G    + + K+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKL 241
Query: 212 CSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAV----SLIASLCSWD 267
                              R+++ +FP           P  + + +     +I  L   D
Sbjct: 242 -------------------RSVSIEFP-----------PDFDDNKMKVEKKIIRLLIDHD 271
Query: 268 PSKRPTAAEALQ 279
           P+KRP A   L 
Sbjct: 272 PNKRPGARTLLN 283

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 6   LIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            +KE+G G FG V    WR         VAIK +K+   S +E +   E K +  +SH  
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-----VAIKMIKEGSMSEDEFI--EEAKVMMNLSHEK 80
Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V  +   ++ + EYM   C L  L + R + F   ++   C  V + + Y+  +
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK 139
Query: 120 GYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSYL 175
            + HRDL   N LV+ +  +K++DFGL+R +      +   S    RW   PEVL+ S  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW-SPPEVLMYSK- 197
Query: 176 YSSKVDMWAMGAIMAELITLRPL----FPGTSEADEI 208
           +SSK D+WA G +M E+ +L  +    F  +  A+ I
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 107/199 (53%), Gaps = 18/199 (9%)
Query: 10  VGDGTFGSVWRA--ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+    I +    +  AIK + +     +    LRE   +R ++HPN++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 67  EVIRENDIL-YFVFEYM-ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            ++   + L + +  YM   +L Q ++  ++  +  ++ ++  QV +G+ Y+ ++ + HR
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148
Query: 125 DLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV--------LLQSYL 175
           DL   N ++ +  T+K+ADFGLAR+I  R    EY S + +R   +         LQ+Y 
Sbjct: 149 DLAARNCMLDESFTVKVADFGLARDILDR----EYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 176 YSSKVDMWAMGAIMAELIT 194
           +++K D+W+ G ++ EL+T
Sbjct: 205 FTTKSDVWSFGVLLWELLT 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 1   MERYKLI--KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           MER  +    ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ 
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK 274
Query: 59  HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNW-CFQVFQGLAYM 116
           HPN+V+L  V       Y + E+M   NL   +++  +    A V  +   Q+   + Y+
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRW---YRAPEVLLQ 172
            ++ + HR+L   N LV ++  +K+ADFGL+R + +   +T +   ++   + APE L  
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 173 SYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           +  +S K D+WA G ++ E+ T  + P +PG  +  ++Y+                 LL 
Sbjct: 394 N-KFSIKSDVWAFGVLLWEIATYGMSP-YPGI-DLSQVYE-----------------LLE 433
Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
           +  +Y+  +  G P  V           L+ +   W+PS RP+ AE  Q
Sbjct: 434 K--DYRMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQ 471

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 111/201 (55%), Gaps = 16/201 (7%)
Query: 7   IKE-VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIV 63
           IKE +G G+FG+V RA  +  G  VA+K + ++ +  E  VN  LREV  ++++ HPNIV
Sbjct: 41  IKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNIV 97
Query: 64  KLKEVIRENDILYFVFEYM-ECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQR 119
                + +   L  V EY+   +LY+L+     RE+   E    +  + V +G+ Y+H R
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR 156
Query: 120 G--YFHRDLKPENLLVSKD-TIKIADFGLAR-EINSRPPFTEYVSTRWYRAPEVLLQSYL 175
                HR+LK  NLLV K  T+K+ DFGL+R + ++         T  + APEV L+   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV-LRDEP 215
Query: 176 YSSKVDMWAMGAIMAELITLR 196
            + K D+++ G I+ EL TL+
Sbjct: 216 SNEKSDVYSFGVILWELATLQ 236

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 82
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 83  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 202
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 203 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 247
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 248 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 294

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 74
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 75  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 194
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 195 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 239
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 240 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 286

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 67
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 68  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 187
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 188 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 232
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 233 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 279

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 66
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 67  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 186
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 187 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 231
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 232 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 278

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 113/227 (49%), Gaps = 19/227 (8%)
Query: 10  VGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V     K  G+    VAIK +K  Y   +    L E   + +  HPNI+ L+
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
            V+ ++  +  V EYME  +L   +K  +  F+  ++      +  G+ Y+   GY HRD
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRD 149
Query: 126 LKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYSSK 179
           L   N+L++ + + K++DFGL+R +   P   +T     +  RW  APE +     ++S 
Sbjct: 150 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEAIAFRK-FTSA 207
Query: 180 VDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPT 219
            D+W+ G +M E+++   RP +  T++      +E Y++ S +  P 
Sbjct: 208 SDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPA 254

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK-SLRKMSHPNIVKL 65
           I E+G G +G V +     SG+++A+K+++    S E+   L ++  S+R +  P  V  
Sbjct: 56  IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 66  -KEVIRENDILYFVFEYMECNL---YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-G 120
              + RE D+ +   E M+ +L   Y+ + D+ +   E  +      + + L ++H +  
Sbjct: 116 YGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 174
Query: 121 YFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL---LQSYLY 176
             HRD+KP N+L++    +K+ DFG++  +      T     + Y APE +   L    Y
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S K D+W++G  M EL  LR  FP  S            GTP Q        L + +   
Sbjct: 235 SVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------LKQVVEEP 274
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH 291
            PQL     S        + V   +     +  +RPT  E +QHPF    F  H 
Sbjct: 275 SPQLPADKFSA-------EFVDFTSQCLKKNSKERPTYPELMQHPF----FTLHE 318

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 68
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 189 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 233
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 234 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 280

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 114/229 (49%), Gaps = 19/229 (8%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+  KL++ +G G FG V   +    G  VA+K +K    +      L E   + ++ H 
Sbjct: 11  MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHS 65
Query: 61  NIVKLKEVI-RENDILYFVFEYM-ECNLYQLMKDREKCFSEAE-VRNWCFQVFQGLAYMH 117
           N+V+L  VI  E   LY V EYM + +L   ++ R +     + +  +   V + + Y+ 
Sbjct: 66  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 125
Query: 118 QRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              + HRDL   N+LVS+D + K++DFGL +E +S    T  +  +W  APE L ++  +
Sbjct: 126 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALREA-AF 182
Query: 177 SSKVDMWAMGAIMAELITLR-------PLFPGTSEADEIYKICSVIGTP 218
           S+K D+W+ G ++ E+ +         PL       ++ YK+ +  G P
Sbjct: 183 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 231

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 16/214 (7%)
Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           K+ + +G G FG V     K  G+    VAIK +K  Y   +    L E   + +  HPN
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 95
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++ L+ V+ ++  +  + E+ME  +L   ++  +  F+  ++      +  G+ Y+    
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 155
Query: 121 YFHRDLKPENLLVSKDTI-KIADFGLAR---EINSRPPFTEY----VSTRWYRAPEVLLQ 172
           Y HRDL   N+LV+ + + K++DFGL+R   +  S P +T      +  RW  APE  +Q
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPEA-IQ 213
Query: 173 SYLYSSKVDMWAMGAIMAELITL--RPLFPGTSE 204
              ++S  D+W+ G +M E+++   RP +  T++
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 247

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 72
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 73  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 192
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 193 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 237
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 238 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 284

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 73
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 74  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 193
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 194 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 238
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 239 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 285

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 68
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 189 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 233
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 234 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 280

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 118
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 119 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 238
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 239 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 283
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 284 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 330

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +RY K I+++G+G FG V    +   +  +GE+VA+K +K            +E+  LR 
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRT 72
Query: 57  MSHPNIVKLKEVIREND--ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           + H +I+K K    +     L  V EY+     +    R      A++  +  Q+ +G+A
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 131
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTR--------WYR 165
           Y+H + Y HR+L   N+L+  D  +KI DFGLA+ +   P   EY   R        WY 
Sbjct: 132 YLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFWY- 187
Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           APE  L+ Y +    D+W+ G  + EL+T
Sbjct: 188 APEC-LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 32/264 (12%)
Query: 4   YKLIKEV-GDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           Y  I+EV G G FG V R   K  G+    VAIK +K  Y   +    L E   + +  H
Sbjct: 15  YVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEH 74
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNI++L+ V+  +  +  + E+ME   L   ++  +  F+  ++      +  G+ Y+ +
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE 134
Query: 119 RGYFHRDLKPENLLVSKDTI-KIADFGLAR---EINSRPPFTEY----VSTRWYRAPEVL 170
             Y HRDL   N+LV+ + + K++DFGL+R   E +S P +T      +  RW  APE +
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT-APEAI 193
Query: 171 LQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEA-----DEIYKICSVIGTPTQ--- 220
                ++S  D W+ G +M E+++   RP +  +++      ++ Y++      PT    
Sbjct: 194 AFRK-FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQ 252
Query: 221 ---DSWADGLLLARAINYKFPQLV 241
              D W       R    +FPQ+V
Sbjct: 253 LMLDCWQKD----RNARPRFPQVV 272

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/340 (23%), Positives = 141/340 (41%), Gaps = 68/340 (20%)
Query: 4   YKLIKEVGDGTFGSVWRAISK-QSG--EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           +K+  ++G+GTF SV+ A ++ Q G  E +A+K +    +       L+ +         
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTV--AGGQD 80
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           N++ +K   R+ND +     Y+E   ++   D     S  EVR +   +F+ L  +HQ G
Sbjct: 81  NVMGVKYCFRKNDHVVIAMPYLE---HESFLDILNSLSFQEVREYMLNLFKALKRIHQFG 137
Query: 121 YFHRDLKPENLLVSKDTIKIA--DFGLARE-----------------------------I 149
             HRD+KP N L ++   K A  DFGLA+                              +
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 150 NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLR-PLFPGTSEADEI 208
           + R        T  +RAPEVL +    ++ +DMW+ G I   L++ R P +  + +   +
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257
Query: 209 YKICSVIGT----PTQDSWADGLLLARAINYK-----FPQLVGVPLSVLMPSANKDAVSL 259
            +I ++ G+        ++   +L ++ +  +       +L G+  S   P    D    
Sbjct: 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSST--PKLTSDIQGH 315
Query: 260 IASLCSW-----------------DPSKRPTAAEALQHPF 282
             +L  W                 +P+ R TA EAL HPF
Sbjct: 316 ATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +RY K I+++G+G FG V    +   +  +GE+VA+K +K            +E+  LR 
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRT 72
Query: 57  MSHPNIVKLKEVIREND--ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           + H +I+K K    +     L  V EY+     +    R      A++  +  Q+ +G+A
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 131
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTR--------WYR 165
           Y+H + Y HR+L   N+L+  D  +KI DFGLA+ +   P   EY   R        WY 
Sbjct: 132 YLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFWY- 187
Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           APE  L+ Y +    D+W+ G  + EL+T
Sbjct: 188 APEC-LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRAS 112
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F         Y    +  +P   +     
Sbjct: 233 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPF---------YSNHGLAISPGMKT----- 277
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 278 -RIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 324

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +RY K I+++G+G FG V    +   +  +GE+VA+K +K            +E+  LR 
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT 89
Query: 57  MSHPNIVKLKEVIRENDI--LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           + H +I+K K    +     L  V EY+     +    R      A++  +  Q+ +G+A
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 148
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTR--------WYR 165
           Y+H + Y HRDL   N+L+  D  +KI DFGLA+ +   P   E    R        WY 
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEXYRVREDGDSPVFWY- 204
Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           APE  L+ Y +    D+W+ G  + EL+T
Sbjct: 205 APEC-LKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 15/218 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G  G VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 69
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC-FSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME  +L   +K       +  ++ +   Q+ +G+A++ +R
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 120 GYFHRDLKPENLLVSKDTI--KIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQSY 174
            Y HRDL+  N+LVS DT+  KIADFGLAR I          +    +W  APE  +   
Sbjct: 129 NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDAEXTAREGAKFPIKW-TAPEA-INYG 185
Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
            ++ K D+W+ G ++ E++T  R  +PG +  + I  +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 19/229 (8%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+  KL++ +G G FG V   +    G  VA+K +K    +      L E   + ++ H 
Sbjct: 20  MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHS 74
Query: 61  NIVKLKEVI-RENDILYFVFEYM-ECNLYQLMKDREKCFSEAE-VRNWCFQVFQGLAYMH 117
           N+V+L  VI  E   LY V EYM + +L   ++ R +     + +  +   V + + Y+ 
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 118 QRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              + HRDL   N+LVS+D + K++DFGL +E +S    T  +  +W  APE L +   +
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALREKK-F 191
Query: 177 SSKVDMWAMGAIMAELITLR-------PLFPGTSEADEIYKICSVIGTP 218
           S+K D+W+ G ++ E+ +         PL       ++ YK+ +  G P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 240

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 64
Query: 62  IVKLKEVIRENDILYFVFEYM-ECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I   V EYM + +L   +K +  K     ++ +   Q+  G+AY+ + 
Sbjct: 65  LVQLYAVVSEEPIX-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 123
Query: 120 GYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVST---RWYRAPEVLLQSYL 175
            Y HRDL+  N+LV ++ + K+ADFGLAR I          +    +W  APE  L    
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAALYGR- 181
Query: 176 YSSKVDMWAMGAIMAELITL-RPLFPG 201
           ++ K D+W+ G ++ EL T  R  +PG
Sbjct: 182 FTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 32/264 (12%)
Query: 4   YKLIKEV-GDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           Y  I+EV G G FG V R   K  G+    VAIK +K  Y   +    L E   + +  H
Sbjct: 17  YVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEH 76
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNI++L+ V+  +  +  + E+ME   L   ++  +  F+  ++      +  G+ Y+ +
Sbjct: 77  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE 136
Query: 119 RGYFHRDLKPENLLVSKDTI-KIADFGLAR--EINSRPP-----FTEYVSTRWYRAPEVL 170
             Y HRDL   N+LV+ + + K++DFGL+R  E NS  P         +  RW  APE +
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT-APEAI 195
Query: 171 LQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEA-----DEIYKICSVIGTPTQ--- 220
                ++S  D W+ G +M E+++   RP +  +++      ++ Y++      PT    
Sbjct: 196 AFRK-FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQ 254
Query: 221 ---DSWADGLLLARAINYKFPQLV 241
              D W       R    +FPQ+V
Sbjct: 255 LMLDCWQKD----RNARPRFPQVV 274

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 19/229 (8%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+  KL++ +G G FG V   +    G  VA+K +K    +      L E   + ++ H 
Sbjct: 5   MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHS 59
Query: 61  NIVKLKEVI-RENDILYFVFEYM-ECNLYQLMKDREKCFSEAE-VRNWCFQVFQGLAYMH 117
           N+V+L  VI  E   LY V EYM + +L   ++ R +     + +  +   V + + Y+ 
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 118 QRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              + HRDL   N+LVS+D + K++DFGL +E +S    T  +  +W  APE L +   +
Sbjct: 120 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALREKK-F 176
Query: 177 SSKVDMWAMGAIMAELITLR-------PLFPGTSEADEIYKICSVIGTP 218
           S+K D+W+ G ++ E+ +         PL       ++ YK+ +  G P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 118/246 (47%), Gaps = 39/246 (15%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E  +  K +G G FG V  A    ISK    + VA+K +K+K  S E    + E+K + +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 57  M-SHPNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRN--------- 104
           + SH NIV L      +  +Y +FEY  C  +L   ++ + + FSE E+           
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYC-CYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 105 -------------WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN 150
                        + +QV +G+ ++  +   HRDL   N+LV+    +KI DFGLAR+I 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 151 SRPPFTEYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEA 205
           S   +    + R    + APE L +  +Y+ K D+W+ G ++ E+ +L   P +PG    
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVD 281
Query: 206 DEIYKI 211
              YK+
Sbjct: 282 ANFYKL 287

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 113/224 (50%), Gaps = 9/224 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYS 181
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQ 220
            + D+W+MG  + E+   R P+ P  ++  E+   C V G   +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 5/194 (2%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE-CVNLREVKSLRKMS-H 59
           + ++ +  +G G++G V++  SK+ G + A+K+    +   ++    L EV S  K+  H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P  V+L++   E  ILY   E    +L Q  +       EA+V  +       LA++H +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 120 GYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
           G  H D+KP N+ +  +   K+ DFGL  E+ +            Y APE+L  S  Y +
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--YGT 234
Query: 179 KVDMWAMGAIMAEL 192
             D++++G  + E+
Sbjct: 235 AADVFSLGLTILEV 248

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK-SLRKMSHPNIVKL 65
           I E+G G +G V +     SG+++A+K+++    S E+   L ++  S+R +  P  V  
Sbjct: 12  IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 66  -KEVIRENDILYFVFEYMECNL---YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-G 120
              + RE D+ +   E M+ +L   Y+ + D+ +   E  +      + + L ++H +  
Sbjct: 72  YGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 121 YFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL---LQSYLY 176
             HRD+KP N+L++    +K+ DFG++  +            + Y APE +   L    Y
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S K D+W++G  M EL  LR  FP  S            GTP Q        L + +   
Sbjct: 191 SVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------LKQVVEEP 230
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            PQL     S        + V   +     +  +RPT  E +QHPF
Sbjct: 231 SPQLPADKFSA-------EFVDFTSQCLKKNSKERPTYPELMQHPF 269

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 113/224 (50%), Gaps = 9/224 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYS 181
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQ 220
            + D+W+MG  + E+   R P+ P  ++  E+   C V G   +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 19/229 (8%)
Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+  KL++ +G G FG V   +    G  VA+K +K    +      L E   + ++ H 
Sbjct: 192 MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHS 246
Query: 61  NIVKLKEVI-RENDILYFVFEYM-ECNLYQLMKDREKCFSEAE-VRNWCFQVFQGLAYMH 117
           N+V+L  VI  E   LY V EYM + +L   ++ R +     + +  +   V + + Y+ 
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 118 QRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              + HRDL   N+LVS+D + K++DFGL +E +S    T  +  +W  APE L +   +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALREKK-F 363
Query: 177 SSKVDMWAMGAIMAELITLR-------PLFPGTSEADEIYKICSVIGTP 218
           S+K D+W+ G ++ E+ +         PL       ++ YK+ +  G P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 412

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 9/220 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 186
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 187 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPE-RLQGTHYS 243
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIG 216
            + D+W+MG  + E+   R P+ P  ++  E+   C V G
Sbjct: 244 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 283

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 113/224 (50%), Gaps = 9/224 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYS 181
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQ 220
            + D+W+MG  + E+   R P+ P  ++  E+   C V G   +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 113/224 (50%), Gaps = 9/224 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYS 181
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQ 220
            + D+W+MG  + E+   R P+ P  ++  E+   C V G   +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 122/259 (47%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGLAR +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 289 KD----RNNRPKFEQIVSI 303

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 14/226 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V +   + SG ++A K +  +         +RE++ L + + P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K+ ++   E  +      V +GLAY+ ++ 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREKH 134
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y APE  LQ   YS
Sbjct: 135 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMAPE-RLQGTHYS 191
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDS 222
            + D+W+MG  + EL   R P+ P   +A E+    ++ G P  D 
Sbjct: 192 VQSDIWSMGLSLVELAVGRYPIPP--PDAKELE---AIFGRPVVDG 232

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 118/241 (48%), Gaps = 39/241 (16%)
Query: 7   IKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++++G+G FG V++A     +  +   +VA+K +K++  +  +    RE   + +  +PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 62  IVKLKEVIRENDILYFVFEYME----------------CNL-YQLMKDREKC-------F 97
           IVKL  V      +  +FEYM                 C+L +  +  R +         
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----R 152
           S AE      QV  G+AY+ +R + HRDL   N LV ++  +KIADFGL+R I S    +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYK 210
               + +  RW   PE +  +  Y+++ D+WA G ++ E+ +  L+P + G +  + IY 
Sbjct: 232 ADGNDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYY-GMAHEEVIYY 288
Query: 211 I 211
           +
Sbjct: 289 V 289

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 75  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LV S D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 188
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 189 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 98  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 154
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LV S D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 155 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 211
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 212 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 253

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 70  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LV S D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 183
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 184 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 70  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LV S D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 183
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 184 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 113/224 (50%), Gaps = 9/224 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 151
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYS 208
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQ 220
            + D+W+MG  + E+   R P+ P  ++  E+   C V G   +
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           ++L++ VG+GT+G V++    ++G++ AIK M       EE    +E+  L+K SH   +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK--QEINMLKKYSHHRNI 83
Query: 64  KL--KEVIREN-----DILYFVFEYMEC-NLYQLMKD-REKCFSEAEVRNWCFQVFQGLA 114
                  I++N     D L+ V E+    ++  L+K+ +     E  +   C ++ +GL+
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFG----LAREINSRPPFTEYVSTRWYRAPEV 169
           ++HQ    HRD+K +N+L++++  +K+ DFG    L R +  R  F   + T ++ APEV
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---IGTPYWMAPEV 200
Query: 170 LL----QSYLYSSKVDMWAMGAIMAELITLRP 197
           +         Y  K D+W++G    E+    P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 70  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LVS  D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 127 LESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 183
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 184 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + E+  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 72  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 128
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LV S D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 129 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 185
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 186 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 227

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 73  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 129
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LV S D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 130 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 186
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 187 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 228

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 67  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LV S D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 180
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 181 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 16/214 (7%)
Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           K+ + +G G FG V     K  G+    VAIK +K  Y   +    L E   + +  HPN
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++ L+ V+ ++  +  + E+ME  +L   ++  +  F+  ++      +  G+ Y+    
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 121 YFHRDLKPENLLVSKDTI-KIADFGLAR---EINSRPPFTEY----VSTRWYRAPEVLLQ 172
           Y HR L   N+LV+ + + K++DFGL+R   +  S P +T      +  RW  APE  +Q
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPEA-IQ 187
Query: 173 SYLYSSKVDMWAMGAIMAELITL--RPLFPGTSE 204
              ++S  D+W+ G +M E+++   RP +  T++
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 221

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 132/307 (42%), Gaps = 61/307 (19%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLK 66
           K +G G+ G+V    S Q G  VA+K+M   +      + L E+K L +   HPN+++  
Sbjct: 21  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVIRYY 75
Query: 67  EVIRENDILYFVFEYMECNLYQLMKDRE------KCFSEAEVRNWCFQVFQGLAYMHQRG 120
                +  LY   E    NL  L++ +       K   E    +   Q+  G+A++H   
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 121 YFHRDLKPENLLVSKDT--------------IKIADFGLAREINS-----RPPFTEYVST 161
             HRDLKP+N+LVS  +              I I+DFGL ++++S     R        T
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 162 RWYRAPEVLLQSYLYSSK------VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI 215
             +RAPE+L +S    +K      +D+++MG +                    Y I S  
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF-------------------YYILSKG 236
Query: 216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA 275
             P  D ++    + R I +   ++  +    L+     +A  LI+ +   DP KRPTA 
Sbjct: 237 KHPFGDKYSRESNIIRGI-FSLDEMKCLHDRSLIA----EATDLISQMIDHDPLKRPTAM 291
Query: 276 EALQHPF 282
           + L+HP 
Sbjct: 292 KVLRHPL 298

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 18/222 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 70  HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY---VSTRWYRAPEVLL 171
           +  + + HRD+   N+LV S D +K+ DFGL+R +            +  +W  APE  +
Sbjct: 127 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM-APES-I 184
Query: 172 QSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
               ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 289 KD----RNNRPKFEQIVSI 303

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 289 KD----RNNRPKFEQIVSI 303

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 289 KD----RNNRPKFEQIVSI 303

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           +K I+ +G G FG V++A  +  G+   IK++K   Y+ E+    REVK+L K+ H NIV
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAE--REVKALAKLDHVNIV 67
Query: 64  KLK----------EVIREND------ILYFVFEYMECNLYQ--LMKDREKCFSEAEVRNW 105
                        E   +N        L+   E+ +    +  + K R +   +      
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENL-LVSKDTIKIADFGLAREINSRPPFTEYVSTRWY 164
             Q+ +G+ Y+H +   +RDLKP N+ LV    +KI DFGL   + +         T  Y
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELI 193
            +PE  + S  Y  +VD++A+G I+AEL+
Sbjct: 188 MSPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL R +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELIT 194
           S  D+W+ G ++ E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 99  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 158
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 159 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 216
Query: 178 SKVDMWAMGAIMAELIT 194
           S  D+W+ G ++ E+++
Sbjct: 217 SASDVWSYGIVLWEVMS 233

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 132/307 (42%), Gaps = 61/307 (19%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLK 66
           K +G G+ G+V    S Q G  VA+K+M   +      + L E+K L +   HPN+++  
Sbjct: 21  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVIRYY 75
Query: 67  EVIRENDILYFVFEYMECNLYQLMKDRE------KCFSEAEVRNWCFQVFQGLAYMHQRG 120
                +  LY   E    NL  L++ +       K   E    +   Q+  G+A++H   
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 121 YFHRDLKPENLLVSKDT--------------IKIADFGLAREINS-----RPPFTEYVST 161
             HRDLKP+N+LVS  +              I I+DFGL ++++S     R        T
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 195
Query: 162 RWYRAPEVLLQSYLYSSK------VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI 215
             +RAPE+L +S    +K      +D+++MG +                    Y I S  
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF-------------------YYILSKG 236
Query: 216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA 275
             P  D ++    + R I +   ++  +    L+     +A  LI+ +   DP KRPTA 
Sbjct: 237 KHPFGDKYSRESNIIRGI-FSLDEMKCLHDRSLIA----EATDLISQMIDHDPLKRPTAM 291
Query: 276 EALQHPF 282
           + L+HP 
Sbjct: 292 KVLRHPL 298

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 289 KD----RNNRPKFEQIVSI 303

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 168
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 169 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 226
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 227 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 286
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 287 KD----RNNRPKFEQIVSI 301

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYS 181
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTSEAD 206
            + D+W+MG  + E+   R P+ P  ++ D
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKED 211

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           K+ K +G G FG V     K  G+    VAIK +K  Y   +    L E   + +  HPN
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I+ L+ V+ +   +  + EYME  +L   ++  +  F+  ++      +  G+ Y+    
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 130
Query: 121 YFHRDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSY 174
           Y HRDL   N+LV+ + + K++DFG++R +   P   +T     +  RW  APE +    
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT-APEAIAYRK 189
Query: 175 LYSSKVDMWAMGAIMAELIT 194
            ++S  D+W+ G +M E+++
Sbjct: 190 -FTSASDVWSYGIVMWEVMS 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 141
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 142 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 199
Query: 178 SKVDMWAMGAIMAELIT 194
           S  D+W+ G ++ E+++
Sbjct: 200 SASDVWSYGIVLWEVMS 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 125/310 (40%), Gaps = 68/310 (21%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP- 60
           ++ I  +G G FG V +A +       AIKK++      EE ++  L EV  L  ++H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVXLLASLNHQY 63
Query: 61  ------------NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCF 107
                       N VK    +++   L+   EY E   LY L+          E      
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN---------------S 151
           Q+ + L+Y+H +G  HR+LKP N+ + +   +KI DFGLA+ ++               S
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
               T  + T  Y A EVL  +  Y+ K+D +++G I  E I   P   G    + + K+
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKL 241
Query: 212 CSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVS--LIASLCSWDPS 269
                              R+++ +FP              NK  V   +I  L   DP+
Sbjct: 242 -------------------RSVSIEFPPDF---------DDNKXKVEKKIIRLLIDHDPN 273
Query: 270 KRPTAAEALQ 279
           KRP A   L 
Sbjct: 274 KRPGARTLLN 283

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 119/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR-----EKCF---------- 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R     E C+          
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 208 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 264

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           K+ K +G G FG V     K  G+    VAIK +K  Y   +    L E   + +  HPN
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 76
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I+ L+ V+ +   +  + EYME  +L   ++  +  F+  ++      +  G+ Y+    
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 136
Query: 121 YFHRDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSY 174
           Y HRDL   N+LV+ + + K++DFG++R +   P   +T     +  RW  APE +    
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT-APEAIAYRK 195
Query: 175 LYSSKVDMWAMGAIMAELIT 194
            ++S  D+W+ G +M E+++
Sbjct: 196 -FTSASDVWSYGIVMWEVMS 214

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 5   KLIKEVGDGTFGSVWRAI-SKQSGEVV--AIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           +L++++GDG+FG V R      SG+ V  A+K +K    S  E ++  +REV ++  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            N+++L  V+    +          +L   ++  +  F    +  +  QV +G+ Y+  +
Sbjct: 81  RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYR-------APEVLL 171
            + HRDL   NLL+ ++D +KI DFGL R +   P   ++   + +R       APE  L
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHXVMQEHRKVPFAWCAPES-L 196
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           ++  +S   D W  G  + E+ T
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 450 HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LV S D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 563
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 564 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 131/303 (43%), Gaps = 57/303 (18%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLK 66
           K +G G+ G+V    S Q G  VA+K+M   +      + L E+K L +   HPN+++  
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVIRYY 93
Query: 67  EVIRENDILYFVFEYMECNLYQLMKDRE------KCFSEAEVRNWCFQVFQGLAYMHQRG 120
                +  LY   E    NL  L++ +       K   E    +   Q+  G+A++H   
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 153
Query: 121 YFHRDLKPENLLVSKDT--------------IKIADFGLAREINS-----RPPFTEYVST 161
             HRDLKP+N+LVS  +              I I+DFGL ++++S     R        T
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 162 RWYRAPEVLLQSY--LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPT 219
             +RAPE+L +S     +  +D+++MG +                    Y I S    P 
Sbjct: 214 SGWRAPELLEESTKRRLTRSIDIFSMGCVF-------------------YYILSKGKHPF 254
Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
            D ++    + R I +   ++  +    L+     +A  LI+ +   DP KRPTA + L+
Sbjct: 255 GDKYSRESNIIRGI-FSLDEMKCLHDRSLIA----EATDLISQMIDHDPLKRPTAMKVLR 309
Query: 280 HPF 282
           HP 
Sbjct: 310 HPL 312

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 201 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 257

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 119/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR-----EKCF---------- 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R     E C+          
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 193 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 249

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 200 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 256

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 249 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 305

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 131/303 (43%), Gaps = 57/303 (18%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLK 66
           K +G G+ G+V    S Q G  VA+K+M   +      + L E+K L +   HPN+++  
Sbjct: 39  KILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVIRYY 93
Query: 67  EVIRENDILYFVFEYMECNLYQLMKDRE------KCFSEAEVRNWCFQVFQGLAYMHQRG 120
                +  LY   E    NL  L++ +       K   E    +   Q+  G+A++H   
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 153
Query: 121 YFHRDLKPENLLVSKDT--------------IKIADFGLAREINS-----RPPFTEYVST 161
             HRDLKP+N+LVS  +              I I+DFGL ++++S     R        T
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 162 RWYRAPEVLLQSY--LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPT 219
             +RAPE+L +S     +  +D+++MG +                    Y I S    P 
Sbjct: 214 SGWRAPELLEESTKRRLTRSIDIFSMGCVF-------------------YYILSKGKHPF 254
Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
            D ++    + R I +   ++  +    L+     +A  LI+ +   DP KRPTA + L+
Sbjct: 255 GDKYSRESNIIRGI-FSLDEMKCLHDRSLIA----EATDLISQMIDHDPLKRPTAMKVLR 309
Query: 280 HPF 282
           HP 
Sbjct: 310 HPL 312

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 127
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
              HRD+KP N+LV S+  IK+ DFG++ ++       E+V TR Y +PE  LQ   YS 
Sbjct: 128 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA-NEFVGTRSYMSPE-RLQGTHYSV 185
Query: 179 KVDMWAMGAIMAELITLR 196
           + D+W+MG  + E+   R
Sbjct: 186 QSDIWSMGLSLVEMAVGR 203

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 208 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 264

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQL---MKDREKCFSEAEVRNWCFQVFQGLAY 115
           HP+IVKL  VI EN + + + E   C L +L   ++ R+     A +  + +Q+   LAY
Sbjct: 450 HPHIVKLIGVITENPV-WIIMEL--CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 116 MHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEV 169
           +  + + HRD+   N+LVS  D +K+ DFGL+R +      T Y +++      + APE 
Sbjct: 507 LESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPES 563
Query: 170 LLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++   ++P F G    D I +I
Sbjct: 564 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +L++++GDG+FG V    W A S ++  V A+K +K    S  E ++  +REV ++  + 
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           H N+++L  V+    +          +L   ++  +  F    +  +  QV +G+ Y+  
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYR-------APEVL 170
           + + HRDL   NLL+ ++D +KI DFGL R +   P   ++   + +R       APE  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHXVMQEHRKVPFAWCAPES- 185
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT 194
           L++  +S   D W  G  + E+ T
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDRE---------------KCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ RE               +  
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 208 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 264

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           +K I+ +G G FG V++A  +  G+   I+++K   Y+ E+    REVK+L K+ H NIV
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVK---YNNEKAE--REVKALAKLDHVNIV 68
Query: 64  KLKEV-------IRENDILYFVFEYMECNLYQLMKDREKCF-------SEAEVRNWCF-- 107
                          +D      +Y   N     + + KC         +  +  W    
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 108 ---------------QVFQGLAYMHQRGYFHRDLKPENL-LVSKDTIKIADFGLAREINS 151
                          Q+ +G+ Y+H +   HRDLKP N+ LV    +KI DFGL   + +
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELI 193
               T    T  Y +PE  + S  Y  +VD++A+G I+AEL+
Sbjct: 189 DGKRTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 117/239 (48%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+      
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 208 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 264

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIK-KMKKKYYSWEECVNLREVKSLR 55
           +R  L K +G+G FG V  A +      +   V  +  KM K   + ++  +L     + 
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D + KIADFGLAR+I+    + 
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G ++ E+ TL    +PG    +E++K+
Sbjct: 197 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 253

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +L++++GDG+FG V    W A S ++  V A+K +K    S  E ++  +REV ++  + 
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           H N+++L  V+    +          +L   ++  +  F    +  +  QV +G+ Y+  
Sbjct: 80  HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYR-------APEVL 170
           + + HRDL   NLL+ ++D +KI DFGL R +   P   ++   + +R       APE  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHYVMQEHRKVPFAWCAPES- 195
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT 194
           L++  +S   D W  G  + E+ T
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLR-EVKSLRKMSHPNIVKLK 66
           +G G FG V+RA     G+ VA+K  +        +   N+R E K    + HPNI+ L+
Sbjct: 15  IGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 67  EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY---FH 123
            V  +   L  V E+        +   ++   +  V NW  Q+ +G+ Y+H        H
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILV-NWAVQIARGMNYLHDEAIVPIIH 131
Query: 124 RDLKPENLLV---------SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           RDLK  N+L+         S   +KI DFGLARE +     +   +  W  APEV +++ 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWM-APEV-IRAS 189
Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPG 201
           ++S   D+W+ G ++ EL+T    F G
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G GT+G V+      +   +AIK++ ++   + + ++  E+   + + H NIV+     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-EEIALHKHLKHKNIVQYLGSF 74
Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKCFSEAE--VRNWCFQVFQGLAYMHQRGYFHRDL 126
            EN  +    E +   +L  L++ +     + E  +  +  Q+ +GL Y+H     HRD+
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 134
Query: 127 KPENLLVS--KDTIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQS-YLYSSKVDM 182
           K +N+L++     +KI+DFG ++ +    P TE +  T  Y APE++ +    Y    D+
Sbjct: 135 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 194
Query: 183 WAMGAIMAELITLRPLF 199
           W++G  + E+ T +P F
Sbjct: 195 WSLGCTIIEMATGKPPF 211

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 261 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 317

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +L++++GDG+FG V    W A S ++  V A+K +K    S  E ++  +REV ++  + 
Sbjct: 15  RLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           H N+++L  V+    +          +L   ++  +  F    +  +  QV +G+ Y+  
Sbjct: 74  HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYR-------APEVL 170
           + + HRDL   NLL+ ++D +KI DFGL R +   P   ++   + +R       APE  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHYVMQEHRKVPFAWCAPES- 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT 194
           L++  +S   D W  G  + E+ T
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           VG G+FG V R   KQ+G   A+KK++ + +  EE V      +   +S P IV L   +
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV------ACAGLSSPRIVPLYGAV 135
Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
           RE   +    E +E  +L QL+K +  C  E     +  Q  +GL Y+H R   H D+K 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 129 ENLLVSKDTIKIA--DFGLA-----REINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKV 180
           +N+L+S D  + A  DFG A       +       +Y+  T  + APEV++      +KV
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKV 253
Query: 181 DMWAMGAIMAELIT 194
           D+W+   +M  ++ 
Sbjct: 254 DIWSSCCMMLHMLN 267

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +L++++GDG+FG V    W A S ++  V A+K +K    S  E ++  +REV ++  + 
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           H N+++L  V+    +          +L   ++  +  F    +  +  QV +G+ Y+  
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYR-------APEVL 170
           + + HRDL   NLL+ ++D +KI DFGL R +   P   ++   + +R       APE  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHYVMQEHRKVPFAWCAPES- 185
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT 194
           L++  +S   D W  G  + E+ T
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 117/239 (48%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
              + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 NTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +L++++GDG+FG V    W A S ++  V A+K +K    S  E ++  +REV ++  + 
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           H N+++L  V+    +          +L   ++  +  F    +  +  QV +G+ Y+  
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYR-------APEVL 170
           + + HRDL   NLL+ ++D +KI DFGL R +   P   ++   + +R       APE  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHYVMQEHRKVPFAWCAPES- 185
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT 194
           L++  +S   D W  G  + E+ T
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 206
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 207 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 263

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 203
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 204 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 260

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYK 201
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 202 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 258

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 122/259 (47%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+   G+ H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 289 KD----RNNRPKFEQIVSI 303

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 94/194 (48%), Gaps = 17/194 (8%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           VG G+FG V R   KQ+G   A+KK++ + +  EE V      +   +S P IV L   +
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV------ACAGLSSPRIVPLYGAV 119
Query: 70  RENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
           RE   +    E +E   L QL+K +  C  E     +  Q  +GL Y+H R   H D+K 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 129 ENLLVSKDTIKIA--DFGLA-----REINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKV 180
           +N+L+S D  + A  DFG A       +       +Y+  T  + APEV++      +KV
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKV 237
Query: 181 DMWAMGAIMAELIT 194
           D+W+   +M  ++ 
Sbjct: 238 DIWSSCCMMLHMLN 251

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 5   KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +L++++GDG+FG V    W A S ++  V A+K +K    S  E ++  +REV ++  + 
Sbjct: 15  RLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLD 73
Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           H N+++L  V+    +          +L   ++  +  F    +  +  QV +G+ Y+  
Sbjct: 74  HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYR-------APEVL 170
           + + HRDL   NLL+ ++D +KI DFGL R +   P   ++   + +R       APE  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL---PQNDDHYVMQEHRKVPFAWCAPES- 189
Query: 171 LQSYLYSSKVDMWAMGAIMAELIT 194
           L++  +S   D W  G  + E+ T
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G GT+G V+      +   +AIK++ ++   + + ++  E+   + + H NIV+     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-EEIALHKHLKHKNIVQYLGSF 88
Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKCFSEAE--VRNWCFQVFQGLAYMHQRGYFHRDL 126
            EN  +    E +   +L  L++ +     + E  +  +  Q+ +GL Y+H     HRD+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 127 KPENLLVS--KDTIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQS-YLYSSKVDM 182
           K +N+L++     +KI+DFG ++ +    P TE +  T  Y APE++ +    Y    D+
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208
Query: 183 WAMGAIMAELITLRPLF 199
           W++G  + E+ T +P F
Sbjct: 209 WSLGCTIIEMATGKPPF 225

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 6   LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL 65
           L +++G G FG V+    +    +VA+K  ++      +   L+E + L++ SHPNIV+L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 66  KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
             V  +   +Y V E ++  +    ++          +         G+ Y+  +   HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237
Query: 125 DLKPENLLVS-KDTIKIADFGLARE----INSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           DL   N LV+ K+ +KI+DFG++RE    + +       V  +W  APE L     YSS+
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT-APEALNYGR-YSSE 295
Query: 180 VDMWAMGAIMAELITL 195
            D+W+ G ++ E  +L
Sbjct: 296 SDVWSFGILLWETFSL 311

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 127/295 (43%), Gaps = 43/295 (14%)
Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL--RKM 57
           ++ YK+  +V G G  G V +  +K++ E  A+K +       ++C   R    L  R  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL-------QDCPKARREVELHWRAS 112
Query: 58  SHPNIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
             P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGE 172
Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    D W++G I   L+   P F         Y    +  +P   +     
Sbjct: 233 EVLGPEK-YDKSCDXWSLGVIXYILLCGYPPF---------YSNHGLAISPGXKT----- 277
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R   Y+FP      +S       ++   LI +L   +P++R T  E   HP+
Sbjct: 278 -RIRXGQYEFPNPEWSEVS-------EEVKXLIRNLLKTEPTQRXTITEFXNHPW 324

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 117/239 (48%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 117/239 (48%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 1   MERYKLIKEVGDGTFGSVW--RAISKQ-SGEVVAIKKMKK-----KYYSWEECVNLREVK 52
           +E ++L+K +G G +G V+  R IS   +G++ A+K +KK     K  + E     R+V 
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 53  SLRKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQ 111
              + S P +V L    +    L+ + +Y+    L+  +  RE+ F+E EV+ +  ++  
Sbjct: 113 EHIRQS-PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVL 170
Query: 112 GLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREI--NSRPPFTEYVSTRWYRAPE 168
            L ++H+ G  +RD+K EN+L+ S   + + DFGL++E   +      ++  T  Y AP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 169 VLLQSYLYSSK-VDMWAMGAIMAELIT 194
           ++        K VD W++G +M EL+T
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 8/196 (4%)
Query: 6   LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL 65
           L +++G G FG V+    +    +VA+K  ++      +   L+E + L++ SHPNIV+L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 66  KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
             V  +   +Y V E ++  +    ++          +         G+ Y+  +   HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237
Query: 125 DLKPENLLVS-KDTIKIADFGLARE----INSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
           DL   N LV+ K+ +KI+DFG++RE    + +       V  +W  APE L     YSS+
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALNYGR-YSSE 295
Query: 180 VDMWAMGAIMAELITL 195
            D+W+ G ++ E  +L
Sbjct: 296 SDVWSFGILLWETFSL 311

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 118/239 (49%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY + EY  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + +IADFGLAR+IN+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 9/207 (4%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR- 119
           IV        +  +    E+M+  +L Q++K   +   E  +      V +GL Y+ ++ 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH 143
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KP N+LV S+  IK+ DFG++ + I+S      +V TR Y +PE  LQ   YS
Sbjct: 144 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYS 200
Query: 178 SKVDMWAMGAIMAELITLR-PLFPGTS 203
            + D+W+MG  + E+   R P+  G+ 
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYPIGSGSG 227

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G+FG V R   KQ+G   A+KK++ + +  EE      + +   ++ P IV L   +
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE------LMACAGLTSPRIVPLYGAV 154
Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
           RE   +    E +E  +L QL+K+ + C  E     +  Q  +GL Y+H R   H D+K 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKE-QGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKA 213
Query: 129 ENLLVSKDTIKIA--DFGLA-----REINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKV 180
           +N+L+S D    A  DFG A       +       +Y+  T  + APEV+L      +KV
Sbjct: 214 DNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC-DAKV 272
Query: 181 DMWAMGAIMAELIT 194
           D+W+   +M  ++ 
Sbjct: 273 DVWSSCCMMLHMLN 286

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMS-HPNIVK 64
           ++++G G FGSV++ + +  G + AIK+ KK    S +E   LREV +   +  H ++V+
Sbjct: 12  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 71
Query: 65  LKEVIRENDILYFVFEYMECN---LYQLMKDREKC---FSEAEVRNWCFQVFQGLAYMHQ 118
                 E+D +    EY  CN   L   + +  +    F EAE+++   QV +GL Y+H 
Sbjct: 72  YFSAWAEDDHMLIQNEY--CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 129
Query: 119 RGYFHRDLKPENLLVSKDTI--------------------KIADFGLAREINSRPPFTEY 158
               H D+KP N+ +S+ +I                    KI D G    I+S  P  E 
Sbjct: 130 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQVEE 187
Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL 198
             +R+  A EVL ++Y +  K D++A+   +       PL
Sbjct: 188 GDSRFL-ANEVLQENYTHLPKADIFALALTVVXAAGAEPL 226

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 17/194 (8%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G+FG V R   KQ+G   A+KK++ + +  EE V      +   +S P IV L   +
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV------ACAGLSSPRIVPLYGAV 133
Query: 70  RENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
           RE   +    E +E   L QL+K +  C  E     +  Q  +GL Y+H R   H D+K 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 192
Query: 129 ENLLVSKDTIKIA--DFGLA-----REINSRPPFTEYV-STRWYRAPEVLLQSYLYSSKV 180
           +N+L+S D  + A  DFG A       +       +Y+  T  + APEV++      +KV
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKV 251
Query: 181 DMWAMGAIMAELIT 194
           D+W+   +M  ++ 
Sbjct: 252 DIWSSCCMMLHMLN 265

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 9/213 (4%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN-- 61
           +  +  +G G+FG V  +  K + E+ A+K +KK     ++ V    V+  R ++ P   
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK-RVLALPGKP 80
Query: 62  --IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
             + +L    +  D LYFV EY+          +   F E     +  ++  GL ++  +
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  +RDLK +N+++ S+  IKIADFG+ +E I        +  T  Y APE++     Y 
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ-PYG 199
Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
             VD WA G ++ E++  +  F G  E DE+++
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 231

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 21/196 (10%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G+FG V R   KQ+G   A+KK++ + +  EE      + +   ++ P IV L   +
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE------LMACAGLTSPRIVPLYGAV 135
Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKP 128
           RE   +    E +E  +L QL+K+ + C  E     +  Q  +GL Y+H R   H D+K 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKE-QGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKA 194
Query: 129 ENLLVSKDTIKIA--DFGLAREINSRPP-------FTEYV-STRWYRAPEVLLQSYLYSS 178
           +N+L+S D    A  DFG A  +  +P          +Y+  T  + APEV+L      +
Sbjct: 195 DNVLLSSDGSHAALCDFGHA--VCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC-DA 251
Query: 179 KVDMWAMGAIMAELIT 194
           KVD+W+   +M  ++ 
Sbjct: 252 KVDVWSSCCMMLHMLN 267

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 144/327 (44%), Gaps = 57/327 (17%)
Query: 6   LIKEVGDGTFGSVWRAISKQSGEVVAIKKMK--KKYYSWEECVNLREVKSLRKMSHPNIV 63
           +I+++GDGTFG V       + +  A+K ++  KKY    +     E   L+K+ + +I 
Sbjct: 39  VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDIN 94
Query: 64  KLKEVIRENDILYF-----VFEYMECNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYMH 117
               V      +Y+     +FE +  +LY+++ ++    F   +++ +C ++ + L Y+ 
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 118 QRGYFHRDLKPENLLV-------------------------SKDT-IKIADFGLAREINS 151
           +    H DLKPEN+L+                         +K T IK+ DFG A   + 
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
                  ++TR YRAPEV+L +  +    DMW+ G ++AEL T   LF      + +  +
Sbjct: 215 Y--HGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271
Query: 212 CSVI----------GTPTQDSW---ADGLLLA---RAINYKFPQLVGVPLSVLMPSANKD 255
            S+I           T T  S     D L LA    A +    + V   L +     ++ 
Sbjct: 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331
Query: 256 AVSLIASLCSWDPSKRPTAAEALQHPF 282
               + S+   DP+ RP+ AE L+H F
Sbjct: 332 FCDFLYSILQIDPTLRPSPAELLKHKF 358

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V E ME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 289 KD----RNNRPKFEQIVSI 303

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V E ME  +L   ++  +  F+  ++      +  G+ Y+   GY H
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 141
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 142 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAIAYRK-FT 199
Query: 178 SKVDMWAMGAIMAELIT 194
           S  D+W+ G ++ E+++
Sbjct: 200 SASDVWSYGIVLWEVMS 216

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 117/239 (48%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY +  Y  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           K+ K +G G FG V     K  G+    VAIK +K  Y   +    L E   + +  HPN
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 91
Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I+ L+ V+ +   +  + EYME  +L   ++  +  F+  ++      +  G+ Y+    
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 151
Query: 121 YFHRDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSY 174
             HRDL   N+LV+ + + K++DFG++R +   P   +T     +  RW  APE +    
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT-APEAIAYRK 210
Query: 175 LYSSKVDMWAMGAIMAELIT 194
            ++S  D+W+ G +M E+++
Sbjct: 211 -FTSASDVWSYGIVMWEVMS 229

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 133/309 (43%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 183
Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +  
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 244 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 299
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 300 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 332
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 333 PTFSELVEH 341

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 7/206 (3%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE---ECVNLREVKSLRKMSHPNIVKLK 66
           +G G+FG V  +  K + E+ A+K +KK     +   EC  + +         P + +L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 67  EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
              +  D LYFV EY+          +   F E     +  ++  GL ++  +G  +RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 127 KPENLLV-SKDTIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWA 184
           K +N+++ S+  IKIADFG+ +E I        +  T  Y APE++     Y   VD WA
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ-PYGKSVDWWA 527
Query: 185 MGAIMAELITLRPLFPGTSEADEIYK 210
            G ++ E++  +  F G  E DE+++
Sbjct: 528 FGVLLYEMLAGQAPFEGEDE-DELFQ 552

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 133/309 (43%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +  
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 207 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 262
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 263 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 295
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 296 PTFSELVEH 304

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMS-HPNIVK 64
           ++++G G FGSV++ + +  G + AIK+ KK    S +E   LREV +   +  H ++V+
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 65  LKEVIRENDILYFVFEYMECN---LYQLMKDREKC---FSEAEVRNWCFQVFQGLAYMHQ 118
                 E+D +    EY  CN   L   + +  +    F EAE+++   QV +GL Y+H 
Sbjct: 74  YFSAWAEDDHMLIQNEY--CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 131
Query: 119 RGYFHRDLKPENLLVSKDTI--------------------KIADFGLAREINSRPPFTEY 158
               H D+KP N+ +S+ +I                    KI D G    I+S  P  E 
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQVEE 189
Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL 198
             +R+  A EVL ++Y +  K D++A+   +       PL
Sbjct: 190 GDSRFL-ANEVLQENYTHLPKADIFALALTVVCAAGAEPL 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 117/239 (48%), Gaps = 31/239 (12%)
Query: 2   ERYKLIKEVGDGTFGSVWRAIS------KQSGEVVAIKKMKKKYYSWEECVNLREVKSLR 55
           ++  L K +G+G FG V  A +      K    V    KM K   + ++  +L     + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 56  KM--SHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDR---------------EKCF 97
           KM   H NI+ L     ++  LY +  Y  + NL + ++ R               E+  
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFT 156
           +  ++ +  +Q+ +G+ Y+  +   HRDL   N+LV+++ + KIADFGLAR+IN+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 157 EYVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKI 211
           +  + R    + APE L    +Y+ + D+W+ G +M E+ TL    +PG    +E++K+
Sbjct: 215 KTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMS-HPNIVK 64
           ++++G G FGSV++ + +  G + AIK+ KK    S +E   LREV +   +  H ++V+
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 65  LKEVIRENDILYFVFEYMECN---LYQLMKDREKC---FSEAEVRNWCFQVFQGLAYMHQ 118
                 E+D +    EY  CN   L   + +  +    F EAE+++   QV +GL Y+H 
Sbjct: 76  YFSAWAEDDHMLIQNEY--CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 119 RGYFHRDLKPENLLVSKDTI--------------------KIADFGLAREINSRPPFTEY 158
               H D+KP N+ +S+ +I                    KI D G    I+S  P  E 
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQVEE 191
Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL 198
             +R+  A EVL ++Y +  K D++A+   +       PL
Sbjct: 192 GDSRFL-ANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMS-HPNIVK 64
           ++++G G FGSV++ + +  G + AIK+ KK    S +E   LREV +   +  H ++V+
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 65  LKEVIRENDILYFVFEYMECN---LYQLMKDREKC---FSEAEVRNWCFQVFQGLAYMHQ 118
                 E+D +    EY  CN   L   + +  +    F EAE+++   QV +GL Y+H 
Sbjct: 74  YFSAWAEDDHMLIQNEY--CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 131
Query: 119 RGYFHRDLKPENLLVSKDTI--------------------KIADFGLAREINSRPPFTEY 158
               H D+KP N+ +S+ +I                    KI D G    I+S  P  E 
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQVEE 189
Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL 198
             +R+  A EVL ++Y +  K D++A+   +       PL
Sbjct: 190 GDSRFL-ANEVLQENYTHLPKADIFALALTVVCAAGAEPL 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 42/295 (14%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK-SLRKMSHP 60
           E  K + E+G G +GSV + + K SG+++A+K+++      E+   L ++   +R    P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 61  NIVKL-KEVIREND------ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
            IV+    + RE D      ++   F+     +Y ++ D      E  +        + L
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD---VIPEEILGKITLATVKAL 138
Query: 114 AYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            ++ +     HRD+KP N+L+ +   IK+ DFG++ ++      T     R Y APE + 
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 172 QSYL---YSSKVDMWAMGAIMAELITLRPLFPG-TSEADEIYKICSVIGTPTQDSWADGL 227
            S     Y  + D+W++G  + EL T R  +P   S  D++ ++  V G P Q S ++  
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDPPQLSNSE-- 254
Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              R  +  F   V + L+                    D SKRP   E L+HPF
Sbjct: 255 --EREFSPSFINFVNLCLTK-------------------DESKRPKYKELLKHPF 288

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 59/307 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQ-SGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K  +   VA+K +K+     E    + E+K L  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +  +         
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 105 ----WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYV 159
               + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P      
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 160 STRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVI 215
             R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C  +
Sbjct: 209 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 264
Query: 216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPT 273
              T+          RA +Y  P++    L                    W  +PS+RPT
Sbjct: 265 KEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQRPT 297
Query: 274 AAEALQH 280
            +E ++H
Sbjct: 298 FSELVEH 304

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 133/309 (43%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +  
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 198 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 253
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 254 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 286
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 287 PTFSELVEH 295

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 132/305 (43%), Gaps = 57/305 (18%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQ-SGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R  L K +G G FG V  A    I K  +   VA+K +K+     E    + E+K L  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYMEC-----------NLYQLMKDREKCFSEAE-V 102
           + H  N+V L     +    L  + E+ +            N +   KD  K F   E +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 103 RNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVST 161
             + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +      
Sbjct: 147 ICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 162 RW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGT 217
           R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C  +  
Sbjct: 207 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKE 262
Query: 218 PTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAA 275
            T+          RA +Y  P++    L                    W  +PS+RPT +
Sbjct: 263 GTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQRPTFS 295
Query: 276 EALQH 280
           E ++H
Sbjct: 296 ELVEH 300

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 133/309 (43%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +  
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 198 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 253
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 254 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 286
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 287 PTFSELVEH 295

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVV----AIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K +K +G G FG+V++ I    GE V    AIK + +          + E   +  M HP
Sbjct: 41  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 100
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++V+L  V     I           L + + + +       + NWC Q+ +G+ Y+ +R 
Sbjct: 101 HLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 160
Query: 121 YFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQS 173
             HRDL   N+LV S + +KI DFGLAR +       EY      +  +W     +  + 
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE--KEYNADGGKMPIKWMALECIHYRK 218
Query: 174 YLYSSKVDMWAMGAIMAELIT 194
           + + S  D+W+ G  + EL+T
Sbjct: 219 FTHQS--DVWSYGVTIWELMT 237

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 9   EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLRE-VKSLRKMSHPNIVKL-- 65
           E+G G+F +V++ +  ++   VA  +++ +  +  E    +E  + L+ + HPNIV+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 66  --KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG--Y 121
             +  ++    +  V E       +    R K      +R+WC Q+ +GL ++H R    
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 122 FHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYV-STRWYRAPEVLLQSYLYSS 178
            HRDLK +N+ ++  T  +KI D GLA     R  F + V  T  + APE   + Y  S 
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLA--TLKRASFAKAVIGTPEFXAPEXYEEKYDES- 209
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
            VD++A G    E  T    +     A +IY+
Sbjct: 210 -VDVYAFGXCXLEXATSEYPYSECQNAAQIYR 240

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR---EVKSLRKMS 58
           +RY+L + +G G    V  A   +    VA+K ++    + +    LR   E ++   ++
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALN 70
Query: 59  HPNIVKLKEV----IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           HP IV + +          + Y V EY++    + +   E   +            Q L 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 115 YMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREI----NSRPPFTEYVSTRWYRAPEV 169
           + HQ G  HRD+KP N+L+S  + +K+ DFG+AR I    NS       + T  Y +PE 
Sbjct: 131 FSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
                +  ++ D++++G ++ E++T  P F G S     Y+
Sbjct: 191 ARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVV----AIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K +K +G G FG+V++ I    GE V    AIK + +          + E   +  M HP
Sbjct: 18  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 77
Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++V+L  V     I           L + + + +       + NWC Q+ +G+ Y+ +R 
Sbjct: 78  HLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 137
Query: 121 YFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQS 173
             HRDL   N+LV S + +KI DFGLAR +       EY      +  +W     +  + 
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE--KEYNADGGKMPIKWMALECIHYRK 195
Query: 174 YLYSSKVDMWAMGAIMAELIT 194
           + + S  D+W+ G  + EL+T
Sbjct: 196 FTHQS--DVWSYGVTIWELMT 214

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVW----RAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+    R I K   E  VA+K + +     E    L E   ++ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++ + + HRDL   N +V+ D T+KI DFG+ R+I      R      +  
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 197 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 228

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 126/276 (45%), Gaps = 27/276 (9%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK----- 56
           + +++++ +G G+FG V       + ++ A+K M K     ++CV   EV+++ K     
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-----QKCVERNEVRNVFKELQIM 69
Query: 57  --MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
             + HP +V L    ++ + ++ V + +     +    +   F E  V+ +  ++   L 
Sbjct: 70  QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL--L 171
           Y+  +   HRD+KP+N+L+ +   + I DF +A  +      T    T+ Y APE+    
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189
Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLF---PGTSEADEIYKI-CSVIGTPTQDSWADGL 227
           +   YS  VD W++G    EL+  R  +     TS  + ++    +V+  P+  +W+  +
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--AWSQEM 247
Query: 228 ------LLARAINYKFPQLVGVPLSVLMPSANKDAV 257
                 LL    + +F QL  V     M   N DAV
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 132/309 (42%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P    
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 207 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 262
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 263 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 295
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 296 PTFSELVEH 304

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 50/289 (17%)
Query: 10  VGDGTFGS-VWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKE 67
           +G G  G+ V+R +       VA+K++  + +S+ +    REV+ LR+   HPN+++   
Sbjct: 32  LGHGAEGTIVYRGMFDNRD--VAVKRILPECFSFAD----REVQLLRESDEHPNVIRYFC 85
Query: 68  VIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLK 127
             ++    Y   E     L + ++ ++      E      Q   GLA++H     HRDLK
Sbjct: 86  TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLK 145
Query: 128 PENLLVS------KDTIKIADFGLAREIN-SRPPFTEYV---STRWYRAPEVLLQSYLYS 177
           P N+L+S      K    I+DFGL +++   R  F+       T  + APE+L +    +
Sbjct: 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKEN 205
Query: 178 S--KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
               VD+++ G +   +I                         ++ S   G  L R  N 
Sbjct: 206 PTYTVDIFSAGCVFYYVI-------------------------SEGSHPFGKSLQRQANI 240
Query: 236 KFPQLVGVPLSVLMPSANKDAVS--LIASLCSWDPSKRPTAAEALQHPF 282
               L    L  L P  ++D ++  LI  + + DP KRP+A   L+HPF
Sbjct: 241 ---LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 132/309 (42%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P    
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 198 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 253
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 254 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 286
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 287 PTFSELVEH 295

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK--------KYYSWEECVNLREVKS 53
           E Y+++K +G G FG V     K + +V A+K + K          + WEE    R++ +
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 129
Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQG 112
               + P +V+L    +++  LY V EYM   +L  LM + +    E   R +  +V   
Sbjct: 130 F--ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLA 185
Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPF--TEYVSTRWYRAPEV 169
           L  +H  G+ HRD+KP+N+L+ K   +K+ADFG   ++N          V T  Y +PEV
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 170 LLQ---SYLYSSKVDMWAMGAIMAELI 193
           L        Y  + D W++G  + E++
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVW----RAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+    R I K   E  VA+K + +     E    L E   ++ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++ + + HRDL   N +V+ D T+KI DFG+ R+I      R      +  
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 197 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 228

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK--------KYYSWEECVNLREVKS 53
           E Y+++K +G G FG V     K + +V A+K + K          + WEE    R++ +
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 129
Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQG 112
               + P +V+L    +++  LY V EYM   +L  LM + +    E   R +  +V   
Sbjct: 130 F--ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLA 185
Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPF--TEYVSTRWYRAPEV 169
           L  +H  G+ HRD+KP+N+L+ K   +K+ADFG   ++N          V T  Y +PEV
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 170 LLQ---SYLYSSKVDMWAMGAIMAELI 193
           L        Y  + D W++G  + E++
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVW----RAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+    R I K   E  VA+K + +     E    L E   ++ 
Sbjct: 14  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 73
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 74  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 133
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++ + + HRDL   N +V+ D T+KI DFG+ R+I      R      +  
Sbjct: 134 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 194 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 225

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 134/309 (43%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCF---SEA---------- 100
           + H  N+V L     +    L  + E+ +  NL   ++ +   F    EA          
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 101 --EVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
              +  + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +  
Sbjct: 149 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 208
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 209 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 264
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 265 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 297
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 298 PTFSELVEH 306

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK--------KYYSWEECVNLREVKS 53
           E Y+++K +G G FG V     K + +V A+K + K          + WEE    R++ +
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 124
Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQG 112
               + P +V+L    +++  LY V EYM   +L  LM + +    E   R +  +V   
Sbjct: 125 F--ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLA 180
Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPF--TEYVSTRWYRAPEV 169
           L  +H  G+ HRD+KP+N+L+ K   +K+ADFG   ++N          V T  Y +PEV
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 170 LLQ---SYLYSSKVDMWAMGAIMAELI 193
           L        Y  + D W++G  + E++
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 132/309 (42%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P    
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 198 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 253
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 254 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 286
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 287 PTFSELVEH 295

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 6   LIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L +E+G+G FG V+ A       +Q   +VA+K +K    +  +  + RE + L  + H 
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQHE 75
Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMK------------DREKCFSEAEVRNWCF 107
           +IVK   V  E D L  VFEYM+  +L + ++            +     +++++ +   
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTR 162
           Q+  G+ Y+  + + HRDL   N LV ++  +KI DFG++R++ S    R      +  R
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           W     ++ +   ++++ D+W++G ++ E+ T
Sbjct: 196 WMPPESIMYRK--FTTESDVWSLGVVLWEIFT 225

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKE 67
           +G G FG V+    K +G++ A KK+ KK     +     + E K L K+    IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 68  VIRENDILYFVFEYMEC-----NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
                  L  V   M       ++Y + +D    F E     +  Q+  GL ++HQR   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKV 180
           +RDLKPEN+L+  D  ++I+D GLA E+ +    T+ Y  T  + APE+LL    Y   V
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSV 370
Query: 181 DMWAMGAIMAELITLRPLFPGTSE 204
           D +A+G  + E+I  R  F    E
Sbjct: 371 DYFALGVTLYEMIAARGPFRARGE 394

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKE 67
           +G G FG V+    K +G++ A KK+ KK     +     + E K L K+    IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 68  VIRENDILYFVFEYMEC-----NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
                  L  V   M       ++Y + +D    F E     +  Q+  GL ++HQR   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKV 180
           +RDLKPEN+L+  D  ++I+D GLA E+ +    T+ Y  T  + APE+LL    Y   V
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSV 370
Query: 181 DMWAMGAIMAELITLRPLFPGTSE 204
           D +A+G  + E+I  R  F    E
Sbjct: 371 DYFALGVTLYEMIAARGPFRARGE 394

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKE 67
           +G G FG V+    K +G++ A KK+ KK     +     + E K L K+    IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 68  VIRENDILYFVFEYMEC-----NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
                  L  V   M       ++Y + +D    F E     +  Q+  GL ++HQR   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKV 180
           +RDLKPEN+L+  D  ++I+D GLA E+ +    T+ Y  T  + APE+LL    Y   V
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSV 370
Query: 181 DMWAMGAIMAELITLRPLFPGTSE 204
           D +A+G  + E+I  R  F    E
Sbjct: 371 DYFALGVTLYEMIAARGPFRARGE 394

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 30  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 85
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  +G+ Y+H +   HRD
Sbjct: 86  MGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 126 LKPENLLVSKD-TIKIADFGLAREI---NSRPPFTEYVSTRWYRAPEV--LLQSYLYSSK 179
           LK  N+ + +D T+KI DFGLA E    +    F +   +  + APEV  +  S  YS +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICS 213
            D++A G ++ EL+T +  +   +  D+I ++  
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR---EVKSLRKMS 58
           +RY+L + +G G    V  A   +    VA+K ++    + +    LR   E ++   ++
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALN 70
Query: 59  HPNIVKLKEV----IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           HP IV + +          + Y V EY++    + +   E   +            Q L 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 115 YMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREI----NSRPPFTEYVSTRWYRAPEV 169
           + HQ G  HRD+KP N+++S  + +K+ DFG+AR I    NS       + T  Y +PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
                +  ++ D++++G ++ E++T  P F G S     Y+
Sbjct: 191 ARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 132/309 (42%), Gaps = 61/309 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRN--------- 104
           + H  N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P    
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 158 YVSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICS 213
               R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C 
Sbjct: 207 KGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 262
Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKR 271
            +   T+          RA +Y  P++    L                    W  +PS+R
Sbjct: 263 RLKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQR 295
Query: 272 PTAAEALQH 280
           PT +E ++H
Sbjct: 296 PTFSELVEH 304

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 111/224 (49%), Gaps = 36/224 (16%)
Query: 6   LIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L K +G+G FG V +A +     +     VA+K +K+     E    L E   L++++HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMKDR-----------------------EKC 96
           +++KL     ++  L  + EY +  +L   +++                        E+ 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 97  FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF 155
            +  ++ ++ +Q+ QG+ Y+ +    HRDL   N+LV++   +KI+DFGL+R++     +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 156 TE----YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            +     +  +W  A E L   ++Y+++ D+W+ G ++ E++TL
Sbjct: 207 VKRSQGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNIVKLKE 67
           +G G FG V+    K +G++ A KK+ KK     +     + E K L K+    IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 68  VIRENDILYFVFEYMEC-----NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
                  L  V   M       ++Y + +D    F E     +  Q+  GL ++HQR   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLYSSKV 180
           +RDLKPEN+L+  D  ++I+D GLA E+ +    T+ Y  T  + APE+LL    Y   V
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSV 370
Query: 181 DMWAMGAIMAELITLRPLFPGTSE 204
           D +A+G  + E+I  R  F    E
Sbjct: 371 DYFALGVTLYEMIAARGPFRARGE 394

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 132/304 (43%), Gaps = 55/304 (18%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQ-SGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R  L K +G G FG V  A    I K  +   VA+K +K+     E    + E+K L  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYMEC-----------NLYQLMKDREKCFSEAE-V 102
           + H  N+V L     +    L  + E+ +            N +   KD  K F   E +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 103 RNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVST 161
             + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +      
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 162 RW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGT 217
           R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E  +       
Sbjct: 207 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXR------- 258
Query: 218 PTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLC-SWDPSKRPTAAE 276
                  +G  + RA +Y  P++    L                  C   +PS+RPT +E
Sbjct: 259 ----RLKEGTRM-RAPDYTTPEMYQTMLD-----------------CWHGEPSQRPTFSE 296
Query: 277 ALQH 280
            ++H
Sbjct: 297 LVEH 300

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVW----RAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+    R I K   E  VA+K + +     E    L E   ++ 
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 75
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 76  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 135
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++ + + HRDL   N +V+ D T+KI DFG+ R+I      R      +  
Sbjct: 136 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 196 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVW----RAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+    R I K   E  VA+K + +     E    L E   ++ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++ + + HRDL   N +V+ D T+KI DFG+ R+I      R      +  
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV 196
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 197 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 228

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 30  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 85
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  +G+ Y+H +   HRD
Sbjct: 86  MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 126 LKPENLLVSKD-TIKIADFGLAREI---NSRPPFTEYVSTRWYRAPEV--LLQSYLYSSK 179
           LK  N+ + +D T+KI DFGLA E    +    F +   +  + APEV  +  S  YS +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICS 213
            D++A G ++ EL+T +  +   +  D+I ++  
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E ME   +L+  + +R     E   R++ +QV + +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITER-GALQEELARSFFWQVLEAV 127
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 186
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMV 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 14  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 69
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 70  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 126 LKPENLLVSKD-TIKIADFGLAREI---NSRPPFTEYVSTRWYRAPEV--LLQSYLYSSK 179
           LK  N+ + +D T+KI DFGLA E    +    F +   +  + APEV  +     YS +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEI 208
            D++A G ++ EL+T +  +   +  D+I
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVW----RAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+    R I K   E  VA+K + +     E    L E   ++ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++ + + HRDL   N +V+ D T+KI DFG+ R+I      R      +  
Sbjct: 137 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 197 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 228

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 7   IKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           +K +G G FG+V++ I    GE     VAIK +++          L E   +  +  P +
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 63  VKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            +L  +   + +   V + M   C L  + ++R +  S+ ++ NWC Q+ +G++Y+    
Sbjct: 82  SRLLGICLTSTV-QLVTQLMPYGCLLDHVRENRGRLGSQ-DLLNWCMQIAKGMSYLEDVR 139
Query: 121 YFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQS 173
             HRDL   N+LV S + +KI DFGLAR ++     TEY      V  +W     +L + 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE--TEYHADGGKVPIKWMALESILRRR 197
Query: 174 YLYSSKVDMWAMGAIMAELIT 194
           + + S  D+W+ G  + EL+T
Sbjct: 198 FTHQS--DVWSYGVTVWELMT 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 14/214 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR---EVKSLRKMS 58
           +RY+L + +G G    V  A   +    VA+K ++    + +    LR   E ++   ++
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALN 70
Query: 59  HPNIVKLKEV----IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           HP IV + +          + Y V EY++    + +   E   +            Q L 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 115 YMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREI----NSRPPFTEYVSTRWYRAPEV 169
           + HQ G  HRD+KP N+++S  + +K+ DFG+AR I    NS       + T  Y +PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS 203
                +  ++ D++++G ++ E++T  P F G S
Sbjct: 191 ARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 14/215 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 18  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 73
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  +G+ Y+H +   HRD
Sbjct: 74  MGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 133
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSR----PPFTEYVSTRWYRAPEV--LLQSYLYSS 178
           LK  N+ + +D T+KI DFGLA  + SR      F +   +  + APEV  +  S  YS 
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS 213
           + D++A G ++ EL+T +  +   +  D+I ++  
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 227

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 29/259 (11%)
Query: 8   KEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  HPNI++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L+ V+ ++  +  V E ME  +L   ++  +  F+  ++      +  G+ Y+   G  H
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVH 170
Query: 124 RDLKPENLLVSKDTI-KIADFGLAREINSRP--PFTEY---VSTRWYRAPEVLLQSYLYS 177
           RDL   N+L++ + + K++DFGL+R +   P   +T     +  RW  +PE +     ++
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT-SPEAIAYRK-FT 228
Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSE-----ADEIYKICSVIGTPTQ------DSWA 224
           S  D+W+ G ++ E+++   RP +  +++      DE Y++   +  P        D W 
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQ 288
Query: 225 DGLLLARAINYKFPQLVGV 243
                 R    KF Q+V +
Sbjct: 289 KD----RNNRPKFEQIVSI 303

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 81  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L 
Sbjct: 140 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 197
Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + Y + S  D+W+ G  + EL+T 
Sbjct: 198 RIYTHQS--DVWSYGVTVWELMTF 219

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 34  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 89
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 90  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 149
Query: 126 LKPENLLVSKD-TIKIADFGLAREI---NSRPPFTEYVSTRWYRAPEV--LLQSYLYSSK 179
           LK  N+ + +D T+KI DFGLA E    +    F +   +  + APEV  +     YS +
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEI 208
            D++A G ++ EL+T +  +   +  D+I
Sbjct: 210 SDVYAFGIVLYELMTGQLPYSNINNRDQI 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-YSWEECVNL--REVKSLRKMSHPNIVK 64
            ++G+G FG V++     +   VA+KK+      + EE      +E+K + K  H N+V+
Sbjct: 37  NKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQ------VFQGLAYMHQ 118
           L     + D L  V+ YM       + DR  C       +W  +         G+ ++H+
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGS---LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAR---EINSRPPFTEYVSTRWYRAPEVLLQSY 174
             + HRD+K  N+L+ +  T KI+DFGLAR   +       +  V T  Y APE L    
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE- 210
Query: 175 LYSSKVDMWAMGAIMAELITLRP 197
             + K D+++ G ++ E+IT  P
Sbjct: 211 -ITPKSDIYSFGVVLLEIITGLP 232

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 6   LIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L K +G+G FG V +A +     +     VA+K +K+     E    L E   L++++HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMKDR-----------------------EKC 96
           +++KL     ++  L  + EY +  +L   +++                        E+ 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 97  FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF 155
            +  ++ ++ +Q+ QG+ Y+ +    HRDL   N+LV++   +KI+DFGL+R++      
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 156 TE----YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            +     +  +W  A E L   ++Y+++ D+W+ G ++ E++TL
Sbjct: 207 VKRSQGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 80  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L 
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 196
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           + Y + S  D+W+ G  + EL+T
Sbjct: 197 RIYTHQS--DVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 79  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L 
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 195
Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + Y + S  D+W+ G  + EL+T 
Sbjct: 196 RIYTHQS--DVWSYGVTVWELMTF 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 78  PHVCRLLGICLTSTV-QLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L 
Sbjct: 137 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 194
Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + Y + S  D+W+ G  + EL+T 
Sbjct: 195 RIYTHQS--DVWSYGVTVWELMTF 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 78  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L 
Sbjct: 137 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 194
Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + Y + S  D+W+ G  + EL+T 
Sbjct: 195 RIYTHQS--DVWSYGVTVWELMTF 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR---EVKSLRKMS 58
           +RY+L + +G G    V  A   +    VA+K ++    + +    LR   E ++   ++
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALN 87
Query: 59  HPNIVKLKEV----IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           HP IV + +          + Y V EY++    + +   E   +            Q L 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 147
Query: 115 YMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREI----NSRPPFTEYVSTRWYRAPEV 169
           + HQ G  HRD+KP N+++S  + +K+ DFG+AR I    NS       + T  Y +PE 
Sbjct: 148 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
                +  ++ D++++G ++ E++T  P F G S     Y+
Sbjct: 208 ARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 247

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 77  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L 
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 193
Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + Y + S  D+W+ G  + EL+T 
Sbjct: 194 RIYTHQS--DVWSYGVTVWELMTF 215

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 16  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 71
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 72  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 131
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSR----PPFTEYVSTRWYRAPEV--LLQSYLYSS 178
           LK  N+ + +D T+KI DFGLA  + SR      F +   +  + APEV  +     YS 
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEI 208
           + D++A G ++ EL+T +  +   +  D+I
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNINNRDQI 220

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-YSWEECVNL--REVKSLRKMSHPNIVK 64
            ++G+G FG V++     +   VA+KK+      + EE      +E+K + K  H N+V+
Sbjct: 31  NKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 88
Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQ------VFQGLAYMHQ 118
           L     + D L  V+ YM       + DR  C       +W  +         G+ ++H+
Sbjct: 89  LLGFSSDGDDLCLVYVYMPNGS---LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 145
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
             + HRD+K  N+L+ +  T KI+DFGLAR   +   F +       V T  Y APE L 
Sbjct: 146 NHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQXVMXXRIVGTTAYMAPEALR 202
Query: 172 QSYLYSSKVDMWAMGAIMAELITLRP 197
                + K D+++ G ++ E+IT  P
Sbjct: 203 GE--ITPKSDIYSFGVVLLEIITGLP 226

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 14  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 69
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 70  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSR----PPFTEYVSTRWYRAPEV--LLQSYLYSS 178
           LK  N+ + +D T+KI DFGLA  + SR      F +   +  + APEV  +     YS 
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEI 208
           + D++A G ++ EL+T +  +   +  D+I
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 195 IYTHQS--DVWSYGVTVWELMTF 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 19  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 74
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 75  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSR----PPFTEYVSTRWYRAPEV--LLQSYLYSS 178
           LK  N+ + +D T+KI DFGLA  + SR      F +   +  + APEV  +     YS 
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEI 208
           + D++A G ++ EL+T +  +   +  D+I
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 42  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 97
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 98  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 126 LKPENLLVSKD-TIKIADFGLAREI---NSRPPFTEYVSTRWYRAPEV--LLQSYLYSSK 179
           LK  N+ + +D T+KI DFGLA E    +    F +   +  + APEV  +     YS +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEI 208
            D++A G ++ EL+T +  +   +  D+I
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 2   ERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           + Y+L K+V G G  G V     +++G+  A+K +     + +E  +       +    P
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDH-----HWQASGGP 82
Query: 61  NIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLA 114
           +IV + +V          L  + E ME   L+  +++R ++ F+E E       +   + 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 115 YMHQRGYFHRDLKPENLLVS---KDTI-KIADFGLAREINSR----PPFTEYVSTRWYRA 166
           ++H     HRD+KPENLL +   KD + K+ DFG A+E        P +T Y     Y A
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-----YVA 197
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
           PEVL     Y    DMW++G IM  L+    P +  T +A                  + 
Sbjct: 198 PEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQA-----------------ISP 239
Query: 226 GL-LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           G+    R   Y FP      +S       +DA  LI  L   DP++R T  + + HP+
Sbjct: 240 GMKRRIRLGQYGFPNPEWSEVS-------EDAKQLIRLLLKTDPTERLTITQFMNHPW 290

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 19  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 74
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 75  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSR----PPFTEYVSTRWYRAPEV--LLQSYLYSS 178
           LK  N+ + +D T+KI DFGLA  + SR      F +   +  + APEV  +     YS 
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEI 208
           + D++A G ++ EL+T +  +   +  D+I
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 2   ERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           + Y+L K+V G G  G V     +++G+  A+K +     + +E  +       +    P
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDH-----HWQASGGP 63
Query: 61  NIVKLKEVIRE----NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLA 114
           +IV + +V          L  + E ME   L+  +++R ++ F+E E       +   + 
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 123
Query: 115 YMHQRGYFHRDLKPENLLVS---KDTI-KIADFGLAREINSR----PPFTEYVSTRWYRA 166
           ++H     HRD+KPENLL +   KD + K+ DFG A+E        P +T Y     Y A
Sbjct: 124 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-----YVA 178
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
           PEVL     Y    DMW++G IM  L+    P +  T +A                  + 
Sbjct: 179 PEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQA-----------------ISP 220
Query: 226 GL-LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           G+    R   Y FP      +S       +DA  LI  L   DP++R T  + + HP+
Sbjct: 221 GMKRRIRLGQYGFPNPEWSEVS-------EDAKQLIRLLLKTDPTERLTITQFMNHPW 271

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY-YSWEECVNL--REVKSLRKMSHPNIVK 64
            ++G+G FG V++     +   VA+KK+      + EE      +E+K + K  H N+V+
Sbjct: 37  NKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQ------VFQGLAYMHQ 118
           L     + D L  V+ YM       + DR  C       +W  +         G+ ++H+
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGS---LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
             + HRD+K  N+L+ +  T KI+DFGLAR   +   F +       V T  Y APE L 
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQTVMXXRIVGTTAYMAPEALR 208
Query: 172 QSYLYSSKVDMWAMGAIMAELITLRP 197
                + K D+++ G ++ E+IT  P
Sbjct: 209 GE--ITPKSDIYSFGVVLLEIITGLP 232

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           ER+ K I ++G G FGSV    +  +   +G +VA+K+++      +     RE++ L+ 
Sbjct: 9   ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ-REIQILKA 67
Query: 57  MSHPNIVKLKEVI--RENDILYFVFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQGL 113
           +    IVK + V        L  V EY+     +    R +     + +  +  Q+ +G+
Sbjct: 68  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 127
Query: 114 AYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR--------WY 164
            Y+  R   HRDL   N+LV S+  +KIADFGLA+ +   P   +Y   R        WY
Sbjct: 128 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL---PLDKDYYVVREPGQSPIFWY 184
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
            APE L  + ++S + D+W+ G ++ EL T
Sbjct: 185 -APESLSDN-IFSRQSDVWSFGVVLYELFT 212

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 74  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 191
Query: 173 SYLYSSKVDMWAMGAIMAELIT 194
            Y + S  D+W+ G  + EL+T
Sbjct: 192 IYTHQS--DVWSYGVTVWELMT 211

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 120/284 (42%), Gaps = 35/284 (12%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH--PNIVK 64
           + E+G GT G VW+   +++G V+A+K+M++     E    L ++  + K SH  P IV+
Sbjct: 30  LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLK-SHDCPYIVQ 88
Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFH 123
                  N  ++   E M     +L K  +    E  +      + + L Y+ ++ G  H
Sbjct: 89  CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148
Query: 124 RDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL----LQSYLYSS 178
           RD+KP N+L+  +  IK+ DFG++  +              Y APE +         Y  
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           + D+W++G  + EL T +  FP        YK C            D  +L + +  + P
Sbjct: 209 RADVWSLGISLVELATGQ--FP--------YKNCKT----------DFEVLTKVLQEEPP 248
Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            L G          + D  S +    + D  KRP   + L+H F
Sbjct: 249 LLPG------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 133/308 (43%), Gaps = 60/308 (19%)
Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R  L K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 57  MSHP-NIVKL-KEVIRENDILYFVFEYME-CNL-------------YQLMKDREKCFSEA 100
           + H  N+V L     +    L  + E+ +  NL             Y+  +D  K F   
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 101 E-VRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEY 158
           E +  + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P     
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 159 VSTRW---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSV 214
              R    + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C  
Sbjct: 208 GDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRR 263
Query: 215 IGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRP 272
           +   T+          RA +Y  P++    L                    W  +PS+RP
Sbjct: 264 LKEGTR---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQRP 296
Query: 273 TAAEALQH 280
           T +E ++H
Sbjct: 297 TFSELVEH 304

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 123/295 (41%), Gaps = 42/295 (14%)
Query: 7   IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK-SLRKMSHPNIVKL 65
           I E+G G +G V +     SG++ A+K+++    S E+   L ++  S R +  P  V  
Sbjct: 39  IXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 66  -KEVIRENDILYFVFEYMECNL---YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-G 120
              + RE D+ +   E  + +L   Y+ + D+ +   E  +      + + L ++H +  
Sbjct: 99  YGALFREGDV-WICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 121 YFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL---LQSYLY 176
             HRD+KP N+L++    +K  DFG++  +            + Y APE +   L    Y
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S K D+W++G    EL  LR  FP  S            GTP Q        L + +   
Sbjct: 218 SVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ-------LKQVVEEP 257
Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH 291
            PQL     S        + V   +     +  +RPT  E  QHPF    F  H 
Sbjct: 258 SPQLPADKFSA-------EFVDFTSQCLKKNSKERPTYPELXQHPF----FTLHE 301

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           ER+ K I ++G G FGSV    +  +   +G +VA+K+++      +     RE++ L+ 
Sbjct: 22  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ-REIQILKA 80
Query: 57  MSHPNIVKLKEVI--RENDILYFVFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQGL 113
           +    IVK + V        L  V EY+     +    R +     + +  +  Q+ +G+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 114 AYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR--------WY 164
            Y+  R   HRDL   N+LV S+  +KIADFGLA+ +   P   +Y   R        WY
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL---PLDKDYYVVREPGQSPIFWY 197
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
            APE L  + ++S + D+W+ G ++ EL T
Sbjct: 198 -APESLSDN-IFSRQSDVWSFGVVLYELFT 225

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 83  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 200
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 201 IYTHQS--DVWSYGVTVWELMTF 221

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 176
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 177 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 234
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 235 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 264

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR---EVKSLRKMS 58
           +RY+L + +G G    V  A   +    VA+K ++    + +    LR   E ++   ++
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALN 70
Query: 59  HPNIVKLKEV----IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           HP IV + +          + Y V EY++    + +   E   +            Q L 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 115 YMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREI----NSRPPFTEYVSTRWYRAPEV 169
           + HQ G  HRD+KP N+++S  + +K+ DFG+AR I    NS       + T  Y +PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
                +  ++ D++++G ++ E++T  P F G S     Y+
Sbjct: 191 ARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 197
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 198 IYTHQS--DVWSYGVTVWELMTF 218

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 6   LIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L K +G+G FG V +A +     +     VA+K +K+     E    L E   L++++HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMKDR-----------------------EKC 96
           +++KL     ++  L  + EY +  +L   +++                        E+ 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 97  FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF 155
            +  ++ ++ +Q+ QG+ Y+ +    HRDL   N+LV++   +KI+DFGL+R++      
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 156 TE----YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            +     +  +W  A E L   ++Y+++ D+W+ G ++ E++TL
Sbjct: 207 VKRSQGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 175
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 176 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 233
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 234 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 263

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 201
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 202 IYTHQS--DVWSYGVTVWELMTF 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 197
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 198 IYTHQS--DVWSYGVTVWELMTF 218

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 149
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 150 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 207
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 208 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 237

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 196
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 197 IYTHQS--DVWSYGVTVWELMTF 217

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           ER+ K I ++G G FGSV    +  +   +G +VA+K+++      +     RE++ L+ 
Sbjct: 10  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ-REIQILKA 68
Query: 57  MSHPNIVKLKEVI--RENDILYFVFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQGL 113
           +    IVK + V        L  V EY+     +    R +     + +  +  Q+ +G+
Sbjct: 69  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 128
Query: 114 AYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR--------WY 164
            Y+  R   HRDL   N+LV S+  +KIADFGLA+ +   P   +Y   R        WY
Sbjct: 129 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL---PLDKDYYVVREPGQSPIFWY 185
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
            APE L  + ++S + D+W+ G ++ EL T
Sbjct: 186 -APESLSDN-IFSRQSDVWSFGVVLYELFT 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 14  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 69
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 70  MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSR----PPFTEYVSTRWYRAPEV--LLQSYLYSS 178
           LK  N+ + +D T+KI DFGLA  + SR      F +   +  + APEV  +     YS 
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEI 208
           + D++A G ++ EL+T +  +   +  D+I
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 195 IYTHQS--DVWSYGVTVWELMTF 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 197
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 198 IYTHQS--DVWSYGVTVWELMTF 218

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 10  VGDGTFGSVWRAISKQSG--EVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSH-PNIVKL 65
           +G+G FG V +A  K+ G     AIK+MK+ Y S ++  +   E++ L K+ H PNI+ L
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 66  KEVIRENDILYFVFEYM-ECNLYQLMKDRE---------------KCFSEAEVRNWCFQV 109
                    LY   EY    NL   ++                     S  ++ ++   V
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAR--EINSRPPFTEYVSTRWYRA 166
            +G+ Y+ Q+ + HRDL   N+LV ++ + KIADFGL+R  E+  +      +  RW  A
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVRWM-A 209
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            E L  S +Y++  D+W+ G ++ E+++L
Sbjct: 210 IESLNYS-VYTTNSDVWSYGVLLWEIVSL 237

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 10  VGDGTFGSVWRAISKQSG--EVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSH-PNIVKL 65
           +G+G FG V +A  K+ G     AIK+MK+ Y S ++  +   E++ L K+ H PNI+ L
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 66  KEVIRENDILYFVFEYM-ECNLYQLMKDRE---------------KCFSEAEVRNWCFQV 109
                    LY   EY    NL   ++                     S  ++ ++   V
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAR--EINSRPPFTEYVSTRWYRA 166
            +G+ Y+ Q+ + HRDL   N+LV ++ + KIADFGL+R  E+  +      +  RW  A
Sbjct: 142 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVRWM-A 199
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            E L  S +Y++  D+W+ G ++ E+++L
Sbjct: 200 IESLNYS-VYTTNSDVWSYGVLLWEIVSL 227

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 155
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 156 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 213
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 214 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 243

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 154
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 212
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 42  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 97
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 98  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSR----PPFTEYVSTRWYRAPEV--LLQSYLYSS 178
           LK  N+ + +D T+KI DFGLA  + SR      F +   +  + APEV  +     YS 
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEI 208
           + D++A G ++ EL+T +  +   +  D+I
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 215
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 216 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 8   KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVKLK 66
           + +G G+FG+V++   K  G+V A+K +     + ++    + EV  LRK  H NI+ L 
Sbjct: 41  QRIGSGSFGTVYKG--KWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 96
Query: 67  EVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 125
                   L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +   HRD
Sbjct: 97  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 156
Query: 126 LKPENLLVSKD-TIKIADFGLAREINSR----PPFTEYVSTRWYRAPEV--LLQSYLYSS 178
           LK  N+ + +D T+KI DFGLA  + SR      F +   +  + APEV  +     YS 
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEI 208
           + D++A G ++ EL+T +  +   +  D+I
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINNRDQI 245

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 157 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 214
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 215 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 244

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 215
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 216 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 152
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +  ++ +  T      +W       LQ+  ++
Sbjct: 153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFT 210
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 211 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 102 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 219
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 220 IYTHQS--DVWSYGVTVWELMTF 240

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVV----AIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE V    AIK++++          L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 173 SYLYSSKVDMWAMGAIMAELIT 194
            Y + S  D+W+ G  + EL+T
Sbjct: 195 IYTHQS--DVWSYGVTVWELMT 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVV----AIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE V    AIK++++          L E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 188
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 189 IYTHQS--DVWSYGVTVWELMTF 209

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 87  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 204
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 205 IYTHQS--DVWSYGVTVWELMTF 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR---EVKSLRKMS 58
           +RY+L + +G G    V  A   +    VA+K ++    + +    LR   E ++   ++
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALN 70
Query: 59  HPNIVKL----KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           HP IV +    +       + Y V EY++    + +   E   +            Q L 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 115 YMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREI----NSRPPFTEYVSTRWYRAPEV 169
           + HQ G  HRD+KP N+++S  + +K+ DFG+AR I    NS       + T  Y +PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
                +  ++ D++++G ++ E++T  P F G S     Y+
Sbjct: 191 ARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 6   LIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVN-LREVKSLRKMSHPN 61
           L K +G+G FGSV     KQ       VA+K MK    S  E    L E   ++  SHPN
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 62  IVKLKEVIREND---------ILYFVFEYMECN---LYQLMKDREKCFSEAEVRNWCFQV 109
           +++L  V  E           IL F+ +Y + +   LY  ++   K      +  +   +
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFM-KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRWY 164
             G+ Y+  R + HRDL   N ++  D T+ +ADFGL+++I S    R      +  +W 
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGT 202
                 L   +Y+SK D+WA G  M E+ T  + P +PG 
Sbjct: 217 AIES--LADRVYTSKSDVWAFGVTMWEIATRGMTP-YPGV 253

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVW----RAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+    R I K   E  VA+K + +     E    L E   ++ 
Sbjct: 18  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 77
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 78  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 137
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++ + + HR+L   N +V+ D T+KI DFG+ R+I      R      +  
Sbjct: 138 AEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 198 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 229

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVW----RAISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  L++E+G G+FG V+    R I K   E  VA+K + +     E    L E   ++ 
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCFSEA-----EVRNWC 106
            +  ++V+L  V+ +      V E M     +  L  L  + E           E+    
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++ + + HR+L   N +V+ D T+KI DFG+ R+I      R      +  
Sbjct: 137 AEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  APE  L+  ++++  DMW+ G ++ E+ +L
Sbjct: 197 RWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 228

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ Y+  + + HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +   + +  T      +W       LQ+  ++
Sbjct: 157 DLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES--LQTQKFT 214
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 215 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 244

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMV 204

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 156
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMV 237

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 16/213 (7%)
Query: 6   LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNIVK 64
           L   +G G+FG+V++   K  G+V A+K +K    + E+    R EV  LRK  H NI+ 
Sbjct: 40  LSTRIGSGSFGTVYKG--KWHGDV-AVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILL 96
Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
               + + D L  V ++ E  +LY+ +  +E  F   ++ +   Q  QG+ Y+H +   H
Sbjct: 97  FMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIH 155
Query: 124 RDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV-----STRWYRAPEV--LLQSYL 175
           RD+K  N+ + +  T+KI DFGLA  + SR   ++ V     S  W  APEV  +  +  
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLA-TVKSRWSGSQQVEQPTGSVLWM-APEVIRMQDNNP 213
Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEI 208
           +S + D+++ G ++ EL+T    +   +  D+I
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHINNRDQI 246

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 155
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMV 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 156
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMV 237

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 156
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMV 237

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 175
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 176 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 234
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMV 256

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 155
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMV 236

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 170
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 229
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMV 251

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 156
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 215
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMV 237

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 155
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMV 236

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 162
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 221
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMV 243

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 155
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 214
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMV 236

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 170
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 229
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMV 251

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 143
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMV 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 142
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 201
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMV 223

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 142
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 201
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMV 223

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 143
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 143
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 202
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMV 224

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 2   ERY-KLIKEVGDGTFGSV----WRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           ER+ K I ++G G FGSV    +  +   +G +VA+K+++      +     RE++ L+ 
Sbjct: 6   ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ-REIQILKA 64
Query: 57  MSHPNIVKLKEVI--RENDILYFVFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQGL 113
           +    IVK + V        L  V EY+     +    R +     + +  +  Q+ +G+
Sbjct: 65  LHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 124
Query: 114 AYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLA------------REINSRPPFTEYVS 160
            Y+  R   HRDL   N+LV S+  +KIADFGLA            RE    P F     
Sbjct: 125 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF----- 179
Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             WY APE L  + ++S + D+W+ G ++ EL T
Sbjct: 180 --WY-APESLSDN-IFSRQSDVWSFGVVLYELFT 209

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 150
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 151 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 209
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMV 231

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 127
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 186
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMV 208

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK--------KYYSWEECVNLREVKS 53
           E Y ++K +G G FG V     K S +V A+K + K          + WEE    R++ +
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 130
Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQG 112
               + P +V+L    +++  LY V EYM   +L  LM + +    E   + +  +V   
Sbjct: 131 F--ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLA 186
Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPF--TEYVSTRWYRAPEV 169
           L  +H  G  HRD+KP+N+L+ K   +K+ADFG   +++          V T  Y +PEV
Sbjct: 187 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV 246
Query: 170 LLQ---SYLYSSKVDMWAMGAIMAELIT 194
           L        Y  + D W++G  + E++ 
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLV 274

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 128
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMV 209

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMV 204

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 128
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMV 209

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 128
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 187
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMV 209

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 79  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFG A+ + +     EY      V  +W     +L 
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE--KEYHAEGGKVPIKWMALESILH 195
Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + Y + S  D+W+ G  + EL+T 
Sbjct: 196 RIYTHQS--DVWSYGVTVWELMTF 217

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 81  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFG A+ + +     EY      V  +W     +L 
Sbjct: 140 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE--KEYHAEGGKVPIKWMALESILH 197
Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + Y + S  D+W+ G  + EL+T 
Sbjct: 198 RIYTHQS--DVWSYGVTVWELMTF 219

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMV 204

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 114/243 (46%), Gaps = 28/243 (11%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQ-SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +Y++   +  G  G ++ A+ +  +G  V +K +     +  + + + E + L ++ HP+
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 62  IVKLKEVIREND-----ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           IV++   +   D     + Y V EY+      L + + +    AE   +  ++   L+Y+
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQ--SLKRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 117 HQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           H  G  + DLKPEN++++++ +K+ D G    INS   F     T  ++APE++      
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGPTV 255
Query: 177 SSKVDMWAMGAIMAELITLRPL-----FPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
           ++  D++ +G  +A L    P        G  E D + K        T DS+  G LL R
Sbjct: 256 AT--DIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK--------TYDSY--GRLLRR 303
Query: 232 AIN 234
           AI+
Sbjct: 304 AID 306

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +  G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 84  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L 
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 200
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           + Y + S  D+W+ G  + EL+T
Sbjct: 201 RIYTHQS--DVWSYGVTVWELMT 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 79  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 137
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFG A+ + +     EY      V  +W     +L 
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE--KEYHAEGGKVPIKWMALESILH 195
Query: 172 QSYLYSSKVDMWAMGAIMAELITL 195
           + Y + S  D+W+ G  + EL+T 
Sbjct: 196 RIYTHQS--DVWSYGVTVWELMTF 217

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLR----EVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S W E  N      EV  L+K+
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E   +L+  + +R     E   R++ +QV + +
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 126
Query: 114 AYMHQRGYFHRDLKPENLLV--SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  ++  +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 185
Query: 172 QSYLYSSKVDMWAMGAIMAELI 193
               +     +W++G ++ +++
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMV 207

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 10  VGDGTFGSVWRAISKQSG--EVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSH-PNIVKL 65
           +G+G FG V +A  K+ G     AIK+MK+ Y S ++  +   E++ L K+ H PNI+ L
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 66  KEVIRENDILYFVFEYM-ECNLYQLMKDRE---------------KCFSEAEVRNWCFQV 109
                    LY   EY    NL   ++                     S  ++ ++   V
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAR--EINSRPPFTEYVSTRWYRA 166
            +G+ Y+ Q+ + HR+L   N+LV ++ + KIADFGL+R  E+  +      +  RW  A
Sbjct: 149 ARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR-LPVRWM-A 206
Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            E L  S +Y++  D+W+ G ++ E+++L
Sbjct: 207 IESLNYS-VYTTNSDVWSYGVLLWEIVSL 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFG A+ + +     EY      V  +W     +L +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 201
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 202 IYTHQS--DVWSYGVTVWELMTF 222

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 9   EVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           E+G G FGSV + + +   +   VAIK +K+     +    +RE + + ++ +P IV+L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 67  EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
            V +   ++  +       L++ +  + +    + V     QV  G+ Y+ ++ + HRDL
Sbjct: 77  GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 127 KPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST-----RWYRAPEVLLQSYLYSSKV 180
              N LLV++   KI+DFGL++ + +   +    S      +WY APE  +    +SS+ 
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APEC-INFRKFSSRS 194
Query: 181 DMWAMGAIMAELIT 194
           D+W+ G  M E ++
Sbjct: 195 DVWSYGVTMWEALS 208

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 11  GDGTFGSVWRAISKQSGEVVAIKKMKKKY-YSWEECVNL--REVKSLRKMSHPNIVKLKE 67
           G+G FG V++     +   VA+KK+      + EE      +E+K   K  H N+V+L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 68  VIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNW---CFQVFQGLA----YMHQRG 120
              + D L  V+ Y        + DR  C       +W   C ++ QG A    ++H+  
Sbjct: 89  FSSDGDDLCLVYVYXPNGS---LLDRLSCLDGTPPLSWHXRC-KIAQGAANGINFLHENH 144
Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAR---EINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           + HRD+K  N+L+ +  T KI+DFGLAR   +       +  V T  Y APE L      
Sbjct: 145 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE--I 202
Query: 177 SSKVDMWAMGAIMAELITLRP 197
           + K D+++ G ++ E+IT  P
Sbjct: 203 TPKSDIYSFGVVLLEIITGLP 223

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAI ++++          L E   +  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           P++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  
Sbjct: 111 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 169
Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLL 171
           R   HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L 
Sbjct: 170 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILH 227
Query: 172 QSYLYSSKVDMWAMGAIMAELIT 194
           + Y + S  D+W+ G  + EL+T
Sbjct: 228 RIYTHQS--DVWSYGVTVWELMT 248

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +  G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 201
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 202 IYTHQS--DVWSYGVTVWELMTF 222

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFG A+ + +     EY      V  +W     +L +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 195 IYTHQS--DVWSYGVTVWELMTF 215

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFG A+ + +     EY      V  +W     +L +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 196
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 197 IYTHQS--DVWSYGVTVWELMTF 217

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +  G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEY------VSTRWYRAPEVLLQ 172
              HRDL   N+LV +   +KI DFGLA+ + +     EY      V  +W     +L +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 173 SYLYSSKVDMWAMGAIMAELITL 195
            Y + S  D+W+ G  + EL+T 
Sbjct: 195 IYTHQS--DVWSYGVTVWELMTF 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 9   EVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           E+G G FGSV + + +   +   VAIK +K+     +    +RE + + ++ +P IV+L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 67  EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDL 126
            V +   ++  +       L++ +  + +    + V     QV  G+ Y+ ++ + HR+L
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462
Query: 127 KPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST-----RWYRAPEVLLQSYLYSSKV 180
              N LLV++   KI+DFGL++ + +   +    S      +WY APE  +    +SS+ 
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APEC-INFRKFSSRS 520
Query: 181 DMWAMGAIMAELIT 194
           D+W+ G  M E ++
Sbjct: 521 DVWSYGVTMWEALS 534

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 9   EVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           E+G+G FG V+ A     + +Q   +VA+K +K+   S  +    RE + L  + H +IV
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTMLQHQHIV 106
Query: 64  KLKEVIRENDILYFVFEYM---ECNLY--------QLMKDREKC----FSEAEVRNWCFQ 108
           +   V  E   L  VFEYM   + N +        +L+   E          ++     Q
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRW 163
           V  G+ Y+    + HRDL   N LV +   +KI DFG++R+I S    R      +  RW
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
                +L +   ++++ D+W+ G ++ E+ T
Sbjct: 227 MPPESILYRK--FTTESDVWSFGVVLWEIFT 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 9   EVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           E+G+G FG V+ A     + +Q   +VA+K +K+   S  +    RE + L  + H +IV
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTMLQHQHIV 83
Query: 64  KLKEVIRENDILYFVFEYM---ECNLY--------QLMKDREKC----FSEAEVRNWCFQ 108
           +   V  E   L  VFEYM   + N +        +L+   E          ++     Q
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRW 163
           V  G+ Y+    + HRDL   N LV +   +KI DFG++R+I S    R      +  RW
Sbjct: 144 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
Query: 164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
                +L +   ++++ D+W+ G ++ E+ T
Sbjct: 204 MPPESILYRK--FTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 9   EVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIV 63
           E+G+G FG V+ A     + +Q   +VA+K +K+   S  +    RE + L  + H +IV
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTMLQHQHIV 77
Query: 64  KLKEVIRENDILYFVFEYM---ECNLY--------QLMKDREKC----FSEAEVRNWCFQ 108
           +   V  E   L  VFEYM   + N +        +L+   E          ++     Q
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRW 163
           V  G+ Y+    + HRDL   N LV +   +KI DFG++R+I S    R      +  RW
Sbjct: 138 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
Query: 164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
                +L +   ++++ D+W+ G ++ E+ T
Sbjct: 198 MPPESILYRK--FTTESDVWSFGVVLWEIFT 226

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 19  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 78
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 138
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 139 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 198
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 199 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 230

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 10  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 69
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 70  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 129
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 130 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 189
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 190 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 221

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ ++  + + HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +   + +  T      +W       LQ+  ++
Sbjct: 159 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFT 216
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 217 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 246

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ ++  + + HR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +   + +  T      +W       LQ+  ++
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFT 274
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 275 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ ++  + + HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +   + +  T      +W       LQ+  ++
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFT 215
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 216 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ ++  + + HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +   + +  T      +W       LQ+  ++
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFT 215
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 216 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 6   LIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           L +E+G+G FG V+ A        +   +VA+K +K    +  +    RE + L  + H 
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTNLQHE 77
Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMK----------DREKCFSEAEVR-----N 104
           +IVK   V  + D L  VFEYM+  +L + ++          D +   ++ E+      +
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINS----RPPFTEYV 159
              Q+  G+ Y+  + + HRDL   N LV  +  +KI DFG++R++ S    R      +
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
             RW     ++ +   ++++ D+W+ G I+ E+ T
Sbjct: 198 PIRWMPPESIMYRK--FTTESDVWSFGVILWEIFT 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ ++  + + HR
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 162
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +   + +  T      +W       LQ+  ++
Sbjct: 163 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFT 220
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 221 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 250

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ ++  + + HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 155
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +   + +  T      +W       LQ+  ++
Sbjct: 156 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFT 213
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 214 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 243

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 10  VGDGTFGSVWRA-ISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V+   +    G+ +  A+K + +     E    L E   ++  SHPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 67  EV-IRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
            + +R       V  YM+  +L   +++     +  ++  +  QV +G+ ++  + + HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 125 DLKPEN-LLVSKDTIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQSYLYS 177
           DL   N +L  K T+K+ADFGLAR++  +   + +  T      +W       LQ+  ++
Sbjct: 159 DLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES--LQTQKFT 216
Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEAD 206
           +K D+W+ G ++ EL+T   P +P  +  D
Sbjct: 217 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 246

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 38/183 (20%)
Query: 104 NWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTR 162
           ++ FQV +G+ ++  R   HRDL   N+L+S++  +KI DFGLAR+I   P +     TR
Sbjct: 203 SYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTR 262
Query: 163 W---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTP 218
               + APE +    +YS+K D+W+ G ++ E+ +L    +PG  + DE +  CS +   
Sbjct: 263 LPLKWMAPESIFDK-IYSTKSDVWSYGVLLWEIFSLGGSPYPGV-QMDEDF--CSRL--- 315
Query: 219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAE 276
                 +G+ + RA  Y  P++  + L                    W  DP +RP  AE
Sbjct: 316 -----REGMRM-RAPEYSTPEIYQIMLDC------------------WHRDPKERPRFAE 351
Query: 277 ALQ 279
            ++
Sbjct: 352 LVE 354

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSEAEVR---------NWC 106
            +  ++V+L  V+ +      + E M   +L   ++      +   V             
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 205 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 236

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 15  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 74
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-ECNLYQLMKDREKCFSE---------AEVRNWC 106
            +  ++V+L  V+ +      + E M   +L   ++      +          +++    
Sbjct: 75  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 134
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 135 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 194
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 195 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 19  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 78
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 138
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 139 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 198
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 199 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 230

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 16  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 75
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 76  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 135
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 136 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 196 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 18  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 77
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 137
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 138 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 198 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 12  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 71
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 131
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 132 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 192 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 223

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 18  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 77
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 137
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 138 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 198 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 47  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 106
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 107 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 166
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 167 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 226
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 227 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 258

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 144
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      R      +  
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 205 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 236

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 93/366 (25%), Positives = 153/366 (41%), Gaps = 95/366 (25%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK-KYYSWEECVNLREVKSLRKMSHPN 61
           RY +I+++G G F +VW +   Q  + VA+K +K  ++Y+      +R +KS+R  S PN
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN-SDPN 80
Query: 62  ------IVKLKEVIRENDI----LYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVF 110
                 +V+L +  + + +    +  VFE +  +L + ++K   +      V+    QV 
Sbjct: 81  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 140
Query: 111 QGLAYMHQRG-YFHRDLKPENLLVS----------------------------------- 134
           QGL Y+H +    H D+KPEN+L+S                                   
Sbjct: 141 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 200
Query: 135 ---------------KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
                          K  +KIAD G A  ++    FTE + TR YR+ EVL+ S  Y++ 
Sbjct: 201 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTP 257
Query: 180 VDMWAMGAIMAELITLRPLFPG------TSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
            D+W+   +  EL T   LF        T + D I  I  ++G   +      L++A   
Sbjct: 258 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK-----LIVAGKY 312
Query: 234 NYKFPQLVG--VPLSVLMP-------------SANKDA--VSLIASLCSWDPSKRPTAAE 276
           + +F    G    ++ L P             S  + A     +  +    P KR TAAE
Sbjct: 313 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 372
Query: 277 ALQHPF 282
            L+HP+
Sbjct: 373 CLRHPW 378

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-----ECVNLREVKSLRK 56
           E +++IK +G G FG V     K +  + A+K + K    WE     E    RE + +  
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNK----WEMLKRAETACFREERDVLV 145
Query: 57  MSHPN-IVKLKEVIRENDILYFVFEY-MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
                 I  L    ++ + LY V +Y +  +L  L+   E    E   R +  ++   + 
Sbjct: 146 NGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 205
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVS--TRWYRAPEVL- 170
            +HQ  Y HRD+KP+N+L+  +  I++ADFG   ++N        V+  T  Y +PE+L 
Sbjct: 206 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 171 -LQSYL--YSSKVDMWAMGAIMAELI 193
            ++  +  Y  + D W++G  M E++
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-----ECVNLREVKSLRK 56
           E +++IK +G G FG V     K +  + A+K + K    WE     E    RE + +  
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNK----WEMLKRAETACFREERDVLV 129
Query: 57  MSHPN-IVKLKEVIRENDILYFVFEY-MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
                 I  L    ++ + LY V +Y +  +L  L+   E    E   R +  ++   + 
Sbjct: 130 NGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 189
Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVS--TRWYRAPEVL- 170
            +HQ  Y HRD+KP+N+L+  +  I++ADFG   ++N        V+  T  Y +PE+L 
Sbjct: 190 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 171 -LQSYL--YSSKVDMWAMGAIMAELI 193
            ++  +  Y  + D W++G  M E++
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 20/226 (8%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-----ECVNLREVKS-LR 55
           + ++++K +G G F  V     KQ+G+V A+K M K    W+     E    RE +  L 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK----WDMLKRGEVSCFREERDVLV 116
Query: 56  KMSHPNIVKLKEVIRENDILYFVFEY-MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
                 I +L    ++ + LY V EY +  +L  L+    +       R +  ++   + 
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 115 YMHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVS--TRWYRAPEVL- 170
            +H+ GY HRD+KP+N+L+ +   I++ADFG   ++ +       V+  T  Y +PE+L 
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 171 -----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
                  +  Y  + D WA+G    E+   +  F   S A+   KI
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 131/292 (44%), Gaps = 60/292 (20%)
Query: 8   KEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPN 61
           K +G G FG V  A +   G+      VA+K +K   ++ E+   + E+K +  +  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 62  IVKLKE---------VIRE----NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQ 108
           IV L           VI E     D+L F+    E +L    K+  +     ++ ++  Q
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL---DKEDGRPLELRDLLHFSSQ 160
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW---Y 164
           V QG+A++  +   HRD+   N+L++   + KI DFGLAR+I +   +    + R    +
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDS 222
            APE +    +Y+ + D+W+ G ++ E+ +  L P +PG                     
Sbjct: 221 MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPGI-------------------- 258
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPS-ANKDAVSLIASLCSWDPSKRPT 273
                     +N KF +LV     +  P+ A K+  S++ +  + +P+ RPT
Sbjct: 259 ---------LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 301

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 38/183 (20%)
Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW 163
           + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +      R 
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 164 ---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPT 219
              + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C  +   T
Sbjct: 256 PLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGT 311
Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEA 277
           +          RA +Y  P++    L                    W  +PS+RPT +E 
Sbjct: 312 R---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQRPTFSEL 344
Query: 278 LQH 280
           ++H
Sbjct: 345 VEH 347

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM-KKKYYSW----EECVNLREVKSLRKMS 58
           Y+L   +G G FG+V+          VAIK + + +   W    +      EV  L K+ 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 59  ----HPNIVKLKEVIRENDILYFVFE--YMECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
               HP +++L +     +    V E      +L+  + ++     E   R +  QV   
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAA 151
Query: 113 LAYMHQRGYFHRDLKPENLLVS--KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           + + H RG  HRD+K EN+L+   +   K+ DFG    ++   P+T++  TR Y  PE +
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWI 210
Query: 171 LQSYLYSSKVDMWAMGAIMAELI 193
            +   ++    +W++G ++ +++
Sbjct: 211 SRHQYHALPATVWSLGILLYDMV 233

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 93/366 (25%), Positives = 153/366 (41%), Gaps = 95/366 (25%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK-KYYSWEECVNLREVKSLRKMSHPN 61
           RY +I+++G G F +VW +   Q  + VA+K +K  ++Y+      +R +KS+R  S PN
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN-SDPN 96
Query: 62  ------IVKLKEVIRENDI----LYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVF 110
                 +V+L +  + + +    +  VFE +  +L + ++K   +      V+    QV 
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 111 QGLAYMHQRG-YFHRDLKPENLLVS----------------------------------- 134
           QGL Y+H +    H D+KPEN+L+S                                   
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 135 ---------------KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
                          K  +KIAD G A  ++    FTE + TR YR+ EVL+ S  Y++ 
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTP 273
Query: 180 VDMWAMGAIMAELITLRPLFPG------TSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
            D+W+   +  EL T   LF        T + D I  I  ++G   +      L++A   
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK-----LIVAGKY 328
Query: 234 NYKFPQLVG--VPLSVLMP-------------SANKDA--VSLIASLCSWDPSKRPTAAE 276
           + +F    G    ++ L P             S  + A     +  +    P KR TAAE
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 277 ALQHPF 282
            L+HP+
Sbjct: 389 CLRHPW 394

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 38/183 (20%)
Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW 163
           + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +      R 
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 164 ---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPT 219
              + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C  +   T
Sbjct: 258 PLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGT 313
Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEA 277
           +          RA +Y  P++    L                    W  +PS+RPT +E 
Sbjct: 314 R---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQRPTFSEL 346
Query: 278 LQH 280
           ++H
Sbjct: 347 VEH 349

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 12  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 71
Query: 57  MSHPNIVKLKEVIRENDILYFVFEYM-----ECNLYQLMKDREKCF-----SEAEVRNWC 106
            +  ++V+L  V+ +      + E M     +  L  L  + E        S +++    
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 131
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVST 161
            ++  G+AY++   + HRDL   N  V++D T+KI DFG+ R+I      R      +  
Sbjct: 132 GEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           RW  +PE  L+  ++++  D+W+ G ++ E+ TL
Sbjct: 192 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 223

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 131/292 (44%), Gaps = 60/292 (20%)
Query: 8   KEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPN 61
           K +G G FG V  A +   G+      VA+K +K   ++ E+   + E+K +  +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 62  IVKLKE---------VIRE----NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQ 108
           IV L           VI E     D+L F+    E +L    K+  +     ++ ++  Q
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL---DKEDGRPLELRDLLHFSSQ 168
Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW---Y 164
           V QG+A++  +   HRD+   N+L++   + KI DFGLAR+I +   +    + R    +
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQDS 222
            APE +    +Y+ + D+W+ G ++ E+ +  L P +PG                     
Sbjct: 229 MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPGI-------------------- 266
Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPS-ANKDAVSLIASLCSWDPSKRPT 273
                     +N KF +LV     +  P+ A K+  S++ +  + +P+ RPT
Sbjct: 267 ---------LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 309

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 38/183 (20%)
Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW 163
           + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +      R 
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 164 ---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPT 219
              + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C  +   T
Sbjct: 263 PLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGT 318
Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEA 277
           +          RA +Y  P++    L                    W  +PS+RPT +E 
Sbjct: 319 R---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQRPTFSEL 351
Query: 278 LQH 280
           ++H
Sbjct: 352 VEH 354

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 60/294 (20%)
Query: 8   KEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPN 61
           K +G G FG V  A +   G+      VA+K +K   ++ E+   + E+K +  +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 62  IVKLKEVIRENDILYFVFEYMEC--NLYQLMKDREKCF----------SEAEVRN---WC 106
           IV L         +  + EY  C  +L   ++ + +            S A  R+   + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYC-CYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW-- 163
            QV QG+A++  +   HRD+   N+L++   + KI DFGLAR+I +   +    + R   
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 164 -YRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPTQ 220
            + APE +    +Y+ + D+W+ G ++ E+ +  L P +PG                   
Sbjct: 231 KWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPGI------------------ 270
Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPS-ANKDAVSLIASLCSWDPSKRPT 273
                       +N KF +LV     +  P+ A K+  S++ +  + +P+ RPT
Sbjct: 271 -----------LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 313

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 38/183 (20%)
Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KDTIKIADFGLAREINSRPPFTEYVSTRW 163
           + FQV +G+ ++  R   HRDL   N+L+S K+ +KI DFGLAR+I   P +      R 
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 164 ---YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPT 219
              + APE +    +Y+ + D+W+ G ++ E+ +L    +PG    +E    C  +   T
Sbjct: 265 PLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGT 320
Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEA 277
           +          RA +Y  P++    L                    W  +PS+RPT +E 
Sbjct: 321 R---------MRAPDYTTPEMYQTMLDC------------------WHGEPSQRPTFSEL 353
Query: 278 LQH 280
           ++H
Sbjct: 354 VEH 356

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 60/295 (20%)
Query: 8   KEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPN 61
           K +G G FG V  A +   G+      VA+K +K   ++ E+   + E+K +  +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 62  IVKLKE---------VIRE----NDILYFVFEYMECNL---YQLMKDREKCFSEAEVRNW 105
           IV L           VI E     D+L F+       L   Y    + E+  S  ++ ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTI-KIADFGLAREINSRPPFTEYVSTRW- 163
             QV QG+A++  +   HRD+   N+L++   + KI DFGLAR+I +   +    + R  
Sbjct: 172 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 231
Query: 164 --YRAPEVLLQSYLYSSKVDMWAMGAIMAELIT--LRPLFPGTSEADEIYKICSVIGTPT 219
             + APE +    +Y+ + D+W+ G ++ E+ +  L P +PG                  
Sbjct: 232 VKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPGI----------------- 272
Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPS-ANKDAVSLIASLCSWDPSKRPT 273
                        +N KF +LV     +  P+ A K+  S++ +  + +P+ RPT
Sbjct: 273 ------------LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 315

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 69/281 (24%)
Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKK-KYYSWEECVNLREVKSLRKM--SH 59
           RY +I+++G G F +VW     Q    VA+K +K  ++Y+      ++ +K +R+   S 
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 60  PNIVKLKEVIRENDI-------LYFVFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQ 111
           PN   + ++I +  I       +  VFE +  +L + ++K   +      V++   QV Q
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQ 151
Query: 112 GLAYMHQR-GYFHRDLKPENLLVSKDT--------------------------------- 137
           GL Y+H +    H D+KPEN+L+  D                                  
Sbjct: 152 GLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAAD 211
Query: 138 ---------------IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDM 182
                          +KIAD G A  ++    FTE + TR YR+ EVL+ +  YS+  D+
Sbjct: 212 LLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYRSIEVLIGAG-YSTPADI 268
Query: 183 WAMGAIMAELITLRPLF-PGTSE-----ADEIYKICSVIGT 217
           W+   +  EL T   LF P + E      D I  I  ++G+
Sbjct: 269 WSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGS 309
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	337
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-140
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-136
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-127
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-123
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-117
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-116
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-114
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-114
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-114
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-113
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-110
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-109
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-109
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-108
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-104
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-103
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-103
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-102
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-100
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-100
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-99
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-99
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-93
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-93
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-92
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-74
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-74
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-72
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-70
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-68
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-68
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-68
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-68
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-68
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-67
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-67
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-67
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-66
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-66
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-66
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-66
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-65
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-65
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-65
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-65
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-65
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-65
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-64
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-64
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-64
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-64
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-64
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-63
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-63
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-63
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-63
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-63
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-63
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-62
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-62
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-62
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-62
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-62
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-61
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-61
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-60
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-60
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-60
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-59
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-59
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-59
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-58
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-58
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-58
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-57
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-57
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-57
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-57
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-57
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-57
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-57
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-57
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-56
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-56
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-55
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-55
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-53
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-53
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-51
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-51
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-51
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-50
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-50
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-50
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-49
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-49
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-49
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-48
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-48
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-48
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-48
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-48
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-48
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-48
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-48
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-47
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-47
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-47
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-47
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-47
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-46
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-46
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-46
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-46
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-45
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-45
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-45
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-45
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-45
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-45
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-44
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-44
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-43
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-42
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-42
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-42
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-41
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-41
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-41
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-40
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-40
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-40
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-40
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-39
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-39
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-39
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-39
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-38
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-36
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-36
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-35
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-35
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-34
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-34
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-34
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-33
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-33
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-33
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-33
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-32
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-32
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-32
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-31
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-30
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-29
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-23
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-23
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-22
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-22
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-19
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-17
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-17
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-16
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-04

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  399 bits (1028), Expect = e-140
 Identities = 98/306 (32%), Positives = 168/306 (54%), Gaps = 10/306 (3%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME+Y+ I ++G+G++G V++  ++ +G++VAIKK    +     + + LRE++ L+++ H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           PN+V L EV R    L+ VFEY +  +   +   ++   E  V++  +Q  Q + + H+ 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KPEN+L++K   IK+ DFG AR +      + + V+TRWYR+PE+L+    Y 
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
             VD+WA+G + AEL++  PL+PG S+ D++Y I   +G                   K 
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241

Query: 238 PQLVGV-PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPE 296
           P    + PL +  P+ +  A+ L+      DP++R T  + L HP+      F ++   E
Sbjct: 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY------FENIREIE 295

Query: 297 QLLQEH 302
            L +EH
Sbjct: 296 DLAKEH 301

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  388 bits (998), Expect = e-136
 Identities = 99/314 (31%), Positives = 160/314 (50%), Gaps = 11/314 (3%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSH 59
           ME+Y+ +  VG+G++G V +  +K +G +VAIKK          + + +RE+K L+++ H
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            N+V L EV ++    Y VFE+++  +   ++          V+ + FQ+  G+ + H  
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+KPEN+LVS+   +K+ DFG AR + +    + + V+TRWYRAPE+L+    Y 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
             VD+WA+G ++ E+    PLFPG S+ D++Y I   +G                   + 
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263

Query: 238 PQLV-GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPE 296
           P++    PL    P  ++  + L       DP KRP  AE L H F      F      E
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF------FQMDGFAE 317

Query: 297 QLLQEHLHLLGQRE 310
           +  QE L L  Q++
Sbjct: 318 RFSQE-LQLKVQKD 330

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  368 bits (947), Expect = e-127
 Identities = 97/293 (33%), Positives = 167/293 (56%), Gaps = 19/293 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
             Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H N
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 108

Query: 62  IVKLKEVIREND------ILYFVFEYMECNLYQLMKDREKC---FSEAEVRNWCFQVFQG 112
           IV+L+     +        L  V +Y+   +Y++ +   +         V+ + +Q+F+ 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168

Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           LAY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRAPE++
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 228

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
             +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +  
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNP 286

Query: 231 RAINYKFPQLVGVPLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               +KFPQ+   P + V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  358 bits (922), Expect = e-123
 Identities = 107/334 (32%), Positives = 173/334 (51%), Gaps = 38/334 (11%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
              Y   K +G+G+FG V++A   +S EV AIKK+ +     ++    RE++ +R + HP
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQ-----DKRFKNRELQIMRIVKHP 92

Query: 61  NIVKLKEVIREND------ILYFVFEYMECNLYQLMKDREKC---FSEAEVRNWCFQVFQ 111
           N+V LK     N        L  V EY+   +Y+  +   K         ++ + +Q+ +
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 112 GLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            LAY+H  G  HRD+KP+NLL+   +  +K+ DFG A+ + +  P   Y+ +R+YRAPE+
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +  +  Y++ +D+W+ G +MAEL+  +PLFPG S  D++ +I  V+GTP+++      + 
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT--MN 270

Query: 230 ARAINYKFPQLVGVPLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF------ 282
              + +KFPQ+   P S V  P    DA+ LI+ L  + PS R TA EAL HPF      
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330

Query: 283 -------SRVA-----FMFHHLSVPEQLLQEHLH 304
                   R       +    LSV   L+   + 
Sbjct: 331 GEARMPNGRELPPLFNWTKEELSVRPDLISRLVP 364

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  340 bits (874), Expect = e-117
 Identities = 107/289 (37%), Positives = 169/289 (58%), Gaps = 10/289 (3%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE----CVNLREVKSLRK 56
            +RY+ +  +G+G F +V++A  K + ++VAIKK+K  + S  +       LRE+K L++
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           +SHPNI+ L +       +  VF++ME +L  ++KD     + + ++ +     QGL Y+
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSY 174
           HQ    HRDLKP NLL+ ++  +K+ADFGLA+   S    +T  V TRWYRAPE+L  + 
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 188

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           +Y   VDMWA+G I+AEL+   P  PG S+ D++ +I   +GTPT++ W D   L    +
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP---D 245

Query: 235 YK-FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           Y  F    G+PL  +  +A  D + LI  L  ++P  R TA +AL+  +
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  336 bits (865), Expect = e-116
 Identities = 101/287 (35%), Positives = 169/287 (58%), Gaps = 8/287 (2%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKM 57
           ME Y  + ++G+GT+ +V++  SK +  +VA+K+++ ++   EE      +REV  L+ +
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH---EEGAPCTAIREVSLLKDL 57

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            H NIV L ++I     L  VFEY++ +L Q + D     +   V+ + FQ+ +GLAY H
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYL 175
           ++   HRDLKP+NLL+++   +K+ADFGLAR  +     +   V T WYR P++LL S  
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS+++DMW +G I  E+ T RPLFPG++  ++++ I  ++GTPT+++W   L       Y
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +P+     L    P  + D   L+  L  ++   R +A +A++HPF
Sbjct: 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  332 bits (855), Expect = e-114
 Identities = 105/287 (36%), Positives = 181/287 (63%), Gaps = 8/287 (2%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKM 57
           ME+Y+ +++VG+GT+G V++A     G +VA+K+++    + +E +    +RE+  L+++
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAEDEGIPSTAIREISLLKEL 76

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            HPNIV L +VI     L  VFE+ME +L +++ + +    +++++ + +Q+ +G+A+ H
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYL 175
           Q    HRDLKP+NLL++ D  +K+ADFGLAR        +T  V T WYRAP+VL+ S  
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK 196

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS+ VD+W++G I AE+IT +PLFPG ++ D++ KI S++GTP    W     L      
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            F      P S ++P   ++ + L++++  +DP+KR +A +A+ HP+
Sbjct: 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  330 bits (849), Expect = e-114
 Identities = 102/289 (35%), Positives = 171/289 (59%), Gaps = 13/289 (4%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKM 57
           ME+Y  ++++G+GT+G V++A +   GE  A+KK++      +E +    +RE+  L+++
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKEL 57

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            H NIVKL +VI     L  VFE+++ +L +L+   E        +++  Q+  G+AY H
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYL 175
            R   HRDLKP+NLL++++  +KIADFGLAR        +T  + T WYRAP+VL+ S  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS+ +D+W++G I AE++   PLFPG SEAD++ +I  ++GTP   +W +   L     Y
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP---KY 234

Query: 236 K--FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              F     +P    +   ++  + L++ +   DP++R TA +AL+H +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  328 bits (843), Expect = e-113
 Identities = 101/290 (34%), Positives = 173/290 (59%), Gaps = 13/290 (4%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKM 57
           M++Y+ ++++G+GT+G+V++A ++++ E+VA+K+++      +E V    LRE+  L+++
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKEL 58

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            H NIV+L +V+  +  L  VFE+ + +L +             V+++ FQ+ +GL + H
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYL 175
            R   HRDLKP+NLL++++  +K+A+FGLAR        ++  V T WYR P+VL  + L
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 176 YSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           YS+ +DMW+ G I AEL     PLFPG    D++ +I  ++GTPT++ W     L    +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP---D 235

Query: 235 YK-FPQLVG-VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           YK +P       L  ++P  N     L+ +L   +P +R +A EALQHP+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  323 bits (831), Expect = e-110
 Identities = 103/296 (34%), Positives = 160/296 (54%), Gaps = 18/296 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK----KKYYSWEECVNLREVKSLRK 56
             RY+ + E+G G +G+V++A    SG  VA+K ++               +REV  LR+
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 57  MS---HPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDR-EKCFSEAEVRNWCF 107
           +    HPN+V+L +V   +       +  VFE+++ +L   +            +++   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRA 166
           Q  +GL ++H     HRDLKPEN+LV+   T+K+ADFGLAR  + +   T  V T WYRA
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEVLLQS  Y++ VDMW++G I AE+   +PLF G SEAD++ KI  +IG P +D W   
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + L       FP     P+  ++P   +    L+  + +++P KR +A  ALQH +
Sbjct: 247 VSLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  321 bits (825), Expect = e-109
 Identities = 110/295 (37%), Positives = 173/295 (58%), Gaps = 19/295 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKM 57
           ++RY+ I ++G+GT+G V++AI   + E VAIK+++      EE V    +REV  L+++
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKEL 90

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            H NI++LK VI  N  L+ +FEY E +L + M D+    S   ++++ +Q+  G+ + H
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH 149

Query: 118 QRGYFHRDLKPENLLVSKDT------IKIADFGLAREINS-RPPFTEYVSTRWYRAPEVL 170
            R   HRDLKP+NLL+S         +KI DFGLAR        FT  + T WYR PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           L S  YS+ VD+W++  I AE++   PLFPG SE D+++KI  V+G P   +W     L 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269

Query: 231 RAINYK--FPQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              ++K  FP+  G  L  ++ +  + + + L+ ++   DP KR +A  AL+HP+
Sbjct: 270 ---DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  320 bits (822), Expect = e-109
 Identities = 98/297 (32%), Positives = 168/297 (56%), Gaps = 19/297 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKM 57
             ++K ++++G+GT+ +V++ ++K +G  VA+K++K      EE      +RE+  ++++
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKEL 60

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDR-----EKCFSEAEVRNWCFQVFQG 112
            H NIV+L +VI   + L  VFE+M+ +L + M  R      +      V+ + +Q+ QG
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVL 170
           LA+ H+    HRDLKP+NLL++K   +K+ DFGLAR        F+  V T WYRAP+VL
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           + S  YS+ +D+W+ G I+AE+IT +PLFPGT++ +++  I  ++GTP +  W   +   
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP-SVTKL 239

Query: 231 RAINYKFPQLVGVPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
              N    Q     L  ++    K     + +  +  L   +P  R +A +AL HP+
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  317 bits (815), Expect = e-108
 Identities = 106/317 (33%), Positives = 172/317 (54%), Gaps = 26/317 (8%)

Query: 1   MERYKLIKEVGDGTFGSVWRAIS-KQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRK 56
            ++Y+ + E+G+G +G V++A   K  G  VA+K+++    + EE +    +REV  LR 
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRH 67

Query: 57  MS---HPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKD-REKCFSEAEVRNWCF 107
           +    HPN+V+L +V   +       L  VFE+++ +L   +    E       +++  F
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRA 166
           Q+ +GL ++H     HRDLKP+N+LV+    IK+ADFGLAR  + +   T  V T WYRA
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEVLLQS  Y++ VD+W++G I AE+   +PLF G+S+ D++ KI  VIG P ++ W   
Sbjct: 188 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
           + L       F      P+   +   ++    L+    +++P+KR +A  AL HP+    
Sbjct: 247 VALP---RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY---- 299

Query: 287 FMFHHLSVPEQLLQEHL 303
             F  L   ++ L  HL
Sbjct: 300 --FQDLERCKENLDSHL 314

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  309 bits (793), Expect = e-104
 Identities = 90/301 (29%), Positives = 156/301 (51%), Gaps = 21/301 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKM 57
           + +Y+ + ++G GTFG V++A  +++G+ VA+KK+     + +E      LRE+K L+ +
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLL 73

Query: 58  SHPNIVKLKEVIREN--------DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQV 109
            H N+V L E+ R            +Y VF++ E +L  L+ +    F+ +E++     +
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-----SRPPFTEYVSTRW 163
             GL Y+H+    HRD+K  N+L+++D  +K+ADFGLAR  +         +T  V T W
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193

Query: 164 YRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW 223
           YR PE+LL    Y   +D+W  G IMAE+ T  P+  G +E  ++  I  + G+ T + W
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKD--AVSLIASLCSWDPSKRPTAAEALQHP 281
            +          +  +     +   + +  +D  A+ LI  L   DP++R  + +AL H 
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313

Query: 282 F 282
           F
Sbjct: 314 F 314

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  306 bits (786), Expect = e-103
 Identities = 87/307 (28%), Positives = 160/307 (52%), Gaps = 36/307 (11%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM--KKKYYSWEECVNLREVKSLRKMS 58
           M+R+++ +  G GTFG+V     K +G  VAIKK+    ++ + E    L+ ++ L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77

Query: 59  HPNIVKLKEVIR------ENDI-LYFVFEYMECNLYQLMKDREKC---FSEAEVRNWCFQ 108
           HPNIV+L+            DI L  V EY+   L++  ++  +         ++ + FQ
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 109 VFQGLAYMHQR--GYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWY 164
           + + +  +H       HRD+KP N+LV++    +K+ DFG A++++   P   Y+ +R+Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
           RAPE++  +  Y++ VD+W++G I AE++   P+F G + A ++++I  V+G P+++   
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL- 256

Query: 225 DGLLLARAIN-----YKFPQLVGVPLSVL----MPSANKDAVSLIASLCSWDPSKRPTAA 275
                 R +N            G+P S +         K+A  L+++L  + P +R    
Sbjct: 257 ------RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310

Query: 276 EALQHPF 282
           EAL HP+
Sbjct: 311 EALCHPY 317

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  306 bits (786), Expect = e-103
 Identities = 87/301 (28%), Positives = 153/301 (50%), Gaps = 23/301 (7%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----------LREV 51
             Y + + +  G++G+V   +    G  VAIK++                      LRE+
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 52  KSLRKMSHPNIVKLKEVIRE------NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNW 105
           + L    HPNI+ L+++         + + Y V E M  +L Q++ D+    S   ++ +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKL-YLVTELMRTDLAQVIHDQRIVISPQHIQYF 139

Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWY 164
            + +  GL  +H+ G  HRDL P N+L++ +  I I DF LARE  +    T YV+ RWY
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWY 199

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
           RAPE+++Q   ++  VDMW+ G +MAE+   + LF G++  +++ KI  V+GTP  +   
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV- 258

Query: 225 DGLLLARAINY---KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                  A +Y       +     + ++P+A+  A+ LIA +  ++P +R +  +AL+HP
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318

Query: 282 F 282
           +
Sbjct: 319 Y 319

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  303 bits (777), Expect = e-102
 Identities = 100/304 (32%), Positives = 163/304 (53%), Gaps = 29/304 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRKM 57
             ++L   +G+G +G V  A  K +GE+VAIKK++     +++ +     LRE+K L+  
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE----PFDKPLFALRTLREIKILKHF 66

Query: 58  SHPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
            H NI+ +  + R +       +Y + E M+ +L++++  +    S+  ++ + +Q  + 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFIYQTLRA 124

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-----------TEYVS 160
           +  +H     HRDLKP NLL++ +  +K+ DFGLAR I+                 E+V+
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
           TRWYRAPEV+L S  YS  +D+W+ G I+AEL   RP+FPG     ++  I  +IGTP  
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244

Query: 221 DSWADGLLLARAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL 278
           D+    +   RA  Y    P     PL  + P  N   + L+  +  +DP+KR TA EAL
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304

Query: 279 QHPF 282
           +HP+
Sbjct: 305 EHPY 308

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  298 bits (766), Expect = e-100
 Identities = 104/297 (35%), Positives = 169/297 (56%), Gaps = 23/297 (7%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRKM 57
            RY  +  +G+G +G V  A    +   VAIKK+      +E        LRE+K L + 
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILLRF 82

Query: 58  SHPNIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
            H NI+ + ++IR   I     +Y V + ME +LY+L+K +    S   +  + +Q+ +G
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRG 140

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR----EINSRPPFTEYVSTRWYRAP 167
           L Y+H     HRDLKP NLL++    +KI DFGLAR    + +     TEYV+TRWYRAP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           E++L S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+   + +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCI 259

Query: 228 LLARAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +  +A NY    P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  298 bits (764), Expect = e-100
 Identities = 111/291 (38%), Positives = 157/291 (53%), Gaps = 16/291 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           + Y     VG G +GSV  AI K+SGE VAIKK+ + + S        RE+  L+ M H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 61  NIVKLKEVIR------ENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V             Y V  +M+ +L ++M  +   FSE +++   +Q+ +GL 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLK 140

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP NL V++D  +KI DFGLAR  +     T YV TRWYRAPEV+L  
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSW 198

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y+  VD+W++G IMAE++T + LF G    D++ +I  V G P  +     L    A 
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV-QKLNDKAAK 257

Query: 234 NY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +Y    PQ      + L P A+  A  L+  +   D  KR TAA+AL HPF
Sbjct: 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  295 bits (758), Expect = 1e-99
 Identities = 98/308 (31%), Positives = 156/308 (50%), Gaps = 37/308 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRKM 57
            RY  +K +G G  G V+ A+     + VAIKK+        +  +    LRE+K +R++
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-----VLTDPQSVKHALREIKIIRRL 65

Query: 58  SHPNIVKLKEVIR---------------ENDILYFVFEYMECNLYQLMKDREKCFSEAEV 102
            H NIVK+ E++                 N + Y V EYME +L  +++       E   
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSV-YIVQEYMETDLANVLEQGP--LLEEHA 122

Query: 103 RNWCFQVFQGLAYMHQRGYFHRDLKPENLLV-SKD-TIKIADFGLAR----EINSRPPFT 156
           R + +Q+ +GL Y+H     HRDLKP NL + ++D  +KI DFGLAR      + +   +
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG 216
           E + T+WYR+P +LL    Y+  +DMWA G I AE++T + LF G  E +++  I   I 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 217 TPTQDSWADGLLLARAINY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA 274
              ++   +  LL+    Y          PL+ L+P  +++AV  +  + ++ P  R TA
Sbjct: 243 VVHEEDRQE--LLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 275 AEALQHPF 282
            EAL HP+
Sbjct: 301 EEALSHPY 308

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  297 bits (761), Expect = 3e-99
 Identities = 84/328 (25%), Positives = 153/328 (46%), Gaps = 55/328 (16%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK--KKYYSWEECVNLREVKSLRKMS 58
            ++Y L K +G G+FG V      +SG+  A+KK+    +Y         RE+  ++ + 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLD 58

Query: 59  HPNIVKLKEVIRENDI--------------------------------------LYFVFE 80
           H NI+KL +                                             L  + E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 81  YMECNLYQLMKDREKC---FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV--SK 135
           Y+   L++++K   +         +  + +Q+F+ + ++H  G  HRD+KP+NLLV    
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178

Query: 136 DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
           +T+K+ DFG A+++    P   Y+ +R+YRAPE++L +  Y+  +D+W++G +  ELI  
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 196 RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSAN-K 254
           +PLF G +  D++ +I  ++GTPT++      +       +FP L       ++P     
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIR--MNPHYTEVRFPTLKAKDWRKILPEGTPS 296

Query: 255 DAVSLIASLCSWDPSKRPTAAEALQHPF 282
            A+ L+  +  ++P  R    EA+ HPF
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPF 324

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  293 bits (753), Expect = 3e-98
 Identities = 107/292 (36%), Positives = 162/292 (55%), Gaps = 17/292 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
             Y+ ++ VG G +G+V  A+  ++G  VAIKK+ + + S        RE++ L+ M H 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 61  NIVKLKEVIRE-------NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           N++ L +V           D  Y V  +M  +L +LMK  +    E  ++   +Q+ +GL
Sbjct: 85  NVIGLLDVFTPDETLDDFTDF-YLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGL 141

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
            Y+H  G  HRDLKP NL V++D  +KI DFGLAR+ +     T YV TRWYRAPEV+L 
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILN 199

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y+  VD+W++G IMAE+IT + LF G+   D++ +I  V GTP  +     L    A
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV-QRLQSDEA 258

Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY    P+L     + ++ +A+  AV+L+  +   D  +R TA EAL HP+
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  292 bits (750), Expect = 1e-97
 Identities = 107/292 (36%), Positives = 160/292 (54%), Gaps = 17/292 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 61  NIVKLKEVIRE-------NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           N++ L +V          ND+ Y V   M  +L  ++K ++   ++  V+   +Q+ +GL
Sbjct: 89  NVIGLLDVFTPARSLEEFNDV-YLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGL 145

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
            Y+H     HRDLKP NL V++D  +KI DFGLAR        T YV+TRWYRAPE++L 
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +     +    A
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL-KKISSESA 262

Query: 233 INY--KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            NY     Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  294 bits (754), Expect = 4e-97
 Identities = 100/349 (28%), Positives = 170/349 (48%), Gaps = 70/349 (20%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           +RY++   +G G++G V  A  K    VVAIKK+ + +    +C   LRE+  L +++H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 61  NIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           ++VK+ +++   D+     LY V E  + +  +L +      +E  ++   + +  G+ Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVY-LTELHIKTLLYNLLVGVKY 171

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-------------------- 154
           +H  G  HRDLKP N LV++D ++K+ DFGLAR ++                        
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231

Query: 155 --------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL----------- 195
                    T +V TRWYRAPE++L    Y+  +D+W++G I AEL+ +           
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291

Query: 196 RPLFPGTS--------------------EADEIYKICSVIGTPTQDSWADGLLLARAINY 235
            PLFPG+S                      D++  I +++GTP+++   + L    A  Y
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI-EALEKEDAKRY 350

Query: 236 --KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              FP+  G  L+   P+++ DA+ L+  +  ++P+KR T  E L HPF
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  285 bits (731), Expect = 2e-94
 Identities = 91/320 (28%), Positives = 155/320 (48%), Gaps = 42/320 (13%)

Query: 2   ERYKLIKE-VGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           + ++     VG GT+G V++A  K  +  +  A+K+++    S       RE+  LR++ 
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELK 76

Query: 59  HPNIVKLKEVIRE--NDILYFVFEYMECNLYQLMK--------DREKCFSEAEVRNWCFQ 108
           HPN++ L++V     +  ++ +F+Y E +L+ ++K         +        V++  +Q
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINS-RPPFTEY---V 159
           +  G+ Y+H     HRDLKP N+LV  +      +KIAD G AR  NS   P  +    V
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---------ADEIYK 210
            T WYRAPE+LL +  Y+  +D+WA+G I AEL+T  P+F    E          D++ +
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256

Query: 211 ICSVIGTPTQDSWAD--GLLLARAINYKFPQ------LVGVPLSVLMPSANKDAVSLIAS 262
           I +V+G P    W D   +     +   F +       +   +       +  A  L+  
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316

Query: 263 LCSWDPSKRPTAAEALQHPF 282
           L + DP KR T+ +A+Q P+
Sbjct: 317 LLTMDPIKRITSEQAMQDPY 336

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  281 bits (722), Expect = 5e-94
 Identities = 74/300 (24%), Positives = 149/300 (49%), Gaps = 30/300 (10%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK----KKYYSWEECVNLREVKSLRK 56
            + Y+L++++G G +  V+ AI+  + E V +K +K    KK          RE+K L  
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI--------KREIKILEN 86

Query: 57  MS-HPNIVKLKEVIR--ENDILYFVFEY-MECNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
           +   PNI+ L ++++   +     VFE+    +  QL +      ++ ++R + +++ + 
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKA 142

Query: 113 LAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           L Y H  G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           +   +Y   +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262

Query: 230 ARAINYK--FPQLVGVPLSVLMPSANK-----DAVSLIASLCSWDPSKRPTAAEALQHPF 282
                +     +         + S N+     +A+  +  L  +D   R TA EA++HP+
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  285 bits (731), Expect = 1e-93
 Identities = 97/303 (32%), Positives = 148/303 (48%), Gaps = 28/303 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           +RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 61  NIVKLKEVIR------ENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           NI+ L  V        E   +Y V E M+ NL Q+++          +    +Q+  G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 178

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV+L  
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-G 237

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +      L     
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK--LQPTVR 295

Query: 234 NY--KFPQLVGVPLSVLMPSA------------NKDAVSLIASLCSWDPSKRPTAAEALQ 279
           NY    P+  G+    L P +               A  L++ +   DP+KR +  +ALQ
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355

Query: 280 HPF 282
           HP+
Sbjct: 356 HPY 358

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  284 bits (728), Expect = 1e-93
 Identities = 102/341 (29%), Positives = 167/341 (48%), Gaps = 62/341 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSHP 60
           + Y +   +G G++G V+ A  K + + VAIKK+ + +    +C   LRE+  L ++   
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 61  NIVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
            I++L ++I  +D+     LY V E  + +L +L K      +E  ++   + +  G  +
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF-LTEEHIKTILYNLLLGENF 144

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF------------------- 155
           +H+ G  HRDLKP N L+++D ++K+ DFGLAR INS                       
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204

Query: 156 ----TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-----------RPLFP 200
               T +V TRWYRAPE++L    Y+  +D+W+ G I AEL+ +            PLFP
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264

Query: 201 GTSEA-----------------DEIYKICSVIGTPTQDSWADGLLLARAINY--KFPQLV 241
           G+S                   D++  I ++IGTPT+D     +     I Y   FP   
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL-KNINKPEVIKYIKLFPHRK 323

Query: 242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            + L    PS + D ++L+ S+  ++P+KR T  +AL HP+
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY 364

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  281 bits (721), Expect = 2e-93
 Identities = 97/304 (31%), Positives = 146/304 (48%), Gaps = 28/304 (9%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 60  PNIVKLKEVIR-ENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
            NI+ L  V   +  +     +Y V E M+ NL Q+++          +    +Q+  G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 140

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
            ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV+L 
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL- 199

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y   VD+W++G IM E+I    LFPGT   D+  K+   +GTP  +      L    
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK--LQPTV 257

Query: 233 INY--------------KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL 278
             Y               FP ++    S         A  L++ +   D SKR +  EAL
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317

Query: 279 QHPF 282
           QHP+
Sbjct: 318 QHPY 321

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  279 bits (716), Expect = 2e-92
 Identities = 98/326 (30%), Positives = 174/326 (53%), Gaps = 48/326 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECV-NLREVKSLRKMS-H 59
            +Y+L+K++G G +G VW++I +++GEVVA+KK+   + +  +     RE+  L ++S H
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 60  PNIVKLKEVIR--ENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            NIV L  V+R   +  +Y VF+YME +L+ +++           +   +Q+ + + Y+H
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI--LEPVHKQYVVYQLIKVIKYLH 126

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--------------------- 155
             G  HRD+KP N+L++ +  +K+ADFGL+R   +                         
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 156 -TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV 214
            T+YV+TRWYRAPE+LL S  Y+  +DMW++G I+ E++  +P+FPG+S  +++ +I  V
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246

Query: 215 IGTPTQDSWADGLLLARAINY--KFPQLVGVPLSVL----------------MPSANKDA 256
           I  P+ +   + +    A        + V +  S                      N++A
Sbjct: 247 IDFPSNEDV-ESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305

Query: 257 VSLIASLCSWDPSKRPTAAEALQHPF 282
           + L+  L  ++P+KR +A +AL+HPF
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPF 331

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  231 bits (591), Expect = 1e-74
 Identities = 77/311 (24%), Positives = 118/311 (37%), Gaps = 60/311 (19%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
             ++ I  +G G FG V +A +       AIKK++           L EV  L  ++H  
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI--LSEVMLLASLNHQY 63

Query: 62  IVKLKEVIREND-------------ILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCF 107
           +V+      E                L+   EY E   LY L+          E      
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 108 QVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF----------- 155
           Q+ + L+Y+H +G  HRDLKP N+ + +   +KI DFGLA+ ++                
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 156 ----TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
               T  + T  Y A EVL  +  Y+ K+DM+++G I  E+  + P   G  E   I K 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTG-MERVNILKK 240

Query: 212 CSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR 271
                              R+++ +FP               K    +I  L   DP+KR
Sbjct: 241 L------------------RSVSIEFPPDFDDNKM-------KVEKKIIRLLIDHDPNKR 275

Query: 272 PTAAEALQHPF 282
           P A   L   +
Sbjct: 276 PGARTLLNSGW 286

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  231 bits (590), Expect = 2e-74
 Identities = 66/285 (23%), Positives = 115/285 (40%), Gaps = 36/285 (12%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKM-S 58
            + ++ +  +G G++G V++  SK+ G + A+K+    +   ++    L EV S  K+  
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP  V+L++   E  ILY   E    +L Q  +       EA+V  +       LA++H 
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           +G  H D+KP N+ +      K+ DFGL  E+ +            Y APE+L  S  Y 
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--YG 233

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           +  D++++G  + E+     L       +   ++      P                 +F
Sbjct: 234 TAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPP-----------------EF 273

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                  LS        +  S++  +   DP  R TA   L  P 
Sbjct: 274 TA----GLS-------SELRSVLVMMLEPDPKLRATAEALLALPV 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  226 bits (577), Expect = 6e-72
 Identities = 88/314 (28%), Positives = 152/314 (48%), Gaps = 37/314 (11%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ME+Y  ++++G+G+FG      S + G    IK++     S +E     REV  L  M H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 60  PNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMH 117
           PNIV+ +E   EN  LY V +Y E  +L++ +  ++   F E ++ +W  Q+   L ++H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYL 175
            R   HRD+K +N+ ++KD T+++ DFG+AR +NS        + T +Y +PE+  ++  
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI-CENKP 201

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y++K D+WA+G ++ EL TL+  F   S  + + KI                      + 
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII---------------------SG 240

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVP 295
            FP     P+S      + D  SL++ L   +P  RP+    L+  F  +A        P
Sbjct: 241 SFP-----PVS---LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF--IAKRIEKFLSP 290

Query: 296 EQLLQEHLHLLGQR 309
           + + +E       +
Sbjct: 291 QLIAEEFCLKTFSK 304

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  221 bits (565), Expect = 1e-70
 Identities = 64/297 (21%), Positives = 115/297 (38%), Gaps = 18/297 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
             + L   +G G   +V+R   K++G++ AIK      +     V +RE + L+K++H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 62  IVKLKEVI--RENDILYFVFEYMEC-NLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYM 116
           IVKL  +           + E+  C +LY ++++        E+E       V  G+ ++
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 117 HQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + G  HR++KP N++           K+ DFG ARE+     F     T  Y  P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 172 QSYL-------YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
           ++ L       Y + VD+W++G       T    F          ++   I T       
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            G+  A      +   + V  S L          ++A++   D  K     +     
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCS-LSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  221 bits (565), Expect = 2e-68
 Identities = 86/286 (30%), Positives = 133/286 (46%), Gaps = 35/286 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           E Y+ +K++G G +G V     K +    AIK ++K   S      L  EV  L+ + HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NI+KL +   +    Y V E  +   L+  +  R   F+E +      QV  G+ Y+H+ 
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 120 GYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
              HRDLKPEN LL SK+    IKI DFGL+    ++    E + T +Y APEVL +   
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-- 213

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y  K D+W++G I+  L+   P F G ++ + + K+                       Y
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------------------EKGKY 254

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            F        S    + ++ A  LI  +  +D  +R +A +AL+HP
Sbjct: 255 TFD-------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  221 bits (564), Expect = 2e-68
 Identities = 90/287 (31%), Positives = 133/287 (46%), Gaps = 36/287 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           +RYK  + +G G+FG V     K +G+  A+K + K+    +      LREV+ L+++ H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 60  PNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNI+KL E   +    Y V E      L+  +  R K FSE +      QV  G+ YMH+
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHK 144

Query: 119 RGYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
               HRDLKPEN LL SK     I+I DFGL+    +     + + T +Y APEVL  + 
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 203

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y  K D+W+ G I+  L++  P F G +E D + K+                       
Sbjct: 204 -YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-------------------EKGK 243

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           Y F               ++ A  LI  + ++ PS R +A +AL H 
Sbjct: 244 YTFE-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  214 bits (548), Expect = 4e-68
 Identities = 58/299 (19%), Positives = 117/299 (39%), Gaps = 47/299 (15%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
              Y ++K++G G    V++ +++   ++ AIK +  +    +   +   E+  L K+  
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 60  PN--IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            +  I++L +    +  +Y V E    +L   +K ++      E +++   + + +  +H
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH 144

Query: 118 QRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQS- 173
           Q G  H DLKP N L+    +K+ DFG+A ++          S   T  Y  PE +    
Sbjct: 145 QHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 174 ---------YLYSSKVDMWAMGAIMAELITLRPLFPG-TSEADEIYKICSVIGTPTQDSW 223
                       S K D+W++G I+  +   +  F    ++  +++ I            
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------- 254

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                       +FP +             KD   ++      DP +R +  E L HP+
Sbjct: 255 -------PNHEIEFPDIP-----------EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  213 bits (545), Expect = 4e-68
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 44/296 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
            E Y+++  +G G++G   +   K  G+++  K++     +  E   L  EV  LR++ H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 60  PNIVKLKEVI--RENDILYFVFEYMEC-NLYQLMKDREK---CFSEAEVRNWCFQVFQGL 113
           PNIV+  + I  R N  LY V EY E  +L  ++    K      E  V     Q+   L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 114 AYMHQRGYF-----HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRA 166
              H+R        HRDLKP N+ +     +K+ DFGLAR +N    F + +V T +Y +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE  +    Y+ K D+W++G ++ EL  L P F   S+ +   KI               
Sbjct: 185 PEQ-MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------------ 231

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                    KF       +         +   +I  + +     RP+  E L++P 
Sbjct: 232 ---------KFR-----RIPYRYS---DELNEIITRMLNLKDYHRPSVEEILENPL 270

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  219 bits (559), Expect = 9e-68
 Identities = 91/288 (31%), Positives = 139/288 (48%), Gaps = 39/288 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           ERY ++  +G G+FG V +   + + +  A+K + K     ++   + REV+ L+K+ HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 61  NIVKLKEVIRENDILYFVFEYMECN---LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           NI+KL E++ ++   Y V E        L+  +  R K FSE +      QVF G+ YMH
Sbjct: 82  NIMKLFEILEDSSSFYIVGEL--YTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH 138

Query: 118 QRGYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPEN LL SK+    IKI DFGL+          + + T +Y APEVL  +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  K D+W+ G I+  L++  P F G +E D + ++                      
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------------------ETG 237

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            Y F             + + DA  LI  + ++ PS R TA + L+HP
Sbjct: 238 KYAFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  213 bits (545), Expect = 1e-67
 Identities = 71/312 (22%), Positives = 132/312 (42%), Gaps = 40/312 (12%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +  +++ K++G G F  V+RA     G  VA+KK++       +     ++E+  L++++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKD---REKCFSEAEVRNWCFQVFQGLA 114
           HPN++K      E++ L  V E  +  +L +++K    +++   E  V  +  Q+   L 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQ 172
           +MH R   HRD+KP N+ ++    +K+ D GL R  +S+       V T +Y +PE +  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-H 209

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y+ K D+W++G ++ E+  L+  F    +   +Y +C  I                 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKI----------------- 250

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHL 292
               +P L     S       ++   L+    + DP KRP                 H  
Sbjct: 251 EQCDYPPLPSDHYS-------EELRQLVNMCINPDPEKRPDVTYVYDVA-----KRMHAC 298

Query: 293 SVPEQLLQEHLH 304
           +        H H
Sbjct: 299 TASSLEHHHHHH 310

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  215 bits (549), Expect = 3e-67
 Identities = 70/337 (20%), Positives = 125/337 (37%), Gaps = 29/337 (8%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
             + L   +G G   +V+R   K++G++ AIK      +     V +RE + L+K++H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 62  IVKLKEVI--RENDILYFVFEYMEC-NLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYM 116
           IVKL  +           + E+  C +LY ++++        E+E       V  G+ ++
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 117 HQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + G  HR++KP N++           K+ DFG ARE+     F     T  Y  P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 172 QSYL-------YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
           ++ L       Y + VD+W++G       T    F          ++   I T       
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ----- 279
            G+  A      +   + V  S L          ++A++   D  K     +        
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCS-LSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 280 ------HPFSRVAFMFHHLSVPEQLLQEHLHLLGQRE 310
                 H FS      H + +         H L  ++
Sbjct: 308 LHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQ 344

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  211 bits (540), Expect = 3e-67
 Identities = 71/301 (23%), Positives = 118/301 (39%), Gaps = 59/301 (19%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
              +K I+ +G G FG V++A  +  G+   IK++K      E+    REVK+L K+ H 
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKA--EREVKALAKLDHV 64

Query: 61  NIVKLKEVIREND----------------ILYFVFEYME-CNLYQLMKDR-EKCFSEAEV 102
           NIV         D                 L+   E+ +   L Q ++ R  +   +   
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 103 RNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST 161
                Q+ +G+ Y+H +   +RDLKP N+ +     +KI DFGL   + +    T    T
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD 221
             Y +PE +  S  Y  +VD++A+G I+AEL+ +      TS+                 
Sbjct: 185 LRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------------- 226

Query: 222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                       +     +            +K   +L+  L S  P  RP  +E L+  
Sbjct: 227 ------FFTDLRDGIISDIF-----------DKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

Query: 282 F 282
            
Sbjct: 270 T 270

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  210 bits (537), Expect = 1e-66
 Identities = 99/307 (32%), Positives = 146/307 (47%), Gaps = 38/307 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y + +E+G G F  V R + K +G   A K +  K  S  +   L RE +  RK+ HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I+E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + +AY H  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSN 124

Query: 120 GYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           G  HR+LKPEN LL SK     +K+ADFGLA E+N    +  +  T  Y +PEVL +   
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-P 183

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS  VD+WA G I+  L+   P F    +     +I +                     Y
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-------------------AY 224

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF----SRVAFMFHH 291
            +P         + P A K    LI S+ + +P KR TA +AL+ P+     RVA   H 
Sbjct: 225 DYP---SPEWDTVTPEA-KS---LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 277

Query: 292 LSVPEQL 298
               + L
Sbjct: 278 QDTVDCL 284

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  210 bits (536), Expect = 1e-66
 Identities = 90/286 (31%), Positives = 140/286 (48%), Gaps = 35/286 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           ERY ++  +G G+FG V +   + + +  A+K + K     ++   + REV+ L+K+ HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NI+KL E++ ++   Y V E      L+  +  R++ FSE +      QVF G+ YMH+ 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH 140

Query: 120 GYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
              HRDLKPEN LL SK+    IKI DFGL+          + + T +Y APEVL  +  
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-- 198

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y  K D+W+ G I+  L++  P F G +E D + ++                       Y
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------------------ETGKY 239

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            F             + + DA  LI  + ++ PS R TA + L+HP
Sbjct: 240 AFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  211 bits (539), Expect = 2e-66
 Identities = 59/298 (19%), Positives = 117/298 (39%), Gaps = 47/298 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
             Y ++K++G G    V++ +++   ++ AIK +  +    +   +   E+  L K+   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 61  N--IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           +  I++L +    +  +Y V E    +L   +K + K     E +++   + + +  +HQ
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 119 RGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQS-- 173
            G  H DLKP N L+    +K+ DFG+A ++          S   T  Y  PE +     
Sbjct: 127 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 174 --------YLYSSKVDMWAMGAIMAELITLRPLFPG-TSEADEIYKICSVIGTPTQDSWA 224
                      S K D+W++G I+  +   +  F    ++  +++ I             
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----------- 235

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                      +FP +             KD   ++      DP +R +  E L HP+
Sbjct: 236 ------PNHEIEFPDIP-----------EKDLQDVLKCCLKRDPKQRISIPELLAHPY 276

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  214 bits (548), Expect = 6e-66
 Identities = 86/297 (28%), Positives = 133/297 (44%), Gaps = 46/297 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN------------LR 49
           E Y  ++++G G +G V     K      AIK +KK  +      +              
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 50  EVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQ 108
           E+  L+ + HPNI+KL +V  +    Y V E+ E   L++ + +R K F E +  N   Q
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQ 154

Query: 109 VFQGLAYMHQRGYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWY 164
           +  G+ Y+H+    HRD+KPEN LL +K+    IKI DFGL+   +      + + T +Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
            APEVL +   Y+ K D+W+ G IM  L+   P F G ++ D I K+             
Sbjct: 215 IAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV------------- 259

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                     Y F             + + +A  LI  + ++D +KR TA EAL   
Sbjct: 260 ------EKGKYYFD-------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  208 bits (531), Expect = 8e-66
 Identities = 70/307 (22%), Positives = 125/307 (40%), Gaps = 61/307 (19%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMS-H 59
             +  ++++G G FGSV++ + +  G + AIK+ KK      +  N LREV +   +  H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 60  PNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREK---CFSEAEVRNWCFQVFQGLAY 115
            ++V+      E+D +    EY    +L   + +  +    F EAE+++   QV +GL Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 116 MHQRGYFHRDLKPENLLVSKD--------------------TIKIADFGLAREINSRPPF 155
           +H     H D+KP N+ +S+                       KI D G    I+S    
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI 215
                   + A EVL ++Y +  K D++A+   +       PL       D+ ++I    
Sbjct: 191 ---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQ-- 242

Query: 216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA 275
           G                   + P++  V LS       ++   L+  +   DP +RP+A 
Sbjct: 243 G-------------------RLPRIPQV-LS-------QEFTELLKVMIHPDPERRPSAM 275

Query: 276 EALQHPF 282
             ++H  
Sbjct: 276 ALVKHSV 282

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  207 bits (529), Expect = 1e-65
 Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 41/288 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y L   +G G++G V  A+ K +    A KK+ K +    +    +E++ ++ + HPN
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEIEIMKSLDHPN 67

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMH 117
           I++L E   +N  +Y V E      L+    +R   ++ F E++       V   +AY H
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELF----ERVVHKRVFRESDAARIMKDVLSAVAYCH 123

Query: 118 QRGYFHRDLKPENLL-VSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +    HRDLKPEN L ++      +K+ DFGLA            V T +Y +P+VL   
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  + D W+ G +M  L+   P F   ++++ + KI                   R  
Sbjct: 184 --YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------------------REG 222

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            + FP            + +  A SLI  L +  P +R T+ +AL+H 
Sbjct: 223 TFTFP-------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  210 bits (536), Expect = 1e-65
 Identities = 94/287 (32%), Positives = 141/287 (49%), Gaps = 34/287 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           + Y + +E+G G F  V R + K +G   A K +  K  S  +   L RE +  RK+ HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I+E    Y VF+ +    L++ +  RE  +SEA+  +   Q+ + +AY H  
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSN 147

Query: 120 GYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
           G  HR+LKPEN LL SK     +K+ADFGLA E+N    +  +  T  Y +PEVL +   
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-P 206

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS  VD+WA G I+  L+   P F    +     +I +                     Y
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-------------------AY 247

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +P       S    +   +A SLI S+ + +P KR TA +AL+ P+
Sbjct: 248 DYP-------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  209 bits (534), Expect = 3e-65
 Identities = 74/286 (25%), Positives = 124/286 (43%), Gaps = 34/286 (11%)

Query: 2   ERYKLIK--EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
             Y + K   +G G FG V +     +G  +A K +K +    +E V   E+  + ++ H
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV-KNEISVMNQLDH 145

Query: 60  PNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            N+++L +     + +  V EY++   L+  + D     +E +   +  Q+ +G+ +MHQ
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 119 RGYFHRDLKPENLLVS---KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
               H DLKPEN+L        IKI DFGLAR    R        T  + APEV+   + 
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF- 264

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
            S   DMW++G I   L++    F G ++A+ +  I                    A  +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI-------------------LACRW 305

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                            +++A   I+ L   + S R +A+EAL+HP
Sbjct: 306 DLE-------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  210 bits (536), Expect = 6e-65
 Identities = 63/294 (21%), Positives = 114/294 (38%), Gaps = 46/294 (15%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPN 61
            +     +G G  G++           VA+K++  + +S+ +    REV+ LR+   HPN
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPN 79

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +++     ++    Y   E     L + ++ ++      E      Q   GLA++H    
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNI 139

Query: 122 FHRDLKPENLLVSKDT------IKIADFGLAREIN----SRPPFTEYVSTRWYRAPEVLL 171
            HRDLKP N+L+S           I+DFGL +++     S    +    T  + APE+L 
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199

Query: 172 QSYL--YSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           +      +  VD+++ G +   +I+     F  + +      +                 
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----------------- 242

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              A +                  +  A  LI  + + DP KRP+A   L+HPF
Sbjct: 243 --GACSLDCLH--------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  208 bits (532), Expect = 7e-65
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 32/284 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y +++E+G G FG V R + K +G V   K +   Y   +  V   E+  + ++ HP 
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHPK 109

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++ L +   +   +  + E++    L+  +   +   SEAEV N+  Q  +GL +MH+  
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169

Query: 121 YFHRDLKPENLLVSK---DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
             H D+KPEN++       ++KI DFGLA ++N         +T  + APE++ +     
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE-PVG 228

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
              DMWA+G +   L++    F G  + + +  +                      +++F
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------------DWEF 269

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                        S + +A   I +L   +P KR T  +AL+HP
Sbjct: 270 D-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  208 bits (532), Expect = 7e-65
 Identities = 58/299 (19%), Positives = 116/299 (38%), Gaps = 47/299 (15%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
              Y ++K++G G    V++ +++   ++ AIK +  +    +   +   E+  L K+  
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 60  PN--IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            +  I++L +    +  +Y V E    +L   +K + K     E +++   + + +  +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH 172

Query: 118 QRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVS---TRWYRAPEVLLQS- 173
           Q G  H DLKP N L+    +K+ DFG+A ++          S      Y  PE +    
Sbjct: 173 QHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 174 ---------YLYSSKVDMWAMGAIMAELITLRPLFPG-TSEADEIYKICSVIGTPTQDSW 223
                       S K D+W++G I+  +   +  F    ++  +++ I            
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------- 282

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                       +FP +             KD   ++      DP +R +  E L HP+
Sbjct: 283 -------PNHEIEFPDIP-----------EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  205 bits (523), Expect = 1e-64
 Identities = 83/288 (28%), Positives = 119/288 (41%), Gaps = 37/288 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + +   +++G G FG V     + SG    IK + K            E++ L+ + HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81

Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDRE---KCFSEAEVRNWCFQVFQGLAYMH 117
           I+K+ EV  +   +Y V E  E   L + +   +   K  SE  V     Q+   LAY H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 118 QRGYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
            +   H+DLKPEN L         IKI DFGLA    S    T    T  Y APEV  + 
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD 201

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
              + K D+W+ G +M  L+T    F GTS  +   K                       
Sbjct: 202 --VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-------------------TYK 240

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              +      PL+   P A  D   L+  + + DP +RP+AA+ L H 
Sbjct: 241 EPNYAVECR-PLT---PQA-VD---LLKQMLTKDPERRPSAAQVLHHE 280

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  209 bits (534), Expect = 1e-64
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 43/296 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-------REVKSL 54
           + Y + K +G G  G V  A  +++ + VAI+ + K+ ++               E++ L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +K++HP I+K+K      D  Y V E ME   L+  +   ++   EA  + + +Q+   +
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 252

Query: 114 AYMHQRGYFHRDLKPENLLV-SKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H+ G  HRDLKPEN+L+ S++    IKI DFG ++ +           T  Y APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312

Query: 170 LLQSYL--YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWADG 226
           L+      Y+  VD W++G I+   ++  P F        +  +I S             
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG------------ 360

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                   Y F   V   +S       + A+ L+  L   DP  R T  EAL+HP+
Sbjct: 361 -------KYNFIPEVWAEVS-------EKALDLVKKLLVVDPKARFTTEEALRHPW 402

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  204 bits (522), Expect = 2e-64
 Identities = 74/328 (22%), Positives = 123/328 (37%), Gaps = 67/328 (20%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           +  ++ I+ +G G FG V+ A +K      AIK+++           +REVK+L K+ HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 61  NIVKLKEVIREND------------ILYFVFEYME-CNLYQLMKDREKC--FSEAEVRNW 105
            IV+      E +             LY   +     NL   M  R        +   + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS------------- 151
             Q+ + + ++H +G  HRDLKP N+  + D  +K+ DFGL   ++              
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
               T  V T+ Y +PE  +    YS KVD++++G I+ EL  L P          +  +
Sbjct: 184 YARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTLTDV 240

Query: 212 CSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR 271
                                 N KFP         L          ++  + S  P +R
Sbjct: 241 R---------------------NLKFPP--------LFTQKYPCEYVMVQDMLSPSPMER 271

Query: 272 PTAAEALQHPFSRVAFMFHHLSVPEQLL 299
           P A   +++        F  L  P + +
Sbjct: 272 PEAINIIENAV------FEDLDFPGKTV 293

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  204 bits (522), Expect = 4e-64
 Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 35/285 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + +  ++ +G G F  V+    + +G++ A+K +KK     +  +   E+  L+K+ H N
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL-ENEIAVLKKIKHEN 67

Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV L+++       Y V + +    L+  + +R   ++E +      QV   + Y+H+ G
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV-YTEKDASLVIQQVLSAVKYLHENG 126

Query: 121 YFHRDLKPENLLV-SKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
             HRDLKPENLL  + +    I I DFGL++   +    +    T  Y APEVL Q   Y
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKP-Y 184

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S  VD W++G I   L+   P F   +E+    KI                       Y+
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-------------------YYE 225

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           F        S      ++ A   I  L   DP++R T  +AL HP
Sbjct: 226 FE-------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  203 bits (519), Expect = 5e-64
 Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 39/291 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----LREVKSLRK 56
           + Y++ +E+G G F  V +   K +G+  A K +KK+  S            REV  LR+
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPNI+ L ++      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGVHY 123

Query: 116 MHQRGYFHRDLKPEN-LLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFG+A +I +   F     T  + APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
                   + DMW++G I   L++    F G ++ + +  I                   
Sbjct: 184 NYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------------- 223

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY F             + ++ A   I  L   DP +R T A++L+H 
Sbjct: 224 SAVNYDFD-------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  203 bits (519), Expect = 1e-63
 Identities = 82/296 (27%), Positives = 132/296 (44%), Gaps = 43/296 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-------REVKSL 54
           + Y + K +G G  G V  A  +++ + VAIK + K+ ++               E++ L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +K++HP I+K+K      D  Y V E ME   L+  +   ++   EA  + + +Q+   +
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 127

Query: 114 AYMHQRGYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H+ G  HRDLKPEN LL S++    IKI DFG ++ +           T  Y APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187

Query: 170 LLQSYL--YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWADG 226
           L+      Y+  VD W++G I+   ++  P F        +  +I S  G          
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS--G---------- 235

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                   Y F          +    ++ A+ L+  L   DP  R T  EAL+HP+
Sbjct: 236 -------KYNFI-------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  206 bits (527), Expect = 2e-63
 Identities = 92/287 (32%), Positives = 138/287 (48%), Gaps = 35/287 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
           E Y+L +E+G G F  V R +   +G+  A   +  K  S  +   L RE +  R + HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+L + I E    Y +F+ +    L++ +  RE  +SEA+  +   Q+ + + + HQ 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQM 129

Query: 120 GYFHRDLKPENLL-VSKD---TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSY 174
           G  HR+LKPENLL  SK     +K+ADFGLA E+   +  +  +  T  Y +PEVL +  
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD- 188

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y   VD+WA G I+  L+   P F    +     +I +                     
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG-------------------A 229

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           Y FP       S    +   +A  LI  + + +PSKR TAAEAL+HP
Sbjct: 230 YDFP-------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  206 bits (526), Expect = 2e-63
 Identities = 91/321 (28%), Positives = 152/321 (47%), Gaps = 48/321 (14%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKMSHP 60
           RY+++K +G G+FG V +A   +  + VA+K  + +K+++         E++ L  +   
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR----QAAEEIRILEHLRKQ 153

Query: 61  NIVKLKEVIRENDILYF------VFEYMECNLYQLMKD-REKCFSEAEVRNWCFQVFQGL 113
           +      VI   +   F       FE +  NLY+L+K  + + FS   VR +   + Q L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 114 AYMHQRGYFHRDLKPENLLV---SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
             +H+    H DLKPEN+L+    +  IK+ DFG +   + R     Y+ +R+YRAPEV+
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTYIQSRFYRAPEVI 271

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP------------ 218
           L    Y   +DMW++G I+AEL+T  PL PG  E D++  +  ++G P            
Sbjct: 272 LG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330

Query: 219 ------------TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDA-----VSLIA 261
                       T  + +DG ++      +  +L G P S    +A K       +  + 
Sbjct: 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390

Query: 262 SLCSWDPSKRPTAAEALQHPF 282
               WDP+ R T  +AL+HP+
Sbjct: 391 QCLEWDPAVRMTPGQALRHPW 411

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  202 bits (515), Expect = 6e-63
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 39/291 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----LREVKSLRK 56
           + Y   +E+G G F  V +   K +G   A K +KK+               REV  L++
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPN++ L EV      +  + E +    L+  + ++E   +E E   +  Q+  G+ Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYY 129

Query: 116 MHQRGYFHRDLKPEN-LLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H     H DLKPEN +L+ ++     IKI DFGLA +I+    F     T  + APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
                   + DMW++G I   L++    F G ++ + +  +                   
Sbjct: 190 NYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------------- 229

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A+NY+F             + +  A   I  L   DP KR T  ++LQHP
Sbjct: 230 SAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  201 bits (514), Expect = 8e-63
 Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 39/291 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----LREVKSLRK 56
           + Y + +E+G G F  V +   K +G   A K +KK+               REV  LR+
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + H N++ L +V      +  + E +    L+  +  +E   SE E  ++  Q+  G+ Y
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNY 130

Query: 116 MHQRGYFHRDLKPEN-LLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFGLA EI     F     T  + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
                   + DMW++G I   L++    F G ++ + +  I                   
Sbjct: 191 NYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------------------- 230

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            +++Y F               ++ A   I  L   +  KR T  EAL+HP
Sbjct: 231 TSVSYDFD-------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  202 bits (517), Expect = 8e-63
 Identities = 79/291 (27%), Positives = 125/291 (42%), Gaps = 39/291 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----LREVKSLRK 56
           + Y + +E+G G F  V +   K +G   A K +KK+               REV  LR+
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + HPNI+ L +V      +  + E +    L+  +  +E   SE E  ++  Q+  G+ Y
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNY 130

Query: 116 MHQRGYFHRDLKPEN-LLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           +H +   H DLKPEN +L+ K+     IK+ DFGLA EI     F     T  + APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
                   + DMW++G I   L++    F G ++ + +  I                   
Sbjct: 191 NYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------------------- 230

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            A++Y F               ++ A   I  L   +  KR T  EAL+HP
Sbjct: 231 TAVSYDFD-------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  202 bits (515), Expect = 1e-62
 Identities = 80/334 (23%), Positives = 131/334 (39%), Gaps = 79/334 (23%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRKM 57
           ++Y L   +G G++G V  AI  Q+  + AIK M K         ++     EV+ ++K+
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 58  SHPNIVKLKEVIRENDILYFVFEYME---------------------------------- 83
            HPNI +L EV  +   +  V E                                     
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 84  ------CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD- 136
                  +++   +  +    E  + N   Q+F  L Y+H +G  HRD+KPEN L S + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 137 --TIKIADFGLAREINSRPP-----FTEYVSTRWYRAPEVL-LQSYLYSSKVDMWAMGAI 188
              IK+ DFGL++E            T    T ++ APEVL   +  Y  K D W+ G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 189 MAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVL 248
           +  L+     FPG ++AD I ++ +                       F        +  
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNK-------------------KLCFE-------NPN 299

Query: 249 MPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               +  A  L+++L + +  +R  A  ALQHP+
Sbjct: 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  202 bits (515), Expect = 1e-62
 Identities = 83/295 (28%), Positives = 132/295 (44%), Gaps = 43/295 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL----REVKSLRKM 57
           + Y+L + +G G F  V R I++++G+  A+K +    ++    ++     RE      +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 58  SHPNIVKLKEVIRENDILYFVFEYME----CNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
            HP+IV+L E    + +LY VFE+M+    C       D    +SEA   ++  Q+ + L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 114 AYMHQRGYFHRDLKPEN-LLVSKD---TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPE 168
            Y H     HRD+KP   LL SK+    +K+  FG+A ++  S       V T  + APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203

Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWADGL 227
           V+ +   Y   VD+W  G I+  L++    F GT E   ++  I                
Sbjct: 204 VVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKG------------- 247

Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                  YK         S +  SA KD   L+  +   DP++R T  EAL HP+
Sbjct: 248 ------KYKMN---PRQWSHISESA-KD---LVRRMLMLDPAERITVYEALNHPW 289

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  200 bits (510), Expect = 3e-62
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 37/286 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E+Y + +++G G FG V R +   S +    K +K K          +E+  L    H N
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV--KKEISILNIARHRN 62

Query: 62  IVKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           I+ L E     + L  +FE++   +  +++ +       +E E+ ++  QV + L ++H 
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 119 RGYFHRDLKPENLL-VSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
               H D++PEN++  ++   TIKI +FG AR++     F    +   Y APEV     +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-V 179

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
            S+  DMW++G ++  L++    F   +    I  I                       Y
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-------------------MNAEY 220

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            F               + +A+  +  L   +   R TA+EALQHP
Sbjct: 221 TFD-------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  206 bits (526), Expect = 4e-62
 Identities = 69/284 (24%), Positives = 127/284 (44%), Gaps = 32/284 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y + +E+G G FG V R   + +G   A K +   + S +E V  +E++++  + HP 
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVLRHPT 215

Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V L +   +++ +  ++E+M    L++ + D     SE E   +  QV +GL +MH+  
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 121 YFHRDLKPENLLVS---KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           Y H DLKPEN++ +    + +K+ DFGL   ++ +        T  + APEV        
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVG 334

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
              DMW++G +   L++    F G ++ + +  + S                    ++  
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-------------------DWNM 375

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                          ++D    I  L   DP+ R T  +AL+HP
Sbjct: 376 D-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  198 bits (506), Expect = 8e-62
 Identities = 58/301 (19%), Positives = 109/301 (36%), Gaps = 49/301 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y  I+++G+G F  V        G   A+K++        E    RE    R  +HPN
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA-QREADMHRLFNHPN 87

Query: 62  IVKLKEVIRE----NDILYFVFEYMEC-NLYQLMKDREK---CFSEAEVRNWCFQVFQGL 113
           I++L              + +  + +   L+  ++  +      +E ++      + +GL
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE----------YVSTR 162
             +H +GY HRDLKP N+L+  +    + D G   +       +              T 
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 163 WYRAPEVL-LQSYL-YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
            YRAPE+  +QS+     + D+W++G ++  ++     +    +  +             
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA---------- 257

Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                   LA       PQ          P  +     L+ S+ + DP +RP     L  
Sbjct: 258 --------LAVQNQLSIPQ---------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300

Query: 281 P 281
            
Sbjct: 301 L 301

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  196 bits (501), Expect = 3e-61
 Identities = 84/300 (28%), Positives = 125/300 (41%), Gaps = 49/300 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--------REVKS 53
           E Y+  + +G G    V R I K + +  A+K +            +        +EV  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 54  LRKMS-HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR---EKCFSEAEVRNWCFQ 108
           LRK+S HPNI++LK+    N   + VF+ M+   L+    D    +   SE E R     
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF----DYLTEKVTLSEKETRKIMRA 132

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
           + + +  +H+    HRDLKPEN+L+  D  IK+ DFG + +++      E   T  Y AP
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192

Query: 168 EVLLQSYL-----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS 222
           E++  S       Y  +VDMW+ G IM  L+   P F    +   +  I S         
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-------- 244

Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                      NY+F        S      +     L++      P KR TA EAL HPF
Sbjct: 245 -----------NYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  196 bits (501), Expect = 8e-61
 Identities = 82/291 (28%), Positives = 120/291 (41%), Gaps = 40/291 (13%)

Query: 2   ERYKLI-KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSH 59
             Y L  KE+G G F  V + ISK +G+  A K +KK+    +    +  E+  L     
Sbjct: 28  NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 60  -PNIVKLKEVIRENDILYFVFEYM---ECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLA 114
            P ++ L EV      +  + EY    E  ++   + +  +  SE +V     Q+ +G+ 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGE--IFSLCLPELAEMVSENDVIRLIKQILEGVY 145

Query: 115 YMHQRGYFHRDLKPEN-LLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
           Y+HQ    H DLKP+N LL S      IKI DFG++R+I       E + T  Y APE+L
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL 205

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
                 ++  DMW +G I   L+T    F G    +    I  V                
Sbjct: 206 NYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---------------- 248

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
              N  +             S ++ A   I SL   +P KRPTA   L H 
Sbjct: 249 ---NVDYS-------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  196 bits (501), Expect = 1e-60
 Identities = 80/285 (28%), Positives = 129/285 (45%), Gaps = 35/285 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + +++  E+G G    V+R   K + +  A+K +KK     ++ V   E+  L ++SHPN
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIV-RTEIGVLLRLSHPN 109

Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I+KLKE+      +  V E +    L+  + ++   +SE +  +   Q+ + +AY+H+ G
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLHENG 168

Query: 121 YFHRDLKPENLL-VSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
             HRDLKPENLL  +      +KIADFGL++ +  +        T  Y APE+L     Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-Y 227

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             +VDMW++G I   L+     F        +++                        Y 
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI------------------LNCEYY 269

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
           F        S      + +A  L+  L   DP KR T  +ALQHP
Sbjct: 270 FI-------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  197 bits (502), Expect = 2e-60
 Identities = 92/329 (27%), Positives = 139/329 (42%), Gaps = 55/329 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKMSH 59
           +RY++   +G G+FG V +A  +   E VAIK  K KK + +        EV+ L  M+ 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN----QAQIEVRLLELMNK 109

Query: 60  PNIVKLKEVIRENDILYF------VFEYMECNLYQLMKDREKC-FSEAEVRNWCFQVFQG 112
            +      ++       F      VFE +  NLY L+++      S    R +  Q+   
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 113 LAYMHQR--GYFHRDLKPENLLV---SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
           L ++        H DLKPEN+L+    +  IKI DFG + ++  R    +Y+ +R+YR+P
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQYIQSRFYRSP 227

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ------- 220
           EVLL    Y   +DMW++G I+ E+ T  PLF G +E D++ KI  V+G P         
Sbjct: 228 EVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286

Query: 221 ------DSWADGLLLARAI-----NYKFPQL----------VGVPLSVLMPSANKDA--- 256
                 +   DG    +        YK P             G P       +       
Sbjct: 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADY 346

Query: 257 ---VSLIASLCSWDPSKRPTAAEALQHPF 282
                LI  +  +DP  R     ALQH F
Sbjct: 347 LKFKDLILRMLDYDPKTRIQPYYALQHSF 375

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  202 bits (515), Expect = 8e-60
 Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 24/295 (8%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
            +++ + +G G FG V R I + +GE VAIK+ +++           E++ ++K++HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 63  VKLKEVIRE------NDILYFVFEYMEC-NLYQLMKDREKC--FSEAEVRNWCFQVFQGL 113
           V  +EV         ND+     EY E  +L + +   E C    E  +R     +   L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 114 AYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H+    HRDLKPEN+++         KI D G A+E++     TE+V T  Y APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI--CSVIGTPTQDSWADGL 227
            L+   Y+  VD W+ G +  E IT    F    +  + +                  G 
Sbjct: 195 -LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG- 252

Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                   KF  ++  P + L           +  +  W   +R T  +      
Sbjct: 253 ------AVKFSSVLPTP-NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  193 bits (493), Expect = 3e-59
 Identities = 79/302 (26%), Positives = 125/302 (41%), Gaps = 54/302 (17%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-------LREVKSL 54
           ++Y     +G G    V R + + +G   A+K M+                   RE   L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 55  RKMS-HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR---EKCFSEAEVRNWCFQV 109
           R+++ HP+I+ L +    +  ++ VF+ M    L+    D    +   SE E R+    +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF----DYLTEKVALSEKETRSIMRSL 209

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
            + ++++H     HRDLKPEN+L+  +  I+++DFG +  +       E   T  Y APE
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269

Query: 169 VLLQSYL-----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSW 223
           +L  S       Y  +VD+WA G I+  L+   P F    +                   
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL----------------- 312

Query: 224 ADGLLLARAI---NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                + R I    Y+F        S    +  KD   LI+ L   DP  R TA +ALQH
Sbjct: 313 -----MLRMIMEGQYQFSSPEWDDRS---STV-KD---LISRLLQVDPEARLTAEQALQH 360

Query: 281 PF 282
           PF
Sbjct: 361 PF 362

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  195 bits (498), Expect = 3e-59
 Identities = 73/314 (23%), Positives = 123/314 (39%), Gaps = 63/314 (20%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HP 60
                 K +G G+ G+V        G  VA+K+M   +          E+K L +   HP
Sbjct: 15  NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHP 69

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDRE------KCFSEAEVRNWCFQVFQGLA 114
           N+++       +  LY   E    NL  L++ +       K   E    +   Q+  G+A
Sbjct: 70  NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 115 YMHQRGYFHRDLKPENLLVSKD--------------TIKIADFGLAREINS-----RPPF 155
           ++H     HRDLKP+N+LVS                 I I+DFGL ++++S     R   
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 156 TEYVSTRWYRAPEVLLQSYL------YSSKVDMWAMGAIMAELITL-RPLFPGTSEADEI 208
                T  +RAPE+L +S         +  +D+++MG +   +++  +  F      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248

Query: 209 YKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDP 268
             I                       +   ++  +    L+  A  D   LI+ +   DP
Sbjct: 249 -NI-------------------IRGIFSLDEMKCLHDRSLIAEA-TD---LISQMIDHDP 284

Query: 269 SKRPTAAEALQHPF 282
            KRPTA + L+HP 
Sbjct: 285 LKRPTAMKVLRHPL 298

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  193 bits (491), Expect = 5e-59
 Identities = 43/316 (13%), Positives = 92/316 (29%), Gaps = 59/316 (18%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP 60
           + KL++ +  G    V+     +  E  A+K       +    +        +  ++   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 61  NIVKLKEVIR---ENDIL-----------------------YFVFEYMECNLYQLMK--- 91
           +  + ++  R    +D +                         +      +L  L     
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 92  ---DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR 147
                        +     Q+ +  A +  +G  H    P+NL +  D  + + D     
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 148 EINSRPPFTEYVSTRWYRAPEVL-LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD 206
           ++ +R           Y   E L   +  ++  ++ W +G  +  +  L   F   +   
Sbjct: 243 KVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 207 EIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW 266
           +       +  P  DS A            F     +P  V      K    LI    ++
Sbjct: 301 KGSWKRPSLRVPGTDSLA------------FGSCTPLPDFV------KT---LIGRFLNF 339

Query: 267 DPSKRPTAAEALQHPF 282
           D  +R    EA++ P 
Sbjct: 340 DRRRRLLPLEAMETPE 355

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  189 bits (483), Expect = 3e-58
 Identities = 83/302 (27%), Positives = 131/302 (43%), Gaps = 38/302 (12%)

Query: 2   ERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-H 59
           + Y+L ++V G+G    V   I+  + +  A+K ++K+       V  REV+ L +   H
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQGH 70

Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            N+++L E   E D  Y VFE M    +   +  R + F+E E       V   L ++H 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHN 129

Query: 119 RGYFHRDLKPENLL-VSKD---TIKIADFGLAREINSRPPFTEYVSTRW--------YRA 166
           +G  HRDLKPEN+L    +    +KI DF L   I      +   +           Y A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 167 PEVLLQSYL----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS 222
           PEV+         Y  + D+W++G I+  L++  P F G   +D  +             
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM- 248

Query: 223 WADGLLLARAI---NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
                 L  +I    Y+FP       + +  +A KD   LI+ L   D  +R +AA+ LQ
Sbjct: 249 ------LFESIQEGKYEFP---DKDWAHISCAA-KD---LISKLLVRDAKQRLSAAQVLQ 295

Query: 280 HP 281
           HP
Sbjct: 296 HP 297

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  188 bits (479), Expect = 4e-58
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 56/297 (18%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +E +K+   +G G+F  V+RA S  +G  VAIK + KK       V     EVK   ++ 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HP+I++L     +++ +Y V E      + + +K+R K FSE E R++  Q+  G+ Y+H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR----------PPFTEYVSTRWYRA 166
             G  HRDL   NLL++++  IKIADFGLA ++             P          Y +
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN---------YIS 180

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWAD 225
           PE+  +S  +  + D+W++G +   L+  RP F  T        K+              
Sbjct: 181 PEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLNKVVLA----------- 227

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                   +Y+ P  +           + +A  LI  L   +P+ R + +  L HPF
Sbjct: 228 --------DYEMPSFL-----------SIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  189 bits (483), Expect = 9e-58
 Identities = 76/342 (22%), Positives = 136/342 (39%), Gaps = 79/342 (23%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKMSH 59
             + +I+++GDGTFG V       + +  A+K  +  KKY          E   L+K+ +
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR----SAKIEADILKKIQN 90

Query: 60  -----PNIVKLKEVIRENDILYF--------VFEYMECNLYQLMKD-REKCFSEAEVRNW 105
                 NIVK            F        +FE +  +LY+++       F   +++ +
Sbjct: 91  DDINNNNIVKYHG--------KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLY 142

Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENLLV--------------------------SKDTIK 139
           C ++ + L Y+ +    H DLKPEN+L+                              IK
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 140 IADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF 199
           + DFG A   +        ++TR YRAPEV+L    +    DMW+ G ++AEL T   LF
Sbjct: 203 LIDFGCATFKSDY--HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF 259

Query: 200 PGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAV-- 257
                 + +  + S+I    ++   +     +    K+     + L+    +++ +++  
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEA---TKTNGSKYVNKDELKLAWPENASSINSIKH 316

Query: 258 -----------------SLIASLCSWDPSKRPTAAEALQHPF 282
                              + S+   DP+ RP+ AE L+H F
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF 358

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  187 bits (476), Expect = 1e-57
 Identities = 74/292 (25%), Positives = 131/292 (44%), Gaps = 49/292 (16%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY---YSWEECVNLREVKSLRKM 57
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K        E  +  REV+    +
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR-REVEIQSHL 66

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
            HPNI++L     +   +Y + EY     +Y+ ++ +   F E     +  ++   L+Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYC 125

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT-----EYVSTRWYRAPEVL 170
           H +   HRD+KPENLL+     +KIADFG +    S          +Y+       PE+ 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEM- 178

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           ++  ++  KVD+W++G +  E +  +P F   +  +   +I  V                
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 222

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               + FP               + A  LI+ L   +PS+RP   E L+HP+
Sbjct: 223 ---EFTFP-----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  188 bits (480), Expect = 1e-57
 Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 44/292 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HP 60
           + Y++ +++G G++    R I K +    A+K + K      +     E++ L +   HP
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-----KRDPTEEIEILLRYGQHP 76

Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NI+ LK+V  +   +Y V E M+   L   +  + K FSE E     F + + + Y+H +
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQ 135

Query: 120 GYFHRDLKPENLLVS-----KDTIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQS 173
           G  HRDLKP N+L        ++I+I DFG A+++ +          T  + APEVL + 
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y +  D+W++G ++  ++T    F    +                        +   I
Sbjct: 196 G-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE-------------------ILARI 235

Query: 234 ---NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               +               S +  A  L++ +   DP +R TAA  L+HP+
Sbjct: 236 GSGKFSLS-------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  187 bits (476), Expect = 2e-57
 Identities = 83/299 (27%), Positives = 118/299 (39%), Gaps = 61/299 (20%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
             RY   + +G G F   +      + EV A K + K              E+   R ++
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN---LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           H ++V       +ND ++ V E   C    L +L K R K  +E E R +  Q+  G  Y
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLEL--CRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQY 130

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR----------PPFTEYVSTRWY 164
           +H+    HRDLK  NL +++D  +KI DFGLA ++             P          Y
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---------Y 181

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSW 223
            APEV L    +S +VD+W++G IM  L+  +P F  TS   E Y +I            
Sbjct: 182 IAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN--------- 230

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                      Y  P              N  A SLI  +   DP+ RPT  E L   F
Sbjct: 231 ----------EYSIP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEF 268

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  187 bits (477), Expect = 4e-57
 Identities = 84/328 (25%), Positives = 134/328 (40%), Gaps = 51/328 (15%)

Query: 2   ERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-H 59
           + Y+L K+V G G  G V     +++G+  A+K +             +EV    + S  
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA-RQEVDHHWQASGG 81

Query: 60  PNIVKLKEV----IRENDILYFVFEYM---ECNLYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
           P+IV + +V          L  + E M   E  L+  +++R ++ F+E E       +  
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGE--LFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 112 GLAYMHQRGYFHRDLKPENLL-VSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAP 167
            + ++H     HRD+KPENLL  SK+    +K+ DFG A+E            T +Y AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAP 198

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           EVL     Y    DMW++G IM  L+   P F   +       +   I            
Sbjct: 199 EVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI------------ 245

Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF 287
              R   Y FP       +      ++DA  LI  L   DP++R T  + + HP     +
Sbjct: 246 ---RLGQYGFP-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP-----W 290

Query: 288 MFHHLSVPEQLLQEHLHLLGQREHWSSK 315
           +   + VP+  L     L   ++HW   
Sbjct: 291 INQSMVVPQTPLHTARVLQEDKDHWDEV 318

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  187 bits (477), Expect = 4e-57
 Identities = 82/327 (25%), Positives = 131/327 (40%), Gaps = 55/327 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRAI-SKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKMS 58
            RY+++  +G+G FG V   I  K  G  VA+K  K   +Y          E++ L  ++
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE----AARSEIQVLEHLN 69

Query: 59  HPNIVKLKEVIRENDILYF------VFEYMECNLYQLMKD-REKCFSEAEVRNWCFQVFQ 111
             +       ++  +          VFE +  + Y  +K+     F    +R   +Q+ +
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 112 GLAYMHQRGYFHRDLKPEN-LLVSKD-------------------TIKIADFGLAREINS 151
            + ++H     H DLKPEN L V  D                    IK+ DFG A   + 
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
               +  VSTR YRAPEV+L    +S   D+W++G I+ E      +FP     + +  +
Sbjct: 190 HH--STLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246

Query: 212 CSVIGTPTQ-------------DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKD--- 255
             ++G   +                 D    + A  Y        PL   M S + +   
Sbjct: 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC--KPLKEFMLSQDVEHER 304

Query: 256 AVSLIASLCSWDPSKRPTAAEALQHPF 282
              LI  +  +DP+KR T  EAL+HPF
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPF 331

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  187 bits (477), Expect = 4e-57
 Identities = 83/299 (27%), Positives = 118/299 (39%), Gaps = 61/299 (20%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
             RY   + +G G F   +      + EV A K + K              E+   R ++
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN---LYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           H ++V       +ND ++ V E   C    L +L K R K  +E E R +  Q+  G  Y
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLEL--CRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQY 156

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR----------PPFTEYVSTRWY 164
           +H+    HRDLK  NL +++D  +KI DFGLA ++             P          Y
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---------Y 207

Query: 165 RAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSW 223
            APEV L    +S +VD+W++G IM  L+  +P F  TS   E Y +I            
Sbjct: 208 IAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN--------- 256

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                      Y  P              N  A SLI  +   DP+ RPT  E L   F
Sbjct: 257 ----------EYSIP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEF 294

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  188 bits (480), Expect = 7e-57
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 41/292 (14%)

Query: 2   ERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-H 59
           + YK+  +V G G  G V +  +K++ E  A+K ++            REV+   + S  
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKA-RREVELHWRASQC 114

Query: 60  PNIVKLKEV----IRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           P+IV++ +V          L  V E ++      ++    ++ F+E E       + + +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 114 AYMHQRGYFHRDLKPENLL-VSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H     HRD+KPENLL  SK     +K+ DFG A+E  S    T    T +Y APEV
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           L     Y    DMW++G IM  L+   P F           + + I              
Sbjct: 235 LGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------------- 279

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
            R   Y+FP       +      +++   LI +L   +P++R T  E + HP
Sbjct: 280 -RMGQYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  187 bits (476), Expect = 8e-57
 Identities = 77/331 (23%), Positives = 135/331 (40%), Gaps = 63/331 (19%)

Query: 2   ERYKLIKEVGDGTFGSVWRAI-SKQSGEVVAIK--KMKKKYYSWEECVNLREVKSLRKMS 58
           ERY+++  +G+GTFG V   +   +    VA+K  +   KY          E+  L+K+ 
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE----AARLEINVLKKIK 74

Query: 59  HPNIVKLKEVIRENDILYF------VFEYMECNLYQLMKD-REKCFSEAEVRNWCFQVFQ 111
             +       +  +D   F       FE +  N ++ +K+   + +    VR+  +Q+  
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 112 GLAYMHQRGYFHRDLKPENLLV--------------------SKDTIKIADFGLAREINS 151
            L ++H+    H DLKPEN+L                        +I++ADFG A   + 
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194

Query: 152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI 211
               T  V+TR YR PEV+L+   ++   D+W++G I+ E      LF      + +  +
Sbjct: 195 HH--TTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251

Query: 212 CSVIGTPTQDSWADGLLLARAINYKF-----------------PQLVGVPLSVLMPSANK 254
             ++G           ++ R    K+                  +    PL   M   + 
Sbjct: 252 EKILGPIPSH------MIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305

Query: 255 D---AVSLIASLCSWDPSKRPTAAEALQHPF 282
           +      L+  +  +DP++R T AEAL HPF
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  185 bits (473), Expect = 1e-56
 Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 41/294 (13%)

Query: 2   ERYKL---IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           + Y L    K +G+G+F    + + K+S +  A+K + K+  +  +    +E+ +L+   
Sbjct: 8   QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ----KEITALKLCE 63

Query: 59  -HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
            HPNIVKL EV  +    + V E +    L++ +K + K FSE E      ++   +++M
Sbjct: 64  GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHM 122

Query: 117 HQRGYFHRDLKPENLL-VSKD---TIKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLL 171
           H  G  HRDLKPENLL   ++    IKI DFG AR       P      T  Y APE+L 
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
           Q+  Y    D+W++G I+  +++ +  F                      +    + + +
Sbjct: 183 QNG-YDESCDLWSLGVILYTMLSGQVPFQSHDR---------------SLTCTSAVEIMK 226

Query: 232 AI---NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            I   ++ F    G     +   A KD   LI  L + DP+KR   +    + +
Sbjct: 227 KIKKGDFSFE---GEAWKNVSQEA-KD---LIQGLLTVDPNKRLKMSGLRYNEW 273

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  187 bits (477), Expect = 1e-56
 Identities = 89/320 (27%), Positives = 139/320 (43%), Gaps = 43/320 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIK--KMKKKYY--SWEE-----CVNLREVKS 53
           RY L++++G G F +VW A    +   VA+K  +  K Y   + +E      VN  +   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 54  LRKMSHPNIVKLKE--VIRENDI--LYFVFEYMECNLYQLMKD-REKCFSEAEVRNWCFQ 108
              M   +I+KL +    +  +   +  VFE +  NL  L+K    +      V+    Q
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 109 VFQGLAYMHQR-GYFHRDLKPENLLVS-------KDTIKIADFGLAREINSRPPFTEYVS 160
           +  GL YMH+R G  H D+KPEN+L+           IKIAD G A   +    +T  + 
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQ 197

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG------TSEADEIYKICSV 214
           TR YR+PEVLL +  +    D+W+   ++ ELIT   LF        T + D I +I  +
Sbjct: 198 TREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256

Query: 215 IGTPTQ---------DSWADGLLLARAI-NYKFPQLVGVPLSVLMPSANKDA--VSLIAS 262
           +G              ++ +   L R I   KF  L  V       S ++       ++ 
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 263 LCSWDPSKRPTAAEALQHPF 282
           +   DP KR  A   + HP+
Sbjct: 317 MLQLDPRKRADAGGLVNHPW 336

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  181 bits (462), Expect = 5e-55
 Identities = 68/295 (23%), Positives = 111/295 (37%), Gaps = 44/295 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           +        VG G+FG V R   KQ+G   A+KK++       E   + E+ +   +S P
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSP 110

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            IV L   +RE   +    E +E  +L QL+K +  C  E     +  Q  +GL Y+H R
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTR 169

Query: 120 GYFHRDLKPENLLVSKD--TIKIADFGLAREI------NSRPPFTEYVSTRWYRAPEVLL 171
              H D+K +N+L+S D     + DFG A  +       S         T  + APEV++
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
                 +KVD+W+   +M  ++     +          KI       ++           
Sbjct: 230 GKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPP--------- 273

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
                       P+  + PS        I      +P  R +A E  +     + 
Sbjct: 274 ------------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  180 bits (458), Expect = 6e-55
 Identities = 70/292 (23%), Positives = 128/292 (43%), Gaps = 49/292 (16%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY---YSWEECVNLREVKSLRKM 57
           ++ + + + +G G FG+V+ A  KQ+  ++A+K + K        E  +  RE++    +
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR-REIEIQSHL 71

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
            HPNI+++     +   +Y + E+     LY+ ++ +   F E     +  ++   L Y 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELADALHYC 130

Query: 117 HQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFT-----EYVSTRWYRAPEVL 170
           H+R   HRD+KPENLL+  K  +KIADFG +    S    T     +Y+       PE+ 
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEM- 183

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           ++   +  KVD+W  G +  E +   P F   S  +   +I +V                
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------------- 227

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              + KFP  +           +  +  LI+ L  + P +R      ++HP+
Sbjct: 228 ---DLKFPPFL-----------SDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  176 bits (448), Expect = 2e-53
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 41/289 (14%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLR-EVKSLRKMSHPNI 62
            K   E+G G+F +V++ +  ++   VA  +++ +  +  E    + E + L+ + HPNI
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 63  VKL----KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           V+     +  ++    +  V E M    L   +K R K      +R+WC Q+ +GL ++H
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 118 QRGYF--HRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
            R     HRDLK +N+ ++  T  +KI D GLA    +       + T  + APE+  + 
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMYEEK 205

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y   VD++A G  M E+ T    +     A +IY+  +                    
Sbjct: 206 --YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-------------------- 243

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                   GV  +     A  +   +I      +  +R +  + L H F
Sbjct: 244 -------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  177 bits (450), Expect = 4e-53
 Identities = 73/310 (23%), Positives = 121/310 (39%), Gaps = 64/310 (20%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPN 61
           R ++ + + +G F  V+ A    SG   A+K++          + ++EV  ++K+S HPN
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-IQEVCFMKKLSGHPN 87

Query: 62  IVKL-------KEVIRENDILYFVFEYMECN--LYQLMKDRE--KCFSEAEVRNWCFQVF 110
           IV+        KE        + +   + C   L + +K  E     S   V    +Q  
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 111 QGLAYMHQRG--YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW---- 163
           + + +MH++     HRDLK ENLL+S   TIK+ DFG A  I+  P ++     R     
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 164 ---------YRAPEV--LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKIC 212
                    YR PE+  L  ++    K D+WA+G I+  L   +  F    E     +I 
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIV 262

Query: 213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP 272
           +                     Y  P            +      SLI ++   +P +R 
Sbjct: 263 NG-------------------KYSIPP---------HDTQYTVFHSLIRAMLQVNPEERL 294

Query: 273 TAAEALQHPF 282
           + AE +    
Sbjct: 295 SIAEVVHQLQ 304

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  173 bits (441), Expect = 1e-51
 Identities = 55/323 (17%), Positives = 121/323 (37%), Gaps = 68/323 (21%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL------------ 48
           +  Y++I+ +  G F  +     ++  +  A+KK +K     +                 
Sbjct: 30  INDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 49  ----REVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME--------CNLYQLMKDREKC 96
                E++ +  + +   +  + +I   D +Y ++EYME           + L K+    
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 97  FSEAEVRNWCFQVFQGLAYMH-QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP 154
                ++     V    +Y+H ++   HRD+KP N+L+ K+  +K++DFG +  +  +  
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 155 FT-----EYVSTRWYRAPEVLLQSYLYS-SKVDMWAMGAIMAELITLRPLFPGTSEADEI 208
                  E++       PE       Y+ +KVD+W++G  +  +      F       E+
Sbjct: 208 KGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

Query: 209 Y-KICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSAN--------KDAVSL 259
           +  I +                    N ++P      L  L    +         + +  
Sbjct: 262 FNNIRTK-------------------NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF 302

Query: 260 IASLCSWDPSKRPTAAEALQHPF 282
           +      +P++R T+ +AL+H +
Sbjct: 303 LKLFLRKNPAERITSEDALKHEW 325

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  173 bits (441), Expect = 1e-51
 Identities = 82/316 (25%), Positives = 134/316 (42%), Gaps = 41/316 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL--REVKSLRKMSH 59
           + +  ++E+G G+FG+V+ A   ++ EVVAIKKM        E      +EV+ L+K+ H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           PN ++ +         + V EY   +   L++  +K   E E+        QGLAY+H  
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL--QSYLY 176
              HRD+K  N+L+S+   +K+ DFG A  +     F   V T ++ APEV+L      Y
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQY 230

Query: 177 SSKVDMWAMGAIMA-ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
             KVD+W++G I   EL   +P     +    +Y I         +S             
Sbjct: 231 DGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI------AQNES------------- 270

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVP 295
             P L     S       +   + + S     P  RPT+   L+H F         +   
Sbjct: 271 --PALQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM-- 319

Query: 296 EQLLQEHLHLLGQREH 311
             L+Q     + + ++
Sbjct: 320 -DLIQRTKDAVRELDN 334

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  169 bits (431), Expect = 7e-51
 Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 38/278 (13%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHPNI 62
            + + +G G+FG+V++      G+V A+K +     +  + +     EV  LRK  H NI
Sbjct: 27  TVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNI 82

Query: 63  VKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +           L  V ++ E  +LY  +   E  F   ++ +   Q  +G+ Y+H +  
Sbjct: 83  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTR-WYR--APEVLLQ--SYL 175
            HRDLK  N+ + +D T+KI DFGLA E +      ++          APEV+    S  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           YS + D++A G ++ EL+T +  +   +  D+I     ++G                   
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---EMVGR----------------GS 242

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT 273
             P L  V       +  K    L+A        +RP+
Sbjct: 243 LSPDLSKVR-----SNCPKRMKRLMAECLKKKRDERPS 275

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  169 bits (431), Expect = 9e-51
 Identities = 74/326 (22%), Positives = 124/326 (38%), Gaps = 67/326 (20%)

Query: 2   ERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-H 59
           + YK+  +V G G  G V +  +K++ E  A+K ++            REV+   + S  
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKA-RREVELHWRASQC 70

Query: 60  PNIVKLKEV----IRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           P+IV++ +V          L  V E ++      ++    ++ F+E E       + + +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 114 AYMHQRGYFHRDLKPENLL-VSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            Y+H     HRD+KPENLL  SK     +K+ DFG                     A E 
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKET 170

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
             +   Y    DMW++G IM  L+   P F           + + I              
Sbjct: 171 TGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------------- 214

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMF 289
            R   Y+FP       +      +++   LI +L   +P++R T  E + HP     ++ 
Sbjct: 215 -RMGQYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP-----WIM 261

Query: 290 HHLSVPEQLLQEHLHLLGQREHWSSK 315
               VP+  L     L   +E W   
Sbjct: 262 QSTKVPQTPLHTSRVLKEDKERWEDV 287

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  169 bits (430), Expect = 3e-50
 Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 53/294 (18%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKK---YYSWEECVNL----REVKS 53
            ++Y  +  +G G FG VW A+ K+  + V +K +KK+      W E   L     E+  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEY----MECNLYQLMKDREKCFSEAEVRNWCFQV 109
           L ++ H NI+K+ ++         V E     ++  L+  +    +   E        Q+
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLD--LFAFIDRHPR-LDEPLASYIFRQL 139

Query: 110 FQGLAYMHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
              + Y+  +   HRD+K EN+++    TIK+ DFG A  +     F  +  T  Y APE
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199

Query: 169 VLL-QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           VL+   Y    +++MW++G  +  L+     F       E+ +                 
Sbjct: 200 VLMGNPYR-GPELEMWSLGVTLYTLVFEENPF------CELEETVEA------------- 239

Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                     P LV           +K+ +SL++ L    P +R T  + +  P
Sbjct: 240 ------AIHPPYLV-----------SKELMSLVSGLLQPVPERRTTLEKLVTDP 276

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  169 bits (429), Expect = 3e-50
 Identities = 73/316 (23%), Positives = 127/316 (40%), Gaps = 55/316 (17%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM-KKKYYSWEECVNL----REVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK + K +   W E  N      EV  L+K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 58  SH--PNIVKLKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E    L+  + +R     E   R++ +QV + +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 162

Query: 114 AYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  +   +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 221

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
               +     +W++G ++ +++     F      +   +I              G     
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEII------------RG----- 258

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH 291
                F Q V           + +   LI    +  PS RPT  E   HP+         
Sbjct: 259 --QVFFRQRV-----------SSECQHLIRWCLALRPSDRPTFEEIQNHPW------MQD 299

Query: 292 LSVPEQLLQEHLHLLG 307
           + +P++  + HLH L 
Sbjct: 300 VLLPQETAEIHLHSLS 315

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  168 bits (427), Expect = 5e-50
 Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 48/287 (16%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIV 63
              + +G G FG   +   +++GEV+ +K++ +  +  E     L+EVK +R + HPN++
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVL 70

Query: 64  KLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           K   V+ ++  L F+ EY++   L  ++K  +  +  ++  ++   +  G+AY+H     
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130

Query: 123 HRDLKPENLLVSKD-TIKIADFGLAREI---------------NSRPPFTEYVSTRWYRA 166
           HRDL   N LV ++  + +ADFGLAR +                 R      V   ++ A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE+ +    Y  KVD+++ G ++ E+I      P                 P      D 
Sbjct: 191 PEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRT---MDF 232

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT 273
            L  R            P S            +    C  DP KRP+
Sbjct: 233 GLNVRG-FLDRYCPPNCPPSFF---------PITVRCCDLDPEKRPS 269

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  166 bits (423), Expect = 1e-49
 Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 35/284 (12%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G GT+G V+      +   +AIK++ ++   + + ++  E+   + + H NIV+     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-EEIALHKHLKHKNIVQYLGSF 88

Query: 70  RENDILYFVFEYMEC-NLYQLMKDREKCFSEAE--VRNWCFQVFQGLAYMHQRGYFHRDL 126
            EN  +    E +   +L  L++ +     + E  +  +  Q+ +GL Y+H     HRD+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148

Query: 127 KPENLLVSKD--TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYL-YSSKVDM 182
           K +N+L++     +KI+DFG ++ +    P TE +  T  Y APE++ +    Y    D+
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208

Query: 183 WAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG 242
           W++G  + E+ T +P F    E  E       +G                     P++  
Sbjct: 209 WSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFKVH----------------PEI-- 247

Query: 243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
            P      S + +A + I      DP KR  A + L   F +V+
Sbjct: 248 -P-----ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  169 bits (429), Expect = 1e-49
 Identities = 65/313 (20%), Positives = 118/313 (37%), Gaps = 33/313 (10%)

Query: 2   ERYKLIKEVGDG--TFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMS 58
             Y+L+  +G G     +V  A  K +GE V ++++  +  S E    L  E+   +  +
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYM 116
           HPNIV  +     ++ L+ V  +M   +   L+        +E  +      V + L Y+
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI-------NSRPPFTEY-VSTRWYRAP 167
           H  GY HR +K  ++L+S D  + ++       +            F +Y V    + +P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 168 EVLLQSYL-YSSKVDMWAMGAIMA-ELITLRP----------LF------PGTSEADEIY 209
           EVL Q+   Y +K D++++G I A EL               L                 
Sbjct: 205 EVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263

Query: 210 KICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPS 269
               +  +P++     GL  +   +   P     P      + +      +      +P 
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323

Query: 270 KRPTAAEALQHPF 282
            RP+A+  L H F
Sbjct: 324 ARPSASTLLNHSF 336

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  165 bits (419), Expect = 1e-48
 Identities = 64/356 (17%), Positives = 115/356 (32%), Gaps = 106/356 (29%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK------------------------ 36
           +  ++ I+ +G G FG V+ A +K      AIK+++                        
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 37  ---KKYYSW------------------------------EECVNLREVKSLRKMSHPNIV 63
              + + +W                                     +++ +   S  N V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 64  KLKEVIRENDILYFVFEYMEC-NLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRG 120
              +       LY   +     NL   M  R   +        +   Q+ + + ++H +G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINS-------------RPPFTEYVSTRWYRA 166
             HRDLKP N+  + D  +K+ DFGL   ++                  T  V T+ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE  +    YS KVD++++G I+ EL  L            I  +               
Sbjct: 245 PEQ-IHGNNYSHKVDIFSLGLILFEL--LYSFSTQMERVRIITDVR-------------- 287

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                  N KFP         L          ++  + S  P++RP A + +++  
Sbjct: 288 -------NLKFPL--------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  165 bits (420), Expect = 2e-48
 Identities = 39/250 (15%), Positives = 87/250 (34%), Gaps = 30/250 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +   +   +G+G F  V+ A        ++ +   +K  K     WE  +  + ++ L+ 
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-PWEFYIGTQLMERLKP 123

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC----NLYQLMKDR-EKCFSEAEVRNWCFQVFQ 111
                 +K        +    V E        N   L K+  EK   +  V ++  ++  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 112 GLAYMHQRGYFHRDLKPENLLV------------SKDTIKIADFGLAREINSRPP---FT 156
            +  +H     H D+KP+N ++                + + D G + ++   P    FT
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI- 215
               T  ++  E+L     ++ ++D + + A +  ++    +           K   +  
Sbjct: 244 AKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMK--VKNEGGECKPEGLFR 300

Query: 216 GTPTQDSWAD 225
             P  D W +
Sbjct: 301 RLPHLDMWNE 310

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  164 bits (417), Expect = 2e-48
 Identities = 77/283 (27%), Positives = 122/283 (43%), Gaps = 34/283 (12%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPN 61
            Y+L+K +G G F  V  A    +G  VAIK + K   +      L REV+ ++ ++HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IVKL EVI     LY + EY     ++  +    +   E E R+   Q+   + Y HQ+ 
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR 134

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             HRDLK ENLL+  D  IKIADFG + E         +     Y APE+         +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           VD+W++G I+  L++    F G +  +   ++                       Y+ P 
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-------------------YRIPF 235

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            +           + D  +L+      +P KR T  + ++  +
Sbjct: 236 YM-----------STDCENLLKRFLVLNPIKRGTLEQIMKDRW 267

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  163 bits (415), Expect = 2e-48
 Identities = 85/316 (26%), Positives = 128/316 (40%), Gaps = 70/316 (22%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIK-----KMKKKYYSWEECVNL--------- 48
           +Y L  E+G G++G V  A ++      A+K     K+ ++                   
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 49  -----------REVKSLRKMSHPNIVKLKEVIR--ENDILYFVFEYMECNLYQLM-KDRE 94
                      +E+  L+K+ HPN+VKL EV+     D LY VFE +      +M     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVMEVPTL 131

Query: 95  KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP 153
           K  SE + R +   + +G+ Y+H +   HRD+KP NLLV +D  IKIADFG++ E     
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 154 PFTE-YVSTRWYRAPEVLLQSY-LYS-SKVDMWAMGAIMAELITLRPLFPGTSEADEIYK 210
                 V T  + APE L ++  ++S   +D+WAMG           L+           
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT---------LY----------- 231

Query: 211 ICSVIGT-PTQDSWADGLLLARAI---NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW 266
            C V G  P  D     + L   I     +FP           P   +D   LI  +   
Sbjct: 232 -CFVFGQCPFMDE--RIMCLHSKIKSQALEFPD---------QPDIAEDLKDLITRMLDK 279

Query: 267 DPSKRPTAAEALQHPF 282
           +P  R    E   HP+
Sbjct: 280 NPESRIVVPEIKLHPW 295

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  162 bits (412), Expect = 3e-48
 Identities = 66/290 (22%), Positives = 127/290 (43%), Gaps = 39/290 (13%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM-KKKYYSWEECVNLREVKSLRKMSH 59
           +E + L++ +G+G +G V  A+++ + E VA+K +  K+     E +  +E+   + ++H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNH 64

Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            N+VK     RE +I Y   EY     L+  ++       E + + +  Q+  G+ Y+H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHG 123

Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR----WYRAPEVLLQS 173
            G  HRD+KPENLL+  +D +KI+DFGLA            ++       Y APE+ L+ 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL-LKR 181

Query: 174 YLYS-SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
             +    VD+W+ G ++  ++     +   S++ + Y             W +       
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----------DWKEK------ 224

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                      P   +        ++L+  +   +PS R T  +  +  +
Sbjct: 225 -KTYLN-----PWKKIDS----APLALLHKILVENPSARITIPDIKKDRW 264

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  163 bits (414), Expect = 4e-48
 Identities = 68/305 (22%), Positives = 126/305 (41%), Gaps = 43/305 (14%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL---REVKSLRKMSH 59
           +Y +   +G+G++G V   +  ++    A+K +KKK             +E++ LR++ H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 60  PNIVKLKEVIR--ENDILYFVFEYMECNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYM 116
            N+++L +V+   E   +Y V EY  C + +++    EK F   +   +  Q+  GL Y+
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTR----WYRAPEVLL 171
           H +G  H+D+KP NLL++   T+KI+  G+A  ++      +   T      ++ PE+  
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA-DDTCRTSQGSPAFQPPEIAN 184

Query: 172 QSYLYS-SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               +S  KVD+W+ G  +  + T    F G +       I                   
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--------------- 229

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFH 290
               Y  P                    L+  +  ++P+KR +  +  QH + R      
Sbjct: 230 ----YAIP-----------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274

Query: 291 HLSVP 295
              VP
Sbjct: 275 EAPVP 279

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  162 bits (413), Expect = 7e-48
 Identities = 61/317 (19%), Positives = 115/317 (36%), Gaps = 55/317 (17%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIV 63
           ++ + +G G FG V+       GEV AI+ +  +  + ++     REV + R+  H N+V
Sbjct: 36  EIGELIGKGRFGQVYHGRWH--GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 64  KLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
                      L  +    +   LY +++D +      + R    ++ +G+ Y+H +G  
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152

Query: 123 HRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEY----VSTRWYR--APEVLLQSYL- 175
           H+DLK +N+      + I DFGL                 +   W    APE++ Q    
Sbjct: 153 HKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 176 -------YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
                  +S   D++A+G I  EL      F        I+++              G+ 
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM------------GTGMK 260

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM 288
                     Q+             K+   ++    +++  +RPT        F+++  M
Sbjct: 261 PN------LSQI----------GMGKEISDILLFCWAFEQEERPT--------FTKLMDM 296

Query: 289 FHHLSVPEQLLQEHLHL 305
              L    + L    H 
Sbjct: 297 LEKLPKRNRRLSHPGHF 313

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  162 bits (412), Expect = 8e-48
 Identities = 64/294 (21%), Positives = 113/294 (38%), Gaps = 55/294 (18%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM-KKKYYSWEECVNL----REVKSLRKM 57
            Y+L   +G G FG+V+          VAIK + + +   W    +      EV  L K+
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 58  S----HPNIVKLKEVIRENDILYFVFEY----MECNLYQLMKDREKCFSEAEVRNWCFQV 109
                HP +++L +     +    V E      +  L+  + ++     E   R +  QV
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD--LFDYITEKGP-LGEGPSRCFFGQV 148

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAP 167
              + + H RG  HRD+K EN+L+       K+ DFG    ++   P+T++  TR Y  P
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPP 207

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           E + +   ++    +W++G ++ +++     F      +   +I                
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEA------------- 248

Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP 281
                    FP      +S        D  +LI    +  PS RP+  E L  P
Sbjct: 249 ------ELHFPA----HVS-------PDCCALIRRCLAPKPSSRPSLEEILLDP 285

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  163 bits (414), Expect = 2e-47
 Identities = 39/326 (11%), Positives = 91/326 (27%), Gaps = 83/326 (25%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----------LREV 51
                  +G     +   A  +++GE   +             +            LR +
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 52  KS----------------LRKMSHPNIVKLKEVIRENDIL--YFVFEYMECNLYQLMKD- 92
           K+                ++      +++++   R+  +L  +F++  M+ NL    +  
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 93  -----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA 146
                  K            QV + LA +H  G  H  L+P ++++ +   + +  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 147 REINSRPPFTEYVSTRWYRAPEVLLQSYL----------YSSKVDMWAMGAIMAELITLR 196
               +R        +R +  PE+  +              +   D WA+G ++  +    
Sbjct: 254 VRDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 197 PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDA 256
                 +       I                         F     +P         +  
Sbjct: 311 LPITKDAALGGSEWI-------------------------FRSCKNIP---------QPV 336

Query: 257 VSLIASLCSWDPSKRPTAAEALQHPF 282
            +L+     +    R    +A++ P 
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPE 362

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  161 bits (409), Expect = 2e-47
 Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 37/301 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y+L + +G G    V  A      E VAIK++  +         L+E++++ +  HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMK-------DREKCFSEAEVRNWCFQVFQGL 113
           IV         D L+ V + +   ++  ++K        +     E+ +     +V +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE------YVSTRWYRA 166
            Y+H+ G  HRD+K  N+L+ +D +++IADFG++  + +    T       +V T  + A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMA-ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
           PEV+ Q   Y  K D+W+ G I A EL T    +        +         P+ ++   
Sbjct: 195 PEVMEQVRGYDFKADIWSFG-ITAIELATGAAPYHKYPPMKVLMLT-LQNDPPSLETGVQ 252

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
              + +     F +++ + L                     DP KRPTAAE L+H F + 
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQK-------------------DPEKRPTAAELLRHKFFQK 293

Query: 286 A 286
           A
Sbjct: 294 A 294

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  160 bits (408), Expect = 2e-47
 Identities = 63/294 (21%), Positives = 109/294 (37%), Gaps = 50/294 (17%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN------LREVKSLRKMS 58
           +  K++G G FG V +    +   VVAIK +       E  +        REV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNIVKL  ++        V E++ C +LY  + D+      +        +  G+ YM 
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 118 QRGYF--HRDLKPENLLVSKD------TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
            +     HRDL+  N+ +           K+ADFGL+++       +  +    + APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPET 197

Query: 170 LL-QSYLYSSKVDMWAMGAIMAELITLRPLFPG--TSEADEIYKICSVIGTPTQDSWADG 226
           +  +   Y+ K D ++   I+  ++T    F      +   I  I      PT       
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT------- 250

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                           +P             ++I    S DP KRP  +  ++ 
Sbjct: 251 ----------------IP-----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  158 bits (403), Expect = 7e-47
 Identities = 68/292 (23%), Positives = 113/292 (38%), Gaps = 50/292 (17%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMSHPN 61
            L + +G G FG V+RA     G+ VA+K  +               +E K    + HPN
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I+ L+ V  +   L  V E+     L +++  +        + NW  Q+ +G+ Y+H   
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEA 125

Query: 121 YF---HRDLKPENLLVSKD---------TIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
                HRDLK  N+L+ +           +KI DFGLARE +     +   +  W  APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPE 184

Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           V +++ ++S   D+W+ G ++ EL+T    F G       Y +                 
Sbjct: 185 V-IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--------- 234

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                         +P      +  +    L+    + DP  RP+    L  
Sbjct: 235 --------------IP-----STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  160 bits (406), Expect = 7e-47
 Identities = 65/291 (22%), Positives = 125/291 (42%), Gaps = 41/291 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKM-KKKYYSWEECVNLREVKSLRKMSH 59
           +E + L++ +G+G +G V  A+++ + E VA+K +  K+     E +  +E+   + ++H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNH 64

Query: 60  PNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            N+VK     RE +I Y   EY     L+  ++       E + + +  Q+  G+ Y+H 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHG 123

Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTR----WYRAPEVLLQS 173
            G  HRD+KPENLL+  +D +KI+DFGLA            ++       Y APE+ L+ 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL-LKR 181

Query: 174 YLYS-SKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWADGLLLAR 231
             +    VD+W+ G ++  ++     +   S++ + Y                       
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----------------- 224

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                       P   +        ++L+  +   +PS R T  +  +  +
Sbjct: 225 --KTYLN-----PWKKIDS----APLALLHKILVENPSARITIPDIKKDRW 264

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  160 bits (408), Expect = 1e-46
 Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 31/286 (10%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
            +RY  +K++G G FG       K + E+VA+K +++     +E V  RE+ + R + HP
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQ-REIINHRSLRHP 76

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV+ KEVI     L  + EY     LY+ + +  + FSE E R +  Q+  G++Y H  
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSM 135

Query: 120 GYFHRDLKPENLLVSKDT---IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              HRDLK EN L+       +KI DFG ++           V T  Y APEVLL+    
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
               D+W+ G  +  ++     F    E  +  K    I                ++ Y 
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI---------------LSVKYS 240

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            P  + +           +   LI+ +   DP+ R +  E   H +
Sbjct: 241 IPDDIRIS---------PECCHLISRIFVADPATRISIPEIKTHSW 277

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  159 bits (404), Expect = 1e-46
 Identities = 78/314 (24%), Positives = 151/314 (48%), Gaps = 41/314 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E + +++++G+G++GSV++AI K++G++VAIK++  +    +E +   E+  +++   P+
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIK--EISIMQQCDSPH 85

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +VK      +N  L+ V EY    ++  +++ R K  +E E+        +GL Y+H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L++ +   K+ADFG+A ++ ++       + T ++ APEV+ +   Y+ 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNC 204

Query: 179 KVDMWAMGAIMA-ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
             D+W++G I A E+   +P +        I+ I      PT                  
Sbjct: 205 VADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMI------PTNPP--------------- 242

Query: 238 PQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPE 296
           P           P   + +    +       P +R TA + LQHPF R A     +S+  
Sbjct: 243 PTFRK-------PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA---KGVSILR 292

Query: 297 QLLQEHLHLLGQRE 310
            L+ E + +  +R+
Sbjct: 293 DLINEAMDVKLKRQ 306

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  159 bits (403), Expect = 2e-46
 Identities = 73/291 (25%), Positives = 139/291 (47%), Gaps = 41/291 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHP 60
           E ++++ E+GDG FG V++A +K++G + A K ++ K     E+ +   E++ L    HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--EIEILATCDHP 76

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            IVKL      +  L+ + E+     +  +M + ++  +E +++  C Q+ + L ++H +
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLL----QS 173
              HRDLK  N+L++ +  I++ADFG++ +   +      ++ T ++ APEV++    + 
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 174 YLYSSKVDMWAMGAIMA-ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
             Y  K D+W++G I   E+  + P     +    + KI         D           
Sbjct: 197 TPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRVLLKI------AKSDP---------- 239

Query: 233 INYKFPQLVGVPLSVLMPSA-NKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                P L       L PS  + +    +      +P  RP+AA+ L+HPF
Sbjct: 240 -----PTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  157 bits (398), Expect = 6e-46
 Identities = 79/293 (26%), Positives = 138/293 (47%), Gaps = 44/293 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHP 60
           ++Y   +++G G  G+V+ A+   +G+ VAI++M  ++    E  +N  E+  +R+  +P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN--EILVMRENKNP 77

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NIV   +     D L+ V EY+   +L  ++   E C  E ++   C +  Q L ++H  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y 
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YG 194

Query: 178 SKVDMWAMGAIMA-ELITLRPLFPGTSEADEIYKICSVIGTPT---QDSWADGLLLARAI 233
            KVD+W++G IMA E+I   P +   +    +Y I +  GTP     +  +         
Sbjct: 195 PKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSA-------- 244

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
              F   +   L +                   D  KR +A E LQH F ++A
Sbjct: 245 --IFRDFLNRCLEM-------------------DVEKRGSAKELLQHQFLKIA 276

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  156 bits (396), Expect = 2e-45
 Identities = 77/307 (25%), Positives = 137/307 (44%), Gaps = 43/307 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E +  ++++G G+FG V++ I  ++ +VVAIK +  +    E     +E+  L +   P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           + K      ++  L+ + EY+   +   L++       E ++     ++ +GL Y+H   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK 139

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
             HRD+K  N+L+S+   +K+ADFG+A ++ +++     +V T ++ APEV+ QS  Y S
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDS 198

Query: 179 KVDMWAMGAIMA-ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           K D+W++G I A EL    P          ++ I      P  +                
Sbjct: 199 KADIWSLG-ITAIELARGEPPHSELHPMKVLFLI------PKNNP--------------- 236

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQ 297
           P L G   S       K     + +  + +PS RPTA E L+H F          +    
Sbjct: 237 PTLEG-NYS-------KPLKEFVEACLNKEPSFRPTAKELLKHKF------ILRNAKKTS 282

Query: 298 LLQEHLH 304
            L E + 
Sbjct: 283 YLTELID 289

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  155 bits (395), Expect = 3e-45
 Identities = 73/284 (25%), Positives = 126/284 (44%), Gaps = 39/284 (13%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIV 63
            + +++G G+FG+V RA     G  VA+K + ++ +  E     LREV  ++++ HPNIV
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 64  KLKEVIRENDILYFVFEYMEC-NLYQLMKDRE--KCFSEAEVRNWCFQVFQGLAYMHQRG 120
                + +   L  V EY+   +LY+L+      +   E    +  + V +G+ Y+H R 
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 121 YF--HRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HR+LK  NLLV K  T+K+ DFGL+R   ++         T  + APEV L+    
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV-LRDEPS 216

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           + K D+++ G I+ EL TL+  +   + A  +  +                         
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE----------------- 259

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                 +P      + N    ++I    + +P KRP+ A  +  
Sbjct: 260 ------IP-----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  155 bits (395), Expect = 3e-45
 Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 44/293 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-KKYYSWEECVNLREVKSLRKMSHP 60
                  ++G+G+ G V  A  K SG  VA+K M  +K    E   N  EV  +R   H 
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN--EVVIMRDYQHF 102

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           N+V++ +     + L+ + E+++   L  ++   +   +E ++   C  V Q LAY+H +
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           G  HRD+K +++L++ D  +K++DFG   +I    P     V T ++ APEV+ +S  Y+
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YA 219

Query: 178 SKVDMWAMGAIMA-ELITLRPLFPGTSEADEIYKICSVIGTPT---QDSWADGLLLARAI 233
           ++VD+W++G IM  E++   P +   S    + ++      P        +         
Sbjct: 220 TEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSP-------- 269

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
                  +   L                     DP +R TA E L HPF    
Sbjct: 270 --VLRDFLERMLVR-------------------DPQERATAQELLDHPFLLQT 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  155 bits (394), Expect = 4e-45
 Identities = 89/330 (26%), Positives = 140/330 (42%), Gaps = 52/330 (15%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           ++ + VG G FG V +A  +   + VAIK+++ +         + E++ L +++HPNIVK
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAF---IVELRQLSRVNHPNIVK 65

Query: 65  LKEVIRENDILYFVFEYMEC-NLYQLMKDREKC--FSEAEVRNWCFQVFQGLAYMHQR-- 119
           L         +  V EY E  +LY ++   E    ++ A   +WC Q  QG+AY+H    
Sbjct: 66  LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 120 -GYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP NLL+      +KI DFG A +I +    T    +  + APEV   S  Y
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGS-NY 180

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S K D+++ G I+ E+IT R  F         ++I   +         +G          
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAV--------HNGTRP------P 224

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEALQHPFSRVAFMFHHLSV 294
             + +  P+  LM              C W  DPS+RP+  E ++   + +   F     
Sbjct: 225 LIKNLPKPIESLMTR------------C-WSKDPSQRPSMEEIVKI-MTHLMRYF--PGA 268

Query: 295 PEQLLQEHLHLLGQREHWSSKVLRGFLGLF 324
            E L     H L   E    +    F   +
Sbjct: 269 DEPLQYPCQHSLPPGEDGRVEPYVDFAEFY 298

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  155 bits (395), Expect = 4e-45
 Identities = 76/319 (23%), Positives = 141/319 (44%), Gaps = 50/319 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HP 60
             ++L++ VG+GT+G V++    ++G++ AIK M       EE     E+  L+K S H 
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ--EINMLKKYSHHR 81

Query: 61  NIVKL------KEVIRENDILYFVFEYMEC-NLYQLMKD-REKCFSEAEVRNWCFQVFQG 112
           NI         K     +D L+ V E+    ++  L+K+ +     E  +   C ++ +G
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVL 170
           L+++HQ    HRD+K +N+L++++  +K+ DFG++ ++  +      ++ T ++ APEV+
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 171 LQSYL----YSSKVDMWAMGAIMA-ELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
                    Y  K D+W++G I A E+    P          ++ I      P   +   
Sbjct: 202 ACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLI------PRNPA--- 251

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
                       P+L     S       K   S I S    + S+RP   + ++HPF R 
Sbjct: 252 ------------PRLKSKKWS-------KKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

Query: 286 AFMFHHLSVPEQLLQEHLH 304
                +       L++H+ 
Sbjct: 293 Q---PNERQVRIQLKDHID 308

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  156 bits (396), Expect = 5e-45
 Identities = 65/299 (21%), Positives = 122/299 (40%), Gaps = 20/299 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
            + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91

Query: 61  NIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            IV        +  +    E+M+   L Q++K +     E  +      V +GL Y+ ++
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 120 GY-FHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
               HRD+KP N+LV+    IK+ DFG++ ++      + +V TR Y +PE L  ++ YS
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTH-YS 208

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            + D+W+MG  + E+   R   P     +        +     ++        R +N   
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268

Query: 238 PQLVG--VPLSVLMPSAN------------KDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                      +L    N             +    +      +P++R    + + H F
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  155 bits (394), Expect = 7e-45
 Identities = 76/317 (23%), Positives = 135/317 (42%), Gaps = 44/317 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP 60
            Y + + +G+G+FG V  A   ++ + VA+K + ++     +      RE+  L+ + HP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +I+KL +VI     +  V EY    L+  + ++++  +E E R +  Q+   + Y H+  
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHK 128

Query: 121 YFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS-S 178
             HRDLKPENLL+     +KIADFGL+  +           +  Y APEV +   LY+  
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV-INGKLYAGP 187

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
           +VD+W+ G ++  ++  R  F      +   K+ S +                   Y  P
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV-------------------YVMP 228

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF--------MFH 290
             +           +  A SLI  +   DP +R T  E  + P+  V             
Sbjct: 229 DFL-----------SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQ 277

Query: 291 HLSVPEQLLQEHLHLLG 307
                 +++ +    +G
Sbjct: 278 GSYADSRIVSKLGEAMG 294

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  156 bits (396), Expect = 1e-44
 Identities = 40/326 (12%), Positives = 91/326 (27%), Gaps = 79/326 (24%)

Query: 2   ERYKLI---KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----------- 47
           ER + +     +G     +   A  +++GE   +             +            
Sbjct: 75  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134

Query: 48  LREVKS----------------LRKMSHPNIVKLKEVIRENDIL--YFVFEYMECNLYQL 89
           LR +K+                ++      +++++   R+  +L  +F++  M+ NL   
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194

Query: 90  MK------DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIAD 142
            +         K            QV + LA +H  G  H  L+P ++++ +   + +  
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254

Query: 143 FGLAREINSR--PPFTEYVSTRWYRAPEVLL----QSYLYSSKVDMWAMGAIMAELITLR 196
           F       +    P     +     A  +L        L +   D W +G  +  +    
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 197 PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDA 256
                 +       I                         F     +P         +  
Sbjct: 315 LPNTDDAALGGSEWI-------------------------FRSCKNIP---------QPV 340

Query: 257 VSLIASLCSWDPSKRPTAAEALQHPF 282
            +L+     +    R    +A++ P 
Sbjct: 341 RALLEGFLRYPKEDRLLPLQAMETPE 366

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  153 bits (388), Expect = 1e-44
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 37/287 (12%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +  Y L   +G GTFG V     + +G  VA+K + ++     + V    RE+++L+   
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HP+I+KL +VI      + V EY+    L+  +    +   E E R    Q+   + Y H
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH 128

Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +    HRDLKPEN+L+ +    KIADFGL+  ++          +  Y APEV +   LY
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV-ISGRLY 187

Query: 177 S-SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           +  +VD+W+ G I+  L+     F          KI   +                   +
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-------------------F 228

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             P+ +           N+   +L+  +   DP KR T  +  +H +
Sbjct: 229 YIPEYL-----------NRSVATLLMHMLQVDPLKRATIKDIREHEW 264

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  152 bits (386), Expect = 1e-43
 Identities = 69/300 (23%), Positives = 111/300 (37%), Gaps = 40/300 (13%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMSHPNIV 63
           +++K++G G +G VW    +  GE VA+K        SW       E+     M H NI+
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWF---RETEIYQTVLMRHENIL 94

Query: 64  KL----KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
                  +       LY + +Y E  +LY  +K          +    +    GL ++H 
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHT 152

Query: 119 RGYF--------HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS-----TRWY 164
             +         HRDLK +N+LV K+ T  IAD GLA +  S     +        T+ Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 165 RAPEVL-----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPT 219
             PEVL        +      DM++ G I+ E+           E    Y++      P+
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE----YQLPYHDLVPS 268

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
             S+ D +     I    P     P         +    L+    + +P+ R TA    +
Sbjct: 269 DPSYED-MREIVCIKKLRPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  151 bits (383), Expect = 1e-43
 Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 55/297 (18%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY---YSWEECVNLREVKSLRKMSHP 60
           +K  K +G+G+F +V  A    +    AIK ++K++    +    V  RE   + ++ HP
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLDHP 90

Query: 61  NIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
             VKL    ++++ LYF   Y        L  +   +   F E   R +  ++   L Y+
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSY--AKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 146

Query: 117 HQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTE---YVSTRWYRAPEVLLQ 172
           H +G  HRDLKPEN+L+++D  I+I DFG A+ ++          +V T  Y +PE+L +
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWADGLLLAR 231
                   D+WA+G I+ +L+   P F   +E   I+ KI  +                 
Sbjct: 207 KS-ACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKIIKL----------------- 247

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT------AAEALQHPF 282
              Y FP                 A  L+  L   D +KR              HPF
Sbjct: 248 --EYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  148 bits (377), Expect = 5e-43
 Identities = 38/218 (17%), Positives = 86/218 (39%), Gaps = 16/218 (7%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIV 63
             + ++ +   G +W+   +  G  + +K +K + +S  +  +   E   LR  SHPN++
Sbjct: 13  NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 64  KLKEVIRE--NDILYFVFEYMEC-NLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            +    +         +  +M   +LY ++ +       +++   +   + +G+A++H  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 120 GYF--HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL--QSY 174
                   L   ++++ +D T +I+   +     S        +  W  APE L      
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---GRMYAPAWV-APEALQKKPED 186

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKIC 212
                 DMW+   ++ EL+T    F   S  +   K+ 
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  149 bits (377), Expect = 2e-42
 Identities = 66/300 (22%), Positives = 112/300 (37%), Gaps = 40/300 (13%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMSHPNIV 63
            L + +G G FG VWR   +  GE VA+K    +   SW       E+     + H NI+
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWF---REAEIYQTVMLRHENIL 99

Query: 64  KL----KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
                  +       L+ V +Y E  +L+  +       +   +         GLA++H 
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHM 157

Query: 119 RGYF--------HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS-----TRWY 164
                       HRDLK +N+LV K+ T  IAD GLA   +S     +        T+ Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 165 RAPEVL-----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPT 219
            APEVL     ++ +    + D++AMG +  E+     +     +    Y++      P+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED----YQLPYYDLVPS 273

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
             S  + +          P +   P       A +    ++      + + R TA    +
Sbjct: 274 DPSVEE-MRKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  150 bits (380), Expect = 9e-42
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 37/287 (12%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +  Y L   +G GTFG V     + +G  VA+K + ++     + V    RE+++L+   
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HP+I+KL +VI     ++ V EY+    L+  +    +   E E R    Q+  G+ Y H
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCH 133

Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           +    HRDLKPEN+L+ +    KIADFGL+  ++          +  Y APEV +   LY
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV-ISGRLY 192

Query: 177 S-SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           +  +VD+W+ G I+  L+     F          KIC  I                   +
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-------------------F 233

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             PQ +           N   +SL+  +   DP KR T  +  +H +
Sbjct: 234 YTPQYL-----------NPSVISLLKHMLQVDPMKRATIKDIREHEW 269

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  146 bits (371), Expect = 1e-41
 Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 35/290 (12%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-H 59
           +   + + E+G GT G VW+   +++G V+A+K+M++     E    L ++  + K    
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH-Q 118
           P IV+       N  ++   E M     +L K  +    E  +      + + L Y+  +
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL-- 175
            G  HRD+KP N+L+ +   IK+ DFG++  +              Y APE +       
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 176 --YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             Y  + D+W++G  + EL T +  +         +++ + +    ++            
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNC---KTDFEVLTKV--LQEEP----------- 247

Query: 234 NYKFPQL-VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               P L   +  S        D  S +    + D  KRP   + L+H F
Sbjct: 248 ----PLLPGHMGFS-------GDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  146 bits (371), Expect = 3e-41
 Identities = 63/284 (22%), Positives = 115/284 (40%), Gaps = 48/284 (16%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
            L +++G G FG V+    +    +VA+K  ++      +   L+E + L++ SHPNIV+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 65  LKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L  V  +   +Y V E ++  +    ++          +         G+ Y+  +   H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236

Query: 124 RDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST--------RWYRAPEVLLQSY 174
           RDL   N LV++   +KI+DFG++RE         Y ++        +W  APE L    
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEAD----GVYAASGGLRQVPVKWT-APEALNYG- 290

Query: 175 LYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
            YSS+ D+W+ G ++ E  +L   P +P  S       +                     
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEK------------------- 330

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE 276
              + P     P +V           L+    +++P +RP+ + 
Sbjct: 331 -GGRLPCPELCPDAV---------FRLMEQCWAYEPGQRPSFST 364

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  143 bits (364), Expect = 6e-41
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 40/293 (13%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK-SLRKMSH 59
            +  + I E+G G +G V +     SG+++A+K+++    S E+   L ++  S+R +  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65

Query: 60  PNIVKLKEV-IRENDILYFVFEYME---CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           P  V       RE D+ +   E M+      Y+ + D+ +   E  +      + + L +
Sbjct: 66  PFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 116 MH-QRGYFHRDLKPENLLVSKD-TIKIADFGLARE-INSRPPFTEYVSTRWYRAPEVL-- 170
           +H +    HRD+KP N+L++    +K+ DFG++   ++           + Y APE +  
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DAGCKPYMAPERINP 183

Query: 171 -LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
            L    YS K D+W++G  M EL  LR  +                GTP Q        L
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDS-------------WGTPFQ-------QL 223

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            + +    PQL     S        + V   +     +  +RPT  E +QHPF
Sbjct: 224 KQVVEEPSPQLPADKFS-------AEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  145 bits (369), Expect = 8e-41
 Identities = 62/292 (21%), Positives = 120/292 (41%), Gaps = 51/292 (17%)

Query: 6   LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS-------LRKMS 58
           +++ +G G+FG V       + ++ A+K M K     ++CV   EV++       ++ + 
Sbjct: 19  ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-----QKCVERNEVRNVFKELQIMQGLE 73

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           HP +V L    ++ + ++ V + +        Y L   +   F E  V+ +  ++   L 
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLL--LGGDLRYHL--QQNVHFKEETVKLFICELVMALD 129

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+  +   HRD+KP+N+L+ +   + I DF +A  +      T    T+ Y APE+    
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 174 YL--YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
               YS  VD W++G    EL+  R  +   S +    +I                    
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-STSSKEIVHTF---------------E 233

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ-HPF 282
                +P            + +++ VSL+  L   +P +R +    +Q  P+
Sbjct: 234 TTVVTYP-----------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  143 bits (363), Expect = 9e-41
 Identities = 69/300 (23%), Positives = 113/300 (37%), Gaps = 40/300 (13%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMSHPNIV 63
            L++ VG G +G VWR   +  GE VA+K    +   SW       E+ +   + H NI+
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWF---RETELYNTVMLRHENIL 65

Query: 64  KL----KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
                       +  L+ +  Y E  +LY  ++                 +  GLA++H 
Sbjct: 66  GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHI 123

Query: 119 RGYF--------HRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS-----TRWY 164
             +         HRDLK +N+LV K+    IAD GLA   +      +  +     T+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 165 RAPEVL-----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPT 219
            APEVL     +  +    +VD+WA G ++ E+           +    YK       P 
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED----YKPPFYDVVPN 239

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
             S+ D +     ++ + P +   P              L+      +PS R TA    +
Sbjct: 240 DPSFED-MRKVVCVDQQRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  146 bits (369), Expect = 1e-40
 Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 53/300 (17%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY--------YSWEECVNLREVKSLR 55
           ++++K +G G F  V     KQ+G+V A+K M K             EE    R+V  L 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE----RDV--LV 116

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
                 I +L    ++ + LY V EY    +L  L+    +       R +  ++   + 
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEY--VSTRWYRAPEVLL 171
            +H+ GY HRD+KP+N+L+ +   I++ADFG   ++ +         V T  Y +PE+L 
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 172 Q------SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
                  +  Y  + D WA+G    E+   +  F   S A+   KI              
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI-------------- 282

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR---PTAAEALQHPF 282
              +    +   P  V   +        ++A   I  L    P  R     A +   HPF
Sbjct: 283 ---VHYKEHLSLPL-VDEGVP-------EEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  142 bits (361), Expect = 2e-40
 Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 45/290 (15%)

Query: 5   KLIKEVGDGTFGSVWRA----ISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           K ++++G G FGSV       +   +GEVVA+KK++    S EE +    RE++ L+ + 
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQ 69

Query: 59  HPNIVKLKEVIRENDI--LYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           H NIVK K V        L  + EY+   +L   ++  ++     ++  +  Q+ +G+ Y
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAP 167
           +  + Y HRDL   N+LV +++ +KI DFGL + +        +           WY AP
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EFFKVKEPGESPIFWY-AP 186

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           E L +S  +S   D+W+ G ++ EL T               +   +IG   Q       
Sbjct: 187 ESLTES-KFSVASDVWSFGVVLYELFTY-----IEKSKSPPAEFMRMIGNDKQGQMIVFH 240

Query: 228 LLAR-AINYKFPQLVGVPLSV--LMPSANKDAVSLIASLC-SWDPSKRPT 273
           L+     N + P+  G P  +  +M            + C + + ++RP+
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIM------------TECWNNNVNQRPS 278

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  145 bits (367), Expect = 3e-40
 Identities = 75/297 (25%), Positives = 121/297 (40%), Gaps = 53/297 (17%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY--------YSWEECVNLREVKSLR 55
           Y+++K +G G FG V     K + +V A+K + K          + WEE    R++  + 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDI--MA 124

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
             + P +V+L    +++  LY V EYM   +L  LM        E   R +  +V   L 
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALD 182

Query: 115 YMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEY--VSTRWYRAPEVLL 171
            +H  G+ HRD+KP+N+L+ K   +K+ADFG   ++N          V T  Y +PEVL 
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 172 Q---SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
                  Y  + D W++G  + E++     F   S      KI                 
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI----------------- 285

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR---PTAAEALQHPF 282
           +    +  FP    +          K+A +LI +  + D   R       E  +H F
Sbjct: 286 MNHKNSLTFPDDNDIS---------KEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  143 bits (363), Expect = 3e-40
 Identities = 78/306 (25%), Positives = 130/306 (42%), Gaps = 73/306 (23%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREV-------KS 53
           ++++  IK +G G+FG V     K+SG   A+K + K     ++ V L+++       + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMECN---LYQLMKDREKCFSEAEVRNWCFQVF 110
           L+ ++ P +VKL+   ++N  LY V EY       ++  ++ R   FSE   R +  Q+ 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEY--VAGGEMFSHLR-RIGRFSEPHARFYAAQIV 151

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-------PPFTEYVSTR 162
               Y+H     +RDLKPENLL+ +   I++ DFG A+ +  R       P   E +   
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EAL--- 205

Query: 163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQD 221
              APE++L    Y+  VD WA+G ++ E+    P F       +IY KI S        
Sbjct: 206 ---APEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSG------- 253

Query: 222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAE 276
                         +FP              + D   L+ +L   D +KR         +
Sbjct: 254 ------------KVRFP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290

Query: 277 ALQHPF 282
              H +
Sbjct: 291 IKNHKW 296

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  141 bits (358), Expect = 5e-40
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 22/223 (9%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           +L++++GDG+FG V R            VA+K +K    S  E ++  +REV ++  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 60  PNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            N+++L  V+    +   V E     +L   ++  +  F    +  +  QV +G+ Y+  
Sbjct: 81  RNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 119 RGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVL 170
           + + HRDL   NLL+ ++D +KI DFGL R +        YV          W  APE L
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFAWC-APESL 196

Query: 171 LQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
                +S   D W  G  + E+ T    P + G + +  ++KI
Sbjct: 197 KTR-TFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 237

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  146 bits (371), Expect = 6e-40
 Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 43/295 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY---YSWEECVNLREVKSLRKM 57
              ++  + +G G FG V     + +G++ A KK++KK       E    L E + L K+
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKV 241

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +   +V L       D L  V   M  N     + +    +  F EA    +  ++  GL
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLM--NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 114 AYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
             +H+    +RDLKPEN+L+     I+I+D GLA  +         V T  Y APEV+  
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y+   D WA+G ++ E+I  +  F    +  +  ++  ++               + 
Sbjct: 360 ER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---------------KE 403

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           +  ++ +                A SL + L   DP++R      +A E  +HP 
Sbjct: 404 VPEEYSERFS-----------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (354), Expect = 9e-40
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 21/221 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
                ++E+G G FG V         +V AIK +++   S E+   + E + + K+SHP 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDF--IEEAEVMMKLSHPK 64

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  E   +  V E+ME   L   ++ +   F+   +   C  V +G+AY+ +  
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQ 172
             HRDL   N LV ++  IK++DFG+ R +       +Y S+       +W  +PEV   
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWA-SPEVFSF 179

Query: 173 SYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           S  YSSK D+W+ G +M E+ +    P +   S ++ +  I
Sbjct: 180 S-RYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDI 218

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  141 bits (358), Expect = 1e-39
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 17/220 (7%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            + K +G G  G V     +  G+    VAIK +K  Y   +    L E   + +  HPN
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I++L+ V+    +   V EYME  +L   ++  +  F+  ++      V  G+ Y+   G
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQS 173
           Y HRDL   N+LV  +   K++DFGL+R +    P   Y +T      RW  APE +   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWT-APEAIAFR 229

Query: 174 YLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
             +SS  D+W+ G +M E++    RP +   +  D I  +
Sbjct: 230 -TFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV 267

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  140 bits (356), Expect = 1e-39
 Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 39/290 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM 57
              K I+++G+G FG V           +GE VA+K +K +          +E++ LR +
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 58  SHPNIVKLKEVIRENDI--LYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
            H NIVK K +  E+    +  + E++   +L + +   +   +  +   +  Q+ +G+ 
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRA 166
           Y+  R Y HRDL   N+LV  +  +KI DFGL + I +      Y           WY A
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVFWY-A 197

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE L+QS  +    D+W+ G  + EL+T        S++  +     +IG          
Sbjct: 198 PECLMQS-KFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPTHGQMTVTR 251

Query: 227 LLLARAINYKFPQLVGVPLSV--LMPSANKDAVSLIASLC-SWDPSKRPT 273
           L+       + P     P  V  LM              C  + PS R +
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLM------------RKCWEFQPSNRTS 289

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  140 bits (356), Expect = 2e-39
 Identities = 71/306 (23%), Positives = 138/306 (45%), Gaps = 73/306 (23%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS------- 53
           ++ +++++ +G G+FG V    S+ +G   A+K +KK     E  V L++V+        
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLM 59

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYM---ECNLYQLMKDREKCFSEAEVRNWCFQVF 110
           L  ++HP I+++    ++   ++ + +Y+   E  L+ L++ + + F     + +  +V 
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE--LFSLLR-KSQRFPNPVAKFYAAEVC 116

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSR-------PPFTEYVSTR 162
             L Y+H +   +RDLKPEN+L+ K+  IKI DFG A+ +          P   +Y+   
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP---DYI--- 170

Query: 163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQD 221
              APEV + +  Y+  +D W+ G ++ E++     F  ++   + Y KI +        
Sbjct: 171 ---APEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNA------- 218

Query: 222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAE 276
                         +FP           P  N+D   L++ L + D S+R         +
Sbjct: 219 ------------ELRFP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 255

Query: 277 ALQHPF 282
              HP+
Sbjct: 256 VKNHPW 261

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (365), Expect = 2e-39
 Identities = 73/312 (23%), Positives = 131/312 (41%), Gaps = 54/312 (17%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
               +  ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ HPN
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIKHPN 277

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V       Y + E+M     L  L +   +  S   +     Q+   + Y+ ++
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
            + HR+L   N LV ++  +K+ADFGL+R +        Y +        +W  APE L 
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APESLA 392

Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
            +  +S K D+WA G ++ E+ T     +PG   +     +                 + 
Sbjct: 393 YN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------------EKDYRME 439

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLC-SWDPSKRPTAAEALQHPFSRVAFMF 289
           R      P+     +  LM +            C  W+PS RP+ AE +   F     MF
Sbjct: 440 R------PEGCPEKVYELMRA------------CWQWNPSDRPSFAE-IHQAFET---MF 477

Query: 290 HHLSVPEQLLQE 301
              S+ +++ +E
Sbjct: 478 QESSISDEVEKE 489

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (356), Expect = 2e-39
 Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 22/222 (9%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +P
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           ++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 78  HVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
              HRDL   N+LV +   +KI DFGLA+ + +     +           +W  A E  +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWM-ALES-I 191

Query: 172 QSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
              +Y+ + D+W+ G  + EL+T   +P + G   ++    +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL 232

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  140 bits (356), Expect = 2e-39
 Identities = 75/290 (25%), Positives = 130/290 (44%), Gaps = 45/290 (15%)

Query: 5   KLIKEVGDGTFGSVWRA----ISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           K ++++G G FGSV       +   +GEVVA+KK++    S EE +    RE++ L+ + 
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQ 100

Query: 59  HPNIVKLKEVIRENDI--LYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           H NIVK K V        L  + EY+   +L   ++  ++     ++  +  Q+ +G+ Y
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 116 MHQRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAP 167
           +  + Y HRDL   N+LV +++ +KI DFGL + +        Y           WY AP
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIFWY-AP 217

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           E L +S  +S   D+W+ G ++ EL T               +   +IG   Q       
Sbjct: 218 ESLTES-KFSVASDVWSFGVVLYELFTY-----IEKSKSPPAEFMRMIGNDKQGQMIVFH 271

Query: 228 LLAR-AINYKFPQLVGVPLSV--LMPSANKDAVSLIASLC-SWDPSKRPT 273
           L+     N + P+  G P  +  +M            + C + + ++RP+
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIM------------TECWNNNVNQRPS 309

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  142 bits (359), Expect = 2e-39
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 17/223 (7%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
               + K VG G FG V     K   +    VAIK +K  Y   +    L E   + +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HPNI++L+ V+ ++  +  V EYME  +L   ++  +  F+  ++      +  G+ Y+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST------RWYRAPEVL 170
             GY HRDL   N+L++ +   K++DFGL R +    P   Y +       RW  +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-PEAAYTTRGGKIPIRWT-SPEAI 222

Query: 171 LQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
                ++S  D+W+ G ++ E+++   RP +   S  D I  +
Sbjct: 223 AYR-KFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAV 263

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  140 bits (354), Expect = 3e-39
 Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 42/301 (13%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMSHPNIV 63
           +L++    G FG VW+A      E VA+K    +   SW+   N  EV SL  M H NI+
Sbjct: 27  QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQ---NEYEVYSLPGMKHENIL 81

Query: 64  KL----KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           +     K     +  L+ +  + E  +L   +K      S  E+ +    + +GLAY+H+
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHE 139

Query: 119 RGYF----------HRDLKPENLLVSKD-TIKIADFGLAREINSRPPF---TEYVSTRWY 164
                         HRD+K +N+L+  + T  IADFGLA +  +          V TR Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 165 RAPEVL----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
            APEVL            ++DM+AMG ++ EL +      G  +   +     +   P+ 
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259

Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSKRPTAAEAL 278
           +   + +++ +                    A    +      C W  D   R +A    
Sbjct: 260 EDMQE-VVVHKKKRPVLRDYW-------QKHAGMAMLCETIEEC-WDHDAEARLSAGCVG 310

Query: 279 Q 279
           +
Sbjct: 311 E 311

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  140 bits (354), Expect = 4e-39
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 18/224 (8%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEV----VAIKKMKKKYYSWEECVNLREVKSLRKM 57
                 K +G G FG V++ + K S       VAIK +K  Y   +    L E   + + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           SH NI++L+ VI +   +  + EYME   L + +++++  FS  ++      +  G+ Y+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST------RWYRAPEV 169
               Y HRDL   N+LV+ +   K++DFGL+R +    P   Y ++      RW  APE 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRWT-APEA 221

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +     ++S  D+W+ G +M E++T   RP +   S  + +  I
Sbjct: 222 ISYR-KFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (351), Expect = 4e-39
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 21/218 (9%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
             +KE+G G FG V     +   +V AIK +K+   S +E   + E K +  +SH  +V+
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEF--IEEAKVMMNLSHEKLVQ 83

Query: 65  LKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           L  V  +   ++ + EYM    L   +++    F   ++   C  V + + Y+  + + H
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143

Query: 124 RDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQSYL 175
           RDL   N LV+    +K++DFGL+R +       EY S+       RW   PEVL+ S  
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PPEVLMYS-K 197

Query: 176 YSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +SSK D+WA G +M E+ +L   P +   + ++    I
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHI 234

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  140 bits (354), Expect = 4e-39
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)

Query: 5   KLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K I ++G G FGSV           +G +VA+K+++      +     RE++ L+ +   
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF-QREIQILKALHSD 84

Query: 61  NIVKLKEVIRENDI--LYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
            IVK + V        L  V EY+    L   ++        + +  +  Q+ +G+ Y+ 
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144

Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEV 169
            R   HRDL   N+LV S+  +KIADFGLA+ +        YV          WY APE 
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK--DYYVVREPGQSPIFWY-APES 201

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITL 195
           L  + ++S + D+W+ G ++ EL T 
Sbjct: 202 LSDN-IFSRQSDVWSFGVVLYELFTY 226

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  142 bits (359), Expect = 5e-39
 Identities = 70/301 (23%), Positives = 117/301 (38%), Gaps = 51/301 (16%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY--------YSWEECVNLREVK 52
            E ++++K +G G FG V     K + +V A+K + K             EE    R+V 
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE----RDV- 127

Query: 53  SLRKMSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQ 111
            L       I  L    ++++ LY V +Y    +L  L+   E    E   R +  ++  
Sbjct: 128 -LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 112 GLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEY--VSTRWYRAPE 168
            +  +HQ  Y HRD+KP+N+L+  +  I++ADFG   ++           V T  Y +PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 169 VLLQSYL----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
           +L         Y  + D W++G  M E++     F   S  +   KI             
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------------- 293

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR---PTAAEALQHP 281
               +     ++FP  V           +++A  LI  L       R       +  +HP
Sbjct: 294 ----MNHKERFQFPTQV--------TDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHP 340

Query: 282 F 282
           F
Sbjct: 341 F 341

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  139 bits (353), Expect = 6e-39
 Identities = 66/292 (22%), Positives = 117/292 (40%), Gaps = 34/292 (11%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK-SLRKMSH 59
            E  K + E+G G +GSV + + K SG+++A+K+++      E+   L ++   +R    
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAY 115
           P IV+    +      +   E M  +  +  K      +    E  +        + L +
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 116 MH-QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           +       HRD+KP N+L+ +   IK+ DFG++ ++      T     R Y APE +  S
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200

Query: 174 YL---YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
                Y  + D+W++G  + EL T R  +P                +           L 
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPK-------------WNSVFD-------QLT 240

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           + +    PQL            +   ++ +    + D SKRP   E L+HPF
Sbjct: 241 QVVKGDPPQLSNSEER----EFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  139 bits (352), Expect = 7e-39
 Identities = 74/290 (25%), Positives = 115/290 (39%), Gaps = 41/290 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM 57
              K I+++G+G FG V        +  +GE+VA+K +K            +E+  LR +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 58  SHPNIVKLKEVIRENDI--LYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
            H +I+K K    +     L  V EY+   +L   +         A++  +  Q+ +G+A
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMA 148

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRA 166
           Y+H + Y HRDL   N+L+  D  +KI DFGLA+ +        Y           WY A
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFWY-A 205

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PE L +   +    D+W+ G  + EL+T        S      K   +IG          
Sbjct: 206 PECLKEYK-FYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQGQMTVLR 259

Query: 227 LLLARAINYKFPQLVGVPLSV--LMPSANKDAVSLIASLC-SWDPSKRPT 273
           L        + P+    P  V  LM              C   + S RPT
Sbjct: 260 LTELLERGERLPRPDKCPAEVYHLM------------KNCWETEASFRPT 297

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 7e-39
 Identities = 68/221 (30%), Positives = 114/221 (51%), Gaps = 21/221 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E   L+KE+G G FG V     K   +V A+K +K+   S +E    +E +++ K+SHP 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEF--FQEAQTMMKLSHPK 64

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +VK   V  +   +Y V EY+    L   ++   K    +++   C+ V +G+A++    
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQ 172
           + HRDL   N LV +D  +K++DFG+ R +       +YVS+       +W  APEV   
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-APEVFHY 179

Query: 173 SYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
              YSSK D+WA G +M E+ +L   P +   + ++ + K+
Sbjct: 180 F-KYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV 218

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (349), Expect = 9e-39
 Identities = 77/315 (24%), Positives = 133/315 (42%), Gaps = 60/315 (19%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
               +  ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIKHPN 70

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V       Y + E+M     L  L +   +  S   +     Q+   + Y+ ++
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
            + HRDL   N LV ++  +K+ADFGL+R +        Y +        +W  APE L 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APESLA 185

Query: 172 QSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
            +  +S K D+WA G ++ E+ T    P +PG   +     +                  
Sbjct: 186 YN-KFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK---------------- 227

Query: 230 ARAINYKFPQLVGVPLSV--LMPSANKDAVSLIASLC-SWDPSKRPTAAEALQHPFSRVA 286
               +Y+  +  G P  V  LM              C  W+PS RP+ AE +   F    
Sbjct: 228 ----DYRMERPEGCPEKVYELM------------RACWQWNPSDRPSFAE-IHQAFET-- 268

Query: 287 FMFHHLSVPEQLLQE 301
            MF   S+ +++ +E
Sbjct: 269 -MFQESSISDEVEKE 282

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  136 bits (346), Expect = 2e-38
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 22/224 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I          VAIK  K           L+E  ++R+  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HP+IVKL  VI EN + + + E      L   ++ R+     A +  + +Q+   LAY+ 
Sbjct: 75  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEV 169
            + + HRD+   N+LVS +  +K+ DFGL+R +      + Y          +W  APE 
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----STYYKASKGKLPIKWM-APES 188

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +     ++S  D+W  G  M E++    +P F G    D I +I
Sbjct: 189 INFR-RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  136 bits (344), Expect = 4e-38
 Identities = 48/322 (14%), Positives = 112/322 (34%), Gaps = 65/322 (20%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEV-------VAIKKMKKKYYSWEECVNLREVKSLRKM 57
              + +G GTF  +++ + ++ G+        V +K + K + ++ E         + K+
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF-FEAASMMSKL 69

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           SH ++V    V    D    V E+++  +L   +K  + C +         Q+   + ++
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 117 HQRGYFHRDLKPENLLVSKD---------TIKIADFGLAREINSRPPFTEYVST--RWYR 165
            +    H ++  +N+L+ ++          IK++D G++  +       + +     W  
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWV- 184

Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKICSVIGTPTQDSW 223
            PE +      +   D W+ G  + E+ +   +P         ++               
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFYED---------- 233

Query: 224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLC-SWDPSKRPTAAEALQHPF 282
                      ++ P      L+ L+            + C  ++P  RP+    +    
Sbjct: 234 ----------RHQLPAPKAAELANLI------------NNCMDYEPDHRPSFRA-IIRDL 270

Query: 283 SRVAFMFHHLSVPEQLLQEHLH 304
           +    +F    VP      H H
Sbjct: 271 NS---LFTPDLVPRGSHHHHHH 289

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  137 bits (346), Expect = 5e-38
 Identities = 49/222 (22%), Positives = 98/222 (44%), Gaps = 22/222 (9%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           + +K +G G FG+V + +    GE     V IK ++ K            + ++  + H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +IV+L  +   + +   V +Y+   +L   ++          + NW  Q+ +G+ Y+ + 
Sbjct: 76  HIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
           G  HR+L   N+L+ S   +++ADFG+A  +       + +         +W  A E  +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSEAKTPIKWM-ALES-I 189

Query: 172 QSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
               Y+ + D+W+ G  + EL+T    P + G   A+    +
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEP-YAGLRLAEVPDLL 230

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  135 bits (342), Expect = 7e-38
 Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 22/224 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           E   L + +G+G FG V+  +          VA+K  KK      +   + E   ++ + 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HP+IVKL  +I E    + + E      L   ++  +       +  +  Q+ + +AY+ 
Sbjct: 72  HPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEV 169
                HRD+   N+LV S + +K+ DFGL+R I       +Y          +W  +PE 
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED----EDYYKASVTRLPIKWM-SPES 185

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +     +++  D+W     M E+++   +P F      D I  +
Sbjct: 186 INFR-RFTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGVL 227

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  140 bits (354), Expect = 1e-37
 Identities = 75/302 (24%), Positives = 118/302 (39%), Gaps = 54/302 (17%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY---YSWEECVNLREVKSLRKM 57
            + +   + +G G FG V+    K +G++ A KK+ KK        +   + E K L K+
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKV 242

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECN----LYQL--MKDREKCFSEAEVRNWCFQVFQ 111
               IV L         L  V   M  N     Y +  + +    F E     +  Q+  
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIM--NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300

Query: 112 GLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTE-YVSTRWYRAPEV 169
           GL ++HQR   +RDLKPEN+L+  D  ++I+D GLA E+ +    T+ Y  T  + APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA---DEIY-KICSVIGTPTQDSWAD 225
           LL    Y   VD +A+G  + E+I  R  F    E     E+  ++              
Sbjct: 361 LLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----------- 408

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAAEAL-QH 280
                      +P              +  +     +L   DP KR      + + L  H
Sbjct: 409 --------AVTYP-----------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449

Query: 281 PF 282
           P 
Sbjct: 450 PL 451

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (353), Expect = 1e-37
 Identities = 81/286 (28%), Positives = 124/286 (43%), Gaps = 56/286 (19%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAF--LQEAQVMKKLRHEK 323

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM     L  L  +  K     ++ +   Q+  G+AY+ + 
Sbjct: 324 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
            Y HRDL+  N+LV ++   K+ADFGLAR I       EY +        +W  APE  L
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWT-APEAAL 437

Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               ++ K D+W+ G ++ EL T  R  +PG    + + ++                   
Sbjct: 438 YG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----------------- 479

Query: 231 RAINYKFPQLVGVPLSV--LMPSANKDAVSLIASLC-SWDPSKRPT 273
               Y+ P     P S+  LM              C   +P +RPT
Sbjct: 480 ---GYRMPCPPECPESLHDLMCQ------------CWRKEPEERPT 510

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (348), Expect = 3e-37
 Identities = 81/286 (28%), Positives = 124/286 (43%), Gaps = 56/286 (19%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAF--LQEAQVMKKLRHEK 240

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E  I Y V EYM     L  L  +  K     ++ +   Q+  G+AY+ + 
Sbjct: 241 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
            Y HRDL+  N+LV ++   K+ADFGLAR I       EY +        +W  APE  L
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWT-APEAAL 354

Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
               ++ K D+W+ G ++ EL T  R  +PG    + + ++                   
Sbjct: 355 YG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----------------- 396

Query: 231 RAINYKFPQLVGVPLSV--LMPSANKDAVSLIASLC-SWDPSKRPT 273
               Y+ P     P S+  LM              C   +P +RPT
Sbjct: 397 ---GYRMPCPPECPESLHDLMCQ------------CWRKEPEERPT 427

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  133 bits (338), Expect = 3e-37
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 20/224 (8%)

Query: 2   ERYKLIK-EVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           +   +   E+G G FGSV + + +   +   VAIK +K+     +    +RE + + ++ 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +P IV+L  V +   +   V E      L++ +  + +    + V     QV  G+ Y+ 
Sbjct: 69  NPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127

Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEV 169
           ++ + HRDL   N+L+ ++   KI+DFGL++ + +      Y +        +WY APE 
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWY-APEC 184

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +     +SS+ D+W+ G  M E ++   +P +      + +  I
Sbjct: 185 INFR-KFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (341), Expect = 3e-37
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 22/222 (9%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +P
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           ++ +L  +   + +   + + M    L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 78  HVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
              HRDL   N+LV +   +KI DFGLA+ + +     +           +W  A E +L
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKWM-ALESIL 192

Query: 172 QSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
              +Y+ + D+W+ G  + EL+T   +P + G   ++    +
Sbjct: 193 HR-IYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL 232

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  132 bits (335), Expect = 1e-36
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 10/209 (4%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           ERYK++ ++G G   +V+ A        VAIK +       EE +    REV +  ++SH
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 60  PNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            NIV + +V  E+D  Y V EY+E   L + ++      S     N+  Q+  G+ + H 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHD 129

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE---YVSTRWYRAPEVLLQSY 174
               HRD+KP+N+L+  + T+KI DFG+A+ ++     T+    + T  Y +PE   +  
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSPE-QAKGE 187

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTS 203
                 D++++G ++ E++   P F G +
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGET 216

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (331), Expect = 3e-36
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 29/223 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +  KL++ +G G FG V     +  G  VA+K +K    +      L E   + ++ H N
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF---LAEASVMTQLRHSN 75

Query: 62  IVKLKEVI-RENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           +V+L  VI  E   LY V EYM     +  L            +  +   V + + Y+  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVL 170
             + HRDL   N+LVS+D   K++DFGL +E           +        +W  APE L
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--------SSTQDTGKLPVKWT-APEAL 186

Query: 171 LQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
            +   +S+K D+W+ G ++ E+ +    P +P     D + ++
Sbjct: 187 REK-KFSTKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRV 227

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  131 bits (332), Expect = 3e-36
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 21/218 (9%)

Query: 8   KEVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIVK 64
           KE+G G FG+V +   +    V  VA+K +K +          L E   ++++ +P IV+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 65  LKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFH 123
           +  +         V E  E   L + ++       +  +     QV  G+ Y+ +  + H
Sbjct: 83  MIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNFVH 140

Query: 124 RDLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQSYL 175
           RDL   N+L+ ++   KI+DFGL++ + +      Y +        +WY APE +     
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWY-APECINYY-K 196

Query: 176 YSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +SSK D+W+ G +M E  +   +P + G   ++    +
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAML 233

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  137 bits (347), Expect = 3e-36
 Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 59/303 (19%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKY---YSWEECVN-----LREVK 52
           M  + + + +G G FG V+      +G++ A+K + KK       E         L  V 
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 53  SLRKMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
           +      P IV +       D L F+ + M  N     Y L   +   FSEA++R +  +
Sbjct: 248 TGD---CPFIVCMSYAFHTPDKLSFILDLM--NGGDLHYHL--SQHGVFSEADMRFYAAE 300

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEYVSTRWYRAP 167
           +  GL +MH R   +RDLKP N+L+ +   ++I+D GLA + + + P    V T  Y AP
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAP 359

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD--EIY-KICSVIGTPTQDSWA 224
           EVL +   Y S  D +++G ++ +L+     F      D  EI     ++          
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------- 409

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAAEAL-Q 279
                      + P              + +  SL+  L   D ++R       A+ + +
Sbjct: 410 ---------AVELPDSF-----------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449

Query: 280 HPF 282
            PF
Sbjct: 450 SPF 452

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  131 bits (331), Expect = 3e-36
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 23/222 (10%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW        +V A+K +K+   S +    L E   ++++ H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF--LAEANLMKQLQHQR 69

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +  I Y + EYME    +  L        +  ++ +   Q+ +G+A++ +R
Sbjct: 70  LVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
            Y HRDL+  N+LVS   + KIADFGLAR I       EY +        +W  APE + 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIED----NEYTAREGAKFPIKWT-APEAIN 183

Query: 172 QSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
               ++ K D+W+ G ++ E++T    P +PG +  + I  +
Sbjct: 184 YG-TFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNL 223

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  134 bits (340), Expect = 3e-36
 Identities = 73/222 (32%), Positives = 113/222 (50%), Gaps = 23/222 (10%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL K++G G FG VW A   +  +V A+K MK    S E    L E   ++ + H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAF--LAEANVMKTLQHDK 244

Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR 119
           +VKL  V+ +  I Y + E+M   +L   +K  E       ++ ++  Q+ +G+A++ QR
Sbjct: 245 LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLL 171
            Y HRDL+  N+LVS     KIADFGLAR I       EY +        +W  APE + 
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWT-APEAIN 358

Query: 172 QSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
               ++ K D+W+ G ++ E++T    P +PG S  + I  +
Sbjct: 359 FG-SFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRAL 398

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  132 bits (333), Expect = 5e-36
 Identities = 69/334 (20%), Positives = 117/334 (35%), Gaps = 48/334 (14%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMSHPNIV 63
           KL++ +G G +G+V++         VA+K        ++    N + +  +  M H NI 
Sbjct: 16  KLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFI---NEKNIYRVPLMEHDNIA 70

Query: 64  KL-----KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +      +           V EY    +L + +                  V +GLAY+H
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH 128

Query: 118 ---------QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY--------- 158
                    +    HRDL   N+LV  D T  I+DFGL+  +                  
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 159 VSTRWYRAPEVLLQSY------LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKIC 212
           V T  Y APEVL  +           +VDM+A+G I  E+   R       E+   Y++ 
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGESVPEYQMA 247

Query: 213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSW--DPSK 270
                    ++ D + +  +   + P+    P +    S    ++      C W  D   
Sbjct: 248 FQTEVGNHPTFED-MQVLVSREKQRPKF---PEAWKENSLAVRSLKETIEDC-WDQDAEA 302

Query: 271 RPTAAEALQHPFSRVAFMFHHLSVPEQLLQEHLH 304
           R TA  A +   + +  ++            H H
Sbjct: 303 RLTAQXAEER-MAELMMIWERNKSVSPTAHHHHH 335

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (330), Expect = 6e-36
 Identities = 53/221 (23%), Positives = 105/221 (47%), Gaps = 17/221 (7%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
              + +G G FG V+      +       A+K + +     E    L E   ++  SHPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 62  IVKLKEVIRENDI-LYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           ++ L  +   ++     V  YM+  +L   +++     +  ++  +  QV +G+ Y+  +
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQ 172
            + HRDL   N ++ +  T+K+ADFGLAR++  +  ++ +  T      +W  A E  LQ
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALES-LQ 205

Query: 173 SYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +  +++K D+W+ G ++ EL+T    P +P  +  D    +
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (328), Expect = 1e-35
 Identities = 55/221 (24%), Positives = 109/221 (49%), Gaps = 17/221 (7%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
              + +G G FG V+        +     AIK + +     +    LRE   +R ++HPN
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 62  IVKLKEV-IRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           ++ L  + +    + + +  YM   +L Q ++  ++  +  ++ ++  QV +G+ Y+ ++
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQ 172
            + HRDL   N ++ +  T+K+ADFGLAR+I  R  ++           +W  A E  LQ
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALES-LQ 201

Query: 173 SYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +Y +++K D+W+ G ++ EL+T    P +      D  + +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFL 241

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  132 bits (334), Expect = 2e-35
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 15/216 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +  KL++ +G G FG V     +  G  VA+K +K    +      L E   + ++ H N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF---LAEASVMTQLRHSN 247

Query: 62  IVKLKEVI-RENDILYFVFEYMEC-NLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQ 118
           +V+L  VI  E   LY V EYM   +L   ++ R         +  +   V + + Y+  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
             + HRDL   N+LVS+D   K++DFGL +E +S     + +  +W  APE L +   +S
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVKWT-APEALREK-KFS 364

Query: 178 SKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +K D+W+ G ++ E+ +    P +P     D + ++
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRV 399

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  134 bits (339), Expect = 3e-35
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 22/224 (9%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I          VAIK  K           L+E  ++R+  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HP+IVKL  VI EN + + + E      L   ++ R+     A +  + +Q+   LAY+ 
Sbjct: 450 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST-------RWYRAPEV 169
            + + HRD+   N+LVS +  +K+ DFGL+R +      + Y          +W  APE 
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----STYYKASKGKLPIKWM-APES 563

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
            +    ++S  D+W  G  M E++    +P F G    D I +I
Sbjct: 564 -INFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  134 bits (338), Expect = 3e-35
 Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 19/217 (8%)

Query: 8   KEVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKL 65
            E+G G FGSV + + +   +   VAIK +K+     +    +RE + + ++ +P IV+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 66  KEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
             V +   +   V E      L++ +  + +    + V     QV  G+ Y+ ++ + HR
Sbjct: 402 IGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460

Query: 125 DLKPENLLV-SKDTIKIADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQSYLY 176
           +L   N+L+ ++   KI+DFGL++ + +      Y +        +WY APE +     +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWY-APECINFR-KF 516

Query: 177 SSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           SS+ D+W+ G  M E ++   +P +      + +  I
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 552

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  129 bits (327), Expect = 4e-35
 Identities = 86/307 (28%), Positives = 127/307 (41%), Gaps = 72/307 (23%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS------- 53
           M  +  +K +G GTFG V     K +G   A+K ++K     E  +   EV         
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRV 58

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQV 109
           L+   HP +  LK   + +D L FV EY   N     + L   RE+ F+E   R +  ++
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEY--ANGGELFFHLS--RERVFTEERARFYGAEI 114

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EYVST 161
              L Y+H R   +RD+K ENL++ KD  IKI DFGL +E  S            EY+  
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL-- 172

Query: 162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQ 220
               APEVL  +  Y   VD W +G +M E++  R  F      + ++  I         
Sbjct: 173 ----APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILME------ 220

Query: 221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAA 275
                          +FP+ +             +A SL+A L   DP +R       A 
Sbjct: 221 -------------EIRFPRTLS-----------PEAKSLLAGLLKKDPKQRLGGGPSDAK 256

Query: 276 EALQHPF 282
           E ++H F
Sbjct: 257 EVMEHRF 263

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  129 bits (327), Expect = 6e-35
 Identities = 52/221 (23%), Positives = 104/221 (47%), Gaps = 17/221 (7%)

Query: 5   KLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
              + +G G FG V+      +       A+K + +     E    L E   ++  SHPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 62  IVKLKEVIRENDI-LYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           ++ L  +   ++     V  YM+  +L   +++     +  ++  +  QV +G+ ++  +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST------RWYRAPEVLLQ 172
            + HRDL   N ++ +  T+K+ADFGLAR++  +   + +  T      +W  A E  LQ
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALES-LQ 269

Query: 173 SYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
           +  +++K D+W+ G ++ EL+T    P +P  +  D    +
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 309

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  130 bits (327), Expect = 8e-35
 Identities = 83/362 (22%), Positives = 132/362 (36%), Gaps = 85/362 (23%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM---- 57
            RY +I+++G G F +VW +   Q  + VA+K +K   +  E    L E++ L+ +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA--LDEIRLLKSVRNSD 94

Query: 58  -SHPN---IVKLK---EVIRENDI-LYFVFEYMECNLYQLMKD-REKCFSEAEVRNWCFQ 108
            + PN   +V+L    ++   N   +  VFE +  +L + +     +      V+    Q
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154

Query: 109 VFQGLAYMH-QRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPP------------- 154
           V QGL Y+H +    H D+KPEN+L+S +   I           R               
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 155 -----------------------------------FTEYVSTRWYRAPEVLLQSYLYSSK 179
                                              FTE + TR YR+ EVL+ S  Y++ 
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG-YNTP 273

Query: 180 VDMWAMGAIMAELITLRPLFPG------TSEADEIYKICSVIGTPTQDSWA--------- 224
            D+W+   +  EL T   LF        T + D I  I  ++G   +             
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333

Query: 225 --DGLLLARAINYKFPQLVGVPLSVL-MPSANKDA-VSLIASLCSWDPSKRPTAAEALQH 280
              G L       K   L  V +                +  +    P KR TAAE L+H
Sbjct: 334 TKKGDLK-HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 281 PF 282
           P+
Sbjct: 393 PW 394

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (334), Expect = 2e-34
 Identities = 57/286 (19%), Positives = 113/286 (39%), Gaps = 57/286 (19%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQ-SGEVVAIKKMKKKYYSWEECVN---LREVKSLRKMS 58
           +Y++   +  G  G ++ A+ +  +G  V +K +    +S +       + E + L ++ 
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV---HSGDAEAQAMAMAERQFLAEVV 137

Query: 59  HPNIVKLKEVIREND-----ILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQG 112
           HP+IV++   +   D     + Y V EY+   +L +    +      AE   +  ++   
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPA 194

Query: 113 LAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
           L+Y+H  G  + DLKPEN++++++ +K+ D G    INS         T  ++APE++  
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRT 251

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
               ++  D++ +G  +A L    P   G                               
Sbjct: 252 GPTVAT--DIYTVGRTLAALTLDLPTRNGRY----------------------------- 280

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL 278
                  + G+P    +         L+      DP +R T AE +
Sbjct: 281 -------VDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (320), Expect = 2e-34
 Identities = 61/289 (21%), Positives = 115/289 (39%), Gaps = 40/289 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           +RY+L + +G G    V  A   +    VA+K ++              RE ++   ++H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 60  PNIVKL----KEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           P IV +    +       + Y V EY++   L  ++       +            Q L 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALN 130

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTE---YVSTRWYRAPEV 169
           + HQ G  HRD+KP N+++S    +K+ DFG+AR I  S    T+    + T  Y +PE 
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE- 189

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
             +     ++ D++++G ++ E++T  P F G S                          
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------------------------- 223

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL 278
             ++ Y+  +   +P S      + D  +++    + +P  R   A  +
Sbjct: 224 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  128 bits (323), Expect = 3e-34
 Identities = 81/307 (26%), Positives = 120/307 (39%), Gaps = 72/307 (23%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS------- 53
              +  +K +G G+FG V  A  K      A+K ++KK       +  +E K        
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA-----ILKKKEEKHIMSERNV 91

Query: 54  -LRKMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
            L+ + HP +V L    +  D LYFV +Y+  N     Y L   RE+CF E   R +  +
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYI--NGGELFYHL--QRERCFLEPRARFYAAE 147

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EYVS 160
           +   L Y+H     +RDLKPEN+L+     I + DFGL +E       T       EY+ 
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYL- 206

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPT 219
                APEVL +   Y   VD W +GA++ E++   P F   +   E+Y  I +      
Sbjct: 207 -----APEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNK----- 254

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAA 275
                           +             P+    A  L+  L   D +KR        
Sbjct: 255 --------------PLQLK-----------PNITNSARHLLEGLLQKDRTKRLGAKDDFM 289

Query: 276 EALQHPF 282
           E   H F
Sbjct: 290 EIKSHVF 296

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  127 bits (321), Expect = 4e-34
 Identities = 75/304 (24%), Positives = 127/304 (41%), Gaps = 69/304 (22%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR----- 55
           +E + L K +G G+FG V+ A  K++ +  AIK +KK     +  +   +V+        
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-----DVVLMDDDVECTMVEKRV 70

Query: 56  ---KMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
                 HP +  +    +  + L+FV EY   N    +Y +       F  +    +  +
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEY--LNGGDLMYHIQ--SCHKFDLSRATFYAAE 126

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EYVS 160
           +  GL ++H +G  +RDLK +N+L+ KD  IKIADFG+ +E       T       +Y+ 
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI- 185

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPT 219
                APE+LL    Y+  VD W+ G ++ E++  +  F G  E +E++  I        
Sbjct: 186 -----APEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMD----- 233

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
                         N  +P               K+A  L+  L   +P KR      ++
Sbjct: 234 --------------NPFYP-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268

Query: 280 -HPF 282
            HP 
Sbjct: 269 QHPL 272

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  124 bits (315), Expect = 2e-33
 Identities = 77/309 (24%), Positives = 132/309 (42%), Gaps = 72/309 (23%)

Query: 1   MERYKLIKEVGDGTFGSVW---RAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS---- 53
            E ++L++ +G G +G V+   +     +G++ A+K +KK         N ++       
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI----VRNAKDTAHTKAE 71

Query: 54  ---LRKMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWC 106
              L ++ HP IV L    +    LY + EY   +      QL  +RE  F E     + 
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGGKLYLILEY--LSGGELFMQL--EREGIFMEDTACFYL 127

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EY 158
            ++   L ++HQ+G  +RDLKPEN++++    +K+ DFGL +E       T       EY
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187

Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP 218
           +      APE+L++S  ++  VD W++GA+M +++T  P F G +    I KI       
Sbjct: 188 M------APEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---- 236

Query: 219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTA 274
                              P  +            ++A  L+  L   + + R    P  
Sbjct: 237 ---------------KLNLPPYLT-----------QEARDLLKKLLKRNAASRLGAGPGD 270

Query: 275 AEALQ-HPF 282
           A  +Q HPF
Sbjct: 271 AGEVQAHPF 279

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  125 bits (315), Expect = 3e-33
 Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 73/308 (23%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR----- 55
           +  +  +  +G G+FG V  +  K + E+ A+K +KK     +  +   +V+        
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRV 73

Query: 56  ---KMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
                  P + +L    +  D LYFV EY   N    +Y +   +   F E     +  +
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEY--VNGGDLMYHI--QQVGRFKEPHAVFYAAE 129

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EYVS 160
           +  GL ++  +G  +RDLK +N+++  +  IKIADFG+ +E       T       +Y+ 
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI- 188

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPT 219
                APE++     Y   VD WA G ++ E++  +  F G  E DE++  I        
Sbjct: 189 -----APEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEH----- 236

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAA 275
                         N  +P            S +K+AV++   L +  P KR    P   
Sbjct: 237 --------------NVAYP-----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGE 271

Query: 276 EALQ-HPF 282
             ++ H F
Sbjct: 272 RDIKEHAF 279

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  126 bits (319), Expect = 3e-33
 Identities = 92/301 (30%), Positives = 135/301 (44%), Gaps = 59/301 (19%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKS------- 53
           M  ++ +K +G GTFG V     K +G   A+K +KK     E  V   EV         
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-----EVIVAKDEVAHTLTENRV 201

Query: 54  LRKMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQV 109
           L+   HP +  LK   + +D L FV EY   N     + L   RE+ FSE   R +  ++
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEY--ANGGELFFHL--SRERVFSEDRARFYGAEI 257

Query: 110 FQGLAYMH-QRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRA 166
              L Y+H ++   +RDLK ENL++ KD  IKI DFGL +E I        +  T  Y A
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
           PEVL  +  Y   VD W +G +M E++  R  F      +++++                
Sbjct: 318 PEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFE---------------- 359

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHP 281
           L+L   I  +FP+ +G            +A SL++ L   DP +R       A E +QH 
Sbjct: 360 LILMEEI--RFPRTLG-----------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406

Query: 282 F 282
           F
Sbjct: 407 F 407

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  124 bits (313), Expect = 4e-33
 Identities = 71/305 (23%), Positives = 129/305 (42%), Gaps = 66/305 (21%)

Query: 1   MERYKLIKEVGDGTFGSVW---RAISKQSGEVVAIKKMKKKY---YSWEECVNLREVKSL 54
             +++L+K +G G+FG V+   +     + ++ A+K +KK              R++  L
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--L 80

Query: 55  RKMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQVF 110
            +++HP IVKL    +    LY + ++          +L   +E  F+E +V+ +  ++ 
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDF--LRGGDLFTRL--SKEVMFTEEDVKFYLAELA 136

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EYVSTR 162
             L ++H  G  +RDLKPEN+L+ ++  IK+ DFGL++E               EY+   
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM--- 193

Query: 163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS 222
              APEV+ +   ++   D W+ G +M E++T    F G    + +  I           
Sbjct: 194 ---APEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-------- 241

Query: 223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAAEAL 278
                          PQ +             +A SL+  L   +P+ R    P   E +
Sbjct: 242 -----------KLGMPQFLS-----------PEAQSLLRMLFKRNPANRLGAGPDGVEEI 279

Query: 279 Q-HPF 282
           + H F
Sbjct: 280 KRHSF 284

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (311), Expect = 4e-33
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 10/210 (4%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP 60
            Y+L + VG G  G V+ A       +VA+K M +   S         RE ++  ++  P
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           ++V + +    +  LY     +   +L  +++ +    +         Q+   L   H  
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAA 153

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE---YVSTRWYRAPEVLLQSYL 175
           G  HRD+KPEN+LVS D    + DFG+A         T+    V T +Y APE   +S+ 
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEA 205
            + + D++A+  ++ E +T  P + G   +
Sbjct: 213 -TYRADIYALTCVLYECLTGSPPYQGDQLS 241

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  124 bits (313), Expect = 5e-33
 Identities = 72/309 (23%), Positives = 136/309 (44%), Gaps = 74/309 (23%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR----- 55
           ++ ++ I+ +G G+FG V  A  K++G++ A+K +KK     +  +   +V+        
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK-----DVILQDDDVECTMTEKRI 76

Query: 56  ---KMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
                +HP + +L    +  D L+FV E+   N    ++ +   + + F EA  R +  +
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEF--VNGGDLMFHI--QKSRRFDEARARFYAAE 132

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EYVS 160
           +   L ++H +G  +RDLK +N+L+  +   K+ADFG+ +E       T       +Y+ 
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYI- 191

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPT 219
                APE+L +  LY   VD WAMG ++ E++     F   +E D+++  I +      
Sbjct: 192 -----APEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILND----- 239

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAA 275
                            +P              ++DA  ++ S  + +P+ R        
Sbjct: 240 --------------EVVYP-----------TWLHEDATGILKSFMTKNPTMRLGSLTQGG 274

Query: 276 EA--LQHPF 282
           E   L+HPF
Sbjct: 275 EHAILRHPF 283

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  123 bits (310), Expect = 6e-33
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 28/217 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVN-LREVKSLRKM 57
               L K +G+G FGSV     KQ       VA+K MK    S  E    L E   ++  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 58  SHPNIVKL-----KEVIRENDILYFVFEYMEC-NLYQ-LMKDR----EKCFSEAEVRNWC 106
           SHPN+++L     +   +       +  +M+  +L+  L+  R     K      +  + 
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST---- 161
             +  G+ Y+  R + HRDL   N ++  D T+ +ADFGL+++I S      Y       
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG---DYYRQGRIAK 210

Query: 162 ---RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
              +W  A E L    +Y+SK D+WA G  M E+ T 
Sbjct: 211 MPVKWI-AIESLADR-VYTSKSDVWAFGVTMWEIATR 245

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  122 bits (308), Expect = 1e-32
 Identities = 64/243 (26%), Positives = 103/243 (42%), Gaps = 40/243 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
            R    K +G G FG V  A    + K    + VA+K +K   +  E    + E+K L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 57  M-SHPNIVKLKEVIRENDILYFVFEYMEC------------------NLYQLMKDREKCF 97
           + +H NIV L            + EY                         +M+D E   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT 156
              ++ ++ +QV +G+A++  +   HRDL   N+L++     KI DFGLAR+I +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199

Query: 157 EYVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADE 207
            YV         +W  APE +    +Y+ + D+W+ G  + EL +L   P +PG     +
Sbjct: 200 NYVVKGNARLPVKWM-APESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSK 256

Query: 208 IYK 210
            YK
Sbjct: 257 FYK 259

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  126 bits (318), Expect = 2e-32
 Identities = 73/302 (24%), Positives = 125/302 (41%), Gaps = 61/302 (20%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR----- 55
           +  +  +  +G G+FG V  +  K + E+ A+K +KK     +  +   +V+        
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRV 394

Query: 56  ---KMSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
                  P + +L    +  D LYFV EY   N    +Y +   +   F E     +  +
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEY--VNGGDLMYHI--QQVGRFKEPHAVFYAAE 450

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLARE-INSRPPFTEYVSTRWYRA 166
           +  GL ++  +G  +RDLK +N+++  +  IKIADFG+ +E I        +  T  Y A
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 510

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWAD 225
           PE++     Y   VD WA G ++ E++  +  F G  E DE++  I              
Sbjct: 511 PEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEH----------- 557

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAAEALQ-H 280
                   N  +P            S +K+AV++   L +  P KR    P     ++ H
Sbjct: 558 --------NVAYP-----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598

Query: 281 PF 282
            F
Sbjct: 599 AF 600

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  122 bits (307), Expect = 2e-32
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 63/302 (20%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVN-LREVKSLRKM 57
           +++ L + +G G FGSV  A  KQ       VA+K +K    +  +    LRE   +++ 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 58  SHPNIVKL------KEVIRENDILYFVFEYMEC-NLYQ-LMKDR----EKCFSEAEVRNW 105
            HP++ KL              I   +  +M+  +L+  L+  R            +  +
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST--- 161
              +  G+ Y+  R + HRDL   N ++++D T+ +ADFGL+R+I S      Y      
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG---DYYRQGCAS 199

Query: 162 ----RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKICSVI 215
               +W  A E L  + LY+   D+WA G  M E++T    P + G   A+    +    
Sbjct: 200 KLPVKWL-ALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYL---- 252

Query: 216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLC-SWDPSKRPTA 274
                     G  L +      P      +  LM              C S DP +RP+ 
Sbjct: 253 --------IGGNRLKQ------PPECMEEVYDLM------------YQCWSADPKQRPSF 286

Query: 275 AE 276
             
Sbjct: 287 TC 288

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  121 bits (306), Expect = 4e-32
 Identities = 71/311 (22%), Positives = 128/311 (41%), Gaps = 69/311 (22%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK---- 56
           ++ + L++ +G G++  V     K++  + A+K +KK     E   +  ++  ++     
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK-----ELVNDDEDIDWVQTEKHV 62

Query: 57  ----MSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
                +HP +V L    +    L+FV EY   N    ++ +   R++   E   R +  +
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEY--VNGGDLMFHMQ--RQRKLPEEHARFYSAE 118

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EYVS 160
           +   L Y+H+RG  +RDLK +N+L+  +  IK+ D+G+ +E       T        Y+ 
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYI- 177

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
                APE+L     Y   VD WA+G +M E++  R  F     +D   +          
Sbjct: 178 -----APEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------- 221

Query: 221 DSWADGLLLARAI---NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----P 272
                   L + I     + P            S +  A S++ S  + DP +R      
Sbjct: 222 ---NTEDYLFQVILEKQIRIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQ 267

Query: 273 TAAEALQ-HPF 282
           T    +Q HPF
Sbjct: 268 TGFADIQGHPF 278

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  121 bits (306), Expect = 5e-32
 Identities = 71/303 (23%), Positives = 127/303 (41%), Gaps = 52/303 (17%)

Query: 1   MERYKLIKEVGDGTFGSVW---RAISKQSGEVVAIKKMKKKYYSWE----ECVNLREVKS 53
           +E ++L+K +G G +G V+   +     +G++ A+K +KK     +    E     E + 
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQV 111

Query: 54  LRKMSH-PNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
           L  +   P +V L    +    L+ + +Y   N       L   + + F+E EV+ +  +
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDY--INGGELFTHL--SQRERFTEHEVQIYVGE 167

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFTEY--VSTRWYR 165
           +   L ++H+ G  +RD+K EN+L+  +  + + DFGL++E  +      Y    T  Y 
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 166 APEVLL-QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA 224
           AP+++      +   VD W++G +M EL+T    F    E +   +I   I         
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--------- 278

Query: 225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR----PTAAEALQ- 279
               L       +P              +  A  LI  L   DP KR    P  A+ ++ 
Sbjct: 279 ----LKSEP--PYP-----------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321

Query: 280 HPF 282
           H F
Sbjct: 322 HLF 324

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  120 bits (304), Expect = 6e-32
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 38/222 (17%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+      + K   E  VAIK + +     E    L E   +++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQ-LMKDREKCFSEAEVRN--------WC 106
            +  ++V+L  V+ +      + E M   +L   L   R    +   +            
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYR 165
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I      T+Y     YR
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDY-----YR 195

Query: 166 ------------APEVLLQSYLYSSKVDMWAMGAIMAELITL 195
                       +PE L    ++++  D+W+ G ++ E+ TL
Sbjct: 196 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATL 236

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  120 bits (302), Expect = 6e-32
 Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 37/241 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAI-----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
              + ++E+G+  FG V++         +  + VAIK +K K           E     +
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYME----------------CNLYQLMKDREKCFSEA 100
           + HPN+V L  V+ ++  L  +F Y                         +  +      
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 101 EVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV 159
           +  +   Q+  G+ Y+      H+DL   N+LV     +KI+D GL RE+ +      Y 
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA---DYYK 185

Query: 160 ST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYK 210
                    RW  APE ++    +S   D+W+ G ++ E+ +   +P + G S  D +  
Sbjct: 186 LLGNSLLPIRWM-APEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQDVVEM 242

Query: 211 I 211
           I
Sbjct: 243 I 243

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (304), Expect = 6e-32
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 39/242 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A    I K +    VA+K +K+     E    + E+K L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 57  M-SHPNIVKLKEV-IRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRN--------- 104
           +  H N+V L     +    L  + E+ +  NL   ++ +   F   +V           
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 105 ------WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE 157
                 + FQV +G+ ++  R   HRDL   N+L+S+   +KI DFGLAR+I   P   +
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---D 203

Query: 158 YVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEI 208
           YV         +W  APE +    +Y+ + D+W+ G ++ E+ +L   P +PG    +E 
Sbjct: 204 YVRKGDARLPLKWM-APETIFDR-VYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 260

Query: 209 YK 210
            +
Sbjct: 261 CR 262

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  120 bits (303), Expect = 9e-32
 Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 36/239 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
              +  K +G G FG V  A    + K+   + VA+K +K   ++ E+   + E+K +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 57  M-SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQ-LMKDREKCFSEAEVRN--------- 104
           +  H NIV L         +  + EY    +L   L +      ++              
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 105 ---WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS 160
              +  QV QG+A++  +   HRD+   N+L++     KI DFGLAR+I +      Y+ 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIV 222

Query: 161 T-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYK 210
                   +W  APE +    +Y+ + D+W+ G ++ E+ +L   P +PG     + YK
Sbjct: 223 KGNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFYK 278

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  119 bits (301), Expect = 1e-31
 Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 42/231 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           +   L K +G+G FG V +A    +  ++G   VA+K +K+     E    L E   L++
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYME------------------------CNLYQLMKD 92
           ++HP+++KL     ++  L  + EY +                         N   L   
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 93  REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS 151
            E+  +  ++ ++ +Q+ QG+ Y+ +    HRDL   N+LV++   +KI+DFGL+R++  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 152 RPPFTEYVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
                 YV         +W  A E L    +Y+++ D+W+ G ++ E++TL
Sbjct: 203 ED---SYVKRSQGRIPVKWM-AIESLFDH-IYTTQSDVWSFGVLLWEIVTL 248

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  118 bits (299), Expect = 2e-31
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 35/223 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
               L +E+G+G FG V+ A    +S    ++ VA+K +K    +       RE + L  
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTN 73

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYME----------------CNLYQLMKDREKCFSEA 100
           + H +IVK   V  + D L  VFEYM+                  +    +  +     +
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 101 EVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV 159
           ++ +   Q+  G+ Y+  + + HRDL   N LV  +  +KI DFG++R++ S      Y 
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---YYR 190

Query: 160 ST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
                    RW   PE ++    ++++ D+W+ G I+ E+ T 
Sbjct: 191 VGGHTMLPIRWM-PPESIMYR-KFTTESDVWSFGVILWEIFTY 231

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  119 bits (301), Expect = 2e-31
 Identities = 53/236 (22%), Positives = 101/236 (42%), Gaps = 33/236 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           +   LI+ +G G FG V+      +      + VA+K + +     +E   L E   + K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQ-LMKDREKC-----FSEAEVRNWCFQV 109
            +H NIV+   V  ++   + + E M   +L   L + R +       +  ++ +    +
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVST---- 161
             G  Y+ +  + HRD+   N L++        KI DFG+AR+I        Y       
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----ASYYRKGGCA 205

Query: 162 ----RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
               +W   PE  ++  +++SK D W+ G ++ E+ +L   P +P  S  + +  +
Sbjct: 206 MLPVKWM-PPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFV 258

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  118 bits (299), Expect = 3e-31
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKM-S 58
              K    +G+G FG V +A  K+ G     AIK+MK+     +      E++ L K+  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NL---------------YQLMKDREKCFSEAEV 102
           HPNI+ L         LY   EY    NL               + +        S  ++
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 103 RNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVST 161
            ++   V +G+ Y+ Q+ + HRDL   N+LV ++   KIADFGL+R          YV  
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKK 198

Query: 162 -------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
                  RW  A E L  S +Y++  D+W+ G ++ E+++L
Sbjct: 199 TMGRLPVRWM-AIESLNYS-VYTTNSDVWSYGVLLWEIVSL 237

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  120 bits (303), Expect = 3e-31
 Identities = 70/311 (22%), Positives = 128/311 (41%), Gaps = 69/311 (22%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK---- 56
           ++ + L++ +G G++  V     K++  + A++ +KK     E   +  ++  ++     
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK-----ELVNDDEDIDWVQTEKHV 105

Query: 57  ----MSHPNIVKLKEVIRENDILYFVFEYMECN----LYQLMKDREKCFSEAEVRNWCFQ 108
                +HP +V L    +    L+FV EY   N    ++ +   R++   E   R +  +
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEY--VNGGDLMFHMQ--RQRKLPEEHARFYSAE 161

Query: 109 VFQGLAYMHQRGYFHRDLKPENLLVSKDT-IKIADFGLAREINSRPPFT-------EYVS 160
           +   L Y+H+RG  +RDLK +N+L+  +  IK+ D+G+ +E       T        Y+ 
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYI- 220

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQ 220
                APE+L     Y   VD WA+G +M E++  R  F     +D   +          
Sbjct: 221 -----APEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------- 264

Query: 221 DSWADGLLLARAI---NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----P 272
                   L + I     + P            S +  A S++ S  + DP +R      
Sbjct: 265 ---NTEDYLFQVILEKQIRIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQ 310

Query: 273 TAAEALQ-HPF 282
           T    +Q HPF
Sbjct: 311 TGFADIQGHPF 321

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  117 bits (296), Expect = 2e-30
 Identities = 53/236 (22%), Positives = 101/236 (42%), Gaps = 33/236 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           +   LI+ +G G FG V+      +      + VA+K + +     +E   L E   + K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQ-LMKDREKC-----FSEAEVRNWCFQV 109
            +H NIV+   V  ++   + + E M   +L   L + R +       +  ++ +    +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 110 FQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVST---- 161
             G  Y+ +  + HRD+   N L++        KI DFG+AR+I        Y       
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----AGYYRKGGCA 246

Query: 162 ----RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGTSEADEIYKI 211
               +W   PE  ++  +++SK D W+ G ++ E+ +L   P +P  S  + +  +
Sbjct: 247 MLPVKWM-PPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFV 299

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  116 bits (293), Expect = 3e-30
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 38/224 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVN-LREVKSLR 55
               L  E+G+G FG V+ A    +  +  ++ VA+K +K+   S     +  RE + L 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 98

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYME---------------CNLYQLMKDREKCFSEA 100
            + H +IV+   V  E   L  VFEYM                  L              
Sbjct: 99  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 101 EVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV 159
           ++     QV  G+ Y+    + HRDL   N LV +   +KI DFG++R+I S    T+Y 
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYY 214

Query: 160 ST--------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
                     RW   PE +L    ++++ D+W+ G ++ E+ T 
Sbjct: 215 RVGGRTMLPIRWM-PPESILYR-KFTTESDVWSFGVVLWEIFTY 256

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  115 bits (290), Expect = 3e-30
 Identities = 34/279 (12%), Positives = 75/279 (26%), Gaps = 57/279 (20%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSHP 60
           RY+L+   G       W+A+       VA+  +  +    ++ +   L     L ++  P
Sbjct: 32  RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91

Query: 61  NIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            + ++ +V+        V E++   +L ++        S          +       H+ 
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP---SPVGAIRAMQSLAAAADAAHRA 148

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS 178
           G       P  + VS D  + +A      + N +                          
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQ-------------------------- 182

Query: 179 KVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
             D+  +GA +  L+  R   P       +                       A   +  
Sbjct: 183 -DDIRGIGASLYALLVNRWPLPEAGVRSGL-----------------------APAERDT 218

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA 277
               +  + +         ++ A     D   R  +   
Sbjct: 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  116 bits (292), Expect = 4e-30
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 37/226 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSL 54
           ++  L K +G+G FG V  A    I K   +    VA+K +K      +    + E++ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 55  RKM-SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRN-------- 104
           + +  H NI+ L     ++  LY + EY    NL + ++ R     E             
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 105 -------WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT 156
                    +Q+ +G+ Y+  +   HRDL   N+LV+++  +KIADFGLAR+IN+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI---D 211

Query: 157 EYVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            Y  T       +W  APE L    +Y+ + D+W+ G +M E+ TL
Sbjct: 212 YYKKTTNGRLPVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTL 255

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  116 bits (292), Expect = 4e-30
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 42/231 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
              + ++++G+G FG V++A    +        VA+K +K++  +  +    RE   + +
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYME------------------------CNLYQLMKD 92
             +PNIVKL  V      +  +FEYM                             ++   
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 93  REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS 151
                S AE      QV  G+AY+ +R + HRDL   N LV ++  +KIADFGL+R I S
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 152 RPPFTEYVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
                 Y +        RW   PE +  +  Y+++ D+WA G ++ E+ + 
Sbjct: 227 AD---YYKADGNDAIPIRWM-PPESIFYN-RYTTESDVWAYGVVLWEIFSY 272

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  115 bits (289), Expect = 1e-29
 Identities = 74/248 (29%), Positives = 116/248 (46%), Gaps = 45/248 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV-VAIKKMKKKYYSWEECVNLREVKSLRK 56
           E  +  K +G G FG V  A    ISK    + VA+K +K+K  S E    + E+K + +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 57  M-SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVR----------- 103
           + SH NIV L      +  +Y +FEY    +L   ++ + + FSE E+            
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 104 -----------NWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS 151
                       + +QV +G+ ++  +   HRDL   N+LV+    +KI DFGLAR+I S
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 152 RPPFTEYVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL--RPLFPGT 202
                 YV         +W  APE L +  +Y+ K D+W+ G ++ E+ +L   P +PG 
Sbjct: 225 DS---NYVVRGNARLPVKWM-APESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP-YPGI 278

Query: 203 SEADEIYK 210
                 YK
Sbjct: 279 PVDANFYK 286

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  115 bits (290), Expect = 1e-29
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 37/226 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSL 54
           ++  L K +G+G FG V  A    I K   +    VA+K +K      +    + E++ +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 55  RKM-SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRN-------- 104
           + +  H NI+ L     ++  LY + EY    NL + ++ R     E             
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 105 -------WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT 156
                    +Q+ +G+ Y+  +   HRDL   N+LV+++  +KIADFGLAR+IN+     
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID--- 257

Query: 157 EYVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            Y  T       +W  APE L    +Y+ + D+W+ G +M E+ TL
Sbjct: 258 YYKKTTNGRLPVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTL 301

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  115 bits (289), Expect = 2e-29
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)

Query: 2   ERYKLIKEVGDGTFGSVWRA----ISKQSGEV---VAIKKMKKKYYSWEECVNLREVKSL 54
           +R  L K +G+G FG V  A    + K        VA+K +K      +    + E++ +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 55  RKM-SHPNIVKLKEVIRENDILYFVFEYME----------------CNLYQLMKDREKCF 97
           + +  H NI+ L     ++  LY + EY                     Y    + E+  
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D  +KIADFGLAR+I+      
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID--- 245

Query: 157 EYVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL 195
            Y  T       +W  APE L    +Y+ + D+W+ G ++ E+ TL
Sbjct: 246 YYKKTTNGRLPVKWM-APEALFDR-IYTHQSDVWSFGVLLWEIFTL 289

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 97.8 bits (244), Expect = 1e-23
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 8/152 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-P 60
            RY+L +++G G+FG ++      +GE VAIK    K    +      E K  + M    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGV 65

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            I  ++    E D    V E +  +L  L     + FS   V     Q+   + Y+H + 
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125

Query: 121 YFHRDLKPENLLVSKD----TIKIADFGLARE 148
           + HRD+KP+N L+        + I DFGLA++
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 97.1 bits (242), Expect = 3e-23
 Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 10/153 (6%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-PN 61
            +++ K++G G FG +    +  + E VAIK    K           E +  +++     
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDG 66

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I ++            V E +  +L  L    ++ FS   V     Q+   + Y+H +  
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 122 FHRDLKPENLLV------SKDTIKIADFGLARE 148
            +RD+KPEN L+      ++  I I DF LA+E
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 94.0 bits (234), Expect = 3e-22
 Identities = 31/154 (20%), Positives = 70/154 (45%), Gaps = 10/154 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-P 60
             YK+ + +G+G+FG ++   +  + + VAIK   ++    +      E ++ + ++   
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCT 66

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            I  +    +E      V + +  +L  L+    + FS   V     Q+   +  +H++ 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 121 YFHRDLKPENLLVSK------DTIKIADFGLARE 148
             +RD+KP+N L+ +      + I + DFG+ + 
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 95.8 bits (238), Expect = 4e-22
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 8/152 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HP 60
            +++L +++G G+FG ++   + Q+ E VAIK    K    +    L E K  R +    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGT 63

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            I  ++    E D    V + +  +L  L     +  S   V     Q+   + ++H + 
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 121 YFHRDLKPENLLVSK----DTIKIADFGLARE 148
           + HRD+KP+N L+      + + I DFGLA++
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 90.3 bits (223), Expect = 1e-20
 Identities = 48/271 (17%), Positives = 89/271 (32%), Gaps = 64/271 (23%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKK-------------MKKKYYSWEECVNL 48
           E+ +  +++G+G FG V++ I+      VAIK               K       E +  
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 49  REVKSLRK---MSHPNIVKLKEV------------------------------IRENDIL 75
           +E+  L           + L  V                                ++D L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 76  YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVS 134
           + V E+    +  L + R K  S A  ++   Q+   LA       + HRDL   N+L+ 
Sbjct: 138 FIVLEFEFGGI-DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 135 KDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT 194
           K ++K   + L  + ++ P     VS               Y+          +  ++  
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIID------------YTLSRLERDGIVVFCDVSM 244

Query: 195 LRPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
              LF G  + D  + I  ++     + W +
Sbjct: 245 DEDLFTG--DGDYQFDIYRLMKKENNNRWGE 273

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 43/290 (14%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI 69
           +G G FG V++      G +VA+K++K++     E     EV+ +    H N+++L+   
Sbjct: 38  LGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96

Query: 70  RENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNW------CFQVFQGLAYMHQRGY- 121
                   V+ YM    +   +++R +        +W           +GLAY+H     
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPE---SQPPLDWPKRQRIALGSARGLAYLHDHCDP 153

Query: 122 --FHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEVLLQS 173
              HRD+K  N+L+ ++    + DFGLA+ +        +V+T       + APE L   
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPEYLSTG 210

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
              S K D++  G ++ ELIT +  F     A++   +  +        W  GLL  +  
Sbjct: 211 KS-SEKTDVFGYGVMLLELITGQRAFDLARLAND-DDVMLL-------DWVKGLLKEK-- 259

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVS---LIASLC-SWDPSKRPTAAEALQ 279
             K   LV      L  +   + V     +A LC    P +RP  +E ++
Sbjct: 260 --KLEALVD---VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 33/166 (19%), Positives = 67/166 (40%), Gaps = 21/166 (12%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK-------------KKYYSWEECVNLR 49
           ++ L K++G G FG ++ A      E  A   +K             K Y    +   ++
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 50  EVKSLRKMSHPNIVKLK----EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNW 105
           +    +++ +  I           +     + V E +  +L ++       F ++ V   
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT-FKKSTVLQL 156

Query: 106 CFQVFQGLAYMHQRGYFHRDLKPENLLV---SKDTIKIADFGLARE 148
             ++   L Y+H+  Y H D+K  NLL+   + D + +AD+GL+  
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 64/293 (21%), Positives = 114/293 (38%), Gaps = 54/293 (18%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW---EECVNLREVKSLRKMSHPNIVKLK 66
           +G G FG V++ + +  G  VA+K+   +  S    EE     E+++L    HP++V L 
Sbjct: 47  IGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFET--EIETLSFCRHPHLVSLI 101

Query: 67  EVIRENDILYFVFEYMECN-----LYQLMKDREKCFSEAEVRNW------CFQVFQGLAY 115
               E + +  +++YME       LY                +W      C    +GL Y
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM-------SWEQRLEICIGAARGLHY 154

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRW-----YRAPE 168
           +H R   HRD+K  N+L+ ++   KI DFG+++         + ++ST       Y  PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLSTVVKGTLGYIDPE 211

Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
             ++  L + K D+++ G ++ E++  R     +   + +              WA    
Sbjct: 212 YFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE----------WAVESH 260

Query: 229 LARAINYKF-PQLVGVPLSVLMPSANKDAVSLIASLC-SWDPSKRPTAAEALQ 279
               +     P L      +   S  K      A  C +     RP+  + L 
Sbjct: 261 NNGQLEQIVDPNLAD---KIRPESLRK--FGDTAVKCLALSSEDRPSMGDVLW 308

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.7 bits (204), Expect = 7e-18
 Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 16/140 (11%)

Query: 81  YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIK 139
                        +   +   +  + FQV +G+ ++  R   HRDL   N+L+S+   +K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233

Query: 140 IADFGLAREINSRPPFTEYVST-------RWYRAPEVLLQSYLYSSKVDMWAMGAIMAEL 192
           I DFGLAR+I   P   +YV         +W  APE +    +Y+ + D+W+ G ++ E+
Sbjct: 234 ICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEI 288

Query: 193 ITL--RPLFPGTSEADEIYK 210
            +L   P +PG    +E  +
Sbjct: 289 FSLGASP-YPGVKIDEEFCR 307

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 8/131 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A         +   VA+K +K+     E    + E+K L  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 57  M-SHPNIVKLK-EVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           +  H N+V L     +    L  + E+ +  NL   ++ +   F   + +   F+  +  
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 114 AYMHQRGYFHR 124
                     R
Sbjct: 142 VGAIPVDLKRR 152

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 36/209 (17%)

Query: 10  VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-----WEECVNLREVKSLRKMSHPNIVK 64
           +G+G FG V++         VA+KK+            ++     E+K + K  H N+V+
Sbjct: 39  MGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQ--EIKVMAKCQHENLVE 94

Query: 65  LKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNW------CFQVFQGLAYMH 117
           L     + D L  V+ YM    L   +   +         +W            G+ ++H
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT----PPLSWHMRCKIAQGAANGINFLH 150

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRW-----YRAPEVLL 171
           +  + HRD+K  N+L+ +  T KI+DFGLAR           +++R      Y APE   
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAYMAPE--- 205

Query: 172 QSYL---YSSKVDMWAMGAIMAELITLRP 197
              L    + K D+++ G ++ E+IT  P
Sbjct: 206 --ALRGEITPKSDIYSFGVVLLEIITGLP 232

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 33/168 (19%), Positives = 63/168 (37%), Gaps = 22/168 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEV-----VAIKKMKKK----------YYSWEECVN 47
            +K+   +G G FG ++ A    S  V       +K               Y    +   
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 48  LREVKSLRKMSHPNIVKLK----EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVR 103
           +++    RK+ +  + K               + + +    +L ++ +   K FS   V 
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 104 NWCFQVFQGLAYMHQRGYFHRDLKPENLLV---SKDTIKIADFGLARE 148
               ++   L Y+H+  Y H D+K  NLL+   + D + + D+GLA  
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 24/169 (14%), Positives = 56/169 (33%), Gaps = 22/169 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSG--------EVVAIKKMKKK---------YYSWEE 44
            ++KL         G ++ A    +         +  ++K   K          +    +
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 45  CVNLREVKSLRKMSHPNIVKLKEV-IRENDILYFVFEYMECNLYQLMKDRE-KCFSEAEV 102
            + + + K L       I       + ++   + V   +  +L   +        SE  V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161

Query: 103 RNWCFQVFQGLAYMHQRGYFHRDLKPENLLV---SKDTIKIADFGLARE 148
                ++   L ++H+  Y H ++  EN+ V    +  + +A +G A  
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.6 bits (94), Expect = 7e-04
 Identities = 50/339 (14%), Positives = 105/339 (30%), Gaps = 97/339 (28%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY------------SWEECVNLREV 51
           YK+  ++    F   W  +   +     ++ ++K  Y            S    + +  +
Sbjct: 174 YKVQCKMDFKIF---WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230

Query: 52  KS-----LRKMSHPN--IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRN 104
           ++     L+   + N  +V L  V        F      C +  L+  R K  ++     
Sbjct: 231 QAELRRLLKSKPYENCLLV-LLNVQNAKAWNAFNLS---CKI--LLTTRFKQVTDFLSAA 284

Query: 105 WCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFT-----EYV 159
               +       H       D + ++LL+     +  D  L RE+ +  P       E +
Sbjct: 285 TTTHISL----DHHSMTLTPD-EVKSLLLKYLDCRPQD--LPREVLTTNPRRLSIIAESI 337

Query: 160 S---TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIG 216
                 W         ++ +   V+   +  I+    +L  L P  +E  +++   SV  
Sbjct: 338 RDGLATW--------DNWKH---VNCDKLTTIIE--SSLNVLEP--AEYRKMFDRLSV-- 380

Query: 217 TPTQDSWADGLLLARAINYKFPQLVGVP---LSVLMPSANKDAVSLIASLCSWDPSKRPT 273
                               FP    +P   LS++     K  V ++ +        + +
Sbjct: 381 --------------------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKL-----HKYS 415

Query: 274 AAEALQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQRE-H 311
             E  + P          +S+P   L+  + L  +   H
Sbjct: 416 LVE--KQPKEST------ISIPSIYLELKVKLENEYALH 446

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	337
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.81
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.17
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.87
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.73
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.56
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.44
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.01
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.98
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.95
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.9
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.6
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.52
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.47
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.4
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.3
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.29
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.29
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.12
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.91
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.63
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.13
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.29
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.27
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.14

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.8e-68  Score=458.69  Aligned_cols=254  Identities=31%  Similarity=0.506  Sum_probs=206.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||+||+|.++.+|+.||+|++.+......  .....+|+.++++++||||+++++++++++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999986544322  33457899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||++|++++.+.+++ .+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|..........+
T Consensus        92 mEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           92 IEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             EECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            9999988888887654 59999999999999999999999999999999999999876 999999999988776666677


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+....+....                   .. 
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-------------------~~-  230 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-------------------YT-  230 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------------CC-
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------------CC-
Confidence            8999999999999877556789999999999999999999999988777766665421                   01 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                .++.+|+++++||.+||++||++|||++|+++||||+.
T Consensus       231 ----------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          231 ----------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                      12457899999999999999999999999999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.9e-67  Score=464.60  Aligned_cols=255  Identities=27%  Similarity=0.485  Sum_probs=221.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|+++++||+|+||.||+|.++.||+.||||++....... .....+|+.+|+.++|||||++++++++++.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            46999999999999999999999999999999997654332 33456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      |+|+.+..+..++ .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|...... ....+.+
T Consensus       153 ~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~  231 (346)
T 4fih_A          153 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  231 (346)
T ss_dssp             CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence            9987666666554 49999999999999999999999999999999999999876 9999999999877544 4456789


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      ||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+..... +..                   
T Consensus       232 GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~-------------------  290 (346)
T 4fih_A          232 GTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRL-------------------  290 (346)
T ss_dssp             SCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCC-------------------
T ss_pred             cCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC-------------------
Confidence            99999999998665 789999999999999999999999999888887777654311 111                   


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                             ..++.+|+++++||.+||++||++|||++|+|+||||+..
T Consensus       291 -------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          291 -------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             -------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence                   1124578999999999999999999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-67  Score=459.80  Aligned_cols=253  Identities=30%  Similarity=0.456  Sum_probs=219.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+....  .......+|+++|++|+|||||+++++|++++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999999999999999999765322  22344578999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---CCC
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---PPF  155 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---~~~  155 (337)
                      |||+|+.+..+..+.+.++|..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.....   ...
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~  191 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA  191 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence            999985554444445569999999999999999999999999999999999999876 9999999999876433   234


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      .+.+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+...++....                   +
T Consensus       192 ~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------------~  251 (311)
T 4aw0_A          192 NSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-------------------Y  251 (311)
T ss_dssp             CCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------------C
T ss_pred             cCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------C
Confidence            567999999999999765 78999999999999999999999999988888887776531                   1


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH------HhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE------ALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------ll~hp~~~~  285 (337)
                      .+           ++.+|+++++||.+||++||.+|||++|      +++||||++
T Consensus       252 ~~-----------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          252 DF-----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             CC-----------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             CC-----------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            11           2467899999999999999999999998      588999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-67  Score=467.08  Aligned_cols=256  Identities=32%  Similarity=0.550  Sum_probs=216.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |++|++++.||+|+||.||+|.++.+|+.||||++........ .....+|+.+|++|+|||||++++++++++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999999987655443 344578999999999999999999999999999999


Q ss_pred             eecCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CC
Q 038835           80 EYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PF  155 (337)
Q Consensus        80 e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~  155 (337)
                      |||+|+ |.+.+... +..++|..++.|+.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+...... ..
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            999975 55555543 3457999999999999999999999999999999999999876 99999999998765432 22


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      .+.+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++.....                   
T Consensus       183 ~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------------------  242 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-------------------  242 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------------------
T ss_pred             cccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-------------------
Confidence            456899999999998765 789999999999999999999999999988888877765311                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                        +        ..+..+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus       243 --~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          243 --P--------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             --C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             --C--------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence              1        1124678999999999999999999999999999999753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-65  Score=467.06  Aligned_cols=284  Identities=36%  Similarity=0.658  Sum_probs=243.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEee------CCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRE------NDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~   74 (337)
                      ++|++++.||+|+||+||+|.++.||+.||||++........ .....+|+.+|+.|+|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            479999999999999999999999999999999987654432 3445689999999999999999999753      367


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC--
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS--  151 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~--  151 (337)
                      +|||||||+|++.+.+.+ ..++++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....  
T Consensus       134 ~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             EEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence            899999999988877765 4569999999999999999999999999999999999999876 999999999986543  


Q ss_pred             ---CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          152 ---RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       152 ---~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                         .....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..|....+.++...|.....
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~  292 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA  292 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred             cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence               22345689999999999988776789999999999999999999999999999999999999999998887765321


Q ss_pred             -hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          229 -LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                       ........++...+.++....+..++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence             2222233455555666667778899999999999999999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-65  Score=466.10  Aligned_cols=255  Identities=27%  Similarity=0.482  Sum_probs=222.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|+++++||+|+||.||+|.++.+|+.||||++....... ...+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            46999999999999999999999999999999997654332 34457899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      |+|+.+..+...+ .+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|...... ....+.+
T Consensus       230 ~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~  308 (423)
T 4fie_A          230 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  308 (423)
T ss_dssp             CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCE
T ss_pred             CCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccc
Confidence            9987666666544 49999999999999999999999999999999999999876 9999999999877543 4456789


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      ||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+..... +                     
T Consensus       309 GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~---------------------  365 (423)
T 4fie_A          309 GTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P---------------------  365 (423)
T ss_dssp             ECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C---------------------
T ss_pred             cCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C---------------------
Confidence            99999999998665 789999999999999999999999999988887777654311 0                     


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                           ....+..+|+++++||.+||++||.+|||++|+|+||||+..
T Consensus       366 -----~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          366 -----RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             -----CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                 011235688999999999999999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-64  Score=439.28  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=210.3

Q ss_pred             Cc-eEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEee----CCEEE
Q 038835            3 RY-KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRE----NDILY   76 (337)
Q Consensus         3 ~y-~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~   76 (337)
                      +| ++.++||+|+||.||+|.++.+|..||+|++........ ...+.+|+.++++|+|||||++++++++    ++.+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            44 678889999999999999999999999999987655443 3445789999999999999999999865    35689


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeC-C-cEEEeeCCCcccCCCC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSK-D-TIKIADFGLAREINSR  152 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~-~-~~kL~Dfg~a~~~~~~  152 (337)
                      ||||||+|+.+..+..+...+++..++.+++||+.||+|||++|  |+||||||+|||++. + .+||+|||+|+.... 
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-  184 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  184 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence            99999998766666566667999999999999999999999999  999999999999974 3 899999999986543 


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ....+.+||+.|+|||++.+  .|+.++|||||||++|+|++|++||.+......+.........               
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~---------------  247 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------------  247 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------------
T ss_pred             CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC---------------
Confidence            33456799999999998854  5899999999999999999999999877665544333211000               


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                  ....++..++++++||.+||++||.+|||++|+|+||||++
T Consensus       248 ------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          248 ------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                        01122456789999999999999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-65  Score=447.41  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=211.9

Q ss_pred             cCceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++++..... ......+|+.++++++|||||++++++++++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999874   468899999997654322 22344689999999999999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~  155 (337)
                      |||||+|+.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.... ....
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  183 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  183 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCC
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccc
Confidence            99999986665555555669999999999999999999999999999999999999876 999999999986543 3344


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      .+.+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.+..                   .
T Consensus       184 ~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-------------------~  243 (304)
T 3ubd_A          184 YSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-------------------L  243 (304)
T ss_dssp             CSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------C
T ss_pred             cccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-------------------C
Confidence            678999999999998765 78999999999999999999999999998888877775431                   0


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                      .           .++.+|+++++||.+||++||++|||     ++|+++||||+.
T Consensus       244 ~-----------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          244 G-----------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             C-----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             C-----------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            1           12457899999999999999999998     589999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-64  Score=448.23  Aligned_cols=251  Identities=26%  Similarity=0.364  Sum_probs=213.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +.|++.++||+|+||.||+|.++.+|+.||||+++.+...      .+|+.+++.|+|||||++++++.+++.+||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4688999999999999999999999999999999865332      4799999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCC-----
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPP-----  154 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~-----  154 (337)
                      |+|+.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+  .+||+|||+|+.......     
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            9986655555555669999999999999999999999999999999999999875  699999999987654321     


Q ss_pred             -CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 -FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 -~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                       ....+||+.|||||++.+. .|+.++||||+||++|+|++|++||.+.+..+....+...                   
T Consensus       212 ~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------------  271 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-------------------  271 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-------------------
T ss_pred             cCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-------------------
Confidence             1345899999999999765 7899999999999999999999999988776666665432                   


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH-------------hcCcCcccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA-------------LQHPFSRVA  286 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-------------l~hp~~~~~  286 (337)
                              ..+....++.+++++.++|.+||++||.+|||+.|+             |+|||+...
T Consensus       272 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          272 --------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             --------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             --------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence                    011223346789999999999999999999999997             679998753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.3e-62  Score=440.72  Aligned_cols=278  Identities=27%  Similarity=0.420  Sum_probs=214.7

Q ss_pred             cCceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||+||+|.++   .+++.||+|.+....   ......+|+++|+.+ +||||+++++++++++.+|+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            57999999999999999999875   467899999986542   233456899999998 79999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCC---
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSR---  152 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~---  152 (337)
                      ||||++|+.+..+..   .+++.+++.+++||+.||+|||++||+||||||+|||++.+  .+||+|||+|+.....   
T Consensus        98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A           98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            999999754444442   38999999999999999999999999999999999999864  8999999999754321   


Q ss_pred             --------------------------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCC-CCCcH
Q 038835          153 --------------------------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFP-GTSEA  205 (337)
Q Consensus       153 --------------------------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~  205 (337)
                                                ....+.+||+.|+|||++.+...|+.++||||+||++|+|++|++||. +.++.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~  254 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL  254 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence                                      123456899999999999877678999999999999999999999984 56667


Q ss_pred             HHHHHHHHHhCCCCccchhhh-------------------hhhHHhhhccCCCCC-----CCcccccCCCCChhHHHHHH
Q 038835          206 DEIYKICSVIGTPTQDSWADG-------------------LLLARAINYKFPQLV-----GVPLSVLMPSANKDAVSLIA  261 (337)
Q Consensus       206 ~~~~~i~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~  261 (337)
                      +.+..|....+.+....+...                   ...........|...     .......++.+|++++|||.
T Consensus       255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~  334 (361)
T 4f9c_A          255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD  334 (361)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred             HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence            888888877664332221110                   000000111111111     11122345788999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCcCccc
Q 038835          262 SLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       262 ~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      +||+.||.+|||++|+|+||||++
T Consensus       335 ~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          335 KLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHCcCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999986

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.3e-61  Score=424.27  Aligned_cols=252  Identities=26%  Similarity=0.433  Sum_probs=193.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC--------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND--------   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------   73 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.+|++|+|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999976554444455678999999999999999999986543        


Q ss_pred             ----EEEEEEeecCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           74 ----ILYFVFEYMECNLYQLMKDREK---CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        74 ----~~~lv~e~~~~~l~~~~~~~~~---~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                          .+|+|||||+|+.+..+.....   ..++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence                4799999999865554444332   24567789999999999999999999999999999999876 999999999


Q ss_pred             cccCCCCC-------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 038835          146 AREINSRP-------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       146 a~~~~~~~-------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  212 (337)
                      |+......             ..++.+||+.|||||++.+. .|+.++|||||||++|+|++   ||.+..  +....+.
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~  238 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLT  238 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHH
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHH
Confidence            98764322             12346899999999998765 78999999999999999996   775432  2222222


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .....                  .+|.        .++..++.+.+||.+||++||.+|||+.|+|+||||++
T Consensus       239 ~~~~~------------------~~p~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          239 DVRNL------------------KFPP--------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHTT------------------CCCH--------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHhcC------------------CCCC--------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            21111                  1110        11234577899999999999999999999999999985

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-60  Score=452.67  Aligned_cols=258  Identities=26%  Similarity=0.473  Sum_probs=226.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++...... ......+|+.+|+.|+||||++++++|++++.+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            47899999999999999999999999999999999765322 23445689999999999999999999999999999999


Q ss_pred             ecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC---CcEEEeeCCCcccCCCCCCCc
Q 038835           81 YMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK---DTIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        81 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~---~~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ||+| +|.+.+......+++.+++.+++||+.||+|||++||+||||||+|||++.   +.+||+|||+|..........
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            9987 566667666667999999999999999999999999999999999999975   389999999999887776667


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+..+.+..+.......+.                
T Consensus       315 ~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------------  377 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------------  377 (573)
T ss_dssp             EECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS----------------
T ss_pred             eeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc----------------
Confidence            78999999999998765 7899999999999999999999999999988888777654222221                


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                ..++.+|+++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       378 ----------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          378 ----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             ----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             ----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence                      1235688999999999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.8e-60  Score=449.99  Aligned_cols=254  Identities=27%  Similarity=0.397  Sum_probs=211.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHH---HHHHHHHhcCCCCCcccceeEEeeCCEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVN---LREVKSLRKMSHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~   75 (337)
                      |++|++++.||+|+||.||+|.++.||+.||+|++.+.....  .....   ..++.+++.++|||||+++++|++.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            579999999999999999999999999999999997643211  11112   2456777888999999999999999999


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      |||||||+||.+..+..+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|....... 
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-  346 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  346 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence            9999999986555555555669999999999999999999999999999999999999886 99999999998775443 


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE---IYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ..+.+||+.|+|||++..+..|+.++|+|||||++|+|++|.+||.+.+..+.   ...+...                 
T Consensus       347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-----------------  409 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----------------  409 (689)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-----------------
T ss_pred             CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-----------------
Confidence            35679999999999997666799999999999999999999999976543222   2222110                 


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                        ..           .+++.+|+++++||.+||++||.+|++     ++|+++||||++
T Consensus       410 --~~-----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          410 --AV-----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             --CC-----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             --CC-----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence              00           123568999999999999999999998     799999999986

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.4e-59  Score=409.20  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=206.7

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|.+.+.||+|+||.||+|.+.     .+|..||||+++... ......+.+|+.+|++|+|||||++++++.+++.+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            47899999999999999999865     468889999997542 223445679999999999999999999999999999


Q ss_pred             EEEeecCCCHHH-HHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEee
Q 038835           77 FVFEYMECNLYQ-LMKDR------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIAD  142 (337)
Q Consensus        77 lv~e~~~~~l~~-~~~~~------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~D  142 (337)
                      ||||||+++.+. .+...            ...+++.++..++.||+.||.|||+++|+||||||+|||++.+ .+||+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D  171 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence            999999976554 44332            2369999999999999999999999999999999999999987 999999


Q ss_pred             CCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 038835          143 FGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTP  218 (337)
Q Consensus       143 fg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~  218 (337)
                      ||+|+.......   .....||+.|+|||++.+. .|+.++|||||||++|||++ |++||.+.+..+....+...... 
T Consensus       172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~-  249 (299)
T 4asz_A          172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL-  249 (299)
T ss_dssp             CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC-
T ss_pred             cccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            999986543322   1335799999999999766 78999999999999999998 99999999888877776543111 


Q ss_pred             CccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                                  ..++..|+++.+|+.+||+.||++|||++|+  ++|++.
T Consensus       250 ----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          250 ----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             ----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence                                        1124578999999999999999999999999  446553

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-58  Score=402.79  Aligned_cols=251  Identities=25%  Similarity=0.335  Sum_probs=201.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++++++++||+|+||+||+|..+.   .||||+++...... ....+.+|+.++++++|||||++++++.+ +.++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            578899999999999999997643   59999997654443 33455789999999999999999998754 56899999


Q ss_pred             ecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---CCC
Q 038835           81 YMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---PPF  155 (337)
Q Consensus        81 ~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---~~~  155 (337)
                      ||+|+.+ +.+......+++.++..++.||+.||+|||+++|+||||||+|||++.+ .+||+|||+|+.....   ...
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  191 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV  191 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence            9997555 5555556679999999999999999999999999999999999999988 9999999999865432   233


Q ss_pred             ccccccccccCchhhcCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          156 TEYVSTRWYRAPEVLLQS--YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ...+||+.|||||++.+.  ..|+.++|||||||++|||++|++||.+.+..+.+..+......                
T Consensus       192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~----------------  255 (307)
T 3omv_A          192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA----------------  255 (307)
T ss_dssp             --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC----------------
T ss_pred             cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----------------
Confidence            557899999999998643  36899999999999999999999999988776665554432111                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                         .|     .....++..++++.+||.+||+.||++|||+.|++++
T Consensus       256 ---~p-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          256 ---SP-----DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             ---CC-----CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ---CC-----CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence               11     1122335678999999999999999999999988643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-58  Score=411.61  Aligned_cols=288  Identities=35%  Similarity=0.651  Sum_probs=247.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      |++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.+++.++||||+++++++.+++..++|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            68999999999999999999999999999999999765433222233479999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      |+++++.+.+...+..+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++...... ......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  160 (324)
T 3mtl_A           81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE  160 (324)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence            99999999888877779999999999999999999999999999999999999876 9999999999866533 333556


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.+....|.............++
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
T 3mtl_A          161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP  240 (324)
T ss_dssp             --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred             cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence            88999999999887667899999999999999999999999999999999999999999999999887766666666666


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      ...........+.+++++.+||.+||+.||.+|||++|+|+||||.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            66665666667789999999999999999999999999999999987543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-58  Score=407.53  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=208.0

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++++++++||+|+||+||+|...     .+++.||||+++..........+.+|+.++++++|||||++++++.+++.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            46789999999999999999853     4678999999986655544556779999999999999999999999999999


Q ss_pred             EEEeecCCCHH-HHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEE
Q 038835           77 FVFEYMECNLY-QLMKDR---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIK  139 (337)
Q Consensus        77 lv~e~~~~~l~-~~~~~~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~k  139 (337)
                      ||||||++|.+ +.+..+               ...+++..+..++.||+.||+|||+++|+||||||+|||++++ .+|
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K  185 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK  185 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence            99999997655 444332               2358999999999999999999999999999999999999987 999


Q ss_pred             EeeCCCcccCCCC---CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 038835          140 IADFGLAREINSR---PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVI  215 (337)
Q Consensus       140 L~Dfg~a~~~~~~---~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~  215 (337)
                      |+|||+|+.....   ......+||+.|+|||++.++ .|+.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus       186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~  264 (308)
T 4gt4_A          186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ  264 (308)
T ss_dssp             ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred             ECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999865432   223457899999999999766 78999999999999999998 899999998887776664321


Q ss_pred             CCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..                             ..++..++++.+++.+||+.||.+|||+.||+++
T Consensus       265 ~~-----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          265 VL-----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11                             1124578899999999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-57  Score=404.14  Aligned_cols=284  Identities=37%  Similarity=0.711  Sum_probs=245.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++|++++.||+|+||.||+|.+. +|+.||+|++....... ......+|+.++++++||||+++++++.+++..++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            479999999999999999999986 58999999997654332 2234568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||+++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...+.. .....
T Consensus        99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A           99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            999999999888877779999999999999999999999999999999999999876 9999999999876533 33455


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+...++.++||||+||++|+|++|++||.+....+.+..+....+.+....|.............+
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF  258 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence            68999999999988766789999999999999999999999999999999999999999999988887665555555455


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ............+.+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence            555555566667889999999999999999999999999999999986

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.6e-58  Score=407.02  Aligned_cols=248  Identities=24%  Similarity=0.337  Sum_probs=200.9

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|.+.++||+|+||.||+|.++     .+|+.||||+++... ......+.+|+.+|++|+|||||++++++.+++.+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46788999999999999999864     468899999997542 223445678999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEE
Q 038835           77 FVFEYMECNLYQLMKDR---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKI  140 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL  140 (337)
                      ||||||+++.+..+...               ..++++.++..++.||+.||+|||+++|+||||||+|||++.+ .+||
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki  199 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI  199 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence            99999998665544332               2358999999999999999999999999999999999999987 9999


Q ss_pred             eeCCCcccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 038835          141 ADFGLAREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIG  216 (337)
Q Consensus       141 ~Dfg~a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~  216 (337)
                      +|||+|+......   .....+||+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.....
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~  278 (329)
T 4aoj_A          200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE  278 (329)
T ss_dssp             CCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred             cccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999998664332   22456899999999998765 78999999999999999998 8999999988877776654311


Q ss_pred             CCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          217 TPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .                             ..++..++++.+|+.+||+.||++|||++|++++
T Consensus       279 ~-----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          279 L-----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             C-----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             C-----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            1                             1124578999999999999999999999999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.6e-56  Score=394.20  Aligned_cols=285  Identities=33%  Similarity=0.636  Sum_probs=241.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.++++++||||+++++++.+++..++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            689999999999999999999999999999999997654433 2344568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||+++++++.+......+++..++.++.||+.||+|||++||+||||||+||+++.+ .+||+|||.+...+.. .....
T Consensus        81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            999999999888877789999999999999999999999999999999999999876 9999999999876533 33456


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..||+.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+.+..+....+.+....|.............
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence            78999999999998776689999999999999999987655 77788888899999999999888887654322221110


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      . ...........+..++++++||.+||+.||.+|||++|+|+||||++.
T Consensus       241 ~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          241 M-YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             C-CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             c-ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            0 001112233446789999999999999999999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-56  Score=392.94  Aligned_cols=283  Identities=35%  Similarity=0.684  Sum_probs=236.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |++|++++.||+|+||.||+|.+ .+|+.||+|++....... ......+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            68999999999999999999998 678999999987653322 1234468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||+++++.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...... .....
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            999998888887766779999999999999999999999999999999999999876 9999999999865432 23345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.+....|........ ....+
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  238 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF  238 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-CCTTC
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc-ccccc
Confidence            68999999999987766789999999999999999999999999999999999999888888877765432211 11122


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ....+.++....+.+++++.++|.+||+.||.+|||++|+++||||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            222333445556788999999999999999999999999999999975

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.4e-56  Score=395.92  Aligned_cols=257  Identities=29%  Similarity=0.418  Sum_probs=221.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++........ .....+|+.+++.++||||+++++++...+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            3689999999999999999999999999999999987655432 334568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||++++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++............
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  173 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF  173 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTT
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccc
Confidence            999875544444444569999999999999999999999999999999999999877 9999999999877666666778


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+.....                   .. 
T Consensus       174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------------~~-  233 (328)
T 3fe3_A          174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-------------------RI-  233 (328)
T ss_dssp             SSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------CC-
T ss_pred             cCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------CC-
Confidence            9999999999998775556899999999999999999999999887777666544211                   11 


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                                +...++++.++|.+||+.||.+|||++|+++||||+...
T Consensus       234 ----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          234 ----------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             ----------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             ----------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                      134689999999999999999999999999999998643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.2e-57  Score=403.13  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=205.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-----CcEEEEEEcccccCChHHhHHHHHHHHHhcCCC-CCcccceeEEee-CCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-----GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-PNIVKLKEVIRE-NDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~-~~~   74 (337)
                      ++|++++.||+|+||.||+|.+..+     ++.||+|.+...........+.+|+.+|++++| ||||++++++.. ++.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            5799999999999999999987654     467999999876555555566789999999965 899999999865 467


Q ss_pred             EEEEEeecCCCHHH-HHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-c
Q 038835           75 LYFVFEYMECNLYQ-LMKDR---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-T  137 (337)
Q Consensus        75 ~~lv~e~~~~~l~~-~~~~~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~  137 (337)
                      ++||||||+++.+. .+...               ...+++..+..++.||+.||+|||+++|+||||||+|||++.+ .
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            89999999976554 44332               2348999999999999999999999999999999999999886 9


Q ss_pred             EEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 038835          138 IKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICS  213 (337)
Q Consensus       138 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  213 (337)
                      +||+|||+|+.......   ....+||+.|||||++.+. .|+.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus       224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~  302 (353)
T 4ase_A          224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  302 (353)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred             EEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            99999999987654432   2346799999999999766 78999999999999999998 9999998765544433332


Q ss_pred             HhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ....+                            ..++..++++.+++.+||+.||.+|||+.|+++|
T Consensus       303 ~g~~~----------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          303 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCC----------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            21110                            1124568999999999999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-55  Score=392.81  Aligned_cols=286  Identities=33%  Similarity=0.618  Sum_probs=224.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            36899999999999999999999999999999999765433333455689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-C
Q 038835           81 YMECNLYQLMKDRE-----KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-P  153 (337)
Q Consensus        81 ~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~  153 (337)
                      |+++++.+.+....     ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...... .
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred             ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence            99998888776542     358999999999999999999999999999999999999876 9999999999876533 3


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|..........
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T 2pmi_A          164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN  243 (317)
T ss_dssp             CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred             cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence            34567899999999998776578999999999999999999999999999999999999999988888776543221110


Q ss_pred             hccCCCCCCCc-----ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          234 NYKFPQLVGVP-----LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       234 ~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                       ...+......     ........+.++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          244 -PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             -TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             -cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence             0111100000     1122346789999999999999999999999999999998743

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.1e-56  Score=414.03  Aligned_cols=281  Identities=34%  Similarity=0.564  Sum_probs=228.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   74 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            68999999999999999999999999999999998654333 234456899999999999999999998544      46


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      +|+||||+++++.+.+..   .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|.......
T Consensus       142 ~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  218 (464)
T 3ttj_A          142 VYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  218 (464)
T ss_dssp             EEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred             EEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence            899999999998887753   38999999999999999999999999999999999999987 99999999999877666


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+....+.+....|..........
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~  297 (464)
T 3ttj_A          219 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY  297 (464)
T ss_dssp             CC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred             ccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence            66778999999999999776 78999999999999999999999999999999999999999998877665543322222


Q ss_pred             hccCCCCCCCcccccCCC------------CChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          234 NYKFPQLVGVPLSVLMPS------------ANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~------------~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ....+...........+.            .++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            222222222222211111            15679999999999999999999999999999853

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.9e-55  Score=397.90  Aligned_cols=257  Identities=28%  Similarity=0.415  Sum_probs=221.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......     ......+|+.++++++||||+++++++.+.+.++
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            57999999999999999999999999999999998654332     1234568999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccCCC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINS  151 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~~~  151 (337)
                      +||||++|+.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+     .+||+|||++.....
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            999999876555555555679999999999999999999999999999999999999754     699999999998776


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      .......+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+.......+.           
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  239 (361)
T 2yab_A          172 GVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE-----------  239 (361)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-----------
T ss_pred             CCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-----------
Confidence            6666778899999999998765 6899999999999999999999999998888777766543221111           


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                     ..++.+++++++||.+||..||.+|||++|+++||||+.
T Consensus       240 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          240 ---------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             ---------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             ---------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence                           123567899999999999999999999999999999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-55  Score=387.56  Aligned_cols=281  Identities=37%  Similarity=0.646  Sum_probs=235.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh----HHhHHHHHHHHHhcC---CCCCcccceeEEeeCC-
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW----EECVNLREVKSLRKM---SHPNIVKLKEVIREND-   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~-   73 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......    ......+|+.+++.+   +||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            68999999999999999999999999999999987543211    112334677777666   5999999999987654 


Q ss_pred             ----EEEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           74 ----ILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        74 ----~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                          ..++||||+++++.+.+.... ..+++..++.++.||+.||+|||++|++||||||+||+++.+ .+||+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  168 (308)
T 3g33_A           89 DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR  168 (308)
T ss_dssp             SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred             CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence                589999999998888776653 348999999999999999999999999999999999999876 99999999998


Q ss_pred             cCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh
Q 038835          148 EINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL  227 (337)
Q Consensus       148 ~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  227 (337)
                      ...........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...|....
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (308)
T 3g33_A          169 IYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  247 (308)
T ss_dssp             TSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred             ccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence            87766666778999999999998766 68999999999999999999999999999999999999999998888876543


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ...   ...++...........+.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       248 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          248 SLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SSC---GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hcc---ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            221   12233334444455567899999999999999999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-54  Score=384.73  Aligned_cols=286  Identities=33%  Similarity=0.603  Sum_probs=229.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++........ .....+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            5899999999999999999999999999999999876544432 334468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||++++++..+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+...... .....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            999999888887777779999999999999999999999999999999999999876 9999999999876533 33356


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+....+....+....+......+..............
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI  241 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence            68999999999998766789999999999999999999999999999998888888777665443322111111111111


Q ss_pred             CCCCC-CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVG-VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      +.... .......+.++.++.++|.+||+.||.+|||++|+++||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence            11111 11122235789999999999999999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-55  Score=408.49  Aligned_cols=284  Identities=34%  Similarity=0.640  Sum_probs=222.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee-----CCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE-----NDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.++||||+++++++..     ...+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            58999999999999999999999999999999997654443 23445689999999999999999999843     3679


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-  153 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-  153 (337)
                      |+||||+++++...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|....... 
T Consensus       133 ~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  211 (458)
T 3rp9_A          133 YVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN  211 (458)
T ss_dssp             EEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred             EEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence            99999999888777755 4559999999999999999999999999999999999999987 99999999998654221 


Q ss_pred             ---------------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-----------C
Q 038835          154 ---------------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-----------L  195 (337)
Q Consensus       154 ---------------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g  195 (337)
                                                 .....+||++|+|||++.....++.++|||||||++|+|++           |
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~  291 (458)
T 3rp9_A          212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR  291 (458)
T ss_dssp             CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred             cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence                                       23456889999999987666679999999999999999998           7


Q ss_pred             CCCCCCCC--------------------cHHHHHHHHHHhCCCCccchhhhhh-hHHhhhccCCCCCCCcccccCCCCCh
Q 038835          196 RPLFPGTS--------------------EADEIYKICSVIGTPTQDSWADGLL-LARAINYKFPQLVGVPLSVLMPSANK  254 (337)
Q Consensus       196 ~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (337)
                      .++|.+.+                    ..+.+..+....+.++...+..... ........++...........+..++
T Consensus       292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  371 (458)
T 3rp9_A          292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA  371 (458)
T ss_dssp             CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred             cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence            88887755                    2577888888888888776654321 11222233455555566667788899


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          255 DAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       255 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            99999999999999999999999999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-54  Score=393.65  Aligned_cols=258  Identities=33%  Similarity=0.480  Sum_probs=221.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++........ .....+|+.+++.++||||+++++++.+++..|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            479999999999999999999999999999999987654433 3345689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCCCCc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      |+.|+.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+    .+||+|||++..........
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~  188 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  188 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence            99985554444445569999999999999999999999999999999999999753    59999999998877665556


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.......+...              
T Consensus       189 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------------  253 (362)
T 2bdw_A          189 GFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE--------------  253 (362)
T ss_dssp             CSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG--------------
T ss_pred             cCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc--------------
Confidence            77899999999998765 689999999999999999999999999887777776655422222211              


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                  ++.+++++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus       254 ------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          254 ------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                        24578999999999999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.3e-55  Score=392.37  Aligned_cols=283  Identities=38%  Similarity=0.686  Sum_probs=227.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++........ .....+|+.++++++||||+++++++.+++..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            4789999999999999999999999999999999976543322 223368999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC------cEEEeeCCCcccCCCC-
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD------TIKIADFGLAREINSR-  152 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~------~~kL~Dfg~a~~~~~~-  152 (337)
                      ||+++++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+      .+||+|||++...+.. 
T Consensus       113 e~~~~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCSEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            99999877777654 459999999999999999999999999999999999999532      5999999999866533 


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|.........
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW  271 (329)
T ss_dssp             --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence            33355688999999999987667899999999999999999999999999999999999999888888877654322111


Q ss_pred             hhccCCCCCCCccc-ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          233 INYKFPQLVGVPLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      . ..++........ .....+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       272 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  324 (329)
T 3gbz_A          272 K-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH  324 (329)
T ss_dssp             C-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             h-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence            1 112211111111 112347899999999999999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-54  Score=401.39  Aligned_cols=285  Identities=30%  Similarity=0.432  Sum_probs=229.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.+|+|++....... ......+|+.+++.++||||+++++++.+++..|+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            57999999999999999999999999999999998765433 23345689999999999999999999999999999999


Q ss_pred             ecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC----CcEEEeeCCCcccCCCCC-C
Q 038835           81 YMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK----DTIKIADFGLAREINSRP-P  154 (337)
Q Consensus        81 ~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~----~~~kL~Dfg~a~~~~~~~-~  154 (337)
                      |+.|+.+ +.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.    +.+||+|||+|....... .
T Consensus        91 ~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           91 LVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            9987544 55544 456999999999999999999999999999999999999974    379999999998765443 3


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      ....+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+.......+..             
T Consensus       170 ~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------  235 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP-------------  235 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT-------------
T ss_pred             eecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc-------------
Confidence            3567899999999998765 68999999999999999999999999988888777776543222222             


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCCCCCChhhhHHhhhhhccccchhh
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQLLQEHLHLLGQREHWSS  314 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (337)
                                   .++.+++++.+||.+||+.||.+|||+.|+|+||||+......... ..+.....++.+..+.+++.
T Consensus       236 -------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~-~~~~~~~~l~~~~~~~klk~  301 (444)
T 3soa_A          236 -------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM-HRQETVDCLKKFNARRKLKG  301 (444)
T ss_dssp             -------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCC-CCHHHHHHHHHHHHHHHHHT
T ss_pred             -------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccc-hhhHHHHHHHHHHHHHHHHH
Confidence                         1346789999999999999999999999999999998643332222 22222344444444444443


Q ss_pred             h
Q 038835          315 K  315 (337)
Q Consensus       315 ~  315 (337)
                      .
T Consensus       302 ~  302 (444)
T 3soa_A          302 A  302 (444)
T ss_dssp             T
T ss_pred             H
Confidence            3

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-54  Score=387.22  Aligned_cols=254  Identities=32%  Similarity=0.478  Sum_probs=217.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+...  ........+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            5789999999999999999999999999999999976432  12233446899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~  156 (337)
                      |||++|+.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++..... .....
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~  163 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  163 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccc
Confidence            9999986665555555669999999999999999999999999999999999999876 999999999986433 33446


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+....+....                   ..
T Consensus       164 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------------------~~  223 (337)
T 1o6l_A          164 TFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-------------------IR  223 (337)
T ss_dssp             CCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------CC
T ss_pred             ccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------CC
Confidence            67899999999998765 68999999999999999999999999887776666554320                   01


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                      +           +..+++++.++|.+||+.||.+||     +++|+++||||..
T Consensus       224 ~-----------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          224 F-----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             C-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             C-----------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            1           245789999999999999999999     9999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-55  Score=392.41  Aligned_cols=285  Identities=37%  Similarity=0.684  Sum_probs=236.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH----HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE----ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++........    .....+|+.+++.++||||+++++++.+.+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            689999999999999999999999999999999976433221    2244689999999999999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~  155 (337)
                      ||||+++++...+......+++..++.++.|++.||+|||++|++||||||+|||++.+ .+||+|||++...... ...
T Consensus        90 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  169 (346)
T 1ua2_A           90 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  169 (346)
T ss_dssp             EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             EEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccC
Confidence            99999998888887776779999999999999999999999999999999999999876 9999999999876533 334


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|.+........  
T Consensus       170 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--  247 (346)
T 1ua2_A          170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV--  247 (346)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC--
T ss_pred             CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc--
Confidence            567899999999998776668999999999999999999999999999999999999999988888876543322211  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .+......+.....+..+.++.+||.+||+.||.+|||++|+|+||||++...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence            11222223333445678899999999999999999999999999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-55  Score=387.93  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=222.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.+|+|.+...  ........+|+.+++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            6899999999999999999999999999999998754  23344456899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC---CcEEEeeCCCcccCCCCCCCcc
Q 038835           82 MECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK---DTIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        82 ~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~---~~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ++|+ +.+.+......+++..++.++.||+.||.|||++|++||||||+|||++.   +.+||+|||++...........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  162 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence            9874 55666555557999999999999999999999999999999999999985   3899999999988766655566


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+.......+.                 
T Consensus       163 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------------  224 (321)
T 1tki_A          163 LFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-----------------  224 (321)
T ss_dssp             EESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-----------------
T ss_pred             ccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-----------------
Confidence            7899999999998765 6789999999999999999999999998888777777654322211                 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                               ..++.++.++.++|.+||..||.+|||+.|+|+||||+...
T Consensus       225 ---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          225 ---------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             ---------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             ---------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence                     11246789999999999999999999999999999998653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-54  Score=393.01  Aligned_cols=281  Identities=37%  Similarity=0.624  Sum_probs=231.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   74 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++........ .....+|+.+++.++||||+++++++...      ..
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            579999999999999999999999999999999976544432 33456899999999999999999999765      34


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      +|+||||+++++.+.+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...... 
T Consensus       105 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-  181 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-  181 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             EEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence            699999996666665544  358999999999999999999999999999999999999977 9999999999876543 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh-hHHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL-LARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~  232 (337)
                       ....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++...+..... ....
T Consensus       182 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          182 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             -cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence             35678999999999988756789999999999999999999999999999999999999999887765543211 1111


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .....+......+....+..++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence            222345555556666678899999999999999999999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.8e-54  Score=390.99  Aligned_cols=287  Identities=31%  Similarity=0.524  Sum_probs=234.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee--------
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE--------   71 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------   71 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999999999999999987654332 22344689999999999999999999876        


Q ss_pred             CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835           72 NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      ++..++||||+++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++....
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            45789999999999999888777779999999999999999999999999999999999999876 99999999997654


Q ss_pred             C-----CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          151 S-----RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       151 ~-----~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      .     .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.++...|..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  255 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            2     22335568899999999997766789999999999999999999999999999999999999988888777765


Q ss_pred             hhhhHHhhhccCCCCCCCcccc--cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          226 GLLLARAINYKFPQLVGVPLSV--LMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      ......................  .....++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            4322211111111100000000  0001367899999999999999999999999999998643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.1e-54  Score=400.85  Aligned_cols=285  Identities=35%  Similarity=0.620  Sum_probs=232.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN-----DIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.++||||+++++++...     +..
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            68999999999999999999999999999999997654433 234557899999999999999999998765     579


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-  153 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-  153 (337)
                      |+||||+++++.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|....... 
T Consensus       106 ~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  184 (432)
T 3n9x_A          106 YIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD  184 (432)
T ss_dssp             EEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred             EEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence            99999999887777654 4559999999999999999999999999999999999999887 99999999998764321 


Q ss_pred             ----------------------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-----------CCCCCC
Q 038835          154 ----------------------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-----------LRPLFP  200 (337)
Q Consensus       154 ----------------------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g~~pf~  200 (337)
                                            .....+||++|+|||++.....++.++||||+||++|+|++           |.++|.
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~  264 (432)
T 3n9x_A          185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP  264 (432)
T ss_dssp             --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCC
T ss_pred             ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCC
Confidence                                  23667899999999997666679999999999999999997           566666


Q ss_pred             CCC-----------------cHHHHHHHHHHhCCCCccchhhhhhh-HHhhhccCCCCCCCcccccCCCCChhHHHHHHH
Q 038835          201 GTS-----------------EADEIYKICSVIGTPTQDSWADGLLL-ARAINYKFPQLVGVPLSVLMPSANKDAVSLIAS  262 (337)
Q Consensus       201 ~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  262 (337)
                      +.+                 ..+.+..+....+.|+...+...... ........+...........+.+++++.+||.+
T Consensus       265 g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~  344 (432)
T 3n9x_A          265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES  344 (432)
T ss_dssp             CSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred             CccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence            654                 36788889999999888766543211 111112334444445555567899999999999


Q ss_pred             hcCCCCCCCCCHHHHhcCcCccccc
Q 038835          263 LCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       263 ~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      ||+.||.+|||++|+|+||||+...
T Consensus       345 mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          345 MLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HhcCCcccCCCHHHHhcChhhhhcc
Confidence            9999999999999999999998743

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-54  Score=396.66  Aligned_cols=282  Identities=34%  Similarity=0.706  Sum_probs=217.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCC-CCCcccceeEEeeC--CEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMS-HPNIVKLKEVIREN--DILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.+. ||||+++++++...  ..+|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            68999999999999999999999999999999997654433 2334468999999996 99999999999754  47899


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-----
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-----  151 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-----  151 (337)
                      ||||+++++...+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|.....     
T Consensus        89 v~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  166 (388)
T 3oz6_A           89 VFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT  166 (388)
T ss_dssp             EEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred             EecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence            999999887777654  358999999999999999999999999999999999999887 999999999976432     


Q ss_pred             -----------------CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 038835          152 -----------------RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSV  214 (337)
Q Consensus       152 -----------------~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  214 (337)
                                       .......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  246 (388)
T 3oz6_A          167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV  246 (388)
T ss_dssp             CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                             122345689999999999987667899999999999999999999999999999999999998


Q ss_pred             hCCCCccchhhhhh-----hHHhhhccCCCCCCCccc-------------ccCCCCChhHHHHHHHhcCCCCCCCCCHHH
Q 038835          215 IGTPTQDSWADGLL-----LARAINYKFPQLVGVPLS-------------VLMPSANKDAVSLIASLCSWDPSKRPTAAE  276 (337)
Q Consensus       215 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  276 (337)
                      .+.|....+.....     ......... ........             ......++++.+||.+||+.||.+|||++|
T Consensus       247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e  325 (388)
T 3oz6_A          247 IDFPSNEDVESIQSPFAKTMIESLKEKV-EIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND  325 (388)
T ss_dssp             HCCCCHHHHHTSCCSSHHHHHHHHHHHC-C-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCCCCHHHHHhccCHHHHHHHHhCcccc-cccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence            88887654432100     000000000 00000000             112367899999999999999999999999


Q ss_pred             HhcCcCcccc
Q 038835          277 ALQHPFSRVA  286 (337)
Q Consensus       277 ll~hp~~~~~  286 (337)
                      +|+||||+..
T Consensus       326 ~l~Hp~~~~~  335 (388)
T 3oz6_A          326 ALKHPFVSIF  335 (388)
T ss_dssp             HTTSTTTTTT
T ss_pred             HhCCHHHHHh
Confidence            9999999763

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.4e-55  Score=391.16  Aligned_cols=255  Identities=28%  Similarity=0.434  Sum_probs=217.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.......  ......+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            368999999999999999999999999999999987543221  123456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||++|++++.+.... .+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++...........
T Consensus        88 ~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~  166 (336)
T 3h4j_B           88 IEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT  166 (336)
T ss_dssp             ECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred             EECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence            9999888888887654 49999999999999999999999999999999999999987 999999999988776666677


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+....+.++||||+||++|+|++|..||.+....+....                           
T Consensus       167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------------------  219 (336)
T 3h4j_B          167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------------------  219 (336)
T ss_dssp             CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------------------
T ss_pred             ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------------------
Confidence            89999999999987764457899999999999999999999976543211100                           


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                         ........++..++++.++|++||+.||.+|||++|+++||||+..
T Consensus       220 ---i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          220 ---VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             ---CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             ---HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence               0001112235678999999999999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.4e-54  Score=391.05  Aligned_cols=285  Identities=36%  Similarity=0.654  Sum_probs=240.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN-----DILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.............+|+.++++++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            48999999999999999999999999999999997644333345557899999999999999999998654     4689


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      +||||+++++.+.+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||.+.......  
T Consensus       107 iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  184 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  184 (364)
T ss_dssp             EEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence            9999999988877754  348999999999999999999999999999999999999887 99999999998665332  


Q ss_pred             --CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh-H
Q 038835          154 --PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL-A  230 (337)
Q Consensus       154 --~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  230 (337)
                        .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++...+...... .
T Consensus       185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  264 (364)
T 3qyz_A          185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  264 (364)
T ss_dssp             CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence              2345689999999999877767899999999999999999999999999999999999999998887766543211 1


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .......+.....++....+..++++.+||.+||+.||.+|||++|+|+||||+....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence            1222334444455556666788999999999999999999999999999999987543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.9e-54  Score=380.00  Aligned_cols=255  Identities=26%  Similarity=0.477  Sum_probs=217.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++....... .....+|+.+++.++||||+++++++..++..++||||
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            58999999999999999999999999999999987654332 33456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      ++|+.+..+.... .+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++...... ......+
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  177 (297)
T 3fxz_A           99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  177 (297)
T ss_dssp             CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred             CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCcc
Confidence            9876666555544 48999999999999999999999999999999999999876 9999999998876543 3345678


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      ||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+.......                     
T Consensus       178 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------------  235 (297)
T 3fxz_A          178 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---------------------  235 (297)
T ss_dssp             SCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC---------------------
T ss_pred             CCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------------
Confidence            99999999998766 68999999999999999999999999888776665554331110                     


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                            ....+.++..+.++|.+||+.||.+|||++|+++||||+..
T Consensus       236 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          236 ------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             ------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                  01123578899999999999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-54  Score=390.83  Aligned_cols=254  Identities=28%  Similarity=0.481  Sum_probs=213.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+.....  ......+|..+++.+ +||||+++++++.+.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999997643211  223345799999988 79999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~  155 (337)
                      ||||++|+.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|..... ....
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  181 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT  181 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccc
Confidence            99999986555555555669999999999999999999999999999999999999876 999999999986433 2334


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....                   .
T Consensus       182 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------------~  241 (353)
T 3txo_A          182 ATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-------------------V  241 (353)
T ss_dssp             ----CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------C
T ss_pred             cccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------C
Confidence            567899999999998765 68999999999999999999999999998888777775421                   1


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA------AEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~~~~  285 (337)
                      .+           +..+++++.++|.+||++||.+||++      +|+++||||+.
T Consensus       242 ~~-----------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          242 VY-----------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             CC-----------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             CC-----------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            11           13478999999999999999999999      89999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-54  Score=384.15  Aligned_cols=258  Identities=28%  Similarity=0.409  Sum_probs=220.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......     ......+|+.+++.++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46999999999999999999999999999999997654321     2344568999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccCCC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINS  151 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~~~  151 (337)
                      +||||++++.+..+......+++..++.++.||+.||.|||++|++||||||+|||++.+     .+||+|||++.....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            999999876555555556679999999999999999999999999999999999999764     699999999988765


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.........           
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  238 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-----------  238 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH-----------
T ss_pred             CCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc-----------
Confidence            5555677899999999998655 6899999999999999999999999998887777666543211111           


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                     ..++..+.++.++|.+||+.||.+|||++|+|+||||+..
T Consensus       239 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          239 ---------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             ---------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             ---------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                           1124578999999999999999999999999999999853

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-54  Score=392.23  Aligned_cols=282  Identities=37%  Similarity=0.610  Sum_probs=219.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeC------CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREN------DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   74 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            58999999999999999999999999999999997654333 234456899999999999999999998653      56


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .|+|+|++++++.+.+..  ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...... 
T Consensus       109 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-  185 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-  185 (367)
T ss_dssp             CEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred             EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence            899999997776665543  459999999999999999999999999999999999999876 9999999999875433 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh-hHHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL-LARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~  232 (337)
                       ....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.|....+..... ....
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~  264 (367)
T 2fst_X          186 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  264 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred             -CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence             35578999999999988756789999999999999999999999999999999999999999887765543221 1111


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      .....+...........+..++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence            1223344444455555678899999999999999999999999999999998643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.2e-54  Score=384.45  Aligned_cols=285  Identities=32%  Similarity=0.597  Sum_probs=232.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++........ .....+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            5799999999999999999999999999999999876544432 333468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||++++++..+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+...... .....
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  183 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD  183 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCC
Confidence            999999998887766779999999999999999999999999999999999999876 9999999999765433 33355


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+......+..............
T Consensus       184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (331)
T 4aaa_A          184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL  263 (331)
T ss_dssp             CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred             CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence            68999999999997766789999999999999999999999999999999888888777665544332222111122222


Q ss_pred             CCCCC-CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVG-VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      +.... .......+.+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            22221 1223344678999999999999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.7e-54  Score=391.73  Aligned_cols=278  Identities=31%  Similarity=0.580  Sum_probs=232.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee----------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE----------   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------   71 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......     ..+|+.+++.++||||+++++++..          
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            6899999999999999999999999999999998654222     1379999999999999999999843          


Q ss_pred             ----------------------------CCEEEEEEeecCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 038835           72 ----------------------------NDILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVFQGLAYMHQRG  120 (337)
Q Consensus        72 ----------------------------~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~qil~al~~LH~~~  120 (337)
                                                  ....++||||+++++.+.+.   ..+..+++..++.++.||+.||+|||++|
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                        34489999999998665554   34567999999999999999999999999


Q ss_pred             ccccCCCCCCeeeeC-C-cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCC
Q 038835          121 YFHRDLKPENLLVSK-D-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL  198 (337)
Q Consensus       121 i~H~dikp~Nili~~-~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (337)
                      |+||||||+|||++. + .+||+|||+|.............||+.|+|||++.+...++.++||||+||++|+|++|++|
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            999999999999983 3 89999999999876666667788999999999988766789999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 038835          199 FPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSV-LMPSANKDAVSLIASLCSWDPSKRPTAAEA  277 (337)
Q Consensus       199 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  277 (337)
                      |.+.+..+.+..+....+.+....+......  .....++......+.. ..+..++++.+||.+||+.||.+|||+.|+
T Consensus       242 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (383)
T 3eb0_A          242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPH--YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA  319 (383)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT--C--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHHHhCcc--cccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            9999999999999999998887766543211  1122333333332222 345688999999999999999999999999


Q ss_pred             hcCcCcccc
Q 038835          278 LQHPFSRVA  286 (337)
Q Consensus       278 l~hp~~~~~  286 (337)
                      |+||||+..
T Consensus       320 l~hp~f~~~  328 (383)
T 3eb0_A          320 MAHPFFDHL  328 (383)
T ss_dssp             HTSGGGHHH
T ss_pred             hcCHHHHHH
Confidence            999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.8e-54  Score=395.53  Aligned_cols=277  Identities=34%  Similarity=0.638  Sum_probs=231.4

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC------CEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN------DILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~   76 (337)
                      +|++++.||+|+||.||+|.++.+|+.||+|++.....     ...+|+++++.++||||+++++++...      ..++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            69999999999999999999999999999999865422     123799999999999999999987431      2467


Q ss_pred             EEEeecCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCC
Q 038835           77 FVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINS  151 (337)
Q Consensus        77 lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~  151 (337)
                      +||||+++++.+.+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.+  .+||+|||++.....
T Consensus       130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            999999998776554   335669999999999999999999999999999999999999954  689999999987765


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      .......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++....+.+..+.|.....  .
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~--~  287 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP--N  287 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS--C
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--h
Confidence            55556778999999999987766789999999999999999999999999999999999999999888776654321  1


Q ss_pred             hhhccCCCCCCCcccc-cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSV-LMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ...+.++.....++.. +.+..++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            1122344333333322 335778999999999999999999999999999999764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-53  Score=378.94  Aligned_cols=252  Identities=25%  Similarity=0.451  Sum_probs=217.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+....  .......+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            47899999999999999999999999999999999764321  1223345799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||++|+.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++......  ...
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~  162 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT  162 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--ccc
Confidence            9999986555555555669999999999999999999999999999999999999876 9999999999876543  245


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+....+....                   ..+
T Consensus       163 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------------------~~~  222 (318)
T 1fot_A          163 LCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-------------------LRF  222 (318)
T ss_dssp             CCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-------------------CCC
T ss_pred             ccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------CCC
Confidence            7899999999998765 68999999999999999999999999988777776665421                   011


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                                 ++.+++++.++|.+||+.||.+||     +++|+++||||+.
T Consensus       223 -----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          223 -----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             -----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             -----------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence                       245789999999999999999999     9999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-53  Score=387.29  Aligned_cols=259  Identities=26%  Similarity=0.453  Sum_probs=220.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+|+.+++.++||||+++++++.+.+..++||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            579999999999999999999999999999999876432 2233456899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC---cEEEeeCCCcccCCCCCCCcc
Q 038835           82 MECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD---TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        82 ~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~---~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ++|+.+ +.+......+++..++.++.||+.||+|||++||+||||||+|||++.+   .+||+|||++...........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  209 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  209 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence            987544 5554445569999999999999999999999999999999999999742   799999999998776655566


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+........                  
T Consensus       210 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------------------  270 (387)
T 1kob_A          210 TTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------------------  270 (387)
T ss_dssp             ECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC------------------
T ss_pred             eccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence            7899999999998765 679999999999999999999999999887777666644311111                  


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                              ...+..+++++.++|.+||+.||.+|||+.|+|+||||+....
T Consensus       271 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          271 --------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             --------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             --------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence                    1122467899999999999999999999999999999987543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-53  Score=384.32  Aligned_cols=254  Identities=29%  Similarity=0.439  Sum_probs=216.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+...  .........|..+++.+ +||||+++++++.+.+.+|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            4789999999999999999999999999999999976432  11233345788888876 99999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~  155 (337)
                      ||||++|+.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++..... ....
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  175 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  175 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcc
Confidence            99999876555555545569999999999999999999999999999999999999876 999999999986532 3334


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+....+....                   .
T Consensus       176 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------------------~  235 (345)
T 1xjd_A          176 NTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------------------P  235 (345)
T ss_dssp             CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------C
T ss_pred             cCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-------------------C
Confidence            667899999999998765 68999999999999999999999999988877766664321                   0


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA-EALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~~~~  285 (337)
                      .           .+..+++++.++|.+||+.||.+||++. ++++||||+.
T Consensus       236 ~-----------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          236 F-----------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             C-----------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             C-----------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            1           1135789999999999999999999998 9999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.3e-54  Score=381.91  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=212.2

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.+++.++||||+++++++.+++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            57999999999999999999999999999999999765444334455789999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---CCCc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---PPFT  156 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---~~~~  156 (337)
                      |++++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++......   ....
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  165 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence            99986555555555569999999999999999999999999999999999999886 9999999999765322   2234


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+................                   
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------------  226 (323)
T 3tki_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------------------  226 (323)
T ss_dssp             SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-------------------
T ss_pred             CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-------------------
Confidence            6789999999999987655688999999999999999999999876553222211111000                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                              ....+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       227 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          227 --------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             --------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             --------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence                    001124578999999999999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.7e-53  Score=390.26  Aligned_cols=277  Identities=36%  Similarity=0.642  Sum_probs=231.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC------EE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND------IL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~   75 (337)
                      .+|++++.||+|+||.||+|.++.+++ +|+|++......     ..+|+.+++.++||||+++++++...+      .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            379999999999999999999987776 788877543221     137999999999999999999985433      38


Q ss_pred             EEEEeecCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee-CC-cEEEeeCCCcccCC
Q 038835           76 YFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KD-TIKIADFGLAREIN  150 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~-~~-~~kL~Dfg~a~~~~  150 (337)
                      ++||||++++++..+..   ....+++..++.++.||+.||+|||++||+||||||+|||++ .+ .+||+|||+|....
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            89999999988766543   355699999999999999999999999999999999999998 44 89999999998876


Q ss_pred             CCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          151 SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       151 ~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      ........+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....+.....  
T Consensus       194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~--  271 (394)
T 4e7w_A          194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP--  271 (394)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG--
T ss_pred             CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--
Confidence            665566788999999999997766789999999999999999999999999999999999999999988776654321  


Q ss_pred             HhhhccCCCCCCCccc-ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          231 RAINYKFPQLVGVPLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ......++.....++. ...+..++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            1222334443333333 2345689999999999999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.3e-54  Score=391.32  Aligned_cols=281  Identities=35%  Similarity=0.537  Sum_probs=216.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCC------E
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIREND------I   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~   74 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            68999999999999999999999999999999997654433 2334568999999999999999999987654      7


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .|+||||+++++.+.+.   ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.......
T Consensus       105 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  181 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  181 (371)
T ss_dssp             EEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred             eEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence            89999999998887774   238999999999999999999999999999999999999976 99999999998776555


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+..........
T Consensus       182 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  260 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY  260 (371)
T ss_dssp             --------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred             ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence            55667899999999998765 68999999999999999999999999999988888888877777655444322111111


Q ss_pred             hccCCCCCCCccccc------------CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          234 NYKFPQLVGVPLSVL------------MPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ....+..........            ....+.++++||.+||+.||.+|||++|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence            111111111111100            01125689999999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3e-53  Score=387.10  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=210.5

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+......  .....+|..+++++ +||||+++++++.+.+.+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999999999999999987644322  23346788998876 89999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC-CCCCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~-~~~~~~  155 (337)
                      ||||++|+.+.....+...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|... ......
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~  210 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  210 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence            99999986655555555669999999999999999999999999999999999999876 9999999999863 333445


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---------HHHHHHHHhCCCCccchhhh
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD---------EIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~~~~~~~~~~~~~~~  226 (337)
                      ...+||+.|+|||++.+. .++.++|+|||||++|+|++|++||.+....+         ....+...            
T Consensus       211 ~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------------  277 (396)
T 4dc2_A          211 STFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------------  277 (396)
T ss_dssp             CCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC------------
T ss_pred             ccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc------------
Confidence            678999999999998765 78999999999999999999999997543211         11111110            


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCcCccc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA------AEALQHPFSRV  285 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~~~~  285 (337)
                             ...           .++.+++++++||++||+.||.+||++      +|+++||||+.
T Consensus       278 -------~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          278 -------QIR-----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             -------CCC-----------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             -------ccC-----------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence                   111           124678999999999999999999985      89999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-53  Score=386.78  Aligned_cols=259  Identities=29%  Similarity=0.406  Sum_probs=199.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......  .....+|+.+++.++||||+++++++.+.+..++||||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            6899999999999999999999999999999999765332  23456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC---cEEEeeCCCcccCCCCCCCccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD---TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~---~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ++++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+   .+||+|||+|............
T Consensus        98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  177 (361)
T 3uc3_A           98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  177 (361)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCC
Confidence            9876554444444569999999999999999999999999999999999999865   4999999999865544445667


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +||+.|+|||++.+....+.++||||+||++|+|++|++||.+.........+......               ....++
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~---------------~~~~~~  242 (361)
T 3uc3_A          178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS---------------VKYSIP  242 (361)
T ss_dssp             ---CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT---------------TCCCCC
T ss_pred             cCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc---------------CCCCCC
Confidence            89999999999977644445599999999999999999999876543222222211100               011111


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .         ...+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus       243 ~---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          243 D---------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             T---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             C---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            1         13578999999999999999999999999999999653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.8e-53  Score=381.03  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=216.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+...  .........|..++..+ +||||+++++++.+.+.+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4789999999999999999999999999999999976432  11223346799999988 89999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~  155 (337)
                      ||||++|+.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..... ....
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  178 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCccc
Confidence            99999886555444444569999999999999999999999999999999999999876 999999999986432 3334


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+....+....                   .
T Consensus       179 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------------~  238 (353)
T 2i0e_A          179 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------------------V  238 (353)
T ss_dssp             CCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------C
T ss_pred             ccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-------------------C
Confidence            567899999999998765 68999999999999999999999999988877777665421                   1


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                      .+           ++.+++++.++|.+||+.||.+||     +++++++||||+.
T Consensus       239 ~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          239 AY-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             CC-----------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             CC-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            11           245789999999999999999999     4699999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.8e-53  Score=381.88  Aligned_cols=255  Identities=30%  Similarity=0.433  Sum_probs=198.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++....   ......+|+.++++++||||+++++++.+.+..++||||
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            46999999999999999999999999999999997643   223446899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC----CcEEEeeCCCcccCCCCCCCcc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK----DTIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~----~~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ++++.+.........+++..++.++.||+.||.|||++|++||||||+|||++.    +.+||+|||++...........
T Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  209 (349)
T 2w4o_A          130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT  209 (349)
T ss_dssp             CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence            987655444444556999999999999999999999999999999999999974    3899999999987765555566


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE-IYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+. ...+......                   
T Consensus       210 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-------------------  269 (349)
T 2w4o_A          210 VCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-------------------  269 (349)
T ss_dssp             ---CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-------------------
T ss_pred             ccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-------------------
Confidence            7899999999998765 689999999999999999999999987766543 3333221100                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                             .....++.++.++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus       270 -------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          270 -------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             -------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             -------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                   0111235678999999999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.1e-53  Score=378.49  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=210.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+......  .....+|..+++++ +||||+++++++.+.+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            4689999999999999999999999999999999987654322  23346799999887 89999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~  155 (337)
                      ||||++|+.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.... .....
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~  167 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  167 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCB
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcc
Confidence            99999886555554455569999999999999999999999999999999999999876 99999999998643 33344


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------HHHHHHHHHhCCCCccchhhh
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA---------DEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      ...+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||......         .....+...            
T Consensus       168 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------------  234 (345)
T 3a8x_A          168 STFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------------  234 (345)
T ss_dssp             CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC------------
T ss_pred             cccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC------------
Confidence            667899999999998765 6799999999999999999999999753221         111111110            


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH------HHHhcCcCccc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA------AEALQHPFSRV  285 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~------~ell~hp~~~~  285 (337)
                             ...           .++.++.++.++|.+||+.||.+||++      +|+++||||+.
T Consensus       235 -------~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          235 -------QIR-----------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             -------CCC-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             -------CCC-----------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence                   011           124678999999999999999999995      89999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-53  Score=385.41  Aligned_cols=255  Identities=22%  Similarity=0.394  Sum_probs=216.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+....  .......+|+.+++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46899999999999999999999999999999998764321  1233456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...........
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~  173 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT  173 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCC
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceec
Confidence            9999987666666666679999999999999999999999999999999999999876 999999999998776666677


Q ss_pred             ccccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          158 YVSTRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD---EIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      .+||+.|+|||++.+  +..++.++|||||||++|+|++|.+||.+.....   ....+...                  
T Consensus       174 ~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------  235 (384)
T 4fr4_A          174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------------------  235 (384)
T ss_dssp             CCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC------------------
T ss_pred             cCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc------------------
Confidence            899999999999864  2357899999999999999999999997644322   22221110                  


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-HHHHhcCcCccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-AAEALQHPFSRV  285 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~ell~hp~~~~  285 (337)
                       .           ...+..++.++.++|.+||+.||.+||+ ++++++||||+.
T Consensus       236 -~-----------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          236 -V-----------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             -C-----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             -c-----------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence             0           0112467899999999999999999998 999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-53  Score=384.03  Aligned_cols=257  Identities=28%  Similarity=0.442  Sum_probs=212.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC----ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY----SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.....    ........+|+.+++.++||||+++++++.+++..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            479999999999999999999999999999999864321    1123445689999999999999999999999999999


Q ss_pred             EEeecCCC-HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccC
Q 038835           78 VFEYMECN-LYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREI  149 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~  149 (337)
                      ||||++|+ +.+.+...   +..+++..++.++.||+.||.|||++||+||||||+|||++.+    .+||+|||++...
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999975 44555432   3358999999999999999999999999999999999999764    4999999999877


Q ss_pred             CCCCC-CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          150 NSRPP-FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       150 ~~~~~-~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      ..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.. .+....+........         
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~---------  252 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN---------  252 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC---------
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC---------
Confidence            65433 3457899999999998765 67999999999999999999999998753 333333333211111         


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                       ...++.++.++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus       253 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          253 -----------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             -----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             -----------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                             11124678999999999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.2e-53  Score=380.67  Aligned_cols=252  Identities=29%  Similarity=0.426  Sum_probs=216.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+....  .......+|+.+++.++||||+++++++.+++.+|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            46899999999999999999999999999999999764321  1223446899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||++|+.+.....+...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++......  ...
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~  197 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT  197 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--ccc
Confidence            9999875554444444569999999999999999999999999999999999999876 9999999999876543  245


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....                   ..+
T Consensus       198 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------------------~~~  257 (350)
T 1rdq_E          198 LCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-------------------VRF  257 (350)
T ss_dssp             CEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------CCC
T ss_pred             ccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-------------------CCC
Confidence            6899999999998765 68999999999999999999999999988777776665421                   011


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                                 +..+++++.++|.+||+.||.+||+     ++|+++||||+.
T Consensus       258 -----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          258 -----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             -----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             -----------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence                       2457899999999999999999998     999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.9e-53  Score=399.13  Aligned_cols=257  Identities=33%  Similarity=0.538  Sum_probs=218.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC-ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY-SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++..... ........+|+.++++++||||+++++++.+.+..|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            579999999999999999999999999999999865432 2233455789999999999999999999999999999999


Q ss_pred             ecCCCH-HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCCCC
Q 038835           81 YMECNL-YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        81 ~~~~~l-~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~~~  155 (337)
                      |+.++. .+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..    .+||+|||++.........
T Consensus       102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  180 (486)
T 3mwu_A          102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (486)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence            998754 455544 4569999999999999999999999999999999999999642    7999999999887766666


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+.........+.             
T Consensus       181 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------  245 (486)
T 3mwu_A          181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-------------  245 (486)
T ss_dssp             -CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG-------------
T ss_pred             CCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc-------------
Confidence            67889999999999865  489999999999999999999999999988888777765432222222             


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                                   ++.+|+++++||.+||+.||.+|||+.++|+||||+...
T Consensus       246 -------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          246 -------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             -------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             -------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                         245789999999999999999999999999999998643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-52  Score=388.83  Aligned_cols=280  Identities=30%  Similarity=0.545  Sum_probs=228.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC------CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM------SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~   75 (337)
                      .+|++++.||+|+||.||+|.+..+|+.||+|++....  .......+|+.+++.+      +|+||+++++++...+..
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            57999999999999999999999999999999997542  1223345677777766      578999999999999999


Q ss_pred             EEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-c--EEEeeCCCcccCCC
Q 038835           76 YFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-T--IKIADFGLAREINS  151 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~--~kL~Dfg~a~~~~~  151 (337)
                      ++||||+++++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .  +||+|||+|.....
T Consensus       175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            9999999999888887653 459999999999999999999999999999999999999876 3  99999999976543


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      .  ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...+........
T Consensus       255 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~  331 (429)
T 3kvw_A          255 R--VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN  331 (429)
T ss_dssp             C--CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred             c--ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence            3  3467899999999999876 689999999999999999999999999999999999999988888766554333222


Q ss_pred             hhhcc-CCCC----------------------------CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          232 AINYK-FPQL----------------------------VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       232 ~~~~~-~~~~----------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                      .+... ++..                            ............++++.+||.+||+.||.+|||++|+|+|||
T Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw  411 (429)
T 3kvw_A          332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW  411 (429)
T ss_dssp             HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence            22110 0000                            000001122345788999999999999999999999999999


Q ss_pred             cccc
Q 038835          283 SRVA  286 (337)
Q Consensus       283 ~~~~  286 (337)
                      |+..
T Consensus       412 ~~~~  415 (429)
T 3kvw_A          412 LRRR  415 (429)
T ss_dssp             TC--
T ss_pred             hccC
Confidence            9864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.1e-54  Score=379.09  Aligned_cols=265  Identities=25%  Similarity=0.290  Sum_probs=187.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC----EEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND----ILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l   77 (337)
                      ++|.+.++||+|+||.||+|.+  +|+.||||++....  ........|+..+.+++|||||++++++..++    .+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            5789999999999999999987  58999999997542  12222235777778899999999999987543    6899


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCCeeeeCC-cEEEeeCCCccc
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR--------GYFHRDLKPENLLVSKD-TIKIADFGLARE  148 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~--------~i~H~dikp~Nili~~~-~~kL~Dfg~a~~  148 (337)
                      |||||+++.+..+.... +++++.+..++.|++.||+|||++        +|+||||||+|||++.+ ++||+|||+|+.
T Consensus        79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999976665555543 489999999999999999999987        99999999999999987 999999999976


Q ss_pred             CCCCCC-----CccccccccccCchhhcCcC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 038835          149 INSRPP-----FTEYVSTRWYRAPEVLLQSY-----LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP  218 (337)
Q Consensus       149 ~~~~~~-----~~~~~gt~~~~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  218 (337)
                      ......     ....+||+.|+|||++.+..     .++.++|||||||++|||++|.+||......+....    ...+
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~----~~~~  233 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY----DLVP  233 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT----TTSC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch----hccc
Confidence            543321     23468999999999986542     357799999999999999999888754432110000    0000


Q ss_pred             CccchhhhhhhHHhh-hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          219 TQDSWADGLLLARAI-NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       219 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ......   ...... ......  ..+........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~---~~~~~~~~~~~rp--~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVE---EMRKVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHH---HHHHHHTTSCCCC--CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHH---HHHHHHhcccCCC--CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            000000   000000 000000  000000011223568899999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-52  Score=378.69  Aligned_cols=284  Identities=35%  Similarity=0.637  Sum_probs=230.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN-----DILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.++++++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            58999999999999999999999999999999997543333344556899999999999999999987654     6789


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      +||||+++++.+.+..  ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.......  
T Consensus        91 lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  168 (353)
T 2b9h_A           91 IIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD  168 (353)
T ss_dssp             EEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence            9999999887777654  358999999999999999999999999999999999999876 99999999998654321  


Q ss_pred             ---------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchh
Q 038835          154 ---------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       154 ---------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  224 (337)
                               .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+......
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T 2b9h_A          169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL  248 (353)
T ss_dssp             -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTT
T ss_pred             ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccc
Confidence                     12345789999999998766678999999999999999999999999999988888888887777644322


Q ss_pred             hhhhhHH--hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          225 DGLLLAR--AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       225 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      .......  ......+...........+.+++++.++|.+||+.||.+|||++|+++||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            2111111  11112232233334455578899999999999999999999999999999998644

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.5e-53  Score=382.31  Aligned_cols=285  Identities=31%  Similarity=0.563  Sum_probs=227.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH----------HhHHHHHHHHHhcCCCCCcccceeEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE----------ECVNLREVKSLRKMSHPNIVKLKEVIRE   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~   71 (337)
                      ++|++++.||+|+||.||+|.+.. |+.||+|++........          .....+|+.++++++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            689999999999999999999865 99999999876433211          1445689999999999999999999843


Q ss_pred             -----CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           72 -----NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        72 -----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                           ....|+||||++|++.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  180 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL  180 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence                 34789999999999999988777779999999999999999999999999999999999999876 999999999


Q ss_pred             cccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          146 AREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       146 a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      +.............||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....+..
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (362)
T 3pg1_A          181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM  260 (362)
T ss_dssp             ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhh
Confidence            98766555556678999999999988755789999999999999999999999999999999999999888877655432


Q ss_pred             hh--hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          226 GL--LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       226 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                      ..  .................+....+..++.+.+||.+||+.||.+|||++|+++||||+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            21  111111122223333344455677899999999999999999999999999999998753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-52  Score=367.49  Aligned_cols=257  Identities=33%  Similarity=0.494  Sum_probs=220.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++........ .....+|+.++++++||||+++++++.+++..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            689999999999999999999999999999999987655443 3344689999999999999999999999999999999


Q ss_pred             ecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCCCC
Q 038835           81 YMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        81 ~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~~~  155 (337)
                      |++++.+ +.+.. ...+++..++.++.|++.||.|||++|++||||||+||+++.+    .+||+|||.+.........
T Consensus        86 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (284)
T 3kk8_A           86 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  164 (284)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence            9998554 55444 4569999999999999999999999999999999999999754    4999999999887766555


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....||+.|+|||++.+. .++.++||||+|+++|+|++|..||.+.+..+....+.......+..              
T Consensus       165 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  229 (284)
T 3kk8_A          165 HGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP--------------  229 (284)
T ss_dssp             CCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--------------
T ss_pred             cCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch--------------
Confidence            667899999999998765 67999999999999999999999999988777766665432221111              


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                  .+...++++.++|.+||+.||.+|||++|+++||||+..
T Consensus       230 ------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          230 ------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             ------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             ------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence                        124578999999999999999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.7e-53  Score=382.39  Aligned_cols=280  Identities=39%  Similarity=0.629  Sum_probs=229.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEE-----
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDIL-----   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-----   75 (337)
                      ++|.+++.||+|+||.||+|.++.+|+.||+|++........ .....+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            589999999999999999999999999999999987554432 34456899999999999999999999876654     


Q ss_pred             -EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           76 -YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        76 -~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                       ++||||+++++.+.+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||.+...+.. 
T Consensus       122 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-  197 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-  197 (371)
T ss_dssp             CEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred             EEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence             9999999987766552   348999999999999999999999999999999999999976 9999999999865433 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh-HHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL-ARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~  232 (337)
                       ....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+...... ...
T Consensus       198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  276 (371)
T 4exu_A          198 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  276 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred             -cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence             345689999999999987567899999999999999999999999999999999999998888776544332111 111


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .....+...........+..++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence            112233333334445567789999999999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5e-53  Score=394.19  Aligned_cols=256  Identities=29%  Similarity=0.411  Sum_probs=221.5

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|.+++.||+|+||.||+|.++.+|+.||+|++.......  ......+|+.+++.++||||+++++++.+.+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999999999999999997643211  223456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...........
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~  174 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT  174 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccc
Confidence            9999876655555556679999999999999999999999999999999999999876 999999999998776666677


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+.....                   . 
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~-  234 (476)
T 2y94_A          175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-------------------Y-  234 (476)
T ss_dssp             CCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-------------------C-
T ss_pred             cCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-------------------C-
Confidence            89999999999998765557899999999999999999999998887776666543211                   0 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                .+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       235 ----------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          235 ----------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ----------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                      113568899999999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-52  Score=396.30  Aligned_cols=256  Identities=31%  Similarity=0.497  Sum_probs=217.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC------------hHHhHHHHHHHHHhcCCCCCcccceeEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS------------WEECVNLREVKSLRKMSHPNIVKLKEVI   69 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   69 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......            .......+|+.++++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            5899999999999999999999999999999999765432            1123456899999999999999999999


Q ss_pred             eeCCEEEEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCC
Q 038835           70 RENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFG  144 (337)
Q Consensus        70 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg  144 (337)
                      .+++..|+||||++|+ +.+.+.. ...+++..++.+++||+.||.|||++||+||||||+|||++.+    .+||+|||
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            9999999999999875 4455544 4559999999999999999999999999999999999999865    69999999


Q ss_pred             CcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchh
Q 038835          145 LAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       145 ~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  224 (337)
                      ++............+||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+....+..........   
T Consensus       195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  269 (504)
T 3q5i_A          195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN---  269 (504)
T ss_dssp             TCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---
T ss_pred             CCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc---
Confidence            9988776666677889999999999863  57999999999999999999999999998888877776542222211   


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                             .++.+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       270 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          270 -----------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             -----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             -----------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence                                   124678999999999999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-52  Score=367.35  Aligned_cols=255  Identities=32%  Similarity=0.455  Sum_probs=209.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|.+.+.||+|+||.||+|.++.+|..+|+|++.............+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            57999999999999999999999999999999998765554455667899999999999999999999999999999999


Q ss_pred             cCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC----CcEEEeeCCCcccCCCCC
Q 038835           82 MEC-NLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK----DTIKIADFGLAREINSRP  153 (337)
Q Consensus        82 ~~~-~l~~~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~----~~~kL~Dfg~a~~~~~~~  153 (337)
                      +++ ++.+.+..   .+..+++..++.++.||+.||+|||++|++||||||+||+++.    +.+||+|||++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            987 45555543   2466999999999999999999999999999999999999954    279999999998766555


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+......                
T Consensus       182 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------------  243 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN----------------  243 (285)
T ss_dssp             -----CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred             cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc----------------
Confidence            5566789999999998853  5789999999999999999999999988766555444321100                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                 ........++++.++|.+||+.||.+|||+.|+|+||||+.
T Consensus       244 -----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          244 -----------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -----------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             -----------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                       01112346899999999999999999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-52  Score=395.01  Aligned_cols=256  Identities=31%  Similarity=0.504  Sum_probs=216.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|..||+|++....... ......+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999999999999999997654322 23445689999999999999999999999999999999


Q ss_pred             ecCCCH-HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCCCC
Q 038835           81 YMECNL-YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        81 ~~~~~l-~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~~~  155 (337)
                      |+.++. .+.+.. ...+++..++.+++||+.||.|||++||+||||||+|||++..    .+||+|||+|.........
T Consensus       117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            998754 455544 4559999999999999999999999999999999999999753    5999999999887766666


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+....+...........             
T Consensus       196 ~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------  260 (494)
T 3lij_A          196 KERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE-------------  260 (494)
T ss_dssp             CCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG-------------
T ss_pred             cccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh-------------
Confidence            77889999999998853  589999999999999999999999999988888777765433222222             


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                   ++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       261 -------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          261 -------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                         34678999999999999999999999999999999863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.2e-53  Score=372.89  Aligned_cols=255  Identities=31%  Similarity=0.472  Sum_probs=208.2

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-------------------------HHhHHHHHHHHHh
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-------------------------EECVNLREVKSLR   55 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------------------------~~~~~~~e~~~l~   55 (337)
                      +++|++.+.||+|+||.||+|.++.+|+.||+|++.......                         ......+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999999999999999999987643211                         1234568999999


Q ss_pred             cCCCCCcccceeEEee--CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee
Q 038835           56 KMSHPNIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV  133 (337)
Q Consensus        56 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili  133 (337)
                      +++||||+++++++.+  .+..++||||++++.+..+.. ...+++..++.++.||+.||.|||++|++||||||+|||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999986  678999999999876655443 3469999999999999999999999999999999999999


Q ss_pred             eCC-cEEEeeCCCcccCCCCC-CCccccccccccCchhhcCcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 038835          134 SKD-TIKIADFGLAREINSRP-PFTEYVSTRWYRAPEVLLQSYL--YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY  209 (337)
Q Consensus       134 ~~~-~~kL~Dfg~a~~~~~~~-~~~~~~gt~~~~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  209 (337)
                      +.+ .+||+|||++....... ......||+.|+|||++.+...  ++.++|||||||++|+|++|..||.+........
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  250 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS  250 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence            876 99999999998765432 2345689999999999875532  4778999999999999999999998877655544


Q ss_pred             HHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          210 KICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       210 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                      .+....                   ..++         ..+.+++++.++|.+||+.||.+|||+.|+++||||+
T Consensus       251 ~~~~~~-------------------~~~~---------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          251 KIKSQA-------------------LEFP---------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHCC-------------------CCCC---------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHhccc-------------------CCCC---------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            443211                   0111         1246789999999999999999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.7e-53  Score=367.22  Aligned_cols=257  Identities=29%  Similarity=0.435  Sum_probs=220.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++.++..+|+|++....... .....+|+.+++.++||||+++++++.+++..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            47999999999999999999999999999999997654432 34556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---eCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili---~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ++++.+.........+++..++.++.|++.||.|||++|++||||||+||++   +.+ .++|+|||.+...........
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~  167 (277)
T 3f3z_A           88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT  167 (277)
T ss_dssp             CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCC
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhc
Confidence            9876554444445569999999999999999999999999999999999999   443 899999999988776666667


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+.......+...               
T Consensus       168 ~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  230 (277)
T 3f3z_A          168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD---------------  230 (277)
T ss_dssp             CCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH---------------
T ss_pred             cCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh---------------
Confidence            789999999998854  379999999999999999999999999888777776655422222111               


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                                 +..+++++.++|.+||+.||.+|||+.++|+||||+...
T Consensus       231 -----------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          231 -----------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             -----------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                       135689999999999999999999999999999998643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.5e-53  Score=382.42  Aligned_cols=284  Identities=30%  Similarity=0.521  Sum_probs=221.4

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC-------
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND-------   73 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------   73 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++......  .....+++..++.++||||+++++++...+       
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            47899999999999999999999999999999988654322  223356788888899999999999986533       


Q ss_pred             EEEEEEeecCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCCeeeeC-C-cEEEeeCCCc
Q 038835           74 ILYFVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVFQGLAYMH--QRGYFHRDLKPENLLVSK-D-TIKIADFGLA  146 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~qil~al~~LH--~~~i~H~dikp~Nili~~-~-~~kL~Dfg~a  146 (337)
                      ..++||||+++++...+.   .....+++..++.++.|++.||.|||  ++||+||||||+|||++. + .+||+|||++
T Consensus       100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            389999999998776554   34566899999999999999999999  999999999999999986 4 9999999999


Q ss_pred             ccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          147 REINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       147 ~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      .............||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            98776665667789999999999877666899999999999999999999999999999999999998888876655432


Q ss_pred             hhhHHhhhccCCCCCCCccc----ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          227 LLLARAINYKFPQLVGVPLS----VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .....  ...+......++.    ......++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       260 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          260 NPSHT--DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CTTCC--CGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             ccchh--hccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            21111  1111111111111    112346788999999999999999999999999999987554

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-52  Score=373.88  Aligned_cols=257  Identities=28%  Similarity=0.406  Sum_probs=219.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......     ......+|+.++++++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            47999999999999999999999999999999997654322     2344568999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccCCC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINS  151 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~~~  151 (337)
                      +||||++++.+..+......+++..++.++.||+.||.|||++|++||||||+||+++.+     .+||+|||.+.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            999999876555555556679999999999999999999999999999999999999765     599999999988776


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+            
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~------------  238 (321)
T 2a2a_A          172 GVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD------------  238 (321)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC------------
T ss_pred             cccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC------------
Confidence            6555677899999999998765 679999999999999999999999998887777666543211111            


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                    ....+..+.++.++|.+||+.||.+|||++|+++||||+.
T Consensus       239 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          239 --------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             --------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             --------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence                          1112457899999999999999999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.7e-53  Score=391.72  Aligned_cols=254  Identities=33%  Similarity=0.466  Sum_probs=210.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++......  .......+|+.+++.++||||+++++++...+.+++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999999764322  1223346799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCC
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPF  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~  155 (337)
                      |||++++.+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+||+|||+|..... ....
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  306 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  306 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence            9999987665555555679999999999999999999998 999999999999999876 999999999986433 3344


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....                   .
T Consensus       307 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------------------~  366 (446)
T 4ejn_A          307 KTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------------I  366 (446)
T ss_dssp             CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------C
T ss_pred             ccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------------------C
Confidence            667899999999998765 78999999999999999999999999888777666654321                   0


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                      .           .++.+++++.+||.+||+.||.+||     |++|+++||||+.
T Consensus       367 ~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          367 R-----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             C-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             C-----------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            1           1245789999999999999999999     9999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-52  Score=395.26  Aligned_cols=257  Identities=33%  Similarity=0.496  Sum_probs=220.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++......  .......+|+.++++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4799999999999999999999999999999998765432  23445578999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee---C-CcEEEeeCCCcccCCCCCCC
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS---K-DTIKIADFGLAREINSRPPF  155 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~---~-~~~kL~Dfg~a~~~~~~~~~  155 (337)
                      ||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++   . +.+||+|||+|.........
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  185 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM  185 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence            9998765544444455699999999999999999999999999999999999995   2 38999999999887766666


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+....+.........+.             
T Consensus       186 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------  250 (484)
T 3nyv_A          186 KDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ-------------  250 (484)
T ss_dssp             HHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG-------------
T ss_pred             ccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc-------------
Confidence            67789999999999865  579999999999999999999999999988888777765432222222             


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                   ++.+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus       251 -------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          251 -------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             -------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             -------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence                         24578999999999999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-52  Score=378.40  Aligned_cols=278  Identities=26%  Similarity=0.427  Sum_probs=223.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-----CCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-----HPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|+++++||+|+||.||+|.+..+|+.||+|++....  ........|+.+++.+.     ||||+++++++...+..+
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            58999999999999999999999999999999997432  22333457899999886     999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC--------------------
Q 038835           77 FVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK--------------------  135 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~--------------------  135 (337)
                      +||||+++++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.                    
T Consensus       113 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence            999999777777776543 45999999999999999999999999999999999999973                    


Q ss_pred             ------CcEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 038835          136 ------DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY  209 (337)
Q Consensus       136 ------~~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  209 (337)
                            ..+||+|||+|......  ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.
T Consensus       193 ~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  269 (360)
T 3llt_A          193 IYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA  269 (360)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence                  38999999999875443  2456899999999998766 68999999999999999999999999999999998


Q ss_pred             HHHHHhCCCCccchhhhhhhHHhhhc-------cCCCCCCC---------cccccCCCCChhHHHHHHHhcCCCCCCCCC
Q 038835          210 KICSVIGTPTQDSWADGLLLARAINY-------KFPQLVGV---------PLSVLMPSANKDAVSLIASLCSWDPSKRPT  273 (337)
Q Consensus       210 ~i~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  273 (337)
                      .+....+..+...+............       .++.....         .........++++.+||.+||+.||.+|||
T Consensus       270 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  349 (360)
T 3llt_A          270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS  349 (360)
T ss_dssp             HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence            88888777665544332211111000       11110000         000111234578889999999999999999


Q ss_pred             HHHHhcCcCcc
Q 038835          274 AAEALQHPFSR  284 (337)
Q Consensus       274 ~~ell~hp~~~  284 (337)
                      ++|+|+||||+
T Consensus       350 a~elL~hp~f~  360 (360)
T 3llt_A          350 PAELLKHKFLE  360 (360)
T ss_dssp             HHHHTTSGGGC
T ss_pred             HHHHhcCcccC
Confidence            99999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.5e-53  Score=379.02  Aligned_cols=253  Identities=28%  Similarity=0.443  Sum_probs=208.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.+....     ..+|+.++.++ +||||+++++++.+++..|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4799999999999999999999999999999999765332     24688888887 79999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccCCCC-CC
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINSR-PP  154 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~~~~-~~  154 (337)
                      |++|+.+.........+++..++.++.||+.||+|||++||+||||||+|||+...     .+||+|||++...... ..
T Consensus        97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~  176 (342)
T 2qr7_A           97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL  176 (342)
T ss_dssp             CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence            99875444444445569999999999999999999999999999999999998542     4999999999876443 33


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS---EADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+..   ..+....+.......             
T Consensus       177 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-------------  242 (342)
T 2qr7_A          177 LMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL-------------  242 (342)
T ss_dssp             BCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC-------------
T ss_pred             eeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc-------------
Confidence            4567899999999998765 57889999999999999999999998642   333444433221110             


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                   ....++.+++++.+||.+||..||.+|||+.++++||||...
T Consensus       243 -------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          243 -------------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             -------------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             -------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                         112245688999999999999999999999999999999764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=372.89  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=205.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|+++++||+|+||.||+|.++.+|+.||+|++........ ......|+..+..+ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            469999999999999999999999999999999876544332 22334566555554 9999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||+++++.+.+...+..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...+........
T Consensus       137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  216 (311)
T 3p1a_A          137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ  216 (311)
T ss_dssp             ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CC
T ss_pred             eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCccc
Confidence            999999998888877789999999999999999999999999999999999999876 9999999999887666555667


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .||+.|+|||++.+  .++.++|||||||++|+|++|..||.+...   ...+...   .                    
T Consensus       217 ~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~---~--------------------  268 (311)
T 3p1a_A          217 EGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQG---Y--------------------  268 (311)
T ss_dssp             CCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTT---C--------------------
T ss_pred             CCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhcc---C--------------------
Confidence            89999999998865  579999999999999999999776654322   1111110   0                    


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                           ........+++++.++|.+||+.||.+|||++|+|+||||+.
T Consensus       269 -----~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 -----LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             -----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             -----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                 001122467899999999999999999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.6e-52  Score=375.15  Aligned_cols=253  Identities=29%  Similarity=0.465  Sum_probs=217.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +|++++.||+|+||.||+|.+..+|+.||+|++........  .....+|+.++++++||||+++++++..++..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            58999999999999999999999999999999976543332  2345689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      |+.|++.+.+......+++..++.++.|++.||.|||++||+||||||+|||++.+ .+||+|||++......   ...+
T Consensus       135 ~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~  211 (348)
T 1u5q_A          135 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFV  211 (348)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCC
T ss_pred             cCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Cccc
Confidence            99999888887767779999999999999999999999999999999999999986 9999999999876543   4568


Q ss_pred             ccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          160 STRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       160 gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+.+..+.+..+.....                     
T Consensus       212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~---------------------  270 (348)
T 1u5q_A          212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------------------  270 (348)
T ss_dssp             SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------------------
T ss_pred             CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------------------
Confidence            9999999999853  34689999999999999999999999998887666655543211                     


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      +.       ......++.+.++|.+||+.||.+|||++++++||||...
T Consensus       271 ~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          271 PA-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             CC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CC-------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            10       0113567899999999999999999999999999999753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.7e-53  Score=387.75  Aligned_cols=257  Identities=27%  Similarity=0.389  Sum_probs=216.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.+....  .......+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999998753211  11223468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ||++|+.+..+.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|.......  ...
T Consensus       149 E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~  227 (410)
T 3v8s_A          149 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD  227 (410)
T ss_dssp             CCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred             eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence            999876555454443 48999999999999999999999999999999999999876 99999999998765443  234


Q ss_pred             cccccccccCchhhcCcC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          157 EYVSTRWYRAPEVLLQSY---LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      +.+||+.|+|||++.+..   .++.++|||||||++|+|++|++||.+.+..+...++.....                 
T Consensus       228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-----------------  290 (410)
T 3v8s_A          228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-----------------  290 (410)
T ss_dssp             SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-----------------
T ss_pred             CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-----------------
Confidence            678999999999987542   278899999999999999999999999888887777754310                 


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK--RPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~~~~  285 (337)
                      ...+|.         ...+++++++||++||+.+|.+  ||+++|+++||||+.
T Consensus       291 ~~~~p~---------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          291 SLTFPD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HCCCCT---------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             cccCCC---------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            111221         1357899999999999999988  999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.1e-52  Score=382.62  Aligned_cols=286  Identities=21%  Similarity=0.262  Sum_probs=212.6

Q ss_pred             cCceEeeeeccc--CceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDG--TFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++++.||+|  +||.||+|.++.+|+.||+|++........ .....+|+.++++++||||+++++++.+++..|+|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            589999999999  999999999999999999999987655443 23446799999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---
Q 038835           79 FEYMECNLYQLMKDR--EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---  152 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~--~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---  152 (337)
                      |||++++.+..+...  ...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||.+......   
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~  184 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR  184 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence            999997655554433  2569999999999999999999999999999999999999876 9999999987643211   


Q ss_pred             -----CCCccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCcc-----
Q 038835          153 -----PPFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD-----  221 (337)
Q Consensus       153 -----~~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----  221 (337)
                           ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....+..........     
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (389)
T 3gni_B          185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP  264 (389)
T ss_dssp             CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------
T ss_pred             ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccc
Confidence                 122345899999999998764 468999999999999999999999999877766655443321110000     


Q ss_pred             --ch-hh------hhhhHHhhh--ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          222 --SW-AD------GLLLARAIN--YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       222 --~~-~~------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                        .+ ..      .........  ...+.............+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             -----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             cccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence              00 00      000000000  00011111112234467889999999999999999999999999999998643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-52  Score=379.45  Aligned_cols=254  Identities=31%  Similarity=0.473  Sum_probs=210.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHH-HhcCCCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKS-LRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+.....  ......+|..+ ++.++||||+++++++.+.+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            368999999999999999999999999999999998765432  22233456666 567899999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~  155 (337)
                      ||||++|+.+.....+...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.... .....
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~  196 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT  196 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCcc
Confidence            99999986555555555569999999999999999999999999999999999999876 99999999998643 33344


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+....+....                   .
T Consensus       197 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------------~  256 (373)
T 2r5t_A          197 STFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------------------L  256 (373)
T ss_dssp             CSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-------------------C
T ss_pred             ccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------------------c
Confidence            667999999999998765 78999999999999999999999999988877777665420                   0


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH----HHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA----AEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~ell~hp~~~~  285 (337)
                                 ...+.++.++.++|.+||+.||.+||++    .++++||||+.
T Consensus       257 -----------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          257 -----------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             -----------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             -----------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence                       1124678999999999999999999987    69999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-52  Score=374.22  Aligned_cols=259  Identities=29%  Similarity=0.431  Sum_probs=193.1

Q ss_pred             cCceEe---eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLI---KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~---~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++.   +.||+|+||.||+|.++.+|+.||+|++...    ......+|+.+++.+. ||||+++++++.++...|+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            467775   7899999999999999999999999999754    2334468999999996 9999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCC-
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSR-  152 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~-  152 (337)
                      ||||++++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+    .+||+|||++...... 
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            99999986555555555679999999999999999999999999999999999999764    7999999999865443 


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCCccchhh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA-------DEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~  225 (337)
                      ......+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..       +....+.......       
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-------  235 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-------  235 (325)
T ss_dssp             --------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-------
T ss_pred             CcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-------
Confidence            334567889999999998665 6899999999999999999999999875432       2222221111000       


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCC
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH  291 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  291 (337)
                                         ....++.+++++.+||.+||+.||.+|||++|+++||||+.......
T Consensus       236 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~  282 (325)
T 3kn6_A          236 -------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS  282 (325)
T ss_dssp             -------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred             -------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCC
Confidence                               11122457899999999999999999999999999999987544433

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-52  Score=388.18  Aligned_cols=259  Identities=25%  Similarity=0.368  Sum_probs=217.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|+++++||+|+||.||+|.++.+|+.||+|++.+....  .......+|..+++.++||||+++++++.+++.+|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            6899999999999999999999999999999999753221  11223468999999999999999999999999999999


Q ss_pred             eecCCCH-HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--C
Q 038835           80 EYMECNL-YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--F  155 (337)
Q Consensus        80 e~~~~~l-~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~  155 (337)
                      ||++|+. .+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|........  .
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~  233 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  233 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence            9998754 45554445679999999999999999999999999999999999999876 999999999976654332  2


Q ss_pred             ccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 TEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ...+||+.|+|||++..    ...++.++|||||||++|+|++|++||.+.+..+....+....                
T Consensus       234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------  297 (437)
T 4aw2_A          234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK----------------  297 (437)
T ss_dssp             CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----------------
T ss_pred             ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc----------------
Confidence            34689999999999862    3468999999999999999999999999988888877775421                


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCC--CCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSK--RPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~ell~hp~~~~  285 (337)
                       ....+|.        ..+.+++++++||++||..+|.+  |++++|+++||||+.
T Consensus       298 -~~~~~p~--------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          298 -ERFQFPT--------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             -HHCCCCS--------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             -ccccCCc--------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence             0112221        12457899999999999998888  999999999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.8e-52  Score=370.96  Aligned_cols=253  Identities=30%  Similarity=0.499  Sum_probs=206.8

Q ss_pred             cCceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCCh---HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSW---EECVNLREVKSLRKMSHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|++++.||+|+||.||+|.+.   .+|+.||+|++.+.....   ......+|+.+++.++||||+++++++..++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            68999999999999999999985   689999999998654321   223345799999999999999999999999999


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-C
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-P  153 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~  153 (337)
                      |+||||++|+.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...... .
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  176 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT  176 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc
Confidence            9999999976555444545569999999999999999999999999999999999999876 9999999998764332 2


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....                  
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------  237 (327)
T 3a62_A          177 VTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK------------------  237 (327)
T ss_dssp             --CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------------------
T ss_pred             cccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------------------
Confidence            33556899999999998765 67999999999999999999999999988777766665421                  


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                       ..           .++.++.++.++|.+||+.||.+||     +++|+++||||+.
T Consensus       238 -~~-----------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          238 -LN-----------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             -CC-----------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             -CC-----------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence             01           1245789999999999999999999     8999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-52  Score=379.91  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=211.7

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCCC-
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMECN-   85 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-   85 (337)
                      .+.||+|+||.||+|.++.+|+.||+|++..... .......+|+.++++++||||+++++++.+.+..++||||++++ 
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            6789999999999999999999999999976432 23345568999999999999999999999999999999999875 


Q ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee--CC-cEEEeeCCCcccCCCCCCCccccccc
Q 038835           86 LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS--KD-TIKIADFGLAREINSRPPFTEYVSTR  162 (337)
Q Consensus        86 l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~--~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~  162 (337)
                      +.+.+......+++..++.++.||+.||+|||++||+||||||+|||++  .+ .+||+|||++............+||+
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  252 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP  252 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCC
Confidence            5566665556699999999999999999999999999999999999994  33 89999999999877666556678999


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCC
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVG  242 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
                      .|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........                      
T Consensus       253 ~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----------------------  309 (373)
T 2x4f_A          253 EFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED----------------------  309 (373)
T ss_dssp             TTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS----------------------
T ss_pred             cEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh----------------------
Confidence            99999998655 6899999999999999999999999999888877777654221111                      


Q ss_pred             CcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          243 VPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       243 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                          ..++.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       310 ----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          310 ----EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             ----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence                1124678999999999999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.4e-52  Score=374.58  Aligned_cols=280  Identities=39%  Similarity=0.626  Sum_probs=227.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCE------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDI------   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------   74 (337)
                      ++|.+.+.||+|+||.||+|.++.+|+.||+|++........ .....+|+.+++.++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            579999999999999999999999999999999976544432 3345689999999999999999999976653      


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      .++||||+++++.+.+.   ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...... 
T Consensus       104 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-  179 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-  179 (353)
T ss_dssp             CEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred             EEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence            59999999987665542   348999999999999999999999999999999999999976 9999999999875433 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh-HHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL-ARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~  232 (337)
                       .....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...... ...
T Consensus       180 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  258 (353)
T 3coi_A          180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  258 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred             -ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence             345689999999999877557899999999999999999999999999999999999888887766544332111 111


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .....+...........+..++++.++|.+||+.||.+|||++|+++||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            111223333333444556789999999999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.9e-52  Score=363.84  Aligned_cols=255  Identities=29%  Similarity=0.463  Sum_probs=212.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.++.+++.||+|++........  .....+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4789999999999999999999999999999999865432221  23446899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||++++.+.........+++..++.++.||+.||.|||++|++||||||+||+++.+ .++|+|||++....... ...
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~  166 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTD  166 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-ccc
Confidence            9999976555444444569999999999999999999999999999999999999876 99999999886554332 245


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+.....                   .+
T Consensus       167 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~  226 (279)
T 3fdn_A          167 LCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------------------TF  226 (279)
T ss_dssp             -CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-------------------CC
T ss_pred             cCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-------------------CC
Confidence            6899999999998765 679999999999999999999999998877766665543211                   11


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                                 +...++++.++|.+||+.||.+|||++|+++||||+...
T Consensus       227 -----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          227 -----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             -----------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             -----------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                       134678999999999999999999999999999998643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-51  Score=368.30  Aligned_cols=281  Identities=35%  Similarity=0.644  Sum_probs=232.9

Q ss_pred             cCceEeeeecccCceEEEEEEEC-CCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcC---CCCCcccceeEEe-----e
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-QSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKM---SHPNIVKLKEVIR-----E   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~   71 (337)
                      ++|++++.||+|+||.||+|.+. .+|+.||+|++....... ......+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            58999999999999999999995 678999999987644322 122334677776665   8999999999986     5


Q ss_pred             CCEEEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           72 NDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      ....++||||+++++.+.+.... ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+...
T Consensus        91 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  170 (326)
T 1blx_A           91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  170 (326)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence            57789999999998888776543 458999999999999999999999999999999999999876 9999999999876


Q ss_pred             CCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          150 NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       150 ~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|......
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (326)
T 1blx_A          171 SFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  249 (326)
T ss_dssp             CGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             cCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence            655445567899999999998765 6899999999999999999999999999999999999998888877777643321


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ..   ..+............+.++.++.++|.+||..||.+|||+.|+++||||+..
T Consensus       250 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          250 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             CG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ch---hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence            11   1222222334445567889999999999999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-52  Score=383.72  Aligned_cols=283  Identities=32%  Similarity=0.587  Sum_probs=213.1

Q ss_pred             CceE-eeeecccCceEEEEEEEC--CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe--eCCEEEE
Q 038835            3 RYKL-IKEVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR--ENDILYF   77 (337)
Q Consensus         3 ~y~~-~~~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~l   77 (337)
                      .|++ +++||+|+||.||+|.++  .+++.||+|++.......   ...+|+.++++++||||+++++++.  .+...++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM---SACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH---HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH---HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            4666 558999999999999966  578899999997654332   3468999999999999999999995  4678999


Q ss_pred             EEeecCCCHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee----eCC-cEEEeeCC
Q 038835           78 VFEYMECNLYQLMKDRE--------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV----SKD-TIKIADFG  144 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~--------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili----~~~-~~kL~Dfg  144 (337)
                      ||||+++++.+.+....        ..+++..++.++.||+.||+|||++||+||||||+|||+    +.+ .+||+|||
T Consensus        98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A           98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            99999999888775321        248999999999999999999999999999999999999    333 89999999


Q ss_pred             CcccCCCC----CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHH
Q 038835          145 LAREINSR----PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---------ADEIYKI  211 (337)
Q Consensus       145 ~a~~~~~~----~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i  211 (337)
                      +|......    ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...         .+.+..+
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99876532    2234578999999999998766789999999999999999999999977654         4788999


Q ss_pred             HHHhCCCCccchhhhhhhHHhhhc--cCCC--CCCCc----ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          212 CSVIGTPTQDSWADGLLLARAINY--KFPQ--LVGVP----LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                      ....+.+....|............  .+..  .....    ........++++.+||.+||+.||.+|||++|+|+||||
T Consensus       258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f  337 (405)
T 3rgf_A          258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  337 (405)
T ss_dssp             HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            999999999888764322111110  0000  00000    001122347889999999999999999999999999999


Q ss_pred             ccccc
Q 038835          284 RVAFM  288 (337)
Q Consensus       284 ~~~~~  288 (337)
                      .....
T Consensus       338 ~~~~~  342 (405)
T 3rgf_A          338 LEDPL  342 (405)
T ss_dssp             TSSSC
T ss_pred             ccCCC
Confidence            87543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-52  Score=382.36  Aligned_cols=258  Identities=26%  Similarity=0.389  Sum_probs=214.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.+.....  ......+|..++..++||||+++++++.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997532211  1223467999999999999999999999999999999


Q ss_pred             eecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--C
Q 038835           80 EYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--F  155 (337)
Q Consensus        80 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~  155 (337)
                      ||++|+ +.+.+.+.+..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++........  .
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~  220 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS  220 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence            999765 555555545579999999999999999999999999999999999999986 999999999987654432  2


Q ss_pred             ccccccccccCchhhcC------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          156 TEYVSTRWYRAPEVLLQ------SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      ...+||+.|+|||++..      ...++.++|+|||||++|+|++|++||.+.+..+...++.....             
T Consensus       221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------------  287 (412)
T 2vd5_A          221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-------------  287 (412)
T ss_dssp             SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-------------
T ss_pred             ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-------------
Confidence            34689999999999873      23689999999999999999999999999888877777654210             


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCC---CCHHHHhcCcCccc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR---PTAAEALQHPFSRV  285 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~ell~hp~~~~  285 (337)
                          ...+|        .....+|+++++||++||. +|.+|   |+++|+++||||+.
T Consensus       288 ----~~~~p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          288 ----HLSLP--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             ----HCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             ----CcCCC--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence                01111        1124678999999999999 99998   59999999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.8e-51  Score=364.74  Aligned_cols=252  Identities=27%  Similarity=0.466  Sum_probs=214.3

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecC
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYME   83 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (337)
                      |+..+.||+|+||.||+|.++.+|+.||+|++...... ......+|+.+++.++||||+++++++...+..++||||++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            78889999999999999999999999999998754433 23345689999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccccc
Q 038835           84 CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVST  161 (337)
Q Consensus        84 ~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~gt  161 (337)
                      ++.+..+.... .+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...... .......||
T Consensus       126 ~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  204 (321)
T 2c30_A          126 GGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  204 (321)
T ss_dssp             SCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred             CCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCC
Confidence            87776666543 49999999999999999999999999999999999999976 9999999998876543 233567899


Q ss_pred             ccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCC
Q 038835          162 RWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLV  241 (337)
Q Consensus       162 ~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
                      +.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.......                       
T Consensus       205 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------------  260 (321)
T 2c30_A          205 PYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-----------------------  260 (321)
T ss_dssp             GGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------------------
T ss_pred             ccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------------------
Confidence            999999998765 67999999999999999999999999887766655544321100                       


Q ss_pred             CCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          242 GVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       242 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                          .......++++.++|.+||+.||.+|||++|+++||||..
T Consensus       261 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          261 ----LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             ----CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             ----cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence                0011346789999999999999999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.6e-52  Score=363.76  Aligned_cols=257  Identities=24%  Similarity=0.387  Sum_probs=198.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHH-HHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++............ .++...++.++||||+++++++.+++..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            6899999999999999999999999999999999765443333333 345555788899999999999999999999999


Q ss_pred             ecCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC
Q 038835           81 YMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        81 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~  155 (337)
                      |+++++.+.+..   .+..+++..++.++.||+.||.|||++ |++||||||+||+++.+ .+||+|||.+.........
T Consensus        87 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  166 (290)
T 3fme_A           87 LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK  166 (290)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred             hhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence            999987665543   456799999999999999999999998 99999999999999986 9999999999877665555


Q ss_pred             ccccccccccCchhh---cCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 TEYVSTRWYRAPEVL---LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ....||+.|+|||++   .....++.++||||+||++|+|++|..||...... ..........                
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  230 (290)
T 3fme_A          167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP----------------  230 (290)
T ss_dssp             ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC----------------
T ss_pred             cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC----------------
Confidence            556899999999997   24446889999999999999999999999864432 3332222210                


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                           .+.       ......++++.++|.+||+.||.+|||++|+++||||+..
T Consensus       231 -----~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          231 -----SPQ-------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             -----CCC-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -----CCC-------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                 010       1124578999999999999999999999999999999853

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.1e-52  Score=368.15  Aligned_cols=258  Identities=30%  Similarity=0.467  Sum_probs=201.9

Q ss_pred             cCceEe-eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLI-KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++. +.||+|+||.||+|.++.+|+.||+|++...... ......+|+.+++++ +||||+++++++.+++..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            578985 7899999999999999999999999999765332 234456899999885 7999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCC---
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSR---  152 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~---  152 (337)
                      ||++++.+.........+++..++.++.||+.||+|||++|++||||||+|||++.+    .+||+|||++......   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            999875554444444569999999999999999999999999999999999999865    3999999998755321   


Q ss_pred             -----CCCccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---------------HH
Q 038835          153 -----PPFTEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD---------------EI  208 (337)
Q Consensus       153 -----~~~~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------------~~  208 (337)
                           ......+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+....+               ..
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                 12234579999999999864    1357899999999999999999999998765321               11


Q ss_pred             HHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          209 YKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       209 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ..+...                   ...++       ...+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       251 ~~i~~~-------------------~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          251 ESIQEG-------------------KYEFP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHC-------------------CCCCC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHhcc-------------------CcccC-------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            111111                   00111       11124578999999999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-52  Score=374.10  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=211.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-------HHhHHHHHHHHHhcCCCCCcccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-------EECVNLREVKSLRKMSHPNIVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   74 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......       ......+|+.++++++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            47999999999999999999999999999999998654321       11233579999999999999999999999999


Q ss_pred             EEEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           75 LYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        75 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      .++||||+.++ .+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++......
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  183 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG  183 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence            99999998754 555555556669999999999999999999999999999999999999877 9999999999887766


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....                           
T Consensus       184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------------  236 (335)
T 3dls_A          184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------------  236 (335)
T ss_dssp             CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------------
T ss_pred             CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------------
Confidence            66667889999999999987655588999999999999999999999653210                           


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ....         ......+++++.++|.+||+.||.+|||++++++||||+..
T Consensus       237 ~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          237 VEAA---------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             TTTC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             Hhhc---------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            0000         01123578999999999999999999999999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.4e-51  Score=372.24  Aligned_cols=257  Identities=28%  Similarity=0.424  Sum_probs=217.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hH-----HhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WE-----ECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++......  ..     .....+|+.+++++ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            4699999999999999999999999999999998764321  11     22345799999999 8999999999999999


Q ss_pred             EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           74 ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ..++||||++|+.+..+......+++..++.++.||+.||.|||+.|++||||||+||+++.+ .+||+|||++......
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            999999999986555555555569999999999999999999999999999999999999876 9999999999887766


Q ss_pred             CCCccccccccccCchhhcC-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQ-----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL  227 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  227 (337)
                      ......+||+.|+|||++.+     ...++.++|||||||++|+|++|.+||.+.+..+....+..........      
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~------  327 (365)
T 2y7j_A          254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP------  327 (365)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH------
T ss_pred             cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc------
Confidence            66677899999999999863     2357889999999999999999999999887776666655432221111      


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                          .++..+.++.++|.+||+.||.+|||++|+++||||+
T Consensus       328 --------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          328 --------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             --------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             --------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence                                1245678999999999999999999999999999996

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=367.38  Aligned_cols=282  Identities=34%  Similarity=0.581  Sum_probs=218.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe-----------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR-----------   70 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----------   70 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.... ........+|+.++++++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            58999999999999999999999999999999987542 123344568999999999999999999873           


Q ss_pred             ---eCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-C-cEEEeeCCC
Q 038835           71 ---ENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-D-TIKIADFGL  145 (337)
Q Consensus        71 ---~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-~-~~kL~Dfg~  145 (337)
                         ..+..++||||++|++.+.+..  ..+++..++.++.||+.||+|||++|++||||||+||+++. + .+||+|||.
T Consensus        90 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           90 SLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             -CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             cccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence               4478899999999877766643  45899999999999999999999999999999999999974 4 899999999


Q ss_pred             cccCCCC----CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSR----PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~----~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +......    .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+..........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            9876432    223456789999999998775678999999999999999999999999999888888887765554443


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .+....................+.....+.++.++.++|.+||+.||.+|||++|+++||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            33321110000000000111122334456789999999999999999999999999999999853

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-51  Score=367.62  Aligned_cols=278  Identities=24%  Similarity=0.508  Sum_probs=218.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEee--CCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRE--NDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv   78 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....    .....+|+.++++++ ||||+++++++.+  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            57999999999999999999999999999999987432    334568999999996 9999999999987  6778999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      |||++++.+..+...   +++..++.++.||+.||+|||++|++||||||+|||++.+  .+||+|||++..........
T Consensus       112 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~  188 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN  188 (330)
T ss_dssp             EECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred             EeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence            999998776666543   8999999999999999999999999999999999999854  79999999998776666667


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCccchhhhhh------h
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFP-GTSEADEIYKICSVIGTPTQDSWADGLL------L  229 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~------~  229 (337)
                      ...||+.|+|||++.+...++.++|||||||++|+|++|..||. +....+.+..+....+.+....+.....      .
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (330)
T 3nsz_A          189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  268 (330)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred             cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence            77899999999999775678999999999999999999999984 4455556666555444322111110000      0


Q ss_pred             HHhhh-ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          230 ARAIN-YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       230 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ..... .................+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            00000 0000000001111223478999999999999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.9e-51  Score=360.10  Aligned_cols=260  Identities=30%  Similarity=0.407  Sum_probs=218.4

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC---C-----hHHhHHHHHHHHHhcCC-CCCcccceeEEee
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY---S-----WEECVNLREVKSLRKMS-HPNIVKLKEVIRE   71 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~-----~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~   71 (337)
                      .++|++.+.||+|++|.||+|.++.+|+.||+|++.....   .     .......+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            4789999999999999999999999999999999875431   1     11233468999999995 9999999999999


Q ss_pred             CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835           72 NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      ++..++||||++++.+..+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+....
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  175 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  175 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence            99999999999975554444445569999999999999999999999999999999999999876 99999999998876


Q ss_pred             CCCCCccccccccccCchhhc-----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          151 SRPPFTEYVSTRWYRAPEVLL-----QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       151 ~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      .........||+.|+|||++.     ....++.++||||||+++|+|++|..||.+.+..+....+..........    
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  251 (298)
T 1phk_A          176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP----  251 (298)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred             CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc----
Confidence            665566778999999999985     23457889999999999999999999999887776666555432111111    


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                            .++.++.++.++|.+||+.||.+|||++|+++||||++.
T Consensus       252 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          252 ----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             ----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ----------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence                                  123568899999999999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2e-51  Score=363.83  Aligned_cols=257  Identities=29%  Similarity=0.416  Sum_probs=213.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|.+++.||+|+||.||+|.++.+|+.||+|++...... ......+|+.+++.++||||+++++++.+.+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            4799999999999999999999999999999999764322 233456899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---eCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili---~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ++++.+.........+++..++.++.||+.||.|||++|++||||||+||++   +.+ .+||+|||.+...... ....
T Consensus        88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~  166 (304)
T 2jam_A           88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMST  166 (304)
T ss_dssp             CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHH
T ss_pred             CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cccc
Confidence            9875444333444569999999999999999999999999999999999999   433 8999999998765432 2345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+........                  
T Consensus       167 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~------------------  227 (304)
T 2jam_A          167 ACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE------------------  227 (304)
T ss_dssp             HHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC------------------
T ss_pred             ccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC------------------
Confidence            6799999999998665 689999999999999999999999998887776666654321111                  


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                              ...++.+++++.++|.+||+.||.+|||++|+++||||+...
T Consensus       228 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          228 --------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             --------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             --------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence                    112346789999999999999999999999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-51  Score=358.68  Aligned_cols=257  Identities=24%  Similarity=0.366  Sum_probs=213.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.+++.++||||+++++++.+++..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            68999999999999999999999999999999997655444455667899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---CCCcc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---PPFTE  157 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---~~~~~  157 (337)
                      ++++.+.........+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+......   .....
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  166 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK  166 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence            9985555455555569999999999999999999999999999999999999876 9999999999765322   22345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE-IYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..||+.|+|||++.+...++.++||||||+++|+|++|..||.+...... .......  .                   
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-------------------  225 (276)
T 2yex_A          167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--K-------------------  225 (276)
T ss_dssp             CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT--C-------------------
T ss_pred             CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc--c-------------------
Confidence            68999999999987664557899999999999999999999987654322 1111110  0                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                       .      ....++.+++++.++|.+||+.||.+|||++|+++||||+..
T Consensus       226 -~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          226 -T------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             -T------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -c------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence             0      001123578999999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.4e-52  Score=382.21  Aligned_cols=258  Identities=29%  Similarity=0.445  Sum_probs=201.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-------hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-------WEECVNLREVKSLRKMSHPNIVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   74 (337)
                      ++|.+.+.||+|+||.||+|.++.+|+.||+|++......       .......+|+.++++++||||+++++++. .+.
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence            5799999999999999999999999999999998764321       11223468999999999999999999985 456


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREIN  150 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~  150 (337)
                      .++||||++++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+    .+||+|||+|...+
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  293 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  293 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence            89999999886555444555669999999999999999999999999999999999999753    59999999999877


Q ss_pred             CCCCCccccccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          151 SRPPFTEYVSTRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       151 ~~~~~~~~~gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      ........+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+......+.........           
T Consensus       294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~-----------  362 (419)
T 3i6u_A          294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-----------  362 (419)
T ss_dssp             -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC-----------
T ss_pred             CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC-----------
Confidence            6655567889999999999853  346788999999999999999999999875543222222111000           


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                    ......++.+++++.++|.+||+.||.+|||++|+|+||||++
T Consensus       363 --------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          363 --------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             --------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             --------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence                          0111223567899999999999999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-51  Score=378.29  Aligned_cols=253  Identities=30%  Similarity=0.474  Sum_probs=198.2

Q ss_pred             cCceEe-eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHh-cCCCCCcccceeEEee----CCEE
Q 038835            2 ERYKLI-KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLR-KMSHPNIVKLKEVIRE----NDIL   75 (337)
Q Consensus         2 ~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~   75 (337)
                      ++|.+. +.||.|+||.||+|.++.+|+.||+|++...      ....+|+.++. ..+||||++++++++.    ...+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            578887 6899999999999999999999999998642      23357888874 4589999999999875    5678


Q ss_pred             EEEEeecCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC---C-cEEEeeCCCcccC
Q 038835           76 YFVFEYMEC-NLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK---D-TIKIADFGLAREI  149 (337)
Q Consensus        76 ~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~---~-~~kL~Dfg~a~~~  149 (337)
                      |+||||++| ++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   + .+||+|||++...
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~  214 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  214 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence            999999987 5555555432 45999999999999999999999999999999999999986   3 8999999999887


Q ss_pred             CCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCccchhh
Q 038835          150 NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD----EIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       150 ~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~  225 (337)
                      .........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.....    ....+...           
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-----------  282 (400)
T 1nxk_A          215 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-----------  282 (400)
T ss_dssp             C-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-----------
T ss_pred             CCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-----------
Confidence            665556678999999999998655 78999999999999999999999997765322    12222111           


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                              .+.++.       ..+..++.++.+||++||+.||.+|||++|+++||||....
T Consensus       283 --------~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          283 --------QYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             --------CCCCCT-------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             --------cccCCC-------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                    111111       12356789999999999999999999999999999997643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.7e-51  Score=360.31  Aligned_cols=257  Identities=27%  Similarity=0.441  Sum_probs=213.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......     ......+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999999999999999999987654322     2344568999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccCCC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINS  151 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~~~  151 (337)
                      +||||++++.+..+......+++..++.++.||+.||.|||++|++||||||+||+++.+     .+||+|||.+.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            999999876555554445569999999999999999999999999999999999999764     699999999987766


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ........||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+........            
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------  231 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD------------  231 (283)
T ss_dssp             -------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC------------
T ss_pred             CCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc------------
Confidence            5555667899999999998665 689999999999999999999999998887766655543211110            


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                    ....+..+..+.++|.+||+.||.+|||+.|+++||||+.
T Consensus       232 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          232 --------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             --------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             --------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence                          1112457889999999999999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.7e-51  Score=357.81  Aligned_cols=255  Identities=27%  Similarity=0.380  Sum_probs=206.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......  .......+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            6899999999999999999999999999999998754321  12234468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||++++.+..+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+............
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  170 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS  170 (276)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred             eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecc
Confidence            999875554444444569999999999999999999999999999999999999876 9999999999887665545567


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .||+.|+|||++.+....+.++||||||+++|+|++|..||.+....+....+.....                      
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------  228 (276)
T 2h6d_A          171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF----------------------  228 (276)
T ss_dssp             ------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------------
T ss_pred             cCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc----------------------
Confidence            8999999999987664456899999999999999999999988776665555433210                      


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                              ......+.++.++|.+||+.||.+|||++|+++||||+..
T Consensus       229 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 --------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             --------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                    0113567899999999999999999999999999999853

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.9e-52  Score=390.96  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=212.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.+....  .......+|+.+++.++||||+++++++.+++.+|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5799999999999999999999999999999999764321  12334468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           80 EYMECNLYQLMKDRE--KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        80 e~~~~~l~~~~~~~~--~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ||++|+.+.......  ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|..........
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~  343 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  343 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence            999876554444332  349999999999999999999999999999999999999876 99999999998876655556


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ..+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....   +.+......                   
T Consensus       344 ~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-------------------  403 (576)
T 2acx_A          344 GRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-------------------  403 (576)
T ss_dssp             CCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-------------------
T ss_pred             ccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-------------------
Confidence            67999999999998765 6899999999999999999999999876432   222211111                   


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                         .+       ...+..+++++.+||.+||+.||.+||     +++|+++||||+.
T Consensus       404 ---~~-------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          404 ---VP-------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             ---CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             ---cc-------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence               00       011246789999999999999999999     8999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.1e-51  Score=366.34  Aligned_cols=257  Identities=32%  Similarity=0.441  Sum_probs=212.1

Q ss_pred             CceEe-eeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLI-KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +|.+. +.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.+ .||||+++++++.+.+..++||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            57777 88999999999999999999999999998654433 234456899999999 5699999999999999999999


Q ss_pred             eecCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC----CcEEEeeCCCcccCCCCC
Q 038835           80 EYMECNLYQLMKD--REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK----DTIKIADFGLAREINSRP  153 (337)
Q Consensus        80 e~~~~~l~~~~~~--~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~----~~~kL~Dfg~a~~~~~~~  153 (337)
                      ||+.++.+..+..  ....+++..++.++.||+.||+|||++|++||||||+||+++.    +.+||+|||++.......
T Consensus       109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            9999865544432  2356999999999999999999999999999999999999986    389999999999876665


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.........             
T Consensus       189 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------  254 (327)
T 3lm5_A          189 ELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-------------  254 (327)
T ss_dssp             -----CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------
T ss_pred             ccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-------------
Confidence            55667899999999998765 6899999999999999999999999998887776666554222211             


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                   ...+..++.+.++|.+||+.||.+|||++++|+||||+..
T Consensus       255 -------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          255 -------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             -------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             -------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence                         1124578999999999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-51  Score=371.01  Aligned_cols=259  Identities=31%  Similarity=0.448  Sum_probs=211.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC----ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY----SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.....    ........+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            479999999999999999999999999999999875421    2233455689999999999999999999999999999


Q ss_pred             EEeecCCCHHHHHhhc----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 038835           78 VFEYMECNLYQLMKDR----------------------------------------EKCFSEAEVRNWCFQVFQGLAYMH  117 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~----------------------------------------~~~l~~~~~~~~~~qil~al~~LH  117 (337)
                      ||||++|+.+......                                        ...+++..++.++.||+.||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999988666555421                                        112467889999999999999999


Q ss_pred             HcCccccCCCCCCeeeeCC---cEEEeeCCCcccCCCC-----CCCccccccccccCchhhcCc-CCCCCcchHHHHHHH
Q 038835          118 QRGYFHRDLKPENLLVSKD---TIKIADFGLAREINSR-----PPFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAI  188 (337)
Q Consensus       118 ~~~i~H~dikp~Nili~~~---~~kL~Dfg~a~~~~~~-----~~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~i  188 (337)
                      ++|++||||||+||+++.+   .+||+|||.+......     .......||+.|+|||++.+. ..++.++|||||||+
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            9999999999999999754   7999999999754321     123456899999999998642 468999999999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCC
Q 038835          189 MAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDP  268 (337)
Q Consensus       189 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  268 (337)
                      +|+|++|..||.+.+..+....+...........                          ...+++++.++|.+||+.||
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN--------------------------YNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG--------------------------GGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc--------------------------cccCCHHHHHHHHHHcCCCh
Confidence            9999999999999888877776655322211111                          13468999999999999999


Q ss_pred             CCCCCHHHHhcCcCcccc
Q 038835          269 SKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       269 ~~Rpt~~ell~hp~~~~~  286 (337)
                      .+|||+.|+|+||||+..
T Consensus       320 ~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          320 DERFDAMRALQHPWISQF  337 (345)
T ss_dssp             TTSCCHHHHHHSHHHHTT
T ss_pred             hHCCCHHHHhcChhhccC
Confidence            999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9e-51  Score=364.50  Aligned_cols=259  Identities=29%  Similarity=0.421  Sum_probs=219.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|.+++.||+|+||.||++.++.+++.+|+|++.......  ......+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999987654332  2334468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||++++.+..+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++...... .....
T Consensus       121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (335)
T 2owb_A          121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV  200 (335)
T ss_dssp             CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccc
Confidence            999976665555555669999999999999999999999999999999999999877 9999999999876532 33355


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+....                   .. 
T Consensus       201 ~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------------~~-  259 (335)
T 2owb_A          201 LCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-------------------YS-  259 (335)
T ss_dssp             CCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------------------CC-
T ss_pred             cCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-------------------CC-
Confidence            6899999999998765 67999999999999999999999998887666555443320                   01 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCC
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH  291 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  291 (337)
                                ....+++++.++|.+||+.||.+|||++|+++||||........
T Consensus       260 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~  303 (335)
T 2owb_A          260 ----------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR  303 (335)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred             ----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence                      12356789999999999999999999999999999987654433

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.6e-51  Score=396.67  Aligned_cols=254  Identities=26%  Similarity=0.429  Sum_probs=217.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+...  .........|..++..+ +||+|+.+++++.+.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            4689999999999999999999999999999999976432  11223346789999988 79999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC-CCCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~-~~~~~  155 (337)
                      ||||++|+.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|.... .....
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~  499 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT  499 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence            99999986555555555569999999999999999999999999999999999999876 99999999998643 33344


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....                   .
T Consensus       500 ~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------------~  559 (674)
T 3pfq_A          500 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------------------V  559 (674)
T ss_dssp             CCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-------------------C
T ss_pred             ccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-------------------C
Confidence            667999999999998665 78999999999999999999999999988887777765321                   1


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA-----AEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~-----~ell~hp~~~~  285 (337)
                      .+           ++.+++++.+||.+||++||.+||++     +||++||||+.
T Consensus       560 ~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          560 AY-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             CC-----------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             CC-----------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            11           24678999999999999999999997     99999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-50  Score=357.54  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=217.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|.+++.||+|+||.||+|.++.+|+.+|+|++.......  ......+|+.+++.++||||+++++++.+++..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            58999999999999999999999999999999987654332  2334468999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||++++.+..+......+++..++.++.||+.||+|||++|++||||||+||+++.+ .+||+|||.+...... .....
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV  174 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccccc
Confidence            999976665555555669999999999999999999999999999999999999876 9999999999876532 23345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+. .++.++||||+|+++|+|++|..||.+....+....+...                   ..  
T Consensus       175 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~--  232 (294)
T 2rku_A          175 LCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------------------EY--  232 (294)
T ss_dssp             CCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------------CC--
T ss_pred             ccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------------cC--
Confidence            6899999999998665 6799999999999999999999999888766555443221                   00  


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                               ......++++.++|.+||+.||.+|||++|+++||||.....
T Consensus       233 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          233 ---------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             ---------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence                     112456789999999999999999999999999999987544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2e-51  Score=376.65  Aligned_cols=279  Identities=29%  Similarity=0.442  Sum_probs=221.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC--------CCCcccceeEEe---
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS--------HPNIVKLKEVIR---   70 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~---   70 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++....  .......+|+.+++.++        |+||+++++++.   
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            58999999999999999999999999999999997542  22334568999999885        788999999987   


Q ss_pred             -eCCEEEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-----------
Q 038835           71 -ENDILYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-----------  136 (337)
Q Consensus        71 -~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-----------  136 (337)
                       ++...++||||+++++++.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+           
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence             556899999999999998887654 5699999999999999999999999 99999999999999754           


Q ss_pred             ---------------------------------------cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCC
Q 038835          137 ---------------------------------------TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS  177 (337)
Q Consensus       137 ---------------------------------------~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~  177 (337)
                                                             .+||+|||.+......  ....+||+.|+|||++.+. .++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~  271 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS-GYN  271 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS-CCC
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCC-CCC
Confidence                                                   6999999999876543  3556899999999999776 689


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc--CCCCCCCc-----
Q 038835          178 SKVDMWAMGAIMAELITLRPLFPGTS------EADEIYKICSVIGTPTQDSWADGLLLARAINYK--FPQLVGVP-----  244 (337)
Q Consensus       178 ~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-----  244 (337)
                      .++|||||||++|+|++|.+||.+.+      ..+.+..+....+.++...+.............  ........     
T Consensus       272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (397)
T 1wak_A          272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF  351 (397)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred             cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence            99999999999999999999998765      456677777777776655443322211111100  00000000     


Q ss_pred             -----ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          245 -----LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       245 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                           ........+.++.+||.+||+.||.+|||++|+|+||||++
T Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                 00011234567899999999999999999999999999973

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.6e-51  Score=357.91  Aligned_cols=253  Identities=27%  Similarity=0.474  Sum_probs=213.7

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.......  ......+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999987543211  123456899999999999999999999999999999


Q ss_pred             EeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           79 FEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      |||++++ +.+.+.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++....... ..
T Consensus        93 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  170 (284)
T 2vgo_A           93 LEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RR  170 (284)
T ss_dssp             ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-BC
T ss_pred             EEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-cc
Confidence            9999874 5455444 4569999999999999999999999999999999999999876 99999999987654332 24


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ...|++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+...                   ...
T Consensus       171 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------------~~~  230 (284)
T 2vgo_A          171 TMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------------------DLK  230 (284)
T ss_dssp             CCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------------CCC
T ss_pred             cccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------------------ccC
Confidence            56899999999998765 6799999999999999999999999887776655544321                   001


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                 ..+.++.++.++|.+||+.||.+|||++++++||||+..
T Consensus       231 -----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          231 -----------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             -----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             -----------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence                       124578999999999999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=357.69  Aligned_cols=255  Identities=31%  Similarity=0.490  Sum_probs=190.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.......  ......+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            478999999999999999999999999999999997543211  123456899999999999999999999999999999


Q ss_pred             EeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCC
Q 038835           79 FEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPF  155 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~  155 (337)
                      |||++++ +.+.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+...... ...
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            9999875 445555555679999999999999999999999999999999999999876 9999999999876532 223


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....||+.|+|||++.+. .++.++||||+|+++|+|++|++||......+....+..                      
T Consensus       170 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------------------  226 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----------------------  226 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----------------------
T ss_pred             eeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----------------------
Confidence            456799999999988665 678999999999999999999999987654433221100                      


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                        .      ....+..++.++.++|.+||+.||.+|||++++++||||...
T Consensus       227 --~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          227 --A------DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             --S------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             --c------ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence              0      001124578999999999999999999999999999999853

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-50  Score=369.81  Aligned_cols=279  Identities=33%  Similarity=0.514  Sum_probs=222.4

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CC-----CcccceeEEeeCCE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HP-----NIVKLKEVIRENDI   74 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~   74 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++....  ........|+.+++.++ |+     +|+++++++...+.
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            368999999999999999999999999999999997532  12233456888888774 44     48999999999999


Q ss_pred             EEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCCeeeeC--C-cEEEeeCCCccc
Q 038835           75 LYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMH--QRGYFHRDLKPENLLVSK--D-TIKIADFGLARE  148 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH--~~~i~H~dikp~Nili~~--~-~~kL~Dfg~a~~  148 (337)
                      .++||||+++++.+.+.... ..+++..++.++.||+.||.|||  +.||+||||||+|||++.  + .+||+|||+|..
T Consensus       131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            99999999998888887653 56999999999999999999999  579999999999999964  2 799999999987


Q ss_pred             CCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          149 INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       149 ~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      .+..  ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...+.....
T Consensus       211 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  287 (382)
T 2vx3_A          211 LGQR--IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK  287 (382)
T ss_dssp             TTCC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred             cccc--cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence            6543  3567899999999998766 689999999999999999999999999999999999999888877655443222


Q ss_pred             hHHhhhccCCCC--------------CCCc---ccc------------------cCCCCChhHHHHHHHhcCCCCCCCCC
Q 038835          229 LARAINYKFPQL--------------VGVP---LSV------------------LMPSANKDAVSLIASLCSWDPSKRPT  273 (337)
Q Consensus       229 ~~~~~~~~~~~~--------------~~~~---~~~------------------~~~~~~~~~~~li~~~L~~dP~~Rpt  273 (337)
                      ....+.. .+..              ....   ...                  .....++++.+||.+||+.||.+|||
T Consensus       288 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          288 ARKFFEK-LPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             HHHHEEE-CTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHh-ccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence            2111110 0000              0000   000                  00001147899999999999999999


Q ss_pred             HHHHhcCcCccc
Q 038835          274 AAEALQHPFSRV  285 (337)
Q Consensus       274 ~~ell~hp~~~~  285 (337)
                      ++|+|+||||+.
T Consensus       367 a~e~L~hp~f~~  378 (382)
T 2vx3_A          367 PYYALQHSFFKK  378 (382)
T ss_dssp             HHHHTTSGGGCC
T ss_pred             HHHHhcCccccc
Confidence            999999999985

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-52  Score=369.21  Aligned_cols=276  Identities=21%  Similarity=0.310  Sum_probs=210.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC--EEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND--ILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            579999999999999999999999999999999986544333445568999999999999999999987654  789999


Q ss_pred             eecCCCHHH-HHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee----eCC-cEEEeeCCCcccCCC
Q 038835           80 EYMECNLYQ-LMKDRE--KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV----SKD-TIKIADFGLAREINS  151 (337)
Q Consensus        80 e~~~~~l~~-~~~~~~--~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili----~~~-~~kL~Dfg~a~~~~~  151 (337)
                      ||++++.+. .+....  ..+++..++.++.||+.||+|||++||+||||||+|||+    +.+ .+||+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence            999875554 444322  238999999999999999999999999999999999998    444 799999999998776


Q ss_pred             CCCCccccccccccCchhhcC-------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCc
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQ-------SYLYSSKVDMWAMGAIMAELITLRPLFPGTSE----ADEIYKICSVIGTPTQ  220 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~  220 (337)
                      ........||+.|+|||++..       ...++.++|||||||++|+|++|..||.....    .+.+..+....   +.
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---p~  245 (319)
T 4euu_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK---PS  245 (319)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC---CT
T ss_pred             CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC---Cc
Confidence            666667789999999999862       34689999999999999999999999975443    34444443332   11


Q ss_pred             cchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                      ..|....... .....+..... ........++..+.++|++||+.||++|||++|+|+||=
T Consensus       246 ~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          246 GAISGVQKAE-NGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TCCEEEECST-TCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             ccchhhhccc-CCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            1111100000 00000100000 001122345678999999999999999999999999973

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4e-51  Score=365.75  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=200.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC--------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND--------   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------   73 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            689999999999999999999999999999999986554445556679999999999999999999985432        


Q ss_pred             -------------------------------------------------EEEEEEeecCCCHHHHHhhcc---CCCCHHH
Q 038835           74 -------------------------------------------------ILYFVFEYMECNLYQLMKDRE---KCFSEAE  101 (337)
Q Consensus        74 -------------------------------------------------~~~lv~e~~~~~l~~~~~~~~---~~l~~~~  101 (337)
                                                                       ..++||||++++.+..+....   ...++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             389999999986555554432   2356677


Q ss_pred             HHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-------------CCccccccccccCc
Q 038835          102 VRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-------------PFTEYVSTRWYRAP  167 (337)
Q Consensus       102 ~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-------------~~~~~~gt~~~~aP  167 (337)
                      ++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++.......             .....+||+.|+||
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            99999999999999999999999999999999976 99999999998765432             22446799999999


Q ss_pred             hhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccc
Q 038835          168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSV  247 (337)
Q Consensus       168 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (337)
                      |++.+. .++.++|||||||++|+|++|..|+..     ....+.......                  ++        .
T Consensus       246 E~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~------------------~~--------~  293 (332)
T 3qd2_B          246 EQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK------------------FP--------L  293 (332)
T ss_dssp             HHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC------------------CC--------H
T ss_pred             HHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC------------------CC--------c
Confidence            998765 689999999999999999998776521     111111111110                  00        0


Q ss_pred             cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          248 LMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       248 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .....++++.++|.+||+.||.+|||++|+++||||++
T Consensus       294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            11234678899999999999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.5e-50  Score=353.41  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=208.9

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEee----CCEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRE----NDILYF   77 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l   77 (337)
                      .|++.+.||+|+||.||+|.+..++..||+|++........ .....+|+.+++.++||||+++++++..    +..+++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            58899999999999999999999999999999987655443 3445689999999999999999999865    466899


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeee-CC-cEEEeeCCCcccCCCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVS-KD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~-~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      ||||++++.+..+......+++..++.++.||+.||.|||++|  ++||||||+||+++ .+ .+||+|||++...... 
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-  185 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  185 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-
Confidence            9999988666555555566999999999999999999999999  99999999999997 44 9999999999765433 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+................                
T Consensus       186 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------  247 (290)
T 1t4h_A          186 FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------------  247 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------------
T ss_pred             ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC----------------
Confidence            2345679999999998753  4799999999999999999999999886665444332211000                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                 ........++++.++|.+||+.||.+|||++|+++||||++
T Consensus       248 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 -----------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                       01112456789999999999999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.3e-51  Score=357.26  Aligned_cols=255  Identities=34%  Similarity=0.552  Sum_probs=216.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++...... .......+|+.++++++||||+++++++.+.+..++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            5799999999999999999999999999999998765432 233455689999999999999999999999999999999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCCCC
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPF  155 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~~~  155 (337)
                      |+.++ +.+.+.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+    .+||+|||.+.........
T Consensus       102 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~  180 (287)
T 2wei_A          102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (287)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence            99875 4455544 4459999999999999999999999999999999999999753    6999999999877665555


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....||+.|+|||++.+  .++.++||||||+++|+|++|.+||.+.+..+....+.........               
T Consensus       181 ~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------  243 (287)
T 2wei_A          181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---------------  243 (287)
T ss_dssp             SCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---------------
T ss_pred             ccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---------------
Confidence            66679999999998864  3789999999999999999999999998877766665443211111               


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                 ..+..+++++.++|.+||+.||.+|||+.|+++||||+.
T Consensus       244 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          244 -----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             -----------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             -----------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence                       112457899999999999999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=364.24  Aligned_cols=255  Identities=22%  Similarity=0.378  Sum_probs=204.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCC--CCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSH--PNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++++.||+|+||.||++.+. +++.||+|++........ .....+|+.+++.++|  |||+++++++.+++..++|
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            47999999999999999999885 688999999976554433 2445689999999976  9999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCCC---C
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPP---F  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~~---~  155 (337)
                      ||+.++++.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+.+||+|||++........   .
T Consensus        88 ~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~  166 (343)
T 3dbq_A           88 MECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK  166 (343)
T ss_dssp             ECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC---------
T ss_pred             EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccC
Confidence            99777777777665 4569999999999999999999999999999999999999988999999999987654322   2


Q ss_pred             ccccccccccCchhhcC----------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCccchh
Q 038835          156 TEYVSTRWYRAPEVLLQ----------SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD-EIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  224 (337)
                      ...+||+.|+|||++.+          ...++.++|||||||++|+|++|.+||.+..... ....+.   ....     
T Consensus       167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~-----  238 (343)
T 3dbq_A          167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNH-----  238 (343)
T ss_dssp             ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTS-----
T ss_pred             CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh---cCCc-----
Confidence            45689999999999864          2467889999999999999999999998754431 121111   1000     


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                          ........+.++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus       239 --------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          239 --------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             --------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             --------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence                                001123456789999999999999999999999999999853

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-50  Score=355.24  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=205.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-hHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-WEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++...... .......+|+..+..+ +||||+++++++.+++..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4799999999999999999999999999999999865433 3344557899999999 9999999999999999999999


Q ss_pred             eecCCC-HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-------------------
Q 038835           80 EYMECN-LYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-------------------  136 (337)
Q Consensus        80 e~~~~~-l~~~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-------------------  136 (337)
                      ||++++ +.+.+...   ...+++..++.++.||+.||.|||++||+||||||+||+++.+                   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999874 55554432   2568999999999999999999999999999999999999732                   


Q ss_pred             -cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 038835          137 -TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVI  215 (337)
Q Consensus       137 -~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  215 (337)
                       .+||+|||.+......   ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+.....   ...+... 
T Consensus       171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~-  243 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG-  243 (289)
T ss_dssp             CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTT-
T ss_pred             eEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcC-
Confidence             6999999999876543   3356999999999997765677899999999999999999988754422   2222110 


Q ss_pred             CCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          216 GTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                          ..        ....+.+++++.++|.+||+.||.+|||+.|+++||||++.
T Consensus       244 --------------------~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          244 --------------------RL--------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             --------------------CC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             --------------------CC--------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence                                11        11224678999999999999999999999999999999863

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.6e-51  Score=368.49  Aligned_cols=276  Identities=22%  Similarity=0.336  Sum_probs=213.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.+++.++||||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            58999999999999999999999999999999998764434445567899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      ++++.+..+......+++..++.++.|++.||.|||++ ||+||||||+||+++.+ .+||+|||++...... ......
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  191 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV  191 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----C
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCC
Confidence            99865555555555699999999999999999999996 99999999999999876 9999999998654322 224568


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccc-h---h-----------
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS-W---A-----------  224 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~---~-----------  224 (337)
                      ||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+........... +   .           
T Consensus       192 gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (360)
T 3eqc_A          192 GTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD  270 (360)
T ss_dssp             CCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred             CCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence            99999999998765 689999999999999999999999988776554333221111000000 0   0           


Q ss_pred             ------hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          225 ------DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       225 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                            .........+...+       ......++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          271 SRPPMAIFELLDYIVNEPPP-------KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ---CCCHHHHHHHHHHSCCC-------CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCCcccchhhhhHHhccCCC-------CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                  00000000111111       11124578899999999999999999999999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-50  Score=381.96  Aligned_cols=253  Identities=28%  Similarity=0.377  Sum_probs=211.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|.+++.||+|+||.||+|.++.+|+.||+|++.+.....  ......+|+.++++++||||+++++++.+.+.+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997643221  1234468999999999999999999999999999999


Q ss_pred             eecCCCHHH-HHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           80 EYMECNLYQ-LMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        80 e~~~~~l~~-~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      ||++|+.+. .+...   ...+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++........
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            999976554 44332   3469999999999999999999999999999999999999876 999999999987655433


Q ss_pred             -CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCccchhhhhhh
Q 038835          155 -FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE----ADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       155 -~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                       ....+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+...    .+....+...               
T Consensus       345 ~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---------------  408 (543)
T 3c4z_A          345 KTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---------------  408 (543)
T ss_dssp             CBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC---------------
T ss_pred             ccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc---------------
Confidence             3446899999999998765 789999999999999999999999987643    2222222211               


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                          ..           ..++.+++++.++|.+||+.||.+||+     ++++++||||+.
T Consensus       409 ----~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          409 ----AV-----------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             ----CC-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             ----cc-----------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence                00           112467899999999999999999995     589999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.4e-51  Score=363.04  Aligned_cols=258  Identities=30%  Similarity=0.466  Sum_probs=207.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-------hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-------WEECVNLREVKSLRKMSHPNIVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   74 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......       .......+|+.++++++||||+++++++..++ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            4799999999999999999999999999999998764321       11223468999999999999999999987665 


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREIN  150 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~  150 (337)
                      .++||||++++.+.........+++..++.++.||+.||.|||++|++||||||+||+++.+    .+||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            89999999875554444455669999999999999999999999999999999999999864    49999999998776


Q ss_pred             CCCCCccccccccccCchhhc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCCccchhhhh
Q 038835          151 SRPPFTEYVSTRWYRAPEVLL--QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIY-KICSVIGTPTQDSWADGL  227 (337)
Q Consensus       151 ~~~~~~~~~gt~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~  227 (337)
                      .........||+.|+|||++.  +...++.++|||||||++|+|++|.+||.+......+. .+......          
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------  238 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN----------  238 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC----------
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc----------
Confidence            544334567999999999974  34468899999999999999999999998765432222 22211000          


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                      ..+..+...+.++.++|.+||+.||.+|||++++++||||+..
T Consensus       239 ----------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          239 ----------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             ----------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             ----------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                            0111224678999999999999999999999999999999863

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-50  Score=368.65  Aligned_cols=255  Identities=22%  Similarity=0.383  Sum_probs=204.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCC--CCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMS--HPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++++.||+|+||.||+|.+.. |+.||+|++....... ......+|+.+++.+.  ||||+++++++..++.+|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            359999999999999999999875 8999999997655443 2344578999999996  59999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCC---CC
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRP---PF  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~---~~  155 (337)
                      ||+.++++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||++.......   ..
T Consensus       135 ~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~  213 (390)
T 2zmd_A          135 MECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK  213 (390)
T ss_dssp             EECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------
T ss_pred             EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccC
Confidence            997666777766554 46899999999999999999999999999999999999988899999999998765432   23


Q ss_pred             ccccccccccCchhhcC----------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCccchh
Q 038835          156 TEYVSTRWYRAPEVLLQ----------SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA-DEIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  224 (337)
                      ...+||+.|+|||++.+          ...++.++|||||||++|+|++|.+||.+.... ..+..+...   ..     
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~---~~-----  285 (390)
T 2zmd_A          214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NH-----  285 (390)
T ss_dssp             CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT---TS-----
T ss_pred             CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc---cc-----
Confidence            45689999999999864          135788999999999999999999999876543 222222110   00     


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                               ..           ......+.++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus       286 ---------~~-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          286 ---------EI-----------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             ---------CC-----------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ---------cC-----------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence                     00           1113346889999999999999999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.9e-50  Score=360.26  Aligned_cols=277  Identities=27%  Similarity=0.470  Sum_probs=220.7

Q ss_pred             cCceEeeeecccCceEEEEEEE-CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCC------CcccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP------NIVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~   74 (337)
                      ++|++++.||+|+||.||+|.+ +.+|+.||+|++....  .......+|+.+++.++|+      +++++++++...+.
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            6899999999999999999998 5688999999987532  2233446788888888655      49999999999999


Q ss_pred             EEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC------------------
Q 038835           75 LYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK------------------  135 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~------------------  135 (337)
                      .++||||+++++.+.+.... .++++..++.++.||+.||+|||++|++||||||+|||++.                  
T Consensus        92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~  171 (339)
T 1z57_A           92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL  171 (339)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence            99999999888888877654 36899999999999999999999999999999999999975                  


Q ss_pred             -C-cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 038835          136 -D-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS  213 (337)
Q Consensus       136 -~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  213 (337)
                       + .+||+|||.+......  .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus       172 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  248 (339)
T 1z57_A          172 INPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER  248 (339)
T ss_dssp             SCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred             cCCCceEeeCcccccCccc--cccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence             2 6999999999875443  2456899999999998765 689999999999999999999999999998888888887


Q ss_pred             HhCCCCccchhhhh----------------hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 038835          214 VIGTPTQDSWADGL----------------LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA  277 (337)
Q Consensus       214 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  277 (337)
                      ..+..+...+....                ...............  .....+..++++.+||.+||+.||.+|||++|+
T Consensus       249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  326 (339)
T 1z57_A          249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE--FMLSQDVEHERLFDLIQKMLEYDPAKRITLREA  326 (339)
T ss_dssp             HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG--GCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhh--hcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence            77766554332211                111111000110000  001112345779999999999999999999999


Q ss_pred             hcCcCccc
Q 038835          278 LQHPFSRV  285 (337)
Q Consensus       278 l~hp~~~~  285 (337)
                      ++||||+.
T Consensus       327 l~hp~f~~  334 (339)
T 1z57_A          327 LKHPFFDL  334 (339)
T ss_dssp             TTSGGGGG
T ss_pred             hcCHHHHH
Confidence            99999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.9e-50  Score=354.11  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=216.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.+++.++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46999999999999999999999999999999997665444455667899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~~~  159 (337)
                      ++++.+..+... ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+....... ......
T Consensus       102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  180 (303)
T 3a7i_A          102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV  180 (303)
T ss_dssp             CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCC
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccC
Confidence            998666555554 458999999999999999999999999999999999999876 99999999997765432 334568


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      ||+.|+|||++.+. .++.++||||||+++|+|++|.+||......+....+....                     .  
T Consensus       181 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~--  236 (303)
T 3a7i_A          181 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---------------------P--  236 (303)
T ss_dssp             SCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---------------------C--
T ss_pred             CCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC---------------------C--
Confidence            99999999998765 67899999999999999999999998877665544432210                     0  


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                            .......+.++.++|.+||+.||.+|||++++++||||...
T Consensus       237 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 ------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                  01124678999999999999999999999999999999753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-50  Score=356.11  Aligned_cols=260  Identities=25%  Similarity=0.436  Sum_probs=213.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC---ChHHhHHHHHHHHHhcCCCCCcccceeEE--eeCCEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY---SWEECVNLREVKSLRKMSHPNIVKLKEVI--RENDIL   75 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~   75 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.....   ........+|+.++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            4789999999999999999999999999999999976432   12334557899999999999999999998  455688


Q ss_pred             EEEEeecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-
Q 038835           76 YFVFEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-  152 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-  152 (337)
                      ++||||+++++.+.+... ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+...... 
T Consensus        84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999999977766543 4569999999999999999999999999999999999999876 9999999999876432 


Q ss_pred             --CCCccccccccccCchhhcCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          153 --PPFTEYVSTRWYRAPEVLLQSY-LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       153 --~~~~~~~gt~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                        .......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+....              
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--------------  229 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--------------  229 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--------------
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--------------
Confidence              2224567999999999987532 34779999999999999999999999887766655543321              


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccC
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFH  290 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  290 (337)
                           .           ......++++.++|.+||+.||.+|||++|+++||||+......
T Consensus       230 -----~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          230 -----Y-----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             -----C-----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             -----C-----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                 0           01235678999999999999999999999999999998755433

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.4e-51  Score=362.78  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=207.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCC----EE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIREND----IL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~   75 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++........  .....+|+.++++++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            689999999999999999999999999999999987543322  234468999999999999999999986543    45


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-  153 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-  153 (337)
                      |+||||++|+.+..+......+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||+|||++....... 
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  171 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  171 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence            9999999876665555555669999999999999999999999999999999999999876 99999999998654332 


Q ss_pred             ---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 ---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 ---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                         .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+            
T Consensus       172 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------  238 (311)
T 3ork_A          172 SVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP------------  238 (311)
T ss_dssp             ----------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC------------
T ss_pred             ccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC------------
Confidence               22345799999999998765 68999999999999999999999999888776655544321111            


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                    .....+.++.++.++|.+||+.||.+||++.+++.|+|++.
T Consensus       239 --------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          239 --------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             --------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                          11123467899999999999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.2e-50  Score=361.79  Aligned_cols=277  Identities=26%  Similarity=0.444  Sum_probs=221.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC-cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC------cccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG-EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN------IVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~   74 (337)
                      ++|++++.||+|+||.||+|.++.++ +.||+|++....  .......+|+.+++.++|++      ++.+++++...+.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            68999999999999999999998877 689999997532  22334467999999887655      8999999999999


Q ss_pred             EEEEEeecCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee-------------------e
Q 038835           75 LYFVFEYMECNLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV-------------------S  134 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili-------------------~  134 (337)
                      .++||||+++++++.+.... ..+++..++.++.||+.||+|||++||+||||||+|||+                   +
T Consensus        97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~  176 (355)
T 2eu9_A           97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV  176 (355)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred             EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence            99999999999998887654 469999999999999999999999999999999999999                   3


Q ss_pred             CC-cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 038835          135 KD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS  213 (337)
Q Consensus       135 ~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  213 (337)
                      .+ .+||+|||++......  .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus       177 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (355)
T 2eu9_A          177 KNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK  253 (355)
T ss_dssp             SCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            33 8999999999865433  2456899999999998765 689999999999999999999999999998888888888


Q ss_pred             HhCCCCccchhhhh----------------hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 038835          214 VIGTPTQDSWADGL----------------LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA  277 (337)
Q Consensus       214 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  277 (337)
                      ..+..+...+....                ..........+...  .........+.++.+||.+||+.||.+|||++|+
T Consensus       254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK--SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG--GGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccc--ccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence            77766654332211                00010000010000  0001112234689999999999999999999999


Q ss_pred             hcCcCccc
Q 038835          278 LQHPFSRV  285 (337)
Q Consensus       278 l~hp~~~~  285 (337)
                      |+||||+.
T Consensus       332 l~hp~f~~  339 (355)
T 2eu9_A          332 LLHPFFAG  339 (355)
T ss_dssp             TTSGGGGG
T ss_pred             hcChhhcC
Confidence            99999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.9e-51  Score=359.05  Aligned_cols=265  Identities=28%  Similarity=0.411  Sum_probs=192.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.............+|+.++++++||||+++++++...+..++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            68999999999999999999999999999999987654433344556899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           82 MECNLY-QLMKD-------REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        82 ~~~~l~-~~~~~-------~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ++++.+ +.+..       ....+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+......
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            987544 44432       24458999999999999999999999999999999999999876 9999999998765432


Q ss_pred             C------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          153 P------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       153 ~------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      .      ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+..............      
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  248 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE------  248 (303)
T ss_dssp             -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT------
T ss_pred             CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc------
Confidence            1      1234579999999999876446899999999999999999999999887765544332211100000      


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                    ............+.++.++|.+||+.||.+|||+.++++||||+..
T Consensus       249 --------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          249 --------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             --------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             --------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence                          0001112335678999999999999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.2e-50  Score=364.52  Aligned_cols=289  Identities=29%  Similarity=0.468  Sum_probs=222.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-----------CCCcccceeEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-----------HPNIVKLKEVIR   70 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~   70 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....  .......+|+.+++++.           ||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            58999999999999999999999999999999997532  12334467899888875           899999999987


Q ss_pred             eCC----EEEEEEeecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeC-----C--c
Q 038835           71 END----ILYFVFEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSK-----D--T  137 (337)
Q Consensus        71 ~~~----~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~-----~--~  137 (337)
                      ..+    ..++||||+++++.+.+... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.     +  .
T Consensus        97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence            654    78999999977888877653 34599999999999999999999998 9999999999999952     1  7


Q ss_pred             EEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHH
Q 038835          138 IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS------EADEIYKI  211 (337)
Q Consensus       138 ~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i  211 (337)
                      +||+|||++......  .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+      ..+.+..+
T Consensus       177 ~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          177 IKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             EEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            999999999876543  3456899999999998766 68999999999999999999999998765      45667777


Q ss_pred             HHHhCCCCccchhhhhhhHHhhhcc--CCCCCCC---c-------ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          212 CSVIGTPTQDSWADGLLLARAINYK--FPQLVGV---P-------LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ....+.++...+..........+..  .......   +       .....+..+.++.+||.+||+.||.+|||++|+|+
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            7777777665554433222221110  0000000   0       00112345678999999999999999999999999


Q ss_pred             CcCcccccccCCCCCC
Q 038835          280 HPFSRVAFMFHHLSVP  295 (337)
Q Consensus       280 hp~~~~~~~~~~~~~~  295 (337)
                      ||||+..........+
T Consensus       334 hp~f~~~~~~~~~~~~  349 (373)
T 1q8y_A          334 HPWLKDTLGMEEIRVP  349 (373)
T ss_dssp             CGGGTTCTTCTTCCCT
T ss_pred             ChhhhcccCcccccCc
Confidence            9999976544443333

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.1e-50  Score=354.24  Aligned_cols=256  Identities=25%  Similarity=0.471  Sum_probs=207.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++...... ......+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            5799999999999999999999999999999998765332 233456899999999999999999999999999999999


Q ss_pred             cCCCHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCccc
Q 038835           82 MECNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~-~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~~~  158 (337)
                      ++++.+..+ ......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++..... .......
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  177 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF  177 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence            998665544 4445669999999999999999999999999999999999999866 999999998753221 1112345


Q ss_pred             cccccccCchhhc----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          159 VSTRWYRAPEVLL----QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       159 ~gt~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      .||+.|+|||++.    ....++.++|||||||++|+|++|.+||...+..+....+......                 
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  240 (302)
T 2j7t_A          178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP-----------------  240 (302)
T ss_dssp             -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------------
T ss_pred             cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc-----------------
Confidence            7999999999984    3446789999999999999999999999988776665554332110                 


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                          .      ......++.++.++|.+||+.||.+|||++++++||||+.
T Consensus       241 ----~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          241 ----T------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             ----C------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             ----c------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence                0      0112356789999999999999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=350.62  Aligned_cols=254  Identities=27%  Similarity=0.479  Sum_probs=208.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|.+.....   .....+|+.+++.++||||+++++++...+..++||||
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            579999999999999999999999999999999976432   23456899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           82 MECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        82 ~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      ++++.+ +.+......+++..++.++.||+.||.|||++|++|+||||+||+++.+ .+||+|||.+...... ......
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence            998544 4544456679999999999999999999999999999999999999876 9999999999766443 223456


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      .||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+.......+.....                     +
T Consensus       186 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------~  243 (314)
T 3com_A          186 IGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP---------------------P  243 (314)
T ss_dssp             CSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------------------C
T ss_pred             CCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC---------------------c
Confidence            899999999998765 679999999999999999999999988776554443322100                     0


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .      ......++.++.++|.+||..||.+|||+.++++||||+..
T Consensus       244 ~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          244 T------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             C------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             c------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            0      00123467899999999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-49  Score=351.09  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=205.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.......  ......+|+.++++++||||+++++++.+++..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            58999999999999999999999999999999986544332  2334568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ||++|+.+..+.....++++..++.++.||+.||+|||++|++||||||+||+++.+ .+||+|||++.......  ...
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  170 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN  170 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccC
Confidence            999986665555555669999999999999999999999999999999999999876 99999999998765432  223


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ...||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.........                     
T Consensus       171 ~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~---------------------  228 (294)
T 4eqm_A          171 HVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS---------------------  228 (294)
T ss_dssp             ----CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC---------------------
T ss_pred             ccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc---------------------
Confidence            46799999999998765 67999999999999999999999999887665543332110                     


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                      .+    .......+.+++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus       229 ~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          229 VP----NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             CC----CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             CC----CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            00    011122356789999999999999999999666666665543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-51  Score=376.17  Aligned_cols=246  Identities=16%  Similarity=0.184  Sum_probs=195.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHH---HHHhcCCCCCcccce-------eEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREV---KSLRKMSHPNIVKLK-------EVI   69 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~   69 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......  .....+.+|+   +.++.++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            5799999999999999999999999999999999754222  2334456899   455566899999998       666


Q ss_pred             eeCC-----------------EEEEEEeecCCCHHHHHhhccCCCC-------HHHHHHHHHHHHHHHHHHHHcCccccC
Q 038835           70 REND-----------------ILYFVFEYMECNLYQLMKDREKCFS-------EAEVRNWCFQVFQGLAYMHQRGYFHRD  125 (337)
Q Consensus        70 ~~~~-----------------~~~lv~e~~~~~l~~~~~~~~~~l~-------~~~~~~~~~qil~al~~LH~~~i~H~d  125 (337)
                      ++.+                 ..|+||||++|++.+.+..... ++       +..++.++.||+.||+|||++||+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            6553                 2899999998888777765432 44       488889999999999999999999999


Q ss_pred             CCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccccCchhhcCc----------CCCCCcchHHHHHHHHHHHHh
Q 038835          126 LKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS----------YLYSSKVDMWAMGAIMAELIT  194 (337)
Q Consensus       126 ikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~  194 (337)
                      |||+|||++.+ .+||+|||+|...+.  .....+| +.|+|||++.+.          ..++.++|||||||++|+|++
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt  308 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC  308 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence            99999999876 999999999986543  2345677 999999998765          268999999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCH
Q 038835          195 LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTA  274 (337)
Q Consensus       195 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  274 (337)
                      |+.||.+.+..+....+                                  ....+.+++++.++|.+||+.||.+|||+
T Consensus       309 g~~Pf~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          309 ADLPITKDAALGGSEWI----------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             SSCCC------CCSGGG----------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             CCCCCcccccccchhhh----------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            99999765432111100                                  01124678999999999999999999999


Q ss_pred             HHHhcCcCccc
Q 038835          275 AEALQHPFSRV  285 (337)
Q Consensus       275 ~ell~hp~~~~  285 (337)
                      .|+++||||+.
T Consensus       355 ~e~l~hp~f~~  365 (377)
T 3byv_A          355 LQAMETPEYEQ  365 (377)
T ss_dssp             HHHHTSHHHHH
T ss_pred             HHHhhChHHHH
Confidence            99999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=352.24  Aligned_cols=259  Identities=23%  Similarity=0.344  Sum_probs=194.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHH-HHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++............ .++..+++.++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            46899999999999999999999999999999999765443333333 34555678889999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ||+++.+..........+++..++.++.||+.||.|||++ |++||||||+||+++.+ .+||+|||.+...........
T Consensus       104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  183 (318)
T 2dyl_A          104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR  183 (318)
T ss_dssp             CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccc
Confidence            9996545444444456799999999999999999999996 99999999999999876 999999999987655544456


Q ss_pred             ccccccccCchhhc----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          158 YVSTRWYRAPEVLL----QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE-ADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       158 ~~gt~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ..||+.|+|||++.    ....++.++|||||||++|+|++|..||..... .+....+....                 
T Consensus       184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------  246 (318)
T 2dyl_A          184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-----------------  246 (318)
T ss_dssp             ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-----------------
T ss_pred             cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-----------------
Confidence            78999999999985    234678999999999999999999999987443 33333332210                 


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                          .+.      ......+++++.++|.+||+.||.+|||++++++||||+..
T Consensus       247 ----~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          247 ----PPL------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             ----CCC------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             ----CCC------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence                000      00113578999999999999999999999999999999853

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-49  Score=348.15  Aligned_cols=256  Identities=28%  Similarity=0.459  Sum_probs=211.2

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEe--eCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIR--ENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~l   77 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|.+........ .....+|+.++++++||||+++++++.  .+...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            3789999999999999999999999999999999986654433 344568999999999999999999874  4678999


Q ss_pred             EEeecCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           78 VFEYMEC-NLYQLMKDR---EKCFSEAEVRNWCFQVFQGLAYMHQRG-----YFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        78 v~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~qil~al~~LH~~~-----i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      ||||+++ ++.+.+...   ...+++..++.++.||+.||.|||++|     ++||||||+||+++.+ .+||+|||.+.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            9999987 455555432   235899999999999999999999999     9999999999999876 89999999998


Q ss_pred             cCCCCCC-CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          148 EINSRPP-FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       148 ~~~~~~~-~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      ....... .....||+.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+....+.....          
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----------  233 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----------  233 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------
T ss_pred             eeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----------
Confidence            7654322 2345789999999998765 679999999999999999999999998877666555543211          


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                 +        ......+.++.++|.+||+.||.+|||++|+++|||+...
T Consensus       234 -----------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 -----------R--------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             -----------C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             -----------c--------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                       1        1123578999999999999999999999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-50  Score=363.58  Aligned_cols=258  Identities=26%  Similarity=0.384  Sum_probs=205.9

Q ss_pred             cCceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCC---hHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYS---WEECVNLREVKSLRKM-SHPNIVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   74 (337)
                      ++|++++.||+|+||.||+|.+.   .+|+.||+|++......   .......+|+.+++.+ .||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            68999999999999999999984   58999999998754321   1122334799999999 79999999999999999


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-  152 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-  152 (337)
                      .++||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...... 
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  213 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE  213 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence            99999999986555554445569999999999999999999999999999999999999876 9999999999765432 


Q ss_pred             -CCCccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          153 -PPFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       153 -~~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                       ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+....               
T Consensus       214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  278 (355)
T 1vzo_A          214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---------------  278 (355)
T ss_dssp             GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---------------
T ss_pred             CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH---------------
Confidence             222446899999999998753 357899999999999999999999997654322222221110               


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                        .. ..+        ...+.++..+.++|.+||..||.+||     |++|+++||||+.
T Consensus       279 --~~-~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          279 --LK-SEP--------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             --HH-CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             --hc-cCC--------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence              00 000        11246788999999999999999999     9999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.2e-49  Score=354.19  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=189.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHH-HHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVK-SLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++..............|+. +++.++||||+++++++..++..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            689999999999999999999999999999999976544333344455655 7777899999999999999999999999


Q ss_pred             ecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           81 YMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQR-GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        81 ~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~-~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      |+++++.+.+..    ....+++..++.++.|++.||.|||++ |++||||||+||+++.+ .+||+|||++........
T Consensus       102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  181 (327)
T 3aln_A          102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA  181 (327)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence            999987766653    245689999999999999999999999 99999999999999876 999999999987765544


Q ss_pred             CccccccccccCchhhc---CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 FTEYVSTRWYRAPEVLL---QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      .....||+.|+|||++.   .+..++.++|||||||++|+|++|..||.+......  .+...                 
T Consensus       182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~-----------------  242 (327)
T 3aln_A          182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQV-----------------  242 (327)
T ss_dssp             ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC-----------------
T ss_pred             cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHH-----------------
Confidence            45568999999999984   233678999999999999999999999976543110  00000                 


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                       .....+.    .........++++.++|.+||+.||.+|||+.++++||||...
T Consensus       243 -~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          243 -VKGDPPQ----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             -CCSCCCC----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -hcCCCCC----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence             0000000    1111234678999999999999999999999999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.7e-50  Score=360.51  Aligned_cols=270  Identities=19%  Similarity=0.314  Sum_probs=212.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH----------------hHHHHHHHHHhcCCCCCcccc
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE----------------CVNLREVKSLRKMSHPNIVKL   65 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~----------------~~~~~e~~~l~~l~h~~iv~~   65 (337)
                      ++|++++.||+|+||.||+|.+  +|+.||+|++.........                ....+|+.++++++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            6899999999999999999998  8999999998764332111                455789999999999999999


Q ss_pred             eeEEeeCCEEEEEEeecCCCHHHHH------hhc--cCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC
Q 038835           66 KEVIRENDILYFVFEYMECNLYQLM------KDR--EKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD  136 (337)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~~~l~~~~------~~~--~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~  136 (337)
                      ++++.+.+..++||||++++.+..+      ...  ...+++..++.++.||+.||.|||+ +|++||||||+||+++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            9999999999999999998655443      333  5679999999999999999999999 999999999999999876


Q ss_pred             -cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHH
Q 038835          137 -TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSS-KVDMWAMGAIMAELITLRPLFPGTSE-ADEIYKICS  213 (337)
Q Consensus       137 -~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~  213 (337)
                       .+||+|||.+...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||.+... .+....+..
T Consensus       189 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~  267 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT  267 (348)
T ss_dssp             SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred             CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence             9999999999876443 3355689999999999876645555 99999999999999999999998777 555544432


Q ss_pred             HhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .....+... ..          ..............+..+.++.++|.+||+.||.+|||++|+++||||+.
T Consensus       268 ~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          268 KNIEYPLDR-NH----------FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             CCCCCCCSS-SS----------STTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cCcCCccch-hh----------hhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            211111000 00          00000011111223578899999999999999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-49  Score=350.89  Aligned_cols=255  Identities=26%  Similarity=0.462  Sum_probs=203.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEee------CCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRE------NDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~   74 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++......  .....+|+.+++++ +||||+++++++..      .+.
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            5899999999999999999999999999999998754332  33456899999998 89999999999976      568


Q ss_pred             EEEEEeecCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC
Q 038835           75 LYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS  151 (337)
Q Consensus        75 ~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~  151 (337)
                      .++||||++++ +.+.+... ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence            99999999985 55554432 3569999999999999999999999999999999999999876 999999999887653


Q ss_pred             C-CCCccccccccccCchhhcC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          152 R-PPFTEYVSTRWYRAPEVLLQ----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       152 ~-~~~~~~~gt~~~~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      . .......||+.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+..+....+....           
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  250 (326)
T 2x7f_A          182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-----------  250 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred             CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------
Confidence            3 22345689999999999863    3467899999999999999999999998877665544432210           


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                .+.       .....++..+.++|.+||..||.+|||++++++||||+..
T Consensus       251 ----------~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          251 ----------APR-------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ----------CCC-------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ----------ccc-------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                      010       1124578999999999999999999999999999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.9e-50  Score=363.67  Aligned_cols=258  Identities=15%  Similarity=0.155  Sum_probs=191.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHH---HHHhcCCCCCcccce-------eEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREV---KSLRKMSHPNIVKLK-------EVIR   70 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~   70 (337)
                      +|++++.||+|+||.||+|.++.+|+.||+|++.......  ......+|+   ..++. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            5999999999999999999999999999999998765432  222334664   55555 799987754       4544


Q ss_pred             eC-----------------CEEEEEEeecCCCHHHHHhhccCCCCHHHH------HHHHHHHHHHHHHHHHcCccccCCC
Q 038835           71 EN-----------------DILYFVFEYMECNLYQLMKDREKCFSEAEV------RNWCFQVFQGLAYMHQRGYFHRDLK  127 (337)
Q Consensus        71 ~~-----------------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~------~~~~~qil~al~~LH~~~i~H~dik  127 (337)
                      ..                 ...|+||||+++++.+.+...+..+++..+      ..++.||+.||+|||++||+|||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence            32                 348999999998888888765555666666      6778999999999999999999999


Q ss_pred             CCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 038835          128 PENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEA  205 (337)
Q Consensus       128 p~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  205 (337)
                      |+|||++.+ .+||+|||+|...+...  ....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+....
T Consensus       222 p~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~  299 (371)
T 3q60_A          222 PDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG  299 (371)
T ss_dssp             GGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTT
T ss_pred             HHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcc
Confidence            999999886 99999999998765432  245677999999999752 36899999999999999999999999876432


Q ss_pred             HHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCC-CCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          206 DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQL-VGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       206 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                      ..             ..|..         ...... .........+.+++++.++|.+||+.||.+|||+.++|+||||+
T Consensus       300 ~~-------------~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          300 IK-------------GSWKR---------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             CT-------------TCCCB---------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             cc-------------cchhh---------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            00             00000         000000 00011112357899999999999999999999999999999998


Q ss_pred             c
Q 038835          285 V  285 (337)
Q Consensus       285 ~  285 (337)
                      .
T Consensus       358 ~  358 (371)
T 3q60_A          358 Q  358 (371)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=352.39  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcE---EEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEV---VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~---vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.++.+|+.   ||+|++...........+.+|+.++++++||||+++++++.+++..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            5799999999999999999999866554   9999998655444455667899999999999999999999999999999


Q ss_pred             EeecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |||++++.+ +.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++........  
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  208 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA  208 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence            999987554 5554555679999999999999999999999999999999999999876 999999999987654321  


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......+             
T Consensus       209 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  274 (325)
T 3kul_A          209 YTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-------------  274 (325)
T ss_dssp             EECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-------------
T ss_pred             eeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-------------
Confidence              1234567889999998755 67999999999999999999 999999988877666554321111             


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                      .....++++.++|.+||..||.+|||+.++++.
T Consensus       275 ----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          275 ----------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             ----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            124578999999999999999999999999873

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-48  Score=346.68  Aligned_cols=252  Identities=28%  Similarity=0.411  Sum_probs=200.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++.+.||+|+||.||+|.+  +|+.||+|++........ .....+|+.++++++||||+++++++.+.+..++|||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            5899999999999999999976  588999999987654433 3345689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-
Q 038835           81 YMECNLYQLMKDREK---CFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-  153 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-  153 (337)
                      |++++.+..+.....   .+++..++.++.||+.||+|||++|  ++||||||+||+++.+ .+||+|||++....... 
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~  194 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL  194 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence            999865554444332   3899999999999999999999999  9999999999999987 99999999997654332 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......                
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------  257 (309)
T 3p86_A          195 SSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR----------------  257 (309)
T ss_dssp             -------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----------------
T ss_pred             ccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Confidence            23456899999999998765 6799999999999999999999999988776665544321111                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CcCcc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ--HPFSR  284 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~  284 (337)
                                  ......+++++.++|.+||+.||.+|||++++++  .++++
T Consensus       258 ------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          258 ------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                        1122467899999999999999999999999987  45544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=360.10  Aligned_cols=253  Identities=21%  Similarity=0.322  Sum_probs=208.9

Q ss_pred             cCceEeeeecccCceEEEEEE-----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAI-----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.     +..+++.||+|++.............+|+.++++++||||+++++++.+.+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            579999999999999999999     556788999999976544444555678999999999999999999999999999


Q ss_pred             EEEeecCC-CHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCC
Q 038835           77 FVFEYMEC-NLYQLMKDRE------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGL  145 (337)
Q Consensus        77 lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~  145 (337)
                      +||||+++ ++.+.+....      ..+++..++.++.||+.||+|||++||+||||||+|||++.+    .+||+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            99999987 4555554432      358999999999999999999999999999999999999843    599999999


Q ss_pred             cccCC---CCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREIN---SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~---~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +....   .........||+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+......    
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~----  305 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM----  305 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            97442   12223456789999999998765 68999999999999999998 99999998877766655432111    


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                               ......+.++.++|.+||+.||.+|||+.+++++.++.
T Consensus       306 -------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          306 -------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                     11245678999999999999999999999999997754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.8e-49  Score=356.35  Aligned_cols=249  Identities=25%  Similarity=0.411  Sum_probs=205.7

Q ss_pred             cCceEeeeecccCceEEEEEEEC-------CCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-------QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|++++.||+|+||.||+|.+.       .++..||+|++.............+|+.+++.+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            57999999999999999999874       356679999998764444445567899999999 8999999999999999


Q ss_pred             EEEEEEeecCCC-HHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           74 ILYFVFEYMECN-LYQLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~-l~~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      .+|+||||++++ +.+.+....               ..+++..++.++.||+.||+|||++||+||||||+|||++.+ 
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            999999999975 444444332               247999999999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~  319 (370)
T 2psq_A          241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  319 (370)
T ss_dssp             CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence            999999999986654322   2345678899999998765 68999999999999999999 999999887766554443


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ....                             ...+...+.++.++|.+||+.||.+|||+.|++++
T Consensus       320 ~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          320 EGHR-----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2210                             01124567899999999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=341.88  Aligned_cols=256  Identities=23%  Similarity=0.359  Sum_probs=203.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeec
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      +|.....||+|+||.||+|.+..+++.||+|.+..... .......+|+.+++.++||||+++++++...+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            44555689999999999999999999999999876532 22344568999999999999999999999999999999999


Q ss_pred             CCCHHH-HHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-C-cEEEeeCCCcccCCCCC-CCc
Q 038835           83 ECNLYQ-LMKDRE--KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-D-TIKIADFGLAREINSRP-PFT  156 (337)
Q Consensus        83 ~~~l~~-~~~~~~--~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-~-~~kL~Dfg~a~~~~~~~-~~~  156 (337)
                      +++.+. .+....  ..+++..++.++.||+.||.|||++|++||||||+||+++. + .+||+|||.+....... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence            875554 444332  34679999999999999999999999999999999999986 3 99999999998765432 234


Q ss_pred             cccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...||+.|+|||++.+. ..++.++||||||+++|+|++|..||.+..............                    
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------------------  241 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--------------------  241 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--------------------
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--------------------
Confidence            56899999999998654 237889999999999999999999997654433211111110                    


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ...       .......++++.++|.+||+.||.+|||++++++||||+..
T Consensus       242 ~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          242 KVH-------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             CCC-------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             ccc-------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            000       01224678999999999999999999999999999999853

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-48  Score=343.43  Aligned_cols=249  Identities=24%  Similarity=0.414  Sum_probs=201.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|.+++.||+|+||.||+|.++.+|+.||+|++.... ........+|+.++++++||||+++++++.+++..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            68999999999999999999999999999999885432 22344557899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC----
Q 038835           82 MECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF----  155 (337)
Q Consensus        82 ~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~----  155 (337)
                      ++++.+ +.+......+++..+..++.||+.||+|||++|++||||||+||+++.+ .+||+|||.+.........    
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence            988555 4554446679999999999999999999999999999999999999887 8999999999765432211    


Q ss_pred             -----------ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchh
Q 038835          156 -----------TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       156 -----------~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  224 (337)
                                 ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||.........            ..  
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------------~~--  233 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------------FG--  233 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------------SS--
T ss_pred             ccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------------Hh--
Confidence                       256899999999998765 7899999999999999999999998654321100            00  


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                        .........           ...+..++++.++|.+||+.||.+|||++++++
T Consensus       234 --~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          234 --LNVRGFLDR-----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             --BCHHHHHHH-----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --hhhhccccc-----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              000000000           112467889999999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.7e-49  Score=349.73  Aligned_cols=255  Identities=25%  Similarity=0.362  Sum_probs=188.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc---EEEEEEcccccCC-hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEE--
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYS-WEECVNLREVKSLRKMSHPNIVKLKEVIRENDIL--   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--   75 (337)
                      ++|++++.||+|+||.||+|.++.++.   .||+|++...... .......+|+.++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            579999999999999999999887775   7999999765432 3344557899999999999999999999776554  


Q ss_pred             ----EEEEeecCCCHHHHHh-hcc-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCC
Q 038835           76 ----YFVFEYMECNLYQLMK-DRE-----KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFG  144 (337)
Q Consensus        76 ----~lv~e~~~~~l~~~~~-~~~-----~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg  144 (337)
                          ++||||++++.+..+. ...     ..+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg  182 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG  182 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence                9999999985554443 221     258999999999999999999999999999999999999987 99999999


Q ss_pred             CcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCc
Q 038835          145 LAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQ  220 (337)
Q Consensus       145 ~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~  220 (337)
                      ++........   .....+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....    
T Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----  257 (323)
T 3qup_A          183 LSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR----  257 (323)
T ss_dssp             C-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred             ccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC----
Confidence            9986644322   2345577899999998765 68999999999999999999 9999998887766655433210    


Q ss_pred             cchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-------HHHHhcCcCcccc
Q 038835          221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-------AAEALQHPFSRVA  286 (337)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~ell~hp~~~~~  286 (337)
                                               ....+..++++.++|.+||+.||.+|||       ++++++|||+...
T Consensus       258 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          258 -------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             -------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                                     0112467899999999999999999999       7888999998763

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.6e-49  Score=353.45  Aligned_cols=261  Identities=27%  Similarity=0.439  Sum_probs=181.4

Q ss_pred             cCceEee-eecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee----CCEEE
Q 038835            2 ERYKLIK-EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE----NDILY   76 (337)
Q Consensus         2 ~~y~~~~-~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~   76 (337)
                      ++|.+.+ .||+|+||.||+|.++.+|+.||+|++....     .........++.++||||+++++++..    +...+
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            6899965 5999999999999999999999999986531     111233344667799999999999876    45689


Q ss_pred             EEEeecCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCC
Q 038835           77 FVFEYMEC-NLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREIN  150 (337)
Q Consensus        77 lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~  150 (337)
                      +||||++| ++.+.+.... ..+++..++.++.||+.||.|||++|++||||||+||+++.+    .+||+|||++....
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            99999988 5555555443 369999999999999999999999999999999999999753    59999999998665


Q ss_pred             CCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          151 SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       151 ~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      .. ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+...............              
T Consensus       183 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  246 (336)
T 3fhr_A          183 QN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR--------------  246 (336)
T ss_dssp             ----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred             cc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh--------------
Confidence            33 23456889999999998654 678899999999999999999999977655433211111000              


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH  291 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  291 (337)
                       .....++       ...+..+++++.++|.+||+.||.+|||++|+++||||+.......
T Consensus       247 -~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  299 (336)
T 3fhr_A          247 -LGQYGFP-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ  299 (336)
T ss_dssp             -----CCC-------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred             -ccccccC-------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence             0000011       1123467899999999999999999999999999999987654443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-48  Score=344.30  Aligned_cols=253  Identities=31%  Similarity=0.477  Sum_probs=197.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee----------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE----------   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------   71 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....  .......+|+.++++++||||+++++++.+          
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            57999999999999999999999999999999996532  223445689999999999999999998754          


Q ss_pred             ---CCEEEEEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           72 ---NDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        72 ---~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                         .+..++||||+++ ++.+.+...+..+++..++.++.||+.||+|||++|++||||||+||+++.+ .+||+|||.+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  163 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA  163 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence               4678999999987 5555555555568899999999999999999999999999999999999876 8999999998


Q ss_pred             ccCCCC---------------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHH
Q 038835          147 REINSR---------------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE-ADEIYK  210 (337)
Q Consensus       147 ~~~~~~---------------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~  210 (337)
                      ......               .......||+.|+|||++.+...++.++|||||||++|+|++   ||..... .+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~  240 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK  240 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence            765421               223456799999999998766578999999999999999998   5543222 222222


Q ss_pred             HHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          211 ICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       211 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      +...                   ...++       .......+..+.++|.+||+.||.+|||++++++||||+.
T Consensus       241 ~~~~-------------------~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          241 LRSV-------------------SIEFP-------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHST-------------------TCCCC-------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             cccc-------------------ccccC-------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            2111                   01111       1122456788999999999999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.8e-49  Score=351.72  Aligned_cols=247  Identities=25%  Similarity=0.421  Sum_probs=205.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcCC--CCCcccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKMS--HPNIVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~   74 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......     ......+|+.++++++  ||||+++++++...+.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            58999999999999999999999999999999997654332     1122357999999995  5999999999999999


Q ss_pred             EEEEEeecCC--CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee-CC-cEEEeeCCCcccCC
Q 038835           75 LYFVFEYMEC--NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KD-TIKIADFGLAREIN  150 (337)
Q Consensus        75 ~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~-~~-~~kL~Dfg~a~~~~  150 (337)
                      .++|||++.+  ++.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .+ .+||+|||++....
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  201 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence            9999999984  55555544 45699999999999999999999999999999999999998 43 99999999998765


Q ss_pred             CCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          151 SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       151 ~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                      .. ......||+.|+|||++.+...++.++|||||||++|+|++|..||.....      +...  .             
T Consensus       202 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~-------------  259 (320)
T 3a99_A          202 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q-------------  259 (320)
T ss_dssp             SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C-------------
T ss_pred             cc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c-------------
Confidence            43 234567999999999987665557889999999999999999999965321      1100  0             


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                          .           .....+++++.++|.+||+.||.+|||++|+++||||++.
T Consensus       260 ----~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          260 ----V-----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             ----C-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ----c-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence                0           0124678999999999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-48  Score=337.50  Aligned_cols=246  Identities=27%  Similarity=0.435  Sum_probs=207.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.+. +++.||+|++......  .....+|+.++++++||||+++++++.+++..++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            58999999999999999999987 4778999999876544  33457899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCcc
Q 038835           82 MECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTE  157 (337)
Q Consensus        82 ~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~  157 (337)
                      ++++.+ +.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||++.......  ....
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence            987644 5554556679999999999999999999999999999999999999876 89999999998654321  2234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+|+.|+|||++.+. .++.++||||+|+++|+|++ |.+||.+....+....+......                   
T Consensus       167 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  226 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------------  226 (269)
T ss_dssp             TTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------------
T ss_pred             cccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-------------------
Confidence            5678889999998755 68999999999999999999 99999988877766655432111                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                ......++++.++|.+||+.||.+|||+.+++++
T Consensus       227 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 ----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                      1123467899999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.8e-49  Score=354.35  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=203.8

Q ss_pred             cCceEeeeecccCceEEEEEE-----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC-E
Q 038835            2 ERYKLIKEVGDGTFGSVWRAI-----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND-I   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~   74 (337)
                      ++|++++.||+|+||.||+|.     +..+++.||+|++.............+|+.+++++ +||||+++++++...+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            689999999999999999998     56678999999998765444445567899999999 7899999999987654 4


Q ss_pred             EEEEEeecCCCHHHHHhhccC-----------------------------------------------------------
Q 038835           75 LYFVFEYMECNLYQLMKDREK-----------------------------------------------------------   95 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~-----------------------------------------------------------   95 (337)
                      .++||||++++.+..+.....                                                           
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            899999999855444433221                                                           


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC---Cccccccccc
Q 038835           96 -------CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---FTEYVSTRWY  164 (337)
Q Consensus        96 -------~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~  164 (337)
                             .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++........   .....||+.|
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y  261 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  261 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence                   18999999999999999999999999999999999999876 999999999986643322   2446788999


Q ss_pred             cCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCC
Q 038835          165 RAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGV  243 (337)
Q Consensus       165 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
                      +|||++.+. .++.++|||||||++|+|++ |.+||.+....+...........+                         
T Consensus       262 ~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------  315 (359)
T 3vhe_A          262 MAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-------------------------  315 (359)
T ss_dssp             CCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-------------------------
T ss_pred             EChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-------------------------
Confidence            999998765 68999999999999999998 999998877655444433321111                         


Q ss_pred             cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          244 PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       244 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                         ......++++.++|.+||+.||.+|||++|+++|
T Consensus       316 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence               1124567899999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.3e-48  Score=340.09  Aligned_cols=250  Identities=18%  Similarity=0.213  Sum_probs=206.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.....   .....+|+..++.+ +|+|++++++++..+...++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            579999999999999999999999999999999865432   23346899999999 89999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC------cEEEeeCCCcccCCCCC-
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD------TIKIADFGLAREINSRP-  153 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~------~~kL~Dfg~a~~~~~~~-  153 (337)
                      |+++++.+.+...+..+++..++.++.||+.||+|||++|++||||||+||+++.+      .+||+|||++....... 
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~  166 (298)
T 1csn_A           87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  166 (298)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence            99667777776666679999999999999999999999999999999999999764      39999999998664332 


Q ss_pred             -------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCccch
Q 038835          154 -------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE---ADEIYKICSVIGTPTQDSW  223 (337)
Q Consensus       154 -------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~  223 (337)
                             ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...   .+....+......+     
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  240 (298)
T 1csn_A          167 KQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-----  240 (298)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-----
T ss_pred             cccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-----
Confidence                   23456799999999998765 679999999999999999999999988543   23333332221000     


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                          +.....+.+++++.++|.+||+.||.+|||++++++.
T Consensus       241 --------------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          241 --------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             --------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             --------------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                                1112224678999999999999999999999999873

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-48  Score=347.58  Aligned_cols=248  Identities=21%  Similarity=0.240  Sum_probs=202.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.....   .....+|+.+++++ +||||+++++++..++..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            579999999999999999999999999999999875432   22356899999999 99999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-c-----EEEeeCCCcccCCCCCC
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-T-----IKIADFGLAREINSRPP  154 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~-----~kL~Dfg~a~~~~~~~~  154 (337)
                      |+++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .     +||+|||++........
T Consensus        86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~  165 (330)
T 2izr_A           86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET  165 (330)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred             eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence            99667777776656679999999999999999999999999999999999999875 4     99999999986543221


Q ss_pred             --------CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCccch
Q 038835          155 --------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE---IYKICSVIGTPTQDSW  223 (337)
Q Consensus       155 --------~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~  223 (337)
                              ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.   ...+.......+    
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~----  240 (330)
T 2izr_A          166 KKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP----  240 (330)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC----
T ss_pred             CccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC----
Confidence                    2467899999999998765 689999999999999999999999988554332   333322110000    


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                           ........+ ++.++|..||+.||.+||+++++++
T Consensus       241 ---------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          241 ---------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             ---------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ---------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                                 001112234 8999999999999999999998865

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.3e-48  Score=342.73  Aligned_cols=255  Identities=22%  Similarity=0.377  Sum_probs=202.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCC--CCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMS--HPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++++.||+|+||.||+|.+. +|+.||+|++....... ......+|+.++++++  ||||+++++++.+++..++|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            47999999999999999999986 58899999997654443 2344568999999996  59999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCCC---C
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPP---F  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~~---~  155 (337)
                      ||+.++++.+.+... ..+++..++.++.||+.||.|||++|++||||||+||+++++.+||+|||++........   .
T Consensus       107 ~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~  185 (313)
T 3cek_A          107 MECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK  185 (313)
T ss_dssp             ECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC----------
T ss_pred             EecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccc
Confidence            997767777776654 468999999999999999999999999999999999999988999999999987654321   2


Q ss_pred             ccccccccccCchhhcC----------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCccchh
Q 038835          156 TEYVSTRWYRAPEVLLQ----------SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEAD-EIYKICSVIGTPTQDSWA  224 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  224 (337)
                      ....||+.|+|||++.+          ...++.++|||||||++|+|++|..||....... ....+..   ..      
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~------  256 (313)
T 3cek_A          186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---PN------  256 (313)
T ss_dssp             ----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---TT------
T ss_pred             cCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh---cc------
Confidence            34679999999999864          1357889999999999999999999997765432 1111110   00      


Q ss_pred             hhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          225 DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                                  .       ........+.++.++|.+||+.||.+|||++|+++||||+..
T Consensus       257 ------------~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          257 ------------H-------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             ------------S-------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             ------------c-------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence                        0       001123457889999999999999999999999999999863

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.9e-48  Score=345.90  Aligned_cols=249  Identities=23%  Similarity=0.422  Sum_probs=205.6

Q ss_pred             cCceEeeeecccCceEEEEEEE-----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|.+++.||+|+||.||+|.+     +.+++.||+|++.............+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            5799999999999999999987     34568899999986544344455678999999999999999999999999999


Q ss_pred             EEEeecCCCHH-HHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCee
Q 038835           77 FVFEYMECNLY-QLMKDRE-----------------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLL  132 (337)
Q Consensus        77 lv~e~~~~~l~-~~~~~~~-----------------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nil  132 (337)
                      +||||++++.+ +.+....                       ..+++..++.++.||+.||.|||++|++||||||+||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            99999996544 4444321                       23899999999999999999999999999999999999


Q ss_pred             eeCC-cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 038835          133 VSKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADE  207 (337)
Q Consensus       133 i~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  207 (337)
                      ++.+ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  261 (314)
T 2ivs_A          183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL  261 (314)
T ss_dssp             EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9976 899999999986644322   2345678899999998765 67999999999999999999 9999988777655


Q ss_pred             HHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       208 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...+.....                             .......++++.++|.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          262 FNLLKTGHR-----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcCCc-----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            544332110                             01124678999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-48  Score=355.46  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++...........+.+|+.++++++||||+++++++..++..++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            57999999999999999999999999999999987653333334456899999999999999999999999999999999


Q ss_pred             cCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC---c
Q 038835           82 MEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF---T  156 (337)
Q Consensus        82 ~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~---~  156 (337)
                      +++ ++.+.+...+..+++..+..++.||+.||+|||++|++||||||+|||++.+ .+||+|||++.........   .
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~  273 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG  273 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence            986 5556665555569999999999999999999999999999999999999876 9999999999865432111   1


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......                  
T Consensus       274 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------  334 (377)
T 3cbl_A          274 LRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL------------------  334 (377)
T ss_dssp             CCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC------------------
T ss_pred             CCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence            23457789999998765 67999999999999999998 99999988776655444321100                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 ..+...++++.++|.+||+.||.+|||++++++
T Consensus       335 -----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 -----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                       012346789999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.8e-48  Score=335.35  Aligned_cols=246  Identities=28%  Similarity=0.426  Sum_probs=206.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++ ++..||+|++......  .....+|+.++++++||||+++++++.+++..++||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            68999999999999999999876 5678999999876544  33457899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--Ccc
Q 038835           82 MECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FTE  157 (337)
Q Consensus        82 ~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~~~  157 (337)
                      ++++ +.+.+...+..+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+........  ...
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence            9876 555555555669999999999999999999999999999999999999876 999999999986654322  233


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+|+.|+|||++.+. .++.++||||+|+++|+|++ |.+||......+....+......                   
T Consensus       165 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  224 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------------------  224 (268)
T ss_dssp             CCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------------------
T ss_pred             CCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-------------------
Confidence            4567789999998765 67899999999999999998 99999988877666554332110                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                ......++++.++|.+||+.||.+|||+.+++++
T Consensus       225 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 ----------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ----------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      0113457899999999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-48  Score=349.94  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=206.0

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.++     .+++.||+|++.............+|+.++++++||||+++++++.+++..+
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            58999999999999999999987     4568999999986654444455678999999999999999999999999999


Q ss_pred             EEEeecCCCHH-HHHhhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCee
Q 038835           77 FVFEYMECNLY-QLMKDR-----------------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLL  132 (337)
Q Consensus        77 lv~e~~~~~l~-~~~~~~-----------------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nil  132 (337)
                      +||||++++.+ +.+...                       ...+++..++.++.||+.||.|||++|++||||||+||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            99999997544 444432                       156899999999999999999999999999999999999


Q ss_pred             eeCC-cEEEeeCCCcccCCCC---CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 038835          133 VSKD-TIKIADFGLAREINSR---PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADE  207 (337)
Q Consensus       133 i~~~-~~kL~Dfg~a~~~~~~---~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  207 (337)
                      ++.+ .+||+|||++......   .......||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  285 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  285 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence            9876 9999999998765332   122345789999999998765 68999999999999999999 9999998877666


Q ss_pred             HHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       208 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...+....                     .        ....+..+.++.++|.+||+.||.+|||+.+++++
T Consensus       286 ~~~~~~~~---------------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          286 IYYVRDGN---------------------I--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHTTC---------------------C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCC---------------------c--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            55543321                     0        01124578899999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-48  Score=352.35  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=207.5

Q ss_pred             cCceEeeeecccCceEEEEEEECC-------CCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|.+++.||+|+||.||+|.+..       ++..||+|++.............+|+.+++++ +||||+++++++..++
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            579999999999999999999754       34579999998764444445567899999999 9999999999999999


Q ss_pred             EEEEEEeecCCC-HHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           74 ILYFVFEYMECN-LYQLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~-l~~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ..++||||++++ +.+.+....               ..+++..++.++.||+.||.|||++||+||||||+|||++.+ 
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence            999999999875 445554432               348999999999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~  307 (382)
T 3tt0_A          229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  307 (382)
T ss_dssp             CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999998765432   23445678999999998765 68999999999999999999 999999887766655543


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .....                             ......++++.++|.+||+.||.+|||++|++++
T Consensus       308 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          308 EGHRM-----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             TTCCC-----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCC-----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32110                             1124578999999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.1e-48  Score=338.69  Aligned_cols=248  Identities=28%  Similarity=0.422  Sum_probs=194.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCC---CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++++.||+|+||.||+|.+..+   +..||+|.+.............+|+.++++++||||+++++++. ++..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            5899999999999999999998754   45699999876544334445678999999999999999999985 4568899


Q ss_pred             EeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |||++++ +.+.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||++........  
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK  173 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccc
Confidence            9999974 555555555579999999999999999999999999999999999999865 999999999987654322  


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+....+.....                 
T Consensus       174 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-----------------  235 (281)
T 1mp8_A          174 ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-----------------  235 (281)
T ss_dssp             -----CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----------------
T ss_pred             cccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-----------------
Confidence            2344677899999998755 68999999999999999996 9999998877766555432210                 


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                  ....+..++++.++|.+||+.||.+|||+.+++++
T Consensus       236 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 ------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        01124678999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.8e-48  Score=336.83  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=204.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||++.+. ++..||+|++......  .....+|+.++++++||||+++++++.+.+..++||||
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            58999999999999999999876 5778999999876544  33457899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCcc
Q 038835           82 MECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTE  157 (337)
Q Consensus        82 ~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~  157 (337)
                      ++++ +.+.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+.......  ....
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence            9875 555555545669999999999999999999999999999999999999876 99999999998654321  1234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+|+.|+|||++.+. .++.++||||+|+++|+|++ |.+||.+.+..+....+.......                  
T Consensus       181 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------  241 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------------  241 (283)
T ss_dssp             TTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC------------------
T ss_pred             CccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC------------------
Confidence            5678889999998765 67999999999999999998 999999888777666554321111                  


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                 .....++.+.++|.+||+.||.+|||++++++|
T Consensus       242 -----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          242 -----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                       113457899999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=346.91  Aligned_cols=248  Identities=25%  Similarity=0.424  Sum_probs=197.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcC----CCCCcccceeEEeeC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKM----SHPNIVKLKEVIREN   72 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~   72 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.......     ......+|+.+++++    +||||+++++++...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            57999999999999999999999999999999997654322     112224689999888    899999999999999


Q ss_pred             CEEEEEEee-cCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee-CC-cEEEeeCCCccc
Q 038835           73 DILYFVFEY-MECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS-KD-TIKIADFGLARE  148 (337)
Q Consensus        73 ~~~~lv~e~-~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~-~~-~~kL~Dfg~a~~  148 (337)
                      +..++|||+ +.++ +.+.+.. ...+++..++.++.||+.||.|||++|++||||||+||+++ .+ .+||+|||.+..
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~  189 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL  189 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred             CeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence            999999999 6654 5555544 45699999999999999999999999999999999999998 44 899999999987


Q ss_pred             CCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          149 INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       149 ~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      .... ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+...      +...              
T Consensus       190 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--------------  248 (312)
T 2iwi_A          190 LHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--------------  248 (312)
T ss_dssp             CCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--------------
T ss_pred             cccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--------------
Confidence            6543 335567999999999987664556689999999999999999999965311      1110              


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                           ..           .....++.++.++|.+||+.||.+|||++|+++||||+...
T Consensus       249 -----~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          249 -----EL-----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             -----CC-----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             -----cc-----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                 00           11245789999999999999999999999999999998643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.2e-48  Score=346.77  Aligned_cols=249  Identities=27%  Similarity=0.397  Sum_probs=202.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEE--EEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVV--AIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.++.+|..+  |+|.+.............+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999999988865  999887644444445567899999999 999999999999999999999


Q ss_pred             EeecCCC-HHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEe
Q 038835           79 FEYMECN-LYQLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIA  141 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~  141 (337)
                      |||++++ +.+.+....               ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~  184 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  184 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence            9999874 555554332               369999999999999999999999999999999999999876 99999


Q ss_pred             eCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCc
Q 038835          142 DFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQ  220 (337)
Q Consensus       142 Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~  220 (337)
                      |||++.............+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....    
T Consensus       185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~----  259 (327)
T 1fvr_A          185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR----  259 (327)
T ss_dssp             CTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC----
T ss_pred             ccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC----
Confidence            99999865444334456778899999998655 67899999999999999998 9999988877655444322100    


Q ss_pred             cchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                               .......++++.++|.+||+.||.+|||+++++++
T Consensus       260 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 -------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             -------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                     01123567899999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-47  Score=339.65  Aligned_cols=251  Identities=25%  Similarity=0.331  Sum_probs=196.2

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++........  .....+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            4789999999999999999999999999999999976543222  24456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CC
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PF  155 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~  155 (337)
                      |||++++.+..+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.......  ..
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  192 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL  192 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence            9999985555555555569999999999999999999999999999999999999876 99999999987665432  23


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ....||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+.......+ ..                     
T Consensus       193 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~---------------------  249 (309)
T 2h34_A          193 GNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQ---------------------  249 (309)
T ss_dssp             ----CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HS---------------------
T ss_pred             cccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-cc---------------------
Confidence            456799999999998765 6799999999999999999999999876544222221 11                     


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-CHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-TAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-t~~ell~  279 (337)
                      ..+     ......+.+++++.++|.+||+.||.+|| |++++++
T Consensus       250 ~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          250 AIP-----RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CCC-----CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCC-----CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            000     11122357889999999999999999999 8888875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=362.94  Aligned_cols=274  Identities=22%  Similarity=0.312  Sum_probs=207.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC--EEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND--ILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~   79 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            579999999999999999999999999999999986544333445568999999999999999999987654  789999


Q ss_pred             eecCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee----eCC-cEEEeeCCCcccCCC
Q 038835           80 EYMECNLYQLMKDRE---KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV----SKD-TIKIADFGLAREINS  151 (337)
Q Consensus        80 e~~~~~l~~~~~~~~---~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili----~~~-~~kL~Dfg~a~~~~~  151 (337)
                      ||++++.+..+....   ..+++..++.++.||+.||+|||++||+||||||+|||+    +.+ .+||+|||.+.....
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            999876555544332   238999999999999999999999999999999999998    444 799999999988766


Q ss_pred             CCCCccccccccccCchhhcCc-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCCCCc
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQS-------YLYSSKVDMWAMGAIMAELITLRPLFPGTS----EADEIYKICSVIGTPTQ  220 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~  220 (337)
                      ........||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||.+..    ..+.+..+...   .+.
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~p~  245 (396)
T 4eut_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG---KPS  245 (396)
T ss_dssp             GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS---CCT
T ss_pred             CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC---CCc
Confidence            6555677899999999998641       356789999999999999999999997533    33444444332   222


Q ss_pred             cchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..+...... ......+....+ ........++..+.++|.+||+.||++|||++|++++
T Consensus       246 ~~~~~~~~~-~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          246 GAISGVQKA-ENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TCCEEEECS-TTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             ccchhheec-cCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            211110000 000001111000 0111223456788999999999999999999998553

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.8e-48  Score=345.98  Aligned_cols=248  Identities=22%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcE----EEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEV----VAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.++.+|+.    ||+|.+.............+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            6899999999999999999999988876    67777654433222333458999999999999999999986 456889


Q ss_pred             EEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           78 VFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        78 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      ||||+.+ ++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.......  
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  171 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ  171 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence            9999986 4556665555669999999999999999999999999999999999999876 99999999998765432  


Q ss_pred             -CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          154 -PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       154 -~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                       ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......              
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------  236 (325)
T 3kex_A          172 LLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL--------------  236 (325)
T ss_dssp             CC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC--------------
T ss_pred             ccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC--------------
Confidence             22446778899999998765 68999999999999999999 99999987776655544322100              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                     ......+.++.++|.+||+.||.+|||+.+++++
T Consensus       237 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          237 ---------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ---------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ---------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           1113456789999999999999999999999886

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-48  Score=358.97  Aligned_cols=251  Identities=25%  Similarity=0.343  Sum_probs=196.3

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +|.+.+.||+|+||.|+. ....+|+.||||++......    ...+|+.+++.+ +||||+++++++.+.+..|+||||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            589999999999999763 34567999999998754322    235799999999 899999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC----C--cEEEeeCCCcccCCCC---
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK----D--TIKIADFGLAREINSR---  152 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~----~--~~kL~Dfg~a~~~~~~---  152 (337)
                      ++|++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.    +  .+||+|||+|......   
T Consensus       100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            999888888776666777778899999999999999999999999999999953    2  6889999999876533   


Q ss_pred             -CCCccccccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          153 -PPFTEYVSTRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       153 -~~~~~~~gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                       ......+||+.|+|||++.+  ...++.++|||||||++|+|++ |.+||...........    ......        
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~----~~~~~~--------  247 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL----LGACSL--------  247 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH----TTCCCC--------
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH----hccCCc--------
Confidence             22345689999999999874  3356789999999999999999 9999976554332211    111000        


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                               ..      .......+..+.+||.+||+.||.+|||++|+++||||..
T Consensus       248 ---------~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          248 ---------DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             ---------TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             ---------cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence                     00      0001223456899999999999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-47  Score=340.97  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=207.1

Q ss_pred             cCceEeeeecccCceEEEEEEE-----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|++++.||+|+||.||+|.+     ..+++.||+|++.............+|+.+++++ +||||+++++++..++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999984     4678899999998654434445567899999999 999999999999999999


Q ss_pred             EEEEeecCC-CHHHHHhhccC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           76 YFVFEYMEC-NLYQLMKDREK-----------------CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        76 ~lv~e~~~~-~l~~~~~~~~~-----------------~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ++||||+++ ++.+.+.....                 .+++..++.++.||+.||.|||++|++||||||+||+++.+ 
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            999999987 55555544332                 48999999999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+......
T Consensus       183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  261 (313)
T 1t46_A          183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI  261 (313)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred             CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence            899999999987655432   2345678899999998765 68999999999999999998 999998877655544443


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .....+                            ......+.++.++|.+||+.||.+|||+.|++++
T Consensus       262 ~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          262 KEGFRM----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCC----------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            321110                            0124568899999999999999999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.5e-47  Score=333.27  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=193.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh---HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW---EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      +++|++.+.||+|+||.||+|.+.  |+.||+|++.......   ......+|+.+++.++||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            478999999999999999999875  8899999987643322   12345689999999999999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCCeeeeC---------CcEEEeeCCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG---YFHRDLKPENLLVSK---------DTIKIADFGL  145 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~---i~H~dikp~Nili~~---------~~~kL~Dfg~  145 (337)
                      ||||++++.+..+... ..+++..++.++.|++.||.|||++|   ++||||||+||+++.         +.+||+|||.
T Consensus        84 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            9999998777666654 45999999999999999999999999   899999999999974         3799999999


Q ss_pred             cccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          146 AREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       146 a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      +........ ....||+.|+|||.+.+. .++.++||||+|+++|+|++|+.||.+.+.......+......        
T Consensus       163 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  232 (271)
T 3dtc_A          163 AREWHRTTK-MSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--------  232 (271)
T ss_dssp             --------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--------
T ss_pred             ccccccccc-cCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--------
Confidence            986654332 356899999999998765 6899999999999999999999999987766554443221000        


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                          .......++++.++|.+||+.||.+|||+.|++++
T Consensus       233 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 --------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                01124678899999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-48  Score=345.98  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=202.7

Q ss_pred             cCceEeeeecccCceEEEEEEE-----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|++++.||+|+||.||+|.+     ..++..||+|++.............+|+.+++++ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            5799999999999999999997     3467789999998654443445567899999999 999999999999999999


Q ss_pred             EEEEeecCC-CHHHHHhhccC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCee
Q 038835           76 YFVFEYMEC-NLYQLMKDREK----------------------CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLL  132 (337)
Q Consensus        76 ~lv~e~~~~-~l~~~~~~~~~----------------------~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nil  132 (337)
                      ++||||+++ ++.+.+.....                      .+++..++.++.||+.||.|||++||+||||||+||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            999999987 45555544332                      3799999999999999999999999999999999999


Q ss_pred             eeCC-cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 038835          133 VSKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADE  207 (337)
Q Consensus       133 i~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  207 (337)
                      ++.+ .+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.
T Consensus       205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  283 (344)
T 1rjb_A          205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  283 (344)
T ss_dssp             EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence            9976 899999999986643322   2345678899999998765 68999999999999999998 9999988776555


Q ss_pred             HHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 038835          208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP  281 (337)
Q Consensus       208 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  281 (337)
                      ...+......+                            ......++++.++|.+||+.||.+|||+.+++++-
T Consensus       284 ~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          284 FYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            44443321000                            11235679999999999999999999999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.5e-47  Score=332.99  Aligned_cols=246  Identities=25%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH------hHHHHHHHHHhcCCCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE------CVNLREVKSLRKMSHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.........      ....+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5899999999999999999999999999999998764433221      34568999999999999999999997666  


Q ss_pred             EEEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeCC-c-----EEEeeCCCc
Q 038835           76 YFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSKD-T-----IKIADFGLA  146 (337)
Q Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~~-~-----~kL~Dfg~a  146 (337)
                      ++||||+++ ++.+.+......+++..++.++.|++.||+|||++|  ++||||||+||+++.+ .     +||+|||.+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            699999985 566777766777999999999999999999999999  9999999999999764 3     999999999


Q ss_pred             ccCCCCCCCccccccccccCchhhcC-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCCccch
Q 038835          147 REINSRPPFTEYVSTRWYRAPEVLLQ-SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE--IYKICSVIGTPTQDSW  223 (337)
Q Consensus       147 ~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~  223 (337)
                      .....  ......||+.|+|||++.. ...++.++||||+||++|+|++|..||.+....+.  ...+...         
T Consensus       177 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------  245 (287)
T 4f0f_A          177 QQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE---------  245 (287)
T ss_dssp             BCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS---------
T ss_pred             ccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc---------
Confidence            86543  2345689999999999843 33578899999999999999999999987665433  2211111         


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                  ..+       .......++++.++|.+||+.||.+|||++|+++
T Consensus       246 ------------~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          246 ------------GLR-------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ------------CCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCC-------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        000       1122467899999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6e-48  Score=338.84  Aligned_cols=244  Identities=16%  Similarity=0.272  Sum_probs=199.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC-------cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG-------EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   74 (337)
                      ++|++.+.||+|+||.||+|.++.+|       ..||+|++...... ......+|+.++++++||||+++++++.+++.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN-YSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG-GHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            68999999999999999999998877       46999998754322 23445689999999999999999999999999


Q ss_pred             EEEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-c--------EEEeeCC
Q 038835           75 LYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-T--------IKIADFG  144 (337)
Q Consensus        75 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~--------~kL~Dfg  144 (337)
                      .++||||++++ +.+.+......+++..++.++.||+.||.|||++|++||||||+|||++.+ .        +||+|||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            99999999964 555555545559999999999999999999999999999999999999875 3        9999999


Q ss_pred             CcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCccch
Q 038835          145 LAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSW  223 (337)
Q Consensus       145 ~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~  223 (337)
                      .+......   ....||+.|+|||++.+...++.++|||||||++|+|++| .+||............ ...        
T Consensus       167 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~--------  234 (289)
T 4fvq_A          167 ISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDR--------  234 (289)
T ss_dssp             SCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT--------
T ss_pred             ccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hcc--------
Confidence            98765432   3456889999999998755789999999999999999995 5666555443332221 110        


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                            .......++++.++|.+||+.||.+|||+++++++
T Consensus       235 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 ----------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ----------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                  01113456889999999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-47  Score=342.71  Aligned_cols=248  Identities=23%  Similarity=0.401  Sum_probs=196.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEE----EEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVV----AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.+..+|+.+    |+|.+...........+.+|+.++++++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57999999999999999999998887764    7777765443334455678999999999999999999998765 678


Q ss_pred             EEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-
Q 038835           78 VFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-  154 (337)
Q Consensus        78 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-  154 (337)
                      |+||+.+ ++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|........ 
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  173 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence            8888886 5666666656679999999999999999999999999999999999999876 999999999986644322 


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......              
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------  238 (327)
T 3poz_A          174 YHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------------  238 (327)
T ss_dssp             ------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------------
T ss_pred             ccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--------------
Confidence              2334568899999998765 78999999999999999999 99999887766554443321100              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                     ...+..+.++.+++.+||+.||.+|||+.+++++
T Consensus       239 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ---------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                           1124567899999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1e-47  Score=343.39  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=203.9

Q ss_pred             cCceEeeeecccCceEEEEEE-----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAI-----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.     +..+++.||+|.+.............+|+.++++++||||+++++++...+..+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            589999999999999999998     567788999999976544444555678999999999999999999999999999


Q ss_pred             EEEeecCCC-HHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCC
Q 038835           77 FVFEYMECN-LYQLMKDRE------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGL  145 (337)
Q Consensus        77 lv~e~~~~~-l~~~~~~~~------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~  145 (337)
                      +||||++++ +.+.+....      ..+++..++.++.||+.||.|||++|++||||||+|||++.+    .+||+|||+
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            999999764 555554432      348999999999999999999999999999999999999842    699999999


Q ss_pred             cccCCCC---CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSR---PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~---~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +......   .......||+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+....+......    
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----  264 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM----  264 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC----
Confidence            8754322   122345789999999998765 68999999999999999998 99999888776665554332100    


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                               ......+.++.++|.+||+.||.+|||+.+++++.|+.
T Consensus       265 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          265 -------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                                     11245788999999999999999999999999998864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.9e-47  Score=341.54  Aligned_cols=249  Identities=25%  Similarity=0.407  Sum_probs=204.7

Q ss_pred             cCceEeeeecccCceEEEEEEEC-------CCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-------QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|++++.||+|+||.||+|.+.       .++..||+|++.............+|+.+++++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            58999999999999999999975       467789999998654444445567899999999 8999999999999999


Q ss_pred             EEEEEEeecCCCHH-HHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           74 ILYFVFEYMECNLY-QLMKDRE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~l~-~~~~~~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ..++||||++++.+ +.+....               ..+++..++.++.||+.||.|||++|++||||||+||+++.+ 
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            99999999987544 4444322               238999999999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  273 (334)
T 2pvf_A          195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  273 (334)
T ss_dssp             CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence            999999999987654322   2345678899999998765 67999999999999999999 999999887766655543


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .....                             ......+.++.++|.+||+.||.+|||+.|++++
T Consensus       274 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          274 EGHRM-----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCC-----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            32110                             1124578899999999999999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-47  Score=348.86  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=194.1

Q ss_pred             cCceEeeeecccCceEEEEEEEC---CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK---QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.++   .++..||+|++...........+.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47999999999999999999887   567789999997654433445567899999999999999999999999999999


Q ss_pred             EeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |||++++ +.+.+...+..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++........  
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  204 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA  204 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence            9999865 555555555579999999999999999999999999999999999999876 999999999987654321  


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......              
T Consensus       205 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~--------------  269 (373)
T 2qol_A          205 YTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL--------------  269 (373)
T ss_dssp             ---------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC--------------
T ss_pred             eeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence              1223457789999998765 68999999999999999998 99999988776665554322111              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                            +         .....+.++.++|.+||+.||.+|||+.++++
T Consensus       270 ------~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 ------P---------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ------C---------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------C---------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                  1         11356789999999999999999999999876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-47  Score=333.01  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=205.5

Q ss_pred             cCceEee-eecccCceEEEEEEEC--CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIK-EVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~-~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||+|++.............+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4688877 9999999999999864  468889999998754434445567899999999999999999999 45668999


Q ss_pred             EeecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |||++++.+ +.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++........  
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  167 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  167 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence            999998544 4554555669999999999999999999999999999999999999876 899999999987654322  


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+....                
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~----------------  230 (287)
T 1u59_A          168 TARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------------  230 (287)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----------------
T ss_pred             eccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC----------------
Confidence              2334568999999998655 67899999999999999998 999999888776655543221                


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                           .        ....+..++++.++|.+||+.||.+|||+.+++++.+
T Consensus       231 -----~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          231 -----R--------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             -----C--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -----c--------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                 0        0112467899999999999999999999999998754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.6e-48  Score=345.02  Aligned_cols=265  Identities=25%  Similarity=0.279  Sum_probs=196.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC----CEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN----DILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.+.  |+.||+|++....  .......+|+.++++++||||+++++++...    ..+++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            58999999999999999999875  8899999997542  2233335699999999999999999998764    34799


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc----------CccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR----------GYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~----------~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      ||||++++.+..+.... .+++..++.++.|++.||.|||+.          ||+||||||+|||++.+ .+||+|||++
T Consensus       100 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            99999986555555443 389999999999999999999999          99999999999999887 9999999999


Q ss_pred             ccCCCCC---CCccccccccccCchhhcCc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 038835          147 REINSRP---PFTEYVSTRWYRAPEVLLQS----YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPT  219 (337)
Q Consensus       147 ~~~~~~~---~~~~~~gt~~~~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  219 (337)
                      .......   ......||+.|+|||++.+.    ..++.++|||||||++|+|++|++||.+..+.............+.
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            7654332   23446899999999998763    2456688999999999999999999987554221111111111111


Q ss_pred             ccchhhhhhhHHhhhccCCCCCCCccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          220 QDSWADGLLLARAINYKFPQLVGVPLSVL--MPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...+..      ..   ............  ....++++.++|.+||+.||.+|||+.|+++.
T Consensus       259 ~~~~~~------~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          259 LEDMQE------VV---VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHHHH------HH---TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhhhh------hh---hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            111110      00   000000000000  11223569999999999999999999999873

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.5e-47  Score=333.82  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=206.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++.++..||+|++.....  ......+|+.++++++||||+++++++.+++..++||||
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            579999999999999999999999999999999976432  344557899999999999999999999999999999999


Q ss_pred             cCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--Cc
Q 038835           82 MEC-NLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FT  156 (337)
Q Consensus        82 ~~~-~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~~  156 (337)
                      +++ ++.+.+... ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .++|+|||.+........  ..
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence            996 455555442 3458999999999999999999999999999999999999876 899999999987654432  23


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+|+.|+|||++.+. .++.++||||||+++|+|++ |.+||.+.+..+....+.....                   
T Consensus       171 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------------------  230 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------------  230 (288)
T ss_dssp             TEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-------------------
T ss_pred             CCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-------------------
Confidence            35668889999998765 67999999999999999999 9999988776655544432110                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                .......++++.++|.+||..||.+|||++++++.
T Consensus       231 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          231 ----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence                      01124678999999999999999999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-47  Score=340.93  Aligned_cols=249  Identities=22%  Similarity=0.377  Sum_probs=206.1

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++.+.||+|+||.||+|.++     .+++.||+|.+.............+|+.+++.++||||+++++++.+++..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            57999999999999999999876     4678899999986544444445678999999999999999999999999999


Q ss_pred             EEEeecCCC-HHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           77 FVFEYMECN-LYQLMKDRE---------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        77 lv~e~~~~~-l~~~~~~~~---------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                      +||||++++ +.+.+....         ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||+
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~  184 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM  184 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcc
Confidence            999999874 545444321         357999999999999999999999999999999999999887 999999999


Q ss_pred             cccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +........   .....||+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+....      
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------  257 (322)
T 1p4o_A          185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG------  257 (322)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC------
T ss_pred             ccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC------
Confidence            976543321   2345678899999998765 67999999999999999999 899998887766555443211      


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                     .        .......+.++.++|.+||+.||.+|||+.|++++
T Consensus       258 ---------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 ---------------L--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             ---------------C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------c--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                           0        01124678999999999999999999999999886

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-47  Score=338.64  Aligned_cols=249  Identities=26%  Similarity=0.405  Sum_probs=199.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC----cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG----EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++.+.||+|+||.||+|.++.++    ..||+|++.............+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            57899999999999999999887654    35999999865443344456789999999999999999999999999999


Q ss_pred             EEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-
Q 038835           78 VFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-  154 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-  154 (337)
                      ||||++++ +.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+........ 
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence            99999985 555555555679999999999999999999999999999999999999877 999999999987654321 


Q ss_pred             ---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          155 ---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       155 ---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                         .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+            
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~------------  270 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------------  270 (333)
T ss_dssp             -------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------------
T ss_pred             ccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC------------
Confidence               1234567889999998765 68999999999999999998 999998887766655543321110            


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                       .....+.++.++|.+||+.||.+|||+.+++++
T Consensus       271 -----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          271 -----------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -----------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             113567899999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.1e-47  Score=332.34  Aligned_cols=249  Identities=23%  Similarity=0.274  Sum_probs=201.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeE-EeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV-IRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++......   ....+|+.+++.++|++++..+.. +..++..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            6899999999999999999999999999999998764332   235689999999998886666555 467788999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee---C-CcEEEeeCCCcccCCCCCC--
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS---K-DTIKIADFGLAREINSRPP--  154 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~---~-~~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |+++++.+.+......+++..++.++.||+.||.|||++|++||||||+|||++   . +.+||+|||.+........  
T Consensus        86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (296)
T 3uzp_A           86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence            997777777765666799999999999999999999999999999999999994   3 3899999999986654322  


Q ss_pred             ------CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCCccchhh
Q 038835          155 ------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       155 ------~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~  225 (337)
                            .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....   +....+......        
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  236 (296)
T 3uzp_A          166 HIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--------  236 (296)
T ss_dssp             BCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--------
T ss_pred             ccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC--------
Confidence                  2456899999999998765 6899999999999999999999999874432   222222221000        


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 .      +.....+.+++++.++|.+||+.||.+|||++++++
T Consensus       237 -----------~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 -----------T------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -----------S------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -----------C------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                       0      111122467899999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=338.93  Aligned_cols=248  Identities=23%  Similarity=0.400  Sum_probs=197.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEE----EEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVV----AIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.+..+|+.+    |+|.+.............+|+.++++++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            68999999999999999999999888765    6666654444444556678999999999999999999998765 678


Q ss_pred             EEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-
Q 038835           78 VFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-  154 (337)
Q Consensus        78 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-  154 (337)
                      |+||+.+ ++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++........ 
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~  173 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence            8888886 5666666666779999999999999999999999999999999999999875 999999999987643322 


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+......              
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--------------  238 (327)
T 3lzb_A          174 YHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------------  238 (327)
T ss_dssp             ------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------------
T ss_pred             ccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence              2335568899999998765 68999999999999999999 99999988776655444322111              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                     ...+..+.++.++|.+||+.||.+|||+.|+++.
T Consensus       239 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          239 ---------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                           1124567899999999999999999999999873

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-47  Score=338.69  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=202.6

Q ss_pred             cCceEeeeecccCceEEEEEEE-----CCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeC-CE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREN-DI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~   74 (337)
                      ++|++++.||+|+||.||+|.+     ..+++.||+|++.............+|+.+++++ +||||+++++++... ..
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999984     4578899999998765444445567899999999 789999999998765 45


Q ss_pred             EEEEEeecCCCHHHHHhhccCC----------------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-c
Q 038835           75 LYFVFEYMECNLYQLMKDREKC----------------FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-T  137 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~----------------l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~  137 (337)
                      .++||||++++.+..+......                +++..++.++.||+.||.|||++|++||||||+||+++.+ .
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence            8999999997554444433222                8999999999999999999999999999999999999876 9


Q ss_pred             EEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 038835          138 IKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICS  213 (337)
Q Consensus       138 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  213 (337)
                      +||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.......
T Consensus       187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~  265 (316)
T 2xir_A          187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  265 (316)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred             EEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence            99999999987654332   2345678899999998765 68999999999999999998 9999988765444333322


Q ss_pred             HhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ....+                            ......++++.++|.+||+.||.+|||+.|+++|
T Consensus       266 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          266 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCccC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21100                            1123567899999999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.6e-47  Score=332.33  Aligned_cols=247  Identities=22%  Similarity=0.334  Sum_probs=200.1

Q ss_pred             cCceEee-eecccCceEEEEEE--ECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIK-EVGDGTFGSVWRAI--SKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~-~ig~G~~g~v~~~~--~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++.+ .||+|+||.||+|.  ++.+++.||+|++....... ......+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4789988 99999999999994  46678899999998654332 234556899999999999999999999 5677899


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-  155 (337)
                      ||||++++.+..+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++......... 
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  174 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence            99999976555555555669999999999999999999999999999999999999876 8999999999876544321 


Q ss_pred             ---ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          156 ---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       156 ---~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                         ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+....                
T Consensus       175 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  237 (291)
T 1xbb_A          175 KAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------------  237 (291)
T ss_dssp             EC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------
T ss_pred             cccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence               234567889999998655 57889999999999999999 999999887766554443210                


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                           .        .......++++.++|.+||+.||.+|||+.++++
T Consensus       238 -----~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 -----R--------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -----C--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----C--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 0        0112467899999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.2e-47  Score=327.73  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=206.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.+. +++.||+|++.......  ....+|+.++++++||||+++++++.+++..++||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            58999999999999999999987 57789999998765442  3457899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCcc
Q 038835           82 MECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTE  157 (337)
Q Consensus        82 ~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~  157 (337)
                      ++++ +.+.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+.......  ....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence            9875 555555555668999999999999999999999999999999999999876 99999999998654321  1234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+++.|+|||++.+. .++.++||||+|+++|+|++ |.+||.+.+..+....+......                   
T Consensus       165 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~-------------------  224 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------------  224 (267)
T ss_dssp             TTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------------
T ss_pred             ccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-------------------
Confidence            5678899999998755 67999999999999999999 89999988776666555332100                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                ......+.++.++|.+||+.||.+|||+++++++
T Consensus       225 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          225 ----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      0113467899999999999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.7e-47  Score=330.97  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=201.1

Q ss_pred             cCceEeeeecccCceEEEEEEECC---CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ---SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||.||+|.+..   ++..||+|.+.............+|+.+++.++||||+++++++.++ ..++|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence            589999999999999999998653   34569999998764444455567899999999999999999998754 46899


Q ss_pred             EeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |||++++ +.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+........  
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  170 (281)
T 3cc6_A           91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK  170 (281)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred             EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccc
Confidence            9999975 555555555669999999999999999999999999999999999999876 899999999987654322  


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+......+               
T Consensus       171 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---------------  234 (281)
T 3cc6_A          171 ASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---------------  234 (281)
T ss_dssp             --CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---------------
T ss_pred             cccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---------------
Confidence            2345678899999998655 67999999999999999998 999998877766555443321110               


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                    .....++.+.++|.+||..||.+|||+.|++++
T Consensus       235 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 --------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                          123567899999999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-46  Score=331.25  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=198.0

Q ss_pred             cCceEeeeecccCceEEEEEE----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee--CCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE--NDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   75 (337)
                      ++|++++.||+|+||.||+|.    +..+|+.||+|++.... ........+|+.++++++||||+++++++..  ....
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            689999999999999999998    67789999999987542 2223445689999999999999999999854  3568


Q ss_pred             EEEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           76 YFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      ++||||+++ ++.+.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||++.......
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            999999987 4555555555569999999999999999999999999999999999999876 99999999998765432


Q ss_pred             C----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          154 P----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       154 ~----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      .    .....+++.|+|||++.+. .++.++|||||||++|+|++|..||......     .....+.............
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHHHHHHHH
T ss_pred             ceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccchhHHHHH
Confidence            1    2345678889999998765 6899999999999999999999998653221     1111122222111111111


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ........        .......++++.++|.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          243 ELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhccCc--------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11111000        1113567899999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-46  Score=331.83  Aligned_cols=249  Identities=23%  Similarity=0.270  Sum_probs=198.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeE-EeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEV-IRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++......   ....+|+.+++.++|++++..+.. +..++..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            5899999999999999999999999999999987654322   234689999999988877666655 467888999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeee---eCC-cEEEeeCCCcccCCCCC---
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLV---SKD-TIKIADFGLAREINSRP---  153 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili---~~~-~~kL~Dfg~a~~~~~~~---  153 (337)
                      |+++++.+.+......+++..++.++.||+.||.|||++|++||||||+|||+   +.+ .+||+|||.+.......   
T Consensus        86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~  165 (296)
T 4hgt_A           86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             CCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence            99777777776666679999999999999999999999999999999999999   444 89999999998664432   


Q ss_pred             -----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCCccchhh
Q 038835          154 -----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA---DEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       154 -----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~  225 (337)
                           ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..   +....+......        
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  236 (296)
T 4hgt_A          166 HIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--------  236 (296)
T ss_dssp             BCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--------
T ss_pred             cCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc--------
Confidence                 22356899999999998765 6899999999999999999999999875432   222222111000        


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 .      +.....+.+++++.++|.+||+.||.+|||++++++
T Consensus       237 -----------~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          237 -----------T------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -----------S------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -----------c------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                       0      111122467899999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.9e-47  Score=344.69  Aligned_cols=258  Identities=17%  Similarity=0.224  Sum_probs=195.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-----CcEEEEEEcccccCChH----------HhHHHHHHHHHhcCCCCCcccce
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-----GEVVAIKKMKKKYYSWE----------ECVNLREVKSLRKMSHPNIVKLK   66 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~   66 (337)
                      ++|++++.||+|+||.||+|.++.+     ++.||+|++........          ......|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4899999999999999999998765     58899999875431110          01113466677888999999999


Q ss_pred             eEEeeC----CEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee--CC-cEE
Q 038835           67 EVIREN----DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS--KD-TIK  139 (337)
Q Consensus        67 ~~~~~~----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~--~~-~~k  139 (337)
                      +++...    ...++||||+++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++  .+ .+|
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k  194 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY  194 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred             eeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence            998654    56899999996666676666657799999999999999999999999999999999999998  44 999


Q ss_pred             EeeCCCcccCCCCC--------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 038835          140 IADFGLAREINSRP--------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKI  211 (337)
Q Consensus       140 L~Dfg~a~~~~~~~--------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  211 (337)
                      |+|||++.......        .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..........
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~  273 (364)
T 3op5_A          195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD  273 (364)
T ss_dssp             ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred             EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH
Confidence            99999997654321        11345699999999998765 6899999999999999999999999864333222221


Q ss_pred             HHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          212 CSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ......+.         ........++          ....+.++.+++..||+.||.+|||++++++
T Consensus       274 ~~~~~~~~---------~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          274 SKIRYREN---------IASLMDKCFP----------AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHC---------HHHHHHHHSC----------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhhhh---------HHHHHHHhcc----------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11100000         0000111111          1456899999999999999999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.8e-47  Score=339.85  Aligned_cols=250  Identities=25%  Similarity=0.398  Sum_probs=205.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc-----EEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|++++.||+|+||.||+|.+..+|+     .||+|.+.............+|+.+++.+ +||||+++++++.+++..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            579999999999999999999987665     79999997655444445567899999999 899999999999999999


Q ss_pred             EEEEeecCC-CHHHHHhhc-------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEE
Q 038835           76 YFVFEYMEC-NLYQLMKDR-------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKI  140 (337)
Q Consensus        76 ~lv~e~~~~-~l~~~~~~~-------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL  140 (337)
                      ++||||+++ ++.+.+...             ...+++..++.++.||+.||.|||++|++||||||+|||++.+ .+||
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl  205 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI  205 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence            999999987 555555432             2358999999999999999999999999999999999999876 8999


Q ss_pred             eeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 038835          141 ADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIG  216 (337)
Q Consensus       141 ~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~  216 (337)
                      +|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus       206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  284 (333)
T 2i1m_A          206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY  284 (333)
T ss_dssp             CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTC
T ss_pred             CccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCC
Confidence            99999986543322   2345678899999998765 68999999999999999998 9999988776555544433211


Q ss_pred             CCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          217 TPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .+                            ......+.++.++|.+||+.||.+|||+.+++++
T Consensus       285 ~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          285 QM----------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC----------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            11                            0113457899999999999999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-46  Score=326.46  Aligned_cols=245  Identities=18%  Similarity=0.325  Sum_probs=201.2

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeC--CEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIREN--DILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l   77 (337)
                      +++|++.+.||+|+||.||+|.+.  |+.||+|++........ .....+|+.++++++||||+++++++.+.  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            368999999999999999999885  88999999987654432 34457899999999999999999999876  78899


Q ss_pred             EEeecCCC-HHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           78 VFEYMECN-LYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~~~~-~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ||||++++ +.+.+..... .+++..++.++.||+.||.|||++|  ++||||||+||+++.+ .++|+|||++..... 
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            99999975 4455444332 5899999999999999999999999  9999999999999977 889998887765332 


Q ss_pred             CCCccccccccccCchhhcCcCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYL--YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                         ....||+.|+|||++.+...  ++.++|||||||++|+|++|..||.+.+..+....+......+            
T Consensus       166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------  230 (271)
T 3kmu_A          166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP------------  230 (271)
T ss_dssp             ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC------------
T ss_pred             ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC------------
Confidence               34578999999999876522  2337999999999999999999999888766655543321111            


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                      ..++..++++.++|.+||+.||.+|||++++++
T Consensus       231 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 ----------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            122467899999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-46  Score=329.49  Aligned_cols=250  Identities=27%  Similarity=0.389  Sum_probs=192.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.+..   .+|+|++........ ...+.+|+.++++++||||++++++. .....++|||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            589999999999999999997643   599999976654433 34456899999999999999999965 4566899999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC---CCCC
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS---RPPF  155 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~---~~~~  155 (337)
                      |++++ +.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.....   ....
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence            99865 555555556679999999999999999999999999999999999999876 899999999976543   2223


Q ss_pred             ccccccccccCchhhc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          156 TEYVSTRWYRAPEVLL--QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ....||+.|+|||++.  ....++.++|||||||++|+|++|..||.+....+.............              
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  245 (289)
T 3og7_A          180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--------------  245 (289)
T ss_dssp             ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC--------------
T ss_pred             cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc--------------
Confidence            4567999999999986  234678899999999999999999999998777666555443311110              


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                .........++++.++|.+||+.||.+|||+.++++
T Consensus       246 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 ----------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ----------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                      111223467899999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3e-47  Score=353.01  Aligned_cols=253  Identities=28%  Similarity=0.404  Sum_probs=191.0

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      .|.+.+.||+|+||+||.+ ...+|+.||+|++....    .....+|+.+++++ +||||+++++++.+++..|+||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            4566788999999999875 45679999999986542    22346899999876 899999999999999999999999


Q ss_pred             cCCCHHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--------------cEEEe
Q 038835           82 MECNLYQLMKDREKC------FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--------------TIKIA  141 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~------l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--------------~~kL~  141 (337)
                      ++|++.+.+......      .++..++.++.||+.||+|||++||+||||||+|||++.+              .+||+
T Consensus        91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            998777777654321      1333467899999999999999999999999999999742              79999


Q ss_pred             eCCCcccCCCCCC-----CccccccccccCchhhcC------cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 038835          142 DFGLAREINSRPP-----FTEYVSTRWYRAPEVLLQ------SYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIY  209 (337)
Q Consensus       142 Dfg~a~~~~~~~~-----~~~~~gt~~~~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  209 (337)
                      |||++........     ....+||+.|+|||++.+      ...++.++|||||||++|+|++ |.+||.+....+  .
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~  248 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--S  248 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--H
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--H
Confidence            9999987654321     234689999999999865      2468999999999999999999 999997765443  1


Q ss_pred             HHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          210 KICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       210 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .+.....                   ..+....    ...+.+++++.++|.+||+.||.+|||+.++++||||..
T Consensus       249 ~i~~~~~-------------------~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          249 NIIRGIF-------------------SLDEMKC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHTCC-------------------CCCCCTT----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHhcCCC-------------------Ccccccc----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            2222110                   0110000    001234578999999999999999999999999999964

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.4e-46  Score=330.62  Aligned_cols=263  Identities=25%  Similarity=0.410  Sum_probs=200.6

Q ss_pred             cCceEeeeecccCceEEEEEE----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC--CEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN--DIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~   75 (337)
                      ++|++++.||+|+||.||+|.    +..+|+.||+|++.............+|+.+++.++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            469999999999999999998    67789999999998654433445567899999999999999999999766  668


Q ss_pred             EEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           76 YFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        76 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      ++||||++++ +.+.+......+++..++.++.|++.||+|||++|++||||||+||+++.+ .+||+|||++.......
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  180 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  180 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence            9999999875 555554556679999999999999999999999999999999999999876 99999999998765443


Q ss_pred             C----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          154 P----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       154 ~----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      .    .....||+.|+|||++.+. .++.++||||+||++|+|++|..|+....     ............. .......
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-~~~~~~~  253 (302)
T 4e5w_A          181 EYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ-MTVTRLV  253 (302)
T ss_dssp             CEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG-GHHHHHH
T ss_pred             cceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc-cCHHHHH
Confidence            2    2446788899999998765 67889999999999999999999864321     1111111211111 1111111


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                       .......       .....+.+++++.++|.+||+.||.+|||+.++++
T Consensus       254 -~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          254 -NTLKEGK-------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             -HHHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             -HHHhccC-------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence             1111000       01123567899999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.1e-47  Score=330.99  Aligned_cols=243  Identities=28%  Similarity=0.431  Sum_probs=201.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee----------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE----------   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------   71 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....     ....+|+.++++++||||+++++++..          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            47999999999999999999999999999999987542     234589999999999999999998854          


Q ss_pred             ------CCEEEEEEeecCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEee
Q 038835           72 ------NDILYFVFEYMECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIAD  142 (337)
Q Consensus        72 ------~~~~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~D  142 (337)
                            ....++||||++++ +.+.+... ...+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D  165 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD  165 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence                  45689999999985 55555433 3569999999999999999999999999999999999999876 999999


Q ss_pred             CCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccc
Q 038835          143 FGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDS  222 (337)
Q Consensus       143 fg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  222 (337)
                      ||.+.............||+.|+|||++.+. .++.++||||||+++|+|++|..||....  .....+.          
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~----------  232 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR----------  232 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH----------
T ss_pred             chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh----------
Confidence            9999887665555667899999999998765 67999999999999999999998874211  1111110          


Q ss_pred             hhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          223 WADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                 ..           ...+.++.++.++|.+||+.||.+|||+.|++++.+.-
T Consensus       233 -----------~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          233 -----------DG-----------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             -----------TT-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------cc-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                       00           01145678999999999999999999999999997753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.7e-46  Score=329.16  Aligned_cols=251  Identities=26%  Similarity=0.461  Sum_probs=190.8

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++.+.||+|+||.||+|.+..+|+.||+|++......  .......+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            36899999999999999999999999999999999764322  2233456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           79 FEYMECNLYQLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        79 ~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      |||++++.+..+..    ....+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.......
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            99999855444332    34568999999999999999999999999999999999999876 99999999988665432


Q ss_pred             -CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 -PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEA--DEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 -~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                       ......|++.|+|||++.+. .++.++||||||+++|+|++|..||.+....  +....+..                 
T Consensus       191 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  252 (310)
T 2wqm_A          191 TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-----------------  252 (310)
T ss_dssp             --------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-----------------
T ss_pred             ccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-----------------
Confidence             22446799999999998765 6899999999999999999999999765322  11111111                 


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                          ..++..       .....+.++.++|.+||..||.+|||+++++++
T Consensus       253 ----~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          253 ----CDYPPL-------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             ----TCSCCC-------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----ccCCCC-------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                011110       124578899999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.6e-48  Score=370.33  Aligned_cols=278  Identities=26%  Similarity=0.373  Sum_probs=207.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee------CCE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE------NDI   74 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~   74 (337)
                      +++|++++.||.|+||.||+|.++.+|+.||+|++.............+|+.++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999999999999999999765444444556789999999999999999998755      677


Q ss_pred             EEEEEeecCCCHHHHHhhc-c--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcc
Q 038835           75 LYFVFEYMECNLYQLMKDR-E--KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAR  147 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~-~--~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~  147 (337)
                      .++||||++|+.+..+... .  ..+++..++.++.|++.||+|||++|++||||||+||+++.+    .+||+|||.+.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            8999999987655544443 2  258999999999999999999999999999999999999865    49999999999


Q ss_pred             cCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh
Q 038835          148 EINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL  227 (337)
Q Consensus       148 ~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  227 (337)
                      ............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.....................+..  
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~--  249 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD--  249 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC--
T ss_pred             ccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh--
Confidence            87766666678999999999998655 789999999999999999999999977543221100000000000000000  


Q ss_pred             hhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                       .  .....+....+ ......+.+++.+.++|.+||..||.+|||+.++++||||+.
T Consensus       250 -l--~g~~~~~~~lp-~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          250 -L--TGAVKFSSVLP-TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             -C--SSSCCCCSSSC-CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             -h--ccccccccccC-CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence             0  00001111111 111223456788999999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=338.88  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=184.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEe--------eC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIR--------EN   72 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~   72 (337)
                      .+|++.+.||+|+||.||+|.++.+|+.||+|++.... ........+|+.+++++. ||||+++++++.        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            37999999999999999999999999999999986542 223344568999999995 999999999983        44


Q ss_pred             CEEEEEEeecCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           73 DILYFVFEYMECNLYQLMKD--REKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        73 ~~~~lv~e~~~~~l~~~~~~--~~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      ..+++||||++|++.+.+..  ....+++..++.++.||+.||.|||++|  ++||||||+|||++.+ .+||+|||++.
T Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence            56899999999988887764  3456999999999999999999999999  9999999999999986 99999999998


Q ss_pred             cCCCCCCC-------------ccccccccccCchhhc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 038835          148 EINSRPPF-------------TEYVSTRWYRAPEVLL--QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       148 ~~~~~~~~-------------~~~~gt~~~~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  212 (337)
                      ........             ....||+.|+|||++.  .+..++.++|||||||++|+|++|..||.+.......... 
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-  265 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK-  265 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc-
Confidence            76543221             1456999999999984  3346788999999999999999999999765432221110 


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF  282 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  282 (337)
                                            ...         ......+..+.++|.+||+.||.+|||+.|++++-+
T Consensus       266 ----------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          266 ----------------------YSI---------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----------------------CCC---------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ----------------------ccC---------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                                  000         012345678999999999999999999999999743

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.2e-46  Score=332.78  Aligned_cols=249  Identities=26%  Similarity=0.328  Sum_probs=193.9

Q ss_pred             cCceEeeeecccCceEEEEEEECC---CCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCC----
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ---SGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIREND----   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   73 (337)
                      ++|.+++.||+|+||.||+|.+..   ++..||+|++........ .....+|+.++++++||||+++++++...+    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            579999999999999999998765   566899999986654432 344568999999999999999999987654    


Q ss_pred             -EEEEEEeecCCCHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           74 -ILYFVFEYMECNLYQLMK------DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        74 -~~~lv~e~~~~~l~~~~~------~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                       ..++||||++++.+..+.      .....+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||+
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~  193 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL  193 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence             359999999975554443      233569999999999999999999999999999999999999887 999999999


Q ss_pred             cccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      +.......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+....+....+.....     
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  267 (313)
T 3brb_A          194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-----  267 (313)
T ss_dssp             C----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----
T ss_pred             ceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-----
Confidence            98664332   12345678899999998765 68999999999999999999 8999988877666554433210     


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                              .......++++.++|.+||..||.+|||+++++++
T Consensus       268 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 ------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    01124678899999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=339.22  Aligned_cols=257  Identities=15%  Similarity=0.189  Sum_probs=192.2

Q ss_pred             cCceEeeeecccCceEEEEEEECC---CCcEEEEEEcccccCChH----------HhHHHHHHHHHhcCCCCCcccceeE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ---SGEVVAIKKMKKKYYSWE----------ECVNLREVKSLRKMSHPNIVKLKEV   68 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~   68 (337)
                      ++|++++.||+|+||.||+|.++.   ++..+|+|++........          .....+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999987   788999999876532110          1123468888999999999999999


Q ss_pred             Eee----CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC---cEEEe
Q 038835           69 IRE----NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD---TIKIA  141 (337)
Q Consensus        69 ~~~----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~---~~kL~  141 (337)
                      +..    ....|+||||+++++.+.+ .....+++..++.++.||+.||+|||++||+||||||+|||++.+   .+||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERLGIDLQKIS-GQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECEEEEHHHHC-BGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEeccCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            887    7889999999944555544 444469999999999999999999999999999999999999864   89999


Q ss_pred             eCCCcccCCCCC--------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHH
Q 038835          142 DFGLAREINSRP--------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGT-SEADEIYKIC  212 (337)
Q Consensus       142 Dfg~a~~~~~~~--------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~  212 (337)
                      |||++.......        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+. ..........
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            999997653221        11456899999999998765 6899999999999999999999999653 2222222222


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..........+..          ..+          ....++++.++|.+||+.||.+|||++++++.
T Consensus       275 ~~~~~~~~~~~~~----------~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          275 TNLLDELPQSVLK----------WAP----------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHTTTHHHHH----------HSC----------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HhhcccccHHHHh----------hcc----------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            2111110000000          000          12678999999999999999999999999763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-47  Score=342.39  Aligned_cols=263  Identities=21%  Similarity=0.332  Sum_probs=202.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++ +|+.||+|++...... ......+|+.+++.++||||+++++++.+.+..++||||
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  116 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY  116 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS-HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence            68999999999999999999965 6899999998765433 334556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---C
Q 038835           82 MECNLYQLMKDRE----KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---P  153 (337)
Q Consensus        82 ~~~~l~~~~~~~~----~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---~  153 (337)
                      ++++.+.......    ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++......   .
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  196 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH  196 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            9976554443322    258999999999999999999999999999999999999877 9999999999764432   2


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+......          |...    ...
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~----------~~~~----~~~  261 (321)
T 2qkw_B          197 LSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE----------WAVE----SHN  261 (321)
T ss_dssp             CBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH----------HTHH----HHT
T ss_pred             cccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH----------Hhhh----ccc
Confidence            22445689999999998765 68999999999999999999999997654422111100          0000    000


Q ss_pred             hccCCCCCCC-cccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 038835          234 NYKFPQLVGV-PLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP  281 (337)
Q Consensus       234 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  281 (337)
                      .......... ......+..+.++.+++.+||+.||.+|||+.|++++-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            0011111111 11112234457799999999999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-46  Score=330.67  Aligned_cols=248  Identities=22%  Similarity=0.344  Sum_probs=199.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC---cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEE-eeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG---EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVI-RENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~l   77 (337)
                      .+|++.+.||+|+||.||+|.+..++   ..+|+|.+.............+|+.++++++||||+++++++ ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            36899999999999999999876443   358999987654444445567899999999999999999985 55678899


Q ss_pred             EEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--
Q 038835           78 VFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--  153 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--  153 (337)
                      ||||++++ +.+.+......+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+.......  
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            99999985 555555556668999999999999999999999999999999999999887 99999999998654322  


Q ss_pred             ---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          154 ---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       154 ---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                         ......||+.|+|||.+.+. .++.++||||+||++|+|++ |.+||.+.+..+....+......            
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------------  251 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------------  251 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC------------
T ss_pred             ccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC------------
Confidence               22345678899999998665 68999999999999999999 67888877766555444322110            


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                       ......+.++.++|.+||+.||.+|||+.|+++
T Consensus       252 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          252 -----------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             112356789999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-47  Score=340.89  Aligned_cols=261  Identities=22%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++ +|+.||+|++.............+|+.+++.++||||+++++++.+.+..++||||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            58999999999999999999754 68999999998765444444567899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           82 MECNLYQLMKDR----EKCFSEAEVRNWCFQVFQGLAYMHQR---GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        82 ~~~~l~~~~~~~----~~~l~~~~~~~~~~qil~al~~LH~~---~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      ++++.+..+...    ..++++..++.++.|++.||.|||++   |++||||||+|||++.+ .+||+|||++.......
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  188 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD  188 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc
Confidence            998655444432    23499999999999999999999999   99999999999999987 99999999998764332


Q ss_pred             --CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHHHhCCCCccchhhh
Q 038835          154 --PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS-----EADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       154 --~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                        ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||....     ..............         
T Consensus       189 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  258 (326)
T 3uim_A          189 THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE---------  258 (326)
T ss_dssp             SCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS---------
T ss_pred             ccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc---------
Confidence              22445699999999998765 57999999999999999999999995211     10000000000000         


Q ss_pred             hhhHHhhhccCCCCCCCc-ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 038835          227 LLLARAINYKFPQLVGVP-LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP  281 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  281 (337)
                              .......... .....+..+.++.+++.+||+.||.+|||++|+++|-
T Consensus       259 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          259 --------KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             --------CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             --------hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence                    0000000000 0111223447799999999999999999999999974

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.8e-46  Score=348.05  Aligned_cols=241  Identities=27%  Similarity=0.436  Sum_probs=198.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC-EEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND-ILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e   80 (337)
                      ++|++++.||+|+||.||++.+.  |+.||+|+++...   ....+.+|+.++++++||||+++++++.... ..++|||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            67999999999999999999875  7899999998653   2334578999999999999999999976554 7999999


Q ss_pred             ecCCC-HHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           81 YMECN-LYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~-~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |++++ +.+.+...+. .+++..++.++.||+.||+|||++|++||||||+|||++.+ .+||+|||++.......  ..
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~  345 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DT  345 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--cC
Confidence            99874 5555554433 37999999999999999999999999999999999999876 99999999998654332  23


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......                   
T Consensus       346 ~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------------  405 (450)
T 1k9a_A          346 GKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------------  405 (450)
T ss_dssp             -CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-------------------
T ss_pred             CCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence            4678899999998765 68999999999999999998 99999987776665554322100                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                ..++..++++.++|.+||+.||.+|||+.++++
T Consensus       406 ----------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          406 ----------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                      112457899999999999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-46  Score=327.63  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=199.9

Q ss_pred             CceEeeeecccCceEEEEEEECCCCc---EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEE-EEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDIL-YFV   78 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv   78 (337)
                      .|++.+.||+|+||.||+|.+..+++   .+|+|.+.............+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46778999999999999999765554   79999987654434445567899999999999999999999766554 999


Q ss_pred             EeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC----
Q 038835           79 FEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR----  152 (337)
Q Consensus        79 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~----  152 (337)
                      |||+.+ ++.+.+......+++..++.++.|++.||+|||++|++||||||+||+++.+ .+||+|||++......    
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  181 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS  181 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence            999976 5555555556678999999999999999999999999999999999999887 9999999999755332    


Q ss_pred             -CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          153 -PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       153 -~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                       .......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+......             
T Consensus       182 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------------  247 (298)
T 3pls_A          182 VQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-------------  247 (298)
T ss_dssp             SCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-------------
T ss_pred             cccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-------------
Confidence             222446788999999998665 68999999999999999999 55667666655544443322110             


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                      ......++++.++|.+||+.||.+|||++++++.
T Consensus       248 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          248 ----------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                            1124567899999999999999999999999873

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-46  Score=353.22  Aligned_cols=246  Identities=24%  Similarity=0.422  Sum_probs=205.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++.++..||+|++......  ...+.+|+.++++++||||+++++++...+..++||||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4689999999999999999999999999999999865443  34567899999999999999999999999999999999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ++++ +.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.......  ...
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence            9964 55555443 3458999999999999999999999999999999999999876 99999999998764432  123


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....                   
T Consensus       378 ~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------  437 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------------  437 (495)
T ss_dssp             TCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-------------------
T ss_pred             CCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            34567889999998765 67999999999999999999 9999998876655544322110                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                ...+...++++.++|.+||+.||.+|||+.++++
T Consensus       438 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 ----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                      0112457899999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=338.58  Aligned_cols=252  Identities=14%  Similarity=0.165  Sum_probs=197.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCC--------CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCccc---------
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS--------GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK---------   64 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------   64 (337)
                      ++|++++.||+|+||.||+|.++.+        ++.||+|++...      ....+|+.++++++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            5899999999999999999999874        889999998754      23468999999999999887         


Q ss_pred             ------ceeEEee-CCEEEEEEeecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC
Q 038835           65 ------LKEVIRE-NDILYFVFEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD  136 (337)
Q Consensus        65 ------~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~  136 (337)
                            +++++.. ++..++||||+++++.+.+... ...+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred             ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence                  5667665 7889999999955666666543 3669999999999999999999999999999999999999986


Q ss_pred             ---cEEEeeCCCcccCCCCC--------CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-c
Q 038835          137 ---TIKIADFGLAREINSRP--------PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTS-E  204 (337)
Q Consensus       137 ---~~kL~Dfg~a~~~~~~~--------~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~  204 (337)
                         .+||+|||++.......        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence               79999999997654321        12345899999999998765 68999999999999999999999998764 3


Q ss_pred             HHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          205 ADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       205 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      .+...........                  ..+....  ....+..+++++.++|.+||+.||.+|||++++++.
T Consensus       275 ~~~~~~~~~~~~~------------------~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          275 TEDIMKQKQKFVD------------------KPGPFVG--PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             HHHHHHHHHHHHH------------------SCCCEEC--TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHHHhccC------------------Chhhhhh--hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            3333222221100                  0000000  001123578999999999999999999999999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.1e-46  Score=346.72  Aligned_cols=244  Identities=30%  Similarity=0.472  Sum_probs=202.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++ ++..||+|++......  ...+.+|+.++++++||||+++++++. .+..++||||
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc--HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            57999999999999999999986 4678999999865433  445678999999999999999999986 5678999999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      +.++ +.+.+... ...+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.......  ...
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence            9875 55555433 2358999999999999999999999999999999999999976 99999999998764321  123


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+++.|+|||++... .++.++|||||||++|+|++ |..||.+.+..+....+......+                 
T Consensus       344 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-----------------  405 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-----------------  405 (454)
T ss_dssp             SSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-----------------
T ss_pred             CCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------
Confidence            34567889999998765 68999999999999999999 999999988877766654431111                 


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                  .+...++++.++|.+||+.||.+|||++++++
T Consensus       406 ------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 ------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                        11356789999999999999999999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.8e-46  Score=328.55  Aligned_cols=241  Identities=26%  Similarity=0.406  Sum_probs=187.1

Q ss_pred             CcCceEe-eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHH-hcCCCCCcccceeEEee----CCE
Q 038835            1 MERYKLI-KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSL-RKMSHPNIVKLKEVIRE----NDI   74 (337)
Q Consensus         1 ~~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~   74 (337)
                      +++|.+. +.||+|+||.||+|.++.+|+.||+|++...      ....+|+.++ +.++||||+++++++..    ...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            3678888 7799999999999999999999999998642      2335788887 56699999999999877    678


Q ss_pred             EEEEEeecCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC---C-cEEEeeCCCccc
Q 038835           75 LYFVFEYMEC-NLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK---D-TIKIADFGLARE  148 (337)
Q Consensus        75 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~---~-~~kL~Dfg~a~~  148 (337)
                      .++||||+++ ++.+.+.... ..+++..++.++.||+.||.|||++|++||||||+||+++.   + .+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            9999999987 5555555443 36999999999999999999999999999999999999986   3 899999998865


Q ss_pred             CCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          149 INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       149 ~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      ..+                      ..++.++||||+||++|+|++|.+||.+....+....+..               
T Consensus       170 ~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~---------------  212 (299)
T 3m2w_A          170 TTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---------------  212 (299)
T ss_dssp             CTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC---------------
T ss_pred             ccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH---------------
Confidence            421                      2467899999999999999999999977654322110000               


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccccCC
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH  291 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  291 (337)
                             .............+..+++++.++|.+||+.||.+|||++|+++||||+.......
T Consensus       213 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~  268 (299)
T 3m2w_A          213 -------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  268 (299)
T ss_dssp             -------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred             -------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence                   00000000011112467899999999999999999999999999999987654333

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-46  Score=334.22  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=201.3

Q ss_pred             cCceEeeeecccCceEEEEEE----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe--eCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR--ENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~   75 (337)
                      ++|++++.||+|+||.||+|.    +..+|+.||+|++..... .......+|+.++++++||||+++++++.  +.+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            589999999999999999998    577899999999876422 22344578999999999999999999876  55779


Q ss_pred             EEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           76 YFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        76 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      ++||||++++ +.+.+......+++..++.++.||+.||+|||++|++||||||+||+++.+ .+||+|||.+.......
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  181 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK  181 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence            9999999765 445554445569999999999999999999999999999999999999876 99999999998765432


Q ss_pred             ----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          154 ----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       154 ----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                          ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..........     .....  ........
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-----~~~~~--~~~~~~~~  253 (327)
T 3lxl_A          182 DYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-----MGCER--DVPALSRL  253 (327)
T ss_dssp             SEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-----CC------CCHHHHH
T ss_pred             ccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-----ccccc--ccccHHHH
Confidence                22345688899999998765 67899999999999999999999996543321110     00000  00000000


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ........       .....+..++++.++|.+||+.||.+|||+++++++
T Consensus       254 ~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          254 LELLEEGQ-------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhccc-------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11111000       011235678999999999999999999999999654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-46  Score=340.10  Aligned_cols=248  Identities=21%  Similarity=0.335  Sum_probs=192.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCC---cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe-eCCEEEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSG---EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR-ENDILYFV   78 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv   78 (337)
                      +|++.+.||+|+||.||+|.+..++   ..||+|.+...........+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4788999999999999999876432   4589999876554455556678999999999999999999864 55678999


Q ss_pred             EeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC---
Q 038835           79 FEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP---  153 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~---  153 (337)
                      |||++++ +.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.......   
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~  249 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  249 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence            9999975 555555555668999999999999999999999999999999999999876 99999999998654322   


Q ss_pred             --CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          154 --PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       154 --~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                        ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....              
T Consensus       250 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--------------  314 (373)
T 3c1x_A          250 VHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------------  314 (373)
T ss_dssp             --------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--------------
T ss_pred             ccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--------------
Confidence              12335678899999998765 68999999999999999999 7899987766555444332110              


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                     ...+...+.++.++|.+||+.||.+|||+.|++++
T Consensus       315 ---------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 ---------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           01124567899999999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.4e-46  Score=323.60  Aligned_cols=244  Identities=27%  Similarity=0.447  Sum_probs=200.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.+. ++..||+|.+......  .....+|+.+++.++||||+++++++.+ +..++||||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            57999999999999999999976 5678999999765433  3455689999999999999999999864 458999999


Q ss_pred             cCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           82 MECNLYQLMKDRE--KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        82 ~~~~l~~~~~~~~--~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ++++.+..+....  ..+++..+..++.|++.||.|||++|++||||||+||+++.+ .+||+|||.+.......  ...
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE  168 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence            9876555544432  258999999999999999999999999999999999999877 99999999998765432  123


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+++.|+|||++.+. .++.++||||||+++|+|++ |.+||.+.+..+....+.....                   
T Consensus       169 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------  228 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-------------------  228 (279)
T ss_dssp             TCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred             CCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-------------------
Confidence            44678889999998655 67899999999999999999 9999998877666555432210                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                .......+.++.++|.+||+.||.+|||++++++
T Consensus       229 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                      0112457899999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=334.23  Aligned_cols=249  Identities=21%  Similarity=0.387  Sum_probs=194.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe----eCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR----ENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~l   77 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.... ........+|+.+++.++||||+++++++.    .....++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            57999999999999999999999999999999986532 223344568999999999999999999986    3357899


Q ss_pred             EEeecCCC-HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           78 VFEYMECN-LYQLMKD---REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        78 v~e~~~~~-l~~~~~~---~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ||||+.++ +.+.+..   .+..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            99999985 4444443   35669999999999999999999999999999999999999876 9999999988765321


Q ss_pred             CC----------CccccccccccCchhhcCcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCC
Q 038835          153 PP----------FTEYVSTRWYRAPEVLLQSY--LYSSKVDMWAMGAIMAELITLRPLFPGTSEA--DEIYKICSVIGTP  218 (337)
Q Consensus       153 ~~----------~~~~~gt~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~  218 (337)
                      ..          .....||+.|+|||++.+..  .++.++|||||||++|+|++|..||......  .....+..     
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----  262 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-----  262 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-----
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-----
Confidence            11          12345799999999986542  3688999999999999999999999431100  00000000     


Q ss_pred             CccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          219 TQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                     ....+         ..+..+.++.++|.+||+.||.+|||+++++++
T Consensus       263 ---------------~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 ---------------QLSIP---------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ---------------C--CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------cCCCC---------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                           00111         124578999999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.3e-46  Score=325.33  Aligned_cols=241  Identities=26%  Similarity=0.426  Sum_probs=190.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee-CCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE-NDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||++.+.  |+.||+|++....   ......+|+.++++++||||+++++++.. ++..++|||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            68999999999999999999774  8899999997643   23345689999999999999999998654 457899999


Q ss_pred             ecCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           81 YMEC-NLYQLMKDRE-KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        81 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |+++ ++.+.+.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ .+||+|||++.......  ..
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~  173 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DT  173 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--cC
Confidence            9997 5555554432 237999999999999999999999999999999999999876 99999999988654432  34


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+++.|+|||++.+. .++.++||||||+++|+|++ |.+||.+.+..+....+....                     
T Consensus       174 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------------------  231 (278)
T 1byg_A          174 GKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------------  231 (278)
T ss_dssp             --CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------------
T ss_pred             CCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------------
Confidence            4678899999998655 67999999999999999998 999998877655544432110                     


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                              ........++++.++|.+||+.||.+|||+.++++
T Consensus       232 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 --------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                    00112467899999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.8e-46  Score=331.41  Aligned_cols=262  Identities=26%  Similarity=0.375  Sum_probs=199.1

Q ss_pred             cCc-eEeeeecccCceEEEEEE----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee--CCE
Q 038835            2 ERY-KLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE--NDI   74 (337)
Q Consensus         2 ~~y-~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   74 (337)
                      ++| ++++.||+|+||.||++.    +..+|+.||+|++.............+|+.++++++||||+++++++.+  ...
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            355 999999999999998775    4457899999999876443444556789999999999999999999987  468


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      +++||||++++.+..+..... +++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+.......
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             EEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            999999999866666655444 8999999999999999999999999999999999999887 89999999998775443


Q ss_pred             C----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          154 P----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       154 ~----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      .    .....||+.|+|||++.+. .++.++|||||||++|+|++|..||........     ....... .... ....
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~-~~~~-~~~~  260 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQ-GQMT-VLRL  260 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCC-HHHH-HHHH
T ss_pred             cccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccc-cchh-HHHH
Confidence            2    2345688899999998765 678899999999999999999999965432110     0000000 0000 0000


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ........       ........+.++.++|.+||+.||.+|||++|+++
T Consensus       261 ~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          261 TELLERGE-------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccc-------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            01111000       01122567899999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-45  Score=344.48  Aligned_cols=249  Identities=21%  Similarity=0.282  Sum_probs=201.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCC-CCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-PNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.+..+|+.||||++......   ....+|+.+++.|.| +++..+..++...+..++|||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            6899999999999999999999999999999987654332   234689999999976 556666666778889999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeee---C-CcEEEeeCCCcccCCCCCC--
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVS---K-DTIKIADFGLAREINSRPP--  154 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~---~-~~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |+++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||++   . +.+||+|||++........  
T Consensus        84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (483)
T 3sv0_A           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ  163 (483)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence            997777777776666799999999999999999999999999999999999994   3 3899999999986644321  


Q ss_pred             ------CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCccchhh
Q 038835          155 ------FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE---IYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       155 ------~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~  225 (337)
                            .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......   +..+.......       
T Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-------  235 (483)
T 3sv0_A          164 HIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT-------  235 (483)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-------
T ss_pred             ccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-------
Confidence                  2357899999999998765 689999999999999999999999988655322   22222210000       


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                        ........++.++.++|..||+.||.+||++++|++
T Consensus       236 ------------------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          236 ------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             ------------------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ------------------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                              011112456899999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-45  Score=344.43  Aligned_cols=244  Identities=29%  Similarity=0.466  Sum_probs=197.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++. +..||+|++......  ...+.+|+.++++++||||+++++++.+ +..++||||
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            579999999999999999999875 467999999875443  3345789999999999999999999876 668999999


Q ss_pred             cCCC-HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           82 MECN-LYQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        82 ~~~~-l~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ++++ +.+.+.. .+..+++..+..++.||+.||+|||++|++||||||+|||++.+ .+||+|||++.......  ...
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence            9875 5555543 23568999999999999999999999999999999999999876 99999999998764332  123


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......                  
T Consensus       340 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------------  400 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------------  400 (452)
T ss_dssp             ---CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------
T ss_pred             CCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence            34567889999998765 68999999999999999999 99999998877766655332111                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 ..++..++++.++|.+||+.||.+|||++++++
T Consensus       401 -----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          401 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                       012456789999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=324.48  Aligned_cols=239  Identities=33%  Similarity=0.513  Sum_probs=186.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||++.+.  ++.||+|++...   .......+|+.++++++||||+++++++.+  ..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            58999999999999999999875  788999998653   234455789999999999999999998864  47899999


Q ss_pred             cCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---cCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCC
Q 038835           82 MECNLYQLMKDREK---CFSEAEVRNWCFQVFQGLAYMHQ---RGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRP  153 (337)
Q Consensus        82 ~~~~l~~~~~~~~~---~l~~~~~~~~~~qil~al~~LH~---~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~  153 (337)
                      ++++.+..+.....   .+++..++.++.||+.||.|||+   +|++||||||+||+++.+  .+||+|||.+...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            98755554444332   47899999999999999999999   899999999999999876  4899999999765433 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCCccchhhhhhhHH
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE--IYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                       .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||........  ...+..                  
T Consensus       160 -~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------------  219 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN------------------  219 (307)
T ss_dssp             ------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT------------------
T ss_pred             -cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc------------------
Confidence             2345799999999998765 689999999999999999999999976543221  111110                  


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                         ...+        ...+..+.++.++|.+||+.||.+|||++++++
T Consensus       220 ---~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          220 ---GTRP--------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ---TCCC--------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CCCC--------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence               0001        112467899999999999999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.6e-46  Score=327.63  Aligned_cols=249  Identities=27%  Similarity=0.377  Sum_probs=188.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhc--CCCCCcccceeEEee----CCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK--MSHPNIVKLKEVIRE----NDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~   75 (337)
                      ++|++++.||+|+||.||+|.+  +|+.||+|++....    .....+|.+++..  ++||||+++++++..    ....
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            5899999999999999999987  68999999987542    2233455555555  899999999998643    3568


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH--------QRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH--------~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      ++||||++++.+..+.+. ..+++..++.++.||+.||+|||        ++|++||||||+|||++.+ .+||+|||+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999998655555443 35899999999999999999999        9999999999999999876 9999999999


Q ss_pred             ccCCCCCC-----CccccccccccCchhhcCcC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCCcH-
Q 038835          147 REINSRPP-----FTEYVSTRWYRAPEVLLQSY-----LYSSKVDMWAMGAIMAELITL----------RPLFPGTSEA-  205 (337)
Q Consensus       147 ~~~~~~~~-----~~~~~gt~~~~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g----------~~pf~~~~~~-  205 (337)
                      ........     .....||+.|+|||++.+..     .++.++|||||||++|+|++|          .+||.+.... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            75543321     23458999999999987653     234689999999999999999          8888654321 


Q ss_pred             ---HHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          206 ---DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       206 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                         +...........                   .+   ..+........++++.++|.+||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~-------------------~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQ-------------------RP---NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCHHHHHHHHTTSCC-------------------CC---CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cchhhhhHHHhccCC-------------------CC---CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence               122111111000                   00   00111111234578999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-45  Score=324.78  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=193.4

Q ss_pred             cCceEeeeecccCceEEEEEEECC-CCc--EEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-SGE--VVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-~~~--~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.+.. +++  .||+|++......  .......+|+.++++++||||+++++++..+. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            589999999999999999998643 333  6899998765332  23445578999999999999999999998765 78


Q ss_pred             EEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           77 FVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        77 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      +||||+++ ++.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+........
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  176 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  176 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence            99999986 5666666655669999999999999999999999999999999999999866 899999999987654332


Q ss_pred             ----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          155 ----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       155 ----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                          .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+......+           
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  244 (291)
T 1u46_A          177 HYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------  244 (291)
T ss_dssp             EEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-----------
T ss_pred             chhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC-----------
Confidence                2345678899999998755 57899999999999999999 999999888766655543211000           


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                       ......+.++.++|.+||..||.+|||+.+++++
T Consensus       245 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          245 -----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                             1124678999999999999999999999999973

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=352.44  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             CceEee-eecccCceEEEEEEEC--CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            3 RYKLIK-EVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         3 ~y~~~~-~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++.+.. .||+|+||.||+|.++  .++..||+|+++..........+.+|++++++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            345555 7999999999999875  45667999999876544445566799999999999999999999876 5689999


Q ss_pred             eecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC--
Q 038835           80 EYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF--  155 (337)
Q Consensus        80 e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~--  155 (337)
                      ||++++.+ +.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.........  
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            99998655 4555555669999999999999999999999999999999999999876 8999999999876533211  


Q ss_pred             --ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          156 --TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       156 --~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                        ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......               
T Consensus       495 ~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------------  558 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---------------  558 (613)
T ss_dssp             -------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---------------
T ss_pred             eccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence              223456889999998765 78999999999999999998 99999998887776665432110               


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                    ..++..++++.++|..||..||.+|||+.++++
T Consensus       559 --------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          559 --------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             --------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             --------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                          112457899999999999999999999999854

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.8e-46  Score=329.56  Aligned_cols=248  Identities=21%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.+..   .+|+|++....... ......+|+.++++++||||+++++++.+.+..++|||
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            689999999999999999998763   49999987643322 12233579999999999999999999999999999999


Q ss_pred             ecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCC------CC
Q 038835           81 YMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINS------RP  153 (337)
Q Consensus        81 ~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~------~~  153 (337)
                      |++++.+..+. .....+++..++.++.||+.||+|||++|++||||||+||+++++.+||+|||++.....      ..
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~~  189 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRRED  189 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------CC
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcccccccccccccc
Confidence            99875555444 444479999999999999999999999999999999999999988999999999765432      12


Q ss_pred             CCccccccccccCchhhcC--------cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          154 PFTEYVSTRWYRAPEVLLQ--------SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      ......||+.|+|||++.+        ...++.++|||||||++|+|++|..||.+....+....+.....         
T Consensus       190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------  260 (319)
T 2y4i_B          190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK---------  260 (319)
T ss_dssp             SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC---------
T ss_pred             ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC---------
Confidence            2344579999999999864        23578899999999999999999999998877666554432210         


Q ss_pred             hhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                  +.       ......+.++.++|.+||..||.+|||+.++++.
T Consensus       261 ------------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          261 ------------PN-------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             ------------CC-------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             ------------CC-------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                        00       0113567899999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.7e-45  Score=352.25  Aligned_cols=241  Identities=22%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             eeecccCceEEEEEEE--CCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAIS--KQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      +.||+|+||.||+|.+  +.+++.||+|+++...... ....+.+|+.++++++||||++++++++. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954  5677899999998754433 23455789999999999999999999865 457899999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC----Ccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP----FTEYV  159 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~----~~~~~  159 (337)
                      +.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|........    .....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~  533 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK  533 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence            7665555566679999999999999999999999999999999999999876 899999999987654321    23345


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......                     
T Consensus       534 ~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------------------  591 (635)
T 4fl3_A          534 WPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------------------  591 (635)
T ss_dssp             -CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------------
T ss_pred             CceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------------
Confidence            67889999998665 68999999999999999998 99999998887766655432111                     


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                              ......++++.++|..||+.||.+|||++++++
T Consensus       592 --------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                    112457899999999999999999999999976

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.4e-45  Score=326.56  Aligned_cols=258  Identities=25%  Similarity=0.313  Sum_probs=197.2

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC---ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY---SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      |..++.||+|+||.||+|.+  +++.||+|++.....   ........+|+.++++++||||+++++++.+.+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44568999999999999976  588999999875432   2233455689999999999999999999999999999999


Q ss_pred             ecCCC-HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           81 YMECN-LYQLMKD--REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        81 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |++++ +.+.+..  ...++++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||.+........  
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            99865 4454442  23469999999999999999999999999999999999999887 999999999986654321  


Q ss_pred             -CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 -FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 -~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                       .....||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+....+......... .+.      ...
T Consensus       191 ~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~------~~~  261 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK-TIE------DYI  261 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC-CHH------HHS
T ss_pred             cccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh-hhh------hhc
Confidence             234579999999998864  3689999999999999999999999876554333332221111000 000      000


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...        ........+..+.+++.+||+.||.+|||+++++++
T Consensus       262 ~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          262 DKK--------MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CSS--------CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccc--------ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            000        011112345678999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=323.10  Aligned_cols=263  Identities=24%  Similarity=0.384  Sum_probs=200.3

Q ss_pred             cCceEeeeecccCceEEEEEE----ECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC--CEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAI----SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN--DIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~   75 (337)
                      ++|++++.||+|+||.||+|.    +..+|+.||+|++.... ........+|+.++++++||||+++++++...  ...
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            469999999999999999998    56789999999987642 33344557899999999999999999998654  368


Q ss_pred             EEEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           76 YFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      ++||||+++ ++.+.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||++.......
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            999999987 5555555555669999999999999999999999999999999999999876 99999999998765443


Q ss_pred             C----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          154 P----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       154 ~----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      .    .....++..|+|||++.+. .++.++|||||||++|+|++|..||.....     ......+......+..... 
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-  272 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQMIVFHL-  272 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHHHHHHH-
T ss_pred             cccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhhhHHHH-
Confidence            2    2335678889999998765 578999999999999999999999864321     1111122222111111000 


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .........       ....+..+.++.++|.+||+.||.+|||+.|+++
T Consensus       273 ~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          273 IELLKNNGR-------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHTTCC-------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhcCCC-------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            011110000       0112467899999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-46  Score=345.82  Aligned_cols=246  Identities=15%  Similarity=0.150  Sum_probs=191.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCC-CCcccc---------ee---
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSH-PNIVKL---------KE---   67 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h-~~iv~~---------~~---   67 (337)
                      +|++.+.||+|+||.||+|.+..+|+.||||++.......  ....+.+|+.+++.+.| +|...+         .+   
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4788999999999999999999999999999987433222  13345689999999976 322111         11   


Q ss_pred             ---------EEee-----CCEEEEEEeecCCCHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 038835           68 ---------VIRE-----NDILYFVFEYMECNLYQLMK------DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLK  127 (337)
Q Consensus        68 ---------~~~~-----~~~~~lv~e~~~~~l~~~~~------~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dik  127 (337)
                               ++..     ....+++|+++.+++.+.+.      ..+..+++..+..++.||+.||+|||++||+|||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK  238 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR  238 (413)
T ss_dssp             CCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence                     1111     23468899998888877763      224457888999999999999999999999999999


Q ss_pred             CCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccccccCchhhc---------CcCCCCCcchHHHHHHHHHHHHhCCC
Q 038835          128 PENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL---------QSYLYSSKVDMWAMGAIMAELITLRP  197 (337)
Q Consensus       128 p~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~---------~~~~~~~~~DiwslG~il~~ll~g~~  197 (337)
                      |+|||++.+ .+||+|||++...+..  ....+| +.|+|||++.         ....++.++|||||||++|+|++|+.
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~  315 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL  315 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             cceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence            999999987 9999999998876543  345678 9999999984         33357889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q 038835          198 LFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA  277 (337)
Q Consensus       198 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  277 (337)
                      ||.+.+..+....+                         +         .....+++++.++|.+||+.||.+|||+.++
T Consensus       316 Pf~~~~~~~~~~~~-------------------------~---------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          316 PNTDDAALGGSEWI-------------------------F---------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             CCCTTGGGSCSGGG-------------------------G---------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCcchhhhHHHH-------------------------H---------hhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            99776432111000                         0         0123578999999999999999999999999


Q ss_pred             hcCcCccc
Q 038835          278 LQHPFSRV  285 (337)
Q Consensus       278 l~hp~~~~  285 (337)
                      ++||||+.
T Consensus       362 l~~~~~~~  369 (413)
T 3dzo_A          362 METPEYEQ  369 (413)
T ss_dssp             TTSHHHHH
T ss_pred             HhCHHHHH
Confidence            99999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=335.11  Aligned_cols=275  Identities=24%  Similarity=0.295  Sum_probs=187.4

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe-----eCCEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR-----ENDIL   75 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (337)
                      +++|++++.||+|+||.||+|.+  +|+.||+|++.....  .......|+..+..++||||+++++.+.     ....+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            57899999999999999999966  689999999875421  1112234555556689999999998653     23467


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR---------GYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~---------~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                      ++||||++++.+..+..... .++..++.++.||+.||.|||++         ||+||||||+|||++.+ .+||+|||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            99999998755554444433 58999999999999999999999         99999999999999986 999999999


Q ss_pred             cccCCCC---------CCCccccccccccCchhhcCc------CCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHH
Q 038835          146 AREINSR---------PPFTEYVSTRWYRAPEVLLQS------YLYSSKVDMWAMGAIMAELITLRPLF-PGTSEADEIY  209 (337)
Q Consensus       146 a~~~~~~---------~~~~~~~gt~~~~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~  209 (337)
                      +......         ......+||+.|+|||++.+.      ..++.++|||||||++|+|++|..|| .+....+...
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            9765432         122356799999999998752      24567899999999999999996555 3332211110


Q ss_pred             HHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHh------cCcCc
Q 038835          210 KICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEAL------QHPFS  283 (337)
Q Consensus       210 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell------~hp~~  283 (337)
                      ......+..+.  .......... ....+...  .........++++.++|.+||+.||.+|||++|++      .++|-
T Consensus       247 ~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          247 AFQTEVGNHPT--FEDMQVLVSR-EKQRPKFP--EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             TTHHHHCSSCC--HHHHHHHHTT-SCCCCCCC--TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hhhcccCCCch--HHHHHhhhcc-cccCCCCC--cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            01111111100  0000000000 00000000  00000112345799999999999999999999994      46666


Q ss_pred             cc
Q 038835          284 RV  285 (337)
Q Consensus       284 ~~  285 (337)
                      ++
T Consensus       322 ~~  323 (336)
T 3g2f_A          322 RN  323 (336)
T ss_dssp             C-
T ss_pred             hc
Confidence            54

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=332.09  Aligned_cols=241  Identities=12%  Similarity=0.167  Sum_probs=188.9

Q ss_pred             cCceEeeeecccCceEEEEE-----EECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC---CCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS---HPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~   73 (337)
                      ++|.+.+.||+|+||.||+|     .+..+++.||+|++....    ......|+.+++.+.   |+||+++++++..++
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            47999999999999999999     467789999999997542    223456777777776   899999999999999


Q ss_pred             EEEEEEeecCCCHH-HHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC-----------C-
Q 038835           74 ILYFVFEYMECNLY-QLMKD----REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK-----------D-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~l~-~~~~~----~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~-----------~-  136 (337)
                      ..++||||++++.+ +.+..    ....+++..++.++.||+.||+|||++||+||||||+|||++.           + 
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence            99999999987544 44443    3456999999999999999999999999999999999999977           4 


Q ss_pred             cEEEeeCCCcccCC---CCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 038835          137 TIKIADFGLAREIN---SRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS  213 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~---~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  213 (337)
                      .+||+|||+|....   ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......       
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------  292 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------  292 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence            89999999996543   33334567899999999998776 58999999999999999999999995432210       


Q ss_pred             HhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 038835          214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHP  281 (337)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  281 (337)
                               |.        ....++.          ...++.+.+++..||..+|.+|++..+.+.+.
T Consensus       293 ---------~~--------~~~~~~~----------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          293 ---------CK--------PEGLFRR----------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             ---------EE--------ECSCCTT----------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             ---------ee--------echhccc----------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence                     00        0000000          12356789999999999999997665555543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.8e-45  Score=345.84  Aligned_cols=244  Identities=29%  Similarity=0.467  Sum_probs=202.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++.+.||+|+||.||+|.++. +..||+|++......  ...+.+|+.+|++++||||+++++++.+ +..++||||
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            579999999999999999999875 467999999875543  3346789999999999999999999876 678999999


Q ss_pred             cCCC-HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           82 MECN-LYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        82 ~~~~-l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      +.++ +.+.+... +..+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||++.......  ...
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence            9874 55555432 3568999999999999999999999999999999999999876 99999999998664321  113


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...++..|+|||++... .++.++|||||||++|+|++ |..||.+....+....+......                  
T Consensus       423 ~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------------  483 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------------  483 (535)
T ss_dssp             STTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC------------------
T ss_pred             CCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence            34567889999998765 68999999999999999999 99999998877766655332111                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                 ...+..+.++.++|.+||+.||.+|||++++++
T Consensus       484 -----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          484 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                       012456889999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-44  Score=349.74  Aligned_cols=248  Identities=28%  Similarity=0.423  Sum_probs=202.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCC---CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++++.||+|+||.||+|.+..+   +..||+|.+.............+|+.++++++||||+++++++. ++..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            5799999999999999999998654   45799999876543334455678999999999999999999985 4568999


Q ss_pred             EeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |||++++ +.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++........  
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~  548 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK  548 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCccee
Confidence            9999965 555555455569999999999999999999999999999999999999876 999999999987654332  


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+....+......                
T Consensus       549 ~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----------------  611 (656)
T 2j0j_A          549 ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------------  611 (656)
T ss_dssp             -----CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----------------
T ss_pred             ccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            2335677899999998765 78999999999999999997 99999998887776665442111                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                   ...+..++++.++|.+||..||.+|||+.++++.
T Consensus       612 -------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          612 -------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                         1124578999999999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=324.48  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=185.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhc--CCCCCcccceeEEeeC----CEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK--MSHPNIVKLKEVIREN----DIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~   75 (337)
                      ++|++++.||+|+||.||+|.+.  |+.||+|++....    .....+|..++..  ++||||+++++++...    ...
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            57999999999999999999875  8999999986432    2223345555554  4999999999999877    789


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR--------GYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~--------~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      ++||||++++.+..+.... .+++..++.++.|++.||.|||++        |++||||||+|||++.+ .+||+|||++
T Consensus       111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            9999999885554444433 489999999999999999999999        99999999999999876 9999999999


Q ss_pred             ccCCCCCC-----CccccccccccCchhhcCcCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCCCcH
Q 038835          147 REINSRPP-----FTEYVSTRWYRAPEVLLQSYLYSSK------VDMWAMGAIMAELITL----------RPLFPGTSEA  205 (337)
Q Consensus       147 ~~~~~~~~-----~~~~~gt~~~~aPE~~~~~~~~~~~------~DiwslG~il~~ll~g----------~~pf~~~~~~  205 (337)
                      ........     .....||+.|+|||++.+. .++..      +|||||||++|+|++|          ..||......
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~  268 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS  268 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence            76543322     1356899999999998765 33444      9999999999999999          6666543221


Q ss_pred             ----HHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          206 ----DEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       206 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                          +.........                    ....  ..+........++++.++|.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~~~~~~~~--------------------~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          269 DPSYEDMREIVCIK--------------------KLRP--SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SCCHHHHHHHHTTS--------------------CCCC--CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCchhhhHHHHhhh--------------------ccCc--cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                1111111000                    0000  000001112445779999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.1e-47  Score=339.69  Aligned_cols=245  Identities=19%  Similarity=0.202  Sum_probs=185.7

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-------hHHhHHHHHHHHHhcCC---------CCCcccc
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-------WEECVNLREVKSLRKMS---------HPNIVKL   65 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~---------h~~iv~~   65 (337)
                      ++|++++.||+|+||.||+|.+  +|+.||+|++......       .......+|+.+++.++         ||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999987  6899999999865421       11234567888888775         5555555


Q ss_pred             ee-----------------EEee-------------CCEEEEEEeecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHH
Q 038835           66 KE-----------------VIRE-------------NDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLA  114 (337)
Q Consensus        66 ~~-----------------~~~~-------------~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~  114 (337)
                      .+                 ++.+             .+..|+||||++++ +++.+.+  ..+++..++.+++||+.||.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            44                 4433             68899999999876 6666644  45899999999999999999


Q ss_pred             HHH-HcCccccCCCCCCeeeeCC---------------------cEEEeeCCCcccCCCCCCCccccccccccCchhhcC
Q 038835          115 YMH-QRGYFHRDLKPENLLVSKD---------------------TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ  172 (337)
Q Consensus       115 ~LH-~~~i~H~dikp~Nili~~~---------------------~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~  172 (337)
                      ||| ++||+||||||+|||++.+                     .+||+|||+|......    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 9999999999999999865                     7999999999876542    4589999999999876


Q ss_pred             cCCCCCcchHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCC
Q 038835          173 SYLYSSKVDMWAMGAI-MAELITLRPLFPGTSEAD-EIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMP  250 (337)
Q Consensus       173 ~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (337)
                      . . +.++||||+|++ .++++.|..||.+..... ....+.....                    +.   .......++
T Consensus       252 ~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------~~---~~~~~~~~~  306 (336)
T 2vuw_A          252 D-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT--------------------FK---TKCNTPAMK  306 (336)
T ss_dssp             C-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC--------------------CS---SCCCSHHHH
T ss_pred             C-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc--------------------cC---cccchhhhh
Confidence            5 3 889999998777 778889999994321111 1111111100                    00   001111223


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHh-cCcCcc
Q 038835          251 SANKDAVSLIASLCSWDPSKRPTAAEAL-QHPFSR  284 (337)
Q Consensus       251 ~~~~~~~~li~~~L~~dP~~Rpt~~ell-~hp~~~  284 (337)
                      .+++++++||.+||++|     |++|+| +||||+
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            46789999999999976     999999 999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.9e-44  Score=320.38  Aligned_cols=250  Identities=27%  Similarity=0.353  Sum_probs=191.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhc--CCCCCcccceeEEeeCC----EE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK--MSHPNIVKLKEVIREND----IL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~   75 (337)
                      ++|++.+.||+|+||.||+|.+  +|+.||+|++...    ......+|+.+++.  ++||||+++++++....    ..
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            4799999999999999999987  5899999998654    23344578888877  79999999999998765    79


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCCeeeeCC-cEEEeeCCCc
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH--------QRGYFHRDLKPENLLVSKD-TIKIADFGLA  146 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH--------~~~i~H~dikp~Nili~~~-~~kL~Dfg~a  146 (337)
                      ++||||++++.+..+.... .+++..++.++.|++.||.|||        ++|++||||||+||+++.+ .+||+|||++
T Consensus       116 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  194 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  194 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence            9999999985554444433 4899999999999999999999        8999999999999999876 9999999999


Q ss_pred             ccCCCCC-----CCccccccccccCchhhcCcCC-----CCCcchHHHHHHHHHHHHhC----------CCCCCCCCc--
Q 038835          147 REINSRP-----PFTEYVSTRWYRAPEVLLQSYL-----YSSKVDMWAMGAIMAELITL----------RPLFPGTSE--  204 (337)
Q Consensus       147 ~~~~~~~-----~~~~~~gt~~~~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~~~~--  204 (337)
                      .......     ......||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||.....  
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            7665433     2345689999999999876422     23689999999999999999          778866432  


Q ss_pred             --HHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          205 --ADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       205 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                        .+........  ...                 .+..   +........+..+.++|.+||+.||.+|||+.+++++
T Consensus       275 ~~~~~~~~~~~~--~~~-----------------~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          275 PSVEEMRKVVCE--QKL-----------------RPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCHHHHHHHHTT--SCC-----------------CCCC---CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHHHH--HHh-----------------CCCC---cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence              1111111100  000                 0000   0000012234678999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.3e-45  Score=356.40  Aligned_cols=240  Identities=23%  Similarity=0.374  Sum_probs=197.9

Q ss_pred             cCceEeeeecccCceEEEEEEECC-CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCE-----E
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDI-----L   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~   75 (337)
                      ++|++++.||+|+||.||+|.++. +|+.||+|++.............+|+.++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            589999999999999999999976 7999999998764333334455789999999999999999999986654     7


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCCCC
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPF  155 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~~~  155 (337)
                      |+||||++|+.+......  .+++..++.++.||+.||.|||++||+||||||+|||++.+.+||+|||++......   
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~---  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF---  234 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC---
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC---
Confidence            999999998766555443  589999999999999999999999999999999999999999999999999876544   


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+.....                             
T Consensus       235 ~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------------------  283 (681)
T 2pzi_A          235 GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------------------  283 (681)
T ss_dssp             SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------------------
T ss_pred             CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc-----------------------------
Confidence            456899999999998654  3889999999999999999999986532100                             


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                       .+..      ......++.+.++|.+||+.||.+||+..+.+.|+|+.
T Consensus       284 -~~~~------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 -LPED------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -CCTT------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -cccc------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence             0000      00012357899999999999999999999999998874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.6e-43  Score=305.62  Aligned_cols=226  Identities=15%  Similarity=0.092  Sum_probs=181.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.......  ......+|+..+++++||||+++++++..++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999999999999999998765432  2244568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY  158 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~  158 (337)
                      ||++|+.+..+.+.+  ..+.++..++.||+.||+|||++||+||||||+|||++.+ .+||++++              
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence            999976665555443  4667789999999999999999999999999999999876 88887543              


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                           |++        .++.++|||||||++|+|++|+.||.+.+..+.+...                       ....
T Consensus       175 -----~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----------------------~~~~  218 (286)
T 3uqc_A          175 -----TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----------------------ERDT  218 (286)
T ss_dssp             -----CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----------------------CBCT
T ss_pred             -----ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----------------------HHHh
Confidence                 222        3588999999999999999999999876542110000                       0000


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...........+.+++++.++|.+||+.||.+| |+.|+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            000111223346788999999999999999999 99999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.1e-36  Score=287.97  Aligned_cols=184  Identities=15%  Similarity=0.060  Sum_probs=131.1

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccCC---------hHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEE
Q 038835           10 VGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS---------WEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus        10 ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      .+.|+.|.+..+.....|+.+++|++.+....         .....+.+|+++|+++ .|+||+++++++++++.+||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            56677777777788888999999999764321         1123346899999999 7999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~  157 (337)
                      ||++|+.+..+..+++++++.   .|+.||+.||+|||++|||||||||+|||++.+ .+||+|||+|+..... ....+
T Consensus       322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t  398 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTN  398 (569)
T ss_dssp             ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHH
T ss_pred             ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccC
Confidence            999997777666667778765   478999999999999999999999999999876 9999999999876543 34466


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL  198 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  198 (337)
                      .+||+.|+|||++.+.  +..++|+||+|++++.+.++..+
T Consensus       399 ~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          399 LVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             ceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence            7999999999998754  46789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=7.7e-30  Score=241.55  Aligned_cols=183  Identities=20%  Similarity=0.201  Sum_probs=140.5

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-------HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-------ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ..+.||+|+||.||++  ...++.+++|..........       .....+|+.++++++||||+++..+....+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3568999999999999  44578899998654332211       12346899999999999999666666667777999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCCC----
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPP----  154 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~~----  154 (337)
                      |||++|+.+..+...        +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|........    
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHHHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCccccccc
Confidence            999997655555443        5689999999999999999999999999999999 999999999998765321    


Q ss_pred             ----CccccccccccCchhhcCc-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 038835          155 ----FTEYVSTRWYRAPEVLLQS-YLYSSKVDMWAMGAIMAELITLRPLF  199 (337)
Q Consensus       155 ----~~~~~gt~~~~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  199 (337)
                          ....+||+.|+|||++... ..|+..+|+|+..+-..+...++.+|
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                1356899999999998751 24677889999999988888877666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.7e-26  Score=200.00  Aligned_cols=145  Identities=21%  Similarity=0.188  Sum_probs=113.5

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----------------HHhHHHHHHHHHhcCCCCCcccc
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----------------EECVNLREVKSLRKMSHPNIVKL   65 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~iv~~   65 (337)
                      .|.+++.||+|+||.||+|.+ .+|+.||+|+++......                 ......+|+.++++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            356679999999999999999 889999999996532211                 2334568999999999  5 677


Q ss_pred             eeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCC
Q 038835           66 KEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGL  145 (337)
Q Consensus        66 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~  145 (337)
                      .+++.. +..|+||||++|+.+..+ .    .  .....++.|++.||.|||++||+||||||+|||++.+.+||+|||+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~l-~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~DFG~  238 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYRV-R----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQ  238 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGGC-C----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTT
T ss_pred             CeEEec-cceEEEEEecCCCcHHHc-c----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEECCC
Confidence            776654 445999999998655433 1    1  2355799999999999999999999999999999955999999999


Q ss_pred             cccCCCCCCCccccccccccCchhhc
Q 038835          146 AREINSRPPFTEYVSTRWYRAPEVLL  171 (337)
Q Consensus       146 a~~~~~~~~~~~~~gt~~~~aPE~~~  171 (337)
                      |...            ..+.|||.+.
T Consensus       239 a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          239 SVEV------------GEEGWREILE  252 (282)
T ss_dssp             CEET------------TSTTHHHHHH
T ss_pred             CeEC------------CCCCHHHHHH
Confidence            8743            3467899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=1.3e-23  Score=180.88  Aligned_cols=140  Identities=14%  Similarity=0.158  Sum_probs=106.4

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcE--EEEEEcccccCCh-----------------------HHhHHHHHHHHHhcCC
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSW-----------------------EECVNLREVKSLRKMS   58 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~   58 (337)
                      |.+.+.||+|+||.||+|.+..+|+.  ||+|+++......                       ......+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67899999999999999998778999  9999875432110                       0123468999999998


Q ss_pred             CCCcccceeEEeeCCEEEEEEeecCC-C----HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCCee
Q 038835           59 HPNIVKLKEVIRENDILYFVFEYMEC-N----LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH-QRGYFHRDLKPENLL  132 (337)
Q Consensus        59 h~~iv~~~~~~~~~~~~~lv~e~~~~-~----l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH-~~~i~H~dikp~Nil  132 (337)
                      |+++....-+..  +..++||||+++ +    .+......   .++..+..++.|++.||.||| +.||+||||||+|||
T Consensus       129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NIL  203 (258)
T 1zth_A          129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIM  203 (258)
T ss_dssp             HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEE
T ss_pred             hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence            876532222222  245899999953 2    34333221   245678899999999999999 999999999999999


Q ss_pred             eeCCcEEEeeCCCcccC
Q 038835          133 VSKDTIKIADFGLAREI  149 (337)
Q Consensus       133 i~~~~~kL~Dfg~a~~~  149 (337)
                      ++. .++|+|||+|...
T Consensus       204 l~~-~~~liDFG~a~~~  219 (258)
T 1zth_A          204 YID-KVYFIDMGQAVTL  219 (258)
T ss_dssp             ESS-SEEECCCTTCEET
T ss_pred             EcC-cEEEEECcccccC
Confidence            999 9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.81  E-value=1.2e-19  Score=162.46  Aligned_cols=138  Identities=12%  Similarity=0.183  Sum_probs=99.5

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-------------hHHh--------HHHHHHHHHhcCCCCCc
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-------------WEEC--------VNLREVKSLRKMSHPNI   62 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~--------~~~~e~~~l~~l~h~~i   62 (337)
                      |.++++||.|++|.||+|.+. +|+.||||+++.....             ....        ...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6999999987542111             0000        11356777777755444


Q ss_pred             ccceeEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCc-----
Q 038835           63 VKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDT-----  137 (337)
Q Consensus        63 v~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~-----  137 (337)
                      ....-+....  .+|||||++|..+..+.      ..+....++.||+.+|.+||++|||||||||.|||++.+.     
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            3322222222  26999999986653322      2234567889999999999999999999999999997652     


Q ss_pred             ------EEEeeCCCcccCC
Q 038835          138 ------IKIADFGLAREIN  150 (337)
Q Consensus       138 ------~kL~Dfg~a~~~~  150 (337)
                            +.|+||+-+....
T Consensus       248 ~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TSEEEEEEECCCTTCEETT
T ss_pred             cccccceEEEEeCCcccCC
Confidence                  8999999887654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=1.9e-13  Score=117.44  Aligned_cols=138  Identities=15%  Similarity=0.189  Sum_probs=108.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +.|++...++.|+.+.||++...  |..+++|+....... ......+|+.+++.+ .+..+.++++++.+.+..|+|||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            56888999999999999999643  678999998753211 122356899999988 46778899999998999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ------------------------------------------  118 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~------------------------------------------  118 (337)
                      |++|..+.....     +......++.++..+|..||+                                          
T Consensus        91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            999976654421     223345788999999999998                                          


Q ss_pred             -----------------cCccccCCCCCCeeeeCCc-EEEeeCCCcc
Q 038835          119 -----------------RGYFHRDLKPENLLVSKDT-IKIADFGLAR  147 (337)
Q Consensus       119 -----------------~~i~H~dikp~Nili~~~~-~kL~Dfg~a~  147 (337)
                                       ..++|+|++|.||+++.+. +.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             4589999999999998875 5699999765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.34  E-value=5.7e-12  Score=107.81  Aligned_cols=133  Identities=13%  Similarity=0.082  Sum_probs=96.7

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC--cccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN--IVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e   80 (337)
                      .|.+....+.|..+.||++.. .+|..+++|+.....    .....+|+.+++.+.+.+  +.+++++...++..++|||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            456555445667799999964 467789999976541    123457889988885434  5668888887788999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG----------------------------------------  120 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~----------------------------------------  120 (337)
                      |++|..+.  ...   .+   ...++.++..+|..||+..                                        
T Consensus        96 ~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           96 EVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             CCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             ecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            99996654  111   22   2356677778888888643                                        


Q ss_pred             ------------------ccccCCCCCCeeeeCCc-EEEeeCCCccc
Q 038835          121 ------------------YFHRDLKPENLLVSKDT-IKIADFGLARE  148 (337)
Q Consensus       121 ------------------i~H~dikp~Nili~~~~-~kL~Dfg~a~~  148 (337)
                                        ++|+|++|.||+++.+. +.|+||+.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              99999999999998885 46999997653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=1.3e-11  Score=110.98  Aligned_cols=140  Identities=14%  Similarity=0.222  Sum_probs=102.9

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcc--cccCChHHhHHHHHHHHHhcCC--CCCcccceeEEeeC---CEEEEE
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMK--KKYYSWEECVNLREVKSLRKMS--HPNIVKLKEVIREN---DILYFV   78 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv   78 (337)
                      .++.|+.|.++.||++...  +..+++|+..  ............+|+.+++.|.  +..+.+++.++.+.   +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4678999999999999754  4678899876  4322222334467999999886  34578888887765   457999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ----------------------------------------  118 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~----------------------------------------  118 (337)
                      |||++|..+..  .....+++.....++.++..+|..||+                                        
T Consensus       120 me~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            99999865421  112337888899999999999999997                                        


Q ss_pred             ------------------cCccccCCCCCCeeeeCC--c-EEEeeCCCcccC
Q 038835          119 ------------------RGYFHRDLKPENLLVSKD--T-IKIADFGLAREI  149 (337)
Q Consensus       119 ------------------~~i~H~dikp~Nili~~~--~-~kL~Dfg~a~~~  149 (337)
                                        ..++|+|++|.||+++.+  . +.|+||+.+...
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              358999999999999865  2 689999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.17  E-value=4e-11  Score=105.17  Aligned_cols=183  Identities=15%  Similarity=0.136  Sum_probs=118.3

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCC--cccceeEEeeCC---EEEEEEe
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPN--IVKLKEVIREND---ILYFVFE   80 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e   80 (337)
                      ++.++.|..+.||++.     ..+++|+....   .......+|+.+++.+ .+..  +.+++......+   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            4568899999999872     46889986543   2234456899999887 3333  334444433332   3489999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ------------------------------------------  118 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~------------------------------------------  118 (337)
                      +++|..+.....  ..++..+...++.|+...|..||+                                          
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999965432211  236788888889999999998886                                          


Q ss_pred             ----------------cCccccCCCCCCeeeeC--C-cEEEeeCCCcccCCCCCCCccccccccccCchhhc---CcC-C
Q 038835          119 ----------------RGYFHRDLKPENLLVSK--D-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL---QSY-L  175 (337)
Q Consensus       119 ----------------~~i~H~dikp~Nili~~--~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~---~~~-~  175 (337)
                                      ..++|+|++|.||+++.  + .+.|+||+.+....+...+........-.+|+...   ... .
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                            13699999999999997  5 57899999887643321111100000002232211   100 0


Q ss_pred             ---------CCCcchHHHHHHHHHHHHhCCCCC
Q 038835          176 ---------YSSKVDMWAMGAIMAELITLRPLF  199 (337)
Q Consensus       176 ---------~~~~~DiwslG~il~~ll~g~~pf  199 (337)
                               ...-.+.|++|.+++.+.+|.++|
T Consensus       255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                     011258999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=1.1e-07  Score=83.19  Aligned_cols=134  Identities=13%  Similarity=0.126  Sum_probs=91.9

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCC---CcccceeEEe-eCCEEEEEEeec
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP---NIVKLKEVIR-ENDILYFVFEYM   82 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~   82 (337)
                      ++.++.|....||+.     |..+++|+....   .......+|+.+|+.|.+.   .+.+++.+.. ..+..++|||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            456888999999998     566888985322   2233456899999998642   2556666653 345678999999


Q ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------
Q 038835           83 ECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-------------------------------------------  119 (337)
Q Consensus        83 ~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-------------------------------------------  119 (337)
                      +|..+....-  ..++......+..++...|..||+.                                           
T Consensus        96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            9965543211  1245555556666666666666542                                           


Q ss_pred             -----------------CccccCCCCCCeeeeC----Cc-EEEeeCCCcccCC
Q 038835          120 -----------------GYFHRDLKPENLLVSK----DT-IKIADFGLAREIN  150 (337)
Q Consensus       120 -----------------~i~H~dikp~Nili~~----~~-~kL~Dfg~a~~~~  150 (337)
                                       .++|+|++|.||+++.    +. +.|+||+.+....
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                             3599999999999987    45 4899999887543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.73  E-value=1.6e-07  Score=80.47  Aligned_cols=132  Identities=17%  Similarity=0.128  Sum_probs=92.3

Q ss_pred             eecccCce-EEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEEeecCCCH
Q 038835            9 EVGDGTFG-SVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFVFEYMECNL   86 (337)
Q Consensus         9 ~ig~G~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l   86 (337)
                      .+..|..| .||+......+..+++|+-...    ......+|...|+.|. +--+.+++.+..+.+..++|||+++|..
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            34446555 6899888777888999986543    2334457899888873 3347778888888999999999999965


Q ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------------
Q 038835           87 YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-----------------------------------------------  119 (337)
Q Consensus        87 ~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~-----------------------------------------------  119 (337)
                      +.......    ......+..++...|..||+.                                               
T Consensus       107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            54433221    122334555566666666631                                               


Q ss_pred             -----------CccccCCCCCCeeeeCCc-EEEeeCCCccc
Q 038835          120 -----------GYFHRDLKPENLLVSKDT-IKIADFGLARE  148 (337)
Q Consensus       120 -----------~i~H~dikp~Nili~~~~-~kL~Dfg~a~~  148 (337)
                                 .++|+|+.|.||+++.+. +-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       278999999999999885 56999997764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.51  E-value=4.5e-07  Score=82.31  Aligned_cols=76  Identities=16%  Similarity=0.222  Sum_probs=47.7

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccC------ChHHhHHHHHHHHHhcCCC--CC-cccceeEEeeCCEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY------SWEECVNLREVKSLRKMSH--PN-IVKLKEVIRENDILYF   77 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~l   77 (337)
                      .+.||.|..+.||++....+++.+++|.......      .........|..+++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5679999999999997766678899998653211      0112233568888887732  33 4455543  3444589


Q ss_pred             EEeecCC
Q 038835           78 VFEYMEC   84 (337)
Q Consensus        78 v~e~~~~   84 (337)
                      |||+++|
T Consensus       113 vmE~l~g  119 (397)
T 2olc_A          113 VMEDLSH  119 (397)
T ss_dssp             EECCCTT
T ss_pred             EEEeCCC
Confidence            9999986

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=8.7e-06  Score=71.97  Aligned_cols=72  Identities=14%  Similarity=0.321  Sum_probs=40.0

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCC--CCccccee------EEeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH--PNIVKLKE------VIRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv   78 (337)
                      ++.|+.|..+.||++...  +..+++|+....   .  .....|..+++.|..  -.+.+++.      +....+..+++
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~--~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---E--KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC---H--HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC---H--HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence            345666778999999753  345889988752   1  122234555554421  12333332      22356778999


Q ss_pred             EeecCCC
Q 038835           79 FEYMECN   85 (337)
Q Consensus        79 ~e~~~~~   85 (337)
                      |+|++|.
T Consensus       110 ~~~i~G~  116 (346)
T 2q83_A          110 YDWIEGR  116 (346)
T ss_dssp             EECCCCB
T ss_pred             EEeecCc
Confidence            9999973

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=1.2e-06  Score=78.15  Aligned_cols=79  Identities=9%  Similarity=0.100  Sum_probs=52.0

Q ss_pred             eeee-cccCceEEEEEEEC--C----CCcEEEEEEcccccC--ChHHhHHHHHHHHHhcCC-C--CCcccceeEEeeC--
Q 038835            7 IKEV-GDGTFGSVWRAISK--Q----SGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMS-H--PNIVKLKEVIREN--   72 (337)
Q Consensus         7 ~~~i-g~G~~g~v~~~~~~--~----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~--   72 (337)
                      .+.| +.|..+.+|++...  .    +|..+++|+......  ........+|+.+++.|. +  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88999999988643  1    256788998765330  001123457888888773 2  3467777776554  


Q ss_pred             -CEEEEEEeecCCC
Q 038835           73 -DILYFVFEYMECN   85 (337)
Q Consensus        73 -~~~~lv~e~~~~~   85 (337)
                       +..++|||+++|.
T Consensus       105 ~g~~~~v~e~l~G~  118 (357)
T 3ats_A          105 LGTPFFLMDYVEGV  118 (357)
T ss_dssp             TSSCEEEEECCCCB
T ss_pred             cCCceEEEEecCCC
Confidence             3568999999873

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.01  E-value=1.5e-05  Score=69.33  Aligned_cols=136  Identities=16%  Similarity=0.105  Sum_probs=75.0

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc-ccceeEEeeCCEEEEEEeec
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI-VKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~   82 (337)
                      +.-++.|+.|..+.+|++      ..+++|+.......  .....+|+.+++.+...++ .++++..  .+.-++++||+
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i   89 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYI   89 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECC
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeec
Confidence            333677888999999999      45788887653211  1112467777777643233 4555443  33346899999


Q ss_pred             -CCCHHHH-------------------HhhccCCCC-----HHHHHHHHHH--------------HHHHHHHHH----H-
Q 038835           83 -ECNLYQL-------------------MKDREKCFS-----EAEVRNWCFQ--------------VFQGLAYMH----Q-  118 (337)
Q Consensus        83 -~~~l~~~-------------------~~~~~~~l~-----~~~~~~~~~q--------------il~al~~LH----~-  118 (337)
                       +|..++.                   +......++     ...+..+..+              +...+..+.    . 
T Consensus        90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~  169 (301)
T 3dxq_A           90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH  169 (301)
T ss_dssp             TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence             6632210                   011111111     1122222111              111122221    1 


Q ss_pred             ---cCccccCCCCCCeeeeCCcEEEeeCCCcccC
Q 038835          119 ---RGYFHRDLKPENLLVSKDTIKIADFGLAREI  149 (337)
Q Consensus       119 ---~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~  149 (337)
                         ..++|+|+.|.||+.+.+.+.++||..+...
T Consensus       170 ~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          170 PLPLAACHCDPLCENFLDTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCCCEEECSCCCGGGEEECSSCEEECCCTTCEEE
T ss_pred             CCCceeeccCCCcCCEEECCCCEEEEecccccCC
Confidence               2389999999999966668999999987753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.98  E-value=2.7e-05  Score=71.06  Aligned_cols=77  Identities=13%  Similarity=0.050  Sum_probs=44.9

Q ss_pred             HcCccccCCCCCCeeeeCCcEEEeeCCCcccCCCCCCCccccc--cccccCchhhcCcC--CCCCcchHHHHHHHHHHHH
Q 038835          118 QRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVS--TRWYRAPEVLLQSY--LYSSKVDMWAMGAIMAELI  193 (337)
Q Consensus       118 ~~~i~H~dikp~Nili~~~~~kL~Dfg~a~~~~~~~~~~~~~g--t~~~~aPE~~~~~~--~~~~~~DiwslG~il~~ll  193 (337)
                      ...++|+|++|.||+++.+.+.++||+.+....+........+  ...|++|+......  ......++...+..++..+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDSTQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSCEEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCCCEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            4579999999999999887899999998875432211111111  12355555432110  0011234446666666665


Q ss_pred             h
Q 038835          194 T  194 (337)
Q Consensus       194 ~  194 (337)
                      .
T Consensus       311 ~  311 (420)
T 2pyw_A          311 N  311 (420)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.95  E-value=0.00012  Score=59.44  Aligned_cols=96  Identities=15%  Similarity=0.143  Sum_probs=61.6

Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCccccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTR  162 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~  162 (337)
                      +|.+.+...+.+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+ +|.+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            4677777788999999999999999999887632 221233345677887765 666553 1111           1223


Q ss_pred             cccCchhhcCcCCCCCcchHHHHHHHHHHHHh
Q 038835          163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT  194 (337)
Q Consensus       163 ~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~  194 (337)
                      .+.|||...  ...+.+.=|+|||+++|..+-
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            466888753  244678899999999999996

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.90  E-value=0.00011  Score=64.10  Aligned_cols=74  Identities=11%  Similarity=0.160  Sum_probs=56.7

Q ss_pred             EeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC---CCCcccceeEEeeCCEEEEEEeec
Q 038835            6 LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS---HPNIVKLKEVIRENDILYFVFEYM   82 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~   82 (337)
                      -.+.|+.|..+.+|++..  ++..+++|+....    .......|+..|+.|.   ...+.+++.+....+..++||||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            356789999999999964  4677889987643    2334467888888873   356788888887788899999999


Q ss_pred             CCC
Q 038835           83 ECN   85 (337)
Q Consensus        83 ~~~   85 (337)
                      +|.
T Consensus       114 ~G~  116 (312)
T 3jr1_A          114 NKS  116 (312)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            874

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.60  E-value=0.00029  Score=63.11  Aligned_cols=136  Identities=13%  Similarity=0.130  Sum_probs=79.6

Q ss_pred             eeeecccCceEEEEEEECC-------CCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQ-------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++.|..|..+.+|++....       +++.+++|+......  ......+|..+++.|. +.-..++++.+.+    .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            4567778889999997642       357899998643211  1223347888888873 2223556666543    289


Q ss_pred             EeecCCCHHH-----------HH-------hhcc----CCC--CHHHHHHHHHHHHH-------------------HHHH
Q 038835           79 FEYMECNLYQ-----------LM-------KDRE----KCF--SEAEVRNWCFQVFQ-------------------GLAY  115 (337)
Q Consensus        79 ~e~~~~~l~~-----------~~-------~~~~----~~l--~~~~~~~~~~qil~-------------------al~~  115 (337)
                      |||++|..+.           .+       ....    ...  -..++..|..++-.                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            9999873211           11       1111    111  24566777665532                   2333


Q ss_pred             HHH--------cCccccCCCCCCeeeeCC-----cEEEeeCCCccc
Q 038835          116 MHQ--------RGYFHRDLKPENLLVSKD-----TIKIADFGLARE  148 (337)
Q Consensus       116 LH~--------~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~  148 (337)
                      |.+        ..++|+|+.+.||+++.+     .+.++||..|..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332        258999999999999864     799999998763

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.52  E-value=0.00015  Score=64.90  Aligned_cols=136  Identities=15%  Similarity=0.215  Sum_probs=74.5

Q ss_pred             eeeecccCceEEEEEEECC--------CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC-cccceeEEeeCCEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQ--------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN-IVKLKEVIRENDILYF   77 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~l   77 (337)
                      ++.|+.|....+|++....        .+..+++|+.......  ......|..+++.|...+ +.++++..  .+  ++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence            5667889899999997643        1367888887543211  111246788887774333 44566544  22  68


Q ss_pred             EEeecCCCHH--------H----------HHhh--c-c---CCCC-----HHHHHHHHHHH-------------------
Q 038835           78 VFEYMECNLY--------Q----------LMKD--R-E---KCFS-----EAEVRNWCFQV-------------------  109 (337)
Q Consensus        78 v~e~~~~~l~--------~----------~~~~--~-~---~~l~-----~~~~~~~~~qi-------------------  109 (337)
                      ||||++|..+        .          .+..  . .   ..++     ...+..+..++                   
T Consensus       112 v~e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (369)
T 3c5i_A          112 IEEWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKE  191 (369)
T ss_dssp             EEECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHH
T ss_pred             EEEEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHH
Confidence            9999987311        0          0111  0 0   0011     11222222111                   


Q ss_pred             -HHHHHHHHH----------cCccccCCCCCCeeeeCCcEEEeeCCCccc
Q 038835          110 -FQGLAYMHQ----------RGYFHRDLKPENLLVSKDTIKIADFGLARE  148 (337)
Q Consensus       110 -l~al~~LH~----------~~i~H~dikp~Nili~~~~~kL~Dfg~a~~  148 (337)
                       -..++.|.+          ..++|+|+.+.|||++.+.+.|+||..+..
T Consensus       192 ~~~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~~  241 (369)
T 3c5i_A          192 SDKFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKCLRLIDFEYSGF  241 (369)
T ss_dssp             HHHHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-CEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCcEEEEEecCCCC
Confidence             122334432          258999999999999887899999997763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.47  E-value=0.00064  Score=59.38  Aligned_cols=137  Identities=12%  Similarity=0.071  Sum_probs=74.4

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC--cccceeE------EeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN--IVKLKEV------IRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv   78 (337)
                      ++.|+.|..+.+|++... +| .+++|+......   ......|+.+++.|...+  +.+++..      ....+..+++
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            456778888999998653 34 688998875311   122335666666652111  2333321      2234678999


Q ss_pred             EeecCCCH---------------HHHHhhc--c--CC----CCHHHHHHH---------------HHHHHHHHHHHHH--
Q 038835           79 FEYMECNL---------------YQLMKDR--E--KC----FSEAEVRNW---------------CFQVFQGLAYMHQ--  118 (337)
Q Consensus        79 ~e~~~~~l---------------~~~~~~~--~--~~----l~~~~~~~~---------------~~qil~al~~LH~--  118 (337)
                      +++++|..               +..+...  .  .+    .....-...               ...+...++.+.+  
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            99998732               1111111  0  00    111000000               0113345555553  


Q ss_pred             -----cCccccCCCCCCeeeeCCcE-EEeeCCCccc
Q 038835          119 -----RGYFHRDLKPENLLVSKDTI-KIADFGLARE  148 (337)
Q Consensus       119 -----~~i~H~dikp~Nili~~~~~-kL~Dfg~a~~  148 (337)
                           .+++|+|+.+.||+++.+.+ .++||+.+..
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 36999999999999998865 7999997653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.40  E-value=0.00055  Score=60.21  Aligned_cols=31  Identities=29%  Similarity=0.378  Sum_probs=26.6

Q ss_pred             cCccccCCCCCCeeeeC-----CcEEEeeCCCcccC
Q 038835          119 RGYFHRDLKPENLLVSK-----DTIKIADFGLAREI  149 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~-----~~~kL~Dfg~a~~~  149 (337)
                      ..++|+|+.+.||+++.     +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            46999999999999986     47899999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.30  E-value=0.0015  Score=59.65  Aligned_cols=71  Identities=14%  Similarity=0.129  Sum_probs=47.3

Q ss_pred             eeeecccCceEEEEEEECC-------CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc-ccceeEEeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQ-------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI-VKLKEVIRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv   78 (337)
                      ++.|+.|..+.+|++....       ++..+++|+..... .  .....+|..+++.|...++ .++++.+.  +  .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence            5678889999999997643       25788999884321 1  1233478888888743333 56666553  2  289


Q ss_pred             EeecCC
Q 038835           79 FEYMEC   84 (337)
Q Consensus        79 ~e~~~~   84 (337)
                      +||++|
T Consensus       151 ~e~l~G  156 (429)
T 1nw1_A          151 EEYIPS  156 (429)
T ss_dssp             ECCCCE
T ss_pred             EEEeCC
Confidence            999986

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.29  E-value=0.0034  Score=53.87  Aligned_cols=75  Identities=11%  Similarity=0.136  Sum_probs=50.5

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCC---CcccceeEEeeCCEEEEEEe
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP---NIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ..-++.+|.|..+.||++.. .+|+.+++|+....... ....+..|+..|+.|.-.   -+.++++.  +.  .++|||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e   90 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME   90 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence            34567899999999999975 47889999987644322 123345788888888432   23444443  22  268999


Q ss_pred             ecCC
Q 038835           81 YMEC   84 (337)
Q Consensus        81 ~~~~   84 (337)
                      |+++
T Consensus        91 ~l~~   94 (288)
T 3f7w_A           91 WVDE   94 (288)
T ss_dssp             CCCC
T ss_pred             eecc
Confidence            9875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.29  E-value=0.0016  Score=57.02  Aligned_cols=73  Identities=8%  Similarity=0.111  Sum_probs=45.0

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC--cccceeE-----EeeCCEEEEEEe
Q 038835            8 KEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN--IVKLKEV-----IRENDILYFVFE   80 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~lv~e   80 (337)
                      ..++ |..+.||++.. .+|+.+++|........  ......|..+++.|...+  +++++..     ...++..+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~--~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC--HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            3466 88889998854 34667999998643222  223345777777663212  3444432     233567789999


Q ss_pred             ecCC
Q 038835           81 YMEC   84 (337)
Q Consensus        81 ~~~~   84 (337)
                      +++|
T Consensus       108 ~i~G  111 (328)
T 1zyl_A          108 SVGG  111 (328)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            9987

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.12  E-value=0.0044  Score=54.59  Aligned_cols=31  Identities=26%  Similarity=0.341  Sum_probs=26.5

Q ss_pred             cCccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835          119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      ..++|+|+.+.||+++.+ .+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            369999999999999864 8999999877654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.91  E-value=0.0036  Score=57.50  Aligned_cols=72  Identities=15%  Similarity=0.064  Sum_probs=46.4

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc-ccceeEEeeCCEEEEEEeecCC
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI-VKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      ++.|+.|....+|++....++..+++|+.......  .....+|..+++.|...++ .++++.+.  +.  +|+||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCC
Confidence            56788899999999987544578889987543211  1111478888888865444 56666653  32  59999986

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.13  E-value=0.033  Score=50.54  Aligned_cols=73  Identities=11%  Similarity=0.077  Sum_probs=46.5

Q ss_pred             eeeecccCceEEEEEEECCC-------CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC-cccceeEEeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQS-------GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN-IVKLKEVIRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv   78 (337)
                      ++.+..|....+|++.....       ++.+++++.......  .....+|..+++.+...+ ..++++.+  .+  +.|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence            56777799999999986521       577899986543211  112246888888774222 44555533  22  689


Q ss_pred             EeecCCC
Q 038835           79 FEYMECN   85 (337)
Q Consensus        79 ~e~~~~~   85 (337)
                      +||++|.
T Consensus       149 ~efI~G~  155 (424)
T 3mes_A          149 EEFIDGE  155 (424)
T ss_dssp             EECCCSE
T ss_pred             EEEeCCc
Confidence            9999873

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.29  E-value=0.033  Score=50.17  Aligned_cols=28  Identities=21%  Similarity=0.465  Sum_probs=23.7

Q ss_pred             ccccCCCCCCeeeeC-------CcEEEeeCCCccc
Q 038835          121 YFHRDLKPENLLVSK-------DTIKIADFGLARE  148 (337)
Q Consensus       121 i~H~dikp~Nili~~-------~~~kL~Dfg~a~~  148 (337)
                      ++|+|+.+.||++..       +.+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999942       2799999998764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.27  E-value=0.085  Score=48.47  Aligned_cols=61  Identities=13%  Similarity=0.053  Sum_probs=17.1

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEE------EEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEe
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAI------KKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIR   70 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vai------K~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~   70 (337)
                      .+.||   ||.||++....+...||+      |.........+ .....+|..+++.++|||+++.+.+..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            45666   999999987765567888      66554333322 223457888888999999999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.14  E-value=2.9  Score=33.68  Aligned_cols=113  Identities=15%  Similarity=0.197  Sum_probs=76.5

Q ss_pred             CCCCcccceeEEeeCCEEEEEEeecC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC
Q 038835           58 SHPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD  136 (337)
Q Consensus        58 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~  136 (337)
                      .+|+++.. .+-+..+.+.+.++.-+ +-.+..+..    .+....++++.+|+....++  ..=+|--+.|+||+++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~----~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS----FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG----SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh----cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence            57888876 56667777666666554 234444433    68899999999998877444  334567799999999998


Q ss_pred             -cEEEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCC
Q 038835          137 -TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLF  199 (337)
Q Consensus       137 -~~kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  199 (337)
                       .+++.--|.-...                +|.      ..+...=.-..=|++..++.++..|
T Consensus       116 ~~p~i~~RGik~~l----------------~P~------~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          116 GLPIAKTRGLQNVV----------------DPL------PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             SCEEESCCEETTTB----------------SCC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CCEEEEEccCccCC----------------CCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence             7898888754332                232      1122333446678888888888777

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	337
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-80
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-80
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-79
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-79
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-78
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-78
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-78
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-77
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-76
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-76
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-76
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-75
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-74
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-73
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-73
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-73
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-73
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-73
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-72
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-70
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-70
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-70
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-69
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-68
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-67
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-67
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-64
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-63
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-62
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-62
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-62
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-61
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-57
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-54
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-54
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-52
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-44
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-25

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  245 bits (627), Expect = 1e-80
 Identities = 104/283 (36%), Positives = 164/283 (57%), Gaps = 8/283 (2%)

Query: 6   LIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN----LREVKSLRKMSHPN 61
            +  +G+G F +V++A  K + ++VAIKK+K  + S  +       LRE+K L+++SHPN
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           I+ L +       +  VF++ME +L  ++KD     + + ++ +     QGL Y+HQ   
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            HRDLKP NLL+ ++  +K+ADFGLA+   S    +T  V TRWYRAPE+L  + +Y   
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           VDMWA+G I+AEL+   P  PG S+ D++ +I   +GTPT++ W D   L   +   F  
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT--FKS 239

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             G+PL  +  +A  D + LI  L  ++P  R TA +AL+  +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (630), Expect = 2e-80
 Identities = 97/292 (33%), Positives = 169/292 (57%), Gaps = 19/292 (6%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
            Y   K +G+G+FG V++A    SGE+VAIKK+ +     ++    RE++ +RK+ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75

Query: 63  VKLKEVI------RENDILYFVFEYMECNLYQLMKD---REKCFSEAEVRNWCFQVFQGL 113
           V+L+         ++   L  V +Y+   +Y++ +     ++      V+ + +Q+F+ L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 114 AYMHQRGYFHRDLKPENLLVSKDT--IKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
           AY+H  G  HRD+KP+NLL+  DT  +K+ DFG A+++    P   Y+ +R+YRAPE++ 
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
            +  Y+S +D+W+ G ++AEL+  +P+FPG S  D++ +I  V+GTPT++   +  +   
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPN 253

Query: 232 AINYKFPQLVGVPLS-VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
              +KFPQ+   P + V  P    +A++L + L  + P+ R T  EA  H F
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  244 bits (624), Expect = 1e-79
 Identities = 69/286 (24%), Positives = 128/286 (44%), Gaps = 32/286 (11%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           ++ Y + +E+G G FG V R   + +G   A K +   + S +E V  +E++++  + HP
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVLRHP 83

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            +V L +   +++ +  ++E+M    L++ + D     SE E   +  QV +GL +MH+ 
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 120 GYFHRDLKPENLLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            Y H DLKPEN++ +      +K+ DFGL   ++ +        T  + APEV       
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-V 202

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
               DMW++G +   L++    F G ++ + +  + S        ++             
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF------------- 249

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                           ++D    I  L   DP+ R T  +AL+HP+
Sbjct: 250 -------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (617), Expect = 3e-79
 Identities = 112/286 (39%), Positives = 177/286 (61%), Gaps = 5/286 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ME ++ ++++G+GT+G V++A +K +GEVVA+KK++    +       +RE+  L++++H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQ 118
           PNIVKL +VI   + LY VFE++  +L + M            ++++ FQ+ QGLA+ H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTEYVSTRWYRAPEVLLQSYLY 176
               HRDLKP+NLL++ +  IK+ADFGLAR        +T  V T WYRAPE+LL    Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S+ VD+W++G I AE++T R LFPG SE D++++I   +GTP +  W  G+         
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW-PGVTSMPDYKPS 239

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           FP+      S ++P  ++D  SL++ +  +DP+KR +A  AL HPF
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 2e-78
 Identities = 64/297 (21%), Positives = 122/297 (41%), Gaps = 18/297 (6%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + ++ I E+G G  G V++   K SG V+A K +  +         +RE++ L + + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR-G 120
           IV        +  +    E+M+      +  +     E  +      V +GL Y+ ++  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
             HRD+KP N+LV+    IK+ DFG++ ++      + +V TR Y +PE L  ++ YS +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTH-YSVQ 183

Query: 180 VDMWAMGAIMAELITLRPLFPG-TSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
            D+W+MG  + E+   R   P   ++  E+   C V G   +             +Y   
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 239 QLVGVPLSVLMPSANK-------------DAVSLIASLCSWDPSKRPTAAEALQHPF 282
               + +  L+                  +    +      +P++R    + + H F
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  238 bits (608), Expect = 4e-78
 Identities = 100/285 (35%), Positives = 170/285 (59%), Gaps = 5/285 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ME+Y  ++++G+GT+G V++A +   GE  A+KK++ +          +RE+  L+++ H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIVKL +VI     L  VFE+++ +L +L+   E        +++  Q+  G+AY H R
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRDLKP+NLL++++  +KIADFGLAR        +T  + T WYRAP+VL+ S  YS
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           + +D+W++G I AE++   PLFPG SEAD++ +I  ++GTP   +W +   L +  +  F
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF 238

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                +P    +   ++  + L++ +   DP++R TA +AL+H +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 6e-78
 Identities = 95/315 (30%), Positives = 158/315 (50%), Gaps = 23/315 (7%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           + +Y+ + ++G GTFG V++A  +++G+ VA+KK+  +       +  LRE+K L+ + H
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 60  PNIVKLKEVIRE--------NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQ 111
            N+V L E+ R            +Y VF++ E +L  L+ +    F+ +E++     +  
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----PFTEYVSTRWYR 165
           GL Y+H+    HRD+K  N+L+++D  +K+ADFGLAR  +         +T  V T WYR
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 166 APEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWA- 224
            PE+LL    Y   +D+W  G IMAE+ T  P+  G +E  ++  I  + G+ T + W  
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 225 -DGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS 283
            D   L   +     Q   V   +     +  A+ LI  L   DP++R  + +AL H F 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF- 307

Query: 284 RVAFMFHHLSVPEQL 298
                F    +P  L
Sbjct: 308 -----FWSDPMPSDL 317

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  238 bits (607), Expect = 6e-77
 Identities = 71/312 (22%), Positives = 135/312 (43%), Gaps = 32/312 (10%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y +++E+G G FG V R + K +G V   K +   Y   +  V   E+  + ++ HP 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHPK 87

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           ++ L +   +   +  + E++    L+  +   +   SEAEV N+  Q  +GL +MH+  
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147

Query: 121 YFHRDLKPENLLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
             H D+KPEN++       ++KI DFGLA ++N         +T  + APE++ +     
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-VG 206

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
              DMWA+G +   L++    F G  + + +  +        +D++              
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF-------------- 252

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPEQ 297
                        S + +A   I +L   +P KR T  +AL+HP+ +         +P  
Sbjct: 253 ------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300

Query: 298 LLQEHLHLLGQR 309
              +    + ++
Sbjct: 301 RYNKIRQKIKEK 312

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 2e-76
 Identities = 69/288 (23%), Positives = 127/288 (44%), Gaps = 35/288 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + +++I E+GDG FG V++A +K++  + A K +  K     E   + E+  L    HPN
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY-MVEIDILASCDHPN 70

Query: 62  IVKLKEVIRENDILYFVFEYMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IVKL +     + L+ + E+     +  +M + E+  +E++++  C Q    L Y+H   
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREI-NSRPPFTEYVSTRWYRAPEVLL----QSY 174
             HRDLK  N+L + D  IK+ADFG++ +   +      ++ T ++ APEV++    +  
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y  K D+W++G  + E+  + P     +    + KI                   ++  
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------------------KSEP 232

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
               Q               +    +      +   R T ++ LQHPF
Sbjct: 233 PTLAQPSRWS---------SNFKDFLKKCLEKNVDARWTTSQLLQHPF 271

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (601), Expect = 3e-76
 Identities = 102/292 (34%), Positives = 162/292 (55%), Gaps = 13/292 (4%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
            RY  +  +G+G +G V  A    +   VAIKK+    +       LRE+K L +  H N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 62  IVKLKEVIRENDI-----LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           I+ + ++IR   I     +Y V   M  +LY+L+K +    S   +  + +Q+ +GL Y+
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYI 125

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS----RPPFTEYVSTRWYRAPEVLL 171
           H     HRDLKP NLL++    +KI DFGLAR  +         TEYV+TRWYRAPE++L
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL-A 230
            S  Y+  +D+W++G I+AE+++ RP+FPG    D++  I  ++G+P+Q+     + L A
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           R      P    VP + L P+A+  A+ L+  + +++P KR    +AL HP+
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 5e-76
 Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 35/285 (12%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           +E +++ + +G G FG+V+ A  KQS  ++A+K + K         +   REV+    + 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HPNI++L     +   +Y + EY           +   F E     +  ++   L+Y H 
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           +   HRD+KPENLL+     +KIADFG +    S    T    T  Y  PE++     + 
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRM-HD 182

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
            KVD+W++G +  E +  +P F   +  +   +I  V                    + F
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------------EFTF 223

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           P  V            + A  LI+ L   +PS+RP   E L+HP+
Sbjct: 224 PDFV-----------TEGARDLISRLLKHNPSQRPMLREVLEHPW 257

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  232 bits (594), Expect = 2e-75
 Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 36/286 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           + +  ++E+G G+FG+V+ A   ++ EVVAIKKM        E     ++EV+ L+K+ H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           PN ++ +         + V EY   +   L++  +K   E E+        QGLAY+H  
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY--LY 176
              HRD+K  N+L+S+   +K+ DFG A  +        +V T ++ APEV+L      Y
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY 191

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
             KVD+W++G    EL   +P     +    +Y I                        +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------------------AQNE 230

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            P L     S       +   + + S     P  RPT+   L+H F
Sbjct: 231 SPALQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 2e-74
 Identities = 98/286 (34%), Positives = 168/286 (58%), Gaps = 5/286 (1%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           M++Y+ ++++G+GT+G+V++A ++++ E+VA+K+++          + LRE+  L+++ H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
            NIV+L +V+  +  L  VFE+ + +L +             V+++ FQ+ +GL + H R
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYS 177
              HRDLKP+NLL++++  +K+A+FGLAR        ++  V T WYR P+VL  + LYS
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           + +DMW+ G I AEL    RPLFPG    D++ +I  ++GTPT++ W     L     Y 
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                   L  ++P  N     L+ +L   +P +R +A EALQHP+
Sbjct: 241 MYPAT-TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 1e-73
 Identities = 105/290 (36%), Positives = 163/290 (56%), Gaps = 13/290 (4%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
             Y+ ++ VG G +G+V  A+  ++G  VAIKK+ + + S        RE++ L+ M H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 61  NIVKLKEVIRENDIL------YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V   ++ L      Y V  +M  +L +LMK   +   E  ++   +Q+ +GL 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLR 135

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H  G  HRDLKP NL V++D  +KI DFGLAR+ +S    T YV TRWYRAPEV+L  
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNW 193

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD-GLLLARA 232
             Y+  VD+W++G IMAE+IT + LF G+   D++ +I  V GTP  +         A+ 
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                P+L     + ++ +A+  AV+L+  +   D  +R TA EAL HP+
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 2e-73
 Identities = 100/293 (34%), Positives = 164/293 (55%), Gaps = 16/293 (5%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQS-GEVVAIKKMKKKYYSWEECVN-LREVKSLRKMS- 58
           ++Y+ + E+G+G +G V++A   ++ G  VA+K+++ +       ++ +REV  LR +  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 59  --HPNIVKLKEVI-----RENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVF 110
             HPN+V+L +V           L  VFE+++      L K  E       +++  FQ+ 
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 111 QGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEV 169
           +GL ++H     HRDLKP+N+LV+    IK+ADFGLAR  + +   T  V T WYRAPEV
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
           LLQS  Y++ VD+W++G I AE+   +PLF G+S+ D++ KI  VIG P ++ W   + L
Sbjct: 187 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
            R     F      P+   +   ++    L+    +++P+KR +A  AL HP+
Sbjct: 246 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (580), Expect = 2e-73
 Identities = 68/285 (23%), Positives = 126/285 (44%), Gaps = 33/285 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E+Y + +++G G FG V R +   S +    K +K K    ++ +  +E+  L    H N
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRN 62

Query: 62  IVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           I+ L E     + L  +FE++   ++++ +       +E E+ ++  QV + L ++H   
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 121 YFHRDLKPENLLVSKD---TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
             H D++PEN++       TIKI +FG AR++     F    +   Y APEV       S
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV-VS 181

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           +  DMW++G ++  L++    F   +    I  I +   T  ++++              
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------------- 227

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                          + +A+  +  L   +   R TA+EALQHP+
Sbjct: 228 ------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 3e-73
 Identities = 71/287 (24%), Positives = 129/287 (44%), Gaps = 32/287 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           ++Y   +++G G  G+V+ A+   +G+ VAI++M  +    +E + + E+  +R+  +PN
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 78

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           IV   +     D L+ V EY+       +     C  E ++   C +  Q L ++H    
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREIN-SRPPFTEYVSTRWYRAPEVLLQSYLYSSK 179
            HRD+K +N+L+  D ++K+ DFG   +I   +   +  V T ++ APEV+ +   Y  K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPK 196

Query: 180 VDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ 239
           VD+W++G +  E+I   P +   +    +Y I +  GTP   +                 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNP---------------- 239

Query: 240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA 286
                        +      +      D  KR +A E LQH F ++A
Sbjct: 240 ----------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 3e-73
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 31/285 (10%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E + L++ +G+G +G V  A+++ + E VA+K +  K          +E+   + ++H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +VK     RE +I Y   EY          + +    E + + +  Q+  G+ Y+H  G 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 122 FHRDLKPENLLVSKD-TIKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
            HRD+KPENLL+ +   +KI+DFGLA      N      +   T  Y APE+L +   ++
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
             VD+W+ G ++  ++     +   S++ + Y       T                    
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW--------------- 229

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                          +   ++L+  +   +PS R T  +  +  +
Sbjct: 230 ------------KKIDSAPLALLHKILVENPSARITIPDIKKDRW 262

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  222 bits (568), Expect = 9e-72
 Identities = 83/286 (29%), Positives = 121/286 (42%), Gaps = 33/286 (11%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           + Y     +G G F  V  A  K++ ++VAIK + KK    +E     E+  L K+ HPN
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           IV L ++      LY + + +    L+  + ++   ++E +     FQV   + Y+H  G
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 121 YFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
             HRDLKPENLL         I I+DFGL++  +     +    T  Y APEVL Q   Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-Y 186

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S  VD W++G I   L+   P F   ++A    +I           W             
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW------------- 233

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                           +  A   I  L   DP KR T  +ALQHP+
Sbjct: 234 -------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  220 bits (562), Expect = 1e-70
 Identities = 70/295 (23%), Positives = 147/295 (49%), Gaps = 20/295 (6%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-H 59
            + Y+L++++G G +  V+ AI+  + E V +K +K       +    RE+K L  +   
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK----REIKILENLRGG 89

Query: 60  PNIVKLKEVIRE--NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           PNI+ L +++++  +     VFE++    +   K   +  ++ ++R + +++ + L Y H
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDF---KQLYQTLTDYDIRFYMYEILKALDYCH 146

Query: 118 QRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYL 175
             G  HRD+KP N+++  +   +++ D+GLA   +    +   V++R+++ PE+L+   +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 176 YSSKVDMWAMGAIMAELITLR-PLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
           Y   +DMW++G ++A +I  + P F G    D++ +I  V+GT     + D   +     
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 235 YK-------FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
           +          +      S      + +A+  +  L  +D   R TA EA++HP+
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  218 bits (556), Expect = 2e-70
 Identities = 81/297 (27%), Positives = 122/297 (41%), Gaps = 43/297 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--------LREVKS 53
           E Y+  + +G G    V R I K + +  A+K +                    L+EV  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 54  LRKMS-HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQ 111
           LRK+S HPNI++LK+    N   + VF+ M+   L+  + ++    SE E R     + +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLE 121

Query: 112 GLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
            +  +H+    HRDLKPEN+L+  D  IK+ DFG + +++      E   T  Y APE++
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 171 LQSYL-----YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD 225
             S       Y  +VDMW+ G IM  L+   P F    +   +  I S         W  
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW-- 239

Query: 226 GLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                                      +     L++      P KR TA EAL HPF
Sbjct: 240 ------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (560), Expect = 4e-70
 Identities = 105/290 (36%), Positives = 158/290 (54%), Gaps = 13/290 (4%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           ERY+ +  VG G +GSV  A   ++G  VA+KK+ + + S        RE++ L+ M H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 61  NIVKLKEVIR------ENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLA 114
           N++ L +V        E + +Y V   M  +L  ++K   +  ++  V+   +Q+ +GL 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135

Query: 115 YMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           Y+H     HRDLKP NL V++D  +KI DFGLAR  +     T YV+TRWYRAPE++L  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNW 193

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL-LLARA 232
             Y+  VD+W++G IMAEL+T R LFPGT   D++  I  ++GTP  +         AR 
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253

Query: 233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                 Q+  +  + +   AN  AV L+  +   D  KR TAA+AL H +
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 7e-69
 Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 44/295 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHP 60
           E Y+++  +G G++G   +   K  G+++  K++     +  E    + EV  LR++ HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 61  NIVKLKEVI--RENDILYFVFEYMEC-NLYQLMKDREK---CFSEAEVRNWCFQVFQGLA 114
           NIV+  + I  R N  LY V EY E  +L  ++    K      E  V     Q+   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 115 YMHQRGY-----FHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-TEYVSTRWYRAP 167
             H+R        HRDLKP N+ +     +K+ DFGLAR +N    F   +V T +Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 168 EVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL 227
           E + +   Y+ K D+W++G ++ EL  L P F   S+ +   KI                
Sbjct: 184 EQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--------------- 227

Query: 228 LLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                   KF ++            + +   +I  + +     RP+  E L++P 
Sbjct: 228 ------EGKFRRIP--------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 2e-68
 Identities = 78/293 (26%), Positives = 125/293 (42%), Gaps = 43/293 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           E +K  K +G+G+F +V  A    +    AIK ++K++   E  V    RE   + ++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P  VKL    ++++ LYF   Y +         +   F E   R +  ++   L Y+H +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREI---NSRPPFTEYVSTRWYRAPEVLLQSYL 175
           G  HRDLKPEN+L+++D  I+I DFG A+ +   + +     +V T  Y +PE+L +   
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS- 186

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
                D+WA+G I+ +L+   P F   +E     KI                     + Y
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------------LEY 227

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA------LQHPF 282
            FP+                A  L+  L   D +KR    E         HPF
Sbjct: 228 DFPEKF-----------FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 5e-68
 Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 39/288 (13%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHPNI 62
            K   E+G G+F +V++ +  ++   VA  +++ +  +  E      E + L+ + HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 63  VKLKEV----IRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           V+  +     ++    +  V E M     +    R K      +R+WC Q+ +GL ++H 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 119 RGY--FHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           R     HRDLK +N+ ++    ++KI D GLA    +       + T  + APE+  + Y
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMYEEKY 189

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
                VD++A G  M E+ T    +     A +IY+                        
Sbjct: 190 --DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------------------- 225

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                  GV  +     A  +   +I      +  +R +  + L H F
Sbjct: 226 -----TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (544), Expect = 1e-67
 Identities = 97/322 (30%), Positives = 153/322 (47%), Gaps = 24/322 (7%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSH 59
           ++RY+ +K +G G  G V  A        VAIKK+ + + +        RE+  ++ ++H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 60  PNIVKLKEVIR------ENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
            NI+ L  V        E   +Y V E M+ NL Q+++          +    +Q+  G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGI 132

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQ 172
            ++H  G  HRDLKP N++V  D T+KI DFGLAR   +    T YV TR+YRAPEV+L 
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 173 SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA 232
              Y   VD+W++G IM E++  + LFPG    D+  K+   +GTP  +         R 
Sbjct: 193 MG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 233 INYKFPQLVGVPLSVLMPSA------------NKDAVSLIASLCSWDPSKRPTAAEALQH 280
                P+  G+    L P +               A  L++ +   DP+KR +  +ALQH
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 281 PFSRVAFMFHHLSVPEQLLQEH 302
           P+  V +    +  P   + + 
Sbjct: 312 PYINVWYDPAEVEAPPPQIYDK 333

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 1e-67
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 37/291 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----LREVKSLRK 56
           + Y   +E+G G F  V +   K +G   A K +KK+               REV  L++
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           + HPN++ L EV      +  + E +           ++  +E E   +  Q+  G+ Y+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 117 HQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
           H     H DLKPEN+++         IKI DFGLA +I+    F     T  + APE++ 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
                  + DMW++G I   L++    F G ++ + +  + +V      + +        
Sbjct: 190 YEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF-------- 240

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
                              + +  A   I  L   DP KR T  ++LQHP+
Sbjct: 241 ------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 9e-67
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 41/294 (13%)

Query: 1   MERYKLIKEV-GDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS- 58
           ++ YK+  +V G G  G V +  +K++ E  A+K ++    +       REV+   + S 
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA------RREVELHWRASQ 63

Query: 59  HPNIVKLKEVIR----ENDILYFVFEYMEC-NLYQLMKDR-EKCFSEAEVRNWCFQVFQG 112
            P+IV++ +V          L  V E ++   L+  ++DR ++ F+E E       + + 
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123

Query: 113 LAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRPPFTEYVSTRWYRAPE 168
           + Y+H     HRD+KPENLL +       +K+ DFG A+E  S    T    T +Y APE
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183

Query: 169 VLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           VL     Y    DMW++G IM  L+   P F           + + I             
Sbjct: 184 VLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------------- 229

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPF 282
             R   Y+FP      +S       ++   LI +L   +P++R T  E + HP+
Sbjct: 230 --RMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPW 274

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 5e-64
 Identities = 68/287 (23%), Positives = 116/287 (40%), Gaps = 36/287 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-REVKSLRKMSHP 60
            +  + + +G G+FG+V++         VA+K +     + ++      EV  LRK  H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 61  NIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           NI+           L  V ++ E  +LY  +   E  F   ++ +   Q  QG+ Y+H +
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAR---EINSRPPFTEYVSTRWYRAPEVLL--QS 173
              HRDLK  N+ + +D T+KI DFGLA      +    F +   +  + APEV+     
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 174 YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
             YS + D++A G ++ EL+T +  +   +  D+I  +                      
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------------- 224

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            Y  P L  V       +  K    L+A        +RP   + L  
Sbjct: 225 GYLSPDLSKVR-----SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 1e-63
 Identities = 69/313 (22%), Positives = 122/313 (38%), Gaps = 55/313 (17%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN-----LREVKSLRKM 57
           +Y++   +G G FGSV+  I       VAIK ++K   S    +        EV  L+K+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 58  S--HPNIVKLKEVIRENDILYFVFEYMECN--LYQLMKDREKCFSEAEVRNWCFQVFQGL 113
           S     +++L +     D    + E  E    L+  + +R     E   R++ +QV + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123

Query: 114 AYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLL 171
            + H  G  HRD+K EN+L+  +   +K+ DFG    +     +T++  TR Y  PE + 
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
               +     +W++G ++ +++     F    E                           
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------------ 218

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHH 291
                F Q V           + +   LI    +  PS RPT  E   HP+         
Sbjct: 219 -GQVFFRQRV-----------SSECQHLIRWCLALRPSDRPTFEEIQNHPW------MQD 260

Query: 292 LSVPEQLLQEHLH 304
           + +P++  + HLH
Sbjct: 261 VLLPQETAEIHLH 273

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  201 bits (511), Expect = 2e-62
 Identities = 68/293 (23%), Positives = 119/293 (40%), Gaps = 39/293 (13%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNL-----REVKSLR 55
           M  + + + +G G FG V+      +G++ A+K + KK    ++   L       +  + 
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 56  KMSHPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
               P IV +       D L F+ + M          +   FSEA++R +  ++  GL +
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 116 MHQRGYFHRDLKPENLLVSK-DTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSY 174
           MH R   +RDLKP N+L+ +   ++I+D GLA + + + P    V T  Y APEVL +  
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGV 181

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y S  D +++G ++ +L+     F      D+       +                   
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---------------- 225

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPF 282
            + P            S + +  SL+  L   D ++R       A E  + PF
Sbjct: 226 VELP-----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 9e-62
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 39/289 (13%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSL-RKM 57
           +E + L K +G G+FG V+ A  K++ +  AIK +KK     ++ V   + E + L    
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
            HP +  +    +  + L+FV EY+   +L   ++   K F  +    +  ++  GL ++
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFL 119

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYVSTRWYRAPEVLLQSY 174
           H +G  +RDLK +N+L+ KD  IKIADFG+ +E          +  T  Y APE+LL   
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 175 LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN 234
            Y+  VD W+ G ++ E++  +  F G  E +  + I                      N
Sbjct: 180 -YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------------------N 219

Query: 235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA-EALQHPF 282
             +P+ +            K+A  L+  L   +P KR     +  QHP 
Sbjct: 220 PFYPRWL-----------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  197 bits (502), Expect = 9e-62
 Identities = 66/290 (22%), Positives = 127/290 (43%), Gaps = 41/290 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           ++ +++++ +G G+FG V    S+ +G   A+K +KK+     + V     E   L  ++
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP I+++    ++   ++ + +Y+E      +  + + F     + +  +V   L Y+H 
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
           +   +RDLKPEN+L+ K+  IKI DFG A+ +           T  Y APEV + +  Y+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEV-VSTKPYN 179

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
             +D W+ G ++ E++     F  ++      KI +                      +F
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------------ELRF 220

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           P           P  N+D   L++ L + D S+R         +   HP+
Sbjct: 221 P-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  195 bits (497), Expect = 2e-61
 Identities = 56/295 (18%), Positives = 103/295 (34%), Gaps = 38/295 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMSH 59
           +RY+L + +G G    V  A   +    VA+K ++              RE ++   ++H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 60  PNIVKLKEVIREND----ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           P IV + +          + Y V EY++    + +   E   +            Q L +
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 116 MHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVL 170
            HQ G  HRD+KP N+++S               +A   NS       + T  Y +PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 171 LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
                  ++ D++++G ++ E++T  P F G S     Y+       P            
Sbjct: 187 RGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------- 238

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV 285
                                 + D  +++    + +P  R   A  ++    RV
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-60
 Identities = 83/291 (28%), Positives = 125/291 (42%), Gaps = 40/291 (13%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           M  +  +K +G GTFG V     K +G   A+K ++K+    ++ V   + E + L+   
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
           HP +  LK   + +D L FV EY           RE+ F+E   R +  ++   L Y+H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE-YVSTRWYRAPEVLLQSYLY 176
           R   +RD+K ENL++ KD  IKI DFGL +E  S     + +  T  Y APEVL  +  Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-Y 182

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
              VD W +G +M E++  R  F           I                        +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------EIR 223

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPF 282
           FP            + + +A SL+A L   DP +R       A E ++H F
Sbjct: 224 FP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-57
 Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 42/285 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHP 60
           M+  KL++ +G G FG V     +  G  VA+K +K    +      L E   + ++ H 
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA---FLAEASVMTQLRHS 60

Query: 61  NIVKLKEV-IRENDILYFVFEYMEC-NLYQLMKDREK-CFSEAEVRNWCFQVFQGLAYMH 117
           N+V+L  V + E   LY V EYM   +L   ++ R +       +  +   V + + Y+ 
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
              + HRDL   N+LVS+D   K++DFGL +E +S            + APE L +   +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKK-F 177

Query: 177 SSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           S+K D+W+ G ++ E+ +  R  +P     D + ++                       Y
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------------------GY 217

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           K     G P              ++ +    D + RP+  +  + 
Sbjct: 218 KMDAPDGCP---------PAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (466), Expect = 5e-56
 Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 41/290 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVN--LREVKSLRKMS 58
           ++++  IK +G G+FG V     K+SG   A+K + K+     + +   L E + L+ ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 59  HPNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ 118
            P +VKL+   ++N  LY V EY+          R   FSE   R +  Q+     Y+H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 119 RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYS 177
               +RDLKPENLL+ +   I++ DFG A+ +  R        T    APE++L    Y+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKG-YN 216

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
             VD WA+G ++ E+    P F          KI S                      +F
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------------------KVRF 257

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKR-----PTAAEALQHPF 282
           P              + D   L+ +L   D +KR         +   H +
Sbjct: 258 P-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 9e-56
 Identities = 67/283 (23%), Positives = 117/283 (41%), Gaps = 36/283 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
                ++E+G G FG V       + + VAIK +++   S E+   + E + + K+SHP 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDF--IEEAEVMMKLSHPK 61

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  E   +  VFE+ME   L   ++ +   F+   +   C  V +G+AY+ +  
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTEYVSTRWYRAPEVLLQSYLYS 177
             HRDL   N LV ++  IK++DFG+ R +        T       + +PEV   S  YS
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YS 180

Query: 178 SKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF 237
           SK D+W+ G +M E+ +   +        E+ +                  ++       
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----------------DISTGFRLYK 223

Query: 238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           P+L            +     ++       P  RP  +  L+ 
Sbjct: 224 PRLA-----------STHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 3e-55
 Identities = 73/313 (23%), Positives = 126/313 (40%), Gaps = 63/313 (20%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E  +  K +G G FG V  A +    +      VA+K +K+K  S E    + E+K + +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 57  M-SHPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSE--------------- 99
           + SH NIV L      +  +Y +FEY    +L   ++ + + FSE               
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 100 -------AEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS 151
                   ++  + +QV +G+ ++  +   HRDL   N+LV+    +KI DFGLAR+I S
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216

Query: 152 RPPFTEY---VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADE 207
              +           + APE L +   Y+ K D+W+ G ++ E+ +L    +PG      
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275

Query: 208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWD 267
            YK+        Q  +A                             ++   ++ S  ++D
Sbjct: 276 FYKLIQNGFKMDQPFYAT----------------------------EEIYIIMQSCWAFD 307

Query: 268 PSKRPTAAEALQH 280
             KRP+       
Sbjct: 308 SRKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 5e-55
 Identities = 61/290 (21%), Positives = 116/290 (40%), Gaps = 40/290 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVN--LREVKSLRK 56
           +  +L++++GDG+FG V R            VA+K +K    S  E ++  +REV ++  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAY 115
           + H N+++L  V+     +  V E     +L   ++  +  F    +  +  QV +G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 116 MHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLL 171
           +  + + HRDL   NLL++    +KI DFGL R +          E+    +       L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 172 QSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA 230
           ++  +S   D W  G  + E+ T  +  + G + +  ++KI                   
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---------------- 230

Query: 231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                + P+    P         +D  +++    +  P  RPT       
Sbjct: 231 ---GERLPRPEDCP---------QDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-54
 Identities = 65/284 (22%), Positives = 118/284 (41%), Gaps = 38/284 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           +    +KE+G G FG V     +     VAIK +K+   S +E   + E K +  +SH  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEF--IEEAKVMMNLSHEK 60

Query: 62  IVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
           +V+L  V  +   ++ + EYM    L   +++    F   ++   C  V + + Y+  + 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 121 YFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FTEYVSTRWYRAPEVLLQSYLYS 177
           + HRDL   N LV+    +K++DFGL+R +                +  PEVL+ S  +S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FS 179

Query: 178 SKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           SK D+WA G +M E+ +L +  +   + ++    I                   + +   
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------------------QGLRLY 221

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
            P L            ++   +++ S       +RPT    L +
Sbjct: 222 RPHLA-----------SEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 80/336 (23%), Positives = 135/336 (40%), Gaps = 47/336 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY L++++G G F +VW A    +   VA+K ++      E      E+K L++++  + 
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA--EDEIKLLQRVNDADN 71

Query: 63  VKLKEVIRENDI-LYFVFEYMECN---------------LYQLMKDREKCFSEAEVRNWC 106
            K   +   + + L   F +   N               L  + K   +      V+   
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 107 FQVFQGLAYM-HQRGYFHRDLKPENLLVSKD-------TIKIADFGLAREINSRPPFTEY 158
            Q+  GL YM  + G  H D+KPEN+L+           IKIAD G A   +        
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--S 189

Query: 159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPG------TSEADEIYKIC 212
           + TR YR+PEVLL +  +    D+W+   ++ ELIT   LF        T + D I +I 
Sbjct: 190 IQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

Query: 213 SVIGTPTQDSWADG-----LLLARAINYKFPQLVGVPLSVLMPS-------ANKDAVSLI 260
            ++G        +G        +R +     +L   PL  ++           K+    +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308

Query: 261 ASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPE 296
           + +   DP KR  A   + HP+ +       + VP+
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-54
 Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 43/291 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  +L  ++G G FG VW      +  V AIK +K    S E    L+E + ++K+ H  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAF--LQEAQVMKKLRHEK 73

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ E   +Y V EYM     L  L  +  K     ++ +   Q+  G+AY+ + 
Sbjct: 74  LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTEYVSTRWYRAPEVLLQSYLY 176
            Y HRDL+  N+LV ++   K+ADFGLAR I                + APE  L    +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-F 191

Query: 177 SSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           + K D+W+ G ++ EL T  R  +PG    + + ++                       Y
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------------------GY 231

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE---ALQHPFS 283
           + P     P         +    L+      +P +RPT       L+  F+
Sbjct: 232 RMPCPPECP---------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (449), Expect = 4e-54
 Identities = 61/301 (20%), Positives = 106/301 (35%), Gaps = 42/301 (13%)

Query: 3   RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI 62
           RY+L +++G G+FG ++      +GE VAIK    K    +      E K  + M     
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGGVG 64

Query: 63  VK-LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGY 121
           +  ++    E D    V E +  +L  L     + FS   V     Q+   + Y+H + +
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 122 FHRDLKPENLLVSKD----TIKIADFGLAREINS--------RPPFTEYVSTRWYRAPEV 169
            HRD+KP+N L+        + I DFGLA++                    T  Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
            L     S + D+ ++G ++         + G   A +  K                   
Sbjct: 185 HLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------------------ 225

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA---EALQHPFSRVA 286
            R    K       P+ VL      +  + +    S     +P  +   +  ++ F R  
Sbjct: 226 ERISEKKMST----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281

Query: 287 F 287
           F
Sbjct: 282 F 282

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (448), Expect = 4e-54
 Identities = 71/305 (23%), Positives = 130/305 (42%), Gaps = 40/305 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
               +  ++G G +G V+  + K+    VA+K +K+     EE   L+E   ++++ HPN
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIKHPN 74

Query: 62  IVKLKEVIRENDILYFVFEYME--CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V       Y + E+M     L  L +   +  S   +     Q+   + Y+ ++
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTEYVSTRWYRAPEVLLQSYLY 176
            + HRDL   N LV ++  +K+ADFGL+R +                + APE L  +  +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-F 193

Query: 177 SSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK 236
           S K D+WA G ++ E+ T         +  ++Y++                      +Y+
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------------------KDYR 234

Query: 237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFMFHHLSVPE 296
             +  G P         +    L+ +   W+PS RP+ AE  Q  F     MF   S+ +
Sbjct: 235 MERPEGCP---------EKVYELMRACWQWNPSDRPSFAEIHQA-FET---MFQESSISD 281

Query: 297 QLLQE 301
           ++ +E
Sbjct: 282 EVEKE 286

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 7e-54
 Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 43/291 (14%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
           E  KL++ +G G FG VW          VA+K +K+   S +    L E   ++++ H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAF--LAEANLMKQLQHQR 69

Query: 62  IVKLKEVIRENDILYFVFEYMECNLYQ--LMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           +V+L  V+ +   +Y + EYME       L        +  ++ +   Q+ +G+A++ +R
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 120 GYFHRDLKPENLLV-SKDTIKIADFGLAREI--NSRPPFTEYVSTRWYRAPEVLLQSYLY 176
            Y HRDL+  N+LV    + KIADFGLAR I  N             + APE +     +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-F 187

Query: 177 SSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           + K D+W+ G ++ E++T  R  +PG +  + I  +                       Y
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--------------------GY 227

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE---ALQHPFS 283
           +  +    P         ++   L+       P  RPT       L+  F+
Sbjct: 228 RMVRPDNCP---------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (441), Expect = 6e-53
 Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 42/292 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKM 57
           +   K+ + +G G FG V     K  G+    VAIK +K  Y   +    L E   + + 
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
            HPN++ L+ V+ ++  +  + E+ME  +L   ++  +  F+  ++      +  G+ Y+
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS------TRWYRAPEV 169
               Y HRDL   N+LV+ +   K++DFGL+R +        Y S         + APE 
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLL 228
           +     ++S  D+W+ G +M E+++     +   +  D I  I                 
Sbjct: 205 IQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--------------- 248

Query: 229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                +Y+ P  +  P              L+      D + RP   + +  
Sbjct: 249 -----DYRLPPPMDCP---------SALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-52
 Identities = 62/285 (21%), Positives = 107/285 (37%), Gaps = 37/285 (12%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEV----VAIKKMKKKYYSWEECVNLREVKSLRKMSH 59
           +K IK +G G FG+V++ +    GE     VAIK++++          L E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 60  PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQR 119
           P++ +L  +   + +           L   +++ +       + NWC Q+ +G+ Y+  R
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 120 GYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYL 175
              HRDL   N+LV     +KI DFGLA+ + +               + A E +L    
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 189

Query: 176 YSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           Y+ + D+W+ G  + EL+T          A EI  I                 L +    
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----------------LEKGERL 232

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
             P           P    D   ++      D   RP   E +  
Sbjct: 233 PQP-----------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-52
 Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 42/298 (14%)

Query: 1   MERYKLIKEVGDGTFGSVWRA---ISKQSGEVVAIKKMKKKYYSWEECVN---LREVKSL 54
           +E ++L+K +G G +G V+         +G++ A+K +KK     +         E + L
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 55  RKMSH-PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
             +   P +V L    +    L+ + +Y+          + + F+E EV+ +  ++   L
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 114 AYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP---PFTEYVSTRWYRAPEV 169
            ++H+ G  +RD+K EN+L+  +  + + DFGL++E  +      +    +  +     V
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 170 LLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL 229
                 +   VD W++G +M EL+T    F    E +   +I   I              
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP------ 256

Query: 230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPF 282
                                  +  A  LI  L   DP KR       A E  +H F
Sbjct: 257 --------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-52
 Identities = 61/296 (20%), Positives = 115/296 (38%), Gaps = 43/296 (14%)

Query: 8   KEVGDGTFGSVWRAI--SKQSGEVVAIKKMKKKYYSWEECVN-LREVKSLRKMSHPNIVK 64
           KE+G G FG+V +     K+  + VA+K +K +          L E   ++++ +P IV+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 65  LKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHR 124
           +  +  E +    V E  E         + +   +  +     QV  G+ Y+ +  + HR
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 125 DLKPENLLVSKD-TIKIADFGLAREINSRPPF----TEYVSTRWYRAPEVLLQSYLYSSK 179
           DL   N+L+      KI+DFGL++ + +   +    T       + APE +     +SSK
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSK 190

Query: 180 VDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP 238
            D+W+ G +M E  +  +  + G   ++    +                        +  
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--------------------GERMG 230

Query: 239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE---ALQHPFSRVAFMFHH 291
              G P         ++   L+    ++D   RP  A     L++ +  V    HH
Sbjct: 231 CPAGCP---------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 5e-52
 Identities = 59/307 (19%), Positives = 118/307 (38%), Gaps = 48/307 (15%)

Query: 2   ERYKLIK-EVGDGTFGSVWRAISKQSGE--VVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           +   +   E+G G FGSV + + +   +   VAIK +K+     +    +RE + + ++ 
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           +P IV+L  V +    L  V E      L++ +  + +    + V     QV  G+ Y+ 
Sbjct: 68  NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126

Query: 118 QRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEY----VSTRWYRAPEVLLQ 172
           ++ + HRDL   N+L+      KI+DFGL++ + +   +            + APE +  
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186

Query: 173 SYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
              +SS+ D+W+ G  M E ++  +  +      + +  I                    
Sbjct: 187 RK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------------------ 227

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE---ALQHPF----SR 284
               +       P          +  +L++    +    RP        ++  +    S+
Sbjct: 228 --GKRMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

Query: 285 VAFMFHH 291
           V    HH
Sbjct: 277 VEGHHHH 283

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  171 bits (433), Expect = 1e-51
 Identities = 45/293 (15%), Positives = 96/293 (32%), Gaps = 41/293 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-P 60
             YK+ + +G+G+FG ++   +  + + VAIK   ++  + +      E ++ + ++   
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL---RDEYRTYKLLAGCT 61

Query: 61  NIVKLKEVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG 120
            I  +    +E      V + +  +L  L+    + FS   V     Q+   +  +H++ 
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 121 YFHRDLKPENLLVSKDT------IKIADFGLAREINS--------RPPFTEYVSTRWYRA 166
             +RD+KP+N L+ +        I + DFG+ +                     T  Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 167 PEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG 226
               L     S + D+ A+G +    +     + G   A    K   +            
Sbjct: 182 INTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------ 234

Query: 227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
                            PL  L     ++    +    +      P       
Sbjct: 235 ----------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 3e-51
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 39/287 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
           ER +L + +G+G FG V + I    +     VAIK  K           L+E  ++R+  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 59  HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMH 117
           HP+IVKL  VI EN  ++ + E      L   ++ R+     A +  + +Q+   LAY+ 
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 118 QRGYFHRDLKPENLLV-SKDTIKIADFGLAREINSRPPF--TEYVSTRWYRAPEVLLQSY 174
            + + HRD+   N+LV S D +K+ DFGL+R +     +  ++      + APE +    
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 175 LYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI 233
            ++S  D+W  G  M E++      F G    D I +I +    P               
Sbjct: 186 -FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--------------- 229

Query: 234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
                         + P+      SL+    ++DPS+RP   E    
Sbjct: 230 --------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-50
 Identities = 67/302 (22%), Positives = 113/302 (37%), Gaps = 38/302 (12%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN 61
               L + +G G FG VWR   K  GE VA+K    +           E+     + H N
Sbjct: 3   RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHEN 58

Query: 62  IVKLKEVIREND----ILYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           I+       +++     L+ V +Y E  +L+  +       +   +         GLA++
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHL 116

Query: 117 HQ--------RGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-----RPPFTEYVSTR 162
           H             HRDLK +N+LV K+ T  IAD GLA   +S            V T+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 163 WYRAPEVL-----LQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGT 217
            Y APEVL     ++ +    + D++AMG +  E+     +  G  E  ++     V   
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSD 235

Query: 218 PTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA 277
           P+ +     +   +      P +   P       A +    ++      + + R TA   
Sbjct: 236 PSVEEMRKVVCEQK----LRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 278 LQ 279
            +
Sbjct: 289 KK 290

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 3e-50
 Identities = 64/288 (22%), Positives = 117/288 (40%), Gaps = 39/288 (13%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKM 57
                 K +G G FG V++ + K S       VAIK +K  Y   +    L E   + + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 58  SHPNIVKLKEVIRENDILYFVFEYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYM 116
           SH NI++L+ VI +   +  + EYME     + +++++  FS  ++      +  G+ Y+
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 117 HQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP----FTEYVSTRWYRAPEVLL 171
               Y HRDL   N+LV+ +   K++DFGL+R +   P      +       + APE + 
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI- 185

Query: 172 QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR 231
               ++S  D+W+ G +M E++T            E+ K  +                  
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN------------------ 227

Query: 232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
              ++ P  +  P              L+      + ++RP  A+ + 
Sbjct: 228 -DGFRLPTPMDCP---------SAIYQLMMQCWQQERARRPKFADIVS 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 8e-50
 Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 51/301 (16%)

Query: 1   MERYKLIKEVGDGTFGSVWRAISKQSGE--VVAIKKMKKKYYSWEECVNLREVKSLRKMS 58
               K    +G+G FG V +A  K+ G     AIK+MK+     +      E++ L K+ 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 59  -HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC---------------FSEAE 101
            HPNI+ L         LY   EY    NL   ++                     S  +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 102 VRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYVS 160
           + ++   V +G+ Y+ Q+ + HRDL   N+LV ++   KIADFGL+R        T    
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 161 TRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPT 219
              + A E L  S  Y++  D+W+ G ++ E+++L    + G + A+   K+        
Sbjct: 189 PVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------ 241

Query: 220 QDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ 279
                          Y+  + +             +   L+       P +RP+ A+ L 
Sbjct: 242 --------------GYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILV 278

Query: 280 H 280
            
Sbjct: 279 S 279

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-49
 Identities = 68/307 (22%), Positives = 115/307 (37%), Gaps = 58/307 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRA-----ISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
            R    K +G G FG V  A     I   +   VA+K +K   +  E    + E+K L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 57  MS-HPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDR-----------------EKCF 97
           +  H NIV L            + EY    +L   ++ +                 E   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF- 155
              ++ ++ +QV +G+A++  +   HRDL   N+L++     KI DFGLAR+I +   + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 156 --TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKIC 212
                     + APE +     Y+ + D+W+ G  + EL +L    +PG     + YK+ 
Sbjct: 203 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM- 260

Query: 213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP 272
                           +        P             A  +   ++ +    DP KRP
Sbjct: 261 ----------------IKEGFRMLSP-----------EHAPAEMYDIMKTCWDADPLKRP 293

Query: 273 TAAEALQ 279
           T  + +Q
Sbjct: 294 TFKQIVQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 5e-49
 Identities = 70/312 (22%), Positives = 127/312 (40%), Gaps = 64/312 (20%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
              + ++++G+G FG V++A +      +   +VA+K +K++  +  +    RE   + +
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYMEC-NLYQLMKDREKC------------------- 96
             +PNIVKL  V      +  +FEYM   +L + ++                        
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 97  ----FSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS 151
                S AE      QV  G+AY+ +R + HRDL   N LV ++  +KIADFGL+R I S
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 152 RPPF---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADE 207
              +           +  PE  +    Y+++ D+WA G ++ E+ +     + G +  + 
Sbjct: 193 ADYYKADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWD 267
           IY +             DG +LA                    +   +  +L+    S  
Sbjct: 252 IYYVR------------DGNILA-----------------CPENCPLELYNLMRLCWSKL 282

Query: 268 PSKRPTAAEALQ 279
           P+ RP+     +
Sbjct: 283 PADRPSFCSIHR 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-45
 Identities = 69/307 (22%), Positives = 122/307 (39%), Gaps = 57/307 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRAIS-----KQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           +R KL K +G G FG V  A +       +   VA+K +K+     E    + E+K L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 57  MSH-PNIVKLKEVIRE-NDILYFVFEYME-CNLYQLMKDREK---------------CFS 98
           + H  N+V L     +    L  + E+ +  NL   ++ +                   +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 99  EAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-- 155
              +  + FQV +G+ ++  R   HRDL   N+L+S+   +KI DFGLAR+I   P +  
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 156 -TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICS 213
             +      + APE +     Y+ + D+W+ G ++ E+ +L    +PG    +E  +   
Sbjct: 193 KGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-- 249

Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT 273
                          L      + P                +    +      +PS+RPT
Sbjct: 250 ---------------LKEGTRMRAPDYT-----------TPEMYQTMLDCWHGEPSQRPT 283

Query: 274 AAEALQH 280
            +E ++H
Sbjct: 284 FSELVEH 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-45
 Identities = 57/285 (20%), Positives = 110/285 (38%), Gaps = 42/285 (14%)

Query: 8   KEVGDGTFGSVWRAI---SKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVK 64
           + +G G FG V+      +       A+K + +     E    L E   ++  SHPN++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 65  LKEVIREND-ILYFVFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYF 122
           L  +   ++     V  YM+  +L   +++     +  ++  +  QV +G+ ++  + + 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152

Query: 123 HRDLKPENLLVSKD-TIKIADFGLAR-----EINSRPPFTEYVSTRWYRAPEVLLQSYLY 176
           HRDL   N ++ +  T+K+ADFGLAR     E +S    T       + A E L     +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-F 211

Query: 177 SSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY 235
           ++K D+W+ G ++ EL+T   P +P  +  D    +                        
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------------------GR 251

Query: 236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH 280
           +  Q    P              ++          RP+ +E +  
Sbjct: 252 RLLQPEYCP---------DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 61/315 (19%), Positives = 124/315 (39%), Gaps = 57/315 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRK 56
           E+  + +E+G G+FG V+  ++K     +    VAIK + +     E    L E   +++
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 57  MSHPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDREKC---------FSEAEVRNWC 106
            +  ++V+L  V+ +      + E M   +L   ++               S +++    
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 107 FQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI---NSRPPFTEYVSTR 162
            ++  G+AY++   + HRDL   N +V++D T+KI DFG+ R+I   +      + +   
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 163 WYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQD 221
            + +PE L     +++  D+W+ G ++ E+ TL    + G S    +  +         D
Sbjct: 200 RWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258

Query: 222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH- 280
           +  D                                 L+     ++P  RP+  E +   
Sbjct: 259 NCPD-----------------------------MLFELMRMCWQYNPKMRPSFLEIISSI 289

Query: 281 ------PFSRVAFMF 289
                  F  V+F +
Sbjct: 290 KEEMEPGFREVSFYY 304

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-44
 Identities = 69/307 (22%), Positives = 126/307 (41%), Gaps = 57/307 (18%)

Query: 2   ERYKLIKEVGDGTFGSVWRAISK-------QSGEVVAIKKMKKKYYSWEECVNLREVKSL 54
           +R  L K +G+G FG V  A +             VA+K +K      +    + E++ +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 55  RKMS-HPNIVKLKEVIRENDILYFVFEYME-CNLYQLMKDR---------------EKCF 97
           + +  H NI+ L     ++  LY + EY    NL + ++ R               E+  
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 98  SEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT 156
           S  ++ +  +QV +G+ Y+  +   HRDL   N+LV++D  +KIADFGLAR+I+    + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 157 E---YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICS 213
           +         + APE L     Y+ + D+W+ G ++ E+ TL          +E++K+  
Sbjct: 193 KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-- 249

Query: 214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT 273
                          L        P            +   +   ++       PS+RPT
Sbjct: 250 ---------------LKEGHRMDKP-----------SNCTNELYMMMRDCWHAVPSQRPT 283

Query: 274 AAEALQH 280
             + ++ 
Sbjct: 284 FKQLVED 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 98.3 bits (244), Expect = 3e-25
 Identities = 31/200 (15%), Positives = 66/200 (33%), Gaps = 22/200 (11%)

Query: 4   YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMK---------KKYYSWEECVNLREVKSL 54
             + K +G+G   +V+   S+       +K  K         K+   + +          
Sbjct: 2   DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 55  RKMSHPNIVKLKEVIRENDILYF-VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGL 113
            +     + KL+ +       +      ME                         + + +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELI----DAKELYRVRVENPDEVLDMILEEV 116

Query: 114 AYMHQRGYFHRDLKPENLLVSKDTIKIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQS 173
           A  + RG  H DL   N+LVS++ I I DF  + E+     + E +     R    ++  
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEV-GEEGWREIL----ERDVRNIITY 171

Query: 174 YL--YSSKVDMWAMGAIMAE 191
           +   Y ++ D+ +    + +
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	337
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.78
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.42
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.3
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.29
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.54

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-66  Score=444.93  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=213.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            57899999999999999999999999999999999776544444456789999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---CCCc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---PPFT  156 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---~~~~  156 (337)
                      |++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||+|......   ....
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~  163 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  163 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence            99986554444555669999999999999999999999999999999999999875 9999999999865432   2345


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.++............                    
T Consensus       164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~--------------------  223 (271)
T d1nvra_         164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------------------  223 (271)
T ss_dssp             CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC--------------------
T ss_pred             ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--------------------
Confidence            678999999999998775567889999999999999999999987665433322221100                    


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                             .....++.+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       224 -------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         224 -------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                   001112467899999999999999999999999999999984

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-65  Score=438.86  Aligned_cols=253  Identities=29%  Similarity=0.472  Sum_probs=219.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++.+.....  ......+|+.++++++||||+++++++.+++.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999987543221  233456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|...... ....
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~  163 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT  163 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence            9999986665555555669999999999999999999999999999999999999876 9999999999876543 2356


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+....                   .. 
T Consensus       164 ~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-------------------~~-  222 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------------------FT-  222 (263)
T ss_dssp             TTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------------------CC-
T ss_pred             cCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------CC-
Confidence            7899999999999765 68999999999999999999999999888777766654321                   11 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                .++.+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       223 ----------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         223 ----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                      12457899999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-64  Score=439.52  Aligned_cols=255  Identities=26%  Similarity=0.478  Sum_probs=220.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++....... .....+|+.++++++||||+++++++.+++.+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            47999999999999999999999999999999997654332 34457899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~~  159 (337)
                      ++|+.+..+...+ .+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|...... ......+
T Consensus        99 ~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~  177 (293)
T d1yhwa1          99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  177 (293)
T ss_dssp             CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred             cCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccc
Confidence            9987776666544 59999999999999999999999999999999999999876 9999999999876543 3446678


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFPQ  239 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
                      ||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+....... .                   
T Consensus       178 gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~-------------------  236 (293)
T d1yhwa1         178 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-L-------------------  236 (293)
T ss_dssp             SCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-C-------------------
T ss_pred             cCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-C-------------------
Confidence            99999999999765 68999999999999999999999999988877776665431110 0                   


Q ss_pred             CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          240 LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                             ..++.+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus       237 -------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         237 -------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             -------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                   1124578999999999999999999999999999999853

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-64  Score=444.13  Aligned_cols=258  Identities=32%  Similarity=0.441  Sum_probs=203.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.............+|+.++++++||||+++++++.+++.+|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            46999999999999999999999999999999998765544444556899999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC----CcEEEeeCCCcccCCCCCCCcc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK----DTIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~----~~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      ++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||+..    +.+||+|||+|...+......+
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  168 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST  168 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence            997555444444566999999999999999999999999999999999999953    3899999999988776666677


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+....+......++                  
T Consensus       169 ~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------  229 (307)
T d1a06a_         169 ACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------------------  229 (307)
T ss_dssp             ----CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC------------------
T ss_pred             eeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC------------------
Confidence            8999999999998765 789999999999999999999999999888777766654321111                  


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                              ...++.+|+++.+||.+||++||.+|||++|+++||||+..
T Consensus       230 --------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         230 --------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             --------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             --------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                    11235688999999999999999999999999999999863

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-64  Score=440.04  Aligned_cols=282  Identities=37%  Similarity=0.675  Sum_probs=238.8

Q ss_pred             eEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH----HhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            5 KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE----ECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         5 ~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +.++.||+|+||+||+|.++.+|+.||+|+++.......    .....+|+.++++++||||+++++++.+++..|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            357899999999999999999999999999976543322    2345689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      |+.++++..+...+..+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||.|...... ......
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            99999988888877789999999999999999999999999999999999999886 9999999999876543 334567


Q ss_pred             cccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          159 VSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       159 ~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      +||+.|+|||++.+...|+.++||||+||++|+|++|.+||.+.++.+.+..+....+.+....|..........  .+.
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~--~~~  238 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV--TFK  238 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC--CCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh--hhc
Confidence            899999999998877678999999999999999999999999999999999999999999888776644322222  122


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .....+.....+..++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            22333444555678999999999999999999999999999999987543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-63  Score=437.94  Aligned_cols=252  Identities=30%  Similarity=0.480  Sum_probs=220.2

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH--hHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE--CVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +|++++.||+|+||+||+|.++.+|+.||+|++.........  ....+|+.++++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            499999999999999999999999999999999876544322  345689999999999999999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      ||.++++..+.....++++..++.+++||+.||.|||++||+||||||+|||++.+ .+||+|||+|......   ...+
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~  172 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFV  172 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Cccc
Confidence            99999888777667779999999999999999999999999999999999999876 9999999999876543   4568


Q ss_pred             ccccccCchhhcC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          160 STRWYRAPEVLLQ--SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       160 gt~~~~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ||+.|+|||++.+  ...|+.++|||||||++|+|++|.+||.+.+..+.+..+.....                     
T Consensus       173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~---------------------  231 (309)
T d1u5ra_         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------------------  231 (309)
T ss_dssp             SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------------------
T ss_pred             cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---------------------
Confidence            9999999999864  23589999999999999999999999999888777766654311                     


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      +..       ....+|+++.+||.+||+.||.+|||++|+|+||||..
T Consensus       232 ~~~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         232 PAL-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             CCC-------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCC-------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            110       12457899999999999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-63  Score=434.29  Aligned_cols=285  Identities=39%  Similarity=0.729  Sum_probs=241.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |++|++++.||+|+||+||+|.++.+|+.||+|+++...... ......+|++++++++||||+++++++.+++.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            789999999999999999999999999999999997654332 2334568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCc
Q 038835           80 EYMECNLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFT  156 (337)
Q Consensus        80 e~~~~~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~  156 (337)
                      ||++++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||.|...... ....
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            99999888766543 5669999999999999999999999999999999999999876 9999999999876543 3445


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....|........ ....
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~  239 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD-YKPS  239 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-CCTT
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc-cccc
Confidence            678999999999988776778999999999999999999999999999999999999988888777765433222 1222


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ++...........+.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            33333344445567889999999999999999999999999999999863

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.4e-63  Score=443.49  Aligned_cols=259  Identities=26%  Similarity=0.453  Sum_probs=226.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++...... ......+|+.++++++||||+++++++++++.+|+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5799999999999999999999999999999999765322 334556899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC---CcEEEeeCCCcccCCCCCCCcc
Q 038835           82 MECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK---DTIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        82 ~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~---~~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |+|+.+ +.+...+.++++.+++.++.||+.||+|||++||+||||||+|||++.   +.+||+|||+|...........
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~  187 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  187 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence            997655 555555667999999999999999999999999999999999999973   3899999999998877766677


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+......++.                 
T Consensus       188 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----------------  249 (352)
T d1koba_         188 TTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-----------------  249 (352)
T ss_dssp             ECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------------
T ss_pred             ccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------------
Confidence            8999999999998765 7899999999999999999999999999988888777654322211                 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                               ..++.+|+++.+||.+||++||.+|||++|+|+||||+....
T Consensus       250 ---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         250 ---------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             ---------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             ---------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence                     123568899999999999999999999999999999987543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-63  Score=434.10  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=217.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      +.|++++.||+|+||.||+|.++.+|+.||+|++..... .......+|++++++++||||+++++++.+++.+|+||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            359999999999999999999999999999999976532 2334557899999999999999999999999999999999


Q ss_pred             cCCCHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCCccc
Q 038835           82 MECNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPFTEY  158 (337)
Q Consensus        82 ~~~~l~~~~-~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~~~~  158 (337)
                      ++|+.+..+ .+...++++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|...... ......
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~  170 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  170 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence            998666544 5556679999999999999999999999999999999999999876 9999999999765332 223457


Q ss_pred             cccccccCchhhc----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          159 VSTRWYRAPEVLL----QSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       159 ~gt~~~~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      +||+.|+|||++.    ....|+.++||||+||++|+|++|++||.+.+..+.+..+.....                  
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~------------------  232 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP------------------  232 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC------------------
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence            8999999999985    234689999999999999999999999999888877776654311                  


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                         +.      ...++.+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       233 ---~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         233 ---PT------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ---CC------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ---CC------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence               00      0112457899999999999999999999999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.1e-63  Score=442.63  Aligned_cols=259  Identities=26%  Similarity=0.467  Sum_probs=225.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++...... ......+|+.++++++||||+++++++.+++.+|+|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh-hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            47899999999999999999999999999999999765332 33445689999999999999999999999999999999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC---CcEEEeeCCCcccCCCCCCCc
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK---DTIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~---~~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ||+|+ +.+.+.+....+++..++.++.||+.||+|||++||+||||||+|||++.   +.+||+|||+|...+......
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            99975 55666566667999999999999999999999999999999999999964   389999999999887776667


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+..+.......+.                
T Consensus       184 ~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------------  246 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------------  246 (350)
T ss_dssp             EECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC----------------
T ss_pred             eecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------------
Confidence            78999999999998765 6799999999999999999999999999888888877654322211                


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                                ...+.+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus       247 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         247 ----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             ----------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             ----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                      11245789999999999999999999999999999998643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-63  Score=432.91  Aligned_cols=257  Identities=28%  Similarity=0.411  Sum_probs=222.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-----HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-----EECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+.....     ....+.+|+.+|++++||||+++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46999999999999999999999999999999997654322     2344578999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-----cEEEeeCCCcccCCC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-----TIKIADFGLAREINS  151 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-----~~kL~Dfg~a~~~~~  151 (337)
                      +|||||+|+.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.+     .+||+|||+|.....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            999999986665555555669999999999999999999999999999999999999764     599999999998876


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      ........||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+..+.......+            
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------  236 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE------------  236 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC------------
T ss_pred             CccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC------------
Confidence            6666778999999999999765 789999999999999999999999999888887777654321111            


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                    ...++..|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       237 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         237 --------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             --------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             --------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                          1122467899999999999999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-63  Score=443.09  Aligned_cols=276  Identities=23%  Similarity=0.352  Sum_probs=213.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||+|+++............+|+.+|++++|||||++++++.+++.+|+||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            68999999999999999999999999999999998765444455667999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcccc
Q 038835           82 MECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTEYV  159 (337)
Q Consensus        82 ~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~~~  159 (337)
                      ++|+.+..+..+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+ .+||+|||+|....+. ...+.+
T Consensus        86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~  164 (322)
T d1s9ja_          86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFV  164 (322)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---C
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-cccccc
Confidence            9987666655555669999999999999999999997 499999999999999876 9999999999865432 224679


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhCCCCcc----chhhh--------
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYK-ICSVIGTPTQD----SWADG--------  226 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~----~~~~~--------  226 (337)
                      ||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+.... +....+.+...    .+...        
T Consensus       165 GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T d1s9ja_         165 GTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD  243 (322)
T ss_dssp             CSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------------
T ss_pred             CCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence            99999999999876 789999999999999999999999987665433111 11111111100    00000        


Q ss_pred             -------hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          227 -------LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       227 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                             ...........+      ........|.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         244 SRPPMAIFELLDYIVNEPP------PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             --CCCCHHHHHHHHHTSCC------CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccchhHHHHHhhhhccCC------ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                   000000000000      01112346899999999999999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-62  Score=428.18  Aligned_cols=283  Identities=35%  Similarity=0.681  Sum_probs=244.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |++|+++++||+|+||+||+|.++ +|+.||+|++....... ......+|+.+|++++||||+++++++.+++..+++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            799999999999999999999986 78999999997654322 2344568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~  157 (337)
                      |++.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||.|....... ....
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence            999999999998878889999999999999999999999999999999999999887 99999999998765432 2345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+|++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+.+.++....+.+....|.......+. ...+
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~  238 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY-DPNF  238 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTTC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc-cccc
Confidence            679999999999987777899999999999999999999999999999999999999999998888765443322 3334


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ......+.....+..++++.+||++||+.||++|||++|+|+||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            444455566667889999999999999999999999999999999974

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-62  Score=434.73  Aligned_cols=254  Identities=32%  Similarity=0.469  Sum_probs=221.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      |++|++++.||+|+||.||+|+++.+|+.||+|++.+....  .......+|+.+|++++||||+++++++.+++.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            68999999999999999999999999999999999865322  2234456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC-CCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS-RPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~-~~~~~  156 (337)
                      |||++|+.+..+..+...+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|..... .....
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~  163 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  163 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence            9999987766666666679999999999999999999999999999999999999876 999999999987644 34456


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+....+....                   ..
T Consensus       164 ~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-------------------~~  223 (337)
T d1o6la_         164 TFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-------------------IR  223 (337)
T ss_dssp             CCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------CC
T ss_pred             cceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-------------------CC
Confidence            68999999999998766 78999999999999999999999999988877766654421                   11


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                                 +++.+|+++++||.+||++||.+|+     +++|+++||||+.
T Consensus       224 -----------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         224 -----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             -----------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence                       1246789999999999999999999     4999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-63  Score=431.49  Aligned_cols=253  Identities=30%  Similarity=0.456  Sum_probs=214.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+...  ........+|++++++++||||+++++++.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            579999999999999999999999999999999976432  122334568999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---CCC
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---PPF  155 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---~~~  155 (337)
                      ||++|+.+..+....+.+++..++.++.|++.||+|||++||+||||||+|||++++ .+||+|||+|......   ...
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~  167 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA  167 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence            999986555455555669999999999999999999999999999999999999876 9999999999876533   223


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      .+.+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+...++....                   .
T Consensus       168 ~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-------------------~  227 (288)
T d1uu3a_         168 NSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-------------------Y  227 (288)
T ss_dssp             --CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-------------------C
T ss_pred             ccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-------------------C
Confidence            457899999999999766 78999999999999999999999999988877777664320                   1


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH------HhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE------ALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------ll~hp~~~~  285 (337)
                      .+           ++.+++++++||.+||+.||.+|||++|      +++||||++
T Consensus       228 ~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         228 DF-----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             CC-----------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             CC-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            11           2457899999999999999999999998      578999976

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-62  Score=425.03  Aligned_cols=253  Identities=28%  Similarity=0.467  Sum_probs=204.1

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEee--CCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRE--NDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l   77 (337)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++........ ...+.+|++++++++||||+++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            3789999999999999999999999999999999987665543 3345689999999999999999999854  466899


Q ss_pred             EEeecCCCHHHHHh-h---ccCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCCeeeeCC-cEEEeeCCCcc
Q 038835           78 VFEYMECNLYQLMK-D---REKCFSEAEVRNWCFQVFQGLAYMHQRG-----YFHRDLKPENLLVSKD-TIKIADFGLAR  147 (337)
Q Consensus        78 v~e~~~~~l~~~~~-~---~~~~l~~~~~~~~~~qil~al~~LH~~~-----i~H~dikp~Nili~~~-~~kL~Dfg~a~  147 (337)
                      ||||++|+.+..+. +   .+..+++..++.++.||+.||+|||++|     |+||||||+|||++.+ .+||+|||+|.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999975544443 2   3457999999999999999999999987     9999999999999876 99999999998


Q ss_pred             cCCCCC-CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          148 EINSRP-PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       148 ~~~~~~-~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      ...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+....           
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-----------  230 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-----------  230 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            765443 33567899999999998665 78999999999999999999999999988877766665431           


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFS  283 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  283 (337)
                                ++        ..+..+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus       231 ----------~~--------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 ----------FR--------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ----------CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----------CC--------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                      11        1124678999999999999999999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-62  Score=419.31  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=209.3

Q ss_pred             Cc-eEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEee----CCEEE
Q 038835            3 RY-KLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIRE----NDILY   76 (337)
Q Consensus         3 ~y-~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~   76 (337)
                      || ++.++||+|+||+||+|.++.+|+.||+|++........ ...+.+|++++++++||||+++++++++    +..+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            45 678899999999999999999999999999987655443 3345689999999999999999999865    45689


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCCeeeeC-C-cEEEeeCCCcccCCCC
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRG--YFHRDLKPENLLVSK-D-TIKIADFGLAREINSR  152 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~--i~H~dikp~Nili~~-~-~~kL~Dfg~a~~~~~~  152 (337)
                      +||||++++.+..+..+...+++..++.++.||+.||+|||++|  |+||||||+|||++. + .+||+|||+|......
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            99999998766665555667999999999999999999999999  999999999999964 4 8999999999865433


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                       ...+.+||+.|+|||++.+  .++.++||||+||++|+|++|++||.+..+.+.+.+.......               
T Consensus       169 -~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~---------------  230 (270)
T d1t4ha_         169 -FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------------  230 (270)
T ss_dssp             -SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------------
T ss_pred             -ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC---------------
Confidence             3356789999999998854  4899999999999999999999999877665544332211000               


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSR  284 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  284 (337)
                                  ........++++.++|.+||+.||++|||++|+|+||||+
T Consensus       231 ------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 ------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                        0112245688999999999999999999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-62  Score=432.31  Aligned_cols=258  Identities=26%  Similarity=0.432  Sum_probs=224.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      .++|++++.||+|+||+||+|.++.+|+.||+|+++...  .......+|+.+|++++||||+++++++++++.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            479999999999999999999999999999999997653  334445689999999999999999999999999999999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC---cEEEeeCCCcccCCCCCCCc
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD---TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~---~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ||+|+ +.+.+...+..+++.+++.++.||+.||+|||++||+||||||+|||++.+   .+||+|||++..........
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence            99975 555565555579999999999999999999999999999999999999753   79999999999877666566


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+||+.|+|||.+.+. .++.++||||+||++|+|++|.+||.+.+..+....+......++..               
T Consensus       162 ~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------  225 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---------------  225 (321)
T ss_dssp             EEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---------------
T ss_pred             ccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh---------------
Confidence            77899999999998765 68999999999999999999999999999888888876643222211               


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                                 .++.+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus       226 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         226 -----------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             -----------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             -----------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence                       1246789999999999999999999999999999997543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-61  Score=420.30  Aligned_cols=258  Identities=30%  Similarity=0.408  Sum_probs=221.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh--------HHhHHHHHHHHHhcCC-CCCcccceeEEeeC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW--------EECVNLREVKSLRKMS-HPNIVKLKEVIREN   72 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   72 (337)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.....        ......+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            79999999999999999999999999999999997654321        1123468999999996 99999999999999


Q ss_pred             CEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCC
Q 038835           73 DILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINS  151 (337)
Q Consensus        73 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~  151 (337)
                      +.+|+||||++|+.+..+....+++++.+++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|...+.
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  162 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  162 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence            9999999999875444444445569999999999999999999999999999999999999876 999999999998877


Q ss_pred             CCCCccccccccccCchhhcC-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhh
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQ-----SYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADG  226 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  226 (337)
                      .......+||+.|+|||.+.+     ...++.++||||+||++|+|++|++||.+.+..+....+......++..     
T Consensus       163 ~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-----  237 (277)
T d1phka_         163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP-----  237 (277)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-----
T ss_pred             CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc-----
Confidence            666677899999999999863     3457889999999999999999999999998888777776542221111     


Q ss_pred             hhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          227 LLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                                           ..+.+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       238 ---------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         238 ---------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             ---------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ---------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                                 12467899999999999999999999999999999985

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-62  Score=429.12  Aligned_cols=252  Identities=25%  Similarity=0.439  Sum_probs=221.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      |++|++++.||+|+||+||+|.++.+|+.||+|++++....  .......+|+.++++++||||+++++++.+++.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            57899999999999999999999999999999999764322  1233456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|......  ..+
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~  160 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT  160 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence            9999998877777777779999999999999999999999999999999999999876 9999999999876543  356


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+...++.....                   . 
T Consensus       161 ~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-------------------~-  219 (316)
T d1fota_         161 LCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-------------------R-  219 (316)
T ss_dssp             CCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-------------------C-
T ss_pred             ccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-------------------C-
Confidence            7899999999998765 689999999999999999999999999888887777654311                   1 


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                                .++.+++++.++|.+||++||.+|+     |++++++||||++
T Consensus       220 ----------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         220 ----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             ----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             ----------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence                      1245789999999999999999996     9999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-61  Score=430.32  Aligned_cols=252  Identities=29%  Similarity=0.412  Sum_probs=219.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC--hHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS--WEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      |++|++++.||+|+||.||+|.++.+|+.||+|++.+....  .......+|+++|+.++||||+++++++.+.+..++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            57899999999999999999999999999999998754322  1223456899999999999999999999999999999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCcc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFTE  157 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~~  157 (337)
                      |||+.|+.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|......  ...
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~  197 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT  197 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence            9999987665555555669999999999999999999999999999999999999876 9999999999887543  346


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccC
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKF  237 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
                      .+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+......                    
T Consensus       198 ~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--------------------  256 (350)
T d1rdqe_         198 LCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--------------------  256 (350)
T ss_dssp             CEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------------
T ss_pred             ccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC--------------------
Confidence            7899999999999765 7899999999999999999999999998887777776543111                    


Q ss_pred             CCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          238 PQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                                .++.+++++.+||++||++||.+|+     |++|+++||||++
T Consensus       257 ----------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         257 ----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             ----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             ----------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence                      1246789999999999999999995     9999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-61  Score=432.72  Aligned_cols=257  Identities=26%  Similarity=0.384  Sum_probs=213.5

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHH---HHHHHHHhcCCCCCcccceeEEeeCCEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVN---LREVKSLRKMSHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~   75 (337)
                      |++|++++.||+|+||.||+|.++.+|+.||+|++.+......  ....   .+++.+++.++||||+++++++.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            6899999999999999999999999999999999875432211  1112   2457788888999999999999999999


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      |+||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|....... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-  161 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  161 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence            9999999987666555555669999999999999999999999999999999999999876 99999999998765443 


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAIN  234 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
                      ....+||+.|+|||++..+..|+.++|||||||++|+|++|++||.+.+..+...........                 
T Consensus       162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-----------------  224 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----------------  224 (364)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-----------------
T ss_pred             ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----------------
Confidence            356789999999999976667899999999999999999999999876554332221111000                 


Q ss_pred             ccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCC-----HHHHhcCcCccc
Q 038835          235 YKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPT-----AAEALQHPFSRV  285 (337)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----~~ell~hp~~~~  285 (337)
                                ....++.+|+++++||.+||++||.+|||     ++|+++||||++
T Consensus       225 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         225 ----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             ----------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence                      01123568899999999999999999999     799999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-61  Score=422.77  Aligned_cols=280  Identities=35%  Similarity=0.652  Sum_probs=234.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCC-CcEEEEEEcccccCChH-HhHHHHHHHHHhcC---CCCCcccceeEEee-----
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS-GEVVAIKKMKKKYYSWE-ECVNLREVKSLRKM---SHPNIVKLKEVIRE-----   71 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----   71 (337)
                      ++|++++.||+|+||+||+|.++.+ ++.||+|+++....... .....+|+.+++.|   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            6899999999999999999999765 66799999976543321 22345677777665   89999999999853     


Q ss_pred             CCEEEEEEeecCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccC
Q 038835           72 NDILYFVFEYMECNLYQLMK-DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREI  149 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~~~~-~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~  149 (337)
                      ....+++|||++++++.... .....+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||.+...
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence            35789999999998776554 345669999999999999999999999999999999999999875 9999999999877


Q ss_pred             CCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          150 NSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       150 ~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                      .........+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+....+.+....|......
T Consensus       167 ~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         167 SFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             cccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            666666778999999999998765 7899999999999999999999999999999999999999998888777654332


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      ...   .+......+.....+.+++++.+||.+||++||++|||++|+|+||||++
T Consensus       246 ~~~---~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         246 PRQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             CGG---GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             hhh---hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence            221   22233333444556788999999999999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-60  Score=421.89  Aligned_cols=254  Identities=29%  Similarity=0.462  Sum_probs=217.0

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccC--ChHHhHHHHHHHHHh-cCCCCCcccceeEEeeCCEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYY--SWEECVNLREVKSLR-KMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      |++|++++.||+|+||+||+|.++.+|+.||+|++.+...  .........|..++. .++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            7899999999999999999999999999999999976432  112223345666654 6899999999999999999999


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC-CCC
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR-PPF  155 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~-~~~  155 (337)
                      ||||++|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++++ .+||+|||.|...... ...
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999987666666666669999999999999999999999999999999999999986 9999999999876543 334


Q ss_pred             ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          156 TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+...  .+                 
T Consensus       161 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-----------------  220 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-----------------  220 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-----------------
T ss_pred             cccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-----------------
Confidence            557899999999999776 6899999999999999999999999998887777666432  11                 


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHH-HHhcCcCccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAA-EALQHPFSRV  285 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~-ell~hp~~~~  285 (337)
                                 ..++.+|+++.+||.+||++||.+|||+. ++++||||++
T Consensus       221 -----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         221 -----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             -----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence                       11245789999999999999999999996 8999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-60  Score=424.11  Aligned_cols=280  Identities=37%  Similarity=0.628  Sum_probs=232.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeCC------E
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIREND------I   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~   74 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||||+++....... .....+|+++|++++||||+++++++...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            589999999999999999999999999999999986554432 334568999999999999999999997554      5


Q ss_pred             EEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC
Q 038835           75 LYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP  153 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~  153 (337)
                      +|+||||+++.+.... +. ..+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||.|...+.. 
T Consensus        98 ~~lv~e~~~~~l~~~~-~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-  174 (346)
T d1cm8a_          98 FYLVMPFMGTDLGKLM-KH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-  174 (346)
T ss_dssp             CEEEEECCSEEHHHHH-HH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             EEEEEecccccHHHHH-Hh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence            7999999965555544 33 349999999999999999999999999999999999999887 9999999999876543 


Q ss_pred             CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh-hHHh
Q 038835          154 PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL-LARA  232 (337)
Q Consensus       154 ~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~  232 (337)
                       .+..+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++...+..... ....
T Consensus       175 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         175 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             -cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence             35678999999999998776789999999999999999999999999999999999999888887765543321 1112


Q ss_pred             hhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          233 INYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .....+......+....+..++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence            22335555555666667889999999999999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-60  Score=423.57  Aligned_cols=278  Identities=35%  Similarity=0.629  Sum_probs=235.0

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee------CCEEE
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE------NDILY   76 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~   76 (337)
                      +|+.+++||+|+||+||+|.++.+|+.||||++......     ..+|+.+|++++||||+++++++..      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            699999999999999999999999999999999765322     2379999999999999999999843      34689


Q ss_pred             EEEeecCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCC
Q 038835           77 FVFEYMECNLYQLMK---DREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINS  151 (337)
Q Consensus        77 lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~  151 (337)
                      +||||+++++...+.   .....+++..++.+++||+.||+|||++||+||||||+|||++.+  .+||+|||++.....
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            999999998766554   345569999999999999999999999999999999999999864  899999999998876


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      .....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....|....... 
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~-  254 (350)
T d1q5ka_         176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY-  254 (350)
T ss_dssp             TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred             CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch-
Confidence            6666778999999999998877689999999999999999999999999999999999999999998877766543221 


Q ss_pred             hhhccCCCCCCCcc-cccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccccc
Q 038835          232 AINYKFPQLVGVPL-SVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAF  287 (337)
Q Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  287 (337)
                       ....++.....+. ....+..++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       255 -~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         255 -TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             -hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence             1222333332222 233457899999999999999999999999999999998643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-59  Score=408.97  Aligned_cols=284  Identities=33%  Similarity=0.639  Sum_probs=241.4

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (337)
                      |+||++++.||+|+||+||+|+++.+|+.||+|+++...... ......+|+.+++.++||||+++++++.+.+..++++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            799999999999999999999999999999999997654433 3445579999999999999999999999999999999


Q ss_pred             eecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-CCcc
Q 038835           80 EYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-PFTE  157 (337)
Q Consensus        80 e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-~~~~  157 (337)
                      |++.++++..+......+++..++.++.|++.||+|||++||+||||||+|||++.+ .+||+|||.|....... ....
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            999999888888878889999999999999999999999999999999999999876 99999999998776443 3345


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPL-FPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..+++.|+|||++.+...++.++||||+||++|+|++|+.| |.+.+..+....+....+.+....|.............
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            67889999999988776789999999999999999999876 56666777888888888888888777654433332222


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                      .... ........+.+++++.+||++||+.||.+||||+|+|+||||++
T Consensus       241 ~~~~-~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         241 MYPA-TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCT-TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             cccc-cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            1111 12233445678999999999999999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-60  Score=418.00  Aligned_cols=286  Identities=31%  Similarity=0.530  Sum_probs=229.3

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEee--------
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRE--------   71 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------   71 (337)
                      +++|++++.||+|+||+||+|.++.+|+.||||++....... ......+|+++|+.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            479999999999999999999999999999999987654432 23345689999999999999999998754        


Q ss_pred             CCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCC
Q 038835           72 NDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREIN  150 (337)
Q Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~  150 (337)
                      ++..|+||||++++++.........+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||++...+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            35689999999999998887777789999999999999999999999999999999999999876 99999999997654


Q ss_pred             CC-----CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhh
Q 038835          151 SR-----PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWAD  225 (337)
Q Consensus       151 ~~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  225 (337)
                      ..     ......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.++.+....+....+.+....+..
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  248 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            32     2334568999999999998776789999999999999999999999999999999999999888887766554


Q ss_pred             hhhhHHhhhccCCCCCCCcccc--cCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          226 GLLLARAINYKFPQLVGVPLSV--LMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      ......................  .....++++++||.+||+.||++|||++|+|+||||+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            3222111111111111100000  001246788999999999999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=412.30  Aligned_cols=247  Identities=24%  Similarity=0.371  Sum_probs=207.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-----HhHHHHHHHHHhcCC--CCCcccceeEEeeCCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-----ECVNLREVKSLRKMS--HPNIVKLKEVIRENDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~   74 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.+......     .....+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            589999999999999999999999999999999976543221     122357999999986  8999999999999999


Q ss_pred             EEEEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCC
Q 038835           75 LYFVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINS  151 (337)
Q Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~  151 (337)
                      .|+||||+.+ +++..+......+++..++.++.||+.||+|||++||+||||||+|||++.+  .+||+|||+|.....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999975 4444444445569999999999999999999999999999999999999854  899999999986543


Q ss_pred             CCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          152 RPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       152 ~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                      . ...+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+      .+...                 
T Consensus       164 ~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-----------------  219 (273)
T d1xwsa_         164 T-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-----------------  219 (273)
T ss_dssp             S-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----------------
T ss_pred             c-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-----------------
Confidence            3 34567899999999999876566788999999999999999999997532      11111                 


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                        ..           ...+.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       220 --~~-----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         220 --QV-----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             --CC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             --cc-----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence              00           112467899999999999999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-60  Score=421.92  Aligned_cols=257  Identities=29%  Similarity=0.474  Sum_probs=207.8

Q ss_pred             CcCceEee-eecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhc-CCCCCcccceeEEee----CCE
Q 038835            1 MERYKLIK-EVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRK-MSHPNIVKLKEVIRE----NDI   74 (337)
Q Consensus         1 ~~~y~~~~-~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~   74 (337)
                      +++|++++ .||+|+||.||+|.++.+|+.||||+++..      ....+|+.++.+ ++||||++++++|++    +..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            47899876 599999999999999999999999998642      234579988654 589999999999875    467


Q ss_pred             EEEEEeecCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCccc
Q 038835           75 LYFVFEYMEC-NLYQLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLARE  148 (337)
Q Consensus        75 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~  148 (337)
                      +|+|||||+| +|.+.+.++ ...+++.+++.++.||+.||+|||++||+||||||+|||++.+    .+||+|||+|..
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            8999999987 555666554 3469999999999999999999999999999999999999753    699999999998


Q ss_pred             CCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          149 INSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       149 ~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                      ..........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+.......          
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~----------  232 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----------  232 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC----------
T ss_pred             ccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC----------
Confidence            7776666778999999999998665 68999999999999999999999998876655444333221100          


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                           .+.++.       ..++.+|+++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       233 -----~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         233 -----QYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             -----SSSCCT-------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             -----CCCCCC-------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence                 001110       1123578999999999999999999999999999999754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-59  Score=419.07  Aligned_cols=282  Identities=33%  Similarity=0.543  Sum_probs=224.9

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHH-hHHHHHHHHHhcCCCCCcccceeEEe------eCC
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEE-CVNLREVKSLRKMSHPNIVKLKEVIR------END   73 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~   73 (337)
                      +++|+++++||+|+||+||+|.++.+|+.||||++.+....... ....+|+.++++++||||++++++|.      +..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            37899999999999999999999999999999999876555433 34568999999999999999999985      347


Q ss_pred             EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           74 ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      .+|+||||+.+++++.+.   ..+++..++.+++||+.||+|||++||+||||||+|||++.+ .+|++|||.+......
T Consensus        96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            899999999999888764   348999999999999999999999999999999999999976 8999999999887776


Q ss_pred             CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHh
Q 038835          153 PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARA  232 (337)
Q Consensus       153 ~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  232 (337)
                      ......+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+.......+....+.+....|.........
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             --------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             cccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            666778999999999998765 7899999999999999999999999999999999999998888887777655444433


Q ss_pred             hhccCCCCCCCccc------------ccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccc
Q 038835          233 INYKFPQLVGVPLS------------VLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVA  286 (337)
Q Consensus       233 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  286 (337)
                      .....+........            ......++++.+||++||+.||++||||+|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            33332222221111            1112346789999999999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=414.64  Aligned_cols=285  Identities=35%  Similarity=0.649  Sum_probs=231.5

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREN-----DILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.............+|+.+|++++||||+++++++...     ...+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            57999999999999999999999999999999997654433444567899999999999999999998654     3466


Q ss_pred             EEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---
Q 038835           77 FVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---  152 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---  152 (337)
                      +++++++|+|.+.+...  .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|......   
T Consensus        88 l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            77666666677666443  49999999999999999999999999999999999999876 9999999999765432   


Q ss_pred             -CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhh-hhH
Q 038835          153 -PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGL-LLA  230 (337)
Q Consensus       153 -~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~  230 (337)
                       ......+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+...........+......... ...
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence             223567899999999998777678999999999999999999999999999888888887777766654432221 111


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      .......+.....+.....+.+++++++||.+||+.||.+|||++|+|+||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            2223345555556666677889999999999999999999999999999999986544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=413.88  Aligned_cols=284  Identities=35%  Similarity=0.552  Sum_probs=227.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH-HhHHHHHHHHHhcCCCCCcccceeEEeeC-----CEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE-ECVNLREVKSLRKMSHPNIVKLKEVIREN-----DIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (337)
                      +||++++.||+|+||+||+|.++.+|+.||||++.+...... .....+|+.+|++++||||+++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            689999999999999999999999999999999987654432 33456899999999999999999998532     233


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      +++++++.|+.+..+... ..+++..++.+++||+.||+|||++||+||||||+|||++.+ .+|++|||.|......  
T Consensus        98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~--  174 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--  174 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG--
T ss_pred             EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc--
Confidence            444555555444444443 359999999999999999999999999999999999999876 9999999999865433  


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh-HHhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL-ARAI  233 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~  233 (337)
                      ..+..||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+....+.+..+.+...... ....
T Consensus       175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  254 (348)
T d2gfsa1         175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY  254 (348)
T ss_dssp             GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred             cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence            356789999999999887767899999999999999999999999999999999999888877766544432211 1112


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCcccccc
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRVAFM  288 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  288 (337)
                      ....+..............++++++||.+||+.||.+|||++|+|+||||+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence            2234444444555556788999999999999999999999999999999986443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.6e-58  Score=409.12  Aligned_cols=277  Identities=24%  Similarity=0.505  Sum_probs=219.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEee--CCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRE--NDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv   78 (337)
                      ++|+++++||+|+||+||+|+++.+|+.||+|+++...    .....+|+.+|+.+. ||||+++++++..  ...+++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            68999999999999999999999999999999987542    334568999999995 9999999999974  4569999


Q ss_pred             EeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC--cEEEeeCCCcccCCCCCCCc
Q 038835           79 FEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD--TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~--~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      |||++++.+..+.   ..+++..++.+++||+.||+|||++||+||||||+|||++.+  .+||+|||+|..........
T Consensus       111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~  187 (328)
T d3bqca1         111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN  187 (328)
T ss_dssp             EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred             EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence            9999987765443   359999999999999999999999999999999999999864  69999999999887766667


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE-ADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ..+||+.|+|||.+.+...++.++||||+||++|+|++|+.||....+ .+....+....+.+....|...........+
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  267 (328)
T d3bqca1         188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  267 (328)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred             ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence            889999999999988777789999999999999999999999976554 4455555555544332222211100000000


Q ss_pred             --cCCC-----CCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCcCccc
Q 038835          236 --KFPQ-----LVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQHPFSRV  285 (337)
Q Consensus       236 --~~~~-----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  285 (337)
                        ....     ............+++++.|||++||+.||.+|||++|+|+||||+.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence              0000     0011111223467899999999999999999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-57  Score=395.16  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=204.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChH--HhHHHHHHHHHhcCCCCCcccceeEEeeCC----EE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWE--ECVNLREVKSLRKMSHPNIVKLKEVIREND----IL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~   75 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|+++.......  ...+.+|+.+++.++||||+++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            579999999999999999999999999999999987654332  234568999999999999999999987543    48


Q ss_pred             EEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC--
Q 038835           76 YFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR--  152 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~--  152 (337)
                      |+||||++|+.+.......+++++.+++.++.||+.||+|||++||+||||||+|||++.+ .++++|||.+......  
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            9999999987666555556679999999999999999999999999999999999999876 9999999988755332  


Q ss_pred             --CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          153 --PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       153 --~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                        ......+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+...++......             
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~-------------  232 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-------------  232 (277)
T ss_dssp             ------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-------------
T ss_pred             cccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-------------
Confidence              233557899999999998765 7899999999999999999999999998887776665542111             


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-CHHHHhcCcCcc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-TAAEALQHPFSR  284 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-t~~ell~hp~~~  284 (337)
                                   +.....+.+|+++.++|.+||++||.+|| |+++ +.|+|.+
T Consensus       233 -------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~-l~~~l~r  273 (277)
T d1o6ya_         233 -------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAE-MRADLVR  273 (277)
T ss_dssp             -------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH-HHHHHHH
T ss_pred             -------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHH-HHHHHHH
Confidence                         11122357899999999999999999999 5555 4566643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-57  Score=395.19  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=199.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc---EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE---VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.+.||+|+||+||+|.++.+|+   .||+|.+...........+.+|+.+|++++|||||++++++..++.+++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            579999999999999999999987765   58899887655544555667999999999999999999999999999999


Q ss_pred             EeecCCCHHHH-HhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCC-
Q 038835           79 FEYMECNLYQL-MKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPF-  155 (337)
Q Consensus        79 ~e~~~~~l~~~-~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~-  155 (337)
                      ||||+++.+.. +....+.+++.++..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+........ 
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~  185 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  185 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence            99999876655 44445679999999999999999999999999999999999999987 9999999999876543211 


Q ss_pred             -----ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          156 -----TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       156 -----~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                           ....||+.|+|||.+.++ .++.++|||||||++|||++ |.+||.+.+..+....+......+           
T Consensus       186 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-----------  253 (299)
T d1jpaa_         186 TYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-----------  253 (299)
T ss_dssp             ----------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-----------
T ss_pred             eeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence                 224578999999998765 78999999999999999998 899999988877766654321111           


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                        .+...++++.++|.+||+.||.+|||+.|++++
T Consensus       254 ------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 ------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                              124578999999999999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=386.95  Aligned_cols=251  Identities=26%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|+.+   ..||||+++...... ....+.+|+.++++++||||++++++..+ +.+++|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            57999999999999999999754   359999997654433 34455789999999999999999998654 56899999


Q ss_pred             ecCCC-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC---CCC
Q 038835           81 YMECN-LYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR---PPF  155 (337)
Q Consensus        81 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~---~~~  155 (337)
                      |++++ +.+.+...+..+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|......   ...
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~  163 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF  163 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence            99965 555565666679999999999999999999999999999999999999987 9999999999766432   233


Q ss_pred             ccccccccccCchhhcCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          156 TEYVSTRWYRAPEVLLQS--YLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       156 ~~~~gt~~~~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      ....||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+..+...........+               
T Consensus       164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---------------  228 (276)
T d1uwha_         164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS---------------  228 (276)
T ss_dssp             --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC---------------
T ss_pred             cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence            556899999999998643  357899999999999999999999999888776655544331111               


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                               +.........++++.++|.+||+.||.+|||++|++++
T Consensus       229 ---------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 ---------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ---------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                     11122335678999999999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-57  Score=391.21  Aligned_cols=252  Identities=21%  Similarity=0.313  Sum_probs=208.4

Q ss_pred             cCceEeee-ecccCceEEEEEEECC--CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKE-VGDGTFGSVWRAISKQ--SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~-ig~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|.+... ||+|+||.||+|.++.  ++..||||+++..........+.+|++++++++|||||++++++.+ +.+|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45777774 9999999999998764  4557999999876544445566799999999999999999999865 458999


Q ss_pred             EeecCCCHHHH-HhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--
Q 038835           79 FEYMECNLYQL-MKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--  154 (337)
Q Consensus        79 ~e~~~~~l~~~-~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--  154 (337)
                      |||++++.+.. +......+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|........  
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence            99999865554 45556679999999999999999999999999999999999999876 999999999987654322  


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....||+.|+|||++.++ .++.++|||||||++|||++ |.+||.+.+..+....+.....               
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---------------  230 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---------------  230 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---------------
T ss_pred             ccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence              2345789999999998766 68999999999999999998 9999999888777666543211               


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---hcCcCcc
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA---LQHPFSR  284 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~  284 (337)
                            +        ..++..|+++.++|.+||+.||++|||+.++   |+|+|+.
T Consensus       231 ------~--------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         231 ------M--------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ------C--------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------C--------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                  0        1124678999999999999999999999888   5678765

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-56  Score=390.39  Aligned_cols=247  Identities=24%  Similarity=0.403  Sum_probs=203.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||+|+++.....  ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4789999999999999999999999999999999865443  33467899999999999999999999999999999999


Q ss_pred             cCCCH-HHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--Cc
Q 038835           82 MECNL-YQLMKD-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FT  156 (337)
Q Consensus        82 ~~~~l-~~~~~~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~~  156 (337)
                      ++++. .+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|........  ..
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence            99754 455443 34568999999999999999999999999999999999999886 999999999987654432  23


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ...|++.|+|||++.++ .++.++|||||||++|+|++|..||....+...+.++......                   
T Consensus       175 ~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-------------------  234 (287)
T d1opja_         175 GAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------------  234 (287)
T ss_dssp             TEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred             cccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-------------------
Confidence            34688999999998766 6899999999999999999966554444443333332221000                   


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                               ...++..++++.+||.+||+.||.+|||++|+++
T Consensus       235 ---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         235 ---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                     0122467899999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=384.68  Aligned_cols=246  Identities=27%  Similarity=0.428  Sum_probs=199.0

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++ +++.||||+++.....  ...+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            58999999999999999999986 5678999999865444  34567899999999999999999999999999999999


Q ss_pred             cCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC--Ccc
Q 038835           82 MECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP--FTE  157 (337)
Q Consensus        82 ~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~--~~~  157 (337)
                      ++++.+ +.+......+++..+..++.||+.||+|||+++|+||||||+|||++++ .+||+|||+|........  ...
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence            997655 4455556678999999999999999999999999999999999999987 999999999987654322  234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..||+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+......+                  
T Consensus       162 ~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~------------------  222 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------------------  222 (263)
T ss_dssp             ---CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC------------------
T ss_pred             eecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC------------------
Confidence            6789999999998766 68999999999999999999 578888777777666665431111                  


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                 .+...++++.++|.+||+.||.+|||++|+++|
T Consensus       223 -----------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         223 -----------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                       113457899999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=382.33  Aligned_cols=246  Identities=25%  Similarity=0.395  Sum_probs=211.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|+++++||+|+||+||+|+++ +++.||||+++.....  ...+.+|+.++++++||||+++++++.+++.+++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            68999999999999999999985 6888999999876554  34567999999999999999999999999999999999


Q ss_pred             cCCCH-HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCcc
Q 038835           82 MECNL-YQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFTE  157 (337)
Q Consensus        82 ~~~~l-~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~~  157 (337)
                      ++++. ...+......+++..++.++.||++||+|||++||+||||||+||+++.+ .+||+|||+|.......  ....
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence            98654 55555666679999999999999999999999999999999999999986 99999999997654332  2234


Q ss_pred             ccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhcc
Q 038835          158 YVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYK  236 (337)
Q Consensus       158 ~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
                      ..||+.|+|||.+.+. .++.++|||||||++|||++ |+.||.+.+..+....+......+                  
T Consensus       161 ~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------------------  221 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------------  221 (258)
T ss_dssp             SCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC------------------
T ss_pred             cCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence            6789999999998765 68999999999999999998 899999998887777665431111                  


Q ss_pred             CCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          237 FPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                 .+...++++.+||.+||+.||++|||++++++|
T Consensus       222 -----------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         222 -----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                       123567899999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=398.23  Aligned_cols=250  Identities=27%  Similarity=0.420  Sum_probs=204.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc-----EEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE-----VVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|+++++||+|+||+||+|.++.+++     .||+|.+.............+|+.+++++ +|||||++++++.+.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            579999999999999999999876554     69999987655444445567899999988 899999999999999999


Q ss_pred             EEEEeecCCCHH-HHHhhcc----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCee
Q 038835           76 YFVFEYMECNLY-QLMKDRE----------------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLL  132 (337)
Q Consensus        76 ~lv~e~~~~~l~-~~~~~~~----------------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nil  132 (337)
                      |+||||++++.+ +.+..+.                      ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            999999997554 4444322                      24899999999999999999999999999999999999


Q ss_pred             eeCC-cEEEeeCCCcccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 038835          133 VSKD-TIKIADFGLAREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADE  207 (337)
Q Consensus       133 i~~~-~~kL~Dfg~a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  207 (337)
                      ++.+ .+||+|||+|+.......   .....||+.|+|||++.++ .++.++|||||||++|||++ |.+||.+.+..+.
T Consensus       197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~  275 (325)
T d1rjba_         197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  275 (325)
T ss_dssp             EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence            9877 999999999986554332   2356789999999998766 78999999999999999997 8999998877666


Q ss_pred             HHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       208 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      +.++......+                            ..+...|+++.+||.+||+.||++|||++||++|
T Consensus       276 ~~~~~~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         276 FYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66554421111                            1124578999999999999999999999999976

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=387.14  Aligned_cols=246  Identities=22%  Similarity=0.338  Sum_probs=199.0

Q ss_pred             eeecccCceEEEEEEEC--CCCcEEEEEEcccccCCh-HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEeecCC
Q 038835            8 KEVGDGTFGSVWRAISK--QSGEVVAIKKMKKKYYSW-EECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEYMEC   84 (337)
Q Consensus         8 ~~ig~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (337)
                      ++||+|+||.||+|.++  .+++.||+|+++...... ....+.+|+.++++++||||+++++++++ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999754  456789999997654332 33456789999999999999999999865 457899999998


Q ss_pred             CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC----Ccccc
Q 038835           85 NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP----FTEYV  159 (337)
Q Consensus        85 ~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~----~~~~~  159 (337)
                      +.+..+.....++++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+.......    .....
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~  171 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK  171 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence            7776666666779999999999999999999999999999999999999876 999999999987654322    23457


Q ss_pred             ccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhccCC
Q 038835          160 STRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINYKFP  238 (337)
Q Consensus       160 gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
                      ||+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+.....                     +
T Consensus       172 gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~---------------------~  229 (277)
T d1xbba_         172 WPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------------------M  229 (277)
T ss_dssp             CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------------C
T ss_pred             CCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC---------------------C
Confidence            89999999998765 68999999999999999997 8999999887766655543210                     0


Q ss_pred             CCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHH---hcCcCcc
Q 038835          239 QLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEA---LQHPFSR  284 (337)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~  284 (337)
                              ..++..|+++.+||.+||+.||.+|||++++   |+|+|++
T Consensus       230 --------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         230 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                    1124578999999999999999999999998   4566653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=386.42  Aligned_cols=249  Identities=27%  Similarity=0.447  Sum_probs=205.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++ +++.||||+++.....  ...+.+|+.++++++|||||++++++.+ +..++||||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            58999999999999999999976 5788999999765443  3456799999999999999999998754 567999999


Q ss_pred             cCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           82 MECNLYQLMKD--REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        82 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ++++.+.....  .+..+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+......  ...
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence            99876655432  23359999999999999999999999999999999999999987 99999999998765432  234


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...||+.|+|||++.++ .++.++|||||||++|||++| .+||...+..+....+......                  
T Consensus       169 ~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~------------------  229 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------------------  229 (272)
T ss_dssp             TCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------
T ss_pred             ccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------------------
Confidence            56789999999998765 689999999999999999994 6677777666665555332111                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CcCcc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ--HPFSR  284 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~  284 (337)
                                 ..++..++++.+||.+||+.||++|||++++++  ++||.
T Consensus       230 -----------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         230 -----------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                       112457899999999999999999999999988  78875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=395.06  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=212.7

Q ss_pred             CcCceEeeeecccCceEEEEEEE---CCCCcEEEEEEcccccCCh---HHhHHHHHHHHHhcCCC-CCcccceeEEeeCC
Q 038835            1 MERYKLIKEVGDGTFGSVWRAIS---KQSGEVVAIKKMKKKYYSW---EECVNLREVKSLRKMSH-PNIVKLKEVIREND   73 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~---~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~   73 (337)
                      +++|++++.||+|+||+||+|.+   +.+|+.||+|++++.....   ......+|+.++++++| |||+++++++++..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            47899999999999999999987   4579999999987643211   12334589999999976 89999999999999


Q ss_pred             EEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCC
Q 038835           74 ILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSR  152 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~  152 (337)
                      ..+++|||+.++.+.........+++..++.+++||+.||+|||++||+||||||+|||++.+ .+||+|||+|......
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence            999999999987666555556668999999999999999999999999999999999999876 9999999999765432


Q ss_pred             --CCCccccccccccCchhhcCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          153 --PPFTEYVSTRWYRAPEVLLQSY-LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       153 --~~~~~~~gt~~~~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                        .......|++.|+|||.+.+.. .++.++||||+||++|+|++|+.||.+.+..+....+.......           
T Consensus       183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-----------  251 (322)
T d1vzoa_         183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----------  251 (322)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----------
T ss_pred             ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-----------
Confidence              2235578999999999987543 47889999999999999999999998877655555544321100           


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCC-----CHHHHhcCcCccc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRP-----TAAEALQHPFSRV  285 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  285 (337)
                            . +        ..+...|+++.+||.+||++||.+||     |++|+++||||+.
T Consensus       252 ------~-~--------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         252 ------E-P--------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             ------C-C--------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             ------C-C--------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence                  0 0        11246789999999999999999999     5899999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=382.68  Aligned_cols=248  Identities=27%  Similarity=0.420  Sum_probs=198.3

Q ss_pred             cCceEeeeecccCceEEEEEEECCC---CcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQS---GEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++++.||+|+||.||+|.+..+   +..||+|.+...........+.+|+.++++++||||+++++++. ++.+|+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            6899999999999999999998754   34689999876554444555679999999999999999999986 4678999


Q ss_pred             EeecCCCHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--C
Q 038835           79 FEYMECNLY-QLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--P  154 (337)
Q Consensus        79 ~e~~~~~l~-~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~  154 (337)
                      |||++++.+ +.+......+++..++.++.||+.||.|||++|++||||||+||+++.+ .+||+|||+|.......  .
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~  165 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK  165 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCccee
Confidence            999997655 4455556679999999999999999999999999999999999999876 99999999998765432  2


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....||+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+......                
T Consensus       166 ~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~----------------  228 (273)
T d1mp8a_         166 ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------------  228 (273)
T ss_dssp             -----CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------------
T ss_pred             ccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            2446789999999998765 78999999999999999998 89999998888777666432111                


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                   ..++..|+++.+||.+||+.||.+|||++|+++|
T Consensus       229 -------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 -------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         1235678999999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-55  Score=386.84  Aligned_cols=248  Identities=23%  Similarity=0.401  Sum_probs=200.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCc----EEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGE----VVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++++.||+|+||+||+|.++.+|+    .||+|.+...........+.+|+.++++++|||||++++++.+++. ++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-EE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-eE
Confidence            479999999999999999999988886    4788887655444445566799999999999999999999987654 56


Q ss_pred             EEeecC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-
Q 038835           78 VFEYME-CNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-  154 (337)
Q Consensus        78 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-  154 (337)
                      ++|++. |++++.+......+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|........ 
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~  167 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  167 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence            666665 56777777777789999999999999999999999999999999999999987 999999999987654322 


Q ss_pred             --CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHH
Q 038835          155 --FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLAR  231 (337)
Q Consensus       155 --~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  231 (337)
                        .....||+.|+|||++.++ .++.++|||||||++|||++ |.+||.+.+..+....+......              
T Consensus       168 ~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------------  232 (317)
T d1xkka_         168 YHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------------  232 (317)
T ss_dssp             -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC--------------
T ss_pred             ccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence              2345689999999998776 78999999999999999998 89999988777665555432111              


Q ss_pred             hhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          232 AINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                     ..++..++++.++|.+||+.||.+|||+.|+++|
T Consensus       233 ---------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                           1124567899999999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=377.98  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=197.8

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC----cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG----EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (337)
                      ++|++.+.||+|+||.||+|.++.++    ..||||++...........+.+|+.++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            57999999999999999999987655    46999999765544444556799999999999999999999999999999


Q ss_pred             EEeecCCCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC-
Q 038835           78 VFEYMECNLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP-  154 (337)
Q Consensus        78 v~e~~~~~l~~-~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~-  154 (337)
                      ||||+.++++. .+......+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+|+....... 
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence            99999986554 445555679999999999999999999999999999999999999987 999999999987643321 


Q ss_pred             ---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhH
Q 038835          155 ---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLA  230 (337)
Q Consensus       155 ---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  230 (337)
                         .....||+.|+|||++.+. .++.++|||||||++|||++| .+||.+.+..+....+......             
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-------------  232 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-------------  232 (283)
T ss_dssp             -------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------
T ss_pred             ceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC-------------
Confidence               2335689999999998766 789999999999999999995 5666666665555444322111             


Q ss_pred             HhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          231 RAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                      ..+...+.++.++|.+||+.||++|||+.|+++
T Consensus       233 ----------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 ----------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ----------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                            112356789999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=376.77  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=201.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEEEEEee
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILYFVFEY   81 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (337)
                      ++|++++.||+|+||.||+|.++.+ +.||||+++.....  ...+.+|+.++++++|||||++++++.+ +..++||||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            6899999999999999999998755 56999999765443  3456799999999999999999999854 557899999


Q ss_pred             cCCCHHHHHh-h-ccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC--CCc
Q 038835           82 MECNLYQLMK-D-REKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP--PFT  156 (337)
Q Consensus        82 ~~~~l~~~~~-~-~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~--~~~  156 (337)
                      ++++.+..+. . ....+++.+++.++.||+.||+|||++||+||||||+|||++++ ++||+|||+|.......  ...
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence            9987554443 3 24569999999999999999999999999999999999999987 99999999998764332  224


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...||+.|+|||++.+. .++.++|||||||++|||++| .+|+.+....+.+..+......                  
T Consensus       173 ~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~------------------  233 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------------  233 (285)
T ss_dssp             ---CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------------
T ss_pred             cccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------------------
Confidence            46799999999999766 679999999999999999995 5667777766666655432111                  


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc--CcCcccc
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ--HPFSRVA  286 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~  286 (337)
                                 ...+..++++.++|.+||+.||++|||++++++  ++||+..
T Consensus       234 -----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                       112467899999999999999999999999987  8888753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=380.08  Aligned_cols=249  Identities=27%  Similarity=0.380  Sum_probs=203.9

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcE--EEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEEEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEV--VAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDILYFV   78 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (337)
                      ++|++.++||+|+||.||+|.++.+|..  ||||.+...........+.+|+++|+++ +||||+++++++.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            6899999999999999999999988875  6778776544444445567999999999 799999999999999999999


Q ss_pred             EeecCCCHHHHHhhc----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEe
Q 038835           79 FEYMECNLYQLMKDR----------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIA  141 (337)
Q Consensus        79 ~e~~~~~l~~~~~~~----------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~  141 (337)
                      |||++++.+..+...                ...+++..+..++.||+.||.|||++|++||||||+|||++.+ .+||+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence            999997655444322                3569999999999999999999999999999999999999887 99999


Q ss_pred             eCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCc
Q 038835          142 DFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQ  220 (337)
Q Consensus       142 Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~  220 (337)
                      |||+|.............||+.|+|||.+.+. .++.++|||||||++|+|++| .+||.+.+..+....+.....    
T Consensus       170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~----  244 (309)
T d1fvra_         170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR----  244 (309)
T ss_dssp             CTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC----
T ss_pred             cccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC----
Confidence            99999876655544566799999999999766 689999999999999999996 578888877776655432110    


Q ss_pred             cchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          221 DSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                                               ...+...++++.+||.+||+.||++|||++|++++
T Consensus       245 -------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 -------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                     01124578999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-54  Score=375.60  Aligned_cols=248  Identities=26%  Similarity=0.386  Sum_probs=205.9

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||+||+|+.+     .+++.||||+++..........+.+|+.++++++||||+++++++...+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            57999999999999999999875     3568899999986554444556679999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhhc------------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCee
Q 038835           77 FVFEYMECNLYQLMKDR------------------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLL  132 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~~------------------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nil  132 (337)
                      ++|||++++.+..+...                        ...+++..+..++.||+.||+|||++|++||||||+|||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            99999997655444321                        124889999999999999999999999999999999999


Q ss_pred             eeCC-cEEEeeCCCcccCCCC---CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHH
Q 038835          133 VSKD-TIKIADFGLAREINSR---PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADE  207 (337)
Q Consensus       133 i~~~-~~kL~Dfg~a~~~~~~---~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~  207 (337)
                      ++.+ .+||+|||+|....+.   ....+..||+.|+|||.+.+. .++.++|||||||++|||++| .+||.+.+..+.
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~  251 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  251 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence            9987 9999999999765332   223456789999999998765 789999999999999999998 478999888877


Q ss_pred             HHHHHHHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          208 IYKICSVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       208 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      ...+.....                             ...++..++++.++|.+||+.||++|||+.|+++
T Consensus       252 ~~~v~~~~~-----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         252 IYYVRDGNI-----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCC-----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            766543211                             1122467899999999999999999999999965

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=375.04  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=192.9

Q ss_pred             cCceEeeeecccCceEEEEEEECC-----CCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEee-CCE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRE-NDI   74 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~   74 (337)
                      ++|++++.||+|+||.||+|.+..     +++.||+|+++............+|...+.++ +|+||+.+++++.. +..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            579999999999999999998754     45789999998665544555556777777776 78999999998754 457


Q ss_pred             EEEEEeecCCCHHHHHh-hc---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-c
Q 038835           75 LYFVFEYMECNLYQLMK-DR---------------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-T  137 (337)
Q Consensus        75 ~~lv~e~~~~~l~~~~~-~~---------------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~  137 (337)
                      +++|||||+++.+..+. ..               ...+++..++.++.||+.||.|||++||+||||||+|||++.+ .
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            89999999976554443 22               2348999999999999999999999999999999999999876 9


Q ss_pred             EEEeeCCCcccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHH
Q 038835          138 IKIADFGLAREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICS  213 (337)
Q Consensus       138 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~  213 (337)
                      +||+|||+|+......   ......||+.|+|||++.++ .++.++||||+||++|+|++| .+||.+.+..+.......
T Consensus       173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~  251 (299)
T d1ywna1         173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  251 (299)
T ss_dssp             EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred             EEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            9999999998654332   23456899999999999765 789999999999999999986 678988766555444333


Q ss_pred             HhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          214 VIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ....+                            ..++..++++.++|.+||+.||.+|||++|+++|
T Consensus       252 ~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         252 EGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            21111                            1124578999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=368.81  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=194.7

Q ss_pred             cCceEeeeecccCceEEEEEEEC-CCC--cEEEEEEcccccCCh--HHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-QSG--EVVAIKKMKKKYYSW--EECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-~~~--~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++.+.||+|+||.||+|... .++  ..||+|++.+.....  ....+.+|+.++++++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            57999999999999999999864 333  368999987654332  23455799999999999999999999976 4678


Q ss_pred             EEEeecCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCC
Q 038835           77 FVFEYMEC-NLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPP  154 (337)
Q Consensus        77 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~  154 (337)
                      +||||+++ ++.+.+..+...+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++........
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~  166 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  166 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence            99999986 4556666666679999999999999999999999999999999999999877 999999999997754432


Q ss_pred             ----CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhh
Q 038835          155 ----FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLL  229 (337)
Q Consensus       155 ----~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  229 (337)
                          .....|++.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+......+           
T Consensus       167 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-----------  234 (273)
T d1u46a_         167 HYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------  234 (273)
T ss_dssp             EEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-----------
T ss_pred             cceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-----------
Confidence                2334678899999999765 68999999999999999998 899999998888777664321110           


Q ss_pred             HHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          230 ARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                       ..++.+|+++.++|.+||..||++|||++|+++
T Consensus       235 -----------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         235 -----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                             112467899999999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=366.83  Aligned_cols=243  Identities=26%  Similarity=0.422  Sum_probs=194.6

Q ss_pred             CcCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEe-eCCEEEEEE
Q 038835            1 MERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIR-ENDILYFVF   79 (337)
Q Consensus         1 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~   79 (337)
                      +++|++++.||+|+||.||+|.++  |+.||+|+++.+..   ...+.+|++++++++||||+++++++. +++.+|+||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            578999999999999999999874  78999999976432   334578999999999999999999884 456689999


Q ss_pred             eecCCCHH-HHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCCCCc
Q 038835           80 EYMECNLY-QLMKDR-EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRPPFT  156 (337)
Q Consensus        80 e~~~~~l~-~~~~~~-~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~~~~  156 (337)
                      ||++++.+ +.+..+ ...+++..++.++.||+.||.|||+++++||||||+|||++.+ .+||+|||++.......  .
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--~  158 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D  158 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC--c
Confidence            99987654 444333 2358999999999999999999999999999999999999987 99999999998765432  4


Q ss_pred             cccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhhhHHhhhc
Q 038835          157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKICSVIGTPTQDSWADGLLLARAINY  235 (337)
Q Consensus       157 ~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
                      ...+|+.|+|||.+.+. .++.++|||||||++|||++ |++||.+.+..+....+.+...                   
T Consensus       159 ~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~-------------------  218 (262)
T d1byga_         159 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------------  218 (262)
T ss_dssp             ---CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-------------------
T ss_pred             cccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            45789999999998765 78999999999999999998 7999988887776666533211                   


Q ss_pred             cCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          236 KFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                        +        ..++..++++.++|.+||+.||.+|||+.+++++
T Consensus       219 --~--------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         219 --M--------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             --C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --C--------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              1        1124577999999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=371.82  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=201.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCC-------cEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCC
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSG-------EVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIREND   73 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   73 (337)
                      ++|++++.||+|+||.||+|++..++       ..||+|+++............+|+..+.++ +||||+++++++.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            68999999999999999999876554       469999998765544455567888888887 8999999999999999


Q ss_pred             EEEEEEeecCCCHHHHHhh-cc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           74 ILYFVFEYMECNLYQLMKD-RE---------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        74 ~~~lv~e~~~~~l~~~~~~-~~---------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ..++||||++++.+..+.. +.               ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ 
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            9999999999765544443 22               358999999999999999999999999999999999999887 


Q ss_pred             cEEEeeCCCcccCCCCC---CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRP---PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+||+|||.+.......   ......||+.|+|||.+.++ .|+.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus       173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~  251 (299)
T d1fgka_         173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  251 (299)
T ss_dssp             CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence            99999999998664332   23456899999999998765 78999999999999999998 799998887766555443


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .....                             ..+...++++.+||.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         252 EGHRM-----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             TTCCC-----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCC-----------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            22100                             112467899999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-52  Score=367.12  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=207.6

Q ss_pred             cCceEeeeecccCceEEEEEEEC-----CCCcEEEEEEcccccCChHHhHHHHHHHHHhcC-CCCCcccceeEEeeCCEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISK-----QSGEVVAIKKMKKKYYSWEECVNLREVKSLRKM-SHPNIVKLKEVIRENDIL   75 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   75 (337)
                      ++|+++++||+|+||.||+|.++     .+++.||+|+++..........+.+|+.+++.+ +|||||++++++.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            57899999999999999999853     567789999998765544555667899999999 699999999999999999


Q ss_pred             EEEEeecCCCHHHHHhhcc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-
Q 038835           76 YFVFEYMECNLYQLMKDRE------------------KCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-  136 (337)
Q Consensus        76 ~lv~e~~~~~l~~~~~~~~------------------~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-  136 (337)
                      ++||||++++.+..+....                  ..+++..+..++.||+.||+|||++|++||||||+||+++.+ 
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            9999999986555444321                  258999999999999999999999999999999999999876 


Q ss_pred             cEEEeeCCCcccCCCCCCC---ccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 038835          137 TIKIADFGLAREINSRPPF---TEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELIT-LRPLFPGTSEADEIYKIC  212 (337)
Q Consensus       137 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  212 (337)
                      .+|++|||.+.........   ...+||+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+.+.++.
T Consensus       183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i  261 (311)
T d1t46a_         183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI  261 (311)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred             cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999876544322   446889999999998765 78999999999999999998 778888877766666554


Q ss_pred             HHhCCCCccchhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          213 SVIGTPTQDSWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                      .....+                            ..+...++++.+||.+||+.||.+|||++++++
T Consensus       262 ~~~~~~----------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         262 KEGFRM----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCCCC----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            432111                            112356799999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-52  Score=366.03  Aligned_cols=258  Identities=22%  Similarity=0.270  Sum_probs=204.4

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc-ccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI-VKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||.||+|.++.+|+.||||++......   .....|+++++.++|+|+ +.+.+++.+++..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4899999999999999999999999999999998764332   234689999999987665 555666788899999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC----cEEEeeCCCcccCCCCC---
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD----TIKIADFGLAREINSRP---  153 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~----~~kL~Dfg~a~~~~~~~---  153 (337)
                      |+++++...+......+++..+..++.|++.||+|||++||+||||||+|||++..    .+||+|||+|.......   
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            99999988888777789999999999999999999999999999999999998642    79999999998764321   


Q ss_pred             -----CCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCccchhhhhh
Q 038835          154 -----PFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTPTQDSWADGLL  228 (337)
Q Consensus       154 -----~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  228 (337)
                           .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+.....            
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~------------  230 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE------------  230 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH------------
T ss_pred             ceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc------------
Confidence                 12456899999999998765 689999999999999999999999988766544433322100            


Q ss_pred             hHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHH---HhcCcCccc
Q 038835          229 LARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAE---ALQHPFSRV  285 (337)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e---ll~hp~~~~  285 (337)
                          ....      .+.....+.+|+++.++|..||+.||.+||++++   +|+|+|.+.
T Consensus       231 ----~~~~------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         231 ----KKMS------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ----HHHH------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----ccCC------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                0000      0111223567899999999999999999999875   467776543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=367.59  Aligned_cols=248  Identities=22%  Similarity=0.350  Sum_probs=206.8

Q ss_pred             cCceEeeeecccCceEEEEEEECC-----CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCCEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQ-----SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRENDILY   76 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (337)
                      ++|++++.||+|+||.||+|.++.     ++..||||+++..........+.+|+.++++++||||+++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            689999999999999999998753     467899999986554444455679999999999999999999999999999


Q ss_pred             EEEeecCCCHHHHHhh-c---------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCC
Q 038835           77 FVFEYMECNLYQLMKD-R---------EKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGL  145 (337)
Q Consensus        77 lv~e~~~~~l~~~~~~-~---------~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~  145 (337)
                      +||||++++.+..+.. .         ...+++..+..++.|++.||.|||+++|+||||||+|||++.+ ++||+|||+
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence            9999999765544432 1         1247899999999999999999999999999999999999987 999999999


Q ss_pred             cccCCCCCC---CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCcc
Q 038835          146 AREINSRPP---FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITL-RPLFPGTSEADEIYKICSVIGTPTQD  221 (337)
Q Consensus       146 a~~~~~~~~---~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~  221 (337)
                      |........   .....||+.|+|||.+.+. .++.++|||||||++|||++| .+||.+.+..+.+..+.+....    
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~----  254 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL----  254 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC----
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC----
Confidence            986543322   2345789999999998766 678999999999999999998 5899988888777666432111    


Q ss_pred             chhhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          222 SWADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                               ..++..++++.++|.+||+.||.+|||++++++
T Consensus       255 -------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         255 -------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     112457789999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-51  Score=357.57  Aligned_cols=249  Identities=18%  Similarity=0.224  Sum_probs=204.6

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCC-CCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH-PNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.....   .....+|++.++.|.| +|++.+++++..+...++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            589999999999999999999999999999999865432   2234678999999965 899999999999999999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeC------CcEEEeeCCCcccCCCC--
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSK------DTIKIADFGLAREINSR--  152 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~------~~~kL~Dfg~a~~~~~~--  152 (337)
                      |+++++.+.+...+..+++..+..++.|++.||+|||++||+||||||+|||++.      +.+||+|||+|+.....  
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            9998888888777777999999999999999999999999999999999999974      37999999999865322  


Q ss_pred             ------CCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCccch
Q 038835          153 ------PPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSEADE---IYKICSVIGTPTQDSW  223 (337)
Q Consensus       153 ------~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~  223 (337)
                            ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......   ..++......      
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~------  234 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------  234 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH------
T ss_pred             ccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC------
Confidence                  123456899999999998765 789999999999999999999999987554322   2222221000      


Q ss_pred             hhhhhhHHhhhccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q 038835          224 ADGLLLARAINYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQ  279 (337)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  279 (337)
                                         .+.....+.+|+++.+++..|+..+|++||+.+.+.+
T Consensus       235 -------------------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 -------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -------------------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                               0111223467899999999999999999998877644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-51  Score=357.59  Aligned_cols=245  Identities=20%  Similarity=0.288  Sum_probs=193.7

Q ss_pred             EeeeecccCceEEEEEEECCCC---cEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEee-CCEEEEEEee
Q 038835            6 LIKEVGDGTFGSVWRAISKQSG---EVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIRE-NDILYFVFEY   81 (337)
Q Consensus         6 ~~~~ig~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   81 (337)
                      ..++||+|+||+||+|.+..++   ..||||.++..........+.+|++++++++||||+++++++.. ++..++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            3678999999999999987643   35899999764444444566799999999999999999999765 5689999999


Q ss_pred             cCCCHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCC-cEEEeeCCCcccCCCCC-----C
Q 038835           82 MECNLYQLM-KDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKD-TIKIADFGLAREINSRP-----P  154 (337)
Q Consensus        82 ~~~~l~~~~-~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~~~~~~-----~  154 (337)
                      |+++++..+ ......+++..+..++.|++.||.|||+.+|+||||||+|||++++ .+||+|||++.......     .
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence            998766554 4455568899999999999999999999999999999999999987 99999999998764332     1


Q ss_pred             CccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCccchhhhhhhHHhh
Q 038835          155 FTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGT-SEADEIYKICSVIGTPTQDSWADGLLLARAI  233 (337)
Q Consensus       155 ~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  233 (337)
                      .....||+.|+|||.+.++ .++.++||||||+++|||++|..||... +..+....+....                  
T Consensus       191 ~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~------------------  251 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------------------  251 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC------------------
T ss_pred             cccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            2345789999999998766 6899999999999999999976666543 3333333322210                  


Q ss_pred             hccCCCCCCCcccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          234 NYKFPQLVGVPLSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                         .+        ..++..++++.+||.+||+.||++|||+.|+++|
T Consensus       252 ---~~--------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ---RL--------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ---CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CC--------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence               00        1124567899999999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.5e-50  Score=360.51  Aligned_cols=291  Identities=27%  Similarity=0.420  Sum_probs=214.8

Q ss_pred             CceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-----------CCCcccceeEEee
Q 038835            3 RYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-----------HPNIVKLKEVIRE   71 (337)
Q Consensus         3 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~   71 (337)
                      ||+++++||+|+||+||+|+++.+|+.||||++++...  ......+|+++++.+.           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            69999999999999999999999999999999986532  2233457888888774           5789999988754


Q ss_pred             --CCEEEEEEeecCC--CHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCCeeeeCC-------cE
Q 038835           72 --NDILYFVFEYMEC--NLYQ-LMKDREKCFSEAEVRNWCFQVFQGLAYMHQ-RGYFHRDLKPENLLVSKD-------TI  138 (337)
Q Consensus        72 --~~~~~lv~e~~~~--~l~~-~~~~~~~~l~~~~~~~~~~qil~al~~LH~-~~i~H~dikp~Nili~~~-------~~  138 (337)
                        ....+++++++.+  +... ........+++..++.+++||+.||+|||+ .||+||||||+|||++.+       .+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence              4566677776654  2232 223345668999999999999999999998 899999999999999753       49


Q ss_pred             EEeeCCCcccCCCCCCCccccccccccCchhhcCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHH
Q 038835          139 KIADFGLAREINSRPPFTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELITLRPLFPGTSE------ADEIYKIC  212 (337)
Q Consensus       139 kL~Dfg~a~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~  212 (337)
                      +++|||.|......  ....+||+.|+|||++.+. .++.++||||+||++++|++|+.||...+.      .+.+....
T Consensus       172 kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~  248 (362)
T d1q8ya_         172 KIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  248 (362)
T ss_dssp             EECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             eEeecccccccccc--cccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence            99999999865443  2567899999999998866 679999999999999999999999975443      34566666


Q ss_pred             HHhCCCCccchhhhhhhHHhhhcc-----CCCCCCCc-------ccccCCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          213 SVIGTPTQDSWADGLLLARAINYK-----FPQLVGVP-------LSVLMPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ..++.++...+.............     .......+       .....+..++++.|||.+||+.||.+|||++|+|+|
T Consensus       249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            677776665544333222222110     00000000       011123456789999999999999999999999999


Q ss_pred             cCcccccccCCCCCChhh
Q 038835          281 PFSRVAFMFHHLSVPEQL  298 (337)
Q Consensus       281 p~~~~~~~~~~~~~~~~~  298 (337)
                      |||++.........|...
T Consensus       329 p~f~~~~~~~~~~~p~~~  346 (362)
T d1q8ya_         329 PWLKDTLGMEEIRVPDRE  346 (362)
T ss_dssp             GGGTTCTTCTTCCCTTSC
T ss_pred             cccCCCCCcccCCCCCcc
Confidence            999976555555555444

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=350.59  Aligned_cols=264  Identities=24%  Similarity=0.258  Sum_probs=187.2

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCcccceeEEeeCC----EEEE
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNIVKLKEVIREND----ILYF   77 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l   77 (337)
                      ++|.+.+.||+|+||.||+|+.  +|+.||||++.....  .......|+..+.+++||||+++++++...+    .+|+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            5799999999999999999975  689999999875421  2222234666667889999999999986543    6899


Q ss_pred             EEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--------cCccccCCCCCCeeeeCC-cEEEeeCCCccc
Q 038835           78 VFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ--------RGYFHRDLKPENLLVSKD-TIKIADFGLARE  148 (337)
Q Consensus        78 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~--------~~i~H~dikp~Nili~~~-~~kL~Dfg~a~~  148 (337)
                      ||||++++.+..+.++. .+++..+..++.|++.||.|||+        +||+||||||+|||++.+ .+||+|||++..
T Consensus        79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999986665555544 48999999999999999999996        599999999999999877 999999999986


Q ss_pred             CCCCC-----CCccccccccccCchhhcCcC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 038835          149 INSRP-----PFTEYVSTRWYRAPEVLLQSY-----LYSSKVDMWAMGAIMAELITLRPLFPGTSEADEIYKICSVIGTP  218 (337)
Q Consensus       149 ~~~~~-----~~~~~~gt~~~~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  218 (337)
                      .....     .....+||+.|+|||++.+..     .++.++|||||||++|||++|.+||......+....      ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~------~~  231 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY------DL  231 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT------TT
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh------hc
Confidence            54322     224568999999999986542     246789999999999999999988854332110000      00


Q ss_pred             CccchhhhhhhHHhhhccCCCCCCCccccc--CCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q 038835          219 TQDSWADGLLLARAINYKFPQLVGVPLSVL--MPSANKDAVSLIASLCSWDPSKRPTAAEALQH  280 (337)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  280 (337)
                      ...................    .+.....  .......+.+++.+||+.||.+|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0000000000000000000    0000000  11223458999999999999999999999874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=1.1e-27  Score=195.10  Aligned_cols=165  Identities=19%  Similarity=0.146  Sum_probs=122.9

Q ss_pred             ceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCC-----------------hHHhHHHHHHHHHhcCCCCCcccce
Q 038835            4 YKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYS-----------------WEECVNLREVKSLRKMSHPNIVKLK   66 (337)
Q Consensus         4 y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~~iv~~~   66 (337)
                      |.++++||+|+||+||+|.+. +|+.||+|+++.....                 .......+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999985 6899999987532111                 0011224688899999999999887


Q ss_pred             eEEeeCCEEEEEEeecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCCeeeeCCcEEEeeCCCc
Q 038835           67 EVIRENDILYFVFEYMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPENLLVSKDTIKIADFGLA  146 (337)
Q Consensus        67 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~~~i~H~dikp~Nili~~~~~kL~Dfg~a  146 (337)
                      ++..    .+++|||++++....       +++..+..++.|++.||+|||++||+||||||+|||++++.++|+|||.|
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG~a  149 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQS  149 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTC
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECCCc
Confidence            6632    269999999864321       45566788999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccccC------chhhcCcCCCCCcchHHHHHHHH
Q 038835          147 REINSRPPFTEYVSTRWYRA------PEVLLQSYLYSSKVDMWAMGAIM  189 (337)
Q Consensus       147 ~~~~~~~~~~~~~gt~~~~a------PE~~~~~~~~~~~~DiwslG~il  189 (337)
                      ...+....       ..|..      .|.+  .+.|+.++|+||+.--+
T Consensus       150 ~~~~~~~~-------~~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         150 VEVGEEGW-------REILERDVRNIITYF--SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETTSTTH-------HHHHHHHHHHHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred             ccCCCCCc-------HHHHHHHHHHHHHHH--cCCCCCcccHHHHHHHH
Confidence            87643211       11111      1222  23578899999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.78  E-value=2.3e-08  Score=83.30  Aligned_cols=139  Identities=15%  Similarity=0.191  Sum_probs=91.1

Q ss_pred             cCceEeeeecccCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCC-CCCcccceeEEeeCCEEEEEEe
Q 038835            2 ERYKLIKEVGDGTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMS-HPNIVKLKEVIRENDILYFVFE   80 (337)
Q Consensus         2 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   80 (337)
                      +.|++.+..+.++.+.||++.  .+++.+++|......... .....+|...++.+. +--+.+++.+..+++..++||+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            567777776666678999885  456677888876543322 222357888877763 3336777888888899999999


Q ss_pred             ecCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 038835           81 YMECNLYQLMKDREKCFSEAEVRNWCFQVFQGLAYMHQ------------------------------------------  118 (337)
Q Consensus        81 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qil~al~~LH~------------------------------------------  118 (337)
                      +++|..+.......     .....+..++...++.||+                                          
T Consensus        91 ~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          91 EADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             eccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            99986553322111     1112223333333333332                                          


Q ss_pred             -----------c------CccccCCCCCCeeeeCCcE-EEeeCCCccc
Q 038835          119 -----------R------GYFHRDLKPENLLVSKDTI-KIADFGLARE  148 (337)
Q Consensus       119 -----------~------~i~H~dikp~Nili~~~~~-kL~Dfg~a~~  148 (337)
                                 .      .++|+|+.|.||+++.+.+ -|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                       1      2799999999999998865 5999997663

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.42  E-value=3.6e-07  Score=80.59  Aligned_cols=76  Identities=17%  Similarity=0.256  Sum_probs=46.8

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEcccc------cCChHHhHHHHHHHHHhcC-CC-C-CcccceeEEeeCCEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQSGEVVAIKKMKKK------YYSWEECVNLREVKSLRKM-SH-P-NIVKLKEVIRENDILYF   77 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~e~~~l~~l-~h-~-~iv~~~~~~~~~~~~~l   77 (337)
                      .+.||.|....||++.+..+|+.+++|.....      .......+...|...|+.+ .+ | .+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            55789999999999998888889999965421      1111122334688888766 22 3 34455544  4445578


Q ss_pred             EEeecCC
Q 038835           78 VFEYMEC   84 (337)
Q Consensus        78 v~e~~~~   84 (337)
                      |||++++
T Consensus       109 vmE~L~~  115 (392)
T d2pula1         109 VMEDLSH  115 (392)
T ss_dssp             EECCCTT
T ss_pred             EEeccCC
Confidence            9999976

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=1.1e-05  Score=66.24  Aligned_cols=72  Identities=13%  Similarity=0.076  Sum_probs=48.9

Q ss_pred             eecccC-ceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCC--CCcccceeEEeeCCEEEEEEeecCCC
Q 038835            9 EVGDGT-FGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSH--PNIVKLKEVIRENDILYFVFEYMECN   85 (337)
Q Consensus         9 ~ig~G~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (337)
                      .+..|. .+.||++... +|..+++|.......    .....|+..++.|..  -.+.+++.+..+++..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            344454 3678988753 466788897655432    233567787777632  23667788888888899999999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.30  E-value=0.00024  Score=62.09  Aligned_cols=71  Identities=14%  Similarity=0.079  Sum_probs=47.4

Q ss_pred             eeeecccCceEEEEEEECC-------CCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCC-cccceeEEeeCCEEEEE
Q 038835            7 IKEVGDGTFGSVWRAISKQ-------SGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPN-IVKLKEVIRENDILYFV   78 (337)
Q Consensus         7 ~~~ig~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv   78 (337)
                      ++.|+.|....+|++....       .++.|++++.-. ...  .....+|..+++.+.-.+ ..++++++.+    .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            5678889999999997653       245677776652 222  223347888888884334 4567777643    578


Q ss_pred             EeecCC
Q 038835           79 FEYMEC   84 (337)
Q Consensus        79 ~e~~~~   84 (337)
                      +||++|
T Consensus       120 ~efi~g  125 (395)
T d1nw1a_         120 EEYIPS  125 (395)
T ss_dssp             ECCCCE
T ss_pred             EEEecc
Confidence            999986

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.29  E-value=0.00019  Score=60.88  Aligned_cols=69  Identities=9%  Similarity=0.117  Sum_probs=43.4

Q ss_pred             cCceEEEEEEECCCCcEEEEEEcccccCChHHhHHHHHHHHHhcCCCCCc--ccce-----eEEeeCCEEEEEEeecCC
Q 038835           13 GTFGSVWRAISKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMSHPNI--VKLK-----EVIRENDILYFVFEYMEC   84 (337)
Q Consensus        13 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~   84 (337)
                      +.-..||++.. .+|..+++|+.+....+  ......|...+..|...++  +..+     ..+..++..+.++++++|
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            33467999965 46888999998765433  2334567777777632222  1111     223556778999999876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.54  E-value=0.0074  Score=50.31  Aligned_cols=30  Identities=30%  Similarity=0.476  Sum_probs=25.9

Q ss_pred             cCccccCCCCCCeeeeCCcE-EEeeCCCccc
Q 038835          119 RGYFHRDLKPENLLVSKDTI-KIADFGLARE  148 (337)
Q Consensus       119 ~~i~H~dikp~Nili~~~~~-kL~Dfg~a~~  148 (337)
                      .|+||+|+.++||+++.+.+ -+.||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            47999999999999999854 7999997763